Citrus Sinensis ID: 008365
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 568 | 2.2.26 [Sep-21-2011] | |||||||
| Q8S8S7 | 801 | U-box domain-containing p | no | no | 0.690 | 0.489 | 0.505 | 1e-112 | |
| Q9FKG5 | 796 | U-box domain-containing p | no | no | 0.735 | 0.525 | 0.491 | 1e-112 | |
| Q9FKG6 | 845 | U-box domain-containing p | no | no | 0.734 | 0.493 | 0.468 | 1e-111 | |
| Q9SW11 | 835 | U-box domain-containing p | no | no | 0.725 | 0.493 | 0.475 | 1e-110 | |
| Q9LU47 | 819 | Putative U-box domain-con | no | no | 0.728 | 0.505 | 0.438 | 1e-98 | |
| Q8GUH1 | 834 | U-box domain-containing p | no | no | 0.684 | 0.466 | 0.422 | 1e-82 | |
| Q94A51 | 805 | U-box domain-containing p | no | no | 0.508 | 0.359 | 0.381 | 1e-60 | |
| Q9FID9 | 880 | Probable receptor-like pr | no | no | 0.473 | 0.305 | 0.390 | 1e-53 | |
| Q9FID8 | 873 | Putative receptor-like pr | no | no | 0.473 | 0.308 | 0.380 | 8e-53 | |
| Q0DR28 | 518 | U-box domain-containing p | no | no | 0.441 | 0.484 | 0.361 | 2e-51 |
| >sp|Q8S8S7|PUB34_ARATH U-box domain-containing protein 34 OS=Arabidopsis thaliana GN=PUB34 PE=3 SV=1 | Back alignment and function desciption |
|---|
Score = 407 bits (1045), Expect = e-112, Method: Compositional matrix adjust.
Identities = 198/392 (50%), Positives = 265/392 (67%)
Query: 106 RLKLELRQTMEMYSTACKEALNAKKKAKELNQWKIEEAQRFEEARMAEETALAIAEMEKA 165
RLK EL+ T+ Y AC+E + + K K L+ + E++R A EE A +EK
Sbjct: 317 RLKNELQSTVFKYKQACEELFSTQNKVKMLSTEYLNESKRVNNAVEKEELQRNTAALEKE 376
Query: 166 KCRAAIEAAEKAQKLADAEAQRRKQAELKAKREAEEKNRALTALANNDVRYRKYTIEEIE 225
+ A++ E A+ L E +R+ AE+ A R EK + + L D RYRKYTIEEI
Sbjct: 377 RYMKAVKEVETAKALLAREFCQRQIAEVNALRTYLEKKKVIDQLLGTDHRYRKYTIEEIV 436
Query: 226 EATDKFSEAMKIGEGGYGPVYRGKLDHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPN 285
AT+ FS IGEGGYG VY+ LD TP A+KV+R D + K++F +EVEVLS +RHP+
Sbjct: 437 TATEGFSPEKVIGEGGYGKVYQCSLDSTPAAVKVVRLDTPEKKQEFLKEVEVLSQLRHPH 496
Query: 286 MVLLLGACPDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAK 345
+VLLLGACP+ GCLVYEY+ NGSLE+ + R N P +PW RF++ E+A L FLH +K
Sbjct: 497 VVLLLGACPENGCLVYEYLENGSLEEYIFHRKNKPPLPWFIRFRVIFEVACGLAFLHSSK 556
Query: 346 PEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEY 405
PEP+VHRDLKP NILL+RNYVSKI+DVGLA+LV D+VT Y + AGT YIDPEY
Sbjct: 557 PEPIVHRDLKPGNILLNRNYVSKIADVGLAKLVTDVAPDNVTMYRNSVLAGTLHYIDPEY 616
Query: 406 QQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAVTDWPAEAA 465
+TG + KSD+Y+FGI++LQ++TAR+P G+ V A++KGTL EMLD +VTDWP
Sbjct: 617 HRTGTIRPKSDLYAFGIIILQLLTARNPSGIVPAVENAVKKGTLTEMLDKSVTDWPLAET 676
Query: 466 ESFSKLAIQCAELRKKDRPDLGTVIVPELNRL 497
E +++ ++CAE R +DRPDL + ++P L RL
Sbjct: 677 EELARIGLKCAEFRCRDRPDLKSEVIPVLKRL 708
|
Functions as an E3 ubiquitin ligase. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: - |
| >sp|Q9FKG5|PUB51_ARATH U-box domain-containing protein 51 OS=Arabidopsis thaliana GN=PUB51 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 405 bits (1040), Expect = e-112, Method: Compositional matrix adjust.
Identities = 212/431 (49%), Positives = 288/431 (66%), Gaps = 13/431 (3%)
Query: 82 SSVPVSPRVSSASQSSRDLEAEMRRLKLELRQTMEMYSTACKEALNAKKKAKELNQWKIE 141
SS S SS+SQ +D E E +LK+ELR MY+ A E ++A KK ++LNQ + E
Sbjct: 279 SSSTYSDPTSSSSQIHKDFELE--KLKIELRHIKGMYAVAQSEVIDASKKMQDLNQRRSE 336
Query: 142 EAQRFEEARMAEETALAIAEMEKAKCRAAIEAAEKAQKLADAEAQRRKQAELKAKREAEE 201
EA R + + EE A + EME+ + A AE ++ + E + R +AE +A+ +E
Sbjct: 337 EATRLKNLTIREEEADEVVEMERERQEDAENEAELVRECIERETEERLEAEARAEEVRKE 396
Query: 202 KNRALTALANNDVR---YRKYTIEEIEEATDKFSEAMKIGEGGYGPVYRGKLDHTPVAIK 258
K R AL ++ Y K+ EEI EAT FS+ +KIG GGYG VYR L HT VA+K
Sbjct: 397 KQRLEDALEGGPLQRQQYMKFEWEEIVEATSSFSDELKIGVGGYGSVYRCNLHHTTVAVK 456
Query: 259 VLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACPDYGCLVYEYMHNGSLEDRLLRR-- 316
VL D + +QF QE+E+LS IRHP+++LLLGACP+ G LVYEYMHNGSLE+RL++R
Sbjct: 457 VLHSDKSSLTKQFHQELEILSKIRHPHLLLLLGACPERGSLVYEYMHNGSLEERLMKRRP 516
Query: 317 -GNTPVIP---WRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDV 372
+TP P W +RF+IA EIA+AL FLH +P P+VHRDLKPANILLDRN VSKI DV
Sbjct: 517 NVDTPQPPPLRWFERFRIAWEIASALYFLHTNEPRPIVHRDLKPANILLDRNNVSKIGDV 576
Query: 373 GLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARS 432
GL+++V + + T ++ T GTF YIDPEYQ+TG++T +SDIY+FGI+LLQ++TARS
Sbjct: 577 GLSKMVNLDPSHASTVFNETGPVGTFFYIDPEYQRTGVVTPESDIYAFGIILLQLVTARS 636
Query: 433 PMGLTHHVSRAI--EKGTLAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVI 490
MGL H + +A+ + G E+LD DWP + A+ + ++CAE+RK+DRPDLG I
Sbjct: 637 AMGLAHSIEKALRDQTGKFTEILDKTAGDWPVKEAKEMVMIGLRCAEMRKRDRPDLGKEI 696
Query: 491 VPELNRLKDLG 501
+P L RLK++
Sbjct: 697 LPVLERLKEVA 707
|
Functions as an E3 ubiquitin ligase. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9FKG6|PUB52_ARATH U-box domain-containing protein 52 OS=Arabidopsis thaliana GN=PUB52 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 403 bits (1035), Expect = e-111, Method: Compositional matrix adjust.
Identities = 196/418 (46%), Positives = 276/418 (66%), Gaps = 1/418 (0%)
Query: 90 VSSASQSSRDLEAEMRRLKLELRQTMEMYSTACKEALNAKKKAKELNQWKIEEAQRFEEA 149
V S + + +L E+ +L+ EL+ EMY+ A E + A KK ELNQ + EE+++ E
Sbjct: 349 VHSITDNQVNLNFEIEKLRAELKHVQEMYAMAQTETVGASKKLTELNQRRFEESEKLVEL 408
Query: 150 RMAEETALAIAEMEKAKCRAAIEAAEKAQKLADAEAQRRKQAELKAKREAEEKNRALTAL 209
+ EE A A EK + A++ AEK ++L EA R++AE KA+R+A EK++ +L
Sbjct: 409 KEKEEVAKDTASKEKQRYEEAMKEAEKVKELMMKEALHRREAEFKAERDAREKDKLQASL 468
Query: 210 ANNDVRYRKYTIEEIEEATDKFSEAMKIGEGGYGPVYRGKLDHTPVAIKVLRPDAAQGKR 269
+ V+Y+ YT EEI AT F+E +KIG G YG VY+ L HT A+KVL Q +
Sbjct: 469 VSPGVQYQHYTWEEIAAATSDFAENLKIGIGAYGSVYKCNLHHTTGAVKVLHAGETQLSK 528
Query: 270 QFQQEVEVLSSIRHPNMVLLLGACPDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFK 329
QF QE+E+LS IRHP++VLLLGACP+ GCLVYEYM NGSL+DRL+ +TP IPW +RF+
Sbjct: 529 QFDQELEILSKIRHPHLVLLLGACPERGCLVYEYMDNGSLDDRLMLVNDTPPIPWFERFR 588
Query: 330 IAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQY 389
IA E+A+AL+FLH++KP P++HRDLKP NILLD N+VSK+ DVGL+ +V S T +
Sbjct: 589 IALEVASALVFLHKSKPRPIIHRDLKPGNILLDHNFVSKLGDVGLSTMVNQDDVSSRTIF 648
Query: 390 HMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAI-EKGT 448
TS GT CYIDPEYQ+TG+++ KSD+YS G+++LQ+ITA+ + +TH V AI +
Sbjct: 649 KQTSPVGTLCYIDPEYQRTGIISPKSDVYSLGVVILQLITAKPAIAITHMVEEAIGDDAE 708
Query: 449 LAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPELNRLKDLGRKLES 506
+LD WP + L + C E+R++DRPDL I+P L RL+ + K ++
Sbjct: 709 FMAILDKKAGSWPISDTRELAALGLCCTEMRRRDRPDLKDQIIPALERLRKVADKAQN 766
|
Functions as an E3 ubiquitin ligase. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9SW11|PUB35_ARATH U-box domain-containing protein 35 OS=Arabidopsis thaliana GN=PUB35 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 398 bits (1023), Expect = e-110, Method: Compositional matrix adjust.
Identities = 197/414 (47%), Positives = 274/414 (66%), Gaps = 2/414 (0%)
Query: 92 SASQSSRDLEAEMRRLKLELRQTMEMYSTACKEALNAKKKAKELNQWKIEEAQRFEEARM 151
S + + +L E+ +L+ ELR EMY+ A E +A +K ELNQ ++EEA + EE ++
Sbjct: 341 SYTDNQVNLNFEVEKLRAELRHVQEMYAVAQTETFDASRKLGELNQRRLEEAIKLEELKL 400
Query: 152 AEETALAIAEMEKAKCRAAIEAAEKAQKLADAEAQRRKQAELKAKREAEEKNRALTALAN 211
E A +AE EK A AE ++ A+ E +R++AE K+ R+ +EK + L +
Sbjct: 401 KEYEARELAEKEKQNFEKARRDAESMRERAEREIAQRREAERKSARDTKEKEKLEGTLGS 460
Query: 212 NDVRYRKYTIEEIEEATDKFSEAMKIGEGGYGPVYRGKLDHTPVAIKVLRPDAAQGKRQF 271
++Y+ + EEI AT FSE +KIG G YG VY+ L HT +KVL+ Q +QF
Sbjct: 461 PQLQYQHFAWEEIMAATSSFSEELKIGMGAYGAVYKCNLHHTTAVVKVLQSAENQLSKQF 520
Query: 272 QQEVEVLSSIRHPNMVLLLGACPDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIA 331
QQE+E+LS IRHP++VLLLGACP+ G LVYEYM NGSLEDRL + N+P +PW +RF+IA
Sbjct: 521 QQELEILSKIRHPHLVLLLGACPEQGALVYEYMENGSLEDRLFQVNNSPPLPWFERFRIA 580
Query: 332 AEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPS-VADSVTQYH 390
E+A AL+FLH++KP+P++HRDLKPANILLD N+VSK+ DVGL+ +V ++ T Y
Sbjct: 581 WEVAAALVFLHKSKPKPIIHRDLKPANILLDHNFVSKVGDVGLSTMVQVDPLSTKFTIYK 640
Query: 391 MTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGT-L 449
TS GT CYIDPEYQ+TG +++KSDIYSFG++LLQ++TA+ + LTH V A++
Sbjct: 641 QTSPVGTLCYIDPEYQRTGRISSKSDIYSFGMILLQLLTAKPAIALTHFVESAMDSNDEF 700
Query: 450 AEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPELNRLKDLGRK 503
++LD +WP E + LA+ C ELR KDRPDL I+P L LK + K
Sbjct: 701 LKILDQKAGNWPIEETRELAALALCCTELRGKDRPDLKDQILPALENLKKVAEK 754
|
Functions as an E3 ubiquitin ligase. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LU47|PUB53_ARATH Putative U-box domain-containing protein 53 OS=Arabidopsis thaliana GN=PUB53 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 361 bits (926), Expect = 1e-98, Method: Compositional matrix adjust.
Identities = 194/442 (43%), Positives = 277/442 (62%), Gaps = 28/442 (6%)
Query: 68 AMGSLDISSKNLDFSSVPVSPRVSSASQSSRDLEAEMRRLKLELRQTMEMYSTACKEALN 127
AM S+ S N ++ +V V+P + ++D E+ +L+ ELR EMY+ A E L+
Sbjct: 318 AMSSM---SSNFEYGNV-VTP-LGHYFTDNQDTLNEISKLRAELRHAHEMYAVAQVETLD 372
Query: 128 AKKKAKELNQWKIEEAQRFEEARMAEETALAIAEMEKAKCRAAIEAAEKAQKLADAEAQR 187
A +K EL +FEE + E IA+ E K + ++ + EA +
Sbjct: 373 ASRKLNEL---------KFEELTLLEHETKGIAKKETEKF--------EQKRREEREAAQ 415
Query: 188 RKQAELKAKREAEEKNRALTAL-ANNDVRYRKYTIEEIEEATDKFSEAMKIGEGGYGPVY 246
R++AE+KA EA+EK + + ++Y+++T EEI AT FSE +KIG G YG VY
Sbjct: 416 RREAEMKATHEAKEKEKLEESSLVAPKLQYQEFTWEEIINATSSFSEDLKIGMGAYGDVY 475
Query: 247 RGKLDHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACPDYGCLVYEYMHN 306
+ L HT A+KVL + +QF QE+E+LS IRHP++VLLLGACPD+G LVYEYM N
Sbjct: 476 KCNLHHTIAAVKVLHSAESSLSKQFDQELEILSKIRHPHLVLLLGACPDHGALVYEYMEN 535
Query: 307 GSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYV 366
GSLEDRL + ++ IPW R +IA E+A+AL+FLH++KP P++HRDLKPANILL+ N+V
Sbjct: 536 GSLEDRLFQVNDSQPIPWFVRLRIAWEVASALVFLHKSKPTPIIHRDLKPANILLNHNFV 595
Query: 367 SKISDVGLARLVPPS--VADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIML 424
SK+ DVGL+ ++ + ++ T Y TS GT CYIDPEYQ+TG ++ KSD+Y+FG+++
Sbjct: 596 SKVGDVGLSTMIQAADPLSTKFTMYKQTSPVGTLCYIDPEYQRTGRISPKSDVYAFGMII 655
Query: 425 LQIITARSPMGLTHHVSRAIEKGT---LAEMLDPAVTDWPAEAAESFSKLAIQCAELRKK 481
LQ++T + M LT+ V A+E L ++LD +WP E + LA+QC ELR K
Sbjct: 656 LQLLTGQQAMALTYTVETAMENNNDDELIQILDEKAGNWPIEETRQLAALALQCTELRSK 715
Query: 482 DRPDLGTVIVPELNRLKDLGRK 503
DRPDL I+P L LK + K
Sbjct: 716 DRPDLEDQILPVLESLKKVADK 737
|
Functions as an E3 ubiquitin ligase. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q8GUH1|PUB33_ARATH U-box domain-containing protein 33 OS=Arabidopsis thaliana GN=PUB33 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 307 bits (787), Expect = 1e-82, Method: Compositional matrix adjust.
Identities = 170/402 (42%), Positives = 246/402 (61%), Gaps = 13/402 (3%)
Query: 90 VSSASQSSRDLEAEMRRLKLELRQTMEMYSTACKEALNAKKKAKELNQWKIEEAQRFEEA 149
+ A QS E++R R+ E+ KE K +E+ +++ A ++A
Sbjct: 347 IRRAKQSESAYSEELKR-----RKDTEIAVAKEKERFITIKNEQEVIMEELQSAMA-QKA 400
Query: 150 RMAEETALAIAEMEKAKCRAAIEAAEKAQKLADAEAQRRKQAELKAKREAEE-KNRALTA 208
+ + A + MEK + I A + QKL D + + + + +A REAEE ++ A T+
Sbjct: 401 MLESQIAKSDGTMEKLNQKLDI-AVKLLQKLRDEREELQTERD-RALREAEELRSHAETS 458
Query: 209 LANNDVRYRKYTIEEIEEATDKFSEAMKIGEGGYGPVYRGKLDHTPVAIKVLRPDAAQGK 268
+ ++ EIEEAT+ F +KIGEGGYG +Y G L HT VAIK+L P+++QG
Sbjct: 459 TLQLPQYFTDFSFSEIEEATNHFDSTLKIGEGGYGSIYVGLLRHTQVAIKMLNPNSSQGP 518
Query: 269 RQFQQEVEVLSSIRHPNMVLLLGACPDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRF 328
++QQEV+VLS +RHPN++ L+GACP+ LVYEY+ GSLEDRL + N+P + W+ R
Sbjct: 519 VEYQQEVDVLSKMRHPNIITLIGACPEGWSLVYEYLPGGSLEDRLTCKDNSPPLSWQNRV 578
Query: 329 KIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQ 388
+IA EI AL+FLH K LVH DLKPANILLD N VSK+SD G L+ P+ + SV
Sbjct: 579 RIATEICAALVFLHSNKAHSLVHGDLKPANILLDSNLVSKLSDFGTCSLLHPNGSKSVR- 637
Query: 389 YHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGT 448
T GT Y+DPE +G LT KSD+YSFGI+LL+++T R + +++ V A++ GT
Sbjct: 638 ---TDVTGTVAYLDPEASSSGELTPKSDVYSFGIILLRLLTGRPALRISNEVKYALDNGT 694
Query: 449 LAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVI 490
L ++LDP DWP AE ++LA++C E ++RPDLGT +
Sbjct: 695 LNDLLDPLAGDWPFVQAEQLARLALRCCETVSENRPDLGTEV 736
|
Functions as an E3 ubiquitin ligase. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q94A51|PUB32_ARATH U-box domain-containing protein 32 OS=Arabidopsis thaliana GN=PUB32 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 234 bits (598), Expect = 1e-60, Method: Compositional matrix adjust.
Identities = 122/320 (38%), Positives = 188/320 (58%), Gaps = 31/320 (9%)
Query: 219 YTIEEIEEATDKFSEAMKIGEGGYGPVYRGKLDHTPVAIKVLRPDAAQGKRQFQQEVEVL 278
Y+ EI EAT++F + K+GEG YG VY+G L H VA+K+L + +F++ VE+L
Sbjct: 448 YSFMEINEATNEFDPSWKLGEGKYGSVYKGNLQHLQVAVKMLPSYGSLNHFEFERRVEIL 507
Query: 279 SSIRHPNMVLLLGACPDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATAL 338
S +RHPN+V L+GACP+ L+Y+Y+ NGSLED N P + W R +IA+EI +AL
Sbjct: 508 SRVRHPNLVTLMGACPESRSLIYQYIPNGSLEDCFSSENNVPALSWESRIRIASEICSAL 567
Query: 339 LFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTF 398
LFLH P ++H +LKP+ ILLD N V+KI+D G+++L+P D
Sbjct: 568 LFLHSNIP-CIIHGNLKPSKILLDSNLVTKINDYGISQLIPIDGLDKSDP---------- 616
Query: 399 CYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAVT 458
++DP Y + +T +SDIY+FGI+LLQ++T R G+ V A+E ++ +LD +
Sbjct: 617 -HVDPHYFVSREMTLESDIYAFGIILLQLLTRRPVSGILRDVKCALENDNISAVLDNSAG 675
Query: 459 DWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPELNRLKDLGRKLESNKSYGYAKREGH 518
DWP + + +AI+C + +RPDL V++ ++R+K ++ S+++ YA +
Sbjct: 676 DWPVARGKKLANVAIRCCKKNPMNRPDLA-VVLRFIDRMK--APEVPSSETSSYANQ--- 729
Query: 519 SHSGSGRTSHTRSNVPRSPP 538
NVPR PP
Sbjct: 730 -------------NVPRRPP 736
|
Functions as an E3 ubiquitin ligase. Arabidopsis thaliana (taxid: 3702) EC: 6 EC: . EC: 3 EC: . EC: 2 EC: . EC: - |
| >sp|Q9FID9|Y5389_ARATH Probable receptor-like protein kinase At5g38990 OS=Arabidopsis thaliana GN=At5g38990 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 211 bits (537), Expect = 1e-53, Method: Compositional matrix adjust.
Identities = 114/292 (39%), Positives = 179/292 (61%), Gaps = 23/292 (7%)
Query: 217 RKYTIEEIEEATDKFSEAMKIGEGGYGPVYRGKLDH--TPVAIKVLRPDAAQGKRQFQQE 274
R+++I EI+ AT+ F E + IG GG+G VY+G++D T VA+K L + QG ++F E
Sbjct: 511 RRFSIYEIKSATNDFEEKLIIGVGGFGSVYKGRIDGGATLVAVKRLEITSNQGAKEFDTE 570
Query: 275 VEVLSSIRHPNMVLLLGACPDYG--CLVYEYMHNGSLEDRLLRR--GNTPVIPWRKRFKI 330
+E+LS +RH ++V L+G C D LVYEYM +G+L+D L RR + P + W++R +I
Sbjct: 571 LEMLSKLRHVHLVSLIGYCDDDNEMVLVYEYMPHGTLKDHLFRRDKASDPPLSWKRRLEI 630
Query: 331 AAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYH 390
A L +LH ++HRD+K NILLD N+V+K+SD GL+R+ P S + Q H
Sbjct: 631 CIGAARGLQYLHTGAKYTIIHRDIKTTNILLDENFVAKVSDFGLSRVGPTSAS----QTH 686
Query: 391 MTSAA-GTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPM----------GLTHH 439
+++ GTF Y+DPEY + +LT KSD+YSFG++LL+++ R P+ L
Sbjct: 687 VSTVVKGTFGYLDPEYYRRQILTEKSDVYSFGVVLLEVLCCR-PIRMQSVPPEQADLIRW 745
Query: 440 VSRAIEKGTLAEMLDPAVT-DWPAEAAESFSKLAIQCAELRKKDRPDLGTVI 490
V K T+ +++D +T D + + E F ++AI+C + R +RP + V+
Sbjct: 746 VKSNFNKRTVDQIIDSDLTADITSTSMEKFCEIAIRCVQDRGMERPPMNDVV 797
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9FID8|Y5900_ARATH Putative receptor-like protein kinase At5g39000 OS=Arabidopsis thaliana GN=At5g39000 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 208 bits (530), Expect = 8e-53, Method: Compositional matrix adjust.
Identities = 111/292 (38%), Positives = 181/292 (61%), Gaps = 23/292 (7%)
Query: 217 RKYTIEEIEEATDKFSEAMKIGEGGYGPVYRGKLDH--TPVAIKVLRPDAAQGKRQFQQE 274
R+++I EI+ AT+ F + + IG GG+G VY+G++D T VA+K L + QG ++F+ E
Sbjct: 504 RRFSIFEIKSATNDFEDKLIIGVGGFGSVYKGQIDGGATLVAVKRLEITSNQGAKEFETE 563
Query: 275 VEVLSSIRHPNMVLLLGACPDYG--CLVYEYMHNGSLEDRLLRRGNT--PVIPWRKRFKI 330
+E+LS +RH ++V L+G C + LVYEYM +G+L+D L RR T P + W++R +I
Sbjct: 564 LEMLSKLRHVHLVSLIGYCDEDNEMVLVYEYMPHGTLKDHLFRRDKTSDPPLSWKRRLEI 623
Query: 331 AAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYH 390
A L +LH ++HRD+K NILLD N+V+K+SD GL+R+ P S + Q H
Sbjct: 624 CIGAARGLQYLHTGAKYTIIHRDIKTTNILLDENFVTKVSDFGLSRVGPTSAS----QTH 679
Query: 391 MTSAA-GTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPM----------GLTHH 439
+++ GTF Y+DPEY + +LT KSD+YSFG++LL+++ R P+ L
Sbjct: 680 VSTVVKGTFGYLDPEYYRRQVLTEKSDVYSFGVVLLEVLCCR-PIRMQSVPPEQADLIRW 738
Query: 440 VSRAIEKGTLAEMLDPAVT-DWPAEAAESFSKLAIQCAELRKKDRPDLGTVI 490
V +GT+ +++D ++ D + + E F ++A++C + R +RP + V+
Sbjct: 739 VKSNYRRGTVDQIIDSDLSADITSTSLEKFCEIAVRCVQDRGMERPPMNDVV 790
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q0DR28|PUB57_ORYSJ U-box domain-containing protein 57 OS=Oryza sativa subsp. japonica GN=PUB57 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 204 bits (519), Expect = 2e-51, Method: Compositional matrix adjust.
Identities = 99/274 (36%), Positives = 160/274 (58%), Gaps = 23/274 (8%)
Query: 219 YTIEEIEEATDKFSEAMKIGEGGYGPVYRGKLDHTPVAIKVLRPDAAQGKRQFQQEVEVL 278
++ +++E+AT+ F A ++G+ YG Y+G + + V IK+ + ++ FQQEV +L
Sbjct: 147 FSRKDMEQATEHFKNAREVGDTEYGHTYKGMIHNMKVLIKL-----SSSQKLFQQEVSIL 201
Query: 279 SSIRHPNMVLLLGACPDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATAL 338
RHPN++ +G C + LVYE++ NG+LEDR++ N+ + W R +I EI AL
Sbjct: 202 RQWRHPNIITFIGVCSEVSALVYEWLPNGNLEDRIICTNNSAPLSWYNRTQIIGEICCAL 261
Query: 339 LFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARL------VPPSVADSVTQYHMT 392
LFLH K LVH DL+P NIL+D NY SKI + G++ L PP++ +
Sbjct: 262 LFLHSNKSTALVHGDLRPCNILIDANYRSKICNFGMSNLFLQLGTFPPNLTARLP----- 316
Query: 393 SAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEM 452
Y+DPE+ TG LTT SD+YS G+++L+++T P+ L+ V+ A+ +L +
Sbjct: 317 -------YMDPEFNTTGELTTLSDVYSLGVIILRLLTGMPPLTLSEKVAEALGSDSLHLL 369
Query: 453 LDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDL 486
+D + DWP A+ + + + C + +K RPDL
Sbjct: 370 IDKSAGDWPYIEAKQLALIGLSCTGMTRKKRPDL 403
|
Possesses E3 ubiquitin-protein ligase in vitro. May be involved in cell death signaling. Oryza sativa subsp. japonica (taxid: 39947) EC: 6 EC: . EC: 3 EC: . EC: 2 EC: . EC: - |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 568 | ||||||
| 343887272 | 763 | serine threonine kinase [Citrus unshiu] | 1.0 | 0.744 | 0.996 | 0.0 | |
| 359475954 | 782 | PREDICTED: U-box domain-containing prote | 0.908 | 0.659 | 0.713 | 0.0 | |
| 255584917 | 752 | kinase, putative [Ricinus communis] gi|2 | 0.901 | 0.680 | 0.728 | 0.0 | |
| 224141575 | 679 | predicted protein [Populus trichocarpa] | 0.859 | 0.718 | 0.718 | 0.0 | |
| 5107827 | 675 | contains similarity to protein kinase do | 0.795 | 0.669 | 0.746 | 0.0 | |
| 15239600 | 703 | protein kinase-like protein [Arabidopsis | 0.795 | 0.642 | 0.746 | 0.0 | |
| 79511817 | 701 | Protein kinase protein with adenine nucl | 0.869 | 0.704 | 0.724 | 0.0 | |
| 7573367 | 703 | putative receptor-like kinase [Arabidops | 0.869 | 0.702 | 0.724 | 0.0 | |
| 297811321 | 700 | kinase [Arabidopsis lyrata subsp. lyrata | 0.869 | 0.705 | 0.714 | 0.0 | |
| 397787611 | 1266 | putative kinase [Brassica napus] | 0.904 | 0.406 | 0.713 | 0.0 |
| >gi|343887272|dbj|BAK61818.1| serine threonine kinase [Citrus unshiu] | Back alignment and taxonomy information |
|---|
Score = 1164 bits (3011), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 566/568 (99%), Positives = 568/568 (100%)
Query: 1 MRGIPRGLATERLSWEKGSTPIRAAAHDRHRSSPSTLALDTIESTLPGRRSTGRDSFSDE 60
MRGIPRGLATERLSWEKGSTPIRAAAHDRHRSSPSTLALDTIESTLPGRRSTGRDSFSDE
Sbjct: 196 MRGIPRGLATERLSWEKGSTPIRAAAHDRHRSSPSTLALDTIESTLPGRRSTGRDSFSDE 255
Query: 61 SDYSGPLAMGSLDISSKNLDFSSVPVSPRVSSASQSSRDLEAEMRRLKLELRQTMEMYST 120
SDYSGPLAMGSLDISSKNLDFSSVPVSPRVSSASQSSRDLEAEMRRLKLELRQTMEMYST
Sbjct: 256 SDYSGPLAMGSLDISSKNLDFSSVPVSPRVSSASQSSRDLEAEMRRLKLELRQTMEMYST 315
Query: 121 ACKEALNAKKKAKELNQWKIEEAQRFEEARMAEETALAIAEMEKAKCRAAIEAAEKAQKL 180
ACKEALNAKKKAKELNQWKIEEAQRFEEARMAEETALAIAEMEKAKCRAAIEAAEKAQKL
Sbjct: 316 ACKEALNAKKKAKELNQWKIEEAQRFEEARMAEETALAIAEMEKAKCRAAIEAAEKAQKL 375
Query: 181 ADAEAQRRKQAELKAKREAEEKNRALTALANNDVRYRKYTIEEIEEATDKFSEAMKIGEG 240
ADAEAQRRKQAELKAKREAEEKNRALTALA+NDVRYRKYTIEEIEEATDKFSEAMKIGEG
Sbjct: 376 ADAEAQRRKQAELKAKREAEEKNRALTALAHNDVRYRKYTIEEIEEATDKFSEAMKIGEG 435
Query: 241 GYGPVYRGKLDHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACPDYGCLV 300
GYGPVYRGKLDHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACPDYGCLV
Sbjct: 436 GYGPVYRGKLDHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACPDYGCLV 495
Query: 301 YEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANIL 360
YEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANIL
Sbjct: 496 YEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANIL 555
Query: 361 LDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSF 420
LDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSF
Sbjct: 556 LDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSF 615
Query: 421 GIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAVTDWPAEAAESFSKLAIQCAELRK 480
GIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAVTDWPAEAAESFSKLAIQCAELRK
Sbjct: 616 GIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAVTDWPAEAAESFSKLAIQCAELRK 675
Query: 481 KDRPDLGTVIVPELNRLKDLGRKLESNKSYGYAKREGHSHSGSGRTSHTRSNVPRSPPPL 540
KDRPDLGTVIVPELNRLKDLGRKLESNKSYGYAKREGHSHSGSGRTSHTRSNVPRSPPPL
Sbjct: 676 KDRPDLGTVIVPELNRLKDLGRKLESNKSYGYAKREGHSHSGSGRTSHTRSNVPRSPPPL 735
Query: 541 SSSSYSNSRISNPSSSQMEDSSIEHEER 568
SSSSYSNSRISNPSSSQME+SSIEHEER
Sbjct: 736 SSSSYSNSRISNPSSSQMEESSIEHEER 763
|
Source: Citrus unshiu Species: Citrus unshiu Genus: Citrus Family: Rutaceae Order: Sapindales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359475954|ref|XP_002279357.2| PREDICTED: U-box domain-containing protein 35-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 766 bits (1979), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 379/531 (71%), Positives = 439/531 (82%), Gaps = 15/531 (2%)
Query: 12 RLSWEKGSTPIRAAAHDRHRSSPSTLALDTIESTLPGRRSTGRDSFSDESDYSGPLAMGS 71
R+++E+ + +R R RS+P+ L++D I+ P ST RDS SD+ D+S P+ S
Sbjct: 196 RVTFERTNNNMRVP---RARSAPTNLSIDNIDLQRP---STSRDSVSDDLDFSTPIRFAS 249
Query: 72 LDISSKNLDFSSVPVSPRVSSASQSSRDLEAEMRRLKLELRQTMEMYSTACKEALNAKKK 131
+D+SS+++DFS S R S S+++L AEM+RLKLEL+QTM+MYSTACKEA+ AK+K
Sbjct: 250 VDLSSQDMDFSITSDSGRDSLTPTSAKELAAEMKRLKLELKQTMDMYSTACKEAITAKQK 309
Query: 132 AKELNQWKIEEAQRFEEARMAEETALAIAEMEKAKCRAAIEAAEKAQKLADAEAQRRKQA 191
AKEL+QW++EEA+RF+EAR++EE ALA+AEMEKA+C+AAIEAAE AQKLA+ EAQRR+ A
Sbjct: 310 AKELHQWRMEEARRFKEARLSEEAALAMAEMEKARCKAAIEAAEVAQKLAEKEAQRRRYA 369
Query: 192 ELKAKREAEEKNRALTALANNDVRYRKYTIEEIEEATDKFSEAMKIGEGGYGPVYRGKLD 251
ELKA REAEEK RALTALA+NDVRYRKY IEEIE AT+KFS+AMKIGEGGYGPVYRGKLD
Sbjct: 370 ELKASREAEEKARALTALAHNDVRYRKYAIEEIEVATEKFSQAMKIGEGGYGPVYRGKLD 429
Query: 252 HTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACPDYGCLVYEYMHNGSLED 311
HTPVAIKVLRPDAAQG RQFQQE+EVLS +RHPNMVLLLGACP+YGCLVYEYM NGSLED
Sbjct: 430 HTPVAIKVLRPDAAQGMRQFQQEIEVLSCMRHPNMVLLLGACPEYGCLVYEYMSNGSLED 489
Query: 312 RLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISD 371
RLLRRG+TP IPWR RFKIAAEIATALLFLHQAKPEP VHRDLKPANILLDRNYVSKISD
Sbjct: 490 RLLRRGDTPSIPWRMRFKIAAEIATALLFLHQAKPEPFVHRDLKPANILLDRNYVSKISD 549
Query: 372 VGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITAR 431
VGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGML TKSD+YS GIMLLQIITA+
Sbjct: 550 VGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLGTKSDVYSMGIMLLQIITAK 609
Query: 432 SPMGLTHHVSRAIEKGTLAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIV 491
PMGLTHHV RAIEKGT A+MLD V DWP E A +F+ LA++C+ELRKKDRPDLG+V++
Sbjct: 610 PPMGLTHHVRRAIEKGTFADMLDQTVPDWPVEEALAFANLALKCSELRKKDRPDLGSVVL 669
Query: 492 PELNRLKDLGRKL-----ESNKSYGYAK---REG-HSHSGSGRTSHTRSNV 533
PELNRL G SN GYA R G H S + T+ N+
Sbjct: 670 PELNRLSGFGMDSSGPDNSSNMFNGYASYTHRSGSHPRLSSTASQATKINI 720
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255584917|ref|XP_002533173.1| kinase, putative [Ricinus communis] gi|223527022|gb|EEF29210.1| kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 729 bits (1881), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 379/520 (72%), Positives = 447/520 (85%), Gaps = 8/520 (1%)
Query: 12 RLSWEKGSTPIRAA-AHDRHRSSPSTLALDTIESTLPG----RRSTGRDSFSDESDYSGP 66
R +E+ + P+R DR R+ PS L++D+I+ + PG R ST R S ++ D+S P
Sbjct: 196 RFPYERSNDPMRGQLIRDRTRT-PSNLSMDSIDISFPGGAAPRISTSRVSTYEDHDFSSP 254
Query: 67 LAMGSLDISSKNLDFSSVPVSPRVSSASQSSRDLEAEMRRLKLELRQTMEMYSTACKEAL 126
A+GS+DISS+N DFS SP+ +ASQ++RD+EAEMRRL++EL+QT++MYSTAC+EAL
Sbjct: 255 FALGSIDISSQNPDFSLG--SPKDLAASQAARDIEAEMRRLRVELKQTIDMYSTACREAL 312
Query: 127 NAKKKAKELNQWKIEEAQRFEEARMAEETALAIAEMEKAKCRAAIEAAEKAQKLADAEAQ 186
AKKKA EL+QWK+EEA+RFEEAR AEE ALAIAEMEKAKC+AAIEAAEKAQ+LA EAQ
Sbjct: 313 TAKKKANELHQWKMEEARRFEEARHAEEAALAIAEMEKAKCKAAIEAAEKAQRLAKMEAQ 372
Query: 187 RRKQAELKAKREAEEKNRALTALANNDVRYRKYTIEEIEEATDKFSEAMKIGEGGYGPVY 246
+RK AELKAKREAEEKNRALTALA+NDVRYRKYTIEEIE+AT+KFS++ KIGEGGYGPVY
Sbjct: 373 KRKYAELKAKREAEEKNRALTALAHNDVRYRKYTIEEIEDATEKFSQSNKIGEGGYGPVY 432
Query: 247 RGKLDHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACPDYGCLVYEYMHN 306
+G LDHT VAIKVLRPDAAQGK+QFQQEVEVLS IRHP+MVLLLGACP+YGCLVYEYM N
Sbjct: 433 KGTLDHTAVAIKVLRPDAAQGKKQFQQEVEVLSCIRHPHMVLLLGACPEYGCLVYEYMDN 492
Query: 307 GSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYV 366
GSLEDRLL+R NTP I WR+RFKIAAEI+TALLFLHQAKPEPLVHRDLKPANILLDRNYV
Sbjct: 493 GSLEDRLLQRDNTPPISWRRRFKIAAEISTALLFLHQAKPEPLVHRDLKPANILLDRNYV 552
Query: 367 SKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQ 426
SKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTT+SDIYS GI+LLQ
Sbjct: 553 SKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTRSDIYSLGILLLQ 612
Query: 427 IITARSPMGLTHHVSRAIEKGTLAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDL 486
IITA+ PMGL HHV +AIE+GT +MLDP+V DWP E A +F+KLA++CAELRKKDRP+L
Sbjct: 613 IITAKPPMGLAHHVGKAIERGTFEKMLDPSVVDWPVEEALNFAKLALKCAELRKKDRPNL 672
Query: 487 GTVIVPELNRLKDLGRKLESNKSYGYAKREGHSHSGSGRT 526
TVIVPEL+R++DLG+ ++ + + + HS+ G +
Sbjct: 673 LTVIVPELSRIRDLGKNVDPLGNSDHPRNYAHSNRNRGHS 712
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224141575|ref|XP_002324143.1| predicted protein [Populus trichocarpa] gi|222865577|gb|EEF02708.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 719 bits (1855), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 357/497 (71%), Positives = 406/497 (81%), Gaps = 9/497 (1%)
Query: 16 EKGSTPIRAAAHDRHRSSPSTLALDTIESTLP---GRRSTGRDSFSDESDYSGPLAMGSL 72
+K + +R + +R R+S S ++D+ + LP GR ST R S SD S++SG A +
Sbjct: 185 DKVNDSMRGSQPERGRNSISNFSMDS--TYLPSSCGRPSTSRVSTSDGSEFSGLFATSIM 242
Query: 73 DISSKNLDFSSVPVS----PRVSSASQSSRDLEAEMRRLKLELRQTMEMYSTACKEALNA 128
D S+++ DFS S SA S LE EMRRL+LEL+QTMEMYSTACKEAL+A
Sbjct: 243 DSSAQSSDFSVASASNLNESNAVSAKWCSDHLEVEMRRLRLELKQTMEMYSTACKEALSA 302
Query: 129 KKKAKELNQWKIEEAQRFEEARMAEETALAIAEMEKAKCRAAIEAAEKAQKLADAEAQRR 188
K+KA ELNQWKI+E ++FEEA++A E ALA+AE+EKAKC+ AIEAAEK+QKLA+ E Q+R
Sbjct: 303 KQKASELNQWKIDEVRKFEEAKLAGEAALAVAELEKAKCKVAIEAAEKSQKLAELEGQKR 362
Query: 189 KQAELKAKREAEEKNRALTALANNDVRYRKYTIEEIEEATDKFSEAMKIGEGGYGPVYRG 248
K AE KA+RE EEKNRAL ALA+NDVRYR+YTIEEIEEATDKFS + KIGEGGYGPVY+G
Sbjct: 363 KHAEKKAERETEEKNRALNALAHNDVRYRRYTIEEIEEATDKFSPSNKIGEGGYGPVYKG 422
Query: 249 KLDHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACPDYGCLVYEYMHNGS 308
KLDHTPVAIK LRPDAAQGK+QFQQEVEVLS IRHP+MVLLLGACP+YG LVYEYM NGS
Sbjct: 423 KLDHTPVAIKALRPDAAQGKKQFQQEVEVLSCIRHPHMVLLLGACPEYGILVYEYMDNGS 482
Query: 309 LEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSK 368
LEDRLL++ NTP IPW RFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLD NYV K
Sbjct: 483 LEDRLLQKHNTPPIPWGIRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDSNYVCK 542
Query: 369 ISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQII 428
ISDVGLARLVP SVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTT+SDIYS GIM LQII
Sbjct: 543 ISDVGLARLVPLSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTRSDIYSLGIMFLQII 602
Query: 429 TARSPMGLTHHVSRAIEKGTLAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGT 488
TA+ PMGL H V RAIE+G A+MLD V DWP E A F+ LA++CAELRKKDRP L T
Sbjct: 603 TAKPPMGLAHQVGRAIERGKFADMLDQTVPDWPVEEALRFAALALKCAELRKKDRPSLAT 662
Query: 489 VIVPELNRLKDLGRKLE 505
VIVPELNRL+DLG E
Sbjct: 663 VIVPELNRLRDLGMNTE 679
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|5107827|gb|AAD40140.1|AF149413_21 contains similarity to protein kinase domains; Pfam PF00069, Score=129.3, E=7e-35, N=1 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 715 bits (1846), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 339/454 (74%), Positives = 394/454 (86%), Gaps = 2/454 (0%)
Query: 49 RRSTGRDSFSDESDYSGPLAMGSLDISSKN-LDFSSVPVSPRVSSASQSSRDLEAEMRRL 107
R T + SFSDESD G MGS+D+SS+N +DF S S QS++D+EAEMRRL
Sbjct: 212 RNPTLQSSFSDESD-GGFGVMGSVDLSSQNSMDFYHGASSSSEESIPQSTKDIEAEMRRL 270
Query: 108 KLELRQTMEMYSTACKEALNAKKKAKELNQWKIEEAQRFEEARMAEETALAIAEMEKAKC 167
KLEL+QTM+MYS+ACKEAL AK+KA ELNQWKIEEA++FE+AR++EE ALA+AE+EKAKC
Sbjct: 271 KLELKQTMDMYSSACKEALTAKRKANELNQWKIEEARKFEKARLSEEAALAVAEIEKAKC 330
Query: 168 RAAIEAAEKAQKLADAEAQRRKQAELKAKREAEEKNRALTALANNDVRYRKYTIEEIEEA 227
R A+EAAEKAQ++A+ E QRRKQAE+KA E ++K+RA++ALA+NDVRYRKY+IEEIEEA
Sbjct: 331 RTAVEAAEKAQRMAELEGQRRKQAEMKAVSEEKDKDRAVSALAHNDVRYRKYSIEEIEEA 390
Query: 228 TDKFSEAMKIGEGGYGPVYRGKLDHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMV 287
T++F+ KIGEGGYGPVY G+LDHTPVAIKVLRPDAAQGK+QFQQEVEVL SIRHP+MV
Sbjct: 391 TERFANHRKIGEGGYGPVYNGELDHTPVAIKVLRPDAAQGKKQFQQEVEVLCSIRHPHMV 450
Query: 288 LLLGACPDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPE 347
LLLGACP+YGCLVYE+M NGSLEDRL R GN+P + WRKRF+IAAEIATAL FLHQAKPE
Sbjct: 451 LLLGACPEYGCLVYEFMENGSLEDRLFRTGNSPPLSWRKRFEIAAEIATALSFLHQAKPE 510
Query: 348 PLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQ 407
PLVHRDLKPANILLD+NYVSKISDVGLARLVP S+ADSVTQ+HMTSAAGTFCYIDPEYQQ
Sbjct: 511 PLVHRDLKPANILLDKNYVSKISDVGLARLVPASIADSVTQFHMTSAAGTFCYIDPEYQQ 570
Query: 408 TGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAVTDWPAEAAES 467
TGMLTTKSD+YS GI+LLQIIT R PMGL H VSRAI KGT EMLDP V DWP + A+S
Sbjct: 571 TGMLTTKSDVYSLGILLLQIITGRPPMGLAHQVSRAISKGTFKEMLDPVVPDWPVQEAQS 630
Query: 468 FSKLAIQCAELRKKDRPDLGTVIVPELNRLKDLG 501
F+ LA++CAELRK+DRPDLG +VP L RLK+ G
Sbjct: 631 FATLALKCAELRKRDRPDLGKEVVPHLIRLKNFG 664
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15239600|ref|NP_197987.1| protein kinase-like protein [Arabidopsis thaliana] gi|332006147|gb|AED93530.1| protein kinase-like protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 714 bits (1843), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 339/454 (74%), Positives = 394/454 (86%), Gaps = 2/454 (0%)
Query: 49 RRSTGRDSFSDESDYSGPLAMGSLDISSKN-LDFSSVPVSPRVSSASQSSRDLEAEMRRL 107
R T + SFSDESD G MGS+D+SS+N +DF S S QS++D+EAEMRRL
Sbjct: 240 RNPTLQSSFSDESD-GGFGVMGSVDLSSQNSMDFYHGASSSSEESIPQSTKDIEAEMRRL 298
Query: 108 KLELRQTMEMYSTACKEALNAKKKAKELNQWKIEEAQRFEEARMAEETALAIAEMEKAKC 167
KLEL+QTM+MYS+ACKEAL AK+KA ELNQWKIEEA++FE+AR++EE ALA+AE+EKAKC
Sbjct: 299 KLELKQTMDMYSSACKEALTAKRKANELNQWKIEEARKFEKARLSEEAALAVAEIEKAKC 358
Query: 168 RAAIEAAEKAQKLADAEAQRRKQAELKAKREAEEKNRALTALANNDVRYRKYTIEEIEEA 227
R A+EAAEKAQ++A+ E QRRKQAE+KA E ++K+RA++ALA+NDVRYRKY+IEEIEEA
Sbjct: 359 RTAVEAAEKAQRMAELEGQRRKQAEMKAVSEEKDKDRAVSALAHNDVRYRKYSIEEIEEA 418
Query: 228 TDKFSEAMKIGEGGYGPVYRGKLDHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMV 287
T++F+ KIGEGGYGPVY G+LDHTPVAIKVLRPDAAQGK+QFQQEVEVL SIRHP+MV
Sbjct: 419 TERFANHRKIGEGGYGPVYNGELDHTPVAIKVLRPDAAQGKKQFQQEVEVLCSIRHPHMV 478
Query: 288 LLLGACPDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPE 347
LLLGACP+YGCLVYE+M NGSLEDRL R GN+P + WRKRF+IAAEIATAL FLHQAKPE
Sbjct: 479 LLLGACPEYGCLVYEFMENGSLEDRLFRTGNSPPLSWRKRFEIAAEIATALSFLHQAKPE 538
Query: 348 PLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQ 407
PLVHRDLKPANILLD+NYVSKISDVGLARLVP S+ADSVTQ+HMTSAAGTFCYIDPEYQQ
Sbjct: 539 PLVHRDLKPANILLDKNYVSKISDVGLARLVPASIADSVTQFHMTSAAGTFCYIDPEYQQ 598
Query: 408 TGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAVTDWPAEAAES 467
TGMLTTKSD+YS GI+LLQIIT R PMGL H VSRAI KGT EMLDP V DWP + A+S
Sbjct: 599 TGMLTTKSDVYSLGILLLQIITGRPPMGLAHQVSRAISKGTFKEMLDPVVPDWPVQEAQS 658
Query: 468 FSKLAIQCAELRKKDRPDLGTVIVPELNRLKDLG 501
F+ LA++CAELRK+DRPDLG +VP L RLK+ G
Sbjct: 659 FATLALKCAELRKRDRPDLGKEVVPHLIRLKNFG 692
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|79511817|ref|NP_196761.2| Protein kinase protein with adenine nucleotide alpha hydrolases-like domain [Arabidopsis thaliana] gi|110741831|dbj|BAE98858.1| putative receptor - like kinase [Arabidopsis thaliana] gi|332004366|gb|AED91749.1| Protein kinase protein with adenine nucleotide alpha hydrolases-like domain [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 709 bits (1831), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 366/505 (72%), Positives = 423/505 (83%), Gaps = 11/505 (2%)
Query: 6 RGLATERLSWE-KGSTPIRAAAHDRHRSSPSTLALDTIESTLPG---RRSTGRDSFSDES 61
R ER S E KG P+R + H+ P+ +LD G R STGR SFSDES
Sbjct: 198 RNTVPERYSHENKGFKPVR----EMHKI-PTNGSLDFNYEFRQGKGQRNSTGRSSFSDES 252
Query: 62 -DYSGPLAMGSLDISSKNLDFSSVPVSPRVSSASQSSRDLEAEMRRLKLELRQTMEMYST 120
D + MGS+D+S++N D S SASQS+RD+EAEM+RLK+EL+QTM+MYS+
Sbjct: 253 SDVGSMMMMGSIDLSAENFDMVGGSGSSD-ESASQSTRDIEAEMKRLKIELKQTMDMYSS 311
Query: 121 ACKEALNAKKKAKELNQWKIEEAQRFEEARMAEETALAIAEMEKAKCRAAIEAAEKAQKL 180
ACKEALNAKKKA ELNQWK+EEA+RFEEAR AEE ALA+AEMEKAKCRAA+EAAEKAQ++
Sbjct: 312 ACKEALNAKKKANELNQWKMEEARRFEEARNAEEAALAVAEMEKAKCRAALEAAEKAQRM 371
Query: 181 ADAEAQRRKQAELKAKREAEEKNRALTALANNDVRYRKYTIEEIEEATDKFSEAMKIGEG 240
A+ E QRRKQAE+KA+RE++EK+RAL+AL NDVRYRKY+I+EIE AT++F+ KIGEG
Sbjct: 372 AELEGQRRKQAEMKARRESQEKDRALSALVQNDVRYRKYSIDEIEVATERFANNRKIGEG 431
Query: 241 GYGPVYRGKLDHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACPDYGCLV 300
GYGPVY G LDHTPVAIKVLRPDAAQGK+QFQQEVEVLSSIRHP+MVLLLGACP+YGCLV
Sbjct: 432 GYGPVYHGTLDHTPVAIKVLRPDAAQGKKQFQQEVEVLSSIRHPHMVLLLGACPEYGCLV 491
Query: 301 YEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANIL 360
YE+M NGSLEDRL RRGN+P + WRKRF+IAAEIATAL FLHQAKPEPLVHRDLKPANIL
Sbjct: 492 YEFMDNGSLEDRLFRRGNSPPLSWRKRFQIAAEIATALSFLHQAKPEPLVHRDLKPANIL 551
Query: 361 LDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSF 420
LD+NYVSKISDVGLARLVP SVA++VTQYHMTSAAGTFCYIDPEYQQTG LTTKSDI+S
Sbjct: 552 LDKNYVSKISDVGLARLVPASVANTVTQYHMTSAAGTFCYIDPEYQQTGKLTTKSDIFSL 611
Query: 421 GIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAVTDWPAEAAESFSKLAIQCAELRK 480
GIMLLQIITA+SPMGL HHVSRAI+KGT +MLDP V DWP E A +F+KL ++CAELRK
Sbjct: 612 GIMLLQIITAKSPMGLAHHVSRAIDKGTFKDMLDPVVPDWPVEEALNFAKLCLRCAELRK 671
Query: 481 KDRPDLGTVIVPELNRLKDLGRKLE 505
+DRPDLG IVPEL RL++LG+ E
Sbjct: 672 RDRPDLGKEIVPELLRLRNLGKDNE 696
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|7573367|emb|CAB87673.1| putative receptor-like kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 709 bits (1831), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 366/505 (72%), Positives = 423/505 (83%), Gaps = 11/505 (2%)
Query: 6 RGLATERLSWE-KGSTPIRAAAHDRHRSSPSTLALDTIESTLPG---RRSTGRDSFSDES 61
R ER S E KG P+R + H+ P+ +LD G R STGR SFSDES
Sbjct: 198 RNTVPERYSHENKGFKPVR----EMHKI-PTNGSLDFNYEFRQGKGQRNSTGRSSFSDES 252
Query: 62 -DYSGPLAMGSLDISSKNLDFSSVPVSPRVSSASQSSRDLEAEMRRLKLELRQTMEMYST 120
D + MGS+D+S++N D S SASQS+RD+EAEM+RLK+EL+QTM+MYS+
Sbjct: 253 SDVGSMMMMGSIDLSAENFDMVGGSGSSD-ESASQSTRDIEAEMKRLKIELKQTMDMYSS 311
Query: 121 ACKEALNAKKKAKELNQWKIEEAQRFEEARMAEETALAIAEMEKAKCRAAIEAAEKAQKL 180
ACKEALNAKKKA ELNQWK+EEA+RFEEAR AEE ALA+AEMEKAKCRAA+EAAEKAQ++
Sbjct: 312 ACKEALNAKKKANELNQWKMEEARRFEEARNAEEAALAVAEMEKAKCRAALEAAEKAQRM 371
Query: 181 ADAEAQRRKQAELKAKREAEEKNRALTALANNDVRYRKYTIEEIEEATDKFSEAMKIGEG 240
A+ E QRRKQAE+KA+RE++EK+RAL+AL NDVRYRKY+I+EIE AT++F+ KIGEG
Sbjct: 372 AELEGQRRKQAEMKARRESQEKDRALSALVQNDVRYRKYSIDEIEVATERFANNRKIGEG 431
Query: 241 GYGPVYRGKLDHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACPDYGCLV 300
GYGPVY G LDHTPVAIKVLRPDAAQGK+QFQQEVEVLSSIRHP+MVLLLGACP+YGCLV
Sbjct: 432 GYGPVYHGTLDHTPVAIKVLRPDAAQGKKQFQQEVEVLSSIRHPHMVLLLGACPEYGCLV 491
Query: 301 YEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANIL 360
YE+M NGSLEDRL RRGN+P + WRKRF+IAAEIATAL FLHQAKPEPLVHRDLKPANIL
Sbjct: 492 YEFMDNGSLEDRLFRRGNSPPLSWRKRFQIAAEIATALSFLHQAKPEPLVHRDLKPANIL 551
Query: 361 LDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSF 420
LD+NYVSKISDVGLARLVP SVA++VTQYHMTSAAGTFCYIDPEYQQTG LTTKSDI+S
Sbjct: 552 LDKNYVSKISDVGLARLVPASVANTVTQYHMTSAAGTFCYIDPEYQQTGKLTTKSDIFSL 611
Query: 421 GIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAVTDWPAEAAESFSKLAIQCAELRK 480
GIMLLQIITA+SPMGL HHVSRAI+KGT +MLDP V DWP E A +F+KL ++CAELRK
Sbjct: 612 GIMLLQIITAKSPMGLAHHVSRAIDKGTFKDMLDPVVPDWPVEEALNFAKLCLRCAELRK 671
Query: 481 KDRPDLGTVIVPELNRLKDLGRKLE 505
+DRPDLG IVPEL RL++LG+ E
Sbjct: 672 RDRPDLGKEIVPELLRLRNLGKDNE 696
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297811321|ref|XP_002873544.1| kinase [Arabidopsis lyrata subsp. lyrata] gi|297319381|gb|EFH49803.1| kinase [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 708 bits (1827), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 360/504 (71%), Positives = 420/504 (83%), Gaps = 10/504 (1%)
Query: 6 RGLATERLSWE-KGSTPIRAAAHDRHRSSPSTLALDT---IESTLPGRRSTGRDSFSDES 61
R ER S + KG P+R + H+ P+ +LD R STGR SFSD++
Sbjct: 198 RNTVPERYSHDNKGFKPVR----EMHKI-PTNGSLDFNYEFRQAKGQRNSTGRSSFSDDA 252
Query: 62 DYSGPLAMGSLDISSKNLDFSSVPVSPRVSSASQSSRDLEAEMRRLKLELRQTMEMYSTA 121
D + MGS+D+S++N D S S SQS+RD+EAEM+RLK+EL+QTM+MYS+A
Sbjct: 253 DVGSMMMMGSIDLSAENFDMVGASGSSD-ESVSQSTRDIEAEMKRLKIELKQTMDMYSSA 311
Query: 122 CKEALNAKKKAKELNQWKIEEAQRFEEARMAEETALAIAEMEKAKCRAAIEAAEKAQKLA 181
CKEALNAKKKA ELNQWK+EEA+RFEEAR AEE ALA+AEMEKAKCRAA+EAAEKAQ++A
Sbjct: 312 CKEALNAKKKANELNQWKLEEARRFEEARNAEEAALAVAEMEKAKCRAALEAAEKAQRMA 371
Query: 182 DAEAQRRKQAELKAKREAEEKNRALTALANNDVRYRKYTIEEIEEATDKFSEAMKIGEGG 241
+ E QRRKQAE+KA+RE++EK+RAL+AL NDVRYR+Y+I+EIE AT++F+ KIGEGG
Sbjct: 372 ELEGQRRKQAEMKARRESQEKDRALSALVQNDVRYRRYSIDEIEVATERFANNRKIGEGG 431
Query: 242 YGPVYRGKLDHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACPDYGCLVY 301
YGPVY G LDHTPVAIKVLRPDAAQGK+QFQQEVEVLSSIRHP+MVLLLGACP+YGCLVY
Sbjct: 432 YGPVYHGTLDHTPVAIKVLRPDAAQGKKQFQQEVEVLSSIRHPHMVLLLGACPEYGCLVY 491
Query: 302 EYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILL 361
E+M NGSLEDRL RRGN+P + WRKRF+IAAEIATAL FLHQAKPEPLVHRDLKPANILL
Sbjct: 492 EFMDNGSLEDRLFRRGNSPPLSWRKRFQIAAEIATALSFLHQAKPEPLVHRDLKPANILL 551
Query: 362 DRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFG 421
D+NYVSKISDVGLARLVP SVA++VTQYHMTSAAGTFCYIDPEYQQTG LTTKSDI+S G
Sbjct: 552 DKNYVSKISDVGLARLVPASVANTVTQYHMTSAAGTFCYIDPEYQQTGKLTTKSDIFSLG 611
Query: 422 IMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAVTDWPAEAAESFSKLAIQCAELRKK 481
IMLLQIITA+SPMGL HHVSRAI+KGT +MLDP V DWP E A +F+KL ++CAELRK+
Sbjct: 612 IMLLQIITAKSPMGLAHHVSRAIDKGTFKDMLDPVVPDWPVEEALNFAKLCLKCAELRKR 671
Query: 482 DRPDLGTVIVPELNRLKDLGRKLE 505
DRPDLG IVPEL RL+ LG+ E
Sbjct: 672 DRPDLGKEIVPELLRLRSLGKDNE 695
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|397787611|gb|AFO66517.1| putative kinase [Brassica napus] | Back alignment and taxonomy information |
|---|
Score = 704 bits (1816), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 371/520 (71%), Positives = 426/520 (81%), Gaps = 6/520 (1%)
Query: 49 RRSTGRDSFSDESDYSGPLAMGSLDISSKNLDFSSVPVSPRVSSASQSSRDLEAEMRRLK 108
R GR+SFSDESD G L MGS+D+S++N DF S SASQS+RD+EAEM+RLK
Sbjct: 744 RNPVGRNSFSDESD-GGSLMMGSVDLSAQNYDFIGASGSSD-ESASQSTRDIEAEMKRLK 801
Query: 109 LELRQTMEMYSTACKEALNAKKKAKELNQWKIEEAQRFEEARMAEETALAIAEMEKAKCR 168
LELRQTM+MYS+ACKEALNAKK A ELN WK EEA+RFEEAR AEE ALA+AEMEKAKC+
Sbjct: 802 LELRQTMDMYSSACKEALNAKKTANELNMWKKEEARRFEEARSAEEAALAVAEMEKAKCK 861
Query: 169 AAIEAAEKAQKLADAEAQRRKQAELKAKREAEEKNRALTALANNDVRYRKYTIEEIEEAT 228
AA+EAAEKAQ++AD E QRRKQAE+KA+RE++EK+RALTAL NDVRYRKY+IEEIEEAT
Sbjct: 862 AAMEAAEKAQRMADLEGQRRKQAEMKARRESQEKDRALTALGQNDVRYRKYSIEEIEEAT 921
Query: 229 DKFSEAMKIGEGGYGPVYRGKLDHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVL 288
D+F+ MK+GEGGYGPVY+G LDHTPVAIKVLRPDAAQGK+QFQQEVEVLS IRHP+MVL
Sbjct: 922 DRFASNMKVGEGGYGPVYKGTLDHTPVAIKVLRPDAAQGKKQFQQEVEVLSCIRHPHMVL 981
Query: 289 LLGACPDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEP 348
LLGACP+YGCLVYE+M NGSLEDRL RRGN+P + WRKRF+IAAEIATAL FLHQ KPEP
Sbjct: 982 LLGACPEYGCLVYEFMENGSLEDRLFRRGNSPPLSWRKRFQIAAEIATALSFLHQTKPEP 1041
Query: 349 LVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQT 408
LVHRDLKPANILLDRNYVSKISDVGLARLVP SVA++VTQYHMTSAAGTFCYIDPEYQQT
Sbjct: 1042 LVHRDLKPANILLDRNYVSKISDVGLARLVPASVANNVTQYHMTSAAGTFCYIDPEYQQT 1101
Query: 409 GMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAVTDWPAEAAESF 468
G LTTKSDIYS GIMLLQIITA++PMGL HHV+RAIEKGT +MLDP VTDWP E A +F
Sbjct: 1102 GKLTTKSDIYSLGIMLLQIITAKNPMGLAHHVARAIEKGTFKDMLDPVVTDWPVEEAINF 1161
Query: 469 SKLAIQCAELRKKDRPDLGTVIVPELNRLKDLGRKLESNKSYGYAKREGHSHSGSGRTSH 528
+KL ++C+ELRK+DRPDLG IVPEL RL++LG ES+ S+ G S+S S
Sbjct: 1162 AKLCLKCSELRKRDRPDLGKDIVPELVRLRNLGLDNESDASHIM----GKSNSKEKPPSS 1217
Query: 529 TRSNVPRSPPPLSSSSYSNSRISNPSSSQMEDSSIEHEER 568
+ P+ + R+ P S + E S HE R
Sbjct: 1218 NSAQSPQIDFEREDQFTYDDRLKTPESHRGEIVSFCHECR 1257
|
Source: Brassica napus Species: Brassica napus Genus: Brassica Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 568 | ||||||
| TAIR|locus:2143094 | 701 | AT5G12000 [Arabidopsis thalian | 0.869 | 0.704 | 0.653 | 1.1e-167 | |
| TAIR|locus:2180677 | 703 | AT5G26150 [Arabidopsis thalian | 0.795 | 0.642 | 0.685 | 3.4e-164 | |
| TAIR|locus:2061012 | 788 | AT2G24370 [Arabidopsis thalian | 0.795 | 0.573 | 0.642 | 8.1e-153 | |
| TAIR|locus:2128131 | 764 | AT4G31230 [Arabidopsis thalian | 0.820 | 0.609 | 0.603 | 3.1e-147 | |
| TAIR|locus:2182613 | 731 | AT5G35380 [Arabidopsis thalian | 0.695 | 0.540 | 0.654 | 8e-140 | |
| TAIR|locus:2015656 | 758 | AT1G16760 [Arabidopsis thalian | 0.820 | 0.614 | 0.567 | 1.5e-136 | |
| TAIR|locus:2063601 | 700 | AT2G07020 [Arabidopsis thalian | 0.713 | 0.578 | 0.632 | 4.7e-135 | |
| TAIR|locus:2087610 | 780 | AT3G20200 [Arabidopsis thalian | 0.838 | 0.610 | 0.496 | 9.8e-119 | |
| TAIR|locus:2007908 | 728 | AT1G17540 [Arabidopsis thalian | 0.677 | 0.528 | 0.571 | 4.9e-117 | |
| TAIR|locus:2030245 | 697 | AT1G72760 [Arabidopsis thalian | 0.595 | 0.484 | 0.605 | 1.3e-113 |
| TAIR|locus:2143094 AT5G12000 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1631 (579.2 bits), Expect = 1.1e-167, P = 1.1e-167
Identities = 330/505 (65%), Positives = 381/505 (75%)
Query: 6 RGLATERLSWE-KGSTPIRAAAHDRHRSSPSTLALDTIESTLPG---RRSTGRDSFSDES 61
R ER S E KG P+R + H+ P+ +LD G R STGR SFSDES
Sbjct: 198 RNTVPERYSHENKGFKPVR----EMHKI-PTNGSLDFNYEFRQGKGQRNSTGRSSFSDES 252
Query: 62 -DYSGPLAMGSLDISSKNLDFXXXXXXXXXXXXXXXXXDLEAEMRRLKLELRQTMEMYST 120
D + MGS+D+S++N D D+EAEM+RLK+EL+QTM+MYS+
Sbjct: 253 SDVGSMMMMGSIDLSAENFDMVGGSGSSDESASQSTR-DIEAEMKRLKIELKQTMDMYSS 311
Query: 121 ACXXXXXXXXXXXXXXQWKIEEAQRFEEARMAEETALAIAEMEKAKCRAAIEAAEKAQKL 180
AC QWK+EEA+RFEEAR AEE ALA+AEMEKAKCRAA+EAAEKAQ++
Sbjct: 312 ACKEALNAKKKANELNQWKMEEARRFEEARNAEEAALAVAEMEKAKCRAALEAAEKAQRM 371
Query: 181 ADAEXXXXXXXXXXXXXXXXXXXXXXTALANNDVRYRKYTIEEIEEATDKFSEAMKIGEG 240
A+ E +AL NDVRYRKY+I+EIE AT++F+ KIGEG
Sbjct: 372 AELEGQRRKQAEMKARRESQEKDRALSALVQNDVRYRKYSIDEIEVATERFANNRKIGEG 431
Query: 241 GYGPVYRGKLDHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACPDYGCLV 300
GYGPVY G LDHTPVAIKVLRPDAAQGK+QFQQEVEVLSSIRHP+MVLLLGACP+YGCLV
Sbjct: 432 GYGPVYHGTLDHTPVAIKVLRPDAAQGKKQFQQEVEVLSSIRHPHMVLLLGACPEYGCLV 491
Query: 301 YEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANIL 360
YE+M NGSLEDRL RRGN+P + WRKRF+IAAEIATAL FLHQAKPEPLVHRDLKPANIL
Sbjct: 492 YEFMDNGSLEDRLFRRGNSPPLSWRKRFQIAAEIATALSFLHQAKPEPLVHRDLKPANIL 551
Query: 361 LDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSF 420
LD+NYVSKISDVGLARLVP SVA++VTQYHMTSAAGTFCYIDPEYQQTG LTTKSDI+S
Sbjct: 552 LDKNYVSKISDVGLARLVPASVANTVTQYHMTSAAGTFCYIDPEYQQTGKLTTKSDIFSL 611
Query: 421 GIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAVTDWPAEAAESFSKLAIQCAELRK 480
GIMLLQIITA+SPMGL HHVSRAI+KGT +MLDP V DWP E A +F+KL ++CAELRK
Sbjct: 612 GIMLLQIITAKSPMGLAHHVSRAIDKGTFKDMLDPVVPDWPVEEALNFAKLCLRCAELRK 671
Query: 481 KDRPDLGTVIVPELNRLKDLGRKLE 505
+DRPDLG IVPEL RL++LG+ E
Sbjct: 672 RDRPDLGKEIVPELLRLRNLGKDNE 696
|
|
| TAIR|locus:2180677 AT5G26150 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1598 (567.6 bits), Expect = 3.4e-164, P = 3.4e-164
Identities = 311/454 (68%), Positives = 358/454 (78%)
Query: 49 RRSTGRDSFSDESDYSGPLAMGSLDISSKN-LDFXXXXXXXXXXXXXXXXXDLEAEMRRL 107
R T + SFSDESD G MGS+D+SS+N +DF D+EAEMRRL
Sbjct: 240 RNPTLQSSFSDESD-GGFGVMGSVDLSSQNSMDFYHGASSSSEESIPQSTKDIEAEMRRL 298
Query: 108 KLELRQTMEMYSTACXXXXXXXXXXXXXXQWKIEEAQRFEEARMAEETALAIAEMEKAKC 167
KLEL+QTM+MYS+AC QWKIEEA++FE+AR++EE ALA+AE+EKAKC
Sbjct: 299 KLELKQTMDMYSSACKEALTAKRKANELNQWKIEEARKFEKARLSEEAALAVAEIEKAKC 358
Query: 168 RAAIEAAEKAQKLADAEXXXXXXXXXXXXXXXXXXXXXXTALANNDVRYRKYTIEEIEEA 227
R A+EAAEKAQ++A+ E +ALA+NDVRYRKY+IEEIEEA
Sbjct: 359 RTAVEAAEKAQRMAELEGQRRKQAEMKAVSEEKDKDRAVSALAHNDVRYRKYSIEEIEEA 418
Query: 228 TDKFSEAMKIGEGGYGPVYRGKLDHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMV 287
T++F+ KIGEGGYGPVY G+LDHTPVAIKVLRPDAAQGK+QFQQEVEVL SIRHP+MV
Sbjct: 419 TERFANHRKIGEGGYGPVYNGELDHTPVAIKVLRPDAAQGKKQFQQEVEVLCSIRHPHMV 478
Query: 288 LLLGACPDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPE 347
LLLGACP+YGCLVYE+M NGSLEDRL R GN+P + WRKRF+IAAEIATAL FLHQAKPE
Sbjct: 479 LLLGACPEYGCLVYEFMENGSLEDRLFRTGNSPPLSWRKRFEIAAEIATALSFLHQAKPE 538
Query: 348 PLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQ 407
PLVHRDLKPANILLD+NYVSKISDVGLARLVP S+ADSVTQ+HMTSAAGTFCYIDPEYQQ
Sbjct: 539 PLVHRDLKPANILLDKNYVSKISDVGLARLVPASIADSVTQFHMTSAAGTFCYIDPEYQQ 598
Query: 408 TGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAVTDWPAEAAES 467
TGMLTTKSD+YS GI+LLQIIT R PMGL H VSRAI KGT EMLDP V DWP + A+S
Sbjct: 599 TGMLTTKSDVYSLGILLLQIITGRPPMGLAHQVSRAISKGTFKEMLDPVVPDWPVQEAQS 658
Query: 468 FSKLAIQCAELRKKDRPDLGTVIVPELNRLKDLG 501
F+ LA++CAELRK+DRPDLG +VP L RLK+ G
Sbjct: 659 FATLALKCAELRKRDRPDLGKEVVPHLIRLKNFG 692
|
|
| TAIR|locus:2061012 AT2G24370 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1474 (523.9 bits), Expect = 8.1e-153, Sum P(2) = 8.1e-153
Identities = 293/456 (64%), Positives = 339/456 (74%)
Query: 47 PGRRSTGRDSFSDESDYSGPLAMGSLDISSKNLDFXXXXXXXXXXXXXXXXX--DLEAEM 104
P R +FSD DYS L S + +++D D+EAEM
Sbjct: 296 PSRTPPRLSNFSD-MDYSSSLDQSS-NYGRRSVDMNSPTDFESERFSSASQSIDDVEAEM 353
Query: 105 RRLKLELRQTMEMYSTACXXXXXXXXXXXXXXQWKIEEAQRFEEARMAEETALAIAEMEK 164
RRLKLEL+QTMEMYSTAC +WK+EE ++ EEAR AEE ALAIAE EK
Sbjct: 354 RRLKLELKQTMEMYSTACKEALTAKQKATELQRWKLEEERKLEEARNAEEAALAIAEKEK 413
Query: 165 AKCRAAIEAAEKAQKLADAEXXXXXXXXXXXXXXXXXXXXXXTALANNDVRYRKYTIEEI 224
AK +AA+EAAE AQ++A+ E TALAN+DVRYRKY+IE+I
Sbjct: 414 AKSKAAMEAAEAAQRIAELEAKKRVNAEMKALKESEEKTKALTALANSDVRYRKYSIEDI 473
Query: 225 EEATDKFSEAMKIGEGGYGPVYRGKLDHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHP 284
E AT+ F+E KIGEGGYGPVY+ LDHTPVA+KVLRPDAAQG+ QFQQEVEVLS IRHP
Sbjct: 474 ELATEFFAEKYKIGEGGYGPVYKCYLDHTPVAVKVLRPDAAQGRSQFQQEVEVLSCIRHP 533
Query: 285 NMVLLLGACPDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQA 344
NMVLLLGACP+ GCLVYE+M NGSLEDRL R GN+P + W+ RF+IAAEI T LLFLHQA
Sbjct: 534 NMVLLLGACPECGCLVYEFMANGSLEDRLFRLGNSPPLSWQMRFRIAAEIGTGLLFLHQA 593
Query: 345 KPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPE 404
KPEPLVHRDLKP NILLDRN+VSKISDVGLARLVPP+VAD+VTQY MTS AGTFCYIDPE
Sbjct: 594 KPEPLVHRDLKPGNILLDRNFVSKISDVGLARLVPPTVADTVTQYRMTSTAGTFCYIDPE 653
Query: 405 YQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAVTDWPAEA 464
YQQTGML KSDIYS GIM LQ+ITA+ PMGLTH+V RA+EKGTL ++LDP V+DWP E
Sbjct: 654 YQQTGMLGVKSDIYSLGIMFLQLITAKPPMGLTHYVERALEKGTLVDLLDPVVSDWPMED 713
Query: 465 AESFSKLAIQCAELRKKDRPDLGTVIVPELNRLKDL 500
E F+KLA++CAELR+KDRPDL VI+PELNRL+ L
Sbjct: 714 TEEFAKLALKCAELRRKDRPDLAKVILPELNRLRTL 749
|
|
| TAIR|locus:2128131 AT4G31230 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1438 (511.3 bits), Expect = 3.1e-147, P = 3.1e-147
Identities = 288/477 (60%), Positives = 344/477 (72%)
Query: 31 RSSPSTLALDTIESTLPGRRSTGRDSFSDESDYSG--PLAMG--SLDISSKNLDFXXXXX 86
R+SPS +++ P R +FSD DY + G S+D+SS
Sbjct: 270 RNSPSLY-----DNSDPNRTPPRLSNFSDV-DYCSFESMTFGRRSMDLSSPTAFSTGSFE 323
Query: 87 XXXXXXXXXXXXDLEAEMRRLKLELRQTMEMYSTACXXXXXXXXXXXXXXQWKIEEAQRF 146
D+EAEMRRLKLEL+QTMEMYSTAC +WK+ E ++F
Sbjct: 324 NERFSSASQGGDDVEAEMRRLKLELKQTMEMYSTACKEALTAKHKATELQRWKLAEERKF 383
Query: 147 EEARMAEETALAIAEMEKAKCRAAIEAAEKAQKLADAEXXXXXXXXXXXXXXXXXXXXXX 206
EEA++AEE ALAIAE EKAK +AA+EAAE AQ++AD E
Sbjct: 384 EEAKLAEEAALAIAEKEKAKSKAAMEAAEAAQRIADIESRKRVDAETKALKESEARTKAV 443
Query: 207 TALANNDVRYRKYTIEEIEEATDKFSEAMKIGEGGYGPVYRGKLDHTPVAIKVLRPDAAQ 266
ALA DVRYRKY+IEEIE+AT+ F + KIGEG YGPVY+ LDHTPVA+K LRPDAAQ
Sbjct: 444 NALAK-DVRYRKYSIEEIEDATEFFDDKYKIGEGSYGPVYKCYLDHTPVAVKALRPDAAQ 502
Query: 267 GKRQFQQEVEVLSSIRHPNMVLLLGACPDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRK 326
G+ QFQ+EVEVL SIRHPNMVLLLGACP+ GCLVYE+M NGSLEDRL R+G++P + W+
Sbjct: 503 GRSQFQKEVEVLCSIRHPNMVLLLGACPECGCLVYEFMANGSLEDRLFRQGDSPALSWQT 562
Query: 327 RFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSV 386
RF+IAAEI T LLFLHQ KPEPLVHRDLKPANILLDRN+VSK++DVGLARLVPPSVA++V
Sbjct: 563 RFRIAAEIGTVLLFLHQTKPEPLVHRDLKPANILLDRNFVSKLADVGLARLVPPSVANTV 622
Query: 387 TQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEK 446
TQYHMTS AGTFCYIDPEYQQTGML KSDIYS GIM LQ+IT + PMGLTH+V RA+EK
Sbjct: 623 TQYHMTSTAGTFCYIDPEYQQTGMLGVKSDIYSLGIMFLQLITGKPPMGLTHYVERALEK 682
Query: 447 GTLAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPELNRLKDLGRK 503
G L ++LDPAV+DWP E F+KLA++CAE+R+KDRPDL VI+PELNRL+ L +
Sbjct: 683 GNLKDLLDPAVSDWPVEDTTEFAKLALKCAEIRRKDRPDLSKVILPELNRLRVLAEE 739
|
|
| TAIR|locus:2182613 AT5G35380 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1368 (486.6 bits), Expect = 8.0e-140, P = 8.0e-140
Identities = 265/405 (65%), Positives = 317/405 (78%)
Query: 99 DLEAEMRRLKLELRQTMEMYSTACXXXXXXXXXXXXXXQWKIEEAQRFEEARMAEETALA 158
+LE EMRRLK+EL+ TMEMY++AC +WK E+ + EE R+++E A+A
Sbjct: 292 ELETEMRRLKMELKHTMEMYNSACKEAISAKKAANELLKWKAEKEHKLEEVRLSKEAAMA 351
Query: 159 IAEMEKAKCRAAIEAAEKAQKLADAEXXXXXXXXXXXXXXXXXXXXXXTALANNDVRYRK 218
+AE EK K RAA+EAA AQKL+D E A + +RYRK
Sbjct: 352 MAEREKEKSRAAMEAAVAAQKLSDLEAEKRKHIETVDEKKR----------AVSSLRYRK 401
Query: 219 YTIEEIEEATDKFSEAMKIGEGGYGPVYRGKLDHTPVAIKVLRPDAAQGKRQFQQEVEVL 278
YTIEEIEEAT+ FS + K+GEGGYGPVY+G LD+T VAIKVLRPDAAQG+ QFQ+EVEVL
Sbjct: 402 YTIEEIEEATEDFSPSRKVGEGGYGPVYKGTLDYTKVAIKVLRPDAAQGRSQFQREVEVL 461
Query: 279 SSIRHPNMVLLLGACPDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATAL 338
+ +RHPNMVLLLGACP+YGCLVYEYM NGSL+D L RRGN+P++ W+ RF+IA+EIAT L
Sbjct: 462 TCMRHPNMVLLLGACPEYGCLVYEYMANGSLDDCLFRRGNSPILSWQLRFRIASEIATGL 521
Query: 339 LFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTF 398
FLHQ KPEPLVHRDLKP NILLD+++VSKISDVGLARLVPPSVAD+ TQY MTS AGTF
Sbjct: 522 HFLHQMKPEPLVHRDLKPGNILLDQHFVSKISDVGLARLVPPSVADTATQYRMTSTAGTF 581
Query: 399 CYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAVT 458
YIDPEYQQTGML TKSDIYSFGIMLLQI+TA+ PMGLTHHV +AIEKGT AEMLDPAV
Sbjct: 582 FYIDPEYQQTGMLGTKSDIYSFGIMLLQILTAKPPMGLTHHVEKAIEKGTFAEMLDPAVP 641
Query: 459 DWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPELNRLKDLGRK 503
DWP E A + +KLA+QCA+LR+KDRPDLG +++PEL +L+DL +
Sbjct: 642 DWPFEEALAAAKLALQCAKLRRKDRPDLGNIVLPELKKLRDLAEE 686
|
|
| TAIR|locus:2015656 AT1G16760 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1337 (475.7 bits), Expect = 1.5e-136, P = 1.5e-136
Identities = 273/481 (56%), Positives = 337/481 (70%)
Query: 35 STLALDTIESTLPGRRSTGRDSFSDESDYSGPLAMGSLDISSKN--LDFXXXXXXXXXXX 92
S+ D ES R ST S++S S L + D+S N
Sbjct: 262 SSFTYDLPESARTSRMSTS----SEQSIGSHRLGIKFTDLSYLNGSSSVSDESGRTSCSF 317
Query: 93 XXXXXXDLEAEMRRLKLELRQTMEMYSTACXXXXXXXXXXXXXXQWKIEEAQRFEEARMA 152
D+EA+M+RL+LEL+QTM+MYS+AC + + EE +R EE +M
Sbjct: 318 SSQSLNDVEAQMKRLRLELKQTMDMYSSACREALTARNEATELQKLRTEEERRLEELKMT 377
Query: 153 EETALAIAEMEKAKCRAAIEAAEKAQKLADAEXXXXXXXXXXXXXXXXXXXXXXTALANN 212
EETA++I E E+AK + A+EAAE A +LA+ E ++
Sbjct: 378 EETAMSIVENERAKAKTALEAAEAANRLAEVEAKRRVHAEMKVLKESDSFSR------HS 431
Query: 213 DVRYRKYTIEEIEEATDKFSEAMKIGEGGYGPVYRGKLDHTPVAIKVLRPDAAQGKRQFQ 272
VRYRKY+++EIEE T F+E+ K+GEGGYGPV+RG LDHT VA+KVLRPDAAQG+ QF
Sbjct: 432 IVRYRKYSVQEIEEGTANFAESRKVGEGGYGPVFRGHLDHTSVAVKVLRPDAAQGRSQFH 491
Query: 273 QEVEVLSSIRHPNMVLLLGACPDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAA 332
+EVEVLS IRHPNMVLLLGACP+YG LVYEYM GSL+DRL RRGNTP I W+ RF+IAA
Sbjct: 492 KEVEVLSCIRHPNMVLLLGACPEYGILVYEYMARGSLDDRLFRRGNTPPISWQLRFRIAA 551
Query: 333 EIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMT 392
EIAT LLFLHQ KPEP+VHRDLKP N+LLD NYVSKISDVGLARLVP +VA++VTQY +T
Sbjct: 552 EIATGLLFLHQTKPEPIVHRDLKPGNVLLDHNYVSKISDVGLARLVP-AVAENVTQYRVT 610
Query: 393 SAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEM 452
SAAGTFCYIDPEYQQTGML KSD+YS GIMLLQ++TA+ PMGL ++V +AIE+GTL +M
Sbjct: 611 SAAGTFCYIDPEYQQTGMLGVKSDVYSLGIMLLQLLTAKQPMGLAYYVEQAIEEGTLKDM 670
Query: 453 LDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPELNRLKDLGRKLESNKSYGY 512
LDPAV DWP E A S +KL++QCAELR+KDRPDLG ++PEL+RL+++G ES S Y
Sbjct: 671 LDPAVPDWPLEEALSLAKLSLQCAELRRKDRPDLGKEVMPELSRLREIGE--ESLDSVYY 728
Query: 513 A 513
A
Sbjct: 729 A 729
|
|
| TAIR|locus:2063601 AT2G07020 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1323 (470.8 bits), Expect = 4.7e-135, P = 4.7e-135
Identities = 256/405 (63%), Positives = 310/405 (76%)
Query: 99 DLEAEMRRLKLELRQTMEMYSTACXXXXXXXXXXXXXXQWKIEEAQRFEEARMAEETALA 158
D+E+EMRRLKLEL+ TM+MY++AC +WK E + EEA +A+E A+A
Sbjct: 287 DVESEMRRLKLELKYTMDMYNSACKEAIAAKKTTIELHKWKEERKHKLEEAILAKEAAMA 346
Query: 159 IAEMEKAKCRAAIEAAEKAQKLADAEXXXXXXXXXXXXXXXXXXXXXXTALANNDVRYRK 218
IAE EKAK RAA+EA E A ++A+ E AL +++ YRK
Sbjct: 347 IAENEKAKSRAAMEALEAAHRMAETEAQKRKQIETAALREVEHENKAMHALPHSNRMYRK 406
Query: 219 YTIEEIEEATDKFSEAMKIGEGGYGPVYRGKLDHTPVAIKVLRPDAAQGKRQFQQEVEVL 278
YTIEEIE+ T KFS++ KIGEG YG VY+G LD+TPVAIKV+RPDA QG+ QFQQEVEVL
Sbjct: 407 YTIEEIEQGTTKFSDSHKIGEGSYGTVYKGTLDYTPVAIKVVRPDATQGRSQFQQEVEVL 466
Query: 279 SSIRHPNMVLLLGACPDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATAL 338
+ IRHPNMVLLLGAC +YGCLVYEYM NGSL+D LLRRGN+PV+ W+ RF+IAAEIAT+L
Sbjct: 467 TCIRHPNMVLLLGACAEYGCLVYEYMSNGSLDDCLLRRGNSPVLSWQLRFRIAAEIATSL 526
Query: 339 LFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTF 398
FLHQ KPEPLVHRDLKPANILLD++ VSKISDVGLARLVPP++ D T Y MTS AGT
Sbjct: 527 NFLHQLKPEPLVHRDLKPANILLDQHMVSKISDVGLARLVPPTIDDIATHYRMTSTAGTL 586
Query: 399 CYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAVT 458
CYIDPEYQQTGML TKSDIYSFGI+LLQI+TA++PMGLT+ V +AIE+G A++LDP VT
Sbjct: 587 CYIDPEYQQTGMLGTKSDIYSFGIVLLQILTAKTPMGLTNQVEKAIEEGNFAKILDPLVT 646
Query: 459 DWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPELNRLKDLGRK 503
DWP E A +K+ +QCAELR+KDRPDLGTV++P L RL +L +
Sbjct: 647 DWPIEEALILAKIGLQCAELRRKDRPDLGTVVLPGLKRLMNLAEE 691
|
|
| TAIR|locus:2087610 AT3G20200 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1169 (416.6 bits), Expect = 9.8e-119, P = 9.8e-119
Identities = 248/499 (49%), Positives = 328/499 (65%)
Query: 3 GIPRGLATERLSWEKGSTPIRAAAHDRHRSSPSTLALDTIESTLPGRRSTGRDSFSDESD 62
G P ++ R S G + I + R S ST + P T R+S S S
Sbjct: 241 GRPSTASSGRPSTSTGRSDISFVSSGR--PSTSTTGSPSFIYDFPDSGLTPRESTS--SG 296
Query: 63 YSGPLAMGSLDISSKNLDFXXXXXXXXXXXXXXXXXDLE---AEMRRLKLELRQTMEMYS 119
+S L + D + ++ DF +LE AEMRRLK EL+ ++MY
Sbjct: 297 HSMRLGIRFNDTNIQH-DFSFVSQDSGRSSCSCSPQNLEEVEAEMRRLKQELKHAIDMYG 355
Query: 120 TACXXXXXXXXXXXXXXQWKIEEAQRFEEARMAEETALAIAEMEKAKCRAAIEAAEKAQK 179
+AC + KIEE +E +++E++ +I E E+A +AA +A+E A K
Sbjct: 356 SACREALAAKQEAKELQRQKIEEEGWVQEGQLSEKSTKSIVEKERAH-KAAKDASETAGK 414
Query: 180 LADAEXXXXXXXXXXXXXXXXXXXXXXTALANNDVRYRKYTIEEIEEATDKFSEAMKIGE 239
+A+ E + +++ +RYR+Y I EIEEAT+ F +A KIGE
Sbjct: 415 IAELETQRRAIEAAG-------------SFSDSSLRYRRYVIGEIEEATNSFDKANKIGE 461
Query: 240 GGYGPVYRGKLDHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACPDYGCL 299
GGYGPVY+G LDHTPVAIK L+ DA QG+ QFQ+EVEVLS IRHP+MVLL+GACP+YG L
Sbjct: 462 GGYGPVYKGYLDHTPVAIKALKADAVQGRSQFQREVEVLSCIRHPHMVLLIGACPEYGVL 521
Query: 300 VYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANI 359
VYEYM GSL DRL + GNTP + W RF+IAAE+AT LLFLHQ KPEP+VHRDLKP NI
Sbjct: 522 VYEYMAKGSLADRLYKYGNTPPLSWELRFRIAAEVATGLLFLHQTKPEPIVHRDLKPGNI 581
Query: 360 LLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYS 419
L+D+NYVSKI DVGLA+LVP +VA++VTQ H++S AGTFCYIDPEYQQTGML KSD+YS
Sbjct: 582 LIDQNYVSKIGDVGLAKLVP-AVAENVTQCHVSSTAGTFCYIDPEYQQTGMLGVKSDVYS 640
Query: 420 FGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAVTDWPAEAAESFSKLAIQCAELR 479
FGI+LL+++TA+ P GL + V +A+E+G +MLDPAV +WP E A S +K+A++CA+LR
Sbjct: 641 FGILLLELLTAKRPTGLAYTVEQAMEQGKFKDMLDPAVPNWPVEEAMSLAKIALKCAQLR 700
Query: 480 KKDRPDLGTVIVPELNRLK 498
+KDRPDLG ++PELN+L+
Sbjct: 701 RKDRPDLGKEVLPELNKLR 719
|
|
| TAIR|locus:2007908 AT1G17540 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1153 (410.9 bits), Expect = 4.9e-117, P = 4.9e-117
Identities = 229/401 (57%), Positives = 291/401 (72%)
Query: 99 DLEAEMRRLKLELRQTMEMYSTACXXXXXXXXXXXXXXQWKIEEAQRFEEARMAEETALA 158
+LEAE+RRL+ EL+Q S E +R EEA+ A E A
Sbjct: 293 NLEAEVRRLRFELQQFNASMSRESAPHLLGPRATA--------ETERLEEAKAAREMLRA 344
Query: 159 IAEMEKAKCRAAIEAAEKAQKLADAEXXXXXXXXXXXXXXXXXXXXXXTALANNDVRYRK 218
++EM+K K + AI+A E AQ+LA+ E +A++ + YR+
Sbjct: 345 LSEMDKQKTQTAIQATEVAQRLAEIETQKRRLVEMQARFKEQN-------MADS-ISYRR 396
Query: 219 YTIEEIEEATDKFSEAMKIGEGGYGPVYRGKLDHTPVAIKVLRPDAAQGKRQFQQEVEVL 278
Y+I ++E ATD FS+A+KIGEGGYGPVY+ L++T VAIK+L+ D +QG +QF QE+EVL
Sbjct: 397 YSIRDVEGATDGFSDALKIGEGGYGPVYKAVLENTSVAIKLLKSDVSQGLKQFNQEIEVL 456
Query: 279 SSIRHPNMVLLLGACPDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATAL 338
S +RHPNMV+LLGACP+YGCLVYEYM NG+LEDRL + NTP + WR RF+IAAEIAT L
Sbjct: 457 SCMRHPNMVILLGACPEYGCLVYEYMENGTLEDRLFCKDNTPPLSWRARFRIAAEIATGL 516
Query: 339 LFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTF 398
LFLHQAKPEPLVHRDLKPANIL+DR++ SKISDVGLARLVP +VADS + YHMT+AAGTF
Sbjct: 517 LFLHQAKPEPLVHRDLKPANILIDRHFTSKISDVGLARLVPAAVADSFSNYHMTAAAGTF 576
Query: 399 CYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAVT 458
CYIDPEYQQTGML KSD+YSFG++LLQIITA MGL+H V +AIEK L E+LDP ++
Sbjct: 577 CYIDPEYQQTGMLGVKSDLYSFGVVLLQIITAMPAMGLSHRVEKAIEKKKLREVLDPKIS 636
Query: 459 DWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPELNRLKD 499
DWP E ++LA+QC ELRKKDRPDL +V++P L++L++
Sbjct: 637 DWPEEETMVLAQLALQCCELRKKDRPDLASVLLPALSKLRE 677
|
|
| TAIR|locus:2030245 AT1G72760 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1081 (385.6 bits), Expect = 1.3e-113, Sum P(2) = 1.3e-113
Identities = 210/347 (60%), Positives = 259/347 (74%)
Query: 154 ETALAIAEMEKAKCR-AAIEAAEKAQKLADAEXXXXXXXXXXXXXXXXXXXXXXTALANN 212
E A+++ E K + AA +AAE A+++A E
Sbjct: 312 ELPRALSDRETQKTQSAAFQAAEIAKRIAKMESQKRRLLEMQANLDKQMMFTT------- 364
Query: 213 DVRYRKYTIEEIEEATDKFSEAMKIGEGGYGPVYRGKLDHTPVAIKVLRPDAAQGKRQFQ 272
V YR+Y+I+++E+AT FS+A+KIGEGGYGPVY+ LD+T VAIK+L+ +G +QFQ
Sbjct: 365 -VSYRRYSIKDVEDATYGFSDALKIGEGGYGPVYKAVLDYTSVAIKILKSGITEGLKQFQ 423
Query: 273 QEVEVLSSIRHPNMVLLLGACPDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAA 332
QE+EVLSS+RHPNMV+LLGACP+YGCLVYEYM NG+LEDRL + NTP + WR RF+IA+
Sbjct: 424 QEIEVLSSMRHPNMVILLGACPEYGCLVYEYMENGTLEDRLFCKNNTPPLSWRARFRIAS 483
Query: 333 EIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMT 392
EIAT LLFLHQAKPEPLVHRDLKPANILLD++ KISDVGLARLVPP+VAD+ + YHMT
Sbjct: 484 EIATGLLFLHQAKPEPLVHRDLKPANILLDKHLTCKISDVGLARLVPPAVADTYSNYHMT 543
Query: 393 SAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEM 452
SAAGTFCYIDPEYQQTGML KSD+YSFG++LLQIITA+ MGL H V A+E L E+
Sbjct: 544 SAAGTFCYIDPEYQQTGMLGVKSDLYSFGVVLLQIITAQPAMGLGHKVEMAVENNNLREI 603
Query: 453 LDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPELNRLKD 499
LDP V++WP E +KLA+QC ELRKKDRPDL V++P LNRLK+
Sbjct: 604 LDPTVSEWPEEETLELAKLALQCCELRKKDRPDLALVLLPALNRLKE 650
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00032218001 | SubName- Full=Chromosome chr4 scaffold_6, whole genome shotgun sequence; (752 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 568 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 9e-50 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-47 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-46 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 6e-46 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-45 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-45 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 7e-44 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-39 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 8e-35 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-34 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-32 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 7e-31 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 8e-31 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 7e-30 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 7e-29 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-27 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-27 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-27 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-26 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-26 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 3e-26 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 4e-26 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 7e-25 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 8e-25 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-24 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 3e-24 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 4e-24 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 5e-24 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-23 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-23 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-23 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 3e-23 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 3e-23 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 6e-23 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 7e-23 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-22 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 4e-22 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 4e-22 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 6e-22 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 7e-22 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-21 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-21 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-21 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 3e-21 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 4e-21 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 5e-21 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 5e-21 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 6e-21 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 8e-21 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-20 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-20 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-20 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 3e-20 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 3e-20 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 4e-20 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 4e-20 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 5e-20 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 5e-20 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 7e-20 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-19 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-19 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-19 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-19 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-19 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-19 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 3e-19 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 3e-19 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 4e-19 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-18 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-18 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-18 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-18 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-18 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 3e-18 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 5e-18 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 5e-18 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 6e-18 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 9e-18 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-17 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-17 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-17 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-17 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-17 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 3e-17 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 4e-17 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 5e-17 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 5e-17 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 5e-17 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 6e-17 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 7e-17 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 7e-17 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-16 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-16 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-16 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-16 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-16 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-16 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-16 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-16 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-16 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 3e-16 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-16 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 4e-16 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 4e-16 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 6e-16 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-15 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-15 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-15 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-15 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 3e-15 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 3e-15 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 5e-15 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 6e-15 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 7e-15 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-14 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-14 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 4e-14 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 4e-14 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 5e-14 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 7e-14 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 8e-14 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 9e-14 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-13 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 1e-13 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-13 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-13 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-13 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-13 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-13 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-13 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-13 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-13 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-13 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 3e-13 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-13 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 3e-13 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 3e-13 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 3e-13 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 5e-13 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 6e-13 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 6e-13 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 6e-13 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 7e-13 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 7e-13 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 8e-13 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 8e-13 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 9e-13 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-12 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-12 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-12 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-12 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-12 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-12 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-12 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-12 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 3e-12 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 4e-12 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 4e-12 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 4e-12 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 4e-12 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 4e-12 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 5e-12 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 5e-12 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 6e-12 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 6e-12 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 6e-12 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 6e-12 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 6e-12 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 6e-12 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 6e-12 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 8e-12 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 8e-12 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 9e-12 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-11 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-11 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 1e-11 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-11 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-11 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-11 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-11 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-11 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-11 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-11 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-11 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-11 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-11 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 3e-11 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 3e-11 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 4e-11 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 4e-11 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 4e-11 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 5e-11 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 6e-11 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 6e-11 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 6e-11 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 6e-11 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 6e-11 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 8e-11 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 9e-11 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-10 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-10 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-10 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-10 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-10 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-10 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-10 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-10 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-10 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 3e-10 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 3e-10 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 3e-10 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 4e-10 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 4e-10 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 4e-10 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 4e-10 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 5e-10 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 5e-10 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 6e-10 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 6e-10 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 6e-10 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 6e-10 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 7e-10 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 9e-10 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 9e-10 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-09 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-09 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-09 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-09 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-09 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-09 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-09 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-09 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 3e-09 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 3e-09 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 3e-09 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 3e-09 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-09 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 4e-09 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 4e-09 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 5e-09 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 5e-09 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 6e-09 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 6e-09 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 7e-09 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 7e-09 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 9e-09 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-08 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-08 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 3e-08 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-08 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 4e-08 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 7e-08 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-07 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-07 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-07 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 1e-07 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-07 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-07 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 3e-07 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 3e-07 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 4e-07 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 4e-07 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 5e-07 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 7e-07 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 8e-07 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 9e-07 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-06 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-06 | |
| PRK09510 | 387 | PRK09510, tolA, cell envelope integrity inner memb | 1e-06 | |
| COG3064 | 387 | COG3064, TolA, Membrane protein involved in colici | 1e-06 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-06 | |
| TIGR02794 | 346 | TIGR02794, tolA_full, TolA protein | 2e-06 | |
| TIGR02794 | 346 | TIGR02794, tolA_full, TolA protein | 2e-06 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 2e-06 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-06 | |
| PRK09510 | 387 | PRK09510, tolA, cell envelope integrity inner memb | 3e-06 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 3e-06 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 3e-06 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 3e-06 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 4e-06 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 4e-06 | |
| PRK09510 | 387 | PRK09510, tolA, cell envelope integrity inner memb | 5e-06 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 5e-06 | |
| TIGR02794 | 346 | TIGR02794, tolA_full, TolA protein | 7e-06 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 8e-06 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 8e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 9e-06 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-05 | |
| PTZ00121 | 2084 | PTZ00121, PTZ00121, MAEBL; Provisional | 1e-05 | |
| COG1196 | 1163 | COG1196, Smc, Chromosome segregation ATPases [Cell | 1e-05 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-05 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-05 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 3e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-05 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 4e-05 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 4e-05 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 4e-05 | |
| COG3064 | 387 | COG3064, TolA, Membrane protein involved in colici | 6e-05 | |
| PTZ00121 | 2084 | PTZ00121, PTZ00121, MAEBL; Provisional | 6e-05 | |
| PTZ00121 | 2084 | PTZ00121, PTZ00121, MAEBL; Provisional | 6e-05 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 6e-05 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 6e-05 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-04 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 1e-04 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-04 | |
| PRK09510 | 387 | PRK09510, tolA, cell envelope integrity inner memb | 2e-04 | |
| PTZ00121 | 2084 | PTZ00121, PTZ00121, MAEBL; Provisional | 2e-04 | |
| PTZ00121 | 2084 | PTZ00121, PTZ00121, MAEBL; Provisional | 3e-04 | |
| pfam09731 | 493 | pfam09731, Mitofilin, Mitochondrial inner membrane | 3e-04 | |
| cd05151 | 170 | cd05151, ChoK, Choline Kinase (ChoK) | 3e-04 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 3e-04 | |
| PRK09510 | 387 | PRK09510, tolA, cell envelope integrity inner memb | 4e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 5e-04 | |
| PTZ00121 | 2084 | PTZ00121, PTZ00121, MAEBL; Provisional | 6e-04 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 8e-04 | |
| PTZ00121 | 2084 | PTZ00121, PTZ00121, MAEBL; Provisional | 0.001 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 0.001 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 0.001 | |
| PRK09510 | 387 | PRK09510, tolA, cell envelope integrity inner memb | 0.002 | |
| TIGR02794 | 346 | TIGR02794, tolA_full, TolA protein | 0.002 | |
| PTZ00121 | 2084 | PTZ00121, PTZ00121, MAEBL; Provisional | 0.002 | |
| pfam09726 | 680 | pfam09726, Macoilin, Transmembrane protein | 0.002 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 0.002 | |
| COG2268 | 548 | COG2268, COG2268, Uncharacterized protein conserve | 0.002 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 0.003 | |
| COG3064 | 387 | COG3064, TolA, Membrane protein involved in colici | 0.003 | |
| COG3064 | 387 | COG3064, TolA, Membrane protein involved in colici | 0.003 | |
| PTZ00121 | 2084 | PTZ00121, PTZ00121, MAEBL; Provisional | 0.003 | |
| PTZ00121 | 2084 | PTZ00121, PTZ00121, MAEBL; Provisional | 0.003 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 0.003 | |
| PTZ00121 | 2084 | PTZ00121, PTZ00121, MAEBL; Provisional | 0.004 | |
| pfam00769 | 244 | pfam00769, ERM, Ezrin/radixin/moesin family | 0.004 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 170 bits (434), Expect = 9e-50
Identities = 67/198 (33%), Positives = 106/198 (53%), Gaps = 18/198 (9%)
Query: 237 IGEGGYGPVYRG--KLDHTPVAIKVLRPDAAQGKRQ-FQQEVEVLSSIRHPNMVLLLGAC 293
+GEGG+G VY K VAIK+++ + + + +E+E+L + HPN+V L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 294 --PDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVH 351
++ LV EY GSL+D LL+ N + + +I +I L +LH ++H
Sbjct: 61 EDENHLYLVMEYCEGGSLKD-LLKE-NEGKLSEDEILRILLQILEGLEYLHS---NGIIH 115
Query: 352 RDLKPANILLD-RNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPE-YQQTG 409
RDLKP NILLD N K++D GL++L+ + + + GT Y+ PE G
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSD------KSLLKTIVGTPAYMAPEVLLGKG 169
Query: 410 MLTTKSDIYSFGIMLLQI 427
+ KSDI+S G++L ++
Sbjct: 170 YYSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 166 bits (423), Expect = 1e-47
Identities = 79/242 (32%), Positives = 114/242 (47%), Gaps = 19/242 (7%)
Query: 236 KIGEGGYGPVYRG--KLDHTPVAIKVLRPDAAQGKR-QFQQEVEVLSSIRHPNMVLLLGA 292
K+GEG +G VY K VAIKV++ + R + +E+++L ++HPN+V L
Sbjct: 6 KLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDV 65
Query: 293 C--PDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLV 350
D LV EY G L D L +RG RF +I +AL +LH +V
Sbjct: 66 FEDEDKLYLVMEYCEGGDLFDLLKKRGRLS--EDEARF-YLRQILSALEYLHSKG---IV 119
Query: 351 HRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGM 410
HRDLKP NILLD + K++D GLAR + P +T+ GT Y+ PE
Sbjct: 120 HRDLKPENILLDEDGHVKLADFGLARQLDPGE-------KLTTFVGTPEYMAPEVLLGKG 172
Query: 411 LTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEK-GTLAEMLDPAVTDWPAEAAESFS 469
DI+S G++L +++T + P + +K G P D EA +
Sbjct: 173 YGKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIR 232
Query: 470 KL 471
KL
Sbjct: 233 KL 234
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 163 bits (414), Expect = 2e-46
Identities = 81/261 (31%), Positives = 119/261 (45%), Gaps = 30/261 (11%)
Query: 236 KIGEGGYGPVYRGKLDHTP------VAIKVLRPDA-AQGKRQFQQEVEVLSSIRHPNMVL 288
K+GEG +G VY+GKL VA+K L+ DA Q +F +E ++ + HPN+V
Sbjct: 6 KLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVK 65
Query: 289 LLGAC--PDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKP 346
LLG C + +V EYM G L L R N P + A +IA + +L
Sbjct: 66 LLGVCTEEEPLYIVMEYMEGGDLLSYL--RKNRPKLSLSDLLSFALQIARGMEYLES--- 120
Query: 347 EPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQ 406
+ +HRDL N L+ N V KISD GL+R + Y ++ PE
Sbjct: 121 KNFIHRDLAARNCLVGENLVVKISDFGLSRDL-----YDDDYYRKRGGKLPIRWMAPESL 175
Query: 407 QTGMLTTKSDIYSFGIMLLQIIT--ARSPMGLT-HHVSRAIEKGTLAEMLDPAVTDWPAE 463
+ G T+KSD++SFG++L +I T + G++ V ++ G L P
Sbjct: 176 KEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNG---YRLPQ-----PPN 227
Query: 464 AAESFSKLAIQCAELRKKDRP 484
L +QC +DRP
Sbjct: 228 CPPELYDLMLQCWAEDPEDRP 248
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 161 bits (411), Expect = 6e-46
Identities = 80/261 (30%), Positives = 119/261 (45%), Gaps = 29/261 (11%)
Query: 236 KIGEGGYGPVYRGKLD------HTPVAIKVLRPDA-AQGKRQFQQEVEVLSSIRHPNMVL 288
K+GEG +G VY+G L VA+K L+ DA Q +F +E ++ + HPN+V
Sbjct: 6 KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVK 65
Query: 289 LLGAC--PDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKP 346
LLG C + +V EYM G L D L + + A +IA + +L
Sbjct: 66 LLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPK-ELSLSDLLSFALQIARGMEYLES--- 121
Query: 347 EPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQ 406
+ +HRDL N L+ N V KISD GL+R + Y + ++ PE
Sbjct: 122 KNFIHRDLAARNCLVGENLVVKISDFGLSRDL-----YDDDYYKVKGGKLPIRWMAPESL 176
Query: 407 QTGMLTTKSDIYSFGIMLLQIIT--ARSPMGLT-HHVSRAIEKGTLAEMLDPAVTDWPAE 463
+ G T+KSD++SFG++L +I T G++ V ++KG L P
Sbjct: 177 KEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKG---YRLPK-----PPN 228
Query: 464 AAESFSKLAIQCAELRKKDRP 484
KL +QC +DRP
Sbjct: 229 CPPELYKLMLQCWAEDPEDRP 249
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 161 bits (409), Expect = 1e-45
Identities = 83/275 (30%), Positives = 122/275 (44%), Gaps = 48/275 (17%)
Query: 236 KIGEGGYGPVYRGKLD-----HTPVAIKVLRPDA-AQGKRQFQQEVEVLSSIRHPNMVLL 289
K+GEG +G VY+GKL T VA+K L+ DA + ++ F +E V+ + HPN+V L
Sbjct: 2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRL 61
Query: 290 LGACPDYG--CLVYEYMHNGSLEDRLLRRGNT------PVIPWRKRFKIAAEIATALLFL 341
LG C + LV EYM G L D L + + + A +IA + +L
Sbjct: 62 LGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYL 121
Query: 342 HQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSA------- 394
+ VHRDL N L+ + V KISD GL+R V Y +
Sbjct: 122 AS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDV-----YDDDYYRKKTGGKLPIRW 173
Query: 395 -AGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPMG--LTHHVSRAIEKGTLA 450
A PE + G+ T+KSD++SFG++L +I T +P V + KG
Sbjct: 174 MA-------PESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRL 226
Query: 451 EMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPD 485
P + +L + C +L +DRP
Sbjct: 227 PK--------PEYCPDELYELMLSCWQLDPEDRPT 253
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 159 bits (406), Expect = 3e-45
Identities = 82/262 (31%), Positives = 123/262 (46%), Gaps = 31/262 (11%)
Query: 236 KIGEGGYGPVYRGKLD------HTPVAIKVLRPDAAQGKRQ-FQQEVEVLSSIRHPNMVL 288
K+GEG +G VY+G L T VA+K L+ A++ +R+ F +E ++ + HPN+V
Sbjct: 6 KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65
Query: 289 LLGACPDYG--CLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKP 346
LLG C +V EYM G L D L + G + ++A +IA + +L
Sbjct: 66 LLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDL--LQMALQIAKGMEYLESKN- 122
Query: 347 EPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGT-FCYIDPEY 405
VHRDL N L+ N V KISD GL+R + Y ++ PE
Sbjct: 123 --FVHRDLAARNCLVTENLVVKISDFGLSRDIYED-----DYYRKRGGGKLPIKWMAPES 175
Query: 406 QQTGMLTTKSDIYSFGIMLLQIIT-ARSPM-GLT-HHVSRAIEKGTLAEMLDPAVTDWPA 462
+ G T+KSD++SFG++L +I T P G++ V +E G L P
Sbjct: 176 LKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDG---YRLPR-----PE 227
Query: 463 EAAESFSKLAIQCAELRKKDRP 484
+ +L +QC +DRP
Sbjct: 228 NCPDELYELMLQCWAYDPEDRP 249
|
Length = 258 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 156 bits (396), Expect = 7e-44
Identities = 70/205 (34%), Positives = 108/205 (52%), Gaps = 19/205 (9%)
Query: 236 KIGEGGYGPVYRGKLDHTP--VAIKVLRPDAA--QGKRQFQQEVEVLSSIRHPNMVLLLG 291
K+G G +G VY+ K T VA+K+L+ + + + ++E+ +L + HPN+V L+
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 292 AC--PDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPL 349
A D+ LV EY G L D L R G + + KIA +I L +LH +
Sbjct: 66 AFEDKDHLYLVMEYCEGGDLFDYLSRGG---PLSEDEAKKIALQILRGLEYLHSNG---I 119
Query: 350 VHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPE-YQQT 408
+HRDLKP NILLD N V KI+D GLA+ + + +T+ GT Y+ PE
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKL------LKSSSSLTTFVGTPWYMAPEVLLGG 173
Query: 409 GMLTTKSDIYSFGIMLLQIITARSP 433
K D++S G++L +++T + P
Sbjct: 174 NGYGPKVDVWSLGVILYELLTGKPP 198
|
Length = 260 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 148 bits (373), Expect = 2e-39
Identities = 88/343 (25%), Positives = 143/343 (41%), Gaps = 21/343 (6%)
Query: 236 KIGEGGYGPVYRGKLDHTPVAIKVLRPDAAQGK---RQFQQEVEVLSSIRHPNMV---LL 289
K+GEG +G VY + D VA+KVL +F +E+++L+S+ HP +
Sbjct: 7 KLGEGSFGEVYLAR-DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYD 65
Query: 290 LGACPDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPL 349
LV EY+ GSLED L + G + + I A+I +AL +LH + +
Sbjct: 66 FFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS---KGI 122
Query: 350 VHRDLKPANILLDRNY-VSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEY--- 405
+HRD+KP NILLDR+ V K+ D GLA+L+P + S +++ GT Y+ PE
Sbjct: 123 IHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLG 182
Query: 406 QQTGMLTTKSDIYSFGIMLLQIITARSP------MGLTHHVSRAIEKGTLAEMLDPAVTD 459
++ SDI+S GI L +++T P T + I + + P
Sbjct: 183 LSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPS 242
Query: 460 WPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPELNRLKDLGRKLESNKSYGYAKREGHS 519
P +++ S L + K+R + + +L L S+
Sbjct: 243 NPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLLKPDDSAPLRL 302
Query: 520 HSGSGRTSHTRSNVPRSPPPLSSSSYSNSRISNPSSSQMEDSS 562
+ S++ S +S S + SS
Sbjct: 303 SLPPSLEAL-ISSLNSLAISGSDLKLDDSNFSKELAPNGVSSS 344
|
Length = 384 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 131 bits (332), Expect = 8e-35
Identities = 71/266 (26%), Positives = 121/266 (45%), Gaps = 40/266 (15%)
Query: 236 KIGEGGYGPVYRGKLDHTP--VAIKVLR--PDAAQGKRQFQQEVEVLSSIRHPNMVLLLG 291
+G G +G VY T +A+K + D+ + ++E+ +LSS++HPN+V G
Sbjct: 7 LLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYG 66
Query: 292 AC----PDYGCLVYEYMHNGSLEDRLLRRG--NTPVIPWRKRFKIAAEIATALLFLHQAK 345
+ + + EY+ GSL L + G PVI +++ +I L +LH
Sbjct: 67 SERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVI---RKY--TRQILEGLAYLHSNG 121
Query: 346 PEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEY 405
+VHRD+K ANIL+D + V K++D G A+ + D T S GT ++ PE
Sbjct: 122 ---IVHRDIKGANILVDSDGVVKLADFGCAK----RLGDIETGEGTGSVRGTPYWMAPEV 174
Query: 406 QQTGMLTTKSDIYSFGIMLLQIITARSP-------MGLTHHVSRAIEKGTLAEMLDPAVT 458
+ +DI+S G ++++ T + P M + + + E P +
Sbjct: 175 IRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEP--------PEIP 226
Query: 459 DWPAEAAESFSKLAIQCAELRKKDRP 484
+ +E A+ F L +C K RP
Sbjct: 227 EHLSEEAKDF--LR-KCLRRDPKKRP 249
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 130 bits (328), Expect = 2e-34
Identities = 61/209 (29%), Positives = 102/209 (48%), Gaps = 28/209 (13%)
Query: 236 KIGEGGYGPVYRG--KLDHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGA- 292
KIG+GG+G VY+ K VAIKV++ ++ + K + E+++L +HPN+V G+
Sbjct: 7 KIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSY 66
Query: 293 -CPDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFK------IAAEIATALLFLHQAK 345
D +V E+ GSL+D LL+ + + E+ L +LH
Sbjct: 67 LKKDELWIVMEFCSGGSLKD-LLK-------STNQTLTESQIAYVCKELLKGLEYLHSNG 118
Query: 346 PEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEY 405
++HRD+K ANILL + K+ D GL+ ++D+ + M GT ++ PE
Sbjct: 119 ---IIHRDIKAANILLTSDGEVKLIDFGLSA----QLSDTKARNTM---VGTPYWMAPEV 168
Query: 406 QQTGMLTTKSDIYSFGIMLLQIITARSPM 434
K+DI+S GI +++ + P
Sbjct: 169 INGKPYDYKADIWSLGITAIELAEGKPPY 197
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 125 bits (317), Expect = 1e-32
Identities = 85/260 (32%), Positives = 121/260 (46%), Gaps = 34/260 (13%)
Query: 236 KIGEGGYGPVYRGK-LDHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGAC- 293
K+G G +G V+ G T VA+K L+P F QE +++ +RH +V L C
Sbjct: 13 KLGAGQFGEVWMGTWNGTTKVAVKTLKP-GTMSPEAFLQEAQIMKKLRHDKLVQLYAVCS 71
Query: 294 ---PDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLV 350
P Y +V EYM GSL D L+ G + + +AA+IA + +L +
Sbjct: 72 EEEPIY--IVTEYMSKGSLLD-FLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN---YI 125
Query: 351 HRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYID---PEYQQ 407
HRDL NIL+ N V KI+D GLARL+ T+ G I PE
Sbjct: 126 HRDLAARNILVGENLVCKIADFGLARLIEDD--------EYTAREGAKFPIKWTAPEAAN 177
Query: 408 TGMLTTKSDIYSFGIMLLQIIT-ARSPM-GLTHH-VSRAIEKGTLAEMLDPAVTDWPAEA 464
G T KSD++SFGI+L +I+T R P G+T+ V +E+G P
Sbjct: 178 YGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPR--------PPNC 229
Query: 465 AESFSKLAIQCAELRKKDRP 484
E L +QC + ++RP
Sbjct: 230 PEELYDLMLQCWDKDPEERP 249
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 7e-31
Identities = 67/229 (29%), Positives = 97/229 (42%), Gaps = 44/229 (19%)
Query: 235 MKIGEGGYGPVYRGKLDHT--PVAIKVLRPDAAQGKRQFQQ---------EVEVLSSI-R 282
IGEG + V K T AIK+L KRQ + E EVL+ +
Sbjct: 7 KIIGEGSFSTVVLAKEKETNKEYAIKILD------KRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 283 HPNMVLLLGACPDYGCL--VYEYMHNGSLEDRLLRRG--NTPVIPWRKRFKIAAEIATAL 338
HP ++ L D L V EY NG L + + G + RF AAEI AL
Sbjct: 61 HPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCT----RF-YAAEILLAL 115
Query: 339 LFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPP----------SVADSVTQ 388
+LH ++HRDLKP NILLD++ KI+D G A+++ P +
Sbjct: 116 EYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQI 172
Query: 389 YHMTSAAGTFC----YIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSP 433
+F Y+ PE SD+++ G ++ Q++T + P
Sbjct: 173 EKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 8e-31
Identities = 80/259 (30%), Positives = 116/259 (44%), Gaps = 29/259 (11%)
Query: 237 IGEGGYGPVYRGKLDHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACPDY 296
IG+G +G V G VA+K L+ D+ + F E V++++RHPN+V LLG
Sbjct: 14 IGKGEFGDVMLGDYRGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQG 72
Query: 297 GCL--VYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDL 354
L V EYM GSL D L RG VI ++ A ++ + +L + VHRDL
Sbjct: 73 NPLYIVTEYMAKGSLVDYLRSRGRA-VITLAQQLGFALDVCEGMEYLEEKN---FVHRDL 128
Query: 355 KPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTK 414
N+L+ + V+K+SD GLA+ S + PE + +TK
Sbjct: 129 AARNVLVSEDLVAKVSDFGLAKEA---------SQGQDSGKLPVKWTAPEALREKKFSTK 179
Query: 415 SDIYSFGIMLLQIIT-ARSP---MGLTHHVSRAIEKGTLAEMLDPAVTDWPAEAAESFSK 470
SD++SFGI+L +I + R P + L V +EKG E P K
Sbjct: 180 SDVWSFGILLWEIYSFGRVPYPRIPLK-DVVPHVEKGYRMEA--------PEGCPPEVYK 230
Query: 471 LAIQCAELRKKDRPDLGTV 489
+ C EL RP +
Sbjct: 231 VMKDCWELDPAKRPTFKQL 249
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 7e-30
Identities = 71/261 (27%), Positives = 116/261 (44%), Gaps = 30/261 (11%)
Query: 236 KIGEGGYGPVYRG--KLDHTPVAIKVLR-PDAAQGKRQFQQEVEVLSSIRHPNMVLLLGA 292
+G+G G VY+ K A+K + + ++Q +E++ L S P +V GA
Sbjct: 8 VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGA 67
Query: 293 CPDYG--CLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLV 350
G +V EYM GSL D L + G IP IA +I L +LH + ++
Sbjct: 68 FYKEGEISIVLEYMDGGSLADLLKKVGK---IPEPVLAYIARQILKGLDYLHTKRH--II 122
Query: 351 HRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGM 410
HRD+KP+N+L++ KI+D G+++++ ++ T GT Y+ PE Q
Sbjct: 123 HRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNT------FVGTVTYMSPERIQGES 176
Query: 411 LTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAVTD-----WPAEAA 465
+ +DI+S G+ LL+ + P + + E++ A+ D PAE
Sbjct: 177 YSYAADIWSLGLTLLECALGKFPF-------LPPGQPSFFELMQ-AICDGPPPSLPAEEF 228
Query: 466 -ESFSKLAIQCAELRKKDRPD 485
F C + K RP
Sbjct: 229 SPEFRDFISACLQKDPKKRPS 249
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 7e-29
Identities = 82/276 (29%), Positives = 129/276 (46%), Gaps = 34/276 (12%)
Query: 225 EEATDKFSEAMKIGEGGYGPVYRGK-LDHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRH 283
E ++F+ K+G G +G V+ G + VAIK+L+ D ++ FQ+EV+ L +RH
Sbjct: 2 ERPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRH 61
Query: 284 PNMVLLLGAC----PDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALL 339
+++ L C P Y ++ E M GSL LR V+P +A ++A +
Sbjct: 62 KHLISLFAVCSVGEPVY--IITELMEKGSLLA-FLRSPEGQVLPVASLIDMACQVAEGMA 118
Query: 340 FLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSV---ADSVTQYHMTSAAG 396
+L + +HRDL NIL+ + V K++D GLARL+ V +D Y T+
Sbjct: 119 YLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTA--- 172
Query: 397 TFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARS---PMGLTHHVSRAIEKGTLAEML 453
PE G +TKSD++SFGI+L ++ T P H V I G
Sbjct: 173 ------PEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRM--- 223
Query: 454 DPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTV 489
P PA+ + K+ ++C +DRP +
Sbjct: 224 -PC----PAKCPQEIYKIMLECWAAEPEDRPSFKAL 254
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 2e-27
Identities = 77/231 (33%), Positives = 114/231 (49%), Gaps = 38/231 (16%)
Query: 223 EIEEATDKFSEAMKIGEGGYGPVYRGKL-------DHTPVAIKVLRPDAAQGKRQ-FQQE 274
EI + +F E + GEG +G VY+G+L T VAIK L+ +A +Q F+QE
Sbjct: 1 EIPLSAVRFLEEL--GEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQE 58
Query: 275 VEVLSSIRHPNMVLLLGAC----PDYGCLVYEYMHNGSLEDRLLRR------------GN 318
E++S ++HPN+V LLG C P C+++EY+ +G L + L+R
Sbjct: 59 AELMSDLQHPNIVCLLGVCTKEQPT--CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDET 116
Query: 319 TPVIPWRKRF-KIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARL 377
F IA +IA + +L VHRDL N L+ KISD GL+R
Sbjct: 117 VKSSLDCSDFLHIAIQIAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRD 173
Query: 378 VPPSVADSVTQYHMTSAAG-TFCYIDPEYQQTGMLTTKSDIYSFGIMLLQI 427
+ S Y + S + ++ PE G TT+SDI+SFG++L +I
Sbjct: 174 IY-----SADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 2e-27
Identities = 82/262 (31%), Positives = 125/262 (47%), Gaps = 37/262 (14%)
Query: 236 KIGEGGYGPVYRG--KLDHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGAC 293
K+G G YG VY G K VA+K L+ D + + +F +E V+ I+HPN+V LLG C
Sbjct: 13 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVC 71
Query: 294 ----PDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPL 349
P Y ++ E+M G+L D LR N + +A +I++A+ +L +
Sbjct: 72 TREPPFY--IITEFMTYGNLLD-YLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---F 125
Query: 350 VHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYID---PEYQ 406
+HRDL N L+ N++ K++D GL+RL +T T+ AG I PE
Sbjct: 126 IHRDLAARNCLVGENHLVKVADFGLSRL--------MTGDTYTAHAGAKFPIKWTAPESL 177
Query: 407 QTGMLTTKSDIYSFGIMLLQIIT-ARSP---MGLTHHVSRAIEKGTLAEMLDPAVTDWPA 462
+ KSD+++FG++L +I T SP + L+ V +EKG E P
Sbjct: 178 AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-QVYELLEKGYRMER--------PE 228
Query: 463 EAAESFSKLAIQCAELRKKDRP 484
+L C + DRP
Sbjct: 229 GCPPKVYELMRACWQWNPSDRP 250
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 3e-27
Identities = 75/270 (27%), Positives = 129/270 (47%), Gaps = 30/270 (11%)
Query: 223 EIEEATDKFSEAMKIGEGGYGPVYRGKL-DHTPVAIKVLRPDAAQGKRQFQQEVEVLSSI 281
EI+ + + K+G G +G V+ G + TPVA+K L+P K F E +++ +
Sbjct: 2 EIDRTSIQLLR--KLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPK-DFLAEAQIMKKL 58
Query: 282 RHPNMVLLLGAC----PDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATA 337
RHP ++ L C P Y +V E M GSL + L + + +AA++A+
Sbjct: 59 RHPKLIQLYAVCTLEEPIY--IVTELMKYGSLLEYLQGGAGR-ALKLPQLIDMAAQVASG 115
Query: 338 LLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGT 397
+ +L + +HRDL N+L+ N + K++D GLAR++ + ++ A
Sbjct: 116 MAYLEA---QNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEA-----REGAKFP 167
Query: 398 FCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPM-GLTHH-VSRAIEKGTLAEMLD 454
+ PE + KSD++SFGI+L +I+T R P G+T+ V + +++G M
Sbjct: 168 IKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGY--RM-- 223
Query: 455 PAVTDWPAEAAESFSKLAIQCAELRKKDRP 484
P P + + + C + DRP
Sbjct: 224 PC----PPGCPKELYDIMLDCWKEDPDDRP 249
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 1e-26
Identities = 84/266 (31%), Positives = 129/266 (48%), Gaps = 34/266 (12%)
Query: 236 KIGEGGYGPVYRGKL-DHTPVAIKVLRPDAAQG-KRQFQQEVEVLSSIRHPNMVLLLGAC 293
KIG+G +G VY+G L +T VA+K R KR+F QE E+L HPN+V L+G C
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 294 ----PDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPL 349
P Y +V E + GSL L R + +K +++ + A + +L
Sbjct: 62 VQKQPIY--IVMELVPGGSLLTFL--RKKKNRLTVKKLLQMSLDAAAGMEYLESKN---C 114
Query: 350 VHRDLKPANILLDRNYVSKISDVGLARLVPP---SVADSVTQYHMTSAAGTFCYIDPEYQ 406
+HRDL N L+ N V KISD G++R +V+D + Q + A PE
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTA-------PEAL 167
Query: 407 QTGMLTTKSDIYSFGIMLLQIIT-ARSPM-GLTHHVSRA-IEKGTLAEMLDPAVTDWPAE 463
G T++SD++S+GI+L + + +P G+++ +R IE G M PA P
Sbjct: 168 NYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESG--YRM--PA----PQL 219
Query: 464 AAESFSKLAIQCAELRKKDRPDLGTV 489
E +L +QC ++RP +
Sbjct: 220 CPEEIYRLMLQCWAYDPENRPSFSEI 245
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 74/287 (25%), Positives = 127/287 (44%), Gaps = 39/287 (13%)
Query: 236 KIGEGGYGPVYRGKLDHTP------VAIKVLRPDA-AQGKRQFQQEVEVLSSIRHPNMVL 288
++GEG +G V + D VA+K L Q + F++E+E+L ++ H N+V
Sbjct: 11 QLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVK 70
Query: 289 LLGACPDYG----CLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQA 344
G C G L+ EY+ +GSL D L + + I ++ +++I + +L
Sbjct: 71 YKGVCEKPGGRSLRLIMEYLPSGSLRDYL--QRHRDQINLKRLLLFSSQICKGMDYLGSQ 128
Query: 345 KPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAG---TFCYI 401
+ +HRDL NIL++ + KISD GLA+++P Y+ G F Y
Sbjct: 129 R---YIHRDLAARNILVESEDLVKISDFGLAKVLPED-----KDYYYVKEPGESPIFWY- 179
Query: 402 DPEYQQTGMLTTKSDIYSFGIMLLQIIT----ARSPMGL------THHVSRAIEKGTLAE 451
PE +T ++ SD++SFG+ L ++ T ++SP + + L E
Sbjct: 180 APECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTR--LLE 237
Query: 452 MLDPAVTDWPAEAAESF-SKLAIQCAELRKKDRPDLGTVIVPELNRL 497
+L + L C E +DRP ++ ++RL
Sbjct: 238 LLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFAD-LILIVDRL 283
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 3e-26
Identities = 59/216 (27%), Positives = 97/216 (44%), Gaps = 38/216 (17%)
Query: 236 KIGEGGYGPVY--RGKLDHTPVAIKV--LRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLG 291
+IG+G +G VY R K D +K L + + + EV++L + HPN++
Sbjct: 7 QIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNII---- 62
Query: 292 AC------PDYGCLVYEYMHNGSLEDRLLRRG--NTPVIPWRKRFKIAAEIATALLFLHQ 343
C+V EY G L ++ ++ P P + ++ AL +LH
Sbjct: 63 KYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKP-FPEEQILDWFVQLCLALKYLHS 121
Query: 344 AKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDP 403
K ++HRD+KP NI L N + K+ D G+++++ S T + GT Y+ P
Sbjct: 122 RK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVL------SSTVDLAKTVVGTPYYLSP 172
Query: 404 E------YQQTGMLTTKSDIYSFGIMLLQIITARSP 433
E Y KSDI+S G +L ++ T + P
Sbjct: 173 ELCQNKPY------NYKSDIWSLGCVLYELCTLKHP 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (268), Expect = 4e-26
Identities = 66/208 (31%), Positives = 95/208 (45%), Gaps = 27/208 (12%)
Query: 237 IGEGGYGPVY--RGKLDHTPVAIKVLRPDAAQGKRQFQQ---EVEVLSSIRHPNMVLLLG 291
+G+G +G V R K A+KVL+ +++ + E +LS I HP +V L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 292 ACPDYG--CLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPL 349
A LV EY G L L + G R RF AAEI AL +LH +
Sbjct: 61 AFQTEEKLYLVLEYAPGGELFSHLSKEGRFSE--ERARF-YAAEIVLALEYLHSLG---I 114
Query: 350 VHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFC----YIDPEY 405
++RDLKP NILLD + K++D GLA+ + S TFC Y+ PE
Sbjct: 115 IYRDLKPENILLDADGHIKLTDFGLAKEL----------SSEGSRTNTFCGTPEYLAPEV 164
Query: 406 QQTGMLTTKSDIYSFGIMLLQIITARSP 433
D +S G++L +++T + P
Sbjct: 165 LLGKGYGKAVDWWSLGVLLYEMLTGKPP 192
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 7e-25
Identities = 59/207 (28%), Positives = 101/207 (48%), Gaps = 24/207 (11%)
Query: 236 KIGEGGYGPVYRG--KLDHTPVAIKVLRP--DAAQGKRQFQQEVEVLSSIRHPNMVLLLG 291
IG G +G VY+G VAIK + + + QE+++L +++HPN+V +G
Sbjct: 7 LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIG 66
Query: 292 ACP--DYGCLVYEYMHNGSLEDRLLRRGNTP---VIPWRKRFKIAAEIATALLFLHQAKP 346
+ D ++ EY NGSL + + G P V ++ L +LH+
Sbjct: 67 SIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVA------VYVYQVLQGLAYLHE--- 117
Query: 347 EPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQ 406
+ ++HRD+K ANIL ++ V K++D G+A + D S GT ++ PE
Sbjct: 118 QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDD------ASVVGTPYWMAPEVI 171
Query: 407 QTGMLTTKSDIYSFGIMLLQIITARSP 433
+ +T SDI+S G +++++T P
Sbjct: 172 EMSGASTASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 8e-25
Identities = 68/241 (28%), Positives = 111/241 (46%), Gaps = 35/241 (14%)
Query: 237 IGEGGYGPVYRGKLDH-------TPVAIKVLR-PDAAQGKRQFQQEVEVLSSIRHPNMVL 288
+GEG +G V+ G+ H VA+K L+ + ++ F++E E+L++ +H N+V
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 289 LLGACPDYGCL--VYEYMHNGSLEDRLLRRGNTPVIPWRKR-----------FKIAAEIA 335
G C + V+EYM +G L L G +IA +IA
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 336 TALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMT--S 393
+ +++L VHRDL N L+ + V KI D G++R V T Y+
Sbjct: 133 SGMVYLASQH---FVHRDLATRNCLVGYDLVVKIGDFGMSRDV------YTTDYYRVGGH 183
Query: 394 AAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSP-MGLTHH-VSRAIEKGTLA 450
++ PE TT+SD++SFG++L +I T + P GL++ V I +G L
Sbjct: 184 TMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGRLL 243
Query: 451 E 451
+
Sbjct: 244 Q 244
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 1e-24
Identities = 76/254 (29%), Positives = 122/254 (48%), Gaps = 29/254 (11%)
Query: 236 KIGEGGYGPVYRGKLDHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACPD 295
IGEG +G V +G+ VA+K ++ D + F +E V++ + H N+V LLG
Sbjct: 13 IIGEGEFGAVLQGEYTGQKVAVKNIKCDVT--AQAFLEETAVMTKLHHKNLVRLLGVILH 70
Query: 296 YGC-LVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDL 354
G +V E M G+L + L RG ++ + + + ++A + +L K LVHRDL
Sbjct: 71 NGLYIVMELMSKGNLVNFLRTRGRA-LVSVIQLLQFSLDVAEGMEYLESKK---LVHRDL 126
Query: 355 KPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTK 414
NIL+ + V+K+SD GLAR+ V +S T+ PE + ++K
Sbjct: 127 AARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWTA---------PEALKHKKFSSK 177
Query: 415 SDIYSFGIMLLQIIT-ARSP---MGLTHHVSRAIEKGTLAEMLDPAVTDWPAEAAESFSK 470
SD++S+G++L ++ + R+P M L V +EKG ++P P
Sbjct: 178 SDVWSYGVLLWEVFSYGRAPYPKMSL-KEVKECVEKGY---RMEP-----PEGCPADVYV 228
Query: 471 LAIQCAELRKKDRP 484
L C E K RP
Sbjct: 229 LMTSCWETEPKKRP 242
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 3e-24
Identities = 82/258 (31%), Positives = 122/258 (47%), Gaps = 29/258 (11%)
Query: 235 MKIGEGGYGPVYRGKLDHTP-VAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGAC 293
+K+G+G +G V+ G + T VAIK L+P F QE +V+ +RH +V L
Sbjct: 12 VKLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 70
Query: 294 ---PDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLV 350
P Y +V EYM GSL D L+ + + +AA+IA+ + ++ + V
Sbjct: 71 SEEPIY--IVTEYMSKGSLLD-FLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YV 124
Query: 351 HRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAG-TFCYIDPEYQQTG 409
HRDL+ ANIL+ N V K++D GLARL+ + +Y A + PE G
Sbjct: 125 HRDLRAANILVGENLVCKVADFGLARLIEDN------EYTARQGAKFPIKWTAPEAALYG 178
Query: 410 MLTTKSDIYSFGIMLLQIITARS---PMGLTHHVSRAIEKGTLAEMLDPAVTDWPAEAAE 466
T KSD++SFGI+L ++ T P + V +E+G P E E
Sbjct: 179 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC--------PPECPE 230
Query: 467 SFSKLAIQCAELRKKDRP 484
S L QC ++RP
Sbjct: 231 SLHDLMCQCWRKEPEERP 248
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 4e-24
Identities = 67/209 (32%), Positives = 106/209 (50%), Gaps = 27/209 (12%)
Query: 235 MKIGEGGYGPVYRGKLDHTP----VAIKVLR--PDAAQGKRQFQQEVEVLSSIRHPNMVL 288
++G G G V K+ H P +A+K +R + A K Q +E+++L P +V
Sbjct: 7 GELGAGNSGVVS--KVLHRPTGKIMAVKTIRLEINEAIQK-QILRELDILHKCNSPYIVG 63
Query: 289 LLGACPDYG----CLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQA 344
GA + G C+ EYM GSL D++L+ IP R KIA + L +LH+
Sbjct: 64 FYGAFYNNGDISICM--EYMDGGSL-DKILKEVQGR-IPERILGKIAVAVLKGLTYLHEK 119
Query: 345 KPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPE 404
++HRD+KP+NIL++ K+ D G++ + S+A + GT Y+ PE
Sbjct: 120 HK--IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTF--------VGTSSYMAPE 169
Query: 405 YQQTGMLTTKSDIYSFGIMLLQIITARSP 433
Q + KSDI+S G+ L+++ T R P
Sbjct: 170 RIQGNDYSVKSDIWSLGLSLIELATGRFP 198
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 5e-24
Identities = 60/201 (29%), Positives = 93/201 (46%), Gaps = 14/201 (6%)
Query: 236 KIGEGGYGPVYRGKL-----DHTPVAIKVLRPDAAQGKRQ-FQQEVEVLSSIRHPNMVLL 289
K+G+G +G V RG+ PVA+K L+ D F +E ++ S+ H N++ L
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 290 LGACPDYGC-LVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEP 348
G + +V E GSL DRL R+ A +IA + +L +
Sbjct: 62 YGVVLTHPLMMVTELAPLGSLLDRL-RKDALGHFLISTLCDYAVQIANGMRYLESKR--- 117
Query: 349 LVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQT 408
+HRDL NILL + KI D GL R +P + V + H+ F + PE +T
Sbjct: 118 FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVP---FAWCAPESLRT 174
Query: 409 GMLTTKSDIYSFGIMLLQIIT 429
+ SD++ FG+ L ++ T
Sbjct: 175 RTFSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 79/287 (27%), Positives = 123/287 (42%), Gaps = 47/287 (16%)
Query: 237 IGEGGYGPVYRGKLDH-------TPVAIKVLRPDAAQGKR-QFQQEVEVLSSIRHPNMVL 288
+G+G +G VY G T VAIK + +A+ +R +F E V+ ++V
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 289 LLGAC----PDYGCLVYEYMHNGSLEDRLLRR-------GNTPVIPWRKRFKIAAEIATA 337
LLG P +V E M G L+ L R +K ++AAEIA
Sbjct: 74 LLGVVSTGQPTL--VVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADG 131
Query: 338 LLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGT 397
+ +L K VHRDL N ++ + KI D G+ R + T Y+ G
Sbjct: 132 MAYLAAKK---FVHRDLAARNCMVAEDLTVKIGDFGMTRDI------YETDYYRKGGKGL 182
Query: 398 FC--YIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSP-MGLTH-HVSRAIEKGTLAEM 452
++ PE + G+ TTKSD++SFG++L ++ T A P GL++ V + + G
Sbjct: 183 LPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDG----- 237
Query: 453 LDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPELNRLKD 499
D P + +L C + K RP ++ + LKD
Sbjct: 238 ---GHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIV----SSLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 2e-23
Identities = 84/257 (32%), Positives = 126/257 (49%), Gaps = 29/257 (11%)
Query: 236 KIGEGGYGPVYRGKLD-HTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGAC- 293
K+G G +G V+ G + HT VAIK L+ + F E ++ ++HP +V L
Sbjct: 13 KLGAGQFGEVWMGYYNGHTKVAIKSLKQ-GSMSPEAFLAEANLMKQLQHPRLVRLYAVVT 71
Query: 294 --PDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVH 351
P Y ++ EYM NGSL D L+ + K +AA+IA + F+ + +H
Sbjct: 72 QEPIY--IITEYMENGSLVD-FLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN---YIH 125
Query: 352 RDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAG-TFCYIDPEYQQTGM 410
RDL+ ANIL+ KI+D GLARL+ +Y A + PE G
Sbjct: 126 RDLRAANILVSETLCCKIADFGLARLI------EDNEYTAREGAKFPIKWTAPEAINYGT 179
Query: 411 LTTKSDIYSFGIMLLQIIT-ARSPM-GLTH-HVSRAIEKGTLAEMLDPAVTDWPAEAAES 467
T KSD++SFGI+L +I+T R P G+T+ V + +E+G M P + P E E
Sbjct: 180 FTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGY--RM--PRPDNCPEELYE- 234
Query: 468 FSKLAIQCAELRKKDRP 484
L C + + ++RP
Sbjct: 235 ---LMRLCWKEKPEERP 248
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 99.6 bits (248), Expect = 2e-23
Identities = 74/263 (28%), Positives = 127/263 (48%), Gaps = 27/263 (10%)
Query: 229 DKFSEAMKIGEGGYGPVYRGK-LDHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMV 287
+ + +IG G +G V+ G L+ VAIK +R + A + F +E +V+ + HP +V
Sbjct: 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIR-EGAMSEEDFIEEAQVMMKLSHPKLV 62
Query: 288 LLLGACPDYG--CLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAK 345
L G C + CLV+E+M +G L D L R + ++ + +L +
Sbjct: 63 QLYGVCTERSPICLVFEFMEHGCLSDYL--RAQRGKFSQETLLGMCLDVCEGMAYLESSN 120
Query: 346 PEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGT---FCYID 402
++HRDL N L+ N V K+SD G+ R V QY TS+ GT +
Sbjct: 121 ---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDD------QY--TSSTGTKFPVKWSS 169
Query: 403 PEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAVTDW-P 461
PE ++KSD++SFG+++ ++ + G T + +R+ + E ++ + P
Sbjct: 170 PEVFSFSKYSSKSDVWSFGVLMWEVFSE----GKTPYENRS--NSEVVETINAGFRLYKP 223
Query: 462 AEAAESFSKLAIQCAELRKKDRP 484
A++S +L C + R +DRP
Sbjct: 224 RLASQSVYELMQHCWKERPEDRP 246
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 99.3 bits (248), Expect = 3e-23
Identities = 65/211 (30%), Positives = 99/211 (46%), Gaps = 25/211 (11%)
Query: 236 KIGEGGYGPVYRG-KLD-HTPVAIKVLRPDAAQGK--RQFQQEVEVLSSIRHPNMVLLLG 291
KIG G +G VY LD +A+K +R K ++ E++VL ++HPN+V G
Sbjct: 7 KIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYG 66
Query: 292 A--CPDYGCLVYEYMHNGSLEDRLLRRGNT---PVIPWRKRFKIAAEIATALLFLHQAKP 346
+ + EY G+LE+ LL G VI + + ++ L +LH
Sbjct: 67 VEVHREKVYIFMEYCSGGTLEE-LLEHGRILDEHVI---RVY--TLQLLEGLAYLHSHG- 119
Query: 347 EPLVHRDLKPANILLDRNYVSKISDVGLA-RLVPPSVADSVTQYHMTSAAGTFCYIDPEY 405
+VHRD+KPANI LD N V K+ D G A +L + + GT Y+ PE
Sbjct: 120 --IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLA---GTPAYMAPEV 174
Query: 406 QQTGMLTTK---SDIYSFGIMLLQIITARSP 433
G +DI+S G ++L++ T + P
Sbjct: 175 ITGGKGKGHGRAADIWSLGCVVLEMATGKRP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 98.9 bits (246), Expect = 3e-23
Identities = 80/257 (31%), Positives = 126/257 (49%), Gaps = 29/257 (11%)
Query: 236 KIGEGGYGPVYRGKLD-HTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGAC- 293
K+G G +G V+ G + +T VA+K L+P F +E +++ +RH +V L
Sbjct: 13 KLGNGQFGEVWMGTWNGNTKVAVKTLKP-GTMSPESFLEEAQIMKKLRHDKLVQLYAVVS 71
Query: 294 --PDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVH 351
P Y +V EYM GSL D L+ G + +AA++A + ++ + +H
Sbjct: 72 EEPIY--IVTEYMSKGSLLD-FLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN---YIH 125
Query: 352 RDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAG-TFCYIDPEYQQTGM 410
RDL+ ANIL+ V KI+D GLARL+ + +Y A + PE G
Sbjct: 126 RDLRSANILVGDGLVCKIADFGLARLIEDN------EYTARQGAKFPIKWTAPEAALYGR 179
Query: 411 LTTKSDIYSFGIMLLQIIT-ARSPM-GLTH-HVSRAIEKGTLAEMLDPAVTDWPAEAAES 467
T KSD++SFGI+L +++T R P G+ + V +E+G P D P S
Sbjct: 180 FTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRM----PCPQDCPI----S 231
Query: 468 FSKLAIQCAELRKKDRP 484
+L +QC + ++RP
Sbjct: 232 LHELMLQCWKKDPEERP 248
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 98.9 bits (246), Expect = 6e-23
Identities = 64/224 (28%), Positives = 105/224 (46%), Gaps = 39/224 (17%)
Query: 236 KIGEGGYGPVY--------------RGKLDHTP--VAIKVLRPDAAQGKRQ-FQQEVEVL 278
K+GEG +G V+ + D P VA+K+LR D + R F +E++++
Sbjct: 12 KLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIM 71
Query: 279 SSIRHPNMVLLLGAC--PDYGCLVYEYMHNGSLEDRLLRR---------GNTPVIPWRKR 327
S +++PN++ LLG C D C++ EYM NG L L +R N P +
Sbjct: 72 SRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANL 131
Query: 328 FKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVT 387
+A +IA+ + +L VHRDL N L+ +Y KI+D G++R +
Sbjct: 132 LYMAVQIASGMKYLASLN---FVHRDLATRNCLVGNHYTIKIADFGMSRNLYSG------ 182
Query: 388 QYHMTSAAGTFC--YIDPEYQQTGMLTTKSDIYSFGIMLLQIIT 429
Y+ ++ E G TT SD+++FG+ L ++ T
Sbjct: 183 DYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 7e-23
Identities = 63/205 (30%), Positives = 102/205 (49%), Gaps = 32/205 (15%)
Query: 237 IGEGGYGPVYRGK-LDHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACPD 295
+G G +G V+ GK VAIK++R + A + F +E +V+ + HPN+V L G C
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIR-EGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70
Query: 296 YG--CLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFK------IAAEIATALLFLHQAKPE 347
+V EYM NG L + L R + + + +++ A+ +L
Sbjct: 71 QRPIFIVTEYMANGCLLNYLRER--------KGKLGTEWLLDMCSDVCEAMEYLESNG-- 120
Query: 348 PLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYID---PE 404
+HRDL N L+ + V K+SD GLAR V + D QY TS+ GT + PE
Sbjct: 121 -FIHRDLAARNCLVGEDNVVKVSDFGLARYV---LDD---QY--TSSQGTKFPVKWAPPE 171
Query: 405 YQQTGMLTTKSDIYSFGIMLLQIIT 429
++KSD++SFG+++ ++ +
Sbjct: 172 VFDYSRFSSKSDVWSFGVLMWEVFS 196
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 1e-22
Identities = 79/258 (30%), Positives = 123/258 (47%), Gaps = 29/258 (11%)
Query: 235 MKIGEGGYGPVYRGKLD-HTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGAC 293
+K+G+G +G V+ G + T VAIK L+P F QE +++ +RH +V L
Sbjct: 12 VKLGQGCFGEVWMGTWNGTTKVAIKTLKP-GTMMPEAFLQEAQIMKKLRHDKLVPLYAVV 70
Query: 294 ---PDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLV 350
P Y +V E+M GSL D L+ G+ + + +AA+IA + ++ + +
Sbjct: 71 SEEPIY--IVTEFMGKGSLLD-FLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN---YI 124
Query: 351 HRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAG-TFCYIDPEYQQTG 409
HRDL+ ANIL+ N V KI+D GLARL+ + +Y A + PE G
Sbjct: 125 HRDLRAANILVGDNLVCKIADFGLARLIEDN------EYTARQGAKFPIKWTAPEAALYG 178
Query: 410 MLTTKSDIYSFGIMLLQIITARS---PMGLTHHVSRAIEKGTLAEMLDPAVTDWPAEAAE 466
T KSD++SFGI+L +++T P + V +E+G P E
Sbjct: 179 RFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPC--------PQGCPE 230
Query: 467 SFSKLAIQCAELRKKDRP 484
S +L C + +RP
Sbjct: 231 SLHELMKLCWKKDPDERP 248
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.9 bits (239), Expect = 4e-22
Identities = 79/272 (29%), Positives = 128/272 (47%), Gaps = 29/272 (10%)
Query: 237 IGEGGYGPVYRGKL-----DHTPVAIKVLRPDAAQGKR-QFQQEVEVLSSIRHPNMVLLL 290
IG G +G V RG+L VAIK L+ ++ +R F E ++ HPN++ L
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLE 71
Query: 291 GACPDYG--CLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEP 348
G ++ EYM NGSL D+ LR N + + IA+ + +L +
Sbjct: 72 GVVTKSRPVMIITEYMENGSL-DKFLRE-NDGKFTVGQLVGMLRGIASGMKYLSEMN--- 126
Query: 349 LVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQT 408
VHRDL NIL++ N V K+SD GL+R + S A T+ T PE
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWT----APEAIAY 182
Query: 409 GMLTTKSDIYSFGIMLLQIIT--ARSPMGLTHH-VSRAIEKGTLAEMLDPAVTDWPAEAA 465
T+ SD++SFGI++ ++++ R +++ V +A+E G L P P +
Sbjct: 183 RKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGY---RLPP-----PMDCP 234
Query: 466 ESFSKLAIQCAELRKKDRPDLGTVIVPELNRL 497
+ +L + C + + +RP IV L+++
Sbjct: 235 SALYQLMLDCWQKDRNERPTFSQ-IVSTLDKM 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 4e-22
Identities = 78/260 (30%), Positives = 121/260 (46%), Gaps = 32/260 (12%)
Query: 237 IGEGGYGPVYRG--KLDHTPVAIKV--LRPDAAQGK---RQFQQEVEVLSSIRHPNMVLL 289
+G G +G VY G D A+K L D G+ +Q +QE+ +LS ++HPN+V
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 290 LGACPDYG--CLVYEYMHNGSLEDRLLRRGN--TPVIPWRKRFKIAAEIATALLFLHQAK 345
LG + + E + GSL L + G+ PVI R +I L +LH
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTR-----QILLGLEYLHDRN 122
Query: 346 PEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEY 405
VHRD+K ANIL+D N V K++D G+A+ V V S G+ ++ PE
Sbjct: 123 ---TVHRDIKGANILVDTNGVVKLADFGMAKQV-------VEFSFAKSFKGSPYWMAPEV 172
Query: 406 -QQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAVTDWPAEA 464
Q G +DI+S G +L++ T + P V+ + G E+ P + D ++
Sbjct: 173 IAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKEL--PPIPDHLSDE 230
Query: 465 AESFSKLAIQCAELRKKDRP 484
A+ F ++C + RP
Sbjct: 231 AKDF---ILKCLQRDPSLRP 247
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 6e-22
Identities = 82/272 (30%), Positives = 135/272 (49%), Gaps = 35/272 (12%)
Query: 223 EIEEATDKFSEAMKIGEGGYGPVYRGKLD-HTPVAIKVLRPDAAQGKRQFQQEVEVLSSI 281
EI + K + K+G G +G V+ + HT VA+K ++P + F E V+ ++
Sbjct: 2 EIPRESLKLEK--KLGAGQFGEVWMATYNKHTKVAVKTMKP-GSMSVEAFLAEANVMKTL 58
Query: 282 RHPNMVLLLGAC---PDYGCLVYEYMHNGSLEDRLLR-RGNTPVIPWRKRFKIAAEIATA 337
+H +V L P Y ++ E+M GSL D L G+ +P K +A+IA
Sbjct: 59 QHDKLVKLHAVVTKEPIY--IITEFMAKGSLLDFLKSDEGSKQPLP--KLIDFSAQIAEG 114
Query: 338 LLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPS--VADSVTQYHMTSAA 395
+ F+ Q +HRDL+ ANIL+ + V KI+D GLAR++ + A ++ + A
Sbjct: 115 MAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTA 171
Query: 396 GTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPM-GLTH-HVSRAIEKGTLAEM 452
PE G T KSD++SFGI+L++I+T R P G+++ V RA+E+G
Sbjct: 172 -------PEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPR 224
Query: 453 LDPAVTDWPAEAAESFSKLAIQCAELRKKDRP 484
+ E + ++C + R ++RP
Sbjct: 225 PE--------NCPEELYNIMMRCWKNRPEERP 248
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 95.0 bits (237), Expect = 7e-22
Identities = 66/207 (31%), Positives = 94/207 (45%), Gaps = 17/207 (8%)
Query: 237 IGEGGYGPVYRGKLDHT--PVAIKVLRPDAAQGKRQFQQ---EVEVLSSIRHPNMVLLLG 291
I +G YG V+ K T AIKV++ K Q Q E ++LS + P +V L
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 292 A--CPDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPL 349
+ LV EY+ G L LL N + AEI AL +LH +
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLA-SLLE--NVGSLDEDVARIYIAEIVLALEYLHSNG---I 114
Query: 350 VHRDLKPANILLDRNYVSKISDVGLAR--LVPPSVADSVTQYHMTSAAGTFCYIDPEYQQ 407
+HRDLKP NIL+D N K++D GL++ LV + + + GT YI PE
Sbjct: 115 IHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEV-I 173
Query: 408 TGMLTTKS-DIYSFGIMLLQIITARSP 433
G +K+ D +S G +L + + P
Sbjct: 174 LGQGHSKTVDWWSLGCILYEFLVGIPP 200
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.9 bits (237), Expect = 1e-21
Identities = 49/159 (30%), Positives = 73/159 (45%), Gaps = 36/159 (22%)
Query: 236 KIGEGGYGPVYRG--KLDHTPVAIKVLRPDAAQGKRQFQQ----EVEVLSSIRHPNMVLL 289
K+GEG YG VY+ K VA+K +R D + E+ +L ++HPN+V L
Sbjct: 6 KLGEGTYGVVYKARDKKTGEIVALKKIRLD--NEEEGIPSTALREISLLKELKHPNIVKL 63
Query: 290 LGACPDYGC--LVYEYM----------HNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATA 337
L LV+EY G L L++ I ++
Sbjct: 64 LDVIHTERKLYLVFEYCDMDLKKYLDKRPGPLSPNLIKS-------------IMYQLLRG 110
Query: 338 LLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLAR 376
L + H + ++HRDLKP NIL++R+ V K++D GLAR
Sbjct: 111 LAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLAR 146
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.0 bits (234), Expect = 1e-21
Identities = 73/266 (27%), Positives = 122/266 (45%), Gaps = 33/266 (12%)
Query: 237 IGEGGYGPVYRGKL-----DHTPVAIKVLRPDA-AQGKRQFQQEVEVLSSIRHPNMVLLL 290
+G G +G V +G VA+K L+ + A GK++F +E V++ + HP +V L+
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 291 GACPDYG-CLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPL 349
G C LV E G L L +R PV ++A ++A + +L
Sbjct: 63 GVCKGEPLMLVMELAPLGPLLKYLKKRREIPVS---DLKELAHQVAMGMAYLESKH---F 116
Query: 350 VHRDLKPANILL-DRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFC--YIDPEYQ 406
VHRDL N+LL +R+ KISD G++R + + Y+ + AG + + PE
Sbjct: 117 VHRDLAARNVLLVNRHQA-KISDFGMSRALGAG-----SDYYRATTAGRWPLKWYAPECI 170
Query: 407 QTGMLTTKSDIYSFGIMLLQIIT--ARSPMGLT-HHVSRAIEKGTLAEMLDPAVTDWPAE 463
G ++KSD++S+G+ L + + A+ + V +E G E L P E
Sbjct: 171 NYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESG---ERLPR-----PEE 222
Query: 464 AAESFSKLAIQCAELRKKDRPDLGTV 489
+ + + C + R +DRP +
Sbjct: 223 CPQEIYSIMLSCWKYRPEDRPTFSEL 248
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 94.3 bits (235), Expect = 2e-21
Identities = 62/197 (31%), Positives = 95/197 (48%), Gaps = 40/197 (20%)
Query: 255 VAIKVLRPDAAQGKRQ-FQQEVEVLSSIRHPNMVLLLGACP--DYGCLVYEYMHNGSLED 311
VA+KVLRPDA+ R+ F +EV++LS + PN+ LLG C C++ EYM NG L
Sbjct: 49 VAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQ 108
Query: 312 RLLRR--------GNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDR 363
L + N+ + + +A +IA+ + +L VHRDL N L+ +
Sbjct: 109 FLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRNCLVGK 165
Query: 364 NYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYID-----P------EYQQTGMLT 412
NY KI+D G++R Y + + + P E G T
Sbjct: 166 NYTIKIADFGMSR----------NLY-----SSDYYRVQGRAPLPIRWMAWESVLLGKFT 210
Query: 413 TKSDIYSFGIMLLQIIT 429
TKSD+++FG+ L +I+T
Sbjct: 211 TKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.6 bits (233), Expect = 3e-21
Identities = 67/226 (29%), Positives = 113/226 (50%), Gaps = 28/226 (12%)
Query: 237 IGEGGYGPVYRG---------KLDHTPVAIKVLRPD-AAQGKRQFQQEVEVLSSIRHPNM 286
+G G +G VY+G K+ PVAIKVLR + + + ++ E V++S+ HP++
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKI---PVAIKVLREETSPKANKEILDEAYVMASVDHPHV 71
Query: 287 VLLLGACPDYG-CLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAK 345
V LLG C L+ + M G L D + R + I + +IA + +L + +
Sbjct: 72 VRLLGICLSSQVQLITQLMPLGCLLDYV--RNHKDNIGSQYLLNWCVQIAKGMSYLEEKR 129
Query: 346 PEPLVHRDLKPANILLD-RNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPE 404
LVHRDL N+L+ +V KI+D GLA+L+ D +YH ++ E
Sbjct: 130 ---LVHRDLAARNVLVKTPQHV-KITDFGLAKLLDV---DE-KEYHAEGGKVPIKWMALE 181
Query: 405 YQQTGMLTTKSDIYSFGIMLLQIIT--ARSPMGL-THHVSRAIEKG 447
+ T KSD++S+G+ + +++T A+ G+ + +EKG
Sbjct: 182 SILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKG 227
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 93.4 bits (233), Expect = 4e-21
Identities = 59/205 (28%), Positives = 94/205 (45%), Gaps = 24/205 (11%)
Query: 237 IGEGGYGPVYRGKLDHT--PVAIKVLRPDAAQGKRQFQQ---EVEVLSSIRHPNMVLLLG 291
+G G +G V + + A+K+L +Q + E +L SIRHP +V L G
Sbjct: 9 LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYG 68
Query: 292 A--CPDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPL 349
+ LV EY+ G L LR+ P + + AA++ AL +LH +
Sbjct: 69 SFQDDSNLYLVMEYVPGGELFS-HLRKSGRFPEPVARFY--AAQVVLALEYLHSLD---I 122
Query: 350 VHRDLKPANILLDRN-YVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQT 408
V+RDLKP N+LLD + Y+ KI+D G A+ V + GT Y+ PE +
Sbjct: 123 VYRDLKPENLLLDSDGYI-KITDFGFAKRVKG---------RTYTLCGTPEYLAPEIILS 172
Query: 409 GMLTTKSDIYSFGIMLLQIITARSP 433
D ++ GI++ +++ P
Sbjct: 173 KGYGKAVDWWALGILIYEMLAGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 5e-21
Identities = 64/206 (31%), Positives = 108/206 (52%), Gaps = 18/206 (8%)
Query: 236 KIGEGGYGPVYRGK--LDHTPVAIKV--LRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLG 291
K+G+G YG VY+ K D+ A+K L + + + E+ +L+S+ HPN++
Sbjct: 7 KLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKE 66
Query: 292 ACPDYG--CLVYEYMHNGSLEDRLLRRGNTP-VIPWRKRFKIAAEIATALLFLHQAKPEP 348
A D C+V EY G L + +R +IP ++ ++I ++ L LH+ K
Sbjct: 67 AFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK--- 123
Query: 349 LVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQT 408
++HRDLK ANILL N + KI D+G+++++ ++A + GT Y+ PE +
Sbjct: 124 ILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQI--------GTPHYMAPEVWKG 175
Query: 409 GMLTTKSDIYSFGIMLLQIITARSPM 434
+ KSDI+S G +L ++ T P
Sbjct: 176 RPYSYKSDIWSLGCLLYEMATFAPPF 201
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 5e-21
Identities = 82/255 (32%), Positives = 120/255 (47%), Gaps = 31/255 (12%)
Query: 237 IGEGGYGPVYRGKLDHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGA-CPD 295
IG+G +G V G VA+K ++ DA + F E V++ +RH N+V LLG +
Sbjct: 14 IGKGEFGDVMLGDYRGNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVIVEE 71
Query: 296 YGCL--VYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRD 353
G L V EYM GSL D L RG + V+ K + ++ A+ +L + VHRD
Sbjct: 72 KGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYL---EANNFVHRD 127
Query: 354 LKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTT 413
L N+L+ + V+K+SD GL + S TQ + + PE + +T
Sbjct: 128 LAARNVLVSEDNVAKVSDFGLTKEA------SSTQ---DTGKLPVKWTAPEALREKKFST 178
Query: 414 KSDIYSFGIMLLQIIT-ARSP---MGLTHHVSRAIEKGTLAEMLDPAVTDWPAEAAESFS 469
KSD++SFGI+L +I + R P + L V R +EKG +M D P
Sbjct: 179 KSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR-VEKGY--KM------DAPDGCPPVVY 229
Query: 470 KLAIQCAELRKKDRP 484
+ QC L RP
Sbjct: 230 DVMKQCWHLDAATRP 244
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 92.3 bits (229), Expect = 6e-21
Identities = 75/265 (28%), Positives = 124/265 (46%), Gaps = 27/265 (10%)
Query: 237 IGEGGYGPVYRGKL-----DHTPVAIKVLRPDAAQGKRQ-FQQEVEVLSSIRHPNMVLLL 290
IG G +G V+RG L VAIK L+P + +RQ F E ++ H N++ L
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72
Query: 291 GACPDY--GCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEP 348
G + ++ EYM NG+L D+ LR + + + + IA + +L
Sbjct: 73 GVVTKFKPAMIITEYMENGAL-DKYLRDHDGEFSSY-QLVGMLRGIAAGMKYLSDMN--- 127
Query: 349 LVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQT 408
VHRDL NIL++ N K+SD GL+R++ D Y + + PE
Sbjct: 128 YVHRDLAARNILVNSNLECKVSDFGLSRVLED---DPEGTYTTSGGKIPIRWTAPEAIAY 184
Query: 409 GMLTTKSDIYSFGIMLLQIIT--ARSPMGLTHH-VSRAIEKGTLAEMLDPAVTDWPAEAA 465
T+ SD++SFGI++ ++++ R +++H V +AI G PA D P+
Sbjct: 185 RKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRL----PAPMDCPS--- 237
Query: 466 ESFSKLAIQCAELRKKDRPDLGTVI 490
+ +L +QC + + RP ++
Sbjct: 238 -AVYQLMLQCWQQDRARRPRFVDIV 261
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 8e-21
Identities = 65/212 (30%), Positives = 101/212 (47%), Gaps = 32/212 (15%)
Query: 237 IGEGGYGPVYRGKLDHTP----VAIKVLRPDAAQGK-RQFQQEVEVLSSIRH---PNMVL 288
IG G YG VYRGK H P VA+K++ D Q+EV +LS +R PN+
Sbjct: 9 IGRGAYGAVYRGK--HVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITK 66
Query: 289 LLGACPDYG---CLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFK--IAAEIATALLFLHQ 343
G G ++ EY GS+ L++ G P +++ I E+ AL ++H+
Sbjct: 67 YYG-SYLKGPRLWIIMEYAEGGSVRT-LMKAG-----PIAEKYISVIIREVLVALKYIHK 119
Query: 344 AKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDP 403
++HRD+K ANIL+ K+ D G+A L+ + ++ GT ++ P
Sbjct: 120 V---GVIHRDIKAANILVTNTGNVKLCDFGVAALL------NQNSSKRSTFVGTPYWMAP 170
Query: 404 EYQQTG-MLTTKSDIYSFGIMLLQIITARSPM 434
E G TK+DI+S GI + ++ T P
Sbjct: 171 EVITEGKYYDTKADIWSLGITIYEMATGNPPY 202
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 1e-20
Identities = 84/299 (28%), Positives = 138/299 (46%), Gaps = 51/299 (17%)
Query: 237 IGEGGYGPVYRGKL----DHTPVAIKVLRPDAAQGK-RQFQQEVEVLSSI-RHPNMVLLL 290
IGEG +G V R + AIK+L+ A++ R F E+EVL + HPN++ LL
Sbjct: 10 IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLL 69
Query: 291 GACPDYGCL--VYEYMHNGSLEDRLLR-------------RGNTPVIPWRKRFKIAAEIA 335
GAC + G L EY G+L D L + G + ++ + A+++A
Sbjct: 70 GACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVA 129
Query: 336 TALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAA 395
T + +L + + +HRDL N+L+ N SKI+D GL+R V ++ + +
Sbjct: 130 TGMQYLSEKQ---FIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRLPVR--- 183
Query: 396 GTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDP 455
++ E + TTKSD++SFG++L +I++ +G T + T AE+ +
Sbjct: 184 ----WMAIESLNYSVYTTKSDVWSFGVLLWEIVS----LGGTPYCGM-----TCAELYEK 230
Query: 456 AVTDW----PAEAAESFSKLAIQCAELRKKDRPDLGTVIVPELNRLKDLGRKLESNKSY 510
+ P + +L QC R +RP + V L R LE+ K+Y
Sbjct: 231 LPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISV-------QLSRMLEARKAY 282
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 2e-20
Identities = 76/284 (26%), Positives = 125/284 (44%), Gaps = 45/284 (15%)
Query: 237 IGEGGYGPVYRGKL-------DHTPVAIKVLRPDA-AQGKRQFQQEVEVLSSIRHPNMVL 288
IG+G +G V++ + T VA+K+L+ +A A + FQ+E +++ HPN+V
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 289 LLGACPDYG--CLVYEYMHNGSLEDRLLRR-------------------GNTPVIPWRKR 327
LLG C CL++EYM G L + L R N + ++
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 328 FKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVT 387
IA ++A + +L + K VHRDL N L+ N V KI+D GL+R +
Sbjct: 133 LCIAKQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNI------YSA 183
Query: 388 QYHMTSA--AGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIE 445
Y+ S A ++ PE TT+SD++++G++L +I + G+ + A E
Sbjct: 184 DYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS----YGMQPYYGMAHE 239
Query: 446 KGTLAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTV 489
+ + + D V P L C DRP ++
Sbjct: 240 E-VIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASI 282
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 90.9 bits (226), Expect = 3e-20
Identities = 65/215 (30%), Positives = 105/215 (48%), Gaps = 23/215 (10%)
Query: 229 DKFSEAMKIGEGGYGPVYRGKLDHTP--VAIK-VLRPDAAQGKRQFQQEVEVLSSIRHPN 285
+K E ++GEG G V + +L +T A+K + ++Q +E+E+ S + P
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 286 MVLLLGACPD-YGCLVY---EYMHNGSLE---DRLLRRGNTPVIPWRKRFKIAAEIATAL 338
+V GA D + EY GSL+ ++ +RG I + KIA + L
Sbjct: 61 IVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGR--IGEKVLGKIAESVLKGL 118
Query: 339 LFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTF 398
+LH K ++HRD+KP+NILL R K+ D G++ + S+A + T GT
Sbjct: 119 SYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT--------GTS 167
Query: 399 CYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSP 433
Y+ PE Q + SD++S G+ LL++ R P
Sbjct: 168 FYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFP 202
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 90.7 bits (225), Expect = 3e-20
Identities = 71/235 (30%), Positives = 109/235 (46%), Gaps = 42/235 (17%)
Query: 237 IGEGGYGPVYRGKL--------DHTPVAIKVLRPDAA-QGKRQFQQEVEVLSSIRHPNMV 287
+G G +G VY G VA+K LR A Q K++F +E ++S+ HPN+V
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 288 LLLGAC----PDYGCLVYEYMHNGSL----EDRLLRRGNTPVIPWRKRFKIAAEIATALL 339
LLG C P Y ++ E M G L D + R P++ ++ I ++A +
Sbjct: 63 KLLGVCLLNEPQY--IIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 340 FLHQAKPEPLVHRDLKPANILL-----DRNYVSKISDVGLARLVPPSVADSVTQYHMTSA 394
+L Q +HRDL N L+ D + V KI D GLAR + S Y+
Sbjct: 121 YLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKS------DYYRKEG 171
Query: 395 AGTFC--YIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-------ARSPMGLTHHV 440
G ++ PE G TT+SD++SFG+++ +I+T A + + HV
Sbjct: 172 EGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHV 226
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 3e-20
Identities = 79/267 (29%), Positives = 120/267 (44%), Gaps = 35/267 (13%)
Query: 236 KIGEGGYGPVYRGKL--DHTPVAIKVLR----PDAAQGKRQFQQEVEVLSSIRHPNMVLL 289
+IG G +G V+ G+L D+TPVA+K R PD K +F QE +L HPN+V L
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDL---KAKFLQEARILKQYSHPNIVRL 58
Query: 290 LGAC----PDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAK 345
+G C P Y +V E + G L G P + ++ ++ A + +L +
Sbjct: 59 IGVCTQKQPIY--IVMELVQGGDFLTFLRTEG--PRLKVKELIQMVENAAAGMEYL---E 111
Query: 346 PEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEY 405
+ +HRDL N L+ V KISD G++R V S T PE
Sbjct: 112 SKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWT----APEA 167
Query: 406 QQTGMLTTKSDIYSFGIMLLQIIT-ARSPM-GLTHHVSR-AIEKGTLAEMLDPAVTDWPA 462
G +++SD++SFGI+L + + P L++ +R AIE+G P
Sbjct: 168 LNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPC--------PE 219
Query: 463 EAAESFSKLAIQCAELRKKDRPDLGTV 489
++ +L +C E RP TV
Sbjct: 220 LCPDAVYRLMERCWEYDPGQRPSFSTV 246
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 4e-20
Identities = 64/206 (31%), Positives = 101/206 (49%), Gaps = 16/206 (7%)
Query: 237 IGEGGYGPVYRGKL-----DHTPVAIKVL-RPDAAQGKRQFQQEVEVLSSIRHPNMVLLL 290
IG+G +G VY G L A+K L R + QF +E ++ HPN++ LL
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 291 GAC-PDYGC--LVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPE 347
G C P G +V YM +G L + + + P + + ++A + +L K
Sbjct: 63 GICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTV--KDLIGFGLQVAKGMEYLASKK-- 118
Query: 348 PLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQ 407
VHRDL N +LD ++ K++D GLAR + SV + A ++ E Q
Sbjct: 119 -FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHT--GAKLPVKWMALESLQ 175
Query: 408 TGMLTTKSDIYSFGIMLLQIITARSP 433
T TTKSD++SFG++L +++T +P
Sbjct: 176 TQKFTTKSDVWSFGVLLWELMTRGAP 201
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.3 bits (225), Expect = 4e-20
Identities = 58/217 (26%), Positives = 94/217 (43%), Gaps = 38/217 (17%)
Query: 236 KIGEGGYGPVYRG--KLDHTPVAIKVLRPDAAQGKRQFQQ----EVEVLSSIRHPNMVLL 289
+IGEG YG VY+ K VA+K +R + K F E+++L +RHPN+V L
Sbjct: 6 QIGEGTYGQVYKARNKKTGELVALKKIRME--NEKEGFPITAIREIKLLQKLRHPNIVRL 63
Query: 290 LGACPDYGC----LVYEYM-HNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQA 344
G +V+EYM H+ + LL + + ++ L +LH
Sbjct: 64 KEIVTSKGKGSIYMVFEYMDHDLT---GLLDSPEVKFTESQIKC-YMKQLLEGLQYLHSN 119
Query: 345 KPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPE 404
++HRD+K +NIL++ + V K++D GLAR T+ T Y PE
Sbjct: 120 G---ILHRDIKGSNILINNDGVLKLADFGLARPY-----TKRNSADYTNRVITLWYRPPE 171
Query: 405 -------YQQTGMLTTKSDIYSFGIMLLQIITARSPM 434
Y + D++S G +L ++ +
Sbjct: 172 LLLGATRY------GPEVDMWSVGCILAELFLGKPIF 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 90.0 bits (224), Expect = 5e-20
Identities = 62/212 (29%), Positives = 92/212 (43%), Gaps = 30/212 (14%)
Query: 228 TDKFSEAMKIGEGGYGPVYRGKLDHT--PVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPN 285
+ + KIGEG G VY+ T VAIK +R Q K E+ ++ +HPN
Sbjct: 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRK-QNKELIINEILIMKDCKHPN 76
Query: 286 MVLLLGACPDYGCL--VYEYMHNGSLEDRLLRRGNTPVIPW-RKRFK---IAA---EIAT 336
+V + L V EYM GSL T +I R IA E+
Sbjct: 77 IVDYYDSYLVGDELWVVMEYMDGGSL---------TDIITQNFVRMNEPQIAYVCREVLQ 127
Query: 337 ALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAG 396
L +LH ++HRD+K NILL ++ K++D G A + + + S G
Sbjct: 128 GLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQL------TKEKSKRNSVVG 178
Query: 397 TFCYIDPEYQQTGMLTTKSDIYSFGIMLLQII 428
T ++ PE + K DI+S GIM +++
Sbjct: 179 TPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMA 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.1 bits (224), Expect = 5e-20
Identities = 58/203 (28%), Positives = 91/203 (44%), Gaps = 19/203 (9%)
Query: 236 KIGEGGYGPVY--RGKLDHTPVAIKVLRPDAAQG--KRQFQQEVEVLSSIRHPNMVLLLG 291
KIGEG YG VY R KL VAIK ++ + +E+++L + HPN++ LL
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLD 65
Query: 292 ACPDYG--CLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPL 349
G LV+E+M + L++ + + ++ L F H +
Sbjct: 66 VFRHKGDLYLVFEFMDTDLYK--LIKDRQRGLPESLIKS-YLYQLLQGLAFCHSHG---I 119
Query: 350 VHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQT- 408
+HRDLKP N+L++ V K++D GLAR T T Y PE
Sbjct: 120 LHRDLKPENLLINTEGVLKLADFGLARSFGSP------VRPYTHYVVTRWYRAPELLLGD 173
Query: 409 GMLTTKSDIYSFGIMLLQIITAR 431
+T DI+S G + ++++ R
Sbjct: 174 KGYSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 89.2 bits (221), Expect = 7e-20
Identities = 80/279 (28%), Positives = 131/279 (46%), Gaps = 40/279 (14%)
Query: 237 IGEGGYGPVYRGKLDH-----TPVAIKVLRPD-AAQGKRQFQQEVEVLSSIRHPNMVLLL 290
IG G +G V RG+L VAIK L+ + +R F E ++ HPN++ L
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 291 G----ACPDYGCLVYEYMHNGSLEDRLLRR--GNTPVIPWRKRFKIAAEIATALLFLHQA 344
G + P ++ E+M NG+L D LR+ G VI + + IA + +L +
Sbjct: 72 GVVTKSRPVM--IITEFMENGAL-DSFLRQNDGQFTVI---QLVGMLRGIAAGMKYLSEM 125
Query: 345 KPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAG---TFCYI 401
VHRDL NIL++ N V K+SD GL+R + +D TS+ G +
Sbjct: 126 N---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPT----YTSSLGGKIPIRWT 178
Query: 402 DPEYQQTGMLTTKSDIYSFGIMLLQIIT--ARSPMGLTHH-VSRAIEKGTLAEMLDPAVT 458
PE T+ SD++S+GI++ ++++ R +++ V AIE+ + P
Sbjct: 179 APEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQ----DYRLPPPM 234
Query: 459 DWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPELNRL 497
D P + +L + C + + RP G IV L+++
Sbjct: 235 DCPT----ALHQLMLDCWQKDRNARPKFGQ-IVSTLDKM 268
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 88.6 bits (220), Expect = 1e-19
Identities = 76/280 (27%), Positives = 129/280 (46%), Gaps = 40/280 (14%)
Query: 228 TDKFSEAMKIGEGGYGPVYRG--KLDHTPVA---IKVLRPDAAQGKRQFQQEVEVLSSIR 282
F KIG+G + VY+ LD VA +++ A+ ++ +E+++L +
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 283 HPNMVLLLGACPDYGCL--VYEYMHNGSLEDRLLR--RGNTPVIPWRKRFKIAAEIATAL 338
HPN++ L + + L V E G L R+++ + +IP R +K ++ +AL
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLS-RMIKHFKKQKRLIPERTIWKYFVQLCSAL 119
Query: 339 LFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTF 398
+H + ++HRD+KPAN+ + V K+ D+GL R + T H S GT
Sbjct: 120 EHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRF----FSSKTTAAH--SLVGTP 170
Query: 399 CYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSP-----MGLTHHVSRAIEKGTLAEML 453
Y+ PE KSDI+S G +L ++ +SP M L + + + IEK
Sbjct: 171 YYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-YSLCKKIEKC------ 223
Query: 454 DPAVTDWPAEAAESFSK----LAIQCAELRKKDRPDLGTV 489
D+P A+ +S+ L +C + RPD+ V
Sbjct: 224 -----DYPPLPADHYSEELRDLVSRCINPDPEKRPDISYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 1e-19
Identities = 73/259 (28%), Positives = 123/259 (47%), Gaps = 33/259 (12%)
Query: 237 IGEGGYGPVYRGKL-DHTPVAIKVLRPDAAQG-KRQFQQEVEVLSSIRHPNMVLLLGAC- 293
+G+G +G V++G L D TPVA+K + D Q K +F E +L HPN+V L+G C
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62
Query: 294 ---PDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLV 350
P Y +V E + G L ++ + + ++ K A + A + +L +
Sbjct: 63 QRQPIY--IVMELVPGGDFLSFLRKKKDE--LKTKQLVKFALDAAAGMAYLESKN---CI 115
Query: 351 HRDLKPANILLDRNYVSKISDVGLARLVPPSVADS--VTQYHMTSAAGTFCYIDPEYQQT 408
HRDL N L+ N V KISD G++R + S + Q + A PE
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTA-------PEALNY 168
Query: 409 GMLTTKSDIYSFGIMLLQIIT-ARSPM-GLTHHVSR-AIEKGTLAEMLDPAVTDWPAEAA 465
G +++SD++S+GI+L + + P G+T+ +R +EKG P +
Sbjct: 169 GRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSC--------PQKCP 220
Query: 466 ESFSKLAIQCAELRKKDRP 484
+ K+ +C + + ++RP
Sbjct: 221 DDVYKVMQRCWDYKPENRP 239
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 1e-19
Identities = 74/254 (29%), Positives = 110/254 (43%), Gaps = 26/254 (10%)
Query: 237 IGEGGYGPVYRGKLDHTP--VAIKVL---RPDAAQGKRQFQQEVEVLSSIRHPNMVLLLG 291
+G+GG+G V ++ T A K L R +G++ E ++L + +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 292 A--CPDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPL 349
A D CLV M+ G L+ + G P P + AA+I L LHQ +
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVG-EPGFPEARAIFYAAQIICGLEHLHQ---RRI 116
Query: 350 VHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTG 409
V+RDLKP N+LLD + +ISD+GLA + + AGT Y+ PE Q
Sbjct: 117 VYRDLKPENVLLDDHGNVRISDLGLAVELK-------GGKKIKGRAGTPGYMAPEVLQGE 169
Query: 410 MLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAVTDWPAEAAESFS 469
+ D ++ G L ++I RSP R ++ E L + E + FS
Sbjct: 170 VYDFSVDWFALGCTLYEMIAGRSPF-------RQRKEKVEKEELKRRTLEMAVEYPDKFS 222
Query: 470 KLAIQ-CAELRKKD 482
A C L +KD
Sbjct: 223 PEAKDLCEALLQKD 236
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 1e-19
Identities = 74/259 (28%), Positives = 131/259 (50%), Gaps = 32/259 (12%)
Query: 236 KIGEGGYGPVYRGKLDH-TPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGAC- 293
K+G G +G V+ G ++ T VA+K L+P + F +E ++ +++H +V L
Sbjct: 13 KLGAGQFGEVWMGYYNNSTKVAVKTLKP-GTMSVQAFLEEANLMKTLQHDKLVRLYAVVT 71
Query: 294 ---PDYGCLVYEYMHNGSLEDRL-LRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPL 349
P Y ++ EYM GSL D L G ++P K +A+IA + ++ +
Sbjct: 72 KEEPIY--IITEYMAKGSLLDFLKSDEGGKVLLP--KLIDFSAQIAEGMAYIERKN---Y 124
Query: 350 VHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAG-TFCYIDPEYQQT 408
+HRDL+ AN+L+ + + KI+D GLAR++ + +Y A + PE
Sbjct: 125 IHRDLRAANVLVSESLMCKIADFGLARVIEDN------EYTAREGAKFPIKWTAPEAINF 178
Query: 409 GMLTTKSDIYSFGIMLLQIIT-ARSPM-GLTH-HVSRAIEKGTLAEMLDPAVTDWPAEAA 465
G T KSD++SFGI+L +I+T + P G+++ V A+++G P + + P E
Sbjct: 179 GSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRM----PRMENCPDELY 234
Query: 466 ESFSKLAIQCAELRKKDRP 484
+ + C + + ++RP
Sbjct: 235 D----IMKTCWKEKAEERP 249
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 88.0 bits (218), Expect = 2e-19
Identities = 83/274 (30%), Positives = 130/274 (47%), Gaps = 32/274 (11%)
Query: 237 IGEGGYGPVYRGKLD-----HTPVAIKVLRPDAAQGKRQ-FQQEVEVLSSIRHPNMVLLL 290
IG G +G V G+L PVAIK L+ + +R+ F E ++ HPN++ L
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 291 GACPDYG--CLVYEYMHNGSLEDRLLRR--GNTPVIPWRKRFKIAAEIATALLFLHQAKP 346
G +V EYM NGSL D LR+ G VI + + IA+ + +L
Sbjct: 72 GVVTKSKPVMIVTEYMENGSL-DAFLRKHDGQFTVI---QLVGMLRGIASGMKYLSDMG- 126
Query: 347 EPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQ 406
VHRDL NIL++ N V K+SD GL+R++ D Y + PE
Sbjct: 127 --YVHRDLAARNILVNSNLVCKVSDFGLSRVLED---DPEAAYTTRGGKIPIRWTAPEAI 181
Query: 407 QTGMLTTKSDIYSFGIMLLQIIT--ARSPMGLTHH-VSRAIEKGTLAEMLDPAVTDWPAE 463
T+ SD++S+GI++ ++++ R +++ V +AIE+G PA D PA
Sbjct: 182 AYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRL----PAPMDCPA- 236
Query: 464 AAESFSKLAIQCAELRKKDRPDLGTVIVPELNRL 497
+ +L + C + + +RP IV L++L
Sbjct: 237 ---ALHQLMLDCWQKDRNERPKFEQ-IVSILDKL 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.5 bits (220), Expect = 2e-19
Identities = 54/170 (31%), Positives = 78/170 (45%), Gaps = 12/170 (7%)
Query: 229 DKFSEAMKIGEGGYGPVYRGKLDHTP--VAIKVL--RPDAAQGKRQFQQEVEVLSSIRHP 284
+K+ +GEG YG V + + T VAIK D K+ +EV+VL +RH
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHE 60
Query: 285 NMVLLLGACPDYG--CLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLH 342
N+V L A G LV+EY+ LE G P R ++ A+ + H
Sbjct: 61 NIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRS---YIWQLLQAIAYCH 117
Query: 343 QAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMT 392
++HRD+KP NIL+ + V K+ D G AR + A +T Y T
Sbjct: 118 SHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVAT 164
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 3e-19
Identities = 65/232 (28%), Positives = 103/232 (44%), Gaps = 48/232 (20%)
Query: 236 KIGEGGYGPVYRGKLDHTP------------------VAIKVLRPDAAQGKRQ-FQQEVE 276
K+GEG +G V+ ++ + VA+K+LRPDA + R F +EV+
Sbjct: 12 KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVK 71
Query: 277 VLSSIRHPNMVLLLGAC--PDYGCLVYEYMHNGSLEDRLLRR----------------GN 318
+LS ++ PN++ LLG C D C++ EYM NG L L
Sbjct: 72 ILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHC 131
Query: 319 TPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLV 378
P I + +A +IA+ + +L VHRDL N L+ N KI+D G++R +
Sbjct: 132 LPAISYSSLLHVALQIASGMKYLSSLN---FVHRDLATRNCLVGENLTIKIADFGMSRNL 188
Query: 379 PPSVADSVTQYHMTSAAGTFC--YIDPEYQQTGMLTTKSDIYSFGIMLLQII 428
Y+ ++ E G TT SD+++FG+ L +I+
Sbjct: 189 ------YAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 88.0 bits (218), Expect = 3e-19
Identities = 78/282 (27%), Positives = 127/282 (45%), Gaps = 41/282 (14%)
Query: 236 KIGEGGYGPVYRGK-------------LDHTP-----VAIKVLRPDAAQGKRQ-FQQEVE 276
K+GEG +G V+ + LD + VA+K+LR DA + R F +E++
Sbjct: 12 KLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIK 71
Query: 277 VLSSIRHPNMVLLLGAC--PDYGCLVYEYMHNGSLEDRLLR--------RGNTPVIPWRK 326
++S ++ PN++ LL C D C++ EYM NG L L R + + I +
Sbjct: 72 IMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYST 131
Query: 327 RFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSV 386
+A +IA+ + +L VHRDL N L+ +NY KI+D G++R + S
Sbjct: 132 LIFMATQIASGMKYLSSLN---FVHRDLATRNCLVGKNYTIKIADFGMSRNLY-----SG 183
Query: 387 TQYHMTS-AAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIE 445
Y + A ++ E G TT SD+++FG+ L +I+T + +
Sbjct: 184 DYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVI 243
Query: 446 KGTLAEMLDPAVTDW---PAEAAESFSKLAIQCAELRKKDRP 484
+ T D + PA +S KL + C K+RP
Sbjct: 244 ENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERP 285
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 4e-19
Identities = 64/216 (29%), Positives = 107/216 (49%), Gaps = 29/216 (13%)
Query: 236 KIGEGGYGPVYRGKL-------DHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVL 288
++GEG +G V+ + D VA+K L+ ++ FQ+E E+L++++H ++V
Sbjct: 12 ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 71
Query: 289 LLGACPDYGCL--VYEYMHNGSLEDRLLRRGNTPVI-----PWRKR--------FKIAAE 333
G C D L V+EYM +G L L G +I P + + IA++
Sbjct: 72 FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 131
Query: 334 IATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTS 393
IA+ +++L + VHRDL N L+ N + KI D G++R V + V + M
Sbjct: 132 IASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 188
Query: 394 AAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT 429
++ PE TT+SD++SFG++L +I T
Sbjct: 189 IR----WMPPESIMYRKFTTESDVWSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 2e-18
Identities = 82/297 (27%), Positives = 135/297 (45%), Gaps = 47/297 (15%)
Query: 237 IGEGGYGPVYRGKLD----HTPVAIKVLRPDAAQGK-RQFQQEVEVLSSI-RHPNMVLLL 290
IGEG +G V + ++ AIK ++ A++ R F E+EVL + HPN++ LL
Sbjct: 15 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 74
Query: 291 GACPDYGCL--VYEYMHNGSLEDRL-------------LRRGNTPVIPWRKRFKIAAEIA 335
GAC G L EY +G+L D L + + ++ AA++A
Sbjct: 75 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 134
Query: 336 TALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAA 395
+ +L Q + +HRDL NIL+ NYV+KI+D GL+R V ++ + +
Sbjct: 135 RGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVR--- 188
Query: 396 GTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPM-GLTHHVSRAIEKGTLAEML 453
++ E + TT SD++S+G++L +I++ +P G+T + EK L
Sbjct: 189 ----WMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT--CAELYEKLPQGYRL 242
Query: 454 DPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPELNRLKDLGRKLESNKSY 510
+ P + L QC + +RP ++V L R LE K+Y
Sbjct: 243 EK-----PLNCDDEVYDLMRQCWREKPYERPSFAQILV-------SLNRMLEERKTY 287
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 85.5 bits (212), Expect = 2e-18
Identities = 65/227 (28%), Positives = 105/227 (46%), Gaps = 35/227 (15%)
Query: 229 DKFSEAMKIGEGGYGPVYRGKLDHTP-------VAIKVLRPDAAQGK-RQFQQEVEVLSS 280
D+ + +GEG +G V + + VA+K+L+ DA + E+E++
Sbjct: 12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKM 71
Query: 281 I-RHPNMVLLLGACPDYGCL--VYEYMHNGSLEDRLLRR-----GNTPVIPWRKRFKI-- 330
I +H N++ LLG C G L V EY +G+L D L R +P P +
Sbjct: 72 IGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQ 131
Query: 331 ------AAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVAD 384
A ++A + FL K +HRDL N+L+ ++V KI+D GLAR +
Sbjct: 132 KDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLVTEDHVMKIADFGLARDI------ 182
Query: 385 SVTQYHMTSAAGTFCY--IDPEYQQTGMLTTKSDIYSFGIMLLQIIT 429
Y+ + G + PE + T +SD++SFG++L +I T
Sbjct: 183 HHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 2e-18
Identities = 79/294 (26%), Positives = 133/294 (45%), Gaps = 51/294 (17%)
Query: 237 IGEGGYGPVYRGKLDHTPV----AIKVLRPDAAQGK-RQFQQEVEVLSSI-RHPNMVLLL 290
IGEG +G V + ++ + AIK ++ A++ R F E+EVL + HPN++ LL
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 291 GACPDYGCL--VYEYMHNGSLEDRLLR-------------RGNTPVIPWRKRFKIAAEIA 335
GAC G L EY +G+L D L + + ++ AA++A
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122
Query: 336 TALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAA 395
+ +L Q + +HRDL NIL+ NYV+KI+D GL+R V ++ + +
Sbjct: 123 RGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVR--- 176
Query: 396 GTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDP 455
++ E + TT SD++S+G++L +I++ +G T + T AE+ +
Sbjct: 177 ----WMAIESLNYSVYTTNSDVWSYGVLLWEIVS----LGGTPYCGM-----TCAELYEK 223
Query: 456 AVTDW----PAEAAESFSKLAIQCAELRKKDRPDLGTVIVPELNRLKDLGRKLE 505
+ P + L QC + +RP ++V L R LE
Sbjct: 224 LPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILV-------SLNRMLE 270
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 2e-18
Identities = 62/208 (29%), Positives = 99/208 (47%), Gaps = 20/208 (9%)
Query: 230 KFSEAMKIGEGGYGPVY--RGKLDHTPVAIKVLRPDAAQGKRQF--QQEVEVLSSIRHPN 285
K+ + +G G +G V+ R K D V IK + + + Q E +VL + HPN
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60
Query: 286 MVLLLGACPDYGCL--VYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQ 343
++ + L V EY G+L + + +R N+ ++ +I AL +H
Sbjct: 61 IIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNS-LLDEDTILHFFVQILLALHHVHT 119
Query: 344 AKPEPLVHRDLKPANILLDRN-YVSKISDVGLAR-LVPPSVADSVTQYHMTSAAGTFCYI 401
++HRDLK NILLD++ V KI D G+++ L S A +V GT CYI
Sbjct: 120 KL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVV--------GTPCYI 168
Query: 402 DPEYQQTGMLTTKSDIYSFGIMLLQIIT 429
PE + KSDI++ G +L ++ +
Sbjct: 169 SPELCEGKPYNQKSDIWALGCVLYELAS 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 2e-18
Identities = 61/213 (28%), Positives = 105/213 (49%), Gaps = 26/213 (12%)
Query: 236 KIGEGGYGPVYRGKL-------DHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVL 288
++GEG +G V+ + D VA+K L+ + ++ F +E E+L++++H ++V
Sbjct: 12 ELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVK 71
Query: 289 LLGAC--PDYGCLVYEYMHNGSL---------EDRLLRRGNTPV-IPWRKRFKIAAEIAT 336
G C D +V+EYM +G L + L+ GN P + + IA +IA
Sbjct: 72 FYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAA 131
Query: 337 ALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAG 396
+++L + VHRDL N L+ N + KI D G++R V + V + M
Sbjct: 132 GMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR- 187
Query: 397 TFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT 429
++ PE TT+SD++S G++L +I T
Sbjct: 188 ---WMPPESIMYRKFTTESDVWSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 3e-18
Identities = 75/277 (27%), Positives = 126/277 (45%), Gaps = 40/277 (14%)
Query: 231 FSEAMKIGEGGYGPVYRGK--LDHTPVAIK---VLRPDAAQGKRQFQQEVEVLSSIRHPN 285
F KIG G + VYR LD PVA+K + A+ + +E+++L + HPN
Sbjct: 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 63
Query: 286 MVLLLGACPDYGCL--VYEYMHNGSLEDRLLR--RGNTPVIPWRKRFKIAAEIATALLFL 341
++ + + L V E G L R+++ + +IP + +K ++ +AL +
Sbjct: 64 VIKYYASFIEDNELNIVLELADAGDLS-RMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM 122
Query: 342 HQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYI 401
H + ++HRD+KPAN+ + V K+ D+GL R + T H S GT Y+
Sbjct: 123 HSRR---VMHRDIKPANVFITATGVVKLGDLGLGRF----FSSKTTAAH--SLVGTPYYM 173
Query: 402 DPEYQQTGMLTTKSDIYSFGIMLLQIITARSP-----MGLTHHVSRAIEKGTLAEMLDPA 456
PE KSDI+S G +L ++ +SP M L + + + IE+
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-YSLCKKIEQ---------- 222
Query: 457 VTDWPAEAAESFS----KLAIQCAELRKKDRPDLGTV 489
D+P ++ +S +L C + RPD+ V
Sbjct: 223 -CDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 5e-18
Identities = 66/258 (25%), Positives = 113/258 (43%), Gaps = 26/258 (10%)
Query: 236 KIGEGGYGPVYRG--KLDHTPVAIKV--LRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLG 291
KIG+G +G V++ K D A+K L + + + E VL+ + ++
Sbjct: 7 KIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYE 66
Query: 292 ACPDYG--CLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPL 349
+ D G +V EY NG L L + P +P + ++ +I L LH K +
Sbjct: 67 SFLDKGKLNIVMEYAENGDLHKLLKMQRGRP-LPEDQVWRFFIQILLGLAHLHSKK---I 122
Query: 350 VHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTG 409
+HRD+K N+ LD KI D+G+A+L+ + + T GT Y+ PE +
Sbjct: 123 LHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT------IVGTPYYLSPELCEDK 176
Query: 410 MLTTKSDIYSFGIMLLQIITARSPMGLTHHVS--RAIEKGTLAEMLDPAVTDWPAEAAES 467
KSD+++ G++L + T + P + + I +G P V ++
Sbjct: 177 PYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVF-----PPV---SQMYSQQ 228
Query: 468 FSKLAIQCAELRKKDRPD 485
++L QC + RPD
Sbjct: 229 LAQLIDQCLTKDYRQRPD 246
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.9 bits (208), Expect = 5e-18
Identities = 65/220 (29%), Positives = 103/220 (46%), Gaps = 24/220 (10%)
Query: 229 DKFSEAMKIGEGGYGPVYRGKLDHTP--VAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNM 286
+ + +IG G YG VY+ + T VAIKV++ + QQE+ +L RHPN+
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNI 62
Query: 287 VLLLGA--CPDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIA---AEIATALLFL 341
V G+ D +V EY GSL+D + + P+ +IA E L +L
Sbjct: 63 VAYFGSYLRRDKLWIVMEYCGGGSLQD-IYQVTRGPL----SELQIAYVCRETLKGLAYL 117
Query: 342 HQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYI 401
H+ +HRD+K ANILL + K++D G++ + ++A S GT ++
Sbjct: 118 HETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKR------KSFIGTPYWM 168
Query: 402 DPEYQQ---TGMLTTKSDIYSFGIMLLQIITARSPMGLTH 438
PE G K DI++ GI +++ + PM H
Sbjct: 169 APEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLH 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 6e-18
Identities = 76/275 (27%), Positives = 126/275 (45%), Gaps = 37/275 (13%)
Query: 230 KFSEAMKIGEGGYGPVY--RGKLDHTPVAIKV--LRPDAAQGKRQFQQEVEVLSSIRHPN 285
++ KIGEG +G +Y + K D IK L + K ++EV +L+ ++HPN
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60
Query: 286 MVLLLGACPDYGCL--VYEYMHNGSLEDRLLR-RG----NTPVIPWRKRFKIAAEIATAL 338
+V + + G L V EY G L R+ R RG ++ W +I+ L
Sbjct: 61 IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSW------FVQISLGL 114
Query: 339 LFLHQAKPEPLVHRDLKPANILLDRN-YVSKISDVGLARLVPPSVADSVTQYHMTSAAGT 397
+H K ++HRD+K NI L +N V+K+ D G+AR + S+ + T GT
Sbjct: 115 KHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYT------CVGT 165
Query: 398 FCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPM--GLTHHVSRAIEKGTLAEMLDP 455
Y+ PE Q K+DI+S G +L ++ T + P H + I +G A P
Sbjct: 166 PYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFA----P 221
Query: 456 AVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVI 490
++ + L Q ++ +DRP + +++
Sbjct: 222 ISPNFSRD----LRSLISQLFKVSPRDRPSITSIL 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 9e-18
Identities = 65/218 (29%), Positives = 107/218 (49%), Gaps = 34/218 (15%)
Query: 236 KIGEGGYGPVYRGKL-------DHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVL 288
++GEG +G V+ + D VA+K L+ + ++ FQ+E E+L+ ++H ++V
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71
Query: 289 LLGACPDYGCL--VYEYMHNGSLEDRLLR---------RGNTPVIPWR----KRFKIAAE 333
G C + L V+EYM +G L +R LR G V P + + IA++
Sbjct: 72 FYGVCTEGRPLLMVFEYMRHGDL-NRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQ 130
Query: 334 IATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTS 393
IA+ +++L VHRDL N L+ + V KI D G++R + T Y+
Sbjct: 131 IASGMVYLASLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDI------YSTDYYRVG 181
Query: 394 AAGTFC--YIDPEYQQTGMLTTKSDIYSFGIMLLQIIT 429
++ PE TT+SDI+SFG++L +I T
Sbjct: 182 GRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 1e-17
Identities = 70/265 (26%), Positives = 121/265 (45%), Gaps = 31/265 (11%)
Query: 237 IGEGGYGPV--YRGKLDHTPVAIKVL--RPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGA 292
+G+G YG V R + D IK L R + + ++ +QE ++LS ++HPN+V +
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67
Query: 293 CPDYGCLVYEYM---HNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPL 349
L+Y M G L +L + ++P + + +IA AL +LH+ + +
Sbjct: 68 WEGEDGLLYIVMGFCEGGDLYHKL-KEQKGKLLPENQVVEWFVQIAMALQYLHE---KHI 123
Query: 350 VHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSA-AGTFCYIDPEYQQT 408
+HRDLK N+ L R + K+ D+G+AR++ Q M S GT Y+ PE
Sbjct: 124 LHRDLKTQNVFLTRTNIIKVGDLGIARVLE-------NQCDMASTLIGTPYYMSPELFSN 176
Query: 409 GMLTTKSDIYSFGIMLLQIITARSPMG---LTHHVSRAIEKGTLAEMLDPAVTDWPAEAA 465
KSD+++ G + ++ T + + V R IE G L M P + +
Sbjct: 177 KPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIE-GKLPPM--------PKDYS 227
Query: 466 ESFSKLAIQCAELRKKDRPDLGTVI 490
+L R + RP + +++
Sbjct: 228 PELGELIATMLSKRPEKRPSVKSIL 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 2e-17
Identities = 76/281 (27%), Positives = 121/281 (43%), Gaps = 44/281 (15%)
Query: 237 IGEGGYGPV----YRGKLDHTP--VAIKVLRPDAAQGKRQ-FQQEVEVLSSIRHPNMVLL 289
+GEG +G V Y D T VA+K L+ + Q +++E+ +L ++ H N+V
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71
Query: 290 LGACPDYG----CLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAK 345
G C + G L+ EY+ GSL D L + + + A +I + +LH
Sbjct: 72 KGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHK----LNLAQLLLFAQQICEGMAYLHSQH 127
Query: 346 PEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAG---TFCYID 402
+HRDL N+LLD + + KI D GLA+ VP +Y+ G F Y
Sbjct: 128 ---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG-----HEYYRVREDGDSPVFWYA- 178
Query: 403 PEYQQTGMLTTKSDIYSFGIMLLQIIT----ARSP----MGLTHHVSRAIEKGTLAEMLD 454
E + + SD++SFG+ L +++T +SP + + L E+L+
Sbjct: 179 VECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLE 238
Query: 455 -----PAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVI 490
P + P E L C E K RP ++I
Sbjct: 239 RGMRLPCPKNCPQEV----YILMKNCWETEAKFRPTFRSLI 275
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 2e-17
Identities = 53/202 (26%), Positives = 103/202 (50%), Gaps = 18/202 (8%)
Query: 237 IGEGGYGP--VYRGKLDHTPVAIKV--LRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGA 292
+G+G +G +YR D + V K L + + +R E+ +LS ++HPN++
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNH 67
Query: 293 CPDYGCLV--YEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLV 350
D L+ EY + G+L D+++R+ + +I +A+ ++H+A ++
Sbjct: 68 FMDDNTLLIEMEYANGGTLYDKIVRQKGQ-LFEEEMVLWYLFQIVSAVSYIHKAG---IL 123
Query: 351 HRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMT-SAAGTFCYIDPEYQQTG 409
HRD+K NI L + + K+ D G+++++ ++Y M + GT Y+ PE Q
Sbjct: 124 HRDIKTLNIFLTKAGLIKLGDFGISKILG-------SEYSMAETVVGTPYYMSPELCQGV 176
Query: 410 MLTTKSDIYSFGIMLLQIITAR 431
KSDI++ G +L +++T +
Sbjct: 177 KYNFKSDIWALGCVLYELLTLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 2e-17
Identities = 65/206 (31%), Positives = 102/206 (49%), Gaps = 24/206 (11%)
Query: 237 IGEGGYGPV----YRGKLDHTP--VAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLL 290
+G+G +G V Y D+T VA+K L+ A+ R F++E+E+L S++H N+V
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71
Query: 291 GACPDYG----CLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKP 346
G C G LV EY+ GSL D L + + + RK A++I + +L +
Sbjct: 72 GVCYSAGRRNLRLVMEYLPYGSLRDYLQK--HRERLDHRKLLLYASQICKGMEYLGSKR- 128
Query: 347 EPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAG---TFCYIDP 403
VHRDL NIL++ KI D GL +++P +Y+ G F Y P
Sbjct: 129 --YVHRDLATRNILVESENRVKIGDFGLTKVLPQD-----KEYYKVREPGESPIFWYA-P 180
Query: 404 EYQQTGMLTTKSDIYSFGIMLLQIIT 429
E + SD++SFG++L ++ T
Sbjct: 181 ESLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 2e-17
Identities = 63/217 (29%), Positives = 103/217 (47%), Gaps = 30/217 (13%)
Query: 236 KIGEGGYGPVYRGKL-----DHTP-VAIKVLRP-DAAQGKRQFQQEVEVLSSIRHPNMVL 288
++GE +G +Y+G L DH VAIK L+ + Q +FQQE +++ + HPN+V
Sbjct: 12 ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVC 71
Query: 289 LLGACPDYG--CLVYEYMHNGSLEDRLLRRGNTPVIPWRKR--------------FKIAA 332
LLG C+++EY++ G L + L+ R + IA
Sbjct: 72 LLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI 131
Query: 333 EIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMT 392
+IA + +L VH+DL NIL+ KISD+GL+R + + V +
Sbjct: 132 QIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLL 188
Query: 393 SAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT 429
++ PE G ++ SDI+SFG++L +I +
Sbjct: 189 PIR----WMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 3e-17
Identities = 57/210 (27%), Positives = 100/210 (47%), Gaps = 19/210 (9%)
Query: 237 IGEGGYGPVYRG--KLDHTPVAIKVLR---PDAAQGKRQ------FQQEVEVLSSIRHPN 285
IG G +G VY G +A+K + A+ R+ +E+ +L ++H N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 286 MVLLLGACPD--YGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQ 343
+V LG+ D + + EY+ GS+ L G R + +I L +LH
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVR---QILKGLNYLHN 124
Query: 344 AKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDP 403
++HRD+K ANIL+D KISD G+++ + + + T S G+ ++ P
Sbjct: 125 RG---IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAP 181
Query: 404 EYQQTGMLTTKSDIYSFGIMLLQIITARSP 433
E + T K+DI+S G ++++++T + P
Sbjct: 182 EVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.6 bits (202), Expect = 4e-17
Identities = 64/221 (28%), Positives = 97/221 (43%), Gaps = 41/221 (18%)
Query: 226 EATDKFSEAMKIGEGGYGPVYRGKLDHTP--VAIKVLRPDAAQGKRQFQQEVEVL---SS 280
+ T F IGEG YG VY+ + T VAIK++ + + + ++E +L S+
Sbjct: 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE-EEEIKEEYNILRKYSN 61
Query: 281 IRHPNMVLLLGA--------CPDYGCLVYEYMHNGSLED---RLLRRGNT---PVIPWRK 326
HPN+ GA D LV E GS+ D L ++G I +
Sbjct: 62 --HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAY-- 117
Query: 327 RFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSV 386
I E L +LH+ K ++HRD+K NILL +N K+ D G++ + DS
Sbjct: 118 ---ILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGVSAQL-----DS- 165
Query: 387 TQYHMTSAAGTFCYIDPE-----YQQTGMLTTKSDIYSFGI 422
T + GT ++ PE Q +SD++S GI
Sbjct: 166 TLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGI 206
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 5e-17
Identities = 63/204 (30%), Positives = 104/204 (50%), Gaps = 22/204 (10%)
Query: 237 IGEGGYGPVYRGKLDHTP----VAIKVLRPDAAQG-KRQFQQEVEVLSSIRHPNMVLLLG 291
+G G G V K+ H P +A KV+ A ++Q +E++++ R P +V G
Sbjct: 13 LGAGNGGSV--SKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYG 70
Query: 292 ACPDYG--CLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPL 349
A + C+ E+M GSL DR+ ++G IP KIA + L +L+ +
Sbjct: 71 AFLNENNICMCMEFMDCGSL-DRIYKKGGP--IPVEILGKIAVAVVEGLTYLYNV--HRI 125
Query: 350 VHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTG 409
+HRD+KP+NIL++ K+ D G++ + S+AD+ GT Y+ PE Q G
Sbjct: 126 MHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFV--------GTSTYMSPERIQGG 177
Query: 410 MLTTKSDIYSFGIMLLQIITARSP 433
T KSD++S GI ++++ + P
Sbjct: 178 KYTVKSDVWSLGISIIELALGKFP 201
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 5e-17
Identities = 73/266 (27%), Positives = 121/266 (45%), Gaps = 28/266 (10%)
Query: 236 KIGEGGYGPVYRGK--LDHTPVAIK---VLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLL 290
KIG G + VYR LD PVA+K + A+ ++ +E+++L + HPN++ L
Sbjct: 9 KIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYL 68
Query: 291 GACPDYGCL--VYEYMHNGSLEDRLLR-RGNTPVIPWRKRFKIAAEIATALLFLHQAKPE 347
+ + L V E G L + + +IP R +K ++ +A+ +H +
Sbjct: 69 DSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR-- 126
Query: 348 PLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQ 407
++HRD+KPAN+ + V K+ D+GL R + T H S GT Y+ PE
Sbjct: 127 -VMHRDIKPANVFITATGVVKLGDLGLGRF----FSSKTTAAH--SLVGTPYYMSPERIH 179
Query: 408 TGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAVTDWPAEAAES 467
KSDI+S G +L ++ +SP + +L + ++ D+P E
Sbjct: 180 ENGYNFKSDIWSLGCLLYEMAALQSPF-----YGDKMNLFSLCQKIEQC--DYPPLPTEH 232
Query: 468 FSK----LAIQCAELRKKDRPDLGTV 489
+S+ L C RPD+G V
Sbjct: 233 YSEKLRELVSMCIYPDPDQRPDIGYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 5e-17
Identities = 65/208 (31%), Positives = 103/208 (49%), Gaps = 17/208 (8%)
Query: 237 IGEGGYGPVYRGKLDHTP-VAIK--VLRP---DAAQGK-RQFQQEVEVLSSIRHPNMVLL 289
+G+G YG VY G + +A+K L AA+ + + Q+EV++L S++H N+V
Sbjct: 8 LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQY 67
Query: 290 LGACPDYGCL--VYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPE 347
LG C D + E++ GS+ L R G P + K K +I + +LH
Sbjct: 68 LGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTK---QILDGVAYLHN---N 121
Query: 348 PLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHM-TSAAGTFCYIDPEYQ 406
+VHRD+K N++L N + K+ D G AR + V T +M S GT ++ PE
Sbjct: 122 CVVHRDIKGNNVMLMPNGIIKLIDFGCARRL-AWVGLHGTHSNMLKSMHGTPYWMAPEVI 180
Query: 407 QTGMLTTKSDIYSFGIMLLQIITARSPM 434
KSDI+S G + ++ T + P+
Sbjct: 181 NESGYGRKSDIWSIGCTVFEMATGKPPL 208
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 6e-17
Identities = 71/279 (25%), Positives = 117/279 (41%), Gaps = 45/279 (16%)
Query: 237 IGEGGYGPVYRGKLDHT-------PVAIKVLRPDAA-QGKRQFQQEVEVLSSIRHPNMVL 288
+G G +G VY G VA+K L + Q + F E ++S H N+V
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73
Query: 289 LLGAC----PDYGCLVYEYMHNGSLEDRLLRRGNTPVIP----WRKRFKIAAEIATALLF 340
L+G P + ++ E M G L+ L P P + A ++A +
Sbjct: 74 LIGVSFERLPRF--ILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKY 131
Query: 341 LHQAKPEPLVHRDLKPANILL-----DRNYVSKISDVGLARLVPPSVADSVTQYHMTS-- 393
L + +HRD+ N LL R V+KI+D G+AR + + Y+
Sbjct: 132 LEENH---FIHRDIAARNCLLTCKGPGR--VAKIADFGMARDIYRA------SYYRKGGR 180
Query: 394 AAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPM-GLTHHVSRAIEKGTLAE 451
A ++ PE G+ T+K+D++SFG++L +I + P G T+ +E T
Sbjct: 181 AMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN--QEVMEFVTGGG 238
Query: 452 MLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVI 490
LDP P ++ C + +DRP+ T++
Sbjct: 239 RLDP-----PKGCPGPVYRIMTDCWQHTPEDRPNFATIL 272
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 80.8 bits (200), Expect = 7e-17
Identities = 53/175 (30%), Positives = 77/175 (44%), Gaps = 17/175 (9%)
Query: 236 KIGEGGYGPVYRGKLDHT--PVAIK--VLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLG 291
+IGEG +G V++ K T VA+K LR Q +E++ L + +HP +V LL
Sbjct: 7 RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLD 66
Query: 292 ACPDYGC--LVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPL 349
P LV EYM L + L K + + + ++H +
Sbjct: 67 VFPHGSGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSY--MRMLLKGVAYMHANG---I 120
Query: 350 VHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPE 404
+HRDLKPAN+L+ + V KI+D GLARL + T Y PE
Sbjct: 121 MHRDLKPANLLISADGVLKIADFGLARLF-----SEEEPRLYSHQVATRWYRAPE 170
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 80.4 bits (199), Expect = 7e-17
Identities = 62/254 (24%), Positives = 95/254 (37%), Gaps = 44/254 (17%)
Query: 237 IGEGGYGPVYRGKLDHTP--------VAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVL 288
IG+G +G V + T K + + + E +L + HP +V
Sbjct: 8 IGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLN---ERRILQELNHPFLVN 64
Query: 289 LLGACPD--YGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFK------IAAEIATALLF 340
L + D LV + + G L L ++ +F EI AL +
Sbjct: 65 LWYSFQDEENMYLVVDLLLGGDLRYHLSQKV---------KFSEEQVKFWICEIVLALEY 115
Query: 341 LHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCY 400
LH ++HRD+KP NILLD I+D +A V P TS +GT Y
Sbjct: 116 LHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT-------LTTSTSGTPGY 165
Query: 401 IDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAVT-- 458
+ PE + D +S G+ + + + P SR I A+ V
Sbjct: 166 MAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPY---RGHSRTIRDQIRAKQETADVLYP 222
Query: 459 -DWPAEAAESFSKL 471
W EA ++ +KL
Sbjct: 223 ATWSTEAIDAINKL 236
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 1e-16
Identities = 52/162 (32%), Positives = 86/162 (53%), Gaps = 19/162 (11%)
Query: 274 EVEVLSSIRHPNMVLLLGACPDYGC--LVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIA 331
E+ + ++HPN+V L+G C L++EY+ +L + L + W +R KIA
Sbjct: 733 EIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN------LSWERRRKIA 786
Query: 332 AEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHM 391
IA AL FLH +V +L P I++D + RL P + + T+ +
Sbjct: 787 IGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL------RLSLPGLLCTDTKCFI 840
Query: 392 TSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSP 433
+SA Y+ PE ++T +T KSDIY FG++L++++T +SP
Sbjct: 841 SSA-----YVAPETRETKDITEKSDIYGFGLILIELLTGKSP 877
|
Length = 968 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 1e-16
Identities = 63/217 (29%), Positives = 105/217 (48%), Gaps = 38/217 (17%)
Query: 236 KIGEGGYGPVYRGKLDHTPV----AIKVL---RPDAAQGKRQFQQEVEVLSSIRHPNMVL 288
+IG G G VY K+ H P A+KV+ D +RQ +E+E+L + HPN+V
Sbjct: 81 RIGSGAGGTVY--KVIHRPTGRLYALKVIYGNHEDTV--RRQICREIEILRDVNHPNVVK 136
Query: 289 LLGACPDYGCL--VYEYMHNGSLEDRLLRRGNTPVIPWRKRF--KIAAEIATALLFLHQA 344
G + + E+M GSLE + ++F +A +I + + +LH+
Sbjct: 137 CHDMFDHNGEIQVLLEFMDGGSLEGTHI---------ADEQFLADVARQILSGIAYLHRR 187
Query: 345 KPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPE 404
+VHRD+KP+N+L++ KI+D G++R++ + T S+ GT Y+ PE
Sbjct: 188 H---IVHRDIKPSNLLINSAKNVKIADFGVSRIL------AQTMDPCNSSVGTIAYMSPE 238
Query: 405 YQQTGMLTTK-----SDIYSFGIMLLQIITARSPMGL 436
T + DI+S G+ +L+ R P G+
Sbjct: 239 RINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGV 275
|
Length = 353 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.0 bits (198), Expect = 1e-16
Identities = 62/219 (28%), Positives = 101/219 (46%), Gaps = 34/219 (15%)
Query: 229 DKFSEAMKIGEGGYGPVYRGKLDHT--PVAIKVLRPDAAQGKRQF-QQEVEVLSSIRHPN 285
+ F+ IG+G +G VY+ T VAIKV+ + A+ + + QQE++ LS R P
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPY 60
Query: 286 MVLLLGACPDYGC--------LVYEYMHNGSLEDRLLRRG--NTPVIPWRKRFKIAAEIA 335
+ YG ++ EY GS D LL+ G + I + I E+
Sbjct: 61 ITKY------YGSFLKGSKLWIIMEYCGGGSCLD-LLKPGKLDETYIAF-----ILREVL 108
Query: 336 TALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAA 395
L +LH+ E +HRD+K ANILL K++D G++ + + T +
Sbjct: 109 LGLEYLHE---EGKIHRDIKAANILLSEEGDVKLADFGVSGQL------TSTMSKRNTFV 159
Query: 396 GTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPM 434
GT ++ PE + K+DI+S GI +++ P+
Sbjct: 160 GTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPL 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 80.3 bits (199), Expect = 1e-16
Identities = 46/154 (29%), Positives = 77/154 (50%), Gaps = 23/154 (14%)
Query: 236 KIGEGGYGPVYRG--KLDHTPVAIKVLRPDAAQGKRQFQQ---------EVEVLSSIRHP 284
K+GEG Y VY+ K VAIK ++ G+R+ + E+++L ++HP
Sbjct: 7 KLGEGTYAVVYKARDKETGRIVAIKKIKL----GERKEAKDGINFTALREIKLLQELKHP 62
Query: 285 NMVLLLGACPDYG--CLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLH 342
N++ LL LV+E+M LE ++++ + + P + L +LH
Sbjct: 63 NIIGLLDVFGHKSNINLVFEFME-TDLE-KVIKDKSIVLTPADIK-SYMLMTLRGLEYLH 119
Query: 343 QAKPEPLVHRDLKPANILLDRNYVSKISDVGLAR 376
++HRDLKP N+L+ + V K++D GLAR
Sbjct: 120 SNW---ILHRDLKPNNLLIASDGVLKLADFGLAR 150
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 2e-16
Identities = 57/207 (27%), Positives = 105/207 (50%), Gaps = 34/207 (16%)
Query: 236 KIGEGGYGPV----YRGKLDHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLG 291
++G G +G V +RG+ D VAIK+++ + + + +F +E +V+ + H +V L G
Sbjct: 11 ELGTGQFGVVKYGKWRGQYD---VAIKMIK-EGSMSEDEFIEEAKVMMKLSHEKLVQLYG 66
Query: 292 AC----PDYGCLVYEYMHNGSLED--RLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAK 345
C P Y +V EYM NG L + R + P + ++ ++ + +L +
Sbjct: 67 VCTKQRPIY--IVTEYMSNGCLLNYLREHGKRFQPS----QLLEMCKDVCEGMAYLESKQ 120
Query: 346 PEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGT---FCYID 402
+HRDL N L+D K+SD GL+R V + D +Y TS+ G+ +
Sbjct: 121 ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYV---LDD---EY--TSSVGSKFPVRWSP 169
Query: 403 PEYQQTGMLTTKSDIYSFGIMLLQIIT 429
PE ++KSD+++FG+++ ++ +
Sbjct: 170 PEVLLYSKFSSKSDVWAFGVLMWEVYS 196
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 2e-16
Identities = 63/217 (29%), Positives = 92/217 (42%), Gaps = 37/217 (17%)
Query: 236 KIGEGGYGPVYRG--KLDHTPVAIKVLRPDAAQGKRQF-QQEVEVLSSIRHPNMVLLLGA 292
IG G VY ++ VAIK + + Q ++EV+ +S HPN+V
Sbjct: 8 VIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVV----- 62
Query: 293 CPDYGC---------LVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAA---EIATALLF 340
Y LV Y+ GSL D + + IA E+ L +
Sbjct: 63 --KYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLD---EAIIATVLKEVLKGLEY 117
Query: 341 LHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHM--TSAAGTF 398
LH +HRD+K NILL + KI+D G V S+AD + + GT
Sbjct: 118 LHS---NGQIHRDIKAGNILLGEDGSVKIADFG----VSASLADGGDRTRKVRKTFVGTP 170
Query: 399 CYIDPE--YQQTGMLTTKSDIYSFGIMLLQIITARSP 433
C++ PE Q G K+DI+SFGI +++ T +P
Sbjct: 171 CWMAPEVMEQVHGY-DFKADIWSFGITAIELATGAAP 206
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 2e-16
Identities = 58/207 (28%), Positives = 96/207 (46%), Gaps = 25/207 (12%)
Query: 237 IGEGGYGPVYRGK---LDHT----PVAIKVLRPDAAQGKRQ-FQQEVEVLSSI-RHPNMV 287
+G G +G V L + VA+K+L+P A +R+ E++++S + H N+V
Sbjct: 43 LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIV 102
Query: 288 LLLGACPDYG--CLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAK 345
LLGAC G ++ EY G L + LRR + + ++A + FL
Sbjct: 103 NLLGACTIGGPILVITEYCCYGDLLN-FLRRKRESFLTLEDLLSFSYQVAKGMAFL---A 158
Query: 346 PEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFC---YID 402
+ +HRDL N+LL + KI D GLAR D + + ++
Sbjct: 159 SKNCIHRDLAARNVLLTHGKIVKICDFGLAR-------DIMNDSNYVVKGNARLPVKWMA 211
Query: 403 PEYQQTGMLTTKSDIYSFGIMLLQIIT 429
PE + T +SD++S+GI+L +I +
Sbjct: 212 PESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 2e-16
Identities = 82/288 (28%), Positives = 130/288 (45%), Gaps = 39/288 (13%)
Query: 225 EEATDKFSEAMKIGEGGYGPVYRGKLD-------HTPVAIKVLRPDAAQGKR-QFQQEVE 276
E A +K + + ++G+G +G VY G T VAIK + A+ +R +F E
Sbjct: 2 EVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 61
Query: 277 VLSSIRHPNMVLLLGACPD--YGCLVYEYMHNGSLED--RLLR--RGNTPVI---PWRKR 327
V+ ++V LLG ++ E M G L+ R LR N PV +K
Sbjct: 62 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKM 121
Query: 328 FKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVT 387
++A EIA + +L+ K VHRDL N ++ ++ KI D G+ R + T
Sbjct: 122 IQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE------T 172
Query: 388 QYHMTSAAGTFC--YIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSP-MGLTH-HVSR 442
Y+ G ++ PE + G+ TT SD++SFG++L +I T A P G+++ V R
Sbjct: 173 DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLR 232
Query: 443 AIEKGTLAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVI 490
+ +G L D P + +L C + K RP +I
Sbjct: 233 FVMEGGL--------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEII 272
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.1 bits (196), Expect = 2e-16
Identities = 51/161 (31%), Positives = 74/161 (45%), Gaps = 28/161 (17%)
Query: 236 KIGEGGYGPVYRGKLDHTP--VAIKVLRPDAAQGKRQFQ--------QEVEVLSSI-RHP 284
++G+G +G VY + T VAIK + K++F +EV+ L + HP
Sbjct: 6 QLGDGTFGSVYLARNKETGELVAIKKM-------KKKFYSWEECMNLREVKSLRKLNEHP 58
Query: 285 NMVLLLGACPDYGCL--VYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLH 342
N+V L + L V+EYM G+L + R P I +I L +H
Sbjct: 59 NIVKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKP-FSESVIRSIIYQILQGLAHIH 116
Query: 343 QAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLV---PP 380
+ HRDLKP N+L+ V KI+D GLAR + PP
Sbjct: 117 KHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP 154
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.2 bits (196), Expect = 3e-16
Identities = 74/267 (27%), Positives = 118/267 (44%), Gaps = 56/267 (20%)
Query: 231 FSEAMKIGEGGYGPVYRGK--LDHTPVAIKVLR-PDAAQGKRQFQ-QEVEVLSSIR---H 283
+ E +IGEG YG VY+ + VA+K +R P + +G +E+ +L + H
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEH 60
Query: 284 PNMVLLLGACPDYGC---------LVYEYMHNGSLED--RLLRRGNTPVIPWRKRFKIAA 332
PN+V LL C +G LV+E++ +D L + P +P +
Sbjct: 61 PNIVRLLDVC--HGPRTDRELKLTLVFEHVD----QDLATYLSKCPKPGLPPETIKDLMR 114
Query: 333 EIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHM- 391
++ + FLH + +VHRDLKP NIL+ + KI+D GLAR + + M
Sbjct: 115 QLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR---------IYSFEMA 162
Query: 392 -TSAAGTFCYIDPE--YQQTGMLTTKSDIYSFGIMLLQIITARSPM--GLTHHVSRAIEK 446
TS T Y PE Q + T D++S G + ++ R P+ G + E
Sbjct: 163 LTSVVVTLWYRAPEVLLQSSYA--TPVDMWSVGCIFAELFR-RRPLFRGTS-------EA 212
Query: 447 GTLAEMLD----PAVTDWPAEAAESFS 469
L ++ D P+ +WP + S
Sbjct: 213 DQLDKIFDVIGLPSEEEWPRNVSLPRS 239
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 3e-16
Identities = 63/250 (25%), Positives = 100/250 (40%), Gaps = 41/250 (16%)
Query: 237 IGEGGYGPVY--RGKLDHTPVAIKVLRPDAAQGKRQ---FQQEVEVLSSIRH-PNMVLLL 290
I +G +G VY + + AIKVL+ K Q + E ++ P + L
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63
Query: 291 GA--CPDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEP 348
+ DY LV EY++ G + G P W K++ AE+ + LHQ
Sbjct: 64 YSFQSKDYLYLVMEYLNGGDCASLIKTLGGLP-EDWAKQY--IAEVVLGVEDLHQ---RG 117
Query: 349 LVHRDLKPANILLDRNYVSKISDVGLAR--LVPPSVADSVTQYHMTSAAGTFCYIDPEYQ 406
++HRD+KP N+L+D+ K++D GL+R L GT Y+ PE
Sbjct: 118 IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKF------------VGTPDYLAPETI 165
Query: 407 QTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAVT---DWPAE 463
SD +S G ++ + + P T + D ++ +WP E
Sbjct: 166 LGVGDDKMSDWWSLGCVIFEFLFGYPPF----------HAETPDAVFDNILSRRINWPEE 215
Query: 464 AAESFSKLAI 473
E S A+
Sbjct: 216 VKEFCSPEAV 225
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 4e-16
Identities = 71/250 (28%), Positives = 115/250 (46%), Gaps = 32/250 (12%)
Query: 255 VAIKVLRPDAAQGKRQ---FQQEVEVLSSIRHPNMVLLL--GACPDYGCL--VYEYMHNG 307
VAIK+LR DA + + Q F++E + + + HPN+V LL G P G L V+EY+
Sbjct: 6 VAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPP-GLLFAVFEYVPGR 64
Query: 308 SLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILL---DRN 364
+L + L G +P + ++ ++ AL H +VHRDLKP NI++
Sbjct: 65 TLREVLAADG---ALPAGETGRLMLQVLDALACAHNQG---IVHRDLKPQNIMVSQTGVR 118
Query: 365 YVSKISDVGLARLVPPSVADSVTQYHMTSAA-GTFCYIDPEYQQTGMLTTKSDIYSFGIM 423
+K+ D G+ L+P V T+ GT Y PE + +T SD+Y++G++
Sbjct: 119 PHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLI 178
Query: 424 LLQIITARSPMG-------LTHHVS-------RAIEKGTLAEMLDPAVTDWPAEAAESFS 469
L+ +T + + L +S I L ++L A+ P + A S
Sbjct: 179 FLECLTGQRVVQGASVAEILYQQLSPVDVSLPPWIAGHPLGQVLRKALNKDPRQRAASAP 238
Query: 470 KLAIQCAELR 479
LA + L
Sbjct: 239 ALAERFRALE 248
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 4e-16
Identities = 71/271 (26%), Positives = 125/271 (46%), Gaps = 30/271 (11%)
Query: 230 KFSEAMKIGEGGYGP--VYRGKLDHTPVAIKVLRPDAAQGK--RQFQQEVEVLSSIRHPN 285
K+ + KIGEG +G + + K D IK + K + ++EV VLS+++HPN
Sbjct: 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPN 60
Query: 286 MVLLLGACPDYGCL--VYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQ 343
+V + + G L V +Y G L ++ + P + +I AL +H
Sbjct: 61 IVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVL-FPEDQILDWFVQICLALKHVHD 119
Query: 344 AKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDP 403
K ++HRD+K NI L ++ K+ D G+AR++ +V + T GT Y+ P
Sbjct: 120 RK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELART------CIGTPYYLSP 170
Query: 404 EYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAVT-DWPA 462
E + KSDI++ G +L ++ T L H A E G + ++ + +P
Sbjct: 171 EICENRPYNNKSDIWALGCVLYEMCT------LKH----AFEAGNMKNLVLKIIRGSYPP 220
Query: 463 EAAESFSKLAIQCAELRKK---DRPDLGTVI 490
++ L ++L K+ DRP + +++
Sbjct: 221 VSSHYSYDLRNLVSQLFKRNPRDRPSVNSIL 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 6e-16
Identities = 55/201 (27%), Positives = 95/201 (47%), Gaps = 22/201 (10%)
Query: 236 KIGEGGYGPVYRGKL-DHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGAC- 293
++G G +G V+ GK VAIK + + A + F +E +V+ + HP +V L G C
Sbjct: 11 ELGSGQFGVVHLGKWRAQIKVAIKAIN-EGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCT 69
Query: 294 ---PDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLV 350
P Y +V E+M NG L + L R + + ++ + +L + +
Sbjct: 70 QQKPLY--IVTEFMENGCLLNYL--RQRQGKLSKDMLLSMCQDVCEGMEYLERNS---FI 122
Query: 351 HRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFC--YIDPEYQQT 408
HRDL N L+ V K+SD G+ R V + + +S+ F + PE
Sbjct: 123 HRDLAARNCLVSSTGVVKVSDFGMTRYV-------LDDEYTSSSGAKFPVKWSPPEVFNF 175
Query: 409 GMLTTKSDIYSFGIMLLQIIT 429
++KSD++SFG+++ ++ T
Sbjct: 176 SKYSSKSDVWSFGVLMWEVFT 196
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 76.9 bits (190), Expect = 1e-15
Identities = 67/265 (25%), Positives = 108/265 (40%), Gaps = 31/265 (11%)
Query: 236 KIGEGGYGPVY--RGKLDHTPVAIKVL--RPDAAQGKRQFQQEVEVLSSIRHPNMVLLLG 291
IG+G +G V R K D + K + + K+Q EV +L ++HPN+V
Sbjct: 7 TIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYD 66
Query: 292 ACPD------YGCLVYEYMHNGSLEDRLLRRG--NTPVIPWRKRFKIAAEIATALLFLH- 342
D Y +V EY G L +L+++ I ++I ++ AL H
Sbjct: 67 RIIDRSNQTLY--IVMEYCEGGDLA-QLIQKCKKERKYIEEEFIWRILTQLLLALYECHN 123
Query: 343 QAKPEPLV-HRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYI 401
++ P V HRDLKPANI LD N K+ D GLA+++ + GT Y+
Sbjct: 124 RSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHD------SSFAKTYVGTPYYM 177
Query: 402 DPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEML-DPAVTDW 460
PE KSDI+S G ++ ++ P + + LA + +
Sbjct: 178 SPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQ-------LASKIKEGKFRRI 230
Query: 461 PAEAAESFSKLAIQCAELRKKDRPD 485
P + +++ + RP
Sbjct: 231 PYRYSSELNEVIKSMLNVDPDKRPS 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 1e-15
Identities = 68/287 (23%), Positives = 113/287 (39%), Gaps = 47/287 (16%)
Query: 237 IGEGGYGPVYRGKL---DHTP--VAIKVLRPD--AAQGKRQFQQEVEVLSSIRHPNMVLL 289
+GEG +G V G+L D + VA+K ++ D +F E + HPN++ L
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 290 LGAC--------PDYGCLVYEYMHNGSLEDRLL--RRGNTPV-IPWRKRFKIAAEIATAL 338
+G C ++ +M +G L LL R G P +P + K +IA +
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126
Query: 339 LFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGT- 397
+L +HRDL N +L + ++D GL++ + S Y A
Sbjct: 127 EYLSNRN---FIHRDLAARNCMLREDMTVCVADFGLSKKIY-----SGDYYRQGRIAKMP 178
Query: 398 FCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLT-------HHVSRAIEKGTLA 450
+I E + T+KSD+++FG+ + +I T G T H + + G
Sbjct: 179 VKWIAIESLADRVYTSKSDVWAFGVTMWEIAT----RGQTPYPGVENHEIYDYLRHGNRL 234
Query: 451 EMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPELNRL 497
+ P + + L C KDRP T + L +
Sbjct: 235 KQ--------PEDCLDELYDLMYSCWRADPKDRPTF-TKLREVLENI 272
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 1e-15
Identities = 63/224 (28%), Positives = 104/224 (46%), Gaps = 38/224 (16%)
Query: 237 IGEGGYGPVYR-------GKLDHTPVAIKVLRPDAAQGK-RQFQQEVEVLSSIRHPNMVL 288
+GEG +G V + G+ +T VA+K+L+ +A+ + R E +L + HP+++
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 289 LLGACPDYG--CLVYEYMHNGSLED--RLLRR-GNTPVIPWRKR---------------- 327
L GAC G L+ EY GSL R R+ G + + R
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127
Query: 328 --FKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADS 385
A +I+ + +L + K LVHRDL N+L+ KISD GL+R V +
Sbjct: 128 DLISFAWQISRGMQYLAEMK---LVHRDLAARNVLVAEGRKMKISDFGLSR----DVYEE 180
Query: 386 VTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT 429
+ + ++ E + TT+SD++SFG++L +I+T
Sbjct: 181 DSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 76.2 bits (188), Expect = 2e-15
Identities = 62/226 (27%), Positives = 95/226 (42%), Gaps = 44/226 (19%)
Query: 236 KIGEGGYGPVYRG--KLDHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGAC 293
K+GEG YG VY+ K VAIKV+ + ++ +E+ +L P +V
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDL--QEIIKEISILKQCDSPYIVKY---- 63
Query: 294 PDYGC--------LVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALL------ 339
YG +V EY GS+ D + T EIA L
Sbjct: 64 --YGSYFKNTDLWIVMEYCGAGSVSDIMKITNKT---------LTEEEIAAILYQTLKGL 112
Query: 340 -FLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTF 398
+LH K +HRD+K NILL+ +K++D G++ + + T + GT
Sbjct: 113 EYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQL------TDTMAKRNTVIGTP 163
Query: 399 CYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAI 444
++ PE Q K+DI+S GI +++ + P H RAI
Sbjct: 164 FWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYS-DIHPMRAI 208
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 3e-15
Identities = 53/206 (25%), Positives = 93/206 (45%), Gaps = 18/206 (8%)
Query: 237 IGEGGYGPVY------RGK-LDHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLL 289
+G+G +G VY G+ L V P+ + + E+++L +++H +V
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 290 LGACPDYG--CLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPE 347
G D + EYM GS++D+L G RK + +I + +LH
Sbjct: 70 YGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTR---QILEGVEYLHSNM-- 124
Query: 348 PLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQ 407
+VHRD+K ANIL D K+ D G ++ + + M S GT ++ PE
Sbjct: 125 -IVHRDIKGANILRDSAGNVKLGDFGASKRLQ---TICSSGTGMKSVTGTPYWMSPEVIS 180
Query: 408 TGMLTTKSDIYSFGIMLLQIITARSP 433
K+D++S G +++++T + P
Sbjct: 181 GEGYGRKADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 3e-15
Identities = 49/200 (24%), Positives = 90/200 (45%), Gaps = 17/200 (8%)
Query: 236 KIGEGGYGPVYRG-----KLDHTPVAIKVLRPDAAQGKRQ-FQQEVEVLSSIRHPNMVLL 289
IGEG +G VY+G + + VA+K + + R+ F QE ++ HP++V L
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 290 LGACPDYGC-LVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEP 348
+G + +V E G L L + + + +++TAL +L +
Sbjct: 73 IGVITENPVWIVMELAPLGELRSYLQVNKYS--LDLASLILYSYQLSTALAYLESKR--- 127
Query: 349 LVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQT 408
VHRD+ N+L+ K+ D GL+R + + + Y + ++ PE
Sbjct: 128 FVHRDIAARNVLVSSPDCVKLGDFGLSRYL-----EDESYYKASKGKLPIKWMAPESINF 182
Query: 409 GMLTTKSDIYSFGIMLLQII 428
T+ SD++ FG+ + +I+
Sbjct: 183 RRFTSASDVWMFGVCMWEIL 202
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 5e-15
Identities = 63/275 (22%), Positives = 114/275 (41%), Gaps = 40/275 (14%)
Query: 232 SEAMKIGEGGYGPVYRGKL-------DHTPVAIKVLRP-DAAQGKRQFQQEVEVLSSIRH 283
E +G G +G V+ K T V +K L+ + +F++E+++ + H
Sbjct: 8 QEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSH 67
Query: 284 PNMVLLLGAC--PDYGCLVYEYMHNGSLEDRLL--RRGNTPVIPW----RKRFKIAAEIA 335
N+V LLG C + ++ EY G L+ L + + + P +++ + +IA
Sbjct: 68 KNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIA 127
Query: 336 TALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAA 395
+ L A+ VHRDL N L+ K+S + L++ V S Y + +A
Sbjct: 128 LGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLLSLSKDVYNS-----EYYKLRNAL 179
Query: 396 GTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITAR----SPMGLTHHVSRAIEKGTLAE 451
++ PE Q +TKSD++SFG+++ ++ T + ++R
Sbjct: 180 IPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGK---- 235
Query: 452 MLDPAVTDWPAEAA--ESFSKLAIQCAELRKKDRP 484
+ P KL +C + KDRP
Sbjct: 236 ------LELPVPEGCPSRLYKLMTRCWAVNPKDRP 264
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 6e-15
Identities = 79/288 (27%), Positives = 133/288 (46%), Gaps = 39/288 (13%)
Query: 225 EEATDKFSEAMKIGEGGYGPVY--------RGKLDHTPVAIKVLRPDAAQGKR-QFQQEV 275
E + +K + ++G+G +G VY +G+ + T VA+K + A+ +R +F E
Sbjct: 2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAE-TRVAVKTVNESASLRERIEFLNEA 60
Query: 276 EVLSSIRHPNMVLLLGACP--DYGCLVYEYMHNGSLED--RLLR--RGNTPVIP---WRK 326
V+ ++V LLG +V E M +G L+ R LR N P P ++
Sbjct: 61 SVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQE 120
Query: 327 RFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSV 386
++AAEIA + +L+ K VHRDL N ++ ++ KI D G+ R +
Sbjct: 121 MIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYE------ 171
Query: 387 TQYHMTSAAGTF--CYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSP-MGLTHHVSR 442
T Y+ G ++ PE + G+ TT SD++SFG++L +I + A P GL++
Sbjct: 172 TDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN---- 227
Query: 443 AIEKGTLAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVI 490
+ L ++D D P E + L C + K RP ++
Sbjct: 228 ---EQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIV 272
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 7e-15
Identities = 68/216 (31%), Positives = 107/216 (49%), Gaps = 24/216 (11%)
Query: 231 FSEAMKIGEGGYGPVYRGKLDHTP--VAIKVLRPDAAQGK-RQFQQEVEVLSSIRHPNMV 287
F++ +IG+G +G V++G + T VAIK++ + A+ + QQE+ VLS P +
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 288 LLLGACPDYGCL--VYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAA---EIATALLFLH 342
G+ L + EY+ GS D LLR G P+ + F+IA EI L +LH
Sbjct: 66 KYYGSYLKGTKLWIIMEYLGGGSALD-LLRAG-----PFDE-FQIATMLKEILKGLDYLH 118
Query: 343 QAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYID 402
K +HRD+K AN+LL K++D G+A + + TQ + GT ++
Sbjct: 119 SEKK---IHRDIKAANVLLSEQGDVKLADFGVAGQL------TDTQIKRNTFVGTPFWMA 169
Query: 403 PEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTH 438
PE Q +K+DI+S GI +++ P H
Sbjct: 170 PEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMH 205
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 1e-14
Identities = 68/220 (30%), Positives = 104/220 (47%), Gaps = 43/220 (19%)
Query: 226 EATDKFSEAMKIGEGGYGPV--YRGKLDHTPVAIK-VLRP--DAAQGKRQFQQEVEVLSS 280
E T+++ + +G G +G V R +L VAIK +++P KR ++ E+++L
Sbjct: 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYR-ELKLLKH 65
Query: 281 IRHPNMVLL----LGACPD-YGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRF--KIAAE 333
+RH N++ L + D Y V E + G+ RLL P K+F +
Sbjct: 66 LRHENIISLSDIFISPLEDIY--FVTELL--GTDLHRLLTSR-----PLEKQFIQYFLYQ 116
Query: 334 IATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTS 393
I L ++H A +VHRDLKP+NIL++ N KI D GLAR+ P MT
Sbjct: 117 ILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQDP---------QMTG 164
Query: 394 AAGTFCYIDPEYQQTGMLT-----TKSDIYSFGIMLLQII 428
T Y PE MLT + DI+S G + +++
Sbjct: 165 YVSTRYYRAPEI----MLTWQKYDVEVDIWSAGCIFAEML 200
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 1e-14
Identities = 67/269 (24%), Positives = 110/269 (40%), Gaps = 37/269 (13%)
Query: 237 IGEGGYGPVYRGKLDHTPVAIKV----LRPDAAQGKRQFQQ--------EVEVLSSIRHP 284
IG+G YG VY T + V L A Q+ E+E L + H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 285 NMVLLLG--ACPDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLH 342
N+V LG +Y + EY+ GS+ LR RF ++ L +LH
Sbjct: 69 NIVQYLGFETTEEYLSIFLEYVPGGSI-GSCLRT-YGRFEEQLVRF-FTEQVLEGLAYLH 125
Query: 343 QAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYID 402
+ ++HRDLK N+L+D + + KISD G+++ D S G+ ++
Sbjct: 126 S---KGILHRDLKADNLLVDADGICKISDFGISK----KSDDIYDNDQNMSMQGSVFWMA 178
Query: 403 PEY---QQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAVTD 459
PE G + K DI+S G ++L++ R P ++ + G P +
Sbjct: 179 PEVIHSYSQGY-SAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSA--PPI-- 233
Query: 460 WPAEAAESFSKLAIQ----CAELRKKDRP 484
P + + + S +A+ C + +RP
Sbjct: 234 -PPDVSMNLSPVALDFLNACFTINPDNRP 261
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 4e-14
Identities = 65/215 (30%), Positives = 103/215 (47%), Gaps = 22/215 (10%)
Query: 231 FSEAMKIGEGGYGPVYRGKLDHTP--VAIKVLRPDAAQGK-RQFQQEVEVLSSIRHPNMV 287
F++ +IG+G +G VY+G + T VAIK++ + A+ + QQE+ VLS P +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 288 LLLGACPDYGCL--VYEYMHNGSLEDRLLRRGNTPVIPWRKRF--KIAAEIATALLFLHQ 343
G+ L + EY+ GS D LL+ G P + + I EI L +LH
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGSALD-LLKPG-----PLEETYIATILREILKGLDYLHS 119
Query: 344 AKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDP 403
E +HRD+K AN+LL K++D G+A + + TQ + GT ++ P
Sbjct: 120 ---ERKIHRDIKAANVLLSEQGDVKLADFGVAGQL------TDTQIKRNTFVGTPFWMAP 170
Query: 404 EYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTH 438
E + K+DI+S GI +++ P H
Sbjct: 171 EVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLH 205
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 4e-14
Identities = 78/269 (28%), Positives = 115/269 (42%), Gaps = 51/269 (18%)
Query: 231 FSEAMKIGEGGYGPVYRGKLDHTP--VAIKVLRPDA-AQGKRQFQ-QEVEVLSSIRHPNM 286
F + KIGEG YG VY+ + T VA+K +R D +G +E+ +L + HPN+
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 61
Query: 287 VLLLGACPDYG--CLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAA---EIATALL-- 339
V LL LV+E++H K+F A+ I L+
Sbjct: 62 VKLLDVIHTENKLYLVFEFLHQD-----------------LKKFMDASPLSGIPLPLIKS 104
Query: 340 FLHQ-------AKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMT 392
+L Q ++HRDLKP N+L++ K++D GLAR A V T
Sbjct: 105 YLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR------AFGVPVRTYT 158
Query: 393 SAAGTFCYIDPE-YQQTGMLTTKSDIYSFGIMLLQIITAR------SPMGLTHHVSRAIE 445
T Y PE +T DI+S G + +++T R S + + R +
Sbjct: 159 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL- 217
Query: 446 KGTLAEMLDPAVTDWPAEAAESFSKLAIQ 474
GT E++ P VT P + SF K A Q
Sbjct: 218 -GTPDEVVWPGVTSLP-DYKPSFPKWARQ 244
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 5e-14
Identities = 57/211 (27%), Positives = 102/211 (48%), Gaps = 37/211 (17%)
Query: 237 IGEGGYGPVYRG------KLDHTPVAIKVLRPDAA-QGKRQFQQEVEVLSSIRHPNMVLL 289
+G G +G VY+G + PVAIK+L + +F E +++S+ HP++V L
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 290 LGACPD-----------YGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATAL 338
LG C +GCL+ +Y+H +D + G+ ++ W +IA +
Sbjct: 75 LGVCLSPTIQLVTQLMPHGCLL-DYVHEH--KDNI---GSQLLLNW------CVQIAKGM 122
Query: 339 LFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTF 398
++L + + LVHRDL N+L+ KI+D GLARL + +Y+
Sbjct: 123 MYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARL----LEGDEKEYNADGGKMPI 175
Query: 399 CYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT 429
++ E T +SD++S+G+ + +++T
Sbjct: 176 KWMALECIHYRKFTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 7e-14
Identities = 63/210 (30%), Positives = 93/210 (44%), Gaps = 30/210 (14%)
Query: 237 IGEGGYGPVYRGKLDHTP--VAIKVLRPDAAQGKRQF---QQEVEVLSSIRHPNMVLLLG 291
+G+G +G V +L T A+KVL+ D E VL+ + L
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLH 62
Query: 292 AC---PDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEP 348
+C D V EY++ G L + R G R RF AAEI L FLH+
Sbjct: 63 SCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEP--RARF-YAAEIVLGLQFLHERG--- 116
Query: 349 LVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFC----YIDPE 404
+++RDLK N+LLD KI+D G+ + + VT TS TFC YI PE
Sbjct: 117 IIYRDLKLDNVLLDSEGHIKIADFGMCK---EGILGGVT----TS---TFCGTPDYIAPE 166
Query: 405 YQQTGMLTTKS-DIYSFGIMLLQIITARSP 433
+ D ++ G++L +++ +SP
Sbjct: 167 ILS-YQPYGPAVDWWALGVLLYEMLAGQSP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 71.5 bits (176), Expect = 8e-14
Identities = 61/210 (29%), Positives = 88/210 (41%), Gaps = 28/210 (13%)
Query: 237 IGEGGYGPVY--RGKLDHTPVAIKVLRPDAAQGKRQ---FQQEVEVLSSIRHPNMVLLLG 291
+G GG+G V + K + A+K ++ Q E E+L HP +V L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 292 ACPD--YGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPL 349
D Y ++ EY G L L RG + RF A + A +LH +
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDRGLFD--EYTARF-YIACVVLAFEYLHNRG---I 114
Query: 350 VHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFC----YIDPEY 405
++RDLKP N+LLD N K+ D G A+ S + TFC Y+ PE
Sbjct: 115 IYRDLKPENLLLDSNGYVKLVDFGFAK-----KLKSGQKTW------TFCGTPEYVAPEI 163
Query: 406 QQTGMLTTKSDIYSFGIMLLQIITARSPMG 435
D +S GI+L +++T R P G
Sbjct: 164 ILNKGYDFSVDYWSLGILLYELLTGRPPFG 193
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 9e-14
Identities = 54/170 (31%), Positives = 82/170 (48%), Gaps = 13/170 (7%)
Query: 229 DKFSEAMKIGEGGYGPVY--RGKLDHTPVAIK--VLRPDAAQGKRQFQQEVEVLSSIRHP 284
+K+ + KIGEG YG V+ R + VAIK V D K+ +E+ +L ++HP
Sbjct: 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHP 60
Query: 285 NMVLLLGACPDYG--CLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLH 342
N+V L+ LV+EY + L + L + N +P KI + A+ F H
Sbjct: 61 NLVNLIEVFRRKRKLHLVFEYCDHTVLNE--LEK-NPRGVPEHLIKKIIWQTLQAVNFCH 117
Query: 343 QAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMT 392
+ +HRD+KP NIL+ + K+ D G AR++ D T Y T
Sbjct: 118 KHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGP-GDDYTDYVAT 163
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 1e-13
Identities = 79/260 (30%), Positives = 115/260 (44%), Gaps = 26/260 (10%)
Query: 231 FSEAMKIGEGGYGPVYRGKLDHTP--VAIKVL---RPDAAQGKRQFQQEVEVLSSIRHPN 285
F + +G+GG+G V ++ T A K L R +G+ E ++L +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 286 MVLLLGA--CPDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQ 343
+V L A D CLV M+ G L+ + G R F AAEI L LHQ
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVF-YAAEICCGLEDLHQ 120
Query: 344 AKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDP 403
E +V+RDLKP NILLD + +ISD+GLA VP + GT Y+ P
Sbjct: 121 ---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-------IKGRVGTVGYMAP 170
Query: 404 EYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAVTDWPAE 463
E + T D ++ G +L ++I +SP + I++ E ++ V + E
Sbjct: 171 EVVKNERYTFSPDWWALGCLLYEMIAGQSPF---QQRKKKIKR----EEVERLVKEVQEE 223
Query: 464 AAESFSKLAIQ-CAELRKKD 482
+E FS A C L KD
Sbjct: 224 YSEKFSPDARSLCKMLLCKD 243
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 1e-13
Identities = 69/233 (29%), Positives = 112/233 (48%), Gaps = 38/233 (16%)
Query: 223 EIEEATDKFSEAMKIGEGGYGPVYRGKLDHTP-------VAIKVLRPDAAQG--KRQFQQ 273
EI +T +F E ++GE +G VY+G L T VAIK L+ D A+G + +F+
Sbjct: 1 EINLSTVRFME--ELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLK-DKAEGPLREEFKH 57
Query: 274 EVEVLSSIRHPNMVLLLGACPDYG--CLVYEYMHNGSLEDRLLRR------GNT------ 319
E + S ++HPN+V LLG +++ Y + L + L+ R G+T
Sbjct: 58 EAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTV 117
Query: 320 -PVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLV 378
+ I +IA + FL +VH+DL N+L+ KISD+GL R V
Sbjct: 118 KSTLEPADFVHIVTQIAAGMEFLSS---HHVVHKDLATRNVLVFDKLNVKISDLGLFREV 174
Query: 379 PPSVADSVTQYH--MTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT 429
AD Y+ M ++ ++ PE G + SDI+S+G++L ++ +
Sbjct: 175 --YAAD----YYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 1e-13
Identities = 64/228 (28%), Positives = 106/228 (46%), Gaps = 36/228 (15%)
Query: 223 EIEEATDKFSEAMKIGEGGYGPVYRGKLDHTPV--AIKVLRPDAAQGKRQFQQEVEVLSS 280
E E D+ E + +G+G YG VY + T V AIK + ++ + +E+ + S
Sbjct: 2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSY 61
Query: 281 IRHPNMVLLLGACP--DYGCLVYEYMHNGSLEDRLLR------RGNTPVIPWRKRFKIAA 332
++H N+V LG+ + + E + GSL LLR + N I + +
Sbjct: 62 LKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSA-LLRSKWGPLKDNEQTIIFYTK----- 115
Query: 333 EIATALLFLHQAKPEPLVHRDLKPANILLDR-NYVSKISDVG----LARLVPPSVADSVT 387
+I L +LH + +VHRD+K N+L++ + V KISD G LA + P ++ T
Sbjct: 116 QILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP--CTETFT 170
Query: 388 QYHMTSAAGTFCYIDPEYQQTGM--LTTKSDIYSFGIMLLQIITARSP 433
GT Y+ PE G +DI+S G ++++ T + P
Sbjct: 171 --------GTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPP 210
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 1e-13
Identities = 74/230 (32%), Positives = 104/230 (45%), Gaps = 36/230 (15%)
Query: 237 IGEGGYGPVY------RGKLDHTPVAIKVL---RPDAAQGKRQFQQEVEVLSSIRH---P 284
IG GG+G VY GK+ A+K L R QG+ E +LS + P
Sbjct: 2 IGRGGFGEVYGCRKADTGKM----YAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCP 57
Query: 285 NMVLLLGA--CPDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLH 342
+V + A PD + + M+ G L L + G V + AAEI L +H
Sbjct: 58 FIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG---VFSEAEMRFYAAEIILGLEHMH 114
Query: 343 QAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVAD-SVTQYHMTSAAGTFCYI 401
+V+RDLKPANILLD + +ISD+GLA D S + H ++ GT Y+
Sbjct: 115 N---RFVVYRDLKPANILLDEHGHVRISDLGLA-------CDFSKKKPH--ASVGTHGYM 162
Query: 402 DPEYQQTGMLTTKS-DIYSFGIMLLQIITARSPM-GLTHHVSRAIEKGTL 449
PE Q G+ S D +S G ML +++ SP I++ TL
Sbjct: 163 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL 212
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 1e-13
Identities = 75/282 (26%), Positives = 125/282 (44%), Gaps = 44/282 (15%)
Query: 237 IGEGGYGPV----YRGKLDHT--PVAIKVLRPDAAQGK-RQFQQEVEVLSSIRHPNMVLL 289
+GEG +G V Y + D+T VA+K L+P++ ++E+E+L ++ H N+V
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 290 LGACPDYGC----LVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAK 345
G C + G L+ E++ +GSL++ L R N I +++ K A +I + +L +
Sbjct: 72 KGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNK--INLKQQLKYAVQICKGMDYLGSRQ 129
Query: 346 PEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEY 405
VHRDL N+L++ + KI D GL + + + + S F Y PE
Sbjct: 130 ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSP--VFWYA-PEC 183
Query: 406 QQTGMLTTKSDIYSFGIMLLQIIT----ARSPM-------GLTH------HVSRAIEKGT 448
SD++SFG+ L +++T SPM G TH + R +E+G
Sbjct: 184 LIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGK 243
Query: 449 LAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVI 490
P E +L +C E + R +I
Sbjct: 244 RLPR--------PPNCPEEVYQLMRKCWEFQPSKRTTFQNLI 277
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 2e-13
Identities = 58/218 (26%), Positives = 88/218 (40%), Gaps = 51/218 (23%)
Query: 237 IGEGGYGPVYRG--KLDHTPVAIKVLR----PDAAQGKRQF----------QQEVEVLSS 280
+GEG YG V + L VAIK ++ + RQ +E+++++
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 281 IRHPN-MVLLLGACP-DYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFK------IAA 332
I+H N M L+ D+ LV + M + L++ V+ + R I
Sbjct: 77 IKHENIMGLVDVYVEGDFINLVMDIMASD------LKK----VVDRKIRLTESQVKCILL 126
Query: 333 EIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLAR------LVPPSVADSV 386
+I L LH+ +HRDL PANI ++ + KI+D GLAR D
Sbjct: 127 QILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDET 183
Query: 387 TQ--YHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGI 422
Q MTS T Y PE L ++ Y F +
Sbjct: 184 MQRREEMTSKVVTLWYRAPE------LLMGAEKYHFAV 215
|
Length = 335 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 2e-13
Identities = 61/224 (27%), Positives = 108/224 (48%), Gaps = 24/224 (10%)
Query: 237 IGEGGYGPVYRG------KLDHTPVAIKVLRPDAAQGKRQFQQEVE---VLSSIRHPNMV 287
+G G +G V++G PVAIK ++ + G++ FQ+ + + S+ H +V
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS--GRQTFQEITDHMLAMGSLDHAYIV 72
Query: 288 LLLGACPDYGC-LVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKP 346
LLG CP LV + GSL D + R + + ++ +IA + +L + +
Sbjct: 73 RLLGICPGASLQLVTQLSPLGSLLDHV--RQHRDSLDPQRLLNWCVQIAKGMYYLEEHR- 129
Query: 347 EPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQ 406
+VHR+L NILL + + +I+D G+A L+ P H T ++ E
Sbjct: 130 --MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIK----WMALESI 183
Query: 407 QTGMLTTKSDIYSFGIMLLQIIT--ARSPMGL-THHVSRAIEKG 447
G T +SD++S+G+ + ++++ A G+ H V +EKG
Sbjct: 184 LFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKG 227
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 2e-13
Identities = 68/272 (25%), Positives = 114/272 (41%), Gaps = 33/272 (12%)
Query: 237 IGEGGYGPVYRGKLDHT----PVAIKVLRPDAAQGKR--QFQQEVEVLSSIRHPNMVLLL 290
+GEG +G V G+L+ VA+K ++ F E + HPN++ L+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 291 GACPDYG--------CLVYEYMHNGSLEDRLL--RRGNTPV-IPWRKRFKIAAEIATALL 339
G C ++ +M +G L LL R G+ P +P + K +IA+ +
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 340 FLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFC 399
+L +HRDL N +L+ N ++D GL++ + D Q + A
Sbjct: 127 YLSSKS---FIHRDLAARNCMLNENMNVCVADFGLSKKI--YNGDYYRQGRI--AKMPVK 179
Query: 400 YIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPMGLTHHVSRAIEKGTLAEMLDPA-V 457
+I E + TTKSD++SFG+ + +I T ++P +E + + L
Sbjct: 180 WIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPY-------PGVENSEIYDYLRQGNR 232
Query: 458 TDWPAEAAESFSKLAIQCAELRKKDRPDLGTV 489
P + + L C L KDRP T+
Sbjct: 233 LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETL 264
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 2e-13
Identities = 58/208 (27%), Positives = 101/208 (48%), Gaps = 17/208 (8%)
Query: 230 KFSEAMKIGEGGYGPVYRGKLD------HTPVAIKVLR-PDAAQGKRQFQQEVEVLSSIR 282
+F + +G G +G VY+G PVAIK LR + + ++ E V++S+
Sbjct: 8 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 67
Query: 283 HPNMVLLLGACPDYGC-LVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFL 341
+P++ LLG C L+ + M G L D + R + I + +IA + +L
Sbjct: 68 NPHVCRLLGICLTSTVQLITQLMPFGCLLDYV--REHKDNIGSQYLLNWCVQIAKGMNYL 125
Query: 342 HQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYI 401
+ + LVHRDL N+L+ KI+D GLA+L+ AD +YH ++
Sbjct: 126 EERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG---ADE-KEYHAEGGKVPIKWM 178
Query: 402 DPEYQQTGMLTTKSDIYSFGIMLLQIIT 429
E + T +SD++S+G+ + +++T
Sbjct: 179 ALESILHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 2e-13
Identities = 71/225 (31%), Positives = 113/225 (50%), Gaps = 39/225 (17%)
Query: 229 DKFSEAMKIGEGGYGPVYRGKLDHTP----VAIKVLRPDA-AQGKRQFQQEVEV-LSSIR 282
D ++G G YG V K+ H P +A+K +R +Q +++ ++++ + S+
Sbjct: 1 DDLEVIEELGRGAYGVVD--KMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVD 58
Query: 283 HPNMVLLLGACPDYG----CLVYEYMHNGSLED---RLLRRGNTPVIPWRKRFKIAAEIA 335
P V GA G C+ E M + SL+ ++ +G T IP KIA I
Sbjct: 59 CPYTVTFYGALFREGDVWICM--EVM-DTSLDKFYKKVYDKGLT--IPEDILGKIAVSIV 113
Query: 336 TALLFLH-QAKPEPLVHRDLKPANILLDRNYVSKISDVGLA-RLVPPSVADSVTQYHMTS 393
AL +LH + ++HRD+KP+N+L++RN K+ D G++ LV DSV + T
Sbjct: 114 KALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLV-----DSVAK---TI 162
Query: 394 AAGTFCY-----IDPEYQQTGMLTTKSDIYSFGIMLLQIITARSP 433
AG Y I+PE Q G KSD++S GI ++++ T R P
Sbjct: 163 DAGCKPYMAPERINPELNQKG-YDVKSDVWSLGITMIELATGRFP 206
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 2e-13
Identities = 61/229 (26%), Positives = 103/229 (44%), Gaps = 36/229 (15%)
Query: 237 IGEGGYGPVYRGKLDHTP---VAIK---VLRPDAAQGKRQFQQEVEVLSS--------IR 282
+G G +G VY+ + + +A+K V P + KR+ + + + S +R
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 283 HPNMV-----LLLGACPDYGCLVYEYMHNGSLEDR---LLRRGNTPVIPWRKRFKIAAEI 334
HPN+V L D +V + + L + L + + + I ++
Sbjct: 68 HPNIVRYYKTFLEN---DRLYIVMDLIEGAPLGEHFNSLKEKKQR--FTEERIWNIFVQM 122
Query: 335 ATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSA 394
AL +LH+ K +VHRDL P NI+L + I+D GLA+ P + +TS
Sbjct: 123 VLALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAKQKQP-------ESKLTSV 173
Query: 395 AGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRA 443
GT Y PE + K+D+++FG +L Q+ T + P T+ +S A
Sbjct: 174 VGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLA 222
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 3e-13
Identities = 60/208 (28%), Positives = 99/208 (47%), Gaps = 17/208 (8%)
Query: 230 KFSEAMKIGEGGYGPVYRG------KLDHTPVAIKVLRPDAA-QGKRQFQQEVEVLSSIR 282
+ + +G G +G VY+G + PVAIKVLR + + + ++ E V++ +
Sbjct: 8 ELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVG 67
Query: 283 HPNMVLLLGACPDYGC-LVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFL 341
P + LLG C LV + M G L D + R N I + +IA + +L
Sbjct: 68 SPYVCRLLGICLTSTVQLVTQLMPYGCLLDYV--RENKDRIGSQDLLNWCVQIAKGMSYL 125
Query: 342 HQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYI 401
+ + LVHRDL N+L+ KI+D GLARL+ D T+YH ++
Sbjct: 126 EEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLD---IDE-TEYHADGGKVPIKWM 178
Query: 402 DPEYQQTGMLTTKSDIYSFGIMLLQIIT 429
E T +SD++S+G+ + +++T
Sbjct: 179 ALESILHRRFTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 3e-13
Identities = 72/262 (27%), Positives = 119/262 (45%), Gaps = 34/262 (12%)
Query: 237 IGEGGYGPVYRGKLDHTPV--AIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACP 294
+G+G +G VY+ + T + A K+++ ++ + F E+++LS +HPN+V L A
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 295 DYGCL--VYEYMHNGSLEDRL--LRRG-NTPVIPWRKRFKIAAEIATALLFLHQAKPEPL 349
L + E+ G+L+ + L RG P I R+ + ++ AL FLH K +
Sbjct: 73 YENKLWILIEFCDGGALDSIMLELERGLTEPQI----RY-VCRQMLEALNFLHSHK---V 124
Query: 350 VHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTG 409
+HRDLK NILL + K++D G+ S + T + GT ++ PE
Sbjct: 125 IHRDLKAGNILLTLDGDVKLADFGV------SAKNKSTLQKRDTFIGTPYWMAPEVVACE 178
Query: 410 MLTT-----KSDIYSFGIMLLQIITARSPMGLTH--HVSRAIEKGTLAEMLDPAVTDWPA 462
K+DI+S GI L+++ P + V I K +P D P+
Sbjct: 179 TFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKS------EPPTLDQPS 232
Query: 463 EAAESFSKLAIQCAELRKKDRP 484
+ + SF+ C DRP
Sbjct: 233 KWSSSFNDFLKSCLVKDPDDRP 254
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 3e-13
Identities = 66/208 (31%), Positives = 97/208 (46%), Gaps = 25/208 (12%)
Query: 237 IGEGGYGPVYRGKLDHTP--VAIKVL---RPDAAQGKRQFQQEVEVLSSIRH---PNMVL 288
IG GG+G VY + T A+K L R QG+ E +LS + P +V
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 289 LLGA--CPDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKP 346
+ A PD C + + M+ G L L + G V ++ A EI L +H
Sbjct: 62 MTYAFHTPDKLCFILDLMNGGDLHYHLSQHG---VFSEKEMRFYATEIILGLEHMHN--- 115
Query: 347 EPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQ 406
+V+RDLKPANILLD + +ISD+GLA ++ ++ GT Y+ PE
Sbjct: 116 RFVVYRDLKPANILLDEHGHVRISDLGLAC--------DFSKKKPHASVGTHGYMAPEVL 167
Query: 407 QTGM-LTTKSDIYSFGIMLLQIITARSP 433
Q G + +D +S G ML +++ SP
Sbjct: 168 QKGTAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 3e-13
Identities = 55/227 (24%), Positives = 107/227 (47%), Gaps = 37/227 (16%)
Query: 273 QEVEVLSSIRHPNMVLLLGA-CPDYGCLVY-EYMHNGSLEDRLLRRGNTPVIPWRKRFKI 330
+E+ +++ + HP+++ +LGA C D ++ E+M GS+ L + G +++ I
Sbjct: 52 KEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYG-----AFKEAVII 106
Query: 331 A--AEIATALLFLHQAKPEPLVHRDLKPANILLDRN-YVSKISDVGLA-RLVPPSVADSV 386
++ L +LH+ + ++HRD+K AN+L+D +I+D G A RL
Sbjct: 107 NYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGE 163
Query: 387 TQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHH------- 439
Q + GT ++ PE + D++S G +++++ TA+ P H
Sbjct: 164 FQGQLL---GTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALI 220
Query: 440 --VSRAIEKGTLAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRP 484
++ A ++ E L P + D + ++C EL+ +DRP
Sbjct: 221 FKIASATTAPSIPEHLSPGLRD-----------VTLRCLELQPEDRP 256
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 3e-13
Identities = 54/195 (27%), Positives = 93/195 (47%), Gaps = 32/195 (16%)
Query: 229 DKFSEAMKIGEGGYGPVY--RGKLDHTPVAIKVLRPDAAQGKRQFQ----QEVEVLSSIR 282
K+ + KIG+G +G V+ R K VA+K + + K F +E+++L ++
Sbjct: 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLME--NEKEGFPITALREIKILQLLK 69
Query: 283 HPNMVLLLGAC-----PDYGC-----LVYEYM-HN--GSLEDRLLRRGNTPVIPWRKRFK 329
H N+V L+ C P LV+E+ H+ G L ++ ++ I K
Sbjct: 70 HENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKF-TLSEIK-----K 123
Query: 330 IAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQY 389
+ + L ++H+ K ++HRD+K ANIL+ ++ + K++D GLAR S +Y
Sbjct: 124 VMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRY 180
Query: 390 HMTSAAGTFCYIDPE 404
T+ T Y PE
Sbjct: 181 --TNRVVTLWYRPPE 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 5e-13
Identities = 61/214 (28%), Positives = 98/214 (45%), Gaps = 31/214 (14%)
Query: 236 KIGEGGYGPVYRGKLDHTP----VAIKVLRPDAAQGK-RQFQQEVEVLSSIRHPNMVLLL 290
++G+G YG VY K+ H P +A+K +R + + K Q E+++L P +V
Sbjct: 8 ELGKGNYGSVY--KVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFY 65
Query: 291 GACPDYGCLVY--EYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFL---HQAK 345
GA G + EYM GSL+ T IP +I + L FL H
Sbjct: 66 GAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN-- 123
Query: 346 PEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEY 405
++HRD+KP N+L++ N K+ D G++ + S+A + G Y+ PE
Sbjct: 124 ---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLA--------KTNIGCQSYMAPER 172
Query: 406 ------QQTGMLTTKSDIYSFGIMLLQIITARSP 433
Q T +SD++S G+ +L++ R P
Sbjct: 173 IKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYP 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 69.9 bits (172), Expect = 6e-13
Identities = 53/172 (30%), Positives = 78/172 (45%), Gaps = 31/172 (18%)
Query: 237 IGEGGYGPVYRG--KLDHTPVAIKVLRP---DAAQGKRQFQQEVEVLSSIRHPNMVLLLG 291
IG G YG V K VAIK + D KR + E+++L +RH N++ LL
Sbjct: 8 IGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILR-EIKLLRHLRHENIIGLLD 66
Query: 292 ACPD---------YGCLVYEYMHNGSLED--RLLRRGNTPVIPWRKRFKIAAEIATALLF 340
Y +V E M D ++++ P+ ++ +I L +
Sbjct: 67 ILRPPSPEDFNDVY--IVTELMET----DLHKVIKSPQ-PLTDDHIQY-FLYQILRGLKY 118
Query: 341 LHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMT 392
LH A ++HRDLKP+NIL++ N KI D GLAR V P D + +T
Sbjct: 119 LHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDP---DEDEKGFLT 164
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 6e-13
Identities = 71/256 (27%), Positives = 117/256 (45%), Gaps = 37/256 (14%)
Query: 229 DKFSEAMKIGEGGYGPVYRGKLDHTP----VAIKVLRPDAAQGKR-QFQQEVEVLSSIRH 283
D F + ++G G G V K+ H P +A K++ + R Q +E++VL
Sbjct: 1 DDFEKLGELGAGNGGVVT--KVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNS 58
Query: 284 PNMVLLLGACPDYG--CLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFL 341
P +V GA G + E+M GSL D++L++ IP KI+ + L +L
Sbjct: 59 PYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGR--IPENILGKISIAVLRGLTYL 115
Query: 342 ---HQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTF 398
H+ ++HRD+KP+NIL++ K+ D G++ + S+A+S GT
Sbjct: 116 REKHK-----IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV--------GTR 162
Query: 399 CYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAVT 458
Y+ PE Q T +SDI+S G+ L+++ R P+ + L M V+
Sbjct: 163 SYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPI-------PPPDAKELEAMFGRPVS 215
Query: 459 DWPAEAAESFSKLAIQ 474
EA ES ++
Sbjct: 216 --EGEAKESHRPVSGH 229
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 6e-13
Identities = 87/311 (27%), Positives = 132/311 (42%), Gaps = 69/311 (22%)
Query: 231 FSEAMKIGEGGYGPVY--RGKLDHTPVAIKVLRPDAAQGKRQFQ---QEVEVLSSIRHPN 285
F++ +IG G +G VY R + VAIK + Q ++Q +EV L +RHPN
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76
Query: 286 MVLLLGACPDY-GC--------LVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIAT 336
+ +Y GC LV EY GS D +L P+ + +IAA
Sbjct: 77 TI-------EYKGCYLREHTAWLVMEYCL-GSASD-ILEVHKKPL----QEVEIAAICHG 123
Query: 337 ALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAG 396
AL L +HRD+K NILL K++D G A LV P+ S G
Sbjct: 124 ALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA----------NSFVG 173
Query: 397 TFCYIDPEY---QQTGMLTTKSDIYSFGIMLLQIITARSP------MGLTHHVSRAIEKG 447
T ++ PE G K D++S GI +++ + P M +H+++ +
Sbjct: 174 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN-DSP 232
Query: 448 TLAEMLDPAVTDWPAEAAESFSKLAIQ--------CAELRK-----KDRPDLGTVIVPEL 494
TL+ DW ++ +F +Q EL K ++RP TVI+ +
Sbjct: 233 TLSS------NDW-SDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRERPP--TVIIDLI 283
Query: 495 NRLKDLGRKLE 505
R KD R+L+
Sbjct: 284 QRTKDAVRELD 294
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 7e-13
Identities = 62/217 (28%), Positives = 106/217 (48%), Gaps = 22/217 (10%)
Query: 225 EEATDKFSEAMKIGEGGYGPVYRGKLDHTP----VAIKVLRPDAAQGKR-QFQQEVEVLS 279
E D F + ++G G G V+ K+ H P +A K++ + R Q +E++VL
Sbjct: 1 ELKDDDFEKISELGAGNGGVVF--KVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLH 58
Query: 280 SIRHPNMVLLLGACPDYG--CLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATA 337
P +V GA G + E+M GSL+ L + G IP + K++ +
Sbjct: 59 ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKG 115
Query: 338 LLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGT 397
L +L + ++HRD+KP+NIL++ K+ D G++ + S+A+S GT
Sbjct: 116 LTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV--------GT 165
Query: 398 FCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPM 434
Y+ PE Q + +SDI+S G+ L+++ R P+
Sbjct: 166 RSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 7e-13
Identities = 64/214 (29%), Positives = 100/214 (46%), Gaps = 36/214 (16%)
Query: 237 IGEGGYGPVY--RGKLDHTPVAIKVL-RPDAAQGKRQFQQEVEV-LSSIRHPNMVLLLGA 292
IG G G VY R K +A+K + R + ++ +++V L S P +V
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIV----K 78
Query: 293 CPDYGCLVY--------EYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQA 344
C YG + E M + D+LL+R P IP K+ I AL +L +
Sbjct: 79 C--YGYFITDSDVFICMELM--STCLDKLLKRIQGP-IPEDILGKMTVAIVKALHYLKEK 133
Query: 345 KPEPLVHRDLKPANILLDRNYVSKISDVGLA-RLVPPSVADSVTQYHMTSAAGTFCYIDP 403
++HRD+KP+NILLD + K+ D G++ RLV DS + T +AG Y+ P
Sbjct: 134 --HGVIHRDVKPSNILLDASGNVKLCDFGISGRLV-----DSKAK---TRSAGCAAYMAP 183
Query: 404 EY----QQTGMLTTKSDIYSFGIMLLQIITARSP 433
E ++D++S GI L+++ T + P
Sbjct: 184 ERIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 8e-13
Identities = 63/232 (27%), Positives = 108/232 (46%), Gaps = 35/232 (15%)
Query: 225 EEATDKFSEAMKIGEGGYGPVYRGKL---------DHTPVAIKVLRPDAAQGK-RQFQQE 274
E + DK + +GEG +G V + + VA+K+L+ DA + E
Sbjct: 11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 70
Query: 275 VEVLSSI-RHPNMVLLLGACPDYGCL--VYEYMHNGSLEDRL-------------LRRGN 318
+E++ I +H N++ LLGAC G L + EY G+L + L + R
Sbjct: 71 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVP 130
Query: 319 TPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLV 378
+ ++ ++A + +L K +HRDL N+L+ N V KI+D GLAR V
Sbjct: 131 DEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLARDV 187
Query: 379 PPSVADSVTQYHMTSAAG-TFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT 429
+++ Y T+ ++ PE + T +SD++SFG+++ +I T
Sbjct: 188 -----NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 8e-13
Identities = 56/203 (27%), Positives = 97/203 (47%), Gaps = 17/203 (8%)
Query: 237 IGEGGYGP--VYRGKLDHTPVAIKVLR-PDAAQGKRQFQQEVEVLSSIRHPNMVLLLGAC 293
+GEG +G + + A+K +R P ++ ++E +L+ ++HPN+V +
Sbjct: 8 VGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESF 67
Query: 294 PDYGCL--VYEYMHNGSLEDRL-LRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLV 350
G L V EY G L ++ L+RG + P + ++ + +H+ + ++
Sbjct: 68 EADGHLYIVMEYCDGGDLMQKIKLQRGK--LFPEDTILQWFVQMCLGVQHIHEKR---VL 122
Query: 351 HRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGM 410
HRD+K NI L +N K+ D G ARL+ A + T GT Y+ PE +
Sbjct: 123 HRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTY------VGTPYYVPPEIWENMP 176
Query: 411 LTTKSDIYSFGIMLLQIITARSP 433
KSDI+S G +L ++ T + P
Sbjct: 177 YNNKSDIWSLGCILYELCTLKHP 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 9e-13
Identities = 61/201 (30%), Positives = 91/201 (45%), Gaps = 27/201 (13%)
Query: 236 KIGEGGYGPVYRGKLDHTP--VAIKVLRPDAAQGKRQFQ--QEVEVLSSIRHPNMVLLL- 290
+IGEG YG VYR + + VA+K +R D + +E+ +L ++RHPN+V L
Sbjct: 14 RIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKE 73
Query: 291 ---GACPDYGCLVYEYMHN--GSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAK 345
G D LV EY SL D + + + + ++ L +LH+
Sbjct: 74 VVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVK-----CLMLQLLRGLQYLHE-- 126
Query: 346 PEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEY 405
++HRDLK +N+LL KI+D GLAR + MT T Y PE
Sbjct: 127 -NFIIHRDLKVSNLLLTDKGCLKIADFGLARTY------GLPAKPMTPKVVTLWYRAPEL 179
Query: 406 QQTGML--TTKSDIYSFGIML 424
G TT D+++ G +L
Sbjct: 180 -LLGCTTYTTAIDMWAVGCIL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 1e-12
Identities = 60/229 (26%), Positives = 97/229 (42%), Gaps = 57/229 (24%)
Query: 230 KFSEAMKIGEGGYGPVYRGKLDHTP--VAIKVLR--------PDAAQGKRQFQQEVEVLS 279
+++ KIGEG YG VY+G+ T VA+K +R P A +E+ +L
Sbjct: 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAI------REISLLK 54
Query: 280 SIRHPNMVLLLGAC--PDYGCLVYEYMH------------NGSLEDRLLRRGNTPVIPWR 325
++HPN+V L L++E++ ++ L++
Sbjct: 55 ELQHPNIVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVK---------- 104
Query: 326 KRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARL--VPPSVA 383
+I +LF H + ++HRDLKP N+L+D V K++D GLAR +P V
Sbjct: 105 ---SYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRV- 157
Query: 384 DSVTQYHMTSAAGTFCYIDPEYQQTGML-TTKSDIYSFGIMLLQIITAR 431
T T Y PE +T DI+S G + ++ T +
Sbjct: 158 -------YTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 1e-12
Identities = 64/238 (26%), Positives = 110/238 (46%), Gaps = 20/238 (8%)
Query: 229 DKFSEAMKIGEGGYGPVYRGKLDHTP--VAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNM 286
+ F +IG G YG VY+ + +T AIKV++ + + QQE+ ++ +H N+
Sbjct: 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNI 68
Query: 287 VLLLGAC--PDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQA 344
V G+ D + E+ GSL+D G P+ + + ++ E L +LH
Sbjct: 69 VAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTG--PLSESQIAY-VSRETLQGLYYLHSK 125
Query: 345 KPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPE 404
+HRD+K ANILL N K++D G++ + ++A S GT ++ PE
Sbjct: 126 GK---MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKR------KSFIGTPYWMAPE 176
Query: 405 ---YQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAVTD 459
++ G DI++ GI +++ + PM H RA+ T + P + D
Sbjct: 177 VAAVERKGGYNQLCDIWAVGITAIELAELQPPM-FDLHPMRALFLMTKSNFQPPKLKD 233
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 1e-12
Identities = 56/207 (27%), Positives = 100/207 (48%), Gaps = 16/207 (7%)
Query: 231 FSEAMKIGEGGYGPVYRGKLDHTP--VAIKVLRPDAAQGKRQFQ-QEVEVLSSIRHPNMV 287
F + K+GEG Y VY+G+ T VA+K + DA +G +E+ ++ ++H N+V
Sbjct: 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIV 61
Query: 288 LLLGA--CPDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAK 345
L + LV+EYM + L+ + G + ++ + F H+ +
Sbjct: 62 RLHDVIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR 120
Query: 346 PEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPE- 404
++HRDLKP N+L+++ K++D GLAR A + ++ T Y P+
Sbjct: 121 ---VLHRDLKPQNLLINKRGELKLADFGLAR------AFGIPVNTFSNEVVTLWYRAPDV 171
Query: 405 YQQTGMLTTKSDIYSFGIMLLQIITAR 431
+ +T DI+S G ++ ++IT R
Sbjct: 172 LLGSRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 1e-12
Identities = 64/213 (30%), Positives = 103/213 (48%), Gaps = 18/213 (8%)
Query: 231 FSEAMKIGEGGYGPVYRGKLDHTP--VAIKVLRPDAAQGK-RQFQQEVEVLSSIRHPNMV 287
F++ KIG+G +G V++G + T VAIK++ + A+ + QQE+ VLS P +
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 288 LLLGACPDYGCL--VYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAK 345
G+ L + EY+ GS D LL G + + I EI L +LH K
Sbjct: 66 KYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGP---LDETQIATILREILKGLDYLHSEK 121
Query: 346 PEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEY 405
+HRD+K AN+LL + K++D G+A + + TQ + GT ++ PE
Sbjct: 122 K---IHRDIKAANVLLSEHGEVKLADFGVAGQL------TDTQIKRNTFVGTPFWMAPEV 172
Query: 406 QQTGMLTTKSDIYSFGIMLLQIITARSPMGLTH 438
+ +K+DI+S GI +++ P H
Sbjct: 173 IKQSAYDSKADIWSLGITAIELAKGEPPHSELH 205
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 1e-12
Identities = 66/225 (29%), Positives = 99/225 (44%), Gaps = 31/225 (13%)
Query: 220 TIEEIEEATDKFSEAMKIGEGGYGPVYRGKLDHT--PVAIKVLRPDAAQGKRQFQQEVEV 277
TI + + K++ KIG+G G VY T VAIK + K E+ V
Sbjct: 10 TIVSVGDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILV 69
Query: 278 LSSIRHPNMVLLLGA--CPDYGCLVYEYMHNGSLEDRL----LRRGNTPVIPWRKRFKIA 331
+ +HPN+V L + D +V EY+ GSL D + + G +IA
Sbjct: 70 MRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEG-----------QIA 118
Query: 332 A---EIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQ 388
A E AL FLH + ++HRD+K NILL + K++D G + P Q
Sbjct: 119 AVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE------Q 169
Query: 389 YHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSP 433
++ GT ++ PE K DI+S GIM ++++ P
Sbjct: 170 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 71/252 (28%), Positives = 113/252 (44%), Gaps = 36/252 (14%)
Query: 199 AEEKNRALTALANNDVRYRKYT--IEEIEEATDKFSEAMKIGEGGYGPV--YRGKLDHTP 254
A KN+ + N RY K I +++ + + IG G +G V R K
Sbjct: 14 ALRKNKNIDNFLN---RYEKIVRKIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKV 70
Query: 255 VAIKVL-------RPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACPD--YGCLVYEYMH 305
A+K+L R D+A F +E ++++ P +V L A D Y +V EYM
Sbjct: 71 YAMKLLSKFEMIKRSDSAF----FWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMP 126
Query: 306 NGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNY 365
G L + L+ + P W K + AE+ AL +H L+HRD+KP N+LLD++
Sbjct: 127 GGDLVN-LMSNYDVPE-KWAKFY--TAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHG 179
Query: 366 VSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQT----GMLTTKSDIYSFG 421
K++D G + D +A GT YI PE ++ G + D +S G
Sbjct: 180 HLKLADFGTCMKM-----DETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVG 234
Query: 422 IMLLQIITARSP 433
+ L +++ +P
Sbjct: 235 VFLFEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 2e-12
Identities = 63/212 (29%), Positives = 98/212 (46%), Gaps = 34/212 (16%)
Query: 237 IGEGGYGPVY--RGKLDHTPVAIKVLRPDAAQGKRQFQ---QEVEVLSSIR-HPNMVLLL 290
+G+G +G V R K A+KVL+ D + E +LS R HP + L
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62
Query: 291 GAC---PDYGCLVYEYMHNGSLEDRL--LRRGNTPVIPWRKRFKIAAEIATALLFLHQAK 345
C PD V E+++ G L + RR + R RF AAEI +AL+FLH
Sbjct: 63 -CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEA----RARF-YAAEITSALMFLHD-- 114
Query: 346 PEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFC----YI 401
+ +++RDLK N+LLD K++D G+ + + + T TFC YI
Sbjct: 115 -KGIIYRDLKLDNVLLDHEGHCKLADFGMCK---EGIFNGKT-------TSTFCGTPDYI 163
Query: 402 DPEYQQTGMLTTKSDIYSFGIMLLQIITARSP 433
PE Q + D ++ G++L +++ +P
Sbjct: 164 APEILQEMLYGPSVDWWAMGVLLYEMLCGHAP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-12
Identities = 67/233 (28%), Positives = 108/233 (46%), Gaps = 37/233 (15%)
Query: 225 EEATDKFSEAMKIGEGGYGPVYRGK---LDH------TPVAIKVLRPDAAQGK-RQFQQE 274
E D+ +GEG +G V + LD T VA+K+L+ DA + E
Sbjct: 14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISE 73
Query: 275 VEVLSSI-RHPNMVLLLGACPDYGCL--VYEYMHNGSLEDRLLRRG--------NTPVIP 323
+E++ I +H N++ LLGAC G L + EY G+L + L R N +P
Sbjct: 74 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVP 133
Query: 324 -----WRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLV 378
++ A ++A + +L K +HRDL N+L+ + V KI+D GLAR +
Sbjct: 134 EEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDI 190
Query: 379 PPSVADSVTQYHMTSAAGTFC--YIDPEYQQTGMLTTKSDIYSFGIMLLQIIT 429
Y+ + G ++ PE + T +SD++SFG++L +I T
Sbjct: 191 ------HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 3e-12
Identities = 50/155 (32%), Positives = 73/155 (47%), Gaps = 27/155 (17%)
Query: 236 KIGEGGYGPVY--RGKLDHTPVAIKVLR--------PDAAQGKRQFQQEVEVLSSIRHPN 285
KIGEG YG VY R KL VA+K +R P A +E+ +L + HPN
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAI------REISLLKELNHPN 59
Query: 286 MVLLLGACPDYGCL--VYEYMHNG--SLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFL 341
+V LL L V+E++ D G P + K + ++ + +
Sbjct: 60 IVRLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLI--KSY--LYQLLQGIAYC 115
Query: 342 HQAKPEPLVHRDLKPANILLDRNYVSKISDVGLAR 376
H + ++HRDLKP N+L+DR K++D GLAR
Sbjct: 116 HSHR---VLHRDLKPQNLLIDREGALKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 4e-12
Identities = 62/205 (30%), Positives = 97/205 (47%), Gaps = 19/205 (9%)
Query: 237 IGEGGYGPV--YRGKLDHTPVAIKVLRPDAAQGKRQFQQ---EVEVLSSIRHPNMVLLLG 291
+G+G +G V R K A+K+L+ + K + E VL + RHP + L
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKY 62
Query: 292 A--CPDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPL 349
+ D C V EY++ G L L R R RF AEI +AL +LH K +
Sbjct: 63 SFQTKDRLCFVMEYVNGGELFFHLSRE--RVFSEDRTRF-YGAEIVSALDYLHSGK---I 116
Query: 350 VHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTG 409
V+RDLK N++LD++ KI+D GL + + D+ T M + GT Y+ PE +
Sbjct: 117 VYRDLKLENLMLDKDGHIKITDFGLCK---EGITDAAT---MKTFCGTPEYLAPEVLEDN 170
Query: 410 MLTTKSDIYSFGIMLLQIITARSPM 434
D + G+++ +++ R P
Sbjct: 171 DYGRAVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 4e-12
Identities = 58/204 (28%), Positives = 92/204 (45%), Gaps = 19/204 (9%)
Query: 235 MKIGEGGYGPVYRGKLDHT--PVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGA 292
+KIGEG G V T VA+K + Q + EV ++ +HPN+V + +
Sbjct: 25 VKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSS 84
Query: 293 --CPDYGCLVYEYMHNGSLEDRLLR-RGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPL 349
D +V E++ G+L D + R N I + + AL FLH +
Sbjct: 85 YLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-----TVCLAVLKALSFLHAQG---V 136
Query: 350 VHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTG 409
+HRD+K +ILL + K+SD G V+ V + S GT ++ PE
Sbjct: 137 IHRDIKSDSILLTSDGRVKLSDFGFC----AQVSKEVPRRK--SLVGTPYWMAPEVISRL 190
Query: 410 MLTTKSDIYSFGIMLLQIITARSP 433
T+ DI+S GIM+++++ P
Sbjct: 191 PYGTEVDIWSLGIMVIEMVDGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 4e-12
Identities = 66/262 (25%), Positives = 116/262 (44%), Gaps = 39/262 (14%)
Query: 237 IGEGGYGPVYRGKLDHTP----VAIKVLRPD-AAQGKRQFQQEVEVLSSIRHPNMVLLLG 291
+G G G VY K H +A+KV+ D + ++Q E+E+L P ++ G
Sbjct: 9 LGHGNGGTVY--KAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYG 66
Query: 292 A--CPDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPL 349
A + + E+M GSL+ + R+ V+ +IA + L +L K +
Sbjct: 67 AFFVENRISICTEFMDGGSLD--VYRKIPEHVLG-----RIAVAVVKGLTYLWSLK---I 116
Query: 350 VHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTG 409
+HRD+KP+N+L++ K+ D G++ + S+A + GT Y+ PE
Sbjct: 117 LHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIA--------KTYVGTNAYMAPERISGE 168
Query: 410 MLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLA--EMLDPAVTDWP-----A 462
SD++S GI +++ R P + +G+L ++L V + P
Sbjct: 169 QYGIHSDVWSLGISFMELALGRFP-----YPQIQKNQGSLMPLQLLQCIVDEDPPVLPVG 223
Query: 463 EAAESFSKLAIQCAELRKKDRP 484
+ +E F QC + K+RP
Sbjct: 224 QFSEKFVHFITQCMRKQPKERP 245
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 4e-12
Identities = 76/258 (29%), Positives = 113/258 (43%), Gaps = 34/258 (13%)
Query: 237 IGEGGYGPV------YRGKLDHTPVAIKVL---RPDAAQGKRQFQQEVEVLSSIRHPNMV 287
+G+GG+G V GK+ A K L R +G+ E ++L + +V
Sbjct: 8 LGKGGFGEVCACQVRATGKM----YACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVV 63
Query: 288 LLLGA--CPDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAK 345
L A D CLV M+ G L+ + GN P + AAEI L LH+
Sbjct: 64 SLAYAYETKDALCLVLTLMNGGDLKFHIYNMGN-PGFDEERAVFYAAEITCGLEDLHR-- 120
Query: 346 PEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEY 405
E +V+RDLKP NILLD +ISD+GLA +P + GT Y+ PE
Sbjct: 121 -ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET-------IRGRVGTVGYMAPEV 172
Query: 406 QQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAVTDWPAEAA 465
+ T D + G ++ ++I +SP R ++ E ++ V + E +
Sbjct: 173 VKNERYTFSPDWWGLGCLIYEMIEGKSPF-------RQRKEKVKREEVERRVKEDQEEYS 225
Query: 466 ESFSKLAIQ-CAELRKKD 482
E FS+ A C +L KD
Sbjct: 226 EKFSEAARSICRQLLTKD 243
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 4e-12
Identities = 64/222 (28%), Positives = 89/222 (40%), Gaps = 53/222 (23%)
Query: 237 IGEGGYGPVYRGKLDHTP--VAIKVLRP------DAAQG----KRQFQQEVEVLSSIRHP 284
+G G +G V + T AIK L+ D + KR F E +S RHP
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIF----ETANSERHP 62
Query: 285 NMVLLLGAC---PDYGCLVYEYMHNGSL-----EDRLLRRGNTPVIPWRKRFKIAAEIAT 336
+V L AC D+ C V EY G L D R F AA +
Sbjct: 63 FLVNLF-ACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEP--------RAVF-YAACVVL 112
Query: 337 ALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAG 396
L +LH+ K +V+RDLK N+LLD KI+D GL +
Sbjct: 113 GLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCK----------EGMGFGDRTS 159
Query: 397 TFCYIDPEYQQTGMLTTKS-----DIYSFGIMLLQIITARSP 433
TFC PE+ +LT S D + G+++ +++ SP
Sbjct: 160 TFCGT-PEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESP 200
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 5e-12
Identities = 66/210 (31%), Positives = 95/210 (45%), Gaps = 18/210 (8%)
Query: 231 FSEAMKIGEGGYGPVYRGKLDHTP--VAIKVL---RPDAAQGKRQFQQEVEVLSSIRHPN 285
F + +G+GG+G V ++ T A K L R +G+ E ++L +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 286 MVLLLGA--CPDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQ 343
+V L A D CLV M+ G L+ + GN R F AAEI L LH+
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALF-YAAEILCGLEDLHR 120
Query: 344 AKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDP 403
E V+RDLKP NILLD +ISD+GLA +P +S+ GT Y+ P
Sbjct: 121 ---ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPE--GESI-----RGRVGTVGYMAP 170
Query: 404 EYQQTGMLTTKSDIYSFGIMLLQIITARSP 433
E T D + G ++ ++I +SP
Sbjct: 171 EVLNNQRYTLSPDYWGLGCLIYEMIEGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 5e-12
Identities = 63/213 (29%), Positives = 94/213 (44%), Gaps = 27/213 (12%)
Query: 236 KIGEGGYGPVYRGKLDH----TPVAIKVLRPDAA-QGKRQFQQEVEVLSSIRHPNMVLLL 290
+IG G +G V G+ V +K LR A + F QEV+ + HPN++ L
Sbjct: 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCL 61
Query: 291 GACPDYG--CLVYEYMHNGSLEDRLLR-RGNTPVIPW-RKRFKIAAEIATALLFLHQAKP 346
G C + LV E+ G L++ L RG + ++A E+A+ LL+LHQA
Sbjct: 62 GQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD- 120
Query: 347 EPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFC--YIDPE 404
+H DL N L + KI D GLA P Y++T ++ PE
Sbjct: 121 --FIHSDLALRNCQLTADLSVKIGDYGLALEQYPE------DYYITKDCHAVPLRWLAPE 172
Query: 405 ----YQQ---TGMLTTKSDIYSFGIMLLQIITA 430
Q T KS+I+S G+ + ++ TA
Sbjct: 173 LVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTA 205
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.5 bits (163), Expect = 6e-12
Identities = 54/183 (29%), Positives = 79/183 (43%), Gaps = 34/183 (18%)
Query: 230 KFSEAMKIGEGGYGPVYRGKL----DHTPVAIKVLRPDAAQGKRQFQ---QEVEVLSSIR 282
K+ IG G YG VY+ K D AIK + D Q Q +E+ +L ++
Sbjct: 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK 60
Query: 283 HPNMVLLLGACPDYGC----LVYEYMHNGSLEDRLL------RRGNTPVIPWRKRFKIAA 332
H N+V L+ ++ L+++Y E L R+ IP +
Sbjct: 61 HENVVSLVEVFLEHADKSVYLLFDYA-----EHDLWQIIKFHRQAKRVSIPPSMVKSLLW 115
Query: 333 EIATALLFLHQAKPEPLVHRDLKPANILLDRNY----VSKISDVGLAR-----LVPPSVA 383
+I + +LH ++HRDLKPANIL+ V KI D+GLAR L P +
Sbjct: 116 QILNGVHYLHS---NWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADL 172
Query: 384 DSV 386
D V
Sbjct: 173 DPV 175
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 6e-12
Identities = 52/172 (30%), Positives = 82/172 (47%), Gaps = 17/172 (9%)
Query: 229 DKFSEAMKIGEGGYGPVYRGKLDHTP--VAIKVL--RPDAAQGKRQFQQEVEVLSSIRHP 284
+K+ +GEG YG V + K T VAIK D K+ +E+ +L +RH
Sbjct: 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHE 60
Query: 285 NMVLLLGACPD----YGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLF 340
N+V L+ Y LV+E++ + L+D L + + R R K +I + F
Sbjct: 61 NLVNLIEVFRRKKRLY--LVFEFVDHTVLDD--LEKYPNGLDESRVR-KYLFQILRGIEF 115
Query: 341 LHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMT 392
H ++HRD+KP NIL+ ++ V K+ D G AR + + + T Y T
Sbjct: 116 CHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTL-AAPGEVYTDYVAT 163
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 6e-12
Identities = 63/180 (35%), Positives = 90/180 (50%), Gaps = 28/180 (15%)
Query: 237 IGEGGYGPVY--RGKLDHTPVAIKVLRPDAAQGKRQFQQ---EVEVL-SSIRHPNMVLLL 290
IG+G +G V + K D A+KVL+ A K++ + E VL +++HP +V L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 291 GA--CPDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEP 348
+ D V +Y++ G L L R + P R RF AAEIA+AL +LH
Sbjct: 63 YSFQTADKLYFVLDYVNGGELFFHLQRERSFPEP--RARF-YAAEIASALGYLHSLN--- 116
Query: 349 LVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFC----YIDPE 404
+++RDLKP NILLD ++D GL + + S T TS TFC Y+ PE
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCK---EGIEHSKT----TS---TFCGTPEYLAPE 166
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 66.1 bits (162), Expect = 6e-12
Identities = 60/218 (27%), Positives = 99/218 (45%), Gaps = 51/218 (23%)
Query: 236 KIGEGGYGPVYRGKLDHTP--VAIKVLRPDAAQGKRQFQ----QEVEVLSSIRHPNMV-- 287
+I EG YG VYR + T VA+K L+ + + K F +E+ +L ++HPN+V
Sbjct: 12 RIEEGTYGVVYRARDKKTGEIVALKKLKME--KEKEGFPITSLREINILLKLQHPNIVTV 69
Query: 288 --LLLGACPDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALL------ 339
+++G+ D +V EY+ + L+ L+ P + +E+ +L
Sbjct: 70 KEVVVGSNLDKIYMVMEYVEH-DLKS-LMETMKQPFLQ--------SEVKCLMLQLLSGV 119
Query: 340 -FLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTF 398
LH ++HRDLK +N+LL+ + KI D GLAR S + T T
Sbjct: 120 AHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYG-----SPLK-PYTQLVVTL 170
Query: 399 CYIDPE-------YQQTGMLTTKSDIYSFGIMLLQIIT 429
Y PE Y +T D++S G + +++T
Sbjct: 171 WYRAPELLLGAKEY------STAIDMWSVGCIFAELLT 202
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 66.8 bits (164), Expect = 6e-12
Identities = 61/185 (32%), Positives = 87/185 (47%), Gaps = 57/185 (30%)
Query: 217 RKYTIEEIEEATDKFSEAMKIGEGGYGPVYRG--KLDHTPVAIKVLRPDA------AQGK 268
RKY I + K+G+G YG V++ + VA+K + DA AQ
Sbjct: 7 RKYEILQ------------KLGKGAYGIVWKAIDRRTKEVVALKKIF-DAFRNATDAQ-- 51
Query: 269 RQFQQEVEVLSSIR-HPNMVLLLG---ACPD---YGCLVYEYM----HN----GSLEDRL 313
R F+ E+ L + HPN+V LL A D Y LV+EYM H LED
Sbjct: 52 RTFR-EIMFLQELGDHPNIVKLLNVIKAENDKDIY--LVFEYMETDLHAVIRANILEDV- 107
Query: 314 LRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVG 373
KR+ I ++ AL ++H ++HRDLKP+NILL+ + K++D G
Sbjct: 108 -----------HKRY-IMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFG 152
Query: 374 LARLV 378
LAR +
Sbjct: 153 LARSL 157
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 6e-12
Identities = 56/210 (26%), Positives = 91/210 (43%), Gaps = 32/210 (15%)
Query: 236 KIGEGGYGPVY--RGKLDHTPVAIKVLRPDAAQGK---RQFQQEVEVLSSIRHPNMVLLL 290
++G+GGYG V+ + K VA+K ++ R E ++L++ + +V LL
Sbjct: 8 QVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLL 67
Query: 291 GAC--PDYGCLVYEYMHNGSLE-----DRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQ 343
A +Y L EY+ G +L + RF +A E+ A+ LH+
Sbjct: 68 YAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHA-------RFYMA-EMFEAVDALHE 119
Query: 344 AKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDP 403
+HRDLKP N L+D + K++D GL+ VT + S G+ Y+ P
Sbjct: 120 LG---YIHRDLKPENFLIDASGHIKLTDFGLS-------KGIVTYAN--SVVGSPDYMAP 167
Query: 404 EYQQTGMLTTKSDIYSFGIMLLQIITARSP 433
E + D +S G ML + + P
Sbjct: 168 EVLRGKGYDFTVDYWSLGCMLYEFLCGFPP 197
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 6e-12
Identities = 65/228 (28%), Positives = 106/228 (46%), Gaps = 35/228 (15%)
Query: 229 DKFSEAMKIGEGGYGPVYRGKL--------DHT-PVAIKVLRPDAA-QGKRQFQQEVEVL 278
D+ +GEG +G V R + D T VA+K+L+ +A + E+E++
Sbjct: 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELM 71
Query: 279 SSI-RHPNMVLLLGACPDYGCL--VYEYMHNGSLEDRL-LRRGNTP------------VI 322
I +H N++ LLG C G L + EY G+L + L RR P +
Sbjct: 72 KLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQL 131
Query: 323 PWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSV 382
++ A ++A + +L + +HRDL N+L+ + V KI+D GLAR V
Sbjct: 132 SFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLVTEDNVMKIADFGLARGV---- 184
Query: 383 ADSVTQYHMTSAAGT-FCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT 429
+ Y TS ++ PE + T +SD++SFGI++ +I T
Sbjct: 185 -HDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 8e-12
Identities = 52/203 (25%), Positives = 91/203 (44%), Gaps = 19/203 (9%)
Query: 237 IGEGGYGPVYRG---------KLDHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMV 287
+G+G + +++G +L T V +KVL F + ++S + H ++V
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 288 LLLGAC--PDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAK 345
L G C D +V EY+ GSL+ L + N I W + ++A ++A AL FL
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISW--KLEVAKQLAWALHFLEDKG 120
Query: 346 PEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPE- 404
L H ++ N+LL R K + +L P ++ +V + ++ PE
Sbjct: 121 ---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLE--RIPWVPPEC 175
Query: 405 YQQTGMLTTKSDIYSFGIMLLQI 427
+ L+ +D +SFG L +I
Sbjct: 176 IENPQNLSLAADKWSFGTTLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 8e-12
Identities = 67/266 (25%), Positives = 119/266 (44%), Gaps = 29/266 (10%)
Query: 235 MKIGEGGYG----PVYRGKLDHTPVAIKVLRPDAAQGKR-QFQQEVEVLSSIRHPNMVLL 289
+++G G +G VY+ + VAIKVL+ + + R + +E E++ + +P +V +
Sbjct: 1 VELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRM 60
Query: 290 LGAC-PDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEP 348
+G C + LV E G L L + + I ++ +++ + +L
Sbjct: 61 IGVCEAEALMLVMEMASGGPLNKFLSGKKDE--ITVSNVVELMHQVSMGMKYLEGKN--- 115
Query: 349 LVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFC--YIDPEYQ 406
VHRDL N+LL + +KISD GL++ + AD Y+ +AG + + PE
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALG---ADD--SYYKARSAGKWPLKWYAPECI 170
Query: 407 QTGMLTTKSDIYSFGIMLLQIIT-ARSPMGLTH--HVSRAIEKGTLAEMLDPAVTDWPAE 463
+++SD++S+GI + + + + P V IE+G D PAE
Sbjct: 171 NFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKR--------LDCPAE 222
Query: 464 AAESFSKLAIQCAELRKKDRPDLGTV 489
L C + +DRP+ V
Sbjct: 223 CPPEMYALMKDCWIYKWEDRPNFAKV 248
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 9e-12
Identities = 81/300 (27%), Positives = 124/300 (41%), Gaps = 45/300 (15%)
Query: 231 FSEAMKIGEGGYGPVY--RGKLDHTPVAIKVLRPDAAQGKRQFQ---QEVEVLSSIRHPN 285
FS+ +IG G +G VY R + VAIK + Q ++Q +EV L +RHPN
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 286 MVLLLGAC--PDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQ 343
+ G LV EY GS D LL P+ + +IAA AL L
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCL-GSASD-LLEVHKKPL----QEVEIAAVTHGALQGLAY 130
Query: 344 AKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDP 403
++HRD+K NILL + K+ D G A ++ P+ GT ++ P
Sbjct: 131 LHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA----------NXFVGTPYWMAP 180
Query: 404 EY---QQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAVTDW 460
E G K D++S GI +++ + P+ + +S +A+ PA+
Sbjct: 181 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH---IAQNESPALQS- 236
Query: 461 PAEAAESFSKLAIQCAELRKKDRPDLG--------------TVIVPELNRLKDLGRKLES 506
+E F C + +DRP TVI+ + R KD R+L++
Sbjct: 237 -GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTKDAVRELDN 295
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 65.9 bits (160), Expect = 1e-11
Identities = 82/312 (26%), Positives = 128/312 (41%), Gaps = 57/312 (18%)
Query: 225 EEATDKFSEAMKIGEGGYGPVYRGKLDHTP--VAIKVLRPDAAQGKRQFQ---QEVEVLS 279
E+ F++ +IG G +G VY + T VAIK + Q ++Q +EV+ L
Sbjct: 21 EDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQ 80
Query: 280 SIRHPNMVLLLGAC--PDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATA 337
I+HPN + G LV EY GS D LL P+ + +IAA A
Sbjct: 81 RIKHPNSIEYKGCYLREHTAWLVMEYCL-GSASD-LLEVHKKPL----QEVEIAAITHGA 134
Query: 338 LLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGT 397
L L ++HRD+K NILL K++D G A + P+ S GT
Sbjct: 135 LQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA----------NSFVGT 184
Query: 398 FCYIDPEY---QQTGMLTTKSDIYSFGIMLLQIITARSP------MGLTHHVSRAIEKGT 448
++ PE G K D++S GI +++ + P M +H+++ E T
Sbjct: 185 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN-ESPT 243
Query: 449 LAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLG--------------TVIVPEL 494
L +W ++ F C + +DRP TV++ +
Sbjct: 244 LQS------NEW----SDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERPETVLIDLI 293
Query: 495 NRLKDLGRKLES 506
R KD R+L++
Sbjct: 294 QRTKDAVRELDN 305
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 1e-11
Identities = 62/216 (28%), Positives = 93/216 (43%), Gaps = 42/216 (19%)
Query: 237 IGEGGYGPVYRGKLDHTP--VAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLG-AC 293
+G+G +G V +L T AIK L+ D +VE R VL L
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKKDVVL----EDDDVECTMVERR---VLALAWEH 55
Query: 294 P------------DYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFL 341
P ++ V EY++ G L + G R RF AAEI L FL
Sbjct: 56 PFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDE--ARARF-YAAEIICGLQFL 112
Query: 342 HQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFC-- 399
H+ + +++RDLK N+LLD++ KI+D G+ + + A TFC
Sbjct: 113 HK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCK----------ENMNGEGKASTFCGT 159
Query: 400 --YIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSP 433
YI PE + D +SFG++L +++ +SP
Sbjct: 160 PDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 1e-11
Identities = 49/203 (24%), Positives = 86/203 (42%), Gaps = 31/203 (15%)
Query: 245 VYRGKLDHTPVAIKVLRPDAAQGK---RQFQQEVEVLSSIRHPNMVLLLGACPD------ 295
+Y+G ++ V I+ + K + E++ L I N++ + G D
Sbjct: 36 IYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLP 95
Query: 296 YGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLK 355
L+ EY G L + L + + + ++ + +A + L L++ +P +++L
Sbjct: 96 RLSLILEYCTRGYLREVLDKEKD---LSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNLT 150
Query: 356 PANILLDRNYVSKISDVGLARL--VPPS--VADSVTQ-YHMTSAAGTFCYIDPEYQQTGM 410
+ L+ NY KI GL ++ PP V V Y M + I EY
Sbjct: 151 SVSFLVTENYKLKIICHGLEKILSSPPFKNVNFMVYFSYKMLND------IFSEY----- 199
Query: 411 LTTKSDIYSFGIMLLQIITARSP 433
T K DIYS G++L +I T + P
Sbjct: 200 -TIKDDIYSLGVVLWEIFTGKIP 221
|
Length = 283 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 1e-11
Identities = 59/218 (27%), Positives = 96/218 (44%), Gaps = 17/218 (7%)
Query: 220 TIEEIEEATDKFSEAMKIGEGGYGPVYRGK--LDHTPVAIKVLRPDAAQGKRQFQQEVEV 277
TI I + K++ KIG+G G V+ VAIK + K E+ V
Sbjct: 10 TIVSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILV 69
Query: 278 LSSIRHPNMVLLLGA--CPDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIA 335
+ +++PN+V L + D +V EY+ GSL D + + + + E
Sbjct: 70 MKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVV----TETCMDEAQIAAVCRECL 125
Query: 336 TALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAA 395
AL FLH + ++HRD+K N+LL + K++D G + P Q ++
Sbjct: 126 QALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE------QSKRSTMV 176
Query: 396 GTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSP 433
GT ++ PE K DI+S GIM ++++ P
Sbjct: 177 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 56/204 (27%), Positives = 96/204 (47%), Gaps = 18/204 (8%)
Query: 237 IGEGGYGPVYRGKLDHTP--VAIKVL---RPDAAQGKRQFQQEVEVLSSIRHPNMVLLLG 291
+G+GG+G V ++ +T A K L R G++ E E+L + P +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 292 A--CPDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPL 349
A + CLV M+ G L+ + G + + +A+I +L LH +
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVG-ERGLEMERVIHYSAQITCGILHLHSMD---I 116
Query: 350 VHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTG 409
V+RD+KP N+LLD ++SD+GLA + ++TQ AGT Y+ PE +
Sbjct: 117 VYRDMKPENVLLDDQGNCRLSDLGLAVELKD--GKTITQ-----RAGTNGYMAPEILKEE 169
Query: 410 MLTTKSDIYSFGIMLLQIITARSP 433
+ D ++ G + +++ R+P
Sbjct: 170 PYSYPVDWFAMGCSIYEMVAGRTP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 1e-11
Identities = 68/239 (28%), Positives = 102/239 (42%), Gaps = 50/239 (20%)
Query: 216 YRKYTIEEIEEATDKFSEAMKIGEGGYGPVYRGKLDHTP--VAIKVL-RP--DAAQGKRQ 270
YR+ + + E D++ +G G YG V T VAIK L RP A KR
Sbjct: 2 YRQELNKTVWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRT 61
Query: 271 FQQEVEVLSSIRHPNMVLLLGA-CPDYGCL----VYEYMHNGSLEDRLLRRGNTPVIPWR 325
++ E+ +L + H N++ LL P VY H L L ++ +
Sbjct: 62 YR-ELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTH---LMGADLNN----IVKCQ 113
Query: 326 K------RFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVP 379
K +F + +I L ++H A ++HRDLKP+NI ++ + KI D GLAR
Sbjct: 114 KLSDDHIQF-LVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLARH-- 167
Query: 380 PSVADSVTQYHMTSAAGTFCYIDPE-------YQQTGMLTTKSDIYSFGIMLLQIITAR 431
T MT T Y PE Y QT DI+S G ++ +++T +
Sbjct: 168 -------TDDEMTGYVATRWYRAPEIMLNWMHYNQT------VDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 1e-11
Identities = 64/248 (25%), Positives = 114/248 (45%), Gaps = 24/248 (9%)
Query: 236 KIGEGGYGPVYRGKLDHTP--VAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGA- 292
++G G YG VY+ + HT A+K+++ + QQE+ ++ +H N+V G+
Sbjct: 16 RVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSY 75
Query: 293 -CPDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVH 351
+ + EY GSL+D G P+ + + + E L +LH +H
Sbjct: 76 LSREKLWICMEYCGGGSLQDIYHVTG--PLSELQIAY-VCRETLQGLAYLHSKGK---MH 129
Query: 352 RDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPE---YQQT 408
RD+K ANILL N K++D G+A + ++A S GT ++ PE ++
Sbjct: 130 RDIKGANILLTDNGDVKLADFGVAAKITATIAKR------KSFIGTPYWMAPEVAAVEKN 183
Query: 409 GMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAVTD---WPAEAA 465
G DI++ GI +++ + PM H RA+ + + P + D W +
Sbjct: 184 GGYNQLCDIWAVGITAIELAELQPPM-FDLHPMRALFLMSKSNFQPPKLKDKTKW-SSTF 241
Query: 466 ESFSKLAI 473
+F K+++
Sbjct: 242 HNFVKISL 249
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 1e-11
Identities = 66/213 (30%), Positives = 104/213 (48%), Gaps = 31/213 (14%)
Query: 237 IGEGGYGPVYRGKLDHTP----VAIKVLRPDAAQ-GKRQFQQEVE-VLSSIRHPNMVLLL 290
IG G +G V K+ H P +A+K +R + +++ +++ V+ S P +V
Sbjct: 12 IGRGAFGTVN--KMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFY 69
Query: 291 GACPDYG-CLVYEYMHNGSLEDRLLR----RGNTPVIPWRKRFKIAAEIATALLFLHQAK 345
GA G C + + + SL D+ + + VIP KIA AL +L K
Sbjct: 70 GALFREGDCWICMELMDISL-DKFYKYVYEVLKS-VIPEEILGKIAVATVKALNYL---K 124
Query: 346 PE-PLVHRDLKPANILLDRNYVSKISDVGLA-RLVPPSVADSVTQYHMTSAAGTFCYIDP 403
E ++HRD+KP+NILLDRN K+ D G++ +LV DS+ + T AG Y+ P
Sbjct: 125 EELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLV-----DSIAK---TRDAGCRPYMAP 176
Query: 404 EYQQTGMLT---TKSDIYSFGIMLLQIITARSP 433
E +SD++S GI L ++ T + P
Sbjct: 177 ERIDPSARDGYDVRSDVWSLGITLYEVATGKFP 209
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 1e-11
Identities = 60/215 (27%), Positives = 96/215 (44%), Gaps = 28/215 (13%)
Query: 229 DKFSEAMKIGEGGYGPVY--RGKLDHTPVAIKVLR-PDAAQGKR--QFQQEVEVLSSIRH 283
D +G G +G V+ R ++ A+KV+ P+ + K+ E VL + H
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60
Query: 284 PNMVLLLGACPDYGCL--VYEYMHNGSLEDRLLRRG---NTPVIPWRKRFKIAAEIATAL 338
P ++ L D L + EY+ G L L G N+ F A+EI AL
Sbjct: 61 PFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNS-----TGLF-YASEIVCAL 114
Query: 339 LFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTF 398
+LH + +V+RDLKP NILLD+ K++D G A+ + D + GT
Sbjct: 115 EYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAK----KLRDRT-----WTLCGTP 162
Query: 399 CYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSP 433
Y+ PE Q+ D ++ GI++ +++ P
Sbjct: 163 EYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 2e-11
Identities = 65/229 (28%), Positives = 97/229 (42%), Gaps = 40/229 (17%)
Query: 237 IGEGGYGPVY--RGKLDHTPVAIKVLRPDAAQGKRQ---FQQEVEVLSSIRHPNMVLLLG 291
IG G +G V+ R K A+KVLR + Q + E ++L+ P +V L
Sbjct: 9 IGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYY 68
Query: 292 ACPD--YGCLVYEYMHNGSLEDRLLRRGNTPVIP--WRKRFKIAAEIATALLFLHQAKPE 347
+ D + LV EYM G L + L+R+ V P RF IA E+ AL +H+
Sbjct: 69 SFQDEEHLYLVMEYMPGGDLMNLLIRKD---VFPEET-ARFYIA-ELVLALDSVHKLG-- 121
Query: 348 PLVHRDLKPANILLDRNYVSKISDVGLA--------------RLVPPSVADSVTQYHMT- 392
+HRD+KP NIL+D + K++D GL D+V
Sbjct: 122 -FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDH 180
Query: 393 --------SAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSP 433
S GT YI PE + + D +S G++L +++ P
Sbjct: 181 KQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPP 229
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 62/204 (30%), Positives = 95/204 (46%), Gaps = 19/204 (9%)
Query: 237 IGEGGYGPV--YRGKLDHTPVAIKVLRPDAAQGKRQFQQ---EVEVLSSIRHPNMVLLLG 291
+G+G +G V R K A+K+LR + K + E VL + RHP + L
Sbjct: 3 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 62
Query: 292 A--CPDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPL 349
A D C V EY + G L L R R RF AEI +AL +LH +
Sbjct: 63 AFQTHDRLCFVMEYANGGELFFHLSRE--RVFTEERARF-YGAEIVSALEYLHS---RDV 116
Query: 350 VHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTG 409
V+RD+K N++LD++ KI+D GL + ++D T M + GT Y+ PE +
Sbjct: 117 VYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGAT---MKTFCGTPEYLAPEVLEDN 170
Query: 410 MLTTKSDIYSFGIMLLQIITARSP 433
D + G+++ +++ R P
Sbjct: 171 DYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 2e-11
Identities = 63/205 (30%), Positives = 102/205 (49%), Gaps = 19/205 (9%)
Query: 236 KIGEGGYGPVYRG--KLDHTPVAIKVLRPDAAQGKR-QFQQEVEVLSSIRHPNMVLLLGA 292
K+GEG Y V++G KL VA+K +R + +G +EV +L +++H N+V L
Sbjct: 12 KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDI 71
Query: 293 CPDYGCL--VYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLV 350
CL V+EY+ + L+ L GN + K F ++ L + H+ K ++
Sbjct: 72 IHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMF--QLLRGLSYCHKRK---IL 125
Query: 351 HRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPE-YQQTG 409
HRDLKP N+L++ K++D GLAR A SV ++ T Y P+ +
Sbjct: 126 HRDLKPQNLLINEKGELKLADFGLAR------AKSVPTKTYSNEVVTLWYRPPDVLLGST 179
Query: 410 MLTTKSDIYSFGIMLLQIITARSPM 434
+T D++ G +L ++ T R PM
Sbjct: 180 EYSTPIDMWGVGCILYEMATGR-PM 203
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 64.4 bits (156), Expect = 2e-11
Identities = 60/219 (27%), Positives = 97/219 (44%), Gaps = 19/219 (8%)
Query: 220 TIEEIEEATDKFSEAMKIGEGGYGPVYRGKLD---HTPVAIKVLRPDAAQGKRQFQQEVE 276
+I + + K++ KIG+G G VY +D VAIK + K E+
Sbjct: 10 SIVSVGDPKKKYTRFEKIGQGASGTVYTA-IDIATGQEVAIKQMNLQQQPKKELIINEIL 68
Query: 277 VLSSIRHPNMVLLLGA--CPDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEI 334
V+ ++PN+V L + D +V EY+ GSL D + + + + E
Sbjct: 69 VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV----TETCMDEGQIAAVCREC 124
Query: 335 ATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSA 394
AL FLH + ++HRD+K NILL + K++D G + P Q ++
Sbjct: 125 LQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE------QSKRSTM 175
Query: 395 AGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSP 433
GT ++ PE K DI+S GIM ++++ P
Sbjct: 176 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 3e-11
Identities = 62/217 (28%), Positives = 104/217 (47%), Gaps = 22/217 (10%)
Query: 225 EEATDKFSEAMKIGEGGYGPVYRGKLDHTP----VAIKVLRPDAAQGKR-QFQQEVEVLS 279
E D F ++G G G V K+ H P +A K++ + R Q +E++VL
Sbjct: 1 ELKDDDFERISELGAGNGGVVT--KVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLH 58
Query: 280 SIRHPNMVLLLGACPDYG--CLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATA 337
P +V GA G + E+M GSL D++L+ IP K++ +
Sbjct: 59 ECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKEAKR--IPEEILGKVSIAVLRG 115
Query: 338 LLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGT 397
L +L + ++HRD+KP+NIL++ K+ D G++ + S+A+S GT
Sbjct: 116 LAYLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV--------GT 165
Query: 398 FCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPM 434
Y+ PE Q + +SDI+S G+ L+++ R P+
Sbjct: 166 RSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 3e-11
Identities = 68/255 (26%), Positives = 106/255 (41%), Gaps = 42/255 (16%)
Query: 230 KFSEAMKIGEGGYGPVYRGKLDHTP--VAIKVLRPDAAQGKRQFQQEVEV-----LSSIR 282
++ +IG G YG VY+ + H+ VA+K +R + EV L +
Sbjct: 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFD 60
Query: 283 HPNMVLLLGACPDYGC-------LVYEYMHNGSLEDRLLR----RGNTPVIPWRKRFKIA 331
HPN+V L+ C LV+E++ D+ LR + P +P +
Sbjct: 61 HPNIVRLMDVCATSRTDRETKVTLVFEHV------DQDLRTYLDKVPPPGLPAETIKDLM 114
Query: 332 AEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHM 391
+ L FLH +VHRDLKP NIL+ K++D GLAR + M
Sbjct: 115 RQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLAR---------IYSCQM 162
Query: 392 --TSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTL 449
T T Y PE T D++S G + ++ R P+ + S A + G +
Sbjct: 163 ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPLFCGN--SEADQLGKI 219
Query: 450 AEMLD-PAVTDWPAE 463
+++ P DWP +
Sbjct: 220 FDLIGLPPEDDWPRD 234
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 4e-11
Identities = 60/211 (28%), Positives = 94/211 (44%), Gaps = 25/211 (11%)
Query: 237 IGEGGYGPVY----RGKLDHTPV-AIKVLRPDAAQGKRQFQQ----EVEVLSSIRH-PNM 286
+G G YG V+ G D + A+KVL+ K + + E +VL ++R P +
Sbjct: 8 LGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFL 67
Query: 287 VLLLGACPDYGCL--VYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQA 344
V L A L + +Y++ G L L +R + R IA EI AL LHQ
Sbjct: 68 VTLHYAFQTDTKLHLILDYVNGGELFTHLYQREH--FTESEVRVYIA-EIVLALDHLHQL 124
Query: 345 KPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPE 404
+++RD+K NILLD ++D GL++ + S GT Y+ PE
Sbjct: 125 G---IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAE-----EEERAYSFCGTIEYMAPE 176
Query: 405 YQQTGMLTTKS--DIYSFGIMLLQIITARSP 433
+ G D +S G++ +++T SP
Sbjct: 177 VIRGGSGGHDKAVDWWSLGVLTFELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 4e-11
Identities = 64/216 (29%), Positives = 103/216 (47%), Gaps = 30/216 (13%)
Query: 236 KIGEGGYGPVYRGKLDHTPV--AIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGAC 293
++G+G +G VY+ K T A KV+ + + + E+E+L++ HP +V LLGA
Sbjct: 19 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78
Query: 294 PDYGCL--VYEYMHNGSLEDRLLR--RGNT-PVIPWRKRFKIAAEIATALLFLHQAKPEP 348
G L + E+ G+++ +L RG T P I I ++ AL +LH K
Sbjct: 79 YWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQ-----VICRQMLEALQYLHSMK--- 130
Query: 349 LVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQT 408
++HRDLK N+LL + K++D G+ S + T S GT ++ PE
Sbjct: 131 IIHRDLKAGNVLLTLDGDIKLADFGV------SAKNVKTLQRRDSFIGTPYWMAPEVVMC 184
Query: 409 GMLTT-----KSDIYSFGIMLLQIITARSPMGLTHH 439
+ K+DI+S GI L+++ P HH
Sbjct: 185 ETMKDTPYDYKADIWSLGITLIEMAQIEPP----HH 216
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 64.0 bits (155), Expect = 4e-11
Identities = 60/218 (27%), Positives = 96/218 (44%), Gaps = 17/218 (7%)
Query: 220 TIEEIEEATDKFSEAMKIGEGGYGPVYRGKLDHT--PVAIKVLRPDAAQGKRQFQQEVEV 277
+I + + K++ KIG+G G VY T VAI+ + K E+ V
Sbjct: 11 SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILV 70
Query: 278 LSSIRHPNMVLLLGA--CPDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIA 335
+ ++PN+V L + D +V EY+ GSL D + + + + E
Sbjct: 71 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV----TETCMDEGQIAAVCRECL 126
Query: 336 TALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAA 395
AL FLH + ++HRD+K NILL + K++D G + P Q ++
Sbjct: 127 QALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE------QSKRSTMV 177
Query: 396 GTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSP 433
GT ++ PE K DI+S GIM +++I P
Sbjct: 178 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 5e-11
Identities = 74/254 (29%), Positives = 109/254 (42%), Gaps = 26/254 (10%)
Query: 237 IGEGGYGPVYRGKLDHTP--VAIKVL---RPDAAQGKRQFQQEVEVLSSIRHPNMVLLLG 291
+G+GG+G V ++ T A K L R +G+ E +L + +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAY 67
Query: 292 A--CPDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPL 349
A D CLV M+ G L+ + GN R F AAE+ L L + E +
Sbjct: 68 AYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIF-YAAELCCGLEDLQR---ERI 123
Query: 350 VHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTG 409
V+RDLKP NILLD +ISD+GLA +P + GT Y+ PE
Sbjct: 124 VYRDLKPENILLDDRGHIRISDLGLAVQIPEGET-------VRGRVGTVGYMAPEVINNE 176
Query: 410 MLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAVTDWPAEAAESFS 469
T D + G ++ ++I +SP R ++ E +D V + E +E FS
Sbjct: 177 KYTFSPDWWGLGCLIYEMIQGQSPF-------RKRKERVKREEVDRRVKEDQEEYSEKFS 229
Query: 470 KLAIQ-CAELRKKD 482
+ A C L K+
Sbjct: 230 EDAKSICRMLLTKN 243
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 6e-11
Identities = 61/206 (29%), Positives = 96/206 (46%), Gaps = 23/206 (11%)
Query: 237 IGEGGYGPVY--RGKLDHTPVAIKVLRPDAAQGKRQFQQ---EVEVLSSIRHPNMVLLLG 291
+G+G +G V R K A+K+L+ + K + E VL + RHP + L
Sbjct: 3 LGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKY 62
Query: 292 A--CPDYGCLVYEYMHNGSLEDRLLRRG--NTPVIPWRKRFKIAAEIATALLFLHQAKPE 347
+ D C V EY + G L L R + R RF AEI +AL +LH
Sbjct: 63 SFQTHDRLCFVMEYANGGELFFHLSRERVFSED----RARF-YGAEIVSALGYLHSCD-- 115
Query: 348 PLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQ 407
+V+RDLK N++LD++ KI+D GL + ++D T M + GT Y+ PE +
Sbjct: 116 -VVYRDLKLENLMLDKDGHIKITDFGLCK---EGISDGAT---MKTFCGTPEYLAPEVLE 168
Query: 408 TGMLTTKSDIYSFGIMLLQIITARSP 433
D + G+++ +++ R P
Sbjct: 169 DNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 6e-11
Identities = 72/273 (26%), Positives = 114/273 (41%), Gaps = 31/273 (11%)
Query: 230 KFSEAMKIGEGGYGPVYRG---KLDHTPVAIKVLRPDAAQGKRQFQ--QEVEVL---SSI 281
++ +IGEG YG V++ K VA+K +R + +EV VL +
Sbjct: 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 61
Query: 282 RHPNMVLLLGACP-------DYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEI 334
HPN+V L C LV+E++ L + P +P + ++
Sbjct: 62 EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTT--YLDKVPEPGVPTETIKDMMFQL 119
Query: 335 ATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSA 394
L FLH + +VHRDLKP NIL+ + K++D GLAR+ Q +TS
Sbjct: 120 LRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYS-------FQMALTSV 169
Query: 395 AGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLD 454
T Y PE T D++S G + ++ R P L S + G + +++
Sbjct: 170 VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKP--LFRGSSDVDQLGKILDVIG 226
Query: 455 -PAVTDWPAEAAESFSKLAIQCAELRKKDRPDL 486
P DWP + A + A+ +K D+
Sbjct: 227 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDI 259
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 6e-11
Identities = 67/259 (25%), Positives = 114/259 (44%), Gaps = 29/259 (11%)
Query: 237 IGEGGYGPVYRGKLD-----HTPVAIKVLRPDA-AQGKRQFQQEVEVLSSIRHPNMVLLL 290
+G G +G + RG L PVAI LR + +R F E L H N+V L
Sbjct: 13 LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLE 72
Query: 291 GACPDYGCL--VYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEP 348
G + V EYM NG+L D LR+ ++ + + +A+ + +L +
Sbjct: 73 GVITRGNTMMIVTEYMSNGAL-DSFLRKHEGQLVA-GQLMGMLPGLASGMKYLSEMG--- 127
Query: 349 LVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQT 408
VH+ L +L++ + V KIS G RL ++++ Y S + PE Q
Sbjct: 128 YVHKGLAAHKVLVNSDLVCKIS--GFRRL-QEDKSEAI--YTTMSGKSPVLWAAPEAIQY 182
Query: 409 GMLTTKSDIYSFGIMLLQIIT--ARSPMGLTHH-VSRAIEKGTLAEMLDPAVTDWPAEAA 465
++ SD++SFGI++ ++++ R ++ V +A+E G PA P
Sbjct: 183 HHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRL----PA----PRNCP 234
Query: 466 ESFSKLAIQCAELRKKDRP 484
+L + C + + +RP
Sbjct: 235 NLLHQLMLDCWQKERGERP 253
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 6e-11
Identities = 51/221 (23%), Positives = 100/221 (45%), Gaps = 43/221 (19%)
Query: 239 EGGYGPVYRGKLDHT------PVAIKVLRPDAAQGKRQ-FQQEVEVLSSIRHPNMVLLLG 291
EG +G ++ G L V +K ++ A++ + QE +L + H N++ +L
Sbjct: 16 EGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILH 75
Query: 292 AC---PDYGCLVYEYMHNGSLED-----RLLRRGNTPVIPWRKRFKIAAEIATALLFLHQ 343
C + ++Y YM+ G+L+ RL N + ++ +A +IA + +LH+
Sbjct: 76 VCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK 135
Query: 344 AKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDP 403
++H+D+ N ++D KI+D L+R + P YH C D
Sbjct: 136 RG---VIHKDIAARNCVIDEELQVKITDNALSRDLFPM------DYH--------CLGDN 178
Query: 404 EYQ----------QTGMLTTKSDIYSFGIMLLQIIT-ARSP 433
E + ++ SD++SFG++L +++T ++P
Sbjct: 179 ENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTP 219
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 6e-11
Identities = 64/213 (30%), Positives = 93/213 (43%), Gaps = 29/213 (13%)
Query: 237 IGEGGYGPVY--RGKLDHTPVAIKVLRPDAAQGKR---QFQQEVEVLSSIRHPNMVLLLG 291
+G G +G V R K A+KV++ + F++E ++LS P + L
Sbjct: 9 VGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQY 68
Query: 292 ACPD----YGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPE 347
A D Y LV EY G L LL R +F +A E+ A+ +HQ
Sbjct: 69 AFQDKDNLY--LVMEYQPGGDLLS-LLNRYEDQFDEDMAQFYLA-ELVLAIHSVHQMG-- 122
Query: 348 PLVHRDLKPANILLDRNYVSKISDVG-LARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQ 406
VHRD+KP N+L+DR K++D G ARL + + GT YI PE
Sbjct: 123 -YVHRDIKPENVLIDRTGHIKLADFGSAARL------TANKMVNSKLPVGTPDYIAPEVL 175
Query: 407 QT------GMLTTKSDIYSFGIMLLQIITARSP 433
T G + D +S G++ ++I RSP
Sbjct: 176 TTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSP 208
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 8e-11
Identities = 67/234 (28%), Positives = 104/234 (44%), Gaps = 43/234 (18%)
Query: 225 EEATDKFSEAMKIGEGGYGPVYRGKLDHTP--VAIKVLRPDAAQGKRQFQ----QEVEVL 278
+ DKF +IGEG YG VY+ + T VA+K +R D K F +E+++L
Sbjct: 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLD--NEKEGFPITAIREIKIL 60
Query: 279 SSIRHPNMVLLLGACPD--------------YGCLVYEYM-HN--GSLEDRLLRRGNTPV 321
+ H N+V L D Y LV+EYM H+ G LE L+ +
Sbjct: 61 RQLNHRNIVNLKEIVTDKQDALDFKKDKGAFY--LVFEYMDHDLMGLLESGLVHFSEDHI 118
Query: 322 IPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPS 381
+ K ++ L + H+ +HRD+K +NILL+ K++D GLARL
Sbjct: 119 KSFMK------QLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADFGLARLY--- 166
Query: 382 VADSVTQYHMTSAAGTFCYIDPE-YQQTGMLTTKSDIYSFGIMLLQIITARSPM 434
++ Y T+ T Y PE D++S G +L ++ T + P+
Sbjct: 167 NSEESRPY--TNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFT-KKPI 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 9e-11
Identities = 62/243 (25%), Positives = 103/243 (42%), Gaps = 54/243 (22%)
Query: 222 EEIEEATDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPD--AAQGKRQFQQEVEV 277
+E K+ + +G G G V K D P A+KV+ + + K + Q EV
Sbjct: 25 ATAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCC 84
Query: 278 L-----------------SSIRHPNMVLLLGACPDYGCLVYEYMHNGSLEDRLLRRGNTP 320
L R+P VL++ LV +Y + G L + R T
Sbjct: 85 LLNCDFFSIVKCHEDFAKKDPRNPENVLMIA-------LVLDYANAGDLRQEIKSRAKTN 137
Query: 321 VIPWRKRFKIAAEIATALLFL------HQAKPEPLVHRDLKPANILLDRNYVSKISDVGL 374
+ E LLF+ H + ++HRD+K ANILL N + K+ D G
Sbjct: 138 --------RTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGF 189
Query: 375 ARLVPPSVADSVTQYHMTSAAGTFC----YIDPEYQQTGMLTTKSDIYSFGIMLLQIITA 430
+++ +V+D V + TFC Y+ PE + + K+D++S G++L +++T
Sbjct: 190 SKMYAATVSDDVGR--------TFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTL 241
Query: 431 RSP 433
+ P
Sbjct: 242 KRP 244
|
Length = 496 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 1e-10
Identities = 65/252 (25%), Positives = 116/252 (46%), Gaps = 23/252 (9%)
Query: 229 DKFSEAMKIGEGGYGPVYRG--KLDHTPVAIKVLRPDAAQGKR-QFQQEVEVLSSIRHPN 285
D + + K+GEG Y VY+G K++ VA+KV+R +G +E +L ++H N
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHAN 64
Query: 286 MVLL--LGACPDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQ 343
+VLL + + LV+EY+H + + + + P + + ++ L ++HQ
Sbjct: 65 IVLLHDIIHTKETLTLVFEYVHTDLCQ--YMDKHPGGLHPENVKLFL-FQLLRGLSYIHQ 121
Query: 344 AKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDP 403
++HRDLKP N+L+ K++D GLAR A SV + ++ T Y P
Sbjct: 122 ---RYILHRDLKPQNLLISDTGELKLADFGLAR------AKSVPSHTYSNEVVTLWYRPP 172
Query: 404 E-YQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEK-----GTLAEMLDPAV 457
+ + +T D++ G + +++I + + +E+ GT E P V
Sbjct: 173 DVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGV 232
Query: 458 TDWPAEAAESFS 469
P E F+
Sbjct: 233 HSLPHFKPERFT 244
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 80/307 (26%), Positives = 127/307 (41%), Gaps = 47/307 (15%)
Query: 225 EEATDKFSEAMKIGEGGYGPVYRGKLDHTP--VAIKVLRPDAAQGKRQFQ---QEVEVLS 279
++ + F +IG G +G VY HT VA+K + Q ++Q +EV+ L
Sbjct: 17 DDPEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQ 76
Query: 280 SIRHPNMVLLLGAC--PDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATA 337
++HPN + G LV EY GS D LL P+ + +IAA A
Sbjct: 77 QLKHPNTIEYKGCYLKEHTAWLVMEYCL-GSASD-LLEVHKKPL----QEVEIAAITHGA 130
Query: 338 LLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGT 397
L L ++HRD+K NILL K++D G A P+ S GT
Sbjct: 131 LQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPA----------NSFVGT 180
Query: 398 FCYIDPEY---QQTGMLTTKSDIYSFGIMLLQIITARSP------MGLTHHVSRAIEKGT 448
++ PE G K D++S GI +++ + P M +H+++ + T
Sbjct: 181 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN-DSPT 239
Query: 449 LAE---------MLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPELNRLKD 499
L +D + P E S L + ++DRP V++ + R KD
Sbjct: 240 LQSNEWTDSFRGFVDYCLQKIPQERPASAELLR---HDFVRRDRP--ARVLIDLIQRTKD 294
Query: 500 LGRKLES 506
R+L++
Sbjct: 295 AVRELDN 301
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 1e-10
Identities = 61/251 (24%), Positives = 111/251 (44%), Gaps = 24/251 (9%)
Query: 236 KIGEGGYGPVYRGKLDHTPV--AIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGAC 293
++G+G +G VY+ + T V A KV+ + + + E+++L+S HPN+V LL A
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71
Query: 294 --PDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVH 351
+ ++ E+ G+++ +L P + + + AL +LH+ K ++H
Sbjct: 72 YYENNLWILIEFCAGGAVDAVMLELERPLTEPQIR--VVCKQTLEALNYLHENK---IIH 126
Query: 352 RDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEY-----Q 406
RDLK NIL + K++D G+ S ++ T S GT ++ PE
Sbjct: 127 RDLKAGNILFTLDGDIKLADFGV------SAKNTRTIQRRDSFIGTPYWMAPEVVMCETS 180
Query: 407 QTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAVTDWPAEAAE 466
+ K+D++S GI L+++ P HH + +P P+ +
Sbjct: 181 KDRPYDYKADVWSLGITLIEMAQIEPP----HHELNPMRVLLKIAKSEPPTLAQPSRWSS 236
Query: 467 SFSKLAIQCAE 477
F +C E
Sbjct: 237 EFKDFLKKCLE 247
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 64/233 (27%), Positives = 107/233 (45%), Gaps = 37/233 (15%)
Query: 225 EEATDKFSEAMKIGEGGYGPVYRGKL---------DHTPVAIKVLRPDAA-QGKRQFQQE 274
E + + + +GEG +G V + VA+K+L+ DA + E
Sbjct: 8 ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSE 67
Query: 275 VEVLSSI-RHPNMVLLLGACPDYGCL--VYEYMHNGSLEDRLLRRG--------NTPVIP 323
+E++ I +H N++ LLGAC G L + EY G+L + L R +T +P
Sbjct: 68 MEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLP 127
Query: 324 -----WRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLV 378
++ A ++A + +L K +HRDL N+L+ + V KI+D GLAR V
Sbjct: 128 EEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLVTEDNVMKIADFGLARDV 184
Query: 379 PPSVADSVTQYHMTSAAGTFC--YIDPEYQQTGMLTTKSDIYSFGIMLLQIIT 429
Y+ + G ++ PE + T +SD++SFG++L +I T
Sbjct: 185 ------HNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 67/222 (30%), Positives = 102/222 (45%), Gaps = 41/222 (18%)
Query: 229 DKFSEAMKIGEGGYGPV----YRGKLDHTPVAIKVLRPDAAQGKRQFQ-----QEVEVLS 279
+ F+ +G G +G V Y+ + D PVAIK R + ++ +Q Q E ++L+
Sbjct: 30 EDFNFIRTLGTGSFGRVILATYKNE-DFPPVAIK--RFEKSKIIKQKQVDHVFSERKILN 86
Query: 280 SIRHPNMVLLLGACPD--YGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFK------IA 331
I HP V L G+ D Y LV E++ G LRR KRF A
Sbjct: 87 YINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFT-FLRRN--------KRFPNDVGCFYA 137
Query: 332 AEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHM 391
A+I +L +V+RDLKP N+LLD++ K++D G A++V D+ T
Sbjct: 138 AQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVV-----DTRTY--- 186
Query: 392 TSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSP 433
+ GT YI PE +D ++ GI + +I+ P
Sbjct: 187 -TLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPP 227
|
Length = 340 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 1e-10
Identities = 66/230 (28%), Positives = 100/230 (43%), Gaps = 58/230 (25%)
Query: 231 FSEAMKIGEGGYGPVYRGKLDHTP--VAIKVLRPDAAQGKRQFQQ--------EVEVLSS 280
F+ M +G+G +G V + T AIK+L+ D Q E VL+
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVI-----IQDDDVECTMVEKRVLAL 56
Query: 281 IRHPNMVLLLGAC---PDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFK------IA 331
P + L +C D V EY++ G L + + G +FK A
Sbjct: 57 PGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVG---------KFKEPHAVFYA 107
Query: 332 AEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHM 391
AEIA L FLH + +++RDLK N++LD KI+D G+ + ++ T
Sbjct: 108 AEIAIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCK---ENIFGGKT---- 157
Query: 392 TSAAGTFC----YIDPE---YQQTGMLTTKS-DIYSFGIMLLQIITARSP 433
TFC YI PE YQ G KS D ++FG++L +++ + P
Sbjct: 158 ---TRTFCGTPDYIAPEIIAYQPYG----KSVDWWAFGVLLYEMLAGQPP 200
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 1e-10
Identities = 63/230 (27%), Positives = 100/230 (43%), Gaps = 38/230 (16%)
Query: 236 KIGEGGYGPVYRGKLDHT--PVAIKVLRPDAAQGKRQFQQ---EVEVLSSIRHPNMVLLL 290
+G+G G V+ +L T A+KVL + + ++ E E+L+++ HP + L
Sbjct: 8 LLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLY 67
Query: 291 G--ACPDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRK-RFKIAAEIATALLFLHQAKPE 347
Y CLV +Y G L RLL+R + RF AAE+ AL +LH
Sbjct: 68 ASFQTETYLCLVMDYCPGGEL-FRLLQRQPGKCLSEEVARF-YAAEVLLALEYLHL---L 122
Query: 348 PLVHRDLKPANILLDRNY--------VSKISDVG----------------LARLVPPSVA 383
+V+RDLKP NILL + +SK SDV + + + +
Sbjct: 123 GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFS 182
Query: 384 DSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSP 433
+ + S GT YI PE + D ++ GI+L +++ +P
Sbjct: 183 EEPSFRSN-SFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTP 231
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 1e-10
Identities = 62/219 (28%), Positives = 100/219 (45%), Gaps = 33/219 (15%)
Query: 230 KFSEAMKIGEGGYGPVYRGKLDHTP--VAIKVLR-PDAAQGKRQFQ-QEVEVLSSIRHPN 285
K+ + KIGEG YG V++ K T VA+K +R D +G +E+ +L ++H N
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 60
Query: 286 MVLLLGACPDYG--CLVYEYMHNGSLEDRLLRR-----GNTPVIPWRKRFKIAAEIATAL 338
+V L LV+EY D+ L++ K F ++ L
Sbjct: 61 IVRLYDVLHSDKKLTLVFEYC------DQDLKKYFDSCNGDIDPEIVKSFMF--QLLKGL 112
Query: 339 LFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARL--VPPSVADSVTQYHMTSAAG 396
F H ++HRDLKP N+L+++N K++D GLAR +P V Y ++
Sbjct: 113 AFCHS---HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP------VRCY--SAEVV 161
Query: 397 TFCYIDPEYQQTGML-TTKSDIYSFGIMLLQIITARSPM 434
T Y P+ L +T D++S G + ++ A P+
Sbjct: 162 TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 60/205 (29%), Positives = 99/205 (48%), Gaps = 20/205 (9%)
Query: 237 IGEGGYGPVY--RGKLDHTPVAIKVLRPDAAQGKRQ----FQQEVEVLSSIRHPNMVLLL 290
IG+G +G V + KLD A+KVL+ +++ + +L +++HP +V L
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 291 GA--CPDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEP 348
+ + V ++++ G L L R + P R RF AAEIA+AL +LH
Sbjct: 63 YSFQTTEKLYFVLDFVNGGELFFHLQRERSFP--EPRARF-YAAEIASALGYLHSIN--- 116
Query: 349 LVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQT 408
+V+RDLKP NILLD ++D GL + + +D+ T + GT Y+ PE +
Sbjct: 117 IVYRDLKPENILLDSQGHVVLTDFGLCK-EGIAQSDTTTTF-----CGTPEYLAPEVIRK 170
Query: 409 GMLTTKSDIYSFGIMLLQIITARSP 433
D + G +L +++ P
Sbjct: 171 QPYDNTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 3e-10
Identities = 61/207 (29%), Positives = 99/207 (47%), Gaps = 24/207 (11%)
Query: 237 IGEGGYGPVYRGKLDHTP--VAIKVLRPDAAQGKRQFQ---QEVEVLS-SIRHPNMVLLL 290
+G+G +G V +L T AIKVL+ D E +L+ + +HP + L
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALH 62
Query: 291 GA--CPDYGCLVYEYMHNGSL--EDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKP 346
D V EY++ G L + + R+ + P R RF AAE+ AL+FLH+
Sbjct: 63 CCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEP----RSRF-YAAEVTLALMFLHR--- 114
Query: 347 EPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQ 406
+++RDLK NILLD K++D G+ + + + VT T+ GT YI PE
Sbjct: 115 HGVIYRDLKLDNILLDAEGHCKLADFGMCK---EGILNGVT---TTTFCGTPDYIAPEIL 168
Query: 407 QTGMLTTKSDIYSFGIMLLQIITARSP 433
Q D ++ G+++ +++ + P
Sbjct: 169 QELEYGPSVDWWALGVLMYEMMAGQPP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 3e-10
Identities = 66/237 (27%), Positives = 104/237 (43%), Gaps = 35/237 (14%)
Query: 215 RYRKYTIEEIEE---ATDKFSEAMKIGEGGYGPVY--RGKLDHTPVAIKVL-------RP 262
RY K E+I + + F IG G +G V R K A+K+L R
Sbjct: 27 RYEK-AAEKITKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRS 85
Query: 263 DAAQGKRQFQQEVEVLSSIRHPNMVLLLGACPD--YGCLVYEYMHNGSLEDRLLRRGNTP 320
D+A F +E ++++ +V L A D Y +V EYM G L + + N
Sbjct: 86 DSAF----FWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLM---SNYD 138
Query: 321 VIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPP 380
+ RF A E+ AL +H +HRD+KP N+LLD++ K++D G +
Sbjct: 139 IPEKWARFYTA-EVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKM-- 192
Query: 381 SVADSVTQYHMTSAAGTFCYIDPEYQQT----GMLTTKSDIYSFGIMLLQIITARSP 433
D+ +A GT YI PE ++ G + D +S G+ L +++ +P
Sbjct: 193 ---DANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 3e-10
Identities = 60/207 (28%), Positives = 101/207 (48%), Gaps = 23/207 (11%)
Query: 237 IGEGGYGPVY-----RGKLDHTPVAIKVLRPDAAQGKRQFQQEVE--VLSSIRHPNMVLL 289
+G+G +G V+ G A+KVL+ + + + + ++E +L+ + HP +V L
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKL 63
Query: 290 LGACPDYG--CLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKI-AAEIATALLFLHQAKP 346
A G L+ +++ G L RL + V+ + K AE+A AL LH
Sbjct: 64 HYAFQTEGKLYLILDFLRGGDLFTRLSKE----VMFTEEDVKFYLAELALALDHLHSLG- 118
Query: 347 EPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQ 406
+++RDLKP NILLD K++D GL++ S+ Y S GT Y+ PE
Sbjct: 119 --IIYRDLKPENILLDEEGHIKLTDFGLSK---ESIDHEKKAY---SFCGTVEYMAPEVV 170
Query: 407 QTGMLTTKSDIYSFGIMLLQIITARSP 433
T +D +SFG+++ +++T P
Sbjct: 171 NRRGHTQSADWWSFGVLMFEMLTGSLP 197
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 4e-10
Identities = 71/277 (25%), Positives = 112/277 (40%), Gaps = 42/277 (15%)
Query: 221 IEEIEEATDKFSEAMKIGEGGYGPVYR--GKLDHTPVAIKVLRPDAAQGKRQFQQEVEVL 278
+E + + TD + IG+G YG VY+ K D + A+K+L P + + + E +L
Sbjct: 14 LESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDP-ISDVDEEIEAEYNIL 72
Query: 279 SSI-RHPNMVLLLGACPDYGC---------LVYEYMHNGSLEDR---LLRRGNTPVIPWR 325
S+ HPN+V G Y LV E + GS+ + LL G
Sbjct: 73 QSLPNHPNVVKFYGMF--YKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEA-- 128
Query: 326 KRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADS 385
I+ + ALL L ++HRD+K NILL K+ D G+ S +
Sbjct: 129 ---MISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGV------SAQLT 179
Query: 386 VTQYHMTSAAGTFCYIDPEY-----QQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHV 440
T+ ++ GT ++ PE Q + D++S GI +++ P+ H V
Sbjct: 180 STRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV 239
Query: 441 SR--AIEKGTLAEMLDPAVTDWPAEAAESFSKLAIQC 475
I + +L P W SF+ QC
Sbjct: 240 KTLFKIPRNPPPTLLHP--EKW----CRSFNHFISQC 270
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 4e-10
Identities = 66/220 (30%), Positives = 101/220 (45%), Gaps = 47/220 (21%)
Query: 237 IGEGGYGPVYR-----GKLDHTPVAIKVLRP--------DAAQGKRQFQQEVEVLSSIRH 283
+G+GGYG V++ G A+KVL+ D A K E +L +++H
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTK----AERNILEAVKH 59
Query: 284 PNMVLLLGACPDYG--CLVYEYMHNGSLEDRLLRRG----NTPVIPWRKRFKIAAEIATA 337
P +V L+ A G L+ EY+ G L L R G +T F ++ EI+ A
Sbjct: 60 PFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTAC------FYLS-EISLA 112
Query: 338 LLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGT 397
L LHQ + +++RDLKP NILLD K++D GL + +S+ + +T T
Sbjct: 113 LEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCK-------ESIHEGTVTH---T 159
Query: 398 FC----YIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSP 433
FC Y+ PE D +S G ++ ++T P
Sbjct: 160 FCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPP 199
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 4e-10
Identities = 51/198 (25%), Positives = 94/198 (47%), Gaps = 20/198 (10%)
Query: 236 KIGEGGYGPVYRG----KLDHTPVAIKVLRPDA--AQGKRQFQQEVEVLSSIRHPNMVLL 289
++G G +G V +G K VA+K+L+ D K + +E V+ + +P +V +
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 290 LGACP-DYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEP 348
+G C + LV E G L L + + + ++ +++ + +L +
Sbjct: 62 IGICEAESWMLVMELAELGPLNKFLQKNKHVTE---KNITELVHQVSMGMKYLEETN--- 115
Query: 349 LVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFC--YIDPEYQ 406
VHRDL N+LL + +KISD GL++ + AD Y+ G + + PE
Sbjct: 116 FVHRDLAARNVLLVTQHYAKISDFGLSKALG---ADE--NYYKAKTHGKWPVKWYAPECM 170
Query: 407 QTGMLTTKSDIYSFGIML 424
++KSD++SFG+++
Sbjct: 171 NYYKFSSKSDVWSFGVLM 188
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 4e-10
Identities = 77/275 (28%), Positives = 114/275 (41%), Gaps = 42/275 (15%)
Query: 237 IGEGGYGPVY--RGKLDHTPVAIKVLRPDAAQGKRQFQQ---EVEVLSSIRHPNMVLLLG 291
I G YG VY R K A+K + + Q QQ E ++L+ +P +V +
Sbjct: 9 ISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFC 68
Query: 292 A--CPDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPL 349
+ + C+V EY+ G L G PV R F AE AL +LH +
Sbjct: 69 SFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYF---AETVLALEYLHNYG---I 122
Query: 350 VHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAA---------GTFCY 400
VHRDLKP N+L+ K++D GL+++ S+ ++ + H+ GT Y
Sbjct: 123 VHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEY 182
Query: 401 IDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPM-GLT------HHVSRAIEKGTLAEML 453
I PE D ++ GI+L + + P G T +S IE E L
Sbjct: 183 IAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGDEAL 242
Query: 454 DPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGT 488
PA+A + S+L LR+ LGT
Sbjct: 243 -------PADAQDLISRL------LRQNPLERLGT 264
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 5e-10
Identities = 62/204 (30%), Positives = 95/204 (46%), Gaps = 18/204 (8%)
Query: 237 IGEGGYGPVYRGKLDHTP--VAIKVLRPDAAQGKRQFQQ---EVEVLSSIRHPNMVLLLG 291
+G+G +G V K T A+K+L+ + K + E VL + RHP + L
Sbjct: 3 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 62
Query: 292 A--CPDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPL 349
+ D C V EY + G L L R R RF AEI +AL +LH K +
Sbjct: 63 SFQTHDRLCFVMEYANGGELFFHLSR--ERVFSEDRARF-YGAEIVSALDYLHSEKN--V 117
Query: 350 VHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTG 409
V+RDLK N++LD++ KI+D GL + + D T M + GT Y+ PE +
Sbjct: 118 VYRDLKLENLMLDKDGHIKITDFGLCK---EGIKDGAT---MKTFCGTPEYLAPEVLEDN 171
Query: 410 MLTTKSDIYSFGIMLLQIITARSP 433
D + G+++ +++ R P
Sbjct: 172 DYGRAVDWWGLGVVMYEMMCGRLP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 5e-10
Identities = 58/209 (27%), Positives = 96/209 (45%), Gaps = 28/209 (13%)
Query: 237 IGEGGYGPVYRGKLDHTP--VAIKVLRPDAAQGKRQFQ---QEVEVLS-SIRHPNMVLLL 290
+G+G +G V +L A+K L+ D + E VL+ + +P + L
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62
Query: 291 GA--CPDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEP 348
++ V E+++ G L + +G + +R F AAEI L FLH +
Sbjct: 63 CTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDL--YRATF-YAAEIVCGLQFLHS---KG 116
Query: 349 LVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFC----YIDPE 404
+++RDLK N++LDR+ KI+D G+ + + A TFC YI PE
Sbjct: 117 IIYRDLKLDNVMLDRDGHIKIADFGMCK----------ENVFGDNRASTFCGTPDYIAPE 166
Query: 405 YQQTGMLTTKSDIYSFGIMLLQIITARSP 433
Q T D +SFG++L +++ +SP
Sbjct: 167 ILQGLKYTFSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 60.4 bits (147), Expect = 6e-10
Identities = 47/169 (27%), Positives = 76/169 (44%), Gaps = 48/169 (28%)
Query: 236 KIGEGGYGPVYRG--KLDHTPVAIK-VLRPDAAQGKRQF----QQEVEVLSSIRHPNMVL 288
K+GEG +G VY+ VA+K +L + G F +E+++L ++HPN+V
Sbjct: 15 KLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDG---FPITALREIKILKKLKHPNVVP 71
Query: 289 LLGACPDY--------GC--LVYEYM-H--NGSLEDRLLRRGNTPVIPWRKRFK------ 329
L+ + G +V YM H +G LE+ K
Sbjct: 72 LIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLEN--------------PSVKLTESQI 117
Query: 330 --IAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLAR 376
++ + +LH+ ++HRD+K ANIL+D + KI+D GLAR
Sbjct: 118 KCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGLAR 163
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 6e-10
Identities = 61/202 (30%), Positives = 89/202 (44%), Gaps = 17/202 (8%)
Query: 229 DKFSEAMKIGEGGYGPVY--RGKLDHTPVAIKVLR--PDAAQGKRQFQQEVEVLSSIRHP 284
+KF +GEG YG V R K VAIK + + + K +E+++L +++
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60
Query: 285 NMVLLLGACPDYG--CLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLH 342
N+V L A G LV+EY+ LE LL V P + R I I +H
Sbjct: 61 NIVELKEAFRRRGKLYLVFEYVEKNMLE--LLEEMPNGVPPEKVRSYIYQLIKA----IH 114
Query: 343 QAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYID 402
+VHRD+KP N+L+ N V K+ D G AR + + T+Y T Y
Sbjct: 115 WCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEY-----VATRWYRS 169
Query: 403 PEYQQTGMLTTKSDIYSFGIML 424
PE D++S G +L
Sbjct: 170 PELLLGAPYGKAVDMWSVGCIL 191
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 6e-10
Identities = 68/225 (30%), Positives = 104/225 (46%), Gaps = 48/225 (21%)
Query: 231 FSEAMKIGEGGYGPVYRGKLDHTP--VAIKVLRPDAAQGKRQFQ---QEVEVLSSIRHPN 285
F+ M +G+G +G V + T AIK+L+ D + E VL+ P
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPP 61
Query: 286 MVLLLGAC---PDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFK------IAAEIAT 336
+ L +C D V EY++ G L ++ + G RFK AAEIA
Sbjct: 62 FLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVG---------RFKEPHAVFYAAEIAI 112
Query: 337 ALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAG 396
L FLH + +++RDLK N++LD KI+D G+ + ++ D VT
Sbjct: 113 GLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCK---ENMWDGVT-------TK 159
Query: 397 TFC----YIDPE---YQQTGMLTTKS-DIYSFGIMLLQIITARSP 433
TFC YI PE YQ G KS D ++FG++L +++ ++P
Sbjct: 160 TFCGTPDYIAPEIIAYQPYG----KSVDWWAFGVLLYEMLAGQAP 200
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 6e-10
Identities = 59/206 (28%), Positives = 99/206 (48%), Gaps = 28/206 (13%)
Query: 236 KIGEGGYGPVYRGKLDHTPVA---IKVLR--------PDAAQGKRQFQQEVEVLSSIRHP 284
++G+G +G VY K D VA +KVL+ P+ Q QE ++LS + HP
Sbjct: 7 RLGKGSFGTVYLVK-DKKAVAEERLKVLKEIPVGELNPNETV---QANQEAQLLSKLDHP 62
Query: 285 NMVLLLGAC--PDYGCLVYEYMHNGSLEDRLLR-RGNTPVIPWRKRFKIAAEIATALLFL 341
+V + D C++ EY L+ +L + + + + ++ + ++
Sbjct: 63 AIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYM 122
Query: 342 HQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYI 401
HQ + ++HRDLK NI L N + KI D G++RL+ S D T + GT Y+
Sbjct: 123 HQRR---ILHRDLKAKNIFLKNNLL-KIGDFGVSRLLMGS-CDLATTF-----TGTPYYM 172
Query: 402 DPEYQQTGMLTTKSDIYSFGIMLLQI 427
PE + +KSDI+S G +L ++
Sbjct: 173 SPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 7e-10
Identities = 59/208 (28%), Positives = 91/208 (43%), Gaps = 30/208 (14%)
Query: 237 IGEGGYGPVYRGKLDHTP--VAIKVLRPDAAQGKRQFQ---QEVEVLSSIRHPNMVLLLG 291
+G G +G V K T AIK L+ +Q Q QE +L + HP +V ++
Sbjct: 26 LGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMC 85
Query: 292 ACPD----YGCLVYEYMHNGSLEDRLLRRGNTP--VIPWRKRFKIAAEIATALLFLHQAK 345
+ D Y + E++ G L L + G P V +F AE+ A +LH
Sbjct: 86 SFQDENRVY--FLLEFVVGGELFTHLRKAGRFPNDV----AKF-YHAELVLAFEYLHSKD 138
Query: 346 PEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEY 405
+++RDLKP N+LLD K++D G A+ VP + GT Y+ PE
Sbjct: 139 ---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT---------FTLCGTPEYLAPEV 186
Query: 406 QQTGMLTTKSDIYSFGIMLLQIITARSP 433
Q+ D ++ G++L + I P
Sbjct: 187 IQSKGHGKAVDWWTMGVLLYEFIAGYPP 214
|
Length = 329 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 9e-10
Identities = 59/202 (29%), Positives = 100/202 (49%), Gaps = 18/202 (8%)
Query: 236 KIGEGGYGPVYRG--KLDHTPVAIKVLRPDAAQGKR-QFQQEVEVLSSIRHPNMVLL--L 290
K+GEG Y VY+G KL VA+K +R + +G +EV +L ++H N+V L +
Sbjct: 13 KLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 291 GACPDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLV 350
LV+EY+ + L+ L GN+ + K F ++ L + H+ K ++
Sbjct: 73 IHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLFLF--QLLRGLNYCHRRK---VL 126
Query: 351 HRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPE-YQQTG 409
HRDLKP N+L++ K++D GLAR A S+ ++ T Y P+ +
Sbjct: 127 HRDLKPQNLLINERGELKLADFGLAR------AKSIPTKTYSNEVVTLWYRPPDILLGST 180
Query: 410 MLTTKSDIYSFGIMLLQIITAR 431
+T+ D++ G + ++ T R
Sbjct: 181 DYSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.0 bits (146), Expect = 9e-10
Identities = 65/216 (30%), Positives = 94/216 (43%), Gaps = 40/216 (18%)
Query: 236 KIGEGGYGPVYRGKLDHTP----VAIKVLRPDAAQGKRQFQQ----EVEVLSSIRHPNMV 287
IGEG YG V H P VAIK + P Q F Q E+++L +H N++
Sbjct: 12 YIGEGAYGMVCSAT--HKPTGVKVAIKKISPFEHQ---TFCQRTLREIKILRRFKHENII 66
Query: 288 LLLGA-CPDYGC------LVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLF 340
+L P +V E M E L + T + +I L +
Sbjct: 67 GILDIIRPPSFESFNDVYIVQELM-----ETDLYKLIKTQHLSNDHIQYFLYQILRGLKY 121
Query: 341 LHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCY 400
+H A ++HRDLKP+N+LL+ N KI D GLAR+ P + +T T Y
Sbjct: 122 IHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIADP---EHDHTGFLTEYVATRWY 175
Query: 401 IDPEYQQTGMLTTKS-----DIYSFGIMLLQIITAR 431
PE ML +K DI+S G +L ++++ R
Sbjct: 176 RAPEI----MLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 1e-09
Identities = 77/260 (29%), Positives = 117/260 (45%), Gaps = 40/260 (15%)
Query: 237 IGEGGYGPVY--RGKLDHTPVAIKVLRPDAAQGKRQ----FQQEVEVLSSIRHPNMVLLL 290
IG+G +G V R K + A+KVL+ A K++ + +L +++HP +V L
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 291 GA--CPDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEP 348
+ D V +Y++ G L L R + R RF AAEIA+AL +LH
Sbjct: 63 FSFQTADKLYFVLDYINGGELFYHLQRE--RCFLEPRARF-YAAEIASALGYLHSLN--- 116
Query: 349 LVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFC----YIDPE 404
+V+RDLKP NILLD ++D GL + +++ TS TFC Y+ PE
Sbjct: 117 IVYRDLKPENILLDSQGHIVLTDFGLCK-------ENIEHNGTTS---TFCGTPEYLAPE 166
Query: 405 YQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAVTDWPAEA 464
D + G +L +++ GL SR AEM D + + P +
Sbjct: 167 VLHKQPYDRTVDWWCLGAVLYEML-----YGLPPFYSR-----NTAEMYD-NILNKPLQL 215
Query: 465 AESFSKLAIQCAE-LRKKDR 483
+ + A E L +KDR
Sbjct: 216 KPNITNSARHLLEGLLQKDR 235
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 1e-09
Identities = 61/259 (23%), Positives = 114/259 (44%), Gaps = 26/259 (10%)
Query: 237 IGEGGYGPVYR-------GKLDHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLL 289
+G+G +G VY +L V P+ ++ + E+++L +++H +V
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 290 LGACPDYG----CLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAK 345
G D + EYM GS++D+L G RK + +I + +LH
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTR---QILEGMSYLHS-- 124
Query: 346 PEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEY 405
+VHRD+K ANIL D K+ D G ++ + ++ S T + S GT ++ PE
Sbjct: 125 -NMIVHRDIKGANILRDSAGNVKLGDFGASKRL-QTICMSGTG--IRSVTGTPYWMSPEV 180
Query: 406 QQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAVTDWPAEAA 465
K+D++S G +++++T + P ++ + T + +P + +E A
Sbjct: 181 ISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIAT--QPTNPQLPSHISEHA 238
Query: 466 ESFSKLAIQCAELRKKDRP 484
F + C + + RP
Sbjct: 239 RDF----LGCIFVEARHRP 253
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 1e-09
Identities = 64/207 (30%), Positives = 96/207 (46%), Gaps = 24/207 (11%)
Query: 237 IGEGGYGPVYRGKLDHTP--VAIKVLRPDAAQGKRQFQ---QEVEVLS-SIRHPNMVLLL 290
+G+G +G V+ +L T AIK L+ D + E VLS + HP + L
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLY 62
Query: 291 GA--CPDYGCLVYEYMHNGSLEDRL--LRRGNTPVIPWRKRFKIAAEIATALLFLHQAKP 346
+ V EY++ G L + + + P R F AAEI L FLH
Sbjct: 63 CTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLP----RATF-YAAEIICGLQFLHS--- 114
Query: 347 EPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQ 406
+ +V+RDLK NILLD + KI+D G+ + + D+ T + GT YI PE
Sbjct: 115 KGIVYRDLKLDNILLDTDGHIKIADFGMCK--ENMLGDAKT----CTFCGTPDYIAPEIL 168
Query: 407 QTGMLTTKSDIYSFGIMLLQIITARSP 433
T D +SFG++L +++ +SP
Sbjct: 169 LGQKYNTSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 2e-09
Identities = 60/211 (28%), Positives = 97/211 (45%), Gaps = 32/211 (15%)
Query: 237 IGEGGYGPVY--RGKLDHTPVAIKVLRPDAAQGKRQ----FQQEVEVLSSIRHPNMVLLL 290
IG+G +G V + K D + A+KVL+ K++ + +L +++HP +V L
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62
Query: 291 GA--CPDYGCLVYEYMHNGSLEDRLLR--RGNTPVIPWRKRFKIAAEIATALLFLHQAKP 346
+ + V +Y++ G L L R P R RF AAE+A+A+ +LH
Sbjct: 63 YSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEP----RARF-YAAEVASAIGYLHSLN- 116
Query: 347 EPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFC----YID 402
+++RDLKP NILLD ++D GL + + V TS TFC Y+
Sbjct: 117 --IIYRDLKPENILLDSQGHVVLTDFGLCK-------EGVEPEETTS---TFCGTPEYLA 164
Query: 403 PEYQQTGMLTTKSDIYSFGIMLLQIITARSP 433
PE + D + G +L +++ P
Sbjct: 165 PEVLRKEPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 67/221 (30%), Positives = 98/221 (44%), Gaps = 49/221 (22%)
Query: 237 IGEGGYGPVY--RGKLDHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVL--LLGA 292
IG+G +G VY R K A+KVL K++ + EV +I N+++ LL
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVL------SKKEIVAKKEVAHTIGERNILVRTLLDE 54
Query: 293 CPD--------------YGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATAL 338
P Y LV +YM G L L + G R +F IA E+ AL
Sbjct: 55 SPFIVGLKFSFQTDSDLY--LVTDYMSGGELFWHLQKEGRFS--EDRAKFYIA-ELVLAL 109
Query: 339 LFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTF 398
LH+ +V+RDLKP NILLD + D GL++ ++ D+ T TF
Sbjct: 110 EHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSK---ANLTDNKT-------TNTF 156
Query: 399 C----YIDPE--YQQTGMLTTKSDIYSFGIMLLQIITARSP 433
C Y+ PE + G T D +S G+++ ++ SP
Sbjct: 157 CGTTEYLAPEVLLDEKGY-TKHVDFWSLGVLVFEMCCGWSP 196
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 2e-09
Identities = 58/202 (28%), Positives = 99/202 (49%), Gaps = 18/202 (8%)
Query: 236 KIGEGGYGPVYRG--KLDHTPVAIKVLRPDAAQGKR-QFQQEVEVLSSIRHPNMVLL--L 290
K+GEG Y V++G KL VA+K +R + +G +EV +L ++H N+V L +
Sbjct: 13 KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 291 GACPDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLV 350
LV+EY+ + L+ + GN + K F +I L + H+ K ++
Sbjct: 73 VHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHNVKIFLY--QILRGLAYCHRRK---VL 126
Query: 351 HRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPE-YQQTG 409
HRDLKP N+L++ K++D GLAR A SV ++ T Y P+ +
Sbjct: 127 HRDLKPQNLLINERGELKLADFGLAR------AKSVPTKTYSNEVVTLWYRPPDVLLGSS 180
Query: 410 MLTTKSDIYSFGIMLLQIITAR 431
+T+ D++ G + ++ + R
Sbjct: 181 EYSTQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 2e-09
Identities = 65/248 (26%), Positives = 101/248 (40%), Gaps = 44/248 (17%)
Query: 236 KIGEGGYGPVYRGKLDHTP-----VAIKVLRPDAAQG---KRQFQQEVEVLSSIRHPNMV 287
IG+GG G VY L + P VA+K +R D ++ K++F +E ++ + + HP +V
Sbjct: 9 LIGKGGMGEVY---LAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIV 65
Query: 288 LLLGACPDYGCLVY---EYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQ- 343
+ C D G VY Y+ +L+ L + K + L H+
Sbjct: 66 PVYSICSD-GDPVYYTMPYIEGYTLKSLLKSVWQKESLS--KELAEKTSVGAFLSIFHKI 122
Query: 344 ------AKPEPLVHRDLKPANILLDRNYVSKISDVGLAR--------LVPPSVADSVTQY 389
+ ++HRDLKP NILL I D G A L+ V + Y
Sbjct: 123 CATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICY 182
Query: 390 H-MT---SAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSP--------MGLT 437
MT GT Y+ PE + +DIY+ G++L Q++T P +
Sbjct: 183 SSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKISYR 242
Query: 438 HHVSRAIE 445
+ IE
Sbjct: 243 DVILSPIE 250
|
Length = 932 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 2e-09
Identities = 44/137 (32%), Positives = 64/137 (46%), Gaps = 10/137 (7%)
Query: 298 CLVYEYMHNGSLEDRLLR-RGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKP 356
CLV M+ G L + P P + A+I + L LHQ + +++RDLKP
Sbjct: 69 CLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKP 125
Query: 357 ANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSD 416
N+LLD + +ISD+GLA V Q AGT ++ PE Q D
Sbjct: 126 ENVLLDNDGNVRISDLGLA------VELKDGQSKTKGYAGTPGFMAPELLQGEEYDFSVD 179
Query: 417 IYSFGIMLLQIITARSP 433
++ G+ L ++I AR P
Sbjct: 180 YFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 3e-09
Identities = 59/216 (27%), Positives = 95/216 (43%), Gaps = 46/216 (21%)
Query: 236 KIGEGGYGPVYRGKLDHTP--VAIKVLRPDAAQGKRQFQ--QEVEVLSSIRHPNMVLL-- 289
K+GEG Y VY+G+ T VA+K +R + +G F +E +L ++H N+V L
Sbjct: 12 KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGA-PFTAIREASLLKDLKHANIVTLHD 70
Query: 290 -------LGACPDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLH 342
L LV+EY+ L+ + G + + F ++ L + H
Sbjct: 71 IIHTKKTL-------TLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLF--QLLRGLAYCH 120
Query: 343 QAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYID 402
Q + ++HRDLKP N+L+ K++D GLAR A SV ++ T Y
Sbjct: 121 QRR---VLHRDLKPQNLLISERGELKLADFGLAR------AKSVPSKTYSNEVVTLWYRP 171
Query: 403 P-------EYQQTGMLTTKSDIYSFGIMLLQIITAR 431
P EY +T D++ G + ++ T R
Sbjct: 172 PDVLLGSTEY------STSLDMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 3e-09
Identities = 63/224 (28%), Positives = 99/224 (44%), Gaps = 46/224 (20%)
Query: 231 FSEAMKIGEGGYGPVYRGKLDHTP--VAIKVLRPDAAQGKRQFQ---QEVEVLSSIRHPN 285
F+ M +G+G +G V + T AIK+L+ D + E VL+ P
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPP 61
Query: 286 MVLLLGAC---PDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFK------IAAEIAT 336
+ L +C D V EY++ G L + + G +FK AAEI+
Sbjct: 62 FLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVG---------KFKEPQAVFYAAEISV 112
Query: 337 ALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAG 396
L FLH+ +++RDLK N++LD KI+D G+ + + D VT
Sbjct: 113 GLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCK---EHMVDGVT-------TR 159
Query: 397 TFC----YIDPE---YQQTGMLTTKSDIYSFGIMLLQIITARSP 433
TFC YI PE YQ G D +++G++L +++ + P
Sbjct: 160 TFCGTPDYIAPEIIAYQPYGK---SVDWWAYGVLLYEMLAGQPP 200
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 3e-09
Identities = 67/235 (28%), Positives = 104/235 (44%), Gaps = 51/235 (21%)
Query: 218 KYTIEEIEEATDKFSEAMKIGEGGYGPVYRGKLDHT--PVAIKVLR------PDAAQGKR 269
+Y I+E+ IG+G YG V HT VAIK + DA + R
Sbjct: 1 RYKIQEV------------IGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILR 48
Query: 270 QFQQEVEVLSSIRHPNMV----LLLGACPD-----YGCLVYEYMHNGSLEDRLLR--RGN 318
E+++L +RHP++V ++L Y +V+E M E L + + N
Sbjct: 49 ----EIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY--VVFELM-----ESDLHQVIKAN 97
Query: 319 TPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLV 378
+ P +F + ++ AL ++H A + HRDLKP NIL + + KI D GLAR
Sbjct: 98 DDLTPEHHQFFLY-QLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLAR-- 151
Query: 379 PPSVADSVTQYHMTSAAGTFCYIDPEYQQT--GMLTTKSDIYSFGIMLLQIITAR 431
+ D+ T T T Y PE + T DI+S G + +++T +
Sbjct: 152 -VAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 3e-09
Identities = 70/278 (25%), Positives = 114/278 (41%), Gaps = 42/278 (15%)
Query: 226 EATDKFSEAMKIGEGGYGPVYR--GKLDHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIR- 282
+ +D + IG+G YG V++ K + + A+K+L P + + E +L ++
Sbjct: 15 DPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDP-IHDIDEEIEAEYNILKALSD 73
Query: 283 HPNMVLLLG-------ACPDYGCLVYEYMHNGSLEDR---LLRRG---NTPVIPWRKRFK 329
HPN+V G D LV E + GS+ D L+RG P+I +
Sbjct: 74 HPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAY----- 128
Query: 330 IAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQY 389
I E L LH K +HRD+K NILL K+ D G+ S + T+
Sbjct: 129 ILHEALMGLQHLHVNKT---IHRDVKGNNILLTTEGGVKLVDFGV------SAQLTSTRL 179
Query: 390 HMTSAAGTFCYIDPEY-----QQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRA- 443
++ GT ++ PE Q + D++S GI +++ P+ H + RA
Sbjct: 180 RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPM-RAL 238
Query: 444 --IEKGTLAEMLDPAVTDWPAEAAESFSKLAIQCAELR 479
I + + P + W E + K + E R
Sbjct: 239 FKIPRNPPPTLHQPEL--WSNEFNDFIRKCLTKDYEKR 274
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 3e-09
Identities = 59/221 (26%), Positives = 99/221 (44%), Gaps = 39/221 (17%)
Query: 229 DKFSEAMKIGEGGYGPVYRGKLDHT--PVAIKVLR--------PDAAQGKRQFQQEVEVL 278
D++ + KIGEG YG VY+ + T +A+K +R P A +E+ +L
Sbjct: 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTA------IREISLL 55
Query: 279 SSIRHPNMVLLLGACPDYGC--LVYEYMHNGSLEDRLLRR--GNTPVIPWRKRF--KIAA 332
++H N+V L LV+EY+ D L++ ++P R
Sbjct: 56 KEMQHGNIVRLQDVVHSEKRLYLVFEYL------DLDLKKHMDSSPDFAKNPRLIKTYLY 109
Query: 333 EIATALLFLHQAKPEPLVHRDLKPANILLDRNYVS-KISDVGLARLVPPSVADSVTQYHM 391
+I + + H + ++HRDLKP N+L+DR + K++D GLAR A +
Sbjct: 110 QILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLAR------AFGIPVRTF 160
Query: 392 TSAAGTFCYIDPE-YQQTGMLTTKSDIYSFGIMLLQIITAR 431
T T Y PE + +T DI+S G + +++ +
Sbjct: 161 THEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 4e-09
Identities = 35/149 (23%), Positives = 52/149 (34%), Gaps = 16/149 (10%)
Query: 236 KIGEGGYGPVYRGKLDHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNM----VLLLG 291
+ G VY +K+ ++EV +L + + VL G
Sbjct: 5 LLKGGLTNRVYLLGTKDEDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASG 62
Query: 292 ACPDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVH 351
+ L+ E+ +E L + IA ++A L LHQ L H
Sbjct: 63 ESDGWSYLLMEW-----IEGETLDEVSEEEKE-----DIAEQLAELLAKLHQLPLLVLCH 112
Query: 352 RDLKPANILLDRNYVSKISDVGLARLVPP 380
DL P NIL+D + I D A PP
Sbjct: 113 GDLHPGNILVDDGKILGIIDWEYAGYGPP 141
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 4e-09
Identities = 70/245 (28%), Positives = 118/245 (48%), Gaps = 34/245 (13%)
Query: 216 YRKYTIEEIEEATDKFSEAMKIGEGGYGPVYRGKLDH---TPVAIKVL-RPDAAQ--GKR 269
YR+ + I E D++ + ++G G YG V LD VAIK L RP ++ KR
Sbjct: 2 YRQEVNKTIWEVPDRYRDLKQVGSGAYGTVCSA-LDRRTGAKVAIKKLYRPFQSELFAKR 60
Query: 270 QFQQEVEVLSSIRHPNMVLLLGA-CPDYGC-------LVYEYMHNGSLEDRLLRRGNTPV 321
++ E+ +L ++H N++ LL PD LV +M G+ +L++ + +
Sbjct: 61 AYR-ELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM--GTDLGKLMK--HEKL 115
Query: 322 IPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPS 381
R +F + ++ L ++H A ++HRDLKP N+ ++ + KI D GLAR
Sbjct: 116 SEDRIQF-LVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQ---- 167
Query: 382 VADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKS-DIYSFGIMLLQIITARSPMGLTHHV 440
DS MT T Y PE M T++ DI+S G ++ +++T + H+
Sbjct: 168 -TDS----EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHL 222
Query: 441 SRAIE 445
+ +E
Sbjct: 223 DQLME 227
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 5e-09
Identities = 65/245 (26%), Positives = 107/245 (43%), Gaps = 25/245 (10%)
Query: 236 KIGEGGYGPVYRG--KLDHTPVAIKVLRPDAAQGKRQFQ--QEVEVLSSIRHPNMVLLLG 291
K+GEG Y VY+G +++ VA+KV+ +G F +E +L ++H N+VLL
Sbjct: 12 KLGEGSYATVYKGISRINGQLVALKVISMKTEEGV-PFTAIREASLLKGLKHANIVLLHD 70
Query: 292 ACPDYGCL--VYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPL 349
L V+EYMH + + G + P+ R ++ L ++H +
Sbjct: 71 IIHTKETLTFVFEYMHTDLAQYMIQHPGG--LHPYNVRL-FMFQLLRGLAYIHGQH---I 124
Query: 350 VHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTG 409
+HRDLKP N+L+ K++D GLAR A S+ +S T Y P+
Sbjct: 125 LHRDLKPQNLLISYLGELKLADFGLAR------AKSIPSQTYSSEVVTLWYRPPDVLLGA 178
Query: 410 M-LTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEK-----GTLAEMLDPAVTDWPAE 463
++ DI+ G + ++++ + V +EK G E P V+ P
Sbjct: 179 TDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNY 238
Query: 464 AAESF 468
E F
Sbjct: 239 KPEWF 243
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 5e-09
Identities = 46/151 (30%), Positives = 69/151 (45%), Gaps = 12/151 (7%)
Query: 236 KIGEGGYGPVYRGK----LDHTPVAIKVLRPDAA-QGKRQFQQEVEVLSSIRHPNMVLLL 290
+IG G +G V G+ V +K LR A+ Q + +F +E + S++H N++ L
Sbjct: 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 291 GACPDYG--CLVYEYMHNGSLED--RLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKP 346
G C + LV E+ G L+ R R+ ++A EIA LL LH+
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN- 120
Query: 347 EPLVHRDLKPANILLDRNYVSKISDVGLARL 377
+H DL N LL + KI D GL+
Sbjct: 121 --FIHSDLALRNCLLTADLTVKIGDYGLSHN 149
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 6e-09
Identities = 72/253 (28%), Positives = 115/253 (45%), Gaps = 38/253 (15%)
Query: 199 AEEKNRALTALANNDVRYRKYTIEEIEEATDKFS--EAMK-IGEGGYGPV--YRGKLDHT 253
A KN+ + N RY+ TI +I + K E +K IG G +G V R K
Sbjct: 14 ALRKNKNIDNFLN---RYKD-TINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRK 69
Query: 254 PVAIKVL-------RPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACPD--YGCLVYEYM 304
A+K+L R D+A F +E ++++ P +V L A D Y +V EYM
Sbjct: 70 VYAMKLLSKFEMIKRSDSAF----FWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYM 125
Query: 305 HNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRN 364
G L + L+ + P W + + AE+ AL +H +HRD+KP N+LLD++
Sbjct: 126 PGGDLVN-LMSNYDVPE-KWARFY--TAEVVLALDAIHSMG---FIHRDVKPDNMLLDKS 178
Query: 365 YVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQT----GMLTTKSDIYSF 420
K++D G + + +A GT YI PE ++ G + D +S
Sbjct: 179 GHLKLADFGTCMKM-----NKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSV 233
Query: 421 GIMLLQIITARSP 433
G+ L +++ +P
Sbjct: 234 GVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 6e-09
Identities = 62/219 (28%), Positives = 95/219 (43%), Gaps = 29/219 (13%)
Query: 237 IGEGGYGPVYRGKLDHTP--VAIKVLRPDAAQGKRQFQQEVEVLSSI-RHPNMVLLLGA- 292
+G G YG VY+G+ T AIKV+ + + + +QE+ +L H N+ GA
Sbjct: 14 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE-EEEIKQEINMLKKYSHHRNIATYYGAF 72
Query: 293 -------CPDYGCLVYEYMHNGSLEDRLLR-RGNTPVIPWRKRFKIAAEIATALLFLHQA 344
D LV E+ GS+ D + +GNT W I EI L LHQ
Sbjct: 73 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY--ICREILRGLSHLHQH 130
Query: 345 KPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPE 404
K ++HRD+K N+LL N K+ D G++ + +V + GT ++ PE
Sbjct: 131 K---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG------RRNTFIGTPYWMAPE 181
Query: 405 Y-----QQTGMLTTKSDIYSFGIMLLQIITARSPMGLTH 438
KSD++S GI +++ P+ H
Sbjct: 182 VIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH 220
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 7e-09
Identities = 53/204 (25%), Positives = 94/204 (46%), Gaps = 19/204 (9%)
Query: 235 MKIGEGGYGPVYRGKLDHT--PVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGA 292
+KIGEG G V + H+ VA+K++ Q + EV ++ +H N+V + +
Sbjct: 27 IKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKS 86
Query: 293 --CPDYGCLVYEYMHNGSLEDRLLR-RGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPL 349
+ ++ E++ G+L D + + R N I + + AL +LH + +
Sbjct: 87 YLVGEELWVLMEFLQGGALTDIVSQTRLNEEQIA-----TVCESVLQALCYLHS---QGV 138
Query: 350 VHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTG 409
+HRD+K +ILL + K+SD G + V S GT ++ PE
Sbjct: 139 IHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKR------KSLVGTPYWMAPEVISRT 192
Query: 410 MLTTKSDIYSFGIMLLQIITARSP 433
T+ DI+S GIM+++++ P
Sbjct: 193 PYGTEVDIWSLGIMVIEMVDGEPP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 7e-09
Identities = 59/210 (28%), Positives = 94/210 (44%), Gaps = 24/210 (11%)
Query: 237 IGEGGYGPVY--RGKLDHTPVAIKVLRPDAAQGKRQF---QQEVEVLSSIRHPNMVLLLG 291
IG G Y V R K + A+KV++ + Q E V ++ L
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62
Query: 292 ACPDYGC---LVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEP 348
+C LV EY++ G L + R+ P RF AAEI AL FLH+
Sbjct: 63 SCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLP--EEHARF-YAAEICIALNFLHE---RG 116
Query: 349 LVHRDLKPANILLDRNYVSKISDVGLAR--LVPPSVADSVTQYHMTSAAGTFCYIDPEYQ 406
+++RDLK N+LLD + K++D G+ + L P D+ + + GT YI PE
Sbjct: 117 IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP---GDTTSTF-----CGTPNYIAPEIL 168
Query: 407 QTGMLTTKSDIYSFGIMLLQIITARSPMGL 436
+ D ++ G+++ +++ RSP +
Sbjct: 169 RGEEYGFSVDWWALGVLMFEMMAGRSPFDI 198
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 9e-09
Identities = 65/239 (27%), Positives = 108/239 (45%), Gaps = 28/239 (11%)
Query: 216 YRKYTIEEIEEATDKFSEAMKIGEGGYGPVYRGKLDHTP--VAIKVL-RP--DAAQGKRQ 270
YR+ + I E +++ +G G YG V T VA+K L RP KR
Sbjct: 4 YRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT 63
Query: 271 FQQEVEVLSSIRHPNMVLLLGACPDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRK---- 326
++ E+ +L ++H N++ LL L E ++ L L+ ++ +K
Sbjct: 64 YR-ELRLLKHMKHENVIGLLDVFTPARSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDD 120
Query: 327 --RFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVAD 384
+F I +I L ++H A ++HRDLKP+N+ ++ + KI D GLAR
Sbjct: 121 HVQFLIY-QILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARH------- 169
Query: 385 SVTQYHMTSAAGTFCYIDPEYQQTGMLTTKS-DIYSFGIMLLQIITARSPMGLTHHVSR 442
T MT T Y PE M ++ DI+S G ++ +++T R+ T H+ +
Sbjct: 170 --TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ 226
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 58/204 (28%), Positives = 90/204 (44%), Gaps = 19/204 (9%)
Query: 235 MKIGEGGYGPVYRGKLDHT--PVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGA 292
+KIGEG G V HT VA+K + Q + EV ++ H N+V + +
Sbjct: 28 IKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNS 87
Query: 293 --CPDYGCLVYEYMHNGSLEDRLLR-RGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPL 349
D +V E++ G+L D + R N I + + AL +LH + +
Sbjct: 88 YLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-----TVCLSVLRALSYLHN---QGV 139
Query: 350 VHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTG 409
+HRD+K +ILL + K+SD G V V S GT ++ PE
Sbjct: 140 IHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKR------KSLVGTPYWMAPEVISRL 193
Query: 410 MLTTKSDIYSFGIMLLQIITARSP 433
T+ DI+S GIM++++I P
Sbjct: 194 PYGTEVDIWSLGIMVIEMIDGEPP 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 1e-08
Identities = 57/214 (26%), Positives = 100/214 (46%), Gaps = 32/214 (14%)
Query: 237 IGEGGYGPVYRGKLDHT--PVAIKVLR-----PDAAQGKRQFQQEVEVLSSIRHPNMVLL 289
+G+G +G VY T +A+K ++ P+ ++ + E+++L ++ H +V
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69
Query: 290 LGACPDYGCL----------VYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALL 339
YGCL E+M GS++D+L G RK + +I +
Sbjct: 70 ------YGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTR---QILEGVS 120
Query: 340 FLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFC 399
+LH +VHRD+K ANIL D K+ D G ++ + ++ S T M S GT
Sbjct: 121 YLHS---NMIVHRDIKGANILRDSVGNVKLGDFGASKRL-QTICLSGTG--MKSVTGTPY 174
Query: 400 YIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSP 433
++ PE K+DI+S G +++++T + P
Sbjct: 175 WMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 3e-08
Identities = 57/215 (26%), Positives = 94/215 (43%), Gaps = 36/215 (16%)
Query: 236 KIGEGGYGPV--YRGKLDHTPVAIKVLRPDA----AQGKRQFQQEVEVLSSIRHPNMVLL 289
IG G YG V VAIK + P A KR + E+++L +H N++ +
Sbjct: 12 NIGSGAYGVVCSAIDTRSGKKVAIKKI-PHAFDVPTLAKRTLR-ELKILRHFKHDNIIAI 69
Query: 290 L------GACPDYGCLVYEYMHNGSLEDRLLR--RGNTPVIPWRKRFKIAAEIATALLFL 341
GA +V + M E L + P+ R+ ++ L ++
Sbjct: 70 RDILRPPGADFKDVYVVMDLM-----ESDLHHIIHSDQPLTEEHIRY-FLYQLLRGLKYI 123
Query: 342 HQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYI 401
H A ++HRDLKP+N+L++ + +I D G+AR + S + +Y MT T Y
Sbjct: 124 HSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEH--KYFMTEYVATRWYR 178
Query: 402 DPEYQQTGML-----TTKSDIYSFGIMLLQIITAR 431
PE +L TT D++S G + +++ R
Sbjct: 179 APEL----LLSLPEYTTAIDMWSVGCIFAEMLGRR 209
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 3e-08
Identities = 64/211 (30%), Positives = 97/211 (45%), Gaps = 32/211 (15%)
Query: 237 IGEGGYGPVYRGK--LDHTPVAIKVLRPDAAQG----KRQFQQEVEVLSSIRHPNMVLLL 290
IG G +G V+ D VA+K + P+ Q KR F+ E+++L +H N++ L
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKM-PNVFQNLVSCKRVFR-ELKMLCFFKHDNVLSAL 65
Query: 291 GAC--PDYGC-----LVYEYMHNGSLEDRLLRRGNTPVIP-WRKRFKIAAEIATALLFLH 342
P +V E M + L ++ P+ K F +I L +LH
Sbjct: 66 DILQPPHIDPFEEIYVVTELMQS-DLHKIIVS--PQPLSSDHVKVF--LYQILRGLKYLH 120
Query: 343 QAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYID 402
A ++HRD+KP N+L++ N V KI D GLAR+ P +S HMT T Y
Sbjct: 121 SAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPD--ESK---HMTQEVVTQYYRA 172
Query: 403 PEYQQTGM--LTTKSDIYSFGIMLLQIITAR 431
PE G T+ DI+S G + +++ R
Sbjct: 173 PEI-LMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 4e-08
Identities = 65/283 (22%), Positives = 117/283 (41%), Gaps = 40/283 (14%)
Query: 231 FSEAMKIGEGGYGPVYRGKLDH-----TPVAIKVLRPD--AAQGKRQFQQEVEVLSSIRH 283
F+ +G+G +G V +L VA+K+L+ D ++ +F +E + H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 284 PNMVLLLGAC-----------PDYGCLVYEYMHNGSLEDRLL--RRGNTPV-IPWRKRFK 329
PN++ L+G P ++ +M +G L LL R G P +P + +
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIP---MVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVR 117
Query: 330 IAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQY 389
+IA+ + +L +HRDL N +L+ N ++D GL++ + S Y
Sbjct: 118 FMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADFGLSKKIY-----SGDYY 169
Query: 390 HMTSAAG-TFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGT 448
A+ ++ E + TT SD+++FG+ + +I+T G T + +E
Sbjct: 170 RQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMT----RGQTPYA--GVENSE 223
Query: 449 LAEMLDPA-VTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVI 490
+ L P + E +L QC K RP +
Sbjct: 224 IYNYLIKGNRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLR 266
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 7e-08
Identities = 54/191 (28%), Positives = 86/191 (45%), Gaps = 26/191 (13%)
Query: 247 RGKLDHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGAC-PDYGCLVYEYMH 305
G V +KVL D + F + ++S + H ++V L G C D +V EY+
Sbjct: 25 VGPGQEVSVVLKVLGSDH-RDSLAFFETASLMSQLSHKHLVKLYGVCVRDENIMVEEYVK 83
Query: 306 NGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNY 365
G L+ L R N + W + +A ++A+AL +L K LVH ++ NIL+ R
Sbjct: 84 FGPLDVFLHREKNNVSLHW--KLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYG 138
Query: 366 VS-------KISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGM--LTTKSD 416
++ K+SD G+ V + + +I PE + G LT +D
Sbjct: 139 LNEGYVPFIKLSDPGIPITVLS------REERVERIP----WIAPECIRNGQASLTIAAD 188
Query: 417 IYSFGIMLLQI 427
+SFG LL+I
Sbjct: 189 KWSFGTTLLEI 199
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 59/210 (28%), Positives = 95/210 (45%), Gaps = 24/210 (11%)
Query: 237 IGEGGYGPVYRGKLDHTP--VAIKVLRPDAAQGKRQF---QQEVEVL-SSIRHPNMVLLL 290
IG G Y V +L T A+KV++ + Q E V + HP +V L
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62
Query: 291 GACPDYGCL--VYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEP 348
L V EY++ G L + R+ P RF +AEI+ AL +LH+
Sbjct: 63 SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLP--EEHARF-YSAEISLALNYLHE---RG 116
Query: 349 LVHRDLKPANILLDRNYVSKISDVGLAR--LVPPSVADSVTQYHMTSAAGTFCYIDPEYQ 406
+++RDLK N+LLD K++D G+ + L P D+ + + GT YI PE
Sbjct: 117 IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP---GDTTSTF-----CGTPNYIAPEIL 168
Query: 407 QTGMLTTKSDIYSFGIMLLQIITARSPMGL 436
+ D ++ G+++ +++ RSP +
Sbjct: 169 RGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 1e-07
Identities = 59/210 (28%), Positives = 94/210 (44%), Gaps = 30/210 (14%)
Query: 237 IGEGGYGPVYRGKLDHTP--VAIKVLRPDAAQGKRQF---QQEVEVL-SSIRHPNMVLLL 290
IG G Y V +L T A+KV++ + Q E V ++ HP +V L
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGL- 61
Query: 291 GAC---PDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPE 347
+C V E++ G L + R+ P RF +AEI+ AL FLH+
Sbjct: 62 HSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLP--EEHARF-YSAEISLALNFLHE---R 115
Query: 348 PLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFC----YIDP 403
+++RDLK N+LLD K++D G+ + + + TS TFC YI P
Sbjct: 116 GIIYRDLKLDNVLLDAEGHIKLTDYGMCK-------EGIRPGDTTS---TFCGTPNYIAP 165
Query: 404 EYQQTGMLTTKSDIYSFGIMLLQIITARSP 433
E + D ++ G+++ +++ RSP
Sbjct: 166 EILRGEDYGFSVDWWALGVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 1e-07
Identities = 60/208 (28%), Positives = 94/208 (45%), Gaps = 27/208 (12%)
Query: 237 IGEGGYGPVYR-GKLDHTPV-AIKVLRPDAAQGKRQFQQ---EVEVLSSIRHPNMVLLLG 291
IG+G +G V + K D + A+K +R + + E VL+ + P +V L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 292 A--CPDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPL 349
+ P+ LV +++ G L L R G + R RF A E+ AL LH+ +
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGRFDL--SRARFYTA-ELLCALENLHKFN---V 114
Query: 350 VHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFC----YIDPEY 405
++RDLKP NILLD + D GL +L ++ D TFC Y+ PE
Sbjct: 115 IYRDLKPENILLDYQGHIALCDFGLCKL---NMKDDDK-------TNTFCGTPEYLAPEL 164
Query: 406 QQTGMLTTKSDIYSFGIMLLQIITARSP 433
T D ++ G++L +++T P
Sbjct: 165 LLGHGYTKAVDWWTLGVLLYEMLTGLPP 192
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 1e-07
Identities = 50/184 (27%), Positives = 82/184 (44%), Gaps = 27/184 (14%)
Query: 255 VAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACPDY--GCLVYEYMHNGSLEDR 312
V +KVL P F + ++ + H ++VLL G C +V E++ G L D
Sbjct: 35 VILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPL-DL 93
Query: 313 LLRRGNTPV-IPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVS---- 367
+ R + + PW +FK+A ++A+AL +L LVH ++ NILL R +
Sbjct: 94 FMHRKSDVLTTPW--KFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECG 148
Query: 368 ---KISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPE-YQQTGMLTTKSDIYSFGIM 423
K+SD G+ +T +I PE + + L+ +D +SFG
Sbjct: 149 PFIKLSDPGI----------PITVLSRQECVERIPWIAPECVEDSKNLSIAADKWSFGTT 198
Query: 424 LLQI 427
L +I
Sbjct: 199 LWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 2e-07
Identities = 53/208 (25%), Positives = 96/208 (46%), Gaps = 20/208 (9%)
Query: 237 IGEGGYGPVYRGKLDHTPVAIKV----LRPDAAQGKRQ---FQQEVEVLSSIRHPNMVLL 289
+G G +G VY T + V PD+ + ++ + E+++L ++RH +V
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69
Query: 290 LGACPDYG----CLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAK 345
G D + EYM GS++D+L G R+ + +I + +LH
Sbjct: 70 YGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTR---QILQGVSYLHS-- 124
Query: 346 PEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEY 405
+VHRD+K ANIL D K+ D G ++ + ++ S T + S GT ++ PE
Sbjct: 125 -NMIVHRDIKGANILRDSAGNVKLGDFGASKRI-QTICMSGTG--IKSVTGTPYWMSPEV 180
Query: 406 QQTGMLTTKSDIYSFGIMLLQIITARSP 433
K+D++S +++++T + P
Sbjct: 181 ISGEGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 68/233 (29%), Positives = 95/233 (40%), Gaps = 54/233 (23%)
Query: 229 DKFSEAMKIGEGGYGPVYRGKLDHTP--VAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNM 286
D F IG G +G V K+ HT A+K+L K + + E + R
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKIL------NKWEMLKRAET-ACFREERN 53
Query: 287 VLLLGAC------------PDYGCLVYEYMHNGSL-------EDRLLRRGNTPVIPWRKR 327
VL+ G C +Y LV +Y G L EDRL R
Sbjct: 54 VLVNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPED--------MAR 105
Query: 328 FKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVG--LARLVPPSVADS 385
F IA E+ A+ +HQ VHRD+KP N+LLD N +++D G L +V S
Sbjct: 106 FYIA-EMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSS 161
Query: 386 VTQYHMTSAAGTFCYIDPEYQQT-----GMLTTKSDIYSFGIMLLQIITARSP 433
V A GT YI PE Q G + D +S G+ + +++ +P
Sbjct: 162 V-------AVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 3e-07
Identities = 56/211 (26%), Positives = 92/211 (43%), Gaps = 20/211 (9%)
Query: 236 KIGEGGYGPV----YRGKLDHTPVAIKVLRPDAAQGK---RQFQQEVEVLSSIR-HPNMV 287
++G+G YG V + VAIK + + K ++ +E+++L R H N+
Sbjct: 7 ELGQGAYGIVCSARNAETSEEETVAIKKI-TNVFSKKILAKRALRELKLLRHFRGHKNIT 65
Query: 288 LLLGA-CPDYGCL--VYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQA 344
L G +Y Y + + R P+ + I +I L ++H A
Sbjct: 66 CLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIY-QILCGLKYIHSA 124
Query: 345 KPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPE 404
++HRDLKP N+L++ + KI D GLAR S MT T Y PE
Sbjct: 125 N---VLHRDLKPGNLLVNADCELKICDFGLARGF--SENPGENAGFMTEYVATRWYRAPE 179
Query: 405 YQQTGMLTTKS-DIYSFGIMLLQIITARSPM 434
+ TK+ D++S G +L +++ R P+
Sbjct: 180 IMLSFQSYTKAIDVWSVGCILAELL-GRKPV 209
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 3e-07
Identities = 49/189 (25%), Positives = 84/189 (44%), Gaps = 27/189 (14%)
Query: 311 DRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKIS 370
R +P + + + ++A + FL VHRDL N+L+ + KI
Sbjct: 225 RRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVLICEGKLVKIC 281
Query: 371 DVGLARLVPPSVADSVTQYHMTSAAGTFC---YIDPEYQQTGMLTTKSDIYSFGIMLLQI 427
D GLAR D + + S TF ++ PE + TT SD++SFGI+L +I
Sbjct: 282 DFGLAR-------DIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEI 334
Query: 428 IT-ARSP---MGLTHHVSRAIEKG-TLAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKD 482
T +P + + AI++G +A+ PA A++ ++ +C E + +
Sbjct: 335 FTLGGTPYPELPMNEQFYNAIKRGYRMAK---------PAHASDEIYEIMQKCWEEKFEI 385
Query: 483 RPDLGTVIV 491
RPD ++
Sbjct: 386 RPDFSQLVH 394
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 4e-07
Identities = 57/208 (27%), Positives = 90/208 (43%), Gaps = 27/208 (12%)
Query: 235 MKIGEGGYGPV------YRGKLDHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVL 288
+KIGEG G V GKL VA+K + Q + EV ++ +H N+V
Sbjct: 26 IKIGEGSTGIVCIATVKSSGKL----VAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVE 81
Query: 289 LLGA--CPDYGCLVYEYMHNGSLEDRLLR-RGNTPVIPWRKRFKIAAEIATALLFLHQAK 345
+ + D +V E++ G+L D + R N I + + AL LH
Sbjct: 82 MYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-----AVCLAVLKALSVLHA-- 134
Query: 346 PEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEY 405
+ ++HRD+K +ILL + K+SD G V V S GT ++ PE
Sbjct: 135 -QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP------RRKSLVGTPYWMAPEL 187
Query: 406 QQTGMLTTKSDIYSFGIMLLQIITARSP 433
+ DI+S GIM+++++ P
Sbjct: 188 ISRLPYGPEVDIWSLGIMVIEMVDGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 4e-07
Identities = 67/236 (28%), Positives = 99/236 (41%), Gaps = 56/236 (23%)
Query: 226 EATDKFSEAMKIGEGGYGPVYRGKLDHT--PVAIKVL------RPDAAQGKRQFQQEVEV 277
E K+ IG G YG V K T VAIK + R DA KR + E+++
Sbjct: 2 EVDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDA---KRTLR-EIKL 57
Query: 278 LSSIRHPNMVLLLGACPD---------YGCLVYEYMHNGSLEDRLLR---RGNTPVIPWR 325
L + H N++ + P Y +VYE M D L R + +
Sbjct: 58 LRHLDHENVIAIKDIMPPPHREAFNDVY--IVYELM------DTDLHQIIRSSQTLSDDH 109
Query: 326 KRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADS 385
++ + ++ L ++H A ++HRDLKP+N+LL+ N KI D GLAR S
Sbjct: 110 CQYFLY-QLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR------TTS 159
Query: 386 VTQYHMTSAAGTFCYIDPE-------YQQTGMLTTKSDIYSFGIMLLQIITARSPM 434
MT T Y PE Y TT D++S G + +++ R P+
Sbjct: 160 EKGDFMTEYVVTRWYRAPELLLNCSEY------TTAIDVWSVGCIFAELLG-RKPL 208
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 5e-07
Identities = 37/135 (27%), Positives = 69/135 (51%), Gaps = 6/135 (4%)
Query: 299 LVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPAN 358
L+ EY G L ++ +R +P+ + +++ +L L + ++HRDLK AN
Sbjct: 142 LIMEYGSGGDLNKQIKQRLKEH-LPF-QEYEVGLLFYQIVLALDEVHSRKMMHRDLKSAN 199
Query: 359 ILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIY 418
I L + K+ D G ++ +DSV+ +S GT Y+ PE + + K+D++
Sbjct: 200 IFLMPTGIIKLGDFGFSK----QYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMW 255
Query: 419 SFGIMLLQIITARSP 433
S G++L +++T P
Sbjct: 256 SLGVILYELLTLHRP 270
|
Length = 478 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 7e-07
Identities = 44/142 (30%), Positives = 67/142 (47%), Gaps = 19/142 (13%)
Query: 299 LVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPAN 358
LV +Y G L LL + + RF +A E+ A+ +HQ VHRD+KP N
Sbjct: 78 LVMDYYVGGDLLT-LLSKFEDRLPEDMARFYLA-EMVLAIDSVHQLG---YVHRDIKPDN 132
Query: 359 ILLDRNYVSKISDVG--LARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQ-----TGML 411
+LLD+N +++D G L L +V +V A GT YI PE Q G
Sbjct: 133 VLLDKNGHIRLADFGSCLRLLADGTVQSNV-------AVGTPDYISPEILQAMEDGKGRY 185
Query: 412 TTKSDIYSFGIMLLQIITARSP 433
+ D +S G+ + +++ +P
Sbjct: 186 GPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 8e-07
Identities = 35/114 (30%), Positives = 50/114 (43%), Gaps = 41/114 (35%)
Query: 333 EIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMT 392
++A + FL K +HRDL NILL N V KI D GLAR +
Sbjct: 181 QVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDI-------------- 223
Query: 393 SAAGTFCYIDPEYQQTG-----------------MLTTKSDIYSFGIMLLQIIT 429
Y DP+Y + G + TT+SD++SFG++L +I +
Sbjct: 224 -------YKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 9e-07
Identities = 60/219 (27%), Positives = 93/219 (42%), Gaps = 29/219 (13%)
Query: 237 IGEGGYGPVYRGKLDHTP--VAIKVLRPDAAQGKRQFQQEVEVLSSI-RHPNMVLLLGA- 292
+G G YG VY+G+ T AIKV+ + + + + E+ +L H N+ GA
Sbjct: 24 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDE-EEEIKLEINMLKKYSHHRNIATYYGAF 82
Query: 293 ---CP----DYGCLVYEYMHNGSLEDRLLR-RGNTPVIPWRKRFKIAAEIATALLFLHQA 344
P D LV E+ GS+ D + +GN W I EI L LH
Sbjct: 83 IKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY--ICREILRGLAHLHAH 140
Query: 345 KPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPE 404
K ++HRD+K N+LL N K+ D G++ + +V + GT ++ PE
Sbjct: 141 K---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG------RRNTFIGTPYWMAPE 191
Query: 405 Y-----QQTGMLTTKSDIYSFGIMLLQIITARSPMGLTH 438
+SDI+S GI +++ P+ H
Sbjct: 192 VIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMH 230
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 1e-06
Identities = 48/199 (24%), Positives = 84/199 (42%), Gaps = 15/199 (7%)
Query: 235 MKIGE----GGYGPVYRGKLDHTPVAIKVLRPDAAQGKR--QFQQEVEVLSSIRHPNMVL 288
IG+ + + K +T VA+K + D+ + QQE+ ++HPN++
Sbjct: 4 TLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILP 63
Query: 289 LLGACPDYGCL--VYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKP 346
+ + L V M GS ED LL+ +P I ++ AL ++H
Sbjct: 64 YVTSFIVDSELYVVSPLMAYGSCED-LLKTHFPEGLPELAIAFILKDVLNALDYIHS--- 119
Query: 347 EPLVHRDLKPANILLDRNYVSKISDVGLAR-LVPPSVADSVTQYHMTSAAGTFCYIDPEY 405
+ +HR +K ++ILL + +S + + ++ V S+ ++ PE
Sbjct: 120 KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEV 179
Query: 406 QQTGML--TTKSDIYSFGI 422
Q + KSDIYS GI
Sbjct: 180 LQQNLQGYNEKSDIYSVGI 198
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 45/152 (29%), Positives = 71/152 (46%), Gaps = 11/152 (7%)
Query: 333 EIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMT 392
++A + FL K +HRDL NILL N V KI D GLAR + D V +
Sbjct: 182 QVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKD-PDYVRK---G 234
Query: 393 SAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEM 452
SA ++ PE + TT+SD++SFG++L +I + +G + + I + +
Sbjct: 235 SARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS----LGASPYPGVQINEEFCQRL 290
Query: 453 LDPAVTDWPAEAAESFSKLAIQCAELRKKDRP 484
D P A ++ + C + K+RP
Sbjct: 291 KDGTRMRAPENATPEIYRIMLACWQGDPKERP 322
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|236545 PRK09510, tolA, cell envelope integrity inner membrane protein TolA; Provisional | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 1e-06
Identities = 36/105 (34%), Positives = 49/105 (46%), Gaps = 6/105 (5%)
Query: 101 EAEMRRLKLELRQTMEMYSTACKEALNAKKKAKELNQWKIEEAQRFEEARMAEETALAIA 160
AE RLK +L + K+A A K+A Q + EEA A+ A
Sbjct: 97 AAEQERLK-QLEKERLAAQEQKKQAEEAAKQAAL-KQKQAEEAA----AKAAAAAKAKAE 150
Query: 161 EMEKAKCRAAIEAAEKAQKLADAEAQRRKQAELKAKREAEEKNRA 205
K AA +AA +A+K A+AEA ++ AE K K EAE +A
Sbjct: 151 AEAKRAAAAAKKAAAEAKKKAEAEAAKKAAAEAKKKAEAEAAAKA 195
|
Length = 387 |
| >gnl|CDD|225606 COG3064, TolA, Membrane protein involved in colicin uptake [Cell envelope biogenesis, outer membrane] | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 1e-06
Identities = 45/132 (34%), Positives = 58/132 (43%), Gaps = 15/132 (11%)
Query: 89 RVSSASQSSRDLEAEMRRLKLELRQTMEMYSTACKEALNAKKKAKELNQWKIEEAQRF-- 146
R+ + Q + EAE K + + A K A KKKA+ EA +
Sbjct: 110 RLKAQEQQKQAEEAE----KQAQLEQKQQEEQARKAAAEQKKKAEAAKAKAAAEAAKLKA 165
Query: 147 --------EEARMAEETALAIAEMEKAKCRAAIEAAEKAQKLADAEAQRRKQAELKAKRE 198
EEA A E A A AE AK +A EA A+K A AEA+ + +AE KA+
Sbjct: 166 AAEAKKKAEEAAKAAEEAKAKAEAAAAKKKAEAEAKAAAEK-AKAEAEAKAKAEKKAEAA 224
Query: 199 AEEKNRALTALA 210
AEEK A A
Sbjct: 225 AEEKAAAEKKKA 236
|
Length = 387 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 2e-06
Identities = 48/150 (32%), Positives = 74/150 (49%), Gaps = 14/150 (9%)
Query: 233 EAMK-IGEGGYGPV--YRGKLDHTPVAIKVLRPDAAQGKRQ---FQQEVEVLSSIRHPNM 286
E++K IG G +G V + K A+K LR K Q + E ++L+ +P +
Sbjct: 4 ESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWV 63
Query: 287 VLLLGACPD--YGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQA 344
V L + D Y L+ EY+ G + L+++ +T RF IA E A+ +H+
Sbjct: 64 VKLYYSFQDENYLYLIMEYLPGGDMMTLLMKK-DT-FTEEETRFYIA-ETILAIDSIHKL 120
Query: 345 KPEPLVHRDLKPANILLDRNYVSKISDVGL 374
+HRD+KP N+LLD K+SD GL
Sbjct: 121 G---YIHRDIKPDNLLLDAKGHIKLSDFGL 147
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|234017 TIGR02794, tolA_full, TolA protein | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 2e-06
Identities = 24/84 (28%), Positives = 45/84 (53%), Gaps = 1/84 (1%)
Query: 123 KEALNAKKKAKELNQWKIEE-AQRFEEARMAEETALAIAEMEKAKCRAAIEAAEKAQKLA 181
E ++ A++ Q ++E+ A + A+ AE+ A E +K A + A +A+ A
Sbjct: 77 AEEAEKQRAAEQARQKELEQRAAAEKAAKQAEQAAKQAEEKQKQAEEAKAKQAAEAKAKA 136
Query: 182 DAEAQRRKQAELKAKREAEEKNRA 205
+AEA+++ + E K + E E K +A
Sbjct: 137 EAEAEKKAKEEAKKQAEEEAKAKA 160
|
TolA couples the inner membrane complex of itself with TolQ and TolR to the outer membrane complex of TolB and OprL (also called Pal). Most of the length of the protein consists of low-complexity sequence that may differ in both length and composition from one species to another, complicating efforts to discriminate TolA (the most divergent gene in the tol-pal system) from paralogs such as TonB. Selection of members of the seed alignment and criteria for setting scoring cutoffs are based largely conserved operon struction. //The Tol-Pal complex is required for maintaining outer membrane integrity. Also involved in transport (uptake) of colicins and filamentous DNA, and implicated in pathogenesis. Transport is energized by the proton motive force. TolA is an inner membrane protein that interacts with periplasmic TolB and with outer membrane porins ompC, phoE and lamB [Transport and binding proteins, Other, Cellular processes, Pathogenesis]. Length = 346 |
| >gnl|CDD|234017 TIGR02794, tolA_full, TolA protein | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 2e-06
Identities = 45/181 (24%), Positives = 68/181 (37%), Gaps = 14/181 (7%)
Query: 101 EAEMRRLKLELRQTMEMYSTACKEALNAKKKAKELNQWKIEEAQR-FEEARMAEETALAI 159
+AE + E +Q + A + A K E + EEA++ EE A+ A A
Sbjct: 106 QAEQAAKQAEEKQKQAEEAKAKQAAEAKAKAEAEAEKKAKEEAKKQAEEEAKAKAAAEAK 165
Query: 160 AEMEKAKCRAAIEAAEKAQKLADAEAQRRK----QAELKAKREAEEKNRALTALANNDVR 215
+ +AK +A EA KA+ A A+A+ K A+ KA EA K A A A
Sbjct: 166 KKAAEAKKKAEAEAKAKAEAKAKAKAEEAKAKAEAAKAKAAAEAAAKAEAEAAAAAAAEA 225
Query: 216 YRKYTIEEI--------EEATDKFSEAMKIGEGGYGPVYRGKLDHTPVAIKVLRPDAAQG 267
RK E+ +K A G Y + + + + +G
Sbjct: 226 ERKADEAELGDIFGLASGSNAEKQGGARGNAAGSEVDKYAAIIQQA-IQQNLYDDPSFRG 284
Query: 268 K 268
K
Sbjct: 285 K 285
|
TolA couples the inner membrane complex of itself with TolQ and TolR to the outer membrane complex of TolB and OprL (also called Pal). Most of the length of the protein consists of low-complexity sequence that may differ in both length and composition from one species to another, complicating efforts to discriminate TolA (the most divergent gene in the tol-pal system) from paralogs such as TonB. Selection of members of the seed alignment and criteria for setting scoring cutoffs are based largely conserved operon struction. //The Tol-Pal complex is required for maintaining outer membrane integrity. Also involved in transport (uptake) of colicins and filamentous DNA, and implicated in pathogenesis. Transport is energized by the proton motive force. TolA is an inner membrane protein that interacts with periplasmic TolB and with outer membrane porins ompC, phoE and lamB [Transport and binding proteins, Other, Cellular processes, Pathogenesis]. Length = 346 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 2e-06
Identities = 50/177 (28%), Positives = 70/177 (39%), Gaps = 40/177 (22%)
Query: 284 PNMVLLLG--ACPDYGCLVYEYMHNGSLEDRLLRRGNTP---VIPWRKRFKIAAEIATAL 338
PNMV L D LV ++ G L + + N P V W AAE+ AL
Sbjct: 45 PNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRW------AAEMVVAL 98
Query: 339 LFLHQAKPEPLVHRDLKPANILLDR------NYVSKISDVGLARLVPPSVADSVTQYHMT 392
LH+ E +V RDL P NILLD Y S+ S+V ++V
Sbjct: 99 DALHR---EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVE-----DSCDGEAVENM--- 147
Query: 393 SAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARS-----PMGLTHHVSRAI 444
Y PE T D +S G +L +++T ++ P G+ H + I
Sbjct: 148 -------YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGINTHTTLNI 197
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 2e-06
Identities = 60/248 (24%), Positives = 99/248 (39%), Gaps = 52/248 (20%)
Query: 231 FSEAMKIGEGGYGPVYRG-KLD-HTPVAIKVLRPDAAQGKRQ---FQQEVEVLSSIRHPN 285
F + IG G +G V K+D + A+K LR + Q + E ++L+ +
Sbjct: 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEW 62
Query: 286 MVLLLGACPDYGCL--VYEYMHNGSLEDRLLRRGNTPVIPWR-KRFKIAAEIATALLFLH 342
+V L + D L V +Y+ G + L+R G + RF IA E+ A+ +H
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLG---IFEEDLARFYIA-ELTCAIESVH 118
Query: 343 QAKPEPLVHRDLKPANILLDRNYVSKISDVGLA---------------------RLVPPS 381
+ +HRD+KP NIL+DR+ K++D GL + P
Sbjct: 119 KMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSE 175
Query: 382 VADSVTQYHMT----------------SAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLL 425
+ + + S GT YI PE T D +S G++L
Sbjct: 176 EWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 235
Query: 426 QIITARSP 433
+++ + P
Sbjct: 236 EMLVGQPP 243
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|236545 PRK09510, tolA, cell envelope integrity inner membrane protein TolA; Provisional | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 3e-06
Identities = 31/97 (31%), Positives = 45/97 (46%), Gaps = 1/97 (1%)
Query: 110 ELRQTMEMYSTACKEALNAKKKAKELNQWKIEEAQRFEEA-RMAEETALAIAEMEKAKCR 168
EL+Q K+ + A+E + E A++ + AEE A A KAK
Sbjct: 91 ELQQKQAAEQERLKQLEKERLAAQEQKKQAEEAAKQAALKQKQAEEAAAKAAAAAKAKAE 150
Query: 169 AAIEAAEKAQKLADAEAQRRKQAELKAKREAEEKNRA 205
A + A A K A AEA+++ +AE K AE K +A
Sbjct: 151 AEAKRAAAAAKKAAAEAKKKAEAEAAKKAAAEAKKKA 187
|
Length = 387 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 3e-06
Identities = 63/222 (28%), Positives = 98/222 (44%), Gaps = 38/222 (17%)
Query: 233 EAMKI-GEGGYGPVY---------RGKLDHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIR 282
E +K+ G G YG V+ GKL V K A+ + E +VL IR
Sbjct: 3 ELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIR 62
Query: 283 H-PNMVLLLGA--CPDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFK------IAAE 333
P +V L A L+ +Y++ G L L +R +RFK + E
Sbjct: 63 QSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQR---------ERFKEQEVQIYSGE 113
Query: 334 IATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTS 393
I AL LH+ +++RD+K NILLD N ++D GL++ D V + + S
Sbjct: 114 IVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK---EFHEDEVERAY--S 165
Query: 394 AAGTFCYIDPEYQQTGML--TTKSDIYSFGIMLLQIITARSP 433
GT Y+ P+ + G D +S G+++ +++T SP
Sbjct: 166 FCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 48.8 bits (117), Expect = 3e-06
Identities = 57/213 (26%), Positives = 97/213 (45%), Gaps = 43/213 (20%)
Query: 236 KIGEGGYGPVYRGK--LDHTPVAIKVLRPDAAQGKRQFQ--QEVEVLSSIR-------HP 284
KIGEG + V + + AIK + K+ F+ ++V L I+ HP
Sbjct: 6 KIGEGTFSEVLKAQSRKTGKYYAIKCM-------KKHFKSLEQVNNLREIQALRRLSPHP 58
Query: 285 NMVLLLGACPD--YGC--LVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLF 340
N++ L+ D G LV+E M + +L + L +G +P ++ ++ +L
Sbjct: 59 NILRLIEVLFDRKTGRLALVFELM-DMNLYE--LIKGRKRPLPEKRVKSYMYQLLKSLDH 115
Query: 341 LHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLV---PPSVADSVTQYHMTSAAGT 397
+H+ + HRD+KP NIL+ + + K++D G R + PP T+Y T
Sbjct: 116 MHR---NGIFHRDIKPENILIK-DDILKLADFGSCRGIYSKPP-----YTEY-----IST 161
Query: 398 FCYIDPEYQQT-GMLTTKSDIYSFGIMLLQIIT 429
Y PE T G K DI++ G + +I++
Sbjct: 162 RWYRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 3e-06
Identities = 52/185 (28%), Positives = 83/185 (44%), Gaps = 29/185 (15%)
Query: 255 VAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGAC--PDYGCLVYEYMHNGSLEDR 312
V +KVL P F + ++S + H ++ + G C +V E++ +G L D
Sbjct: 47 VVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPL-DV 105
Query: 313 LLRR--GNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVS--- 367
LR+ G PV W+ +A ++A+AL +L + LVH ++ NILL R ++
Sbjct: 106 CLRKEKGRVPV-AWK--ITVAQQLASALSYLED---KNLVHGNVCAKNILLARLGLAEGT 159
Query: 368 ----KISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPE-YQQTGMLTTKSDIYSFGI 422
K+SD G+ S T +I PE L+T +D +SFG
Sbjct: 160 SPFIKLSDPGV----------SFTALSREERVERIPWIAPECVPGGNSLSTAADKWSFGT 209
Query: 423 MLLQI 427
LL+I
Sbjct: 210 TLLEI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 4e-06
Identities = 56/217 (25%), Positives = 96/217 (44%), Gaps = 28/217 (12%)
Query: 233 EAMKIGEGGYGPVYRGKL----DHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVL 288
E K+G G YG VY+ K D A+K + + +E+ +L ++HPN++
Sbjct: 5 EGCKVGRGTYGHVYKAKRKDGKDDRDYALKQI--EGTGISMSACREIALLRELKHPNVIS 62
Query: 289 L----LGACPDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLF---- 340
L L L+++Y + R + +K ++ + +LL+
Sbjct: 63 LQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKAN---KKPVQLPRGMVKSLLYQILD 119
Query: 341 -LHQAKPEPLVHRDLKPANILL-----DRNYVSKISDVGLARLVPPSVADSVTQYHMTSA 394
+H ++HRDLKPANIL+ +R V KI+D+G ARL + +
Sbjct: 120 GIHYLHANWVLHRDLKPANILVMGEGPERGRV-KIADMGFARLFNSPLKPLAD---LDPV 175
Query: 395 AGTFCYIDPEYQQTGMLTTKS-DIYSFGIMLLQIITA 430
TF Y PE TK+ DI++ G + +++T+
Sbjct: 176 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS 212
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 4e-06
Identities = 56/217 (25%), Positives = 96/217 (44%), Gaps = 28/217 (12%)
Query: 233 EAMKIGEGGYGPVYRGKL----DHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVL 288
E K+G G YG VY+ K D A+K + + +E+ +L ++HPN++
Sbjct: 5 EGCKVGRGTYGHVYKAKRKDGKDEKEYALKQI--EGTGISMSACREIALLRELKHPNVIA 62
Query: 289 L----LGACPDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLF---- 340
L L L+++Y + R + +K ++ + +LL+
Sbjct: 63 LQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKAN---KKPMQLPRSMVKSLLYQILD 119
Query: 341 -LHQAKPEPLVHRDLKPANILL-----DRNYVSKISDVGLARLVPPSVADSVTQYHMTSA 394
+H ++HRDLKPANIL+ +R V KI+D+G ARL + +
Sbjct: 120 GIHYLHANWVLHRDLKPANILVMGEGPERGRV-KIADMGFARLFNSPLKPLAD---LDPV 175
Query: 395 AGTFCYIDPEYQQTGMLTTKS-DIYSFGIMLLQIITA 430
TF Y PE TK+ DI++ G + +++T+
Sbjct: 176 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS 212
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|236545 PRK09510, tolA, cell envelope integrity inner membrane protein TolA; Provisional | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 5e-06
Identities = 42/129 (32%), Positives = 56/129 (43%), Gaps = 19/129 (14%)
Query: 93 ASQSSRDLEAEMRRLKLELRQTMEMYSTACKEALNAKKKAKELNQWKIEEAQRFEEARMA 152
A+Q + E + ++ E A K A AK KA+ E + A+ A
Sbjct: 112 AAQEQKKQAEEAAKQAALKQKQAEE--AAAKAAAAAKAKAEA------EAKRAAAAAKKA 163
Query: 153 EETA--LAIAEMEK-----AKCRAAIEAAEK----AQKLADAEAQRRKQAELKAKREAEE 201
A A AE K AK +A EAA K A+K A+AEA+++ AE K K AE
Sbjct: 164 AAEAKKKAEAEAAKKAAAEAKKKAEAEAAAKAAAEAKKKAEAEAKKKAAAEAKKKAAAEA 223
Query: 202 KNRALTALA 210
K A A A
Sbjct: 224 KAAAAKAAA 232
|
Length = 387 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 5e-06
Identities = 30/83 (36%), Positives = 44/83 (53%), Gaps = 10/83 (12%)
Query: 350 VHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFC---YIDPEYQ 406
VHRDL N+LL + + KI D GLAR D + + S TF ++ PE
Sbjct: 259 VHRDLAARNVLLAQGKIVKICDFGLAR-------DIMHDSNYVSKGSTFLPVKWMAPESI 311
Query: 407 QTGMLTTKSDIYSFGIMLLQIIT 429
+ TT SD++S+GI+L +I +
Sbjct: 312 FDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|234017 TIGR02794, tolA_full, TolA protein | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 7e-06
Identities = 36/90 (40%), Positives = 50/90 (55%), Gaps = 5/90 (5%)
Query: 123 KEALNAKKKAKELNQWKIEEAQRFEEAR---MAEETALAIAEME-KAKCRAAIEAAEKAQ 178
A A K+A++ + E+ ++ EEA+ AE A A AE E KAK A +A E+A+
Sbjct: 98 AAAEKAAKQAEQAAKQAEEKQKQAEEAKAKQAAEAKAKAEAEAEKKAKEEAKKQAEEEAK 157
Query: 179 KLADAEAQRRKQAELKAKREAEEKNRALTA 208
A AEA++ K AE K K EAE K +A
Sbjct: 158 AKAAAEAKK-KAAEAKKKAEAEAKAKAEAK 186
|
TolA couples the inner membrane complex of itself with TolQ and TolR to the outer membrane complex of TolB and OprL (also called Pal). Most of the length of the protein consists of low-complexity sequence that may differ in both length and composition from one species to another, complicating efforts to discriminate TolA (the most divergent gene in the tol-pal system) from paralogs such as TonB. Selection of members of the seed alignment and criteria for setting scoring cutoffs are based largely conserved operon struction. //The Tol-Pal complex is required for maintaining outer membrane integrity. Also involved in transport (uptake) of colicins and filamentous DNA, and implicated in pathogenesis. Transport is energized by the proton motive force. TolA is an inner membrane protein that interacts with periplasmic TolB and with outer membrane porins ompC, phoE and lamB [Transport and binding proteins, Other, Cellular processes, Pathogenesis]. Length = 346 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 8e-06
Identities = 40/165 (24%), Positives = 68/165 (41%), Gaps = 31/165 (18%)
Query: 274 EVEVLSSIRHPNMVLLLG-------AC---PDYGCLVYEYMHNGSLEDRLLRRGNTPVIP 323
E +L ++ HP+++ + C P Y +Y Y+ S R +P
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSSDLYTYLTKRS------RP-----LP 155
Query: 324 WRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVA 383
+ I +I L +LH + ++HRD+K NI ++ I D+G A+
Sbjct: 156 IDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQF------ 206
Query: 384 DSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQII 428
V AGT PE +K+DI+S GI+L +++
Sbjct: 207 -PVVAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 8e-06
Identities = 58/225 (25%), Positives = 93/225 (41%), Gaps = 42/225 (18%)
Query: 229 DKFSEAMKIGEGGYGPVYRGKLDHTP--VAIKVLR--------PDAAQGKRQFQQEVEVL 278
D + + KIGEG YG VY+ + +T VA+K R P A +E+ +L
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTAL------REISLL 54
Query: 279 SSIRHPNMVLLL----------GACPDYGCLVYEYMHNG--SLEDRLLRRGNTPVIPWRK 326
+ ++ L G Y LV+EY+ + D RG +P +
Sbjct: 55 QMLSESIYIVRLLDVEHVEEKNGKPSLY--LVFEYLDSDLKKFMDSN-GRGPGRPLPAKT 111
Query: 327 RFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNY-VSKISDVGLARLVPPSVADS 385
++ + H+ ++HRDLKP N+L+D+ + KI+D+GL R A S
Sbjct: 112 IKSFMYQLLKGVAHCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLGLGR------AFS 162
Query: 386 VTQYHMTSAAGTFCYIDPEYQQTGM-LTTKSDIYSFGIMLLQIIT 429
+ T T Y PE +T DI+S G + ++
Sbjct: 163 IPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSR 207
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 9e-06
Identities = 34/97 (35%), Positives = 50/97 (51%), Gaps = 7/97 (7%)
Query: 333 EIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMT 392
++A + FL K +HRDL NILL N V KI D GLAR + D V +
Sbjct: 187 QVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKD-PDYVRK---G 239
Query: 393 SAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT 429
A ++ PE + T +SD++SFG++L +I +
Sbjct: 240 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 1e-05
Identities = 58/226 (25%), Positives = 108/226 (47%), Gaps = 23/226 (10%)
Query: 216 YRKYTIEEIEEATDKFSEAMKIGEGGYGPVYRG--KLDHTPVAIKVL-RPDAAQ--GKRQ 270
YR+ + + E ++++ ++G G YG V K VAIK L RP ++ KR
Sbjct: 2 YREEVNKTVWELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRA 61
Query: 271 FQQEVEVLSSIRHPNMVLLLG---ACPDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKR 327
++ E+ +L ++H N++ LL + Y+ ++ L + P+ + +
Sbjct: 62 YR-ELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQ 120
Query: 328 FKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVT 387
+ + ++ L ++H A ++HRDLKP N+ ++ + KI D GLAR AD+
Sbjct: 121 YLVY-QMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLAR-----HADA-- 169
Query: 388 QYHMTSAAGTFCYIDPEYQQTGMLTTKS-DIYSFGIMLLQIITARS 432
MT T Y PE M ++ DI+S G ++ +++T ++
Sbjct: 170 --EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKT 213
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173412 PTZ00121, PTZ00121, MAEBL; Provisional | Back alignment and domain information |
|---|
Score = 48.2 bits (114), Expect = 1e-05
Identities = 41/144 (28%), Positives = 71/144 (49%), Gaps = 5/144 (3%)
Query: 101 EAEMRRLKLELRQTMEMYST-ACKEALNAKKKAKELNQWKIEEAQRFEEARMAEETALAI 159
+AE ++ E ++ E K+ KKA E + E ++ + A+ E A
Sbjct: 1285 KAEEKKKADEAKKAEEKKKADEAKKKAEEAKKADEAKKKAEEAKKKADAAKKKAEEAKKA 1344
Query: 160 AEMEKAKCRAAIEAAEKAQKLADAEAQRRKQAELKA---KREAEEKNRALTALANNDVRY 216
AE KA+ AA + AE A++ A+A +++++A+ KA K++AEEK +A A +
Sbjct: 1345 AEAAKAEAEAAADEAEAAEEKAEAAEKKKEEAKKKADAAKKKAEEKKKADEAKKKAEEDK 1404
Query: 217 RKY-TIEEIEEATDKFSEAMKIGE 239
+K +++ A K EA K E
Sbjct: 1405 KKADELKKAAAAKKKADEAKKKAE 1428
|
Length = 2084 |
| >gnl|CDD|224117 COG1196, Smc, Chromosome segregation ATPases [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 1e-05
Identities = 38/211 (18%), Positives = 78/211 (36%), Gaps = 18/211 (8%)
Query: 73 DISSKNLDFSSVPVSPRVSSASQSSRDLEAEMRRLKLELRQTMEMYSTACKEALNAKKKA 132
+I + + + + +L+ E+ L+ E+ E E +++
Sbjct: 268 EIEELKSELEEL--REELEELQEELLELKEEIEELEGEISLLRERLEELENELEELEERL 325
Query: 133 KELNQWKIEEAQRFEEARMAEETALAIAEMEKAKCRAAIEAAEKAQKLADAEAQRRKQAE 192
+EL E+ + +E ET L E A+ A E E+ E + +A
Sbjct: 326 EEL----KEKIEALKEELEERETLLEELEQLLAELEEAKEELEEKLSALLEELEELFEA- 380
Query: 193 LKAKREAEEKNRALTALANNDVRYRKYTIEEIEEATDKFSEAMKIGEGGYGPVYRGKLDH 252
+ E E L A N++ K IE +EE ++ SE ++ + +L
Sbjct: 381 --LREELAELEAEL-AEIRNELEELKREIESLEERLERLSERLE--------DLKEELKE 429
Query: 253 TPVAIKVLRPDAAQGKRQFQQEVEVLSSIRH 283
++ L+ + + + ++ E L +R
Sbjct: 430 LEAELEELQTELEELNEELEELEEQLEELRD 460
|
Length = 1163 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 1e-05
Identities = 47/209 (22%), Positives = 80/209 (38%), Gaps = 38/209 (18%)
Query: 240 GGYGPVY----RGKLDHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGA--- 292
G G V+ G V +K A G + +E+++L +I H ++ L+ A
Sbjct: 103 GSEGEVFVCTKHGDEQRKKVIVK-----AVTGGKTPGREIDILKTISHRAIINLIHAYRW 157
Query: 293 ----C---PDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAK 345
C P Y C ++ Y+ + P +P + I + AL +LH
Sbjct: 158 KSTVCMVMPKYKCDLFTYVD-----------RSGP-LPLEQAITIQRRLLEALAYLHG-- 203
Query: 346 PEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEY 405
++HRD+K NI LD + + D G A + +GT PE
Sbjct: 204 -RGIIHRDVKTENIFLDEPENAVLGDFGAA----CKLDAHPDTPQCYGWSGTLETNSPEL 258
Query: 406 QQTGMLTTKSDIYSFGIMLLQIITARSPM 434
K+DI+S G++L ++ +
Sbjct: 259 LALDPYCAKTDIWSAGLVLFEMSVKNVTL 287
|
Length = 392 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 2e-05
Identities = 44/195 (22%), Positives = 82/195 (42%), Gaps = 29/195 (14%)
Query: 255 VAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACPDYG----------------C 298
VA+K + Q + +E++++ + H N+V + G
Sbjct: 33 VAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVY 92
Query: 299 LVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPAN 358
+V EYM E L + ++ L ++H A ++HRDLKPAN
Sbjct: 93 IVQEYM-----ETDLANVLEQGPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPAN 144
Query: 359 ILLD-RNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKS-D 416
+ ++ + V KI D GLAR+V P + +++ T Y P + TK+ D
Sbjct: 145 VFINTEDLVLKIGDFGLARIVDPHYSHK---GYLSEGLVTKWYRSPRLLLSPNNYTKAID 201
Query: 417 IYSFGIMLLQIITAR 431
+++ G + +++T +
Sbjct: 202 MWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 3e-05
Identities = 63/219 (28%), Positives = 95/219 (43%), Gaps = 40/219 (18%)
Query: 237 IGEGGYGPVYRGKLDHTP--VAIKVLRPDAAQGKRQ---FQQEVEVLSSIRHPNMVLLLG 291
IG G +G V KL + A+K+L + + F++E +VL + + + L
Sbjct: 9 IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHY 68
Query: 292 ACPDYG--CLVYEYMHNGSL-------EDRLLRRGNTPVIPWRKRFKIAAEIATALLFLH 342
A D LV +Y G L EDRL RF +A E+ A+ +H
Sbjct: 69 AFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPED--------MARFYLA-EMVIAIDSVH 119
Query: 343 QAKPEPLVHRDLKPANILLDRNYVSKISDVG--LARLVPPSVADSVTQYHMTSAAGTFCY 400
Q VHRD+KP NIL+D N +++D G L + +V SV A GT Y
Sbjct: 120 QLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSV-------AVGTPDY 169
Query: 401 IDPEYQQT-----GMLTTKSDIYSFGIMLLQIITARSPM 434
I PE Q G + D +S G+ + +++ +P
Sbjct: 170 ISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 3e-05
Identities = 49/169 (28%), Positives = 77/169 (45%), Gaps = 28/169 (16%)
Query: 220 TIEEIEEATDKFSEAMKIGEGGYGPVY--RGKLDHTPVAIKVLRPDAAQGK---RQFQQE 274
+IEE F I G +G VY R K + A+KV++ K Q Q E
Sbjct: 2 SIEE-------FVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAE 54
Query: 275 VEVLSSIRHPNMVLLLGA--CPDYGCLVYEYMHNGSLEDRLLRRG----NTPVIPWRKRF 328
+ L+ + P +V L + + LV EY+ G ++ L G V
Sbjct: 55 RDALALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAV------- 107
Query: 329 KIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARL 377
K +E+A AL +LH+ ++HRDLKP N+L+ K++D GL+++
Sbjct: 108 KYISEVALALDYLHR---HGIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 4e-05
Identities = 60/227 (26%), Positives = 94/227 (41%), Gaps = 32/227 (14%)
Query: 230 KFSEAMKIGEGGYGPVYRGKLDHT---PVAIKVL-RP--DAAQGKRQFQQEVEVLSSIRH 283
++ + IG G G V D VA+K L RP + KR ++ E+ +L + H
Sbjct: 22 RYQQLKPIGSGAQGIVC-AAFDTVLGINVAVKKLSRPFQNQTHAKRAYR-ELVLLKCVNH 79
Query: 284 PNMVLLLGACPDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLF--- 340
N++ LL L E + L L+ VI ++ E + LL+
Sbjct: 80 KNIISLLNVFTPQKSL--EEFQDVYLVMELMDANLCQVI----HMELDHERMSYLLYQML 133
Query: 341 -----LHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAA 395
LH A ++HRDLKP+NI++ + KI D GLAR + T + MT
Sbjct: 134 CGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR-------TACTNFMMTPYV 183
Query: 396 GTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSR 442
T Y PE DI+S G ++ +++ T H+ +
Sbjct: 184 VTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQ 230
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 4e-05
Identities = 65/222 (29%), Positives = 98/222 (44%), Gaps = 33/222 (14%)
Query: 233 EAMKI-GEGGYGPVY---------RGKLDHTPVAIKVLRPDAAQGKRQFQQ----EVEVL 278
E +K+ G G YG V+ GKL A+KVL+ A K + + E VL
Sbjct: 3 ELLKVLGTGAYGKVFLVRKVTGHDTGKL----YAMKVLQKAALVQKAKTVEHTRTERNVL 58
Query: 279 SSIRH-PNMVLLLGACPDYG--CLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIA 335
+R P +V L A L+ +Y+ G + L +R N R + EI
Sbjct: 59 EHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRF---YSGEII 115
Query: 336 TALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAA 395
AL LH+ +V+RD+K NILLD ++D GL++ S + S
Sbjct: 116 LALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEFL-----SEEKERTYSFC 167
Query: 396 GTFCYIDPEYQQTGMLTTKS-DIYSFGIMLLQIITARSPMGL 436
GT Y+ PE + K+ D +S GI++ +++T SP L
Sbjct: 168 GTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTL 209
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 4e-05
Identities = 77/277 (27%), Positives = 114/277 (41%), Gaps = 76/277 (27%)
Query: 237 IGEGGYGPV---YRGKLDHTPVAIKVL-RP--DAAQGKRQFQQEVEVLSSIRHPNMVLLL 290
IG G G V Y VAIK L RP + KR ++ E+ ++ + H N++ LL
Sbjct: 24 IGSGAQGIVCAAYDTVTGQN-VAIKKLSRPFQNVTHAKRAYR-ELVLMKLVNHKNIIGLL 81
Query: 291 GA-CPD---------YGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLF 340
P Y LV E M + +L VI + + E + LL+
Sbjct: 82 NVFTPQKSLEEFQDVY--LVMELM-DANL---------CQVI----QMDLDHERMSYLLY 125
Query: 341 --------LHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMT 392
LH A ++HRDLKP+NI++ + KI D GLAR + T + MT
Sbjct: 126 QMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART-------AGTSFMMT 175
Query: 393 SAAGTFCYIDPE------YQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHV---SRA 443
T Y PE Y++ DI+S G ++ ++I T H+ ++
Sbjct: 176 PYVVTRYYRAPEVILGMGYKE------NVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKI 229
Query: 444 IEK-GT----LAEMLDPAVTDW----PAEAAESFSKL 471
IE+ GT L P V ++ P A SF +L
Sbjct: 230 IEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEEL 266
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|225606 COG3064, TolA, Membrane protein involved in colicin uptake [Cell envelope biogenesis, outer membrane] | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 6e-05
Identities = 34/99 (34%), Positives = 50/99 (50%), Gaps = 7/99 (7%)
Query: 111 LRQTMEMYSTACKEALNAK--KKAKELNQWKIEEAQRFE--EARMAEETALAIAEMEKAK 166
L+Q + A ++ A+ +K +L Q + EE R E + E A A A E AK
Sbjct: 103 LKQLEKERLKAQEQQKQAEEAEKQAQLEQKQQEEQARKAAAEQKKKAEAAKAKAAAEAAK 162
Query: 167 CRAAIEAAEKAQKLADAEAQRRKQAE---LKAKREAEEK 202
+AA EA +KA++ A A + + +AE K K EAE K
Sbjct: 163 LKAAAEAKKKAEEAAKAAEEAKAKAEAAAAKKKAEAEAK 201
|
Length = 387 |
| >gnl|CDD|173412 PTZ00121, PTZ00121, MAEBL; Provisional | Back alignment and domain information |
|---|
Score = 45.9 bits (108), Expect = 6e-05
Identities = 37/109 (33%), Positives = 59/109 (54%), Gaps = 9/109 (8%)
Query: 101 EAEMRRLKLELRQTMEMYSTACKE---ALNAKKKAKELNQWKIEEAQRFEEARMAEETAL 157
+AE + E ++ E E A AKKKA E K EEA++ +EA+ AEE
Sbjct: 1478 KAEEAKKADEAKKKAEEAKKKADEAKKAAEAKKKADEAK--KAEEAKKADEAKKAEEAKK 1535
Query: 158 AIAEMEKAKCRAAIEAAEKAQKLADAEAQRRKQAELKAKREAEEKNRAL 206
A E +KA+ + + +KA++L AE +++ + +AK+ E+KN AL
Sbjct: 1536 A-DEAKKAEEKKKADELKKAEELKKAEEKKKAE---EAKKAEEDKNMAL 1580
|
Length = 2084 |
| >gnl|CDD|173412 PTZ00121, PTZ00121, MAEBL; Provisional | Back alignment and domain information |
|---|
Score = 45.9 bits (108), Expect = 6e-05
Identities = 44/152 (28%), Positives = 68/152 (44%), Gaps = 10/152 (6%)
Query: 90 VSSASQSSRDLEAEMRRLKLELRQTMEMYSTACKEALNAKKKAKELNQWKIEEAQRFEEA 149
V + + ++AE + E + E K+A KKK ++L + + EE ++ EE
Sbjct: 1597 VMKLYEEEKKMKAEEAKKAEEAKIKAE----ELKKAEEEKKKVEQLKKKEAEEKKKAEEL 1652
Query: 150 RMAEETALAIAEMEKAKCRAAIEAAEKAQKLADAEAQRRKQAELKAKREAEEKNRA--LT 207
+ AEE A E K A E +KA++ AE +K AE K+EAEE +A L
Sbjct: 1653 KKAEEENKIKAAEEAKK---AEEDKKKAEEAKKAEEDEKKAAE-ALKKEAEEAKKAEELK 1708
Query: 208 ALANNDVRYRKYTIEEIEEATDKFSEAMKIGE 239
+ + + + EE K EA K E
Sbjct: 1709 KKEAEEKKKAEELKKAEEENKIKAEEAKKEAE 1740
|
Length = 2084 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 6e-05
Identities = 48/160 (30%), Positives = 72/160 (45%), Gaps = 25/160 (15%)
Query: 229 DKFSEAMKIGEGGYGPV-YRGKLDHTPV-AIKVLRPDAAQGKRQF---QQEVEVLSSIRH 283
+ F IG+G +G V K D + A+K L K Q + E +VL+
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS 60
Query: 284 PNMVLLLGACPD--YGCLVYEYMHNGSLEDRLLRRGNTPVIPWR------KRFKIAAEIA 335
P +V L + D Y L+ E++ G L T +I + RF +A E
Sbjct: 61 PWVVSLYYSFQDAQYLYLIMEFLPGGDLM--------TMLIKYDTFSEDVTRFYMA-ECV 111
Query: 336 TALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLA 375
A+ +H+ +HRD+KP NIL+DR K+SD GL+
Sbjct: 112 LAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 45.1 bits (106), Expect = 6e-05
Identities = 56/212 (26%), Positives = 89/212 (41%), Gaps = 30/212 (14%)
Query: 230 KFSEAMKIGEGGYGPV---YRGKLDHTPVAIKVLRP--DAAQGKRQFQQEVEVLSSIRHP 284
++ IG G G V Y LD K+ RP + KR ++ E+ ++ + H
Sbjct: 18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHK 76
Query: 285 NMVLLLGACPDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLF---- 340
N++ LL L E + L L+ VI + ++ E + LL+
Sbjct: 77 NIISLLNVFTPQKSL--EEFQDVYLVMELMDANLCQVI----QMELDHERMSYLLYQMLC 130
Query: 341 ----LHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAG 396
LH A ++HRDLKP+NI++ + KI D GLAR + T + MT
Sbjct: 131 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR-------TAGTSFMMTPYVV 180
Query: 397 TFCYIDPEYQQTGMLTTKSDIYSFGIMLLQII 428
T Y PE DI+S G ++ +++
Sbjct: 181 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 1e-04
Identities = 53/228 (23%), Positives = 100/228 (43%), Gaps = 26/228 (11%)
Query: 216 YRKYTIEEIEEATDKFSEAMKIGEGGYGPV---YRGKLDHTPVAIKVLRP-DAAQGKRQF 271
YR+ + + E +++ +G G YG V Y +L K+ RP + R+
Sbjct: 2 YRQELNKTVWEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRT 61
Query: 272 QQEVEVLSSIRHPNMVLLLGACPDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRK----- 326
+E+ +L ++H N++ LL + E + L L+ ++ +K
Sbjct: 62 YRELRLLKHMKHENVIGLLDVFTPATSI--ENFNEVYLVTNLMGADLNNIVKCQKLSDEH 119
Query: 327 -RFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADS 385
+F I ++ L ++H A ++HRDLKP+N+ ++ + +I D GLAR
Sbjct: 120 VQFLIY-QLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQ-------- 167
Query: 386 VTQYHMTSAAGTFCYIDPEYQQTGMLTTKS-DIYSFGIMLLQIITARS 432
MT T Y PE M ++ DI+S G ++ +++ ++
Sbjct: 168 -ADDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKA 214
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 1e-04
Identities = 39/150 (26%), Positives = 73/150 (48%), Gaps = 17/150 (11%)
Query: 236 KIGEGGYGPVYRGKLDHTP----VAIKVLRPDAA-QGKRQFQQEVEVLSSIRHPNMVLLL 290
+IG G +G V ++ V +K L+ +A+ + + +F Q+ + ++HPN++ L
Sbjct: 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCL 61
Query: 291 GACPDY--GCLVYEYMHNGSLEDRLLR----RGNTPVIPWRKRFKIAAEIATALLFLHQA 344
G C + LV+EY G L+ L + R N+ ++ + ++A EIA + +H+
Sbjct: 62 GQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQ---RMACEIAAGVTHMHKH 118
Query: 345 KPEPLVHRDLKPANILLDRNYVSKISDVGL 374
+H DL N L + K+ D G+
Sbjct: 119 N---FLHSDLALRNCFLTSDLTVKVGDYGI 145
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 1e-04
Identities = 74/286 (25%), Positives = 117/286 (40%), Gaps = 46/286 (16%)
Query: 215 RYRKYTIEEIEEAT----DKFSEAMKIGEGGYGPV---YRGKLDHTPVAIKVLRP--DAA 265
R + EI ++T ++ IG G G V Y L+ K+ RP +
Sbjct: 6 RDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQT 65
Query: 266 QGKRQFQQEVEVLSSIRHPNMVLLLGACPDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWR 325
KR ++ E+ ++ + H N++ LL L E + + L+ VI
Sbjct: 66 HAKRAYR-ELVLMKCVNHKNIIGLLNVFTPQKSL--EEFQDVYIVMELMDANLCQVI--- 119
Query: 326 KRFKIAAEIATALLF--------LHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARL 377
+ ++ E + LL+ LH A ++HRDLKP+NI++ + KI D GLAR
Sbjct: 120 -QMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR- 174
Query: 378 VPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLT 437
+ T + MT T Y PE DI+S G ++ ++I T
Sbjct: 175 ------TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGT 228
Query: 438 HHV---SRAIEK-GT----LAEMLDPAVTDW----PAEAAESFSKL 471
H+ ++ IE+ GT + L P V + P A SF KL
Sbjct: 229 DHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKL 274
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|236545 PRK09510, tolA, cell envelope integrity inner membrane protein TolA; Provisional | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 2e-04
Identities = 29/89 (32%), Positives = 43/89 (48%), Gaps = 13/89 (14%)
Query: 128 AKKKAKELNQWKIEEAQRF-----------EEARMAEETALAIAEMEKAKCRAAIEAAEK 176
+++A+EL Q + E +R E+ + AEE A A +K AA +AA
Sbjct: 85 EQQQAEELQQKQAAEQERLKQLEKERLAAQEQKKQAEEAAKQAALKQKQAEEAAAKAAAA 144
Query: 177 AQKLADAEAQRRKQAELKAKREAEEKNRA 205
A+ A+AEA+R A K AE K +A
Sbjct: 145 AKAKAEAEAKR--AAAAAKKAAAEAKKKA 171
|
Length = 387 |
| >gnl|CDD|173412 PTZ00121, PTZ00121, MAEBL; Provisional | Back alignment and domain information |
|---|
Score = 44.0 bits (103), Expect = 2e-04
Identities = 44/146 (30%), Positives = 67/146 (45%), Gaps = 8/146 (5%)
Query: 101 EAEMRRLKLELRQTMEMYSTACKEALNAKKKAKELNQWKIEEAQRFEEARM-AEETALAI 159
+AE E E A K+ AKKKA + K EE ++ +EA+ AEE
Sbjct: 1349 KAEAEAAADEAEAAEEKAEAAEKKKEEAKKKADAAKK-KAEEKKKADEAKKKAEEDKKKA 1407
Query: 160 AEMEKAKC--RAAIEAAEKAQKLADAEAQRRKQAELK----AKREAEEKNRALTALANND 213
E++KA + A EA +KA++ A+ ++K E K AK++AEE +A A +
Sbjct: 1408 DELKKAAAAKKKADEAKKKAEEKKKADEAKKKAEEAKKADEAKKKAEEAKKAEEAKKKAE 1467
Query: 214 VRYRKYTIEEIEEATDKFSEAMKIGE 239
+ ++ E K EA K E
Sbjct: 1468 EAKKADEAKKKAEEAKKADEAKKKAE 1493
|
Length = 2084 |
| >gnl|CDD|173412 PTZ00121, PTZ00121, MAEBL; Provisional | Back alignment and domain information |
|---|
Score = 43.6 bits (102), Expect = 3e-04
Identities = 41/121 (33%), Positives = 64/121 (52%), Gaps = 11/121 (9%)
Query: 123 KEALNAKKKAKELNQWKIEEAQRFEEARMAEETALAI-AEMEKAKCRAAIEAAEKAQKLA 181
K+A AKKKA + K EEA++ EA AE A A AE + K AA + E+A+K A
Sbjct: 1322 KKAEEAKKKADAAKK-KAEEAKKAAEAAKAEAEAAADEAEAAEEKAEAAEKKKEEAKKKA 1380
Query: 182 DA---EAQRRKQAELKAKREAEEKNRALTALANNDVRYRKYTIEEIEEATDKFSEAMKIG 238
DA +A+ +K+A+ K+ E+K +A ++++ ++ +EA K E K
Sbjct: 1381 DAAKKKAEEKKKADEAKKKAEEDKKKA------DELKKAAAAKKKADEAKKKAEEKKKAD 1434
Query: 239 E 239
E
Sbjct: 1435 E 1435
|
Length = 2084 |
| >gnl|CDD|220369 pfam09731, Mitofilin, Mitochondrial inner membrane protein | Back alignment and domain information |
|---|
Score = 43.1 bits (102), Expect = 3e-04
Identities = 36/156 (23%), Positives = 57/156 (36%), Gaps = 27/156 (17%)
Query: 92 SASQSSRDLEAEMRRLKLELRQTMEMYSTACKEALNAKKKAKELNQWKIEEAQRFEEARM 151
Q S+ L + EL + ++ L + A+ +E + E ++
Sbjct: 171 ELDQLSKKLAELKAEEEEELERALKEKREELLSKLEEELLAR------LESKEAALEKQL 224
Query: 152 AEETALAIAEMEKA---KCRAAIEAAEKA--QKLADA------EAQRRKQAELKAKREAE 200
E E+ K K R +E +A QKL + E QR E+K K E E
Sbjct: 225 RLEFEREKEELRKKYEEKLRQELERQAEAHEQKLKNELALQAIELQREFNKEIKEKVEEE 284
Query: 201 EKNR--ALTALANNDVRYRKYTIEEIEEATDKFSEA 234
R L L + ++ +E+A D SEA
Sbjct: 285 RNGRLAKLAELNSR--------LKGLEKALDSRSEA 312
|
Mitofilin controls mitochondrial cristae morphology. Mitofilin is enriched in the narrow space between the inner boundary and the outer membranes, where it forms a homotypic interaction and assembles into a large multimeric protein complex. The first 78 amino acids contain a typical amino-terminal-cleavable mitochondrial presequence rich in positive-charged and hydroxylated residues and a membrane anchor domain. In addition, it has three centrally located coiled coil domains. Length = 493 |
| >gnl|CDD|240172 cd05151, ChoK, Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Score = 41.1 bits (97), Expect = 3e-04
Identities = 20/73 (27%), Positives = 26/73 (35%), Gaps = 13/73 (17%)
Query: 294 PDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLV--H 351
P+ G L+ E++ L KIA + LH + LV H
Sbjct: 63 PETGVLITEFIEGSELLTEDFSDP-------ENLEKIAKLLKK----LHSSPLPDLVPCH 111
Query: 352 RDLKPANILLDRN 364
DL P N LLD
Sbjct: 112 NDLLPGNFLLDDG 124
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate and displays negligible activity towards N-methylated derivatives of Etn. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Length = 170 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 3e-04
Identities = 46/152 (30%), Positives = 73/152 (48%), Gaps = 15/152 (9%)
Query: 231 FSEAMKIGEGGYGPV-YRGKLD-HTPVAIKVLRPDAAQGKRQF---QQEVEVLSSIRHPN 285
F + +G G +G V K+D H A+K LR + Q + E ++L+ +
Sbjct: 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEW 62
Query: 286 MVLLLGACPDYGCL--VYEYMHNGSLEDRLLRRGNTPVIPWR-KRFKIAAEIATALLFLH 342
+V L + D L V +Y+ G + L+R V P RF IA E+ A+ +H
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRME---VFPEVLARFYIA-ELTLAIESVH 118
Query: 343 QAKPEPLVHRDLKPANILLDRNYVSKISDVGL 374
+ +HRD+KP NIL+D + K++D GL
Sbjct: 119 KMG---FIHRDIKPDNILIDLDGHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|236545 PRK09510, tolA, cell envelope integrity inner membrane protein TolA; Provisional | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 4e-04
Identities = 29/91 (31%), Positives = 38/91 (41%)
Query: 123 KEALNAKKKAKELNQWKIEEAQRFEEARMAEETALAIAEMEKAKCRAAIEAAEKAQKLAD 182
K A KKA + K E + A A++ A A A+ + A AAE A
Sbjct: 170 KAEAEAAKKAAAEAKKKAEAEAAAKAAAEAKKKAEAEAKKKAAAEAKKKAAAEAKAAAAK 229
Query: 183 AEAQRRKQAELKAKREAEEKNRALTALANND 213
A A+ + AE A +A EK A A A D
Sbjct: 230 AAAEAKAAAEKAAAAKAAEKAAAAKAAAEVD 260
|
Length = 387 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 5e-04
Identities = 30/86 (34%), Positives = 48/86 (55%), Gaps = 7/86 (8%)
Query: 350 VHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAG-TFCYIDPEYQQT 408
+HRD+ N+LL V+KI D GLAR + + DS Y + A ++ PE
Sbjct: 234 IHRDVAARNVLLTDGRVAKICDFGLARDI---MNDS--NYVVKGNARLPVKWMAPESIFD 288
Query: 409 GMLTTKSDIYSFGIMLLQIIT-ARSP 433
+ T +SD++S+GI+L +I + +SP
Sbjct: 289 CVYTVQSDVWSYGILLWEIFSLGKSP 314
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173412 PTZ00121, PTZ00121, MAEBL; Provisional | Back alignment and domain information |
|---|
Score = 42.8 bits (100), Expect = 6e-04
Identities = 40/125 (32%), Positives = 56/125 (44%), Gaps = 6/125 (4%)
Query: 121 ACKEALNAKKKAKELNQWKIEEAQRFEEARMAEETALAIAEMEKAKCRAAIEAAEKAQKL 180
A +EA ++AK+ K EEA++ EEA+ E A E KA+ E A KA+
Sbjct: 1092 ATEEAFGKAEEAKKTETGKAEEARKAEEAKKKAEDARKAEEARKAEDARKAEEARKAEDA 1151
Query: 181 ADAEAQRRKQAELKAK--REAEEKNRALTALANNDVR----YRKYTIEEIEEATDKFSEA 234
E R+ + KA+ R+AE+ +A A +VR RK EA K E
Sbjct: 1152 KRVEIARKAEDARKAEEARKAEDAKKAEAARKAEEVRKAEELRKAEDARKAEAARKAEEE 1211
Query: 235 MKIGE 239
K E
Sbjct: 1212 RKAEE 1216
|
Length = 2084 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 8e-04
Identities = 26/80 (32%), Positives = 42/80 (52%), Gaps = 4/80 (5%)
Query: 350 VHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTG 409
+HRDL NILL ++KI D GLAR + + +A ++ PE
Sbjct: 236 IHRDLAARNILLTHGRITKICDFGLAR----DIRNDSNYVVKGNARLPVKWMAPESIFNC 291
Query: 410 MLTTKSDIYSFGIMLLQIIT 429
+ T +SD++S+GI+L +I +
Sbjct: 292 VYTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173412 PTZ00121, PTZ00121, MAEBL; Provisional | Back alignment and domain information |
|---|
Score = 41.7 bits (97), Expect = 0.001
Identities = 38/135 (28%), Positives = 68/135 (50%), Gaps = 15/135 (11%)
Query: 101 EAEMRRLKLELRQTMEMYSTACKEALNAKKKAKELNQWKIEEAQ-RFEEARMAEETALAI 159
+AE + E ++ E K+A AKKKA+E K +EA+ + EEA+ A+E
Sbjct: 1439 KAEEAKKADEAKKKAE----EAKKAEEAKKKAEEAK--KADEAKKKAEEAKKADEAKKKA 1492
Query: 160 AEMEKA--KCRAAIEAAEKAQKLADAEAQRRKQAELKA--KREAEEKNRALTALANNDVR 215
E +K + + A EA +KA + AE ++ KA ++A+E +A ++++
Sbjct: 1493 EEAKKKADEAKKAAEAKKKADEAKKAEEAKKADEAKKAEEAKKADEAKKAEEKKKADELK 1552
Query: 216 YRKYTIEEIEEATDK 230
EE+++A +K
Sbjct: 1553 ----KAEELKKAEEK 1563
|
Length = 2084 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.001
Identities = 34/113 (30%), Positives = 55/113 (48%), Gaps = 11/113 (9%)
Query: 222 EEIEEATDKFSEAMKIGEGGYGPVYR------GKLDHT-PVAIKVLRPDAAQGKRQ-FQQ 273
E+ E D +G G +G V GK D+ VA+K+L+ A +R+
Sbjct: 31 EKWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMS 90
Query: 274 EVEVLSSI-RHPNMVLLLGACPDYG--CLVYEYMHNGSLEDRLLRRGNTPVIP 323
E+++LS + +H N+V LLGAC G ++ EY G L + L ++ T +
Sbjct: 91 ELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNF 143
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.001
Identities = 45/151 (29%), Positives = 72/151 (47%), Gaps = 13/151 (8%)
Query: 231 FSEAMKIGEGGYGPVYRGKLDHTPV--AIKVLRPDAAQGKRQF---QQEVEVLSSIRHPN 285
F + +G G +G V + T A+K LR + Q + E ++L+ +
Sbjct: 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62
Query: 286 MVLLLGACPDYGCL--VYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQ 343
+V L + D L V +Y+ G + L+R G P RF IA E+ A+ +H+
Sbjct: 63 VVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFP--EDLARFYIA-ELTCAVESVHK 119
Query: 344 AKPEPLVHRDLKPANILLDRNYVSKISDVGL 374
+HRD+KP NIL+DR+ K++D GL
Sbjct: 120 MG---FIHRDIKPDNILIDRDGHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|236545 PRK09510, tolA, cell envelope integrity inner membrane protein TolA; Provisional | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.002
Identities = 37/132 (28%), Positives = 52/132 (39%), Gaps = 8/132 (6%)
Query: 101 EAEMRRLKLELRQTMEMYSTACKEALNAKKKAKELNQWKIEEAQRFEEARMAEETALAIA 160
A + K E + + A K A AKKKA+ K E + AE A A A
Sbjct: 141 AAAAAKAKAE-AEAKRAAAAAKKAAAEAKKKAEAEAAKKAAA----EAKKKAEAEAAAKA 195
Query: 161 EMEKAKCRAAIEAAEKAQKLADAEAQRRKQAELKAKREAEEKNRALTALANNDVRYRKYT 220
E AK +A EA +KA A+A+ + +A+ A + A E A A +
Sbjct: 196 AAE-AKKKAEAEAKKKAA--AEAKKKAAAEAKAAAAKAAAEAKAAAEKAAAAKAAEKAAA 252
Query: 221 IEEIEEATDKFS 232
+ E D F
Sbjct: 253 AKAAAEVDDLFG 264
|
Length = 387 |
| >gnl|CDD|234017 TIGR02794, tolA_full, TolA protein | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.002
Identities = 25/82 (30%), Positives = 44/82 (53%), Gaps = 3/82 (3%)
Query: 124 EALNAKKKAKELNQWKIEEAQRFEEARMAEETALAIAEMEKAKCRAAIEAAEKAQKLADA 183
+ A KK +E + ++A+ E+ R AE+ E A +AA +A + A++ A
Sbjct: 58 QKKPAAKKEQERQKKLEQQAEEAEKQRAAEQARQKELEQRAAAEKAAKQAEQAAKQ---A 114
Query: 184 EAQRRKQAELKAKREAEEKNRA 205
E ++++ E KAK+ AE K +A
Sbjct: 115 EEKQKQAEEAKAKQAAEAKAKA 136
|
TolA couples the inner membrane complex of itself with TolQ and TolR to the outer membrane complex of TolB and OprL (also called Pal). Most of the length of the protein consists of low-complexity sequence that may differ in both length and composition from one species to another, complicating efforts to discriminate TolA (the most divergent gene in the tol-pal system) from paralogs such as TonB. Selection of members of the seed alignment and criteria for setting scoring cutoffs are based largely conserved operon struction. //The Tol-Pal complex is required for maintaining outer membrane integrity. Also involved in transport (uptake) of colicins and filamentous DNA, and implicated in pathogenesis. Transport is energized by the proton motive force. TolA is an inner membrane protein that interacts with periplasmic TolB and with outer membrane porins ompC, phoE and lamB [Transport and binding proteins, Other, Cellular processes, Pathogenesis]. Length = 346 |
| >gnl|CDD|173412 PTZ00121, PTZ00121, MAEBL; Provisional | Back alignment and domain information |
|---|
Score = 40.9 bits (95), Expect = 0.002
Identities = 35/117 (29%), Positives = 53/117 (45%), Gaps = 7/117 (5%)
Query: 123 KEALNAKKKAKELNQWKIEEAQRFEEARMAEETALAIAEMEKAKCRAAIEAAEKAQKLAD 182
K+A AKKKA E + K EE ++ +EA+ E A E +K E A+KA++
Sbjct: 1411 KKAAAAKKKADEAKK-KAEEKKKADEAKKKAEEAKKADEAKKKA-----EEAKKAEEAKK 1464
Query: 183 AEAQRRKQAELKAKREAEEKNRALTALANNDVRYRKYTIEEIEEATDKFSEAMKIGE 239
+ +K E K K E +K A + + + ++ EA K EA K E
Sbjct: 1465 KAEEAKKADEAKKKAEEAKKADEAKKKA-EEAKKKADEAKKAAEAKKKADEAKKAEE 1520
|
Length = 2084 |
| >gnl|CDD|220365 pfam09726, Macoilin, Transmembrane protein | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.002
Identities = 36/171 (21%), Positives = 72/171 (42%), Gaps = 38/171 (22%)
Query: 89 RVSSASQSSRDLEAEMRRLKL----------ELRQTMEMYST---ACKEALNAKKKAKEL 135
++S+ S R LE ++++L+ ELR + + ++ + K L KK ++
Sbjct: 401 KISTPSAIER-LEQDIKKLQAELQQARQNESELRNQISLLTSLERSLKSDLGQLKKENDM 459
Query: 136 NQWKIEEAQRFEEARMAEETALAIAEMEKAKCRAAIEAAEKAQKLADAEAQRRKQAELKA 195
Q K+ A+ ++ + + MEK + ++ ++ A+K E +R+K+ E A
Sbjct: 460 LQTKLNSMV---SAKQKDKQS--MQSMEK-RLKSEADSRVNAEKQLAEEKKRKKEEEETA 513
Query: 196 KREA-------EEKNRALTALANNDVRYRKYTIEEIEEATDKFSEAMKIGE 239
R A EE +L K +++E K +K+ E
Sbjct: 514 ARAAAQAAASREECAESL-----------KQAKQDLEMEIKKLEHDLKLKE 553
|
This entry is a highly conserved protein present in eukaryotes. Length = 680 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 39.8 bits (94), Expect = 0.002
Identities = 30/116 (25%), Positives = 50/116 (43%), Gaps = 34/116 (29%)
Query: 329 KIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRN----YVSKISDVGLARLV-PPSVA 383
KI ++ AL LH+ ++H D+K N+L DR Y + D GL +++ PS
Sbjct: 113 KIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIY---LCDYGLCKIIGTPSCY 166
Query: 384 DSVTQYHMTSAAGTFCYIDPE------YQQTGMLTTKSDIYSFGIMLLQIITARSP 433
D GT Y PE Y + D ++ G++ +++T + P
Sbjct: 167 D-----------GTLDYFSPEKIKGHNYDVS------FDWWAVGVLTYELLTGKHP 205
|
Length = 267 |
| >gnl|CDD|225177 COG2268, COG2268, Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.002
Identities = 36/159 (22%), Positives = 58/159 (36%), Gaps = 29/159 (18%)
Query: 98 RDLEAEMRRLKLELRQTMEMYSTACKEALNAKKKAKELNQWKIEEAQRFEEARMAEETAL 157
++ E E + + K A N + + +E A+ EEA AE+ AL
Sbjct: 331 KETELEPQERSYFINAAQRQAQEEAKAAANIAEAIGAQAEAAVETARETEEAERAEQAAL 390
Query: 158 ---------------AIAEMEKAKCRAAIEAAEKAQKLADAEAQRRK-QAELKAKR---E 198
AE KA+ A + A+AEA R K +AE +AKR E
Sbjct: 391 VAAAEAAEQEQVEIAVRAEAAKAEAEAQAAEIK-----AEAEAIREKGKAEAEAKRALAE 445
Query: 199 AEEKNRALTALANNDVRYRKYTIEEIEEATDKFSEAMKI 237
A + A ++ + E ++ ++ MK
Sbjct: 446 AIQVLGDAAAAELFKAL-----VQALPEVAEEAAQPMKN 479
|
Length = 548 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.003
Identities = 33/106 (31%), Positives = 50/106 (47%), Gaps = 11/106 (10%)
Query: 225 EEATDKFSEAMKIGEGGYGPVYRGK---LDHT----PVAIKVLRPDAAQGKRQ-FQQEVE 276
E D +G G +G V L H+ VA+K+L+ A ++Q E++
Sbjct: 33 EMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELK 92
Query: 277 VLSSI-RHPNMVLLLGACPDYG--CLVYEYMHNGSLEDRLLRRGNT 319
++S + H N+V LLGAC G ++ EY G L D L R +T
Sbjct: 93 IMSHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHT 138
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|225606 COG3064, TolA, Membrane protein involved in colicin uptake [Cell envelope biogenesis, outer membrane] | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.003
Identities = 36/112 (32%), Positives = 47/112 (41%), Gaps = 7/112 (6%)
Query: 93 ASQSSRDLEAEMRRLKLELRQTMEMYSTACKEALNAKKKAKELNQWKIEEAQRFEEARMA 152
A + AE +LK + + A K A AK KA+ K EA EA+ A
Sbjct: 149 AEAAKAKAAAEAAKLKAA-AEAKKKAEEAAKAAEEAKAKAEAAAAKKKAEA----EAKAA 203
Query: 153 EETALAIAEM-EKAKCRAAIEAAEKAQK-LADAEAQRRKQAELKAKREAEEK 202
E A A AE KA+ +A A EKA A A+ + A + AE K
Sbjct: 204 AEKAKAEAEAKAKAEKKAEAAAEEKAAAEKKKAAAKAKADKAAAAAKAAERK 255
|
Length = 387 |
| >gnl|CDD|225606 COG3064, TolA, Membrane protein involved in colicin uptake [Cell envelope biogenesis, outer membrane] | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.003
Identities = 38/144 (26%), Positives = 59/144 (40%), Gaps = 15/144 (10%)
Query: 94 SQSSRDLEAEMRRLKLELRQTMEMYSTACKEALNAKKKAKE--LNQWKIEEAQRFEEARM 151
SQ S + E +R K E + E L K+ A++ L Q + E + E+ +
Sbjct: 69 SQQSSAKKGEQQRKKKEEQVA---------EELKPKQAAEQERLKQLEKERLKAQEQQKQ 119
Query: 152 AEETA-LAIAEMEKAKCRAAIEAAEKAQKLADAEAQRRKQAELKAKREAEEKNRALTALA 210
AEE A E ++ + +A AAE+ +K AEA + K A AK +A + + A
Sbjct: 120 AEEAEKQAQLEQKQQEEQARKAAAEQKKK---AEAAKAKAAAEAAKLKAAAEAKKKAEEA 176
Query: 211 NNDVRYRKYTIEEIEEATDKFSEA 234
K E +EA
Sbjct: 177 AKAAEEAKAKAEAAAAKKKAEAEA 200
|
Length = 387 |
| >gnl|CDD|173412 PTZ00121, PTZ00121, MAEBL; Provisional | Back alignment and domain information |
|---|
Score = 40.5 bits (94), Expect = 0.003
Identities = 30/86 (34%), Positives = 44/86 (51%), Gaps = 10/86 (11%)
Query: 139 KIEEAQRFEEARMAEETALAIAEMEKAKCRAAIEAAEKAQKLADAEAQRRKQAELK---- 194
K E+A++ E AR AEE A E+ KA+ EAA KA++ AE R+ + K
Sbjct: 1171 KAEDAKKAEAARKAEEVRKA-EELRKAEDARKAEAARKAEEERKAEEARKAEDAKKAEAV 1229
Query: 195 -----AKREAEEKNRALTALANNDVR 215
AK++AEE +A N ++R
Sbjct: 1230 KKAEEAKKDAEEAKKAEEERNNEEIR 1255
|
Length = 2084 |
| >gnl|CDD|173412 PTZ00121, PTZ00121, MAEBL; Provisional | Back alignment and domain information |
|---|
Score = 40.5 bits (94), Expect = 0.003
Identities = 36/108 (33%), Positives = 55/108 (50%), Gaps = 10/108 (9%)
Query: 103 EMRRLKLELRQTMEMYSTA--CKEALNAKKKAKELNQWKIEEA-QRFEEARMAEETALAI 159
E ++ E ++ E A K+A AKKKA+E K EEA ++ EEA+ A+E
Sbjct: 1422 EAKKKAEEKKKADEAKKKAEEAKKADEAKKKAEEAK--KAEEAKKKAEEAKKADEAKKKA 1479
Query: 160 AEMEKAK--CRAAIEAAEKAQKLADAEAQRRKQAELKAKREAEEKNRA 205
E +KA + A EA +KA + A ++K E ++AEE +A
Sbjct: 1480 EEAKKADEAKKKAEEAKKKADEAKKAAEAKKKADEA---KKAEEAKKA 1524
|
Length = 2084 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.003
Identities = 42/179 (23%), Positives = 67/179 (37%), Gaps = 31/179 (17%)
Query: 267 GKRQ-FQQEVEVLSSIRHPNMVLLLGA-------C---PDYGCLVYEYMHNGSLEDRLLR 315
G+R E +L +I HP+++ L G C P Y +Y Y L + R
Sbjct: 125 GQRGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTDLYCY-----LAAK--R 177
Query: 316 RGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLA 375
I I + A+ +LH+ + ++HRD+K NI +++ DV L
Sbjct: 178 N-----IAICDILAIERSVLRAIQYLHENR---IIHRDIKAENI-----FINHPGDVCLG 224
Query: 376 RLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPM 434
+ AGT PE DI+S GI+L ++ T +
Sbjct: 225 DFGAACFPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSL 283
|
Length = 391 |
| >gnl|CDD|173412 PTZ00121, PTZ00121, MAEBL; Provisional | Back alignment and domain information |
|---|
Score = 40.1 bits (93), Expect = 0.004
Identities = 40/119 (33%), Positives = 60/119 (50%), Gaps = 6/119 (5%)
Query: 123 KEALNAKKKAKELNQWKIEEAQR-FEEARMAEETALAIAEMEKAK-CRAAIEAAEKAQKL 180
K+A AKKKA+E K +EA++ EEA+ A+E E +KA+ + E A+KA +
Sbjct: 1418 KKADEAKKKAEEKK--KADEAKKKAEEAKKADEAKKKAEEAKKAEEAKKKAEEAKKADEA 1475
Query: 181 ADAEAQRRKQAELKAKREAEEKNRALTALANNDVRYRKYTIEEIEEATDKFSEAMKIGE 239
+ +K E K K E E K +A A + + + ++ EEA K EA K E
Sbjct: 1476 KKKAEEAKKADEAKKKAE-EAKKKADEAKKAAEAKKKADEAKKAEEAK-KADEAKKAEE 1532
|
Length = 2084 |
| >gnl|CDD|216108 pfam00769, ERM, Ezrin/radixin/moesin family | Back alignment and domain information |
|---|
Score = 38.6 bits (90), Expect = 0.004
Identities = 28/107 (26%), Positives = 44/107 (41%), Gaps = 13/107 (12%)
Query: 103 EMRRLKLELRQTMEMYST----ACKEALNAKKKAKELNQWKIEEAQRFEEARMAEETALA 158
E R + EL + ME A KE ++ A EL E+ ++ EE E
Sbjct: 2 EAEREQQELEERMEQMEEDMRRAQKELEEYEETALELE----EKLKQEEEEAQLLEKKAD 57
Query: 159 IAEMEKAKCRAAIEAAEK-----AQKLADAEAQRRKQAELKAKREAE 200
E E + A+E+ ++ +A A+ K E + K+EAE
Sbjct: 58 ELEEENRRLEEEAAASEEERERLEAEVDEATAEVAKLEEEREKKEAE 104
|
This family of proteins contain a band 4.1 domain (pfam00373), at their amino terminus. This family represents the rest of these proteins. Length = 244 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 568 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.98 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.98 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.97 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.97 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.97 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.96 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.96 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.95 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.94 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.94 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.93 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.92 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.92 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.88 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.87 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.87 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.87 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.87 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.86 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.85 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.84 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.83 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.81 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.8 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.79 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.79 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.78 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.78 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.77 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.76 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.76 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.75 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.75 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.68 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.67 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.65 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.59 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.55 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.47 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.43 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.42 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.34 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.3 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.29 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.27 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.24 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.21 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.2 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.18 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.97 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.96 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.95 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.91 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.75 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.7 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.69 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.61 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.6 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.6 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.45 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.42 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.41 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.4 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.38 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.37 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.28 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.17 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.15 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.14 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 98.02 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.94 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.91 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.9 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.88 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.87 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.86 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.84 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.72 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.69 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.53 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 97.51 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.5 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.45 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.36 | |
| PLN02236 | 344 | choline kinase | 97.16 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.13 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.03 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.83 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.74 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 96.64 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 96.56 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.4 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.38 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.36 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.19 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.1 | |
| PF04655 | 253 | APH_6_hur: Aminoglycoside/hydroxyurea antibiotic r | 95.93 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 95.84 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.82 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.4 | |
| PTZ00296 | 442 | choline kinase; Provisional | 95.25 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 95.24 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 94.89 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-49 Score=414.92 Aligned_cols=268 Identities=44% Similarity=0.817 Sum_probs=231.3
Q ss_pred cccccCHHHHHHHhcccccceeecccCceeEEEEEeCC-ccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCceeeecccc
Q 008365 215 RYRKYTIEEIEEATDKFSEAMKIGEGGYGPVYRGKLDH-TPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGAC 293 (568)
Q Consensus 215 ~~~~~~~~ei~~~~~~y~~~~~IG~G~fg~Vy~~~~~~-~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~ 293 (568)
....|++.++..+|++|.....||+||||.||+|...+ +.||||.+.........+|.+|+.+|.+++|||+|+|+|+|
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 46679999999999999999999999999999999855 89999988765543134599999999999999999999999
Q ss_pred CCC---ceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEec
Q 008365 294 PDY---GCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKIS 370 (568)
Q Consensus 294 ~~~---~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~ 370 (568)
.+. .+||||||++|+|.++|...... .++|..|++||.++|+||+|||...+.+||||||||+|||||.++.+||+
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls 219 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS 219 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence 543 59999999999999999876544 68999999999999999999999888889999999999999999999999
Q ss_pred ccccccccCC-CCCccccccccccc-cccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCc---------hH
Q 008365 371 DVGLARLVPP-SVADSVTQYHMTSA-AGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLT---------HH 439 (568)
Q Consensus 371 DFGla~~~~~-~~~~~~~~~~~~~~-~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~---------~~ 439 (568)
|||+|+..+. .. ..... .||.+|+|||++..+..+.++|||||||+|+||++|+.|.+.. .+
T Consensus 220 DFGLa~~~~~~~~-------~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w 292 (361)
T KOG1187|consen 220 DFGLAKLGPEGDT-------SVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEW 292 (361)
T ss_pred CccCcccCCcccc-------ceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHH
Confidence 9999976543 11 11112 7999999999999999999999999999999999999888632 22
Q ss_pred HHHHHHhCccccccCccCC--CCCh-HHHHHHHHHHHHhhccCCCCCCChHHhH
Q 008365 440 VSRAIEKGTLAEMLDPAVT--DWPA-EAAESFSKLAIQCAELRKKDRPDLGTVI 490 (568)
Q Consensus 440 ~~~~~~~~~~~~~l~~~~~--~~p~-~~~~~l~~li~~Cl~~dP~~RPs~~~vl 490 (568)
....+..+.+.+++|+.+. .++. .....+..++.+|++.+|.+||+|.+|+
T Consensus 293 ~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv 346 (361)
T KOG1187|consen 293 AKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVV 346 (361)
T ss_pred HHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHH
Confidence 3345667789999999975 4453 5677899999999999999999999985
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-49 Score=395.04 Aligned_cols=247 Identities=28% Similarity=0.442 Sum_probs=209.3
Q ss_pred cccceeecccCceeEEEEEe--CCccEEEEEeCcC-hhHhHHHHHHHHHHHHcCCCCceeeeccccCCC---ceEEEEec
Q 008365 231 FSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPD-AAQGKRQFQQEVEVLSSIRHPNMVLLLGACPDY---GCLVYEYM 304 (568)
Q Consensus 231 y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~-~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~---~~lV~E~~ 304 (568)
.+.++.||+|..|+||++++ +++.+|+|++..+ .....+++.+|+++++.++||+||.+||+|.+. .+|+||||
T Consensus 81 le~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYM 160 (364)
T KOG0581|consen 81 LERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYM 160 (364)
T ss_pred hhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhc
Confidence 44566899999999999998 5779999999544 344567899999999999999999999998443 57999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCC
Q 008365 305 HNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQ-AKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVA 383 (568)
Q Consensus 305 ~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~-~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~ 383 (568)
++|||++++...+. +++.....|+.+|++||.|||. .+ ||||||||+||||+..|.|||||||.++.+..+
T Consensus 161 DgGSLd~~~k~~g~---i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS-- 232 (364)
T KOG0581|consen 161 DGGSLDDILKRVGR---IPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS-- 232 (364)
T ss_pred CCCCHHHHHhhcCC---CCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccHHhhhh--
Confidence 99999999987643 8999999999999999999996 77 999999999999999999999999999876443
Q ss_pred ccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCch----HHHHHHHhCccccccCccCCC
Q 008365 384 DSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTH----HVSRAIEKGTLAEMLDPAVTD 459 (568)
Q Consensus 384 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~----~~~~~~~~~~~~~~l~~~~~~ 459 (568)
...+++||..|||||.+.+..|+.++||||||++++|+.+|+.||.... .... -+..+++...+.
T Consensus 233 ------~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~-----Ll~~Iv~~ppP~ 301 (364)
T KOG0581|consen 233 ------IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFE-----LLCAIVDEPPPR 301 (364)
T ss_pred ------hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHH-----HHHHHhcCCCCC
Confidence 2357899999999999999999999999999999999999999996531 1111 122333444445
Q ss_pred CChH-HHHHHHHHHHHhhccCCCCCCChHHhHhHHHHH
Q 008365 460 WPAE-AAESFSKLAIQCAELRKKDRPDLGTVIVPELNR 496 (568)
Q Consensus 460 ~p~~-~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l~~ 496 (568)
.|.+ ++++|..|+..||++||.+||++.+++.|.+-+
T Consensus 302 lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~ 339 (364)
T KOG0581|consen 302 LPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIK 339 (364)
T ss_pred CCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHh
Confidence 5665 889999999999999999999999999887743
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-47 Score=399.48 Aligned_cols=247 Identities=35% Similarity=0.574 Sum_probs=206.1
Q ss_pred cccceeecccCceeEEEEEeCCcc-EEEEEeCcChhHh--HHHHHHHHHHHHcCCCCceeeeccccCCC---ceEEEEec
Q 008365 231 FSEAMKIGEGGYGPVYRGKLDHTP-VAIKVLRPDAAQG--KRQFQQEVEVLSSIRHPNMVLLLGACPDY---GCLVYEYM 304 (568)
Q Consensus 231 y~~~~~IG~G~fg~Vy~~~~~~~~-vAvK~l~~~~~~~--~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~---~~lV~E~~ 304 (568)
..+...||.|+||+||+|.+.|+. ||||++....... ...|.+|+.+|.+++|||||+++|+|.+. .+||||||
T Consensus 43 l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~ 122 (362)
T KOG0192|consen 43 LPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYM 122 (362)
T ss_pred hhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeC
Confidence 344556999999999999999998 9999997653222 56899999999999999999999999665 48999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCc-eeEecccccccccCCCCC
Q 008365 305 HNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNY-VSKISDVGLARLVPPSVA 383 (568)
Q Consensus 305 ~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~-~vKL~DFGla~~~~~~~~ 383 (568)
++|+|.+++... ....+++..++.|+.||+.||.|||+.++ ||||||||+||||+.++ ++||+|||+++......
T Consensus 123 ~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~- 198 (362)
T KOG0192|consen 123 PGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK- 198 (362)
T ss_pred CCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccc-
Confidence 999999999875 23359999999999999999999999985 99999999999999998 99999999998653321
Q ss_pred ccccccccccccccccCCChhhhh--cCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHhCccccccCccCCCCC
Q 008365 384 DSVTQYHMTSAAGTFCYIDPEYQQ--TGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAVTDWP 461 (568)
Q Consensus 384 ~~~~~~~~~~~~GT~~Y~APE~~~--~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~l~~~~~~~p 461 (568)
...+...||+.|||||++. ...|+.|+|||||||+||||+||+.||.....+..... ... ....+..|
T Consensus 199 -----~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~--v~~---~~~Rp~~p 268 (362)
T KOG0192|consen 199 -----TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASA--VVV---GGLRPPIP 268 (362)
T ss_pred -----ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHH--HHh---cCCCCCCC
Confidence 2334578999999999999 56899999999999999999999999987665322211 111 11223345
Q ss_pred hHHHHHHHHHHHHhhccCCCCCCChHHhHh
Q 008365 462 AEAAESFSKLAIQCAELRKKDRPDLGTVIV 491 (568)
Q Consensus 462 ~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~ 491 (568)
..+++.+..|+..||..+|..||++.+|+.
T Consensus 269 ~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 269 KECPPHLSSLMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred ccCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence 558888999999999999999999999874
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-48 Score=393.87 Aligned_cols=252 Identities=26% Similarity=0.376 Sum_probs=209.7
Q ss_pred HhcccccceeecccCceeEEEEEe--CCccEEEEEeCcChhH-------hHHHHHHHHHHHHcCCCCceeeeccccC--C
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQ-------GKRQFQQEVEVLSSIRHPNMVLLLGACP--D 295 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~-------~~~~~~~Ev~iL~~l~HpnIv~l~g~~~--~ 295 (568)
..+.|.+.+.||+|+||.|-+|.. +++.||||++++.... ....+.+|++||++|+|||||+++++|. +
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 567899999999999999999976 6789999999764322 1223579999999999999999999994 4
Q ss_pred CceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCC---ceeEeccc
Q 008365 296 YGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRN---YVSKISDV 372 (568)
Q Consensus 296 ~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~---~~vKL~DF 372 (568)
+.||||||++||+|.+++..++. +.+..-.-+++|++.||.|||+.| |+||||||+|||+..+ ..+||+||
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk~---l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDF 323 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANKY---LREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDF 323 (475)
T ss_pred ceEEEEEEecCccHHHHHHhccc---cccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEeccc
Confidence 56999999999999999987653 666667789999999999999999 9999999999999665 89999999
Q ss_pred ccccccCCCCCccccccccccccccccCCChhhhhcCC---CCCcceehhHHHHHHHHHhCCCCCCC---chHHHHHHHh
Q 008365 373 GLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGM---LTTKSDIYSFGIMLLQIITARSPMGL---THHVSRAIEK 446 (568)
Q Consensus 373 Gla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~---~s~ksDvwSlGvil~elltG~~Pf~~---~~~~~~~~~~ 446 (568)
|+|+..+. ...+.+.||||.|.|||++.+.. +..++||||||||||-+|+|.+||.. ......++.+
T Consensus 324 GlAK~~g~-------~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~ 396 (475)
T KOG0615|consen 324 GLAKVSGE-------GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILK 396 (475)
T ss_pred chhhcccc-------ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhc
Confidence 99997642 23567899999999999998765 34588999999999999999999953 2226667777
Q ss_pred CccccccCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHHHH
Q 008365 447 GTLAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPELNR 496 (568)
Q Consensus 447 ~~~~~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l~~ 496 (568)
|.+... +..-..++++..+||.++|..||+.||++.++|.|.|-+
T Consensus 397 G~y~f~-----p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~ 441 (475)
T KOG0615|consen 397 GRYAFG-----PLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFK 441 (475)
T ss_pred Cccccc-----ChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhh
Confidence 765321 111246778899999999999999999999999887754
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-47 Score=404.05 Aligned_cols=246 Identities=25% Similarity=0.401 Sum_probs=213.2
Q ss_pred cccccceeecccCceeEEEEEe--CCccEEEEEeCcCh---hHhHHHHHHHHHHHHcCCCCceeeeccccCCCc--eEEE
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDA---AQGKRQFQQEVEVLSSIRHPNMVLLLGACPDYG--CLVY 301 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~--~lV~ 301 (568)
..|...+.||+|||+.||.+++ .|..||+|++.+.. ....+.+.+||+|.+.|.|||||+++++|+|.. |||+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 4699999999999999999987 67899999997642 334566889999999999999999999998754 8999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCC
Q 008365 302 EYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPS 381 (568)
Q Consensus 302 E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~ 381 (568)
|+|..++|..++.+.. .+++.+++.++.||+.||.|||+.+ |||||||..||||+++.+|||+|||||..+...
T Consensus 98 ELC~~~sL~el~Krrk---~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~ 171 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRRK---PLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD 171 (592)
T ss_pred EecCCccHHHHHHhcC---CCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCc
Confidence 9999999999887544 4899999999999999999999999 999999999999999999999999999887543
Q ss_pred CCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCc--hHHHHHHHhCccccccCccCCC
Q 008365 382 VADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLT--HHVSRAIEKGTLAEMLDPAVTD 459 (568)
Q Consensus 382 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~--~~~~~~~~~~~~~~~l~~~~~~ 459 (568)
. .+..+.||||.|+|||++.....+..+||||+|||||-||.|++||... ......|+.... .
T Consensus 172 ~------Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y---------~ 236 (592)
T KOG0575|consen 172 G------ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEY---------S 236 (592)
T ss_pred c------cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCc---------c
Confidence 2 2346789999999999999999999999999999999999999999754 334444443332 2
Q ss_pred CChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHHH
Q 008365 460 WPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPELN 495 (568)
Q Consensus 460 ~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l~ 495 (568)
+|..++.+..+||..+|+.+|.+||++.+|+.+.+-
T Consensus 237 ~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff 272 (592)
T KOG0575|consen 237 MPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFF 272 (592)
T ss_pred cccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhh
Confidence 356777889999999999999999999999987764
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-47 Score=383.58 Aligned_cols=249 Identities=32% Similarity=0.520 Sum_probs=204.1
Q ss_pred HhcccccceeecccCceeEEEEEe--CCccEEEEEeCcC--hhHhHHHHHHHHHHHHcCCCCceeeeccccCC--CceEE
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPD--AAQGKRQFQQEVEVLSSIRHPNMVLLLGACPD--YGCLV 300 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--~~~lV 300 (568)
..++|.+.+.||+|+||+||+|++ .+..||||.+.+. .....+-+..|+.+|+.++|||||.+++++.. +.|||
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV 87 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV 87 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence 346799999999999999999987 5679999999766 45556678899999999999999999999854 55899
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCC------ceeEeccccc
Q 008365 301 YEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRN------YVSKISDVGL 374 (568)
Q Consensus 301 ~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~------~~vKL~DFGl 374 (568)
||||.||+|.++|..++. +++.++..++.||+.||++||.++ ||||||||+||||+.. -.+||+|||+
T Consensus 88 MEyC~gGDLs~yi~~~~~---l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGf 161 (429)
T KOG0595|consen 88 MEYCNGGDLSDYIRRRGR---LPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGF 161 (429)
T ss_pred EEeCCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccch
Confidence 999999999999998864 899999999999999999999999 9999999999999654 5689999999
Q ss_pred ccccCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHH--HHHHHhCccccc
Q 008365 375 ARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHV--SRAIEKGTLAEM 452 (568)
Q Consensus 375 a~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~--~~~~~~~~~~~~ 452 (568)
|+.+.+. ....+.||+|.|||||++..+.|+.|+|+||+|+|+|+|++|+.||...... ...++++.-
T Consensus 162 AR~L~~~-------~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~--- 231 (429)
T KOG0595|consen 162 ARFLQPG-------SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNE--- 231 (429)
T ss_pred hhhCCch-------hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcccc---
Confidence 9988643 2345789999999999999999999999999999999999999999744332 223333321
Q ss_pred cCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 453 LDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 453 l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
.+...+..+...+.+|+...++.++.+|-++.+-+.+.+
T Consensus 232 ---~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~ 270 (429)
T KOG0595|consen 232 ---IVPVLPAELSNPLRELLISLLQRNPKDRISFEDFFDHPF 270 (429)
T ss_pred ---ccCchhhhccCchhhhhhHHHhcCccccCchHHhhhhhh
Confidence 112223444455667888888888888888776654443
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-48 Score=372.26 Aligned_cols=248 Identities=28% Similarity=0.459 Sum_probs=207.3
Q ss_pred cccccceeecccCceeEEEEEe--CCccEEEEEeCcCh--hHhHHHHHHHHHHHHcCCCCceeeecc-ccCCC---ceEE
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDA--AQGKRQFQQEVEVLSSIRHPNMVLLLG-ACPDY---GCLV 300 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~--~~~~~~~~~Ev~iL~~l~HpnIv~l~g-~~~~~---~~lV 300 (568)
.+|+++++||+|+||.||++.. ++..||.|.++... ....+++..|+.+|++|+|||||++|+ .|.+. .+||
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 4588899999999999999876 78899999987653 344567899999999999999999998 45332 3799
Q ss_pred EEecCCCCHHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHHcCCC-CcccCCCCCCCeeccCCceeEeccccccccc
Q 008365 301 YEYMHNGSLEDRLLRR-GNTPVIPWRKRFKIAAEIATALLFLHQAKPE-PLVHRDLKPANILLDRNYVSKISDVGLARLV 378 (568)
Q Consensus 301 ~E~~~ggsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~-~IiHrDIKp~NILld~~~~vKL~DFGla~~~ 378 (568)
||||.+|+|..++... .....+++.++++++.|++.||..+|+.-+. .|+||||||.||+|+.+|.|||+||||++.+
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 9999999999998763 3445699999999999999999999994322 3899999999999999999999999999987
Q ss_pred CCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchH--HHHHHHhCccccccCcc
Q 008365 379 PPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHH--VSRAIEKGTLAEMLDPA 456 (568)
Q Consensus 379 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~--~~~~~~~~~~~~~l~~~ 456 (568)
.... ....+.+|||.||+||.+.+.+|+.++||||+||++|||..-++||.+.+- ....|+.+.+
T Consensus 179 ~s~~------tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~------- 245 (375)
T KOG0591|consen 179 SSKT------TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDY------- 245 (375)
T ss_pred cchh------HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCC-------
Confidence 5432 234578999999999999999999999999999999999999999976643 3344555532
Q ss_pred CCCCC-hHHHHHHHHHHHHhhccCCCCCCChHHhH
Q 008365 457 VTDWP-AEAAESFSKLAIQCAELRKKDRPDLGTVI 490 (568)
Q Consensus 457 ~~~~p-~~~~~~l~~li~~Cl~~dP~~RPs~~~vl 490 (568)
+.+| ...+..+..||..|+..||..||+.-.++
T Consensus 246 -~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v 279 (375)
T KOG0591|consen 246 -PPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYV 279 (375)
T ss_pred -CCCcHHHhhhHHHHHHHHHccCCcccCCCcchHH
Confidence 2344 56788899999999999999999964444
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-47 Score=379.09 Aligned_cols=237 Identities=29% Similarity=0.378 Sum_probs=201.6
Q ss_pred hcccccceeecccCceeEEEEEe--CCccEEEEEeCcChhH---hHHHHHHHHHHHHcCCCCceeeeccccCCCc--eEE
Q 008365 228 TDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQ---GKRQFQQEVEVLSSIRHPNMVLLLGACPDYG--CLV 300 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~---~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~--~lV 300 (568)
.++|+++++||+|+||.||.++. +++.+|+|++++.... .......|.+||..++||+||+++..|++.. |||
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 46799999999999999999876 6779999999876432 3456789999999999999999999997754 999
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCC
Q 008365 301 YEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPP 380 (568)
Q Consensus 301 ~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~ 380 (568)
+||+.||.|...|.+.+. +++..+..++.+|+.||.|||+.| ||||||||+|||||.+|+++|+|||||+..-.
T Consensus 104 ld~~~GGeLf~hL~~eg~---F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~ 177 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQREGR---FSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLK 177 (357)
T ss_pred EeccCCccHHHHHHhcCC---cchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence 999999999999987764 889989999999999999999999 99999999999999999999999999985322
Q ss_pred CCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchH--HHHHHHhCccccccCccCC
Q 008365 381 SVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHH--VSRAIEKGTLAEMLDPAVT 458 (568)
Q Consensus 381 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~--~~~~~~~~~~~~~l~~~~~ 458 (568)
. .....++|||+.|||||++.+..|+..+|+|||||++|||++|.+||...+. +...+..+. +.
T Consensus 178 ~------~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k--------~~ 243 (357)
T KOG0598|consen 178 D------GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGK--------LP 243 (357)
T ss_pred C------CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCc--------CC
Confidence 1 1223458999999999999999999999999999999999999999976543 333444433 22
Q ss_pred CCChHHHHHHHHHHHHhhccCCCCCC
Q 008365 459 DWPAEAAESFSKLAIQCAELRKKDRP 484 (568)
Q Consensus 459 ~~p~~~~~~l~~li~~Cl~~dP~~RP 484 (568)
..|.-++....+++...+..+|.+|-
T Consensus 244 ~~p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 244 LPPGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred CCCccCCHHHHHHHHHHhccCHHHhc
Confidence 23344667789999999999999995
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-45 Score=381.19 Aligned_cols=247 Identities=23% Similarity=0.310 Sum_probs=199.6
Q ss_pred HhcccccceeecccCceeEEEEEe--CCccEEEEEeCcChhHhHH---HHHHHHHHHHcCCCCceeeeccccCCC--ceE
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQGKR---QFQQEVEVLSSIRHPNMVLLLGACPDY--GCL 299 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~---~~~~Ev~iL~~l~HpnIv~l~g~~~~~--~~l 299 (568)
..++|+++++||+|+||.||+|+. +|..+|+|++++.....+. .++.|.++|...++|+||+||..|++. .||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 557899999999999999999975 7889999999987655444 467899999999999999999999764 589
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccC
Q 008365 300 VYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVP 379 (568)
Q Consensus 300 V~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~ 379 (568)
||||++||++..+|.+.+. |++..+..++.+++.|+..||+.| ||||||||+|+|||..|++||+|||||..+.
T Consensus 219 iMEylPGGD~mTLL~~~~~---L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~ 292 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLMRKDT---LTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLD 292 (550)
T ss_pred EEEecCCccHHHHHHhcCc---CchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchhh
Confidence 9999999999999988764 888899999999999999999999 9999999999999999999999999995432
Q ss_pred CC-------------------CCccccc----c------------------ccccccccccCCChhhhhcCCCCCcceeh
Q 008365 380 PS-------------------VADSVTQ----Y------------------HMTSAAGTFCYIDPEYQQTGMLTTKSDIY 418 (568)
Q Consensus 380 ~~-------------------~~~~~~~----~------------------~~~~~~GT~~Y~APE~~~~~~~s~ksDvw 418 (568)
.. ....... . ...+.+|||.|||||++.+..|+..||+|
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwW 372 (550)
T KOG0605|consen 293 KKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWW 372 (550)
T ss_pred hhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHH
Confidence 10 0000010 0 01257999999999999999999999999
Q ss_pred hHHHHHHHHHhCCCCCCCchH--HHHHHHhCccccccCccCCCCChHHHHHHHHHHHHhhccCCCCCCC
Q 008365 419 SFGIMLLQIITARSPMGLTHH--VSRAIEKGTLAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPD 485 (568)
Q Consensus 419 SlGvil~elltG~~Pf~~~~~--~~~~~~~~~~~~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs 485 (568)
||||||||||.|.+||..... ....+..-. ..+.... ...++.+..+||.+||. ||..|--
T Consensus 373 SLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr--~~l~fP~---~~~~s~eA~DLI~rll~-d~~~RLG 435 (550)
T KOG0605|consen 373 SLGCIMYEMLVGYPPFCSETPQETYRKIVNWR--ETLKFPE---EVDLSDEAKDLITRLLC-DPENRLG 435 (550)
T ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh--hhccCCC---cCcccHHHHHHHHHHhc-CHHHhcC
Confidence 999999999999999965443 333332221 1111100 12344788999999999 9999986
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-45 Score=382.65 Aligned_cols=253 Identities=28% Similarity=0.378 Sum_probs=211.0
Q ss_pred cccccceeecccCceeEEEEEe--CCccEEEEEeCcChh---HhHHHHHHHHHHHHcC-CCCceeeeccccCCCc--eEE
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAA---QGKRQFQQEVEVLSSI-RHPNMVLLLGACPDYG--CLV 300 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~---~~~~~~~~Ev~iL~~l-~HpnIv~l~g~~~~~~--~lV 300 (568)
++|.+++.||.|+|++||+|+. .++.|||||+.+... ...+.+..|-++|.+| .||.||+||-.|+|.. |+|
T Consensus 73 ~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFv 152 (604)
T KOG0592|consen 73 NDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFV 152 (604)
T ss_pred hhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEE
Confidence 5688888999999999999987 667999999976532 2234577899999999 7999999999998765 899
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCC
Q 008365 301 YEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPP 380 (568)
Q Consensus 301 ~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~ 380 (568)
+||+++|+|.++|.+.|. |.+.....++.+|+.||+|||++| ||||||||+|||||++|++||+|||.|+.+++
T Consensus 153 Le~A~nGdll~~i~K~Gs---fde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~l~~ 226 (604)
T KOG0592|consen 153 LEYAPNGDLLDLIKKYGS---FDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKILSP 226 (604)
T ss_pred EEecCCCcHHHHHHHhCc---chHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccccCCh
Confidence 999999999999998864 888888999999999999999999 99999999999999999999999999999876
Q ss_pred CCCc-----cc--cccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHhCcccccc
Q 008365 381 SVAD-----SV--TQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEML 453 (568)
Q Consensus 381 ~~~~-----~~--~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~l 453 (568)
.... .. ......+++||..|.+||++..+..+..+|||+||||||+|+.|.+||...+......+...+
T Consensus 227 ~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l---- 302 (604)
T KOG0592|consen 227 SQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQAL---- 302 (604)
T ss_pred hhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHh----
Confidence 5433 11 111235699999999999999999999999999999999999999999766543221111111
Q ss_pred CccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 454 DPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 454 ~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
--.+|++.++...+|+.+.|-.||.+|++..+|-.|.+
T Consensus 303 ---~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpF 340 (604)
T KOG0592|consen 303 ---DYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPF 340 (604)
T ss_pred ---cccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCcc
Confidence 11456677788999999999999999999998876544
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-45 Score=380.22 Aligned_cols=243 Identities=30% Similarity=0.503 Sum_probs=204.5
Q ss_pred ccccceeecccCceeEEEEEeCCc-cEEEEEeCcChhHhHHHHHHHHHHHHcCCCCceeeeccccCCC--ceEEEEecCC
Q 008365 230 KFSEAMKIGEGGYGPVYRGKLDHT-PVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACPDY--GCLVYEYMHN 306 (568)
Q Consensus 230 ~y~~~~~IG~G~fg~Vy~~~~~~~-~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~--~~lV~E~~~g 306 (568)
.+..++.||+|-||.||+|.++++ .||+|.++.... ..+.|.+|+++|++|+|+|||+++|+|... .+||||||+.
T Consensus 207 ~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m-~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~ 285 (468)
T KOG0197|consen 207 ELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSM-SPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPK 285 (468)
T ss_pred HHHHHHHhcCCccceEEEEEEcCCCcccceEEecccc-ChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEeccc
Confidence 345677899999999999999877 999999987643 346788999999999999999999999654 4999999999
Q ss_pred CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCCccc
Q 008365 307 GSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSV 386 (568)
Q Consensus 307 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~~~~ 386 (568)
|+|.++|...+ ...+...+.+.++.|||.|++||++++ +|||||-+.||||+++..+||+|||||+.+.++..
T Consensus 286 GsLl~yLr~~~-~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y--- 358 (468)
T KOG0197|consen 286 GSLLDYLRTRE-GGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDEY--- 358 (468)
T ss_pred CcHHHHhhhcC-CCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCce---
Confidence 99999998733 234888999999999999999999999 99999999999999999999999999995533221
Q ss_pred cccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh-CCCCCCCchH--HHHHHHhCccccccCccCCCCChH
Q 008365 387 TQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPMGLTHH--VSRAIEKGTLAEMLDPAVTDWPAE 463 (568)
Q Consensus 387 ~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~--~~~~~~~~~~~~~l~~~~~~~p~~ 463 (568)
......--...|+|||.+..+.++.+||||||||+||||+| |+.||..... +...++.|. ....|..
T Consensus 359 --~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~Gy--------Rlp~P~~ 428 (468)
T KOG0197|consen 359 --TASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGY--------RLPRPEG 428 (468)
T ss_pred --eecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccC--------cCCCCCC
Confidence 11122233567999999999999999999999999999999 9999875543 334454443 2356888
Q ss_pred HHHHHHHHHHHhhccCCCCCCChHHhH
Q 008365 464 AAESFSKLAIQCAELRKKDRPDLGTVI 490 (568)
Q Consensus 464 ~~~~l~~li~~Cl~~dP~~RPs~~~vl 490 (568)
||..+.++|..||+.+|++||++..+.
T Consensus 429 CP~~vY~lM~~CW~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 429 CPDEVYELMKSCWHEDPEDRPTFETLR 455 (468)
T ss_pred CCHHHHHHHHHHhhCCcccCCCHHHHH
Confidence 999999999999999999999999553
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-44 Score=365.79 Aligned_cols=256 Identities=25% Similarity=0.438 Sum_probs=208.7
Q ss_pred hcccccceeecccCceeEEEEEeC--CccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCceeeeccc--cCC--CceEEE
Q 008365 228 TDKFSEAMKIGEGGYGPVYRGKLD--HTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGA--CPD--YGCLVY 301 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~~~~~--~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~--~~~--~~~lV~ 301 (568)
..+|...+.||+|+||.||++.+. +...|||..........+.+.+|+.+|++|+|||||+++|. ..+ ..+++|
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence 345778889999999999999884 68999999866543336678999999999999999999996 333 368999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccC-CceeEecccccccccCC
Q 008365 302 EYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDR-NYVSKISDVGLARLVPP 380 (568)
Q Consensus 302 E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~-~~~vKL~DFGla~~~~~ 380 (568)
||+++|+|.+++.+.+. .+++..+..+..||+.||.|||+++ ||||||||+||||+. ++.+||+|||+++....
T Consensus 96 Ey~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~ 170 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLES 170 (313)
T ss_pred eccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence 99999999999998775 3999999999999999999999999 999999999999999 79999999999986643
Q ss_pred CCCccccccccccccccccCCChhhhhcCC-CCCcceehhHHHHHHHHHhCCCCCCCc-hHHHHHHHhCccccccCccCC
Q 008365 381 SVADSVTQYHMTSAAGTFCYIDPEYQQTGM-LTTKSDIYSFGIMLLQIITARSPMGLT-HHVSRAIEKGTLAEMLDPAVT 458 (568)
Q Consensus 381 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~-~s~ksDvwSlGvil~elltG~~Pf~~~-~~~~~~~~~~~~~~~l~~~~~ 458 (568)
. ...........||+.|||||++.++. ...++|||||||+++||+||++||... ......+..+. ....+
T Consensus 171 ~---~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~-----~~~~P 242 (313)
T KOG0198|consen 171 K---GTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGR-----EDSLP 242 (313)
T ss_pred c---cccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhc-----cCCCC
Confidence 0 11112234578999999999998643 445999999999999999999999652 22222222221 12233
Q ss_pred CCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHHHH
Q 008365 459 DWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPELNR 496 (568)
Q Consensus 459 ~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l~~ 496 (568)
.+|..++....+|+..|+..+|..||++.+++.|.+..
T Consensus 243 ~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~ 280 (313)
T KOG0198|consen 243 EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLK 280 (313)
T ss_pred CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhh
Confidence 66777888999999999999999999999999777644
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=352.09 Aligned_cols=253 Identities=25% Similarity=0.346 Sum_probs=202.2
Q ss_pred cccccceeecccCceeEEEEEe--CCccEEEEEeCcC--hhHhHHHHHHHHHHHHcCCCCceeeeccccCCC--ceEEEE
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPD--AAQGKRQFQQEVEVLSSIRHPNMVLLLGACPDY--GCLVYE 302 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~--~~lV~E 302 (568)
++|+.+.++|+|+||+||++++ +|+.||||++... .....+...+|+++|++|+|||+|.++.+|... .+||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 4688899999999999999987 6789999999654 344456678999999999999999999999554 489999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCC
Q 008365 303 YMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSV 382 (568)
Q Consensus 303 ~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~ 382 (568)
||+..-| +.|.+..+. ++...+..|++|++.|+.|+|+++ +|||||||+||||+.+|.+||||||+|+.+...
T Consensus 82 ~~dhTvL-~eLe~~p~G--~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p- 154 (396)
T KOG0593|consen 82 YCDHTVL-HELERYPNG--VPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSAP- 154 (396)
T ss_pred ecchHHH-HHHHhccCC--CCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcCC-
Confidence 9976555 446554433 788899999999999999999999 999999999999999999999999999987531
Q ss_pred CccccccccccccccccCCChhhhhc-CCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHh----Cc---------
Q 008365 383 ADSVTQYHMTSAAGTFCYIDPEYQQT-GMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEK----GT--------- 448 (568)
Q Consensus 383 ~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~----~~--------- 448 (568)
....+..+.|.||.|||.+.+ ..|+..+||||+||++.||++|.+-|-+...+++.... |.
T Consensus 155 -----gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF 229 (396)
T KOG0593|consen 155 -----GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIF 229 (396)
T ss_pred -----cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHh
Confidence 122356789999999998777 68999999999999999999999999766665544321 11
Q ss_pred -----cccccCccCC------CCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHH
Q 008365 449 -----LAEMLDPAVT------DWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPE 493 (568)
Q Consensus 449 -----~~~~l~~~~~------~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~ 493 (568)
+..+.-|... ...+.+...+.+|+..||+.||.+|++-++++.|.
T Consensus 230 ~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~ 285 (396)
T KOG0593|consen 230 SSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHP 285 (396)
T ss_pred ccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcCh
Confidence 1111111111 11234566789999999999999999999987644
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-44 Score=348.57 Aligned_cols=232 Identities=27% Similarity=0.400 Sum_probs=201.4
Q ss_pred hcccccceeecccCceeEEEEEe--CCccEEEEEeCcChhHhH---HHHHHHHHHHHcCCCCceeeeccccCCCc--eEE
Q 008365 228 TDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQGK---RQFQQEVEVLSSIRHPNMVLLLGACPDYG--CLV 300 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~---~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~--~lV 300 (568)
.++|+.++.||.|+||.|.+++. ++..+|+|++.+...-.. +...+|..+|+.+.||+++++++.|.+.. +||
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv 122 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV 122 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence 35688899999999999999987 667999999987654443 34679999999999999999999997755 899
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCC
Q 008365 301 YEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPP 380 (568)
Q Consensus 301 ~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~ 380 (568)
|||++||.|..+|++.+. +++..+..++.||+.||+|||+++ ||+|||||+|||||.+|++||+|||+|+.+..
T Consensus 123 meyv~GGElFS~Lrk~~r---F~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~ 196 (355)
T KOG0616|consen 123 MEYVPGGELFSYLRKSGR---FSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSG 196 (355)
T ss_pred EeccCCccHHHHHHhcCC---CCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecC
Confidence 999999999999998765 889999999999999999999999 99999999999999999999999999987643
Q ss_pred CCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchH--HHHHHHhCccccccCccCC
Q 008365 381 SVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHH--VSRAIEKGTLAEMLDPAVT 458 (568)
Q Consensus 381 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~--~~~~~~~~~~~~~l~~~~~ 458 (568)
. ..+.||||.|+|||++...+|+.++|+|||||++|||+.|.+||...+. +...|..+.+
T Consensus 197 r---------T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v--------- 258 (355)
T KOG0616|consen 197 R---------TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKV--------- 258 (355)
T ss_pred c---------EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcc---------
Confidence 2 3578999999999999999999999999999999999999999976654 3344444432
Q ss_pred CCChHHHHHHHHHHHHhhccCCCCC
Q 008365 459 DWPAEAAESFSKLAIQCAELRKKDR 483 (568)
Q Consensus 459 ~~p~~~~~~l~~li~~Cl~~dP~~R 483 (568)
.+|.-.+..+.+|+...++.|-..|
T Consensus 259 ~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 259 KFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred cCCcccCHHHHHHHHHHHhhhhHhh
Confidence 3566667788999999999988888
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=370.71 Aligned_cols=248 Identities=26% Similarity=0.408 Sum_probs=211.5
Q ss_pred cccccceeecccCceeEEEEEe--CCccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCceeeecccc--CCCceEEEEec
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGAC--PDYGCLVYEYM 304 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~--~~~~~lV~E~~ 304 (568)
..|....+||+|+.|.||.+.. .++.||||.+.......++-+.+|+.+|+.++|+|||.+++.| .+..++|||||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym 352 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM 352 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence 4567778999999999999976 5678999999877766677789999999999999999999887 45679999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCCc
Q 008365 305 HNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVAD 384 (568)
Q Consensus 305 ~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~~ 384 (568)
+||+|.|.+.... +++.++..|+.+++.||.|||..+ |||||||.+|||++.+|.+||+|||+|..+....
T Consensus 353 ~ggsLTDvVt~~~----~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~-- 423 (550)
T KOG0578|consen 353 EGGSLTDVVTKTR----MTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQ-- 423 (550)
T ss_pred CCCchhhhhhccc----ccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeecccccc--
Confidence 9999999886543 889999999999999999999999 9999999999999999999999999998775433
Q ss_pred cccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHH--HHhCccccccCccCCCCCh
Q 008365 385 SVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRA--IEKGTLAEMLDPAVTDWPA 462 (568)
Q Consensus 385 ~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~--~~~~~~~~~l~~~~~~~p~ 462 (568)
....+.+|||+|||||+.....|+.++||||||+|++||+-|.+||-..+.+... +.... .+.+ ..+.
T Consensus 424 ----~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng-----~P~l-k~~~ 493 (550)
T KOG0578|consen 424 ----SKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNG-----TPKL-KNPE 493 (550)
T ss_pred ----CccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcC-----CCCc-CCcc
Confidence 2456789999999999999999999999999999999999999999644443322 11111 1111 3356
Q ss_pred HHHHHHHHHHHHhhccCCCCCCChHHhHhHHHH
Q 008365 463 EAAESFSKLAIQCAELRKKDRPDLGTVIVPELN 495 (568)
Q Consensus 463 ~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l~ 495 (568)
.++..|.+|+.+||..|+.+||++.++|.|.+-
T Consensus 494 klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl 526 (550)
T KOG0578|consen 494 KLSPELKDFLDRCLVVDVEQRASAKELLEHPFL 526 (550)
T ss_pred ccCHHHHHHHHHHhhcchhcCCCHHHHhcChhh
Confidence 788899999999999999999999999987764
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=367.32 Aligned_cols=247 Identities=28% Similarity=0.448 Sum_probs=210.1
Q ss_pred cccccceeecccCceeEEEEEe--CCccEEEEEeCcCh--hHhHHHHHHHHHHHHcCCCCceeeeccccCCCc--eEEEE
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDA--AQGKRQFQQEVEVLSSIRHPNMVLLLGACPDYG--CLVYE 302 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~--~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~--~lV~E 302 (568)
++|.+.+.||+|+||.||+|+. +.+.||||.+.+.. ....+.+.+|++|++.|+|||||.++++|+... ++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 4688888999999999999976 45689999997653 334566899999999999999999999997654 89999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCC
Q 008365 303 YMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSV 382 (568)
Q Consensus 303 ~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~ 382 (568)
|+.| +|..+|...+. +++..+..|+.+++.||.|||+++ |+|||+||.|||++++|++|+||||+|+.+...
T Consensus 82 ~a~g-~L~~il~~d~~---lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~- 153 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDGK---LPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN- 153 (808)
T ss_pred hhhh-hHHHHHHhccC---CCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcccC-
Confidence 9965 99999987664 899999999999999999999999 999999999999999999999999999976442
Q ss_pred CccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHhCccccccCccCCCCCh
Q 008365 383 ADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAVTDWPA 462 (568)
Q Consensus 383 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~l~~~~~~~p~ 462 (568)
....+++.|||.|||||...++.|+..+|+||||||+||+++|++||... .+...+ +.+-.....||.
T Consensus 154 -----t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~-si~~Lv------~~I~~d~v~~p~ 221 (808)
T KOG0597|consen 154 -----TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR-SITQLV------KSILKDPVKPPS 221 (808)
T ss_pred -----ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH-HHHHHH------HHHhcCCCCCcc
Confidence 23456788999999999999999999999999999999999999999422 222222 222223345677
Q ss_pred HHHHHHHHHHHHhhccCCCCCCChHHhHhHHHH
Q 008365 463 EAAESFSKLAIQCAELRKKDRPDLGTVIVPELN 495 (568)
Q Consensus 463 ~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l~ 495 (568)
..+..|..|+...|.+||..|-+..+++.|.+-
T Consensus 222 ~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~ 254 (808)
T KOG0597|consen 222 TASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFW 254 (808)
T ss_pred cccHHHHHHHHHHhhcChhhcccHHHHhcChHH
Confidence 889999999999999999999999999877653
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=365.99 Aligned_cols=250 Identities=26% Similarity=0.398 Sum_probs=208.7
Q ss_pred HhcccccceeecccCceeEEEEEe--CCccEEEEEeCcC----hh-HhHHHHHHHHHHHHcCC-CCceeeeccccC--CC
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPD----AA-QGKRQFQQEVEVLSSIR-HPNMVLLLGACP--DY 296 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~----~~-~~~~~~~~Ev~iL~~l~-HpnIv~l~g~~~--~~ 296 (568)
..++|.+.+.||+|+||.|+.|.+ .+..||||++... .. ...+.+.+|+.+++.++ ||||++++.++. ..
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 557899999999999999999987 6789999987654 22 23456778999999999 999999999884 44
Q ss_pred ceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCC-ceeEecccccc
Q 008365 297 GCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRN-YVSKISDVGLA 375 (568)
Q Consensus 297 ~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~-~~vKL~DFGla 375 (568)
.++|||||.||+|.+++...+. +.+..+..++.||+.||.|||+.| |+||||||+|||++.+ +++||+|||++
T Consensus 95 ~~ivmEy~~gGdL~~~i~~~g~---l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~s 168 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVNKGR---LKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGLS 168 (370)
T ss_pred EEEEEEecCCccHHHHHHHcCC---CChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEeccccc
Confidence 6899999999999999988543 778899999999999999999999 9999999999999999 99999999999
Q ss_pred cccCCCCCccccccccccccccccCCChhhhhcCC-CC-CcceehhHHHHHHHHHhCCCCCCCchHHH--HHHHhCcccc
Q 008365 376 RLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGM-LT-TKSDIYSFGIMLLQIITARSPMGLTHHVS--RAIEKGTLAE 451 (568)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~-~s-~ksDvwSlGvil~elltG~~Pf~~~~~~~--~~~~~~~~~~ 451 (568)
.... .........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||+..+... ..+..+.
T Consensus 169 ~~~~------~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~--- 239 (370)
T KOG0583|consen 169 AISP------GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGE--- 239 (370)
T ss_pred cccC------CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCC---
Confidence 8763 1122346789999999999999977 75 78999999999999999999997643321 2222222
Q ss_pred ccCccCCCCChHH-HHHHHHHHHHhhccCCCCCCChHHhHhHHHHHH
Q 008365 452 MLDPAVTDWPAEA-AESFSKLAIQCAELRKKDRPDLGTVIVPELNRL 497 (568)
Q Consensus 452 ~l~~~~~~~p~~~-~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l~~L 497 (568)
-.+|..+ +..+..|+.+||..+|..|+++.+|+.+.+-+.
T Consensus 240 ------~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 240 ------FKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred ------ccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 2345555 788999999999999999999999997776543
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-43 Score=359.92 Aligned_cols=256 Identities=25% Similarity=0.369 Sum_probs=207.8
Q ss_pred HhcccccceeecccCceeEEEEEe--CCccEEEEEeCcChhHhHHH--HHHHHHHHHcCC-CCceeeeccccCCCc---e
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQGKRQ--FQQEVEVLSSIR-HPNMVLLLGACPDYG---C 298 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~--~~~Ev~iL~~l~-HpnIv~l~g~~~~~~---~ 298 (568)
.-++|.++++||.|+||.||+|+. .+..||||.++..-.. .++ =.+|+..|++|+ |||||++.+++.+.. +
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~ 86 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY 86 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence 457899999999999999999986 6678999998755332 222 258999999999 999999999985543 8
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEeccccccccc
Q 008365 299 LVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLV 378 (568)
Q Consensus 299 lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~ 378 (568)
+||||| ..+|.+++..++ ..|++..+..|+.||++||.|+|.+| +.|||+||+||||..+..+||+||||||.+
T Consensus 87 fVfE~M-d~NLYqLmK~R~--r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev 160 (538)
T KOG0661|consen 87 FVFEFM-DCNLYQLMKDRN--RLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREV 160 (538)
T ss_pred eeHHhh-hhhHHHHHhhcC--CcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEeccccccccc
Confidence 899999 589999988773 45999999999999999999999999 999999999999999999999999999965
Q ss_pred CCCCCccccccccccccccccCCChhhh-hcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHhC----------
Q 008365 379 PPSVADSVTQYHMTSAAGTFCYIDPEYQ-QTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKG---------- 447 (568)
Q Consensus 379 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~-~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~---------- 447 (568)
.. ....+..+.|.+|.|||++ ..+.|+.++|||++|||++|+.+-++.|-+...+++..+..
T Consensus 161 ~S-------kpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~ 233 (538)
T KOG0661|consen 161 RS-------KPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDS 233 (538)
T ss_pred cc-------CCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCcccc
Confidence 32 3345778899999999955 56779999999999999999999999997776666543211
Q ss_pred -----ccccccCccCC--------CCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHHHH
Q 008365 448 -----TLAEMLDPAVT--------DWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPELNR 496 (568)
Q Consensus 448 -----~~~~~l~~~~~--------~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l~~ 496 (568)
.+...++-.++ ..-+.++.++.++|.+||++||.+||++.+.+.+.+-+
T Consensus 234 ~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq 295 (538)
T KOG0661|consen 234 WPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQ 295 (538)
T ss_pred chhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcccc
Confidence 11111111111 12234778899999999999999999999998766544
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-43 Score=362.64 Aligned_cols=256 Identities=28% Similarity=0.367 Sum_probs=204.1
Q ss_pred hcccccceeecccCceeEEEEEe--CCccEEEEEeCcChh--HhHHHHHHHHHHHHcCCCCceeeeccccCCC----ceE
Q 008365 228 TDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAA--QGKRQFQQEVEVLSSIRHPNMVLLLGACPDY----GCL 299 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~--~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~----~~l 299 (568)
.+.|+.+++||+|+||.||+|++ +|+.||+|.++.+.. ....-..+||.||++|+|||||+|.+...+. .||
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 45688889999999999999998 677899999977652 2234457999999999999999999987443 489
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccC
Q 008365 300 VYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVP 379 (568)
Q Consensus 300 V~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~ 379 (568)
|+|||+ -+|.-++...+- .|+..++..|+.||+.||.|||.+| |+|||||.+|||||++|.+||+|||||+++.
T Consensus 196 VFeYMd-hDL~GLl~~p~v--kft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~ 269 (560)
T KOG0600|consen 196 VFEYMD-HDLSGLLSSPGV--KFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYT 269 (560)
T ss_pred EEeccc-chhhhhhcCCCc--ccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeecc
Confidence 999995 588877765432 3899999999999999999999999 9999999999999999999999999999886
Q ss_pred CCCCccccccccccccccccCCChhhhhcC-CCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHH----hCcccc---
Q 008365 380 PSVADSVTQYHMTSAAGTFCYIDPEYQQTG-MLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIE----KGTLAE--- 451 (568)
Q Consensus 380 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~----~~~~~~--- 451 (568)
.... ...+..+-|.+|.|||.+.|. .|+.++|+||.||||.||++|++.|.+...+.+... .|.-.+
T Consensus 270 ~~~~-----~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W 344 (560)
T KOG0600|consen 270 PSGS-----APYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYW 344 (560)
T ss_pred CCCC-----cccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcc
Confidence 5432 235778899999999987765 599999999999999999999999988777665432 111110
Q ss_pred ---------ccCcc------CCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 452 ---------MLDPA------VTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 452 ---------~l~~~------~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
.+.+. +.+.....+....+|+..+|.+||.+|.++.+++.+++
T Consensus 345 ~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~sey 402 (560)
T KOG0600|consen 345 PVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEY 402 (560)
T ss_pred ccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcc
Confidence 01000 00011234556778999999999999999999886443
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=359.00 Aligned_cols=249 Identities=28% Similarity=0.445 Sum_probs=198.3
Q ss_pred hcccccceeecccCceeEEEEEe-------CCccEEEEEeCcCh-hHhHHHHHHHHHHHHcC-CCCceeeeccccCC---
Q 008365 228 TDKFSEAMKIGEGGYGPVYRGKL-------DHTPVAIKVLRPDA-AQGKRQFQQEVEVLSSI-RHPNMVLLLGACPD--- 295 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~~~~-------~~~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l-~HpnIv~l~g~~~~--- 295 (568)
.++|++.++||.|+||.||+|.+ .+..||||+++... ......+.+|+.+|..+ +|||||+++++|..
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 46799999999999999999974 23579999997543 23345688999999999 89999999998754
Q ss_pred CceEEEEecCCCCHHHHHhhcCC---------------------------------------------------------
Q 008365 296 YGCLVYEYMHNGSLEDRLLRRGN--------------------------------------------------------- 318 (568)
Q Consensus 296 ~~~lV~E~~~ggsL~~~l~~~~~--------------------------------------------------------- 318 (568)
..++||||+++|+|.+++.....
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 24789999999999999875321
Q ss_pred --CCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCCccccccccccccc
Q 008365 319 --TPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAG 396 (568)
Q Consensus 319 --~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~G 396 (568)
...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+..... ........+
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~----~~~~~~~~~ 238 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPD----YVRKGSARL 238 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcc----hhcccCCCC
Confidence 123778888999999999999999999 99999999999999999999999999986532211 111223456
Q ss_pred cccCCChhhhhcCCCCCcceehhHHHHHHHHHh-CCCCCCCchH---HHHHHHhCccccccCccCCCCChHHHHHHHHHH
Q 008365 397 TFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPMGLTHH---VSRAIEKGTLAEMLDPAVTDWPAEAAESFSKLA 472 (568)
Q Consensus 397 T~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~---~~~~~~~~~~~~~l~~~~~~~p~~~~~~l~~li 472 (568)
++.|+|||++.+..++.++|||||||++|||++ |..||..... +...+..+. ....|..++..+.+|+
T Consensus 239 ~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~l~~li 310 (338)
T cd05102 239 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGT--------RMRAPENATPEIYRIM 310 (338)
T ss_pred CccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCC--------CCCCCCCCCHHHHHHH
Confidence 789999999999999999999999999999997 9999965332 222222221 1122445667899999
Q ss_pred HHhhccCCCCCCChHHhHh
Q 008365 473 IQCAELRKKDRPDLGTVIV 491 (568)
Q Consensus 473 ~~Cl~~dP~~RPs~~~vl~ 491 (568)
.+||+.+|.+||++.+|+.
T Consensus 311 ~~cl~~dp~~RPs~~el~~ 329 (338)
T cd05102 311 LACWQGDPKERPTFSALVE 329 (338)
T ss_pred HHHccCChhhCcCHHHHHH
Confidence 9999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=345.44 Aligned_cols=234 Identities=20% Similarity=0.326 Sum_probs=194.5
Q ss_pred eeecccCceeEEEEEeCCccEEEEEeCcChhHh---HHHHHHHHHHHHcCCCCceeeeccccCC------CceEEEEecC
Q 008365 235 MKIGEGGYGPVYRGKLDHTPVAIKVLRPDAAQG---KRQFQQEVEVLSSIRHPNMVLLLGACPD------YGCLVYEYMH 305 (568)
Q Consensus 235 ~~IG~G~fg~Vy~~~~~~~~vAvK~l~~~~~~~---~~~~~~Ev~iL~~l~HpnIv~l~g~~~~------~~~lV~E~~~ 305 (568)
..||+|++|.||+|.++++.||||++....... .+.|.+|+.+|.+++|||||+++|+|.+ ..++||||++
T Consensus 26 ~~i~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~ 105 (283)
T PHA02988 26 VLIKENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCT 105 (283)
T ss_pred eEEeeCCceEEEEEEECCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeCC
Confidence 579999999999999999999999997653322 4678899999999999999999998754 3489999999
Q ss_pred CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHc-CCCCcccCCCCCCCeeccCCceeEecccccccccCCCCCc
Q 008365 306 NGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQA-KPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVAD 384 (568)
Q Consensus 306 ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~-~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~~ 384 (568)
+|+|.+++.... .+++.....++.+++.||.|||.. + ++||||||+|||++.++.+||+|||+++.+....
T Consensus 106 ~g~L~~~l~~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~-- 177 (283)
T PHA02988 106 RGYLREVLDKEK---DLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP-- 177 (283)
T ss_pred CCcHHHHHhhCC---CCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhhhcccc--
Confidence 999999997643 378899999999999999999985 6 8999999999999999999999999998653211
Q ss_pred cccccccccccccccCCChhhhhc--CCCCCcceehhHHHHHHHHHhCCCCCCCchH--HHHHHHhCccccccCccCCCC
Q 008365 385 SVTQYHMTSAAGTFCYIDPEYQQT--GMLTTKSDIYSFGIMLLQIITARSPMGLTHH--VSRAIEKGTLAEMLDPAVTDW 460 (568)
Q Consensus 385 ~~~~~~~~~~~GT~~Y~APE~~~~--~~~s~ksDvwSlGvil~elltG~~Pf~~~~~--~~~~~~~~~~~~~l~~~~~~~ 460 (568)
....||..|+|||++.+ ..++.++|||||||++|||++|..||..... +...+..... . ...
T Consensus 178 -------~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~----~---~~~ 243 (283)
T PHA02988 178 -------FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNN----S---LKL 243 (283)
T ss_pred -------ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCC----C---CCC
Confidence 23468999999999876 6799999999999999999999999975432 2222211111 1 123
Q ss_pred ChHHHHHHHHHHHHhhccCCCCCCChHHhH
Q 008365 461 PAEAAESFSKLAIQCAELRKKDRPDLGTVI 490 (568)
Q Consensus 461 p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl 490 (568)
|..++..+.+|+.+||+.+|.+||++.+++
T Consensus 244 ~~~~~~~l~~li~~cl~~dp~~Rps~~ell 273 (283)
T PHA02988 244 PLDCPLEIKCIVEACTSHDSIKRPNIKEIL 273 (283)
T ss_pred CCcCcHHHHHHHHHHhcCCcccCcCHHHHH
Confidence 445678899999999999999999999987
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=365.42 Aligned_cols=260 Identities=26% Similarity=0.493 Sum_probs=205.5
Q ss_pred HHHHhcccccceeecccCceeEEEEEeCCccEEEEEeCcCh--hHhHHHHHHHHHHHHcCCCCceeeeccccCC-CceEE
Q 008365 224 IEEATDKFSEAMKIGEGGYGPVYRGKLDHTPVAIKVLRPDA--AQGKRQFQQEVEVLSSIRHPNMVLLLGACPD-YGCLV 300 (568)
Q Consensus 224 i~~~~~~y~~~~~IG~G~fg~Vy~~~~~~~~vAvK~l~~~~--~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~-~~~lV 300 (568)
.++..+.+.+...||+|.||+||+|++- -.||||+++.+. ....+.|++||.+|++-+|.||+-+.|+|-. ...||
T Consensus 387 WeIp~~ev~l~~rIGsGsFGtV~Rg~wh-GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~AIi 465 (678)
T KOG0193|consen 387 WEIPPEEVLLGERIGSGSFGTVYRGRWH-GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPLAII 465 (678)
T ss_pred cccCHHHhhccceeccccccceeecccc-cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCceeee
Confidence 3334556677889999999999999984 469999997653 3346789999999999999999999999954 34899
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCC
Q 008365 301 YEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPP 380 (568)
Q Consensus 301 ~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~ 380 (568)
..+|+|-+|+.+|+-... .|...+.+.|+.||++|+.|||.++ |||||||..||||.+++.|||+||||+..-..
T Consensus 466 TqwCeGsSLY~hlHv~et--kfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~ 540 (678)
T KOG0193|consen 466 TQWCEGSSLYTHLHVQET--KFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLATVKTR 540 (678)
T ss_pred ehhccCchhhhhccchhh--hhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccceeeeee
Confidence 999999999999976543 3888899999999999999999999 99999999999999999999999999964321
Q ss_pred CCCccccccccccccccccCCChhhhhc---CCCCCcceehhHHHHHHHHHhCCCCCCCch--HHHHHHHhCccccccCc
Q 008365 381 SVADSVTQYHMTSAAGTFCYIDPEYQQT---GMLTTKSDIYSFGIMLLQIITARSPMGLTH--HVSRAIEKGTLAEMLDP 455 (568)
Q Consensus 381 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~---~~~s~ksDvwSlGvil~elltG~~Pf~~~~--~~~~~~~~~~~~~~l~~ 455 (568)
.. .........|...|||||++.. .+|+..+||||||||+|||++|..||.... .+-.++..|. +.+
T Consensus 541 w~----g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~----l~p 612 (678)
T KOG0193|consen 541 WS----GEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGY----LMP 612 (678)
T ss_pred ec----cccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccc----cCc
Confidence 11 1111233458889999998764 469999999999999999999999997221 1111222222 223
Q ss_pred cCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHHHHH
Q 008365 456 AVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPELNRL 497 (568)
Q Consensus 456 ~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l~~L 497 (568)
.+.....+|++++.+|+..||..++++||.+.+|+..++..+
T Consensus 613 d~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~ 654 (678)
T KOG0193|consen 613 DLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELL 654 (678)
T ss_pred cchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhh
Confidence 333344578889999999999999999999999985444433
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=347.79 Aligned_cols=260 Identities=24% Similarity=0.324 Sum_probs=211.3
Q ss_pred hcccccceeecccCceeEEEEEe--CCccEEEEEeCcChhHh-HHHHHHHHHHHHcCCCCceeeecccc--CCCceEEEE
Q 008365 228 TDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQG-KRQFQQEVEVLSSIRHPNMVLLLGAC--PDYGCLVYE 302 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~-~~~~~~Ev~iL~~l~HpnIv~l~g~~--~~~~~lV~E 302 (568)
.+.|++...||.|..++||+|+. .+..||||++..+.... ...+.+|+..|+.++|||||.++..| ....++||.
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 46799999999999999999987 66899999998765444 47889999999999999999999988 445589999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCC
Q 008365 303 YMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSV 382 (568)
Q Consensus 303 ~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~ 382 (568)
||.+||+.+++...-... +++..+..|++++++||.|||++| .||||||+.||||+.+|.|||+|||.+-.+....
T Consensus 105 fMa~GS~ldIik~~~~~G-l~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G 180 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYYPDG-LEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG 180 (516)
T ss_pred hhcCCcHHHHHHHHcccc-ccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence 999999999998765443 899999999999999999999999 9999999999999999999999999986665433
Q ss_pred CccccccccccccccccCCChhhhh--cCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHhCc--cccccCccCC
Q 008365 383 ADSVTQYHMTSAAGTFCYIDPEYQQ--TGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGT--LAEMLDPAVT 458 (568)
Q Consensus 383 ~~~~~~~~~~~~~GT~~Y~APE~~~--~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~--~~~~l~~~~~ 458 (568)
.....+...++||++|||||++. ...|+.|+|||||||..+||.+|..||.....+...+.+-. ....+ ....
T Consensus 181 --~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~-t~~~ 257 (516)
T KOG0582|consen 181 --DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLL-TSGL 257 (516)
T ss_pred --ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcc-cccC
Confidence 22222337789999999999743 35699999999999999999999999987766554433211 10000 0000
Q ss_pred --CCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 459 --DWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 459 --~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
+.....+..|.+++..||..||.+||++.+++.+.+
T Consensus 258 ~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~F 295 (516)
T KOG0582|consen 258 DKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAF 295 (516)
T ss_pred ChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHH
Confidence 112245568999999999999999999999986554
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=355.00 Aligned_cols=242 Identities=25% Similarity=0.347 Sum_probs=200.1
Q ss_pred cccccceeecccCceeEEEEEe--CCccEEEEEeCcChh---HhHHHHHHHHHHHHcCCCCceeeeccccCC--CceEEE
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAA---QGKRQFQQEVEVLSSIRHPNMVLLLGACPD--YGCLVY 301 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~---~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--~~~lV~ 301 (568)
++|.+.+.||+|+||.||+|.+ +++.||||++..... .....+.+|+.+|+.++||||++++++|.+ ..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 5799999999999999999987 567899999875432 234568899999999999999999998854 448999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCC
Q 008365 302 EYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPS 381 (568)
Q Consensus 302 E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~ 381 (568)
||++||+|.+++...+ .+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+...
T Consensus 98 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 171 (329)
T PTZ00263 98 EFVVGGELFTHLRKAG---RFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR 171 (329)
T ss_pred cCCCCChHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence 9999999999987654 3788889999999999999999999 999999999999999999999999999865322
Q ss_pred CCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHH--HHHHhCccccccCccCCC
Q 008365 382 VADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVS--RAIEKGTLAEMLDPAVTD 459 (568)
Q Consensus 382 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~--~~~~~~~~~~~l~~~~~~ 459 (568)
. ...+||+.|+|||++.+..++.++|||||||++|+|++|..||....... ..+..+. ..
T Consensus 172 ~---------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~---------~~ 233 (329)
T PTZ00263 172 T---------FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGR---------LK 233 (329)
T ss_pred c---------ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC---------cC
Confidence 1 23579999999999999999999999999999999999999996544322 2222221 12
Q ss_pred CChHHHHHHHHHHHHhhccCCCCCCC-----hHHhHhHHH
Q 008365 460 WPAEAAESFSKLAIQCAELRKKDRPD-----LGTVIVPEL 494 (568)
Q Consensus 460 ~p~~~~~~l~~li~~Cl~~dP~~RPs-----~~~vl~~~l 494 (568)
+|..++..+.+|+.+||+.||.+||+ +.+++.|.+
T Consensus 234 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~ 273 (329)
T PTZ00263 234 FPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPY 273 (329)
T ss_pred CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCc
Confidence 33445567899999999999999997 577765543
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=346.49 Aligned_cols=249 Identities=25% Similarity=0.363 Sum_probs=199.3
Q ss_pred ccccceeecccCceeEEEEEe--CCccEEEEEeCcChh---HhHHHHHHHHHHHHcCCCCceeeeccccCC--CceEEEE
Q 008365 230 KFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAA---QGKRQFQQEVEVLSSIRHPNMVLLLGACPD--YGCLVYE 302 (568)
Q Consensus 230 ~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~---~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--~~~lV~E 302 (568)
.|+..+.||+|+||.||+|.+ +++.||||++..... .....+.+|+.++..++|+||+.++++|.+ ..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 378889999999999999986 578999999875432 223457789999999999999999988754 4589999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCC
Q 008365 303 YMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSV 382 (568)
Q Consensus 303 ~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~ 382 (568)
|+++|+|.+++..... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++..+....
T Consensus 81 ~~~~g~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05631 81 IMNGGDLKFHIYNMGN-PGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE 156 (285)
T ss_pred ecCCCcHHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence 9999999988865433 24889999999999999999999999 9999999999999999999999999997653221
Q ss_pred CccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHH--HHHHhCccccccCccCCCC
Q 008365 383 ADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVS--RAIEKGTLAEMLDPAVTDW 460 (568)
Q Consensus 383 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~--~~~~~~~~~~~l~~~~~~~ 460 (568)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||....... ..+.. .+......+
T Consensus 157 -------~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~-----~~~~~~~~~ 224 (285)
T cd05631 157 -------TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDR-----RVKEDQEEY 224 (285)
T ss_pred -------eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHH-----HhhcccccC
Confidence 1234579999999999999999999999999999999999999996543211 11111 011111233
Q ss_pred ChHHHHHHHHHHHHhhccCCCCCCC-----hHHhHhHHH
Q 008365 461 PAEAAESFSKLAIQCAELRKKDRPD-----LGTVIVPEL 494 (568)
Q Consensus 461 p~~~~~~l~~li~~Cl~~dP~~RPs-----~~~vl~~~l 494 (568)
+...+..+.+|+.+||+.+|.+||+ +.+++.+.+
T Consensus 225 ~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~ 263 (285)
T cd05631 225 SEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPI 263 (285)
T ss_pred CccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHh
Confidence 4456678999999999999999997 677775543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-42 Score=354.73 Aligned_cols=239 Identities=25% Similarity=0.331 Sum_probs=195.2
Q ss_pred eeecccCceeEEEEEe--CCccEEEEEeCcCh---hHhHHHHHHHHHHHHcCCCCceeeeccccCCC--ceEEEEecCCC
Q 008365 235 MKIGEGGYGPVYRGKL--DHTPVAIKVLRPDA---AQGKRQFQQEVEVLSSIRHPNMVLLLGACPDY--GCLVYEYMHNG 307 (568)
Q Consensus 235 ~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~--~~lV~E~~~gg 307 (568)
+.||+|+||.||++.+ +++.||||+++... ......+.+|+.+|+.++||||++++++|.+. .|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 3699999999999986 56789999997543 22334677899999999999999999888544 48999999999
Q ss_pred CHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCCcccc
Q 008365 308 SLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVT 387 (568)
Q Consensus 308 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~ 387 (568)
+|.+++...+ .+++..+..|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.....
T Consensus 81 ~L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~------ 148 (323)
T cd05571 81 ELFFHLSRER---VFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISD------ 148 (323)
T ss_pred cHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccC------
Confidence 9999887643 3789999999999999999999999 999999999999999999999999998753211
Q ss_pred ccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHH--HHHHhCccccccCccCCCCChHHH
Q 008365 388 QYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVS--RAIEKGTLAEMLDPAVTDWPAEAA 465 (568)
Q Consensus 388 ~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~--~~~~~~~~~~~l~~~~~~~p~~~~ 465 (568)
.......+||+.|+|||++.+..++.++|||||||++|||++|..||....... ..+..+ ...+|..++
T Consensus 149 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~---------~~~~p~~~~ 219 (323)
T cd05571 149 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME---------EIRFPRTLS 219 (323)
T ss_pred CCcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcC---------CCCCCCCCC
Confidence 112234679999999999999999999999999999999999999996543321 111111 113345567
Q ss_pred HHHHHHHHHhhccCCCCCC-----ChHHhHhHHH
Q 008365 466 ESFSKLAIQCAELRKKDRP-----DLGTVIVPEL 494 (568)
Q Consensus 466 ~~l~~li~~Cl~~dP~~RP-----s~~~vl~~~l 494 (568)
..+.+|+.+||..||.+|| ++.+++.|.+
T Consensus 220 ~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~ 253 (323)
T cd05571 220 PEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRF 253 (323)
T ss_pred HHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCC
Confidence 7899999999999999999 7888876544
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=367.99 Aligned_cols=238 Identities=24% Similarity=0.322 Sum_probs=199.6
Q ss_pred HhcccccceeecccCceeEEEEEe--CCccEEEEEeCcCh---hHhHHHHHHHHHHHHcCC-CCceeeeccccCC--Cce
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDA---AQGKRQFQQEVEVLSSIR-HPNMVLLLGACPD--YGC 298 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l~-HpnIv~l~g~~~~--~~~ 298 (568)
..++|.++++||+|+||.|+++.. ++..+|||+++++. .+..+....|..|+.... ||+++.++..|+. ..|
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~ 445 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF 445 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence 447899999999999999999988 45689999999874 334566788999888775 9999999999964 458
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEeccccccccc
Q 008365 299 LVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLV 378 (568)
Q Consensus 299 lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~ 378 (568)
+||||+.||++..+... ..+++..+..++.+|+.||.|||+++ |||||||.+|||||.+|++||+|||||+..
T Consensus 446 fvmey~~Ggdm~~~~~~----~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe~ 518 (694)
T KOG0694|consen 446 FVMEYVAGGDLMHHIHT----DVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKEG 518 (694)
T ss_pred EEEEecCCCcEEEEEec----ccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEeccccccccc
Confidence 99999999995433322 24899999999999999999999999 999999999999999999999999999843
Q ss_pred CCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchH--HHHHHHhCccccccCcc
Q 008365 379 PPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHH--VSRAIEKGTLAEMLDPA 456 (568)
Q Consensus 379 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~--~~~~~~~~~~~~~l~~~ 456 (568)
- .......++||||.|||||++.+..|+.++|+|||||+|||||.|..||.+.+. +...|....
T Consensus 519 m------~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~-------- 584 (694)
T KOG0694|consen 519 M------GQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDE-------- 584 (694)
T ss_pred C------CCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC--------
Confidence 1 123355789999999999999999999999999999999999999999975543 222222211
Q ss_pred CCCCChHHHHHHHHHHHHhhccCCCCCCCh
Q 008365 457 VTDWPAEAAESFSKLAIQCAELRKKDRPDL 486 (568)
Q Consensus 457 ~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~ 486 (568)
.-+|..++.+...++.+.|..+|..|--+
T Consensus 585 -~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 585 -VRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred -CCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 23577888999999999999999999876
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-42 Score=349.75 Aligned_cols=242 Identities=24% Similarity=0.337 Sum_probs=200.3
Q ss_pred cccccceeecccCceeEEEEEe--CCccEEEEEeCcChh---HhHHHHHHHHHHHHcCCCCceeeeccccCCC--ceEEE
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAA---QGKRQFQQEVEVLSSIRHPNMVLLLGACPDY--GCLVY 301 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~---~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~--~~lV~ 301 (568)
++|.+.+.||+|+||.||+|.+ +++.||||++..... .....+.+|+.+|+.++||||+++++++.+. .++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 4688999999999999999987 477999999865432 2345688999999999999999999988654 48999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCC
Q 008365 302 EYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPS 381 (568)
Q Consensus 302 E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~ 381 (568)
||+++|+|.+++...+ .+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~ 154 (291)
T cd05612 81 EYVPGGELFSYLRNSG---RFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR 154 (291)
T ss_pred eCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCC
Confidence 9999999999987654 3788899999999999999999999 999999999999999999999999999765321
Q ss_pred CCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHH--HHHHHhCccccccCccCCC
Q 008365 382 VADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHV--SRAIEKGTLAEMLDPAVTD 459 (568)
Q Consensus 382 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~--~~~~~~~~~~~~l~~~~~~ 459 (568)
....+||+.|+|||++.+..++.++|||||||++|+|++|+.||...... ...+..+. ..
T Consensus 155 ---------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~---------~~ 216 (291)
T cd05612 155 ---------TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGK---------LE 216 (291)
T ss_pred ---------cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC---------cC
Confidence 12357999999999999999999999999999999999999999755432 22222221 12
Q ss_pred CChHHHHHHHHHHHHhhccCCCCCCC-----hHHhHhHHH
Q 008365 460 WPAEAAESFSKLAIQCAELRKKDRPD-----LGTVIVPEL 494 (568)
Q Consensus 460 ~p~~~~~~l~~li~~Cl~~dP~~RPs-----~~~vl~~~l 494 (568)
+|...+..+.+|+.+||+.||.+||+ +.+++.|.+
T Consensus 217 ~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~ 256 (291)
T cd05612 217 FPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRW 256 (291)
T ss_pred CCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCcc
Confidence 34455677999999999999999995 777765443
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=327.73 Aligned_cols=247 Identities=26% Similarity=0.394 Sum_probs=209.7
Q ss_pred HhcccccceeecccCceeEEEEEe--CCccEEEEEeCcCh---hHhHHHHHHHHHHHHcCCCCceeeeccccCCCc--eE
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDA---AQGKRQFQQEVEVLSSIRHPNMVLLLGACPDYG--CL 299 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~--~l 299 (568)
..++|++.+.||+|-||.||+|+. ++-.||+||+.+.. .....++.+|++|-..|+||||+++|++|.|.. ||
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL 99 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL 99 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence 446799999999999999999987 44589999997653 233568999999999999999999999997754 99
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccC
Q 008365 300 VYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVP 379 (568)
Q Consensus 300 V~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~ 379 (568)
++||..+|+|...|...... .+++.....++.|+|.||.|+|..+ ||||||||+|+|++..+.+||+|||.+...+
T Consensus 100 ilEya~~gel~k~L~~~~~~-~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p 175 (281)
T KOG0580|consen 100 ILEYAPRGELYKDLQEGRMK-RFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP 175 (281)
T ss_pred EEEecCCchHHHHHHhcccc-cccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecC
Confidence 99999999999999854333 3788888999999999999999999 9999999999999999999999999986543
Q ss_pred CCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCch--HHHHHHHhCccccccCccC
Q 008365 380 PSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTH--HVSRAIEKGTLAEMLDPAV 457 (568)
Q Consensus 380 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~--~~~~~~~~~~~~~~l~~~~ 457 (568)
..+..+.|||..|.+||+..+..++..+|+|++|++.||+|.|.+||.... .....+.+-.
T Consensus 176 --------~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~--------- 238 (281)
T KOG0580|consen 176 --------SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVD--------- 238 (281)
T ss_pred --------CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHcc---------
Confidence 123457899999999999999999999999999999999999999996433 2222232221
Q ss_pred CCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 458 TDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 458 ~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
..+|..++....++|.+|+..+|.+|....+++.+.+
T Consensus 239 ~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpw 275 (281)
T KOG0580|consen 239 LKFPSTISGGAADLISRLLVKNPIERLALTEVMDHPW 275 (281)
T ss_pred ccCCcccChhHHHHHHHHhccCccccccHHHHhhhHH
Confidence 1345667788999999999999999999999998776
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-42 Score=362.03 Aligned_cols=243 Identities=25% Similarity=0.424 Sum_probs=209.4
Q ss_pred cccccceeecccCceeEEEEEe--CCccEEEEEeCcCh---hHhHHHHHHHHHHHHcCCCCceeeeccccCCC--ceEEE
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDA---AQGKRQFQQEVEVLSSIRHPNMVLLLGACPDY--GCLVY 301 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~--~~lV~ 301 (568)
+-|++++-||.|+-|.|.+|++ +|+.+|||++.+.. ......+.+|+-||+.|.||||+.+|+++.+. .|+|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 5688999999999999999998 78899999997652 12234578999999999999999999999664 48999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCC
Q 008365 302 EYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPS 381 (568)
Q Consensus 302 E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~ 381 (568)
||++||.|.++|..+|. +++.++.+++.||+.|+.|+|..+ |+||||||+|+|||..+.+||+|||+|.+-.++
T Consensus 92 Eyv~gGELFdylv~kG~---l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g 165 (786)
T KOG0588|consen 92 EYVPGGELFDYLVRKGP---LPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVPG 165 (786)
T ss_pred EecCCchhHHHHHhhCC---CCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccCC
Confidence 99999999999998875 889999999999999999999999 999999999999999999999999999764332
Q ss_pred CCccccccccccccccccCCChhhhhcCCC-CCcceehhHHHHHHHHHhCCCCCCCchHHHHH---HHhCccccccCccC
Q 008365 382 VADSVTQYHMTSAAGTFCYIDPEYQQTGML-TTKSDIYSFGIMLLQIITARSPMGLTHHVSRA---IEKGTLAEMLDPAV 457 (568)
Q Consensus 382 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~-s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~---~~~~~~~~~l~~~~ 457 (568)
....+.||+|.|.+||++.|..| +.++||||.|||||.||+|++||+..+ +... +..|.+
T Consensus 166 -------klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN-ir~LLlKV~~G~f-------- 229 (786)
T KOG0588|consen 166 -------KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN-IRVLLLKVQRGVF-------- 229 (786)
T ss_pred -------ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc-HHHHHHHHHcCcc--------
Confidence 23456799999999999999987 578999999999999999999998433 3322 333332
Q ss_pred CCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 458 TDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 458 ~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
++|..++.+.++|+.+|+..||..|.++.+|+.|.|
T Consensus 230 -~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~ 265 (786)
T KOG0588|consen 230 -EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPF 265 (786)
T ss_pred -cCCCcCCHHHHHHHHHHhccCccccccHHHHhhCch
Confidence 457788889999999999999999999999987665
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=359.48 Aligned_cols=235 Identities=28% Similarity=0.470 Sum_probs=196.4
Q ss_pred ceeecccCceeEEEEEeCCccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCceeeeccccCC--CceEEEEecCCCCHHH
Q 008365 234 AMKIGEGGYGPVYRGKLDHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACPD--YGCLVYEYMHNGSLED 311 (568)
Q Consensus 234 ~~~IG~G~fg~Vy~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--~~~lV~E~~~ggsL~~ 311 (568)
++-||.|+-|.||+|++.+..||||.++.- -..+|+.|++|+||||+.|.|+|.. ..|||||||..|-|..
T Consensus 129 LeWlGSGaQGAVF~Grl~netVAVKKV~el-------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~ 201 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRLHNETVAVKKVREL-------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYE 201 (904)
T ss_pred hhhhccCcccceeeeeccCceehhHHHhhh-------hhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHH
Confidence 357999999999999999999999986522 2457889999999999999999955 4589999999999999
Q ss_pred HHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCCcccccccc
Q 008365 312 RLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHM 391 (568)
Q Consensus 312 ~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~ 391 (568)
+|.... .+.......|..+||.|+.|||.+. |||||||.-||||..+..|||+|||-++..... ..+
T Consensus 202 VLka~~---~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~-------STk 268 (904)
T KOG4721|consen 202 VLKAGR---PITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDK-------STK 268 (904)
T ss_pred HHhccC---ccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhh-------hhh
Confidence 997654 3667788899999999999999999 999999999999999999999999999865321 223
Q ss_pred ccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHhCccccccCccCCCCChHHHHHHHHH
Q 008365 392 TSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAVTDWPAEAAESFSKL 471 (568)
Q Consensus 392 ~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~l~~~~~~~p~~~~~~l~~l 471 (568)
-+++||..|||||++.+.+.+.|+|||||||||||||||..||...+...-.+.-| ...| -...|..||+.|.-|
T Consensus 269 MSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVG--sNsL---~LpvPstcP~GfklL 343 (904)
T KOG4721|consen 269 MSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVG--SNSL---HLPVPSTCPDGFKLL 343 (904)
T ss_pred hhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEecc--CCcc---cccCcccCchHHHHH
Confidence 46899999999999999999999999999999999999999995443321111111 1111 123577888999999
Q ss_pred HHHhhccCCCCCCChHHhHhHH
Q 008365 472 AIQCAELRKKDRPDLGTVIVPE 493 (568)
Q Consensus 472 i~~Cl~~dP~~RPs~~~vl~~~ 493 (568)
+.+||+-.|..||+|.+|++|+
T Consensus 344 ~Kqcw~sKpRNRPSFrqil~Hl 365 (904)
T KOG4721|consen 344 LKQCWNSKPRNRPSFRQILLHL 365 (904)
T ss_pred HHHHHhcCCCCCccHHHHHHHH
Confidence 9999999999999999998754
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=352.01 Aligned_cols=249 Identities=24% Similarity=0.314 Sum_probs=202.2
Q ss_pred cccccceeecccCceeEEEEEe--CCccEEEEEeCcChh---HhHHHHHHHHHHHHcCCCCceeeeccccCCC--ceEEE
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAA---QGKRQFQQEVEVLSSIRHPNMVLLLGACPDY--GCLVY 301 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~---~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~--~~lV~ 301 (568)
++|.+.+.||+|+||.||+|.+ .+..||||++..... .....+.+|+.++..++||||++++++|.+. .||||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 3689999999999999999987 467999999975432 2345678999999999999999999988554 48999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCC
Q 008365 302 EYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPS 381 (568)
Q Consensus 302 E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~ 381 (568)
||++||+|.+++...+ .+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++....
T Consensus 81 e~~~g~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~- 153 (333)
T cd05600 81 EYVPGGDFRTLLNNLG---VLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT- 153 (333)
T ss_pred eCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc-
Confidence 9999999999987654 3788899999999999999999999 99999999999999999999999999975432
Q ss_pred CCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHH--HHHhCccccccC-ccCC
Q 008365 382 VADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSR--AIEKGTLAEMLD-PAVT 458 (568)
Q Consensus 382 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~--~~~~~~~~~~l~-~~~~ 458 (568)
.....+||+.|+|||++.+..++.++|||||||++|||++|..||........ .+... ...+. +...
T Consensus 154 --------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~ 223 (333)
T cd05600 154 --------YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYW--KETLQRPVYD 223 (333)
T ss_pred --------ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhc--cccccCCCCC
Confidence 22346799999999999999999999999999999999999999975443221 12111 11111 1111
Q ss_pred CCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 459 DWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 459 ~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
.....++..+.+|+.+||..+|..||++.+++.+.+
T Consensus 224 ~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~ 259 (333)
T cd05600 224 DPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPF 259 (333)
T ss_pred ccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcc
Confidence 111245678899999999999999999999986654
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=342.66 Aligned_cols=255 Identities=29% Similarity=0.463 Sum_probs=196.8
Q ss_pred cccccceeecccCceeEEEEEeC------------------CccEEEEEeCcCh-hHhHHHHHHHHHHHHcCCCCceeee
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKLD------------------HTPVAIKVLRPDA-AQGKRQFQQEVEVLSSIRHPNMVLL 289 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~~------------------~~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l~HpnIv~l 289 (568)
++|.+.++||+|+||.||+|.+. +..||||++.... ......|.+|+.+|..++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 56888999999999999999752 2369999997653 3345678999999999999999999
Q ss_pred ccccCC--CceEEEEecCCCCHHHHHhhcC----------------CCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCccc
Q 008365 290 LGACPD--YGCLVYEYMHNGSLEDRLLRRG----------------NTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVH 351 (568)
Q Consensus 290 ~g~~~~--~~~lV~E~~~ggsL~~~l~~~~----------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiH 351 (568)
+++|.+ ..++||||+++|+|.+++.... ....+++..++.|+.||+.||.|||+.+ |+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---ccc
Confidence 998854 4589999999999999886532 1134788889999999999999999999 999
Q ss_pred CCCCCCCeeccCCceeEecccccccccCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh--
Q 008365 352 RDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-- 429 (568)
Q Consensus 352 rDIKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-- 429 (568)
|||||+||||+.++.+||+|||+++.+..... ........++..|+|||++.++.++.++|||||||++|+|++
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~ 237 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDY----YRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLC 237 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCce----eEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHcc
Confidence 99999999999999999999999976533211 111233456889999999988899999999999999999987
Q ss_pred CCCCCCCchHHHHHHHhC-ccccccCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhH
Q 008365 430 ARSPMGLTHHVSRAIEKG-TLAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVI 490 (568)
Q Consensus 430 G~~Pf~~~~~~~~~~~~~-~~~~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl 490 (568)
+..||............. .+...........++.++..+.+|+.+||+.+|.+||++.+|+
T Consensus 238 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~ 299 (304)
T cd05096 238 KEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIH 299 (304)
T ss_pred CCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHH
Confidence 567886433211110000 0000001111122445677899999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-41 Score=321.60 Aligned_cols=252 Identities=24% Similarity=0.364 Sum_probs=199.9
Q ss_pred cccccceeecccCceeEEEEEe--CCccEEEEEeCcChhHh--HHHHHHHHHHHHcCCCCceeeeccccCCCc--eEEEE
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQG--KRQFQQEVEVLSSIRHPNMVLLLGACPDYG--CLVYE 302 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~--~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~--~lV~E 302 (568)
++|...++||+|.||.||+|++ +|+.||||.++.....+ .....+|++.|+.++|+||+.++++|.... .||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 4677888999999999999998 67799999997653321 234679999999999999999999997654 78999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCC
Q 008365 303 YMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSV 382 (568)
Q Consensus 303 ~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~ 382 (568)
||+ .+|...+.... ..++...+..++.++++||+|||.+. |+||||||.|+||+.+|.+||+|||+|+.+.+..
T Consensus 82 fm~-tdLe~vIkd~~--i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~ 155 (318)
T KOG0659|consen 82 FMP-TDLEVVIKDKN--IILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN 155 (318)
T ss_pred ecc-ccHHHHhcccc--cccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence 994 79998886654 35888999999999999999999999 9999999999999999999999999999886543
Q ss_pred CccccccccccccccccCCChhhhhc-CCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHh----Cc--------c
Q 008365 383 ADSVTQYHMTSAAGTFCYIDPEYQQT-GMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEK----GT--------L 449 (568)
Q Consensus 383 ~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~----~~--------~ 449 (568)
.. .+..+-|.+|.|||.+-| ..|+..+||||.|||+.||+-|.+-|.+..++++.-.. |. +
T Consensus 156 ~~------~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~ 229 (318)
T KOG0659|consen 156 RI------QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEM 229 (318)
T ss_pred cc------cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccc
Confidence 22 123378999999996654 56999999999999999999998888666655543210 10 0
Q ss_pred ccc---------cCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhH
Q 008365 450 AEM---------LDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVP 492 (568)
Q Consensus 450 ~~~---------l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~ 492 (568)
..+ -.+......+.++....+|+..++..||..|.++.+.+.+
T Consensus 230 ~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 230 TSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred cccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 000 0011111223456677999999999999999999998743
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=341.88 Aligned_cols=248 Identities=26% Similarity=0.408 Sum_probs=213.7
Q ss_pred HHhcccccceeecccCceeEEEEEe--CCccEEEEEeCcChhHhH---HHHHHHHHHHHcCCCCceeeeccccCCC--ce
Q 008365 226 EATDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQGK---RQFQQEVEVLSSIRHPNMVLLLGACPDY--GC 298 (568)
Q Consensus 226 ~~~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~---~~~~~Ev~iL~~l~HpnIv~l~g~~~~~--~~ 298 (568)
+...+|++.+.||+|.||.|-++.. .|+.||||.++++...+. -.+.+|++||..|+||||+.+|.+|++. ..
T Consensus 50 nlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIv 129 (668)
T KOG0611|consen 50 NLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIV 129 (668)
T ss_pred chhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEE
Confidence 4567899999999999999999975 678999999988765544 4578999999999999999999999765 48
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEeccccccccc
Q 008365 299 LVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLV 378 (568)
Q Consensus 299 lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~ 378 (568)
|||||..+|.|.|++..++. +++.++..|+.||..|+.|+|.++ ++|||||.+|||||.|+++||+||||+.++
T Consensus 130 ivMEYaS~GeLYDYiSer~~---LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly 203 (668)
T KOG0611|consen 130 IVMEYASGGELYDYISERGS---LSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLY 203 (668)
T ss_pred EEEEecCCccHHHHHHHhcc---ccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhh
Confidence 89999999999999998874 899999999999999999999999 999999999999999999999999999877
Q ss_pred CCCCCccccccccccccccccCCChhhhhcCCC-CCcceehhHHHHHHHHHhCCCCCCCchH--HHHHHHhCccccccCc
Q 008365 379 PPSVADSVTQYHMTSAAGTFCYIDPEYQQTGML-TTKSDIYSFGIMLLQIITARSPMGLTHH--VSRAIEKGTLAEMLDP 455 (568)
Q Consensus 379 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~-s~ksDvwSlGvil~elltG~~Pf~~~~~--~~~~~~~~~~~~~l~~ 455 (568)
... ....++||+|-|.+||++.+.+| ++.+|.|||||+||.|+.|..||++.++ +..+|..|.+.+.-
T Consensus 204 ~~~-------kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~-- 274 (668)
T KOG0611|consen 204 ADK-------KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPE-- 274 (668)
T ss_pred ccc-------cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCC--
Confidence 432 24578999999999999999887 5789999999999999999999987654 44556666554321
Q ss_pred cCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHHHH
Q 008365 456 AVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPELNR 496 (568)
Q Consensus 456 ~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l~~ 496 (568)
.|....-||.+||-.+|..|.++.+|-.|+|.-
T Consensus 275 --------~PSdA~gLIRwmLmVNP~RRATieDiAsHWWvN 307 (668)
T KOG0611|consen 275 --------TPSDASGLIRWMLMVNPERRATIEDIASHWWVN 307 (668)
T ss_pred --------CCchHHHHHHHHHhcCcccchhHHHHhhhheee
Confidence 123356799999999999999999998877744
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=345.23 Aligned_cols=255 Identities=23% Similarity=0.360 Sum_probs=200.8
Q ss_pred HhcccccceeecccCceeEEEEEe--CCccEEEEEeCcChhH--------------hHHHHHHHHHHHHcCCCCceeeec
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQ--------------GKRQFQQEVEVLSSIRHPNMVLLL 290 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~--------------~~~~~~~Ev~iL~~l~HpnIv~l~ 290 (568)
..++|++.+.||+|.||.|-+|++ +++.||||++.+.... ..+.+.+|+.||++|+|||||+|+
T Consensus 95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li 174 (576)
T KOG0585|consen 95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI 174 (576)
T ss_pred ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence 457899999999999999999987 6789999999653211 134678999999999999999999
Q ss_pred cccCC----CceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCce
Q 008365 291 GACPD----YGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYV 366 (568)
Q Consensus 291 g~~~~----~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~ 366 (568)
.+..+ ..|||+|||..|.+... ....+.++..++++|+.+++.||+|||.+| ||||||||+|+||+.+|+
T Consensus 175 EvLDDP~s~~~YlVley~s~G~v~w~---p~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~g~ 248 (576)
T KOG0585|consen 175 EVLDDPESDKLYLVLEYCSKGEVKWC---PPDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSDGT 248 (576)
T ss_pred EeecCcccCceEEEEEeccCCccccC---CCCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCCCc
Confidence 88754 45999999999887542 122233889999999999999999999999 999999999999999999
Q ss_pred eEecccccccccCCCCCccccccccccccccccCCChhhhhcCC----CCCcceehhHHHHHHHHHhCCCCCCCchHHHH
Q 008365 367 SKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGM----LTTKSDIYSFGIMLLQIITARSPMGLTHHVSR 442 (568)
Q Consensus 367 vKL~DFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~----~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~ 442 (568)
|||+|||.+..++.... ..........+|||.|+|||...++. .+.+.||||+||+||-|+.|+.||.....+.-
T Consensus 249 VKIsDFGVs~~~~~~~~-~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l 327 (576)
T KOG0585|consen 249 VKISDFGVSNEFPQGSD-EGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELEL 327 (576)
T ss_pred EEeeccceeeecccCCc-cccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHH
Confidence 99999999987654422 22223344589999999999776632 46788999999999999999999964433221
Q ss_pred HHHhCccccccCccCC-CCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 443 AIEKGTLAEMLDPAVT-DWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 443 ~~~~~~~~~~l~~~~~-~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
. .++++..+. .-.+++.+.+.+||.++|.+||..|.++.+|..|.+
T Consensus 328 ~------~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpw 374 (576)
T KOG0585|consen 328 F------DKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPW 374 (576)
T ss_pred H------HHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecce
Confidence 1 111221111 112356788999999999999999999999977665
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-41 Score=349.28 Aligned_cols=248 Identities=24% Similarity=0.383 Sum_probs=209.1
Q ss_pred cccccceeecccCceeEEEEEe--CCccEEEEEeCcChh--HhHHHHHHHHHHHHcCCCCceeeeccccCCC---ceEEE
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAA--QGKRQFQQEVEVLSSIRHPNMVLLLGACPDY---GCLVY 301 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~--~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~---~~lV~ 301 (568)
++|.++++||+|+||.++++++ +.+.||+|.+..... ..+....+|+.+++++.|||||.+++.|.+. .||||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 5789999999999999998765 567899999876532 2234578999999999999999999999654 37999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCC
Q 008365 302 EYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPS 381 (568)
Q Consensus 302 E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~ 381 (568)
+||+||+|.+.+.+.. ...++++.++.|+.|++.||.|||+++ |+|||||+.|||++.++.|||+|||+|+.+.+.
T Consensus 84 ~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred eecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 9999999999998765 335899999999999999999999998 999999999999999999999999999988654
Q ss_pred CCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHhCccccccCccCCCCC
Q 008365 382 VADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAVTDWP 461 (568)
Q Consensus 382 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~l~~~~~~~p 461 (568)
. ....+.+||+.||.||++.+.+|+.|+|||||||++|||++-+++|...+...-.. +++.......|
T Consensus 160 ~------~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~------ki~~~~~~Plp 227 (426)
T KOG0589|consen 160 D------SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELIL------KINRGLYSPLP 227 (426)
T ss_pred h------hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHH------HHhhccCCCCC
Confidence 3 12356789999999999999999999999999999999999999997655422111 11111233456
Q ss_pred hHHHHHHHHHHHHhhccCCCCCCChHHhHhH
Q 008365 462 AEAAESFSKLAIQCAELRKKDRPDLGTVIVP 492 (568)
Q Consensus 462 ~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~ 492 (568)
...+.++..+|..|+..+|..||++.+++..
T Consensus 228 ~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 228 SMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred ccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 7778889999999999999999999999865
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-41 Score=352.74 Aligned_cols=256 Identities=22% Similarity=0.280 Sum_probs=199.2
Q ss_pred cccccceeecccCceeEEEEEe--CCccEEEEEeCcCh---hHhHHHHHHHHHHHHcCCCCceeeeccccCCC--ceEEE
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDA---AQGKRQFQQEVEVLSSIRHPNMVLLLGACPDY--GCLVY 301 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~--~~lV~ 301 (568)
++|++.+.||+|+||.||+|++ .++.||||++.... ......+.+|+.+|..++||||++++++|.+. .+|||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 4689999999999999999987 56799999997542 22334578899999999999999999988554 48999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCC
Q 008365 302 EYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPS 381 (568)
Q Consensus 302 E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~ 381 (568)
|||+||+|.+++...+ .+++..+..|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+...
T Consensus 81 E~~~~g~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 154 (364)
T cd05599 81 EYLPGGDMMTLLMKKD---TFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS 154 (364)
T ss_pred CCCCCcHHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence 9999999999987654 3889999999999999999999999 999999999999999999999999999765321
Q ss_pred CCcccc--------------------------------ccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh
Q 008365 382 VADSVT--------------------------------QYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT 429 (568)
Q Consensus 382 ~~~~~~--------------------------------~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt 429 (568)
...... .......+||+.|+|||++.+..++.++|||||||++|+|++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~ 234 (364)
T cd05599 155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV 234 (364)
T ss_pred ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc
Confidence 110000 001123579999999999999999999999999999999999
Q ss_pred CCCCCCCchHHHHHHHhCccccccCccCCCCChHHHHHHHHHHHHhhccCCCCCCC---hHHhHhHHH
Q 008365 430 ARSPMGLTHHVSRAIEKGTLAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPD---LGTVIVPEL 494 (568)
Q Consensus 430 G~~Pf~~~~~~~~~~~~~~~~~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs---~~~vl~~~l 494 (568)
|..||..................+ .... ...+++.+.+|+.+|+. +|.+|++ +.+++.+.+
T Consensus 235 G~~Pf~~~~~~~~~~~i~~~~~~~--~~~~-~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~ 298 (364)
T cd05599 235 GYPPFCSDNPQETYRKIINWKETL--QFPD-EVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPF 298 (364)
T ss_pred CCCCCCCCCHHHHHHHHHcCCCcc--CCCC-CCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCC
Confidence 999997654432211110100101 0000 11345678899999996 8999998 888876554
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=346.40 Aligned_cols=239 Identities=27% Similarity=0.365 Sum_probs=193.7
Q ss_pred eeecccCceeEEEEEe-----CCccEEEEEeCcChh----HhHHHHHHHHHHHHcCCCCceeeeccccCCC--ceEEEEe
Q 008365 235 MKIGEGGYGPVYRGKL-----DHTPVAIKVLRPDAA----QGKRQFQQEVEVLSSIRHPNMVLLLGACPDY--GCLVYEY 303 (568)
Q Consensus 235 ~~IG~G~fg~Vy~~~~-----~~~~vAvK~l~~~~~----~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~--~~lV~E~ 303 (568)
+.||+|+||.||+++. .++.||||+++.... .....+.+|+.+|+.++||||++++++|.+. .++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5799999999999875 467899999875422 2234577899999999999999999988554 4899999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCC
Q 008365 304 MHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVA 383 (568)
Q Consensus 304 ~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~ 383 (568)
+++|+|.+++...+ .+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++......
T Consensus 82 ~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 154 (323)
T cd05584 82 LSGGELFMHLEREG---IFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG- 154 (323)
T ss_pred CCCchHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCC-
Confidence 99999999987654 3778888889999999999999999 9999999999999999999999999987432211
Q ss_pred ccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHH--HHHhCccccccCccCCCCC
Q 008365 384 DSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSR--AIEKGTLAEMLDPAVTDWP 461 (568)
Q Consensus 384 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~--~~~~~~~~~~l~~~~~~~p 461 (568)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||...+.... .+..+. ...|
T Consensus 155 -----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~---------~~~~ 220 (323)
T cd05584 155 -----TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGK---------LNLP 220 (323)
T ss_pred -----CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC---------CCCC
Confidence 112345799999999999988899999999999999999999999976544221 111111 1334
Q ss_pred hHHHHHHHHHHHHhhccCCCCCC-----ChHHhHhHHH
Q 008365 462 AEAAESFSKLAIQCAELRKKDRP-----DLGTVIVPEL 494 (568)
Q Consensus 462 ~~~~~~l~~li~~Cl~~dP~~RP-----s~~~vl~~~l 494 (568)
..++..+.+|+.+||+.+|.+|| ++.+++.+.+
T Consensus 221 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~ 258 (323)
T cd05584 221 PYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPF 258 (323)
T ss_pred CCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCC
Confidence 55667899999999999999999 7777765443
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=345.35 Aligned_cols=256 Identities=23% Similarity=0.339 Sum_probs=202.4
Q ss_pred hcccccceeecccCceeEEEEEe--CCccEEEEEeCcCh-hHhHHHHHHHHHHHHcCCCCceeeeccccCC--CceEEEE
Q 008365 228 TDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDA-AQGKRQFQQEVEVLSSIRHPNMVLLLGACPD--YGCLVYE 302 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--~~~lV~E 302 (568)
.++|++.+.||+|+||.||++.+ .+..||+|++.... ......+.+|+++|+.++||||++++++|.+ ..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 36799999999999999999988 46789999987642 2335678999999999999999999998854 3489999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCC
Q 008365 303 YMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSV 382 (568)
Q Consensus 303 ~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~ 382 (568)
|+++|+|.+++.... .+++..+..++.|++.||.|||+.+ +|+||||||+|||++.++.+||+|||++..+...
T Consensus 84 ~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 157 (331)
T cd06649 84 HMDGGSLDQVLKEAK---RIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 157 (331)
T ss_pred cCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc-
Confidence 999999999987654 3788999999999999999999863 2999999999999999999999999999765322
Q ss_pred CccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHH--HHHhCcc-----------
Q 008365 383 ADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSR--AIEKGTL----------- 449 (568)
Q Consensus 383 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~--~~~~~~~----------- 449 (568)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||........ .+.....
T Consensus 158 -------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (331)
T cd06649 158 -------MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSIS 230 (331)
T ss_pred -------ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccC
Confidence 12345799999999999999999999999999999999999999964432111 1100000
Q ss_pred ---------------------------ccccCccCCCC-ChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHHHH
Q 008365 450 ---------------------------AEMLDPAVTDW-PAEAAESFSKLAIQCAELRKKDRPDLGTVIVPELNR 496 (568)
Q Consensus 450 ---------------------------~~~l~~~~~~~-p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l~~ 496 (568)
..+........ ....+..+.+|+.+||+.+|.+||++.+++.+.+-.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~ 305 (331)
T cd06649 231 PRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIK 305 (331)
T ss_pred cccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHh
Confidence 00000000111 113466799999999999999999999999877643
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=341.79 Aligned_cols=263 Identities=25% Similarity=0.435 Sum_probs=212.0
Q ss_pred HHHHHhcccccceeecccCceeEEEEEe--CCccEEEEEeCcChhHh-------HHHHHHHHHHHHcCCCCceeeecccc
Q 008365 223 EIEEATDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQG-------KRQFQQEVEVLSSIRHPNMVLLLGAC 293 (568)
Q Consensus 223 ei~~~~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~-------~~~~~~Ev~iL~~l~HpnIv~l~g~~ 293 (568)
+...+.++|-.+++||+|||+.||++.+ .++.||||+...+..+. .+...+|..|.+.|+||.||++|++|
T Consensus 457 DHptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyf 536 (775)
T KOG1151|consen 457 DHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYF 536 (775)
T ss_pred cCcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeee
Confidence 3445778899999999999999999987 56799999975443221 22345899999999999999999998
Q ss_pred ---CCCceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccC---Ccee
Q 008365 294 ---PDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDR---NYVS 367 (568)
Q Consensus 294 ---~~~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~---~~~v 367 (568)
.+..|-|+|||+|.+|+.+|..+. .++++++..|+.||+.||.||.... .||||-||||.||||-+ -|.+
T Consensus 537 slDtdsFCTVLEYceGNDLDFYLKQhk---lmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeI 612 (775)
T KOG1151|consen 537 SLDTDSFCTVLEYCEGNDLDFYLKQHK---LMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEI 612 (775)
T ss_pred eeccccceeeeeecCCCchhHHHHhhh---hhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCccccee
Confidence 455699999999999999997654 4899999999999999999999986 58999999999999943 5899
Q ss_pred EecccccccccCCCCCccccccccc-cccccccCCChhhhhcC----CCCCcceehhHHHHHHHHHhCCCCCCCchHHHH
Q 008365 368 KISDVGLARLVPPSVADSVTQYHMT-SAAGTFCYIDPEYQQTG----MLTTKSDIYSFGIMLLQIITARSPMGLTHHVSR 442 (568)
Q Consensus 368 KL~DFGla~~~~~~~~~~~~~~~~~-~~~GT~~Y~APE~~~~~----~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~ 442 (568)
||.||||++.+.....+.......+ ..+||.||++||++.-+ .++.++||||+|||||++|.|+.||+.......
T Consensus 613 KITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQd 692 (775)
T KOG1151|consen 613 KITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQD 692 (775)
T ss_pred EeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHH
Confidence 9999999999977665544444443 57999999999976543 478999999999999999999999987766555
Q ss_pred HHHhCccccccCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhH
Q 008365 443 AIEKGTLAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVI 490 (568)
Q Consensus 443 ~~~~~~~~~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl 490 (568)
.+....+...-.-.++.. +.++.+...||.+||+...++|.+.-++.
T Consensus 693 ILqeNTIlkAtEVqFP~K-PvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 693 ILQENTILKATEVQFPPK-PVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred HHhhhchhcceeccCCCC-CccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 555555443322222222 34566788999999999999999877664
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=362.66 Aligned_cols=254 Identities=22% Similarity=0.297 Sum_probs=204.6
Q ss_pred HhcccccceeecccCceeEEEEEeC-C-ccEEEEEeCcChhHhHHHHHHHHHHHHcCC-CCceeeeccccC-----CC--
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKLD-H-TPVAIKVLRPDAAQGKRQFQQEVEVLSSIR-HPNMVLLLGACP-----DY-- 296 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~~-~-~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~-HpnIv~l~g~~~-----~~-- 296 (568)
...++++.+.|.+|||+.||+|.+. + ..||+|.+........+.+.+||++|+.|. |+|||.+++.+. +.
T Consensus 35 g~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~ 114 (738)
T KOG1989|consen 35 GSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV 114 (738)
T ss_pred CCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence 3457888999999999999999983 3 799999998888888899999999999997 999999999431 11
Q ss_pred --ceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEeccccc
Q 008365 297 --GCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGL 374 (568)
Q Consensus 297 --~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGl 374 (568)
.+|.||||.||.|-|++..+.... |++.++++|+.|+++|+.+||... .||||||||-+||||+.+|..||||||.
T Consensus 115 ~EvllLmEyC~gg~Lvd~mn~Rlq~~-lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDFGS 192 (738)
T KOG1989|consen 115 WEVLLLMEYCKGGSLVDFMNTRLQTR-LTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDFGS 192 (738)
T ss_pred eEEEeehhhccCCcHHHHHHHHHhcc-CChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCcccc
Confidence 268999999999999998765554 999999999999999999999997 5899999999999999999999999999
Q ss_pred ccccCCCCCcc--ccc-cccccccccccCCChhhh---hcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHhCc
Q 008365 375 ARLVPPSVADS--VTQ-YHMTSAAGTFCYIDPEYQ---QTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGT 448 (568)
Q Consensus 375 a~~~~~~~~~~--~~~-~~~~~~~GT~~Y~APE~~---~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~ 448 (568)
|...-...... ... .......-|+.|.|||++ .+..++.|+|||+|||+||-|+....||+.. .
T Consensus 193 att~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~s----------g 262 (738)
T KOG1989|consen 193 ATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEES----------G 262 (738)
T ss_pred cccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcC----------c
Confidence 86432221100 000 000123469999999965 5778999999999999999999999999533 2
Q ss_pred cccccCccCCC-CChHHHHHHHHHHHHhhccCCCCCCChHHhHhH
Q 008365 449 LAEMLDPAVTD-WPAEAAESFSKLAIQCAELRKKDRPDLGTVIVP 492 (568)
Q Consensus 449 ~~~~l~~~~~~-~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~ 492 (568)
...+++....- -.+..+..|..||..||+.+|.+||++.+|+..
T Consensus 263 ~laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~ 307 (738)
T KOG1989|consen 263 KLAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEE 307 (738)
T ss_pred ceeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHH
Confidence 23344333221 124678899999999999999999999998743
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-41 Score=347.77 Aligned_cols=248 Identities=25% Similarity=0.321 Sum_probs=194.4
Q ss_pred ccccceeecccCceeEEEEEe-----CCccEEEEEeCcCh----hHhHHHHHHHHHHHHcCC-CCceeeeccccCCC--c
Q 008365 230 KFSEAMKIGEGGYGPVYRGKL-----DHTPVAIKVLRPDA----AQGKRQFQQEVEVLSSIR-HPNMVLLLGACPDY--G 297 (568)
Q Consensus 230 ~y~~~~~IG~G~fg~Vy~~~~-----~~~~vAvK~l~~~~----~~~~~~~~~Ev~iL~~l~-HpnIv~l~g~~~~~--~ 297 (568)
+|++.+.||+|+||.||+++. .+..||||++.+.. ......+..|+.+|..++ ||||+++++++.+. .
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 488999999999999999875 46789999986532 222345788999999995 99999999888554 4
Q ss_pred eEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccc
Q 008365 298 CLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARL 377 (568)
Q Consensus 298 ~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~ 377 (568)
++||||+++|+|.+++.... .+++..+..|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~ 154 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRD---NFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKE 154 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence 89999999999999987654 3788999999999999999999999 99999999999999999999999999976
Q ss_pred cCCCCCccccccccccccccccCCChhhhhcC-CCCCcceehhHHHHHHHHHhCCCCCCCchH--HHHHHHhCccccccC
Q 008365 378 VPPSVADSVTQYHMTSAAGTFCYIDPEYQQTG-MLTTKSDIYSFGIMLLQIITARSPMGLTHH--VSRAIEKGTLAEMLD 454 (568)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDvwSlGvil~elltG~~Pf~~~~~--~~~~~~~~~~~~~l~ 454 (568)
+..... ......+||+.|+|||++.+. .++.++|||||||++|+|++|..||..... ....+..... ..+
T Consensus 155 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~--~~~ 227 (332)
T cd05614 155 FLSEEK-----ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRIL--KCD 227 (332)
T ss_pred ccccCC-----CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHh--cCC
Confidence 532211 112346799999999998765 478999999999999999999999953211 0111111000 011
Q ss_pred ccCCCCChHHHHHHHHHHHHhhccCCCCCC-----ChHHhHhHH
Q 008365 455 PAVTDWPAEAAESFSKLAIQCAELRKKDRP-----DLGTVIVPE 493 (568)
Q Consensus 455 ~~~~~~p~~~~~~l~~li~~Cl~~dP~~RP-----s~~~vl~~~ 493 (568)
..++..++..+.+++.+||+.+|.+|| ++.+++.+.
T Consensus 228 ---~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~ 268 (332)
T cd05614 228 ---PPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHP 268 (332)
T ss_pred ---CCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCC
Confidence 123445667789999999999999999 566776543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=345.44 Aligned_cols=235 Identities=24% Similarity=0.330 Sum_probs=188.8
Q ss_pred cccceeecccCceeEEEEEe--CCccEEEEEeCcCh---hHhHHHHHHHHHHH---HcCCCCceeeeccccCC--CceEE
Q 008365 231 FSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDA---AQGKRQFQQEVEVL---SSIRHPNMVLLLGACPD--YGCLV 300 (568)
Q Consensus 231 y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~Ev~iL---~~l~HpnIv~l~g~~~~--~~~lV 300 (568)
|.+.+.||+|+||.||+|.+ +++.||||+++... ......+.+|+.++ +.++||||+++++++.+ ..|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 67889999999999999987 56789999997543 12234566676655 56789999999998854 34899
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCC
Q 008365 301 YEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPP 380 (568)
Q Consensus 301 ~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~ 380 (568)
|||++||+|..++... .+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++....
T Consensus 81 ~E~~~~~~L~~~~~~~----~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05589 81 MEYAAGGDLMMHIHTD----VFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG 153 (324)
T ss_pred EcCCCCCcHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence 9999999998877542 3899999999999999999999999 99999999999999999999999999874321
Q ss_pred CCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHH--HHHHhCccccccCccCC
Q 008365 381 SVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVS--RAIEKGTLAEMLDPAVT 458 (568)
Q Consensus 381 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~--~~~~~~~~~~~l~~~~~ 458 (568)
. .......+||+.|+|||++.+..++.++|||||||++|+|++|+.||....... ..+..+. .
T Consensus 154 ~------~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~---------~ 218 (324)
T cd05589 154 F------GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDE---------V 218 (324)
T ss_pred C------CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC---------C
Confidence 1 112235679999999999999999999999999999999999999997544322 2221111 1
Q ss_pred CCChHHHHHHHHHHHHhhccCCCCCCChH
Q 008365 459 DWPAEAAESFSKLAIQCAELRKKDRPDLG 487 (568)
Q Consensus 459 ~~p~~~~~~l~~li~~Cl~~dP~~RPs~~ 487 (568)
.+|..++..+.+++.+||..+|.+||+..
T Consensus 219 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~ 247 (324)
T cd05589 219 RYPRFLSREAISIMRRLLRRNPERRLGSG 247 (324)
T ss_pred CCCCCCCHHHHHHHHHHhhcCHhHcCCCC
Confidence 23445667789999999999999999543
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=346.82 Aligned_cols=238 Identities=26% Similarity=0.333 Sum_probs=193.7
Q ss_pred eeecccCceeEEEEEe--CCccEEEEEeCcCh---hHhHHHHHHHHHHHHcCCCCceeeeccccCC--CceEEEEecCCC
Q 008365 235 MKIGEGGYGPVYRGKL--DHTPVAIKVLRPDA---AQGKRQFQQEVEVLSSIRHPNMVLLLGACPD--YGCLVYEYMHNG 307 (568)
Q Consensus 235 ~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--~~~lV~E~~~gg 307 (568)
+.||+|+||.||++.+ ++..||+|++.... ......+.+|+.+++.++||||++++++|.+ ..|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 3699999999999986 57799999997542 2234457789999999999999999998854 348999999999
Q ss_pred CHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCCcccc
Q 008365 308 SLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVT 387 (568)
Q Consensus 308 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~ 387 (568)
+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++......
T Consensus 81 ~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~----- 149 (323)
T cd05595 81 ELFFHLSRER---VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG----- 149 (323)
T ss_pred cHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCC-----
Confidence 9998886653 3789999999999999999999999 9999999999999999999999999987532211
Q ss_pred ccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHH--HHHHhCccccccCccCCCCChHHH
Q 008365 388 QYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVS--RAIEKGTLAEMLDPAVTDWPAEAA 465 (568)
Q Consensus 388 ~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~--~~~~~~~~~~~l~~~~~~~p~~~~ 465 (568)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||....... ..+.... ..+|..++
T Consensus 150 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~---------~~~p~~~~ 219 (323)
T cd05595 150 -ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE---------IRFPRTLS 219 (323)
T ss_pred -CccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC---------CCCCCCCC
Confidence 11234579999999999999999999999999999999999999996544322 1111111 12345567
Q ss_pred HHHHHHHHHhhccCCCCCC-----ChHHhHhHH
Q 008365 466 ESFSKLAIQCAELRKKDRP-----DLGTVIVPE 493 (568)
Q Consensus 466 ~~l~~li~~Cl~~dP~~RP-----s~~~vl~~~ 493 (568)
..+.+++.+||..+|.+|| ++.+++.+.
T Consensus 220 ~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~ 252 (323)
T cd05595 220 PEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHR 252 (323)
T ss_pred HHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCC
Confidence 7899999999999999998 777777543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=345.94 Aligned_cols=255 Identities=23% Similarity=0.305 Sum_probs=195.5
Q ss_pred ccccceeecccCceeEEEEEe--CCccEEEEEeCcC--hhHhHHHHHHHHHHHHcCCCCceeeeccccCC-------Cce
Q 008365 230 KFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPD--AAQGKRQFQQEVEVLSSIRHPNMVLLLGACPD-------YGC 298 (568)
Q Consensus 230 ~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~-------~~~ 298 (568)
+|.+.++||+|+||.||+|.+ ++..||||++... .......+.+|+.+|+.++||||+++++++.. ..|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 588999999999999999987 5679999998643 22234568899999999999999999988632 248
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEeccccccccc
Q 008365 299 LVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLV 378 (568)
Q Consensus 299 lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~ 378 (568)
+||||| +++|.+++.... .+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~-~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 81 VVFELM-ESDLHQVIKAND---DLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVA 153 (338)
T ss_pred EEEecC-CCCHHHHHHhcc---cCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccc
Confidence 999999 578988886543 3889999999999999999999999 999999999999999999999999999754
Q ss_pred CCCCCccccccccccccccccCCChhhhhc--CCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHH-------------
Q 008365 379 PPSVADSVTQYHMTSAAGTFCYIDPEYQQT--GMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRA------------- 443 (568)
Q Consensus 379 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~--~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~------------- 443 (568)
...... .......+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.........
T Consensus 154 ~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 230 (338)
T cd07859 154 FNDTPT---AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPE 230 (338)
T ss_pred ccccCc---cccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 322111 111234679999999998876 67899999999999999999999999654322110
Q ss_pred ----HHhCcc---ccccCcc----CCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 444 ----IEKGTL---AEMLDPA----VTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 444 ----~~~~~~---~~~l~~~----~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
+..... ...+... .....+.++..+.+++.+||..+|.+||++.+++.+.+
T Consensus 231 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~ 292 (338)
T cd07859 231 TISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPY 292 (338)
T ss_pred HHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCch
Confidence 000000 0000000 00011134566889999999999999999999987654
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=339.29 Aligned_cols=253 Identities=24% Similarity=0.296 Sum_probs=196.4
Q ss_pred cccccceeecccCceeEEEEEe--CCccEEEEEeCcCh--hHhHHHHHHHHHHHHcCCCCceeeeccccCCC--ceEEEE
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDA--AQGKRQFQQEVEVLSSIRHPNMVLLLGACPDY--GCLVYE 302 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~--~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~--~~lV~E 302 (568)
++|.+.+.||+|+||.||+|++ ++..||||++.... ......+.+|+.+++.++||||++++++|.+. .++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 4689999999999999999988 45689999987542 22345678999999999999999999988543 489999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCC
Q 008365 303 YMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSV 382 (568)
Q Consensus 303 ~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~ 382 (568)
|++++.+..+... . ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+....
T Consensus 81 ~~~~~~l~~~~~~-~--~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 154 (287)
T cd07848 81 YVEKNMLELLEEM-P--NGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS 154 (287)
T ss_pred cCCCCHHHHHHhc-C--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence 9988777654332 2 23888999999999999999999999 9999999999999999999999999998653321
Q ss_pred CccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHhCccc------------
Q 008365 383 ADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLA------------ 450 (568)
Q Consensus 383 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~------------ 450 (568)
. .......||+.|+|||++.+..++.++|||||||++|+|++|++||..............+.
T Consensus 155 ~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (287)
T cd07848 155 N-----ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFY 229 (287)
T ss_pred c-----ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhh
Confidence 1 11234579999999999999899999999999999999999999997544322211100000
Q ss_pred ------cccCccC-------CCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhH
Q 008365 451 ------EMLDPAV-------TDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVP 492 (568)
Q Consensus 451 ------~~l~~~~-------~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~ 492 (568)
....+.. ..+...++..+.+|+.+||+.+|.+||++.+++.|
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 230 SNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred ccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0000000 00112356779999999999999999999998754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=370.49 Aligned_cols=246 Identities=32% Similarity=0.557 Sum_probs=206.8
Q ss_pred cccccceeecccCceeEEEEEeC-------CccEEEEEeCcChhH-hHHHHHHHHHHHHcCCCCceeeeccccCC--Cce
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKLD-------HTPVAIKVLRPDAAQ-GKRQFQQEVEVLSSIRHPNMVLLLGACPD--YGC 298 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~~-------~~~vAvK~l~~~~~~-~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--~~~ 298 (568)
.+-...+.||+|.||.||+|+.. .+.||||.++..... ...+|++|+++|..|+|||||+|+|+|.+ ..|
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~ 565 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLC 565 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeE
Confidence 34456678999999999999763 246999999887655 67889999999999999999999999954 459
Q ss_pred EEEEecCCCCHHHHHhhcCC-----------CCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCcee
Q 008365 299 LVYEYMHNGSLEDRLLRRGN-----------TPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVS 367 (568)
Q Consensus 299 lV~E~~~ggsL~~~l~~~~~-----------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~v 367 (568)
+|+|||..|||.++|...+. .+.++..+.+.||.|||.|+.||-+++ +|||||-..|+||.++..|
T Consensus 566 MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~V 642 (774)
T KOG1026|consen 566 MVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLVV 642 (774)
T ss_pred EEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceEE
Confidence 99999999999999976532 223788899999999999999999999 9999999999999999999
Q ss_pred EecccccccccCCCCCccccccccc-cccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh-CCCCCCCch--HHHHH
Q 008365 368 KISDVGLARLVPPSVADSVTQYHMT-SAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPMGLTH--HVSRA 443 (568)
Q Consensus 368 KL~DFGla~~~~~~~~~~~~~~~~~-~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~--~~~~~ 443 (568)
||+||||++.+-.. ..++.. ...-..+||+||.+..+.|+.+||||||||+|||+++ |+.||.... .+-..
T Consensus 643 KIsDfGLsRdiYss-----DYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~ 717 (774)
T KOG1026|consen 643 KISDFGLSRDIYSS-----DYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIEC 717 (774)
T ss_pred Eecccccchhhhhh-----hhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHH
Confidence 99999999865322 222222 3445689999999999999999999999999999999 999996543 33344
Q ss_pred HHhCccccccCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhH
Q 008365 444 IEKGTLAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVI 490 (568)
Q Consensus 444 ~~~~~~~~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl 490 (568)
+..|.+ ..+|.+||.++..||..||+.+|.+||++.+|=
T Consensus 718 i~~g~l--------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~ 756 (774)
T KOG1026|consen 718 IRAGQL--------LSCPENCPTEVYSLMLECWNENPKRRPSFKEIH 756 (774)
T ss_pred HHcCCc--------ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence 444433 467889999999999999999999999999984
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-42 Score=349.12 Aligned_cols=247 Identities=25% Similarity=0.382 Sum_probs=204.8
Q ss_pred cccccceeecccCceeEEEEEe--CCccEEEEEeCcChh-HhHHHHHHHHHHHHcCCCCceeeeccccCC--CceEEEEe
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAA-QGKRQFQQEVEVLSSIRHPNMVLLLGACPD--YGCLVYEY 303 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~-~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--~~~lV~E~ 303 (568)
..|..+..||+|+||.||+|.+ .++.||||++..... .....+++|+.+|..++++||.++||.+.. ..+++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 3466678999999999999998 466899999987643 345778999999999999999999998744 44889999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCC
Q 008365 304 MHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVA 383 (568)
Q Consensus 304 ~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~ 383 (568)
|.||++.+.|.... .+.+..+..|+.+++.||.|||..+ .||||||+.||||..+|.|||+|||++-.+...
T Consensus 93 ~~gGsv~~lL~~~~---~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~-- 164 (467)
T KOG0201|consen 93 CGGGSVLDLLKSGN---ILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNT-- 164 (467)
T ss_pred hcCcchhhhhccCC---CCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeech--
Confidence 99999999886554 2477778889999999999999999 999999999999999999999999999765432
Q ss_pred ccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHhCccccccCccC-CCCCh
Q 008365 384 DSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAV-TDWPA 462 (568)
Q Consensus 384 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~l~~~~-~~~p~ 462 (568)
..+..+++|||.|||||++....|+.++||||||++.+||++|.+||...+.+. ....+.... +....
T Consensus 165 ----~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmr-------vlflIpk~~PP~L~~ 233 (467)
T KOG0201|consen 165 ----VKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMR-------VLFLIPKSAPPRLDG 233 (467)
T ss_pred ----hhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcce-------EEEeccCCCCCcccc
Confidence 233467899999999999998899999999999999999999999997666521 112222111 12223
Q ss_pred HHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 463 EAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 463 ~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
.+++.|.+|+..||..+|+.||++.+++.|.+
T Consensus 234 ~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~F 265 (467)
T KOG0201|consen 234 DFSPPFKEFVEACLDKNPEFRPSAKELLKHKF 265 (467)
T ss_pred ccCHHHHHHHHHHhhcCcccCcCHHHHhhhHH
Confidence 66778999999999999999999999987654
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-41 Score=349.66 Aligned_cols=256 Identities=25% Similarity=0.319 Sum_probs=202.5
Q ss_pred cccccceeecccCceeEEEEEeC--CccEEEEEeCcChh---HhHHHHHHHHHHHHcCCCCceeeeccccCCC--ceEEE
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKLD--HTPVAIKVLRPDAA---QGKRQFQQEVEVLSSIRHPNMVLLLGACPDY--GCLVY 301 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~~--~~~vAvK~l~~~~~---~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~--~~lV~ 301 (568)
++|.+.+.||+|+||.||+|.+. +..||||+++.... .....+..|+.++..++||||++++++|.+. .++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 46899999999999999999984 78999999975432 2345688999999999999999999988554 48999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCC
Q 008365 302 EYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPS 381 (568)
Q Consensus 302 E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~ 381 (568)
||+++|+|.+++...+ .+++..+..|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+...
T Consensus 81 e~~~~~~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 154 (350)
T cd05573 81 EYMPGGDLMNLLIRKD---VFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKA 154 (350)
T ss_pred cCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence 9999999999997763 3888999999999999999999999 999999999999999999999999999866433
Q ss_pred CCc-----------------------cccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCch
Q 008365 382 VAD-----------------------SVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTH 438 (568)
Q Consensus 382 ~~~-----------------------~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~ 438 (568)
... ...........||+.|+|||++.+..++.++|||||||++|+|++|+.||....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~ 234 (350)
T cd05573 155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT 234 (350)
T ss_pred CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence 200 000112234679999999999999999999999999999999999999997655
Q ss_pred HHHHHHHhCccccccCccCCCCChHHHHHHHHHHHHhhccCCCCCCC-hHHhHhHHH
Q 008365 439 HVSRAIEKGTLAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPD-LGTVIVPEL 494 (568)
Q Consensus 439 ~~~~~~~~~~~~~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs-~~~vl~~~l 494 (568)
..............+ ..+. ...++..+.+|+..|+. +|.+||+ +.+++.+.+
T Consensus 235 ~~~~~~~i~~~~~~~--~~p~-~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~ 287 (350)
T cd05573 235 LQETYNKIINWKESL--RFPP-DPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPF 287 (350)
T ss_pred HHHHHHHHhccCCcc--cCCC-CCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCC
Confidence 322211111100111 0111 11246779999999997 9999999 999986644
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=350.95 Aligned_cols=256 Identities=22% Similarity=0.254 Sum_probs=196.0
Q ss_pred cccccceeecccCceeEEEEEe--CCccEEEEEeCcCh---hHhHHHHHHHHHHHHcCCCCceeeeccccCCC--ceEEE
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDA---AQGKRQFQQEVEVLSSIRHPNMVLLLGACPDY--GCLVY 301 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~--~~lV~ 301 (568)
++|.+++.||.|+||.||++.+ +++.||||++.... ......+.+|+.+++.++|||||+++++|.+. .||||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 4688999999999999999987 66789999986542 22345678999999999999999999998654 48999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCC
Q 008365 302 EYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPS 381 (568)
Q Consensus 302 E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~ 381 (568)
||++||+|.+++...+ .+++..+..++.|++.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~~~~---~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~ 154 (377)
T cd05629 81 EFLPGGDLMTMLIKYD---TFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ 154 (377)
T ss_pred eCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence 9999999999987643 3788889999999999999999999 999999999999999999999999999643211
Q ss_pred CCcc----------cc-------------------------------ccccccccccccCCChhhhhcCCCCCcceehhH
Q 008365 382 VADS----------VT-------------------------------QYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSF 420 (568)
Q Consensus 382 ~~~~----------~~-------------------------------~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSl 420 (568)
.... .. .......+||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 234 (377)
T cd05629 155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL 234 (377)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence 0000 00 000113579999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCchHHHHHHHhCccccccCccCCCCChHHHHHHHHHHHHhhccCCCCC---CChHHhHhHHH
Q 008365 421 GIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDR---PDLGTVIVPEL 494 (568)
Q Consensus 421 Gvil~elltG~~Pf~~~~~~~~~~~~~~~~~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~R---Ps~~~vl~~~l 494 (568)
||++|||++|..||..................+ .+++ ...++..+.+|+.+|+. +|.+| |++.+++.+.+
T Consensus 235 Gvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~--~~p~-~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~ 307 (377)
T cd05629 235 GAIMFECLIGWPPFCSENSHETYRKIINWRETL--YFPD-DIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPF 307 (377)
T ss_pred chhhhhhhcCCCCCCCCCHHHHHHHHHccCCcc--CCCC-CCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCC
Confidence 999999999999996544322111110100001 0111 11345678999999997 67665 59999887654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-41 Score=349.99 Aligned_cols=242 Identities=26% Similarity=0.344 Sum_probs=199.2
Q ss_pred hcccccceeecccCceeEEEEEeCC---ccEEEEEeCcCh---hHhHHHHHHHHHHHHcCCCCceeeeccccCCC--ceE
Q 008365 228 TDKFSEAMKIGEGGYGPVYRGKLDH---TPVAIKVLRPDA---AQGKRQFQQEVEVLSSIRHPNMVLLLGACPDY--GCL 299 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~~~~~~---~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~--~~l 299 (568)
.++|.+.+.||+|+||.||+|.+.+ ..||||++.... ......+.+|+.+++.++|||||+++++|.+. .++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 3579999999999999999998632 479999986542 22345678999999999999999999998654 489
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccC
Q 008365 300 VYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVP 379 (568)
Q Consensus 300 V~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~ 379 (568)
||||+++|+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 109 v~Ey~~~g~L~~~i~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~ 182 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRRNK---RFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVD 182 (340)
T ss_pred EEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence 999999999999987654 3788999999999999999999999 9999999999999999999999999998653
Q ss_pred CCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHH--HHHHhCccccccCccC
Q 008365 380 PSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVS--RAIEKGTLAEMLDPAV 457 (568)
Q Consensus 380 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~--~~~~~~~~~~~l~~~~ 457 (568)
.. ....+||+.|+|||++.+..++.++|||||||++|+|++|..||....... ..+..+.
T Consensus 183 ~~---------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~--------- 244 (340)
T PTZ00426 183 TR---------TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGI--------- 244 (340)
T ss_pred CC---------cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCC---------
Confidence 21 134579999999999999999999999999999999999999997654422 2222221
Q ss_pred CCCChHHHHHHHHHHHHhhccCCCCCC-----ChHHhHhHH
Q 008365 458 TDWPAEAAESFSKLAIQCAELRKKDRP-----DLGTVIVPE 493 (568)
Q Consensus 458 ~~~p~~~~~~l~~li~~Cl~~dP~~RP-----s~~~vl~~~ 493 (568)
..+|..++..+.+++.+||+.+|.+|+ ++.+++.|.
T Consensus 245 ~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp 285 (340)
T PTZ00426 245 IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHP 285 (340)
T ss_pred CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCC
Confidence 123445566789999999999999996 777776543
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=344.75 Aligned_cols=240 Identities=25% Similarity=0.320 Sum_probs=194.3
Q ss_pred eeecccCceeEEEEEe--CCccEEEEEeCcCh---hHhHHHHHHHHHHHHcCCCCceeeeccccCC--CceEEEEecCCC
Q 008365 235 MKIGEGGYGPVYRGKL--DHTPVAIKVLRPDA---AQGKRQFQQEVEVLSSIRHPNMVLLLGACPD--YGCLVYEYMHNG 307 (568)
Q Consensus 235 ~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--~~~lV~E~~~gg 307 (568)
+.||+|+||.||++.+ ++..||||++.... ......+.+|+.+|+.++||||+++++++.+ ..|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 3699999999999987 56799999997542 2234567889999999999999999988854 348999999999
Q ss_pred CHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCCcccc
Q 008365 308 SLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVT 387 (568)
Q Consensus 308 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~ 387 (568)
+|.+++.... .+++..+..|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++......
T Consensus 81 ~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~----- 149 (328)
T cd05593 81 ELFFHLSRER---VFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA----- 149 (328)
T ss_pred CHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCcc-----
Confidence 9998886543 3889999999999999999999999 9999999999999999999999999987532111
Q ss_pred ccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHhCccccccCccCCCCChHHHHH
Q 008365 388 QYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAVTDWPAEAAES 467 (568)
Q Consensus 388 ~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~l~~~~~~~p~~~~~~ 467 (568)
......+||+.|+|||++.+..++.++|||||||++|+|++|+.||......... .. +......+|..++..
T Consensus 150 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~-~~------~~~~~~~~p~~~~~~ 221 (328)
T cd05593 150 -ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF-EL------ILMEDIKFPRTLSAD 221 (328)
T ss_pred -cccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHH-HH------hccCCccCCCCCCHH
Confidence 1123457999999999999999999999999999999999999999654432111 10 001111345556778
Q ss_pred HHHHHHHhhccCCCCCC-----ChHHhHhHH
Q 008365 468 FSKLAIQCAELRKKDRP-----DLGTVIVPE 493 (568)
Q Consensus 468 l~~li~~Cl~~dP~~RP-----s~~~vl~~~ 493 (568)
+.+|+.+||..+|.+|| ++.+++.+.
T Consensus 222 ~~~li~~~L~~dP~~R~~~~~~~~~~il~h~ 252 (328)
T cd05593 222 AKSLLSGLLIKDPNKRLGGGPDDAKEIMRHS 252 (328)
T ss_pred HHHHHHHHcCCCHHHcCCCCCCCHHHHhcCC
Confidence 99999999999999997 788887653
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=363.28 Aligned_cols=250 Identities=21% Similarity=0.280 Sum_probs=203.9
Q ss_pred ccccceeecccCceeEEEEEe--C-CccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCceeeeccccCC--CceEEEEec
Q 008365 230 KFSEAMKIGEGGYGPVYRGKL--D-HTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACPD--YGCLVYEYM 304 (568)
Q Consensus 230 ~y~~~~~IG~G~fg~Vy~~~~--~-~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--~~~lV~E~~ 304 (568)
.|.+.+.||+|+||.||+|.. + +..||+|.+..........+.+|+.+|+.++|||||+++++|.. ..||||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 489999999999999999976 2 56789998766655555678899999999999999999999854 458999999
Q ss_pred CCCCHHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCC
Q 008365 305 HNGSLEDRLLRR-GNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVA 383 (568)
Q Consensus 305 ~ggsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~ 383 (568)
+||+|.++|... .....+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+.....
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 999999988643 22334888899999999999999999999 99999999999999999999999999987643221
Q ss_pred ccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHH--HHHHhCccccccCccCCCCC
Q 008365 384 DSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVS--RAIEKGTLAEMLDPAVTDWP 461 (568)
Q Consensus 384 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~--~~~~~~~~~~~l~~~~~~~p 461 (568)
.......+||+.|+|||++.+..++.++|||||||++|+|++|+.||....... ..+..+. ....|
T Consensus 225 ----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~--------~~~~~ 292 (478)
T PTZ00267 225 ----LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGK--------YDPFP 292 (478)
T ss_pred ----cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--------CCCCC
Confidence 112345679999999999999999999999999999999999999997544321 1111111 12234
Q ss_pred hHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 462 AEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 462 ~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
..++..+.+|+..||..+|..||++.+++.+.+
T Consensus 293 ~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~ 325 (478)
T PTZ00267 293 CPVSSGMKALLDPLLSKNPALRPTTQQLLHTEF 325 (478)
T ss_pred ccCCHHHHHHHHHHhccChhhCcCHHHHHhCHH
Confidence 455678999999999999999999999986544
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=352.02 Aligned_cols=256 Identities=22% Similarity=0.300 Sum_probs=196.7
Q ss_pred ccccceeecccCceeEEEEEe--CCccEEEEEeCcCh---hHhHHHHHHHHHHHHcCCCCceeeeccccCCC--ceEEEE
Q 008365 230 KFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDA---AQGKRQFQQEVEVLSSIRHPNMVLLLGACPDY--GCLVYE 302 (568)
Q Consensus 230 ~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~--~~lV~E 302 (568)
.|.+++.||+|+||.||+|.+ ++..||||++.... ......+.+|+.+|+.++|||||+++++|.+. .++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 588999999999999999987 56789999997543 22345688999999999999999999998554 489999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCC
Q 008365 303 YMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSV 382 (568)
Q Consensus 303 ~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~ 382 (568)
||+||+|.+++...+ .+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+....
T Consensus 82 ~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~ 155 (381)
T cd05626 82 YIPGGDMMSLLIRME---VFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH 155 (381)
T ss_pred cCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence 999999999987654 3788888999999999999999999 9999999999999999999999999986432110
Q ss_pred Ccc-----------------------------------------ccccccccccccccCCChhhhhcCCCCCcceehhHH
Q 008365 383 ADS-----------------------------------------VTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFG 421 (568)
Q Consensus 383 ~~~-----------------------------------------~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlG 421 (568)
... .........+||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (381)
T cd05626 156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG 235 (381)
T ss_pred ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence 000 000011245799999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCchHHHHHHHhCccccccCccCCCCChHHHHHHHHHHHH--hhccCCCCCCChHHhHhHHH
Q 008365 422 IMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAVTDWPAEAAESFSKLAIQ--CAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 422 vil~elltG~~Pf~~~~~~~~~~~~~~~~~~l~~~~~~~p~~~~~~l~~li~~--Cl~~dP~~RPs~~~vl~~~l 494 (568)
|++|||++|..||..................+ ..+. ...++.++.+|+.+ |+..++..||++.+++.|.+
T Consensus 236 ~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~--~~~~-~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~ 307 (381)
T cd05626 236 VILFEMLVGQPPFLAPTPTETQLKVINWENTL--HIPP-QVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPF 307 (381)
T ss_pred hHHHHHHhCCCCCcCCCHHHHHHHHHcccccc--CCCC-CCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcc
Confidence 99999999999997654432222111100000 1111 11345667888887 55566667999999987665
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=342.69 Aligned_cols=236 Identities=25% Similarity=0.294 Sum_probs=191.8
Q ss_pred ecccCceeEEEEEe--CCccEEEEEeCcCh---hHhHHHHHHHHHHHHcCCCCceeeeccccCC--CceEEEEecCCCCH
Q 008365 237 IGEGGYGPVYRGKL--DHTPVAIKVLRPDA---AQGKRQFQQEVEVLSSIRHPNMVLLLGACPD--YGCLVYEYMHNGSL 309 (568)
Q Consensus 237 IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--~~~lV~E~~~ggsL 309 (568)
||+|+||.||+|.+ ++..||||++.... ......+.+|+.+|..++||||++++++|.+ ..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 79999999999987 46689999986532 2334567889999999999999999998854 34899999999999
Q ss_pred HHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCCcccccc
Q 008365 310 EDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQY 389 (568)
Q Consensus 310 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~ 389 (568)
.+++...+ .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...... .
T Consensus 81 ~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~------~ 148 (312)
T cd05585 81 FHHLQREG---RFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD------D 148 (312)
T ss_pred HHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCC------C
Confidence 99987654 3788999999999999999999999 9999999999999999999999999997542211 1
Q ss_pred ccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHH--HHHHhCccccccCccCCCCChHHHHH
Q 008365 390 HMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVS--RAIEKGTLAEMLDPAVTDWPAEAAES 467 (568)
Q Consensus 390 ~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~--~~~~~~~~~~~l~~~~~~~p~~~~~~ 467 (568)
.....+||+.|+|||++.+..++.++|||||||++|+|++|+.||....... ..+..+ ...+|..++..
T Consensus 149 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~---------~~~~~~~~~~~ 219 (312)
T cd05585 149 KTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQE---------PLRFPDGFDRD 219 (312)
T ss_pred ccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcC---------CCCCCCcCCHH
Confidence 1234679999999999999999999999999999999999999996543321 111111 11344556778
Q ss_pred HHHHHHHhhccCCCCCCC---hHHhHhHH
Q 008365 468 FSKLAIQCAELRKKDRPD---LGTVIVPE 493 (568)
Q Consensus 468 l~~li~~Cl~~dP~~RPs---~~~vl~~~ 493 (568)
+.+++.+||..+|.+||+ +.+++.|.
T Consensus 220 ~~~li~~~L~~dp~~R~~~~~~~e~l~hp 248 (312)
T cd05585 220 AKDLLIGLLSRDPTRRLGYNGAQEIKNHP 248 (312)
T ss_pred HHHHHHHHcCCCHHHcCCCCCHHHHHcCC
Confidence 999999999999999985 46666543
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=363.13 Aligned_cols=256 Identities=23% Similarity=0.346 Sum_probs=207.6
Q ss_pred HHHHhcccccceeecccCceeEEEEEe--CCccEEEEEeCcCh--hHhHHHHHHHHHHHHcCCCCceeeeccccCC----
Q 008365 224 IEEATDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDA--AQGKRQFQQEVEVLSSIRHPNMVLLLGACPD---- 295 (568)
Q Consensus 224 i~~~~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~--~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~---- 295 (568)
.....++|.+.+.||+|+||.||+|++ +++.||||++.... ......+.+|+.+|..++|+||+++++.+..
T Consensus 27 ~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~ 106 (496)
T PTZ00283 27 AKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPR 106 (496)
T ss_pred ccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccccc
Confidence 344568999999999999999999986 67899999986542 3345568899999999999999998876521
Q ss_pred ------CceEEEEecCCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeE
Q 008365 296 ------YGCLVYEYMHNGSLEDRLLRRG-NTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSK 368 (568)
Q Consensus 296 ------~~~lV~E~~~ggsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vK 368 (568)
..++||||+++|+|.+++.... ....+++..+..|+.|++.||.|||+.+ |+||||||+||||+.++.+|
T Consensus 107 ~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vk 183 (496)
T PTZ00283 107 NPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVK 183 (496)
T ss_pred CcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEE
Confidence 1368999999999999987532 2345889999999999999999999999 99999999999999999999
Q ss_pred ecccccccccCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHH--HHHHh
Q 008365 369 ISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVS--RAIEK 446 (568)
Q Consensus 369 L~DFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~--~~~~~ 446 (568)
|+|||+++.+...... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..+..
T Consensus 184 L~DFGls~~~~~~~~~----~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~ 259 (496)
T PTZ00283 184 LGDFGFSKMYAATVSD----DVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLA 259 (496)
T ss_pred EEecccCeeccccccc----cccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc
Confidence 9999999876432211 12235679999999999999999999999999999999999999997544321 11111
Q ss_pred CccccccCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 447 GTLAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 447 ~~~~~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
+ .....|..++..+.+|+..||+.+|.+||++.+++.+.+
T Consensus 260 ~--------~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~ 299 (496)
T PTZ00283 260 G--------RYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPI 299 (496)
T ss_pred C--------CCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHH
Confidence 1 122235566778999999999999999999999987654
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=336.59 Aligned_cols=252 Identities=25% Similarity=0.375 Sum_probs=193.3
Q ss_pred cccccceeecccCceeEEEEEe---CCccEEEEEeCcChhH--hHHHHHHHHHHHHcC---CCCceeeeccccC------
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKL---DHTPVAIKVLRPDAAQ--GKRQFQQEVEVLSSI---RHPNMVLLLGACP------ 294 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~---~~~~vAvK~l~~~~~~--~~~~~~~Ev~iL~~l---~HpnIv~l~g~~~------ 294 (568)
++|.+.+.||+|+||.||+|.+ .+..||||+++..... ....+.+|+.+++.+ +||||++++++|.
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 3688999999999999999986 3568999998654221 223456777777665 6999999999873
Q ss_pred -CCceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccc
Q 008365 295 -DYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVG 373 (568)
Q Consensus 295 -~~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFG 373 (568)
...++||||+. ++|.+++...... .+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~-~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg 155 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEP-GVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG 155 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCC-CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEcccc
Confidence 23489999995 6999988764432 3889999999999999999999999 9999999999999999999999999
Q ss_pred cccccCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHH---HHhCc--
Q 008365 374 LARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRA---IEKGT-- 448 (568)
Q Consensus 374 la~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~---~~~~~-- 448 (568)
+++.+... .......||+.|+|||++.+..++.++|||||||++|||++|.+||......... +....
T Consensus 156 ~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~ 228 (290)
T cd07862 156 LARIYSFQ-------MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLP 228 (290)
T ss_pred ceEeccCC-------cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCC
Confidence 99765332 1223457999999999999889999999999999999999999999755432211 11000
Q ss_pred ----cc-------cccCccC----CCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhH
Q 008365 449 ----LA-------EMLDPAV----TDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVP 492 (568)
Q Consensus 449 ----~~-------~~l~~~~----~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~ 492 (568)
.. ..+.+.. ..+.+.++..+.+|+.+||+.+|.+||++.+++.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h 287 (290)
T cd07862 229 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 287 (290)
T ss_pred ChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 00 0000000 01112355678899999999999999999999854
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=350.93 Aligned_cols=256 Identities=23% Similarity=0.302 Sum_probs=197.6
Q ss_pred cccccceeecccCceeEEEEEe--CCccEEEEEeCcChh---HhHHHHHHHHHHHHcCCCCceeeeccccCCC--ceEEE
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAA---QGKRQFQQEVEVLSSIRHPNMVLLLGACPDY--GCLVY 301 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~---~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~--~~lV~ 301 (568)
++|++++.||+|+||.||++++ .++.||||++..... .....+.+|+.+|+.++||||+++++.|.+. .|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 3699999999999999999987 567899999875432 2234578999999999999999999988554 48999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCC
Q 008365 302 EYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPS 381 (568)
Q Consensus 302 E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~ 381 (568)
|||++|+|.+++...+ .+++..+..|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+|..+...
T Consensus 81 E~~~~g~L~~~i~~~~---~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~ 154 (376)
T cd05598 81 DYIPGGDMMSLLIRLG---IFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (376)
T ss_pred eCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCcccccc
Confidence 9999999999987654 3788888899999999999999999 999999999999999999999999998543210
Q ss_pred CCcc-------------------------------------ccccccccccccccCCChhhhhcCCCCCcceehhHHHHH
Q 008365 382 VADS-------------------------------------VTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIML 424 (568)
Q Consensus 382 ~~~~-------------------------------------~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil 424 (568)
.... .........+||+.|+|||++.+..++.++|||||||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 234 (376)
T cd05598 155 HDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 234 (376)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeecccee
Confidence 0000 000011245799999999999999999999999999999
Q ss_pred HHHHhCCCCCCCchHHHHHHHhCccccccCccCCCCChHHHHHHHHHHHHhhccCCCCCC---ChHHhHhHHH
Q 008365 425 LQIITARSPMGLTHHVSRAIEKGTLAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRP---DLGTVIVPEL 494 (568)
Q Consensus 425 ~elltG~~Pf~~~~~~~~~~~~~~~~~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RP---s~~~vl~~~l 494 (568)
|+|++|+.||..................+. . .....++..+.+++.+|+ .+|.+|+ ++.+++.|.+
T Consensus 235 yell~G~~Pf~~~~~~~~~~~i~~~~~~~~--~-~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~ 303 (376)
T cd05598 235 YEMLVGQPPFLADTPAETQLKVINWETTLH--I-PSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPF 303 (376)
T ss_pred eehhhCCCCCCCCCHHHHHHHHhccCcccc--C-CCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCC
Confidence 999999999976554332211111111110 0 111234566788888876 4999999 8899887655
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=344.02 Aligned_cols=233 Identities=26% Similarity=0.339 Sum_probs=191.0
Q ss_pred eeecccCceeEEEEEe-----CCccEEEEEeCcChhH--hHHHHHHHHHHHHcCCCCceeeeccccCCC--ceEEEEecC
Q 008365 235 MKIGEGGYGPVYRGKL-----DHTPVAIKVLRPDAAQ--GKRQFQQEVEVLSSIRHPNMVLLLGACPDY--GCLVYEYMH 305 (568)
Q Consensus 235 ~~IG~G~fg~Vy~~~~-----~~~~vAvK~l~~~~~~--~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~--~~lV~E~~~ 305 (568)
+.||+|+||.||+++. .++.||||++...... ....+..|+.+|+.++||||++++++|.+. .|+||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999998864 4678999999754322 234567899999999999999999988554 489999999
Q ss_pred CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCCcc
Q 008365 306 NGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADS 385 (568)
Q Consensus 306 ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~~~ 385 (568)
+|+|.+++.... .+++..+..|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++......
T Consensus 82 ~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--- 152 (318)
T cd05582 82 GGDLFTRLSKEV---MFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--- 152 (318)
T ss_pred CCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCC---
Confidence 999999886543 3889999999999999999999999 9999999999999999999999999987543221
Q ss_pred ccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHH--HHHhCccccccCccCCCCChH
Q 008365 386 VTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSR--AIEKGTLAEMLDPAVTDWPAE 463 (568)
Q Consensus 386 ~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~--~~~~~~~~~~l~~~~~~~p~~ 463 (568)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||........ .+... ....|..
T Consensus 153 ---~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~---------~~~~p~~ 220 (318)
T cd05582 153 ---KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKA---------KLGMPQF 220 (318)
T ss_pred ---CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcC---------CCCCCCC
Confidence 112346799999999999988899999999999999999999999975543221 11111 1123455
Q ss_pred HHHHHHHHHHHhhccCCCCCCChHH
Q 008365 464 AAESFSKLAIQCAELRKKDRPDLGT 488 (568)
Q Consensus 464 ~~~~l~~li~~Cl~~dP~~RPs~~~ 488 (568)
++..+.+|+.+||+.+|.+||++.+
T Consensus 221 ~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 221 LSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 6678999999999999999999655
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=332.72 Aligned_cols=248 Identities=31% Similarity=0.514 Sum_probs=200.5
Q ss_pred cccccceeecccCceeEEEEEeCC-------ccEEEEEeCcCh-hHhHHHHHHHHHHHHcCCCCceeeeccccCC--Cce
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKLDH-------TPVAIKVLRPDA-AQGKRQFQQEVEVLSSIRHPNMVLLLGACPD--YGC 298 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~~~-------~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--~~~ 298 (568)
++|++.+.||+|+||.||+|.+.+ ..||+|.++... ......|.+|+.++..++||||+++++++.+ ..+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 468888999999999999998633 359999987543 3334568999999999999999999998854 348
Q ss_pred EEEEecCCCCHHHHHhhcCCC-------------CCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCc
Q 008365 299 LVYEYMHNGSLEDRLLRRGNT-------------PVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNY 365 (568)
Q Consensus 299 lV~E~~~ggsL~~~l~~~~~~-------------~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~ 365 (568)
++|||+++|+|.+++...... ..+++..+..++.||+.||.|||+.+ |+||||||+|||+++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence 999999999999999764221 34788899999999999999999999 99999999999999999
Q ss_pred eeEecccccccccCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh-CCCCCCCchH--HHH
Q 008365 366 VSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPMGLTHH--VSR 442 (568)
Q Consensus 366 ~vKL~DFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~--~~~ 442 (568)
.+||+|||+++....... ........+++.|+|||++.+..++.++|||||||++|||++ |..||..... +..
T Consensus 162 ~~~L~dfg~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~ 237 (283)
T cd05048 162 TVKISDFGLSRDIYSADY----YRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIE 237 (283)
T ss_pred cEEECCCcceeecccccc----ccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 999999999976532211 111234467889999999988899999999999999999998 9999965332 222
Q ss_pred HHHhCccccccCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHh
Q 008365 443 AIEKGTLAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIV 491 (568)
Q Consensus 443 ~~~~~~~~~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~ 491 (568)
.+..+ .....+..++..+.+|+.+||+.+|.+||++.+|+.
T Consensus 238 ~i~~~--------~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~ 278 (283)
T cd05048 238 MIRSR--------QLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHT 278 (283)
T ss_pred HHHcC--------CcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 22222 122335567788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=345.09 Aligned_cols=239 Identities=26% Similarity=0.324 Sum_probs=193.1
Q ss_pred eeecccCceeEEEEEe--CCccEEEEEeCcCh---hHhHHHHHHHHHHHHcCCCCceeeeccccCC--CceEEEEecCCC
Q 008365 235 MKIGEGGYGPVYRGKL--DHTPVAIKVLRPDA---AQGKRQFQQEVEVLSSIRHPNMVLLLGACPD--YGCLVYEYMHNG 307 (568)
Q Consensus 235 ~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--~~~lV~E~~~gg 307 (568)
+.||+|+||.||++.+ ++..||||++.... ......+..|+.++..++||||++++++|.+ ..||||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 3699999999999986 56799999997542 2233557789999999999999999988754 348999999999
Q ss_pred CHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCCccc
Q 008365 308 SLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQ-AKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSV 386 (568)
Q Consensus 308 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~-~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~~~~ 386 (568)
+|.+++.... .+++..+..|+.||+.||.|||+ .+ |+||||||+||||+.++.+||+|||+++......
T Consensus 81 ~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~---- 150 (325)
T cd05594 81 ELFFHLSRER---VFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG---- 150 (325)
T ss_pred cHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCC----
Confidence 9998886543 38899999999999999999997 67 9999999999999999999999999987532211
Q ss_pred cccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHH--HHHHhCccccccCccCCCCChHH
Q 008365 387 TQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVS--RAIEKGTLAEMLDPAVTDWPAEA 464 (568)
Q Consensus 387 ~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~--~~~~~~~~~~~l~~~~~~~p~~~ 464 (568)
......+||+.|+|||++.+..++.++|||||||++|+|++|..||....... ..+... ...+|..+
T Consensus 151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~---------~~~~p~~~ 219 (325)
T cd05594 151 --ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME---------EIRFPRTL 219 (325)
T ss_pred --cccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcC---------CCCCCCCC
Confidence 11234579999999999999999999999999999999999999996543321 111111 11234456
Q ss_pred HHHHHHHHHHhhccCCCCCC-----ChHHhHhHHH
Q 008365 465 AESFSKLAIQCAELRKKDRP-----DLGTVIVPEL 494 (568)
Q Consensus 465 ~~~l~~li~~Cl~~dP~~RP-----s~~~vl~~~l 494 (568)
+..+.+|+.+||+.+|.+|+ ++.+++.|.+
T Consensus 220 ~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~ 254 (325)
T cd05594 220 SPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKF 254 (325)
T ss_pred CHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCC
Confidence 67899999999999999997 7888876543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-40 Score=348.18 Aligned_cols=250 Identities=27% Similarity=0.407 Sum_probs=197.3
Q ss_pred hcccccceeecccCceeEEEEEe-------CCccEEEEEeCcCh-hHhHHHHHHHHHHHHcC-CCCceeeeccccCCC--
Q 008365 228 TDKFSEAMKIGEGGYGPVYRGKL-------DHTPVAIKVLRPDA-AQGKRQFQQEVEVLSSI-RHPNMVLLLGACPDY-- 296 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~~~~-------~~~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l-~HpnIv~l~g~~~~~-- 296 (568)
.++|++.+.||+|+||.||+|.+ .+..||||+++... ....+.+.+|+.+|..+ +|||||+++++|.+.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 35789999999999999999864 24479999997543 33345788999999999 899999999998554
Q ss_pred ceEEEEecCCCCHHHHHhhcCC----------------------------------------------------------
Q 008365 297 GCLVYEYMHNGSLEDRLLRRGN---------------------------------------------------------- 318 (568)
Q Consensus 297 ~~lV~E~~~ggsL~~~l~~~~~---------------------------------------------------------- 318 (568)
.++|||||+||+|.+++.....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 4899999999999999865321
Q ss_pred --------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCCc
Q 008365 319 --------------TPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVAD 384 (568)
Q Consensus 319 --------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~~ 384 (568)
...+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.....
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~- 269 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSN- 269 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCccc-
Confidence 123788889999999999999999999 99999999999999999999999999986533211
Q ss_pred cccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh-CCCCCCCchH---HHHHHHhCccccccCccCCCC
Q 008365 385 SVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPMGLTHH---VSRAIEKGTLAEMLDPAVTDW 460 (568)
Q Consensus 385 ~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~---~~~~~~~~~~~~~l~~~~~~~ 460 (568)
........++..|+|||++.+..++.++|||||||++|||++ |..||..... ....+..+. . ...
T Consensus 270 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~-----~---~~~ 338 (375)
T cd05104 270 ---YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGY-----R---MLS 338 (375)
T ss_pred ---ccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCc-----c---CCC
Confidence 111123345678999999999999999999999999999998 8999964322 222222221 0 111
Q ss_pred ChHHHHHHHHHHHHhhccCCCCCCChHHhHhH
Q 008365 461 PAEAAESFSKLAIQCAELRKKDRPDLGTVIVP 492 (568)
Q Consensus 461 p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~ 492 (568)
|...+..+.+|+.+||+.+|.+||++.+|+..
T Consensus 339 ~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 339 PECAPSEMYDIMKSCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred CCCCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 23345679999999999999999999999743
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=350.29 Aligned_cols=255 Identities=23% Similarity=0.311 Sum_probs=195.5
Q ss_pred ccccceeecccCceeEEEEEe--CCccEEEEEeCcChh---HhHHHHHHHHHHHHcCCCCceeeeccccCCC--ceEEEE
Q 008365 230 KFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAA---QGKRQFQQEVEVLSSIRHPNMVLLLGACPDY--GCLVYE 302 (568)
Q Consensus 230 ~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~---~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~--~~lV~E 302 (568)
.|.++++||+|+||.||+|++ +++.||||++..... .....+.+|+.+++.++|||||++++.|.+. .++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 588999999999999999987 567899999875432 2345688999999999999999999998554 489999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCC
Q 008365 303 YMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSV 382 (568)
Q Consensus 303 ~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~ 382 (568)
||++|+|.+++...+ .+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++..+....
T Consensus 82 ~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~ 155 (382)
T cd05625 82 YIPGGDMMSLLIRMG---IFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (382)
T ss_pred CCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence 999999999987653 3788888999999999999999999 9999999999999999999999999986432100
Q ss_pred Ccc-----------------------------------------ccccccccccccccCCChhhhhcCCCCCcceehhHH
Q 008365 383 ADS-----------------------------------------VTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFG 421 (568)
Q Consensus 383 ~~~-----------------------------------------~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlG 421 (568)
... .........+||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (382)
T cd05625 156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 235 (382)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence 000 000011235799999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCchHHHHHHHhCccccccCccCCCCChHHHHHHHHHHHHhhccCCCCCCC---hHHhHhHHH
Q 008365 422 IMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPD---LGTVIVPEL 494 (568)
Q Consensus 422 vil~elltG~~Pf~~~~~~~~~~~~~~~~~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs---~~~vl~~~l 494 (568)
|++|||++|++||..................+ ..+ .....+..+.+++.+++ .+|.+|++ +.+++.|.+
T Consensus 236 vil~elltG~~Pf~~~~~~~~~~~i~~~~~~~--~~p-~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~ 307 (382)
T cd05625 236 VILYEMLVGQPPFLAQTPLETQMKVINWQTSL--HIP-PQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPF 307 (382)
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHccCCCc--CCC-CcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCC
Confidence 99999999999997655433222111111100 011 11234566778887766 49999997 777775543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=334.85 Aligned_cols=250 Identities=26% Similarity=0.348 Sum_probs=199.6
Q ss_pred ccccceeecccCceeEEEEEe--CCccEEEEEeCcChhH---hHHHHHHHHHHHHcCCCCceeeeccccCC--CceEEEE
Q 008365 230 KFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQ---GKRQFQQEVEVLSSIRHPNMVLLLGACPD--YGCLVYE 302 (568)
Q Consensus 230 ~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~---~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--~~~lV~E 302 (568)
+|++.++||+|+||.||++.+ +++.||||++...... ....+.+|+.+++.++||||+++++.|.+ ..|+|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 488899999999999999987 5679999998754322 23457789999999999999999998754 4589999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCC
Q 008365 303 YMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSV 382 (568)
Q Consensus 303 ~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~ 382 (568)
|+++|+|.+++..... ..+++..+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++..+....
T Consensus 81 ~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 81 LMNGGDLKFHIYNMGN-PGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE 156 (285)
T ss_pred ccCCCcHHHHHHhcCc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence 9999999988865433 34899999999999999999999999 9999999999999999999999999997653221
Q ss_pred CccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHhCccccccCccCCCCCh
Q 008365 383 ADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAVTDWPA 462 (568)
Q Consensus 383 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~l~~~~~~~p~ 462 (568)
......||+.|+|||++.+..++.++|||||||++|+|++|..||.......... .+...+......++.
T Consensus 157 -------~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~---~~~~~~~~~~~~~~~ 226 (285)
T cd05605 157 -------TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKRE---EVERRVKEDQEEYSE 226 (285)
T ss_pred -------ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHH---HHHHHhhhcccccCc
Confidence 1134579999999999998899999999999999999999999997543211100 001111112223345
Q ss_pred HHHHHHHHHHHHhhccCCCCCC-----ChHHhHhHH
Q 008365 463 EAAESFSKLAIQCAELRKKDRP-----DLGTVIVPE 493 (568)
Q Consensus 463 ~~~~~l~~li~~Cl~~dP~~RP-----s~~~vl~~~ 493 (568)
..+..+.+|+.+||..||.+|| ++.+++.+.
T Consensus 227 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~ 262 (285)
T cd05605 227 KFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHP 262 (285)
T ss_pred ccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCc
Confidence 5677899999999999999999 777776543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=336.27 Aligned_cols=247 Identities=26% Similarity=0.460 Sum_probs=198.6
Q ss_pred cccccceeecccCceeEEEEEe--CCc----cEEEEEeCcCh-hHhHHHHHHHHHHHHcCCCCceeeeccccCC-CceEE
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKL--DHT----PVAIKVLRPDA-AQGKRQFQQEVEVLSSIRHPNMVLLLGACPD-YGCLV 300 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~--~~~----~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~-~~~lV 300 (568)
.+|++.+.||+|+||.||+|.+ ++. .||||+++... ....+.+.+|+.+++.++||||++++|+|.. ..++|
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~~~~~v 86 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLI 86 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCCCceee
Confidence 4689999999999999999986 333 48999987543 3445678899999999999999999998854 45899
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCC
Q 008365 301 YEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPP 380 (568)
Q Consensus 301 ~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~ 380 (568)
++|+++|+|.+++..... .+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+..
T Consensus 87 ~e~~~~g~l~~~l~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 161 (316)
T cd05108 87 TQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 161 (316)
T ss_pred eecCCCCCHHHHHHhccc--cCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEccccccccccC
Confidence 999999999999876542 3788899999999999999999999 99999999999999999999999999987643
Q ss_pred CCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh-CCCCCCCchH--HHHHHHhCccccccCccC
Q 008365 381 SVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPMGLTHH--VSRAIEKGTLAEMLDPAV 457 (568)
Q Consensus 381 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~--~~~~~~~~~~~~~l~~~~ 457 (568)
... ........++..|+|||++.+..++.++|||||||++|||++ |..||..... +...+..+. .
T Consensus 162 ~~~----~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~--------~ 229 (316)
T cd05108 162 DEK----EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE--------R 229 (316)
T ss_pred CCc----ceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCC--------C
Confidence 221 111122345778999999999999999999999999999998 9999965432 222222111 1
Q ss_pred CCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhH
Q 008365 458 TDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVP 492 (568)
Q Consensus 458 ~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~ 492 (568)
...+..++..+.+++.+||..+|.+||++.+++..
T Consensus 230 ~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 230 LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 11233455678999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=368.65 Aligned_cols=246 Identities=31% Similarity=0.530 Sum_probs=203.8
Q ss_pred cccccceeecccCceeEEEEEeC---Cc----cEEEEEeCcC-hhHhHHHHHHHHHHHHcCCCCceeeeccccCCCc--e
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKLD---HT----PVAIKVLRPD-AAQGKRQFQQEVEVLSSIRHPNMVLLLGACPDYG--C 298 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~~---~~----~vAvK~l~~~-~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~--~ 298 (568)
++-.....||+|.||.||.|... +. .||||.++.. ..+....|.+|..+|+.++|||||+++|+|.+.. +
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~ 771 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL 771 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence 34556778999999999999872 32 3999999775 4556778999999999999999999999996643 8
Q ss_pred EEEEecCCCCHHHHHhhcCC----CCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEeccccc
Q 008365 299 LVYEYMHNGSLEDRLLRRGN----TPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGL 374 (568)
Q Consensus 299 lV~E~~~ggsL~~~l~~~~~----~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGl 374 (568)
|++|||+||+|..+|.+... ...++....+.|+.|||+|+.||++++ +|||||-..|+||+....|||+||||
T Consensus 772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFGl 848 (1025)
T KOG1095|consen 772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFGL 848 (1025)
T ss_pred EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccch
Confidence 99999999999999987621 234889999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCcccccccccc-ccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh-CCCCCCCchHHHHH---HHhCcc
Q 008365 375 ARLVPPSVADSVTQYHMTS-AAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPMGLTHHVSRA---IEKGTL 449 (568)
Q Consensus 375 a~~~~~~~~~~~~~~~~~~-~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~~~---~~~~~~ 449 (568)
|+.+-.. ..+.... ..-...|||||.+..+.++.|+|||||||+|||++| |..||...++.... ...|
T Consensus 849 ArDiy~~-----~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg-- 921 (1025)
T KOG1095|consen 849 ARDIYDK-----DYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG-- 921 (1025)
T ss_pred hHhhhhc-----hheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC--
Confidence 9943221 1122222 234468999999999999999999999999999999 99999766554332 2222
Q ss_pred ccccCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHh
Q 008365 450 AEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIV 491 (568)
Q Consensus 450 ~~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~ 491 (568)
..+.|..||..+.++|..||+.+|.+||++..|+.
T Consensus 922 -------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 922 -------RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred -------ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 23457889999999999999999999999999874
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=343.58 Aligned_cols=242 Identities=27% Similarity=0.407 Sum_probs=199.3
Q ss_pred ccccceeecccCceeEEEEEe--CCccEEEEEeCcChh---HhHHHHHHHHHHHHcCCCCceeeeccccCC--CceEEEE
Q 008365 230 KFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAA---QGKRQFQQEVEVLSSIRHPNMVLLLGACPD--YGCLVYE 302 (568)
Q Consensus 230 ~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~---~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--~~~lV~E 302 (568)
.|..++.||.|+||.||.+++ +...||||.+..... ...+++..||..|.+++|||+|.+.|+|.. ..+||||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 377788999999999999987 556899999875533 334678899999999999999999998843 4489999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCC
Q 008365 303 YMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSV 382 (568)
Q Consensus 303 ~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~ 382 (568)
|| -||-.|+|.-... ++-+..+..|+.+.+.||.|||+.+ .||||||..||||.+.|.|||+|||.|..+.+.
T Consensus 107 YC-lGSAsDlleVhkK--plqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA- 179 (948)
T KOG0577|consen 107 YC-LGSASDLLEVHKK--PLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAPA- 179 (948)
T ss_pred HH-hccHHHHHHHHhc--cchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCch-
Confidence 99 6788887765432 3788899999999999999999999 999999999999999999999999999876443
Q ss_pred CccccccccccccccccCCChhhhh---cCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHhCccccccCccCCC
Q 008365 383 ADSVTQYHMTSAAGTFCYIDPEYQQ---TGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAVTD 459 (568)
Q Consensus 383 ~~~~~~~~~~~~~GT~~Y~APE~~~---~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~l~~~~~~ 459 (568)
.+++|||+|||||++. .+.|+-++|||||||+..||...++|+...+.+...+-. ...-.|.+.
T Consensus 180 ---------nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHI---AQNesPtLq- 246 (948)
T KOG0577|consen 180 ---------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI---AQNESPTLQ- 246 (948)
T ss_pred ---------hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHH---HhcCCCCCC-
Confidence 5789999999999764 567999999999999999999999998666654433211 111122222
Q ss_pred CChHHHHHHHHHHHHhhccCCCCCCChHHhHhH
Q 008365 460 WPAEAAESFSKLAIQCAELRKKDRPDLGTVIVP 492 (568)
Q Consensus 460 ~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~ 492 (568)
..+.+..|..|+..||++-|.+||+..+++.|
T Consensus 247 -s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 247 -SNEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred -CchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 34678899999999999999999998877543
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-40 Score=345.99 Aligned_cols=255 Identities=20% Similarity=0.290 Sum_probs=194.7
Q ss_pred cccccceeecccCceeEEEEEe--CCccEEEEEeCcChh---HhHHHHHHHHHHHHcCCCCceeeeccccCCC--ceEEE
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAA---QGKRQFQQEVEVLSSIRHPNMVLLLGACPDY--GCLVY 301 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~---~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~--~~lV~ 301 (568)
++|++.+.||+|+||.||++.+ .++.||||++..... .....+.+|+.++..++||||+++++.+.+. .||||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 4689999999999999999987 567899999975432 2234678899999999999999999988654 48999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCC
Q 008365 302 EYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPS 381 (568)
Q Consensus 302 E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~ 381 (568)
|||+||+|.+++...+ .+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~ 154 (363)
T cd05628 81 EFLPGGDMMTLLMKKD---TLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA 154 (363)
T ss_pred cCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence 9999999999987654 3889999999999999999999999 999999999999999999999999999765321
Q ss_pred CCcc-----------------------------ccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCC
Q 008365 382 VADS-----------------------------VTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARS 432 (568)
Q Consensus 382 ~~~~-----------------------------~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~ 432 (568)
.... .........+||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~ 234 (363)
T cd05628 155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (363)
T ss_pred ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence 1000 00001124589999999999999999999999999999999999999
Q ss_pred CCCCchHHH--HHHHhCccccccCccCCCCChHHHHHHHHHHHHhhc--cCCCCCCChHHhHhHHH
Q 008365 433 PMGLTHHVS--RAIEKGTLAEMLDPAVTDWPAEAAESFSKLAIQCAE--LRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 433 Pf~~~~~~~--~~~~~~~~~~~l~~~~~~~p~~~~~~l~~li~~Cl~--~dP~~RPs~~~vl~~~l 494 (568)
||....... ..+......-.+.+. ..++..+.+++.+++. .++..||++.+|+.|.+
T Consensus 235 Pf~~~~~~~~~~~i~~~~~~~~~p~~-----~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~hp~ 295 (363)
T cd05628 235 PFCSETPQETYKKVMNWKETLIFPPE-----VPISEKAKDLILRFCCEWEHRIGAPGVEEIKTNPF 295 (363)
T ss_pred CCCCCCHHHHHHHHHcCcCcccCCCc-----CCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCCCC
Confidence 997544322 222211100011110 1234567777777443 23345789999987643
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-40 Score=336.19 Aligned_cols=255 Identities=24% Similarity=0.345 Sum_probs=195.6
Q ss_pred hcccccceeecccCceeEEEEEe--CCccEEEEEeCcChh-HhHHHHHHHHHHHHcCCCCceeeeccccCC--CceEEEE
Q 008365 228 TDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAA-QGKRQFQQEVEVLSSIRHPNMVLLLGACPD--YGCLVYE 302 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~-~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--~~~lV~E 302 (568)
.++|.+.+.||.|+||.||+|.+ +++.||||++..... .....+.+|+.+++.++||||+++++++.+ ..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 36799999999999999999987 577899999875432 223456789999999999999999998854 4489999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCC
Q 008365 303 YMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSV 382 (568)
Q Consensus 303 ~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~ 382 (568)
|+ .++|.+++..... .++...+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 84 ~~-~~~l~~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 157 (303)
T cd07869 84 YV-HTDLCQYMDKHPG--GLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS 157 (303)
T ss_pred CC-CcCHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence 99 4788887765432 3788889999999999999999999 9999999999999999999999999987542211
Q ss_pred CccccccccccccccccCCChhhhhc-CCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHhC-----cccc-----
Q 008365 383 ADSVTQYHMTSAAGTFCYIDPEYQQT-GMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKG-----TLAE----- 451 (568)
Q Consensus 383 ~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~-----~~~~----- 451 (568)
.......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.........+... ....
T Consensus 158 ------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (303)
T cd07869 158 ------HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPG 231 (303)
T ss_pred ------ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccc
Confidence 11234578999999998765 458999999999999999999999997654332222110 0000
Q ss_pred -----ccCcc-CC-CCCh---------HHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 452 -----MLDPA-VT-DWPA---------EAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 452 -----~l~~~-~~-~~p~---------~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
.+.+. .. ..+. ..+..+.+|+..||+.||.+||++.+++.|.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~ 290 (303)
T cd07869 232 VHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEY 290 (303)
T ss_pred hhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcc
Confidence 00000 00 0010 12356789999999999999999999987655
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-40 Score=329.62 Aligned_cols=246 Identities=24% Similarity=0.405 Sum_probs=197.6
Q ss_pred hcccccceeecccCceeEEEEEeC-----CccEEEEEeCcChh-HhHHHHHHHHHHHHcCCCCceeeeccccCC--CceE
Q 008365 228 TDKFSEAMKIGEGGYGPVYRGKLD-----HTPVAIKVLRPDAA-QGKRQFQQEVEVLSSIRHPNMVLLLGACPD--YGCL 299 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~~~~~-----~~~vAvK~l~~~~~-~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--~~~l 299 (568)
.++|++.+.||+|+||.||+|.+. +..||+|+++.... .....|.+|+.++..++||||+++++++.. ..++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 356889999999999999999752 45899999876532 334568899999999999999999998754 4589
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccC
Q 008365 300 VYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVP 379 (568)
Q Consensus 300 V~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~ 379 (568)
||||+++|+|.+++..... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||.+....
T Consensus 84 v~e~~~~~~L~~~l~~~~~--~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~ 158 (266)
T cd05064 84 VTEYMSNGALDSFLRKHEG--QLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDK 158 (266)
T ss_pred EEEeCCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCccccccc
Confidence 9999999999999876432 4889999999999999999999999 9999999999999999999999999876432
Q ss_pred CCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh-CCCCCCCchHHH--HHHHhCccccccCcc
Q 008365 380 PSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPMGLTHHVS--RAIEKGTLAEMLDPA 456 (568)
Q Consensus 380 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~--~~~~~~~~~~~l~~~ 456 (568)
... ........++..|+|||.+.+..++.++|||||||++||+++ |..||....... ..+..+.
T Consensus 159 ~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~-------- 225 (266)
T cd05064 159 SEA-----IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGF-------- 225 (266)
T ss_pred ccc-----hhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCC--------
Confidence 111 111123346678999999999999999999999999999875 999996543322 2222221
Q ss_pred CCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHh
Q 008365 457 VTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIV 491 (568)
Q Consensus 457 ~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~ 491 (568)
....|..++..+.+++.+||+.+|.+||++.+|+.
T Consensus 226 ~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 226 RLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence 11224556778999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=348.19 Aligned_cols=244 Identities=25% Similarity=0.413 Sum_probs=190.5
Q ss_pred ccccceeecccCceeEEEEEe--CCccEEEEEeCcCh-hHhHHHHHHHHHHHHcCCCCceeeeccccCCC--ceEEEEec
Q 008365 230 KFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDA-AQGKRQFQQEVEVLSSIRHPNMVLLLGACPDY--GCLVYEYM 304 (568)
Q Consensus 230 ~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~--~~lV~E~~ 304 (568)
+|+.+++||+|+||.||+|.+ +++.||||++.... ......+.+|+.+|+.++|+||++++++|.+. .++||||+
T Consensus 75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 154 (353)
T PLN00034 75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFM 154 (353)
T ss_pred HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecC
Confidence 456677899999999999987 57899999986543 23346788999999999999999999998654 48999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCCc
Q 008365 305 HNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVAD 384 (568)
Q Consensus 305 ~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~~ 384 (568)
++|+|.+.. ...+..+..|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+.....
T Consensus 155 ~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~- 223 (353)
T PLN00034 155 DGGSLEGTH-------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD- 223 (353)
T ss_pred CCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceecccccc-
Confidence 999986532 2566778889999999999999999 99999999999999999999999999986532211
Q ss_pred cccccccccccccccCCChhhhhc-----CCCCCcceehhHHHHHHHHHhCCCCCCCchH--HHHHHHhCccccccCccC
Q 008365 385 SVTQYHMTSAAGTFCYIDPEYQQT-----GMLTTKSDIYSFGIMLLQIITARSPMGLTHH--VSRAIEKGTLAEMLDPAV 457 (568)
Q Consensus 385 ~~~~~~~~~~~GT~~Y~APE~~~~-----~~~s~ksDvwSlGvil~elltG~~Pf~~~~~--~~~~~~~~~~~~~l~~~~ 457 (568)
.....+||..|+|||++.. ...+.++|||||||++|||++|+.||..... ......... ....
T Consensus 224 -----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~-----~~~~ 293 (353)
T PLN00034 224 -----PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAIC-----MSQP 293 (353)
T ss_pred -----cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHh-----ccCC
Confidence 1234579999999998743 3345689999999999999999999963221 111111100 0111
Q ss_pred CCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 458 TDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 458 ~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
...+..++..+.+||.+||+.+|.+||++.+++.+.+
T Consensus 294 ~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~ 330 (353)
T PLN00034 294 PEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPF 330 (353)
T ss_pred CCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcc
Confidence 2234456678999999999999999999999985543
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=333.62 Aligned_cols=258 Identities=24% Similarity=0.308 Sum_probs=204.3
Q ss_pred HHhcccccceeecccCceeEEEEEe--CCccEEEEEeC--cChhHhHHHHHHHHHHHHcCCCCceeeeccccCC------
Q 008365 226 EATDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLR--PDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACPD------ 295 (568)
Q Consensus 226 ~~~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~--~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~------ 295 (568)
.+...|..++.||+|+||.|..+.+ ++..||||.+. .......+...+|+.+|+.++|+||+.+++++..
T Consensus 19 ~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f 98 (359)
T KOG0660|consen 19 EIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKF 98 (359)
T ss_pred eccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccc
Confidence 3456677789999999999999987 67799999986 3444445667899999999999999999998843
Q ss_pred -CceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEeccccc
Q 008365 296 -YGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGL 374 (568)
Q Consensus 296 -~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGl 374 (568)
..|+|+|+| +.+|...+.... .++......+++||++||.|+|+.+ |+||||||.|+|++.+..+||||||+
T Consensus 99 ~DvYiV~elM-etDL~~iik~~~---~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGL 171 (359)
T KOG0660|consen 99 NDVYLVFELM-ETDLHQIIKSQQ---DLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGL 171 (359)
T ss_pred ceeEEehhHH-hhHHHHHHHcCc---cccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccc
Confidence 238999999 789988886543 3888889999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCccccccccccccccccCCChhhh-hcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHH---------
Q 008365 375 ARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQ-QTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAI--------- 444 (568)
Q Consensus 375 a~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~-~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~--------- 444 (568)
|+..... .....++..+-|.+|.|||++ ....|+.++||||+||||.|||+|++-|-+.+.+.+..
T Consensus 172 AR~~~~~----~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP 247 (359)
T KOG0660|consen 172 ARYLDKF----FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTP 247 (359)
T ss_pred eeecccc----CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCC
Confidence 9987543 223455778999999999954 56679999999999999999999999996655544321
Q ss_pred --------HhCccccccC--ccC-----CCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 445 --------EKGTLAEMLD--PAV-----TDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 445 --------~~~~~~~~l~--~~~-----~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
........+. +.. ...-+...+...+|+.+||..||.+|+++++.|.|..
T Consensus 248 ~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPY 312 (359)
T KOG0660|consen 248 SEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPY 312 (359)
T ss_pred CHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChh
Confidence 1000000010 001 1112355677889999999999999999999986543
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=334.80 Aligned_cols=252 Identities=23% Similarity=0.338 Sum_probs=194.7
Q ss_pred cccccceeecccCceeEEEEEe--CCccEEEEEeCcChh-HhHHHHHHHHHHHHcCCCCceeeeccccCCC--ceEEEEe
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAA-QGKRQFQQEVEVLSSIRHPNMVLLLGACPDY--GCLVYEY 303 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~-~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~--~~lV~E~ 303 (568)
++|.+.++||.|+||.||+|.+ ++..||||+++.... .....+.+|+.+++.++||||+++++++.+. .++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 5699999999999999999987 567899999865432 2234677999999999999999999988654 4799999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCC
Q 008365 304 MHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVA 383 (568)
Q Consensus 304 ~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~ 383 (568)
++ |+|.+++...+. .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 85 ~~-~~l~~~l~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~- 157 (288)
T cd07871 85 LD-SDLKQYLDNCGN--LMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPT- 157 (288)
T ss_pred CC-cCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCC-
Confidence 96 589988876543 3788899999999999999999999 9999999999999999999999999997543211
Q ss_pred ccccccccccccccccCCChhhhhc-CCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHH---HHh-C-----------
Q 008365 384 DSVTQYHMTSAAGTFCYIDPEYQQT-GMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRA---IEK-G----------- 447 (568)
Q Consensus 384 ~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~---~~~-~----------- 447 (568)
.......||+.|+|||++.+ ..++.++|||||||++|+|++|++||......... +.. +
T Consensus 158 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T cd07871 158 -----KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGIT 232 (288)
T ss_pred -----ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccc
Confidence 11234578999999998765 56899999999999999999999999654322111 000 0
Q ss_pred ---ccccccCccCC-----CCChHHHHHHHHHHHHhhccCCCCCCChHHhHhH
Q 008365 448 ---TLAEMLDPAVT-----DWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVP 492 (568)
Q Consensus 448 ---~~~~~l~~~~~-----~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~ 492 (568)
.+...+.+... .....++..+.+|+.+||..||.+||++.+++.|
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 233 SNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred cchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00000101000 0112345678899999999999999999999854
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=326.90 Aligned_cols=256 Identities=25% Similarity=0.310 Sum_probs=201.4
Q ss_pred HhcccccceeecccCceeEEEEEe--CCccEEEEEeCcChhHh--HHHHHHHHHHHHcCCCCceeeecccc----CCCce
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQG--KRQFQQEVEVLSSIRHPNMVLLLGAC----PDYGC 298 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~--~~~~~~Ev~iL~~l~HpnIv~l~g~~----~~~~~ 298 (568)
..+.|+.++.|++|+||.||+|++ ++..||+|.++.+.... .-...+||++|.+++|||||.+-.+. -+..|
T Consensus 74 sv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy 153 (419)
T KOG0663|consen 74 SVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIY 153 (419)
T ss_pred cHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceee
Confidence 345688899999999999999998 45689999998664221 11246899999999999999987654 45569
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEeccccccccc
Q 008365 299 LVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLV 378 (568)
Q Consensus 299 lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~ 378 (568)
||||||+ -+|..++..... .|...++..++.|++.||.|||.+. |+||||||+|+|++..|.+||+|||||+.+
T Consensus 154 ~VMe~~E-hDLksl~d~m~q--~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~y 227 (419)
T KOG0663|consen 154 IVMEYVE-HDLKSLMETMKQ--PFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREY 227 (419)
T ss_pred eeHHHHH-hhHHHHHHhccC--CCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhh
Confidence 9999995 689888877653 4888899999999999999999999 999999999999999999999999999988
Q ss_pred CCCCCccccccccccccccccCCChhhhhcC-CCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHH----hCcccccc
Q 008365 379 PPSVADSVTQYHMTSAAGTFCYIDPEYQQTG-MLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIE----KGTLAEML 453 (568)
Q Consensus 379 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~----~~~~~~~l 453 (568)
+... ..++..+.|.+|.|||.+.+. .|+..+|+||+|||+.||+++++-|.+...+.+... -|.-.+.+
T Consensus 228 gsp~------k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~i 301 (419)
T KOG0663|consen 228 GSPL------KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAI 301 (419)
T ss_pred cCCc------ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCcccc
Confidence 6542 245678899999999977765 599999999999999999999999976554443221 11111111
Q ss_pred CccCC--------------------CCChH-HHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 454 DPAVT--------------------DWPAE-AAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 454 ~~~~~--------------------~~p~~-~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
-|.+. .++.. +++.-.+|+...|.+||..|-++.+.+.|.+
T Consensus 302 wpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~ 363 (419)
T KOG0663|consen 302 WPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEY 363 (419)
T ss_pred CCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccc
Confidence 11111 11111 4466788999999999999999999875543
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=341.30 Aligned_cols=252 Identities=25% Similarity=0.301 Sum_probs=199.2
Q ss_pred cccccceeecccCceeEEEEEe--CCccEEEEEeCcChh---HhHHHHHHHHHHHHcCCCCceeeeccccCCC--ceEEE
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAA---QGKRQFQQEVEVLSSIRHPNMVLLLGACPDY--GCLVY 301 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~---~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~--~~lV~ 301 (568)
++|.+.+.||+|+||.||++.+ +++.||||+++.... .....+.+|+.+++.++||||+++++++.+. .++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 4689999999999999999987 577899999976432 2345688999999999999999999988553 48999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCC
Q 008365 302 EYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPS 381 (568)
Q Consensus 302 E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~ 381 (568)
||+++|+|.+++..... .+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++..+...
T Consensus 81 e~~~~~~L~~~l~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 155 (330)
T cd05601 81 EYQPGGDLLSLLNRYED--QFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTAN 155 (330)
T ss_pred CCCCCCCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence 99999999999876532 3889999999999999999999999 999999999999999999999999999866432
Q ss_pred CCccccccccccccccccCCChhhhh------cCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHhCccccccCc
Q 008365 382 VADSVTQYHMTSAAGTFCYIDPEYQQ------TGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDP 455 (568)
Q Consensus 382 ~~~~~~~~~~~~~~GT~~Y~APE~~~------~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~l~~ 455 (568)
.. .......||+.|+|||++. ...++.++|||||||++|+|++|..||............-.....+
T Consensus 156 ~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~-- 228 (330)
T cd05601 156 KM-----VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFL-- 228 (330)
T ss_pred Cc-----eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCcc--
Confidence 11 1123357999999999886 4568899999999999999999999996544322211100000111
Q ss_pred cCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 456 AVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 456 ~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
..+. ...++..+.+|+..|+. +|.+||++.+++.|.+
T Consensus 229 ~~~~-~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~ 265 (330)
T cd05601 229 KFPE-DPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPF 265 (330)
T ss_pred CCCC-CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCC
Confidence 0111 12356678999999998 9999999999986544
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=349.31 Aligned_cols=245 Identities=26% Similarity=0.408 Sum_probs=200.6
Q ss_pred eecccCceeEEEEEeCCc--cEEEEEeCcChhHhHHHHHHHHHHHHcCCCCceeeeccccCCCce--EEEEecCCCCHHH
Q 008365 236 KIGEGGYGPVYRGKLDHT--PVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACPDYGC--LVYEYMHNGSLED 311 (568)
Q Consensus 236 ~IG~G~fg~Vy~~~~~~~--~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~--lV~E~~~ggsL~~ 311 (568)
+||+|.||+||-|++..+ .+|||-+........+-+..|+.+.+.|+|.|||+++|.|.+.++ |+||-++||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 799999999999998544 689999877666666678899999999999999999999977664 6999999999999
Q ss_pred HHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccC-CceeEecccccccccCCCCCccccccc
Q 008365 312 RLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDR-NYVSKISDVGLARLVPPSVADSVTQYH 390 (568)
Q Consensus 312 ~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~-~~~vKL~DFGla~~~~~~~~~~~~~~~ 390 (568)
+|...-..-.-.+.+...+..||+.||.|||.+. |||||||-+||||+. .|.+||+|||-++.+.. -...
T Consensus 662 LLrskWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg------inP~ 732 (1226)
T KOG4279|consen 662 LLRSKWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG------INPC 732 (1226)
T ss_pred HHHhccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhcc------CCcc
Confidence 9976432111267888889999999999999999 999999999999964 79999999999986521 1123
Q ss_pred cccccccccCCChhhhhcC--CCCCcceehhHHHHHHHHHhCCCCCCCc-hHHHHHHHhCccccccCccCCCCChHHHHH
Q 008365 391 MTSAAGTFCYIDPEYQQTG--MLTTKSDIYSFGIMLLQIITARSPMGLT-HHVSRAIEKGTLAEMLDPAVTDWPAEAAES 467 (568)
Q Consensus 391 ~~~~~GT~~Y~APE~~~~~--~~s~ksDvwSlGvil~elltG~~Pf~~~-~~~~~~~~~~~~~~~l~~~~~~~p~~~~~~ 467 (568)
..++.||..|||||++..+ .|+.++|||||||.+.||.||++||--. ..-...+.-|.+ +.-+..|.+++.+
T Consensus 733 TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmy-----KvHP~iPeelsae 807 (1226)
T KOG4279|consen 733 TETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMY-----KVHPPIPEELSAE 807 (1226)
T ss_pred ccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcce-----ecCCCCcHHHHHH
Confidence 3567899999999998766 4999999999999999999999999422 222222233322 2334678899999
Q ss_pred HHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 468 FSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 468 l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
...+|.+|+.++|.+||++.+++...+
T Consensus 808 ak~FilrcFepd~~~R~sA~~LL~DpF 834 (1226)
T KOG4279|consen 808 AKNFILRCFEPDPCDRPSAKDLLQDPF 834 (1226)
T ss_pred HHHHHHHHcCCCcccCccHHHhccCcc
Confidence 999999999999999999999986544
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=338.89 Aligned_cols=255 Identities=26% Similarity=0.404 Sum_probs=200.6
Q ss_pred hcccccceeecccCceeEEEEEe--CCccEEEEEeCcCh-hHhHHHHHHHHHHHHcCCCCceeeeccccCC--CceEEEE
Q 008365 228 TDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDA-AQGKRQFQQEVEVLSSIRHPNMVLLLGACPD--YGCLVYE 302 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--~~~lV~E 302 (568)
.++|++.++||.|+||.||++.+ .+..||+|++.... ......+.+|+++|+.++|||||+++++|.+ ..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 46799999999999999999988 46689999887542 2334678999999999999999999999854 3489999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHc-CCCCcccCCCCCCCeeccCCceeEecccccccccCCC
Q 008365 303 YMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQA-KPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPS 381 (568)
Q Consensus 303 ~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~-~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~ 381 (568)
|+++|+|.+++...+ .+++..+..++.|++.||.|||+. + |+||||||+|||++.++.+||+|||++..+...
T Consensus 84 ~~~~~~L~~~l~~~~---~~~~~~~~~~~~~l~~~l~~lH~~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~ 157 (333)
T cd06650 84 HMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (333)
T ss_pred cCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChhhEEEcCCCCEEEeeCCcchhhhhh
Confidence 999999999987654 378888899999999999999985 5 999999999999999999999999999755321
Q ss_pred CCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHH--HHH---hCcccc-----
Q 008365 382 VADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSR--AIE---KGTLAE----- 451 (568)
Q Consensus 382 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~--~~~---~~~~~~----- 451 (568)
. .....||..|+|||++.+..++.++|||||||++|+|++|+.||........ .+. .+....
T Consensus 158 ~--------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (333)
T cd06650 158 M--------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSP 229 (333)
T ss_pred c--------cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCc
Confidence 1 1335799999999999998999999999999999999999999964432111 110 000000
Q ss_pred ----------------------------ccCccCCCCC-hHHHHHHHHHHHHhhccCCCCCCChHHhHhHHHHH
Q 008365 452 ----------------------------MLDPAVTDWP-AEAAESFSKLAIQCAELRKKDRPDLGTVIVPELNR 496 (568)
Q Consensus 452 ----------------------------~l~~~~~~~p-~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l~~ 496 (568)
.+.......+ ...+.++.+|+.+||+.+|.+||++.+++.+.+-+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~ 303 (333)
T cd06650 230 RPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIK 303 (333)
T ss_pred ccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHh
Confidence 0000000011 11346789999999999999999999999877643
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=343.77 Aligned_cols=247 Identities=23% Similarity=0.298 Sum_probs=191.3
Q ss_pred eeecccCceeEEEEEe--CCccEEEEEeCcChh---HhHHHHHHHHHHHHcC-CCCceeeeccccCCC--ceEEEEecCC
Q 008365 235 MKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAA---QGKRQFQQEVEVLSSI-RHPNMVLLLGACPDY--GCLVYEYMHN 306 (568)
Q Consensus 235 ~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~---~~~~~~~~Ev~iL~~l-~HpnIv~l~g~~~~~--~~lV~E~~~g 306 (568)
+.||+|+||.||++.+ ++..||||+++.... .....+..|..++..+ +||||++++++|.+. .++|||||+|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 3699999999999987 567899999976432 2334578899999988 699999999988554 4899999999
Q ss_pred CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCCccc
Q 008365 307 GSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSV 386 (568)
Q Consensus 307 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~~~~ 386 (568)
|+|.+++...+ .+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 g~L~~~~~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~----- 149 (329)
T cd05588 81 GDLMFHMQRQR---KLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP----- 149 (329)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccC-----
Confidence 99998886553 3899999999999999999999999 999999999999999999999999998742111
Q ss_pred cccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHH--HHHHhCccccccCccCCCCChHH
Q 008365 387 TQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVS--RAIEKGTLAEMLDPAVTDWPAEA 464 (568)
Q Consensus 387 ~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~--~~~~~~~~~~~l~~~~~~~p~~~ 464 (568)
.......+||+.|+|||++.+..++.++|||||||++|+|++|+.||....... .......+.+.+.......|..+
T Consensus 150 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~ 228 (329)
T cd05588 150 -GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSL 228 (329)
T ss_pred -CCccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCCCC
Confidence 112234679999999999999999999999999999999999999995321100 00000000000111111234556
Q ss_pred HHHHHHHHHHhhccCCCCCCC------hHHhHhHH
Q 008365 465 AESFSKLAIQCAELRKKDRPD------LGTVIVPE 493 (568)
Q Consensus 465 ~~~l~~li~~Cl~~dP~~RPs------~~~vl~~~ 493 (568)
+..+.+++.+||..+|.+||+ +.+++.|.
T Consensus 229 ~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp 263 (329)
T cd05588 229 SVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHP 263 (329)
T ss_pred CHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCC
Confidence 677999999999999999998 56666443
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=345.09 Aligned_cols=249 Identities=25% Similarity=0.410 Sum_probs=195.9
Q ss_pred hcccccceeecccCceeEEEEEeC-------CccEEEEEeCcCh-hHhHHHHHHHHHHHHcC-CCCceeeeccccCCC--
Q 008365 228 TDKFSEAMKIGEGGYGPVYRGKLD-------HTPVAIKVLRPDA-AQGKRQFQQEVEVLSSI-RHPNMVLLLGACPDY-- 296 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~~~~~-------~~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l-~HpnIv~l~g~~~~~-- 296 (568)
.++|++.+.||+|+||.||+|.+. +..||||+++... ......+.+|+.+++.+ +|||||+++++|.+.
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP 116 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence 357999999999999999998752 2479999997543 33345688999999999 899999999998554
Q ss_pred ceEEEEecCCCCHHHHHhhcCC----------------------------------------------------------
Q 008365 297 GCLVYEYMHNGSLEDRLLRRGN---------------------------------------------------------- 318 (568)
Q Consensus 297 ~~lV~E~~~ggsL~~~l~~~~~---------------------------------------------------------- 318 (568)
.++|||||++|+|.+++.....
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence 4899999999999999864321
Q ss_pred ---------CCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCCcccccc
Q 008365 319 ---------TPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQY 389 (568)
Q Consensus 319 ---------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~ 389 (568)
...+++..+.+|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+..... ..
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~----~~ 269 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSN----YV 269 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcc----ee
Confidence 123678889999999999999999999 99999999999999999999999999976533211 11
Q ss_pred ccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh-CCCCCCCchHH---HHHHHhCccccccCccCCCCChHHH
Q 008365 390 HMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPMGLTHHV---SRAIEKGTLAEMLDPAVTDWPAEAA 465 (568)
Q Consensus 390 ~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~---~~~~~~~~~~~~l~~~~~~~p~~~~ 465 (568)
......++..|+|||++.+..++.++|||||||++|+|++ |+.||...... ...+..+ ... ..+...+
T Consensus 270 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~-----~~~---~~~~~~~ 341 (374)
T cd05106 270 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRG-----YQM---SRPDFAP 341 (374)
T ss_pred eccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcc-----cCc---cCCCCCC
Confidence 1122345678999999998999999999999999999997 99999643321 1111111 111 1233345
Q ss_pred HHHHHHHHHhhccCCCCCCChHHhHh
Q 008365 466 ESFSKLAIQCAELRKKDRPDLGTVIV 491 (568)
Q Consensus 466 ~~l~~li~~Cl~~dP~~RPs~~~vl~ 491 (568)
..+.+++.+||+.+|.+||++.+|+.
T Consensus 342 ~~l~~li~~cl~~dp~~RPs~~~l~~ 367 (374)
T cd05106 342 PEIYSIMKMCWNLEPTERPTFSQISQ 367 (374)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 77999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=327.72 Aligned_cols=250 Identities=28% Similarity=0.433 Sum_probs=198.6
Q ss_pred HhcccccceeecccCceeEEEEEeCC-------ccEEEEEeCcCh-hHhHHHHHHHHHHHHcCCCCceeeeccccCCC--
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKLDH-------TPVAIKVLRPDA-AQGKRQFQQEVEVLSSIRHPNMVLLLGACPDY-- 296 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~~~-------~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~-- 296 (568)
..++|++.+.||+|+||.||+|.+.+ ..||||++.... ......+.+|+.+++.++||||+++++++.+.
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 45789999999999999999987642 469999986542 23345688999999999999999999998643
Q ss_pred ceEEEEecCCCCHHHHHhhcCC-------CCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEe
Q 008365 297 GCLVYEYMHNGSLEDRLLRRGN-------TPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKI 369 (568)
Q Consensus 297 ~~lV~E~~~ggsL~~~l~~~~~-------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL 369 (568)
.++||||+++|+|.+++..... ...+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence 4899999999999999875322 123678889999999999999999998 999999999999999999999
Q ss_pred cccccccccCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh-CCCCCCCchHHH--HHHHh
Q 008365 370 SDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPMGLTHHVS--RAIEK 446 (568)
Q Consensus 370 ~DFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~--~~~~~ 446 (568)
+|||+++.+..... ........+++.|+|||++.+..++.++|||||||++|||++ |..||....... ..+..
T Consensus 161 ~dfg~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~ 236 (277)
T cd05062 161 GDFGMTRDIYETDY----YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVME 236 (277)
T ss_pred CCCCCccccCCcce----eecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 99999976532211 111122356788999999998899999999999999999999 788996543211 11111
Q ss_pred CccccccCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHh
Q 008365 447 GTLAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIV 491 (568)
Q Consensus 447 ~~~~~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~ 491 (568)
+ .....+..++..+.+++.+||+.+|.+||++.+++.
T Consensus 237 ~--------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 273 (277)
T cd05062 237 G--------GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 273 (277)
T ss_pred C--------CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 1 112234456678999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=337.33 Aligned_cols=232 Identities=24% Similarity=0.309 Sum_probs=185.0
Q ss_pred eeecccCceeEEEEEe--CCccEEEEEeCcChh---HhHHHHHHHH-HHHHcCCCCceeeeccccCC--CceEEEEecCC
Q 008365 235 MKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAA---QGKRQFQQEV-EVLSSIRHPNMVLLLGACPD--YGCLVYEYMHN 306 (568)
Q Consensus 235 ~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~---~~~~~~~~Ev-~iL~~l~HpnIv~l~g~~~~--~~~lV~E~~~g 306 (568)
+.||+|+||.||+|++ ++..||||++..... .....+..|. .+++.++||||++++++|.+ ..++||||++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 3699999999999987 567899999875432 1223445555 46788999999999998854 34899999999
Q ss_pred CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCCccc
Q 008365 307 GSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSV 386 (568)
Q Consensus 307 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~~~~ 386 (568)
|+|...+.... .+++..+..|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++......
T Consensus 81 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~---- 150 (321)
T cd05603 81 GELFFHLQRER---CFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE---- 150 (321)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCCC----
Confidence 99998886543 3788888899999999999999999 9999999999999999999999999987432111
Q ss_pred cccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHH--HHHHhCccccccCccCCCCChHH
Q 008365 387 TQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVS--RAIEKGTLAEMLDPAVTDWPAEA 464 (568)
Q Consensus 387 ~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~--~~~~~~~~~~~l~~~~~~~p~~~ 464 (568)
......+||+.|+|||++.+..++.++|||||||++|+|++|..||...+... ..+... ...+|...
T Consensus 151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~---------~~~~~~~~ 219 (321)
T cd05603 151 --ETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHK---------PLQLPGGK 219 (321)
T ss_pred --CccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcC---------CCCCCCCC
Confidence 11234579999999999999999999999999999999999999997554321 111111 11234455
Q ss_pred HHHHHHHHHHhhccCCCCCCChH
Q 008365 465 AESFSKLAIQCAELRKKDRPDLG 487 (568)
Q Consensus 465 ~~~l~~li~~Cl~~dP~~RPs~~ 487 (568)
+..+.+++.+||+.+|.+||+..
T Consensus 220 ~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 220 TVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CHHHHHHHHHHccCCHhhcCCCC
Confidence 67799999999999999999865
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=340.66 Aligned_cols=252 Identities=23% Similarity=0.291 Sum_probs=195.1
Q ss_pred HhcccccceeecccCceeEEEEEe--CCccEEEEEeCcC--hhHhHHHHHHHHHHHHcCCCCceeeeccccCC-------
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPD--AAQGKRQFQQEVEVLSSIRHPNMVLLLGACPD------- 295 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~------- 295 (568)
..++|.+.+.||+|+||.||++.+ .+..||||++... .......+.+|+.+++.++||||++++++|..
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 457899999999999999999987 5678999998653 22334567899999999999999999998742
Q ss_pred -CceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEeccccc
Q 008365 296 -YGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGL 374 (568)
Q Consensus 296 -~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGl 374 (568)
..|+||||++ ++|.+.+.. .+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+
T Consensus 99 ~~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~ 169 (359)
T cd07876 99 QDVYLVMELMD-ANLCQVIHM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 169 (359)
T ss_pred ceeEEEEeCCC-cCHHHHHhc-----cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCC
Confidence 2489999996 566665532 2778888999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHH---Hh-C---
Q 008365 375 ARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAI---EK-G--- 447 (568)
Q Consensus 375 a~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~---~~-~--- 447 (568)
++..... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+...... .. +
T Consensus 170 a~~~~~~-------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~ 242 (359)
T cd07876 170 ARTACTN-------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPS 242 (359)
T ss_pred ccccccC-------ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCc
Confidence 9754221 12234578999999999999999999999999999999999999997544322110 00 0
Q ss_pred ---------ccc---------------cc----cCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 448 ---------TLA---------------EM----LDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 448 ---------~~~---------------~~----l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
... +. ..+.........+..+.+|+.+||..||.+||++.+++.|.+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~ 317 (359)
T cd07876 243 AEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPY 317 (359)
T ss_pred HHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCch
Confidence 000 00 000000011123467899999999999999999999987655
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-40 Score=339.70 Aligned_cols=237 Identities=24% Similarity=0.320 Sum_probs=191.8
Q ss_pred ccccceeecccCceeEEEEEeC--CccEEEEEeCcCh---hHhHHHHHHHHHHHHcCCCC-ceeeeccccCC--CceEEE
Q 008365 230 KFSEAMKIGEGGYGPVYRGKLD--HTPVAIKVLRPDA---AQGKRQFQQEVEVLSSIRHP-NMVLLLGACPD--YGCLVY 301 (568)
Q Consensus 230 ~y~~~~~IG~G~fg~Vy~~~~~--~~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l~Hp-nIv~l~g~~~~--~~~lV~ 301 (568)
+|.+++.||+|+||.||+|.+. ++.||||++.+.. ......+..|+.++..+.|+ +|+.+++++.+ ..|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4888999999999999999874 4689999997643 23345677899999999765 57788877743 458999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCC
Q 008365 302 EYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPS 381 (568)
Q Consensus 302 E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~ 381 (568)
||++||+|.+++...+ .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~~~---~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05587 81 EYVNGGDLMYHIQQVG---KFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG 154 (324)
T ss_pred cCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence 9999999999887654 3788999999999999999999999 999999999999999999999999998643211
Q ss_pred CCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHH--HHHHhCccccccCccCCC
Q 008365 382 VADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVS--RAIEKGTLAEMLDPAVTD 459 (568)
Q Consensus 382 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~--~~~~~~~~~~~l~~~~~~ 459 (568)
. ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||....... ..+... ...
T Consensus 155 ~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~---------~~~ 219 (324)
T cd05587 155 G------KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEH---------NVS 219 (324)
T ss_pred C------CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcC---------CCC
Confidence 1 11234679999999999999999999999999999999999999997554322 222111 123
Q ss_pred CChHHHHHHHHHHHHhhccCCCCCCChH
Q 008365 460 WPAEAAESFSKLAIQCAELRKKDRPDLG 487 (568)
Q Consensus 460 ~p~~~~~~l~~li~~Cl~~dP~~RPs~~ 487 (568)
+|..++..+.+++.+||..+|.+|++..
T Consensus 220 ~~~~~~~~~~~li~~~l~~~P~~R~~~~ 247 (324)
T cd05587 220 YPKSLSKEAVSICKGLLTKHPAKRLGCG 247 (324)
T ss_pred CCCCCCHHHHHHHHHHhhcCHHHcCCCC
Confidence 3445667889999999999999999873
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=346.49 Aligned_cols=248 Identities=22% Similarity=0.299 Sum_probs=192.6
Q ss_pred cccccceeecccCceeEEEEEe--CCccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCceeeeccccCC--CceEEEEec
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACPD--YGCLVYEYM 304 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--~~~lV~E~~ 304 (568)
.+|.+++.||+|+||.||++.+ .+..||||+.. ...+.+|+.+|+.|+|||||+++++|.. ..|+|||++
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~ 165 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY 165 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC
Confidence 5699999999999999999987 56789999753 2346789999999999999999998843 458999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCCc
Q 008365 305 HNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVAD 384 (568)
Q Consensus 305 ~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~~ 384 (568)
+++|..++.... .+++..++.|+.||+.||.|||+.+ ||||||||+||||+.++.+||+|||+++......
T Consensus 166 -~~~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~-- 236 (391)
T PHA03212 166 -KTDLYCYLAAKR---NIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN-- 236 (391)
T ss_pred -CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCccccccccc--
Confidence 578888876543 3788999999999999999999999 9999999999999999999999999997532211
Q ss_pred cccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCch----------HHHHHHHh-Ccc----
Q 008365 385 SVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTH----------HVSRAIEK-GTL---- 449 (568)
Q Consensus 385 ~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~----------~~~~~~~~-~~~---- 449 (568)
.......+||+.|+|||++.+..++.++|||||||++|||++|+.||.... .+...+.. +..
T Consensus 237 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~ 313 (391)
T PHA03212 237 ---ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEF 313 (391)
T ss_pred ---ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhc
Confidence 112235689999999999999999999999999999999999998873211 11111110 000
Q ss_pred --------cccc---------Ccc-CCCC--ChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 450 --------AEML---------DPA-VTDW--PAEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 450 --------~~~l---------~~~-~~~~--p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
...+ .+. ...+ ....+..+.+|+.+||+.||.+||++.+++.+.+
T Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~ 378 (391)
T PHA03212 314 PIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAA 378 (391)
T ss_pred CcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChh
Confidence 0000 000 0001 0134668999999999999999999999986554
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=329.06 Aligned_cols=242 Identities=24% Similarity=0.361 Sum_probs=191.6
Q ss_pred ecccCceeEEEEEe--CCccEEEEEeCcChhH---hHHHHHHHHHHHHcCCCCceeeeccccCCC--ceEEEEecCCCCH
Q 008365 237 IGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQ---GKRQFQQEVEVLSSIRHPNMVLLLGACPDY--GCLVYEYMHNGSL 309 (568)
Q Consensus 237 IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~---~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~--~~lV~E~~~ggsL 309 (568)
||+|+||.||++.+ +++.||||++...... ....+..|+.+++.++||||++++++|... .++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 79999999999987 5678999998754322 234567899999999999999999887543 4899999999999
Q ss_pred HHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCCccccc
Q 008365 310 EDRLLRRG-NTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQ 388 (568)
Q Consensus 310 ~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~ 388 (568)
.+++.... ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+.....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~----- 152 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS----- 152 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-----
Confidence 98875432 2345899999999999999999999999 99999999999999999999999999976543221
Q ss_pred cccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHH--HHHHHhCccccccCccCCCCChHHHH
Q 008365 389 YHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHV--SRAIEKGTLAEMLDPAVTDWPAEAAE 466 (568)
Q Consensus 389 ~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~--~~~~~~~~~~~~l~~~~~~~p~~~~~ 466 (568)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||...... ...+... .+.. ...++..++.
T Consensus 153 -~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~----~~~~-~~~~~~~~~~ 226 (280)
T cd05608 153 -KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQR----ILND-SVTYPDKFSP 226 (280)
T ss_pred -cccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHh----hccc-CCCCcccCCH
Confidence 123457999999999999999999999999999999999999999643221 1111111 1111 1133455677
Q ss_pred HHHHHHHHhhccCCCCCCC-----hHHhHhH
Q 008365 467 SFSKLAIQCAELRKKDRPD-----LGTVIVP 492 (568)
Q Consensus 467 ~l~~li~~Cl~~dP~~RPs-----~~~vl~~ 492 (568)
.+.+++.+||+.+|.+||+ +.+++.+
T Consensus 227 ~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 227 ASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred HHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 8999999999999999994 5555544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=323.34 Aligned_cols=244 Identities=25% Similarity=0.432 Sum_probs=196.6
Q ss_pred cccccceeecccCceeEEEEEeC-CccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCceeeeccccCCC--ceEEEEecC
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKLD-HTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACPDY--GCLVYEYMH 305 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~~-~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~--~~lV~E~~~ 305 (568)
++|++.+.||+|+||.||++.+. +..+|+|.+..... ....+.+|+.+|+.++||||++++++|.+. .++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAM-SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCc-cHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 45888899999999999999874 45899999865432 245788999999999999999999988553 489999999
Q ss_pred CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCCcc
Q 008365 306 NGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADS 385 (568)
Q Consensus 306 ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~~~ 385 (568)
+|+|.+++..... .+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++.......
T Consensus 83 ~~~L~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~-- 155 (256)
T cd05114 83 NGCLLNYLRQRQG--KLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY-- 155 (256)
T ss_pred CCcHHHHHHhCcc--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCce--
Confidence 9999998875432 3789999999999999999999999 99999999999999999999999999976532211
Q ss_pred ccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh-CCCCCCCchHHH--HHHHhCccccccCccCCCCCh
Q 008365 386 VTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPMGLTHHVS--RAIEKGTLAEMLDPAVTDWPA 462 (568)
Q Consensus 386 ~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~--~~~~~~~~~~~l~~~~~~~p~ 462 (568)
.......++..|+|||++.+..++.++|||||||++|+|++ |+.||....... ..+..+.. ...|.
T Consensus 156 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~--------~~~~~ 224 (256)
T cd05114 156 ---TSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFR--------LYRPK 224 (256)
T ss_pred ---eccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCC--------CCCCC
Confidence 11123346678999999988899999999999999999999 999996544322 22222211 11233
Q ss_pred HHHHHHHHHHHHhhccCCCCCCChHHhHh
Q 008365 463 EAAESFSKLAIQCAELRKKDRPDLGTVIV 491 (568)
Q Consensus 463 ~~~~~l~~li~~Cl~~dP~~RPs~~~vl~ 491 (568)
..+..+.+++.+||+.+|.+||++.+++.
T Consensus 225 ~~~~~~~~li~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 225 LASMTVYEVMYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred CCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 34567899999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=335.89 Aligned_cols=235 Identities=25% Similarity=0.299 Sum_probs=187.1
Q ss_pred eeecccCceeEEEEEe--CCccEEEEEeCcChh---HhHHHHHHHHHHHHc-CCCCceeeeccccCC--CceEEEEecCC
Q 008365 235 MKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAA---QGKRQFQQEVEVLSS-IRHPNMVLLLGACPD--YGCLVYEYMHN 306 (568)
Q Consensus 235 ~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~---~~~~~~~~Ev~iL~~-l~HpnIv~l~g~~~~--~~~lV~E~~~g 306 (568)
+.||+|+||.||+|.+ ++..||||+++.... .....+..|..++.. ++||||+++++++.. ..++||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 3699999999999987 456899999976432 223445667777765 479999999998754 34899999999
Q ss_pred CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCCccc
Q 008365 307 GSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSV 386 (568)
Q Consensus 307 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~~~~ 386 (568)
|+|.+++...+ .+++..+..|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++......
T Consensus 81 g~L~~~~~~~~---~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~---- 150 (316)
T cd05592 81 GDLMFHIQSSG---RFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE---- 150 (316)
T ss_pred CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC----
Confidence 99999887654 3788899999999999999999999 9999999999999999999999999997542211
Q ss_pred cccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHhCccccccCccCCCCChHHHH
Q 008365 387 TQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAVTDWPAEAAE 466 (568)
Q Consensus 387 ~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~l~~~~~~~p~~~~~ 466 (568)
......+||+.|+|||++.+..++.++|||||||++|+|++|..||............ .......|..++.
T Consensus 151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i-------~~~~~~~~~~~~~ 221 (316)
T cd05592 151 --GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSI-------LNDRPHFPRWISK 221 (316)
T ss_pred --CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHH-------HcCCCCCCCCCCH
Confidence 1223467999999999999999999999999999999999999999755432211110 0111223445667
Q ss_pred HHHHHHHHhhccCCCCCCChHH
Q 008365 467 SFSKLAIQCAELRKKDRPDLGT 488 (568)
Q Consensus 467 ~l~~li~~Cl~~dP~~RPs~~~ 488 (568)
.+.+++..||..+|.+||++.+
T Consensus 222 ~~~~ll~~~l~~~P~~R~~~~~ 243 (316)
T cd05592 222 EAKDCLSKLFERDPTKRLGVDG 243 (316)
T ss_pred HHHHHHHHHccCCHHHcCCChH
Confidence 7899999999999999999763
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-40 Score=340.09 Aligned_cols=231 Identities=24% Similarity=0.317 Sum_probs=187.9
Q ss_pred eeecccCceeEEEEEe--CCccEEEEEeCcChh---HhHHHHHHHHHHHHcC-CCCceeeeccccCCC--ceEEEEecCC
Q 008365 235 MKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAA---QGKRQFQQEVEVLSSI-RHPNMVLLLGACPDY--GCLVYEYMHN 306 (568)
Q Consensus 235 ~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~---~~~~~~~~Ev~iL~~l-~HpnIv~l~g~~~~~--~~lV~E~~~g 306 (568)
+.||+|+||.||+|++ +++.||||++.+... .....+..|+.++..+ +||||+++++++.+. .++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 3699999999999987 467899999875432 2334567888888876 699999999988554 4899999999
Q ss_pred CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCCccc
Q 008365 307 GSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSV 386 (568)
Q Consensus 307 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~~~~ 386 (568)
|+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 g~L~~~i~~~~---~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~---- 150 (320)
T cd05590 81 GDLMFHIQKSR---RFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG---- 150 (320)
T ss_pred chHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC----
Confidence 99999887654 3788999999999999999999999 9999999999999999999999999987532111
Q ss_pred cccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHH--HHHHhCccccccCccCCCCChHH
Q 008365 387 TQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVS--RAIEKGTLAEMLDPAVTDWPAEA 464 (568)
Q Consensus 387 ~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~--~~~~~~~~~~~l~~~~~~~p~~~ 464 (568)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||....... ..+..+. ...|..+
T Consensus 151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~---------~~~~~~~ 219 (320)
T cd05590 151 --KTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDE---------VVYPTWL 219 (320)
T ss_pred --CcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC---------CCCCCCC
Confidence 12234679999999999999999999999999999999999999997554322 2222111 1224445
Q ss_pred HHHHHHHHHHhhccCCCCCCCh
Q 008365 465 AESFSKLAIQCAELRKKDRPDL 486 (568)
Q Consensus 465 ~~~l~~li~~Cl~~dP~~RPs~ 486 (568)
+..+.+++..||+.+|.+||+.
T Consensus 220 ~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 220 SQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred CHHHHHHHHHHcccCHHHCCCC
Confidence 6778999999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-40 Score=339.70 Aligned_cols=238 Identities=24% Similarity=0.308 Sum_probs=191.4
Q ss_pred eeecccCceeEEEEEeC--CccEEEEEeCcCh---hHhHHHHHHHHHHHHcC-CCCceeeeccccCCC--ceEEEEecCC
Q 008365 235 MKIGEGGYGPVYRGKLD--HTPVAIKVLRPDA---AQGKRQFQQEVEVLSSI-RHPNMVLLLGACPDY--GCLVYEYMHN 306 (568)
Q Consensus 235 ~~IG~G~fg~Vy~~~~~--~~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l-~HpnIv~l~g~~~~~--~~lV~E~~~g 306 (568)
+.||+|+||.||+|++. ++.||||++.... ......+..|..++..+ +||||++++++|.+. .|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 36999999999999874 5689999997643 22334567889998866 799999999998554 4899999999
Q ss_pred CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCCccc
Q 008365 307 GSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSV 386 (568)
Q Consensus 307 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~~~~ 386 (568)
|+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++......
T Consensus 81 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~---- 150 (321)
T cd05591 81 GDLMFQIQRSR---KFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG---- 150 (321)
T ss_pred CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCC----
Confidence 99998887654 3788899999999999999999999 9999999999999999999999999987532211
Q ss_pred cccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHH--HHHHhCccccccCccCCCCChHH
Q 008365 387 TQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVS--RAIEKGTLAEMLDPAVTDWPAEA 464 (568)
Q Consensus 387 ~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~--~~~~~~~~~~~l~~~~~~~p~~~ 464 (568)
......+||+.|+|||++.+..++.++|||||||++|+|++|+.||....... ..+..+. ...|..+
T Consensus 151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~---------~~~p~~~ 219 (321)
T cd05591 151 --VTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDD---------VLYPVWL 219 (321)
T ss_pred --ccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCC---------CCCCCCC
Confidence 11234579999999999999999999999999999999999999997554322 2221111 1223345
Q ss_pred HHHHHHHHHHhhccCCCCCC-------ChHHhHhHH
Q 008365 465 AESFSKLAIQCAELRKKDRP-------DLGTVIVPE 493 (568)
Q Consensus 465 ~~~l~~li~~Cl~~dP~~RP-------s~~~vl~~~ 493 (568)
+..+.+++..||..+|.+|| ++.+++.+.
T Consensus 220 ~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp 255 (321)
T cd05591 220 SKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHP 255 (321)
T ss_pred CHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCC
Confidence 67789999999999999999 667776544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=335.75 Aligned_cols=252 Identities=25% Similarity=0.275 Sum_probs=194.2
Q ss_pred cccccceeecccCceeEEEEEe--CCccEEEEEeCcCh---hHhHHHHHHHHHHHHcCCCCceeeeccccCCC--ceEEE
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDA---AQGKRQFQQEVEVLSSIRHPNMVLLLGACPDY--GCLVY 301 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~--~~lV~ 301 (568)
++|++.+.||+|+||.||++++ .++.||||++.+.. ......+.+|+.++..++|+||+.++++|.+. .|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 4689999999999999999987 46789999997532 22335588999999999999999999988554 48999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCC
Q 008365 302 EYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPS 381 (568)
Q Consensus 302 E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~ 381 (568)
||++||+|.+++..... .+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++..+...
T Consensus 81 e~~~g~~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (331)
T cd05597 81 DYYVGGDLLTLLSKFED--RLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD 155 (331)
T ss_pred ecCCCCcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence 99999999999876432 3788999999999999999999999 999999999999999999999999998765332
Q ss_pred CCccccccccccccccccCCChhhhhc-----CCCCCcceehhHHHHHHHHHhCCCCCCCchHHHH--HHHhCccccccC
Q 008365 382 VADSVTQYHMTSAAGTFCYIDPEYQQT-----GMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSR--AIEKGTLAEMLD 454 (568)
Q Consensus 382 ~~~~~~~~~~~~~~GT~~Y~APE~~~~-----~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~--~~~~~~~~~~l~ 454 (568)
.. ......+||+.|+|||++.. ..++.++|||||||++|+|++|+.||........ .+.... ..+
T Consensus 156 ~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~--~~~- 227 (331)
T cd05597 156 GT-----VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHK--EHF- 227 (331)
T ss_pred CC-----ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCC--Ccc-
Confidence 11 11123469999999998863 4578899999999999999999999965433221 111111 001
Q ss_pred ccCCCCChHHHHHHHHHHHHhhccCC--CCCCChHHhHhHHH
Q 008365 455 PAVTDWPAEAAESFSKLAIQCAELRK--KDRPDLGTVIVPEL 494 (568)
Q Consensus 455 ~~~~~~p~~~~~~l~~li~~Cl~~dP--~~RPs~~~vl~~~l 494 (568)
.+......++..+.+++.+|+...+ ..||++.+++.+.+
T Consensus 228 -~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~ 268 (331)
T cd05597 228 -QFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPF 268 (331)
T ss_pred -cCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCC
Confidence 1111122356678889988775533 34789999887654
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=338.66 Aligned_cols=236 Identities=24% Similarity=0.320 Sum_probs=191.9
Q ss_pred ccccceeecccCceeEEEEEe--CCccEEEEEeCcChh---HhHHHHHHHHHHHHcC-CCCceeeeccccCC--CceEEE
Q 008365 230 KFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAA---QGKRQFQQEVEVLSSI-RHPNMVLLLGACPD--YGCLVY 301 (568)
Q Consensus 230 ~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~---~~~~~~~~Ev~iL~~l-~HpnIv~l~g~~~~--~~~lV~ 301 (568)
+|.+.+.||+|+||.||+|.+ ++..||||++.+... .....+..|..++..+ +|++|+.++++|.+ ..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 488899999999999999987 456899999976432 2234566788888877 48899999988754 348999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCC
Q 008365 302 EYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPS 381 (568)
Q Consensus 302 E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~ 381 (568)
||+++|+|.+++...+ .+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~ 154 (323)
T cd05616 81 EYVNGGDLMYQIQQVG---RFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD 154 (323)
T ss_pred cCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence 9999999999887654 3788999999999999999999999 999999999999999999999999999753221
Q ss_pred CCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHH--HHHHhCccccccCccCCC
Q 008365 382 VADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVS--RAIEKGTLAEMLDPAVTD 459 (568)
Q Consensus 382 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~--~~~~~~~~~~~l~~~~~~ 459 (568)
. ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||....... ..+.... ..
T Consensus 155 ~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~---------~~ 219 (323)
T cd05616 155 G------VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN---------VA 219 (323)
T ss_pred C------CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCC---------CC
Confidence 1 12234679999999999999999999999999999999999999997654322 2222211 12
Q ss_pred CChHHHHHHHHHHHHhhccCCCCCCCh
Q 008365 460 WPAEAAESFSKLAIQCAELRKKDRPDL 486 (568)
Q Consensus 460 ~p~~~~~~l~~li~~Cl~~dP~~RPs~ 486 (568)
+|..++..+.+++.+|++.+|.+|++.
T Consensus 220 ~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 220 YPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred CCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 345567789999999999999999986
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=335.49 Aligned_cols=232 Identities=26% Similarity=0.325 Sum_probs=185.6
Q ss_pred eeecccCceeEEEEEe--CCccEEEEEeCcChh---HhHHHHHHHHH-HHHcCCCCceeeeccccCC--CceEEEEecCC
Q 008365 235 MKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAA---QGKRQFQQEVE-VLSSIRHPNMVLLLGACPD--YGCLVYEYMHN 306 (568)
Q Consensus 235 ~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~---~~~~~~~~Ev~-iL~~l~HpnIv~l~g~~~~--~~~lV~E~~~g 306 (568)
+.||+|+||.||+|.+ +++.||||++..... .....+..|.. +++.++||||+++++.|.+ ..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 3699999999999988 577899999875432 12234445554 5678999999999988754 44899999999
Q ss_pred CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCCccc
Q 008365 307 GSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSV 386 (568)
Q Consensus 307 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~~~~ 386 (568)
|+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.....
T Consensus 81 g~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~----- 149 (323)
T cd05575 81 GELFFHLQRER---SFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH----- 149 (323)
T ss_pred CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccC-----
Confidence 99999887643 3788899999999999999999999 999999999999999999999999998743211
Q ss_pred cccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHH--HHHHhCccccccCccCCCCChHH
Q 008365 387 TQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVS--RAIEKGTLAEMLDPAVTDWPAEA 464 (568)
Q Consensus 387 ~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~--~~~~~~~~~~~l~~~~~~~p~~~ 464 (568)
.......+||+.|+|||++.+..++.++|||||||++|+|++|..||....... ..+..+. ...+...
T Consensus 150 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~---------~~~~~~~ 219 (323)
T cd05575 150 -SKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKP---------LRLKPNI 219 (323)
T ss_pred -CCccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCC---------CCCCCCC
Confidence 112234579999999999999999999999999999999999999997543321 1121111 1223345
Q ss_pred HHHHHHHHHHhhccCCCCCCChH
Q 008365 465 AESFSKLAIQCAELRKKDRPDLG 487 (568)
Q Consensus 465 ~~~l~~li~~Cl~~dP~~RPs~~ 487 (568)
+..+.+++.+||+.+|.+||++.
T Consensus 220 ~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 220 SVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CHHHHHHHHHHhhcCHHhCCCCC
Confidence 67799999999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=322.12 Aligned_cols=245 Identities=27% Similarity=0.460 Sum_probs=197.4
Q ss_pred hcccccceeecccCceeEEEEEe-CCccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCceeeeccccCC--CceEEEEec
Q 008365 228 TDKFSEAMKIGEGGYGPVYRGKL-DHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACPD--YGCLVYEYM 304 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~~~~-~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--~~~lV~E~~ 304 (568)
.++|++.++||+|+||.||+|.+ ++..||+|.+..... ..+.+.+|+.+++.++||||+++++.+.+ ..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM-SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM 83 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCch-hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence 35799999999999999999987 456799999876443 35678999999999999999999988754 348999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCCc
Q 008365 305 HNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVAD 384 (568)
Q Consensus 305 ~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~~ 384 (568)
++|+|.+++..... ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++........
T Consensus 84 ~~~~L~~~l~~~~~-~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~- 158 (261)
T cd05072 84 AKGSLLDFLKSDEG-GKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY- 158 (261)
T ss_pred CCCcHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCce-
Confidence 99999999876432 23788899999999999999999999 99999999999999999999999999986543211
Q ss_pred cccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh-CCCCCCCchH--HHHHHHhCccccccCccCCCCC
Q 008365 385 SVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPMGLTHH--VSRAIEKGTLAEMLDPAVTDWP 461 (568)
Q Consensus 385 ~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~--~~~~~~~~~~~~~l~~~~~~~p 461 (568)
.......++..|+|||++.+..++.++|||||||++|+|++ |..||..... ....+..+. . ...+
T Consensus 159 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~-----~---~~~~ 226 (261)
T cd05072 159 ----TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGY-----R---MPRM 226 (261)
T ss_pred ----eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCC-----C---CCCC
Confidence 11123446778999999988889999999999999999998 9999964332 222222211 1 1112
Q ss_pred hHHHHHHHHHHHHhhccCCCCCCChHHhH
Q 008365 462 AEAAESFSKLAIQCAELRKKDRPDLGTVI 490 (568)
Q Consensus 462 ~~~~~~l~~li~~Cl~~dP~~RPs~~~vl 490 (568)
..++..+.+++.+||..+|.+||++.+++
T Consensus 227 ~~~~~~~~~li~~~l~~~p~~Rp~~~~i~ 255 (261)
T cd05072 227 ENCPDELYDIMKTCWKEKAEERPTFDYLQ 255 (261)
T ss_pred CCCCHHHHHHHHHHccCCcccCcCHHHHH
Confidence 23556789999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=319.56 Aligned_cols=247 Identities=23% Similarity=0.389 Sum_probs=201.6
Q ss_pred ccccceeecccCceeEEEEEe--CCccEEEEEeCcC--hhHhHHHHHHHHHHHHcCCCCceeeeccccCCC--ceEEEEe
Q 008365 230 KFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPD--AAQGKRQFQQEVEVLSSIRHPNMVLLLGACPDY--GCLVYEY 303 (568)
Q Consensus 230 ~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~--~~lV~E~ 303 (568)
+|.+.+.||+|+||.||+|.+ ++..|++|.+... .......+.+|+.+++.++||||+++++++.+. .++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 477889999999999999987 5678999998643 233456788999999999999999999988654 4899999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCC
Q 008365 304 MHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVA 383 (568)
Q Consensus 304 ~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~ 383 (568)
++|++|.+++..... ..+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||+++.+.....
T Consensus 81 ~~~~~L~~~l~~~~~-~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~ 156 (256)
T cd08529 81 AENGDLHKLLKMQRG-RPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN 156 (256)
T ss_pred CCCCcHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence 999999999876522 34889999999999999999999998 99999999999999999999999999986643211
Q ss_pred ccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHhCccccccCccCCCCChH
Q 008365 384 DSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAVTDWPAE 463 (568)
Q Consensus 384 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~l~~~~~~~p~~ 463 (568)
......|++.|+|||++.+..++.++|||||||++|+|++|+.||........... .+.......+..
T Consensus 157 ------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~------~~~~~~~~~~~~ 224 (256)
T cd08529 157 ------FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILK------IIRGVFPPVSQM 224 (256)
T ss_pred ------hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHH------HHcCCCCCCccc
Confidence 12345689999999999999999999999999999999999999976553221110 111112223335
Q ss_pred HHHHHHHHHHHhhccCCCCCCChHHhHhH
Q 008365 464 AAESFSKLAIQCAELRKKDRPDLGTVIVP 492 (568)
Q Consensus 464 ~~~~l~~li~~Cl~~dP~~RPs~~~vl~~ 492 (568)
++..+.+++.+||+.+|++||++.+++.+
T Consensus 225 ~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 225 YSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred cCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 56789999999999999999999998753
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=334.99 Aligned_cols=237 Identities=24% Similarity=0.312 Sum_probs=191.8
Q ss_pred eeecccCceeEEEEEe--CCccEEEEEeCcCh---hHhHHHHHHHHHHHHcC-CCCceeeeccccCC--CceEEEEecCC
Q 008365 235 MKIGEGGYGPVYRGKL--DHTPVAIKVLRPDA---AQGKRQFQQEVEVLSSI-RHPNMVLLLGACPD--YGCLVYEYMHN 306 (568)
Q Consensus 235 ~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l-~HpnIv~l~g~~~~--~~~lV~E~~~g 306 (568)
+.||+|+||.||+|.+ ++..||||+++... ......+..|..++..+ +||||+++++++.+ ..|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 3699999999999987 45689999997643 22344567899999887 69999999998854 34899999999
Q ss_pred CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCCccc
Q 008365 307 GSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSV 386 (568)
Q Consensus 307 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~~~~ 386 (568)
|+|.+++...+ .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 ~~L~~~~~~~~---~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~---- 150 (318)
T cd05570 81 GDLMFHIQRSG---RFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG---- 150 (318)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCC----
Confidence 99998887654 3889999999999999999999999 9999999999999999999999999986432111
Q ss_pred cccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHH--HHHHhCccccccCccCCCCChHH
Q 008365 387 TQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVS--RAIEKGTLAEMLDPAVTDWPAEA 464 (568)
Q Consensus 387 ~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~--~~~~~~~~~~~l~~~~~~~p~~~ 464 (568)
......+||+.|+|||++.+..++.++|||||||++|+|++|+.||....... ..+.... ..+|..+
T Consensus 151 --~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~---------~~~~~~~ 219 (318)
T cd05570 151 --VTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDE---------VRYPRWL 219 (318)
T ss_pred --CcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCC---------CCCCCcC
Confidence 11234579999999999999999999999999999999999999997544322 1111111 1234456
Q ss_pred HHHHHHHHHHhhccCCCCCCCh-----HHhHhH
Q 008365 465 AESFSKLAIQCAELRKKDRPDL-----GTVIVP 492 (568)
Q Consensus 465 ~~~l~~li~~Cl~~dP~~RPs~-----~~vl~~ 492 (568)
+..+.+|+.+||..+|.+||++ .+++.+
T Consensus 220 ~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 220 SKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred CHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 6789999999999999999999 776644
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=343.56 Aligned_cols=249 Identities=24% Similarity=0.309 Sum_probs=198.3
Q ss_pred HhcccccceeecccCceeEEEEEe--CCccEEEEEeCcCh---hHhHHHHHHHHHHHHcCCCCceeeeccccCCC--ceE
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDA---AQGKRQFQQEVEVLSSIRHPNMVLLLGACPDY--GCL 299 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~--~~l 299 (568)
..++|.+.+.||+|+||.||++++ ++..||||++.... ......+.+|+.+++.++||||+++++++.+. .++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 346799999999999999999987 56789999986532 22234577899999999999999999988554 489
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccC
Q 008365 300 VYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVP 379 (568)
Q Consensus 300 V~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~ 379 (568)
||||++||+|.+++... .++...+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++..+.
T Consensus 121 v~Ey~~gg~L~~~l~~~----~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~ 193 (370)
T cd05596 121 VMEYMPGGDLVNLMSNY----DIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMD 193 (370)
T ss_pred EEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence 99999999999988653 2778888899999999999999999 9999999999999999999999999997653
Q ss_pred CCCCccccccccccccccccCCChhhhhcC----CCCCcceehhHHHHHHHHHhCCCCCCCchHHHH--HHHhCcccccc
Q 008365 380 PSVADSVTQYHMTSAAGTFCYIDPEYQQTG----MLTTKSDIYSFGIMLLQIITARSPMGLTHHVSR--AIEKGTLAEML 453 (568)
Q Consensus 380 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~----~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~--~~~~~~~~~~l 453 (568)
... .......+||+.|+|||++.+. .++.++|||||||++|||++|+.||........ .+.....
T Consensus 194 ~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~---- 264 (370)
T cd05596 194 ANG-----MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKN---- 264 (370)
T ss_pred CCC-----cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCC----
Confidence 221 1112346799999999988653 488999999999999999999999976544221 1111110
Q ss_pred CccCCCCCh--HHHHHHHHHHHHhhccCCCC--CCChHHhHhHHH
Q 008365 454 DPAVTDWPA--EAAESFSKLAIQCAELRKKD--RPDLGTVIVPEL 494 (568)
Q Consensus 454 ~~~~~~~p~--~~~~~l~~li~~Cl~~dP~~--RPs~~~vl~~~l 494 (568)
...+|. .++..+.+|+..||..+|.. ||++.+++.|.+
T Consensus 265 ---~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~ 306 (370)
T cd05596 265 ---SLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPF 306 (370)
T ss_pred ---cCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcc
Confidence 011122 35678999999999999987 999999987654
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=329.25 Aligned_cols=252 Identities=26% Similarity=0.351 Sum_probs=203.4
Q ss_pred cccccceeecccCceeEEEEEeCC--ccEEEEEeCcChhHh---HHHHHHHHHHHHcCCCCceeeeccccCC--CceEEE
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKLDH--TPVAIKVLRPDAAQG---KRQFQQEVEVLSSIRHPNMVLLLGACPD--YGCLVY 301 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~~~--~~vAvK~l~~~~~~~---~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--~~~lV~ 301 (568)
+.|++++.||.|.-|+||++...+ ..+|+||+.+..... ..+.+.|-+||+.++||.++.||..|+. +.||||
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 457788899999999999999865 689999998765443 3456789999999999999999999954 559999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCC
Q 008365 302 EYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPS 381 (568)
Q Consensus 302 E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~ 381 (568)
|||+||+|..+++++.. ..|++..+..++.+|+.||+|||-.| ||+|||||+||||-++|++.|+||.|+......
T Consensus 157 eyCpGGdL~~LrqkQp~-~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~~ 232 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQKQPG-KRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPVS 232 (459)
T ss_pred ecCCCccHHHHHhhCCC-CccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence 99999999987776554 45999999999999999999999999 999999999999999999999999998543110
Q ss_pred C-------------------------------C-c------------------cccccccccccccccCCChhhhhcCCC
Q 008365 382 V-------------------------------A-D------------------SVTQYHMTSAAGTFCYIDPEYQQTGML 411 (568)
Q Consensus 382 ~-------------------------------~-~------------------~~~~~~~~~~~GT~~Y~APE~~~~~~~ 411 (568)
. . . .....+..+++||-.|+|||++.|...
T Consensus 233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH 312 (459)
T KOG0610|consen 233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH 312 (459)
T ss_pred CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence 0 0 0 001123346899999999999999999
Q ss_pred CCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHhCccccccCc--cCCCCChHHHHHHHHHHHHhhccCCCCCCC----
Q 008365 412 TTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDP--AVTDWPAEAAESFSKLAIQCAELRKKDRPD---- 485 (568)
Q Consensus 412 s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~l~~--~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs---- 485 (568)
+.++|+|+|||++||||.|..||.+.+.-. ++..++.. .+++.| ..+..+.+||.+.|.+||.+|-.
T Consensus 313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~------Tl~NIv~~~l~Fp~~~-~vs~~akDLIr~LLvKdP~kRlg~~rG 385 (459)
T KOG0610|consen 313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKE------TLRNIVGQPLKFPEEP-EVSSAAKDLIRKLLVKDPSKRLGSKRG 385 (459)
T ss_pred CchhhHHHHHHHHHHHHhCCCCcCCCCchh------hHHHHhcCCCcCCCCC-cchhHHHHHHHHHhccChhhhhccccc
Confidence 999999999999999999999997655422 22222222 222333 56778999999999999999998
Q ss_pred hHHhHh
Q 008365 486 LGTVIV 491 (568)
Q Consensus 486 ~~~vl~ 491 (568)
+.+|=.
T Consensus 386 A~eIK~ 391 (459)
T KOG0610|consen 386 AAEIKR 391 (459)
T ss_pred hHHhhc
Confidence 666543
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=326.31 Aligned_cols=247 Identities=27% Similarity=0.468 Sum_probs=198.9
Q ss_pred cccccceeecccCceeEEEEEeC-------CccEEEEEeCcChhH-hHHHHHHHHHHHHcCCCCceeeeccccCC--Cce
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKLD-------HTPVAIKVLRPDAAQ-GKRQFQQEVEVLSSIRHPNMVLLLGACPD--YGC 298 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~~-------~~~vAvK~l~~~~~~-~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--~~~ 298 (568)
++|.+.+.||+|+||.||+|.+. +..||||+++..... ....+.+|+++|+.++||||+++++++.. ..+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 45888889999999999999752 357999999765443 45689999999999999999999998854 448
Q ss_pred EEEEecCCCCHHHHHhhcCC-----------CCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCcee
Q 008365 299 LVYEYMHNGSLEDRLLRRGN-----------TPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVS 367 (568)
Q Consensus 299 lV~E~~~ggsL~~~l~~~~~-----------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~v 367 (568)
+||||+++++|.+++...+. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCeE
Confidence 99999999999999976432 234788899999999999999999999 9999999999999999999
Q ss_pred EecccccccccCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh-CCCCCCCchHHH--HHH
Q 008365 368 KISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPMGLTHHVS--RAI 444 (568)
Q Consensus 368 KL~DFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~--~~~ 444 (568)
||+|||+++.+..... ........+++.|+|||++.+..++.++|||||||++|+|++ |..||....... ..+
T Consensus 162 kl~d~g~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~ 237 (280)
T cd05049 162 KIGDFGMSRDVYTTDY----YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECI 237 (280)
T ss_pred EECCcccceecccCcc----eecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence 9999999975432111 011123456789999999999999999999999999999998 999986433321 222
Q ss_pred HhCccccccCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhH
Q 008365 445 EKGTLAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVI 490 (568)
Q Consensus 445 ~~~~~~~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl 490 (568)
..+. ....+..++..+.+++.+||+.+|.+||++.+|+
T Consensus 238 ~~~~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil 275 (280)
T cd05049 238 TQGR--------LLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIH 275 (280)
T ss_pred HcCC--------cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHH
Confidence 2221 1122334567799999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=340.93 Aligned_cols=250 Identities=27% Similarity=0.415 Sum_probs=211.7
Q ss_pred HHhcccccceeecccCceeEEEEEe--CCccEEEEEeCcChhH---hHHHHHHHHHHHHcCC-CCceeeeccccCCCc--
Q 008365 226 EATDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQ---GKRQFQQEVEVLSSIR-HPNMVLLLGACPDYG-- 297 (568)
Q Consensus 226 ~~~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~---~~~~~~~Ev~iL~~l~-HpnIv~l~g~~~~~~-- 297 (568)
.....|.+.+.||+|.||.||+++. +|+.+|+|++.+.... ....+.+|+.+|+.+. |||||.++++|++..
T Consensus 32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~ 111 (382)
T KOG0032|consen 32 DIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSV 111 (382)
T ss_pred cccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeE
Confidence 3556799999999999999999987 5778999999776543 3457899999999998 999999999997654
Q ss_pred eEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccC----CceeEecccc
Q 008365 298 CLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDR----NYVSKISDVG 373 (568)
Q Consensus 298 ~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~----~~~vKL~DFG 373 (568)
++|||+|.||.|.+.+... . +++..+..++.||+.++.|||+.| |+||||||+|||+.. ++.+|++|||
T Consensus 112 ~lvmEL~~GGeLfd~i~~~---~-~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFG 184 (382)
T KOG0032|consen 112 YLVMELCEGGELFDRIVKK---H-YSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFG 184 (382)
T ss_pred EEEEEecCCchHHHHHHHc---c-CCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCC
Confidence 8999999999999999887 2 899999999999999999999999 999999999999943 3589999999
Q ss_pred cccccCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchH--HHHHHHhCcccc
Q 008365 374 LARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHH--VSRAIEKGTLAE 451 (568)
Q Consensus 374 la~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~--~~~~~~~~~~~~ 451 (568)
++..+.. .......+||+.|+|||++....|+..+||||+||++|.|++|.+||..... ....+..+.+
T Consensus 185 la~~~~~-------~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~-- 255 (382)
T KOG0032|consen 185 LAKFIKP-------GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDF-- 255 (382)
T ss_pred CceEccC-------CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCC--
Confidence 9987644 2345678999999999999999999999999999999999999999976553 3334444444
Q ss_pred ccCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 452 MLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 452 ~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
+-. .++-+.++..+.+++..|+..||..|+++.+++.|.|
T Consensus 256 --~f~-~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpW 295 (382)
T KOG0032|consen 256 --DFT-SEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPW 295 (382)
T ss_pred --CCC-CCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCcc
Confidence 111 1223456788999999999999999999999987654
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-40 Score=341.21 Aligned_cols=235 Identities=23% Similarity=0.315 Sum_probs=186.3
Q ss_pred eeecccCceeEEEEEe--CCccEEEEEeCcCh---hHhHHHHHHHHHHHHcC-CCCceeeeccccCC--CceEEEEecCC
Q 008365 235 MKIGEGGYGPVYRGKL--DHTPVAIKVLRPDA---AQGKRQFQQEVEVLSSI-RHPNMVLLLGACPD--YGCLVYEYMHN 306 (568)
Q Consensus 235 ~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l-~HpnIv~l~g~~~~--~~~lV~E~~~g 306 (568)
+.||+|+||.||++.+ +++.||+|++++.. ......+..|+.++..+ +||||+++++++.+ ..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 3699999999999987 56789999997642 22344577899988776 79999999998854 44899999999
Q ss_pred CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCCccc
Q 008365 307 GSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSV 386 (568)
Q Consensus 307 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~~~~ 386 (568)
|+|..++.... .+++..+..|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++......
T Consensus 81 ~~L~~~~~~~~---~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~---- 150 (329)
T cd05618 81 GDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG---- 150 (329)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCC----
Confidence 99998886543 3889999999999999999999999 9999999999999999999999999987532111
Q ss_pred cccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCch-------HHHHHHHhCccccccCccCCC
Q 008365 387 TQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTH-------HVSRAIEKGTLAEMLDPAVTD 459 (568)
Q Consensus 387 ~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~-------~~~~~~~~~~~~~~l~~~~~~ 459 (568)
......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.... .....+. +.+......
T Consensus 151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~-----~~i~~~~~~ 223 (329)
T cd05618 151 --DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLF-----QVILEKQIR 223 (329)
T ss_pred --CccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHH-----HHHhcCCCC
Confidence 11234679999999999999999999999999999999999999995211 0000000 001111113
Q ss_pred CChHHHHHHHHHHHHhhccCCCCCCCh
Q 008365 460 WPAEAAESFSKLAIQCAELRKKDRPDL 486 (568)
Q Consensus 460 ~p~~~~~~l~~li~~Cl~~dP~~RPs~ 486 (568)
.|..++..+.+++.+||..+|.+||+.
T Consensus 224 ~p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 224 IPRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred CCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 455566788999999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=335.42 Aligned_cols=235 Identities=25% Similarity=0.304 Sum_probs=185.9
Q ss_pred eeecccCceeEEEEEe--CCccEEEEEeCcChh---HhHHHHHHHH-HHHHcCCCCceeeeccccCC--CceEEEEecCC
Q 008365 235 MKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAA---QGKRQFQQEV-EVLSSIRHPNMVLLLGACPD--YGCLVYEYMHN 306 (568)
Q Consensus 235 ~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~---~~~~~~~~Ev-~iL~~l~HpnIv~l~g~~~~--~~~lV~E~~~g 306 (568)
+.||+|+||.||+|++ ++..||+|++..... .....+..|. .+++.++||||+++++++.+ ..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 3699999999999987 456899999875432 1122344444 45788999999999998754 45899999999
Q ss_pred CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCCccc
Q 008365 307 GSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSV 386 (568)
Q Consensus 307 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~~~~ 386 (568)
|+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++......
T Consensus 81 ~~L~~~~~~~~---~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~---- 150 (325)
T cd05602 81 GELFYHLQRER---CFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN---- 150 (325)
T ss_pred CcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccCC----
Confidence 99999887643 3677888889999999999999999 9999999999999999999999999997532211
Q ss_pred cccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHH--HHHHhCccccccCccCCCCChHH
Q 008365 387 TQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVS--RAIEKGTLAEMLDPAVTDWPAEA 464 (568)
Q Consensus 387 ~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~--~~~~~~~~~~~l~~~~~~~p~~~ 464 (568)
......+||+.|+|||++.+..++.++|||||||++|+|++|..||....... ..+.... ...++.+
T Consensus 151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~---------~~~~~~~ 219 (325)
T cd05602 151 --GTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKP---------LQLKPNI 219 (325)
T ss_pred --CCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCC---------cCCCCCC
Confidence 11234679999999999999999999999999999999999999997544322 1111111 1223455
Q ss_pred HHHHHHHHHHhhccCCCCCCChHHhH
Q 008365 465 AESFSKLAIQCAELRKKDRPDLGTVI 490 (568)
Q Consensus 465 ~~~l~~li~~Cl~~dP~~RPs~~~vl 490 (568)
+..+.+++.+||+.+|.+||+..+.+
T Consensus 220 ~~~~~~li~~~l~~~p~~R~~~~~~~ 245 (325)
T cd05602 220 TNSARHLLEGLLQKDRTKRLGAKDDF 245 (325)
T ss_pred CHHHHHHHHHHcccCHHHCCCCCCCH
Confidence 67799999999999999999987544
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-39 Score=321.92 Aligned_cols=251 Identities=24% Similarity=0.391 Sum_probs=200.8
Q ss_pred ccccceeecccCceeEEEEEe--CCccEEEEEeCcChhH---------hHHHHHHHHHHHHcCCCCceeeeccccCC--C
Q 008365 230 KFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQ---------GKRQFQQEVEVLSSIRHPNMVLLLGACPD--Y 296 (568)
Q Consensus 230 ~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~---------~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--~ 296 (568)
+|.+...||.|+||.||+|.+ .++.||+|.+...... ..+.+.+|+.+++.++||||+++++++.+ .
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 477888999999999999986 5678999988653221 22467899999999999999999998744 4
Q ss_pred ceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEeccccccc
Q 008365 297 GCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLAR 376 (568)
Q Consensus 297 ~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~ 376 (568)
.++||||+++++|.+++...+ .+++..+..++.|++.||.|||+.+ |+||||+|+||+++.++.+||+|||+++
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~ 154 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYG---AFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISK 154 (267)
T ss_pred cEEEEEecCCCCHHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCc
Confidence 589999999999999997653 3788889999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHhCccccccCcc
Q 008365 377 LVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPA 456 (568)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~l~~~ 456 (568)
.+.................|+..|+|||++.+..++.++|||||||++|+|++|+.||.............. ..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~------~~ 228 (267)
T cd06628 155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGE------NA 228 (267)
T ss_pred ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhc------cC
Confidence 764321111111122345689999999999988899999999999999999999999976544333222111 11
Q ss_pred CCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhH
Q 008365 457 VTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVP 492 (568)
Q Consensus 457 ~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~ 492 (568)
....+...+..+.+++.+||+.+|.+||++.+|+.+
T Consensus 229 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 229 SPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred CCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 123344566789999999999999999999998753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=324.15 Aligned_cols=251 Identities=24% Similarity=0.350 Sum_probs=197.9
Q ss_pred hcccccceeecccCceeEEEEEe--CCccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCceeeeccccCC--CceEEEEe
Q 008365 228 TDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACPD--YGCLVYEY 303 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--~~~lV~E~ 303 (568)
.++|++.+.||+|+||.||+|.+ ++..||||++..........+.+|+.+++.++||||++++++|.. ..++||||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 35799999999999999999986 567899999976544445568899999999999999999998744 44899999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCC
Q 008365 304 MHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVA 383 (568)
Q Consensus 304 ~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~ 383 (568)
+++++|.+++...+ .+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++..+.....
T Consensus 88 ~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06646 88 CGGGSLQDIYHVTG---PLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATIA 161 (267)
T ss_pred CCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeeccccc
Confidence 99999999886543 3788999999999999999999999 99999999999999999999999999986532211
Q ss_pred ccccccccccccccccCCChhhhh---cCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHhCccccccCccCCCC
Q 008365 384 DSVTQYHMTSAAGTFCYIDPEYQQ---TGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAVTDW 460 (568)
Q Consensus 384 ~~~~~~~~~~~~GT~~Y~APE~~~---~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~l~~~~~~~ 460 (568)
......|++.|+|||.+. ...++.++|||||||++|+|++|+.||............ ....+.+.....
T Consensus 162 ------~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~--~~~~~~~~~~~~ 233 (267)
T cd06646 162 ------KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM--SKSNFQPPKLKD 233 (267)
T ss_pred ------ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheee--ecCCCCCCCCcc
Confidence 113456899999999874 445788999999999999999999999543322111100 000111111111
Q ss_pred ChHHHHHHHHHHHHhhccCCCCCCChHHhHhH
Q 008365 461 PAEAAESFSKLAIQCAELRKKDRPDLGTVIVP 492 (568)
Q Consensus 461 p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~ 492 (568)
+...+..+.+++.+||..+|.+||++.+++.+
T Consensus 234 ~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 265 (267)
T cd06646 234 KTKWSSTFHNFVKISLTKNPKKRPTAERLLTH 265 (267)
T ss_pred ccccCHHHHHHHHHHhhCChhhCcCHHHHhcC
Confidence 22356789999999999999999999998753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=326.52 Aligned_cols=247 Identities=26% Similarity=0.454 Sum_probs=199.3
Q ss_pred cccccceeecccCceeEEEEEe-------CCccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCceeeeccccCC--CceE
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKL-------DHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACPD--YGCL 299 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~-------~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--~~~l 299 (568)
++|.+.+.||+|+||.||++.. .+..||+|.+..........+.+|+.+++.++||||++++++|.+ ..++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 5688899999999999999974 234689999876655556779999999999999999999998854 4589
Q ss_pred EEEecCCCCHHHHHhhcCC----------CCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEe
Q 008365 300 VYEYMHNGSLEDRLLRRGN----------TPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKI 369 (568)
Q Consensus 300 V~E~~~ggsL~~~l~~~~~----------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL 369 (568)
||||+++++|.+++...+. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEe
Confidence 9999999999999875431 124899999999999999999999999 999999999999999999999
Q ss_pred cccccccccCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh-CCCCCCCchH--HHHHHHh
Q 008365 370 SDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPMGLTHH--VSRAIEK 446 (568)
Q Consensus 370 ~DFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~--~~~~~~~ 446 (568)
+|||+++.+.... .........++..|+|||++.+..++.++|||||||++|+|++ |.+||..... ....+..
T Consensus 162 ~dfg~~~~~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~ 237 (288)
T cd05093 162 GDFGMSRDVYSTD----YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQ 237 (288)
T ss_pred ccCCccccccCCc----eeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence 9999997653221 1111223456788999999998999999999999999999998 9999965433 2222222
Q ss_pred CccccccCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhH
Q 008365 447 GTLAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVI 490 (568)
Q Consensus 447 ~~~~~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl 490 (568)
+.. ...+..++..+.+|+.+||+.+|.+||++.+++
T Consensus 238 ~~~--------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~ 273 (288)
T cd05093 238 GRV--------LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIH 273 (288)
T ss_pred CCc--------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHH
Confidence 221 112233456799999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=321.40 Aligned_cols=239 Identities=24% Similarity=0.427 Sum_probs=193.4
Q ss_pred eecccCceeEEEEEe----CCccEEEEEeCcCh--hHhHHHHHHHHHHHHcCCCCceeeeccccCC-CceEEEEecCCCC
Q 008365 236 KIGEGGYGPVYRGKL----DHTPVAIKVLRPDA--AQGKRQFQQEVEVLSSIRHPNMVLLLGACPD-YGCLVYEYMHNGS 308 (568)
Q Consensus 236 ~IG~G~fg~Vy~~~~----~~~~vAvK~l~~~~--~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~-~~~lV~E~~~ggs 308 (568)
.||+|+||.||+|.+ ++..||||+++... ....+.+.+|+.+++.++||||+++++++.+ ..++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~e~~~~~~ 81 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEAESWMLVMELAELGP 81 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCcEEEEecCCCCc
Confidence 589999999999965 45689999986543 2345678999999999999999999998854 4489999999999
Q ss_pred HHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCCccccc
Q 008365 309 LEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQ 388 (568)
Q Consensus 309 L~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~ 388 (568)
|.+++.... .+++..+..|+.|++.||.|||+.+ |+||||||.|||++.++.+||+|||+++.+...... .
T Consensus 82 L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~---~ 152 (257)
T cd05116 82 LNKFLQKNK---HVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENY---Y 152 (257)
T ss_pred HHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCe---e
Confidence 999986543 3789999999999999999999999 999999999999999999999999999866432211 0
Q ss_pred cccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh-CCCCCCCchH--HHHHHHhCccccccCccCCCCChHHH
Q 008365 389 YHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPMGLTHH--VSRAIEKGTLAEMLDPAVTDWPAEAA 465 (568)
Q Consensus 389 ~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~--~~~~~~~~~~~~~l~~~~~~~p~~~~ 465 (568)
.......++..|+|||++....++.++|||||||++|||++ |..||..... +...+..+. ....|..++
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~--------~~~~~~~~~ 224 (257)
T cd05116 153 KAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGE--------RMECPQRCP 224 (257)
T ss_pred eecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCC--------CCCCCCCCC
Confidence 11122345689999999988889999999999999999998 9999965432 222333221 123345567
Q ss_pred HHHHHHHHHhhccCCCCCCChHHhHh
Q 008365 466 ESFSKLAIQCAELRKKDRPDLGTVIV 491 (568)
Q Consensus 466 ~~l~~li~~Cl~~dP~~RPs~~~vl~ 491 (568)
..+.++|.+||+.+|.+||++..|+.
T Consensus 225 ~~l~~li~~~~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 225 PEMYDLMKLCWTYGVDERPGFAVVEL 250 (257)
T ss_pred HHHHHHHHHHhccCchhCcCHHHHHH
Confidence 78999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=338.82 Aligned_cols=253 Identities=22% Similarity=0.271 Sum_probs=196.1
Q ss_pred HHhcccccceeecccCceeEEEEEe--CCccEEEEEeCcC--hhHhHHHHHHHHHHHHcCCCCceeeeccccCC------
Q 008365 226 EATDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPD--AAQGKRQFQQEVEVLSSIRHPNMVLLLGACPD------ 295 (568)
Q Consensus 226 ~~~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~------ 295 (568)
...++|.+.+.||+|+||.||++.+ .+..||||++... .......+.+|+.+++.++||||++++++|..
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 3567899999999999999999986 5678999998653 22334567789999999999999999998732
Q ss_pred --CceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccc
Q 008365 296 --YGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVG 373 (568)
Q Consensus 296 --~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFG 373 (568)
..++||||++ ++|.+.+.. .+++..+..++.|++.||.|||+.+ |+||||||+||||+.++.+||+|||
T Consensus 94 ~~~~~lv~e~~~-~~l~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg 164 (355)
T cd07874 94 FQDVYLVMELMD-ANLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 164 (355)
T ss_pred cceeEEEhhhhc-ccHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCc
Confidence 2389999996 567666643 2788889999999999999999999 9999999999999999999999999
Q ss_pred cccccCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHH---HHh-C--
Q 008365 374 LARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRA---IEK-G-- 447 (568)
Q Consensus 374 la~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~---~~~-~-- 447 (568)
+++...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..... +.. +
T Consensus 165 ~~~~~~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 237 (355)
T cd07874 165 LARTAGTSF-------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP 237 (355)
T ss_pred ccccCCCcc-------ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 997653221 123457999999999999999999999999999999999999999654432211 000 0
Q ss_pred --------------------cc-----ccccCcc----CCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 448 --------------------TL-----AEMLDPA----VTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 448 --------------------~~-----~~~l~~~----~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
.. ...+... ....+...+..+.+|+.+||..||.+||++.+++.+.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~ 313 (355)
T cd07874 238 CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPY 313 (355)
T ss_pred CHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcc
Confidence 00 0000000 00112223457899999999999999999999986654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=342.70 Aligned_cols=249 Identities=24% Similarity=0.324 Sum_probs=196.1
Q ss_pred HhcccccceeecccCceeEEEEEe--CCccEEEEEeCcCh---hHhHHHHHHHHHHHHcCCCCceeeeccccCCC--ceE
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDA---AQGKRQFQQEVEVLSSIRHPNMVLLLGACPDY--GCL 299 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~--~~l 299 (568)
..++|++.+.||+|+||.||++.+ ++..||+|++.+.. ......+.+|+.+++.++||||++++++|.+. .|+
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l 120 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYM 120 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence 446799999999999999999987 46789999986432 22234578999999999999999999988554 489
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccC
Q 008365 300 VYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVP 379 (568)
Q Consensus 300 V~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~ 379 (568)
|||||+||+|.+++... .+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++..+.
T Consensus 121 v~Ey~~gg~L~~~l~~~----~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~ 193 (370)
T cd05621 121 VMEYMPGGDLVNLMSNY----DVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKMD 193 (370)
T ss_pred EEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccceecc
Confidence 99999999999988653 2788889999999999999999999 9999999999999999999999999998653
Q ss_pred CCCCccccccccccccccccCCChhhhhcCC----CCCcceehhHHHHHHHHHhCCCCCCCchHHHH--HHHhCcccccc
Q 008365 380 PSVADSVTQYHMTSAAGTFCYIDPEYQQTGM----LTTKSDIYSFGIMLLQIITARSPMGLTHHVSR--AIEKGTLAEML 453 (568)
Q Consensus 380 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~----~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~--~~~~~~~~~~l 453 (568)
... .......+||+.|+|||++.+.. ++.++|||||||++|+|++|+.||........ .+.....
T Consensus 194 ~~~-----~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~---- 264 (370)
T cd05621 194 ETG-----MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKN---- 264 (370)
T ss_pred cCC-----ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCc----
Confidence 221 11223567999999999887643 78999999999999999999999975543221 1111110
Q ss_pred CccCCCCCh--HHHHHHHHHHHHhhccCCC--CCCChHHhHhHHH
Q 008365 454 DPAVTDWPA--EAAESFSKLAIQCAELRKK--DRPDLGTVIVPEL 494 (568)
Q Consensus 454 ~~~~~~~p~--~~~~~l~~li~~Cl~~dP~--~RPs~~~vl~~~l 494 (568)
...+|. .++..+.+++..|+..++. .||++.+++.|.+
T Consensus 265 ---~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~ 306 (370)
T cd05621 265 ---SLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPF 306 (370)
T ss_pred ---ccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcc
Confidence 011222 3467788999999985554 3889999886654
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=332.31 Aligned_cols=252 Identities=24% Similarity=0.281 Sum_probs=194.5
Q ss_pred cccccceeecccCceeEEEEEe--CCccEEEEEeCcCh---hHhHHHHHHHHHHHHcCCCCceeeeccccCCC--ceEEE
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDA---AQGKRQFQQEVEVLSSIRHPNMVLLLGACPDY--GCLVY 301 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~--~~lV~ 301 (568)
++|.+.+.||+|+||.||++++ .+..||||++.+.. ......+.+|+.++..++|+||+.++++|.+. .|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 4799999999999999999987 45689999987532 22234578899999999999999999988543 48999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCC
Q 008365 302 EYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPS 381 (568)
Q Consensus 302 E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~ 381 (568)
||++||+|.+++..... .+++..+..++.|++.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+...
T Consensus 81 Ey~~gg~L~~~l~~~~~--~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 155 (331)
T cd05624 81 DYYVGGDLLTLLSKFED--RLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD 155 (331)
T ss_pred eCCCCCcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence 99999999999976432 3788899999999999999999999 999999999999999999999999999765332
Q ss_pred CCccccccccccccccccCCChhhhhc-----CCCCCcceehhHHHHHHHHHhCCCCCCCchHHHH--HHHhCccccccC
Q 008365 382 VADSVTQYHMTSAAGTFCYIDPEYQQT-----GMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSR--AIEKGTLAEMLD 454 (568)
Q Consensus 382 ~~~~~~~~~~~~~~GT~~Y~APE~~~~-----~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~--~~~~~~~~~~l~ 454 (568)
.. ......+||+.|+|||++.+ +.++.++|||||||++|+|++|+.||........ .+..... .
T Consensus 156 ~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~----~ 226 (331)
T cd05624 156 GT-----VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEE----R 226 (331)
T ss_pred Cc-----eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCC----c
Confidence 11 11223579999999998876 5688999999999999999999999975443221 1111110 0
Q ss_pred ccCCCCChHHHHHHHHHHHHhhccCCCC--CCChHHhHhHHH
Q 008365 455 PAVTDWPAEAAESFSKLAIQCAELRKKD--RPDLGTVIVPEL 494 (568)
Q Consensus 455 ~~~~~~p~~~~~~l~~li~~Cl~~dP~~--RPs~~~vl~~~l 494 (568)
..++....+++..+.+++.+|+..++.. |+++.+++.+.+
T Consensus 227 ~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~ 268 (331)
T cd05624 227 FQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAF 268 (331)
T ss_pred ccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCC
Confidence 1111112234677899999999865543 457777775543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=325.93 Aligned_cols=247 Identities=27% Similarity=0.449 Sum_probs=197.2
Q ss_pred cccccceeecccCceeEEEEEe------CCccEEEEEeCcCh-hHhHHHHHHHHHHHHcCCCCceeeeccccCC--CceE
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKL------DHTPVAIKVLRPDA-AQGKRQFQQEVEVLSSIRHPNMVLLLGACPD--YGCL 299 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~------~~~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--~~~l 299 (568)
+.|++.+.||+|+||.||+|.+ .+..||||.+.... ......+.+|+.+++.++||||+++++++.. ..|+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4578889999999999999974 34679999987533 3334678899999999999999999998744 4589
Q ss_pred EEEecCCCCHHHHHhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCc
Q 008365 300 VYEYMHNGSLEDRLLRRGN--------------TPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNY 365 (568)
Q Consensus 300 V~E~~~ggsL~~~l~~~~~--------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~ 365 (568)
||||+++++|.+++..... ...+++.....++.|++.||.|||+.+ |+||||||+|||++.++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence 9999999999999864321 124788889999999999999999999 99999999999999999
Q ss_pred eeEecccccccccCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh-CCCCCCCchH--HHH
Q 008365 366 VSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPMGLTHH--VSR 442 (568)
Q Consensus 366 ~vKL~DFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~--~~~ 442 (568)
.+||+|||+++.+..... ........++..|+|||++.+..++.++|||||||++|||++ |..||..... +..
T Consensus 162 ~~kl~dfg~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~ 237 (283)
T cd05090 162 HVKISDLGLSREIYSADY----YRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIE 237 (283)
T ss_pred cEEeccccccccccCCcc----eecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 999999999976533211 111233456788999999988889999999999999999998 9999964332 222
Q ss_pred HHHhCccccccCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhH
Q 008365 443 AIEKGTLAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVI 490 (568)
Q Consensus 443 ~~~~~~~~~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl 490 (568)
.+.... ....+..++..+.+++.+||+.+|.+||++.+|.
T Consensus 238 ~~~~~~--------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~ 277 (283)
T cd05090 238 MVRKRQ--------LLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIH 277 (283)
T ss_pred HHHcCC--------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHH
Confidence 222211 1123445667899999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=323.26 Aligned_cols=245 Identities=29% Similarity=0.522 Sum_probs=202.2
Q ss_pred hcccccceeecccCceeEEEEEe-CCccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCceeeeccccCC--CceEEEEec
Q 008365 228 TDKFSEAMKIGEGGYGPVYRGKL-DHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACPD--YGCLVYEYM 304 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~~~~-~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--~~~lV~E~~ 304 (568)
..+|.+.++||.|+||.||+|.+ .+..||+|++..........+..|+.+++.++||||+++++++.+ ..++||||+
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM 84 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence 45688899999999999999987 467899999987766566789999999999999999999998754 458999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCCc
Q 008365 305 HNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVAD 384 (568)
Q Consensus 305 ~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~~ 384 (568)
++++|.+++..... ..+++..+..++.||+.||.|||+.+ |+|+||||+||||+.++.+||+|||++..+.....
T Consensus 85 ~~~~L~~~~~~~~~-~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~- 159 (261)
T cd05148 85 EKGSLLAFLRSPEG-QVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY- 159 (261)
T ss_pred ccCCHHHHHhcCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCccc-
Confidence 99999999976433 24789999999999999999999999 99999999999999999999999999976533211
Q ss_pred cccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh-CCCCCCCchHH--HHHHHhCccccccCccCCCCC
Q 008365 385 SVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPMGLTHHV--SRAIEKGTLAEMLDPAVTDWP 461 (568)
Q Consensus 385 ~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~--~~~~~~~~~~~~l~~~~~~~p 461 (568)
......++..|++||.+.+..++.++|||||||++|+|++ |+.||...... ...+..+ .....+
T Consensus 160 -----~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~--------~~~~~~ 226 (261)
T cd05148 160 -----LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAG--------YRMPCP 226 (261)
T ss_pred -----cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhC--------CcCCCC
Confidence 1123446778999999988899999999999999999998 89999654322 1222111 111234
Q ss_pred hHHHHHHHHHHHHhhccCCCCCCChHHhH
Q 008365 462 AEAAESFSKLAIQCAELRKKDRPDLGTVI 490 (568)
Q Consensus 462 ~~~~~~l~~li~~Cl~~dP~~RPs~~~vl 490 (568)
..++..+.+++.+||+.+|.+||++.+++
T Consensus 227 ~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~ 255 (261)
T cd05148 227 AKCPQEIYKIMLECWAAEPEDRPSFKALR 255 (261)
T ss_pred CCCCHHHHHHHHHHcCCCchhCcCHHHHH
Confidence 56677899999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-39 Score=326.78 Aligned_cols=247 Identities=27% Similarity=0.458 Sum_probs=200.2
Q ss_pred cccccceeecccCceeEEEEEeC-------CccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCceeeeccccCC--CceE
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKLD-------HTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACPD--YGCL 299 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~~-------~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--~~~l 299 (568)
.+|.+...||+|+||.||+|... +..|++|.+..........+.+|+.+++.++||||+++++++.+ ..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 35788899999999999999752 34699999887766666789999999999999999999999854 3489
Q ss_pred EEEecCCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCce
Q 008365 300 VYEYMHNGSLEDRLLRRGN-------------TPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYV 366 (568)
Q Consensus 300 V~E~~~ggsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~ 366 (568)
||||+++++|.+++...+. ...+++..++.|+.||+.||.|||+.+ |+||||||+|||++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence 9999999999999976431 124789999999999999999999999 999999999999999999
Q ss_pred eEecccccccccCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh-CCCCCCCchH--HHHH
Q 008365 367 SKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPMGLTHH--VSRA 443 (568)
Q Consensus 367 vKL~DFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~--~~~~ 443 (568)
++|+|||+++....... ........|+..|+|||++.+..++.++|||||||++|+|++ |..||..... ....
T Consensus 162 ~~l~dfg~a~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~ 237 (291)
T cd05094 162 VKIGDFGMSRDVYSTDY----YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIEC 237 (291)
T ss_pred EEECCCCcccccCCCce----eecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 99999999975532211 111234557889999999999999999999999999999999 9999854433 1122
Q ss_pred HHhCccccccCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhH
Q 008365 444 IEKGTLAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVI 490 (568)
Q Consensus 444 ~~~~~~~~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl 490 (568)
+..+. ....+..++..+.+++.+||+.+|.+||++.+|+
T Consensus 238 ~~~~~--------~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~ 276 (291)
T cd05094 238 ITQGR--------VLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIY 276 (291)
T ss_pred HhCCC--------CCCCCccCCHHHHHHHHHHcccChhhCcCHHHHH
Confidence 22221 1122334567799999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-39 Score=342.41 Aligned_cols=248 Identities=26% Similarity=0.410 Sum_probs=197.5
Q ss_pred hcccccceeecccCceeEEEEEeCC-------ccEEEEEeCcCh-hHhHHHHHHHHHHHHcCC-CCceeeeccccCCC--
Q 008365 228 TDKFSEAMKIGEGGYGPVYRGKLDH-------TPVAIKVLRPDA-AQGKRQFQQEVEVLSSIR-HPNMVLLLGACPDY-- 296 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~~~~~~-------~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l~-HpnIv~l~g~~~~~-- 296 (568)
.++|.+.++||+|+||.||+|.+.+ ..||||++.... ....+.+.+|+.+|+.+. |||||+++++|.+.
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 4678899999999999999998632 359999997543 333467899999999996 99999999999654
Q ss_pred ceEEEEecCCCCHHHHHhhcCC----------------------------------------------------------
Q 008365 297 GCLVYEYMHNGSLEDRLLRRGN---------------------------------------------------------- 318 (568)
Q Consensus 297 ~~lV~E~~~ggsL~~~l~~~~~---------------------------------------------------------- 318 (568)
.|||||||++|+|.++|.....
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 4899999999999998865321
Q ss_pred -----------------------------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccC
Q 008365 319 -----------------------------------TPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDR 363 (568)
Q Consensus 319 -----------------------------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~ 363 (568)
...+++..+..++.||+.||.|||+.+ |+||||||+|||++.
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~~ 272 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEeC
Confidence 123778888999999999999999999 999999999999999
Q ss_pred CceeEecccccccccCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh-CCCCCCCchH---
Q 008365 364 NYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPMGLTHH--- 439 (568)
Q Consensus 364 ~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~--- 439 (568)
++.+||+|||+++.+..... ........+++.|+|||++.+..++.++|||||||++|+|++ |..||.....
T Consensus 273 ~~~~kL~DfGla~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~ 348 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSN----YVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST 348 (400)
T ss_pred CCEEEEEeCCcceecccccc----ccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH
Confidence 99999999999986533211 111233457889999999998899999999999999999997 9999964321
Q ss_pred HHHHHHhCccccccCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhH
Q 008365 440 VSRAIEKGTLAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVI 490 (568)
Q Consensus 440 ~~~~~~~~~~~~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl 490 (568)
+...+..+. ....+..++..+.+++.+||+.+|.+||++.+|+
T Consensus 349 ~~~~~~~~~--------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~ 391 (400)
T cd05105 349 FYNKIKSGY--------RMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLS 391 (400)
T ss_pred HHHHHhcCC--------CCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHH
Confidence 112221111 1123445677899999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=337.05 Aligned_cols=235 Identities=25% Similarity=0.325 Sum_probs=188.5
Q ss_pred eeecccCceeEEEEEe--CCccEEEEEeCcChh---HhHHHHHHHHHHHHc-CCCCceeeeccccCCC--ceEEEEecCC
Q 008365 235 MKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAA---QGKRQFQQEVEVLSS-IRHPNMVLLLGACPDY--GCLVYEYMHN 306 (568)
Q Consensus 235 ~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~---~~~~~~~~Ev~iL~~-l~HpnIv~l~g~~~~~--~~lV~E~~~g 306 (568)
+.||+|+||.||+|.+ ++..||||+++.... .....+..|..++.. ++||||++++++|.+. .++||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 3699999999999987 567899999976432 223456678888875 4899999999988554 4899999999
Q ss_pred CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCCccc
Q 008365 307 GSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSV 386 (568)
Q Consensus 307 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~~~~ 386 (568)
|+|.+++...+ .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 g~L~~~i~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~----- 149 (316)
T cd05620 81 GDLMFHIQDKG---RFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG----- 149 (316)
T ss_pred CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccC-----
Confidence 99999887653 3788899999999999999999999 999999999999999999999999998743211
Q ss_pred cccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHH--HHHHhCccccccCccCCCCChHH
Q 008365 387 TQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVS--RAIEKGTLAEMLDPAVTDWPAEA 464 (568)
Q Consensus 387 ~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~--~~~~~~~~~~~l~~~~~~~p~~~ 464 (568)
.......+||+.|+|||++.+..++.++|||||||++|+|++|..||....... ..+.. .....|..+
T Consensus 150 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~---------~~~~~~~~~ 219 (316)
T cd05620 150 -DNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRV---------DTPHYPRWI 219 (316)
T ss_pred -CCceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh---------CCCCCCCCC
Confidence 112245679999999999999999999999999999999999999996544321 11111 112234445
Q ss_pred HHHHHHHHHHhhccCCCCCCChH-HhH
Q 008365 465 AESFSKLAIQCAELRKKDRPDLG-TVI 490 (568)
Q Consensus 465 ~~~l~~li~~Cl~~dP~~RPs~~-~vl 490 (568)
+..+.+++.+||..+|.+||++. +++
T Consensus 220 ~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 220 TKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 67789999999999999999985 454
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-39 Score=321.19 Aligned_cols=247 Identities=28% Similarity=0.481 Sum_probs=198.7
Q ss_pred cccccceeecccCceeEEEEEeC-----CccEEEEEeCcCh-hHhHHHHHHHHHHHHcCCCCceeeeccccCC--CceEE
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKLD-----HTPVAIKVLRPDA-AQGKRQFQQEVEVLSSIRHPNMVLLLGACPD--YGCLV 300 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~~-----~~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--~~~lV 300 (568)
++|.+.+.||+|+||.||+|.+. ...||||++.... ......|.+|+.+++.++||||+++++++.+ ..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 56889999999999999999873 2479999987543 3334578899999999999999999998754 34899
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCC
Q 008365 301 YEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPP 380 (568)
Q Consensus 301 ~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~ 380 (568)
|||+++++|.+++..... .+++..+..++.|++.||.|||+.+ |+|+||||+||||+.++.+||+|||+++.+..
T Consensus 84 ~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd05033 84 TEYMENGSLDKFLRENDG--KFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLED 158 (266)
T ss_pred EEcCCCCCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence 999999999999876443 4889999999999999999999999 99999999999999999999999999987642
Q ss_pred CCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh-CCCCCCCchH--HHHHHHhCccccccCccC
Q 008365 381 SVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPMGLTHH--VSRAIEKGTLAEMLDPAV 457 (568)
Q Consensus 381 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~--~~~~~~~~~~~~~l~~~~ 457 (568)
... ........+++.|+|||.+.+..++.++|||||||++|+|++ |..||..... +...+..+. .
T Consensus 159 ~~~----~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~--------~ 226 (266)
T cd05033 159 SEA----TYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGY--------R 226 (266)
T ss_pred ccc----ceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCC--------C
Confidence 111 111123345678999999998899999999999999999998 9999954332 112222111 1
Q ss_pred CCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhH
Q 008365 458 TDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVP 492 (568)
Q Consensus 458 ~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~ 492 (568)
...+..++..+.+++.+||+.+|.+||++.+|+..
T Consensus 227 ~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 227 LPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 12234556789999999999999999999998743
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=327.07 Aligned_cols=243 Identities=34% Similarity=0.591 Sum_probs=190.9
Q ss_pred cceeecccCceeEEEEEeC------CccEEEEEeCcCh-hHhHHHHHHHHHHHHcCCCCceeeeccccCC--CceEEEEe
Q 008365 233 EAMKIGEGGYGPVYRGKLD------HTPVAIKVLRPDA-AQGKRQFQQEVEVLSSIRHPNMVLLLGACPD--YGCLVYEY 303 (568)
Q Consensus 233 ~~~~IG~G~fg~Vy~~~~~------~~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--~~~lV~E~ 303 (568)
+.+.||.|.||.||+|.+. +..|+||+++... ......|.+|++++++++||||++++|+|.+ ..++||||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 4578999999999999887 5689999996643 3346789999999999999999999999863 34899999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCC
Q 008365 304 MHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVA 383 (568)
Q Consensus 304 ~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~ 383 (568)
+++|+|.++|..... ..+++..+..|+.||+.||.|||+.+ |+|+||+++||||+.++.+||+|||++........
T Consensus 83 ~~~g~L~~~L~~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 83 CPGGSLDDYLKSKNK-EPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp -TTEBHHHHHHHTCT-TTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred ccccccccccccccc-cccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence 999999999988722 24899999999999999999999999 99999999999999999999999999986622111
Q ss_pred ccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh-CCCCCCCchHH--HHHHHhCccccccCccCCCC
Q 008365 384 DSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPMGLTHHV--SRAIEKGTLAEMLDPAVTDW 460 (568)
Q Consensus 384 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~--~~~~~~~~~~~~l~~~~~~~ 460 (568)
........+...|+|||.+.+..++.++||||||+++|||++ |+.||...... ...+..+.. ...
T Consensus 159 ----~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~--------~~~ 226 (259)
T PF07714_consen 159 ----YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQR--------LPI 226 (259)
T ss_dssp ----EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEE--------TTS
T ss_pred ----ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc--------cee
Confidence 112233457789999999999999999999999999999999 78999654332 222222221 223
Q ss_pred ChHHHHHHHHHHHHhhccCCCCCCChHHhHh
Q 008365 461 PAEAAESFSKLAIQCAELRKKDRPDLGTVIV 491 (568)
Q Consensus 461 p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~ 491 (568)
+..++..+.+++..||..+|.+||++.+|+.
T Consensus 227 ~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 227 PDNCPKDIYSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp BTTSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred ccchhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 4456677999999999999999999999873
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=319.17 Aligned_cols=253 Identities=25% Similarity=0.417 Sum_probs=201.3
Q ss_pred ccccceeecccCceeEEEEEe-CCccEEEEEeCcCh------hHhHHHHHHHHHHHHcCCCCceeeeccccCCC--ceEE
Q 008365 230 KFSEAMKIGEGGYGPVYRGKL-DHTPVAIKVLRPDA------AQGKRQFQQEVEVLSSIRHPNMVLLLGACPDY--GCLV 300 (568)
Q Consensus 230 ~y~~~~~IG~G~fg~Vy~~~~-~~~~vAvK~l~~~~------~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~--~~lV 300 (568)
+|.+.+.||.|+||.||+|.. ++..+|||.+.... ......+.+|+.+|+.++|+||++++++|.+. .++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 478889999999999999987 66789999886432 22235688999999999999999999998554 4899
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCC
Q 008365 301 YEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPP 380 (568)
Q Consensus 301 ~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~ 380 (568)
|||+++++|.+++...+ .+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.+||+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 154 (265)
T cd06631 81 MEFVPGGSISSILNRFG---PLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW 154 (265)
T ss_pred EecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence 99999999999997654 3788899999999999999999999 99999999999999999999999999976532
Q ss_pred CCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHhCccccccCccCCCC
Q 008365 381 SVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAVTDW 460 (568)
Q Consensus 381 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~l~~~~~~~ 460 (568)
...............|+..|+|||++.+..++.++|||||||++|+|++|..||.................. ....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~----~~~~ 230 (265)
T cd06631 155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGL----MPRL 230 (265)
T ss_pred ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCC----CCCC
Confidence 111111111223456899999999999989999999999999999999999999765543332221111111 1223
Q ss_pred ChHHHHHHHHHHHHhhccCCCCCCChHHhHhH
Q 008365 461 PAEAAESFSKLAIQCAELRKKDRPDLGTVIVP 492 (568)
Q Consensus 461 p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~ 492 (568)
+...+..+..++.+||..+|.+||++.+++.+
T Consensus 231 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 262 (265)
T cd06631 231 PDSFSAAAIDFVTSCLTRDQHERPSALQLLRH 262 (265)
T ss_pred CCCCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 44556778999999999999999999998754
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=326.28 Aligned_cols=248 Identities=26% Similarity=0.402 Sum_probs=197.7
Q ss_pred cccccceeecccCceeEEEEEeC-------CccEEEEEeCcChh-HhHHHHHHHHHHHHcCCCCceeeeccccCC--Cce
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKLD-------HTPVAIKVLRPDAA-QGKRQFQQEVEVLSSIRHPNMVLLLGACPD--YGC 298 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~~-------~~~vAvK~l~~~~~-~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--~~~ 298 (568)
.+|.+.+.||.|+||.||+|.+. +..||||+++.... .....+.+|+.++..++||||+++++++.+ ..+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 35777889999999999999863 35799999975533 234568899999999999999999998854 448
Q ss_pred EEEEecCCCCHHHHHhhcC-------------CCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCc
Q 008365 299 LVYEYMHNGSLEDRLLRRG-------------NTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNY 365 (568)
Q Consensus 299 lV~E~~~ggsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~ 365 (568)
+++||+.+++|.+++.... ....+++..+..++.|++.||.|||+.+ |+||||||+|||+++++
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKL 161 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCC
Confidence 8999999999999985321 1124788889999999999999999999 99999999999999999
Q ss_pred eeEecccccccccCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh-CCCCCCCchH--HHH
Q 008365 366 VSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPMGLTHH--VSR 442 (568)
Q Consensus 366 ~vKL~DFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~--~~~ 442 (568)
.+||+|||+++.+..... ........+++.|+|||.+.++.++.++|||||||++|||++ |..||..... +..
T Consensus 162 ~~kl~Dfg~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~ 237 (283)
T cd05091 162 NVKISDLGLFREVYAADY----YKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIE 237 (283)
T ss_pred ceEecccccccccccchh----eeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 999999999886532211 111233456789999999988889999999999999999998 8889864332 222
Q ss_pred HHHhCccccccCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHh
Q 008365 443 AIEKGTLAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIV 491 (568)
Q Consensus 443 ~~~~~~~~~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~ 491 (568)
.+.. .....++.+++..+.+|+..||+.+|.+||++.+|+.
T Consensus 238 ~i~~--------~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~ 278 (283)
T cd05091 238 MIRN--------RQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHS 278 (283)
T ss_pred HHHc--------CCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 2222 2222345567788999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=322.59 Aligned_cols=246 Identities=24% Similarity=0.422 Sum_probs=196.2
Q ss_pred cccccceeecccCceeEEEEEe--CCc----cEEEEEeCcCh-hHhHHHHHHHHHHHHcCCCCceeeeccccCCC-ceEE
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKL--DHT----PVAIKVLRPDA-AQGKRQFQQEVEVLSSIRHPNMVLLLGACPDY-GCLV 300 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~--~~~----~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~-~~lV 300 (568)
++|++.+.||+|+||.||+|.+ ++. .|++|.+.... ......+..|+.+++.++||||+++++++... .++|
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~~~~~~i 86 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPGASLQLV 86 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECCCccEEE
Confidence 4688889999999999999987 344 47788875432 22345678889999999999999999988544 4789
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCC
Q 008365 301 YEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPP 380 (568)
Q Consensus 301 ~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~ 380 (568)
+||+++|+|.+++..... .+++..+..|+.||+.||.|||+.+ ++||||||+|||++.++.+||+|||+++.+..
T Consensus 87 ~e~~~~gsL~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~ 161 (279)
T cd05111 87 TQLSPLGSLLDHVRQHRD--SLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYP 161 (279)
T ss_pred EEeCCCCcHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence 999999999999976443 3899999999999999999999999 99999999999999999999999999986643
Q ss_pred CCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh-CCCCCCCchH--HHHHHHhCccccccCccC
Q 008365 381 SVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPMGLTHH--VSRAIEKGTLAEMLDPAV 457 (568)
Q Consensus 381 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~--~~~~~~~~~~~~~l~~~~ 457 (568)
... ........++..|+|||++.++.++.++|||||||++|||++ |..||..... +...+..+...
T Consensus 162 ~~~----~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~------- 230 (279)
T cd05111 162 DDK----KYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERL------- 230 (279)
T ss_pred CCc----ccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcC-------
Confidence 221 111233557788999999998899999999999999999998 9999965433 22233222211
Q ss_pred CCCChHHHHHHHHHHHHhhccCCCCCCChHHhHh
Q 008365 458 TDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIV 491 (568)
Q Consensus 458 ~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~ 491 (568)
..+..++..+..++.+||..+|..||++.+++.
T Consensus 231 -~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 231 -AQPQICTIDVYMVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred -CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 112234556888999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=351.00 Aligned_cols=252 Identities=22% Similarity=0.323 Sum_probs=192.5
Q ss_pred hcccccceeecccCceeEEEEEe--CCccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCceeeeccccCC----------
Q 008365 228 TDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACPD---------- 295 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~---------- 295 (568)
..+|.+.++||+|+||.||+|.+ .+..||||++.... ....+|+.+|+.++|||||+++++|..
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 140 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI 140 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence 35799999999999999999987 56789999886442 234579999999999999999876521
Q ss_pred CceEEEEecCCCCHHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCC-ceeEecccc
Q 008365 296 YGCLVYEYMHNGSLEDRLLRR-GNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRN-YVSKISDVG 373 (568)
Q Consensus 296 ~~~lV~E~~~ggsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~-~~vKL~DFG 373 (568)
..++||||++ ++|.+++... .....+++..+..|+.||+.||.|||+.+ |+||||||+||||+.+ +.+||+|||
T Consensus 141 ~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DFG 216 (440)
T PTZ00036 141 FLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFG 216 (440)
T ss_pred EEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeeccc
Confidence 1358999996 5777766532 22235889999999999999999999999 9999999999999865 479999999
Q ss_pred cccccCCCCCccccccccccccccccCCChhhhhc-CCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHH---HHh-Cc
Q 008365 374 LARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQT-GMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRA---IEK-GT 448 (568)
Q Consensus 374 la~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~---~~~-~~ 448 (568)
+|+.+.... .....+||+.|+|||++.+ ..++.++|||||||++|||++|.+||......... +.. +.
T Consensus 217 la~~~~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~ 289 (440)
T PTZ00036 217 SAKNLLAGQ-------RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGT 289 (440)
T ss_pred cchhccCCC-------CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence 998653321 1234578999999998765 46999999999999999999999999754432221 110 00
Q ss_pred ------------cccccCccC------CCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 449 ------------LAEMLDPAV------TDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 449 ------------~~~~l~~~~------~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
+....-+.+ ..+|...+..+.+|+.+||..+|.+||++.+++.|.+
T Consensus 290 p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~ 353 (440)
T PTZ00036 290 PTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPF 353 (440)
T ss_pred CCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChh
Confidence 000000000 0123345678999999999999999999999998776
|
|
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=318.95 Aligned_cols=245 Identities=29% Similarity=0.501 Sum_probs=198.3
Q ss_pred hcccccceeecccCceeEEEEEe-CCccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCceeeeccccCC-CceEEEEecC
Q 008365 228 TDKFSEAMKIGEGGYGPVYRGKL-DHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACPD-YGCLVYEYMH 305 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~~~~-~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~-~~~lV~E~~~ 305 (568)
.++|++.++||+|+||.||+|.+ .+..||+|.+..... ....+.+|+.++++++||||+++++++.+ ..++||||++
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~lv~e~~~ 83 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVSEEPIYIVTEYMS 83 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEECCCCcEEEEEecC
Confidence 35688999999999999999987 456799999876443 24578999999999999999999998754 4589999999
Q ss_pred CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCCcc
Q 008365 306 NGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADS 385 (568)
Q Consensus 306 ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~~~ 385 (568)
+++|.+++..... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++..+......
T Consensus 84 ~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~- 158 (260)
T cd05070 84 KGSLLDFLKDGEG-RALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT- 158 (260)
T ss_pred CCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCcccc-
Confidence 9999999876432 24789999999999999999999999 999999999999999999999999999765432110
Q ss_pred ccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh-CCCCCCCchHHH--HHHHhCccccccCccCCCCCh
Q 008365 386 VTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPMGLTHHVS--RAIEKGTLAEMLDPAVTDWPA 462 (568)
Q Consensus 386 ~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~--~~~~~~~~~~~l~~~~~~~p~ 462 (568)
......++..|+|||++.+..++.++|||||||++|+|++ |.+||....... ..+..+ .....+.
T Consensus 159 ----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~--------~~~~~~~ 226 (260)
T cd05070 159 ----ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERG--------YRMPCPQ 226 (260)
T ss_pred ----cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC--------CCCCCCC
Confidence 1122345678999999988889999999999999999999 899996543322 111111 1112344
Q ss_pred HHHHHHHHHHHHhhccCCCCCCChHHhH
Q 008365 463 EAAESFSKLAIQCAELRKKDRPDLGTVI 490 (568)
Q Consensus 463 ~~~~~l~~li~~Cl~~dP~~RPs~~~vl 490 (568)
..+..+.+|+.+||..+|.+||++.+++
T Consensus 227 ~~~~~~~~li~~~l~~~p~~Rpt~~~l~ 254 (260)
T cd05070 227 DCPISLHELMLQCWKKDPEERPTFEYLQ 254 (260)
T ss_pred cCCHHHHHHHHHHcccCcccCcCHHHHH
Confidence 5667899999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=319.17 Aligned_cols=250 Identities=23% Similarity=0.359 Sum_probs=201.2
Q ss_pred cccccceeecccCceeEEEEEe--CCccEEEEEeCcCh-----hHhHHHHHHHHHHHHcCCCCceeeeccccCCC--ceE
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDA-----AQGKRQFQQEVEVLSSIRHPNMVLLLGACPDY--GCL 299 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~-----~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~--~~l 299 (568)
++|.+.+.||.|+||.||++.+ .+..||||++.... ......+.+|+.+++.++||||+++++++.+. .++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 4688999999999999999976 56899999986532 12235688999999999999999999998554 489
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccC
Q 008365 300 VYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVP 379 (568)
Q Consensus 300 V~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~ 379 (568)
||||+++++|.+++...+ .+++..+..++.|++.||.|||..+ |+||||+|+||+++.++.++|+|||+++.+.
T Consensus 82 v~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~ 155 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYG---ALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ 155 (263)
T ss_pred EEEECCCCcHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence 999999999999887654 3788889999999999999999999 9999999999999999999999999997653
Q ss_pred CCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHhCccccccCccCCC
Q 008365 380 PSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAVTD 459 (568)
Q Consensus 380 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~l~~~~~~ 459 (568)
..... ........|+..|+|||++.+..++.++|||||||++|+|++|+.||.............. ......
T Consensus 156 ~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~-----~~~~~~ 227 (263)
T cd06625 156 TICSS---GTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIAT-----QPTNPQ 227 (263)
T ss_pred ccccc---cccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhc-----cCCCCC
Confidence 32111 0111235688999999999998899999999999999999999999965544332221111 111123
Q ss_pred CChHHHHHHHHHHHHhhccCCCCCCChHHhHhH
Q 008365 460 WPAEAAESFSKLAIQCAELRKKDRPDLGTVIVP 492 (568)
Q Consensus 460 ~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~ 492 (568)
.+..++..+.+++.+||..+|.+||++.+++.+
T Consensus 228 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 228 LPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred CCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 345566789999999999999999999999854
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=335.92 Aligned_cols=236 Identities=26% Similarity=0.324 Sum_probs=188.5
Q ss_pred eeecccCceeEEEEEe--CCccEEEEEeCcChh---HhHHHHHHHHHHHHc-CCCCceeeeccccCCC--ceEEEEecCC
Q 008365 235 MKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAA---QGKRQFQQEVEVLSS-IRHPNMVLLLGACPDY--GCLVYEYMHN 306 (568)
Q Consensus 235 ~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~---~~~~~~~~Ev~iL~~-l~HpnIv~l~g~~~~~--~~lV~E~~~g 306 (568)
+.||+|+||.||+|.+ .+..||||+++.... .....+..|..++.. ++||||+++++++.+. .++||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 3699999999999987 456899999976431 223456678888876 5899999999988544 4899999999
Q ss_pred CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCCccc
Q 008365 307 GSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSV 386 (568)
Q Consensus 307 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~~~~ 386 (568)
|+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 g~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~---- 150 (316)
T cd05619 81 GDLMFHIQSCH---KFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD---- 150 (316)
T ss_pred CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCC----
Confidence 99999887643 3788899999999999999999999 9999999999999999999999999987432111
Q ss_pred cccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHH--HHHHhCccccccCccCCCCChHH
Q 008365 387 TQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVS--RAIEKGTLAEMLDPAVTDWPAEA 464 (568)
Q Consensus 387 ~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~--~~~~~~~~~~~l~~~~~~~p~~~ 464 (568)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||....... ..+... . ..+|..+
T Consensus 151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~------~---~~~~~~~ 219 (316)
T cd05619 151 --AKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMD------N---PCYPRWL 219 (316)
T ss_pred --CceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC------C---CCCCccC
Confidence 11234679999999999999999999999999999999999999996544321 112111 1 1223345
Q ss_pred HHHHHHHHHHhhccCCCCCCChH-HhHh
Q 008365 465 AESFSKLAIQCAELRKKDRPDLG-TVIV 491 (568)
Q Consensus 465 ~~~l~~li~~Cl~~dP~~RPs~~-~vl~ 491 (568)
+..+.+++.+||+.+|.+||++. ++..
T Consensus 220 ~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 220 TREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred CHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 66789999999999999999997 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=325.01 Aligned_cols=251 Identities=26% Similarity=0.339 Sum_probs=198.0
Q ss_pred ccccceeecccCceeEEEEEe--CCccEEEEEeCcChhH---hHHHHHHHHHHHHcCCCCceeeeccccCC--CceEEEE
Q 008365 230 KFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQ---GKRQFQQEVEVLSSIRHPNMVLLLGACPD--YGCLVYE 302 (568)
Q Consensus 230 ~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~---~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--~~~lV~E 302 (568)
.|+..+.||.|+||+||++.+ +++.||+|++...... ....+.+|+.+|+.++|+||+.+++.|.+ ..|+|||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 377788999999999999987 5678999998654322 23457789999999999999999987744 4589999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCC
Q 008365 303 YMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSV 382 (568)
Q Consensus 303 ~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~ 382 (568)
|+++++|.+++...+.. .+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~~~-~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05632 81 IMNGGDLKFHIYNMGNP-GFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE 156 (285)
T ss_pred eccCccHHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCC
Confidence 99999999888765432 4899999999999999999999999 9999999999999999999999999997653211
Q ss_pred CccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHhCccccccCccCCCCCh
Q 008365 383 ADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAVTDWPA 462 (568)
Q Consensus 383 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~l~~~~~~~p~ 462 (568)
......|++.|+|||++.+..++.++|||||||++|+|++|..||........... +...+......++.
T Consensus 157 -------~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~---~~~~~~~~~~~~~~ 226 (285)
T cd05632 157 -------SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREE---VDRRVLETEEVYSA 226 (285)
T ss_pred -------cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHhhhccccccCc
Confidence 11345799999999999989999999999999999999999999975433211100 00011111112344
Q ss_pred HHHHHHHHHHHHhhccCCCCCCC-----hHHhHhHHH
Q 008365 463 EAAESFSKLAIQCAELRKKDRPD-----LGTVIVPEL 494 (568)
Q Consensus 463 ~~~~~l~~li~~Cl~~dP~~RPs-----~~~vl~~~l 494 (568)
..+..+.+|+..||+.+|.+||+ +.+++.+.+
T Consensus 227 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~ 263 (285)
T cd05632 227 KFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPF 263 (285)
T ss_pred cCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChh
Confidence 55667899999999999999999 566665543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=324.74 Aligned_cols=251 Identities=26% Similarity=0.420 Sum_probs=194.8
Q ss_pred cc-ccceeecccCceeEEEEEe------CCccEEEEEeCcChh-HhHHHHHHHHHHHHcCCCCceeeeccccCC----Cc
Q 008365 230 KF-SEAMKIGEGGYGPVYRGKL------DHTPVAIKVLRPDAA-QGKRQFQQEVEVLSSIRHPNMVLLLGACPD----YG 297 (568)
Q Consensus 230 ~y-~~~~~IG~G~fg~Vy~~~~------~~~~vAvK~l~~~~~-~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~----~~ 297 (568)
+| .+.+.||+|+||+||++.. .+..||+|+++.... .....+.+|+++|+.++||||++++++|.. ..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (283)
T cd05080 4 RYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGL 83 (283)
T ss_pred hhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceE
Confidence 44 8889999999999988653 456899999976532 334678899999999999999999998743 24
Q ss_pred eEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccc
Q 008365 298 CLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARL 377 (568)
Q Consensus 298 ~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~ 377 (568)
++||||+++++|.+++... .+++..++.|+.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 84 ~lv~e~~~~~~l~~~~~~~----~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~ 156 (283)
T cd05080 84 QLIMEYVPLGSLRDYLPKH----KLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKA 156 (283)
T ss_pred EEEecCCCCCCHHHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccc
Confidence 7999999999999998654 2899999999999999999999999 99999999999999999999999999986
Q ss_pred cCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchH-HHHHHHh-------Ccc
Q 008365 378 VPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHH-VSRAIEK-------GTL 449 (568)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~-~~~~~~~-------~~~ 449 (568)
+...... ........++..|+|||++.+..++.++|||||||++|+|++|..||..... ....+.. ..+
T Consensus 157 ~~~~~~~---~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd05080 157 VPEGHEY---YRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRL 233 (283)
T ss_pred cCCcchh---hccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhh
Confidence 6432110 0011223456779999999888899999999999999999999999854322 1111100 000
Q ss_pred ccccCcc-CCCCChHHHHHHHHHHHHhhccCCCCCCChHHhH
Q 008365 450 AEMLDPA-VTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVI 490 (568)
Q Consensus 450 ~~~l~~~-~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl 490 (568)
...++.. ....+..++..+.+++.+||+.+|.+||++.+|+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~ 275 (283)
T cd05080 234 IELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLI 275 (283)
T ss_pred hhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHH
Confidence 1111111 1123445678899999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-39 Score=339.42 Aligned_cols=253 Identities=23% Similarity=0.307 Sum_probs=195.7
Q ss_pred ccccceeecccCceeEEEEEe--CCccEEEEEeCcC--hhHhHHHHHHHHHHHHcCCCCceeeeccccCC-------Cce
Q 008365 230 KFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPD--AAQGKRQFQQEVEVLSSIRHPNMVLLLGACPD-------YGC 298 (568)
Q Consensus 230 ~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~-------~~~ 298 (568)
+|++.+.||+|+||.||++.+ +++.||||++... .......+.+|+.+|+.++||||+++++++.. ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 478889999999999999986 6789999998643 22334568899999999999999999998843 348
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEeccccccccc
Q 008365 299 LVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLV 378 (568)
Q Consensus 299 lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~ 378 (568)
+||||+. ++|.+++.... .+++..+..|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~l~~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~ 153 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSPQ---PLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVE 153 (372)
T ss_pred EEeeccc-cCHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeec
Confidence 9999995 68888775433 3889999999999999999999999 999999999999999999999999999865
Q ss_pred CCCCCccccccccccccccccCCChhhhhcC-CCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHh----C------
Q 008365 379 PPSVADSVTQYHMTSAAGTFCYIDPEYQQTG-MLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEK----G------ 447 (568)
Q Consensus 379 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~----~------ 447 (568)
..... .......+|+.|+|||++.+. .++.++|||||||++|||++|+.||...+........ +
T Consensus 154 ~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~ 228 (372)
T cd07853 154 EPDES-----KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEA 228 (372)
T ss_pred ccCcc-----ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHH
Confidence 33211 122345689999999988764 5899999999999999999999999654432211000 0
Q ss_pred ------cccccc-----Cc----cCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 448 ------TLAEML-----DP----AVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 448 ------~~~~~l-----~~----~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
.....+ .+ .........+..+.+|+.+||+.||.+||++.+++.+.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~ 290 (372)
T cd07853 229 MRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPY 290 (372)
T ss_pred HHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHh
Confidence 000000 00 000112234567899999999999999999999987665
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-39 Score=334.85 Aligned_cols=251 Identities=28% Similarity=0.433 Sum_probs=197.5
Q ss_pred hcccccceeecccCceeEEEEEeC-------CccEEEEEeCcCh-hHhHHHHHHHHHHHHcC-CCCceeeeccccCC---
Q 008365 228 TDKFSEAMKIGEGGYGPVYRGKLD-------HTPVAIKVLRPDA-AQGKRQFQQEVEVLSSI-RHPNMVLLLGACPD--- 295 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~~~~~-------~~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l-~HpnIv~l~g~~~~--- 295 (568)
.++|++.+.||.|+||.||+|... ++.||+|+++... ....+.+..|+.++.++ +||||++++++|..
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 357899999999999999999642 3579999987543 23345678899999999 79999999998743
Q ss_pred CceEEEEecCCCCHHHHHhhcCC---------------------------------------------------------
Q 008365 296 YGCLVYEYMHNGSLEDRLLRRGN--------------------------------------------------------- 318 (568)
Q Consensus 296 ~~~lV~E~~~ggsL~~~l~~~~~--------------------------------------------------------- 318 (568)
..++||||+++|+|.+++.....
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 34789999999999999864321
Q ss_pred -CCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCCcccccccccccccc
Q 008365 319 -TPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGT 397 (568)
Q Consensus 319 -~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~GT 397 (568)
...+++..+..++.||+.||.|||+.+ |+||||||.|||++.++.+||+|||+++.+..... ........++
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~----~~~~~~~~~~ 238 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPD----YVRKGDARLP 238 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcc----hhhccCCCCC
Confidence 124789999999999999999999999 99999999999999999999999999986533211 1112334567
Q ss_pred ccCCChhhhhcCCCCCcceehhHHHHHHHHHh-CCCCCCCch---HHHHHHHhCccccccCccCCCCChHHHHHHHHHHH
Q 008365 398 FCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPMGLTH---HVSRAIEKGTLAEMLDPAVTDWPAEAAESFSKLAI 473 (568)
Q Consensus 398 ~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~---~~~~~~~~~~~~~~l~~~~~~~p~~~~~~l~~li~ 473 (568)
..|+|||++.+..++.++|||||||++|+|++ |..||.... .....+..+.. ...+...+..+.+++.
T Consensus 239 ~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~l~~ 310 (337)
T cd05054 239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTR--------MRAPEYATPEIYSIML 310 (337)
T ss_pred ccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCC--------CCCCccCCHHHHHHHH
Confidence 88999999999999999999999999999998 999995422 12222222211 1123345567999999
Q ss_pred HhhccCCCCCCChHHhHhHH
Q 008365 474 QCAELRKKDRPDLGTVIVPE 493 (568)
Q Consensus 474 ~Cl~~dP~~RPs~~~vl~~~ 493 (568)
+||+.+|.+||++.+|+.++
T Consensus 311 ~cl~~~p~~RPs~~ell~~l 330 (337)
T cd05054 311 DCWHNNPEDRPTFSELVEIL 330 (337)
T ss_pred HHccCChhhCcCHHHHHHHH
Confidence 99999999999999987543
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-39 Score=325.76 Aligned_cols=251 Identities=25% Similarity=0.369 Sum_probs=192.4
Q ss_pred ccccceeecccCceeEEEEEe--CCccEEEEEeCcChhH--hHHHHHHHHHHHHcC---CCCceeeeccccCC-------
Q 008365 230 KFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQ--GKRQFQQEVEVLSSI---RHPNMVLLLGACPD------- 295 (568)
Q Consensus 230 ~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~--~~~~~~~Ev~iL~~l---~HpnIv~l~g~~~~------- 295 (568)
+|++.+.||+|+||.||+|.+ +++.||||+++..... ....+.+|+.+++.+ +||||++++++|.+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 488899999999999999987 5678999998754221 123456777777665 79999999998743
Q ss_pred CceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccc
Q 008365 296 YGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLA 375 (568)
Q Consensus 296 ~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla 375 (568)
..++||||+. ++|.+++..... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKVPP-PGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcc
Confidence 2389999996 588888866433 34899999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHH---HHhC-----
Q 008365 376 RLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRA---IEKG----- 447 (568)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~---~~~~----- 447 (568)
+.+.... ......||+.|+|||++.+..++.++|||||||++|+|++|.+||......... +...
T Consensus 156 ~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~ 228 (288)
T cd07863 156 RIYSCQM-------ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPE 228 (288)
T ss_pred ccccCcc-------cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCCh
Confidence 8653221 123456899999999999889999999999999999999999999654332111 1100
Q ss_pred -cccc-------ccCc----cCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhH
Q 008365 448 -TLAE-------MLDP----AVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVP 492 (568)
Q Consensus 448 -~~~~-------~l~~----~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~ 492 (568)
.... .+.+ ....+.+.++..+.+++.+||+.||.+||++.+++.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 229 DDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred hhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0000 0000 0011223456778999999999999999999998854
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=335.66 Aligned_cols=252 Identities=23% Similarity=0.315 Sum_probs=195.1
Q ss_pred HHhcccccceeecccCceeEEEEEe--CCccEEEEEeCcChh--HhHHHHHHHHHHHHcCCCCceeeeccccCC------
Q 008365 226 EATDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAA--QGKRQFQQEVEVLSSIRHPNMVLLLGACPD------ 295 (568)
Q Consensus 226 ~~~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~--~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~------ 295 (568)
...++|.+++.||.|+||.||+|.+ .+..||||++..... .....+.+|+.+|+.++||||++++++|..
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 3567899999999999999999986 566899999875432 233457789999999999999999988742
Q ss_pred --CceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccc
Q 008365 296 --YGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVG 373 (568)
Q Consensus 296 --~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFG 373 (568)
..|++|+++ +++|.+++... .+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg 163 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVKCQ----KLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFG 163 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCc
Confidence 237899998 88998877532 3889999999999999999999999 9999999999999999999999999
Q ss_pred cccccCCCCCccccccccccccccccCCChhhhhc-CCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHH---Hh-Cc
Q 008365 374 LARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQT-GMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAI---EK-GT 448 (568)
Q Consensus 374 la~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~---~~-~~ 448 (568)
+++..... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+...... .. +.
T Consensus 164 ~~~~~~~~---------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 234 (343)
T cd07878 164 LARQADDE---------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGT 234 (343)
T ss_pred cceecCCC---------cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCC
Confidence 99865321 234579999999998876 568999999999999999999999996543322111 00 00
Q ss_pred -ccccc-----------CccCCCCC--------hHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 449 -LAEML-----------DPAVTDWP--------AEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 449 -~~~~l-----------~~~~~~~p--------~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
..+.+ ...+...+ ....+.+.+|+.+||..||.+||++.+++.|.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~ 300 (343)
T cd07878 235 PSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPY 300 (343)
T ss_pred CCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcc
Confidence 00000 00001111 122345789999999999999999999986654
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=319.88 Aligned_cols=244 Identities=23% Similarity=0.421 Sum_probs=197.0
Q ss_pred cccccceeecccCceeEEEEEeCC-ccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCceeeeccccCC--CceEEEEecC
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKLDH-TPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACPD--YGCLVYEYMH 305 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~~~-~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--~~~lV~E~~~ 305 (568)
++|.+.+.||+|+||.||+|.+.+ ..||||.+..... ....|.+|+.+++.++||||++++++|.+ ..++||||+.
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc-cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 458889999999999999998755 4699999875433 24578899999999999999999998854 3489999999
Q ss_pred CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCCcc
Q 008365 306 NGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADS 385 (568)
Q Consensus 306 ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~~~ 385 (568)
+|+|.+++..... .+++..++.++.||+.||.|||+.+ |+|+||||.|||++.++.+||+|||+++.+.....
T Consensus 83 ~~~l~~~i~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~-- 155 (256)
T cd05113 83 NGCLLNYLREHGK--RFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY-- 155 (256)
T ss_pred CCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCce--
Confidence 9999999876433 4899999999999999999999999 99999999999999999999999999976533211
Q ss_pred ccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh-CCCCCCCchHH--HHHHHhCccccccCccCCCCCh
Q 008365 386 VTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPMGLTHHV--SRAIEKGTLAEMLDPAVTDWPA 462 (568)
Q Consensus 386 ~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~--~~~~~~~~~~~~l~~~~~~~p~ 462 (568)
.......++..|++||++.+..++.++|||||||++|+|++ |..||...... ...+..+. ....+.
T Consensus 156 ---~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~--------~~~~~~ 224 (256)
T cd05113 156 ---TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGL--------RLYRPH 224 (256)
T ss_pred ---eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCC--------CCCCCC
Confidence 11123346678999999998889999999999999999998 99999654332 22222111 111223
Q ss_pred HHHHHHHHHHHHhhccCCCCCCChHHhHh
Q 008365 463 EAAESFSKLAIQCAELRKKDRPDLGTVIV 491 (568)
Q Consensus 463 ~~~~~l~~li~~Cl~~dP~~RPs~~~vl~ 491 (568)
..+..+.+++.+||..+|.+||++.+|+.
T Consensus 225 ~~~~~~~~li~~cl~~~p~~Rp~~~~ll~ 253 (256)
T cd05113 225 LASEKVYAIMYSCWHEKAEERPTFQQLLS 253 (256)
T ss_pred CCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 34577999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=341.09 Aligned_cols=253 Identities=21% Similarity=0.294 Sum_probs=194.8
Q ss_pred cccccceeecccCceeEEEEEe--CCccEEEEEeCcCh---hHhHHHHHHHHHHHHcCCCCceeeeccccCCC--ceEEE
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDA---AQGKRQFQQEVEVLSSIRHPNMVLLLGACPDY--GCLVY 301 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~--~~lV~ 301 (568)
++|++.+.||+|+||.||++.. .+..||||++.... ......+..|+.++..++||||+++++.|.+. .||||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 4688999999999999999987 56789999997543 22345678899999999999999999988654 48999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCC
Q 008365 302 EYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPS 381 (568)
Q Consensus 302 E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~ 381 (568)
|||+||+|.+++...+ .+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~ 154 (360)
T cd05627 81 EFLPGGDMMTLLMKKD---TLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA 154 (360)
T ss_pred eCCCCccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence 9999999999987654 3788999999999999999999999 999999999999999999999999998755321
Q ss_pred CCccc-----------------------------cccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCC
Q 008365 382 VADSV-----------------------------TQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARS 432 (568)
Q Consensus 382 ~~~~~-----------------------------~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~ 432 (568)
..... ........+||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~ 234 (360)
T cd05627 155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (360)
T ss_pred cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence 10000 0001124579999999999999999999999999999999999999
Q ss_pred CCCCchHHHH--HHHhCccccccCccCCCCChHHHHHHHHHHHHhhccCCCCCCC---hHHhHhHH
Q 008365 433 PMGLTHHVSR--AIEKGTLAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPD---LGTVIVPE 493 (568)
Q Consensus 433 Pf~~~~~~~~--~~~~~~~~~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs---~~~vl~~~ 493 (568)
||........ .+.... ..+ ..+. ...++..+.+|+.+|+. +|.+|++ +.+++.|.
T Consensus 235 Pf~~~~~~~~~~~i~~~~--~~~--~~p~-~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp 294 (360)
T cd05627 235 PFCSETPQETYRKVMNWK--ETL--VFPP-EVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHP 294 (360)
T ss_pred CCCCCCHHHHHHHHHcCC--Cce--ecCC-CCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcCC
Confidence 9965443221 111110 000 0010 11245668888888764 9999985 56666544
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-39 Score=337.35 Aligned_cols=252 Identities=23% Similarity=0.282 Sum_probs=195.3
Q ss_pred HhcccccceeecccCceeEEEEEe--CCccEEEEEeCcCh--hHhHHHHHHHHHHHHcCCCCceeeeccccCC-------
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDA--AQGKRQFQQEVEVLSSIRHPNMVLLLGACPD------- 295 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~--~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~------- 295 (568)
..++|.+.+.||+|+||.||++.+ .+..||||++.... ......+.+|+.+++.++||||+++++++..
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 467899999999999999999987 56789999986532 2334567889999999999999999987742
Q ss_pred -CceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEeccccc
Q 008365 296 -YGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGL 374 (568)
Q Consensus 296 -~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGl 374 (568)
..|+||||++ ++|.+.+.. .+++..+..++.|++.||.|||+.+ |+||||||+||||+.++.+||+|||+
T Consensus 102 ~~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~ 172 (364)
T cd07875 102 QDVYIVMELMD-ANLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 172 (364)
T ss_pred CeEEEEEeCCC-CCHHHHHHh-----cCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCC
Confidence 2389999995 577776643 2778889999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHh----Cc--
Q 008365 375 ARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEK----GT-- 448 (568)
Q Consensus 375 a~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~----~~-- 448 (568)
++...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+........ +.
T Consensus 173 a~~~~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~ 245 (364)
T cd07875 173 ARTAGTSF-------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPC 245 (364)
T ss_pred ccccCCCC-------cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 97653221 123457999999999999999999999999999999999999999754432211100 00
Q ss_pred --c-----------------------ccccC----ccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 449 --L-----------------------AEMLD----PAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 449 --~-----------------------~~~l~----~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
+ ...+. +............+.+|+.+||..||.+||++.+++.|.+
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~ 320 (364)
T cd07875 246 PEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPY 320 (364)
T ss_pred HHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcc
Confidence 0 00000 0000011112356889999999999999999999986544
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=351.67 Aligned_cols=253 Identities=20% Similarity=0.288 Sum_probs=190.8
Q ss_pred HHHhcccccceeecccCceeEEEEEe--CCccEEEEEeCcChhHhHHHHHHHHHHHHcCCC------CceeeeccccCC-
Q 008365 225 EEATDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRH------PNMVLLLGACPD- 295 (568)
Q Consensus 225 ~~~~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~H------pnIv~l~g~~~~- 295 (568)
....++|.+.++||+|+||.||+|.+ .+..||||+++.... ....+..|+.++..++| +++++++++|..
T Consensus 125 ~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~-~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~ 203 (467)
T PTZ00284 125 DVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK-YTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE 203 (467)
T ss_pred ccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchh-hHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcC
Confidence 33567899999999999999999987 567899999965322 23345667777776654 458888888743
Q ss_pred --CceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCCCCcccCCCCCCCeeccCCc-------
Q 008365 296 --YGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQ-AKPEPLVHRDLKPANILLDRNY------- 365 (568)
Q Consensus 296 --~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~-~~~~~IiHrDIKp~NILld~~~------- 365 (568)
..|+||+++ |++|.+++...+ .+++..+..|+.||+.||.|||+ .+ ||||||||+||||+.++
T Consensus 204 ~~~~~iv~~~~-g~~l~~~l~~~~---~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~~~ 276 (467)
T PTZ00284 204 TGHMCIVMPKY-GPCLLDWIMKHG---PFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDPVT 276 (467)
T ss_pred CceEEEEEecc-CCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCccccccc
Confidence 348999998 889999887654 38899999999999999999998 58 99999999999998665
Q ss_pred ---------eeEecccccccccCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCC
Q 008365 366 ---------VSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGL 436 (568)
Q Consensus 366 ---------~vKL~DFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~ 436 (568)
.+||+|||++..... .....+||+.|+|||++.+..|+.++|||||||++|||++|++||..
T Consensus 277 ~~~~~~~~~~vkl~DfG~~~~~~~---------~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~ 347 (467)
T PTZ00284 277 NRALPPDPCRVRICDLGGCCDERH---------SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDT 347 (467)
T ss_pred ccccCCCCceEEECCCCccccCcc---------ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 499999998854221 12456899999999999999999999999999999999999999975
Q ss_pred chHHHHHH--Hh--Ccccc-------------cc------CccCC-----------CC-ChHHHHHHHHHHHHhhccCCC
Q 008365 437 THHVSRAI--EK--GTLAE-------------ML------DPAVT-----------DW-PAEAAESFSKLAIQCAELRKK 481 (568)
Q Consensus 437 ~~~~~~~~--~~--~~~~~-------------~l------~~~~~-----------~~-p~~~~~~l~~li~~Cl~~dP~ 481 (568)
........ .. +.+.. .+ .+... .. .......+.+||.+||..||.
T Consensus 348 ~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~ 427 (467)
T PTZ00284 348 HDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQ 427 (467)
T ss_pred CChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChh
Confidence 54322111 00 00000 00 00000 00 001134578999999999999
Q ss_pred CCCChHHhHhHHH
Q 008365 482 DRPDLGTVIVPEL 494 (568)
Q Consensus 482 ~RPs~~~vl~~~l 494 (568)
+||++.+++.|.+
T Consensus 428 ~R~ta~e~L~Hp~ 440 (467)
T PTZ00284 428 KRLNARQMTTHPY 440 (467)
T ss_pred hCCCHHHHhcCcc
Confidence 9999999997765
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=337.67 Aligned_cols=232 Identities=25% Similarity=0.320 Sum_probs=187.2
Q ss_pred eeecccCceeEEEEEe--CCccEEEEEeCcChh---HhHHHHHHHHHHHHcC-CCCceeeeccccCC--CceEEEEecCC
Q 008365 235 MKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAA---QGKRQFQQEVEVLSSI-RHPNMVLLLGACPD--YGCLVYEYMHN 306 (568)
Q Consensus 235 ~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~---~~~~~~~~Ev~iL~~l-~HpnIv~l~g~~~~--~~~lV~E~~~g 306 (568)
+.||+|+||.||+|.+ +++.||||++..... .....+.+|+.++..+ +||||+.+++++.+ ..|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 3699999999999987 567899999976532 2344578899999888 59999999998854 34899999999
Q ss_pred CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCCccc
Q 008365 307 GSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSV 386 (568)
Q Consensus 307 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~~~~ 386 (568)
|+|.+++...+ .+++..+..|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++......
T Consensus 81 ~~L~~~~~~~~---~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~---- 150 (327)
T cd05617 81 GDLMFHMQRQR---KLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG---- 150 (327)
T ss_pred CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCC----
Confidence 99998886543 3889999999999999999999999 9999999999999999999999999987432111
Q ss_pred cccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCch---------HHHHHHHhCccccccCccC
Q 008365 387 TQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTH---------HVSRAIEKGTLAEMLDPAV 457 (568)
Q Consensus 387 ~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~---------~~~~~~~~~~~~~~l~~~~ 457 (568)
......+||+.|+|||++.+..++.++|||||||++|+|++|..||.... .+...+.. ..
T Consensus 151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~---------~~ 219 (327)
T cd05617 151 --DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILE---------KP 219 (327)
T ss_pred --CceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHh---------CC
Confidence 11234679999999999999999999999999999999999999995321 11111111 11
Q ss_pred CCCChHHHHHHHHHHHHhhccCCCCCCChH
Q 008365 458 TDWPAEAAESFSKLAIQCAELRKKDRPDLG 487 (568)
Q Consensus 458 ~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~ 487 (568)
...|..++..+.+++.+||..+|.+||+..
T Consensus 220 ~~~p~~~~~~~~~li~~~L~~dP~~R~~~~ 249 (327)
T cd05617 220 IRIPRFLSVKASHVLKGFLNKDPKERLGCQ 249 (327)
T ss_pred CCCCCCCCHHHHHHHHHHhccCHHHcCCCC
Confidence 123445667789999999999999999853
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=320.69 Aligned_cols=246 Identities=25% Similarity=0.434 Sum_probs=193.3
Q ss_pred cccceeecccCceeEEEEEeCCc----cEEEEEeCcC--hhHhHHHHHHHHHHHHcCCCCceeeeccccCC--------C
Q 008365 231 FSEAMKIGEGGYGPVYRGKLDHT----PVAIKVLRPD--AAQGKRQFQQEVEVLSSIRHPNMVLLLGACPD--------Y 296 (568)
Q Consensus 231 y~~~~~IG~G~fg~Vy~~~~~~~----~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--------~ 296 (568)
|.+.++||+|+||.||+|.+... .||||.++.. .......+.+|+.+++.++||||++++++|.. .
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 34667899999999999987432 5899988654 23345678899999999999999999987621 2
Q ss_pred ceEEEEecCCCCHHHHHhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccc
Q 008365 297 GCLVYEYMHNGSLEDRLLRRG---NTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVG 373 (568)
Q Consensus 297 ~~lV~E~~~ggsL~~~l~~~~---~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFG 373 (568)
.++||||+++|+|.+++.... ....+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCC
Confidence 379999999999998875321 2234789999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh-CCCCCCCchH--HHHHHHhCccc
Q 008365 374 LARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPMGLTHH--VSRAIEKGTLA 450 (568)
Q Consensus 374 la~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~--~~~~~~~~~~~ 450 (568)
+++.+..... ........+++.|++||++.+..++.++|||||||++|+|++ |..||..... ....+..+..
T Consensus 158 ~~~~~~~~~~----~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~- 232 (272)
T cd05075 158 LSKKIYNGDY----YRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNR- 232 (272)
T ss_pred cccccCcccc----eecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC-
Confidence 9987643211 001122346778999999999999999999999999999999 8999965332 2222222211
Q ss_pred cccCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHh
Q 008365 451 EMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIV 491 (568)
Q Consensus 451 ~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~ 491 (568)
...+..++..+.+++.+||+.+|.+||++.+|+.
T Consensus 233 -------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~ 266 (272)
T cd05075 233 -------LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRC 266 (272)
T ss_pred -------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 1223455677999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=322.72 Aligned_cols=252 Identities=24% Similarity=0.378 Sum_probs=204.1
Q ss_pred hcccccceeecccCceeEEEEEe--CCccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCceeeeccccCCC--ceEEEEe
Q 008365 228 TDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACPDY--GCLVYEY 303 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~--~~lV~E~ 303 (568)
.++|++.+.||.|+||.||+|.+ ++..||+|++..........+.+|+.+++.++||||+++++++.+. .++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 45689999999999999999987 4678999999876666667889999999999999999999988543 4899999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCC
Q 008365 304 MHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVA 383 (568)
Q Consensus 304 ~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~ 383 (568)
+++++|.+++...+. .+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~L~~~~~~~~~--~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~- 157 (280)
T cd06611 84 CDGGALDSIMLELER--GLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL- 157 (280)
T ss_pred cCCCcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhcccc-
Confidence 999999998876443 3889999999999999999999999 9999999999999999999999999987543221
Q ss_pred ccccccccccccccccCCChhhhh-----cCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHhCccccccCccCC
Q 008365 384 DSVTQYHMTSAAGTFCYIDPEYQQ-----TGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAVT 458 (568)
Q Consensus 384 ~~~~~~~~~~~~GT~~Y~APE~~~-----~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~l~~~~~ 458 (568)
.......||+.|++||++. ...++.++|||||||++|+|++|+.||.............. ...+ ..
T Consensus 158 -----~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---~~~~-~~ 228 (280)
T cd06611 158 -----QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILK---SEPP-TL 228 (280)
T ss_pred -----cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhc---CCCC-Cc
Confidence 1123456899999999875 34578899999999999999999999976544332221111 0011 11
Q ss_pred CCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 459 DWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 459 ~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
..+..++..+.+++..||..+|.+||++.+++.+.+
T Consensus 229 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~ 264 (280)
T cd06611 229 DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPF 264 (280)
T ss_pred CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChh
Confidence 223445677899999999999999999999987655
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=318.37 Aligned_cols=240 Identities=31% Similarity=0.476 Sum_probs=197.5
Q ss_pred cccccceeecccCceeEEEEEeCCccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCceeeecccc-C--CCceEEEEecC
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKLDHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGAC-P--DYGCLVYEYMH 305 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~-~--~~~~lV~E~~~ 305 (568)
++|.+.+.||+|+||.||++...+..||+|.+..... .+.+.+|+.+++.++|+|++++++++ . +..++||||++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~ 83 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 83 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEcCCcEEEEEeCCCch--HHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCC
Confidence 4688899999999999999999999999999875432 35688999999999999999999875 2 23489999999
Q ss_pred CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCCcc
Q 008365 306 NGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADS 385 (568)
Q Consensus 306 ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~~~ 385 (568)
+++|.+++..... ..+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 84 ~~~L~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--- 156 (256)
T cd05082 84 KGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--- 156 (256)
T ss_pred CCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC---
Confidence 9999999876543 34789999999999999999999999 9999999999999999999999999987543211
Q ss_pred ccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh-CCCCCCCchH--HHHHHHhCccccccCccCCCCCh
Q 008365 386 VTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPMGLTHH--VSRAIEKGTLAEMLDPAVTDWPA 462 (568)
Q Consensus 386 ~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~--~~~~~~~~~~~~~l~~~~~~~p~ 462 (568)
....++..|+|||++.+..++.++|||||||++|+|++ |+.||..... +...+..+. ....+.
T Consensus 157 ------~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~--------~~~~~~ 222 (256)
T cd05082 157 ------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY--------KMDAPD 222 (256)
T ss_pred ------CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC--------CCCCCC
Confidence 22345678999999999899999999999999999998 9999964332 222222221 112334
Q ss_pred HHHHHHHHHHHHhhccCCCCCCChHHhHh
Q 008365 463 EAAESFSKLAIQCAELRKKDRPDLGTVIV 491 (568)
Q Consensus 463 ~~~~~l~~li~~Cl~~dP~~RPs~~~vl~ 491 (568)
.++..+.+++.+||+.+|.+||++.+++.
T Consensus 223 ~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 223 GCPPVVYDVMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred CCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 56678999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=333.42 Aligned_cols=233 Identities=26% Similarity=0.314 Sum_probs=185.4
Q ss_pred eeecccCceeEEEEEe--CCccEEEEEeCcChh---HhHHHHHHHHH-HHHcCCCCceeeeccccCC--CceEEEEecCC
Q 008365 235 MKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAA---QGKRQFQQEVE-VLSSIRHPNMVLLLGACPD--YGCLVYEYMHN 306 (568)
Q Consensus 235 ~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~---~~~~~~~~Ev~-iL~~l~HpnIv~l~g~~~~--~~~lV~E~~~g 306 (568)
+.||+|+||.||+|.+ +++.||||++..... .....+..|.. +++.++||||++++++|.. ..++||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 3699999999999987 577999999865422 22334555554 5678999999999988754 45899999999
Q ss_pred CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCCccc
Q 008365 307 GSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSV 386 (568)
Q Consensus 307 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~~~~ 386 (568)
|+|..++.... .+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++......
T Consensus 81 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~---- 150 (325)
T cd05604 81 GELFFHLQRER---SFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS---- 150 (325)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCCC----
Confidence 99998886543 3889999999999999999999999 9999999999999999999999999987432111
Q ss_pred cccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHH--HHHHhCccccccCccCCCCChHH
Q 008365 387 TQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVS--RAIEKGTLAEMLDPAVTDWPAEA 464 (568)
Q Consensus 387 ~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~--~~~~~~~~~~~l~~~~~~~p~~~ 464 (568)
......+||+.|+|||++.+..++.++|||||||++|+|++|..||....... ..+.... ...++..
T Consensus 151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~---------~~~~~~~ 219 (325)
T cd05604 151 --DTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKP---------LVLRPGA 219 (325)
T ss_pred --CCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCC---------ccCCCCC
Confidence 11234679999999999999999999999999999999999999996543322 1121111 1122345
Q ss_pred HHHHHHHHHHhhccCCCCCCChHH
Q 008365 465 AESFSKLAIQCAELRKKDRPDLGT 488 (568)
Q Consensus 465 ~~~l~~li~~Cl~~dP~~RPs~~~ 488 (568)
+..+.+++.+|+..+|.+||++..
T Consensus 220 ~~~~~~ll~~ll~~~p~~R~~~~~ 243 (325)
T cd05604 220 SLTAWSILEELLEKDRQRRLGAKE 243 (325)
T ss_pred CHHHHHHHHHHhccCHHhcCCCCC
Confidence 567889999999999999998864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-39 Score=324.52 Aligned_cols=239 Identities=25% Similarity=0.371 Sum_probs=188.6
Q ss_pred ecccCceeEEEEEe--CCccEEEEEeCcChhH---hHHHHHHHHHHHHcCCCCceeeeccccCCC--ceEEEEecCCCCH
Q 008365 237 IGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQ---GKRQFQQEVEVLSSIRHPNMVLLLGACPDY--GCLVYEYMHNGSL 309 (568)
Q Consensus 237 IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~---~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~--~~lV~E~~~ggsL 309 (568)
||+|+||.||++.. .+..||+|++...... ....+..|+++++.++||||++++++|.+. .++||||++||+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 79999999999986 5789999998653221 233456799999999999999999888543 4899999999999
Q ss_pred HHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCCcccccc
Q 008365 310 EDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQY 389 (568)
Q Consensus 310 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~ 389 (568)
.+++...... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.++|+|||++..+....
T Consensus 81 ~~~~~~~~~~-~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~------- 149 (277)
T cd05607 81 KYHIYNVGER-GLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK------- 149 (277)
T ss_pred HHHHHhcccc-CCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc-------
Confidence 9888665433 3788999999999999999999999 9999999999999999999999999997653321
Q ss_pred ccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchH-H-HHHHHhCccccccCccCCCCChHHHHH
Q 008365 390 HMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHH-V-SRAIEKGTLAEMLDPAVTDWPAEAAES 467 (568)
Q Consensus 390 ~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~-~-~~~~~~~~~~~~l~~~~~~~p~~~~~~ 467 (568)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||..... . ...+..... ..........++..
T Consensus 150 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~ 225 (277)
T cd05607 150 TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTL----EDEVKFEHQNFTEE 225 (277)
T ss_pred eeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhh----ccccccccccCCHH
Confidence 11335689999999999988899999999999999999999999964322 1 111111111 11111111235667
Q ss_pred HHHHHHHhhccCCCCCCChHHhH
Q 008365 468 FSKLAIQCAELRKKDRPDLGTVI 490 (568)
Q Consensus 468 l~~li~~Cl~~dP~~RPs~~~vl 490 (568)
+.+|+..||+.+|.+||++.+++
T Consensus 226 ~~~li~~~L~~~P~~R~~~~~~~ 248 (277)
T cd05607 226 SKDICRLFLAKKPEDRLGSREKN 248 (277)
T ss_pred HHHHHHHHhccCHhhCCCCccch
Confidence 89999999999999999997665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=319.73 Aligned_cols=245 Identities=29% Similarity=0.463 Sum_probs=198.4
Q ss_pred cccccceeecccCceeEEEEEe--CCccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCceeeeccccCC--CceEEEEec
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACPD--YGCLVYEYM 304 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--~~~lV~E~~ 304 (568)
..|.+.+.||.|+||.||+|.+ .++.||+|++..+. .....+.+|+.+++.++||||++++++|.. ..++||||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 3578889999999999999987 46789999987553 334678899999999999999999998844 448999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCCc
Q 008365 305 HNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVAD 384 (568)
Q Consensus 305 ~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~~ 384 (568)
++++|.+++..... ..+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||++........
T Consensus 85 ~~~~L~~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~- 159 (263)
T cd05052 85 TYGNLLDYLRECNR-QEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY- 159 (263)
T ss_pred CCCcHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCcccccccccee-
Confidence 99999999876443 34889999999999999999999999 99999999999999999999999999976543211
Q ss_pred cccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh-CCCCCCCchHHH--HHHHhCccccccCccCCCCC
Q 008365 385 SVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPMGLTHHVS--RAIEKGTLAEMLDPAVTDWP 461 (568)
Q Consensus 385 ~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~--~~~~~~~~~~~l~~~~~~~p 461 (568)
.......++..|+|||.+.+..++.++|||||||++|+|++ |..||....... ..+..+ . ....+
T Consensus 160 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~-----~---~~~~~ 227 (263)
T cd05052 160 ----TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKG-----Y---RMERP 227 (263)
T ss_pred ----eccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCC-----C---CCCCC
Confidence 11112334678999999999999999999999999999998 999996543221 122111 1 11334
Q ss_pred hHHHHHHHHHHHHhhccCCCCCCChHHhHh
Q 008365 462 AEAAESFSKLAIQCAELRKKDRPDLGTVIV 491 (568)
Q Consensus 462 ~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~ 491 (568)
..++..+.+++.+||..+|.+||++.+++.
T Consensus 228 ~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 257 (263)
T cd05052 228 EGCPPKVYELMRACWQWNPSDRPSFAEIHQ 257 (263)
T ss_pred CCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 556778999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=321.29 Aligned_cols=249 Identities=28% Similarity=0.429 Sum_probs=199.6
Q ss_pred hcccccceeecccCceeEEEEEeCC-------ccEEEEEeCcCh-hHhHHHHHHHHHHHHcCCCCceeeeccccCC--Cc
Q 008365 228 TDKFSEAMKIGEGGYGPVYRGKLDH-------TPVAIKVLRPDA-AQGKRQFQQEVEVLSSIRHPNMVLLLGACPD--YG 297 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~~~~~~-------~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--~~ 297 (568)
.++|.+.+.||.|+||.||+|.+.+ ..||||.+.... ......+.+|+.+|+.++||||+++++++.+ ..
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 4678999999999999999998642 579999987553 2334568899999999999999999998754 45
Q ss_pred eEEEEecCCCCHHHHHhhcCC-------CCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEec
Q 008365 298 CLVYEYMHNGSLEDRLLRRGN-------TPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKIS 370 (568)
Q Consensus 298 ~lV~E~~~ggsL~~~l~~~~~-------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~ 370 (568)
++||||+++|+|.+++..... ...+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence 899999999999999875432 223688899999999999999999999 9999999999999999999999
Q ss_pred ccccccccCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh-CCCCCCCchH--HHHHHHhC
Q 008365 371 DVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPMGLTHH--VSRAIEKG 447 (568)
Q Consensus 371 DFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~--~~~~~~~~ 447 (568)
|||+++.+..... ........++..|+|||.+.+..++.++|||||||++|||++ |..||..... ....+..+
T Consensus 162 dfg~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~ 237 (277)
T cd05032 162 DFGMTRDIYETDY----YRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDG 237 (277)
T ss_pred CcccchhhccCcc----cccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcC
Confidence 9999976543211 011233457889999999988889999999999999999998 9999964332 11222211
Q ss_pred ccccccCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHh
Q 008365 448 TLAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIV 491 (568)
Q Consensus 448 ~~~~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~ 491 (568)
.....|..++..+.+++.+||+.+|.+||++.+++.
T Consensus 238 --------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 238 --------GHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred --------CCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 112234455778999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=326.63 Aligned_cols=251 Identities=24% Similarity=0.325 Sum_probs=194.8
Q ss_pred cccccceeecccCceeEEEEEe--CCccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCceeeeccccC----C---CceE
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACP----D---YGCL 299 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~----~---~~~l 299 (568)
-.|...++||.|+||.||+|.. .+..||||..-.+.. --.+|+.+|+.++|||||+|+-+|. . +.+|
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnl 99 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNL 99 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHH
Confidence 3578889999999999999987 456899998765543 2247999999999999999987762 2 2368
Q ss_pred EEEecCCCCHHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCC-ceeEecccccccc
Q 008365 300 VYEYMHNGSLEDRLLRR-GNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRN-YVSKISDVGLARL 377 (568)
Q Consensus 300 V~E~~~ggsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~-~~vKL~DFGla~~ 377 (568)
|||||+ .+|...+... .....++...+.-+.+||++||.|||+.+ |+||||||.|+|||.+ |.+||||||.|+.
T Consensus 100 VleymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~ 175 (364)
T KOG0658|consen 100 VLEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKV 175 (364)
T ss_pred HHHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCccee
Confidence 999996 6888888742 11223677777789999999999999998 9999999999999986 9999999999998
Q ss_pred cCCCCCccccccccccccccccCCChhhhhc-CCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHh----------
Q 008365 378 VPPSVADSVTQYHMTSAAGTFCYIDPEYQQT-GMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEK---------- 446 (568)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~---------- 446 (568)
+..... ..+...|..|.|||.+.+ ..|+.+.||||.|||+.||+-|++-|.+...+.+...-
T Consensus 176 L~~~ep-------niSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e 248 (364)
T KOG0658|consen 176 LVKGEP-------NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTRE 248 (364)
T ss_pred eccCCC-------ceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHH
Confidence 755432 245678999999996655 56999999999999999999999999765554443221
Q ss_pred ------CccccccCccCC-----C-CChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 447 ------GTLAEMLDPAVT-----D-WPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 447 ------~~~~~~l~~~~~-----~-~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
....+...+.+. . +....+++..+|+.+++..+|..|.++.+++.+.+
T Consensus 249 ~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~f 308 (364)
T KOG0658|consen 249 DIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPF 308 (364)
T ss_pred HHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchh
Confidence 011111111111 1 23456778999999999999999999999987655
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-39 Score=322.61 Aligned_cols=250 Identities=25% Similarity=0.365 Sum_probs=198.3
Q ss_pred HhcccccceeecccCceeEEEEEe--CCccEEEEEeCcChhHhHHHHHHHHHHHHcC-CCCceeeeccccCC--------
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQGKRQFQQEVEVLSSI-RHPNMVLLLGACPD-------- 295 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l-~HpnIv~l~g~~~~-------- 295 (568)
+.+.|.+.+.||+|+||.||+|.+ .+..||||++.... .....+.+|+.++..+ +||||++++++|..
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence 566788899999999999999987 56789999986543 2345678999999998 69999999998742
Q ss_pred CceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccc
Q 008365 296 YGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLA 375 (568)
Q Consensus 296 ~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla 375 (568)
..++||||+.+|+|.+++..... ..+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~~ 158 (272)
T cd06637 83 QLWLVMEFCGAGSVTDLIKNTKG-NTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVS 158 (272)
T ss_pred EEEEEEEcCCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCCc
Confidence 24799999999999999876432 24889999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCccccccccccccccccCCChhhhh-----cCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHhCccc
Q 008365 376 RLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQ-----TGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLA 450 (568)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-----~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~ 450 (568)
....... .......|++.|+|||++. +..++.++|||||||++|+|++|..||..............
T Consensus 159 ~~~~~~~------~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~-- 230 (272)
T cd06637 159 AQLDRTV------GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR-- 230 (272)
T ss_pred eeccccc------ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhc--
Confidence 7653221 1123457999999999876 34588899999999999999999999965443322221110
Q ss_pred cccCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhH
Q 008365 451 EMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVP 492 (568)
Q Consensus 451 ~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~ 492 (568)
.......+..++..+.+|+.+||..+|.+||++.+++.+
T Consensus 231 ---~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 231 ---NPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred ---CCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 000111122455679999999999999999999998754
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=321.40 Aligned_cols=246 Identities=26% Similarity=0.451 Sum_probs=197.5
Q ss_pred hcccccceeecccCceeEEEEEe--CCc----cEEEEEeCcCh-hHhHHHHHHHHHHHHcCCCCceeeeccccCC-CceE
Q 008365 228 TDKFSEAMKIGEGGYGPVYRGKL--DHT----PVAIKVLRPDA-AQGKRQFQQEVEVLSSIRHPNMVLLLGACPD-YGCL 299 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~~~~--~~~----~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~-~~~l 299 (568)
.++|++.++||.|+||+||+|.+ ++. .||||+++... ......+.+|+.+++.+.||||++++++|.. ..++
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~l 85 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTSTVQL 85 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCCCcEE
Confidence 35688999999999999999986 333 48999987543 3345678899999999999999999998854 4489
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccC
Q 008365 300 VYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVP 379 (568)
Q Consensus 300 V~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~ 379 (568)
+|+|+++|+|.+++.... ..+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++.+.
T Consensus 86 ~~~~~~~g~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~ 160 (279)
T cd05109 86 VTQLMPYGCLLDYVRENK--DRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLD 160 (279)
T ss_pred EEEcCCCCCHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeecc
Confidence 999999999999987543 24889999999999999999999999 9999999999999999999999999998764
Q ss_pred CCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh-CCCCCCCchH--HHHHHHhCccccccCcc
Q 008365 380 PSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPMGLTHH--VSRAIEKGTLAEMLDPA 456 (568)
Q Consensus 380 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~--~~~~~~~~~~~~~l~~~ 456 (568)
.... ........+++.|+|||.+.+..++.++|||||||++|||++ |..||..... +...+..+..
T Consensus 161 ~~~~----~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~------- 229 (279)
T cd05109 161 IDET----EYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGER------- 229 (279)
T ss_pred cccc----eeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCc-------
Confidence 3211 111122345778999999988899999999999999999998 9999965332 2222222211
Q ss_pred CCCCChHHHHHHHHHHHHhhccCCCCCCChHHhH
Q 008365 457 VTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVI 490 (568)
Q Consensus 457 ~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl 490 (568)
...+..++..+.+++.+||..+|..||++.+++
T Consensus 230 -~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~ 262 (279)
T cd05109 230 -LPQPPICTIDVYMIMVKCWMIDSECRPRFRELV 262 (279)
T ss_pred -CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHH
Confidence 112334567789999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-39 Score=326.50 Aligned_cols=251 Identities=26% Similarity=0.357 Sum_probs=197.6
Q ss_pred ccccceeecccCceeEEEEEe--CCccEEEEEeCcChh---HhHHHHHHHHHHHHcCCCCceeeeccccCC--CceEEEE
Q 008365 230 KFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAA---QGKRQFQQEVEVLSSIRHPNMVLLLGACPD--YGCLVYE 302 (568)
Q Consensus 230 ~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~---~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--~~~lV~E 302 (568)
.|+..+.||+|+||.||++.+ +++.||||.+..... .....+.+|+.+++.++|+||+.+++.+.+ ..|+|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 377788999999999999987 567899999865432 223457789999999999999999988754 4589999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCC
Q 008365 303 YMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSV 382 (568)
Q Consensus 303 ~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~ 382 (568)
|++|++|.+++...+.. .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++.......
T Consensus 81 ~~~g~~L~~~l~~~~~~-~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05630 81 LMNGGDLKFHIYHMGEA-GFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ 156 (285)
T ss_pred ecCCCcHHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCc
Confidence 99999999988654432 3889999999999999999999999 9999999999999999999999999987543221
Q ss_pred CccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHhCccccccCccCCCCCh
Q 008365 383 ADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAVTDWPA 462 (568)
Q Consensus 383 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~l~~~~~~~p~ 462 (568)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||......... ......+.......+.
T Consensus 157 -------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~---~~~~~~~~~~~~~~~~ 226 (285)
T cd05630 157 -------TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR---EEVERLVKEVQEEYSE 226 (285)
T ss_pred -------cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchH---HHHHhhhhhhhhhcCc
Confidence 112357999999999999999999999999999999999999999643211000 0000011111112234
Q ss_pred HHHHHHHHHHHHhhccCCCCCCC-----hHHhHhHHH
Q 008365 463 EAAESFSKLAIQCAELRKKDRPD-----LGTVIVPEL 494 (568)
Q Consensus 463 ~~~~~l~~li~~Cl~~dP~~RPs-----~~~vl~~~l 494 (568)
.++..+.+|+..||+.+|.+||+ +.+++.+.+
T Consensus 227 ~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~ 263 (285)
T cd05630 227 KFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPL 263 (285)
T ss_pred cCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChh
Confidence 45667899999999999999999 778876554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=321.98 Aligned_cols=248 Identities=25% Similarity=0.383 Sum_probs=197.9
Q ss_pred cccccceeecccCceeEEEEEe--CCccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCceeeeccccCC--CceEEEEec
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACPD--YGCLVYEYM 304 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--~~~lV~E~~ 304 (568)
++|.+.+.||+|+||.||+|.+ +++.||||+++.........+.+|+.+++.++||||+++++++.+ ..++||||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 4688889999999999999987 567899999876655555668899999999999999999998744 458999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCCc
Q 008365 305 HNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVAD 384 (568)
Q Consensus 305 ~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~~ 384 (568)
++++|.+++...+ .+++.++..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++..+....
T Consensus 89 ~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~-- 160 (267)
T cd06645 89 GGGSLQDIYHVTG---PLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATI-- 160 (267)
T ss_pred CCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCcc--
Confidence 9999999887654 3889999999999999999999999 9999999999999999999999999987653221
Q ss_pred cccccccccccccccCCChhhhh---cCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHH--HhCccccccCccCCC
Q 008365 385 SVTQYHMTSAAGTFCYIDPEYQQ---TGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAI--EKGTLAEMLDPAVTD 459 (568)
Q Consensus 385 ~~~~~~~~~~~GT~~Y~APE~~~---~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~--~~~~~~~~l~~~~~~ 459 (568)
.......|++.|+|||++. ...++.++|||||||++|+|++|..||.......... ...... .+...
T Consensus 161 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~---~~~~~- 232 (267)
T cd06645 161 ----AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQ---PPKLK- 232 (267)
T ss_pred ----cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCC---CCccc-
Confidence 1123457999999999874 4568899999999999999999999985433222111 111111 11111
Q ss_pred CChHHHHHHHHHHHHhhccCCCCCCChHHhHhH
Q 008365 460 WPAEAAESFSKLAIQCAELRKKDRPDLGTVIVP 492 (568)
Q Consensus 460 ~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~ 492 (568)
....++..+.+++.+||+.+|.+||++.+|+.+
T Consensus 233 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 233 DKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred ccCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 111345578999999999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=325.34 Aligned_cols=250 Identities=25% Similarity=0.377 Sum_probs=203.9
Q ss_pred hcccccceeecccCceeEEEEEe--CCccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCceeeeccccCC--CceEEEEe
Q 008365 228 TDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACPD--YGCLVYEY 303 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--~~~lV~E~ 303 (568)
..+|.+.+.||.|+||.||+|.+ .+..||||.+..........+.+|+.+++.++||||+++++.|.+ ..|+||||
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~ 98 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence 35799999999999999999986 567999999877655556778899999999999999999998744 45899999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCC
Q 008365 304 MHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVA 383 (568)
Q Consensus 304 ~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~ 383 (568)
+++++|.+++... .+++.++..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 99 ~~~~~L~~~~~~~----~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~ 171 (296)
T cd06654 99 LAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (296)
T ss_pred cCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhcccccc
Confidence 9999999988542 3788899999999999999999999 99999999999999999999999999876532211
Q ss_pred ccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHhCccccccCccCCCCChH
Q 008365 384 DSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAVTDWPAE 463 (568)
Q Consensus 384 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~l~~~~~~~p~~ 463 (568)
......|++.|+|||++.+..++.++|||||||++|+|++|+.||.............. ...+. ...+..
T Consensus 172 ------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~---~~~~~-~~~~~~ 241 (296)
T cd06654 172 ------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT---NGTPE-LQNPEK 241 (296)
T ss_pred ------ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhc---CCCCC-CCCccc
Confidence 11334689999999999988899999999999999999999999975544322211110 00111 122445
Q ss_pred HHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 464 AAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 464 ~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
.+..+.+++.+||..+|.+||++.+|+.+.+
T Consensus 242 ~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~ 272 (296)
T cd06654 242 LSAIFRDFLNRCLDMDVEKRGSAKELLQHQF 272 (296)
T ss_pred cCHHHHHHHHHHCcCCcccCcCHHHHhhChh
Confidence 6677999999999999999999999987554
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=322.82 Aligned_cols=250 Identities=22% Similarity=0.346 Sum_probs=199.3
Q ss_pred ccccceeecccCceeEEEEEeC--CccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCceeeeccccCC--CceEEEEecC
Q 008365 230 KFSEAMKIGEGGYGPVYRGKLD--HTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACPD--YGCLVYEYMH 305 (568)
Q Consensus 230 ~y~~~~~IG~G~fg~Vy~~~~~--~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--~~~lV~E~~~ 305 (568)
.|++.+.||.|+||.||+|.+. +..+++|.+..........+.+|+.+++.++||||++++++|.. ..++||||++
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~ 85 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA 85 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecC
Confidence 3678889999999999999884 56789999876655556778899999999999999999998744 3489999999
Q ss_pred CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCCcc
Q 008365 306 NGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADS 385 (568)
Q Consensus 306 ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~~~ 385 (568)
+++|..++.... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 86 ~~~l~~~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~--- 157 (282)
T cd06643 86 GGAVDAVMLELE--RPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--- 157 (282)
T ss_pred CCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccccccccccc---
Confidence 999988876533 24899999999999999999999999 9999999999999999999999999987543211
Q ss_pred ccccccccccccccCCChhhhh-----cCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHhCccccccCccCCCC
Q 008365 386 VTQYHMTSAAGTFCYIDPEYQQ-----TGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAVTDW 460 (568)
Q Consensus 386 ~~~~~~~~~~GT~~Y~APE~~~-----~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~l~~~~~~~ 460 (568)
.......||+.|+|||++. +..++.++|||||||++|+|++|.+||............... ..+. ...
T Consensus 158 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~---~~~~-~~~ 230 (282)
T cd06643 158 ---QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS---EPPT-LAQ 230 (282)
T ss_pred ---cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhc---CCCC-CCC
Confidence 1123456899999999874 455788999999999999999999999755443322221110 0111 112
Q ss_pred ChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 461 PAEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 461 p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
+..++..+.+|+.+||+.+|.+||++.+++.+.+
T Consensus 231 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 264 (282)
T cd06643 231 PSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPF 264 (282)
T ss_pred ccccCHHHHHHHHHHccCChhhCcCHHHHhcCCC
Confidence 3345677999999999999999999999986554
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=318.83 Aligned_cols=245 Identities=33% Similarity=0.507 Sum_probs=197.6
Q ss_pred hcccccceeecccCceeEEEEEeCC-ccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCceeeeccccCC-CceEEEEecC
Q 008365 228 TDKFSEAMKIGEGGYGPVYRGKLDH-TPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACPD-YGCLVYEYMH 305 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~~~~~~-~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~-~~~lV~E~~~ 305 (568)
.++|.+.++||+|+||.||+|.+.+ ..||||++..... ....+.+|+.+++.++||||+++++.+.+ ..++||||++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~lv~e~~~ 83 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMS 83 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEECCCCcEEEEEcCC
Confidence 3569999999999999999998744 4799999875433 23578899999999999999999987744 4589999999
Q ss_pred CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCCcc
Q 008365 306 NGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADS 385 (568)
Q Consensus 306 ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~~~ 385 (568)
+|+|.+++..... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++.+......
T Consensus 84 ~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~- 158 (262)
T cd05071 84 KGSLLDFLKGEMG-KYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT- 158 (262)
T ss_pred CCcHHHHHhhccc-cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeeccccccc-
Confidence 9999999976432 24789999999999999999999999 999999999999999999999999999766432211
Q ss_pred ccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh-CCCCCCCchH--HHHHHHhCccccccCccCCCCCh
Q 008365 386 VTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPMGLTHH--VSRAIEKGTLAEMLDPAVTDWPA 462 (568)
Q Consensus 386 ~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~--~~~~~~~~~~~~~l~~~~~~~p~ 462 (568)
......++..|+|||+..+..++.++|||||||++|+|++ |..||..... ....+..+ .....+.
T Consensus 159 ----~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~--------~~~~~~~ 226 (262)
T cd05071 159 ----ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG--------YRMPCPP 226 (262)
T ss_pred ----cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcC--------CCCCCcc
Confidence 1123456778999999988899999999999999999999 8889964432 11111111 0112234
Q ss_pred HHHHHHHHHHHHhhccCCCCCCChHHhH
Q 008365 463 EAAESFSKLAIQCAELRKKDRPDLGTVI 490 (568)
Q Consensus 463 ~~~~~l~~li~~Cl~~dP~~RPs~~~vl 490 (568)
.++..+.+|+.+|++.+|.+||++.+++
T Consensus 227 ~~~~~l~~li~~~l~~~p~~Rp~~~~~~ 254 (262)
T cd05071 227 ECPESLHDLMCQCWRKEPEERPTFEYLQ 254 (262)
T ss_pred ccCHHHHHHHHHHccCCcccCCCHHHHH
Confidence 5677899999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-39 Score=339.58 Aligned_cols=252 Identities=23% Similarity=0.292 Sum_probs=196.0
Q ss_pred HHhcccccceeecccCceeEEEEEe--CCccEEEEEeCcCh---hHhHHHHHHHHHHHHcCCCCceeeeccccCCC--ce
Q 008365 226 EATDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDA---AQGKRQFQQEVEVLSSIRHPNMVLLLGACPDY--GC 298 (568)
Q Consensus 226 ~~~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~--~~ 298 (568)
...++|.+.+.||+|+||.||++.+ .+..||+|++.... ......+.+|+.+++.++||||+++++.+.+. .+
T Consensus 40 ~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~ 119 (371)
T cd05622 40 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLY 119 (371)
T ss_pred cchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEE
Confidence 3457899999999999999999987 46789999986432 22234578999999999999999999988554 48
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEeccccccccc
Q 008365 299 LVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLV 378 (568)
Q Consensus 299 lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~ 378 (568)
+|||||+||+|.+++.... ++...+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+
T Consensus 120 lv~Ey~~gg~L~~~~~~~~----~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~a~~~ 192 (371)
T cd05622 120 MVMEYMPGGDLVNLMSNYD----VPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKM 192 (371)
T ss_pred EEEcCCCCCcHHHHHHhcC----CCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCceeEc
Confidence 9999999999999886532 788888899999999999999999 999999999999999999999999999865
Q ss_pred CCCCCccccccccccccccccCCChhhhhcCC----CCCcceehhHHHHHHHHHhCCCCCCCchHHHH--HHHhCccccc
Q 008365 379 PPSVADSVTQYHMTSAAGTFCYIDPEYQQTGM----LTTKSDIYSFGIMLLQIITARSPMGLTHHVSR--AIEKGTLAEM 452 (568)
Q Consensus 379 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~----~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~--~~~~~~~~~~ 452 (568)
.... .......+||+.|+|||++.+.. ++.++|||||||++|||++|..||........ .+.... ..
T Consensus 193 ~~~~-----~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~--~~ 265 (371)
T cd05622 193 NKEG-----MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHK--NS 265 (371)
T ss_pred CcCC-----cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCC--Cc
Confidence 3221 11123567999999999887543 78999999999999999999999976544221 111111 00
Q ss_pred cCccCCCCChHHHHHHHHHHHHhhccCCCC--CCChHHhHhHHH
Q 008365 453 LDPAVTDWPAEAAESFSKLAIQCAELRKKD--RPDLGTVIVPEL 494 (568)
Q Consensus 453 l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~--RPs~~~vl~~~l 494 (568)
+ ..+ .+..++..+.+++..|+...+.. ||++.+++.+.+
T Consensus 266 ~--~~~-~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~ 306 (371)
T cd05622 266 L--TFP-DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLF 306 (371)
T ss_pred c--cCC-CcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcc
Confidence 0 011 12245677899999999844432 778888876543
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=323.35 Aligned_cols=248 Identities=26% Similarity=0.439 Sum_probs=198.8
Q ss_pred cccccceeecccCceeEEEEEe-------CCccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCceeeeccccCC--CceE
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKL-------DHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACPD--YGCL 299 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~-------~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--~~~l 299 (568)
.+|...++||+|+||.||++.. .+..||+|.+..........+.+|+++++.++||||+++++++.+ ..++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 4577788999999999999864 245799999887666666789999999999999999999998854 4489
Q ss_pred EEEecCCCCHHHHHhhcCC------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCcee
Q 008365 300 VYEYMHNGSLEDRLLRRGN------------TPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVS 367 (568)
Q Consensus 300 V~E~~~ggsL~~~l~~~~~------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~v 367 (568)
||||+++|+|.+++..... ...+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence 9999999999999876432 124788999999999999999999999 9999999999999999999
Q ss_pred EecccccccccCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh-CCCCCCCchHHH--HHH
Q 008365 368 KISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPMGLTHHVS--RAI 444 (568)
Q Consensus 368 KL~DFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~--~~~ 444 (568)
||+|||+++.+..... ........+++.|+|||++.+..++.++|||||||++|+|++ |.+||....... ..+
T Consensus 162 kL~dfg~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~ 237 (280)
T cd05092 162 KIGDFGMSRDIYSTDY----YRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECI 237 (280)
T ss_pred EECCCCceeEcCCCce----eecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHH
Confidence 9999999976532211 111123346788999999999999999999999999999998 999995433321 112
Q ss_pred HhCccccccCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHh
Q 008365 445 EKGTLAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIV 491 (568)
Q Consensus 445 ~~~~~~~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~ 491 (568)
..+. ....+..++..+.+|+.+||+.+|.+||++.+|+.
T Consensus 238 ~~~~--------~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 238 TQGR--------ELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred HcCc--------cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 1111 11223345677999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=328.87 Aligned_cols=252 Identities=24% Similarity=0.273 Sum_probs=194.4
Q ss_pred cccccceeecccCceeEEEEEeC--CccEEEEEeCcCh---hHhHHHHHHHHHHHHcCCCCceeeeccccCCC--ceEEE
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKLD--HTPVAIKVLRPDA---AQGKRQFQQEVEVLSSIRHPNMVLLLGACPDY--GCLVY 301 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~~--~~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~--~~lV~ 301 (568)
++|.+.++||+|+||.||++++. +..||||++.+.. ......+..|+.++..++|+||+++++.+.+. .++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 46899999999999999999874 5689999986532 12234578899999999999999999988543 48999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCC
Q 008365 302 EYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPS 381 (568)
Q Consensus 302 E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~ 381 (568)
||+++|+|.+++..... .+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 ey~~~g~L~~~l~~~~~--~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~ 155 (332)
T cd05623 81 DYYVGGDLLTLLSKFED--RLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 155 (332)
T ss_pred eccCCCcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence 99999999999976432 3788899999999999999999999 999999999999999999999999998754321
Q ss_pred CCccccccccccccccccCCChhhhh-----cCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHH--HHhCccccccC
Q 008365 382 VADSVTQYHMTSAAGTFCYIDPEYQQ-----TGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRA--IEKGTLAEMLD 454 (568)
Q Consensus 382 ~~~~~~~~~~~~~~GT~~Y~APE~~~-----~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~--~~~~~~~~~l~ 454 (568)
. .......+||+.|+|||++. ...++.++|||||||++|||++|+.||......... +..... .
T Consensus 156 ~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~----~ 226 (332)
T cd05623 156 G-----TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKE----R 226 (332)
T ss_pred C-----cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCc----c
Confidence 1 11123457999999999886 346889999999999999999999999755432221 111110 0
Q ss_pred ccCCCCChHHHHHHHHHHHHhhccCCC--CCCChHHhHhHHH
Q 008365 455 PAVTDWPAEAAESFSKLAIQCAELRKK--DRPDLGTVIVPEL 494 (568)
Q Consensus 455 ~~~~~~p~~~~~~l~~li~~Cl~~dP~--~RPs~~~vl~~~l 494 (568)
...+..+..++..+.+|+.+|+..++. .||++.+++.|.+
T Consensus 227 ~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~ 268 (332)
T cd05623 227 FQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPF 268 (332)
T ss_pred ccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCC
Confidence 111122234567788999998865443 4688998887643
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=319.31 Aligned_cols=245 Identities=27% Similarity=0.502 Sum_probs=198.1
Q ss_pred hcccccceeecccCceeEEEEEe-CCccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCceeeeccccCCC--ceEEEEec
Q 008365 228 TDKFSEAMKIGEGGYGPVYRGKL-DHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACPDY--GCLVYEYM 304 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~~~~-~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~--~~lV~E~~ 304 (568)
.++|.+.+.||+|+||.||+|.+ .++.||||.++.... ....+.+|+.++++++||||+++++++... .++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM-DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcc-cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 45689999999999999999987 446799999876543 345788999999999999999999988543 48999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCCc
Q 008365 305 HNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVAD 384 (568)
Q Consensus 305 ~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~~ 384 (568)
++++|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++.+......
T Consensus 84 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05068 84 KYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE 159 (261)
T ss_pred cCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCccc
Confidence 9999999987644 234889999999999999999999999 999999999999999999999999999876422111
Q ss_pred cccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh-CCCCCCCchHHH--HHHHhCccccccCccCCCCC
Q 008365 385 SVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPMGLTHHVS--RAIEKGTLAEMLDPAVTDWP 461 (568)
Q Consensus 385 ~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~--~~~~~~~~~~~l~~~~~~~p 461 (568)
......++..|+|||++.+..++.++|||||||++|+|++ |+.||....... ..+.... ....+
T Consensus 160 -----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~--------~~~~~ 226 (261)
T cd05068 160 -----AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGY--------RMPCP 226 (261)
T ss_pred -----ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC--------CCCCC
Confidence 1112223467999999998899999999999999999999 999996544321 1221110 01223
Q ss_pred hHHHHHHHHHHHHhhccCCCCCCChHHhH
Q 008365 462 AEAAESFSKLAIQCAELRKKDRPDLGTVI 490 (568)
Q Consensus 462 ~~~~~~l~~li~~Cl~~dP~~RPs~~~vl 490 (568)
..++..+.+++.+|++.+|.+||++.+++
T Consensus 227 ~~~~~~~~~li~~~l~~~P~~Rp~~~~l~ 255 (261)
T cd05068 227 PGCPKELYDIMLDCWKEDPDDRPTFETLQ 255 (261)
T ss_pred CcCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence 45567899999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=318.01 Aligned_cols=246 Identities=24% Similarity=0.413 Sum_probs=195.2
Q ss_pred cccceeecccCceeEEEEEeC-----CccEEEEEeCcCh--hHhHHHHHHHHHHHHcCCCCceeeeccccCC--------
Q 008365 231 FSEAMKIGEGGYGPVYRGKLD-----HTPVAIKVLRPDA--AQGKRQFQQEVEVLSSIRHPNMVLLLGACPD-------- 295 (568)
Q Consensus 231 y~~~~~IG~G~fg~Vy~~~~~-----~~~vAvK~l~~~~--~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~-------- 295 (568)
|.+.+.||+|+||.||+|... +..||||+++... ......+.+|+.+++.++||||+++++++..
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 567889999999999999863 2569999987542 2334578999999999999999999987632
Q ss_pred CceEEEEecCCCCHHHHHhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEeccc
Q 008365 296 YGCLVYEYMHNGSLEDRLLRRG---NTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDV 372 (568)
Q Consensus 296 ~~~lV~E~~~ggsL~~~l~~~~---~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DF 372 (568)
..++||||+++|+|..++.... ....+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence 1479999999999999885532 2234889999999999999999999999 999999999999999999999999
Q ss_pred ccccccCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh-CCCCCCCchHHH--HHHHhCcc
Q 008365 373 GLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPMGLTHHVS--RAIEKGTL 449 (568)
Q Consensus 373 Gla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~--~~~~~~~~ 449 (568)
|+++.+...... .......++..|+|||++.+..++.++|||||||++|||++ |..||....... ..+..+
T Consensus 158 g~~~~~~~~~~~----~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~-- 231 (273)
T cd05035 158 GLSKKIYSGDYY----RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHG-- 231 (273)
T ss_pred cceeeccccccc----cccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC--
Confidence 999865432110 11122345678999999988899999999999999999999 899996543321 222211
Q ss_pred ccccCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHh
Q 008365 450 AEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIV 491 (568)
Q Consensus 450 ~~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~ 491 (568)
.....+..++..+.+++.+||+.+|.+||++.+++.
T Consensus 232 ------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~ 267 (273)
T cd05035 232 ------NRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLRE 267 (273)
T ss_pred ------CCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 112234556778999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=321.61 Aligned_cols=251 Identities=25% Similarity=0.410 Sum_probs=198.0
Q ss_pred HhcccccceeecccCceeEEEEEeCC-------ccEEEEEeCcCh-hHhHHHHHHHHHHHHcCCCCceeeeccccCC--C
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKLDH-------TPVAIKVLRPDA-AQGKRQFQQEVEVLSSIRHPNMVLLLGACPD--Y 296 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~~~-------~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--~ 296 (568)
..++|.+.+.||+|+||.||+|.+.+ ..||+|.+.... ......|.+|+.+++.++|+||+++++++.+ .
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 34679999999999999999998743 578999886543 3334568899999999999999999998744 4
Q ss_pred ceEEEEecCCCCHHHHHhhcCC----CCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCc---eeEe
Q 008365 297 GCLVYEYMHNGSLEDRLLRRGN----TPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNY---VSKI 369 (568)
Q Consensus 297 ~~lV~E~~~ggsL~~~l~~~~~----~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~---~vKL 369 (568)
.++||||++|++|.+++..... ...+++..+..++.||+.||.|||+.+ ++||||||+|||++.++ .+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEe
Confidence 5899999999999999876532 124889999999999999999999999 99999999999998654 6999
Q ss_pred cccccccccCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh-CCCCCCCchH--HHHHHHh
Q 008365 370 SDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPMGLTHH--VSRAIEK 446 (568)
Q Consensus 370 ~DFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~--~~~~~~~ 446 (568)
+|||+++.+..... ........++..|+|||++.+..++.++|||||||++|+|++ |..||..... +...+..
T Consensus 161 ~dfg~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~ 236 (277)
T cd05036 161 ADFGMARDIYRASY----YRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTG 236 (277)
T ss_pred ccCccccccCCccc----eecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 99999986532111 011122334578999999998999999999999999999997 9999965432 1122211
Q ss_pred CccccccCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhH
Q 008365 447 GTLAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVP 492 (568)
Q Consensus 447 ~~~~~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~ 492 (568)
. .....|..++..+.+++.+||+.+|.+||++.+|+.+
T Consensus 237 ~--------~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 237 G--------GRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred C--------CcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 1 1112345567789999999999999999999998744
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=324.37 Aligned_cols=251 Identities=29% Similarity=0.458 Sum_probs=196.2
Q ss_pred cccccceeecccCceeEEEEEeC--Cc--cEEEEEeCcC-hhHhHHHHHHHHHHHHcC-CCCceeeeccccCCC--ceEE
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKLD--HT--PVAIKVLRPD-AAQGKRQFQQEVEVLSSI-RHPNMVLLLGACPDY--GCLV 300 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~~--~~--~vAvK~l~~~-~~~~~~~~~~Ev~iL~~l-~HpnIv~l~g~~~~~--~~lV 300 (568)
++|.+.+.||+|+||.||+|.+. +. .+++|.++.. .....+.+.+|+.++.++ +||||+++++++.+. .++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 46888999999999999999863 32 4788888742 333456788999999999 799999999988554 4899
Q ss_pred EEecCCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCcee
Q 008365 301 YEYMHNGSLEDRLLRRGN-------------TPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVS 367 (568)
Q Consensus 301 ~E~~~ggsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~v 367 (568)
|||+++|+|.+++..... ...+++..++.|+.||+.||.|||+.+ |+||||||+|||++.++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence 999999999999975421 124788999999999999999999999 9999999999999999999
Q ss_pred EecccccccccCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh-CCCCCCCchHH--HHHH
Q 008365 368 KISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPMGLTHHV--SRAI 444 (568)
Q Consensus 368 KL~DFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~--~~~~ 444 (568)
||+|||++....... .......+..|+|||++.+..++.++|||||||++|+|++ |..||...... ...+
T Consensus 159 kl~dfg~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~ 231 (297)
T cd05089 159 KIADFGLSRGEEVYV-------KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKL 231 (297)
T ss_pred EECCcCCCcccccee-------ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 999999986432110 1111233567999999998889999999999999999997 99999654332 1111
Q ss_pred HhCccccccCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHHHHH
Q 008365 445 EKGTLAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPELNRL 497 (568)
Q Consensus 445 ~~~~~~~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l~~L 497 (568)
..+ .....+..++..+.+|+.+||..+|.+||++.+++..+..-+
T Consensus 232 ~~~--------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~ 276 (297)
T cd05089 232 PQG--------YRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRML 276 (297)
T ss_pred hcC--------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 111 111223446678999999999999999999999986544333
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=318.04 Aligned_cols=246 Identities=31% Similarity=0.493 Sum_probs=199.9
Q ss_pred HhcccccceeecccCceeEEEEEe-CCccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCceeeeccccCC-CceEEEEec
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKL-DHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACPD-YGCLVYEYM 304 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~-~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~-~~~lV~E~~ 304 (568)
..++|++.++||.|+||.||+|.. +++.||+|.+...... ...+.+|+.+++.++||||+++++++.+ ..++||||+
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~-~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~~ 82 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS-PEAFLAEANLMKQLQHPRLVRLYAVVTQEPIYIITEYM 82 (260)
T ss_pred chHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCc-HHHHHHHHHHHHhcCCcCeeeEEEEEccCCcEEEEEcC
Confidence 346799999999999999999987 5678999998765433 4578899999999999999999998744 458999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCCc
Q 008365 305 HNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVAD 384 (568)
Q Consensus 305 ~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~~ 384 (568)
.+++|.+++..... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++........
T Consensus 83 ~~~~L~~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~- 157 (260)
T cd05067 83 ENGSLVDFLKTPEG-IKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEY- 157 (260)
T ss_pred CCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCc-
Confidence 99999998876443 24889999999999999999999999 99999999999999999999999999976542111
Q ss_pred cccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh-CCCCCCCchH--HHHHHHhCccccccCccCCCCC
Q 008365 385 SVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPMGLTHH--VSRAIEKGTLAEMLDPAVTDWP 461 (568)
Q Consensus 385 ~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~--~~~~~~~~~~~~~l~~~~~~~p 461 (568)
.......++..|+|||++.+..++.++|||||||++|+|++ |++||..... ....+..+. . ...+
T Consensus 158 ----~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-----~---~~~~ 225 (260)
T cd05067 158 ----TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGY-----R---MPRP 225 (260)
T ss_pred ----ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCC-----C---CCCC
Confidence 11123456788999999998999999999999999999999 9999964432 212221111 0 1223
Q ss_pred hHHHHHHHHHHHHhhccCCCCCCChHHhH
Q 008365 462 AEAAESFSKLAIQCAELRKKDRPDLGTVI 490 (568)
Q Consensus 462 ~~~~~~l~~li~~Cl~~dP~~RPs~~~vl 490 (568)
...+..+.+++.+||..+|.+||++.+++
T Consensus 226 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~ 254 (260)
T cd05067 226 DNCPEELYELMRLCWKEKPEERPTFEYLR 254 (260)
T ss_pred CCCCHHHHHHHHHHccCChhhCCCHHHHH
Confidence 34566799999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=321.13 Aligned_cols=256 Identities=29% Similarity=0.474 Sum_probs=198.9
Q ss_pred cccccceeecccCceeEEEEEeCC------------------ccEEEEEeCcCh-hHhHHHHHHHHHHHHcCCCCceeee
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKLDH------------------TPVAIKVLRPDA-AQGKRQFQQEVEVLSSIRHPNMVLL 289 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~~~------------------~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l~HpnIv~l 289 (568)
.+|++.+.||+|+||.||++.+.. ..||+|++.... ......+.+|+++++.++||||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~ 84 (296)
T cd05051 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARL 84 (296)
T ss_pred hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 578999999999999999987632 358999987653 3345678999999999999999999
Q ss_pred ccccCC--CceEEEEecCCCCHHHHHhhcCC--------CCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCe
Q 008365 290 LGACPD--YGCLVYEYMHNGSLEDRLLRRGN--------TPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANI 359 (568)
Q Consensus 290 ~g~~~~--~~~lV~E~~~ggsL~~~l~~~~~--------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NI 359 (568)
+++|.+ ..++||||+++++|.+++..... ...+++..++.++.|++.||.|||+.+ |+||||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~Ni 161 (296)
T cd05051 85 LGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRNC 161 (296)
T ss_pred EEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhce
Confidence 998854 45899999999999999876541 124789999999999999999999999 99999999999
Q ss_pred eccCCceeEecccccccccCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh--CCCCCCCc
Q 008365 360 LLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT--ARSPMGLT 437 (568)
Q Consensus 360 Lld~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt--G~~Pf~~~ 437 (568)
|++.++.++|+|||+++.+..... ........+++.|+|||++.+..++.++|||||||++|+|++ |..||...
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~ 237 (296)
T cd05051 162 LVGKNYTIKIADFGMSRNLYSSDY----YRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHL 237 (296)
T ss_pred eecCCCceEEccccceeecccCcc----eeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCc
Confidence 999999999999999976532211 111234457789999999988889999999999999999998 77888653
Q ss_pred hHHHHHHHhCcc-ccccCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHh
Q 008365 438 HHVSRAIEKGTL-AEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIV 491 (568)
Q Consensus 438 ~~~~~~~~~~~~-~~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~ 491 (568)
............ ...-.......+..++..+.+++.+||+.+|.+||++.+|+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 238 TDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred ChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 321111100100 000011111223445678999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=322.56 Aligned_cols=246 Identities=27% Similarity=0.425 Sum_probs=195.5
Q ss_pred ccccceeecccCceeEEEEEeCC-------ccEEEEEeCcCh-hHhHHHHHHHHHHHHcCCCCceeeeccccCC--CceE
Q 008365 230 KFSEAMKIGEGGYGPVYRGKLDH-------TPVAIKVLRPDA-AQGKRQFQQEVEVLSSIRHPNMVLLLGACPD--YGCL 299 (568)
Q Consensus 230 ~y~~~~~IG~G~fg~Vy~~~~~~-------~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--~~~l 299 (568)
+|++.+.||+|+||.||+|.... ..|++|++.... ......+.+|+.+++.++||||+++++.|.. ..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 47788899999999999998632 468999886543 2334678899999999999999999998754 4589
Q ss_pred EEEecCCCCHHHHHhhcC---------------------CCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCC
Q 008365 300 VYEYMHNGSLEDRLLRRG---------------------NTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPAN 358 (568)
Q Consensus 300 V~E~~~ggsL~~~l~~~~---------------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~N 358 (568)
||||+.+|+|.+++.... ....+++..++.++.|++.||.|||+.+ |+||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence 999999999999886421 1124788999999999999999999999 9999999999
Q ss_pred eeccCCceeEecccccccccCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh-CCCCCCCc
Q 008365 359 ILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPMGLT 437 (568)
Q Consensus 359 ILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~ 437 (568)
|||++++.+||+|||+++.+..... ........++..|+|||++.+..++.++|||||||++|+|++ |..||...
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~----~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~ 233 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDS----YVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI 233 (290)
T ss_pred EEEcCCCcEEeccccccccccCccc----hhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCC
Confidence 9999999999999999976532211 111123456778999999988899999999999999999998 99999654
Q ss_pred hHH--HHHHHhCccccccCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhH
Q 008365 438 HHV--SRAIEKGTLAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVI 490 (568)
Q Consensus 438 ~~~--~~~~~~~~~~~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl 490 (568)
... ...+..+. ....+..++..+.+++..||+.+|.+||++.+++
T Consensus 234 ~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~ 280 (290)
T cd05045 234 APERLFNLLKTGY--------RMERPENCSEEMYNLMLTCWKQEPDKRPTFADIS 280 (290)
T ss_pred CHHHHHHHHhCCC--------CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHH
Confidence 322 12222111 1122345567899999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=323.33 Aligned_cols=251 Identities=23% Similarity=0.362 Sum_probs=200.8
Q ss_pred hcccccceeecccCceeEEEEEe--CCccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCceeeeccccCC--CceEEEEe
Q 008365 228 TDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACPD--YGCLVYEY 303 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--~~~lV~E~ 303 (568)
.+.|+++++||.|+||.||+|.+ .+..||+|++..........+.+|+.+++.++||||+++++.|.. ..++||||
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 90 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF 90 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence 36789999999999999999987 467899999987766667788999999999999999999998743 44899999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCC
Q 008365 304 MHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVA 383 (568)
Q Consensus 304 ~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~ 383 (568)
+++++|..++..... .+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 91 ~~~~~l~~~~~~~~~--~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~- 164 (292)
T cd06644 91 CPGGAVDAIMLELDR--GLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL- 164 (292)
T ss_pred CCCCcHHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceeccccc-
Confidence 999999887765432 3889999999999999999999998 9999999999999999999999999987542211
Q ss_pred ccccccccccccccccCCChhhhh-----cCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHhCccccccCccCC
Q 008365 384 DSVTQYHMTSAAGTFCYIDPEYQQ-----TGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAVT 458 (568)
Q Consensus 384 ~~~~~~~~~~~~GT~~Y~APE~~~-----~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~l~~~~~ 458 (568)
.......|++.|+|||++. ...++.++|||||||++|+|++|..||.............. ...+..
T Consensus 165 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~---~~~~~~- 235 (292)
T cd06644 165 -----QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAK---SEPPTL- 235 (292)
T ss_pred -----cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhc---CCCccC-
Confidence 1123456889999999874 34578899999999999999999999976543322211111 111111
Q ss_pred CCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHH
Q 008365 459 DWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPE 493 (568)
Q Consensus 459 ~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~ 493 (568)
..+..++..+.+++.+||..+|.+||++.+++.+.
T Consensus 236 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 270 (292)
T cd06644 236 SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHP 270 (292)
T ss_pred CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 12344566789999999999999999999998543
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=339.86 Aligned_cols=253 Identities=24% Similarity=0.397 Sum_probs=210.5
Q ss_pred cccccceeecccCceeEEEEEeCCc--cEEEEEeCcChhHhHHHHHHHHHHHHcCCCCceeeecccc--CCCceEEEEec
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKLDHT--PVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGAC--PDYGCLVYEYM 304 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~~~~--~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~--~~~~~lV~E~~ 304 (568)
+.|.++..||.|+||.||++....+ ..|-|++........++|.-|++||..++||+||+||+.| .+..+|+.|||
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC 111 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC 111 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence 4578888999999999999987543 5788998877777788999999999999999999999854 55668999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCCc
Q 008365 305 HNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVAD 384 (568)
Q Consensus 305 ~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~~ 384 (568)
.||-++.++...+. .+.+.++..+++|++.||.|||+.+ |||||||..|||++-+|.++|+|||.+...
T Consensus 112 ~GGAVDaimlEL~r--~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn------ 180 (1187)
T KOG0579|consen 112 GGGAVDAIMLELGR--VLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKN------ 180 (1187)
T ss_pred CCchHhHHHHHhcc--ccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccc------
Confidence 99999998887664 4899999999999999999999999 999999999999999999999999998532
Q ss_pred cccccccccccccccCCChhhh-----hcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHhCccccccCccCCC
Q 008365 385 SVTQYHMTSAAGTFCYIDPEYQ-----QTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAVTD 459 (568)
Q Consensus 385 ~~~~~~~~~~~GT~~Y~APE~~-----~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~l~~~~~~ 459 (568)
..+.....+++|||+|||||+. ...+|+.++||||||+.|.||.-+.+|-...+.+...+.... .-.|.+ -
T Consensus 181 ~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaK---SePPTL-l 256 (1187)
T KOG0579|consen 181 KSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAK---SEPPTL-L 256 (1187)
T ss_pred hhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhh---cCCCcc-c
Confidence 2233345678999999999965 456799999999999999999999999866666555443221 112222 2
Q ss_pred CChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHHHH
Q 008365 460 WPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPELNR 496 (568)
Q Consensus 460 ~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l~~ 496 (568)
.|...+..|.+|+.+||..||..||++++++.|.+..
T Consensus 257 qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~ 293 (1187)
T KOG0579|consen 257 QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQ 293 (1187)
T ss_pred CcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccc
Confidence 3566778899999999999999999999998776643
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=315.77 Aligned_cols=239 Identities=30% Similarity=0.491 Sum_probs=190.6
Q ss_pred eecccCceeEEEEEe--CCccEEEEEeCcCh-hHhHHHHHHHHHHHHcCCCCceeeeccccCCC--ceEEEEecCCCCHH
Q 008365 236 KIGEGGYGPVYRGKL--DHTPVAIKVLRPDA-AQGKRQFQQEVEVLSSIRHPNMVLLLGACPDY--GCLVYEYMHNGSLE 310 (568)
Q Consensus 236 ~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~--~~lV~E~~~ggsL~ 310 (568)
.||+|+||.||+|.+ +++.||+|.+.... ......+.+|+++++.++||||++++++|.+. .++||||+++++|.
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 81 (252)
T cd05084 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFL 81 (252)
T ss_pred ccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHH
Confidence 699999999999987 67889999876542 33456789999999999999999999988543 48999999999999
Q ss_pred HHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCCccccccc
Q 008365 311 DRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYH 390 (568)
Q Consensus 311 ~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~ 390 (568)
+++...+ ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++......... ..
T Consensus 82 ~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~----~~ 152 (252)
T cd05084 82 TFLRTEG--PRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYA----ST 152 (252)
T ss_pred HHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCccccccccc----cc
Confidence 9987543 24789999999999999999999999 999999999999999999999999998754322110 00
Q ss_pred cccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh-CCCCCCCchH--HHHHHHhCccccccCccCCCCChHHHHH
Q 008365 391 MTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPMGLTHH--VSRAIEKGTLAEMLDPAVTDWPAEAAES 467 (568)
Q Consensus 391 ~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~--~~~~~~~~~~~~~l~~~~~~~p~~~~~~ 467 (568)
.....++..|+|||++.++.++.++|||||||++|+|++ |..||..... ....+... . ....+..++..
T Consensus 153 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~-----~---~~~~~~~~~~~ 224 (252)
T cd05084 153 GGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQG-----V---RLPCPELCPDA 224 (252)
T ss_pred CCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcC-----C---CCCCcccCCHH
Confidence 011223567999999999899999999999999999998 9999964332 11222111 0 11234455678
Q ss_pred HHHHHHHhhccCCCCCCChHHhHh
Q 008365 468 FSKLAIQCAELRKKDRPDLGTVIV 491 (568)
Q Consensus 468 l~~li~~Cl~~dP~~RPs~~~vl~ 491 (568)
+.+|+.+||..+|.+||++.+|+.
T Consensus 225 ~~~li~~~l~~~p~~Rps~~~~~~ 248 (252)
T cd05084 225 VYRLMERCWEYDPGQRPSFSTVHQ 248 (252)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHH
Confidence 999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=317.39 Aligned_cols=243 Identities=26% Similarity=0.450 Sum_probs=195.2
Q ss_pred ccccceeecccCceeEEEEEeC-CccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCceeeeccccCCC--ceEEEEecCC
Q 008365 230 KFSEAMKIGEGGYGPVYRGKLD-HTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACPDY--GCLVYEYMHN 306 (568)
Q Consensus 230 ~y~~~~~IG~G~fg~Vy~~~~~-~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~--~~lV~E~~~g 306 (568)
+|.+.+.||+|+||.||+|.+. +..+|||++..... ....+.+|+.+++.++||||+++++++.+. .++||||+++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN 83 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence 4778889999999999999874 45799999865432 234678899999999999999999987543 4899999999
Q ss_pred CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCCccc
Q 008365 307 GSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSV 386 (568)
Q Consensus 307 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~~~~ 386 (568)
++|.+++..... .+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 84 ~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~--- 155 (256)
T cd05059 84 GCLLNYLRERKG--KLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY--- 155 (256)
T ss_pred CCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceecccccc---
Confidence 999999876443 4889999999999999999999999 99999999999999999999999999976532111
Q ss_pred cccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh-CCCCCCCchHHH--HHHHhCccccccCccCCCCChH
Q 008365 387 TQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPMGLTHHVS--RAIEKGTLAEMLDPAVTDWPAE 463 (568)
Q Consensus 387 ~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~--~~~~~~~~~~~l~~~~~~~p~~ 463 (568)
.......++..|+|||++.+..++.++|||||||++|+|++ |..||....... ..+..+ .. ...+..
T Consensus 156 --~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~-----~~---~~~~~~ 225 (256)
T cd05059 156 --TSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAG-----YR---LYRPKL 225 (256)
T ss_pred --cccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcC-----Cc---CCCCCC
Confidence 01112234567999999998999999999999999999999 899996543322 111111 11 122344
Q ss_pred HHHHHHHHHHHhhccCCCCCCChHHhHh
Q 008365 464 AAESFSKLAIQCAELRKKDRPDLGTVIV 491 (568)
Q Consensus 464 ~~~~l~~li~~Cl~~dP~~RPs~~~vl~ 491 (568)
++..+.+++.+||..+|.+||++.+++.
T Consensus 226 ~~~~~~~li~~cl~~~p~~Rpt~~~~l~ 253 (256)
T cd05059 226 APTEVYTIMYSCWHEKPEDRPAFKKLLS 253 (256)
T ss_pred CCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 6778999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=322.87 Aligned_cols=249 Identities=27% Similarity=0.431 Sum_probs=196.9
Q ss_pred HhcccccceeecccCceeEEEEEeC-------CccEEEEEeCcCh-hHhHHHHHHHHHHHHcCCCCceeeeccccCC--C
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKLD-------HTPVAIKVLRPDA-AQGKRQFQQEVEVLSSIRHPNMVLLLGACPD--Y 296 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~~-------~~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--~ 296 (568)
..++|.+.++||+|+||.||+|... +..||||.+.... ......+.+|+.+++.++||||+++++++.+ .
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4578999999999999999998642 3479999986543 2334467889999999999999999998744 4
Q ss_pred ceEEEEecCCCCHHHHHhhcCC-------CCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEe
Q 008365 297 GCLVYEYMHNGSLEDRLLRRGN-------TPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKI 369 (568)
Q Consensus 297 ~~lV~E~~~ggsL~~~l~~~~~-------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL 369 (568)
.++||||+++|+|.+++..... .+.+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEE
Confidence 5899999999999999975331 234567788899999999999999999 999999999999999999999
Q ss_pred cccccccccCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh-CCCCCCCchHHH--HHHHh
Q 008365 370 SDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPMGLTHHVS--RAIEK 446 (568)
Q Consensus 370 ~DFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~--~~~~~ 446 (568)
+|||+++.+..... ........++..|+|||++.++.++.++|||||||++|||++ |..||....... ..+..
T Consensus 161 ~Dfg~~~~~~~~~~----~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~ 236 (288)
T cd05061 161 GDFGMTRDIYETDY----YRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMD 236 (288)
T ss_pred CcCCcccccccccc----ccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence 99999976532211 111122346778999999998899999999999999999998 788996543321 11111
Q ss_pred CccccccCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhH
Q 008365 447 GTLAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVI 490 (568)
Q Consensus 447 ~~~~~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl 490 (568)
......+..++..+.+++.+||+.+|.+||++.+++
T Consensus 237 --------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll 272 (288)
T cd05061 237 --------GGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIV 272 (288)
T ss_pred --------CCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 111223345567899999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=320.10 Aligned_cols=255 Identities=25% Similarity=0.414 Sum_probs=197.1
Q ss_pred cccccceeecccCceeEEEEEe------CCccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCceeeeccccC----CCce
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKL------DHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACP----DYGC 298 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~------~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~----~~~~ 298 (568)
..|++.+.||+|+||.||++.. .+..||||++..........|.+|+++++.++||||+++++++. ...+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 4688899999999999999874 35689999998776666678899999999999999999998763 2348
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEeccccccccc
Q 008365 299 LVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLV 378 (568)
Q Consensus 299 lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~ 378 (568)
+||||+++|+|.+++..... .+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+
T Consensus 84 lv~e~~~~~~L~~~l~~~~~--~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKHRE--RLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred EEEEecCCCCHHHHHHhcCc--CCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 99999999999999875432 3789999999999999999999999 999999999999999999999999999876
Q ss_pred CCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHH-HHHHHhCc--------c
Q 008365 379 PPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHV-SRAIEKGT--------L 449 (568)
Q Consensus 379 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~-~~~~~~~~--------~ 449 (568)
....... .......++..|+|||++.+..++.++|||||||++|||++|..|+...... ...+.... +
T Consensus 159 ~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd05081 159 PQDKEYY---KVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHL 235 (284)
T ss_pred cCCCcce---eecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHH
Confidence 4322110 0111223455699999999889999999999999999999988776432211 11000000 0
Q ss_pred ccccCc-cCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHh
Q 008365 450 AEMLDP-AVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIV 491 (568)
Q Consensus 450 ~~~l~~-~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~ 491 (568)
.+.+.. .....+..++..+.+|+.+||+.+|.+||++.+|+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 236 IELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred HHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 001110 011223456678999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=316.19 Aligned_cols=251 Identities=25% Similarity=0.382 Sum_probs=202.9
Q ss_pred cccccceeecccCceeEEEEEe--CCccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCceeeeccccCC--CceEEEEec
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACPD--YGCLVYEYM 304 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--~~~lV~E~~ 304 (568)
++|.+.+.||.|+||.||+|.+ .++.+++|++..........+.+|+.+++.++||||+++++++.+ ..++||||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 5789999999999999999987 457899999987655556788999999999999999999998754 348999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCCc
Q 008365 305 HNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVAD 384 (568)
Q Consensus 305 ~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~~ 384 (568)
++++|.+++..... .+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.+||+|||++..+....
T Consensus 83 ~~~~l~~~~~~~~~--~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-- 155 (262)
T cd06613 83 GGGSLQDIYQVTRG--PLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATI-- 155 (262)
T ss_pred CCCcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhh--
Confidence 99999998876422 3889999999999999999999999 9999999999999999999999999997653221
Q ss_pred cccccccccccccccCCChhhhhcC---CCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHhCccccccCccCCCCC
Q 008365 385 SVTQYHMTSAAGTFCYIDPEYQQTG---MLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAVTDWP 461 (568)
Q Consensus 385 ~~~~~~~~~~~GT~~Y~APE~~~~~---~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~l~~~~~~~p 461 (568)
.......|+..|+|||++.+. .++.++|||||||++|+|++|..||.............. ..+.+.....+
T Consensus 156 ----~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~ 229 (262)
T cd06613 156 ----AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISK--SNFPPPKLKDK 229 (262)
T ss_pred ----hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--ccCCCccccch
Confidence 112345789999999998776 789999999999999999999999975543322211110 11111111223
Q ss_pred hHHHHHHHHHHHHhhccCCCCCCChHHhHhH
Q 008365 462 AEAAESFSKLAIQCAELRKKDRPDLGTVIVP 492 (568)
Q Consensus 462 ~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~ 492 (568)
...+..+.+++.+||..+|.+||++.+|+.+
T Consensus 230 ~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 230 EKWSPVFHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred hhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 4556789999999999999999999998743
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=317.23 Aligned_cols=239 Identities=25% Similarity=0.426 Sum_probs=191.7
Q ss_pred eecccCceeEEEEEeC----CccEEEEEeCcChh-HhHHHHHHHHHHHHcCCCCceeeeccccCC-CceEEEEecCCCCH
Q 008365 236 KIGEGGYGPVYRGKLD----HTPVAIKVLRPDAA-QGKRQFQQEVEVLSSIRHPNMVLLLGACPD-YGCLVYEYMHNGSL 309 (568)
Q Consensus 236 ~IG~G~fg~Vy~~~~~----~~~vAvK~l~~~~~-~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~-~~~lV~E~~~ggsL 309 (568)
.||+|+||.||+|.+. +..||||++..... ...+.+.+|+.+++.++||||++++++|.. ..++||||+++|+|
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~lv~e~~~~~~L 81 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEAEALMLVMEMASGGPL 81 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcCCCeEEEEEeCCCCCH
Confidence 4899999999999763 34699999876532 334568999999999999999999998854 44899999999999
Q ss_pred HHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCCcccccc
Q 008365 310 EDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQY 389 (568)
Q Consensus 310 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~ 389 (568)
.+++.... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+...... ..
T Consensus 82 ~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~---~~ 153 (257)
T cd05115 82 NKFLSGKK--DEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSY---YK 153 (257)
T ss_pred HHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccc---ee
Confidence 99886543 24899999999999999999999999 999999999999999999999999999765332111 11
Q ss_pred ccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh-CCCCCCCchHH--HHHHHhCccccccCccCCCCChHHHH
Q 008365 390 HMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPMGLTHHV--SRAIEKGTLAEMLDPAVTDWPAEAAE 466 (568)
Q Consensus 390 ~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~--~~~~~~~~~~~~l~~~~~~~p~~~~~ 466 (568)
......+++.|+|||++.+..++.++|||||||++|+|++ |..||...... ...+..+. ....+..++.
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~--------~~~~~~~~~~ 225 (257)
T cd05115 154 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGK--------RLDCPAECPP 225 (257)
T ss_pred ccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCC--------CCCCCCCCCH
Confidence 1122334678999999988889999999999999999996 99999654332 22222221 1233455678
Q ss_pred HHHHHHHHhhccCCCCCCChHHhH
Q 008365 467 SFSKLAIQCAELRKKDRPDLGTVI 490 (568)
Q Consensus 467 ~l~~li~~Cl~~dP~~RPs~~~vl 490 (568)
++.+++.+||..+|.+||++.+|.
T Consensus 226 ~l~~li~~c~~~~~~~Rp~~~~i~ 249 (257)
T cd05115 226 EMYALMKDCWIYKWEDRPNFAKVE 249 (257)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHH
Confidence 899999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=315.37 Aligned_cols=241 Identities=32% Similarity=0.509 Sum_probs=200.2
Q ss_pred cccccceeecccCceeEEEEEeCCccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCceeeeccccCC--CceEEEEecCC
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKLDHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACPD--YGCLVYEYMHN 306 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--~~~lV~E~~~g 306 (568)
++|.+.+.||.|+||.||+|...++.||||.+..... ..+.+.+|+.+++.++|+||+++++++.+ ..++||||+++
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 84 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAK 84 (256)
T ss_pred hhccceeeeecCCCceEEEEEecCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCC
Confidence 5688899999999999999999999999999986654 45678999999999999999999998753 44899999999
Q ss_pred CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCCccc
Q 008365 307 GSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSV 386 (568)
Q Consensus 307 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~~~~ 386 (568)
++|.+++...... .+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.+||+|||+++......
T Consensus 85 ~~L~~~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~---- 156 (256)
T cd05039 85 GSLVDYLRSRGRA-VITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ---- 156 (256)
T ss_pred CcHHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEccccccccccccc----
Confidence 9999998765432 4899999999999999999999999 9999999999999999999999999998653221
Q ss_pred cccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh-CCCCCCCchHH--HHHHHhCccccccCccCCCCChH
Q 008365 387 TQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPMGLTHHV--SRAIEKGTLAEMLDPAVTDWPAE 463 (568)
Q Consensus 387 ~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~--~~~~~~~~~~~~l~~~~~~~p~~ 463 (568)
....++..|+|||++.+..++.++|||||||++|+|++ |..||...... ...+..+. ....+..
T Consensus 157 -----~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~--------~~~~~~~ 223 (256)
T cd05039 157 -----DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGY--------RMEAPEG 223 (256)
T ss_pred -----ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCC--------CCCCccC
Confidence 12345678999999988889999999999999999997 99999654322 12222111 1122344
Q ss_pred HHHHHHHHHHHhhccCCCCCCChHHhHh
Q 008365 464 AAESFSKLAIQCAELRKKDRPDLGTVIV 491 (568)
Q Consensus 464 ~~~~l~~li~~Cl~~dP~~RPs~~~vl~ 491 (568)
++..+.+++.+||..+|.+||++.+++.
T Consensus 224 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 224 CPPEVYKVMKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred CCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 5678999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=315.80 Aligned_cols=245 Identities=24% Similarity=0.410 Sum_probs=200.5
Q ss_pred ccccceeecccCceeEEEEEe--CCccEEEEEeCcCh--hHhHHHHHHHHHHHHcCCCCceeeeccccCC-C--ceEEEE
Q 008365 230 KFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDA--AQGKRQFQQEVEVLSSIRHPNMVLLLGACPD-Y--GCLVYE 302 (568)
Q Consensus 230 ~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~--~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~-~--~~lV~E 302 (568)
.|++.+.||+|+||.||++.+ ++..||||.+.... ......+.+|+.+++.++|||++++++.+.. . .++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 488999999999999999987 45789999986542 2334568899999999999999999988743 2 379999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCC
Q 008365 303 YMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSV 382 (568)
Q Consensus 303 ~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~ 382 (568)
|+++++|.+++..... ..+++.++..++.+++.||.|||+.+ |+||||||+||+++.++.++|+|||++..+....
T Consensus 81 ~~~~~~l~~~l~~~~~-~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 81 FCEGGDLYHKLKEQKG-KLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred ccCCCcHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence 9999999999876432 24899999999999999999999999 9999999999999999999999999997663221
Q ss_pred CccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHH--HHHhCccccccCccCCCC
Q 008365 383 ADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSR--AIEKGTLAEMLDPAVTDW 460 (568)
Q Consensus 383 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~--~~~~~~~~~~l~~~~~~~ 460 (568)
.......|++.|+|||++.+..++.++|||||||++|+|++|+.||...+.... .+..+. ....
T Consensus 157 ------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~--------~~~~ 222 (257)
T cd08223 157 ------DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGK--------LPPM 222 (257)
T ss_pred ------CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcC--------CCCC
Confidence 112345689999999999999999999999999999999999999975443221 121221 1223
Q ss_pred ChHHHHHHHHHHHHhhccCCCCCCChHHhHhH
Q 008365 461 PAEAAESFSKLAIQCAELRKKDRPDLGTVIVP 492 (568)
Q Consensus 461 p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~ 492 (568)
+...+..+.+++.+||+.+|.+||++.+++.+
T Consensus 223 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 223 PKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred ccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 44566789999999999999999999999854
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=316.06 Aligned_cols=247 Identities=28% Similarity=0.450 Sum_probs=198.2
Q ss_pred cccccceeecccCceeEEEEEe--CCccEEEEEeCcC---hhHhHHHHHHHHHHHHcCCCCceeeeccccCC--CceEEE
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPD---AAQGKRQFQQEVEVLSSIRHPNMVLLLGACPD--YGCLVY 301 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~---~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--~~~lV~ 301 (568)
++|.+.+.||+|+||.||+|.. +++.||||.+... .......+.+|+.+++.++||||+++++++.+ ..++||
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 5789999999999999999987 6789999987542 23334568899999999999999999998754 458999
Q ss_pred EecCCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCC
Q 008365 302 EYMHNGSLEDRLLRRG-NTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPP 380 (568)
Q Consensus 302 E~~~ggsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~ 380 (568)
||+++|+|.+++.... ....++...+..++.||+.||.|||+.+ |+|+||||+|||++.++.++|+|||++..+..
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 9999999999886432 2234788999999999999999999999 99999999999999999999999999986543
Q ss_pred CCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchH----HHHHHHhCccccccCcc
Q 008365 381 SVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHH----VSRAIEKGTLAEMLDPA 456 (568)
Q Consensus 381 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~----~~~~~~~~~~~~~l~~~ 456 (568)
.. .......|++.|+|||.+.+..++.++|||||||++|+|++|+.||..... ....+.... .+.
T Consensus 159 ~~------~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~-----~~~ 227 (267)
T cd08228 159 KT------TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCD-----YPP 227 (267)
T ss_pred hh------HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCC-----CCC
Confidence 21 111235688999999999988899999999999999999999999954321 111111111 111
Q ss_pred CCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHh
Q 008365 457 VTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIV 491 (568)
Q Consensus 457 ~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~ 491 (568)
..+...+..+.+++.+||..+|.+||++.+|+.
T Consensus 228 --~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~ 260 (267)
T cd08228 228 --LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQ 260 (267)
T ss_pred --CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHH
Confidence 112345677999999999999999999999873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-39 Score=332.48 Aligned_cols=238 Identities=23% Similarity=0.323 Sum_probs=191.8
Q ss_pred ccccceeecccCceeEEEEEe--CCccEEEEEeCcChh---HhHHHHHHHHHHHHcCC-CCceeeeccccCC--CceEEE
Q 008365 230 KFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAA---QGKRQFQQEVEVLSSIR-HPNMVLLLGACPD--YGCLVY 301 (568)
Q Consensus 230 ~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~---~~~~~~~~Ev~iL~~l~-HpnIv~l~g~~~~--~~~lV~ 301 (568)
+|...+.||+|+||.||+|.+ ++..||||++..... .....+..|+.++..+. |++|+++++++.+ ..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 477889999999999999987 567899999975432 22345778899998886 5677788887754 458999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCC
Q 008365 302 EYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPS 381 (568)
Q Consensus 302 E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~ 381 (568)
||++||+|.+++...+ .+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 Ey~~~g~L~~~i~~~~---~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~ 154 (323)
T cd05615 81 EYVNGGDLMYHIQQVG---KFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD 154 (323)
T ss_pred cCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence 9999999999887654 3889999999999999999999999 999999999999999999999999998753221
Q ss_pred CCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHH--HHHHHhCccccccCccCCC
Q 008365 382 VADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHV--SRAIEKGTLAEMLDPAVTD 459 (568)
Q Consensus 382 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~--~~~~~~~~~~~~l~~~~~~ 459 (568)
. .......||+.|+|||++.+..++.++|||||||++|+|++|..||...... ...+.... ..
T Consensus 155 ~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~---------~~ 219 (323)
T cd05615 155 G------VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHN---------VS 219 (323)
T ss_pred C------ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC---------CC
Confidence 1 1123457999999999999999999999999999999999999999765432 12221111 12
Q ss_pred CChHHHHHHHHHHHHhhccCCCCCCChHH
Q 008365 460 WPAEAAESFSKLAIQCAELRKKDRPDLGT 488 (568)
Q Consensus 460 ~p~~~~~~l~~li~~Cl~~dP~~RPs~~~ 488 (568)
+|..++..+.+++.+||+.+|.+|++..+
T Consensus 220 ~p~~~~~~~~~li~~~l~~~p~~R~~~~~ 248 (323)
T cd05615 220 YPKSLSKEAVSICKGLMTKHPSKRLGCGP 248 (323)
T ss_pred CCccCCHHHHHHHHHHcccCHhhCCCCCC
Confidence 34456677899999999999999998643
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=323.26 Aligned_cols=256 Identities=27% Similarity=0.435 Sum_probs=195.9
Q ss_pred cccccceeecccCceeEEEEEeCC----------------ccEEEEEeCcCh-hHhHHHHHHHHHHHHcCCCCceeeecc
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKLDH----------------TPVAIKVLRPDA-AQGKRQFQQEVEVLSSIRHPNMVLLLG 291 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~~~----------------~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l~HpnIv~l~g 291 (568)
++|++.+.||+|+||.||++.+.+ ..||||+++... ......|.+|+++++.++||||+++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 578899999999999999987532 248999987653 333457899999999999999999999
Q ss_pred ccCC--CceEEEEecCCCCHHHHHhhcCC---------CCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCee
Q 008365 292 ACPD--YGCLVYEYMHNGSLEDRLLRRGN---------TPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANIL 360 (568)
Q Consensus 292 ~~~~--~~~lV~E~~~ggsL~~~l~~~~~---------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NIL 360 (568)
++.. ..++||||+++++|.+++..... .+.+++..+..++.|++.||.|||+.+ |+||||||+|||
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhEE
Confidence 8844 45899999999999999865321 123688899999999999999999999 999999999999
Q ss_pred ccCCceeEecccccccccCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh--CCCCCCCch
Q 008365 361 LDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT--ARSPMGLTH 438 (568)
Q Consensus 361 ld~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt--G~~Pf~~~~ 438 (568)
++.++.+||+|||++..+..... ........++..|+|||++.++.++.++|||||||++|+|++ |..||....
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~ 237 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDY----YRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLS 237 (295)
T ss_pred EcCCCcEEecccccccccccCcc----eeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccC
Confidence 99999999999999976532211 111223456789999999988899999999999999999998 667886533
Q ss_pred HHHHHHHhCcccc-ccCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHh
Q 008365 439 HVSRAIEKGTLAE-MLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIV 491 (568)
Q Consensus 439 ~~~~~~~~~~~~~-~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~ 491 (568)
..........+.. .........+..++..+.+|+.+||+.+|.+||++.+|+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 238 DEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred hHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 2111100000000 0011111123345678999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=312.07 Aligned_cols=242 Identities=33% Similarity=0.558 Sum_probs=198.9
Q ss_pred eeecccCceeEEEEEeC-----CccEEEEEeCcChhHh-HHHHHHHHHHHHcCCCCceeeeccccCC--CceEEEEecCC
Q 008365 235 MKIGEGGYGPVYRGKLD-----HTPVAIKVLRPDAAQG-KRQFQQEVEVLSSIRHPNMVLLLGACPD--YGCLVYEYMHN 306 (568)
Q Consensus 235 ~~IG~G~fg~Vy~~~~~-----~~~vAvK~l~~~~~~~-~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--~~~lV~E~~~g 306 (568)
+.||+|+||.||+|.+. +..|+||++....... ...+.+|+.++..++|+||+++++++.+ ..++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 36999999999999884 6789999998764433 5678999999999999999999998855 34899999999
Q ss_pred CCHHHHHhhcCC------CCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCC
Q 008365 307 GSLEDRLLRRGN------TPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPP 380 (568)
Q Consensus 307 gsL~~~l~~~~~------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~ 380 (568)
++|.+++..... ...+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence 999999877521 245899999999999999999999999 99999999999999999999999999987654
Q ss_pred CCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh-CCCCCCCchHHH--HHHHhCccccccCccC
Q 008365 381 SVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPMGLTHHVS--RAIEKGTLAEMLDPAV 457 (568)
Q Consensus 381 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~--~~~~~~~~~~~l~~~~ 457 (568)
... ........+++.|+|||.+.+..++.++|||||||++|+|++ |..||....... ..+.. ...
T Consensus 158 ~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~--------~~~ 225 (262)
T cd00192 158 DDY----YRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRK--------GYR 225 (262)
T ss_pred ccc----cccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc--------CCC
Confidence 321 112234568899999999988899999999999999999999 699997553321 22211 112
Q ss_pred CCCChHHHHHHHHHHHHhhccCCCCCCChHHhHh
Q 008365 458 TDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIV 491 (568)
Q Consensus 458 ~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~ 491 (568)
...+..++..+.+++.+||..+|.+||++.+++.
T Consensus 226 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~ 259 (262)
T cd00192 226 LPKPEYCPDELYELMLSCWQLDPEDRPTFSELVE 259 (262)
T ss_pred CCCCccCChHHHHHHHHHccCCcccCcCHHHHHH
Confidence 2335556788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=324.62 Aligned_cols=252 Identities=29% Similarity=0.469 Sum_probs=195.8
Q ss_pred cccccceeecccCceeEEEEEe--CCc--cEEEEEeCcC-hhHhHHHHHHHHHHHHcC-CCCceeeeccccCC--CceEE
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKL--DHT--PVAIKVLRPD-AAQGKRQFQQEVEVLSSI-RHPNMVLLLGACPD--YGCLV 300 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~--~~~--~vAvK~l~~~-~~~~~~~~~~Ev~iL~~l-~HpnIv~l~g~~~~--~~~lV 300 (568)
++|++.+.||+|+||.||+|.+ ++. .+|+|.+... .......+.+|+.++.++ +||||++++++|.+ ..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 4688899999999999999986 343 4677777643 233456788999999999 89999999998854 44899
Q ss_pred EEecCCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCcee
Q 008365 301 YEYMHNGSLEDRLLRRGN-------------TPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVS 367 (568)
Q Consensus 301 ~E~~~ggsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~v 367 (568)
|||+++|+|.+++...+. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcE
Confidence 999999999999976431 124789999999999999999999999 9999999999999999999
Q ss_pred EecccccccccCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh-CCCCCCCchHHHHHHHh
Q 008365 368 KISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPMGLTHHVSRAIEK 446 (568)
Q Consensus 368 KL~DFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~ 446 (568)
||+|||+++..... .......++..|+|||++.+..++.++|||||||++|+|++ |..||......... ..
T Consensus 164 kl~dfg~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~-~~ 235 (303)
T cd05088 164 KIADFGLSRGQEVY-------VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY-EK 235 (303)
T ss_pred EeCccccCcccchh-------hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHH-HH
Confidence 99999998632111 01112234678999999988889999999999999999998 99999644322111 11
Q ss_pred CccccccCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHHHH
Q 008365 447 GTLAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPELNR 496 (568)
Q Consensus 447 ~~~~~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l~~ 496 (568)
+. .......+..++..+.+|+.+||+.+|.+||++.+++......
T Consensus 236 --~~---~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~ 280 (303)
T cd05088 236 --LP---QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 280 (303)
T ss_pred --Hh---cCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 00 0111112334556789999999999999999999998654433
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=319.92 Aligned_cols=249 Identities=31% Similarity=0.484 Sum_probs=196.8
Q ss_pred cccceeecccCceeEEEEEeC--CccEEEEEeCcChhHhHH--HHHHHHHHHHcCCCCceeeeccccCC--CceEEEEec
Q 008365 231 FSEAMKIGEGGYGPVYRGKLD--HTPVAIKVLRPDAAQGKR--QFQQEVEVLSSIRHPNMVLLLGACPD--YGCLVYEYM 304 (568)
Q Consensus 231 y~~~~~IG~G~fg~Vy~~~~~--~~~vAvK~l~~~~~~~~~--~~~~Ev~iL~~l~HpnIv~l~g~~~~--~~~lV~E~~ 304 (568)
|++.+.||+|+||+||++... +..||+|++......... ...+|+.+++.++||||+++++++.+ ..++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 778899999999999999984 447999999876544332 34569999999999999999998844 448999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCCc
Q 008365 305 HNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVAD 384 (568)
Q Consensus 305 ~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~~ 384 (568)
++++|.+++.... .+++..+..++.||+.||.+||+.+ |+|+||||+|||++.++.++|+|||++..+...
T Consensus 81 ~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~--- 151 (260)
T PF00069_consen 81 PGGSLQDYLQKNK---PLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLSEN--- 151 (260)
T ss_dssp TTEBHHHHHHHHS---SBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEESTST---
T ss_pred ccccccccccccc---ccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc---
Confidence 9999999998433 3899999999999999999999999 999999999999999999999999999754111
Q ss_pred cccccccccccccccCCChhhhh-cCCCCCcceehhHHHHHHHHHhCCCCCCCch--HHHHHHHhCccccccCccCCCCC
Q 008365 385 SVTQYHMTSAAGTFCYIDPEYQQ-TGMLTTKSDIYSFGIMLLQIITARSPMGLTH--HVSRAIEKGTLAEMLDPAVTDWP 461 (568)
Q Consensus 385 ~~~~~~~~~~~GT~~Y~APE~~~-~~~~s~ksDvwSlGvil~elltG~~Pf~~~~--~~~~~~~~~~~~~~l~~~~~~~p 461 (568)
........+|..|+|||++. +..++.++||||||+++|+|++|..||.... .....+....... +..... ..
T Consensus 152 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~-~~ 226 (260)
T PF00069_consen 152 ---NENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRP-LPSSSQ-QS 226 (260)
T ss_dssp ---TSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTH-HHHHTT-SH
T ss_pred ---ccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccccc-cccccc-cc
Confidence 11234567899999999998 8889999999999999999999999997652 1111111111100 000000 01
Q ss_pred hHHHHHHHHHHHHhhccCCCCCCChHHhHhHH
Q 008365 462 AEAAESFSKLAIQCAELRKKDRPDLGTVIVPE 493 (568)
Q Consensus 462 ~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~ 493 (568)
......+.+++..||+.+|.+||++.+++.+.
T Consensus 227 ~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~ 258 (260)
T PF00069_consen 227 REKSEELRDLIKKMLSKDPEQRPSAEELLKHP 258 (260)
T ss_dssp TTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSG
T ss_pred chhHHHHHHHHHHHccCChhHCcCHHHHhcCC
Confidence 11237899999999999999999999998543
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=315.65 Aligned_cols=244 Identities=23% Similarity=0.374 Sum_probs=199.3
Q ss_pred ccccceeecccCceeEEEEEe--CCccEEEEEeCcC-hhHhHHHHHHHHHHHHcCCCCceeeeccccCCC--ceEEEEec
Q 008365 230 KFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPD-AAQGKRQFQQEVEVLSSIRHPNMVLLLGACPDY--GCLVYEYM 304 (568)
Q Consensus 230 ~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~-~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~--~~lV~E~~ 304 (568)
+|++.+.||.|+||.||++.+ ++..||+|.++.. .....+.+.+|+.+++.++||||+++++.+.+. .++||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 478899999999999999987 5678999998643 233456788999999999999999999988543 48999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCCc
Q 008365 305 HNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVAD 384 (568)
Q Consensus 305 ~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~~ 384 (568)
++|+|.+++..... ..++...+..++.||+.||.|||+.+ |+|+||||+|||++.++.++|+|||++.......
T Consensus 81 ~~~~l~~~~~~~~~-~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~-- 154 (255)
T cd08219 81 DGGDLMQKIKLQRG-KLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG-- 154 (255)
T ss_pred CCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeecccc--
Confidence 99999998865332 24788999999999999999999999 9999999999999999999999999997653221
Q ss_pred cccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHH--HHHhCccccccCccCCCCCh
Q 008365 385 SVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSR--AIEKGTLAEMLDPAVTDWPA 462 (568)
Q Consensus 385 ~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~--~~~~~~~~~~l~~~~~~~p~ 462 (568)
.......|++.|+|||++.+..++.++|||||||++|+|++|..||........ .+..+.. ...+.
T Consensus 155 ----~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~--------~~~~~ 222 (255)
T cd08219 155 ----AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSY--------KPLPS 222 (255)
T ss_pred ----cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCC--------CCCCc
Confidence 112345789999999999998999999999999999999999999975543221 2222211 12234
Q ss_pred HHHHHHHHHHHHhhccCCCCCCChHHhHh
Q 008365 463 EAAESFSKLAIQCAELRKKDRPDLGTVIV 491 (568)
Q Consensus 463 ~~~~~l~~li~~Cl~~dP~~RPs~~~vl~ 491 (568)
.++..+.+|+.+||+.+|.+||++.+|+.
T Consensus 223 ~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 251 (255)
T cd08219 223 HYSYELRSLIKQMFKRNPRSRPSATTILS 251 (255)
T ss_pred ccCHHHHHHHHHHHhCCcccCCCHHHHhh
Confidence 45667899999999999999999999873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=337.74 Aligned_cols=244 Identities=28% Similarity=0.474 Sum_probs=198.1
Q ss_pred cccccceeecccCceeEEEEEeC---C--cc-EEEEEeCcC---hhHhHHHHHHHHHHHHcCCCCceeeeccccCC--Cc
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKLD---H--TP-VAIKVLRPD---AAQGKRQFQQEVEVLSSIRHPNMVLLLGACPD--YG 297 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~~---~--~~-vAvK~l~~~---~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--~~ 297 (568)
++-.+.++||+|+||.||+|.+. + .. ||||..+.. .......|.+|.++|+.++|||||++||++.+ ..
T Consensus 157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl 236 (474)
T KOG0194|consen 157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPL 236 (474)
T ss_pred cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCcc
Confidence 34445689999999999999862 2 13 899998853 34556779999999999999999999998844 45
Q ss_pred eEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccc
Q 008365 298 CLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARL 377 (568)
Q Consensus 298 ~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~ 377 (568)
+||||+|.||+|.++|.+.+. .++..++..++.+.+.||.|||+++ +|||||-..|+|++.++.+||+||||++.
T Consensus 237 ~ivmEl~~gGsL~~~L~k~~~--~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGLs~~ 311 (474)
T KOG0194|consen 237 MLVMELCNGGSLDDYLKKNKK--SLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGLSRA 311 (474)
T ss_pred EEEEEecCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCccccccC
Confidence 899999999999999998765 3899999999999999999999999 99999999999999999999999999875
Q ss_pred cCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh-CCCCCCCchHH--HHHHHhCccccccC
Q 008365 378 VPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPMGLTHHV--SRAIEKGTLAEMLD 454 (568)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~--~~~~~~~~~~~~l~ 454 (568)
-.... ......--...|+|||.+..+.|+.++|||||||++||+++ |..||...... ...+....+
T Consensus 312 ~~~~~------~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~----- 380 (474)
T KOG0194|consen 312 GSQYV------MKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGY----- 380 (474)
T ss_pred Cccee------eccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCc-----
Confidence 32100 00111124578999999999999999999999999999999 88899765543 233322221
Q ss_pred ccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhH
Q 008365 455 PAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVI 490 (568)
Q Consensus 455 ~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl 490 (568)
....|...|..+..++.+||..+|.+||+|.++.
T Consensus 381 --r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~ 414 (474)
T KOG0194|consen 381 --RMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIK 414 (474)
T ss_pred --cCCCCCCCHHHHHHHHHHhccCChhhccCHHHHH
Confidence 1233456778899999999999999999999986
|
|
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=325.32 Aligned_cols=249 Identities=27% Similarity=0.434 Sum_probs=198.1
Q ss_pred hcccccceeecccCceeEEEEEeCC---------ccEEEEEeCcCh-hHhHHHHHHHHHHHHcC-CCCceeeeccccCC-
Q 008365 228 TDKFSEAMKIGEGGYGPVYRGKLDH---------TPVAIKVLRPDA-AQGKRQFQQEVEVLSSI-RHPNMVLLLGACPD- 295 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~~~~~~---------~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l-~HpnIv~l~g~~~~- 295 (568)
.++|.+.+.||+|+||.||++.+.+ ..||+|++.... ......+..|+.+++.+ +||||++++++|.+
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 4679999999999999999997522 369999998653 33445688899999999 79999999998854
Q ss_pred -CceEEEEecCCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeec
Q 008365 296 -YGCLVYEYMHNGSLEDRLLRRGN-------------TPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILL 361 (568)
Q Consensus 296 -~~~lV~E~~~ggsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILl 361 (568)
..++||||+++|+|.+++..... ...+++.+++.|+.||+.||.|||+.+ |+||||||+|||+
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEE
Confidence 34899999999999999976432 124788999999999999999999999 9999999999999
Q ss_pred cCCceeEecccccccccCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh-CCCCCCCchH-
Q 008365 362 DRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPMGLTHH- 439 (568)
Q Consensus 362 d~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~- 439 (568)
+.++.+||+|||+++.+...... .......+++.|+|||++.+..++.++|||||||++|+|++ |..||.....
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~ 249 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYY----KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 249 (307)
T ss_pred cCCCcEEECCCcccccccccchh----hccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH
Confidence 99999999999999765321100 01112235578999999998899999999999999999998 8899865432
Q ss_pred -HHHHHHhCccccccCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHh
Q 008365 440 -VSRAIEKGTLAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIV 491 (568)
Q Consensus 440 -~~~~~~~~~~~~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~ 491 (568)
+...+..+. ....+..++..+.+|+.+||..+|.+||++.+|+.
T Consensus 250 ~~~~~~~~~~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~ 294 (307)
T cd05098 250 ELFKLLKEGH--------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 294 (307)
T ss_pred HHHHHHHcCC--------CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 222222211 11234456678999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=327.39 Aligned_cols=254 Identities=22% Similarity=0.345 Sum_probs=195.0
Q ss_pred cccccceeecccCceeEEEEEe--CCccEEEEEeCcChh-HhHHHHHHHHHHHHcCCCCceeeeccccCC--CceEEEEe
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAA-QGKRQFQQEVEVLSSIRHPNMVLLLGACPD--YGCLVYEY 303 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~-~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--~~~lV~E~ 303 (568)
++|.+.++||+|+||.||+|.+ .+..||||+++.... .....+.+|+.+++.++||||+++++++.+ ..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 5699999999999999999987 566899999875432 223457789999999999999999998854 45899999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCC
Q 008365 304 MHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVA 383 (568)
Q Consensus 304 ~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~ 383 (568)
++ ++|.+++...+. .+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++......
T Consensus 86 ~~-~~l~~~~~~~~~--~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~- 158 (309)
T cd07872 86 LD-KDLKQYMDDCGN--IMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPT- 158 (309)
T ss_pred CC-CCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCc-
Confidence 96 588888766543 3788889999999999999999999 9999999999999999999999999997543221
Q ss_pred ccccccccccccccccCCChhhhhc-CCCCCcceehhHHHHHHHHHhCCCCCCCchHHHH---HHHh-Cc-----c----
Q 008365 384 DSVTQYHMTSAAGTFCYIDPEYQQT-GMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSR---AIEK-GT-----L---- 449 (568)
Q Consensus 384 ~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~---~~~~-~~-----~---- 449 (568)
.......+|+.|+|||++.+ ..++.++|||||||++|+|++|++||........ .... +. .
T Consensus 159 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (309)
T cd07872 159 -----KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGIS 233 (309)
T ss_pred -----cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhc
Confidence 11123468999999998765 4689999999999999999999999965432111 1000 00 0
Q ss_pred --ccccCccCC--------CCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 450 --AEMLDPAVT--------DWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 450 --~~~l~~~~~--------~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
....+.... .....++..+.+|+.+||..+|.+||++.+++.+.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~ 288 (309)
T cd07872 234 SNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAY 288 (309)
T ss_pred chhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChh
Confidence 000000000 111235667899999999999999999999987665
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=323.40 Aligned_cols=251 Identities=24% Similarity=0.370 Sum_probs=205.7
Q ss_pred cccccceeecccCceeEEEEEe--CCccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCceeeeccccCC--CceEEEEec
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACPD--YGCLVYEYM 304 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--~~~lV~E~~ 304 (568)
.+|.+.+.||.|+||.||+|.+ .++.||||.+..........+.+|+.+++.++||||++++++|.+ ..++||||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 4699999999999999999986 678999999876554455678899999999999999999998854 458999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCCc
Q 008365 305 HNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVAD 384 (568)
Q Consensus 305 ~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~~ 384 (568)
++++|..++... .+++.++..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++........
T Consensus 99 ~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~- 170 (296)
T cd06655 99 AGGSLTDVVTET----CMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS- 170 (296)
T ss_pred CCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhcccccc-
Confidence 999999988643 3789999999999999999999999 99999999999999999999999999876533211
Q ss_pred cccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHhCccccccCccCCCCChHH
Q 008365 385 SVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAVTDWPAEA 464 (568)
Q Consensus 385 ~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~l~~~~~~~p~~~ 464 (568)
......|++.|+|||.+.+..++.++|||||||++|+|++|+.||...+........... .......+..+
T Consensus 171 -----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~----~~~~~~~~~~~ 241 (296)
T cd06655 171 -----KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN----GTPELQNPEKL 241 (296)
T ss_pred -----cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc----CCcccCCcccC
Confidence 123356899999999999888999999999999999999999999766554332211110 00111223455
Q ss_pred HHHHHHHHHHhhccCCCCCCChHHhHhHHHHH
Q 008365 465 AESFSKLAIQCAELRKKDRPDLGTVIVPELNR 496 (568)
Q Consensus 465 ~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l~~ 496 (568)
+..+.+++.+||..+|.+||++.+|+.+.+-+
T Consensus 242 ~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~ 273 (296)
T cd06655 242 SPIFRDFLNRCLEMDVEKRGSAKELLQHPFLK 273 (296)
T ss_pred CHHHHHHHHHHhhcChhhCCCHHHHhhChHhh
Confidence 67799999999999999999999999777644
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=317.11 Aligned_cols=246 Identities=23% Similarity=0.395 Sum_probs=198.7
Q ss_pred hcccccceeecccCceeEEEEEeCC-----ccEEEEEeCcCh-hHhHHHHHHHHHHHHcCCCCceeeeccccCCC-ceEE
Q 008365 228 TDKFSEAMKIGEGGYGPVYRGKLDH-----TPVAIKVLRPDA-AQGKRQFQQEVEVLSSIRHPNMVLLLGACPDY-GCLV 300 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~~~~~~-----~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~-~~lV 300 (568)
.++|.+.+.||+|+||.||+|.+.. ..||||...... ....+.+.+|+.+++.++||||++++++|.+. .++|
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~lv 84 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITENPVWIV 84 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcCCCcEEE
Confidence 3468888999999999999998632 369999987654 44556789999999999999999999988554 5899
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCC
Q 008365 301 YEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPP 380 (568)
Q Consensus 301 ~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~ 380 (568)
|||+++|+|.+++..... .+++..+..++.|++.||.|||+.+ ++|+||||+|||++.++.+||+|||+++....
T Consensus 85 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 159 (270)
T cd05056 85 MELAPLGELRSYLQVNKY--SLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLED 159 (270)
T ss_pred EEcCCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeeccc
Confidence 999999999999976432 3889999999999999999999999 99999999999999999999999999976533
Q ss_pred CCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh-CCCCCCCchHHHH--HHHhCccccccCccC
Q 008365 381 SVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPMGLTHHVSR--AIEKGTLAEMLDPAV 457 (568)
Q Consensus 381 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~~--~~~~~~~~~~l~~~~ 457 (568)
.. ........++..|+|||.+....++.++|||||||++|+|++ |..||........ .+..+. .
T Consensus 160 ~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~--------~ 226 (270)
T cd05056 160 ES-----YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGE--------R 226 (270)
T ss_pred cc-----ceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC--------c
Confidence 21 111123345678999999988889999999999999999996 9999965443221 122211 1
Q ss_pred CCCChHHHHHHHHHHHHhhccCCCCCCChHHhHh
Q 008365 458 TDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIV 491 (568)
Q Consensus 458 ~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~ 491 (568)
...+..++..+.+++.+|+..+|.+||++.+++.
T Consensus 227 ~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~ 260 (270)
T cd05056 227 LPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKA 260 (270)
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 1224456778999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=322.01 Aligned_cols=251 Identities=27% Similarity=0.433 Sum_probs=199.3
Q ss_pred HhcccccceeecccCceeEEEEEeCC-------ccEEEEEeCcCh-hHhHHHHHHHHHHHHcC-CCCceeeeccccCCC-
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKLDH-------TPVAIKVLRPDA-AQGKRQFQQEVEVLSSI-RHPNMVLLLGACPDY- 296 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~~~-------~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l-~HpnIv~l~g~~~~~- 296 (568)
..++|++.+.||+|+||.||++...+ ..||+|++.... ......+.+|+.++..+ +||||++++++|...
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG 89 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence 34678999999999999999997632 479999987642 23345688999999999 799999999988554
Q ss_pred -ceEEEEecCCCCHHHHHhhcC-------------CCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeecc
Q 008365 297 -GCLVYEYMHNGSLEDRLLRRG-------------NTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLD 362 (568)
Q Consensus 297 -~~lV~E~~~ggsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld 362 (568)
.++||||+++|+|.+++.... ....+++..++.++.|++.||.|||+.+ |+||||||+|||++
T Consensus 90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~~ 166 (293)
T cd05053 90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLVT 166 (293)
T ss_pred CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEEc
Confidence 489999999999999986531 2234889999999999999999999999 99999999999999
Q ss_pred CCceeEecccccccccCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh-CCCCCCCchH--
Q 008365 363 RNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPMGLTHH-- 439 (568)
Q Consensus 363 ~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~-- 439 (568)
.++.+||+|||+++.+...... .......++..|+|||++.+..++.++|||||||++|+|++ |..||.....
T Consensus 167 ~~~~~kL~Dfg~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~ 242 (293)
T cd05053 167 EDHVMKIADFGLARDIHHIDYY----RKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE 242 (293)
T ss_pred CCCeEEeCccccccccccccce----eccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH
Confidence 9999999999999866432110 01122345678999999988899999999999999999998 9999964432
Q ss_pred HHHHHHhCccccccCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhH
Q 008365 440 VSRAIEKGTLAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVP 492 (568)
Q Consensus 440 ~~~~~~~~~~~~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~ 492 (568)
+...+..+. ....+..++..+.+|+.+||..+|.+||++.+++..
T Consensus 243 ~~~~~~~~~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 243 LFKLLKEGY--------RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred HHHHHHcCC--------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 222222111 112344556789999999999999999999999743
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-39 Score=330.45 Aligned_cols=249 Identities=23% Similarity=0.378 Sum_probs=211.5
Q ss_pred HhcccccceeecccCceeEEEEEe--CCccEEEEEeCcChhHh--HHHHHHHHHHHHcCCCCceeeeccccCC--CceEE
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQG--KRQFQQEVEVLSSIRHPNMVLLLGACPD--YGCLV 300 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~--~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--~~~lV 300 (568)
+..-|.+.+.||+|.|++|-++++ .|..||||++.+..... ...+.+|+..|+.++|||||+||.+... ..|||
T Consensus 16 IAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLi 95 (864)
T KOG4717|consen 16 IAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLI 95 (864)
T ss_pred eeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEE
Confidence 345688888999999999999876 89999999998775443 3567899999999999999999999744 45999
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeec-cCCceeEecccccccccC
Q 008365 301 YEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILL-DRNYVSKISDVGLARLVP 379 (568)
Q Consensus 301 ~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILl-d~~~~vKL~DFGla~~~~ 379 (568)
+|+-.+|+|.|+|.++... +.+....+++.||+.|+.|+|+.+ +|||||||+||.+ .+-|.|||.|||++..+.
T Consensus 96 LELGD~GDl~DyImKHe~G--l~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~ 170 (864)
T KOG4717|consen 96 LELGDGGDLFDYIMKHEEG--LNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ 170 (864)
T ss_pred EEecCCchHHHHHHhhhcc--ccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCC
Confidence 9999999999999987654 889999999999999999999999 9999999999976 567999999999997765
Q ss_pred CCCCccccccccccccccccCCChhhhhcCCCCC-cceehhHHHHHHHHHhCCCCCCCchHHHHHHHhCccccccCccCC
Q 008365 380 PSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTT-KSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAVT 458 (568)
Q Consensus 380 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~-ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~l~~~~~ 458 (568)
+. ...++.||+..|-|||++.+..|+. ++||||||||||.|++|++||.-.+. ...+..++|...
T Consensus 171 PG-------~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeAND------SETLTmImDCKY- 236 (864)
T KOG4717|consen 171 PG-------KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEAND------SETLTMIMDCKY- 236 (864)
T ss_pred Cc-------chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccc------hhhhhhhhcccc-
Confidence 43 3457789999999999999998874 78999999999999999999965443 233444444332
Q ss_pred CCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 459 DWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 459 ~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
..|..++.++.+||..||..||.+|.++++|+.+.|
T Consensus 237 tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~W 272 (864)
T KOG4717|consen 237 TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSW 272 (864)
T ss_pred cCchhhhHHHHHHHHHHHhcCchhhccHHHHhcccc
Confidence 357889999999999999999999999999975443
|
|
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=312.97 Aligned_cols=247 Identities=25% Similarity=0.388 Sum_probs=202.0
Q ss_pred cccccceeecccCceeEEEEEeC--CccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCceeeeccccCCC--ceEEEEec
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKLD--HTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACPDY--GCLVYEYM 304 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~~--~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~--~~lV~E~~ 304 (568)
++|++.+.||.|+||.||+|... +..|++|.+..... ...+.+|+.+++.++||||+++++.+.+. .|++|||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 56888999999999999999874 57899999876543 56899999999999999999999988544 48999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCCc
Q 008365 305 HNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVAD 384 (568)
Q Consensus 305 ~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~~ 384 (568)
.+++|.+++...+. .+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.+||+|||++..+.....
T Consensus 81 ~~~~L~~~l~~~~~--~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~- 154 (256)
T cd06612 81 GAGSVSDIMKITNK--TLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA- 154 (256)
T ss_pred CCCcHHHHHHhCcc--CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc-
Confidence 99999999865442 4899999999999999999999999 99999999999999999999999999986643221
Q ss_pred cccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHhCccccccCccCCCCChHH
Q 008365 385 SVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAVTDWPAEA 464 (568)
Q Consensus 385 ~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~l~~~~~~~p~~~ 464 (568)
......|+..|+|||++.+..++.++|||||||++|+|++|+.||.............. . .......+..+
T Consensus 155 -----~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~---~-~~~~~~~~~~~ 225 (256)
T cd06612 155 -----KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPN---K-PPPTLSDPEKW 225 (256)
T ss_pred -----ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhcc---C-CCCCCCchhhc
Confidence 11234588999999999999999999999999999999999999975444322221111 0 01111223455
Q ss_pred HHHHHHHHHHhhccCCCCCCChHHhHhH
Q 008365 465 AESFSKLAIQCAELRKKDRPDLGTVIVP 492 (568)
Q Consensus 465 ~~~l~~li~~Cl~~dP~~RPs~~~vl~~ 492 (568)
+..+.+++.+||+.+|.+||++.+|+.+
T Consensus 226 ~~~~~~~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 226 SPEFNDFVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred CHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence 6789999999999999999999999854
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=357.00 Aligned_cols=262 Identities=23% Similarity=0.292 Sum_probs=200.6
Q ss_pred cccccceeecccCceeEEEEEe--CCccEEEEEeCcCh---hHhHHHHHHHHHHHHcCCCCceeeeccccCCC--ceEEE
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDA---AQGKRQFQQEVEVLSSIRHPNMVLLLGACPDY--GCLVY 301 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~--~~lV~ 301 (568)
++|++.++||+|+||.||+|.+ .++.||||++.... ......|.+|+.+++.++|||||++++++.+. .++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 5799999999999999999987 46789999987542 22345788999999999999999999998554 48999
Q ss_pred EecCCCCHHHHHhhcCC--------CCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccc
Q 008365 302 EYMHNGSLEDRLLRRGN--------TPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVG 373 (568)
Q Consensus 302 E~~~ggsL~~~l~~~~~--------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFG 373 (568)
||++||+|.+++..... ...+++..+..|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence 99999999998864211 123566778899999999999999999 9999999999999999999999999
Q ss_pred cccccCCCCCcc------------ccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHH
Q 008365 374 LARLVPPSVADS------------VTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVS 441 (568)
Q Consensus 374 la~~~~~~~~~~------------~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~ 441 (568)
+++......... .........+||+.|+|||++.+..++.++|||||||++|||++|..||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 998662111000 00011123579999999999999999999999999999999999999996533211
Q ss_pred HHHHhCccccccCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHHHHH
Q 008365 442 RAIEKGTLAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPELNRL 497 (568)
Q Consensus 442 ~~~~~~~~~~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l~~L 497 (568)
.... ... ..+........++..+.+++.+|+..+|.+||+..+.+...+...
T Consensus 239 i~~~-~~i---~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~ 290 (932)
T PRK13184 239 ISYR-DVI---LSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPH 290 (932)
T ss_pred hhhh-hhc---cChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 1111 111 111110111245677899999999999999998777665555443
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=319.61 Aligned_cols=255 Identities=24% Similarity=0.357 Sum_probs=199.5
Q ss_pred hcccccceeecccCceeEEEEEe--CCccEEEEEeCcChhH--hHHHHHHHHHHHHcCCCCc-eeeeccccCC-------
Q 008365 228 TDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQ--GKRQFQQEVEVLSSIRHPN-MVLLLGACPD------- 295 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~--~~~~~~~Ev~iL~~l~Hpn-Iv~l~g~~~~------- 295 (568)
...|..+++||+|+||+||+|+. +|+.||+|+++..... ......+|+.+|+.|+|+| ||.+++++..
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 34577778899999999999987 6789999999765432 2334579999999999999 9999999843
Q ss_pred -CceEEEEecCCCCHHHHHhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccc
Q 008365 296 -YGCLVYEYMHNGSLEDRLLRRGNT-PVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVG 373 (568)
Q Consensus 296 -~~~lV~E~~~ggsL~~~l~~~~~~-~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFG 373 (568)
..++||||+ .-+|.+++...... ..++...+..++.||+.||.|||+++ |+||||||.||||+++|.+||+|||
T Consensus 90 ~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFG 165 (323)
T KOG0594|consen 90 GKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFG 165 (323)
T ss_pred ceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccc
Confidence 236899999 58999999876532 23666889999999999999999999 9999999999999999999999999
Q ss_pred cccccCCCCCccccccccccccccccCCChhhhhcC-CCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHh----Cc
Q 008365 374 LARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTG-MLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEK----GT 448 (568)
Q Consensus 374 la~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~----~~ 448 (568)
+|+.+.- .....+..++|.+|.|||++.+. .|+..+||||+|||++||+++++-|.+...+.+...- |.
T Consensus 166 lAra~~i------p~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGt 239 (323)
T KOG0594|consen 166 LARAFSI------PMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGT 239 (323)
T ss_pred hHHHhcC------CcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCC
Confidence 9986532 22235677899999999988877 7999999999999999999999999766554443221 10
Q ss_pred cccc----------cCccCCCCC--hH-------HHHHHHHHHHHhhccCCCCCCChHHhHhH
Q 008365 449 LAEM----------LDPAVTDWP--AE-------AAESFSKLAIQCAELRKKDRPDLGTVIVP 492 (568)
Q Consensus 449 ~~~~----------l~~~~~~~p--~~-------~~~~l~~li~~Cl~~dP~~RPs~~~vl~~ 492 (568)
-.+. .+.....++ .. ......+++.+|++.+|..|.++...+.|
T Consensus 240 P~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 240 PNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 0000 011111121 11 11378899999999999999999988754
|
|
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=318.30 Aligned_cols=250 Identities=21% Similarity=0.353 Sum_probs=200.5
Q ss_pred HhcccccceeecccCceeEEEEEeC------CccEEEEEeCcCh-hHhHHHHHHHHHHHHcCCCCceeeeccccCC---C
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKLD------HTPVAIKVLRPDA-AQGKRQFQQEVEVLSSIRHPNMVLLLGACPD---Y 296 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~~------~~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~---~ 296 (568)
..++|.+.+.||+|+||.||+|.+. +..|++|++.... ......+.+|+.+++.++||||+++++++.+ .
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 3567999999999999999999874 4689999987542 3345668899999999999999999998643 4
Q ss_pred ceEEEEecCCCCHHHHHhhcCCC-----CCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecc
Q 008365 297 GCLVYEYMHNGSLEDRLLRRGNT-----PVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISD 371 (568)
Q Consensus 297 ~~lV~E~~~ggsL~~~l~~~~~~-----~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~D 371 (568)
.+++++|+++|+|.+++...... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECC
Confidence 58999999999999998764322 45899999999999999999999999 99999999999999999999999
Q ss_pred cccccccCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh-CCCCCCCchHHH--HHHHhCc
Q 008365 372 VGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPMGLTHHVS--RAIEKGT 448 (568)
Q Consensus 372 FGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~--~~~~~~~ 448 (568)
||+++.+...... .......++..|+|||++.+..++.++|||||||++|++++ |+.||....... ..+..+.
T Consensus 161 ~g~~~~~~~~~~~----~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~ 236 (280)
T cd05043 161 NALSRDLFPMDYH----CLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGY 236 (280)
T ss_pred CCCcccccCCceE----EeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCC
Confidence 9999866432211 11122346778999999998899999999999999999999 999996544322 1111111
Q ss_pred cccccCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHh
Q 008365 449 LAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIV 491 (568)
Q Consensus 449 ~~~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~ 491 (568)
....+..++..+.+++.+||..+|.+||++.+++.
T Consensus 237 --------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 237 --------RLAQPINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred --------CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 11123345678999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=315.01 Aligned_cols=244 Identities=31% Similarity=0.492 Sum_probs=197.2
Q ss_pred cccccceeecccCceeEEEEEeCC-ccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCceeeeccccCC-CceEEEEecCC
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKLDH-TPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACPD-YGCLVYEYMHN 306 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~~~-~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~-~~~lV~E~~~g 306 (568)
++|.+...||.|+||.||+|.+.+ ..||+|.+..... ....+.+|+.+++.++|||++++++++.. ..++||||+.+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~~~~ 84 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM-MPEAFLQEAQIMKKLRHDKLVPLYAVVSEEPIYIVTEFMGK 84 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc-cHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCcEEEEEcCCC
Confidence 568899999999999999998744 4799998865432 24568899999999999999999988754 44899999999
Q ss_pred CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCCccc
Q 008365 307 GSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSV 386 (568)
Q Consensus 307 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~~~~ 386 (568)
|+|.+++..... ..+++..+..++.|++.||.|||+.+ |+|+||||+|||+++++.++|+|||+++.+.....
T Consensus 85 ~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~--- 157 (260)
T cd05069 85 GSLLDFLKEGDG-KYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY--- 157 (260)
T ss_pred CCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCcc---
Confidence 999999876432 24789999999999999999999999 99999999999999999999999999976533211
Q ss_pred cccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh-CCCCCCCchHHH--HHHHhCccccccCccCCCCChH
Q 008365 387 TQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPMGLTHHVS--RAIEKGTLAEMLDPAVTDWPAE 463 (568)
Q Consensus 387 ~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~--~~~~~~~~~~~l~~~~~~~p~~ 463 (568)
.......++..|+|||.+.+..++.++|||||||++|+|++ |..||....... ..+..+ . ....+..
T Consensus 158 --~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~-----~---~~~~~~~ 227 (260)
T cd05069 158 --TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERG-----Y---RMPCPQG 227 (260)
T ss_pred --cccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-----C---CCCCCcc
Confidence 11123346778999999998899999999999999999999 999996543321 111111 1 1123445
Q ss_pred HHHHHHHHHHHhhccCCCCCCChHHhH
Q 008365 464 AAESFSKLAIQCAELRKKDRPDLGTVI 490 (568)
Q Consensus 464 ~~~~l~~li~~Cl~~dP~~RPs~~~vl 490 (568)
.+..+.+++.+||..+|.+||++.+|+
T Consensus 228 ~~~~~~~li~~~l~~~p~~Rp~~~~i~ 254 (260)
T cd05069 228 CPESLHELMKLCWKKDPDERPTFEYIQ 254 (260)
T ss_pred cCHHHHHHHHHHccCCcccCcCHHHHH
Confidence 677899999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=321.17 Aligned_cols=253 Identities=25% Similarity=0.327 Sum_probs=195.6
Q ss_pred ccccceeecccCceeEEEEEe--CCccEEEEEeCcChh--HhHHHHHHHHHHHHcCCCCceeeeccccCC--CceEEEEe
Q 008365 230 KFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAA--QGKRQFQQEVEVLSSIRHPNMVLLLGACPD--YGCLVYEY 303 (568)
Q Consensus 230 ~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~--~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--~~~lV~E~ 303 (568)
+|.+.+.||.|+||.||+|.+ ++..||||++..... .....+.+|+.+++.++||||+++++++.+ ..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 488899999999999999987 567899999865422 223567899999999999999999999854 44899999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCC
Q 008365 304 MHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVA 383 (568)
Q Consensus 304 ~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~ 383 (568)
++ ++|.+++........+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 155 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV- 155 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCc-
Confidence 96 689888866444345899999999999999999999999 9999999999999999999999999997553221
Q ss_pred ccccccccccccccccCCChhhhhcC-CCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHh----Cc----------
Q 008365 384 DSVTQYHMTSAAGTFCYIDPEYQQTG-MLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEK----GT---------- 448 (568)
Q Consensus 384 ~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~----~~---------- 448 (568)
.......+++.|+|||++.+. .++.++|||||||++|+|++|++||............ +.
T Consensus 156 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (285)
T cd07861 156 -----RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVT 230 (285)
T ss_pred -----ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcch
Confidence 112334678999999987654 5789999999999999999999999755433222110 00
Q ss_pred ----cc----cccCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhH
Q 008365 449 ----LA----EMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVP 492 (568)
Q Consensus 449 ----~~----~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~ 492 (568)
.. .............++.++.+++.+||..||.+||++.+|+.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 231 SLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred hhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 00 000000011122346678899999999999999999998754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=311.77 Aligned_cols=252 Identities=23% Similarity=0.370 Sum_probs=208.8
Q ss_pred HhcccccceeecccCceeEEEEEe--CCccEEEEEeCcC--hhHhHHHHHHHHHHHHcCCCCceeeeccccCCC--ceEE
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPD--AAQGKRQFQQEVEVLSSIRHPNMVLLLGACPDY--GCLV 300 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~--~~lV 300 (568)
+.+.|++.+.||+|.|+.||++.+ .|+.+|+|+++.. .....+.+.+|+.|-+.|+|||||++.+.+... .+||
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 456788888999999999998876 6788999987543 233567789999999999999999999987543 4899
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeec---cCCceeEecccccccc
Q 008365 301 YEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILL---DRNYVSKISDVGLARL 377 (568)
Q Consensus 301 ~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILl---d~~~~vKL~DFGla~~ 377 (568)
+|+|.|++|..-+..+ ..+++..+-.++.||+.+|.|+|.++ |||||+||.|+|| +..-.+||+|||+|..
T Consensus 89 Fe~m~G~dl~~eIV~R---~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~ 162 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVAR---EFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIE 162 (355)
T ss_pred EecccchHHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEE
Confidence 9999999998766654 23778888889999999999999999 9999999999999 3456789999999987
Q ss_pred cCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCC--chHHHHHHHhCccccccCc
Q 008365 378 VPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGL--THHVSRAIEKGTLAEMLDP 455 (568)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~--~~~~~~~~~~~~~~~~l~~ 455 (568)
+.. .....+++|||.|||||++...+|+..+|||+.|||||-||.|++||.. .+.+.+.|..+.. |-
T Consensus 163 l~~-------g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~y----d~ 231 (355)
T KOG0033|consen 163 VND-------GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAY----DY 231 (355)
T ss_pred eCC-------ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhcccc----CC
Confidence 642 2234578999999999999999999999999999999999999999954 4557777776654 22
Q ss_pred cCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHHHH
Q 008365 456 AVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPELNR 496 (568)
Q Consensus 456 ~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l~~ 496 (568)
..+.|+ .+.++..+|+.+||..||.+|.++.+.+.|.|-.
T Consensus 232 ~~~~w~-~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~ 271 (355)
T KOG0033|consen 232 PSPEWD-TVTPEAKSLIRRMLTVNPKKRITADEALKHPWIC 271 (355)
T ss_pred CCcccC-cCCHHHHHHHHHHhccChhhhccHHHHhCCchhc
Confidence 222333 4567789999999999999999999998776644
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=334.08 Aligned_cols=252 Identities=24% Similarity=0.450 Sum_probs=210.5
Q ss_pred cccceeecccCceeEEEEEeCC----c--cEEEEEeCcC-hhHhHHHHHHHHHHHHcCCCCceeeeccccCCCc-eEEEE
Q 008365 231 FSEAMKIGEGGYGPVYRGKLDH----T--PVAIKVLRPD-AAQGKRQFQQEVEVLSSIRHPNMVLLLGACPDYG-CLVYE 302 (568)
Q Consensus 231 y~~~~~IG~G~fg~Vy~~~~~~----~--~vAvK~l~~~-~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~-~lV~E 302 (568)
....++||.|-||.||+|.+.. . -||||..+.+ .....+.|..|..+|+.++|||||+++|+|.+.. +||||
T Consensus 391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~P~WivmE 470 (974)
T KOG4257|consen 391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQPMWIVME 470 (974)
T ss_pred ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeeccceeEEEe
Confidence 3455789999999999998732 2 5999999874 4455778999999999999999999999997654 99999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCC
Q 008365 303 YMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSV 382 (568)
Q Consensus 303 ~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~ 382 (568)
+++-|.|..+|..+... ++......++.||..||.|||+.. +|||||-..||||...-.|||+||||++.+...
T Consensus 471 L~~~GELr~yLq~nk~s--L~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~- 544 (974)
T KOG4257|consen 471 LAPLGELREYLQQNKDS--LPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRYLEDD- 544 (974)
T ss_pred cccchhHHHHHHhcccc--chHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhhcccc-
Confidence 99999999999886653 888899999999999999999999 999999999999999999999999999987543
Q ss_pred CccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh-CCCCCCCchHHHHHHHhCccccccCccCCCCC
Q 008365 383 ADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPMGLTHHVSRAIEKGTLAEMLDPAVTDWP 461 (568)
Q Consensus 383 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~l~~~~~~~p 461 (568)
..+..+...-..-|||||-+....++.++|||-|||+|||+|. |..||....+. ..+..+-+.....+|
T Consensus 545 ----~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNs------DVI~~iEnGeRlP~P 614 (974)
T KOG4257|consen 545 ----AYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNS------DVIGHIENGERLPCP 614 (974)
T ss_pred ----chhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccccccc------ceEEEecCCCCCCCC
Confidence 3344444445678999999999999999999999999999998 99999655431 222233344455778
Q ss_pred hHHHHHHHHHHHHhhccCCCCCCChHHhHhHHHHHHH
Q 008365 462 AEAAESFSKLAIQCAELRKKDRPDLGTVIVPELNRLK 498 (568)
Q Consensus 462 ~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l~~L~ 498 (568)
+.||+.+..|+.+||+.+|.+||.+.++...+-.-++
T Consensus 615 ~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 615 PNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred CCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 9999999999999999999999999998654443333
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=324.18 Aligned_cols=251 Identities=25% Similarity=0.363 Sum_probs=204.3
Q ss_pred HhcccccceeecccCceeEEEEEe--CCccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCceeeeccccCC--CceEEEE
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACPD--YGCLVYE 302 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--~~~lV~E 302 (568)
...+|.+.+.||.|+||.||+|.+ ++..||||.+..........+.+|+.+++.++||||++++++|.. ..++|||
T Consensus 17 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 96 (297)
T cd06656 17 PKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 96 (297)
T ss_pred hhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeec
Confidence 346799999999999999999986 678999999976655556678899999999999999999998854 4589999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCC
Q 008365 303 YMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSV 382 (568)
Q Consensus 303 ~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~ 382 (568)
|+++++|.+++... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++.......
T Consensus 97 ~~~~~~L~~~~~~~----~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~ 169 (297)
T cd06656 97 YLAGGSLTDVVTET----CMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (297)
T ss_pred ccCCCCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCc
Confidence 99999999988643 3788899999999999999999999 9999999999999999999999999997653322
Q ss_pred CccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHhCccccccCccCCCCCh
Q 008365 383 ADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAVTDWPA 462 (568)
Q Consensus 383 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~l~~~~~~~p~ 462 (568)
. ......|++.|+|||.+.+..++.++|||||||++|+|++|..||...+.......... . .......+.
T Consensus 170 ~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~---~-~~~~~~~~~ 239 (297)
T cd06656 170 S------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT---N-GTPELQNPE 239 (297)
T ss_pred c------CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeecc---C-CCCCCCCcc
Confidence 1 11334689999999999998899999999999999999999999965443222111000 0 000112244
Q ss_pred HHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 463 EAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 463 ~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
..+..+.+|+.+||..+|.+||++.+++.+.+
T Consensus 240 ~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~ 271 (297)
T cd06656 240 RLSAVFRDFLNRCLEMDVDRRGSAKELLQHPF 271 (297)
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHhcCch
Confidence 56677899999999999999999999986654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=315.21 Aligned_cols=240 Identities=29% Similarity=0.476 Sum_probs=197.5
Q ss_pred cccccceeecccCceeEEEEEeCCccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCceeeeccccCC-CceEEEEecCCC
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKLDHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACPD-YGCLVYEYMHNG 307 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~-~~~lV~E~~~gg 307 (568)
++|.+.+.||+|+||.||++...+..||+|++..... ...+.+|+.+++.++||||+++++++.. ..++||||+.++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~~~~--~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~v~e~~~~~ 83 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDVT--AQAFLEETAVMTKLHHKNLVRLLGVILHNGLYIVMELMSKG 83 (254)
T ss_pred HHceeeeeeccCCCCceEecccCCCceEEEeecCcch--HHHHHHHHHHHHhCCCCCcCeEEEEEcCCCcEEEEECCCCC
Confidence 4688899999999999999999999999999875432 3578899999999999999999998744 458999999999
Q ss_pred CHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCCcccc
Q 008365 308 SLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVT 387 (568)
Q Consensus 308 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~ 387 (568)
+|.+++..... ..+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++.......
T Consensus 84 ~L~~~l~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~----- 154 (254)
T cd05083 84 NLVNFLRTRGR-ALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV----- 154 (254)
T ss_pred CHHHHHHhcCc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceeccccC-----
Confidence 99999876543 24788999999999999999999999 9999999999999999999999999987542211
Q ss_pred ccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh-CCCCCCCchHH--HHHHHhCccccccCccCCCCChHH
Q 008365 388 QYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPMGLTHHV--SRAIEKGTLAEMLDPAVTDWPAEA 464 (568)
Q Consensus 388 ~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~--~~~~~~~~~~~~l~~~~~~~p~~~ 464 (568)
.....+..|+|||++.+..++.++|||||||++|+|++ |+.||...... ...+..+. ....+..+
T Consensus 155 ----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~--------~~~~~~~~ 222 (254)
T cd05083 155 ----DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGY--------RMEPPEGC 222 (254)
T ss_pred ----CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCC--------CCCCCCcC
Confidence 12234578999999998899999999999999999998 99999654332 22222221 11123345
Q ss_pred HHHHHHHHHHhhccCCCCCCChHHhHh
Q 008365 465 AESFSKLAIQCAELRKKDRPDLGTVIV 491 (568)
Q Consensus 465 ~~~l~~li~~Cl~~dP~~RPs~~~vl~ 491 (568)
+..+.+++.+||+.+|..||++.+++.
T Consensus 223 ~~~~~~li~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 223 PADVYVLMTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 678899999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=320.90 Aligned_cols=252 Identities=24% Similarity=0.391 Sum_probs=199.7
Q ss_pred cccccceeecccCceeEEEEEe--CCccEEEEEeCcC-hhHhHHHHHHHHHHHHcCCCCceeeeccccCC--CceEEEEe
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPD-AAQGKRQFQQEVEVLSSIRHPNMVLLLGACPD--YGCLVYEY 303 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~-~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--~~~lV~E~ 303 (568)
++|++++.||.|+||.||++.+ .+..||+|.+... .......+.+|+.++++++||||+++++.|.. ..++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 3688899999999999999988 4779999988654 22334678899999999999999999998754 44899999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCCCCcccCCCCCCCeeccCCceeEecccccccccCCCC
Q 008365 304 MHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQ-AKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSV 382 (568)
Q Consensus 304 ~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~-~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~ 382 (568)
+++++|..++........+++..+..++.||+.||.|||. .+ |+|+||||+|||++.++.+||+|||++..+....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL 157 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccccCCc
Confidence 9999999888764323348999999999999999999997 47 9999999999999999999999999997653221
Q ss_pred CccccccccccccccccCCChhhhhcC------CCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHhCccccccCcc
Q 008365 383 ADSVTQYHMTSAAGTFCYIDPEYQQTG------MLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPA 456 (568)
Q Consensus 383 ~~~~~~~~~~~~~GT~~Y~APE~~~~~------~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~l~~~ 456 (568)
.....|++.|+|||++.+. .++.++|||||||++|+|++|..||......... ..+.......
T Consensus 158 --------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~---~~~~~~~~~~ 226 (286)
T cd06622 158 --------AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIF---AQLSAIVDGD 226 (286)
T ss_pred --------cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHH---HHHHHHhhcC
Confidence 1234688899999987554 3588999999999999999999999643221110 0011111222
Q ss_pred CCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 457 VTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 457 ~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
....+..++..+.+|+.+||..+|.+||++.+++.+.+
T Consensus 227 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~ 264 (286)
T cd06622 227 PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPW 264 (286)
T ss_pred CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChh
Confidence 23345567788999999999999999999999987655
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=309.86 Aligned_cols=252 Identities=23% Similarity=0.381 Sum_probs=206.3
Q ss_pred HHhcccccceeecccCceeEEEEEe--CCccEEEEEeCcC--------hhHhHHHHHHHHHHHHcC-CCCceeeeccccC
Q 008365 226 EATDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPD--------AAQGKRQFQQEVEVLSSI-RHPNMVLLLGACP 294 (568)
Q Consensus 226 ~~~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~--------~~~~~~~~~~Ev~iL~~l-~HpnIv~l~g~~~ 294 (568)
....+|...+.||+|..++|.++.+ .+..+|+|++... ...-.+.-.+|+.||+++ .||+|+.+.++++
T Consensus 14 ~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye 93 (411)
T KOG0599|consen 14 GFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE 93 (411)
T ss_pred hHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc
Confidence 3556788888899999999998866 6678999988532 122234557899999998 5999999999997
Q ss_pred CCc--eEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEeccc
Q 008365 295 DYG--CLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDV 372 (568)
Q Consensus 295 ~~~--~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DF 372 (568)
... ++|+|+|+.|.|.|+|...- .++++...+|+.|++.|+.|||.++ ||||||||+|||+|++.++||+||
T Consensus 94 s~sF~FlVFdl~prGELFDyLts~V---tlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDF 167 (411)
T KOG0599|consen 94 SDAFVFLVFDLMPRGELFDYLTSKV---TLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDF 167 (411)
T ss_pred CcchhhhhhhhcccchHHHHhhhhe---eecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEecc
Confidence 654 78999999999999997754 3899999999999999999999999 999999999999999999999999
Q ss_pred ccccccCCCCCccccccccccccccccCCChhhhhc------CCCCCcceehhHHHHHHHHHhCCCCCCCchHH--HHHH
Q 008365 373 GLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQT------GMLTTKSDIYSFGIMLLQIITARSPMGLTHHV--SRAI 444 (568)
Q Consensus 373 Gla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~------~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~--~~~~ 444 (568)
|+++.+.++. .....||||+|+|||.+.. ..|+..+|+|++|||||.||.|.+||-.-..+ ...|
T Consensus 168 GFa~~l~~Ge-------kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~I 240 (411)
T KOG0599|consen 168 GFACQLEPGE-------KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMI 240 (411)
T ss_pred ceeeccCCch-------hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHH
Confidence 9999876542 4467899999999997654 35888999999999999999999999543332 2334
Q ss_pred HhCccccccCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHHH
Q 008365 445 EKGTLAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPELN 495 (568)
Q Consensus 445 ~~~~~~~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l~ 495 (568)
..|.+. .-.+ +| .+++....+||.+||+.||..|.+..+.+.|.+-
T Consensus 241 meGkyq-F~sp---eW-adis~~~KdLIsrlLqVdp~~Ritake~LaHpff 286 (411)
T KOG0599|consen 241 MEGKYQ-FRSP---EW-ADISATVKDLISRLLQVDPTKRITAKEALAHPFF 286 (411)
T ss_pred Hhcccc-cCCc---ch-hhccccHHHHHHHHHeeCchhcccHHHHhcChHH
Confidence 445432 1122 33 3566778999999999999999999999988764
|
|
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=312.05 Aligned_cols=245 Identities=26% Similarity=0.403 Sum_probs=196.1
Q ss_pred eeecccCceeEEEEEeC---Cc--cEEEEEeCcChh-HhHHHHHHHHHHHHcCCCCceeeeccccCC-CceEEEEecCCC
Q 008365 235 MKIGEGGYGPVYRGKLD---HT--PVAIKVLRPDAA-QGKRQFQQEVEVLSSIRHPNMVLLLGACPD-YGCLVYEYMHNG 307 (568)
Q Consensus 235 ~~IG~G~fg~Vy~~~~~---~~--~vAvK~l~~~~~-~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~-~~~lV~E~~~gg 307 (568)
++||+|+||.||+|.+. ++ .||||++..... ...+.+.+|+.++++++||||+++++++.+ ..++||||+++|
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v~e~~~~~ 80 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLTHPLMMVTELAPLG 80 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcCCeEEEEEEecCCC
Confidence 36899999999999863 22 699999987765 556789999999999999999999998765 348999999999
Q ss_pred CHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCCcccc
Q 008365 308 SLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVT 387 (568)
Q Consensus 308 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~ 387 (568)
+|.+++..... ..+++..++.++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||+++.+......
T Consensus 81 ~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~--- 153 (257)
T cd05040 81 SLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDH--- 153 (257)
T ss_pred cHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEeccccccccccccccc---
Confidence 99999977543 34899999999999999999999999 999999999999999999999999999876432111
Q ss_pred ccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh-CCCCCCCchHHHHHHHhCccccccCccCCCCChHHHH
Q 008365 388 QYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPMGLTHHVSRAIEKGTLAEMLDPAVTDWPAEAAE 466 (568)
Q Consensus 388 ~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~l~~~~~~~p~~~~~ 466 (568)
........++..|+|||++.+..++.++|||||||++|+|++ |..||.............. .......+..++.
T Consensus 154 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~ 228 (257)
T cd05040 154 YVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDK-----EGERLERPEACPQ 228 (257)
T ss_pred eecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh-----cCCcCCCCccCCH
Confidence 011123457889999999999999999999999999999998 9999964433221111110 0111122344567
Q ss_pred HHHHHHHHhhccCCCCCCChHHhHh
Q 008365 467 SFSKLAIQCAELRKKDRPDLGTVIV 491 (568)
Q Consensus 467 ~l~~li~~Cl~~dP~~RPs~~~vl~ 491 (568)
.+.+++.+||+.+|.+||++.+++.
T Consensus 229 ~~~~li~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 229 DIYNVMLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred HHHHHHHHHCCCCcccCCCHHHHHH
Confidence 8999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=323.11 Aligned_cols=248 Identities=24% Similarity=0.364 Sum_probs=194.0
Q ss_pred cccccceeecccCceeEEEEEe--CCccEEEEEeCcCh-hHhHHHHHHHHHHHHcCCCCceeeeccccCC--CceEEEEe
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDA-AQGKRQFQQEVEVLSSIRHPNMVLLLGACPD--YGCLVYEY 303 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--~~~lV~E~ 303 (568)
++|++.++||+|+||.||+|.+ ++..||||++..+. ......+.+|+.++++++||||++++++|.. ..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 3578889999999999999986 56789999986542 3334568899999999999999999998744 45899999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCC
Q 008365 304 MHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVA 383 (568)
Q Consensus 304 ~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~ 383 (568)
+++++|..+. .+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.+||+|||++..+...
T Consensus 81 ~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~-- 148 (279)
T cd06619 81 MDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS-- 148 (279)
T ss_pred CCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecccc--
Confidence 9999996542 2678888999999999999999999 999999999999999999999999999765322
Q ss_pred ccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHH-HhCccccccCccCCCC-C
Q 008365 384 DSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAI-EKGTLAEMLDPAVTDW-P 461 (568)
Q Consensus 384 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~-~~~~~~~~l~~~~~~~-p 461 (568)
.....+||..|+|||++.+..++.++|||||||++|+|++|+.||.......... .........+...... .
T Consensus 149 ------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (279)
T cd06619 149 ------IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPV 222 (279)
T ss_pred ------cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCC
Confidence 1234579999999999998899999999999999999999999995322100000 0000000011111111 1
Q ss_pred hHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 462 AEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 462 ~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
...+..+.+++.+||+.+|..||++.+++.+.+
T Consensus 223 ~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~ 255 (279)
T cd06619 223 GQFSEKFVHFITQCMRKQPKERPAPENLMDHPF 255 (279)
T ss_pred CcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcc
Confidence 224567899999999999999999999986654
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=316.44 Aligned_cols=255 Identities=23% Similarity=0.334 Sum_probs=199.7
Q ss_pred HHhcccccceeecccCceeEEEEEe--CCccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCceeeeccccCC--CceEEE
Q 008365 226 EATDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACPD--YGCLVY 301 (568)
Q Consensus 226 ~~~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--~~~lV~ 301 (568)
..++.+.....||+|+||.||+|.+ ++..||+|.+........+.+.+|+.+++.++|+||+++++++.. ..++||
T Consensus 5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 84 (268)
T cd06624 5 YEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFM 84 (268)
T ss_pred cccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEE
Confidence 3456666677999999999999986 456899999877766666789999999999999999999998854 448999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccC-CceeEecccccccccCC
Q 008365 302 EYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDR-NYVSKISDVGLARLVPP 380 (568)
Q Consensus 302 E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~-~~~vKL~DFGla~~~~~ 380 (568)
||+++++|.+++.........++..+..++.||+.||.|||+.+ |+||||||+||+++. ++.++|+|||++..+..
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~ 161 (268)
T cd06624 85 EQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG 161 (268)
T ss_pred ecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheeccc
Confidence 99999999999876432111277888889999999999999999 999999999999976 67999999999876532
Q ss_pred CCCccccccccccccccccCCChhhhhcCC--CCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHhCccccccCccCC
Q 008365 381 SVADSVTQYHMTSAAGTFCYIDPEYQQTGM--LTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAVT 458 (568)
Q Consensus 381 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~--~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~l~~~~~ 458 (568)
... ......|++.|+|||++.+.. ++.++|||||||++|+|++|+.||............. .......
T Consensus 162 ~~~------~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~----~~~~~~~ 231 (268)
T cd06624 162 INP------CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKV----GMFKIHP 231 (268)
T ss_pred CCC------ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhh----hhhccCC
Confidence 211 112345899999999886644 7899999999999999999999996432211111110 0111122
Q ss_pred CCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHH
Q 008365 459 DWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPE 493 (568)
Q Consensus 459 ~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~ 493 (568)
..|..++..+.+++.+||+.+|.+||++.+++.+.
T Consensus 232 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~ 266 (268)
T cd06624 232 EIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDP 266 (268)
T ss_pred CCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCC
Confidence 34556677899999999999999999999998653
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=323.22 Aligned_cols=252 Identities=26% Similarity=0.366 Sum_probs=197.9
Q ss_pred cccccceeecccCceeEEEEEe--CCccEEEEEeCcCh-hHhHHHHHHHHHHHHcCCCCceeeeccccCC--CceEEEEe
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDA-AQGKRQFQQEVEVLSSIRHPNMVLLLGACPD--YGCLVYEY 303 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--~~~lV~E~ 303 (568)
++|++.+.||+|+||.||++.+ ++..||+|.+.... .....++.+|+++++.++||||++++++|.+ ..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 3689999999999999999987 45679999886542 3334568899999999999999999998854 44899999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCCCCcccCCCCCCCeeccCCceeEecccccccccCCCC
Q 008365 304 MHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQ-AKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSV 382 (568)
Q Consensus 304 ~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~-~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~ 382 (568)
+++++|.+++...+ .+++..+..++.||+.||.|||+ .+ |+|+||||+|||++.++.+||+|||++..+....
T Consensus 81 ~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (308)
T cd06615 81 MDGGSLDQVLKKAG---RIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 154 (308)
T ss_pred cCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCcccccccc
Confidence 99999999987653 37889999999999999999998 46 9999999999999999999999999987543221
Q ss_pred CccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHhCcccccc---------
Q 008365 383 ADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEML--------- 453 (568)
Q Consensus 383 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~l--------- 453 (568)
.....|++.|+|||++.+..++.++|||||||++|+|++|+.||..................+
T Consensus 155 --------~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (308)
T cd06615 155 --------ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPV 226 (308)
T ss_pred --------cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccc
Confidence 134578999999999988889999999999999999999999995433211110000000000
Q ss_pred ---------------------CccCCCCC-hHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 454 ---------------------DPAVTDWP-AEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 454 ---------------------~~~~~~~p-~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
.......| ...+..+.+|+.+||..+|.+||++.+|+.+.+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~ 289 (308)
T cd06615 227 SGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPF 289 (308)
T ss_pred cCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence 00000011 124567999999999999999999999987665
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=329.85 Aligned_cols=251 Identities=27% Similarity=0.420 Sum_probs=195.9
Q ss_pred hcccccceeecccCceeEEEEEe-------CCccEEEEEeCcCh-hHhHHHHHHHHHHHHcC-CCCceeeeccccCC---
Q 008365 228 TDKFSEAMKIGEGGYGPVYRGKL-------DHTPVAIKVLRPDA-AQGKRQFQQEVEVLSSI-RHPNMVLLLGACPD--- 295 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~~~~-------~~~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l-~HpnIv~l~g~~~~--- 295 (568)
.++|++.+.||+|+||.||+|.+ .++.||||+++... ......+.+|+.+|.++ +||||++++++|..
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 35799999999999999999974 34689999997643 23345688999999999 68999999998743
Q ss_pred CceEEEEecCCCCHHHHHhhcCC---------------------------------------------------------
Q 008365 296 YGCLVYEYMHNGSLEDRLLRRGN--------------------------------------------------------- 318 (568)
Q Consensus 296 ~~~lV~E~~~ggsL~~~l~~~~~--------------------------------------------------------- 318 (568)
..++|||||++|+|.+++.....
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 34899999999999999865321
Q ss_pred -------CCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCCcccccccc
Q 008365 319 -------TPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHM 391 (568)
Q Consensus 319 -------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~ 391 (568)
...+++..+..++.||+.||.|||+.+ |+||||||.|||++.++.+||+|||+++.+..... ....
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~----~~~~ 238 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPD----YVRK 238 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcc----hhhc
Confidence 123678888999999999999999999 99999999999999999999999999976532211 1111
Q ss_pred ccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh-CCCCCCCchH---HHHHHHhCccccccCccCCCCChHHHHH
Q 008365 392 TSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPMGLTHH---VSRAIEKGTLAEMLDPAVTDWPAEAAES 467 (568)
Q Consensus 392 ~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~---~~~~~~~~~~~~~l~~~~~~~p~~~~~~ 467 (568)
....+++.|+|||++.+..++.++|||||||++|+|++ |..||..... ....+..+.. ...|...+..
T Consensus 239 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~ 310 (343)
T cd05103 239 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR--------MRAPDYTTPE 310 (343)
T ss_pred CCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCC--------CCCCCCCCHH
Confidence 23346778999999988899999999999999999997 9999964322 2222222211 1112234457
Q ss_pred HHHHHHHhhccCCCCCCChHHhHhHH
Q 008365 468 FSKLAIQCAELRKKDRPDLGTVIVPE 493 (568)
Q Consensus 468 l~~li~~Cl~~dP~~RPs~~~vl~~~ 493 (568)
+.+++..||+.+|.+||++.+|+.++
T Consensus 311 ~~~~~~~cl~~~p~~Rps~~eil~~l 336 (343)
T cd05103 311 MYQTMLDCWHGEPSQRPTFSELVEHL 336 (343)
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHH
Confidence 89999999999999999999998543
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=361.88 Aligned_cols=256 Identities=23% Similarity=0.354 Sum_probs=200.1
Q ss_pred HHhcccccceeecccCceeEEEEEe--CCccEEEEEeCcCh--hHhHHHHHHHHHHHHcCCCCceeeeccccCC----Cc
Q 008365 226 EATDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDA--AQGKRQFQQEVEVLSSIRHPNMVLLLGACPD----YG 297 (568)
Q Consensus 226 ~~~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~--~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~----~~ 297 (568)
...++|.++++||.|+||.||++.+ .+..||+|++.... ......|..|+.+|+.|+|||||+++++|.+ ..
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l 89 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL 89 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence 3567899999999999999999987 45689999986542 3334678899999999999999999998732 34
Q ss_pred eEEEEecCCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHcCC----CCcccCCCCCCCeeccC---------
Q 008365 298 CLVYEYMHNGSLEDRLLRRG-NTPVIPWRKRFKIAAEIATALLFLHQAKP----EPLVHRDLKPANILLDR--------- 363 (568)
Q Consensus 298 ~lV~E~~~ggsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~----~~IiHrDIKp~NILld~--------- 363 (568)
||||||+++|+|.++|.... ....+++..++.|+.||+.||.|||+.+. .+||||||||+||||+.
T Consensus 90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~ 169 (1021)
T PTZ00266 90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT 169 (1021)
T ss_pred EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence 89999999999999987532 22348999999999999999999999542 34999999999999954
Q ss_pred --------CceeEecccccccccCCCCCccccccccccccccccCCChhhhhc--CCCCCcceehhHHHHHHHHHhCCCC
Q 008365 364 --------NYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQT--GMLTTKSDIYSFGIMLLQIITARSP 433 (568)
Q Consensus 364 --------~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~--~~~s~ksDvwSlGvil~elltG~~P 433 (568)
.+.+||+|||++..+.... .....+||+.|+|||++.+ ..++.++||||||||||+|++|..|
T Consensus 170 ~~~~n~ng~~iVKLsDFGlAr~l~~~s-------~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~P 242 (1021)
T PTZ00266 170 AQANNLNGRPIAKIGDFGLSKNIGIES-------MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTP 242 (1021)
T ss_pred ccccccCCCCceEEccCCccccccccc-------cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCC
Confidence 3458999999998653221 1234579999999998854 4589999999999999999999999
Q ss_pred CCCchHHHHHHHhCccccccCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 434 MGLTHHVSRAIEKGTLAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 434 f~~~~~~~~~~~~~~~~~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
|.........+.... .. +.+. ....+..+.+||..||..+|.+||++.+++.+.+
T Consensus 243 F~~~~~~~qli~~lk--~~--p~lp--i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ 297 (1021)
T PTZ00266 243 FHKANNFSQLISELK--RG--PDLP--IKGKSKELNILIKNLLNLSAKERPSALQCLGYQI 297 (1021)
T ss_pred CCcCCcHHHHHHHHh--cC--CCCC--cCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHH
Confidence 975544333322111 00 1110 1234567999999999999999999999987654
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=339.38 Aligned_cols=250 Identities=21% Similarity=0.285 Sum_probs=193.5
Q ss_pred hcccccceeecccCceeEEEEEeC----CccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCceeeeccccCC--CceEEE
Q 008365 228 TDKFSEAMKIGEGGYGPVYRGKLD----HTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACPD--YGCLVY 301 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~~~~~----~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--~~~lV~ 301 (568)
..+|.+++.||.|+||.||++... +..||||.+... ..+.+|+.+|+.++|||||+++++|.. ..|+||
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 457999999999999999998753 357999988643 234689999999999999999998854 458999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCC
Q 008365 302 EYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPS 381 (568)
Q Consensus 302 E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~ 381 (568)
||+ +++|.+++.... .+++..+..|+.||+.||.|||+.+ ||||||||+||||+.++.+||+|||+++.+...
T Consensus 166 e~~-~~~l~~~l~~~~---~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~ 238 (392)
T PHA03207 166 PKY-KCDLFTYVDRSG---PLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238 (392)
T ss_pred hhc-CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence 999 578888884432 4899999999999999999999999 999999999999999999999999999765432
Q ss_pred CCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCch------HHHHHHHhCc-------
Q 008365 382 VADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTH------HVSRAIEKGT------- 448 (568)
Q Consensus 382 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~------~~~~~~~~~~------- 448 (568)
.. ........||+.|+|||++.+..++.++|||||||++|||++|+.||.... .+...+..-.
T Consensus 239 ~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~ 314 (392)
T PHA03207 239 PD----TPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFP 314 (392)
T ss_pred cc----cccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccC
Confidence 21 112235679999999999999999999999999999999999999995422 1111111000
Q ss_pred -------------cccccCccCCCCC-----hHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 449 -------------LAEMLDPAVTDWP-----AEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 449 -------------~~~~l~~~~~~~p-----~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
+.....+.. ..+ ...+..+.++|.+||..+|.+||++.+++.+.+
T Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~ 377 (392)
T PHA03207 315 QNGSTNLCKHFKQYAIVLRPPY-TIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPL 377 (392)
T ss_pred CccchhHHHHHHhhcccccCCc-cccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCch
Confidence 000000000 001 123456888999999999999999999987654
|
|
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=313.89 Aligned_cols=239 Identities=28% Similarity=0.485 Sum_probs=192.8
Q ss_pred eeecccCceeEEEEEeC-----CccEEEEEeCcChh-HhHHHHHHHHHHHHcCCCCceeeeccccCC-CceEEEEecCCC
Q 008365 235 MKIGEGGYGPVYRGKLD-----HTPVAIKVLRPDAA-QGKRQFQQEVEVLSSIRHPNMVLLLGACPD-YGCLVYEYMHNG 307 (568)
Q Consensus 235 ~~IG~G~fg~Vy~~~~~-----~~~vAvK~l~~~~~-~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~-~~~lV~E~~~gg 307 (568)
++||+|+||.||+|.+. +..||+|.+..... .....+.+|+.+++.+.|||||++++++.. ..++||||+++|
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v~e~~~~~ 80 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKGEPLMLVMELAPLG 80 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcCCceEEEEEeCCCC
Confidence 36999999999999762 25799999876654 345678899999999999999999998854 458999999999
Q ss_pred CHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCCcccc
Q 008365 308 SLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVT 387 (568)
Q Consensus 308 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~ 387 (568)
+|.+++.... .+++..+..++.|++.||.|||..+ |+|+||||+|||++.++.+||+|||+++.+......
T Consensus 81 ~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~--- 151 (257)
T cd05060 81 PLLKYLKKRR---EIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDY--- 151 (257)
T ss_pred cHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCcc---
Confidence 9999997654 3789999999999999999999999 999999999999999999999999999866432211
Q ss_pred ccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh-CCCCCCCchHH--HHHHHhCccccccCccCCCCChHH
Q 008365 388 QYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPMGLTHHV--SRAIEKGTLAEMLDPAVTDWPAEA 464 (568)
Q Consensus 388 ~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~--~~~~~~~~~~~~l~~~~~~~p~~~ 464 (568)
........++..|+|||++.+..++.++|||||||++|+|++ |.+||...... ...+..+. ....+..+
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~--------~~~~~~~~ 223 (257)
T cd05060 152 YRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGE--------RLPRPEEC 223 (257)
T ss_pred cccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCC--------cCCCCCCC
Confidence 011112234578999999998999999999999999999998 99999654432 22222211 11234456
Q ss_pred HHHHHHHHHHhhccCCCCCCChHHhH
Q 008365 465 AESFSKLAIQCAELRKKDRPDLGTVI 490 (568)
Q Consensus 465 ~~~l~~li~~Cl~~dP~~RPs~~~vl 490 (568)
+..+.+++.+||..+|.+||++.+++
T Consensus 224 ~~~l~~li~~cl~~~p~~Rp~~~~l~ 249 (257)
T cd05060 224 PQEIYSIMLSCWKYRPEDRPTFSELE 249 (257)
T ss_pred CHHHHHHHHHHhcCChhhCcCHHHHH
Confidence 67899999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-38 Score=319.69 Aligned_cols=256 Identities=28% Similarity=0.458 Sum_probs=195.9
Q ss_pred cccccceeecccCceeEEEEEeC------------------CccEEEEEeCcCh-hHhHHHHHHHHHHHHcCCCCceeee
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKLD------------------HTPVAIKVLRPDA-AQGKRQFQQEVEVLSSIRHPNMVLL 289 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~~------------------~~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l~HpnIv~l 289 (568)
++|++.++||+|+||.||++.+. ...||||++.... ......+.+|+.+|+.++||||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 56899999999999999998542 2368999987543 3345678999999999999999999
Q ss_pred ccccCC--CceEEEEecCCCCHHHHHhhcCCC--------CCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCe
Q 008365 290 LGACPD--YGCLVYEYMHNGSLEDRLLRRGNT--------PVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANI 359 (568)
Q Consensus 290 ~g~~~~--~~~lV~E~~~ggsL~~~l~~~~~~--------~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NI 359 (568)
++++.+ ..++||||+++|+|.+++...... ..+++.++..++.||+.||.|||+.+ |+||||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChheE
Confidence 998743 458999999999999998764321 23678889999999999999999999 99999999999
Q ss_pred eccCCceeEecccccccccCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh--CCCCCCCc
Q 008365 360 LLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT--ARSPMGLT 437 (568)
Q Consensus 360 Lld~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt--G~~Pf~~~ 437 (568)
|++.++.++|+|||+++.+..... ........+++.|++||+..++.++.++|||||||++|||++ |..||...
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~ 237 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDY----YRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQL 237 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcc----eeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCcccc
Confidence 999999999999999976533211 111122345678999999888899999999999999999998 77898643
Q ss_pred hHHHHHHHhCcc-ccccCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHh
Q 008365 438 HHVSRAIEKGTL-AEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIV 491 (568)
Q Consensus 438 ~~~~~~~~~~~~-~~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~ 491 (568)
.........+.. ...........+..++..+.+|+.+||+.+|.+||++.+|+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 238 SDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred ChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 321111100000 000000011123445678999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=314.54 Aligned_cols=248 Identities=27% Similarity=0.483 Sum_probs=196.8
Q ss_pred hcccccceeecccCceeEEEEEeC--Cc---cEEEEEeCcCh-hHhHHHHHHHHHHHHcCCCCceeeeccccCCC--ceE
Q 008365 228 TDKFSEAMKIGEGGYGPVYRGKLD--HT---PVAIKVLRPDA-AQGKRQFQQEVEVLSSIRHPNMVLLLGACPDY--GCL 299 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~~~~~--~~---~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~--~~l 299 (568)
.++|...+.||+|+||.||+|.+. +. .||||.+.... ......+.+|+.+++.++||||+++++++.+. .++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 356888899999999999999863 32 69999987653 33456788999999999999999999998543 489
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccC
Q 008365 300 VYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVP 379 (568)
Q Consensus 300 V~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~ 379 (568)
||||+++++|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 84 v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 158 (268)
T cd05063 84 ITEYMENGALDKYLRDHD--GEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLE 158 (268)
T ss_pred EEEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceecc
Confidence 999999999999987643 24889999999999999999999999 9999999999999999999999999997654
Q ss_pred CCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh-CCCCCCCchH--HHHHHHhCccccccCcc
Q 008365 380 PSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPMGLTHH--VSRAIEKGTLAEMLDPA 456 (568)
Q Consensus 380 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~--~~~~~~~~~~~~~l~~~ 456 (568)
...... ........++.|+|||++.+..++.++|||||||++|+|++ |..||..... ....+..+.
T Consensus 159 ~~~~~~---~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~-------- 227 (268)
T cd05063 159 DDPEGT---YTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGF-------- 227 (268)
T ss_pred cccccc---eeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCC--------
Confidence 322111 11112234567999999998889999999999999999998 9999954332 222222110
Q ss_pred CCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHh
Q 008365 457 VTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIV 491 (568)
Q Consensus 457 ~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~ 491 (568)
....+..++..+.+++.+||+.+|.+||++.+|+.
T Consensus 228 ~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 228 RLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 11223345677999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=326.59 Aligned_cols=251 Identities=22% Similarity=0.326 Sum_probs=184.1
Q ss_pred ceeecccCceeEEEEEe----CCccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCceeeeccccCC----CceEEEEecC
Q 008365 234 AMKIGEGGYGPVYRGKL----DHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACPD----YGCLVYEYMH 305 (568)
Q Consensus 234 ~~~IG~G~fg~Vy~~~~----~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~----~~~lV~E~~~ 305 (568)
..+||+|+||.||+|.. .+..||||++..... ...+.+|+.+|+.++||||++++++|.. ..++||||+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~- 82 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA- 82 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC--cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEecc-
Confidence 45899999999999985 346899999875432 2346789999999999999999998733 247999999
Q ss_pred CCCHHHHHhhcC------CCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeec----cCCceeEecccccc
Q 008365 306 NGSLEDRLLRRG------NTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILL----DRNYVSKISDVGLA 375 (568)
Q Consensus 306 ggsL~~~l~~~~------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILl----d~~~~vKL~DFGla 375 (568)
+++|.+++.... ....+++..+..|+.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||++
T Consensus 83 ~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 83 EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 568888775421 1124788999999999999999999999 9999999999999 45689999999999
Q ss_pred cccCCCCCccccccccccccccccCCChhhhhc-CCCCCcceehhHHHHHHHHHhCCCCCCCchH------------HHH
Q 008365 376 RLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQT-GMLTTKSDIYSFGIMLLQIITARSPMGLTHH------------VSR 442 (568)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDvwSlGvil~elltG~~Pf~~~~~------------~~~ 442 (568)
+.+..... .........||+.|+|||++.+ ..++.++|||||||++|+|++|++||..... ...
T Consensus 160 ~~~~~~~~---~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~ 236 (317)
T cd07868 160 RLFNSPLK---PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDR 236 (317)
T ss_pred eccCCCCc---cccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHH
Confidence 87643211 1112245679999999998876 4589999999999999999999999953221 111
Q ss_pred HHHhCc------------------cccccCc-cCCC---------CChHHHHHHHHHHHHhhccCCCCCCChHHhHhHH
Q 008365 443 AIEKGT------------------LAEMLDP-AVTD---------WPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPE 493 (568)
Q Consensus 443 ~~~~~~------------------~~~~l~~-~~~~---------~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~ 493 (568)
.+.... ....+.. .... ........+.+|+.+||+.||.+||++.+++.|.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp 315 (317)
T cd07868 237 IFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDP 315 (317)
T ss_pred HHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCC
Confidence 100000 0000000 0000 0001123577899999999999999999998543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=318.43 Aligned_cols=257 Identities=24% Similarity=0.349 Sum_probs=201.1
Q ss_pred CHHHHHHHhcccccceeecccCceeEEEEEe--CCccEEEEEeCcChhHhHHHHHHHHHHHHcC-CCCceeeeccccC--
Q 008365 220 TIEEIEEATDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQGKRQFQQEVEVLSSI-RHPNMVLLLGACP-- 294 (568)
Q Consensus 220 ~~~ei~~~~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l-~HpnIv~l~g~~~-- 294 (568)
+..++....+.|++...||.|+||.||+|.+ .+..||+|++..... ....+..|+.+++++ +||||++++++|.
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTED-EEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChH-HHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 3444445667899999999999999999987 567899999865533 345688999999998 6999999999873
Q ss_pred ------CCceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeE
Q 008365 295 ------DYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSK 368 (568)
Q Consensus 295 ------~~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vK 368 (568)
+..++||||+++|+|.+++..... ..+++..+..++.||+.||.|||+.+ |+|+||||+||+++.++.++
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~ 161 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTKG-NALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVK 161 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEE
Confidence 234899999999999998876433 23788888999999999999999999 99999999999999999999
Q ss_pred ecccccccccCCCCCccccccccccccccccCCChhhhh-----cCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHH
Q 008365 369 ISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQ-----TGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRA 443 (568)
Q Consensus 369 L~DFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-----~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~ 443 (568)
|+|||++....... .......|++.|+|||.+. ...++.++|||||||++|+|++|..||.........
T Consensus 162 l~dfg~~~~~~~~~------~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~ 235 (282)
T cd06636 162 LVDFGVSAQLDRTV------GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRAL 235 (282)
T ss_pred EeeCcchhhhhccc------cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhh
Confidence 99999987543211 1123457899999999875 346888999999999999999999999654432222
Q ss_pred HHhCccccccCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhH
Q 008365 444 IEKGTLAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVP 492 (568)
Q Consensus 444 ~~~~~~~~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~ 492 (568)
.... ....+.. .+..++..+.+|+.+||..+|.+||++.+++.+
T Consensus 236 ~~~~---~~~~~~~--~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 236 FLIP---RNPPPKL--KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred hhHh---hCCCCCC--cccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence 1110 1111111 122456779999999999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=319.48 Aligned_cols=258 Identities=22% Similarity=0.347 Sum_probs=201.3
Q ss_pred HHHHHHhcccccceeecccCceeEEEEEe--CCccEEEEEeCcChhHhHHHHHHHHHHHHcC-CCCceeeeccccC----
Q 008365 222 EEIEEATDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQGKRQFQQEVEVLSSI-RHPNMVLLLGACP---- 294 (568)
Q Consensus 222 ~ei~~~~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l-~HpnIv~l~g~~~---- 294 (568)
..+....++|++.+.||+|+||.||++.+ .++.||||++..... ....+.+|+.+++.+ +||||++++++|.
T Consensus 11 ~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 89 (286)
T cd06638 11 DSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD-IDEEIEAEYNILKALSDHPNVVKFYGMYYKKDV 89 (286)
T ss_pred ecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc-hHHHHHHHHHHHHHHhcCCCeeeeeeeeeeccc
Confidence 33445778999999999999999999987 567899999865332 235678899999999 6999999999862
Q ss_pred ---CCceEEEEecCCCCHHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEec
Q 008365 295 ---DYGCLVYEYMHNGSLEDRLLRR-GNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKIS 370 (568)
Q Consensus 295 ---~~~~lV~E~~~ggsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~ 370 (568)
+..++||||++|++|.+++... .....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+
T Consensus 90 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~kl~ 166 (286)
T cd06638 90 KNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKLV 166 (286)
T ss_pred CCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEEEc
Confidence 2348999999999999987642 22234788899999999999999999998 9999999999999999999999
Q ss_pred ccccccccCCCCCccccccccccccccccCCChhhhhc-----CCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHH
Q 008365 371 DVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQT-----GMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIE 445 (568)
Q Consensus 371 DFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-----~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~ 445 (568)
|||+++.+.... .......|++.|+|||++.. ..++.++|||||||++|+|++|+.||...+.......
T Consensus 167 dfg~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~ 240 (286)
T cd06638 167 DFGVSAQLTSTR------LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFK 240 (286)
T ss_pred cCCceeecccCC------CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhh
Confidence 999997653221 11234569999999998753 4578999999999999999999999976544333221
Q ss_pred hCccccccCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHH
Q 008365 446 KGTLAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPE 493 (568)
Q Consensus 446 ~~~~~~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~ 493 (568)
... ...+.. ..+..++..+.+|+.+||+.+|.+||++.+++.+.
T Consensus 241 ~~~---~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 241 IPR---NPPPTL-HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred ccc---cCCCcc-cCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 111 000111 11233456799999999999999999999998654
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=312.45 Aligned_cols=250 Identities=22% Similarity=0.334 Sum_probs=199.4
Q ss_pred cccccceeecccCceeEEEEEe--CCccEEEEEeCcCh-----hHhHHHHHHHHHHHHcCCCCceeeeccccCCC----c
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDA-----AQGKRQFQQEVEVLSSIRHPNMVLLLGACPDY----G 297 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~-----~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~----~ 297 (568)
.+|.+.+.||+|+||.||+|.+ ++..||||++.... ......+.+|+.+++.++||||+++++++.+. .
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 4688999999999999999986 56789999885421 22345788999999999999999999987542 3
Q ss_pred eEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccc
Q 008365 298 CLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARL 377 (568)
Q Consensus 298 ~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~ 377 (568)
++||||+++++|.+++.... .+++.....++.|++.||.|||+.+ |+|+||||+|||++.++.++|+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~ 155 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYG---ALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKR 155 (265)
T ss_pred EEEEEecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccc
Confidence 78999999999999987653 2778888999999999999999999 99999999999999999999999999976
Q ss_pred cCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHhCccccccCccC
Q 008365 378 VPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAV 457 (568)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~l~~~~ 457 (568)
+..... .........|+..|+|||++.+..++.++|||||||++|+|++|+.||............. ..+..
T Consensus 156 ~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~-----~~~~~ 227 (265)
T cd06652 156 LQTICL---SGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIA-----TQPTN 227 (265)
T ss_pred cccccc---cccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHh-----cCCCC
Confidence 532110 1111233568999999999988889999999999999999999999997554333222111 11112
Q ss_pred CCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHH
Q 008365 458 TDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPE 493 (568)
Q Consensus 458 ~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~ 493 (568)
...|...+..+..++.+|+. +|.+||++.+|+.+.
T Consensus 228 ~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~ 262 (265)
T cd06652 228 PVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHT 262 (265)
T ss_pred CCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCc
Confidence 23455667788999999994 999999999998554
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=318.32 Aligned_cols=246 Identities=24% Similarity=0.375 Sum_probs=199.4
Q ss_pred ccccceeecccCceeEEEEEe--CCccEEEEEeCcCh-hHhHHHHHHHHHHHHcCCCCceeeeccccCCC--ceEEEEec
Q 008365 230 KFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDA-AQGKRQFQQEVEVLSSIRHPNMVLLLGACPDY--GCLVYEYM 304 (568)
Q Consensus 230 ~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~--~~lV~E~~ 304 (568)
.|...+.||.|+||.||+|.+ .+..||||++.... ......+.+|+.+++.++||||++++++|.+. .++||||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 467778899999999999987 46789999987543 33456788999999999999999999988543 58999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCCc
Q 008365 305 HNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVAD 384 (568)
Q Consensus 305 ~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~~ 384 (568)
++++|.+++... .+++..+..++.||+.||.|||+.+ |+|+||+|+||+++.++.++|+|||++..+....
T Consensus 85 ~~~~L~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~-- 155 (277)
T cd06642 85 GGGSALDLLKPG----PLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-- 155 (277)
T ss_pred CCCcHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcc--
Confidence 999999987542 3788999999999999999999998 9999999999999999999999999997653321
Q ss_pred cccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHhCccccccCccCCCCChHH
Q 008365 385 SVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAVTDWPAEA 464 (568)
Q Consensus 385 ~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~l~~~~~~~p~~~ 464 (568)
.......|+..|+|||++.+..++.++|||||||++|+|++|..||........... + ........+..+
T Consensus 156 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~---~---~~~~~~~~~~~~ 225 (277)
T cd06642 156 ----IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFL---I---PKNSPPTLEGQY 225 (277)
T ss_pred ----hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhh---h---hcCCCCCCCccc
Confidence 112235689999999999998999999999999999999999999964332211110 0 011111223345
Q ss_pred HHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 465 AESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 465 ~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
+..+.+++.+||..+|.+||++.+|+.+.+
T Consensus 226 ~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 255 (277)
T cd06642 226 SKPFKEFVEACLNKDPRFRPTAKELLKHKF 255 (277)
T ss_pred CHHHHHHHHHHccCCcccCcCHHHHHHhHH
Confidence 677999999999999999999999998765
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-38 Score=311.75 Aligned_cols=245 Identities=22% Similarity=0.377 Sum_probs=200.2
Q ss_pred ccccceeecccCceeEEEEEe--CCccEEEEEeCcC--hhHhHHHHHHHHHHHHcCCCCceeeeccccCCCc--eEEEEe
Q 008365 230 KFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPD--AAQGKRQFQQEVEVLSSIRHPNMVLLLGACPDYG--CLVYEY 303 (568)
Q Consensus 230 ~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~--~lV~E~ 303 (568)
+|++++.||.|+||.||.++. ++..|++|.+... .......+.+|+.++++++|+||+++++++.+.. ++||||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 488999999999999988776 6678999987643 2344567889999999999999999999985544 789999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCC
Q 008365 304 MHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVA 383 (568)
Q Consensus 304 ~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~ 383 (568)
+++|+|.+++..... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 81 ANGGTLYDKIVRQKG-QLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS 156 (256)
T ss_pred cCCCcHHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence 999999999876532 34889999999999999999999999 99999999999999999999999999986643221
Q ss_pred ccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHH--HHHhCccccccCccCCCCC
Q 008365 384 DSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSR--AIEKGTLAEMLDPAVTDWP 461 (568)
Q Consensus 384 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~--~~~~~~~~~~l~~~~~~~p 461 (568)
......|++.|+|||++.+..++.++|||||||++|+|++|..||........ .+..+. ....+
T Consensus 157 ------~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~--------~~~~~ 222 (256)
T cd08221 157 ------MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGN--------YTPVV 222 (256)
T ss_pred ------cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCC--------CCCCc
Confidence 12345689999999999888899999999999999999999999965443221 122221 11223
Q ss_pred hHHHHHHHHHHHHhhccCCCCCCChHHhHhH
Q 008365 462 AEAAESFSKLAIQCAELRKKDRPDLGTVIVP 492 (568)
Q Consensus 462 ~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~ 492 (568)
..++..+.+++.+||..+|.+||++.+++.+
T Consensus 223 ~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 223 SVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred cccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 4456779999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=315.24 Aligned_cols=249 Identities=27% Similarity=0.463 Sum_probs=196.3
Q ss_pred cccccceeecccCceeEEEEEeC--C---ccEEEEEeCcC-hhHhHHHHHHHHHHHHcCCCCceeeeccccCCC--ceEE
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKLD--H---TPVAIKVLRPD-AAQGKRQFQQEVEVLSSIRHPNMVLLLGACPDY--GCLV 300 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~~--~---~~vAvK~l~~~-~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~--~~lV 300 (568)
..|.+.+.||+|+||.||+|.+. + ..||||++... .......|..|+.+++.++||||+++++++.+. .++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 35788999999999999999873 2 35999998764 334456799999999999999999999988543 4899
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCC
Q 008365 301 YEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPP 380 (568)
Q Consensus 301 ~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~ 380 (568)
|||+++|+|.+++..... .+++..+..++.|++.||.|||+.+ ++|+||||+|||++.++.+||+|||++..+..
T Consensus 84 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 158 (269)
T cd05065 84 TEFMENGALDSFLRQNDG--QFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 158 (269)
T ss_pred EecCCCCcHHHHHhhCCC--CCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCcccccccc
Confidence 999999999998876432 3789999999999999999999999 99999999999999999999999999976643
Q ss_pred CCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh-CCCCCCCchHHH--HHHHhCccccccCccC
Q 008365 381 SVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPMGLTHHVS--RAIEKGTLAEMLDPAV 457 (568)
Q Consensus 381 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~--~~~~~~~~~~~l~~~~ 457 (568)
..... .........++..|+|||++.+..++.++|||||||++|||++ |..||....... ..+... . .
T Consensus 159 ~~~~~-~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~-----~---~ 229 (269)
T cd05065 159 DTSDP-TYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQD-----Y---R 229 (269)
T ss_pred Ccccc-ccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcC-----C---c
Confidence 22111 0001111123467999999999999999999999999999886 999996543321 222111 0 1
Q ss_pred CCCChHHHHHHHHHHHHhhccCCCCCCChHHhHh
Q 008365 458 TDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIV 491 (568)
Q Consensus 458 ~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~ 491 (568)
...+.+++..+.+++.+||+.+|.+||++.+|+.
T Consensus 230 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 230 LPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 1223456677999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=313.11 Aligned_cols=250 Identities=26% Similarity=0.417 Sum_probs=198.3
Q ss_pred cccccceeecccCceeEEEEEe--CCccEEEEEeCcC---hhHhHHHHHHHHHHHHcCCCCceeeeccccCC--CceEEE
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPD---AAQGKRQFQQEVEVLSSIRHPNMVLLLGACPD--YGCLVY 301 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~---~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--~~~lV~ 301 (568)
++|.+.+.||.|+||.||++.+ ++..||||.+... .......+.+|+.+++.++||||++++++|.+ ..++||
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4688888999999999999986 6789999987643 22334578899999999999999999998854 458999
Q ss_pred EecCCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCC
Q 008365 302 EYMHNGSLEDRLLRRG-NTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPP 380 (568)
Q Consensus 302 E~~~ggsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~ 380 (568)
||+++++|.+++.... ....+++..++.++.||+.||.|||+.+ |+|+||||+||+++.++.++|+|||++..+..
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 9999999999886532 2335899999999999999999999999 99999999999999999999999999876533
Q ss_pred CCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchH-HHHHHHhCccccccCccCCC
Q 008365 381 SVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHH-VSRAIEKGTLAEMLDPAVTD 459 (568)
Q Consensus 381 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~-~~~~~~~~~~~~~l~~~~~~ 459 (568)
... ......|+..|+|||++.+..++.++|||||||++|+|++|..||..... ...... .+.....+. .
T Consensus 159 ~~~------~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~--~~~~~~~~~--~ 228 (267)
T cd08229 159 KTT------AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCK--KIEQCDYPP--L 228 (267)
T ss_pred CCc------ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhh--hhhcCCCCC--C
Confidence 211 11235689999999999988999999999999999999999999954321 111111 111111111 1
Q ss_pred CChHHHHHHHHHHHHhhccCCCCCCChHHhHh
Q 008365 460 WPAEAAESFSKLAIQCAELRKKDRPDLGTVIV 491 (568)
Q Consensus 460 ~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~ 491 (568)
.+...+..+.+++.+||..+|.+||++.+|+.
T Consensus 229 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 229 PSDHYSEELRQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred CcccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence 12346678999999999999999999998873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=321.82 Aligned_cols=250 Identities=27% Similarity=0.432 Sum_probs=198.5
Q ss_pred HhcccccceeecccCceeEEEEEeC---------CccEEEEEeCcCh-hHhHHHHHHHHHHHHcC-CCCceeeeccccCC
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKLD---------HTPVAIKVLRPDA-AQGKRQFQQEVEVLSSI-RHPNMVLLLGACPD 295 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~~---------~~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l-~HpnIv~l~g~~~~ 295 (568)
..++|.+...||+|+||.||+|+.. +..||+|++.... ......+.+|+.+++.+ +||||++++++|.+
T Consensus 13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 92 (304)
T cd05101 13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 92 (304)
T ss_pred cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence 3567899999999999999999741 2369999987543 33456788999999999 79999999998854
Q ss_pred C--ceEEEEecCCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCee
Q 008365 296 Y--GCLVYEYMHNGSLEDRLLRRGN-------------TPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANIL 360 (568)
Q Consensus 296 ~--~~lV~E~~~ggsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NIL 360 (568)
. .++||||+++|+|.+++..... ...+++..+..++.||+.||.|||+.+ |+||||||+|||
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nil 169 (304)
T cd05101 93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVL 169 (304)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEE
Confidence 4 4899999999999999976421 124788899999999999999999999 999999999999
Q ss_pred ccCCceeEecccccccccCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh-CCCCCCCchH
Q 008365 361 LDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPMGLTHH 439 (568)
Q Consensus 361 ld~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~ 439 (568)
++.++.+||+|||+++.+...... .......+++.|+|||++.+..++.++|||||||++|+|++ |..||.....
T Consensus 170 i~~~~~~kl~D~g~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~ 245 (304)
T cd05101 170 VTENNVMKIADFGLARDVNNIDYY----KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 245 (304)
T ss_pred EcCCCcEEECCCccceeccccccc----ccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH
Confidence 999999999999999866432111 11123456788999999988889999999999999999998 8888864332
Q ss_pred --HHHHHHhCccccccCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHh
Q 008365 440 --VSRAIEKGTLAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIV 491 (568)
Q Consensus 440 --~~~~~~~~~~~~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~ 491 (568)
+...+..+. ....+..++..+.+|+.+||..+|.+||++.+|+.
T Consensus 246 ~~~~~~~~~~~--------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~ 291 (304)
T cd05101 246 EELFKLLKEGH--------RMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVE 291 (304)
T ss_pred HHHHHHHHcCC--------cCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 212221111 11224456678999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=333.59 Aligned_cols=250 Identities=29% Similarity=0.448 Sum_probs=198.4
Q ss_pred HhcccccceeecccCceeEEEEEeC-------CccEEEEEeCcChh-HhHHHHHHHHHHHHcCC-CCceeeeccccCCC-
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKLD-------HTPVAIKVLRPDAA-QGKRQFQQEVEVLSSIR-HPNMVLLLGACPDY- 296 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~~-------~~~vAvK~l~~~~~-~~~~~~~~Ev~iL~~l~-HpnIv~l~g~~~~~- 296 (568)
..++|.+.++||+|+||.||+|++. +..||||+++.... ...+.+.+|+.+|..+. |||||+++++|...
T Consensus 35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~ 114 (401)
T cd05107 35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGG 114 (401)
T ss_pred cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCC
Confidence 3456888899999999999999853 24799999976532 23456889999999997 99999999998654
Q ss_pred -ceEEEEecCCCCHHHHHhhcCC---------------------------------------------------------
Q 008365 297 -GCLVYEYMHNGSLEDRLLRRGN--------------------------------------------------------- 318 (568)
Q Consensus 297 -~~lV~E~~~ggsL~~~l~~~~~--------------------------------------------------------- 318 (568)
.++|||||.+|+|.+++.....
T Consensus 115 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (401)
T cd05107 115 PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQD 194 (401)
T ss_pred CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhc
Confidence 4899999999999999975421
Q ss_pred --------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCee
Q 008365 319 --------------------------------------TPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANIL 360 (568)
Q Consensus 319 --------------------------------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NIL 360 (568)
.+.+++..+..|+.||+.||.|||+.+ |+||||||+|||
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiL 271 (401)
T cd05107 195 MKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVL 271 (401)
T ss_pred chhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEE
Confidence 124677888999999999999999998 999999999999
Q ss_pred ccCCceeEecccccccccCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh-CCCCCCCchH
Q 008365 361 LDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPMGLTHH 439 (568)
Q Consensus 361 ld~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~ 439 (568)
++.++.+||+|||+++.+...... .......+++.|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus 272 l~~~~~~kL~DfGla~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~ 347 (401)
T cd05107 272 ICEGKLVKICDFGLARDIMRDSNY----ISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM 347 (401)
T ss_pred EeCCCEEEEEecCcceeccccccc----ccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc
Confidence 999999999999999765322110 11123457889999999998889999999999999999998 8999964332
Q ss_pred HH---HHHHhCccccccCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHh
Q 008365 440 VS---RAIEKGTLAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIV 491 (568)
Q Consensus 440 ~~---~~~~~~~~~~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~ 491 (568)
.. ..+..+. ....|..++..+.+|+.+||..+|.+||++.+|+.
T Consensus 348 ~~~~~~~~~~~~--------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~ 394 (401)
T cd05107 348 NEQFYNAIKRGY--------RMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVH 394 (401)
T ss_pred hHHHHHHHHcCC--------CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 11 1122111 11224456678999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=313.41 Aligned_cols=251 Identities=23% Similarity=0.378 Sum_probs=198.5
Q ss_pred cccccceeecccCceeEEEEEe--CCccEEEEEeCcCh-----hHhHHHHHHHHHHHHcCCCCceeeeccccCC----Cc
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDA-----AQGKRQFQQEVEVLSSIRHPNMVLLLGACPD----YG 297 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~-----~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~----~~ 297 (568)
.+|.+.+.||+|+||.||+|.+ .+..||+|++.... ......+.+|+.+++.++||||+++++++.+ ..
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 3688899999999999999986 56789999886432 2234568899999999999999999998743 23
Q ss_pred eEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccc
Q 008365 298 CLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARL 377 (568)
Q Consensus 298 ~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~ 377 (568)
++||||+++++|.+++...+ .+++.....++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~ 155 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYG---ALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence 78999999999999987644 3788889999999999999999998 99999999999999999999999999976
Q ss_pred cCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHhCccccccCccC
Q 008365 378 VPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAV 457 (568)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~l~~~~ 457 (568)
+...... ........|+..|+|||++.+..++.++|||||||++|+|++|+.||.............. ....
T Consensus 156 ~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~-----~~~~ 227 (266)
T cd06651 156 LQTICMS---GTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIAT-----QPTN 227 (266)
T ss_pred ccccccc---CCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhc-----CCCC
Confidence 5321110 1111235689999999999988899999999999999999999999975543332221111 1111
Q ss_pred CCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 458 TDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 458 ~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
...|..++..+..++ .||..+|.+||++.+|+.|.+
T Consensus 228 ~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~ 263 (266)
T cd06651 228 PQLPSHISEHARDFL-GCIFVEARHRPSAEELLRHPF 263 (266)
T ss_pred CCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcc
Confidence 233455566777787 788899999999999986544
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=317.00 Aligned_cols=254 Identities=24% Similarity=0.407 Sum_probs=195.4
Q ss_pred ccccceeecccCceeEEEEEe------CCccEEEEEeCcCh-hHhHHHHHHHHHHHHcCCCCceeeeccccCCC----ce
Q 008365 230 KFSEAMKIGEGGYGPVYRGKL------DHTPVAIKVLRPDA-AQGKRQFQQEVEVLSSIRHPNMVLLLGACPDY----GC 298 (568)
Q Consensus 230 ~y~~~~~IG~G~fg~Vy~~~~------~~~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~----~~ 298 (568)
.|.+++.||+|+||.||++.+ .+..||||.++... ......+.+|+.+++.++||||+++++++.+. .+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 84 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence 478889999999999999874 35689999987553 33346789999999999999999999988543 47
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEeccccccccc
Q 008365 299 LVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLV 378 (568)
Q Consensus 299 lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~ 378 (568)
+||||++|++|.+++..... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+
T Consensus 85 lv~e~~~g~~L~~~l~~~~~--~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05079 85 LIMEFLPSGSLKEYLPRNKN--KINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAI 159 (284)
T ss_pred EEEEccCCCCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCcccccc
Confidence 99999999999999865432 3789999999999999999999999 999999999999999999999999999866
Q ss_pred CCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHh---C-----ccc
Q 008365 379 PPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEK---G-----TLA 450 (568)
Q Consensus 379 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~---~-----~~~ 450 (568)
...... ........|+..|+|||++.+..++.++|||||||++|+|++++.|+............ + ...
T Consensus 160 ~~~~~~---~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05079 160 ETDKEY---YTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLV 236 (284)
T ss_pred ccCccc---eeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHH
Confidence 432211 01112355778899999998888999999999999999999987765321110000000 0 000
Q ss_pred ccc-CccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHh
Q 008365 451 EML-DPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIV 491 (568)
Q Consensus 451 ~~l-~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~ 491 (568)
..+ .......+..++..+.+|+.+||+.+|.+||++.+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 278 (284)
T cd05079 237 RVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIE 278 (284)
T ss_pred HHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 000 00111223456678999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=318.32 Aligned_cols=248 Identities=30% Similarity=0.498 Sum_probs=197.4
Q ss_pred hcccccceeecccCceeEEEEEe-------CCccEEEEEeCcCh-hHhHHHHHHHHHHHHcCCCCceeeeccccCC--Cc
Q 008365 228 TDKFSEAMKIGEGGYGPVYRGKL-------DHTPVAIKVLRPDA-AQGKRQFQQEVEVLSSIRHPNMVLLLGACPD--YG 297 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~~~~-------~~~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--~~ 297 (568)
.++|++...||+|+||.||++.+ .+..||||++.... ......+.+|+.+++.++||||++++++|.+ ..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 35789999999999999999986 34689999987643 3345678899999999999999999998855 45
Q ss_pred eEEEEecCCCCHHHHHhhcC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCC
Q 008365 298 CLVYEYMHNGSLEDRLLRRG-------------------NTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPAN 358 (568)
Q Consensus 298 ~lV~E~~~ggsL~~~l~~~~-------------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~N 358 (568)
++||||+++|+|.+++.... ....+++..++.++.||+.||.|||+.+ ++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence 99999999999999987432 1124788889999999999999999999 9999999999
Q ss_pred eeccCCceeEecccccccccCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh-CCCCCCCc
Q 008365 359 ILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPMGLT 437 (568)
Q Consensus 359 ILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~ 437 (568)
||++.++.+||+|||++..+..... ........++..|+|||.+.+..++.++|||||||++|+|++ |..||...
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~ 236 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADY----YKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGM 236 (288)
T ss_pred eEecCCCceEECccccceecccCcc----ccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999875432210 001112335677999999998899999999999999999998 88898543
Q ss_pred hH--HHHHHHhCccccccCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhH
Q 008365 438 HH--VSRAIEKGTLAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVI 490 (568)
Q Consensus 438 ~~--~~~~~~~~~~~~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl 490 (568)
.. ....+..+. ....+..++..+.+|+.+||+.+|.+||++.+++
T Consensus 237 ~~~~~~~~~~~~~--------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~ 283 (288)
T cd05050 237 AHEEVIYYVRDGN--------VLSCPDNCPLELYNLMRLCWSKLPSDRPSFASIN 283 (288)
T ss_pred CHHHHHHHHhcCC--------CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHH
Confidence 22 222222222 1223445667899999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=315.00 Aligned_cols=247 Identities=28% Similarity=0.491 Sum_probs=196.8
Q ss_pred cccccceeecccCceeEEEEEeC-----CccEEEEEeCcCh-hHhHHHHHHHHHHHHcCCCCceeeeccccCC--CceEE
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKLD-----HTPVAIKVLRPDA-AQGKRQFQQEVEVLSSIRHPNMVLLLGACPD--YGCLV 300 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~~-----~~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--~~~lV 300 (568)
.+|++.+.||+|+||.||+|.+. +..||||.++... ......+.+|+.+++.++||||+++++++.+ ..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 46888999999999999999762 2369999987543 2334678999999999999999999998743 45899
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCC
Q 008365 301 YEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPP 380 (568)
Q Consensus 301 ~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~ 380 (568)
|||+++++|.+++..... .+++.++..|+.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++..+..
T Consensus 84 ~e~~~~~~L~~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 84 TEYMENGSLDAFLRKHDG--QFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 158 (267)
T ss_pred EEcCCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence 999999999999976542 3789999999999999999999999 99999999999999999999999999987643
Q ss_pred CCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh-CCCCCCCchH--HHHHHHhCccccccCccC
Q 008365 381 SVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPMGLTHH--VSRAIEKGTLAEMLDPAV 457 (568)
Q Consensus 381 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~--~~~~~~~~~~~~~l~~~~ 457 (568)
.... ........++..|++||++.+..++.++|||||||++|++++ |..||..... ....+..+. .
T Consensus 159 ~~~~---~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~--------~ 227 (267)
T cd05066 159 DPEA---AYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGY--------R 227 (267)
T ss_pred ccce---eeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCC--------c
Confidence 2211 111122334678999999998899999999999999999886 9999964332 222222211 1
Q ss_pred CCCChHHHHHHHHHHHHhhccCCCCCCChHHhHh
Q 008365 458 TDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIV 491 (568)
Q Consensus 458 ~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~ 491 (568)
...+..++..+.+++.+|++.+|.+||++.+++.
T Consensus 228 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 228 LPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred CCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence 1223345677899999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=330.71 Aligned_cols=237 Identities=24% Similarity=0.279 Sum_probs=183.9
Q ss_pred ecccCceeEEEEEe--CCccEEEEEeCcChhH---hHHHHHHHHHHHHcC---CCCceeeeccccCC--CceEEEEecCC
Q 008365 237 IGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQ---GKRQFQQEVEVLSSI---RHPNMVLLLGACPD--YGCLVYEYMHN 306 (568)
Q Consensus 237 IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~---~~~~~~~Ev~iL~~l---~HpnIv~l~g~~~~--~~~lV~E~~~g 306 (568)
||+|+||.||+|++ .+..||||++...... ....+..|..++..+ +||||+.++++|.+ ..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 79999999999987 5779999998653221 223345677777665 69999999998854 45899999999
Q ss_pred CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCCccc
Q 008365 307 GSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSV 386 (568)
Q Consensus 307 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~~~~ 386 (568)
|+|.+++...+ .+++..+..|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++......
T Consensus 81 g~L~~~l~~~~---~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~---- 150 (330)
T cd05586 81 GELFWHLQKEG---RFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDN---- 150 (330)
T ss_pred ChHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC----
Confidence 99999887644 3789999999999999999999999 9999999999999999999999999987532211
Q ss_pred cccccccccccccCCChhhhhcC-CCCCcceehhHHHHHHHHHhCCCCCCCchHHH--HHHHhCccccccCccCCCCChH
Q 008365 387 TQYHMTSAAGTFCYIDPEYQQTG-MLTTKSDIYSFGIMLLQIITARSPMGLTHHVS--RAIEKGTLAEMLDPAVTDWPAE 463 (568)
Q Consensus 387 ~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~--~~~~~~~~~~~l~~~~~~~p~~ 463 (568)
......+||+.|+|||++.+. .++.++|||||||++|+|++|+.||....... ..+..+.. .+. ...
T Consensus 151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~------~~~--~~~ 220 (330)
T cd05586 151 --KTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKV------RFP--KNV 220 (330)
T ss_pred --CCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCC------CCC--Ccc
Confidence 112346799999999988754 48999999999999999999999996544321 22222211 011 112
Q ss_pred HHHHHHHHHHHhhccCCCCCCC----hHHhHhHH
Q 008365 464 AAESFSKLAIQCAELRKKDRPD----LGTVIVPE 493 (568)
Q Consensus 464 ~~~~l~~li~~Cl~~dP~~RPs----~~~vl~~~ 493 (568)
++..+.+++.+||..+|.+||+ +.+++.+.
T Consensus 221 ~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~ 254 (330)
T cd05586 221 LSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHP 254 (330)
T ss_pred CCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCc
Confidence 4567889999999999999984 56665443
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=312.81 Aligned_cols=232 Identities=25% Similarity=0.440 Sum_probs=183.7
Q ss_pred eecccCceeEEEEEeC--------------CccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCceeeeccccCC--CceE
Q 008365 236 KIGEGGYGPVYRGKLD--------------HTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACPD--YGCL 299 (568)
Q Consensus 236 ~IG~G~fg~Vy~~~~~--------------~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--~~~l 299 (568)
.||+|+||.||+|... ...|++|++..........|.+|+.+++.++||||+++++++.+ ..++
T Consensus 2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~l 81 (262)
T cd05077 2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIM 81 (262)
T ss_pred ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCEE
Confidence 6899999999999742 12589999877655555678899999999999999999998854 4589
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCce-------eEeccc
Q 008365 300 VYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYV-------SKISDV 372 (568)
Q Consensus 300 V~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~-------vKL~DF 372 (568)
||||+++|+|..++..... .+++..++.|+.||+.||.|||+.+ |+||||||+||||+.++. +|++||
T Consensus 82 v~e~~~~~~l~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~ 156 (262)
T cd05077 82 VEEFVEFGPLDLFMHRKSD--VLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSDP 156 (262)
T ss_pred EEecccCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence 9999999999888765432 3888999999999999999999999 999999999999976654 899999
Q ss_pred ccccccCCCCCccccccccccccccccCCChhhhh-cCCCCCcceehhHHHHHHHHH-hCCCCCCCchHHHHH-HHhCcc
Q 008365 373 GLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQ-TGMLTTKSDIYSFGIMLLQII-TARSPMGLTHHVSRA-IEKGTL 449 (568)
Q Consensus 373 Gla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~s~ksDvwSlGvil~ell-tG~~Pf~~~~~~~~~-~~~~~~ 449 (568)
|++..+.. .....|+..|+|||++. +..++.++|||||||++|+|+ +|..||......... +..+..
T Consensus 157 g~~~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~ 226 (262)
T cd05077 157 GIPITVLS----------RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFYEGQC 226 (262)
T ss_pred CCCccccC----------cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHHHhcCc
Confidence 99865421 12346888999999876 567899999999999999998 588888643321111 111111
Q ss_pred ccccCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHh
Q 008365 450 AEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIV 491 (568)
Q Consensus 450 ~~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~ 491 (568)
. .....+..+.+|+.+||+.+|.+||++.+|+.
T Consensus 227 --------~-~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~ 259 (262)
T cd05077 227 --------M-LVTPSCKELADLMTHCMNYDPNQRPFFRAIMR 259 (262)
T ss_pred --------c-CCCCChHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0 11122456899999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=309.79 Aligned_cols=245 Identities=28% Similarity=0.470 Sum_probs=198.6
Q ss_pred cccccceeecccCceeEEEEEe--CCccEEEEEeCcC---hhHhHHHHHHHHHHHHcCCCCceeeeccccCCC--ceEEE
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPD---AAQGKRQFQQEVEVLSSIRHPNMVLLLGACPDY--GCLVY 301 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~---~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~--~~lV~ 301 (568)
++|.+.+.||.|+||.||+|.. +++.||+|.++.. .......+.+|+.++++++|+||+++++++.+. .++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 5789999999999999999988 5789999988642 223356788999999999999999999988543 48999
Q ss_pred EecCCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCC
Q 008365 302 EYMHNGSLEDRLLRRG-NTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPP 380 (568)
Q Consensus 302 E~~~ggsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~ 380 (568)
||+++|+|.+++.... ....+++..+..++.+++.||.|||+.+ |+||||+|+||+++.++.++|+|||++..+..
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 9999999999886532 2334889999999999999999999999 99999999999999999999999999876533
Q ss_pred CCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchH----HHHHHHhCccccccCcc
Q 008365 381 SVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHH----VSRAIEKGTLAEMLDPA 456 (568)
Q Consensus 381 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~----~~~~~~~~~~~~~l~~~ 456 (568)
... ......|++.|+|||.+.+..++.++|||||||++|+|++|+.||..... +...+..+.
T Consensus 159 ~~~------~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-------- 224 (267)
T cd08224 159 KTT------AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCD-------- 224 (267)
T ss_pred CCc------ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCC--------
Confidence 211 11234688999999999988899999999999999999999999954321 111111111
Q ss_pred CCCCCh-HHHHHHHHHHHHhhccCCCCCCChHHhH
Q 008365 457 VTDWPA-EAAESFSKLAIQCAELRKKDRPDLGTVI 490 (568)
Q Consensus 457 ~~~~p~-~~~~~l~~li~~Cl~~dP~~RPs~~~vl 490 (568)
....|. ..+..+.+++.+||..+|.+||++.+|+
T Consensus 225 ~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il 259 (267)
T cd08224 225 YPPLPADHYSEELRDLVSRCINPDPEKRPDISYVL 259 (267)
T ss_pred CCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHH
Confidence 112222 4566799999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=309.73 Aligned_cols=238 Identities=27% Similarity=0.480 Sum_probs=191.3
Q ss_pred eecccCceeEEEEEe-CCccEEEEEeCcChh-HhHHHHHHHHHHHHcCCCCceeeeccccCC--CceEEEEecCCCCHHH
Q 008365 236 KIGEGGYGPVYRGKL-DHTPVAIKVLRPDAA-QGKRQFQQEVEVLSSIRHPNMVLLLGACPD--YGCLVYEYMHNGSLED 311 (568)
Q Consensus 236 ~IG~G~fg~Vy~~~~-~~~~vAvK~l~~~~~-~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--~~~lV~E~~~ggsL~~ 311 (568)
+||.|+||.||+|.. ++..||+|++..... .....+.+|+.+++.++||||++++++|.+ ..++||||+++++|.+
T Consensus 2 ~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 81 (250)
T cd05085 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLS 81 (250)
T ss_pred ccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHH
Confidence 699999999999986 567899999876532 334468899999999999999999998854 4589999999999999
Q ss_pred HHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCCcccccccc
Q 008365 312 RLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHM 391 (568)
Q Consensus 312 ~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~ 391 (568)
++..... .+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++......... ..
T Consensus 82 ~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-----~~ 151 (250)
T cd05085 82 FLRKKKD--ELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS-----SS 151 (250)
T ss_pred HHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccc-----cC
Confidence 8865432 3789999999999999999999999 999999999999999999999999998754322110 11
Q ss_pred ccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh-CCCCCCCchHHH--HHHHhCccccccCccCCCCChHHHHHH
Q 008365 392 TSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPMGLTHHVS--RAIEKGTLAEMLDPAVTDWPAEAAESF 468 (568)
Q Consensus 392 ~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~--~~~~~~~~~~~l~~~~~~~p~~~~~~l 468 (568)
....++..|+|||++.+..++.++|||||||++|+|++ |..||....... ..+..+. ....+..++..+
T Consensus 152 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~ 223 (250)
T cd05085 152 GLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGY--------RMSCPQKCPDDV 223 (250)
T ss_pred CCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCC--------CCCCCCCCCHHH
Confidence 12244678999999998899999999999999999998 999996543322 1121111 112234566789
Q ss_pred HHHHHHhhccCCCCCCChHHhHh
Q 008365 469 SKLAIQCAELRKKDRPDLGTVIV 491 (568)
Q Consensus 469 ~~li~~Cl~~dP~~RPs~~~vl~ 491 (568)
.+++.+||..+|.+||++.+++.
T Consensus 224 ~~li~~~l~~~p~~Rp~~~~l~~ 246 (250)
T cd05085 224 YKVMQRCWDYKPENRPKFSELQK 246 (250)
T ss_pred HHHHHHHcccCcccCCCHHHHHH
Confidence 99999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=316.49 Aligned_cols=248 Identities=25% Similarity=0.372 Sum_probs=201.3
Q ss_pred cccccceeecccCceeEEEEEe--CCccEEEEEeCcCh-hHhHHHHHHHHHHHHcCCCCceeeeccccCCC--ceEEEEe
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDA-AQGKRQFQQEVEVLSSIRHPNMVLLLGACPDY--GCLVYEY 303 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~--~~lV~E~ 303 (568)
++|.+.+.||.|+||.||+|.+ +++.||||++.... ......+.+|+.+++.++||||+++++++.+. .++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 3688889999999999999987 56789999987543 33345688999999999999999999987543 4899999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCC
Q 008365 304 MHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVA 383 (568)
Q Consensus 304 ~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~ 383 (568)
+++++|.+++... .+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||+++.+....
T Consensus 81 ~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~- 152 (274)
T cd06609 81 CGGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM- 152 (274)
T ss_pred eCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeecccc-
Confidence 9999999988754 4889999999999999999999999 9999999999999999999999999998764332
Q ss_pred ccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHhCccccccCccCCCCChH
Q 008365 384 DSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAVTDWPAE 463 (568)
Q Consensus 384 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~l~~~~~~~p~~ 463 (568)
.......|++.|+|||++.+..++.++|||||||++|+|++|..||...+....... +.....+.+... .
T Consensus 153 -----~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~---~~~~~~~~~~~~--~ 222 (274)
T cd06609 153 -----SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFL---IPKNNPPSLEGN--K 222 (274)
T ss_pred -----cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHH---hhhcCCCCCccc--c
Confidence 112345689999999999988899999999999999999999999975543222111 111111111111 1
Q ss_pred HHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 464 AAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 464 ~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
++..+.+++.+||..+|.+||++.+++.+.+
T Consensus 223 ~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~ 253 (274)
T cd06609 223 FSKPFKDFVSLCLNKDPKERPSAKELLKHKF 253 (274)
T ss_pred cCHHHHHHHHHHhhCChhhCcCHHHHhhChh
Confidence 5667999999999999999999999986554
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=311.75 Aligned_cols=241 Identities=27% Similarity=0.418 Sum_probs=186.9
Q ss_pred eecccCceeEEEEEeC-----CccEEEEEeCcC-hhHhHHHHHHHHHHHHcCCCCceeeeccccC--C-CceEEEEecCC
Q 008365 236 KIGEGGYGPVYRGKLD-----HTPVAIKVLRPD-AAQGKRQFQQEVEVLSSIRHPNMVLLLGACP--D-YGCLVYEYMHN 306 (568)
Q Consensus 236 ~IG~G~fg~Vy~~~~~-----~~~vAvK~l~~~-~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~--~-~~~lV~E~~~g 306 (568)
.||+|+||.||+|.+. ...||||.+... .......+.+|+.+++.++||||++++++|. + ..++||||+.+
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~ 81 (262)
T cd05058 2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKH 81 (262)
T ss_pred cccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCCC
Confidence 6899999999999852 247999998543 3344567889999999999999999999763 2 35899999999
Q ss_pred CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCCccc
Q 008365 307 GSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSV 386 (568)
Q Consensus 307 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~~~~ 386 (568)
|+|.+++..... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+......
T Consensus 82 ~~L~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~-- 154 (262)
T cd05058 82 GDLRNFIRSETH--NPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY-- 154 (262)
T ss_pred CCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCcce--
Confidence 999999876433 2577788889999999999999998 999999999999999999999999999755322110
Q ss_pred cccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhC-CCCCCCchHHH--HHHHhCccccccCccCCCCChH
Q 008365 387 TQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITA-RSPMGLTHHVS--RAIEKGTLAEMLDPAVTDWPAE 463 (568)
Q Consensus 387 ~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG-~~Pf~~~~~~~--~~~~~~~~~~~l~~~~~~~p~~ 463 (568)
.........++..|+|||++.+..++.++|||||||++|||++| .+||....... ..+..+ .....+..
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~ 226 (262)
T cd05058 155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQG--------RRLLQPEY 226 (262)
T ss_pred eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC--------CCCCCCCc
Confidence 01111234567889999999888999999999999999999994 66675433221 111111 11112334
Q ss_pred HHHHHHHHHHHhhccCCCCCCChHHhHh
Q 008365 464 AAESFSKLAIQCAELRKKDRPDLGTVIV 491 (568)
Q Consensus 464 ~~~~l~~li~~Cl~~dP~~RPs~~~vl~ 491 (568)
++..+.+++..||..+|.+||++.+|+.
T Consensus 227 ~~~~~~~li~~cl~~~p~~Rp~~~~il~ 254 (262)
T cd05058 227 CPDPLYEVMLSCWHPKPEMRPTFSELVS 254 (262)
T ss_pred CCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 5667999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=314.87 Aligned_cols=247 Identities=25% Similarity=0.361 Sum_probs=201.9
Q ss_pred ccccceeecccCceeEEEEEe--CCccEEEEEeCcCh-hHhHHHHHHHHHHHHcCCCCceeeeccccCC--CceEEEEec
Q 008365 230 KFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDA-AQGKRQFQQEVEVLSSIRHPNMVLLLGACPD--YGCLVYEYM 304 (568)
Q Consensus 230 ~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--~~~lV~E~~ 304 (568)
.|+..+.||.|+||.||+|.+ .+..||||++.... ......+.+|+.+++.++||||++++++|.+ ..++||||+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 477788999999999999987 46789999987543 3445678899999999999999999998854 358999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCCc
Q 008365 305 HNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVAD 384 (568)
Q Consensus 305 ~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~~ 384 (568)
+||+|.+++... .+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++..+.....
T Consensus 85 ~~~~L~~~i~~~----~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06640 85 GGGSALDLLRAG----PFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred CCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCcc-
Confidence 999999988642 3788889999999999999999999 99999999999999999999999999976543211
Q ss_pred cccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHhCccccccCccCCCCChHH
Q 008365 385 SVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAVTDWPAEA 464 (568)
Q Consensus 385 ~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~l~~~~~~~p~~~ 464 (568)
......++..|+|||++.+..++.++|||||||++|+|++|..||............ ........+..+
T Consensus 157 -----~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~------~~~~~~~~~~~~ 225 (277)
T cd06640 157 -----KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLI------PKNNPPTLTGEF 225 (277)
T ss_pred -----ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhh------hcCCCCCCchhh
Confidence 123346889999999998888999999999999999999999999654432211100 001112334567
Q ss_pred HHHHHHHHHHhhccCCCCCCChHHhHhHHHH
Q 008365 465 AESFSKLAIQCAELRKKDRPDLGTVIVPELN 495 (568)
Q Consensus 465 ~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l~ 495 (568)
+..+.+++.+||+.+|.+||++.+++.+.+-
T Consensus 226 ~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 256 (277)
T cd06640 226 SKPFKEFIDACLNKDPSFRPTAKELLKHKFI 256 (277)
T ss_pred hHHHHHHHHHHcccCcccCcCHHHHHhChHh
Confidence 7889999999999999999999999887663
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-38 Score=333.78 Aligned_cols=255 Identities=24% Similarity=0.329 Sum_probs=200.8
Q ss_pred HhcccccceeecccCceeEEEEEe--CCccEEEEEeCcChhHhHHHHHHHHHHHHcCC-C-----Cceeeecccc--CCC
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIR-H-----PNMVLLLGAC--PDY 296 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~-H-----pnIv~l~g~~--~~~ 296 (568)
+..+|.+++.||+|+||.|.+|.+ ++..||||+++....- ..+-..|+.+|..|+ | -|+|+++++| .+.
T Consensus 184 i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f-~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~H 262 (586)
T KOG0667|consen 184 IAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRF-LRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNH 262 (586)
T ss_pred eEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHH-HHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccc
Confidence 334899999999999999999988 5679999999866543 456678999999997 4 3899999987 456
Q ss_pred ceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccC--CceeEeccccc
Q 008365 297 GCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDR--NYVSKISDVGL 374 (568)
Q Consensus 297 ~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~--~~~vKL~DFGl 374 (568)
.|||+|++ ..+|.++|..+...+ ++...+..|+.||+.||.+||..+ |||+||||+||||.. ...|||+|||+
T Consensus 263 lciVfELL-~~NLYellK~n~f~G-lsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGS 337 (586)
T KOG0667|consen 263 LCIVFELL-STNLYELLKNNKFRG-LSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGS 337 (586)
T ss_pred eeeeehhh-hhhHHHHHHhcCCCC-CCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEeccc
Confidence 69999999 789999998766544 999999999999999999999999 999999999999954 34899999999
Q ss_pred ccccCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHH----------
Q 008365 375 ARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAI---------- 444 (568)
Q Consensus 375 a~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~---------- 444 (568)
|+...... ...+-+..|.|||++.|..|+.+.||||||||++||++|.+.|-+.+..++..
T Consensus 338 Sc~~~q~v---------ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp 408 (586)
T KOG0667|consen 338 SCFESQRV---------YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPP 408 (586)
T ss_pred ccccCCcc---------eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCC
Confidence 98754322 24567889999999999999999999999999999999988885544333211
Q ss_pred ----H----------h-Ccccc-----------------------cc---Cc-cCCC----CChHHHHHHHHHHHHhhcc
Q 008365 445 ----E----------K-GTLAE-----------------------ML---DP-AVTD----WPAEAAESFSKLAIQCAEL 478 (568)
Q Consensus 445 ----~----------~-~~~~~-----------------------~l---~~-~~~~----~p~~~~~~l~~li~~Cl~~ 478 (568)
+ . ..+.. .. -| .... .+...-..|.+++.+||.+
T Consensus 409 ~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~ 488 (586)
T KOG0667|consen 409 PKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEW 488 (586)
T ss_pred HHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhcc
Confidence 0 0 00000 00 00 0000 1113345789999999999
Q ss_pred CCCCCCChHHhHhHHHHH
Q 008365 479 RKKDRPDLGTVIVPELNR 496 (568)
Q Consensus 479 dP~~RPs~~~vl~~~l~~ 496 (568)
||..|++..+.+.|.+-.
T Consensus 489 dP~~R~tp~qal~Hpfl~ 506 (586)
T KOG0667|consen 489 DPAERITPAQALNHPFLT 506 (586)
T ss_pred CchhcCCHHHHhcCcccc
Confidence 999999999999877644
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=330.80 Aligned_cols=258 Identities=28% Similarity=0.454 Sum_probs=208.1
Q ss_pred cccccceeecccCceeEEEEEeCC-ccEEEEEeCcChhHh-HHHHHHHHHHHHcCCCCceeeecccc--CCCceEEEEec
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKLDH-TPVAIKVLRPDAAQG-KRQFQQEVEVLSSIRHPNMVLLLGAC--PDYGCLVYEYM 304 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~~~-~~vAvK~l~~~~~~~-~~~~~~Ev~iL~~l~HpnIv~l~g~~--~~~~~lV~E~~ 304 (568)
+...+.++||+|-||.|.++...+ ..||||+++.+.... ...|.+|+++|.+|+|||||.++|+| .+..|+|+|||
T Consensus 538 s~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYm 617 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYM 617 (807)
T ss_pred hheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHH
Confidence 455677899999999999999876 899999999876544 47899999999999999999999999 45569999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCCc
Q 008365 305 HNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVAD 384 (568)
Q Consensus 305 ~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~~ 384 (568)
++|+|..++..+.... +......+|+.||+.|++||.+.+ +|||||.+.|+|+|.++++||+|||+++-+-....
T Consensus 618 EnGDLnqFl~aheapt-~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~y- 692 (807)
T KOG1094|consen 618 ENGDLNQFLSAHELPT-AETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDY- 692 (807)
T ss_pred hcCcHHHHHHhccCcc-cccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccCCc-
Confidence 9999999998874322 445566779999999999999999 99999999999999999999999999985432211
Q ss_pred cccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh--CCCCCCCchHHHHHHHhCccc-cccCccCCCCC
Q 008365 385 SVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT--ARSPMGLTHHVSRAIEKGTLA-EMLDPAVTDWP 461 (568)
Q Consensus 385 ~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt--G~~Pf~~~~~~~~~~~~~~~~-~~l~~~~~~~p 461 (568)
.......+-..+|||||.+..++++.++|||+||+++||+++ ...||.....-...-+.+.+. ..-...+...|
T Consensus 693 ---y~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P 769 (807)
T KOG1094|consen 693 ---YRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRP 769 (807)
T ss_pred ---eeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCC
Confidence 111234566789999999999999999999999999999876 678996544322221222211 11122334568
Q ss_pred hHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 462 AEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 462 ~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
..|+..+.++|.+||..+-.+||++.++..++.
T Consensus 770 ~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq 802 (807)
T KOG1094|consen 770 PACPQGLYELMLRCWRRESEQRPSFEQLHLFLQ 802 (807)
T ss_pred CcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHH
Confidence 889999999999999999999999999875543
|
|
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=320.60 Aligned_cols=249 Identities=26% Similarity=0.429 Sum_probs=196.9
Q ss_pred hcccccceeecccCceeEEEEEeC---------CccEEEEEeCcCh-hHhHHHHHHHHHHHHcC-CCCceeeeccccCC-
Q 008365 228 TDKFSEAMKIGEGGYGPVYRGKLD---------HTPVAIKVLRPDA-AQGKRQFQQEVEVLSSI-RHPNMVLLLGACPD- 295 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~~~~~---------~~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l-~HpnIv~l~g~~~~- 295 (568)
.++|.+.++||+|+||.||++... ...||+|+++... ......+.+|+.+++.+ +||||++++++|.+
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 357889999999999999999752 2369999987543 33355688999999999 59999999998854
Q ss_pred -CceEEEEecCCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeec
Q 008365 296 -YGCLVYEYMHNGSLEDRLLRRGN-------------TPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILL 361 (568)
Q Consensus 296 -~~~lV~E~~~ggsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILl 361 (568)
..++||||+++|+|.+++..... ...+++..+..++.||+.||.|||+.+ |+||||||+|||+
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 167 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLV 167 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEE
Confidence 34899999999999999976421 234889999999999999999999999 9999999999999
Q ss_pred cCCceeEecccccccccCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh-CCCCCCCchH-
Q 008365 362 DRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPMGLTHH- 439 (568)
Q Consensus 362 d~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~- 439 (568)
+.++.+||+|||+++.+...... .......++..|+|||++.+..++.++|||||||++|+|++ |..||.....
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~ 243 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYY----KKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE 243 (314)
T ss_pred cCCCcEEEccccccccccccccc----cccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999865422110 01112234568999999998899999999999999999999 8999965432
Q ss_pred -HHHHHHhCccccccCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHh
Q 008365 440 -VSRAIEKGTLAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIV 491 (568)
Q Consensus 440 -~~~~~~~~~~~~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~ 491 (568)
+...+..+. ....+..++..+.+++.+||..+|.+||++.+++.
T Consensus 244 ~~~~~~~~~~--------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 244 ELFKLLREGH--------RMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred HHHHHHHcCC--------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 222222211 11234456678999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=310.14 Aligned_cols=245 Identities=27% Similarity=0.417 Sum_probs=200.0
Q ss_pred ccccceeecccCceeEEEEEe--CCccEEEEEeCcCh-----hHhHHHHHHHHHHHHcCCCCceeeeccccCC--CceEE
Q 008365 230 KFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDA-----AQGKRQFQQEVEVLSSIRHPNMVLLLGACPD--YGCLV 300 (568)
Q Consensus 230 ~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~-----~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--~~~lV 300 (568)
+|+..+.||+|+||.||+|.. ++..|+||++.... ......+.+|+.+++.++||||+++++++.+ ..++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 467778999999999999987 57899999986533 2234678899999999999999999998854 34899
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCC
Q 008365 301 YEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPP 380 (568)
Q Consensus 301 ~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~ 380 (568)
|||+++++|.+++.... .+++..+..++.||+.||.|||+.+ |+|+||+|+||+++.++.+||+|||++.....
T Consensus 81 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~ 154 (258)
T cd06632 81 LELVPGGSLAKLLKKYG---SFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVE 154 (258)
T ss_pred EEecCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 99999999999987653 3788999999999999999999999 99999999999999999999999999876533
Q ss_pred CCCccccccccccccccccCCChhhhhcCC-CCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHhCccccccCccCCC
Q 008365 381 SVADSVTQYHMTSAAGTFCYIDPEYQQTGM-LTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAVTD 459 (568)
Q Consensus 381 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~-~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~l~~~~~~ 459 (568)
.. ......|++.|++||.+.... ++.++|+|||||++|+|++|..||............... .....
T Consensus 155 ~~-------~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~-----~~~~~ 222 (258)
T cd06632 155 FS-------FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRS-----KELPP 222 (258)
T ss_pred cc-------cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhc-----ccCCC
Confidence 21 123456899999999887776 899999999999999999999999765443333222211 11122
Q ss_pred CChHHHHHHHHHHHHhhccCCCCCCChHHhHhH
Q 008365 460 WPAEAAESFSKLAIQCAELRKKDRPDLGTVIVP 492 (568)
Q Consensus 460 ~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~ 492 (568)
.+..++..+.+++.+||+.+|.+||++.+++.+
T Consensus 223 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 223 IPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred cCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 344566788999999999999999999998754
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=311.06 Aligned_cols=246 Identities=31% Similarity=0.517 Sum_probs=198.5
Q ss_pred HhcccccceeecccCceeEEEEEeC-CccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCceeeeccccCC--CceEEEEe
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKLD-HTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACPD--YGCLVYEY 303 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~~-~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--~~~lV~E~ 303 (568)
..++|.+.++||.|+||.||+|.+. +..||||.+..... ....+.+|+.+++.++||||+++++++.+ ..++||||
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY 82 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence 3467999999999999999999874 46799999876543 34578899999999999999999998854 45899999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCC
Q 008365 304 MHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVA 383 (568)
Q Consensus 304 ~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~ 383 (568)
+++++|.+++..... ..+++..+..++.||+.||.|||+.+ |+|+||||+||+|+.++.+||+|||++..+....
T Consensus 83 ~~~~~L~~~i~~~~~-~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~- 157 (261)
T cd05034 83 MSKGSLLDFLKSGEG-KKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDE- 157 (261)
T ss_pred cCCCCHHHHHhcccc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchh-
Confidence 999999999876432 24889999999999999999999999 9999999999999999999999999997664311
Q ss_pred ccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh-CCCCCCCchHHH--HHHHhCccccccCccCCCC
Q 008365 384 DSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPMGLTHHVS--RAIEKGTLAEMLDPAVTDW 460 (568)
Q Consensus 384 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~--~~~~~~~~~~~l~~~~~~~ 460 (568)
........++..|+|||.+.+..++.++|||||||++|+|++ |+.||....... ..+..+ + ....
T Consensus 158 ----~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~-----~---~~~~ 225 (261)
T cd05034 158 ----YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERG-----Y---RMPR 225 (261)
T ss_pred ----hhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-----C---CCCC
Confidence 111122335678999999998899999999999999999999 999996543221 111111 0 1122
Q ss_pred ChHHHHHHHHHHHHhhccCCCCCCChHHhH
Q 008365 461 PAEAAESFSKLAIQCAELRKKDRPDLGTVI 490 (568)
Q Consensus 461 p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl 490 (568)
+...+..+.+++.+|+..+|.+||++.+++
T Consensus 226 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~ 255 (261)
T cd05034 226 PPNCPEELYDLMLQCWDKDPEERPTFEYLQ 255 (261)
T ss_pred CCCCCHHHHHHHHHHcccCcccCCCHHHHH
Confidence 334467799999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=321.56 Aligned_cols=254 Identities=23% Similarity=0.337 Sum_probs=195.3
Q ss_pred cccccceeecccCceeEEEEEe--CCccEEEEEeCcChh-HhHHHHHHHHHHHHcCCCCceeeeccccCCC--ceEEEEe
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAA-QGKRQFQQEVEVLSSIRHPNMVLLLGACPDY--GCLVYEY 303 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~-~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~--~~lV~E~ 303 (568)
++|.+.+.||.|+||.||+|.+ .+..||+|.+..... .....+.+|+.+++.++||||+++++++.+. .++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 5689999999999999999987 467899999865432 2234577899999999999999999998543 4899999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCC
Q 008365 304 MHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVA 383 (568)
Q Consensus 304 ~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~ 383 (568)
+. ++|.+++..... .+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||++.......
T Consensus 86 ~~-~~l~~~l~~~~~--~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~- 158 (301)
T cd07873 86 LD-KDLKQYLDDCGN--SINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT- 158 (301)
T ss_pred cc-cCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCC-
Confidence 96 689888876533 3788999999999999999999999 9999999999999999999999999997543211
Q ss_pred ccccccccccccccccCCChhhhhc-CCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHH--h-------Ccccccc
Q 008365 384 DSVTQYHMTSAAGTFCYIDPEYQQT-GMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIE--K-------GTLAEML 453 (568)
Q Consensus 384 ~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~--~-------~~~~~~l 453 (568)
.......+++.|+|||++.+ ..++.++|||||||++|+|++|++||........... . ......+
T Consensus 159 -----~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (301)
T cd07873 159 -----KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGIL 233 (301)
T ss_pred -----CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhh
Confidence 11123467899999998765 4588899999999999999999999965433211100 0 0000000
Q ss_pred C---------cc-----CCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 454 D---------PA-----VTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 454 ~---------~~-----~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
. +. .......++..+.+|+.+||..+|.+||++.+++.+.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~ 288 (301)
T cd07873 234 SNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPY 288 (301)
T ss_pred ccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence 0 00 00111235667899999999999999999999986655
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=301.21 Aligned_cols=257 Identities=24% Similarity=0.351 Sum_probs=204.4
Q ss_pred HhcccccceeecccCceeEEEEEe--CCccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCceeeeccccC-------CCc
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACP-------DYG 297 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~-------~~~ 297 (568)
..++|.+.++||+|||+.||+++. ++..+|+|.+........+...+|++..++++|||++++++++- ...
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~ 98 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA 98 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence 456899999999999999999885 67789999998887777888899999999999999999998761 124
Q ss_pred eEEEEecCCCCHHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEeccccccc
Q 008365 298 CLVYEYMHNGSLEDRLLRRGN-TPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLAR 376 (568)
Q Consensus 298 ~lV~E~~~ggsL~~~l~~~~~-~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~ 376 (568)
||++.|...|+|.+.+....- ...+++.+.+.|+.+|++||.+||...+ |++||||||.|||+.+.+.++|.|||.++
T Consensus 99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~-~yAH~DiKP~NILls~~~~~vl~D~GS~~ 177 (302)
T KOG2345|consen 99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEP-PYAHRDIKPANILLSDSGLPVLMDLGSAT 177 (302)
T ss_pred EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCC-cccccCCCcceeEecCCCceEEEeccCcc
Confidence 899999999999999877543 2368999999999999999999999974 79999999999999999999999999997
Q ss_pred ccCCCCCccc---cccccccccccccCCChhhhh---cCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHhC-cc
Q 008365 377 LVPPSVADSV---TQYHMTSAAGTFCYIDPEYQQ---TGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKG-TL 449 (568)
Q Consensus 377 ~~~~~~~~~~---~~~~~~~~~GT~~Y~APE~~~---~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~-~~ 449 (568)
..+-...... .-.....-..|..|.|||.+. +...+.++|||||||+||.|+.|..||+.. ...| .+
T Consensus 178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~------~~~GgSl 251 (302)
T KOG2345|consen 178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERI------YQQGGSL 251 (302)
T ss_pred ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHH------hhcCCeE
Confidence 6543222111 111123445789999999775 345789999999999999999999999421 1122 22
Q ss_pred c-cccCccCCCCC--hHHHHHHHHHHHHhhccCCCCCCChHHhHh
Q 008365 450 A-EMLDPAVTDWP--AEAAESFSKLAIQCAELRKKDRPDLGTVIV 491 (568)
Q Consensus 450 ~-~~l~~~~~~~p--~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~ 491 (568)
. ...+... .+| .-.++.+.+|+.+|++.||.+||+..+++.
T Consensus 252 aLAv~n~q~-s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~ 295 (302)
T KOG2345|consen 252 ALAVQNAQI-SIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLS 295 (302)
T ss_pred EEeeecccc-ccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence 1 1122111 111 126788999999999999999999999873
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=335.56 Aligned_cols=239 Identities=22% Similarity=0.404 Sum_probs=194.3
Q ss_pred eecccCceeEEEEEeCCccEEEEE--eCc----ChhHhHHHHHHHHHHHHcCCCCceeeeccccCCC----ceEEEEecC
Q 008365 236 KIGEGGYGPVYRGKLDHTPVAIKV--LRP----DAAQGKRQFQQEVEVLSSIRHPNMVLLLGACPDY----GCLVYEYMH 305 (568)
Q Consensus 236 ~IG~G~fg~Vy~~~~~~~~vAvK~--l~~----~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~----~~lV~E~~~ 305 (568)
+||+|+|-+||+|.+..+.|.|-+ ++. ......+.|..|+.+|+.|+|||||++|+++.+. ..+|.|+|.
T Consensus 47 vLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~T 126 (632)
T KOG0584|consen 47 VLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITELFT 126 (632)
T ss_pred hcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeeccc
Confidence 699999999999998554333221 111 1234457899999999999999999999988543 367999999
Q ss_pred CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCC-ceeEecccccccccCCCCCc
Q 008365 306 NGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRN-YVSKISDVGLARLVPPSVAD 384 (568)
Q Consensus 306 ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~-~~vKL~DFGla~~~~~~~~~ 384 (568)
.|+|..++.+.+. +..+.+..|+.||+.||.|||+.. +||||||||.+||||+.+ |.|||+|+|||.....+.
T Consensus 127 SGtLr~Y~kk~~~---vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~-- 200 (632)
T KOG0584|consen 127 SGTLREYRKKHRR---VNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH-- 200 (632)
T ss_pred CCcHHHHHHHhcc---CCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhccc--
Confidence 9999999988765 778899999999999999999987 589999999999999765 999999999998765433
Q ss_pred cccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCc---hHHHHHHHhCccccccCccCCCCC
Q 008365 385 SVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLT---HHVSRAIEKGTLAEMLDPAVTDWP 461 (568)
Q Consensus 385 ~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~---~~~~~~~~~~~~~~~l~~~~~~~p 461 (568)
....+|||.|||||+.. ..|+..+||||||++|+||+|+..||.-. ..++..+-.|.....|...-
T Consensus 201 ------aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~---- 269 (632)
T KOG0584|consen 201 ------AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVK---- 269 (632)
T ss_pred ------cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccC----
Confidence 34578999999999887 77999999999999999999999999643 34555555565544443211
Q ss_pred hHHHHHHHHHHHHhhccCCCCCCChHHhHhHHHH
Q 008365 462 AEAAESFSKLAIQCAELRKKDRPDLGTVIVPELN 495 (568)
Q Consensus 462 ~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l~ 495 (568)
.+++.+||.+|+.. ..+||++.++|.+.+-
T Consensus 270 ---dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff 299 (632)
T KOG0584|consen 270 ---DPEVREFIEKCLAT-KSERLSAKELLKDPFF 299 (632)
T ss_pred ---CHHHHHHHHHHhcC-chhccCHHHHhhChhh
Confidence 25689999999999 9999999999876653
|
|
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=322.84 Aligned_cols=250 Identities=27% Similarity=0.424 Sum_probs=197.1
Q ss_pred hcccccceeecccCceeEEEEEeC---------CccEEEEEeCcCh-hHhHHHHHHHHHHHHcC-CCCceeeeccccCCC
Q 008365 228 TDKFSEAMKIGEGGYGPVYRGKLD---------HTPVAIKVLRPDA-AQGKRQFQQEVEVLSSI-RHPNMVLLLGACPDY 296 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~~~~~---------~~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l-~HpnIv~l~g~~~~~ 296 (568)
..+|.+.+.||+|+||.||++.+. ...||+|+++... ......+.+|+.+++++ +||||++++++|.+.
T Consensus 11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (334)
T cd05100 11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 90 (334)
T ss_pred HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence 346899999999999999999752 1268999987543 33456788999999999 799999999988554
Q ss_pred --ceEEEEecCCCCHHHHHhhcC-------------CCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeec
Q 008365 297 --GCLVYEYMHNGSLEDRLLRRG-------------NTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILL 361 (568)
Q Consensus 297 --~~lV~E~~~ggsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILl 361 (568)
.++||||+++|+|.+++.... ....+++..+..++.||+.||.|||..+ |+||||||+|||+
T Consensus 91 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill 167 (334)
T cd05100 91 GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLV 167 (334)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEE
Confidence 489999999999999987642 1224788899999999999999999999 9999999999999
Q ss_pred cCCceeEecccccccccCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh-CCCCCCCchHH
Q 008365 362 DRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPMGLTHHV 440 (568)
Q Consensus 362 d~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~ 440 (568)
+.++.+||+|||+++.+..... ........++..|+|||++.+..++.++|||||||++|||++ |..||......
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~ 243 (334)
T cd05100 168 TEDNVMKIADFGLARDVHNIDY----YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE 243 (334)
T ss_pred cCCCcEEECCcccceecccccc----cccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHH
Confidence 9999999999999976532211 011122345678999999999999999999999999999998 88999654322
Q ss_pred H--HHHHhCccccccCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhH
Q 008365 441 S--RAIEKGTLAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVP 492 (568)
Q Consensus 441 ~--~~~~~~~~~~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~ 492 (568)
. ..+..+ .....+..++..+.+++.+||+.+|.+||++.+++..
T Consensus 244 ~~~~~~~~~--------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 244 ELFKLLKEG--------HRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred HHHHHHHcC--------CCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 1 222111 1112344556789999999999999999999998743
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=310.58 Aligned_cols=245 Identities=24% Similarity=0.341 Sum_probs=185.4
Q ss_pred eecccCceeEEEEEeCC----ccEEEEEeCcCh-hHhHHHHHHHHHHHHcCCCCceeeeccccCC--CceEEEEecCCCC
Q 008365 236 KIGEGGYGPVYRGKLDH----TPVAIKVLRPDA-AQGKRQFQQEVEVLSSIRHPNMVLLLGACPD--YGCLVYEYMHNGS 308 (568)
Q Consensus 236 ~IG~G~fg~Vy~~~~~~----~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--~~~lV~E~~~ggs 308 (568)
.||+|+||.||+|...+ ..+|+|.++... ......+.+|+.+++.++||||++++++|.+ ..++||||+++|+
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD 81 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCc
Confidence 69999999999997532 469999887653 2334578899999999999999999998854 3589999999999
Q ss_pred HHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCCccc
Q 008365 309 LEDRLLRRGN--TPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSV 386 (568)
Q Consensus 309 L~~~l~~~~~--~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~~~~ 386 (568)
|.+++..... ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~---- 154 (269)
T cd05087 82 LKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKED---- 154 (269)
T ss_pred HHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcc----
Confidence 9999875332 223567778889999999999999999 9999999999999999999999999987542211
Q ss_pred cccccccccccccCCChhhhhcC-------CCCCcceehhHHHHHHHHHh-CCCCCCCchHHHHHH--HhCccccccCcc
Q 008365 387 TQYHMTSAAGTFCYIDPEYQQTG-------MLTTKSDIYSFGIMLLQIIT-ARSPMGLTHHVSRAI--EKGTLAEMLDPA 456 (568)
Q Consensus 387 ~~~~~~~~~GT~~Y~APE~~~~~-------~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~~~~--~~~~~~~~l~~~ 456 (568)
.........|+..|+|||++.+. .++.++|||||||++|||++ |..||.......... ..+.......+
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~- 233 (269)
T cd05087 155 YYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKP- 233 (269)
T ss_pred eeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCC-
Confidence 11112335678899999987642 35789999999999999996 999996543322111 11111111111
Q ss_pred CCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHh
Q 008365 457 VTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIV 491 (568)
Q Consensus 457 ~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~ 491 (568)
......+..+.+++..|| .+|.+||++.+|+.
T Consensus 234 --~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 234 --RLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred --ccCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 112234567889999999 68999999999873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=322.49 Aligned_cols=258 Identities=20% Similarity=0.216 Sum_probs=192.4
Q ss_pred cceeeccc--CceeEEEEEe--CCccEEEEEeCcCh--hHhHHHHHHHHHHHHcCCCCceeeeccccCC--CceEEEEec
Q 008365 233 EAMKIGEG--GYGPVYRGKL--DHTPVAIKVLRPDA--AQGKRQFQQEVEVLSSIRHPNMVLLLGACPD--YGCLVYEYM 304 (568)
Q Consensus 233 ~~~~IG~G--~fg~Vy~~~~--~~~~vAvK~l~~~~--~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--~~~lV~E~~ 304 (568)
++.+||+| +||+||++.+ ++..||||++.... ......+.+|+.+++.++|||||+++++|.. ..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45689999 7899999987 56789999987543 2334567889999999999999999998843 458999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCC-
Q 008365 305 HNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVA- 383 (568)
Q Consensus 305 ~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~- 383 (568)
++|+|.+++...... .+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.++++|||.+........
T Consensus 82 ~~~~l~~~~~~~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 82 AYGSAKDLICTHFMD-GMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred CCCcHHHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence 999999998654322 3889999999999999999999999 99999999999999999999999987643321100
Q ss_pred ccccccccccccccccCCChhhhhc--CCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHH--HHhCccccccCcc---
Q 008365 384 DSVTQYHMTSAAGTFCYIDPEYQQT--GMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRA--IEKGTLAEMLDPA--- 456 (568)
Q Consensus 384 ~~~~~~~~~~~~GT~~Y~APE~~~~--~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~--~~~~~~~~~l~~~--- 456 (568)
............++..|+|||++.+ ..++.++|||||||++|+|++|+.||......... ...+.....++..
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIP 237 (327)
T ss_pred ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchh
Confidence 0000001122457888999999876 45899999999999999999999999643221111 1111111111000
Q ss_pred ----------------------------------CCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 457 ----------------------------------VTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 457 ----------------------------------~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
.......++..+.+|+.+||+.||.+||++.+++.+.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~ 309 (327)
T cd08227 238 AEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSF 309 (327)
T ss_pred hhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChh
Confidence 00011234567999999999999999999999987655
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=311.59 Aligned_cols=250 Identities=21% Similarity=0.407 Sum_probs=199.4
Q ss_pred ccccceeecccCceeEEEEEe--CCccEEEEEeCcCh------hHhHHHHHHHHHHHHcCCCCceeeeccccCCC--ceE
Q 008365 230 KFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDA------AQGKRQFQQEVEVLSSIRHPNMVLLLGACPDY--GCL 299 (568)
Q Consensus 230 ~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~------~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~--~~l 299 (568)
+|+..+.||+|+||.||++.+ ++..||||++.... ......+.+|+.+++.++||||++++++|.+. .++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477888999999999999986 67799999986532 12346788999999999999999999998654 489
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCc-eeEeccccccccc
Q 008365 300 VYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNY-VSKISDVGLARLV 378 (568)
Q Consensus 300 V~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~-~vKL~DFGla~~~ 378 (568)
||||+++++|.+++...+ .+++..+..++.||+.||.|||+.+ |+|+||+|+||+++.++ .+||+|||++..+
T Consensus 81 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~ 154 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYG---AFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARL 154 (268)
T ss_pred EEeccCCCcHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence 999999999999987643 3788999999999999999999999 99999999999998765 6999999999776
Q ss_pred CCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchH---HHHHHHhCccccccCc
Q 008365 379 PPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHH---VSRAIEKGTLAEMLDP 455 (568)
Q Consensus 379 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~---~~~~~~~~~~~~~l~~ 455 (568)
....... ........||..|+|||++.+..++.++|||||||++|+|++|..||..... ......... ..
T Consensus 155 ~~~~~~~--~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-----~~ 227 (268)
T cd06630 155 AAKGTGA--GEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIAS-----AT 227 (268)
T ss_pred ccccccC--CccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhc-----cC
Confidence 4431111 1112345689999999999888899999999999999999999999964322 111111000 01
Q ss_pred cCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhH
Q 008365 456 AVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVP 492 (568)
Q Consensus 456 ~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~ 492 (568)
.....+...+..+.+++.+||..+|.+||++.+++.+
T Consensus 228 ~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 228 TAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred CCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 1223455677889999999999999999999998854
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=311.12 Aligned_cols=247 Identities=24% Similarity=0.411 Sum_probs=200.0
Q ss_pred ccccceeecccCceeEEEEEe--CCccEEEEEeCcC--hhHhHHHHHHHHHHHHcCCCCceeeeccccCCC--ceEEEEe
Q 008365 230 KFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPD--AAQGKRQFQQEVEVLSSIRHPNMVLLLGACPDY--GCLVYEY 303 (568)
Q Consensus 230 ~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~--~~lV~E~ 303 (568)
+|++.+.||+|+||.||++.. ++..||||.+... .......+.+|+.+++.++||||+++++++.+. .++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 588899999999999999886 6778999998643 223345788999999999999999999988554 4899999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCC
Q 008365 304 MHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVA 383 (568)
Q Consensus 304 ~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~ 383 (568)
+.+++|.+++..... ..+++..+..|+.|++.||.|||+.+ ++|+||+|+|||++.++.++|+|||++..+....
T Consensus 81 ~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~- 155 (256)
T cd08218 81 CEGGDLYKKINAQRG-VLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV- 155 (256)
T ss_pred CCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcch-
Confidence 999999998876432 23788999999999999999999999 9999999999999999999999999997653321
Q ss_pred ccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHhCccccccCccCCCCChH
Q 008365 384 DSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAVTDWPAE 463 (568)
Q Consensus 384 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~l~~~~~~~p~~ 463 (568)
.......|++.|+|||++.+..++.++|||||||++|+|++|+.||........... .+.......+..
T Consensus 156 -----~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~------~~~~~~~~~~~~ 224 (256)
T cd08218 156 -----ELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLK------IIRGSYPPVSSH 224 (256)
T ss_pred -----hhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHH------HhcCCCCCCccc
Confidence 112234688999999999988899999999999999999999999965433221111 111111223445
Q ss_pred HHHHHHHHHHHhhccCCCCCCChHHhHhH
Q 008365 464 AAESFSKLAIQCAELRKKDRPDLGTVIVP 492 (568)
Q Consensus 464 ~~~~l~~li~~Cl~~dP~~RPs~~~vl~~ 492 (568)
++..+.+++.+||+.+|.+||++.+|+.+
T Consensus 225 ~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 225 YSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred CCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 56779999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=317.84 Aligned_cols=249 Identities=26% Similarity=0.429 Sum_probs=197.6
Q ss_pred cccccceeecccCceeEEEEEe--CCccEEEEEeCcCh-hHhHHHHHHHHHHHHcCCCCceeeeccccCCC--ceEEEEe
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDA-AQGKRQFQQEVEVLSSIRHPNMVLLLGACPDY--GCLVYEY 303 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~--~~lV~E~ 303 (568)
++|++.+.||+|+||.||++.+ +++.||+|++.... ......+.+|+++++.++||||+++++++.+. .++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 5688889999999999999987 47889999886543 33456789999999999999999999998543 4899999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCCCCcccCCCCCCCeeccCCceeEecccccccccCCCC
Q 008365 304 MHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQ-AKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSV 382 (568)
Q Consensus 304 ~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~-~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~ 382 (568)
+++++|.+++...+ .+++..+..++.+++.||.|||+ .+ |+||||||+||+++.++.++|+|||++.......
T Consensus 85 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~ 158 (284)
T cd06620 85 MDCGSLDRIYKKGG---PIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI 158 (284)
T ss_pred CCCCCHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccchhhhc
Confidence 99999999887643 37899999999999999999997 46 9999999999999999999999999986542211
Q ss_pred CccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHH------HHHHhCccccccCcc
Q 008365 383 ADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVS------RAIEKGTLAEMLDPA 456 (568)
Q Consensus 383 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~------~~~~~~~~~~~l~~~ 456 (568)
.....|+..|+|||++.+..++.++|||||||++|+|++|..||....... ..+. ..+...+...
T Consensus 159 --------~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 229 (284)
T cd06620 159 --------ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGIL-DLLQQIVQEP 229 (284)
T ss_pred --------cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHH-HHHHHHhhcc
Confidence 123578999999999988899999999999999999999999996432210 0000 0011111111
Q ss_pred CCCCCh-HHHHHHHHHHHHhhccCCCCCCChHHhHhH
Q 008365 457 VTDWPA-EAAESFSKLAIQCAELRKKDRPDLGTVIVP 492 (568)
Q Consensus 457 ~~~~p~-~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~ 492 (568)
....+. .++..+.+|+.+||..+|.+||++.+++.+
T Consensus 230 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~ 266 (284)
T cd06620 230 PPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAM 266 (284)
T ss_pred CCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 112222 356779999999999999999999999853
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=309.39 Aligned_cols=245 Identities=31% Similarity=0.508 Sum_probs=197.8
Q ss_pred hcccccceeecccCceeEEEEEe-CCccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCceeeeccccCCC-ceEEEEecC
Q 008365 228 TDKFSEAMKIGEGGYGPVYRGKL-DHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACPDY-GCLVYEYMH 305 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~~~~-~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~-~~lV~E~~~ 305 (568)
.++|.+.++||+|+||.||++.+ .+..||+|.+..... ....+.+|+.+++.++|+||+++++.+.+. .++||||++
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~v~e~~~ 83 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM-SVEAFLAEANVMKTLQHDKLVKLHAVVTKEPIYIITEFMA 83 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCChh-HHHHHHHHHHHHHhcCCCCcceEEEEEcCCCeEEEEEeCC
Confidence 46799999999999999999986 456799998875533 346788999999999999999999887553 389999999
Q ss_pred CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCCcc
Q 008365 306 NGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADS 385 (568)
Q Consensus 306 ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~~~ 385 (568)
+++|.+++..... ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++..+.....
T Consensus 84 ~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 157 (260)
T cd05073 84 KGSLLDFLKSDEG-SKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEY-- 157 (260)
T ss_pred CCcHHHHHHhCCc-cccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCc--
Confidence 9999999876432 24788899999999999999999998 99999999999999999999999999976533211
Q ss_pred ccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh-CCCCCCCchH--HHHHHHhCccccccCccCCCCCh
Q 008365 386 VTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPMGLTHH--VSRAIEKGTLAEMLDPAVTDWPA 462 (568)
Q Consensus 386 ~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~--~~~~~~~~~~~~~l~~~~~~~p~ 462 (568)
.......++..|+|||++....++.++|||||||++|++++ |..||..... +...+..+.. ...+.
T Consensus 158 ---~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~--------~~~~~ 226 (260)
T cd05073 158 ---TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYR--------MPRPE 226 (260)
T ss_pred ---ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCC--------CCCcc
Confidence 11122346678999999998889999999999999999999 9999965432 2222222211 11223
Q ss_pred HHHHHHHHHHHHhhccCCCCCCChHHhH
Q 008365 463 EAAESFSKLAIQCAELRKKDRPDLGTVI 490 (568)
Q Consensus 463 ~~~~~l~~li~~Cl~~dP~~RPs~~~vl 490 (568)
..+..+.+++.+||..+|.+||++.+++
T Consensus 227 ~~~~~~~~~i~~~l~~~p~~Rp~~~~l~ 254 (260)
T cd05073 227 NCPEELYNIMMRCWKNRPEERPTFEYIQ 254 (260)
T ss_pred cCCHHHHHHHHHHcccCcccCcCHHHHH
Confidence 4556799999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=319.72 Aligned_cols=253 Identities=25% Similarity=0.321 Sum_probs=199.8
Q ss_pred cccccceeecccCceeEEEEEe--CCccEEEEEeCcChhH---hHHHHHHHHHHHHcCCCCceeeeccccCCC--ceEEE
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQ---GKRQFQQEVEVLSSIRHPNMVLLLGACPDY--GCLVY 301 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~---~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~--~~lV~ 301 (568)
++|.+.+.||.|+||.||+|.. .+..||||.+...... ....+..|+++++.++||||+++++.+.+. .|+||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 3688999999999999999987 4679999998765322 445688999999999999999999988554 48999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCC
Q 008365 302 EYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPS 381 (568)
Q Consensus 302 E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~ 381 (568)
||+.|++|.+++..... ..+++..+..++.||+.||.|||+.+ |+|+||||+||||+.++.++|+|||++......
T Consensus 81 e~~~~~~L~~~~~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 156 (316)
T cd05574 81 DYCPGGELFRLLQRQPG-KCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVE 156 (316)
T ss_pred EecCCCCHHHHHHhCCC-CccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence 99999999998875432 34889999999999999999999999 999999999999999999999999998765322
Q ss_pred CCccc-----------------------cccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCch
Q 008365 382 VADSV-----------------------TQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTH 438 (568)
Q Consensus 382 ~~~~~-----------------------~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~ 438 (568)
..... .........||..|+|||++.+..++.++|||||||++|+|++|..||....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 236 (316)
T cd05574 157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236 (316)
T ss_pred ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 11000 0011123578999999999998889999999999999999999999997554
Q ss_pred HHHHHHHhCccccccCccCCCCC--hHHHHHHHHHHHHhhccCCCCCCC----hHHhHhH
Q 008365 439 HVSRAIEKGTLAEMLDPAVTDWP--AEAAESFSKLAIQCAELRKKDRPD----LGTVIVP 492 (568)
Q Consensus 439 ~~~~~~~~~~~~~~l~~~~~~~p--~~~~~~l~~li~~Cl~~dP~~RPs----~~~vl~~ 492 (568)
....... ...... .++ ...+..+.+++.+||..+|.+||+ +.+++.+
T Consensus 237 ~~~~~~~------~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~ 289 (316)
T cd05574 237 RDETFSN------ILKKEV-TFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289 (316)
T ss_pred hHHHHHH------HhcCCc-cCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence 4322211 111111 111 125678999999999999999999 6666643
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=317.68 Aligned_cols=247 Identities=26% Similarity=0.329 Sum_probs=202.7
Q ss_pred cccccceeecccCceeEEEEEe--CCccEEEEEeCcChhHh---HHHHHHHHHHHHcCCCCceeeeccccC--CCceEEE
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQG---KRQFQQEVEVLSSIRHPNMVLLLGACP--DYGCLVY 301 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~---~~~~~~Ev~iL~~l~HpnIv~l~g~~~--~~~~lV~ 301 (568)
++|..+++||+|.||.|.+++- .++.+|||++++...-. ...-..|-.+|+..+||.+..+-..|+ +..|+||
T Consensus 168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVM 247 (516)
T KOG0690|consen 168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVM 247 (516)
T ss_pred chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEE
Confidence 6789999999999999999876 67899999998764332 233457899999999999998887774 4569999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCC
Q 008365 302 EYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPS 381 (568)
Q Consensus 302 E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~ 381 (568)
||..||.|...|.+.. .+++.....+..+|+.||.|||+.+ ||+||||.+|+|||++|++||+|||||+--
T Consensus 248 eyanGGeLf~HLsrer---~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~--- 318 (516)
T KOG0690|consen 248 EYANGGELFFHLSRER---VFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEE--- 318 (516)
T ss_pred EEccCceEeeehhhhh---cccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhc---
Confidence 9999999988887643 4888888889999999999999999 999999999999999999999999999742
Q ss_pred CCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHhCccccccCccCCCCC
Q 008365 382 VADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAVTDWP 461 (568)
Q Consensus 382 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~l~~~~~~~p 461 (568)
......+.++||||.|+|||++....|+.++|+|.+||+||||++|++||...++- .+-+++-..-..+|
T Consensus 319 ---I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~-------kLFeLIl~ed~kFP 388 (516)
T KOG0690|consen 319 ---IKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHE-------KLFELILMEDLKFP 388 (516)
T ss_pred ---ccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchh-------HHHHHHHhhhccCC
Confidence 22233456899999999999999999999999999999999999999999755441 11112111122467
Q ss_pred hHHHHHHHHHHHHhhccCCCCCC-----ChHHhHhHHH
Q 008365 462 AEAAESFSKLAIQCAELRKKDRP-----DLGTVIVPEL 494 (568)
Q Consensus 462 ~~~~~~l~~li~~Cl~~dP~~RP-----s~~~vl~~~l 494 (568)
..++++...|+...|..||.+|- ++.+|..+.+
T Consensus 389 r~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~F 426 (516)
T KOG0690|consen 389 RTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRF 426 (516)
T ss_pred ccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhh
Confidence 77888899999999999999996 3566665544
|
|
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=318.49 Aligned_cols=249 Identities=26% Similarity=0.417 Sum_probs=198.0
Q ss_pred HhcccccceeecccCceeEEEEEe-------CCccEEEEEeCcCh-hHhHHHHHHHHHHHHcC-CCCceeeeccccCC--
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKL-------DHTPVAIKVLRPDA-AQGKRQFQQEVEVLSSI-RHPNMVLLLGACPD-- 295 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~-------~~~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l-~HpnIv~l~g~~~~-- 295 (568)
..++|.+.+.||+|+||.||++.+ .+..||||+++... ....+.+.+|+.+++++ +||||++++++|..
T Consensus 33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 112 (302)
T cd05055 33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGG 112 (302)
T ss_pred cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC
Confidence 446799999999999999999874 22379999987543 33346789999999999 79999999998854
Q ss_pred CceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccc
Q 008365 296 YGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLA 375 (568)
Q Consensus 296 ~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla 375 (568)
..++||||+.+|+|.+++..... ..+++.++..|+.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||++
T Consensus 113 ~~~lv~e~~~~~~L~~~i~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~ 188 (302)
T cd05055 113 PILVITEYCCYGDLLNFLRRKRE-SFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLA 188 (302)
T ss_pred ceEEEEEcCCCCcHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCccc
Confidence 34899999999999999875432 23799999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh-CCCCCCCchHHH---HHHHhCcccc
Q 008365 376 RLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPMGLTHHVS---RAIEKGTLAE 451 (568)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~---~~~~~~~~~~ 451 (568)
+.+..... ........++..|+|||++.+..++.++|||||||++|+|++ |..||....... ..+..+.
T Consensus 189 ~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~--- 261 (302)
T cd05055 189 RDIMNDSN----YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGY--- 261 (302)
T ss_pred ccccCCCc----eeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCC---
Confidence 76543211 011123456788999999999999999999999999999998 999996433211 1111111
Q ss_pred ccCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHh
Q 008365 452 MLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIV 491 (568)
Q Consensus 452 ~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~ 491 (568)
. ...+...+..+.+++.+||..+|.+||++.+++.
T Consensus 262 --~---~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 262 --R---MAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred --c---CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 0 1122334567999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=313.76 Aligned_cols=246 Identities=27% Similarity=0.460 Sum_probs=197.4
Q ss_pred cccccceeecccCceeEEEEEeC--Cc----cEEEEEeCcChh-HhHHHHHHHHHHHHcCCCCceeeeccccCC-CceEE
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKLD--HT----PVAIKVLRPDAA-QGKRQFQQEVEVLSSIRHPNMVLLLGACPD-YGCLV 300 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~~--~~----~vAvK~l~~~~~-~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~-~~~lV 300 (568)
.+|.+.+.||+|+||.||+|.+. +. .||+|++..... .....+.+|+.+++.++||||++++++|.. ..++|
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~v 86 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLSSQVQLI 86 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCceEEE
Confidence 56888999999999999999862 22 589999876543 345678899999999999999999998854 45899
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCC
Q 008365 301 YEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPP 380 (568)
Q Consensus 301 ~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~ 380 (568)
|||+++|+|.+++..... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 87 ~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~ 161 (279)
T cd05057 87 TQLMPLGCLLDYVRNHKD--NIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLDV 161 (279)
T ss_pred EecCCCCcHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCcccccccC
Confidence 999999999999876433 3889999999999999999999998 99999999999999999999999999987643
Q ss_pred CCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh-CCCCCCCchH--HHHHHHhCccccccCccC
Q 008365 381 SVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPMGLTHH--VSRAIEKGTLAEMLDPAV 457 (568)
Q Consensus 381 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~--~~~~~~~~~~~~~l~~~~ 457 (568)
... ........++..|+|||.+....++.++|||||||++|||++ |..||..... +...+..+. .
T Consensus 162 ~~~----~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~--------~ 229 (279)
T cd05057 162 DEK----EYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGE--------R 229 (279)
T ss_pred ccc----ceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCC--------C
Confidence 211 111122334678999999988899999999999999999998 9999975443 222222211 1
Q ss_pred CCCChHHHHHHHHHHHHhhccCCCCCCChHHhHh
Q 008365 458 TDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIV 491 (568)
Q Consensus 458 ~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~ 491 (568)
...|..++..+.+++.+||..+|..||++.+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 230 LPQPPICTIDVYMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 1223345567899999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=318.46 Aligned_cols=249 Identities=23% Similarity=0.326 Sum_probs=199.4
Q ss_pred cccccceeecccCceeEEEEEe--CCccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCceeeeccccC--CCceEEEEec
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACP--DYGCLVYEYM 304 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~--~~~~lV~E~~ 304 (568)
+.|.....||.|+||.||++.+ ++..||||++..........+.+|+.+++.++||||+++++.|. +..++||||+
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 101 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFL 101 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCC
Confidence 3455556899999999999986 56789999987665555677899999999999999999998874 3458999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCCc
Q 008365 305 HNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVAD 384 (568)
Q Consensus 305 ~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~~ 384 (568)
++++|.+++... .+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++..+.....
T Consensus 102 ~~~~L~~~~~~~----~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~- 173 (292)
T cd06658 102 EGGALTDIVTHT----RMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP- 173 (292)
T ss_pred CCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-
Confidence 999999987542 2788999999999999999999999 99999999999999999999999999876532211
Q ss_pred cccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHhCccccccCccCCCCChHH
Q 008365 385 SVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAVTDWPAEA 464 (568)
Q Consensus 385 ~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~l~~~~~~~p~~~ 464 (568)
......|+..|+|||++.+..++.++|||||||++|||++|+.||........... +...+.+.+.. ....
T Consensus 174 -----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~---~~~~~~~~~~~-~~~~ 244 (292)
T cd06658 174 -----KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRR---IRDNLPPRVKD-SHKV 244 (292)
T ss_pred -----cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHhcCCCcccc-cccc
Confidence 11335689999999999888899999999999999999999999965443222111 11111222111 2234
Q ss_pred HHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 465 AESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 465 ~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
+..+..++..||..+|.+||++.+++.+.+
T Consensus 245 ~~~~~~li~~~l~~~P~~Rpt~~~il~~~~ 274 (292)
T cd06658 245 SSVLRGFLDLMLVREPSQRATAQELLQHPF 274 (292)
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhhChh
Confidence 567899999999999999999999986544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=312.14 Aligned_cols=238 Identities=29% Similarity=0.498 Sum_probs=187.4
Q ss_pred eecccCceeEEEEEeCC--c--cEEEEEeCcC-hhHhHHHHHHHHHHHHcC-CCCceeeeccccCCC--ceEEEEecCCC
Q 008365 236 KIGEGGYGPVYRGKLDH--T--PVAIKVLRPD-AAQGKRQFQQEVEVLSSI-RHPNMVLLLGACPDY--GCLVYEYMHNG 307 (568)
Q Consensus 236 ~IG~G~fg~Vy~~~~~~--~--~vAvK~l~~~-~~~~~~~~~~Ev~iL~~l-~HpnIv~l~g~~~~~--~~lV~E~~~gg 307 (568)
.||+|+||.||+|.+.+ . .+++|.++.. .......+.+|+.++.++ +||||++++++|... .++||||+++|
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 81 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHG 81 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCC
Confidence 58999999999998733 2 4788888753 234456788999999999 799999999988544 48999999999
Q ss_pred CHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEeccccc
Q 008365 308 SLEDRLLRRGN-------------TPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGL 374 (568)
Q Consensus 308 sL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGl 374 (568)
+|.+++..... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 82 ~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfgl 158 (270)
T cd05047 82 NLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGL 158 (270)
T ss_pred cHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCCC
Confidence 99999875421 124789999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh-CCCCCCCchHH--HHHHHhCcccc
Q 008365 375 ARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPMGLTHHV--SRAIEKGTLAE 451 (568)
Q Consensus 375 a~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~--~~~~~~~~~~~ 451 (568)
+...... ........+..|+|||++.+..++.++|||||||++|+|++ |..||...... ...+..+
T Consensus 159 ~~~~~~~-------~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~---- 227 (270)
T cd05047 159 SRGQEVY-------VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG---- 227 (270)
T ss_pred ccccchh-------hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCC----
Confidence 8632111 01112234667999999988899999999999999999997 99999543321 1111111
Q ss_pred ccCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHh
Q 008365 452 MLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIV 491 (568)
Q Consensus 452 ~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~ 491 (568)
.....+..++..+.+|+.+||..+|.+||++.+++.
T Consensus 228 ----~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 228 ----YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred ----CCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 111223345567899999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=309.81 Aligned_cols=247 Identities=24% Similarity=0.422 Sum_probs=199.0
Q ss_pred ccccceeecccCceeEEEEEe--CCccEEEEEeCcCh--hHhHHHHHHHHHHHHcCCCCceeeeccccCC--CceEEEEe
Q 008365 230 KFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDA--AQGKRQFQQEVEVLSSIRHPNMVLLLGACPD--YGCLVYEY 303 (568)
Q Consensus 230 ~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~--~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--~~~lV~E~ 303 (568)
+|++.+.||+|+||.||++.. .+..||||++.... ......+.+|+.+|+.++||||+++++.+.. ..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 588899999999999999876 56789999986542 2335678899999999999999999988744 34899999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCC-ceeEecccccccccCCCC
Q 008365 304 MHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRN-YVSKISDVGLARLVPPSV 382 (568)
Q Consensus 304 ~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~-~~vKL~DFGla~~~~~~~ 382 (568)
+++++|.+++..... ..+++..+..++.+++.||.|||+++ |+|+||+|+||+++.+ +.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (256)
T cd08220 81 APGGTLAEYIQKRCN-SLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS 156 (256)
T ss_pred CCCCCHHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence 999999999976433 23789999999999999999999999 9999999999999754 578999999998664321
Q ss_pred CccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHhCccccccCccCCCCCh
Q 008365 383 ADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAVTDWPA 462 (568)
Q Consensus 383 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~l~~~~~~~p~ 462 (568)
......|+..|+|||++.+..++.++|||||||++|+|++|+.||............ ........+.
T Consensus 157 -------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~ 223 (256)
T cd08220 157 -------KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKI------MSGTFAPISD 223 (256)
T ss_pred -------cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHH------HhcCCCCCCC
Confidence 112356899999999998888999999999999999999999999654432221111 1111122334
Q ss_pred HHHHHHHHHHHHhhccCCCCCCChHHhHhHH
Q 008365 463 EAAESFSKLAIQCAELRKKDRPDLGTVIVPE 493 (568)
Q Consensus 463 ~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~ 493 (568)
.++..+.+++.+||..+|.+||++.+++.+.
T Consensus 224 ~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p 254 (256)
T cd08220 224 RYSPDLRQLILSMLNLDPSKRPQLSQIMAQP 254 (256)
T ss_pred CcCHHHHHHHHHHccCChhhCCCHHHHhhCC
Confidence 4567799999999999999999999998653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=308.96 Aligned_cols=256 Identities=24% Similarity=0.317 Sum_probs=202.6
Q ss_pred cccccceeecccCceeEEEEEe--CCccEEEEEeCcCh-hHhHHHHHHHHHHHHcCCCCceeeeccccCC--CceEEEEe
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDA-AQGKRQFQQEVEVLSSIRHPNMVLLLGACPD--YGCLVYEY 303 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--~~~lV~E~ 303 (568)
++|++.+.||.|+||+||+|.. ++..||+|++.... ......+.+|+.+|+.++|+||+++++.+.+ ..++||||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 4689999999999999999986 56789999986543 2345678999999999999999999988744 44899999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCC
Q 008365 304 MHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVA 383 (568)
Q Consensus 304 ~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~ 383 (568)
+++++|.+++........+++..+..++.|++.||.|||+.+ |+||||+|+||++++++.++|+|||++..+.....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 999999999876543334889999999999999999999999 99999999999999999999999999977654322
Q ss_pred ccccccccccccccccCCChhhhhcC-CCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHhCccccccCccCCCC--
Q 008365 384 DSVTQYHMTSAAGTFCYIDPEYQQTG-MLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAVTDW-- 460 (568)
Q Consensus 384 ~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~l~~~~~~~-- 460 (568)
.. ........|+..|+|||++... .++.++|||||||++|+|++|+.||............... ..+.....
T Consensus 158 ~~--~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~ 232 (267)
T cd06610 158 RT--RKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQN---DPPSLETGAD 232 (267)
T ss_pred cc--ccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcC---CCCCcCCccc
Confidence 11 0112345789999999988776 7899999999999999999999999654432211111000 01111111
Q ss_pred ChHHHHHHHHHHHHhhccCCCCCCChHHhHhH
Q 008365 461 PAEAAESFSKLAIQCAELRKKDRPDLGTVIVP 492 (568)
Q Consensus 461 p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~ 492 (568)
...++..+.+++..||..+|.+||++.+|+.+
T Consensus 233 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 233 YKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred cccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 12556789999999999999999999999854
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=310.07 Aligned_cols=247 Identities=25% Similarity=0.400 Sum_probs=200.7
Q ss_pred ccccceeecccCceeEEEEEe--CCccEEEEEeCcC--hhHhHHHHHHHHHHHHcCCCCceeeeccccCC----CceEEE
Q 008365 230 KFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPD--AAQGKRQFQQEVEVLSSIRHPNMVLLLGACPD----YGCLVY 301 (568)
Q Consensus 230 ~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~----~~~lV~ 301 (568)
+|++.+.||.|+||.||++.+ ++..||+|++... .......+..|+.+++.++||||+++++++.. ..+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 478889999999999999987 5678999998653 23334568899999999999999999987632 238999
Q ss_pred EecCCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHH-----HcCCCCcccCCCCCCCeeccCCceeEecccccc
Q 008365 302 EYMHNGSLEDRLLRRG-NTPVIPWRKRFKIAAEIATALLFLH-----QAKPEPLVHRDLKPANILLDRNYVSKISDVGLA 375 (568)
Q Consensus 302 E~~~ggsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~yLH-----~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla 375 (568)
||+++++|.+++.... ....+++..+..++.||+.||.||| ..+ |+|+||||+||+++.++.+||+|||++
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCCEEEeccccc
Confidence 9999999999987642 2235899999999999999999999 666 999999999999999999999999999
Q ss_pred cccCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchH--HHHHHHhCcccccc
Q 008365 376 RLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHH--VSRAIEKGTLAEML 453 (568)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~--~~~~~~~~~~~~~l 453 (568)
........ ......|++.|+|||++.+..++.++|||||||++|+|++|+.||..... +...+..+
T Consensus 158 ~~~~~~~~------~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~------ 225 (265)
T cd08217 158 KILGHDSS------FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEG------ 225 (265)
T ss_pred ccccCCcc------cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcC------
Confidence 87643221 11234689999999999988899999999999999999999999976542 11122211
Q ss_pred CccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHH
Q 008365 454 DPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPE 493 (568)
Q Consensus 454 ~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~ 493 (568)
.....+...+..+.+++.+|++.+|.+||++.+|+.+.
T Consensus 226 --~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~ 263 (265)
T cd08217 226 --KFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLP 263 (265)
T ss_pred --CCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhCC
Confidence 22234556677899999999999999999999998653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=317.86 Aligned_cols=246 Identities=26% Similarity=0.469 Sum_probs=195.8
Q ss_pred cccccceeecccCceeEEEEEe--CCc----cEEEEEeCcChh-HhHHHHHHHHHHHHcCCCCceeeeccccCC-CceEE
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKL--DHT----PVAIKVLRPDAA-QGKRQFQQEVEVLSSIRHPNMVLLLGACPD-YGCLV 300 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~--~~~----~vAvK~l~~~~~-~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~-~~~lV 300 (568)
++|+..+.||+|+||.||+|.+ ++. .||+|++..... .....+.+|+.+++.++||||++++++|.. ..++|
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~v 86 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQLV 86 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCCCceee
Confidence 4678889999999999999986 333 479998876532 333468899999999999999999998854 45799
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCC
Q 008365 301 YEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPP 380 (568)
Q Consensus 301 ~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~ 380 (568)
+||+++|+|.+++..... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 87 ~e~~~~g~l~~~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~ 161 (303)
T cd05110 87 TQLMPHGCLLDYVHEHKD--NIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLEG 161 (303)
T ss_pred ehhcCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccccccccccC
Confidence 999999999999876532 3788999999999999999999999 99999999999999999999999999986643
Q ss_pred CCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh-CCCCCCCch--HHHHHHHhCccccccCccC
Q 008365 381 SVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPMGLTH--HVSRAIEKGTLAEMLDPAV 457 (568)
Q Consensus 381 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~--~~~~~~~~~~~~~~l~~~~ 457 (568)
... ........++..|+|||++.+..++.++|||||||++|||++ |..||.... .....+..+..
T Consensus 162 ~~~----~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~-------- 229 (303)
T cd05110 162 DEK----EYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGER-------- 229 (303)
T ss_pred ccc----ccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCC--------
Confidence 211 111223456789999999999999999999999999999997 999996432 22222222211
Q ss_pred CCCChHHHHHHHHHHHHhhccCCCCCCChHHhHh
Q 008365 458 TDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIV 491 (568)
Q Consensus 458 ~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~ 491 (568)
...+..++..+.+++..||..+|.+||++.+++.
T Consensus 230 ~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~ 263 (303)
T cd05110 230 LPQPPICTIDVYMVMVKCWMIDADSRPKFKELAA 263 (303)
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 1112334567899999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=310.44 Aligned_cols=244 Identities=27% Similarity=0.374 Sum_probs=183.8
Q ss_pred eecccCceeEEEEEe-C---CccEEEEEeCcCh-hHhHHHHHHHHHHHHcCCCCceeeeccccCC--CceEEEEecCCCC
Q 008365 236 KIGEGGYGPVYRGKL-D---HTPVAIKVLRPDA-AQGKRQFQQEVEVLSSIRHPNMVLLLGACPD--YGCLVYEYMHNGS 308 (568)
Q Consensus 236 ~IG~G~fg~Vy~~~~-~---~~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--~~~lV~E~~~ggs 308 (568)
.||+|+||.||+|.. . ...+|+|.+.... ......+.+|+.+++.++||||+++++.|.+ ..++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 599999999999975 2 2468888876443 2334568899999999999999999998854 3489999999999
Q ss_pred HHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCCccc
Q 008365 309 LEDRLLRRGN--TPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSV 386 (568)
Q Consensus 309 L~~~l~~~~~--~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~~~~ 386 (568)
|.+++..... ....++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~--- 155 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDY--- 155 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchh---
Confidence 9999876432 123467788899999999999999999 99999999999999999999999999865322110
Q ss_pred cccccccccccccCCChhhhhc-------CCCCCcceehhHHHHHHHHHh-CCCCCCCchHHHH--HHHhCccccccCcc
Q 008365 387 TQYHMTSAAGTFCYIDPEYQQT-------GMLTTKSDIYSFGIMLLQIIT-ARSPMGLTHHVSR--AIEKGTLAEMLDPA 456 (568)
Q Consensus 387 ~~~~~~~~~GT~~Y~APE~~~~-------~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~~--~~~~~~~~~~l~~~ 456 (568)
........+++.|+|||++.. ..++.++|||||||++|||++ |..||........ .+..........
T Consensus 156 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~-- 232 (269)
T cd05042 156 -YITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPK-- 232 (269)
T ss_pred -eeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCC--
Confidence 001123456788999998643 357889999999999999999 7889865433211 111111111111
Q ss_pred CCCCChHHHHHHHHHHHHhhccCCCCCCChHHhH
Q 008365 457 VTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVI 490 (568)
Q Consensus 457 ~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl 490 (568)
...+..++..+.+++..|| .+|.+||++.+|+
T Consensus 233 -~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~ 264 (269)
T cd05042 233 -PQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVH 264 (269)
T ss_pred -CcccccCCHHHHHHHHHHh-cCcccccCHHHHH
Confidence 1233455677888999999 5999999999986
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=317.76 Aligned_cols=247 Identities=21% Similarity=0.311 Sum_probs=197.3
Q ss_pred cccceeecccCceeEEEEEe--CCccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCceeeeccccCC--CceEEEEecCC
Q 008365 231 FSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACPD--YGCLVYEYMHN 306 (568)
Q Consensus 231 y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--~~~lV~E~~~g 306 (568)
|.....||.|+||.||++.+ .++.||||++..........+.+|+.++..++||||++++++|.. ..++||||+++
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~ 102 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG 102 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence 33445799999999999987 578999999876544455678899999999999999999998743 45899999999
Q ss_pred CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCCccc
Q 008365 307 GSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSV 386 (568)
Q Consensus 307 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~~~~ 386 (568)
++|..++... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++..+.....
T Consensus 103 ~~L~~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~--- 172 (297)
T cd06659 103 GALTDIVSQT----RLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--- 172 (297)
T ss_pred CCHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhcccccc---
Confidence 9999877542 3789999999999999999999999 99999999999999999999999999975533211
Q ss_pred cccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHhCccccccCccCCCCChHHHH
Q 008365 387 TQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAVTDWPAEAAE 466 (568)
Q Consensus 387 ~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~l~~~~~~~p~~~~~ 466 (568)
......|+..|+|||++.+..++.++|||||||++|+|++|+.||............... .... ...+...+.
T Consensus 173 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~---~~~~-~~~~~~~~~ 245 (297)
T cd06659 173 ---KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDS---PPPK-LKNAHKISP 245 (297)
T ss_pred ---cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc---CCCC-ccccCCCCH
Confidence 123457899999999999889999999999999999999999999655433222111100 0111 111223456
Q ss_pred HHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 467 SFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 467 ~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
.+.+++.+||+.+|.+||++.+++.+.+
T Consensus 246 ~l~~~i~~~l~~~P~~Rps~~~ll~~~~ 273 (297)
T cd06659 246 VLRDFLERMLTREPQERATAQELLDHPF 273 (297)
T ss_pred HHHHHHHHHhcCCcccCcCHHHHhhChh
Confidence 7899999999999999999999986543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=314.71 Aligned_cols=252 Identities=23% Similarity=0.327 Sum_probs=195.1
Q ss_pred cccccceeecccCceeEEEEEe--CCccEEEEEeCcCh--hHhHHHHHHHHHHHHcCCCCceeeeccccCCC--ceEEEE
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDA--AQGKRQFQQEVEVLSSIRHPNMVLLLGACPDY--GCLVYE 302 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~--~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~--~~lV~E 302 (568)
++|++...||+|+||.||+|.+ +++.||+|++.... ....+.+.+|+.+++.++||||++++++|.+. .++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 4688999999999999999987 47899999986432 22235678999999999999999999988554 489999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCC
Q 008365 303 YMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSV 382 (568)
Q Consensus 303 ~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~ 382 (568)
|+++++|..++.... .+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++..+....
T Consensus 81 ~~~~~~l~~~~~~~~---~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07847 81 YCDHTVLNELEKNPR---GVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPG 154 (286)
T ss_pred ccCccHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence 999888877664432 3889999999999999999999999 9999999999999999999999999998764322
Q ss_pred CccccccccccccccccCCChhhhhc-CCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHh----Ccc-c------
Q 008365 383 ADSVTQYHMTSAAGTFCYIDPEYQQT-GMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEK----GTL-A------ 450 (568)
Q Consensus 383 ~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~----~~~-~------ 450 (568)
. ......++..|+|||++.+ ..++.++|||||||++|+|++|..||............ +.. .
T Consensus 155 ~------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (286)
T cd07847 155 D------DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIF 228 (286)
T ss_pred c------cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhc
Confidence 1 1123468899999998876 45889999999999999999999999654432221110 000 0
Q ss_pred -------cccCccCC------CCChHHHHHHHHHHHHhhccCCCCCCChHHhHhH
Q 008365 451 -------EMLDPAVT------DWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVP 492 (568)
Q Consensus 451 -------~~l~~~~~------~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~ 492 (568)
....+... .+....+..+.+|+.+||+.+|.+||++.+++.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 229 STNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred ccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 00000000 0012345678999999999999999999998754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=306.37 Aligned_cols=244 Identities=27% Similarity=0.501 Sum_probs=195.8
Q ss_pred cccccceeecccCceeEEEEEeC-CccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCceeeeccccCC--CceEEEEecC
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKLD-HTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACPD--YGCLVYEYMH 305 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~~-~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--~~~lV~E~~~ 305 (568)
.+|++.+.||.|+||.||++.+. +..+|||++...... ...|.+|+++++.++||||+++++++.+ ..++||||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~-~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMS-EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCC-HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 46888899999999999999874 678999998754332 3568899999999999999999998854 4489999999
Q ss_pred CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCCcc
Q 008365 306 NGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADS 385 (568)
Q Consensus 306 ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~~~ 385 (568)
+++|.+++..... .+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++.........
T Consensus 83 ~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~- 156 (256)
T cd05112 83 HGCLSDYLRAQRG--KFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT- 156 (256)
T ss_pred CCcHHHHHHhCcc--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCccc-
Confidence 9999998875432 3788999999999999999999999 999999999999999999999999999765332110
Q ss_pred ccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh-CCCCCCCchHH--HHHHHhCccccccCccCCCCCh
Q 008365 386 VTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPMGLTHHV--SRAIEKGTLAEMLDPAVTDWPA 462 (568)
Q Consensus 386 ~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~--~~~~~~~~~~~~l~~~~~~~p~ 462 (568)
......++..|+|||++.++.++.++|||||||++|+|++ |..||...... ...+..+. ... .+.
T Consensus 157 ----~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~--~~~------~~~ 224 (256)
T cd05112 157 ----SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGF--RLY------KPR 224 (256)
T ss_pred ----ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCC--CCC------CCC
Confidence 1122345678999999998899999999999999999998 99999654322 12221110 111 122
Q ss_pred HHHHHHHHHHHHhhccCCCCCCChHHhHh
Q 008365 463 EAAESFSKLAIQCAELRKKDRPDLGTVIV 491 (568)
Q Consensus 463 ~~~~~l~~li~~Cl~~dP~~RPs~~~vl~ 491 (568)
..+..+.+|+.+||+.+|.+||++.+++.
T Consensus 225 ~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~ 253 (256)
T cd05112 225 LASQSVYELMQHCWKERPEDRPSFSLLLH 253 (256)
T ss_pred CCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 34567999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=315.69 Aligned_cols=261 Identities=24% Similarity=0.342 Sum_probs=202.8
Q ss_pred cCHHHHHHHhcccccceeecccCceeEEEEEe--CCccEEEEEeCcChhHhHHHHHHHHHHHHcC-CCCceeeeccccCC
Q 008365 219 YTIEEIEEATDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQGKRQFQQEVEVLSSI-RHPNMVLLLGACPD 295 (568)
Q Consensus 219 ~~~~ei~~~~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l-~HpnIv~l~g~~~~ 295 (568)
++..++..++++|.+...||.|+||.||++.. +++.||+|++..... ....+.+|+.++.++ +||||++++++|..
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD-VDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc-HHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 33455556788999999999999999999987 567899999865432 235678899999998 79999999998732
Q ss_pred -------CceEEEEecCCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCcee
Q 008365 296 -------YGCLVYEYMHNGSLEDRLLRRG-NTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVS 367 (568)
Q Consensus 296 -------~~~lV~E~~~ggsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~v 367 (568)
..++||||+++|+|.+++.... ....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~ 167 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGV 167 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCE
Confidence 3489999999999999886421 2234889999999999999999999998 9999999999999999999
Q ss_pred EecccccccccCCCCCccccccccccccccccCCChhhhhcC-----CCCCcceehhHHHHHHHHHhCCCCCCCchHHHH
Q 008365 368 KISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTG-----MLTTKSDIYSFGIMLLQIITARSPMGLTHHVSR 442 (568)
Q Consensus 368 KL~DFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-----~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~ 442 (568)
||+|||++..+..... ......|+..|+|||++... .++.++|||||||++|+|++|+.||........
T Consensus 168 kl~dfg~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~ 241 (291)
T cd06639 168 KLVDFGVSAQLTSTRL------RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT 241 (291)
T ss_pred EEeecccchhcccccc------cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHH
Confidence 9999999976532211 11234689999999987543 368899999999999999999999975544322
Q ss_pred HHHhCccccccCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHH
Q 008365 443 AIEKGTLAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPE 493 (568)
Q Consensus 443 ~~~~~~~~~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~ 493 (568)
..... ....+.. ..+...+..+.+++.+||+.+|.+||++.+++.+.
T Consensus 242 ~~~~~---~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~ 288 (291)
T cd06639 242 LFKIP---RNPPPTL-LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHP 288 (291)
T ss_pred HHHHh---cCCCCCC-CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCc
Confidence 21110 0000111 11233456799999999999999999999998653
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=312.07 Aligned_cols=250 Identities=29% Similarity=0.410 Sum_probs=199.1
Q ss_pred cccccceeecccCceeEEEEEe--CCccEEEEEeCcChh-HhHHHHHHHHHHHHcCCCCceeeeccccCC----CceEEE
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAA-QGKRQFQQEVEVLSSIRHPNMVLLLGACPD----YGCLVY 301 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~-~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~----~~~lV~ 301 (568)
++|...+.||.|+||.||++.+ .++.||+|++..... .....+.+|+++++.++||||++++++|.+ ..++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 4688899999999999999987 567899999875432 345678899999999999999999998743 348999
Q ss_pred EecCCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCC
Q 008365 302 EYMHNGSLEDRLLRRG-NTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPP 380 (568)
Q Consensus 302 E~~~ggsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~ 380 (568)
||+++++|.+++.... ....++...+..|+.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 9999999998876422 2334788899999999999999999999 99999999999999999999999999875432
Q ss_pred CCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchH-------HHHHHHhCcccccc
Q 008365 381 SVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHH-------VSRAIEKGTLAEML 453 (568)
Q Consensus 381 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~-------~~~~~~~~~~~~~l 453 (568)
.. .....++..|+|||.+.+..++.++|||||||++|+|++|..||..... ....+....
T Consensus 158 ~~--------~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----- 224 (287)
T cd06621 158 SL--------AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMP----- 224 (287)
T ss_pred cc--------cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCC-----
Confidence 21 1234578899999999999999999999999999999999999965411 111111111
Q ss_pred CccCCCCC---hHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 454 DPAVTDWP---AEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 454 ~~~~~~~p---~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
.+.+...+ ...+..+.+++.+||..+|.+||++.+++.+.+
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~ 268 (287)
T cd06621 225 NPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPW 268 (287)
T ss_pred chhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcc
Confidence 01111111 134577999999999999999999999987655
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=331.73 Aligned_cols=247 Identities=26% Similarity=0.432 Sum_probs=206.5
Q ss_pred ccccceeecccCceeEEEEEeC---Cc--cEEEEEeCcChhH-hHHHHHHHHHHHHcCCCCceeeeccccCCC-ceEEEE
Q 008365 230 KFSEAMKIGEGGYGPVYRGKLD---HT--PVAIKVLRPDAAQ-GKRQFQQEVEVLSSIRHPNMVLLLGACPDY-GCLVYE 302 (568)
Q Consensus 230 ~y~~~~~IG~G~fg~Vy~~~~~---~~--~vAvK~l~~~~~~-~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~-~~lV~E 302 (568)
+....++||+|+||.|++|.++ |+ .||||+++.+... ....|.+|+.+|.+|+|||+|+|||+..+. ..||||
T Consensus 111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~qp~mMV~E 190 (1039)
T KOG0199|consen 111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLDQPAMMVFE 190 (1039)
T ss_pred HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeeccchhhHHhh
Confidence 3455678999999999999884 33 6999999887654 567899999999999999999999998764 478999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCC
Q 008365 303 YMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSV 382 (568)
Q Consensus 303 ~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~ 382 (568)
+++.|+|.+.|.+ .....|.......++.|||.|+.||..++ +|||||-..||||-....||||||||.+-++...
T Consensus 191 LaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ne 266 (1039)
T KOG0199|consen 191 LAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGENE 266 (1039)
T ss_pred hcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCCC
Confidence 9999999999988 44556888999999999999999999999 9999999999999999999999999999876543
Q ss_pred Cccccccccc-cccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh-CCCCCCCchHHH--HHHHhCccccccCccCC
Q 008365 383 ADSVTQYHMT-SAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPMGLTHHVS--RAIEKGTLAEMLDPAVT 458 (568)
Q Consensus 383 ~~~~~~~~~~-~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~--~~~~~~~~~~~l~~~~~ 458 (568)
..|.+. ..--.+.|+|||.+....++.++|||+|||++|||++ |.-||-+..... ..++. ....
T Consensus 267 ----d~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~--------~erL 334 (1039)
T KOG0199|consen 267 ----DMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDA--------GERL 334 (1039)
T ss_pred ----cceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccc--------cccC
Confidence 222222 2234568999999999999999999999999999999 889996654432 22222 2223
Q ss_pred CCChHHHHHHHHHHHHhhccCCCCCCChHHhHhH
Q 008365 459 DWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVP 492 (568)
Q Consensus 459 ~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~ 492 (568)
..|..|++.+.+++..||..+|.+||+|..|...
T Consensus 335 pRPk~csedIY~imk~cWah~paDRptFsair~~ 368 (1039)
T KOG0199|consen 335 PRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRED 368 (1039)
T ss_pred CCCCCChHHHHHHHHHhccCCccccccHHHHHHh
Confidence 4588899999999999999999999999998643
|
|
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=314.51 Aligned_cols=231 Identities=26% Similarity=0.441 Sum_probs=181.4
Q ss_pred eecccCceeEEEEEeC--------------------------CccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCceeee
Q 008365 236 KIGEGGYGPVYRGKLD--------------------------HTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLL 289 (568)
Q Consensus 236 ~IG~G~fg~Vy~~~~~--------------------------~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l 289 (568)
.||+|+||.||+|... ...||+|++..........|.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 6999999999998641 12589999876655555678899999999999999999
Q ss_pred ccccCC--CceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCc--
Q 008365 290 LGACPD--YGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNY-- 365 (568)
Q Consensus 290 ~g~~~~--~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~-- 365 (568)
+++|.+ ..++||||+++|+|..++..... .+++..+..|+.||+.||.|||+.+ |+||||||+|||++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~ 156 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKG--RVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLA 156 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcc
Confidence 999854 45899999999999998865432 3788999999999999999999998 99999999999997543
Q ss_pred -----eeEecccccccccCCCCCccccccccccccccccCCChhhhhc-CCCCCcceehhHHHHHHHHH-hCCCCCCCch
Q 008365 366 -----VSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQT-GMLTTKSDIYSFGIMLLQII-TARSPMGLTH 438 (568)
Q Consensus 366 -----~vKL~DFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDvwSlGvil~ell-tG~~Pf~~~~ 438 (568)
.+||+|||++...... ....++..|+|||++.+ ..++.++|||||||++|||+ +|..||....
T Consensus 157 ~~~~~~~kl~d~g~~~~~~~~----------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~ 226 (274)
T cd05076 157 EGTSPFIKLSDPGVSFTALSR----------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERT 226 (274)
T ss_pred cCccceeeecCCccccccccc----------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccC
Confidence 4899999988643211 22357888999998765 56899999999999999995 6999996432
Q ss_pred HHH--HHHHhCccccccCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHh
Q 008365 439 HVS--RAIEKGTLAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIV 491 (568)
Q Consensus 439 ~~~--~~~~~~~~~~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~ 491 (568)
... ..+... ...+......+.+++.+||+.+|.+||++.+|+.
T Consensus 227 ~~~~~~~~~~~----------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~ 271 (274)
T cd05076 227 PSEKERFYEKK----------HRLPEPSCKELATLISQCLTYEPTQRPSFRTILR 271 (274)
T ss_pred hHHHHHHHHhc----------cCCCCCCChHHHHHHHHHcccChhhCcCHHHHHH
Confidence 211 111110 0112223346899999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=320.79 Aligned_cols=249 Identities=22% Similarity=0.330 Sum_probs=182.9
Q ss_pred eeecccCceeEEEEEeC----CccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCceeeeccccCC----CceEEEEecCC
Q 008365 235 MKIGEGGYGPVYRGKLD----HTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACPD----YGCLVYEYMHN 306 (568)
Q Consensus 235 ~~IG~G~fg~Vy~~~~~----~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~----~~~lV~E~~~g 306 (568)
.+||+|+||.||+|... +..||+|.+..... ...+.+|+.+|+.++||||++++++|.. ..++||||+.
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~- 83 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI--SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE- 83 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCCC--cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC-
Confidence 58999999999999862 35799999875432 2356789999999999999999998732 3489999995
Q ss_pred CCHHHHHhhcC------CCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeec----cCCceeEeccccccc
Q 008365 307 GSLEDRLLRRG------NTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILL----DRNYVSKISDVGLAR 376 (568)
Q Consensus 307 gsL~~~l~~~~------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILl----d~~~~vKL~DFGla~ 376 (568)
++|.+++.... ....+++..+..|+.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++
T Consensus 84 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 84 HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 67877765321 1224788899999999999999999999 9999999999999 566899999999998
Q ss_pred ccCCCCCccccccccccccccccCCChhhhhc-CCCCCcceehhHHHHHHHHHhCCCCCCCchH------------HHHH
Q 008365 377 LVPPSVADSVTQYHMTSAAGTFCYIDPEYQQT-GMLTTKSDIYSFGIMLLQIITARSPMGLTHH------------VSRA 443 (568)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDvwSlGvil~elltG~~Pf~~~~~------------~~~~ 443 (568)
.+...... ........||+.|+|||++.+ ..++.++|||||||++|||++|.+||..... ....
T Consensus 161 ~~~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~ 237 (317)
T cd07867 161 LFNSPLKP---LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRI 237 (317)
T ss_pred ccCCCccc---ccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHH
Confidence 76432211 112235678999999998876 4589999999999999999999999953221 0000
Q ss_pred HHh-C--------------cc---ccccCc----------cCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhH
Q 008365 444 IEK-G--------------TL---AEMLDP----------AVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVP 492 (568)
Q Consensus 444 ~~~-~--------------~~---~~~l~~----------~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~ 492 (568)
+.. + .+ ...+.. ............+.+|+.+|+..||.+||++.+++.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~h 314 (317)
T cd07867 238 FSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQD 314 (317)
T ss_pred HHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcC
Confidence 000 0 00 000000 0000011123457789999999999999999999854
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=311.43 Aligned_cols=252 Identities=25% Similarity=0.378 Sum_probs=199.4
Q ss_pred HhcccccceeecccCceeEEEEEe--CCccEEEEEeCcChhHhHHHHHHHHHHHHcC-CCCceeeeccccCC--------
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQGKRQFQQEVEVLSSI-RHPNMVLLLGACPD-------- 295 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l-~HpnIv~l~g~~~~-------- 295 (568)
.+++|++.+.||.|+||.||+|.+ .+..|++|++..... ....+.+|+.+++++ +||||++++++|.+
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 568899999999999999999987 456899999876544 346789999999999 69999999998833
Q ss_pred CceEEEEecCCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEeccccc
Q 008365 296 YGCLVYEYMHNGSLEDRLLRRG-NTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGL 374 (568)
Q Consensus 296 ~~~lV~E~~~ggsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGl 374 (568)
..++||||+++++|.+++.... ....+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.+||+|||+
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCcc
Confidence 2389999999999999886533 1234889999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCccccccccccccccccCCChhhhhc-----CCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHhCcc
Q 008365 375 ARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQT-----GMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTL 449 (568)
Q Consensus 375 a~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-----~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~ 449 (568)
+....... .......|+..|+|||++.. ..++.++|||||||+||+|++|..||...+........
T Consensus 160 ~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~--- 230 (275)
T cd06608 160 SAQLDSTL------GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKI--- 230 (275)
T ss_pred ceecccch------hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHh---
Confidence 87653221 11234568999999998754 34778999999999999999999999654332222111
Q ss_pred ccccCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhH
Q 008365 450 AEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVP 492 (568)
Q Consensus 450 ~~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~ 492 (568)
.....+.+ ..+...+..+.+|+.+||..+|.+||++.+++.+
T Consensus 231 ~~~~~~~~-~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 231 PRNPPPTL-KSPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred hccCCCCC-CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 00011111 1223456789999999999999999999999854
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=314.37 Aligned_cols=255 Identities=27% Similarity=0.467 Sum_probs=197.9
Q ss_pred cccccceeecccCceeEEEEEeC------CccEEEEEeCcChhH-hHHHHHHHHHHHHcCCCCceeeeccccCC----Cc
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKLD------HTPVAIKVLRPDAAQ-GKRQFQQEVEVLSSIRHPNMVLLLGACPD----YG 297 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~~------~~~vAvK~l~~~~~~-~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~----~~ 297 (568)
..|.+.+.||+|+||.||++.+. +..||||++...... ....|.+|+++++.+.||||+++++++.+ ..
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 35777889999999999999863 568999999766443 45679999999999999999999998754 45
Q ss_pred eEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccc
Q 008365 298 CLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARL 377 (568)
Q Consensus 298 ~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~ 377 (568)
++||||+++++|.+++..... .+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.++|+|||++..
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~~--~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHRD--QINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKV 158 (284)
T ss_pred EEEEecCCCCCHHHHHHhCcc--ccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccc
Confidence 899999999999999976543 3889999999999999999999999 99999999999999999999999999987
Q ss_pred cCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHH--------HhCcc
Q 008365 378 VPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAI--------EKGTL 449 (568)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~--------~~~~~ 449 (568)
....... ........++..|++||++.+..++.++|||||||++|+|++|..||.........+ ....+
T Consensus 159 ~~~~~~~---~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd05038 159 LPEDKDY---YYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRL 235 (284)
T ss_pred cccCCcc---eeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHH
Confidence 6432111 011112345677999999988899999999999999999999999985422111000 00000
Q ss_pred ccccCcc-CCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHh
Q 008365 450 AEMLDPA-VTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIV 491 (568)
Q Consensus 450 ~~~l~~~-~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~ 491 (568)
.+.+... ....+..++..+.+|+.+||..+|.+||++.+|+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 236 LELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred HHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 0011000 11123455678999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=310.16 Aligned_cols=251 Identities=24% Similarity=0.387 Sum_probs=197.5
Q ss_pred ccccceeecccCceeEEEEEe--CCccEEEEEeCcChh----------HhHHHHHHHHHHHHcCCCCceeeeccccCC--
Q 008365 230 KFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAA----------QGKRQFQQEVEVLSSIRHPNMVLLLGACPD-- 295 (568)
Q Consensus 230 ~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~----------~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~-- 295 (568)
+|.+.+.||.|+||.||+|.. ++..||||.++.... ...+.+.+|+.+++.++||||+++++++..
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 477888999999999999976 577899998754211 112457889999999999999999998854
Q ss_pred CceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccc
Q 008365 296 YGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLA 375 (568)
Q Consensus 296 ~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla 375 (568)
..++||||+++++|.+++...+ .+++..+..++.||+.||.|||+.+ ++||||+|+||+++.++.++|+|||++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~ 155 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYG---RFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGIS 155 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecccc
Confidence 4489999999999999987653 3788899999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCccccccccccccccccCCChhhhhcCC--CCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHhCcccccc
Q 008365 376 RLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGM--LTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEML 453 (568)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~--~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~l 453 (568)
+...... .........|+..|+|||.+.... ++.++|||||||++|++++|..||................ .
T Consensus 156 ~~~~~~~----~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--~ 229 (272)
T cd06629 156 KKSDDIY----DNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKR--S 229 (272)
T ss_pred ccccccc----cccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccc--c
Confidence 7643211 111223456899999999887654 8999999999999999999999997554433322211110 0
Q ss_pred CccC-CCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhH
Q 008365 454 DPAV-TDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVP 492 (568)
Q Consensus 454 ~~~~-~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~ 492 (568)
...+ ......++..+.+++..||..+|.+||++.+|+.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 230 APPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred CCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 1111 11223456789999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=314.47 Aligned_cols=248 Identities=24% Similarity=0.354 Sum_probs=207.8
Q ss_pred ccccceeecccCceeEEEEEe--CCccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCceeeeccccC-C-CceEEEEecC
Q 008365 230 KFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACP-D-YGCLVYEYMH 305 (568)
Q Consensus 230 ~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~-~-~~~lV~E~~~ 305 (568)
-|.++.+||+|+||.||++.+ .|..||||....+. +.+.+..|+.||++++.|++|++||.+- . ..+||||||.
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s--DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG 111 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT--DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG 111 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc--hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence 378889999999999999976 67899999876543 4567889999999999999999999763 3 4599999999
Q ss_pred CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCCcc
Q 008365 306 NGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADS 385 (568)
Q Consensus 306 ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~~~ 385 (568)
.|++.|++..+.. .+++.++..|+...+.||+|||... -||||||..||||+.+|++||+|||.|-.+.+
T Consensus 112 AGSiSDI~R~R~K--~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD----- 181 (502)
T KOG0574|consen 112 AGSISDIMRARRK--PLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTD----- 181 (502)
T ss_pred CCcHHHHHHHhcC--CccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhh-----
Confidence 9999998876543 4899999999999999999999999 89999999999999999999999999976533
Q ss_pred ccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHhCccccccCc-cCCCCChHH
Q 008365 386 VTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDP-AVTDWPAEA 464 (568)
Q Consensus 386 ~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~l~~-~~~~~p~~~ 464 (568)
+.-...+..|||.|||||++..-.|+.++||||||+...||..|++||...+.+...+ .-.-.| ..-..|...
T Consensus 182 -TMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIF-----MIPT~PPPTF~KPE~W 255 (502)
T KOG0574|consen 182 -TMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIF-----MIPTKPPPTFKKPEEW 255 (502)
T ss_pred -hHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeE-----eccCCCCCCCCChHhh
Confidence 2223467889999999999999999999999999999999999999997766643221 111111 111346778
Q ss_pred HHHHHHHHHHhhccCCCCCCChHHhHhHHHH
Q 008365 465 AESFSKLAIQCAELRKKDRPDLGTVIVPELN 495 (568)
Q Consensus 465 ~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l~ 495 (568)
+.+|.+++..||-..|++|-++.+++.|.+-
T Consensus 256 S~~F~DFi~~CLiK~PE~R~TA~~L~~H~Fi 286 (502)
T KOG0574|consen 256 SSEFNDFIRSCLIKKPEERKTALRLCEHTFI 286 (502)
T ss_pred hhHHHHHHHHHhcCCHHHHHHHHHHhhhhhh
Confidence 8899999999999999999999998876653
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=316.65 Aligned_cols=241 Identities=27% Similarity=0.378 Sum_probs=198.4
Q ss_pred cccccceeecccCceeEEEEEe--CCccEEEEEeCcChh---HhHHHHHHHHHHHHcCCCCceeeeccccCCC--ceEEE
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAA---QGKRQFQQEVEVLSSIRHPNMVLLLGACPDY--GCLVY 301 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~---~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~--~~lV~ 301 (568)
++|.+.+.||.|+||.||++.+ .+..||||++..... .....+.+|+++|++++||||+++++++.+. .++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 4688999999999999999987 567999999865432 2345688999999999999999999988554 48999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCC
Q 008365 302 EYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPS 381 (568)
Q Consensus 302 E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~ 381 (568)
||+++++|.+++...+ .++...+..++.||+.||.|||+.+ |+|+||+|.||||+.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~~~---~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 154 (290)
T cd05580 81 EYVPGGELFSHLRKSG---RFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR 154 (290)
T ss_pred ecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence 9999999999987654 3788999999999999999999999 999999999999999999999999999765332
Q ss_pred CCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHH--HHHHhCccccccCccCCC
Q 008365 382 VADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVS--RAIEKGTLAEMLDPAVTD 459 (568)
Q Consensus 382 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~--~~~~~~~~~~~l~~~~~~ 459 (568)
.....|++.|+|||.+.+..++.++||||||+++|+|++|..||....... ..+..+. ..
T Consensus 155 ---------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~---------~~ 216 (290)
T cd05580 155 ---------TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGK---------VR 216 (290)
T ss_pred ---------CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC---------cc
Confidence 134468999999999988889999999999999999999999997554321 1111111 12
Q ss_pred CChHHHHHHHHHHHHhhccCCCCCC-----ChHHhHhHH
Q 008365 460 WPAEAAESFSKLAIQCAELRKKDRP-----DLGTVIVPE 493 (568)
Q Consensus 460 ~p~~~~~~l~~li~~Cl~~dP~~RP-----s~~~vl~~~ 493 (568)
.|...+..+.+++.+||..+|.+|| ++.+++.+.
T Consensus 217 ~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~ 255 (290)
T cd05580 217 FPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHP 255 (290)
T ss_pred CCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCc
Confidence 3344567899999999999999999 666665443
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=312.14 Aligned_cols=233 Identities=26% Similarity=0.416 Sum_probs=185.8
Q ss_pred eecccCceeEEEEEeC---------CccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCceeeeccccC--CCceEEEEec
Q 008365 236 KIGEGGYGPVYRGKLD---------HTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACP--DYGCLVYEYM 304 (568)
Q Consensus 236 ~IG~G~fg~Vy~~~~~---------~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~--~~~~lV~E~~ 304 (568)
.||.|+||.||+|... ...||+|++........+.+.+|+.+++.++||||+++++++. +..++||||+
T Consensus 2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (258)
T cd05078 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYV 81 (258)
T ss_pred CCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEecC
Confidence 6999999999999762 2358899887665555667889999999999999999999884 4558999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCce--------eEeccccccc
Q 008365 305 HNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYV--------SKISDVGLAR 376 (568)
Q Consensus 305 ~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~--------vKL~DFGla~ 376 (568)
++|+|.+++...+. .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++. ++++|||++.
T Consensus 82 ~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~ 156 (258)
T cd05078 82 KFGSLDTYLKKNKN--LINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI 156 (258)
T ss_pred CCCcHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEeccccccc
Confidence 99999999876543 4788999999999999999999999 999999999999977654 6999999886
Q ss_pred ccCCCCCccccccccccccccccCCChhhhhc-CCCCCcceehhHHHHHHHHHhC-CCCCCCchHHHHHHHhCccccccC
Q 008365 377 LVPPSVADSVTQYHMTSAAGTFCYIDPEYQQT-GMLTTKSDIYSFGIMLLQIITA-RSPMGLTHHVSRAIEKGTLAEMLD 454 (568)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDvwSlGvil~elltG-~~Pf~~~~~~~~~~~~~~~~~~l~ 454 (568)
..... ....+++.|+|||++.+ ..++.++|||||||++|+|++| .+||..............
T Consensus 157 ~~~~~----------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~~~------ 220 (258)
T cd05078 157 TVLPK----------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYED------ 220 (258)
T ss_pred ccCCc----------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHHHc------
Confidence 54221 23468889999998876 4589999999999999999998 467654433222111110
Q ss_pred ccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHh
Q 008365 455 PAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIV 491 (568)
Q Consensus 455 ~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~ 491 (568)
....|......+.+|+.+||+.+|.+||++.+++.
T Consensus 221 --~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 255 (258)
T cd05078 221 --RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIR 255 (258)
T ss_pred --cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 11223334567899999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=309.28 Aligned_cols=248 Identities=27% Similarity=0.467 Sum_probs=198.0
Q ss_pred cccccceeecccCceeEEEEEeC-------CccEEEEEeCcChhH-hHHHHHHHHHHHHcCCCCceeeeccccCC--Cce
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKLD-------HTPVAIKVLRPDAAQ-GKRQFQQEVEVLSSIRHPNMVLLLGACPD--YGC 298 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~~-------~~~vAvK~l~~~~~~-~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--~~~ 298 (568)
++|.+...||.|+||.||+|+.. ...|++|.+...... ....+.+|+.++++++||||++++++|.+ ..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 56888999999999999999852 357999998654433 45678999999999999999999999865 458
Q ss_pred EEEEecCCCCHHHHHhhcCCC------CCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEeccc
Q 008365 299 LVYEYMHNGSLEDRLLRRGNT------PVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDV 372 (568)
Q Consensus 299 lV~E~~~ggsL~~~l~~~~~~------~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DF 372 (568)
+||||+++|+|.+++...... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.++|+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence 999999999999998765421 14899999999999999999999999 999999999999999999999999
Q ss_pred ccccccCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh-CCCCCCCchH--HHHHHHhCcc
Q 008365 373 GLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPMGLTHH--VSRAIEKGTL 449 (568)
Q Consensus 373 Gla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~--~~~~~~~~~~ 449 (568)
|+++..... .........++..|+|||.+.+..++.++|||||||++|+|++ |..||..... +...+..+..
T Consensus 162 ~~~~~~~~~-----~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~ 236 (275)
T cd05046 162 SLSKDVYNS-----EYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKL 236 (275)
T ss_pred ccccccCcc-----cccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCc
Confidence 998644221 1112234467888999999988889999999999999999999 8889954322 1122221211
Q ss_pred ccccCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHh
Q 008365 450 AEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIV 491 (568)
Q Consensus 450 ~~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~ 491 (568)
.. ..+..++..+.+++.+||+.+|.+||++.+++.
T Consensus 237 ~~-------~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~ 271 (275)
T cd05046 237 EL-------PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVS 271 (275)
T ss_pred CC-------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 11 112345678999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=315.96 Aligned_cols=252 Identities=25% Similarity=0.352 Sum_probs=195.9
Q ss_pred cccccceeecccCceeEEEEEe--CCccEEEEEeCcChh--HhHHHHHHHHHHHHcCCCCceeeeccccCCC--ceEEEE
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAA--QGKRQFQQEVEVLSSIRHPNMVLLLGACPDY--GCLVYE 302 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~--~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~--~~lV~E 302 (568)
++|++.++||+|+||.||+|.+ .++.||||++..... ...+.+.+|+.+++.++||||++++++|.+. .++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 4688999999999999999987 467899999765322 2345688999999999999999999998554 489999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCC
Q 008365 303 YMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSV 382 (568)
Q Consensus 303 ~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~ 382 (568)
|+++++|..+..... .+++..+..++.||+.||.|||+.+ |+|+||+|+||+++.++.++|+|||++..+....
T Consensus 81 ~~~~~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07846 81 FVDHTVLDDLEKYPN---GLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 154 (286)
T ss_pred cCCccHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence 999988887665432 2789999999999999999999999 9999999999999999999999999997653322
Q ss_pred CccccccccccccccccCCChhhhhc-CCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHh----Cccc-------
Q 008365 383 ADSVTQYHMTSAAGTFCYIDPEYQQT-GMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEK----GTLA------- 450 (568)
Q Consensus 383 ~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~----~~~~------- 450 (568)
. ......|+..|+|||++.+ ..++.++|||||||++|+|++|.+||............ +.+.
T Consensus 155 ~------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (286)
T cd07846 155 E------VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIF 228 (286)
T ss_pred c------ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHh
Confidence 1 1233568999999998765 45788999999999999999999999654432211110 0000
Q ss_pred -------cccCccCC------CCChHHHHHHHHHHHHhhccCCCCCCChHHhHhH
Q 008365 451 -------EMLDPAVT------DWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVP 492 (568)
Q Consensus 451 -------~~l~~~~~------~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~ 492 (568)
.+..+... ...+.++..+.+|+.+||..+|.+||++.+++.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 229 QKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred ccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 00000000 1123456789999999999999999999998854
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=306.35 Aligned_cols=233 Identities=28% Similarity=0.451 Sum_probs=185.2
Q ss_pred eeecccCceeEEEEEeCCc------------cEEEEEeCcChhHhHHHHHHHHHHHHcCCCCceeeeccccC-CCceEEE
Q 008365 235 MKIGEGGYGPVYRGKLDHT------------PVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACP-DYGCLVY 301 (568)
Q Consensus 235 ~~IG~G~fg~Vy~~~~~~~------------~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~-~~~~lV~ 301 (568)
+.||+|+||.||+|.+... .|++|++...... ...|.+|+.+|+.++||||++++++|. +..++||
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~ 79 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVRDENIMVE 79 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEecCCcEEEE
Confidence 3699999999999988433 3888887655443 567889999999999999999999874 4458999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCc-------eeEeccccc
Q 008365 302 EYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNY-------VSKISDVGL 374 (568)
Q Consensus 302 E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~-------~vKL~DFGl 374 (568)
||+++|+|.+++..... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||+
T Consensus 80 e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~ 154 (259)
T cd05037 80 EYVKFGPLDVFLHREKN--NVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI 154 (259)
T ss_pred EcCCCCcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCCc
Confidence 99999999999876543 4888999999999999999999999 99999999999999887 899999999
Q ss_pred ccccCCCCCccccccccccccccccCCChhhhhcC--CCCCcceehhHHHHHHHHHh-CCCCCCCchHHHHHHHhCcccc
Q 008365 375 ARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTG--MLTTKSDIYSFGIMLLQIIT-ARSPMGLTHHVSRAIEKGTLAE 451 (568)
Q Consensus 375 a~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~--~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~ 451 (568)
+..... .....++..|+|||++.+. .++.++|||||||++|+|++ |..||.............
T Consensus 155 a~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~---- 220 (259)
T cd05037 155 PITVLS----------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ---- 220 (259)
T ss_pred cccccc----------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh----
Confidence 976432 1234577889999998876 78999999999999999999 588885443211111000
Q ss_pred ccCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHh
Q 008365 452 MLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIV 491 (568)
Q Consensus 452 ~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~ 491 (568)
.... .+......+.+++.+||..+|.+||++.+|+.
T Consensus 221 --~~~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 221 --DQHR--LPMPDCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred --cCCC--CCCCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 0000 11111267899999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=309.19 Aligned_cols=243 Identities=28% Similarity=0.464 Sum_probs=191.2
Q ss_pred eecccCceeEEEEEeCC--------ccEEEEEeCcCh-hHhHHHHHHHHHHHHcCCCCceeeeccccCC--CceEEEEec
Q 008365 236 KIGEGGYGPVYRGKLDH--------TPVAIKVLRPDA-AQGKRQFQQEVEVLSSIRHPNMVLLLGACPD--YGCLVYEYM 304 (568)
Q Consensus 236 ~IG~G~fg~Vy~~~~~~--------~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--~~~lV~E~~ 304 (568)
.||+|+||.||+|+... ..||||.+.... ......+.+|+.+++.++||||++++++|.+ ..++||||+
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELM 81 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEecc
Confidence 69999999999998632 469999886543 2345678899999999999999999998854 348999999
Q ss_pred CCCCHHHHHhhcC----CCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCc-----eeEecccccc
Q 008365 305 HNGSLEDRLLRRG----NTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNY-----VSKISDVGLA 375 (568)
Q Consensus 305 ~ggsL~~~l~~~~----~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~-----~vKL~DFGla 375 (568)
++++|.+++.... ....+++..+..++.||+.||.|||+.+ ++|+||||+|||++.++ .+||+|||++
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 82 EGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred CCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 9999999987532 1234788999999999999999999999 99999999999998877 8999999999
Q ss_pred cccCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh-CCCCCCCchHHHHHHHhCccccccC
Q 008365 376 RLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPMGLTHHVSRAIEKGTLAEMLD 454 (568)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~l~ 454 (568)
+.+..... ........++..|+|||++.++.++.++|||||||++|+|++ |..||............. .
T Consensus 159 ~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~------~ 228 (269)
T cd05044 159 RDIYKSDY----YRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVT------A 228 (269)
T ss_pred cccccccc----cccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHh------c
Confidence 76532211 011123356788999999999999999999999999999998 999996443322111100 0
Q ss_pred ccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHh
Q 008365 455 PAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIV 491 (568)
Q Consensus 455 ~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~ 491 (568)
......+..++..+.+++.+||..+|.+||++.+|+.
T Consensus 229 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 229 GGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred CCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 1111234456778999999999999999999999863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=314.08 Aligned_cols=251 Identities=24% Similarity=0.337 Sum_probs=191.6
Q ss_pred ccccceeecccCceeEEEEEe--CCccEEEEEeCcChh--HhHHHHHHHHHHHHcCCCCceeeeccccCCC--ceEEEEe
Q 008365 230 KFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAA--QGKRQFQQEVEVLSSIRHPNMVLLLGACPDY--GCLVYEY 303 (568)
Q Consensus 230 ~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~--~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~--~~lV~E~ 303 (568)
+|++.+.||.|+||.||+|.+ ++..||+|++..... .....+.+|+.+++.++||||+++++++.+. .++||||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 488889999999999999987 577899999865422 1224577899999999999999999998554 4899999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCC
Q 008365 304 MHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVA 383 (568)
Q Consensus 304 ~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~ 383 (568)
+. ++|.+++..... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 81 ~~-~~l~~~~~~~~~--~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~- 153 (284)
T cd07839 81 CD-QDLKKYFDSCNG--DIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPV- 153 (284)
T ss_pred CC-CCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCC-
Confidence 96 688887765432 3899999999999999999999999 9999999999999999999999999997653221
Q ss_pred ccccccccccccccccCCChhhhhcC-CCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHh-----C--------cc
Q 008365 384 DSVTQYHMTSAAGTFCYIDPEYQQTG-MLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEK-----G--------TL 449 (568)
Q Consensus 384 ~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~-----~--------~~ 449 (568)
.......+++.|+|||++.+. .++.++|||||||++|+|++|..||.........+.. + .+
T Consensus 154 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (284)
T cd07839 154 -----RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGV 228 (284)
T ss_pred -----CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHh
Confidence 112334678999999988764 4799999999999999999999886432221111110 0 00
Q ss_pred ccccC-ccCC---------CCChHHHHHHHHHHHHhhccCCCCCCChHHhHhH
Q 008365 450 AEMLD-PAVT---------DWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVP 492 (568)
Q Consensus 450 ~~~l~-~~~~---------~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~ 492 (568)
....+ .... ...+.++..+.+|+.+||+.+|.+||++.+++.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 229 SKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred hhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 00000 0000 1112356788999999999999999999998754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=306.77 Aligned_cols=249 Identities=27% Similarity=0.432 Sum_probs=203.9
Q ss_pred cccccceeecccCceeEEEEEe--CCccEEEEEeCcChh-HhHHHHHHHHHHHHcCCCCceeeeccccCC--CceEEEEe
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAA-QGKRQFQQEVEVLSSIRHPNMVLLLGACPD--YGCLVYEY 303 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~-~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--~~~lV~E~ 303 (568)
++|++.+.||.|+||.||++.+ .+..|+||++..... .....+.+|+.++..++||||+++++++.. ..++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 3688899999999999999987 477899999876644 445678999999999999999999998855 34899999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCCCCcccCCCCCCCeeccCCceeEecccccccccCCCC
Q 008365 304 MHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQ-AKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSV 382 (568)
Q Consensus 304 ~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~-~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~ 382 (568)
+++++|.+++.... .+++..+..++.|++.||.|||+ .+ ++|+||+|+||+++.++.++|+|||++..+....
T Consensus 81 ~~~~~L~~~l~~~~---~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~ 154 (264)
T cd06623 81 MDGGSLADLLKKVG---KIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTL 154 (264)
T ss_pred cCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence 99999999997653 48899999999999999999999 98 9999999999999999999999999998664322
Q ss_pred CccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCch--HHHHHHHhCccccccCccCCCC
Q 008365 383 ADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTH--HVSRAIEKGTLAEMLDPAVTDW 460 (568)
Q Consensus 383 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~--~~~~~~~~~~~~~~l~~~~~~~ 460 (568)
.. .....++..|+|||.+.+..++.++||||||+++|+|++|..||.... .....+.. .........
T Consensus 155 ~~------~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~-----~~~~~~~~~ 223 (264)
T cd06623 155 DQ------CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQA-----ICDGPPPSL 223 (264)
T ss_pred Cc------ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHH-----HhcCCCCCC
Confidence 11 124468899999999999999999999999999999999999996553 11111111 111111223
Q ss_pred ChH-HHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 461 PAE-AAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 461 p~~-~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
+.. ++..+.+++..||..+|.+||++.+++.+.+
T Consensus 224 ~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~ 258 (264)
T cd06623 224 PAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPF 258 (264)
T ss_pred CcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHH
Confidence 334 6678999999999999999999999987654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=314.82 Aligned_cols=252 Identities=25% Similarity=0.380 Sum_probs=203.8
Q ss_pred hcccccceeecccCceeEEEEEe--CCccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCceeeeccccCC--CceEEEEe
Q 008365 228 TDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACPD--YGCLVYEY 303 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--~~~lV~E~ 303 (568)
.++|.+.+.||.|+||.||++.. ++..||+|.+..........+.+|+.+++.++||||++++++|.+ ..++||||
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~ 97 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY 97 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence 36899999999999999999976 567899999876554555678899999999999999999998844 45899999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCC
Q 008365 304 MHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVA 383 (568)
Q Consensus 304 ~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~ 383 (568)
+++++|.+++... .+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++..+.....
T Consensus 98 ~~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~ 170 (293)
T cd06647 98 LAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (293)
T ss_pred CCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccccccc
Confidence 9999999988653 2788899999999999999999999 99999999999999999999999999876543221
Q ss_pred ccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHhCccccccCccCCCCChH
Q 008365 384 DSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAVTDWPAE 463 (568)
Q Consensus 384 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~l~~~~~~~p~~ 463 (568)
......|++.|++||++.+..++.++|||||||++|++++|+.||............... -.+.. ..+..
T Consensus 171 ------~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~---~~~~~-~~~~~ 240 (293)
T cd06647 171 ------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN---GTPEL-QNPEK 240 (293)
T ss_pred ------ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcC---CCCCC-CCccc
Confidence 123346899999999998888999999999999999999999999755432221110000 00111 12334
Q ss_pred HHHHHHHHHHHhhccCCCCCCChHHhHhHHHHH
Q 008365 464 AAESFSKLAIQCAELRKKDRPDLGTVIVPELNR 496 (568)
Q Consensus 464 ~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l~~ 496 (568)
.+..+.+++.+||..+|.+||++.+++.+.+-+
T Consensus 241 ~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~ 273 (293)
T cd06647 241 LSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLK 273 (293)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHhcCHHHh
Confidence 566799999999999999999999999776543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=326.88 Aligned_cols=247 Identities=21% Similarity=0.306 Sum_probs=187.0
Q ss_pred cccccceeecccCceeEEEEEeC--CccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCceeeeccccCC--CceEEEEec
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKLD--HTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACPD--YGCLVYEYM 304 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~~--~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--~~~lV~E~~ 304 (568)
.+|.+++.||+|+||.||+|.+. +..||+|+.... ....|+.+++.++|||||+++++|.+ ..++||||+
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 139 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY 139 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEcc
Confidence 46999999999999999999984 458999986433 23469999999999999999998854 348999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCCc
Q 008365 305 HNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVAD 384 (568)
Q Consensus 305 ~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~~ 384 (568)
.++|.+++..... .+++..+..|+.||+.||.|||..+ ||||||||+||||+.++.+||+|||+++.....
T Consensus 140 -~~~l~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--- 210 (357)
T PHA03209 140 -SSDLYTYLTKRSR--PLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA--- 210 (357)
T ss_pred -CCcHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccC---
Confidence 5788888865433 4899999999999999999999999 999999999999999999999999999743211
Q ss_pred cccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCC-CCCchH------------HHHHHHh-Cccc
Q 008365 385 SVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSP-MGLTHH------------VSRAIEK-GTLA 450 (568)
Q Consensus 385 ~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~P-f~~~~~------------~~~~~~~-~~~~ 450 (568)
.......||+.|+|||++.+..++.++|||||||++|||+++..| |..... +...+.. +...
T Consensus 211 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 286 (357)
T PHA03209 211 ----PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHP 286 (357)
T ss_pred ----cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccCh
Confidence 112345799999999999999999999999999999999985544 432110 1111110 0000
Q ss_pred cccC--c-----------------cCCCC----ChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 451 EMLD--P-----------------AVTDW----PAEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 451 ~~l~--~-----------------~~~~~----p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
..+. + ....+ ...++..+..||.+||+.||.+||++.+++.|.+
T Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~ 353 (357)
T PHA03209 287 EEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPM 353 (357)
T ss_pred hhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCch
Confidence 0000 0 00000 0123445667999999999999999999987654
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=347.65 Aligned_cols=249 Identities=24% Similarity=0.314 Sum_probs=200.9
Q ss_pred HhcccccceeecccCceeEEEEEe--CCccEEEEEeCcChh---HhHHHHHHHHHHHHcCCCCceeeeccccCCCc--eE
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAA---QGKRQFQQEVEVLSSIRHPNMVLLLGACPDYG--CL 299 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~---~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~--~l 299 (568)
-.++|.++++||+|+||.|.+++. .++.||+|++++-.. .....|..|..||...+.++||.+..+|+|.. |+
T Consensus 73 ~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYl 152 (1317)
T KOG0612|consen 73 KAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYL 152 (1317)
T ss_pred CHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEE
Confidence 346799999999999999999987 567899999987432 23456899999999999999999999997754 89
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccC
Q 008365 300 VYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVP 379 (568)
Q Consensus 300 V~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~ 379 (568)
|||||+||+|..++.+.+ .+|+.-+..++..|+.||.-||+.| +|||||||+|||||..|++||+|||.|-.+.
T Consensus 153 VMdY~pGGDlltLlSk~~---~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFGsClkm~ 226 (1317)
T KOG0612|consen 153 VMDYMPGGDLLTLLSKFD---RLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFGSCLKMD 226 (1317)
T ss_pred EEecccCchHHHHHhhcC---CChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccchhHHhcC
Confidence 999999999999998876 3888889999999999999999999 9999999999999999999999999997764
Q ss_pred CCCCccccccccccccccccCCChhhhhc-----CCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHhCccccccC
Q 008365 380 PSVADSVTQYHMTSAAGTFCYIDPEYQQT-----GMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLD 454 (568)
Q Consensus 380 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-----~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~l~ 454 (568)
.. ........+|||.|++||++.. +.|+..||+||+||++||||.|..||.....+... ..+++
T Consensus 227 ~d-----G~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY------~KIm~ 295 (1317)
T KOG0612|consen 227 AD-----GTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETY------GKIMN 295 (1317)
T ss_pred CC-----CcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHH------HHHhc
Confidence 32 2234467899999999998753 56999999999999999999999999654443322 11111
Q ss_pred c-cCCCCC--hHHHHHHHHHHHHhhccCCCCCCC---hHHhHhHH
Q 008365 455 P-AVTDWP--AEAAESFSKLAIQCAELRKKDRPD---LGTVIVPE 493 (568)
Q Consensus 455 ~-~~~~~p--~~~~~~l~~li~~Cl~~dP~~RPs---~~~vl~~~ 493 (568)
- ....+| .++++...+||...+. +|..|-. +.++-.|.
T Consensus 296 hk~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~Hp 339 (1317)
T KOG0612|consen 296 HKESLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHP 339 (1317)
T ss_pred hhhhcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCc
Confidence 1 112344 4577888899888665 4777776 77665443
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=336.24 Aligned_cols=252 Identities=20% Similarity=0.249 Sum_probs=192.7
Q ss_pred HhcccccceeecccCceeEEEEEeC--CccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCceeeeccccCC--CceEEEE
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKLD--HTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACPD--YGCLVYE 302 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~~--~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--~~~lV~E 302 (568)
....|.+.+.||+|+||.||++.+. +..||||.... ..+.+|+++|++|+|||||++++++.. ..++|||
T Consensus 167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e 240 (461)
T PHA03211 167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLP 240 (461)
T ss_pred ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEE
Confidence 3457999999999999999999984 56899996432 235689999999999999999998743 4589999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCC
Q 008365 303 YMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSV 382 (568)
Q Consensus 303 ~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~ 382 (568)
++ .++|.+++..... .+++..++.|+.||+.||.|||+.+ ||||||||+||||+.++.+||+|||+++.+....
T Consensus 241 ~~-~~~L~~~l~~~~~--~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~ 314 (461)
T PHA03211 241 KY-RSDLYTYLGARLR--PLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSW 314 (461)
T ss_pred cc-CCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceeccccc
Confidence 99 5788888865432 4899999999999999999999999 9999999999999999999999999998653321
Q ss_pred CccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCC-c---------hHHHHHHHhCccc-c
Q 008365 383 ADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGL-T---------HHVSRAIEKGTLA-E 451 (568)
Q Consensus 383 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~-~---------~~~~~~~~~~~~~-~ 451 (568)
.. ......+||+.|+|||++.+..++.++|||||||+||||++|..|+.. . ..+...+...... .
T Consensus 315 ~~----~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~ 390 (461)
T PHA03211 315 ST----PFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVD 390 (461)
T ss_pred cc----ccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccc
Confidence 11 112346799999999999999999999999999999999998765421 1 1222222221110 0
Q ss_pred ccCc--------------------c--CCCCC--hHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 452 MLDP--------------------A--VTDWP--AEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 452 ~l~~--------------------~--~~~~p--~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
.+.. . ...|. ......+.+||.+||+.||.+||++.++|.+.+
T Consensus 391 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~ 457 (461)
T PHA03211 391 EFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPL 457 (461)
T ss_pred cCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcc
Confidence 0000 0 00111 022346889999999999999999999986543
|
|
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=311.02 Aligned_cols=248 Identities=26% Similarity=0.408 Sum_probs=199.8
Q ss_pred cccccceeecccCceeEEEEEeC--CccEEEEEeCcCh-hHhHHHHHHHHHHHHcCCCCceeeeccccCCC--ceEEEEe
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKLD--HTPVAIKVLRPDA-AQGKRQFQQEVEVLSSIRHPNMVLLLGACPDY--GCLVYEY 303 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~~--~~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~--~~lV~E~ 303 (568)
++|+..+.||.|+||.||++.+. +..||+|++.... ......+.+|+++++.++||||+++++.|... .++||||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 35778889999999999999884 6789999987653 34456788999999999999999999987543 4899999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCCCCcccCCCCCCCeeccCCceeEecccccccccCCCC
Q 008365 304 MHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQ-AKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSV 382 (568)
Q Consensus 304 ~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~-~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~ 382 (568)
+++++|.+++.... ..++...+..++.|++.||.|||+ .+ |+|+||||+||+++.++.++|+|||++..+....
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~ 155 (265)
T cd06605 81 MDGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL 155 (265)
T ss_pred cCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence 99999999987653 348889999999999999999999 88 9999999999999999999999999987542211
Q ss_pred CccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCch----HHHHHHHhCccccccCccCC
Q 008365 383 ADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTH----HVSRAIEKGTLAEMLDPAVT 458 (568)
Q Consensus 383 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~----~~~~~~~~~~~~~~l~~~~~ 458 (568)
.....|+..|+|||++.+..++.++|||||||++|+|++|..||.... .....+.. .+.....
T Consensus 156 --------~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-----~~~~~~~ 222 (265)
T cd06605 156 --------AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQY-----IVNEPPP 222 (265)
T ss_pred --------hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHH-----HhcCCCC
Confidence 112678999999999999999999999999999999999999996442 11111111 1111112
Q ss_pred CCChH-HHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 459 DWPAE-AAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 459 ~~p~~-~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
..+.. ++..+.++|.+||..+|.+||++.+++.+.+
T Consensus 223 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~ 259 (265)
T cd06605 223 RLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPF 259 (265)
T ss_pred CCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCch
Confidence 22333 6677999999999999999999999986543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=336.95 Aligned_cols=245 Identities=27% Similarity=0.494 Sum_probs=204.0
Q ss_pred cccceeecccCceeEEEEEe--CC---ccEEEEEeCcCh-hHhHHHHHHHHHHHHcCCCCceeeeccccCCCc--eEEEE
Q 008365 231 FSEAMKIGEGGYGPVYRGKL--DH---TPVAIKVLRPDA-AQGKRQFQQEVEVLSSIRHPNMVLLLGACPDYG--CLVYE 302 (568)
Q Consensus 231 y~~~~~IG~G~fg~Vy~~~~--~~---~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~--~lV~E 302 (568)
..+.++||.|.||.||+|++ .+ ..||||.++... ...+..|..|..||.+++||||++|-|+..... .||.|
T Consensus 631 i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTE 710 (996)
T KOG0196|consen 631 VKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITE 710 (996)
T ss_pred eEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhh
Confidence 45678999999999999987 23 379999998764 444667999999999999999999999986544 78999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCC
Q 008365 303 YMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSV 382 (568)
Q Consensus 303 ~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~ 382 (568)
||++|+|+.+|..+... |.+-+..-+++.|+.|+.||-+.+ +|||||-..|||||.+..+|++||||+|.+.++.
T Consensus 711 yMENGsLDsFLR~~DGq--ftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~ 785 (996)
T KOG0196|consen 711 YMENGSLDSFLRQNDGQ--FTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 785 (996)
T ss_pred hhhCCcHHHHHhhcCCc--eEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeecccCC
Confidence 99999999999887643 888899999999999999999999 9999999999999999999999999999875443
Q ss_pred CccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh-CCCCCC-C-chHHHHHHHhCccccccCccCCC
Q 008365 383 ADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPMG-L-THHVSRAIEKGTLAEMLDPAVTD 459 (568)
Q Consensus 383 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~-~-~~~~~~~~~~~~~~~~l~~~~~~ 459 (568)
. ..+...+.--..+|.|||.+....++.++|||||||+|||.++ |..||- . .+.+-.+++.+. ...
T Consensus 786 ~---~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gy--------RLP 854 (996)
T KOG0196|consen 786 E---AAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGY--------RLP 854 (996)
T ss_pred C---ccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhcc--------CCC
Confidence 1 2222222233578999999999999999999999999999887 999973 2 233444555442 123
Q ss_pred CChHHHHHHHHHHHHhhccCCCCCCChHHhHh
Q 008365 460 WPAEAAESFSKLAIQCAELRKKDRPDLGTVIV 491 (568)
Q Consensus 460 ~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~ 491 (568)
.|.+||..+.+||+.||++|...||.+.+|+.
T Consensus 855 pPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~ 886 (996)
T KOG0196|consen 855 PPMDCPAALYQLMLDCWQKDRNRRPKFAQIVS 886 (996)
T ss_pred CCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHH
Confidence 47789999999999999999999999999984
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=312.96 Aligned_cols=253 Identities=23% Similarity=0.323 Sum_probs=197.2
Q ss_pred ccccceeecccCceeEEEEEe--CCccEEEEEeCcCh--hHhHHHHHHHHHHHHcCCCCceeeeccccCCC--ceEEEEe
Q 008365 230 KFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDA--AQGKRQFQQEVEVLSSIRHPNMVLLLGACPDY--GCLVYEY 303 (568)
Q Consensus 230 ~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~--~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~--~~lV~E~ 303 (568)
+|.+.+.||.|+||.||+|.+ +++.||||++.... ......+.+|+.+++.++||||+++++++.+. .++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 488899999999999999987 57899999987543 23345788999999999999999999988543 4899999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCC
Q 008365 304 MHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVA 383 (568)
Q Consensus 304 ~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~ 383 (568)
+ +++|.+++.... ..+++..+..++.||+.||.|||+.+ |+|+||||+||+++.++.++|+|||++........
T Consensus 81 ~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (286)
T cd07832 81 M-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP 154 (286)
T ss_pred c-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence 9 999999887654 34899999999999999999999999 99999999999999999999999999986643221
Q ss_pred ccccccccccccccccCCChhhhhcC-CCCCcceehhHHHHHHHHHhCCCCCCCchHHHH---HHHh-Cc----------
Q 008365 384 DSVTQYHMTSAAGTFCYIDPEYQQTG-MLTTKSDIYSFGIMLLQIITARSPMGLTHHVSR---AIEK-GT---------- 448 (568)
Q Consensus 384 ~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~---~~~~-~~---------- 448 (568)
.......|+..|+|||++.+. .++.++|||||||++|+|++|.+||........ .+.. +.
T Consensus 155 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (286)
T cd07832 155 -----RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLT 229 (286)
T ss_pred -----CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhcc
Confidence 112345789999999987654 468999999999999999999888865433211 1110 00
Q ss_pred ----cccccCcc-----CCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHH
Q 008365 449 ----LAEMLDPA-----VTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPE 493 (568)
Q Consensus 449 ----~~~~l~~~-----~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~ 493 (568)
......+. +....++.+..+.+++.+||..+|.+||++.+++.|.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~ 283 (286)
T cd07832 230 SLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHP 283 (286)
T ss_pred CcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCc
Confidence 00000000 0011124457899999999999999999999998653
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=303.84 Aligned_cols=240 Identities=30% Similarity=0.479 Sum_probs=192.2
Q ss_pred eeecccCceeEEEEEeC-CccEEEEEeCcChhH-hHHHHHHHHHHHHcCCCCceeeeccccCCC--ceEEEEecCCCCHH
Q 008365 235 MKIGEGGYGPVYRGKLD-HTPVAIKVLRPDAAQ-GKRQFQQEVEVLSSIRHPNMVLLLGACPDY--GCLVYEYMHNGSLE 310 (568)
Q Consensus 235 ~~IG~G~fg~Vy~~~~~-~~~vAvK~l~~~~~~-~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~--~~lV~E~~~ggsL~ 310 (568)
++||.|+||.||++.+. ++.||+|++...... ....+.+|+++++.++||||+++++++.+. .++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 36999999999999874 789999998765433 456789999999999999999999988554 48999999999999
Q ss_pred HHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCCccccccc
Q 008365 311 DRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYH 390 (568)
Q Consensus 311 ~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~ 390 (568)
+++..... .+++..+..++.+++.||.|||+++ |+||||||+||||+.++.+||+|||++......... ..
T Consensus 81 ~~l~~~~~--~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~----~~ 151 (251)
T cd05041 81 TFLRKKKN--RLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYT----VS 151 (251)
T ss_pred HHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcce----ec
Confidence 99876433 3788899999999999999999999 999999999999999999999999999755321110 00
Q ss_pred cccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh-CCCCCCCchHHH--HHHHhCccccccCccCCCCChHHHHH
Q 008365 391 MTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPMGLTHHVS--RAIEKGTLAEMLDPAVTDWPAEAAES 467 (568)
Q Consensus 391 ~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~--~~~~~~~~~~~l~~~~~~~p~~~~~~ 467 (568)
.....++..|+|||.+.++.++.++|||||||++|+|++ |..||....... ..+..+. ....+..++..
T Consensus 152 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~ 223 (251)
T cd05041 152 DGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGY--------RMPAPQLCPEE 223 (251)
T ss_pred cccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCC--------CCCCCccCCHH
Confidence 012234667999999988899999999999999999999 889996543322 1111110 11124456678
Q ss_pred HHHHHHHhhccCCCCCCChHHhHh
Q 008365 468 FSKLAIQCAELRKKDRPDLGTVIV 491 (568)
Q Consensus 468 l~~li~~Cl~~dP~~RPs~~~vl~ 491 (568)
+.+++.+||..+|.+||++.+|+.
T Consensus 224 ~~~li~~~l~~~p~~Rp~~~ell~ 247 (251)
T cd05041 224 IYRLMLQCWAYDPENRPSFSEIYN 247 (251)
T ss_pred HHHHHHHHhccChhhCcCHHHHHH
Confidence 999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=304.64 Aligned_cols=243 Identities=33% Similarity=0.550 Sum_probs=196.8
Q ss_pred cccceeecccCceeEEEEEeCC------ccEEEEEeCcChhH-hHHHHHHHHHHHHcCCCCceeeeccccCC--CceEEE
Q 008365 231 FSEAMKIGEGGYGPVYRGKLDH------TPVAIKVLRPDAAQ-GKRQFQQEVEVLSSIRHPNMVLLLGACPD--YGCLVY 301 (568)
Q Consensus 231 y~~~~~IG~G~fg~Vy~~~~~~------~~vAvK~l~~~~~~-~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--~~~lV~ 301 (568)
|.+.+.||.|+||.||++.+.. ..||+|++...... ....+..|+.++..++|+||+++++++.+ ..++||
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 3567889999999999998854 67999999766543 45688999999999999999999998865 448999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCC
Q 008365 302 EYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPS 381 (568)
Q Consensus 302 E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~ 381 (568)
||+++++|.+++...... .+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 81 e~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPK-ELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD 156 (258)
T ss_pred eccCCCCHHHHHHhhhhc-cCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecccc
Confidence 999999999998764321 1789999999999999999999999 999999999999999999999999999866433
Q ss_pred CCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh-CCCCCCCchH--HHHHHHhCccccccCccCC
Q 008365 382 VADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPMGLTHH--VSRAIEKGTLAEMLDPAVT 458 (568)
Q Consensus 382 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~--~~~~~~~~~~~~~l~~~~~ 458 (568)
.. .......+++.|+|||.+.+..++.++|||||||++|+|++ |.+||..... +...+..+.. .
T Consensus 157 ~~-----~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~--------~ 223 (258)
T smart00219 157 DY-----YKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYR--------L 223 (258)
T ss_pred cc-----cccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC--------C
Confidence 11 11112337889999999988889999999999999999998 8899964332 2222222211 1
Q ss_pred CCChHHHHHHHHHHHHhhccCCCCCCChHHhH
Q 008365 459 DWPAEAAESFSKLAIQCAELRKKDRPDLGTVI 490 (568)
Q Consensus 459 ~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl 490 (568)
..+..++..+.+++.+|+..+|.+||++.+++
T Consensus 224 ~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll 255 (258)
T smart00219 224 PKPENCPPEIYKLMLQCWAEDPEDRPTFSELV 255 (258)
T ss_pred CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHH
Confidence 22334667899999999999999999999986
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=313.71 Aligned_cols=247 Identities=23% Similarity=0.315 Sum_probs=193.3
Q ss_pred cccccceeecccCceeEEEEEe--CCccEEEEEeCcChh---HhHHHHHHHHHHHHcCCCCceeeeccccCCCc--eEEE
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAA---QGKRQFQQEVEVLSSIRHPNMVLLLGACPDYG--CLVY 301 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~---~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~--~lV~ 301 (568)
++|.+.+.||+|+||.||++.+ .+..||||.+..... .....+.+|+++++.++||||+++++.+.... ++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 4688999999999999999987 456899999876532 23456789999999999999999999885544 8999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCC
Q 008365 302 EYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPS 381 (568)
Q Consensus 302 E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~ 381 (568)
||++|++|.+++...+ .+++..+..++.|++.||.|||+.+ |+||||||.||||+.++.+||+|||+++.....
T Consensus 81 e~~~g~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~ 154 (305)
T cd05609 81 EYVEGGDCATLLKNIG---ALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS 154 (305)
T ss_pred ecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence 9999999999987653 3788999999999999999999999 999999999999999999999999998742111
Q ss_pred CCc---------cccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHH--HHHHHhCccc
Q 008365 382 VAD---------SVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHV--SRAIEKGTLA 450 (568)
Q Consensus 382 ~~~---------~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~--~~~~~~~~~~ 450 (568)
... ...........|+..|+|||++.+..++.++|||||||++|+|++|..||...... ...+..+..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~- 233 (305)
T cd05609 155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDI- 233 (305)
T ss_pred ccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc-
Confidence 100 00111112356889999999998888999999999999999999999999643321 111111111
Q ss_pred cccCccCCCCChHHHHHHHHHHHHhhccCCCCCCChH
Q 008365 451 EMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLG 487 (568)
Q Consensus 451 ~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~ 487 (568)
..+ ..+..++..+.+++.+||+.+|.+||+..
T Consensus 234 --~~~---~~~~~~~~~~~~li~~~l~~~P~~R~~~~ 265 (305)
T cd05609 234 --EWP---EGDEALPADAQDLISRLLRQNPLERLGTG 265 (305)
T ss_pred --CCC---CccccCCHHHHHHHHHHhccChhhccCcc
Confidence 011 11123566789999999999999999954
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-37 Score=308.32 Aligned_cols=246 Identities=25% Similarity=0.394 Sum_probs=197.4
Q ss_pred ccccceeecccCceeEEEEEe--CCccEEEEEeCcCh-hHhHHHHHHHHHHHHcCC---CCceeeeccccCCC--ceEEE
Q 008365 230 KFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDA-AQGKRQFQQEVEVLSSIR---HPNMVLLLGACPDY--GCLVY 301 (568)
Q Consensus 230 ~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l~---HpnIv~l~g~~~~~--~~lV~ 301 (568)
.|++.+.||.|+||.||+|.+ ++..||||++.... ......+.+|+.+++.++ |||+++++++|.+. .++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 477888999999999999987 56789999987542 334457889999999997 99999999988543 48999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCC
Q 008365 302 EYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPS 381 (568)
Q Consensus 302 E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~ 381 (568)
||+++++|.+++... .+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++..+...
T Consensus 82 e~~~~~~L~~~~~~~----~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06917 82 EYAEGGSVRTLMKAG----PIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQN 154 (277)
T ss_pred ecCCCCcHHHHHHcc----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence 999999999988543 3889999999999999999999999 999999999999999999999999999876433
Q ss_pred CCccccccccccccccccCCChhhhhc-CCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHhCccccccCccCCCC
Q 008365 382 VADSVTQYHMTSAAGTFCYIDPEYQQT-GMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAVTDW 460 (568)
Q Consensus 382 ~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~l~~~~~~~ 460 (568)
.. ......|+..|+|||++.+ ..++.++|||||||++|+|++|..||............. .... ..+
T Consensus 155 ~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~---~~~~---~~~ 222 (277)
T cd06917 155 SS------KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIP---KSKP---PRL 222 (277)
T ss_pred cc------ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccc---cCCC---CCC
Confidence 21 1234568999999998765 457899999999999999999999997554432221110 0111 112
Q ss_pred Ch-HHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 461 PA-EAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 461 p~-~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
+. ..+..+.+++.+||..+|.+||++.+++.+.+
T Consensus 223 ~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~ 257 (277)
T cd06917 223 EDNGYSKLLREFVAACLDEEPKERLSAEELLKSKW 257 (277)
T ss_pred CcccCCHHHHHHHHHHcCCCcccCcCHHHHhhChH
Confidence 22 25567999999999999999999999986554
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=308.57 Aligned_cols=246 Identities=24% Similarity=0.371 Sum_probs=199.1
Q ss_pred ccccceeecccCceeEEEEEe--CCccEEEEEeCcCh-hHhHHHHHHHHHHHHcCCCCceeeeccccCC--CceEEEEec
Q 008365 230 KFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDA-AQGKRQFQQEVEVLSSIRHPNMVLLLGACPD--YGCLVYEYM 304 (568)
Q Consensus 230 ~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--~~~lV~E~~ 304 (568)
-|++.+.||.|+||.||+|.+ ++..||||++.... ......+.+|+.++..++||||++++++|.+ ..++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 377888999999999999976 56789999986443 2334578899999999999999999998854 458999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCCc
Q 008365 305 HNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVAD 384 (568)
Q Consensus 305 ~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~~ 384 (568)
++++|.+++... .+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++..+....
T Consensus 85 ~~~~l~~~i~~~----~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~-- 155 (277)
T cd06641 85 GGGSALDLLEPG----PLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-- 155 (277)
T ss_pred CCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccch--
Confidence 999999988542 3789999999999999999999999 9999999999999999999999999987653321
Q ss_pred cccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHhCccccccCccCCCCChHH
Q 008365 385 SVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAVTDWPAEA 464 (568)
Q Consensus 385 ~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~l~~~~~~~p~~~ 464 (568)
.......|+..|+|||++.+..++.++|||||||++|+|++|..||............. .......+..+
T Consensus 156 ----~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~------~~~~~~~~~~~ 225 (277)
T cd06641 156 ----IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIP------KNNPPTLEGNY 225 (277)
T ss_pred ----hhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHh------cCCCCCCCccc
Confidence 11233568899999999988889999999999999999999999996544322111100 01111233455
Q ss_pred HHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 465 AESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 465 ~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
+..+.+++.+||..+|.+||++.+++.+.+
T Consensus 226 ~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~ 255 (277)
T cd06641 226 SKPLKEFVEACLNKEPSFRPTAKELLKHKF 255 (277)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHhCHH
Confidence 677999999999999999999999997654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=305.26 Aligned_cols=251 Identities=27% Similarity=0.413 Sum_probs=198.7
Q ss_pred ccccceeecccCceeEEEEEe--CCccEEEEEeCcChh--HhHHHHHHHHHHHHcCCCCceeeeccccCC--CceEEEEe
Q 008365 230 KFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAA--QGKRQFQQEVEVLSSIRHPNMVLLLGACPD--YGCLVYEY 303 (568)
Q Consensus 230 ~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~--~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--~~~lV~E~ 303 (568)
+|.+.+.||+|+||.||+|.+ ++..||||+++.... .....+.+|+.+++.++|+||+++++++.+ ..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 488889999999999999986 567899999876544 256678999999999999999999998754 34899999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCC
Q 008365 304 MHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVA 383 (568)
Q Consensus 304 ~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~ 383 (568)
+++++|.+++.... .+++..+..|+.+++.||.|||+.+ |+|+||+|+||+++.++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~ 154 (264)
T cd06626 81 CSGGTLEELLEHGR---ILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT 154 (264)
T ss_pred CCCCcHHHHHhhcC---CCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence 99999999887643 3788889999999999999999999 99999999999999999999999999987643321
Q ss_pred ccccccccccccccccCCChhhhhcCC---CCCcceehhHHHHHHHHHhCCCCCCCchH-HHHHHHhCccccccCccCCC
Q 008365 384 DSVTQYHMTSAAGTFCYIDPEYQQTGM---LTTKSDIYSFGIMLLQIITARSPMGLTHH-VSRAIEKGTLAEMLDPAVTD 459 (568)
Q Consensus 384 ~~~~~~~~~~~~GT~~Y~APE~~~~~~---~s~ksDvwSlGvil~elltG~~Pf~~~~~-~~~~~~~~~~~~~l~~~~~~ 459 (568)
... .......+++.|+|||++.+.. ++.++|||||||++|+|++|+.||...+. ......... ...+.++.
T Consensus 155 ~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~---~~~~~~~~ 229 (264)
T cd06626 155 TMG--EEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA---GHKPPIPD 229 (264)
T ss_pred ccc--ccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhc---CCCCCCCc
Confidence 111 1012356889999999988766 89999999999999999999999964422 111111111 11111111
Q ss_pred CChHHHHHHHHHHHHhhccCCCCCCChHHhHhH
Q 008365 460 WPAEAAESFSKLAIQCAELRKKDRPDLGTVIVP 492 (568)
Q Consensus 460 ~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~ 492 (568)
...++..+.+++.+||+.+|.+||++.+++.+
T Consensus 230 -~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~ 261 (264)
T cd06626 230 -SLQLSPEGKDFLDRCLESDPKKRPTASELLQH 261 (264)
T ss_pred -ccccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 11236778899999999999999999998754
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=308.79 Aligned_cols=242 Identities=24% Similarity=0.297 Sum_probs=198.7
Q ss_pred ccccceeecccCceeEEEEEeC--CccEEEEEeCcCh---hHhHHHHHHHHHHHHcCCCCceeeeccccCC--CceEEEE
Q 008365 230 KFSEAMKIGEGGYGPVYRGKLD--HTPVAIKVLRPDA---AQGKRQFQQEVEVLSSIRHPNMVLLLGACPD--YGCLVYE 302 (568)
Q Consensus 230 ~y~~~~~IG~G~fg~Vy~~~~~--~~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--~~~lV~E 302 (568)
+|.+.+.||.|+||.||+|.+. +..||+|++.... ......+.+|++++++++||||+++++.+.+ ..++|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4888999999999999999874 7799999997543 2345678899999999999999999998854 3489999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCC
Q 008365 303 YMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSV 382 (568)
Q Consensus 303 ~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~ 382 (568)
|+.|++|.+++.... .+++..+..|+.||+.||.|||+.+ |+|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~l~~~~---~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 154 (258)
T cd05578 81 LLLGGDLRYHLSQKV---KFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT 154 (258)
T ss_pred CCCCCCHHHHHHhcC---CcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence 999999999987652 4888999999999999999999999 9999999999999999999999999997654321
Q ss_pred CccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchH--HHHHHHhCccccccCccCCCC
Q 008365 383 ADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHH--VSRAIEKGTLAEMLDPAVTDW 460 (568)
Q Consensus 383 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~--~~~~~~~~~~~~~l~~~~~~~ 460 (568)
......|+..|+|||++.+..++.++|+|||||++|+|++|..||..... ........ .......
T Consensus 155 -------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~------~~~~~~~ 221 (258)
T cd05578 155 -------LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQ------ETADVLY 221 (258)
T ss_pred -------cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHh------ccccccC
Confidence 12345688999999999988899999999999999999999999975442 11111111 1112233
Q ss_pred ChHHHHHHHHHHHHhhccCCCCCCCh--HHhH
Q 008365 461 PAEAAESFSKLAIQCAELRKKDRPDL--GTVI 490 (568)
Q Consensus 461 p~~~~~~l~~li~~Cl~~dP~~RPs~--~~vl 490 (568)
|...+..+.+++.+||..+|.+||++ .+++
T Consensus 222 ~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 222 PATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred cccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 45566889999999999999999999 6654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=312.22 Aligned_cols=252 Identities=25% Similarity=0.351 Sum_probs=193.7
Q ss_pred ccccceeecccCceeEEEEEe--CCccEEEEEeCcChh--HhHHHHHHHHHHHHcCCCCceeeeccccCCC--ceEEEEe
Q 008365 230 KFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAA--QGKRQFQQEVEVLSSIRHPNMVLLLGACPDY--GCLVYEY 303 (568)
Q Consensus 230 ~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~--~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~--~~lV~E~ 303 (568)
+|+.++.||.|+||.||+|.+ ++..||||++..... .....+.+|++++++++||||+++++++.+. .++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 488899999999999999987 577899999865432 2234688999999999999999999998543 4899999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCC
Q 008365 304 MHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVA 383 (568)
Q Consensus 304 ~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~ 383 (568)
+. ++|..++..... ..+++..+..++.||+.||.|||..+ |+|+||+|+||+++.++.+||+|||++..+.....
T Consensus 81 ~~-~~l~~~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~ 155 (284)
T cd07860 81 LH-QDLKKFMDASPL-SGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 155 (284)
T ss_pred cc-cCHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence 95 689888865433 34889999999999999999999999 99999999999999999999999999876533211
Q ss_pred ccccccccccccccccCCChhhhhcC-CCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHH---hCc-----------
Q 008365 384 DSVTQYHMTSAAGTFCYIDPEYQQTG-MLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIE---KGT----------- 448 (568)
Q Consensus 384 ~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~---~~~----------- 448 (568)
......+++.|+|||++.+. .++.++|||||||++|+|+||+.||........... ...
T Consensus 156 ------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (284)
T cd07860 156 ------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT 229 (284)
T ss_pred ------ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhh
Confidence 11234578999999977654 468899999999999999999999965443222111 000
Q ss_pred --------cccccCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhH
Q 008365 449 --------LAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVP 492 (568)
Q Consensus 449 --------~~~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~ 492 (568)
+..............++..+.+++.+||+.+|.+||++.+++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 230 SLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred HHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 00000000111112345678899999999999999999998854
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=305.83 Aligned_cols=247 Identities=26% Similarity=0.440 Sum_probs=198.2
Q ss_pred ccccceeecccCceeEEEEEe--CCccEEEEEeCcCh--hHhHHHHHHHHHHHHcCCCCceeeeccccCCC--ceEEEEe
Q 008365 230 KFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDA--AQGKRQFQQEVEVLSSIRHPNMVLLLGACPDY--GCLVYEY 303 (568)
Q Consensus 230 ~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~--~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~--~~lV~E~ 303 (568)
+|.+.+.||.|+||.||+|.. ++..||+|.+.... ......+.+|+.+++.++|+||+++++.+.+. .++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 478899999999999999987 56789999986542 12345688999999999999999999988554 4899999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCc-eeEecccccccccCCCC
Q 008365 304 MHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNY-VSKISDVGLARLVPPSV 382 (568)
Q Consensus 304 ~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~-~vKL~DFGla~~~~~~~ 382 (568)
+++++|.+++..... ..+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++ .+||+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (257)
T cd08225 81 CDGGDLMKRINRQRG-VLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM 156 (257)
T ss_pred CCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence 999999999876433 24789999999999999999999999 99999999999998875 57999999997654321
Q ss_pred CccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHhCccccccCccCCCCCh
Q 008365 383 ADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAVTDWPA 462 (568)
Q Consensus 383 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~l~~~~~~~p~ 462 (568)
. ......|++.|+|||++.+..++.++|||||||++|+|++|..||........... .....+...++
T Consensus 157 ~------~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~------~~~~~~~~~~~ 224 (257)
T cd08225 157 E------LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLK------ICQGYFAPISP 224 (257)
T ss_pred c------cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHH------HhcccCCCCCC
Confidence 1 11234689999999999888899999999999999999999999975443222111 11111222233
Q ss_pred HHHHHHHHHHHHhhccCCCCCCChHHhHhH
Q 008365 463 EAAESFSKLAIQCAELRKKDRPDLGTVIVP 492 (568)
Q Consensus 463 ~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~ 492 (568)
..+..+.+++.+||..+|.+||++.+++.+
T Consensus 225 ~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 225 NFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred CCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 455679999999999999999999999754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=308.51 Aligned_cols=252 Identities=26% Similarity=0.409 Sum_probs=192.5
Q ss_pred cccccceeecccCceeEEEEEe--CCccEEEEEeCcChh-HhHHHHHHHHHH-HHcCCCCceeeeccccCC--CceEEEE
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAA-QGKRQFQQEVEV-LSSIRHPNMVLLLGACPD--YGCLVYE 302 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~-~~~~~~~~Ev~i-L~~l~HpnIv~l~g~~~~--~~~lV~E 302 (568)
++|++.+.||+|+||.||++.+ ++..||||+++.... .....+..|+.+ ++.++||||+++++++.. ..++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 4688999999999999999987 578999999876432 223445556665 667789999999998844 4589999
Q ss_pred ecCCCCHHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHHc-CCCCcccCCCCCCCeeccCCceeEecccccccccCC
Q 008365 303 YMHNGSLEDRLLRR-GNTPVIPWRKRFKIAAEIATALLFLHQA-KPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPP 380 (568)
Q Consensus 303 ~~~ggsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~yLH~~-~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~ 380 (568)
|++ |+|.+++... .....+++..+..++.||+.||.|||+. + |+||||||+|||++.++.+||+|||++..+..
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 995 7888887653 2234589999999999999999999997 7 99999999999999999999999999976532
Q ss_pred CCCccccccccccccccccCCChhhhhc----CCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHhCccccccCcc
Q 008365 381 SVADSVTQYHMTSAAGTFCYIDPEYQQT----GMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPA 456 (568)
Q Consensus 381 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~----~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~l~~~ 456 (568)
.. ......|+..|+|||++.+ ..++.++|+|||||++|+|++|+.||.........+.. .+...
T Consensus 157 ~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~-----~~~~~ 224 (283)
T cd06617 157 SV-------AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQ-----VVEEP 224 (283)
T ss_pred cc-------ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHH-----HHhcC
Confidence 11 1123468899999998765 45688999999999999999999999643211111110 01111
Q ss_pred CCCCC-hHHHHHHHHHHHHhhccCCCCCCChHHhHhHHHHH
Q 008365 457 VTDWP-AEAAESFSKLAIQCAELRKKDRPDLGTVIVPELNR 496 (568)
Q Consensus 457 ~~~~p-~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l~~ 496 (568)
....+ ..++..+.+++.+||..+|.+||++.+++.+.+-.
T Consensus 225 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~ 265 (283)
T cd06617 225 SPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFE 265 (283)
T ss_pred CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhh
Confidence 11111 23467799999999999999999999998765533
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=312.31 Aligned_cols=251 Identities=23% Similarity=0.301 Sum_probs=195.0
Q ss_pred ccccceeecccCceeEEEEEe--CCccEEEEEeCcChhH-----hHHHHHHHHHHHHcCCCCceeeeccccCCC--ceEE
Q 008365 230 KFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQ-----GKRQFQQEVEVLSSIRHPNMVLLLGACPDY--GCLV 300 (568)
Q Consensus 230 ~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~-----~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~--~~lV 300 (568)
+|.+.+.||.|+||.||+|.+ +++.||||.+...... ....+..|+.+++.++|+||+++++++.+. .++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 477888999999999999987 5679999999765332 234567899999999999999999998653 4899
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCC
Q 008365 301 YEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPP 380 (568)
Q Consensus 301 ~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~ 380 (568)
|||+ +|+|.+++.... ..+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.++|+|||+++.+..
T Consensus 81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGS 154 (298)
T ss_pred Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence 9999 999999987644 24899999999999999999999999 99999999999999999999999999986643
Q ss_pred CCCccccccccccccccccCCChhhhhc-CCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHhCc-----------
Q 008365 381 SVADSVTQYHMTSAAGTFCYIDPEYQQT-GMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGT----------- 448 (568)
Q Consensus 381 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~----------- 448 (568)
.. .......+++.|+|||.+.+ ..++.++|||||||++|+|++|.+||..............
T Consensus 155 ~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (298)
T cd07841 155 PN------RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWP 228 (298)
T ss_pred CC------ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhh
Confidence 21 11223457889999998754 4678999999999999999999888864443221100000
Q ss_pred ----ccccc------CccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhH
Q 008365 449 ----LAEML------DPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVP 492 (568)
Q Consensus 449 ----~~~~l------~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~ 492 (568)
..... ...........+..+.+++.+||..+|.+||++.+++.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 229 GVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred hcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 00000 000001123446788999999999999999999999854
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=299.35 Aligned_cols=247 Identities=26% Similarity=0.440 Sum_probs=201.6
Q ss_pred ccccceeecccCceeEEEEEeC--CccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCceeeeccccCC--CceEEEEecC
Q 008365 230 KFSEAMKIGEGGYGPVYRGKLD--HTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACPD--YGCLVYEYMH 305 (568)
Q Consensus 230 ~y~~~~~IG~G~fg~Vy~~~~~--~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--~~~lV~E~~~ 305 (568)
+|.+.+.||.|+||.||++.+. +..|++|++..........+.+|+.+++.++||||+++++++.. ..++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 4778899999999999999884 77899999987665556788999999999999999999998744 4489999999
Q ss_pred CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCCcc
Q 008365 306 NGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADS 385 (568)
Q Consensus 306 ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~~~ 385 (568)
+++|.+++.... ..+++..+..++.|++.||.|||..+ ++||||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 153 (253)
T cd05122 81 GGSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-- 153 (253)
T ss_pred CCcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc--
Confidence 999999887653 24899999999999999999999998 99999999999999999999999999976644321
Q ss_pred ccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHhCccccccCccCCCCChHHH
Q 008365 386 VTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAVTDWPAEAA 465 (568)
Q Consensus 386 ~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~l~~~~~~~p~~~~ 465 (568)
.....|+..|++||++.+..++.++|||||||++|+|++|..||............... ..+.. ..+..++
T Consensus 154 -----~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~---~~~~~-~~~~~~~ 224 (253)
T cd05122 154 -----RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATN---GPPGL-RNPEKWS 224 (253)
T ss_pred -----ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhc---CCCCc-CcccccC
Confidence 23456899999999998888999999999999999999999999765332222111110 00111 1122235
Q ss_pred HHHHHHHHHhhccCCCCCCChHHhHhH
Q 008365 466 ESFSKLAIQCAELRKKDRPDLGTVIVP 492 (568)
Q Consensus 466 ~~l~~li~~Cl~~dP~~RPs~~~vl~~ 492 (568)
..+.+++.+||..+|.+||++.+++.+
T Consensus 225 ~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 225 DEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred HHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 679999999999999999999998754
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=309.39 Aligned_cols=247 Identities=23% Similarity=0.332 Sum_probs=198.0
Q ss_pred cccceeecccCceeEEEEEe--CCccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCceeeeccccC--CCceEEEEecCC
Q 008365 231 FSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACP--DYGCLVYEYMHN 306 (568)
Q Consensus 231 y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~--~~~~lV~E~~~g 306 (568)
|...+.||.|+||.||++.+ .+..|+||++..........+.+|+.+++.++||||+++++++. +..++|+||++|
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 45557999999999999986 56789999987655555567889999999999999999999874 455899999999
Q ss_pred CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCCccc
Q 008365 307 GSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSV 386 (568)
Q Consensus 307 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~~~~ 386 (568)
++|.+++... .+++..+..|+.|++.||.|||+.+ |+||||+|+||+++.++.++|+|||++........
T Consensus 101 ~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~--- 170 (285)
T cd06648 101 GALTDIVTHT----RMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP--- 170 (285)
T ss_pred CCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCc---
Confidence 9999988762 2788999999999999999999999 99999999999999999999999999875432211
Q ss_pred cccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHhCccccccCccCCCCChHHHH
Q 008365 387 TQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAVTDWPAEAAE 466 (568)
Q Consensus 387 ~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~l~~~~~~~p~~~~~ 466 (568)
......|++.|+|||.+.+..++.++|||||||++|+|++|+.||...+....... +.....+.. ..+..++.
T Consensus 171 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~---~~~~~~~~~-~~~~~~~~ 243 (285)
T cd06648 171 ---RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKR---IRDNLPPKL-KNLHKVSP 243 (285)
T ss_pred ---ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHH---HHhcCCCCC-cccccCCH
Confidence 11235689999999999888899999999999999999999999965443222111 011111111 11223567
Q ss_pred HHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 467 SFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 467 ~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
.+.+++.+||..+|.+||++.+++.+.+
T Consensus 244 ~l~~li~~~l~~~p~~Rpt~~~il~~~~ 271 (285)
T cd06648 244 RLRSFLDRMLVRDPAQRATAAELLNHPF 271 (285)
T ss_pred HHHHHHHHHcccChhhCcCHHHHccCcc
Confidence 8999999999999999999999985443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=324.17 Aligned_cols=246 Identities=30% Similarity=0.482 Sum_probs=205.9
Q ss_pred cccceeecccCceeEEEEEeCC--ccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCceeeeccccCC--CceEEEEecCC
Q 008365 231 FSEAMKIGEGGYGPVYRGKLDH--TPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACPD--YGCLVYEYMHN 306 (568)
Q Consensus 231 y~~~~~IG~G~fg~Vy~~~~~~--~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--~~~lV~E~~~g 306 (568)
....++||-|-||.||.|.+.. ..||||.++.+... .+.|..|..+|+.+.|||+|+|+|+|.. ..|||.|||..
T Consensus 269 ItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMe-veEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~y 347 (1157)
T KOG4278|consen 269 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCY 347 (1157)
T ss_pred eeeeeccCCCcccceeeeeeeccceeeehhhhhhcchh-HHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccC
Confidence 3455799999999999999854 47999999877655 5789999999999999999999999954 45999999999
Q ss_pred CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCCccc
Q 008365 307 GSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSV 386 (568)
Q Consensus 307 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~~~~ 386 (568)
|+|.++|.++... .++.-..+.++.||..|+.||..++ +|||||-..|+||.++..|||+||||++++..+....
T Consensus 348 GNLLdYLRecnr~-ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTA- 422 (1157)
T KOG4278|consen 348 GNLLDYLRECNRS-EVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTA- 422 (1157)
T ss_pred ccHHHHHHHhchh-hcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhhhcCCceec-
Confidence 9999999987654 3667778899999999999999999 9999999999999999999999999999885432211
Q ss_pred cccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh-CCCCCCCch--HHHHHHHhCccccccCccCCCCChH
Q 008365 387 TQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPMGLTH--HVSRAIEKGTLAEMLDPAVTDWPAE 463 (568)
Q Consensus 387 ~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~--~~~~~~~~~~~~~~l~~~~~~~p~~ 463 (568)
..+.--..-|.|||-+..+.++.|+|||+|||+||||.| |..||-+.+ .++..++++.- .+-|.+
T Consensus 423 ----HAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyR--------M~~PeG 490 (1157)
T KOG4278|consen 423 ----HAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYR--------MDGPEG 490 (1157)
T ss_pred ----ccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhcccc--------ccCCCC
Confidence 111222467999999999999999999999999999999 888996544 35555555432 245788
Q ss_pred HHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 464 AAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 464 ~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
||+.+.+||..||+++|.+||+++++-+.+.
T Consensus 491 CPpkVYeLMraCW~WsPsDRPsFaeiHqafE 521 (1157)
T KOG4278|consen 491 CPPKVYELMRACWNWSPSDRPSFAEIHQAFE 521 (1157)
T ss_pred CCHHHHHHHHHHhcCCcccCccHHHHHHHHH
Confidence 9999999999999999999999998854433
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=311.59 Aligned_cols=253 Identities=24% Similarity=0.351 Sum_probs=196.8
Q ss_pred cccccceeecccCceeEEEEEe--CCccEEEEEeCcCh--hHhHHHHHHHHHHHHcCCCCceeeeccccCC--CceEEEE
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDA--AQGKRQFQQEVEVLSSIRHPNMVLLLGACPD--YGCLVYE 302 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~--~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--~~~lV~E 302 (568)
++|++.+.||.|+||.||+|.+ ++..||||+++... ......+.+|+++++.++|+||++++++|.+ ..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 3689999999999999999987 46789999986532 2234678899999999999999999999854 3489999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCC
Q 008365 303 YMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSV 382 (568)
Q Consensus 303 ~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~ 382 (568)
|++++.+..++.... .+++..+..++.||+.||.|||+.+ |+|+||+|+||+++.++.+||+|||++..+....
T Consensus 81 ~~~~~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 154 (288)
T cd07833 81 YVERTLLELLEASPG---GLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARP 154 (288)
T ss_pred cCCCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence 998876665544322 3788999999999999999999999 9999999999999999999999999998764332
Q ss_pred CccccccccccccccccCCChhhhhcC-CCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHhC----ccc-------
Q 008365 383 ADSVTQYHMTSAAGTFCYIDPEYQQTG-MLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKG----TLA------- 450 (568)
Q Consensus 383 ~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~----~~~------- 450 (568)
. .......++..|+|||++.+. .++.++|||||||++|+|++|++||............. .+.
T Consensus 155 ~-----~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (288)
T cd07833 155 A-----SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELF 229 (288)
T ss_pred c-----ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhc
Confidence 1 112345688999999998888 88999999999999999999999997544332211100 000
Q ss_pred ---------cccCccC-----CCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhH
Q 008365 451 ---------EMLDPAV-----TDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVP 492 (568)
Q Consensus 451 ---------~~l~~~~-----~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~ 492 (568)
+..+... ..++..++..+.+|+.+||..+|.+||++.+++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 230 SSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred ccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 0000000 01233347789999999999999999999998753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=312.30 Aligned_cols=255 Identities=18% Similarity=0.228 Sum_probs=183.3
Q ss_pred HhcccccceeecccCceeEEEEEeCC-----ccEEEEEeCcChhHh--H---------HHHHHHHHHHHcCCCCceeeec
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKLDH-----TPVAIKVLRPDAAQG--K---------RQFQQEVEVLSSIRHPNMVLLL 290 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~~~-----~~vAvK~l~~~~~~~--~---------~~~~~Ev~iL~~l~HpnIv~l~ 290 (568)
..++|.+.++||+|+||.||+|.+.+ ..+|+|+........ . .....+...+..+.|+||+.++
T Consensus 10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~ 89 (294)
T PHA02882 10 TGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYY 89 (294)
T ss_pred CCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEE
Confidence 34689999999999999999998743 367777643322110 0 1122344556677899999999
Q ss_pred cccCC------CceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCC
Q 008365 291 GACPD------YGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRN 364 (568)
Q Consensus 291 g~~~~------~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~ 364 (568)
+.+.. ..+++|+++ ..++.+.+.... ..++..+..|+.|++.||.|||+.+ |+||||||+|||++.+
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~ 162 (294)
T PHA02882 90 GCGSFKRCRMYYRFILLEKL-VENTKEIFKRIK---CKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGN 162 (294)
T ss_pred EeeeEecCCceEEEEEEehh-ccCHHHHHHhhc---cCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCC
Confidence 86532 226788877 457777665432 2567888899999999999999999 9999999999999999
Q ss_pred ceeEecccccccccCCCCCcc-ccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHH-
Q 008365 365 YVSKISDVGLARLVPPSVADS-VTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSR- 442 (568)
Q Consensus 365 ~~vKL~DFGla~~~~~~~~~~-~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~- 442 (568)
+.+||+|||+|+.+....... ..........||+.|+|||++.+..++.++|||||||++|||++|..||........
T Consensus 163 ~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~ 242 (294)
T PHA02882 163 NRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNL 242 (294)
T ss_pred CcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHH
Confidence 999999999998764321111 011112345799999999999999999999999999999999999999965421111
Q ss_pred --HHHhCccccccCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhH
Q 008365 443 --AIEKGTLAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVI 490 (568)
Q Consensus 443 --~~~~~~~~~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl 490 (568)
....+-+..+..... .+..++..+.+++..|+.++|.+||++.+++
T Consensus 243 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~ 290 (294)
T PHA02882 243 IHAAKCDFIKRLHEGKI--KIKNANKFIYDFIECVTKLSYEEKPDYDALI 290 (294)
T ss_pred HHHhHHHHHHHhhhhhh--ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHH
Confidence 111111111111111 1234467899999999999999999999886
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=299.24 Aligned_cols=250 Identities=26% Similarity=0.383 Sum_probs=204.5
Q ss_pred ccccceeecccCceeEEEEEeC--CccEEEEEeCcChh--HhHHHHHHHHHHHHcCCCCceeeeccccCCC----ceEEE
Q 008365 230 KFSEAMKIGEGGYGPVYRGKLD--HTPVAIKVLRPDAA--QGKRQFQQEVEVLSSIRHPNMVLLLGACPDY----GCLVY 301 (568)
Q Consensus 230 ~y~~~~~IG~G~fg~Vy~~~~~--~~~vAvK~l~~~~~--~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~----~~lV~ 301 (568)
+|...+.||+|+||.||+|.+. ++.|+||++..... .....+.+|+.++++++||||+++++.+.+. .++||
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4778899999999999999884 78899999876543 4456788999999999999999999988554 48999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCC
Q 008365 302 EYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPS 381 (568)
Q Consensus 302 E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~ 381 (568)
||+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+......
T Consensus 81 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 154 (260)
T cd06606 81 EYVSGGSLSSLLKKFG---KLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDI 154 (260)
T ss_pred EecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence 9999999999987654 4899999999999999999999998 999999999999999999999999999876443
Q ss_pred CCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHhCccccccCccCCCCC
Q 008365 382 VADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAVTDWP 461 (568)
Q Consensus 382 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~l~~~~~~~p 461 (568)
... .......++..|++||.+.+..++.++|||||||++|+|++|..||............-.. .......+
T Consensus 155 ~~~----~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~----~~~~~~~~ 226 (260)
T cd06606 155 ETG----EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGS----SGEPPEIP 226 (260)
T ss_pred ccc----ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccc----cCCCcCCC
Confidence 211 0123456889999999999888999999999999999999999999765422111111110 11222345
Q ss_pred hHHHHHHHHHHHHhhccCCCCCCChHHhHhHH
Q 008365 462 AEAAESFSKLAIQCAELRKKDRPDLGTVIVPE 493 (568)
Q Consensus 462 ~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~ 493 (568)
...+..+.+++.+|+..+|.+||++.+++.+.
T Consensus 227 ~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~ 258 (260)
T cd06606 227 EHLSEEAKDFLRKCLRRDPKKRPTADELLQHP 258 (260)
T ss_pred cccCHHHHHHHHHhCcCChhhCCCHHHHhhCC
Confidence 56678899999999999999999999998653
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=310.86 Aligned_cols=245 Identities=27% Similarity=0.399 Sum_probs=195.3
Q ss_pred cccccceeecccCceeEEEEEe--CCccEEEEEeCcCh---hHhHHHHHHHHHHHHcCCCCceeeeccccCC--CceEEE
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDA---AQGKRQFQQEVEVLSSIRHPNMVLLLGACPD--YGCLVY 301 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--~~~lV~ 301 (568)
..|...+.||+|+||.||+|.. .++.||||++.... ......+.+|+.+++.++||||++++++|.+ ..++||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 4588889999999999999987 57899999986432 2334568899999999999999999998854 458999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCC
Q 008365 302 EYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPS 381 (568)
Q Consensus 302 E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~ 381 (568)
||+. |+|.+++..... .+++..+..++.||+.||.|||+.+ |+||||+|+||+++.++.+||+|||++......
T Consensus 95 e~~~-g~l~~~~~~~~~--~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~ 168 (307)
T cd06607 95 EYCL-GSASDILEVHKK--PLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSPA 168 (307)
T ss_pred HhhC-CCHHHHHHHccc--CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCCC
Confidence 9996 677777754432 3889999999999999999999999 999999999999999999999999998765322
Q ss_pred CCccccccccccccccccCCChhhhh---cCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHhCccccccCccCC
Q 008365 382 VADSVTQYHMTSAAGTFCYIDPEYQQ---TGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAVT 458 (568)
Q Consensus 382 ~~~~~~~~~~~~~~GT~~Y~APE~~~---~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~l~~~~~ 458 (568)
....|++.|+|||++. ...++.++|||||||++|+|++|+.||...+.......... ...+..
T Consensus 169 ----------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~---~~~~~~- 234 (307)
T cd06607 169 ----------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ---NDSPTL- 234 (307)
T ss_pred ----------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhc---CCCCCC-
Confidence 2346889999999774 45688999999999999999999999976544332211110 000111
Q ss_pred CCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 459 DWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 459 ~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
.+..++..+.+++.+||..+|.+||++.+|+.+.+
T Consensus 235 -~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 269 (307)
T cd06607 235 -SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRF 269 (307)
T ss_pred -CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChh
Confidence 12345678999999999999999999999987544
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=322.10 Aligned_cols=250 Identities=24% Similarity=0.342 Sum_probs=196.5
Q ss_pred cccccceeecccCceeEEEEEeC-CccEEEEEeCc--ChhHhHHHHHHHHHHHHcCC-CCceeeecccc--CCCceEEEE
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKLD-HTPVAIKVLRP--DAAQGKRQFQQEVEVLSSIR-HPNMVLLLGAC--PDYGCLVYE 302 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~~-~~~vAvK~l~~--~~~~~~~~~~~Ev~iL~~l~-HpnIv~l~g~~--~~~~~lV~E 302 (568)
..|+++++||+||.+.||++... .+.||+|.+.. ...+....|.+|+..|.+|. |.+||.||+|- ..+.|||||
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE 440 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVME 440 (677)
T ss_pred chhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEee
Confidence 46999999999999999999874 45777776543 34455677999999999996 99999999885 445689999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCC
Q 008365 303 YMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSV 382 (568)
Q Consensus 303 ~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~ 382 (568)
|- ..+|..+|...... ++.-.+..+..|++.|+.++|+.| |||.||||.|||+-+ |.+||+|||+|..+.+..
T Consensus 441 ~G-d~DL~kiL~k~~~~--~~~~~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~DT 513 (677)
T KOG0596|consen 441 CG-DIDLNKILKKKKSI--DPDWFLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLVK-GRLKLIDFGIANAIQPDT 513 (677)
T ss_pred cc-cccHHHHHHhccCC--CchHHHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEEe-eeEEeeeechhcccCccc
Confidence 86 67999999877654 332256678899999999999999 999999999999854 689999999999876654
Q ss_pred CccccccccccccccccCCChhhhhcCC-----------CCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHhCcccc
Q 008365 383 ADSVTQYHMTSAAGTFCYIDPEYQQTGM-----------LTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAE 451 (568)
Q Consensus 383 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~-----------~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~ 451 (568)
.. ....+.+||+.||+||.+.... .+.++||||||||||+|+.|+.||+....... .+..
T Consensus 514 Ts----I~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~a-----Kl~a 584 (677)
T KOG0596|consen 514 TS----IVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIA-----KLHA 584 (677)
T ss_pred cc----eeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHH-----HHHh
Confidence 32 2345679999999999775432 56899999999999999999999965443222 2334
Q ss_pred ccCccC----CCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHHHH
Q 008365 452 MLDPAV----TDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPELNR 496 (568)
Q Consensus 452 ~l~~~~----~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l~~ 496 (568)
+.+|.. +..|.. .++.+++..||+.||.+||+..++|.|.+-.
T Consensus 585 I~~P~~~Iefp~~~~~--~~li~~mK~CL~rdPkkR~si~eLLqhpFl~ 631 (677)
T KOG0596|consen 585 ITDPNHEIEFPDIPEN--DELIDVMKCCLARDPKKRWSIPELLQHPFLQ 631 (677)
T ss_pred hcCCCccccccCCCCc--hHHHHHHHHHHhcCcccCCCcHHHhcCcccc
Confidence 445532 233332 2389999999999999999999998765533
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=305.51 Aligned_cols=246 Identities=23% Similarity=0.416 Sum_probs=193.1
Q ss_pred cccceeecccCceeEEEEEe-----CCccEEEEEeCcCh--hHhHHHHHHHHHHHHcCCCCceeeeccccCCC-------
Q 008365 231 FSEAMKIGEGGYGPVYRGKL-----DHTPVAIKVLRPDA--AQGKRQFQQEVEVLSSIRHPNMVLLLGACPDY------- 296 (568)
Q Consensus 231 y~~~~~IG~G~fg~Vy~~~~-----~~~~vAvK~l~~~~--~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~------- 296 (568)
|.+.+.||+|+||.||+|.+ .+..||||++.... ....+.+.+|+.+++.++||||+++++++...
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 56778999999999999975 24689999987542 33456788999999999999999999976321
Q ss_pred -ceEEEEecCCCCHHHHHhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEeccc
Q 008365 297 -GCLVYEYMHNGSLEDRLLRRG---NTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDV 372 (568)
Q Consensus 297 -~~lV~E~~~ggsL~~~l~~~~---~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DF 372 (568)
.+++++|+.+|+|.+++.... ....+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence 268899999999998875321 2224788899999999999999999999 999999999999999999999999
Q ss_pred ccccccCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh-CCCCCCCchHHH--HHHHhCcc
Q 008365 373 GLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPMGLTHHVS--RAIEKGTL 449 (568)
Q Consensus 373 Gla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~--~~~~~~~~ 449 (568)
|+++.+..... ........+++.|++||.+.+..++.++|||||||++|+|++ |++||....... ..+..+.
T Consensus 158 g~~~~~~~~~~----~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~- 232 (273)
T cd05074 158 GLSKKIYSGDY----YRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGN- 232 (273)
T ss_pred cccccccCCcc----eecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCC-
Confidence 99986533211 111123346678999999999999999999999999999999 899996544322 2222211
Q ss_pred ccccCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHh
Q 008365 450 AEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIV 491 (568)
Q Consensus 450 ~~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~ 491 (568)
....+..++..+.+++.+||+.+|.+||++.+++.
T Consensus 233 -------~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~ 267 (273)
T cd05074 233 -------RLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRD 267 (273)
T ss_pred -------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 11123345678999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=309.33 Aligned_cols=253 Identities=26% Similarity=0.345 Sum_probs=193.1
Q ss_pred ccccceeecccCceeEEEEEe--CCccEEEEEeCcCh-hHhHHHHHHHHHHHHcCC-CCceeeeccccCC--CceEEEEe
Q 008365 230 KFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDA-AQGKRQFQQEVEVLSSIR-HPNMVLLLGACPD--YGCLVYEY 303 (568)
Q Consensus 230 ~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l~-HpnIv~l~g~~~~--~~~lV~E~ 303 (568)
+|.....||+|+||.||++.+ +++.||||.+.... ......+.+|+.++.++. ||||+++++++.+ ..+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 456667899999999999987 56789999987543 234556889999999996 9999999998744 34899999
Q ss_pred cCCCCHHHHHhh--cCCCCCCCHHHHHHHHHHHHHHHHHHHHc-CCCCcccCCCCCCCeeccCCceeEecccccccccCC
Q 008365 304 MHNGSLEDRLLR--RGNTPVIPWRKRFKIAAEIATALLFLHQA-KPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPP 380 (568)
Q Consensus 304 ~~ggsL~~~l~~--~~~~~~l~~~~~~~i~~qia~aL~yLH~~-~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~ 380 (568)
+. ++|.++... ......+++..+..++.+++.||.|||+. + |+||||||+|||++.++.+||+|||+++.+..
T Consensus 85 ~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 85 MD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred cc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 84 566554322 11123488999999999999999999985 7 99999999999999999999999999976532
Q ss_pred CCCccccccccccccccccCCChhhhhcC---CCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHhCccccccCccC
Q 008365 381 SVADSVTQYHMTSAAGTFCYIDPEYQQTG---MLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAV 457 (568)
Q Consensus 381 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~---~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~l~~~~ 457 (568)
.. ......|++.|+|||++.+. .++.++|||||||++|+|++|+.||.........+..... ...+.+
T Consensus 161 ~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~--~~~~~~ 231 (288)
T cd06616 161 SI-------AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVK--GDPPIL 231 (288)
T ss_pred CC-------ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcC--CCCCcC
Confidence 21 11234689999999988776 6899999999999999999999999654432222211100 001111
Q ss_pred -CCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHHH
Q 008365 458 -TDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPELN 495 (568)
Q Consensus 458 -~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l~ 495 (568)
...+..++..+.+|+.+||+.+|.+||++.+|+.+.+-
T Consensus 232 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~ 270 (288)
T cd06616 232 SNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFI 270 (288)
T ss_pred CCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhh
Confidence 11123466789999999999999999999999977663
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-37 Score=309.05 Aligned_cols=253 Identities=24% Similarity=0.340 Sum_probs=195.7
Q ss_pred ccccceeecccCceeEEEEEe--CCccEEEEEeCcChhH-hHHHHHHHHHHHHcCCCCceeeeccccCC--CceEEEEec
Q 008365 230 KFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQ-GKRQFQQEVEVLSSIRHPNMVLLLGACPD--YGCLVYEYM 304 (568)
Q Consensus 230 ~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~-~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--~~~lV~E~~ 304 (568)
+|++.++||.|+||.||+|.+ ++..||||+++..... ....+.+|+.+++.++||||++++++|.+ ..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 488899999999999999997 5778999998765322 23567789999999999999999999854 358999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCCc
Q 008365 305 HNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVAD 384 (568)
Q Consensus 305 ~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~~ 384 (568)
+ ++|.+++........+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||++........
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~- 155 (284)
T cd07836 81 D-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN- 155 (284)
T ss_pred C-ccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence 7 588888876554445899999999999999999999999 99999999999999999999999999975532211
Q ss_pred cccccccccccccccCCChhhhhc-CCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHH---HhC-----------cc
Q 008365 385 SVTQYHMTSAAGTFCYIDPEYQQT-GMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAI---EKG-----------TL 449 (568)
Q Consensus 385 ~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~---~~~-----------~~ 449 (568)
......+|..|++||++.+ ..++.++|||||||++|+|++|+.||.......... ... ..
T Consensus 156 -----~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07836 156 -----TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQ 230 (284)
T ss_pred -----ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhc
Confidence 1123467899999998765 457899999999999999999999996543321111 000 00
Q ss_pred ccccCccC--------CCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhH
Q 008365 450 AEMLDPAV--------TDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVP 492 (568)
Q Consensus 450 ~~~l~~~~--------~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~ 492 (568)
...+.... ..+.+.++..+.+++.+|++.+|.+||++.+++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 231 LPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred CchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 00000000 01122345678899999999999999999998753
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=317.36 Aligned_cols=252 Identities=23% Similarity=0.281 Sum_probs=196.9
Q ss_pred HhcccccceeecccCceeEEEEEe--CCccEEEEEeCcC--hhHhHHHHHHHHHHHHcCCCCceeeeccccCC-------
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPD--AAQGKRQFQQEVEVLSSIRHPNMVLLLGACPD------- 295 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~------- 295 (568)
..++|.+.+.||+|+||.||+|.+ ++..||||++... .......+.+|+.+++.++||||++++++|..
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 567899999999999999999987 6779999998643 22334567789999999999999999988742
Q ss_pred -CceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEeccccc
Q 008365 296 -YGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGL 374 (568)
Q Consensus 296 -~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGl 374 (568)
..|+||||+. ++|.+.+... ++...+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~~-----l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~ 164 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQMD-----LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 164 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhhc-----CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCcc
Confidence 2389999995 6888877532 788889999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHh----Cc--
Q 008365 375 ARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEK----GT-- 448 (568)
Q Consensus 375 a~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~----~~-- 448 (568)
++...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+........ +.
T Consensus 165 ~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 237 (353)
T cd07850 165 ARTAGTSF-------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPS 237 (353)
T ss_pred ceeCCCCC-------CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 98653321 123456899999999999999999999999999999999999999654332111000 00
Q ss_pred -------------------------cccccCccC-----CCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 449 -------------------------LAEMLDPAV-----TDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 449 -------------------------~~~~l~~~~-----~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
+.+.+.... ...+...+..+.+++.+||+.||.+||++.+++.+.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~ 313 (353)
T cd07850 238 DEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPY 313 (353)
T ss_pred HHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChh
Confidence 000000000 0002234667899999999999999999999987655
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=306.89 Aligned_cols=252 Identities=25% Similarity=0.386 Sum_probs=204.0
Q ss_pred HhcccccceeecccCceeEEEEEeC--CccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCceeeeccccC--CCceEEEE
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKLD--HTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACP--DYGCLVYE 302 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~~--~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~--~~~~lV~E 302 (568)
..+.|.+...||.|+||.||+|.+. +..|++|++..... ....+.+|+.+++.++|+||+++++.|. +..++|||
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 4567888899999999999999984 77899999976654 4567889999999999999999999874 34589999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCC
Q 008365 303 YMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSV 382 (568)
Q Consensus 303 ~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~ 382 (568)
|+++++|.+++.... ..+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++.......
T Consensus 96 ~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 170 (286)
T cd06614 96 YMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK 170 (286)
T ss_pred ccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccch
Confidence 999999999998764 24899999999999999999999998 9999999999999999999999999986543221
Q ss_pred CccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHhCccccccCccCCCCCh
Q 008365 383 ADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAVTDWPA 462 (568)
Q Consensus 383 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~l~~~~~~~p~ 462 (568)
. ......++..|++||++.+..++.++|||||||++|+|++|..||.............. ... +.. ..+.
T Consensus 171 ~------~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~--~~~-~~~-~~~~ 240 (286)
T cd06614 171 S------KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITT--KGI-PPL-KNPE 240 (286)
T ss_pred h------hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--cCC-CCC-cchh
Confidence 1 11234588999999999888899999999999999999999999976554332221111 000 011 1122
Q ss_pred HHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 463 EAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 463 ~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
.++..+.+++.+||+.+|..||++.+|+.+.+
T Consensus 241 ~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~ 272 (286)
T cd06614 241 KWSPEFKDFLNKCLVKDPEKRPSAEELLQHPF 272 (286)
T ss_pred hCCHHHHHHHHHHhccChhhCcCHHHHhhChH
Confidence 35677999999999999999999999986443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=302.91 Aligned_cols=249 Identities=22% Similarity=0.346 Sum_probs=199.5
Q ss_pred cccccceeecccCceeEEEEEe--CCccEEEEEeCcC-----hhHhHHHHHHHHHHHHcCCCCceeeeccccCCC----c
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPD-----AAQGKRQFQQEVEVLSSIRHPNMVLLLGACPDY----G 297 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~-----~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~----~ 297 (568)
.+|.+.+.||+|+||.||+|.+ ++..||+|++... .......+.+|+.+++.++||||+++++++.+. .
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 4688999999999999999986 5678999987532 123345788999999999999999999987442 3
Q ss_pred eEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccc
Q 008365 298 CLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARL 377 (568)
Q Consensus 298 ~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~ 377 (568)
++||||+++++|.+++...+ .+++.....|+.||+.||.|||+.+ |+|+||||+||+++.++.++|+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~---~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 155 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYG---ALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccc
Confidence 78999999999999887644 2788889999999999999999999 99999999999999999999999999986
Q ss_pred cCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHhCccccccCccC
Q 008365 378 VPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAV 457 (568)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~l~~~~ 457 (568)
...... .........|+..|+|||++.+..++.++|||||||++|+|++|+.||............. ..+..
T Consensus 156 ~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~-----~~~~~ 227 (264)
T cd06653 156 IQTICM---SGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIA-----TQPTK 227 (264)
T ss_pred cccccc---cCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHH-----cCCCC
Confidence 532111 1111234568999999999998889999999999999999999999997654433322111 01111
Q ss_pred CCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhH
Q 008365 458 TDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVP 492 (568)
Q Consensus 458 ~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~ 492 (568)
...|...+..+.+++.+||. +|..||+..+++.|
T Consensus 228 ~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 228 PMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred CCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 23456677889999999999 57999999988754
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=308.49 Aligned_cols=251 Identities=24% Similarity=0.332 Sum_probs=194.2
Q ss_pred cccceeecccCceeEEEEEe--CCccEEEEEeCcChh--HhHHHHHHHHHHHHcCCCCceeeeccccCCC--ceEEEEec
Q 008365 231 FSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAA--QGKRQFQQEVEVLSSIRHPNMVLLLGACPDY--GCLVYEYM 304 (568)
Q Consensus 231 y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~--~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~--~~lV~E~~ 304 (568)
|++.+.||.|++|.||+|.+ ++..||||++..... .....+.+|+.+++.++||||+++++++.+. .++||||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 67788999999999999987 678999999865432 2234678899999999999999999998553 48999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCCc
Q 008365 305 HNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVAD 384 (568)
Q Consensus 305 ~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~~ 384 (568)
+++|.+++..... ..+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||++..+.....
T Consensus 81 -~~~l~~~~~~~~~-~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~- 154 (283)
T cd07835 81 -DLDLKKYMDSSPL-TGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR- 154 (283)
T ss_pred -CcCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc-
Confidence 5789998876542 24889999999999999999999998 99999999999999999999999999976532211
Q ss_pred cccccccccccccccCCChhhhhcC-CCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHh----Cc-----------
Q 008365 385 SVTQYHMTSAAGTFCYIDPEYQQTG-MLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEK----GT----------- 448 (568)
Q Consensus 385 ~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~----~~----------- 448 (568)
......+++.|+|||++.+. .++.++|||||||++|+|++|++||............ +.
T Consensus 155 -----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (283)
T cd07835 155 -----TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTS 229 (283)
T ss_pred -----ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhh
Confidence 11233578999999977654 5789999999999999999999999755443222110 00
Q ss_pred -------cccccCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhH
Q 008365 449 -------LAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVP 492 (568)
Q Consensus 449 -------~~~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~ 492 (568)
+...............+..+.+++.+||+.+|.+||++.+++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 230 LPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred chhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00000011111223445678999999999999999999998754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=309.68 Aligned_cols=252 Identities=22% Similarity=0.341 Sum_probs=191.2
Q ss_pred cccccceeecccCceeEEEEEe--CCccEEEEEeCcChhH-hHHHHHHHHHHHHcCCCCceeeeccccCCC--ceEEEEe
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQ-GKRQFQQEVEVLSSIRHPNMVLLLGACPDY--GCLVYEY 303 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~-~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~--~~lV~E~ 303 (568)
++|.+.+.||.|+||.||+|.. +++.||||.+...... ....+.+|+.+++.++||||+++++++.+. .++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 5789999999999999999987 5678999998654322 223467899999999999999999998544 4899999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCC
Q 008365 304 MHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVA 383 (568)
Q Consensus 304 ~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~ 383 (568)
+. ++|.+++..... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 85 ~~-~~L~~~~~~~~~--~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~- 157 (291)
T cd07844 85 LD-TDLKQYMDDCGG--GLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPS- 157 (291)
T ss_pred CC-CCHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCC-
Confidence 96 599998876543 4788999999999999999999999 9999999999999999999999999987532111
Q ss_pred ccccccccccccccccCCChhhhhc-CCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHH----h-Cc---------
Q 008365 384 DSVTQYHMTSAAGTFCYIDPEYQQT-GMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIE----K-GT--------- 448 (568)
Q Consensus 384 ~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~----~-~~--------- 448 (568)
.......++..|+|||++.+ ..++.++|||||||++|+|++|+.||.........+. . +.
T Consensus 158 -----~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (291)
T cd07844 158 -----KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGV 232 (291)
T ss_pred -----ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhh
Confidence 11123357889999998765 4589999999999999999999999964432111110 0 00
Q ss_pred -----cccccC-----ccCCCCChHHH--HHHHHHHHHhhccCCCCCCChHHhHhH
Q 008365 449 -----LAEMLD-----PAVTDWPAEAA--ESFSKLAIQCAELRKKDRPDLGTVIVP 492 (568)
Q Consensus 449 -----~~~~l~-----~~~~~~p~~~~--~~l~~li~~Cl~~dP~~RPs~~~vl~~ 492 (568)
...... ..+........ ..+.+++.+||+.+|.+||++.+++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~ 288 (291)
T cd07844 233 SSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH 288 (291)
T ss_pred hhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence 000000 00000000112 567899999999999999999998754
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=308.92 Aligned_cols=254 Identities=24% Similarity=0.327 Sum_probs=192.2
Q ss_pred HhcccccceeecccCceeEEEEEe--CCccEEEEEeCcChhH-hHHHHHHHHHHHHcCCCCceeeeccccCCC--ceEEE
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQ-GKRQFQQEVEVLSSIRHPNMVLLLGACPDY--GCLVY 301 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~-~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~--~~lV~ 301 (568)
++++|.+.+.||+|+||.||+|.. ++..||||++...... ....+.+|+.+++.++|+||+++++++.+. .++||
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 346799999999999999999976 5779999998654322 223567899999999999999999988554 48999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCC
Q 008365 302 EYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPS 381 (568)
Q Consensus 302 E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~ 381 (568)
||+. ++|.+++..... .+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||+++.....
T Consensus 83 e~~~-~~l~~~~~~~~~--~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 156 (291)
T cd07870 83 EYMH-TDLAQYMIQHPG--GLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIP 156 (291)
T ss_pred eccc-CCHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence 9995 777777654332 3678888899999999999999999 999999999999999999999999999754221
Q ss_pred CCccccccccccccccccCCChhhhhcC-CCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHhC-------------
Q 008365 382 VADSVTQYHMTSAAGTFCYIDPEYQQTG-MLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKG------------- 447 (568)
Q Consensus 382 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~------------- 447 (568)
. .......+++.|+|||++.+. .++.++|||||||++|+|++|..||.........+...
T Consensus 157 ~------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (291)
T cd07870 157 S------QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWP 230 (291)
T ss_pred C------CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhh
Confidence 1 111234578999999988654 58899999999999999999999997544322221110
Q ss_pred ---ccccccCccCCCC-C---------hHHHHHHHHHHHHhhccCCCCCCChHHhHhH
Q 008365 448 ---TLAEMLDPAVTDW-P---------AEAAESFSKLAIQCAELRKKDRPDLGTVIVP 492 (568)
Q Consensus 448 ---~~~~~l~~~~~~~-p---------~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~ 492 (568)
.+........... + ...+..+.+++.+|+..+|.+||++.+++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h 288 (291)
T cd07870 231 GVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH 288 (291)
T ss_pred hhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence 0000000000000 0 0124578899999999999999999998754
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=312.95 Aligned_cols=256 Identities=25% Similarity=0.319 Sum_probs=192.4
Q ss_pred ccccceeecccCceeEEEEEe----CCccEEEEEeCcCh---hHhHHHHHHHHHHHHcCCCCceeeeccccCCC----ce
Q 008365 230 KFSEAMKIGEGGYGPVYRGKL----DHTPVAIKVLRPDA---AQGKRQFQQEVEVLSSIRHPNMVLLLGACPDY----GC 298 (568)
Q Consensus 230 ~y~~~~~IG~G~fg~Vy~~~~----~~~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~----~~ 298 (568)
+|.+.+.||+|+||.||+|.+ .+..||||++.... ......+.+|+.+++.++||||++++++|.+. .+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 488899999999999999987 45799999997643 22335678899999999999999999998554 48
Q ss_pred EEEEecCCCCHHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccC----CceeEeccc
Q 008365 299 LVYEYMHNGSLEDRLLRRGN--TPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDR----NYVSKISDV 372 (568)
Q Consensus 299 lV~E~~~ggsL~~~l~~~~~--~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~----~~~vKL~DF 372 (568)
+||||++ ++|.+++..... ...++...+..|+.||+.||.|||+.+ |+||||||+|||++. ++.+||+||
T Consensus 81 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 9999996 577776654321 225888999999999999999999999 999999999999999 999999999
Q ss_pred ccccccCCCCCccccccccccccccccCCChhhhhc-CCCCCcceehhHHHHHHHHHhCCCCCCCchHHH----------
Q 008365 373 GLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQT-GMLTTKSDIYSFGIMLLQIITARSPMGLTHHVS---------- 441 (568)
Q Consensus 373 Gla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~---------- 441 (568)
|+++.+...... ........+|+.|+|||++.+ ..++.++|||||||++|+|++|++||.......
T Consensus 157 g~~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 233 (316)
T cd07842 157 GLARLFNAPLKP---LADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQ 233 (316)
T ss_pred ccccccCCCccc---ccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHH
Confidence 999866432211 112234578999999998766 458999999999999999999999996432211
Q ss_pred --HHHHh---------------Ccccccc-CccCCCCC-----------hHHHHHHHHHHHHhhccCCCCCCChHHhHhH
Q 008365 442 --RAIEK---------------GTLAEML-DPAVTDWP-----------AEAAESFSKLAIQCAELRKKDRPDLGTVIVP 492 (568)
Q Consensus 442 --~~~~~---------------~~~~~~l-~~~~~~~p-----------~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~ 492 (568)
..+.. ....... ......++ ...+..+.+++.+||+.+|.+||++.+++.+
T Consensus 234 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 234 LERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred HHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 00000 0000000 00000011 0234568899999999999999999998754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=302.08 Aligned_cols=244 Identities=21% Similarity=0.345 Sum_probs=183.3
Q ss_pred eecccCceeEEEEEe-CC---ccEEEEEeCcCh-hHhHHHHHHHHHHHHcCCCCceeeeccccCC--CceEEEEecCCCC
Q 008365 236 KIGEGGYGPVYRGKL-DH---TPVAIKVLRPDA-AQGKRQFQQEVEVLSSIRHPNMVLLLGACPD--YGCLVYEYMHNGS 308 (568)
Q Consensus 236 ~IG~G~fg~Vy~~~~-~~---~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--~~~lV~E~~~ggs 308 (568)
.||+|+||.||+|.. ++ ..+++|.+.... ......+.+|+.+++.++||||+++++.|.+ ..++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 599999999999975 22 246677766543 3345678999999999999999999998864 4489999999999
Q ss_pred HHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCCcccc
Q 008365 309 LEDRLLRRGN-TPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVT 387 (568)
Q Consensus 309 L~~~l~~~~~-~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~ 387 (568)
|.+++..... ...++...+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++....... .
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~----~ 154 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKED----Y 154 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcch----h
Confidence 9999876432 234667778889999999999999999 9999999999999999999999999986421110 0
Q ss_pred ccccccccccccCCChhhhhc-------CCCCCcceehhHHHHHHHHHh-CCCCCCCchHHH--HHHHhCccccccCccC
Q 008365 388 QYHMTSAAGTFCYIDPEYQQT-------GMLTTKSDIYSFGIMLLQIIT-ARSPMGLTHHVS--RAIEKGTLAEMLDPAV 457 (568)
Q Consensus 388 ~~~~~~~~GT~~Y~APE~~~~-------~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~--~~~~~~~~~~~l~~~~ 457 (568)
........|+..|+|||++.. ..++.++|||||||++|||++ |..||....... ..+..+......++.+
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (268)
T cd05086 155 IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQL 234 (268)
T ss_pred hhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCcc
Confidence 011134568899999998743 245789999999999999997 577886443321 1111222222233322
Q ss_pred CCCChHHHHHHHHHHHHhhccCCCCCCChHHhH
Q 008365 458 TDWPAEAAESFSKLAIQCAELRKKDRPDLGTVI 490 (568)
Q Consensus 458 ~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl 490 (568)
+...+..+.+++..|| .+|.+||++.+|+
T Consensus 235 ---~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~ 263 (268)
T cd05086 235 ---ELPYSERWYEVLQFCW-LSPEKRATAEEVH 263 (268)
T ss_pred ---CCCCcHHHHHHHHHHh-hCcccCCCHHHHH
Confidence 2334567888999999 6799999999986
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=317.62 Aligned_cols=244 Identities=27% Similarity=0.389 Sum_probs=199.2
Q ss_pred cccccceeecccCceeEEEEE--eCCccEEEEEeCcChhH---hHHHHHHHHHHHHcCCCCceeeecccc--CCCceEEE
Q 008365 229 DKFSEAMKIGEGGYGPVYRGK--LDHTPVAIKVLRPDAAQ---GKRQFQQEVEVLSSIRHPNMVLLLGAC--PDYGCLVY 301 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~--~~~~~vAvK~l~~~~~~---~~~~~~~Ev~iL~~l~HpnIv~l~g~~--~~~~~lV~ 301 (568)
+.|..-++||+||||.||-++ .+|+.+|+|.+.+.... ...-..+|-.||.+++.++||.+-.+| .+..||||
T Consensus 185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL 264 (591)
T KOG0986|consen 185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL 264 (591)
T ss_pred cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence 568888999999999999665 48889999998654322 223467899999999999999998777 45569999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCC
Q 008365 302 EYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPS 381 (568)
Q Consensus 302 E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~ 381 (568)
..|+||+|.-.|...++ +.+++..+..++.+|+.||++||+.+ ||+||+||+|||||+.|+|.|+|+|||..++..
T Consensus 265 tlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g 340 (591)
T KOG0986|consen 265 TLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIPEG 340 (591)
T ss_pred EeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecCCC
Confidence 99999999988887776 56999999999999999999999999 999999999999999999999999999877543
Q ss_pred CCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHhCccccccCccCCCCC
Q 008365 382 VADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAVTDWP 461 (568)
Q Consensus 382 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~l~~~~~~~p 461 (568)
. ...+.+||.+|||||++.++.|+...|+|||||++|||+.|+.||.....- ++...+...+...-..++
T Consensus 341 ~-------~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeK---vk~eEvdrr~~~~~~ey~ 410 (591)
T KOG0986|consen 341 K-------PIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEK---VKREEVDRRTLEDPEEYS 410 (591)
T ss_pred C-------ccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhh---hhHHHHHHHHhcchhhcc
Confidence 2 234568999999999999999999999999999999999999999532211 111111111112223456
Q ss_pred hHHHHHHHHHHHHhhccCCCCCCCh
Q 008365 462 AEAAESFSKLAIQCAELRKKDRPDL 486 (568)
Q Consensus 462 ~~~~~~l~~li~~Cl~~dP~~RPs~ 486 (568)
...+++...|....|+.||.+|---
T Consensus 411 ~kFS~eakslc~~LL~Kdp~~RLGc 435 (591)
T KOG0986|consen 411 DKFSEEAKSLCEGLLTKDPEKRLGC 435 (591)
T ss_pred cccCHHHHHHHHHHHccCHHHhccC
Confidence 7778889999999999999998643
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=309.36 Aligned_cols=258 Identities=23% Similarity=0.333 Sum_probs=192.8
Q ss_pred HhcccccceeecccCceeEEEEEe--CCccEEEEEeCcChh--HhHHHHHHHHHHHHcCCCCceeeeccccCCC------
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAA--QGKRQFQQEVEVLSSIRHPNMVLLLGACPDY------ 296 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~--~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~------ 296 (568)
..++|.+.++||+|+||.||+|.. ++..||||++..... .....+.+|+.+++.++||||++++++|...
T Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (310)
T cd07865 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR 89 (310)
T ss_pred hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence 346799999999999999999987 567999998854321 1223456899999999999999999887332
Q ss_pred ----ceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEeccc
Q 008365 297 ----GCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDV 372 (568)
Q Consensus 297 ----~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DF 372 (568)
.++||||+. ++|.+++..... .+++.++..++.||+.||.|||+.+ |+|+||||+|||++.++.+||+||
T Consensus 90 ~~~~~~lv~e~~~-~~l~~~l~~~~~--~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~df 163 (310)
T cd07865 90 YKGSFYLVFEFCE-HDLAGLLSNKNV--KFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADF 163 (310)
T ss_pred CCceEEEEEcCCC-cCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcC
Confidence 289999995 688887765432 3889999999999999999999999 999999999999999999999999
Q ss_pred ccccccCCCCCccccccccccccccccCCChhhhhcC-CCCCcceehhHHHHHHHHHhCCCCCCCchHHHHH--HHh--C
Q 008365 373 GLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTG-MLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRA--IEK--G 447 (568)
Q Consensus 373 Gla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~--~~~--~ 447 (568)
|++..+....... ........++..|+|||++.+. .++.++|||||||++|+|++|++||......... +.. +
T Consensus 164 g~~~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~ 241 (310)
T cd07865 164 GLARAFSLSKNSK--PNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCG 241 (310)
T ss_pred CCcccccCCcccC--CCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 9998664322111 1122345688999999987664 4788999999999999999999999654432111 110 1
Q ss_pred ccccccCccC-----------C-C---------CChHHHHHHHHHHHHhhccCCCCCCChHHhHhH
Q 008365 448 TLAEMLDPAV-----------T-D---------WPAEAAESFSKLAIQCAELRKKDRPDLGTVIVP 492 (568)
Q Consensus 448 ~~~~~l~~~~-----------~-~---------~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~ 492 (568)
.+...+.+.. . . .+......+.+||.+||..+|.+||++.+++.+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 242 SITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred CCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 1100000000 0 0 000123457789999999999999999999854
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=306.53 Aligned_cols=241 Identities=27% Similarity=0.389 Sum_probs=191.0
Q ss_pred ecccCceeEEEEEe--CCccEEEEEeCcChh---HhHHHHHHHHHHHHcCCCCceeeeccccCC--CceEEEEecCCCCH
Q 008365 237 IGEGGYGPVYRGKL--DHTPVAIKVLRPDAA---QGKRQFQQEVEVLSSIRHPNMVLLLGACPD--YGCLVYEYMHNGSL 309 (568)
Q Consensus 237 IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~---~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--~~~lV~E~~~ggsL 309 (568)
||.|+||.||++.+ ++..||||++..... .....+..|+.+|+.++||||+++++++.. ..|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 69999999999976 577999999865432 223456789999999999999999988744 45899999999999
Q ss_pred HHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCCcccccc
Q 008365 310 EDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQY 389 (568)
Q Consensus 310 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~ 389 (568)
.+++..... ..+++..+..++.|++.||.|||+.+ |+||||+|+|||++.++.+||+|||++.......
T Consensus 81 ~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~------- 149 (277)
T cd05577 81 KYHIYNVGE-PGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK------- 149 (277)
T ss_pred HHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccCC-------
Confidence 999876543 34889999999999999999999999 9999999999999999999999999987653211
Q ss_pred ccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchH--HHHHHHhCccccccCccCCCCChHHHHH
Q 008365 390 HMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHH--VSRAIEKGTLAEMLDPAVTDWPAEAAES 467 (568)
Q Consensus 390 ~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~--~~~~~~~~~~~~~l~~~~~~~p~~~~~~ 467 (568)
......|+..|+|||++.+..++.++|||||||++|+|++|+.||..... ....+..... ......+...+..
T Consensus 150 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~ 224 (277)
T cd05577 150 KIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTL-----EMAVEYPDKFSPE 224 (277)
T ss_pred ccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccc-----cccccCCccCCHH
Confidence 11234688899999999888899999999999999999999999965432 1111111111 1112234455678
Q ss_pred HHHHHHHhhccCCCCCC-----ChHHhHhHH
Q 008365 468 FSKLAIQCAELRKKDRP-----DLGTVIVPE 493 (568)
Q Consensus 468 l~~li~~Cl~~dP~~RP-----s~~~vl~~~ 493 (568)
+.+++.+||+.+|.+|| ++.+++.+.
T Consensus 225 ~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~ 255 (277)
T cd05577 225 AKDLCEALLQKDPEKRLGCRGGSADEVREHP 255 (277)
T ss_pred HHHHHHHHccCChhHccCCCcccHHHHHhCh
Confidence 99999999999999999 555565433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=317.14 Aligned_cols=257 Identities=23% Similarity=0.282 Sum_probs=194.1
Q ss_pred HhcccccceeecccCceeEEEEEe--CCccEEEEEeCcCh-hHhHHHHHHHHHHHHcCCCCceeeeccccCC-------C
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDA-AQGKRQFQQEVEVLSSIRHPNMVLLLGACPD-------Y 296 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~-------~ 296 (568)
.+++|.+.++||+|+||.||+|.+ +++.||||++.... ......+.+|+.+++.++||||+++++++.. .
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence 457899999999999999999987 57799999986432 2234567889999999999999999987632 2
Q ss_pred ceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEeccccccc
Q 008365 297 GCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLAR 376 (568)
Q Consensus 297 ~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~ 376 (568)
.++||||+. ++|.+++... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 83 ~~lv~e~~~-~~l~~~~~~~----~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~ 154 (336)
T cd07849 83 VYIVQELME-TDLYKLIKTQ----HLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLAR 154 (336)
T ss_pred EEEEehhcc-cCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECccccee
Confidence 489999995 5887776442 3889999999999999999999999 9999999999999999999999999997
Q ss_pred ccCCCCCccccccccccccccccCCChhhhhc-CCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHh---------
Q 008365 377 LVPPSVADSVTQYHMTSAAGTFCYIDPEYQQT-GMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEK--------- 446 (568)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~--------- 446 (568)
........ ........||+.|+|||.+.+ ..++.++|||||||++|+|++|+.||...+........
T Consensus 155 ~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~ 231 (336)
T cd07849 155 IADPEHDH---TGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQ 231 (336)
T ss_pred eccccccc---cCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCH
Confidence 65332111 111234578999999997654 56899999999999999999999999654321111000
Q ss_pred CccccccCc----------cCC-----CCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 447 GTLAEMLDP----------AVT-----DWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 447 ~~~~~~l~~----------~~~-----~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
..+....+. ... ...+..+..+.+++.+||+.+|.+||++.+++.+.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~ 294 (336)
T cd07849 232 EDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPY 294 (336)
T ss_pred HHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcc
Confidence 000000000 000 011223567889999999999999999999986543
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=308.83 Aligned_cols=255 Identities=22% Similarity=0.291 Sum_probs=193.6
Q ss_pred cccccceeecccCceeEEEEEe--CCccEEEEEeCcChh--HhHHHHHHHHHHHHcCC-CCceeeeccccCC--C-----
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAA--QGKRQFQQEVEVLSSIR-HPNMVLLLGACPD--Y----- 296 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~--~~~~~~~~Ev~iL~~l~-HpnIv~l~g~~~~--~----- 296 (568)
++|++.+.||.|+||.||+|.+ +++.||||++..... .....+.+|+.+++.+. ||||+++++++.. .
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 4688999999999999999987 567999999865432 12346788999999995 6999999988732 2
Q ss_pred ceEEEEecCCCCHHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccC-CceeEecccc
Q 008365 297 GCLVYEYMHNGSLEDRLLRRGN--TPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDR-NYVSKISDVG 373 (568)
Q Consensus 297 ~~lV~E~~~ggsL~~~l~~~~~--~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~-~~~vKL~DFG 373 (568)
.++||||+++ +|.+++..... ...+++..+..++.||+.||.|||..+ |+||||||+|||++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence 4899999975 88888765432 234899999999999999999999999 999999999999998 8999999999
Q ss_pred cccccCCCCCccccccccccccccccCCChhhhhc-CCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHhCcc---
Q 008365 374 LARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQT-GMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTL--- 449 (568)
Q Consensus 374 la~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~--- 449 (568)
+++.+..... ......+++.|+|||++.+ ..++.++|||||||++|+|++|..||...............
T Consensus 157 ~~~~~~~~~~------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~ 230 (295)
T cd07837 157 LGRAFSIPVK------SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGT 230 (295)
T ss_pred cceecCCCcc------ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCC
Confidence 9976532211 1123357889999998765 45799999999999999999999999655443322110000
Q ss_pred --cccc----------------CccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHH
Q 008365 450 --AEML----------------DPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPE 493 (568)
Q Consensus 450 --~~~l----------------~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~ 493 (568)
.... ...+....+.++..+.+||.+||..+|.+||++.+++.+.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~ 292 (295)
T cd07837 231 PTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHP 292 (295)
T ss_pred CChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCC
Confidence 0000 0000001123567789999999999999999999998653
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=297.39 Aligned_cols=244 Identities=25% Similarity=0.416 Sum_probs=201.7
Q ss_pred ccccceeecccCceeEEEEEe--CCccEEEEEeCcChh--HhHHHHHHHHHHHHcCCCCceeeeccccCCC--ceEEEEe
Q 008365 230 KFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAA--QGKRQFQQEVEVLSSIRHPNMVLLLGACPDY--GCLVYEY 303 (568)
Q Consensus 230 ~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~--~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~--~~lV~E~ 303 (568)
+|.+.+.||.|+||.||++.+ .+..|+||.+..... .....+.+|++++.+++|||++++++++.+. .++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 478889999999999999987 467899999976643 4456789999999999999999999887543 4899999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCC
Q 008365 304 MHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVA 383 (568)
Q Consensus 304 ~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~ 383 (568)
+++++|.+++...+ .+++..+..++.|++.||.|||+.+ |+||||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~L~~~~~~~~---~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (254)
T cd06627 81 AENGSLRQIIKKFG---PFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK 154 (254)
T ss_pred CCCCcHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence 99999999987653 3899999999999999999999999 99999999999999999999999999987644321
Q ss_pred ccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHhCccccccCccCCCCChH
Q 008365 384 DSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAVTDWPAE 463 (568)
Q Consensus 384 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~l~~~~~~~p~~ 463 (568)
. .....|+..|+|||.+.+..++.++||||||+++|+|++|..||............. .......+..
T Consensus 155 ~------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~------~~~~~~~~~~ 222 (254)
T cd06627 155 D------DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIV------QDDHPPLPEG 222 (254)
T ss_pred c------ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHh------ccCCCCCCCC
Confidence 1 233568999999999888889999999999999999999999996554433222211 1111223445
Q ss_pred HHHHHHHHHHHhhccCCCCCCChHHhHh
Q 008365 464 AAESFSKLAIQCAELRKKDRPDLGTVIV 491 (568)
Q Consensus 464 ~~~~l~~li~~Cl~~dP~~RPs~~~vl~ 491 (568)
++..+.+++.+||..+|++||++.+++.
T Consensus 223 ~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 223 ISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 5678999999999999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=306.73 Aligned_cols=255 Identities=24% Similarity=0.336 Sum_probs=193.3
Q ss_pred cccccceeecccCceeEEEEEe--CCccEEEEEeCcChh--HhHHHHHHHHHHHHcCCCCceeeeccccCC--CceEEEE
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAA--QGKRQFQQEVEVLSSIRHPNMVLLLGACPD--YGCLVYE 302 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~--~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--~~~lV~E 302 (568)
++|.+.+.||.|+||.||+|.+ +++.||||++..... .....+.+|+.+++.++||||+++++++.+ ..++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 4689999999999999999987 567899999865422 223567899999999999999999999854 4489999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccC-CceeEecccccccccCCC
Q 008365 303 YMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDR-NYVSKISDVGLARLVPPS 381 (568)
Q Consensus 303 ~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~-~~~vKL~DFGla~~~~~~ 381 (568)
|++ ++|.+.+...... .+++..+..++.||+.||.|||+.+ |+|+||+|+||+++. ++.+||+|||++......
T Consensus 82 ~~~-~~l~~~~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 82 YLD-LDLKKHMDSSPDF-AKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (294)
T ss_pred ccc-ccHHHHHHhCCCC-CcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence 995 6888877654432 3577888899999999999999999 999999999999985 568999999999765332
Q ss_pred CCccccccccccccccccCCChhhhhc-CCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHh----C-ccccccC-
Q 008365 382 VADSVTQYHMTSAAGTFCYIDPEYQQT-GMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEK----G-TLAEMLD- 454 (568)
Q Consensus 382 ~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~----~-~~~~~l~- 454 (568)
.. ......|++.|+|||++.+ ..++.++|||||||++|+|++|.+||............ + ......+
T Consensus 157 ~~------~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (294)
T PLN00009 157 VR------TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPG 230 (294)
T ss_pred cc------ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccc
Confidence 11 1123467899999998766 45789999999999999999999999654332221110 0 0000000
Q ss_pred ----------------ccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 455 ----------------PAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 455 ----------------~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
.......+..+..+.+++.+|++.+|.+||++.+++.+.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~ 286 (294)
T PLN00009 231 VTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEY 286 (294)
T ss_pred cccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCch
Confidence 0000012234567899999999999999999999986544
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=308.49 Aligned_cols=260 Identities=22% Similarity=0.254 Sum_probs=197.1
Q ss_pred cccceeecccCceeEEEEEeCCccEEEEEeCcC--hhHhHHHHHHHHHHHHcCCCCceeeeccccCC--CceEEEEecCC
Q 008365 231 FSEAMKIGEGGYGPVYRGKLDHTPVAIKVLRPD--AAQGKRQFQQEVEVLSSIRHPNMVLLLGACPD--YGCLVYEYMHN 306 (568)
Q Consensus 231 y~~~~~IG~G~fg~Vy~~~~~~~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--~~~lV~E~~~g 306 (568)
|.+.+.+|.|+++.||++..+++.||||++... .......+.+|+.+++.++||||++++++|.+ ..+++|||+++
T Consensus 4 ~~i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~ 83 (314)
T cd08216 4 TLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAY 83 (314)
T ss_pred hhhhHhhcCCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCC
Confidence 334455677788888888888999999998765 23445678999999999999999999998854 34899999999
Q ss_pred CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCCc-c
Q 008365 307 GSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVAD-S 385 (568)
Q Consensus 307 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~~-~ 385 (568)
|+|.+++...... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||.+..+...... .
T Consensus 84 ~~l~~~l~~~~~~-~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~ 159 (314)
T cd08216 84 GSCEDLLKTHFPE-GLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQR 159 (314)
T ss_pred CCHHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeecccccccc
Confidence 9999998764332 3788889999999999999999999 999999999999999999999999998755321110 0
Q ss_pred ccccccccccccccCCChhhhhc--CCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHh--CccccccC-------
Q 008365 386 VTQYHMTSAAGTFCYIDPEYQQT--GMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEK--GTLAEMLD------- 454 (568)
Q Consensus 386 ~~~~~~~~~~GT~~Y~APE~~~~--~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~--~~~~~~l~------- 454 (568)
..........++..|+|||++.. ..++.++|||||||++|+|++|..||.........+.. +.....++
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (314)
T cd08216 160 VVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLY 239 (314)
T ss_pred ccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhh
Confidence 01111234567889999998876 35889999999999999999999999755443322211 11111100
Q ss_pred -------------cc-----CCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 455 -------------PA-----VTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 455 -------------~~-----~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
+. ....+......+.+|+..||..+|.+||++.+++.+.+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~ 297 (314)
T cd08216 240 EDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSF 297 (314)
T ss_pred cCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCch
Confidence 00 00112344567899999999999999999999997766
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=299.33 Aligned_cols=248 Identities=24% Similarity=0.456 Sum_probs=202.3
Q ss_pred ccccceeecccCceeEEEEEeC--CccEEEEEeCcChh--HhHHHHHHHHHHHHcCCCCceeeeccccCC--CceEEEEe
Q 008365 230 KFSEAMKIGEGGYGPVYRGKLD--HTPVAIKVLRPDAA--QGKRQFQQEVEVLSSIRHPNMVLLLGACPD--YGCLVYEY 303 (568)
Q Consensus 230 ~y~~~~~IG~G~fg~Vy~~~~~--~~~vAvK~l~~~~~--~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--~~~lV~E~ 303 (568)
+|.+.+.||.|+||.||++.+. +..||+|++..... .....+.+|+++++.++|||++++++.+.+ ..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4888899999999999999985 77999999876533 445678899999999999999999988744 34899999
Q ss_pred cCCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCC
Q 008365 304 MHNGSLEDRLLRRG-NTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSV 382 (568)
Q Consensus 304 ~~ggsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~ 382 (568)
+++++|.+++.... ....+++..+..|+.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 99999999987642 1235899999999999999999999998 9999999999999999999999999997654322
Q ss_pred CccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHhCccccccCccCCCCCh
Q 008365 383 ADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAVTDWPA 462 (568)
Q Consensus 383 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~l~~~~~~~p~ 462 (568)
.......|++.|+|||.+.+..++.++||||||+++|+|++|..||........... .........+.
T Consensus 158 ------~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~------~~~~~~~~~~~ 225 (258)
T cd08215 158 ------DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALK------ILKGQYPPIPS 225 (258)
T ss_pred ------ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHH------HhcCCCCCCCC
Confidence 112335789999999999888899999999999999999999999965542211111 11111223344
Q ss_pred HHHHHHHHHHHHhhccCCCCCCChHHhHhH
Q 008365 463 EAAESFSKLAIQCAELRKKDRPDLGTVIVP 492 (568)
Q Consensus 463 ~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~ 492 (568)
.++..+.+++.+||..+|.+||++.+++.+
T Consensus 226 ~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 226 QYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 566789999999999999999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=299.99 Aligned_cols=238 Identities=26% Similarity=0.372 Sum_probs=193.3
Q ss_pred ecccCceeEEEEEeC--CccEEEEEeCcChh---HhHHHHHHHHHHHHcCCCCceeeeccccCC--CceEEEEecCCCCH
Q 008365 237 IGEGGYGPVYRGKLD--HTPVAIKVLRPDAA---QGKRQFQQEVEVLSSIRHPNMVLLLGACPD--YGCLVYEYMHNGSL 309 (568)
Q Consensus 237 IG~G~fg~Vy~~~~~--~~~vAvK~l~~~~~---~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--~~~lV~E~~~ggsL 309 (568)
||.|+||.||++.+. ++.||||++..... .....+.+|+.+++.++||||+++++++.+ ..++||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 799999999999985 78999999875432 234578899999999999999999998754 35899999999999
Q ss_pred HHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCCcccccc
Q 008365 310 EDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQY 389 (568)
Q Consensus 310 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~ 389 (568)
.+++.+.. .+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~l~~~~---~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~------- 147 (262)
T cd05572 81 WTILRDRG---LFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ------- 147 (262)
T ss_pred HHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-------
Confidence 99987653 3788999999999999999999999 9999999999999999999999999998664321
Q ss_pred ccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCch--HHHHHHHhCccccccC-ccCCCCChHHHH
Q 008365 390 HMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTH--HVSRAIEKGTLAEMLD-PAVTDWPAEAAE 466 (568)
Q Consensus 390 ~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~--~~~~~~~~~~~~~~l~-~~~~~~p~~~~~ 466 (568)
......|++.|++||.+.+..++.++|+|||||++|+|++|..||.... ....... .+. .....+|..++.
T Consensus 148 ~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~ 221 (262)
T cd05572 148 KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYND------ILKGNGKLEFPNYIDK 221 (262)
T ss_pred ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHH------HhccCCCCCCCcccCH
Confidence 1123468999999999988889999999999999999999999997554 2111111 110 112233445577
Q ss_pred HHHHHHHHhhccCCCCCCC-----hHHhHhHH
Q 008365 467 SFSKLAIQCAELRKKDRPD-----LGTVIVPE 493 (568)
Q Consensus 467 ~l~~li~~Cl~~dP~~RPs-----~~~vl~~~ 493 (568)
.+.+++.+||..+|.+||+ +.+++.+.
T Consensus 222 ~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~ 253 (262)
T cd05572 222 AAKDLIKQLLRRNPEERLGNLKGGIKDIKKHK 253 (262)
T ss_pred HHHHHHHHHccCChhhCcCCcccCHHHHhcCh
Confidence 8999999999999999999 66666443
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=315.45 Aligned_cols=258 Identities=20% Similarity=0.304 Sum_probs=197.6
Q ss_pred hcccccceeecccCceeEEEEEe--CCccEEEEEeCcCh--hHhHHHHHHHHHHHHcCCCCceeeeccccCC------Cc
Q 008365 228 TDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDA--AQGKRQFQQEVEVLSSIRHPNMVLLLGACPD------YG 297 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~--~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~------~~ 297 (568)
.++|++.+.||.|+||.||+|.. ++..||||++.... ......+.+|+.+|+.++||||++++++|.. ..
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 46899999999999999999986 57799999987542 2234567789999999999999999988742 24
Q ss_pred eEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccc
Q 008365 298 CLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARL 377 (568)
Q Consensus 298 ~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~ 377 (568)
++||||+. |+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 84 ~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~ 156 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSDQ---PLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARG 156 (334)
T ss_pred EEEEehhh-hhHHHHhccCC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEeccccccee
Confidence 89999994 68988876543 3889999999999999999999999 99999999999999999999999999976
Q ss_pred cCCCCCccccccccccccccccCCChhhhhc-CCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHH---HH--------
Q 008365 378 VPPSVADSVTQYHMTSAAGTFCYIDPEYQQT-GMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRA---IE-------- 445 (568)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~---~~-------- 445 (568)
+...... .........|+..|+|||++.+ ..++.++|||||||++|+|++|+.||......... ..
T Consensus 157 ~~~~~~~--~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~ 234 (334)
T cd07855 157 LSSSPTE--HKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEE 234 (334)
T ss_pred ecccCcC--CCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhH
Confidence 5332211 1111234578999999998765 46899999999999999999999999654322110 00
Q ss_pred ------hCccccccCc--cC-----CCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 446 ------KGTLAEMLDP--AV-----TDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 446 ------~~~~~~~l~~--~~-----~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
...+...+.. .. .......+..+.+++.+||+.+|.+||++.+++.+.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~ 296 (334)
T cd07855 235 VLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPF 296 (334)
T ss_pred hhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChh
Confidence 0000000000 00 0111335678999999999999999999999987655
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=337.00 Aligned_cols=260 Identities=18% Similarity=0.266 Sum_probs=185.4
Q ss_pred HHHhcccccceeecccCceeEEEEEeCC---ccEEEE------------------EeCcChhHhHHHHHHHHHHHHcCCC
Q 008365 225 EEATDKFSEAMKIGEGGYGPVYRGKLDH---TPVAIK------------------VLRPDAAQGKRQFQQEVEVLSSIRH 283 (568)
Q Consensus 225 ~~~~~~y~~~~~IG~G~fg~Vy~~~~~~---~~vAvK------------------~l~~~~~~~~~~~~~Ev~iL~~l~H 283 (568)
....++|.++++||+|+||.||++.... ..+++| .+. ........+.+|+.+|+.++|
T Consensus 144 ~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~H 222 (501)
T PHA03210 144 DEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNH 222 (501)
T ss_pred hhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCC
Confidence 3456789999999999999999986521 122222 111 111234568899999999999
Q ss_pred CceeeeccccCC--CceEEEEecCCCCHHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCe
Q 008365 284 PNMVLLLGACPD--YGCLVYEYMHNGSLEDRLLRRGN--TPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANI 359 (568)
Q Consensus 284 pnIv~l~g~~~~--~~~lV~E~~~ggsL~~~l~~~~~--~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NI 359 (568)
||||++++++.+ ..++|++++ +++|..++..... ........+..|+.||+.||.|||+.+ ||||||||+||
T Consensus 223 pnIv~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NI 298 (501)
T PHA03210 223 ENILKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENI 298 (501)
T ss_pred CCcCcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHE
Confidence 999999999844 458999999 5677777654321 112345667789999999999999999 99999999999
Q ss_pred eccCCceeEecccccccccCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCC-CCCCc-
Q 008365 360 LLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARS-PMGLT- 437 (568)
Q Consensus 360 Lld~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~-Pf~~~- 437 (568)
||+.++.+||+|||+++.+..... ......+||+.|+|||++.+..++.++|||||||+||||++|.. ||...
T Consensus 299 Ll~~~~~vkL~DFGla~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~ 373 (501)
T PHA03210 299 FLNCDGKIVLGDFGTAMPFEKERE-----AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGG 373 (501)
T ss_pred EECCCCCEEEEeCCCceecCcccc-----cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCC
Confidence 999999999999999987643211 12234679999999999999999999999999999999999875 44321
Q ss_pred -h---HHHHHHHhCc-----cc-------cccCc-cCC----CCC-----hHHHHHHHHHHHHhhccCCCCCCChHHhHh
Q 008365 438 -H---HVSRAIEKGT-----LA-------EMLDP-AVT----DWP-----AEAAESFSKLAIQCAELRKKDRPDLGTVIV 491 (568)
Q Consensus 438 -~---~~~~~~~~~~-----~~-------~~l~~-~~~----~~p-----~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~ 491 (568)
. .+...+.... +. ..++. ... ..+ ..++..+.+++.+||+.||.+||++.+++.
T Consensus 374 ~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~ 453 (501)
T PHA03210 374 GKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA 453 (501)
T ss_pred CCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence 1 1111111000 00 00000 000 000 113346778899999999999999999997
Q ss_pred HHH
Q 008365 492 PEL 494 (568)
Q Consensus 492 ~~l 494 (568)
+.+
T Consensus 454 hp~ 456 (501)
T PHA03210 454 LPL 456 (501)
T ss_pred Chh
Confidence 665
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=303.48 Aligned_cols=251 Identities=27% Similarity=0.390 Sum_probs=202.1
Q ss_pred cccccceeecccCceeEEEEEe--CCccEEEEEeCcCh---hHhHHHHHHHHHHHHcCC-CCceeeeccccCCC--ceEE
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDA---AQGKRQFQQEVEVLSSIR-HPNMVLLLGACPDY--GCLV 300 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l~-HpnIv~l~g~~~~~--~~lV 300 (568)
++|.+.+.||.|+||.||+|.. ++..||||++.... ......+.+|+.+++.++ ||||+++++++.+. .++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 4688999999999999999987 67899999987632 223456789999999999 99999999988554 4899
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCC
Q 008365 301 YEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPP 380 (568)
Q Consensus 301 ~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~ 380 (568)
|||+++++|.+++...+ .+++..+..|+.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~~~---~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~ 154 (280)
T cd05581 81 LEYAPNGELLQYIRKYG---SLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDP 154 (280)
T ss_pred EcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence 99999999999997654 4899999999999999999999999 99999999999999999999999999976643
Q ss_pred CCCccc--------------cccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHh
Q 008365 381 SVADSV--------------TQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEK 446 (568)
Q Consensus 381 ~~~~~~--------------~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~ 446 (568)
...... .........|+..|+|||.+.+..++.++|||||||+++++++|+.||............
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~ 234 (280)
T cd05581 155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKI 234 (280)
T ss_pred ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHH
Confidence 321100 012223457899999999998888999999999999999999999999765432211110
Q ss_pred CccccccCccCCCCChHHHHHHHHHHHHhhccCCCCCCCh----HHhHhH
Q 008365 447 GTLAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDL----GTVIVP 492 (568)
Q Consensus 447 ~~~~~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~----~~vl~~ 492 (568)
. .....++...+..+.+++..||..+|.+||++ .+++.+
T Consensus 235 ~-------~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~ 277 (280)
T cd05581 235 L-------KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH 277 (280)
T ss_pred H-------hcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence 0 11112344557789999999999999999999 777643
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=301.64 Aligned_cols=247 Identities=24% Similarity=0.384 Sum_probs=198.6
Q ss_pred Hhcccccc-eeecccCceeEEEEEe--CCccEEEEEeCcChhHhHHHHHHHHHHHHcC-CCCceeeeccccCCCc-----
Q 008365 227 ATDKFSEA-MKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQGKRQFQQEVEVLSSI-RHPNMVLLLGACPDYG----- 297 (568)
Q Consensus 227 ~~~~y~~~-~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l-~HpnIv~l~g~~~~~~----- 297 (568)
++++|.+. .+||-|-.|.|..+.+ ++..+|+|++... ...++||++.-.. .|||||.++++|.+..
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 45566654 4799999999998876 6678999998633 2346788775554 5999999999986532
Q ss_pred -eEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeecc---CCceeEecccc
Q 008365 298 -CLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLD---RNYVSKISDVG 373 (568)
Q Consensus 298 -~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld---~~~~vKL~DFG 373 (568)
.+|||+|+||.|...+..++.. .++++++..|+.||..|+.|||+.+ |.||||||+|+|.. .|-.+||+|||
T Consensus 134 LLiVmE~meGGeLfsriq~~g~~-afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfG 209 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDRGDQ-AFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFG 209 (400)
T ss_pred eEeeeecccchHHHHHHHHcccc-cchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecccc
Confidence 4799999999999999988765 4899999999999999999999999 99999999999995 35689999999
Q ss_pred cccccCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchH------HHHHHHhC
Q 008365 374 LARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHH------VSRAIEKG 447 (568)
Q Consensus 374 la~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~------~~~~~~~~ 447 (568)
+|+.-. ......+.+-||+|.|||++....|+..+|+||+||+||-||+|++||...+. +...|..|
T Consensus 210 FAK~t~-------~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~g 282 (400)
T KOG0604|consen 210 FAKETQ-------EPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTG 282 (400)
T ss_pred cccccC-------CCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhcc
Confidence 998532 12344567889999999999999999999999999999999999999975543 22333333
Q ss_pred ccccccCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 448 TLAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 448 ~~~~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
.+. . .-++| ..+++...++|...|..+|.+|-++.+++.+.|
T Consensus 283 qy~-F---P~pEW-s~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpw 324 (400)
T KOG0604|consen 283 QYE-F---PEPEW-SCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPW 324 (400)
T ss_pred Ccc-C---CChhH-hHHHHHHHHHHHHHhcCCchhheeHHHhhcCch
Confidence 221 0 01122 356788999999999999999999999986554
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=315.24 Aligned_cols=255 Identities=23% Similarity=0.294 Sum_probs=197.0
Q ss_pred HhcccccceeecccCceeEEEEEe--CCccEEEEEeCcC--hhHhHHHHHHHHHHHHcCCCCceeeeccccCC-------
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPD--AAQGKRQFQQEVEVLSSIRHPNMVLLLGACPD------- 295 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~------- 295 (568)
+.++|.+.+.||+|+||.||+|.+ ++..||||.+... .......+.+|+.+++.++||||+++++++..
T Consensus 3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (337)
T cd07858 3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN 82 (337)
T ss_pred cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence 346799999999999999999987 5679999998653 22233456789999999999999999998743
Q ss_pred CceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccc
Q 008365 296 YGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLA 375 (568)
Q Consensus 296 ~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla 375 (568)
..++||||+ +++|.+++...+ .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 83 ~~~lv~e~~-~~~L~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~ 155 (337)
T cd07858 83 DVYIVYELM-DTDLHQIIRSSQ---TLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLA 155 (337)
T ss_pred cEEEEEeCC-CCCHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCccc
Confidence 248999999 478988886543 3889999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCccccccccccccccccCCChhhhhc-CCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHH--HH-------
Q 008365 376 RLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQT-GMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRA--IE------- 445 (568)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~--~~------- 445 (568)
+...... .......|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||...+..... +.
T Consensus 156 ~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 229 (337)
T cd07858 156 RTTSEKG------DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPS 229 (337)
T ss_pred cccCCCc------ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 8653321 11234568899999998765 56899999999999999999999999654321110 00
Q ss_pred --------hCcccc-------ccCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 446 --------KGTLAE-------MLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 446 --------~~~~~~-------~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
...... ..........+.++..+.+++.+||+.+|.+||++.+++.+.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~ 293 (337)
T cd07858 230 EEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPY 293 (337)
T ss_pred hHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcc
Confidence 000000 0001111112345677899999999999999999999997655
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=307.33 Aligned_cols=252 Identities=23% Similarity=0.306 Sum_probs=194.2
Q ss_pred cccccceeecccCceeEEEEEe--CCccEEEEEeCcChhH--hHHHHHHHHHHHHcCCCCceeeeccccC----CCceEE
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQ--GKRQFQQEVEVLSSIRHPNMVLLLGACP----DYGCLV 300 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~--~~~~~~~Ev~iL~~l~HpnIv~l~g~~~----~~~~lV 300 (568)
++|.+.+.||.|+||.||+|.+ +++.||||.++..... ....+.+|+.++..++||||+++++++. +..++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 4688889999999999999998 4678999998754322 2235678999999999999999999874 445999
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCC
Q 008365 301 YEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPP 380 (568)
Q Consensus 301 ~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~ 380 (568)
|||+. ++|.+++..... .+++..+..|+.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||++..+..
T Consensus 85 ~e~~~-~~L~~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 85 MEYVE-HDLKSLMETMKQ--PFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158 (293)
T ss_pred ehhcC-cCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence 99996 599998876443 4899999999999999999999999 99999999999999999999999999986643
Q ss_pred CCCccccccccccccccccCCChhhhhcC-CCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHH--h-----------
Q 008365 381 SVADSVTQYHMTSAAGTFCYIDPEYQQTG-MLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIE--K----------- 446 (568)
Q Consensus 381 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~--~----------- 446 (568)
.. .......+++.|+|||.+.+. .++.++|||||||++|+|++|.+||........... .
T Consensus 159 ~~------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (293)
T cd07843 159 PL------KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWP 232 (293)
T ss_pred Cc------cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHH
Confidence 21 111334678999999987654 468999999999999999999999965433211100 0
Q ss_pred ----------CccccccCccC-CCCChH-HHHHHHHHHHHhhccCCCCCCChHHhHhH
Q 008365 447 ----------GTLAEMLDPAV-TDWPAE-AAESFSKLAIQCAELRKKDRPDLGTVIVP 492 (568)
Q Consensus 447 ----------~~~~~~l~~~~-~~~p~~-~~~~l~~li~~Cl~~dP~~RPs~~~vl~~ 492 (568)
..........+ ..++.. .++.+.+++..||+.+|++||++.+++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 233 GFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred HhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 00000000000 112222 46778999999999999999999999854
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=314.48 Aligned_cols=262 Identities=24% Similarity=0.315 Sum_probs=201.5
Q ss_pred ccccCHHHHHHHhcccccceeecccCceeEEEEEe--CCccEEEEEeCcCh--hHhHHHHHHHHHHHHcCCCCceeeecc
Q 008365 216 YRKYTIEEIEEATDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDA--AQGKRQFQQEVEVLSSIRHPNMVLLLG 291 (568)
Q Consensus 216 ~~~~~~~ei~~~~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~--~~~~~~~~~Ev~iL~~l~HpnIv~l~g 291 (568)
|++....++..+.++|.+.+.||+|+||.||+|.+ ++..||||++.... ......+.+|+.+++.++||||+++++
T Consensus 4 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~ 83 (345)
T cd07877 4 YRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 83 (345)
T ss_pred chhhHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceee
Confidence 45556667778889999999999999999999986 57789999987542 223456788999999999999999998
Q ss_pred ccCC--------CceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccC
Q 008365 292 ACPD--------YGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDR 363 (568)
Q Consensus 292 ~~~~--------~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~ 363 (568)
++.. ..+++++++ +++|.+++... .+++..+..++.||+.||.|||+.+ |+||||||+||+++.
T Consensus 84 ~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~ 155 (345)
T cd07877 84 VFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNE 155 (345)
T ss_pred eeeecccccccccEEEEehhc-ccCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcC
Confidence 7732 247788887 88998877543 2889999999999999999999999 999999999999999
Q ss_pred CceeEecccccccccCCCCCccccccccccccccccCCChhhhhc-CCCCCcceehhHHHHHHHHHhCCCCCCCchHHHH
Q 008365 364 NYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQT-GMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSR 442 (568)
Q Consensus 364 ~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~ 442 (568)
++.+||+|||+++..... .....||..|+|||.+.+ ..++.++|||||||++|+|++|+.||........
T Consensus 156 ~~~~kl~dfg~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~ 226 (345)
T cd07877 156 DCELKILDFGLARHTDDE---------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ 226 (345)
T ss_pred CCCEEEeccccccccccc---------ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 999999999998754221 133568999999998766 5688999999999999999999999964332211
Q ss_pred H---HHh-Cc----cc------------ccc----CccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 443 A---IEK-GT----LA------------EML----DPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 443 ~---~~~-~~----~~------------~~l----~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
. ... +. +. ..+ .....+.....+..+.+++.+|+..+|.+||++.+++.+.+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~ 302 (345)
T cd07877 227 LKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 302 (345)
T ss_pred HHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChh
Confidence 1 000 00 00 000 00000111123556889999999999999999999986544
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=307.00 Aligned_cols=242 Identities=27% Similarity=0.408 Sum_probs=192.7
Q ss_pred ccccceeecccCceeEEEEEe--CCccEEEEEeCcCh---hHhHHHHHHHHHHHHcCCCCceeeeccccCC--CceEEEE
Q 008365 230 KFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDA---AQGKRQFQQEVEVLSSIRHPNMVLLLGACPD--YGCLVYE 302 (568)
Q Consensus 230 ~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--~~~lV~E 302 (568)
.|...+.||+|+||.||++++ ++..||||++.... ......+.+|+.+++.++|||+++++++|.+ ..++|||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 377788999999999999987 56789999986432 2334568899999999999999999998854 3489999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCC
Q 008365 303 YMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSV 382 (568)
Q Consensus 303 ~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~ 382 (568)
|+. |+|.+++..... .+++..+..++.||+.||.|||+.+ |+||||+|+||+++.++.+||+|||++......
T Consensus 106 ~~~-g~l~~~~~~~~~--~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~- 178 (317)
T cd06635 106 YCL-GSASDLLEVHKK--PLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPA- 178 (317)
T ss_pred CCC-CCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCCc-
Confidence 996 578777755432 3889999999999999999999999 999999999999999999999999998754321
Q ss_pred CccccccccccccccccCCChhhhh---cCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHH--HHhCccccccCccC
Q 008365 383 ADSVTQYHMTSAAGTFCYIDPEYQQ---TGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRA--IEKGTLAEMLDPAV 457 (568)
Q Consensus 383 ~~~~~~~~~~~~~GT~~Y~APE~~~---~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~--~~~~~~~~~l~~~~ 457 (568)
....|++.|+|||++. .+.++.++|||||||++|+|++|..||......... +..+.. +
T Consensus 179 ---------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~-----~-- 242 (317)
T cd06635 179 ---------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES-----P-- 242 (317)
T ss_pred ---------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccC-----C--
Confidence 2346889999999874 456899999999999999999999998654332211 111111 0
Q ss_pred CCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 458 TDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 458 ~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
...+...+..+.+++.+||+.+|.+||++.+|+.+.+
T Consensus 243 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~ 279 (317)
T cd06635 243 TLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMF 279 (317)
T ss_pred CCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChh
Confidence 0112345567899999999999999999999987654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=301.23 Aligned_cols=245 Identities=25% Similarity=0.436 Sum_probs=193.1
Q ss_pred ccccceeecccCceeEEEEEeC---CccEEEEEeCcC----------hhHhHHHHHHHHHHHHc-CCCCceeeeccccCC
Q 008365 230 KFSEAMKIGEGGYGPVYRGKLD---HTPVAIKVLRPD----------AAQGKRQFQQEVEVLSS-IRHPNMVLLLGACPD 295 (568)
Q Consensus 230 ~y~~~~~IG~G~fg~Vy~~~~~---~~~vAvK~l~~~----------~~~~~~~~~~Ev~iL~~-l~HpnIv~l~g~~~~ 295 (568)
.|++.+.||+|+||.||+|.+. +..+|||.+... .......+.+|+.++.. ++||||++++++|.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 4778889999999999999874 468999987532 12233456788888865 799999999998854
Q ss_pred C--ceEEEEecCCCCHHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHH-cCCCCcccCCCCCCCeeccCCceeEecc
Q 008365 296 Y--GCLVYEYMHNGSLEDRLLRR-GNTPVIPWRKRFKIAAEIATALLFLHQ-AKPEPLVHRDLKPANILLDRNYVSKISD 371 (568)
Q Consensus 296 ~--~~lV~E~~~ggsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~yLH~-~~~~~IiHrDIKp~NILld~~~~vKL~D 371 (568)
. .++||||++|++|.+++... .....+++..++.++.|++.||.|||+ .+ |+|+||+|.|||++.++.+||+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEec
Confidence 3 48999999999999987542 222348899999999999999999996 56 99999999999999999999999
Q ss_pred cccccccCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHH--HHhCcc
Q 008365 372 VGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRA--IEKGTL 449 (568)
Q Consensus 372 FGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~--~~~~~~ 449 (568)
||++....... ......|+..|++||++.+..++.++|||||||++|+|++|+.||......... +..+..
T Consensus 158 fg~~~~~~~~~-------~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~ 230 (269)
T cd08528 158 FGLAKQKQPES-------KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVY 230 (269)
T ss_pred ccceeeccccc-------ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccC
Confidence 99997653321 223457899999999999888999999999999999999999999655432221 111111
Q ss_pred ccccCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHh
Q 008365 450 AEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIV 491 (568)
Q Consensus 450 ~~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~ 491 (568)
.+.. ....+..+.+++.+||+.+|.+||++.++..
T Consensus 231 ----~~~~---~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~ 265 (269)
T cd08528 231 ----EPLP---EGMYSEDVTDVITSCLTPDAEARPDIIQVSA 265 (269)
T ss_pred ----CcCC---cccCCHHHHHHHHHHCCCCCccCCCHHHHHH
Confidence 1111 1134567899999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=304.26 Aligned_cols=248 Identities=22% Similarity=0.293 Sum_probs=189.0
Q ss_pred cccceeecccCceeEEEEEe--CCccEEEEEeCcChh-HhHHHHHHHHHHHHcCC-CCceeeeccccCCC----ceEEEE
Q 008365 231 FSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAA-QGKRQFQQEVEVLSSIR-HPNMVLLLGACPDY----GCLVYE 302 (568)
Q Consensus 231 y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~-~~~~~~~~Ev~iL~~l~-HpnIv~l~g~~~~~----~~lV~E 302 (568)
|.+.++||+|+||.||+|.+ ++..||||+++.... .......+|+.++.++. ||||++++++|.+. .++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 67788999999999999987 577899999875421 12223457899999885 99999999988543 489999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCC
Q 008365 303 YMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSV 382 (568)
Q Consensus 303 ~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~ 382 (568)
|++ |+|.+.+.... ..+++..+..++.||+.||.|||+.+ |+||||||+||+++. +.+||+|||+++.+....
T Consensus 81 ~~~-~~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~ 153 (282)
T cd07831 81 LMD-MNLYELIKGRK--RPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKP 153 (282)
T ss_pred cCC-ccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence 996 68888776543 24899999999999999999999999 999999999999999 999999999997653221
Q ss_pred CccccccccccccccccCCChhhhh-cCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHh----Cccc-------
Q 008365 383 ADSVTQYHMTSAAGTFCYIDPEYQQ-TGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEK----GTLA------- 450 (568)
Q Consensus 383 ~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~----~~~~------- 450 (568)
......++..|+|||++. ++.++.++|||||||++|+|++|.+||...+........ +...
T Consensus 154 -------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (282)
T cd07831 154 -------PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKF 226 (282)
T ss_pred -------CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhh
Confidence 112346889999999664 456789999999999999999999999655432211100 0000
Q ss_pred ---cccCcc--------CCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhH
Q 008365 451 ---EMLDPA--------VTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVP 492 (568)
Q Consensus 451 ---~~l~~~--------~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~ 492 (568)
...+.. +......++..+.+|+.+||..+|.+||++.+++.+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 227 RKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred cccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 000000 001122456889999999999999999999999854
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=318.08 Aligned_cols=204 Identities=26% Similarity=0.364 Sum_probs=171.3
Q ss_pred hcccccceeecccCceeEEEEEe--CCccEEEEEeCcChhHhHH---HHHHHHHHHHcCCCCceeeeccccCCC--ceEE
Q 008365 228 TDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQGKR---QFQQEVEVLSSIRHPNMVLLLGACPDY--GCLV 300 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~---~~~~Ev~iL~~l~HpnIv~l~g~~~~~--~~lV 300 (568)
..-|..++.||-|+||.|.++.. +...+|+|.|++.....+. .++.|..||...+.++||+||..|+|. .|+|
T Consensus 628 KSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFV 707 (1034)
T KOG0608|consen 628 KSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFV 707 (1034)
T ss_pred ccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEE
Confidence 35688899999999999999875 4558999999876544433 467899999999999999999999765 4889
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCC
Q 008365 301 YEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPP 380 (568)
Q Consensus 301 ~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~ 380 (568)
|+|++||++..+|.+.+ .|++..+..++.++..|+++.|..| +|||||||+|||||.+|++||.|||||.-+..
T Consensus 708 MdYIPGGDmMSLLIrmg---IFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRW 781 (1034)
T KOG0608|consen 708 MDYIPGGDMMSLLIRMG---IFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 781 (1034)
T ss_pred EeccCCccHHHHHHHhc---cCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeecccccccee
Confidence 99999999999998876 4888888899999999999999999 99999999999999999999999999964321
Q ss_pred ---------CCC---ccccc------------------------cccccccccccCCChhhhhcCCCCCcceehhHHHHH
Q 008365 381 ---------SVA---DSVTQ------------------------YHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIML 424 (568)
Q Consensus 381 ---------~~~---~~~~~------------------------~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil 424 (568)
... ++... ....+.+||+.|+|||++....|+..||+||.||||
T Consensus 782 THdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil 861 (1034)
T KOG0608|consen 782 THDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVIL 861 (1034)
T ss_pred ccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHH
Confidence 100 00000 001256899999999999999999999999999999
Q ss_pred HHHHhCCCCCCCc
Q 008365 425 LQIITARSPMGLT 437 (568)
Q Consensus 425 ~elltG~~Pf~~~ 437 (568)
|||+.|++||-..
T Consensus 862 ~em~~g~~pf~~~ 874 (1034)
T KOG0608|consen 862 YEMLVGQPPFLAD 874 (1034)
T ss_pred HHHhhCCCCccCC
Confidence 9999999999543
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=314.19 Aligned_cols=254 Identities=23% Similarity=0.303 Sum_probs=197.4
Q ss_pred HHHHhcccccceeecccCceeEEEEEe--CCccEEEEEeCcCh--hHhHHHHHHHHHHHHcCCCCceeeeccccCCC---
Q 008365 224 IEEATDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDA--AQGKRQFQQEVEVLSSIRHPNMVLLLGACPDY--- 296 (568)
Q Consensus 224 i~~~~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~--~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~--- 296 (568)
+....++|.+.+.||.|+||.||++.+ ++..||||++.... ......+.+|+.+|+.++||||++++++|...
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07880 10 IWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL 89 (343)
T ss_pred hhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence 334678899999999999999999986 56789999986432 22345678999999999999999999987432
Q ss_pred -----ceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecc
Q 008365 297 -----GCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISD 371 (568)
Q Consensus 297 -----~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~D 371 (568)
.++||+|+ +++|.+++... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|
T Consensus 90 ~~~~~~~lv~e~~-~~~l~~~~~~~----~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~d 161 (343)
T cd07880 90 DRFHDFYLVMPFM-GTDLGKLMKHE----KLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILD 161 (343)
T ss_pred cccceEEEEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEee
Confidence 37999999 78998877532 3889999999999999999999999 99999999999999999999999
Q ss_pred cccccccCCCCCccccccccccccccccCCChhhhhc-CCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHhCc--
Q 008365 372 VGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQT-GMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGT-- 448 (568)
Q Consensus 372 FGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~-- 448 (568)
||++...... .....+++.|+|||++.+ ..++.++|||||||++|+|++|..||..............
T Consensus 162 fg~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~ 232 (343)
T cd07880 162 FGLARQTDSE---------MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVT 232 (343)
T ss_pred cccccccccC---------ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence 9999754321 123467899999998876 4588999999999999999999999975543222111000
Q ss_pred ------cccc------------c----CccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 449 ------LAEM------------L----DPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 449 ------~~~~------------l----~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
+... + ...+......++..+.+++.+|+..+|.+||++.+++.+.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~ 300 (343)
T cd07880 233 GTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPY 300 (343)
T ss_pred CCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCcc
Confidence 0000 0 00001112234567889999999999999999999986554
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=305.18 Aligned_cols=244 Identities=23% Similarity=0.322 Sum_probs=195.2
Q ss_pred ceeecccCceeEEEEEe--CCccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCceeeeccccC--CCceEEEEecCCCCH
Q 008365 234 AMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACP--DYGCLVYEYMHNGSL 309 (568)
Q Consensus 234 ~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~--~~~~lV~E~~~ggsL 309 (568)
..+||+|+||.||++.. ++..||||++..........+.+|+.+++.++|+||+++++.|. +..++||||+++++|
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 35799999999999987 56799999986555555667899999999999999999999874 455899999999999
Q ss_pred HHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCCcccccc
Q 008365 310 EDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQY 389 (568)
Q Consensus 310 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~ 389 (568)
.+++... .+++.....++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++..+.....
T Consensus 105 ~~~~~~~----~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~------ 171 (292)
T cd06657 105 TDIVTHT----RMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP------ 171 (292)
T ss_pred HHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceecccccc------
Confidence 9877532 2788999999999999999999999 99999999999999999999999999875532211
Q ss_pred ccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHhCccccccCccCCCCChHHHHHHH
Q 008365 390 HMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAVTDWPAEAAESFS 469 (568)
Q Consensus 390 ~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~l~~~~~~~p~~~~~~l~ 469 (568)
......|++.|++||++.+..++.++|||||||++|+|++|..||........... +...+...+.. ...++..+.
T Consensus 172 ~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~---~~~~~~~~~~~-~~~~~~~l~ 247 (292)
T cd06657 172 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKM---IRDNLPPKLKN-LHKVSPSLK 247 (292)
T ss_pred cccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHhhCCcccCC-cccCCHHHH
Confidence 11335689999999999888899999999999999999999999975443322110 00111111111 223456788
Q ss_pred HHHHHhhccCCCCCCChHHhHhHHH
Q 008365 470 KLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 470 ~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
+++.+||..+|.+||++.+++.+.+
T Consensus 248 ~li~~~l~~~P~~R~~~~~ll~~~~ 272 (292)
T cd06657 248 GFLDRLLVRDPAQRATAAELLKHPF 272 (292)
T ss_pred HHHHHHHhCCcccCcCHHHHhcChH
Confidence 9999999999999999999986544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=309.12 Aligned_cols=255 Identities=25% Similarity=0.291 Sum_probs=194.8
Q ss_pred hcccccceeecccCceeEEEEEe--CCccEEEEEeCcChhH--hHHHHHHHHHHHHcCCCCceeeeccccCC----CceE
Q 008365 228 TDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQ--GKRQFQQEVEVLSSIRHPNMVLLLGACPD----YGCL 299 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~--~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~----~~~l 299 (568)
.++|++.+.||.|+||.||+|.+ ++..||+|++...... ....+.+|+.+++.++|+||+++++++.+ ..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 46799999999999999999987 5779999998644321 12345689999999999999999998743 3489
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccC
Q 008365 300 VYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVP 379 (568)
Q Consensus 300 V~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~ 379 (568)
||||+. ++|.+++.... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+.
T Consensus 86 v~e~~~-~~l~~~l~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~ 159 (309)
T cd07845 86 VMEYCE-QDLASLLDNMP--TPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYG 159 (309)
T ss_pred EEecCC-CCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecC
Confidence 999995 58888887543 24899999999999999999999999 9999999999999999999999999998764
Q ss_pred CCCCccccccccccccccccCCChhhhhc-CCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHhCcc----ccccC
Q 008365 380 PSVADSVTQYHMTSAAGTFCYIDPEYQQT-GMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTL----AEMLD 454 (568)
Q Consensus 380 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~----~~~l~ 454 (568)
.... ......+++.|+|||.+.+ ..++.++|||||||++|+|++|++||............... ...+.
T Consensus 160 ~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 233 (309)
T cd07845 160 LPAK------PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIW 233 (309)
T ss_pred CccC------CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhc
Confidence 3211 1123356889999998765 56899999999999999999999999655433221110000 00000
Q ss_pred c-----------cCCCC--------ChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 455 P-----------AVTDW--------PAEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 455 ~-----------~~~~~--------p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
+ ..... ....++.+.++|.+||..||.+||++.+++.+.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~ 292 (309)
T cd07845 234 PGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSY 292 (309)
T ss_pred hhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChh
Confidence 0 00000 0123567889999999999999999999986554
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=304.33 Aligned_cols=240 Identities=28% Similarity=0.365 Sum_probs=183.6
Q ss_pred eecccCceeEEEEEe--CCccEEEEEeCcChh---HhHHHHHHHHHHH---HcCCCCceeeeccccCC--CceEEEEecC
Q 008365 236 KIGEGGYGPVYRGKL--DHTPVAIKVLRPDAA---QGKRQFQQEVEVL---SSIRHPNMVLLLGACPD--YGCLVYEYMH 305 (568)
Q Consensus 236 ~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~---~~~~~~~~Ev~iL---~~l~HpnIv~l~g~~~~--~~~lV~E~~~ 305 (568)
.||+|+||.||++.+ +++.||||++..... .....+.+|..++ ...+||||+.+++++.. ..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999987 567999999865422 1122334454443 34579999999988743 4589999999
Q ss_pred CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCCcc
Q 008365 306 NGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADS 385 (568)
Q Consensus 306 ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~~~ 385 (568)
+|+|.+++...+ .+++..+..|+.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++.......
T Consensus 81 ~~~L~~~i~~~~---~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~--- 151 (279)
T cd05633 81 GGDLHYHLSQHG---VFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--- 151 (279)
T ss_pred CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccC---
Confidence 999999887654 3899999999999999999999999 9999999999999999999999999987543211
Q ss_pred ccccccccccccccCCChhhhh-cCCCCCcceehhHHHHHHHHHhCCCCCCCchHH-HHHHHhCccccccCccCCCCChH
Q 008365 386 VTQYHMTSAAGTFCYIDPEYQQ-TGMLTTKSDIYSFGIMLLQIITARSPMGLTHHV-SRAIEKGTLAEMLDPAVTDWPAE 463 (568)
Q Consensus 386 ~~~~~~~~~~GT~~Y~APE~~~-~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~-~~~~~~~~~~~~l~~~~~~~p~~ 463 (568)
.....||+.|+|||.+. +..++.++|||||||++|+|++|..||...... ...+..... ......+..
T Consensus 152 -----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~-----~~~~~~~~~ 221 (279)
T cd05633 152 -----PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL-----TVNVELPDS 221 (279)
T ss_pred -----ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhh-----cCCcCCccc
Confidence 12346999999999876 456899999999999999999999999543211 111111111 111123455
Q ss_pred HHHHHHHHHHHhhccCCCCCC-----ChHHhHhHHH
Q 008365 464 AAESFSKLAIQCAELRKKDRP-----DLGTVIVPEL 494 (568)
Q Consensus 464 ~~~~l~~li~~Cl~~dP~~RP-----s~~~vl~~~l 494 (568)
++..+.+++.+||..+|.+|| ++.+++.|.+
T Consensus 222 ~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~ 257 (279)
T cd05633 222 FSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVF 257 (279)
T ss_pred cCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCcc
Confidence 677899999999999999999 5887765543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=294.13 Aligned_cols=244 Identities=27% Similarity=0.463 Sum_probs=200.4
Q ss_pred ccccceeecccCceeEEEEEe--CCccEEEEEeCcCh--hHhHHHHHHHHHHHHcCCCCceeeeccccCCC--ceEEEEe
Q 008365 230 KFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDA--AQGKRQFQQEVEVLSSIRHPNMVLLLGACPDY--GCLVYEY 303 (568)
Q Consensus 230 ~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~--~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~--~~lV~E~ 303 (568)
+|++.+.||.|+||.||++.. ++..+|||++.... ......+.+|+.+++.++||||+++++++.+. .++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 478889999999999999976 56789999987542 23345678899999999999999999887543 4899999
Q ss_pred cCCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCC
Q 008365 304 MHNGSLEDRLLRRG-NTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSV 382 (568)
Q Consensus 304 ~~ggsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~ 382 (568)
+++++|.+++.... ....+++..+..++.|++.||.|||+.+ ++|+||+|.||+++.++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 157 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKNM 157 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccCC
Confidence 99999999886632 1234889999999999999999999999 9999999999999999999999999998764431
Q ss_pred CccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHH--HHHHhCccccccCccCCCC
Q 008365 383 ADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVS--RAIEKGTLAEMLDPAVTDW 460 (568)
Q Consensus 383 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~--~~~~~~~~~~~l~~~~~~~ 460 (568)
.....|++.|++||.+.+..++.++|+||||+++|+|++|+.||...+... ..+.. ......
T Consensus 158 --------~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~--------~~~~~~ 221 (256)
T cd08530 158 --------AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQR--------GKYPPI 221 (256)
T ss_pred --------cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc--------CCCCCC
Confidence 123458899999999999899999999999999999999999997655422 11211 122233
Q ss_pred ChHHHHHHHHHHHHhhccCCCCCCChHHhHhH
Q 008365 461 PAEAAESFSKLAIQCAELRKKDRPDLGTVIVP 492 (568)
Q Consensus 461 p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~ 492 (568)
+...+..+.+++.+||..+|.+||++.+++.+
T Consensus 222 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 222 PPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred chhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 44667789999999999999999999999854
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=308.06 Aligned_cols=259 Identities=23% Similarity=0.313 Sum_probs=192.7
Q ss_pred hcccccceeecccCceeEEEEEe--CCccEEEEEeCcChhH--hHHHHHHHHHHHHcCCCCceeeeccccCC--------
Q 008365 228 TDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQ--GKRQFQQEVEVLSSIRHPNMVLLLGACPD-------- 295 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~--~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~-------- 295 (568)
.++|.+.++||.|+||.||+|.+ +++.||||++...... ....+.+|+++++.++||||+++++++.+
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 47899999999999999999987 4678999998543221 12356789999999999999999987632
Q ss_pred --CceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccc
Q 008365 296 --YGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVG 373 (568)
Q Consensus 296 --~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFG 373 (568)
..++||+|+. ++|...+.... ..+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||
T Consensus 87 ~~~~~lv~~~~~-~~l~~~~~~~~--~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg 160 (311)
T cd07866 87 RGSVYMVTPYMD-HDLSGLLENPS--VKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFG 160 (311)
T ss_pred CceEEEEEecCC-cCHHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCc
Confidence 2378999995 57777665433 24899999999999999999999999 9999999999999999999999999
Q ss_pred cccccCCCCCccc-----cccccccccccccCCChhhhhc-CCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHH---H
Q 008365 374 LARLVPPSVADSV-----TQYHMTSAAGTFCYIDPEYQQT-GMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRA---I 444 (568)
Q Consensus 374 la~~~~~~~~~~~-----~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~---~ 444 (568)
+++.......... .....+...|++.|+|||++.+ ..++.++|||||||++|+|++|++||......... +
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~ 240 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIF 240 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 9976543221111 1112234568899999997765 45899999999999999999999999654432211 1
Q ss_pred Hh-Cc-----------cccccC-ccCCCCC-------hHHHHHHHHHHHHhhccCCCCCCChHHhHhH
Q 008365 445 EK-GT-----------LAEMLD-PAVTDWP-------AEAAESFSKLAIQCAELRKKDRPDLGTVIVP 492 (568)
Q Consensus 445 ~~-~~-----------~~~~l~-~~~~~~p-------~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~ 492 (568)
.. +. +....+ ......+ ......+.+++.+||+.+|.+||++.+++.+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 241 KLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred HHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 00 00 000000 0000111 1223568899999999999999999998754
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=301.66 Aligned_cols=250 Identities=24% Similarity=0.321 Sum_probs=196.5
Q ss_pred cccceeecccCceeEEEEEe--CCccEEEEEeCcChhH--hHHHHHHHHHHHHcCCCCceeeeccccCCC--ceEEEEec
Q 008365 231 FSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQ--GKRQFQQEVEVLSSIRHPNMVLLLGACPDY--GCLVYEYM 304 (568)
Q Consensus 231 y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~--~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~--~~lV~E~~ 304 (568)
|.+.+.||.|++|.||+|.. ++..+++|.+...... ....+.+|+.+|+.++||||+++++++.+. .++||||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 56778999999999999987 5778999998654322 345678899999999999999999988543 48999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCCc
Q 008365 305 HNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVAD 384 (568)
Q Consensus 305 ~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~~ 384 (568)
+ ++|.+++.... ..+++..+..++.||+.||.|||+.+ |+|+||||+||+++.++.+||+|||.+.......
T Consensus 81 ~-~~l~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-- 152 (283)
T cd05118 81 D-TDLYKLIKDRQ--RGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-- 152 (283)
T ss_pred C-CCHHHHHHhhc--ccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--
Confidence 6 58888887643 24889999999999999999999999 9999999999999999999999999997764432
Q ss_pred cccccccccccccccCCChhhhhcC-CCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHhCc---------ccccc-
Q 008365 385 SVTQYHMTSAAGTFCYIDPEYQQTG-MLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGT---------LAEML- 453 (568)
Q Consensus 385 ~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~---------~~~~l- 453 (568)
.......++..|+|||.+.+. .++.++|||||||++|+|++|+.||...+.......... .....
T Consensus 153 ----~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (283)
T cd05118 153 ----RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTS 228 (283)
T ss_pred ----ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchh
Confidence 011234688899999988776 789999999999999999999999966554332211000 00000
Q ss_pred -------------CccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhH
Q 008365 454 -------------DPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVP 492 (568)
Q Consensus 454 -------------~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~ 492 (568)
..........++..+.+++..||+.+|.+||++.+++.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 229 LARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 000011123467789999999999999999999999854
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=306.13 Aligned_cols=256 Identities=23% Similarity=0.276 Sum_probs=195.3
Q ss_pred HHhcccccceeecccCceeEEEEEe--CCccEEEEEeCcChh--HhHHHHHHHHHHHHcCCCCceeeeccccCC------
Q 008365 226 EATDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAA--QGKRQFQQEVEVLSSIRHPNMVLLLGACPD------ 295 (568)
Q Consensus 226 ~~~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~--~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~------ 295 (568)
...++|++.+.||.|+||.||+|.+ +++.||||+++.... .....+.+|+.+++.++||||+++++++.+
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 3567899999999999999999987 567899999865432 223457789999999999999999998743
Q ss_pred ------CceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEe
Q 008365 296 ------YGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKI 369 (568)
Q Consensus 296 ------~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL 369 (568)
..++||||+++ +|.+.+.... ..+++..+..|+.||+.||.|||+.+ |+|+||||+||++++++.+||
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl 157 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESGL--VHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKL 157 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEe
Confidence 34899999965 7777765542 24899999999999999999999999 999999999999999999999
Q ss_pred cccccccccCCCCCccccccccccccccccCCChhhhhc-CCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHH--h
Q 008365 370 SDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQT-GMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIE--K 446 (568)
Q Consensus 370 ~DFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~--~ 446 (568)
+|||++..+..... .......++..|+|||++.+ ..++.++|||||||++|+|++|++||........... .
T Consensus 158 ~dfg~~~~~~~~~~-----~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~ 232 (302)
T cd07864 158 ADFGLARLYNSEES-----RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISR 232 (302)
T ss_pred CcccccccccCCcc-----cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 99999986643221 11122356888999997764 4578999999999999999999999975544322110 0
Q ss_pred ---Ccccccc------------C------ccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhH
Q 008365 447 ---GTLAEML------------D------PAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVP 492 (568)
Q Consensus 447 ---~~~~~~l------------~------~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~ 492 (568)
+...... + .........++..+.+++..||..+|.+||++.+++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 233 LCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred HhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0000000 0 00000112346789999999999999999999998754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=307.07 Aligned_cols=256 Identities=20% Similarity=0.273 Sum_probs=191.1
Q ss_pred eeccc--CceeEEEEEe--CCccEEEEEeCcCh--hHhHHHHHHHHHHHHcCCCCceeeeccccCC--CceEEEEecCCC
Q 008365 236 KIGEG--GYGPVYRGKL--DHTPVAIKVLRPDA--AQGKRQFQQEVEVLSSIRHPNMVLLLGACPD--YGCLVYEYMHNG 307 (568)
Q Consensus 236 ~IG~G--~fg~Vy~~~~--~~~~vAvK~l~~~~--~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--~~~lV~E~~~gg 307 (568)
.||+| +||+||++.+ .++.||||++.... ....+.+.+|+.+++.++||||++++++|.. ..++||||+.++
T Consensus 5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~ 84 (328)
T cd08226 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84 (328)
T ss_pred HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCC
Confidence 46666 9999999987 67899999987542 2334678899999999999999999999854 458999999999
Q ss_pred CHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCCcc-c
Q 008365 308 SLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADS-V 386 (568)
Q Consensus 308 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~~~-~ 386 (568)
+|.+++...... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.++|+|||.+.......... .
T Consensus 85 ~l~~~l~~~~~~-~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (328)
T cd08226 85 SANSLLKTYFPE-GMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV 160 (328)
T ss_pred CHHHHHHhhccc-CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence 999988765432 3888999999999999999999999 9999999999999999999999998654332111000 0
Q ss_pred cccccccccccccCCChhhhhcC--CCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHh--Cccc------------
Q 008365 387 TQYHMTSAAGTFCYIDPEYQQTG--MLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEK--GTLA------------ 450 (568)
Q Consensus 387 ~~~~~~~~~GT~~Y~APE~~~~~--~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~--~~~~------------ 450 (568)
.........++..|+|||++.+. .++.++|||||||++|+|++|..||............ ....
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (328)
T cd08226 161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEE 240 (328)
T ss_pred cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhh
Confidence 00001122456779999998764 4789999999999999999999999654332221111 0000
Q ss_pred -------------------------cccCccC-CCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHHH
Q 008365 451 -------------------------EMLDPAV-TDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPELN 495 (568)
Q Consensus 451 -------------------------~~l~~~~-~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l~ 495 (568)
......+ ...+..++..+.+|+.+||+.+|.+||++.+++.+.+-
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~ 311 (328)
T cd08226 241 SRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFF 311 (328)
T ss_pred hhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHH
Confidence 0000000 01123466789999999999999999999999977763
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=299.77 Aligned_cols=248 Identities=19% Similarity=0.284 Sum_probs=189.7
Q ss_pred HHHHHHhcccccceee--cccCceeEEEEEe--CCccEEEEEeCcChhHhHHHHHHHHHHHHcC-CCCceeeeccccC--
Q 008365 222 EEIEEATDKFSEAMKI--GEGGYGPVYRGKL--DHTPVAIKVLRPDAAQGKRQFQQEVEVLSSI-RHPNMVLLLGACP-- 294 (568)
Q Consensus 222 ~ei~~~~~~y~~~~~I--G~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l-~HpnIv~l~g~~~-- 294 (568)
.++....++|.+.+.+ |.|+||.||++.. ++..+|+|++....... .|+.+...+ +||||+++++.|.
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~~ 81 (267)
T PHA03390 7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTTL 81 (267)
T ss_pred HHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEecC
Confidence 3444455677777776 9999999999986 56789999986543221 122222222 6999999999874
Q ss_pred CCceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCc-eeEecccc
Q 008365 295 DYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNY-VSKISDVG 373 (568)
Q Consensus 295 ~~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~-~vKL~DFG 373 (568)
+..++||||+++++|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+||+++.++ .++|+|||
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg 155 (267)
T PHA03390 82 KGHVLIMDYIKDGDLFDLLKKEG---KLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYG 155 (267)
T ss_pred CeeEEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCc
Confidence 34589999999999999987654 4899999999999999999999999 99999999999999988 99999999
Q ss_pred cccccCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHhCcccccc
Q 008365 374 LARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEML 453 (568)
Q Consensus 374 la~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~l 453 (568)
++...... ....|+..|+|||++.+..++.++|||||||++|+|++|+.||.......... ..+....
T Consensus 156 ~~~~~~~~----------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~--~~~~~~~ 223 (267)
T PHA03390 156 LCKIIGTP----------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDL--ESLLKRQ 223 (267)
T ss_pred cceecCCC----------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhH--HHHHHhh
Confidence 98765321 23468999999999999899999999999999999999999996432211000 0000011
Q ss_pred CccCCCCChHHHHHHHHHHHHhhccCCCCCCC-hHHhHhHH
Q 008365 454 DPAVTDWPAEAAESFSKLAIQCAELRKKDRPD-LGTVIVPE 493 (568)
Q Consensus 454 ~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs-~~~vl~~~ 493 (568)
.. ....+..++..+.+++.+||+.+|.+||+ +.+++.+.
T Consensus 224 ~~-~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~ 263 (267)
T PHA03390 224 QK-KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHP 263 (267)
T ss_pred cc-cCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcCC
Confidence 11 11223356778999999999999999996 68887543
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=301.55 Aligned_cols=251 Identities=24% Similarity=0.326 Sum_probs=192.7
Q ss_pred cccceeecccCceeEEEEEe--CCccEEEEEeCcCh--hHhHHHHHHHHHHHHcCCCCceeeeccccCCC----ceEEEE
Q 008365 231 FSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDA--AQGKRQFQQEVEVLSSIRHPNMVLLLGACPDY----GCLVYE 302 (568)
Q Consensus 231 y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~--~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~----~~lV~E 302 (568)
|.+.+.||.|+||.||+|.+ .++.||||++.... ......+.+|+.+++.++|||++++++++.+. .++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 67888999999999999987 45789999997653 22335678999999999999999999998544 589999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCC
Q 008365 303 YMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSV 382 (568)
Q Consensus 303 ~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~ 382 (568)
|++ ++|.+++.... ..+++..+..++.||+.||.|||+.+ ++|+||+|+|||+++++.+||+|||++.......
T Consensus 81 ~~~-~~l~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 81 YMD-HDLTGLLDSPE--VKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRN 154 (287)
T ss_pred ccc-ccHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence 996 58888876543 24889999999999999999999999 9999999999999999999999999998664332
Q ss_pred CccccccccccccccccCCChhhhhc-CCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHhCc------------c
Q 008365 383 ADSVTQYHMTSAAGTFCYIDPEYQQT-GMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGT------------L 449 (568)
Q Consensus 383 ~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~------------~ 449 (568)
. .......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.............. +
T Consensus 155 ~-----~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (287)
T cd07840 155 S-----ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGV 229 (287)
T ss_pred c-----ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhcccc
Confidence 1 11223457889999997654 4578999999999999999999999965443221110000 0
Q ss_pred ccc-----cCc------cCCCCChH-HHHHHHHHHHHhhccCCCCCCChHHhHhH
Q 008365 450 AEM-----LDP------AVTDWPAE-AAESFSKLAIQCAELRKKDRPDLGTVIVP 492 (568)
Q Consensus 450 ~~~-----l~~------~~~~~p~~-~~~~l~~li~~Cl~~dP~~RPs~~~vl~~ 492 (568)
... +.+ .+.+.... ++..+.+++.+||..+|.+||++.+++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 230 SKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred ccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 000 000 00000111 26778999999999999999999998743
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=302.87 Aligned_cols=251 Identities=24% Similarity=0.363 Sum_probs=192.6
Q ss_pred hcccccceeecccCceeEEEEEeC--CccEEEEEeCcCh-hHhHHHHHHHHHHHHcCC-CCceeeeccccCCC--ceEEE
Q 008365 228 TDKFSEAMKIGEGGYGPVYRGKLD--HTPVAIKVLRPDA-AQGKRQFQQEVEVLSSIR-HPNMVLLLGACPDY--GCLVY 301 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~~~~~--~~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l~-HpnIv~l~g~~~~~--~~lV~ 301 (568)
.++|.+.+.||.|+||.||+|.+. ++.||||+++... ......+..|+.++..+. ||||++++++|.+. .++||
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 93 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM 93 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence 367889999999999999999985 7899999997543 223345666777776665 99999999998554 48999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCCCCcccCCCCCCCeeccCCceeEecccccccccCC
Q 008365 302 EYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQ-AKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPP 380 (568)
Q Consensus 302 E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~-~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~ 380 (568)
||+ +++|.+++..... .+++..+..|+.||+.||.|||+ .+ |+||||+|+||+++.++.+||+|||++..+..
T Consensus 94 e~~-~~~l~~l~~~~~~--~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~ 167 (296)
T cd06618 94 ELM-STCLDKLLKRIQG--PIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLVD 167 (296)
T ss_pred ecc-CcCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhccC
Confidence 998 5678777665433 48899999999999999999997 47 99999999999999999999999999876532
Q ss_pred CCCccccccccccccccccCCChhhhhcCC----CCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHhCccccccCcc
Q 008365 381 SVADSVTQYHMTSAAGTFCYIDPEYQQTGM----LTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPA 456 (568)
Q Consensus 381 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~----~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~l~~~ 456 (568)
... .....++..|+|||++.+.. ++.++|||||||++|+|++|+.||.........+... +.. ..+.
T Consensus 168 ~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~-~~~-~~~~ 238 (296)
T cd06618 168 SKA-------KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKI-LQE-EPPS 238 (296)
T ss_pred CCc-------ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHH-hcC-CCCC
Confidence 211 12335788999999887553 8899999999999999999999996533221111110 000 0111
Q ss_pred CCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 457 VTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 457 ~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
. .....++..+.+|+.+||..+|.+||++.+++.+.+
T Consensus 239 ~-~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~ 275 (296)
T cd06618 239 L-PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPF 275 (296)
T ss_pred C-CCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChh
Confidence 1 111235677999999999999999999999997765
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=311.27 Aligned_cols=259 Identities=24% Similarity=0.344 Sum_probs=196.4
Q ss_pred HhcccccceeecccCceeEEEEEe--CCccEEEEEeCcC--hhHhHHHHHHHHHHHHcC-CCCceeeeccccCC----Cc
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPD--AAQGKRQFQQEVEVLSSI-RHPNMVLLLGACPD----YG 297 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l-~HpnIv~l~g~~~~----~~ 297 (568)
..++|.+.+.||.|+||.||+|.+ .+..||||++... .......+.+|+.+++.+ +||||++++++|.. ..
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 457899999999999999999987 5678999988542 222334577899999999 99999999998743 24
Q ss_pred eEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccc
Q 008365 298 CLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARL 377 (568)
Q Consensus 298 ~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~ 377 (568)
++||||++ ++|..++... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 85 ~lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~ 156 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN----ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARS 156 (337)
T ss_pred EEEecccc-cCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence 89999996 6998887653 3788889999999999999999999 99999999999999999999999999986
Q ss_pred cCCCCCccccccccccccccccCCChhhhhc-CCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHH---Hh-C-----
Q 008365 378 VPPSVADSVTQYHMTSAAGTFCYIDPEYQQT-GMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAI---EK-G----- 447 (568)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~---~~-~----- 447 (568)
+....... .........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.......... .. +
T Consensus 157 ~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 235 (337)
T cd07852 157 LSELEENP-ENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAE 235 (337)
T ss_pred cccccccc-cCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 64332110 1112234578999999997654 568899999999999999999999996443222110 00 0
Q ss_pred -----------ccccccC----ccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 448 -----------TLAEMLD----PAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 448 -----------~~~~~l~----~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
.+...+. .......+.++..+.+++.+||+.+|.+||++.+++.+.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~ 297 (337)
T cd07852 236 DIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPY 297 (337)
T ss_pred HHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChh
Confidence 0000000 0001111235678999999999999999999999986543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=294.85 Aligned_cols=239 Identities=27% Similarity=0.341 Sum_probs=191.4
Q ss_pred ecccCceeEEEEEeC--CccEEEEEeCcChh---HhHHHHHHHHHHHHcCCCCceeeeccccCCC--ceEEEEecCCCCH
Q 008365 237 IGEGGYGPVYRGKLD--HTPVAIKVLRPDAA---QGKRQFQQEVEVLSSIRHPNMVLLLGACPDY--GCLVYEYMHNGSL 309 (568)
Q Consensus 237 IG~G~fg~Vy~~~~~--~~~vAvK~l~~~~~---~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~--~~lV~E~~~ggsL 309 (568)
||.|+||.||++.+. +..|+||++..... .....+.+|+++++.++||||+++++.+... .|+||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 699999999999984 78999999976543 3455688999999999999999999887544 4899999999999
Q ss_pred HHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCCcc--cc
Q 008365 310 EDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADS--VT 387 (568)
Q Consensus 310 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~~~--~~ 387 (568)
.+++...+ .+++..+..|+.||+.||.|||+.+ |+|+||+|+||+++.++.++|+|||++.......... ..
T Consensus 81 ~~~l~~~~---~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 154 (265)
T cd05579 81 ASLLENVG---SLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD 154 (265)
T ss_pred HHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence 99987654 3889999999999999999999999 9999999999999999999999999987543221100 00
Q ss_pred ccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHH--HHHhCccccccCccCCCCChHH-
Q 008365 388 QYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSR--AIEKGTLAEMLDPAVTDWPAEA- 464 (568)
Q Consensus 388 ~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~--~~~~~~~~~~l~~~~~~~p~~~- 464 (568)
........++..|++||.+....++.++|||||||++|+|++|..||........ .+..+. ..++..+
T Consensus 155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~---------~~~~~~~~ 225 (265)
T cd05579 155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGK---------IEWPEDVE 225 (265)
T ss_pred cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC---------cCCCcccc
Confidence 1122345688999999999888899999999999999999999999965543221 111111 1223333
Q ss_pred -HHHHHHHHHHhhccCCCCCCCh---HHhH
Q 008365 465 -AESFSKLAIQCAELRKKDRPDL---GTVI 490 (568)
Q Consensus 465 -~~~l~~li~~Cl~~dP~~RPs~---~~vl 490 (568)
+..+.+++.+||+.+|.+||++ .+++
T Consensus 226 ~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l 255 (265)
T cd05579 226 VSDEAIDLISKLLVPDPEKRLGAKSIEEIK 255 (265)
T ss_pred CCHHHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence 6789999999999999999999 5554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=310.00 Aligned_cols=255 Identities=25% Similarity=0.303 Sum_probs=198.9
Q ss_pred ccccceeecccCceeEEEEEe--CCccEEEEEeCcCh--hHhHHHHHHHHHHHHcCCCCceeeeccccCCC-------ce
Q 008365 230 KFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDA--AQGKRQFQQEVEVLSSIRHPNMVLLLGACPDY-------GC 298 (568)
Q Consensus 230 ~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~--~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~-------~~ 298 (568)
+|.+.+.||.|+||.||+|.. .+..||||++.... ....+.+.+|+.+++.++||||+++++++.+. .+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 588899999999999999987 46789999987643 33446788999999999999999999988543 48
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEeccccccccc
Q 008365 299 LVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLV 378 (568)
Q Consensus 299 lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~ 378 (568)
+||+|++ ++|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||.|||++.++.++|+|||++...
T Consensus 81 lv~e~~~-~~l~~~l~~~~---~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~ 153 (330)
T cd07834 81 IVTELME-TDLHKVIKSPQ---PLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGV 153 (330)
T ss_pred EEecchh-hhHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence 9999996 58888876543 4899999999999999999999999 999999999999999999999999999876
Q ss_pred CCCCCccccccccccccccccCCChhhhhcC-CCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHH---Hh-C------
Q 008365 379 PPSVADSVTQYHMTSAAGTFCYIDPEYQQTG-MLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAI---EK-G------ 447 (568)
Q Consensus 379 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~---~~-~------ 447 (568)
...... ........+|+.|+|||++.+. .++.++|||||||++|+|++|.+||.......... .. +
T Consensus 154 ~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 230 (330)
T cd07834 154 DPDEDE---KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEED 230 (330)
T ss_pred cccccc---cccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhH
Confidence 443211 1122345689999999998887 89999999999999999999999996554322110 00 0
Q ss_pred -------ccccccC---c----cCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 448 -------TLAEMLD---P----AVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 448 -------~~~~~l~---~----~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
.....+. . .+.......+..+.+++.+||+.+|.+||++.+++.+.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~ 291 (330)
T cd07834 231 LKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPY 291 (330)
T ss_pred hhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCcc
Confidence 0000000 0 000112235677899999999999999999999987644
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=304.51 Aligned_cols=246 Identities=24% Similarity=0.333 Sum_probs=192.2
Q ss_pred ccccceeecccCceeEEEEEe-----CCccEEEEEeCcChh----HhHHHHHHHHHHHHcC-CCCceeeeccccCCC--c
Q 008365 230 KFSEAMKIGEGGYGPVYRGKL-----DHTPVAIKVLRPDAA----QGKRQFQQEVEVLSSI-RHPNMVLLLGACPDY--G 297 (568)
Q Consensus 230 ~y~~~~~IG~G~fg~Vy~~~~-----~~~~vAvK~l~~~~~----~~~~~~~~Ev~iL~~l-~HpnIv~l~g~~~~~--~ 297 (568)
+|++.+.||.|+||.||++.. ++..||+|++..... .....+.+|+.+|..+ +|+||+.+++.|... .
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 478889999999999999876 567899999875432 2235678899999999 599999999888554 4
Q ss_pred eEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccc
Q 008365 298 CLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARL 377 (568)
Q Consensus 298 ~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~ 377 (568)
++||||+++++|.+++.... .+++..+..++.||+.||.|||+.+ ++||||+|+|||++.++.+||+|||++..
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 154 (290)
T cd05613 81 HLILDYINGGELFTHLSQRE---RFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE 154 (290)
T ss_pred EEEEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCcccee
Confidence 79999999999999987653 3788889999999999999999999 99999999999999999999999999976
Q ss_pred cCCCCCccccccccccccccccCCChhhhhcC--CCCCcceehhHHHHHHHHHhCCCCCCCchHH--HHHHHhCcccccc
Q 008365 378 VPPSVADSVTQYHMTSAAGTFCYIDPEYQQTG--MLTTKSDIYSFGIMLLQIITARSPMGLTHHV--SRAIEKGTLAEML 453 (568)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~--~~s~ksDvwSlGvil~elltG~~Pf~~~~~~--~~~~~~~~~~~~l 453 (568)
+..... .......|+..|+|||++.+. .++.++|||||||++|+|++|..||...... ...+.. .+
T Consensus 155 ~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~-----~~ 224 (290)
T cd05613 155 FHEDEV-----ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISR-----RI 224 (290)
T ss_pred cccccc-----cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHH-----Hh
Confidence 533211 112345689999999988653 4788999999999999999999999642211 011111 11
Q ss_pred CccCCCCChHHHHHHHHHHHHhhccCCCCCC-----ChHHhHh
Q 008365 454 DPAVTDWPAEAAESFSKLAIQCAELRKKDRP-----DLGTVIV 491 (568)
Q Consensus 454 ~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RP-----s~~~vl~ 491 (568)
......++..++..+.+++.+||..+|.+|| +..+++.
T Consensus 225 ~~~~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 225 LKSEPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred hccCCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 1111233455667899999999999999998 5555543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=311.53 Aligned_cols=256 Identities=20% Similarity=0.304 Sum_probs=194.2
Q ss_pred hcccccceeecccCceeEEEEEe--CCccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCceeeeccccCC----------
Q 008365 228 TDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACPD---------- 295 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~---------- 295 (568)
..+|.+.+.||.|+||.||+|.+ ++..||||++..........+.+|+.+++.++||||+++++++..
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 46899999999999999999987 567899999876655556678899999999999999999987643
Q ss_pred ------CceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeecc-CCceeE
Q 008365 296 ------YGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLD-RNYVSK 368 (568)
Q Consensus 296 ------~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld-~~~~vK 368 (568)
..++||||+. ++|.+++... .+++..+..++.||+.||.|||+.+ |+||||||+|||++ .++.+|
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~k 155 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLEQG----PLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLK 155 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEE
Confidence 2379999996 6888877532 3788999999999999999999999 99999999999997 456889
Q ss_pred ecccccccccCCCCCccccccccccccccccCCChhhhhc-CCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHhC
Q 008365 369 ISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQT-GMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKG 447 (568)
Q Consensus 369 L~DFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~ 447 (568)
|+|||+++.+...... ........|+..|+|||++.. ..++.++|||||||++|+|++|+.||...+.........
T Consensus 156 l~dfg~~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~ 232 (342)
T cd07854 156 IGDFGLARIVDPHYSH---KGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLIL 232 (342)
T ss_pred ECCcccceecCCcccc---ccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 9999999765322110 011123468899999997654 568899999999999999999999996554322211100
Q ss_pred c------------c----ccccC-------ccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 448 T------------L----AEMLD-------PAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 448 ~------------~----~~~l~-------~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
. + ...+. .....+....+..+.+|+..||..+|.+||++.+++.+.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~ 302 (342)
T cd07854 233 ESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPY 302 (342)
T ss_pred HhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCc
Confidence 0 0 00000 0000111234567889999999999999999999986544
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=311.02 Aligned_cols=250 Identities=22% Similarity=0.296 Sum_probs=191.7
Q ss_pred HhcccccceeecccCceeEEEEEe--CCccEEEEEeCcCh--hHhHHHHHHHHHHHHcCCCCceeeeccccCCC------
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDA--AQGKRQFQQEVEVLSSIRHPNMVLLLGACPDY------ 296 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~--~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~------ 296 (568)
..++|.+...||.|+||.||+|.+ ++..||||++.... ......+.+|+.+++.++||||++++++|...
T Consensus 13 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 92 (342)
T cd07879 13 LPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEF 92 (342)
T ss_pred cccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCC
Confidence 357899999999999999999986 57899999986532 22234578999999999999999999987432
Q ss_pred --ceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEeccccc
Q 008365 297 --GCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGL 374 (568)
Q Consensus 297 --~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGl 374 (568)
.++||||+. ++|..++. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 93 ~~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~ 163 (342)
T cd07879 93 QDFYLVMPYMQ-TDLQKIMG-----HPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGL 163 (342)
T ss_pred ceEEEEecccc-cCHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCC
Confidence 379999995 57766542 13788999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCccccccccccccccccCCChhhhhc-CCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHH---HHhC---
Q 008365 375 ARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQT-GMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRA---IEKG--- 447 (568)
Q Consensus 375 a~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~---~~~~--- 447 (568)
++..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......... +...
T Consensus 164 ~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 234 (342)
T cd07879 164 ARHADAE---------MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVP 234 (342)
T ss_pred CcCCCCC---------CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 8754221 123468899999998866 46899999999999999999999999754432211 1000
Q ss_pred --------------ccccccC----ccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 448 --------------TLAEMLD----PAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 448 --------------~~~~~l~----~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
.....+. .......+..+..+.+|+.+||+.+|.+||++.+++.+.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~ 299 (342)
T cd07879 235 GPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPY 299 (342)
T ss_pred CHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcc
Confidence 0000000 0000011134566889999999999999999999986544
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=317.18 Aligned_cols=246 Identities=24% Similarity=0.383 Sum_probs=202.6
Q ss_pred HhcccccceeecccCceeEEEEEe--CCccEEEEEeCcChh--HhHHHHHHHHHHHHcCCCCceeeeccccC--CCceEE
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAA--QGKRQFQQEVEVLSSIRHPNMVLLLGACP--DYGCLV 300 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~--~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~--~~~~lV 300 (568)
-...|.+.+.||+|.|+.|.++++ .++.||||++.+... ...+.+.+|+++|+.|+|||||++|.+.. ...|+|
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 456799999999999999999987 678999999987642 23345889999999999999999999874 456999
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCC
Q 008365 301 YEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPP 380 (568)
Q Consensus 301 ~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~ 380 (568)
|||+.+|.+.++|.+.+. ..+..+..++.|+..|++|||+.+ |||||||++||||+.+.++||+|||++..+..
T Consensus 134 ~eya~~ge~~~yl~~~gr---~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~ 207 (596)
T KOG0586|consen 134 MEYASGGELFDYLVKHGR---MKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFDY 207 (596)
T ss_pred EEeccCchhHHHHHhccc---chhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeecc
Confidence 999999999999998875 445778889999999999999999 99999999999999999999999999987753
Q ss_pred CCCccccccccccccccccCCChhhhhcCCC-CCcceehhHHHHHHHHHhCCCCCCCchH--HHHHHHhCccccccCccC
Q 008365 381 SVADSVTQYHMTSAAGTFCYIDPEYQQTGML-TTKSDIYSFGIMLLQIITARSPMGLTHH--VSRAIEKGTLAEMLDPAV 457 (568)
Q Consensus 381 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~-s~ksDvwSlGvil~elltG~~Pf~~~~~--~~~~~~~~~~~~~l~~~~ 457 (568)
. ....+++|++.|.|||++.+..| ++.+|+||+|++||-|+.|.+||++... .......+.+
T Consensus 208 ~-------~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~-------- 272 (596)
T KOG0586|consen 208 G-------LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKY-------- 272 (596)
T ss_pred c-------ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeee--------
Confidence 2 23457899999999999988775 5799999999999999999999964322 1111111111
Q ss_pred CCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 458 TDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 458 ~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
..|--++.++.+++.+++-++|..|++..+++.+.|
T Consensus 273 -rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W 308 (596)
T KOG0586|consen 273 -RIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRW 308 (596)
T ss_pred -cccceeechhHHHHHHhhccCccccCCHHHhhhhcc
Confidence 123334556788999999999999999999875443
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=294.47 Aligned_cols=247 Identities=23% Similarity=0.373 Sum_probs=194.6
Q ss_pred ccccceeecccCceeEEEEEeCC--ccEEEEEeCcCh-----hHhHHHHHHHHHHHHcCCCCceeeeccccCC--CceEE
Q 008365 230 KFSEAMKIGEGGYGPVYRGKLDH--TPVAIKVLRPDA-----AQGKRQFQQEVEVLSSIRHPNMVLLLGACPD--YGCLV 300 (568)
Q Consensus 230 ~y~~~~~IG~G~fg~Vy~~~~~~--~~vAvK~l~~~~-----~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--~~~lV 300 (568)
+|.+.++||+|+||.||++.+.. ..+++|+++... ......+..|+.+++.++||||+++++++.+ ..++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 47888999999999999998743 456777765421 1223456789999999999999999998854 34899
Q ss_pred EEecCCCCHHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccC
Q 008365 301 YEYMHNGSLEDRLLRR-GNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVP 379 (568)
Q Consensus 301 ~E~~~ggsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~ 379 (568)
|||+++++|.+++... .....+++..+..++.|++.||.|||+.+ |+|+||+|+||+++. +.+||+|||+++.+.
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence 9999999999988652 22235899999999999999999999999 999999999999975 569999999997653
Q ss_pred CCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHhCccccccCccCCC
Q 008365 380 PSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAVTD 459 (568)
Q Consensus 380 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~l~~~~~~ 459 (568)
.... ......|++.|+|||.+.+..++.++|+||||+++|+|++|..||........... ........
T Consensus 157 ~~~~------~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~------~~~~~~~~ 224 (260)
T cd08222 157 GSCD------LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLR------IVEGPTPS 224 (260)
T ss_pred CCcc------cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHH------HHcCCCCC
Confidence 3211 11234688999999999888899999999999999999999999965443222211 11112223
Q ss_pred CChHHHHHHHHHHHHhhccCCCCCCChHHhHhH
Q 008365 460 WPAEAAESFSKLAIQCAELRKKDRPDLGTVIVP 492 (568)
Q Consensus 460 ~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~ 492 (568)
.+..++..+.+++.+||..+|.+||++.+++.+
T Consensus 225 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 225 LPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred CcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 355667789999999999999999999999854
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=293.59 Aligned_cols=237 Identities=22% Similarity=0.262 Sum_probs=184.7
Q ss_pred eeecccCceeEEEEEe--CCccEEEEEeCcChhH---hHHHHHHHHHHH-HcCCCCceeeeccccCC--CceEEEEecCC
Q 008365 235 MKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQ---GKRQFQQEVEVL-SSIRHPNMVLLLGACPD--YGCLVYEYMHN 306 (568)
Q Consensus 235 ~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~---~~~~~~~Ev~iL-~~l~HpnIv~l~g~~~~--~~~lV~E~~~g 306 (568)
+.||.|+||.||+|.+ .++.||||++...... ....+..|..++ ..++||||++++++|.+ ..++||||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 4699999999999987 5679999998754322 122344555544 45689999999999854 35899999999
Q ss_pred CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCCccc
Q 008365 307 GSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSV 386 (568)
Q Consensus 307 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~~~~ 386 (568)
++|.+++...+ .+++..+..|+.||+.||.|||+.+ |+||||+|+|||++.++.+||+|||+++....
T Consensus 82 ~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------ 149 (260)
T cd05611 82 GDCASLIKTLG---GLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------ 149 (260)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc------
Confidence 99999987654 3788999999999999999999999 99999999999999999999999999875422
Q ss_pred cccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHH--HHHhCccccccCccCCCCChHH
Q 008365 387 TQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSR--AIEKGTLAEMLDPAVTDWPAEA 464 (568)
Q Consensus 387 ~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~--~~~~~~~~~~l~~~~~~~p~~~ 464 (568)
.....|++.|++||.+.+..++.++||||||+++|+|++|..||........ .+..+... .. ...+..+
T Consensus 150 ----~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~---~~~~~~~ 220 (260)
T cd05611 150 ----NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRIN--WP---EEVKEFC 220 (260)
T ss_pred ----cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccC--CC---CcccccC
Confidence 1234688999999999888899999999999999999999999965443221 11111110 00 1112245
Q ss_pred HHHHHHHHHHhhccCCCCCCCh---HHhHhH
Q 008365 465 AESFSKLAIQCAELRKKDRPDL---GTVIVP 492 (568)
Q Consensus 465 ~~~l~~li~~Cl~~dP~~RPs~---~~vl~~ 492 (568)
+..+.+++.+||..+|.+||++ .+++.+
T Consensus 221 ~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~ 251 (260)
T cd05611 221 SPEAVDLINRLLCMDPAKRLGANGYQEIKSH 251 (260)
T ss_pred CHHHHHHHHHHccCCHHHccCCCcHHHHHcC
Confidence 6779999999999999999966 455433
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=296.39 Aligned_cols=250 Identities=26% Similarity=0.371 Sum_probs=191.6
Q ss_pred cccceeecccCceeEEEEEe--CCccEEEEEeCcChh--HhHHHHHHHHHHHHcC---CCCceeeeccccCC--C-----
Q 008365 231 FSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAA--QGKRQFQQEVEVLSSI---RHPNMVLLLGACPD--Y----- 296 (568)
Q Consensus 231 y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~--~~~~~~~~Ev~iL~~l---~HpnIv~l~g~~~~--~----- 296 (568)
|++.+.||.|+||.||+|.+ +++.||||+++.... .....+.+|+.+++.+ +||||++++++|.+ .
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 67788999999999999998 468999999974322 1223466788777665 69999999998743 3
Q ss_pred ceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEeccccccc
Q 008365 297 GCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLAR 376 (568)
Q Consensus 297 ~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~ 376 (568)
.+++|||+. ++|.+++..... ..+++..+..++.||+.||.|||+.+ |+|+||+|+||+++.++.+||+|||++.
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~~-~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCPK-PGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred eEEEehhcc-cCHHHHHHHccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcce
Confidence 579999996 589888876443 24899999999999999999999999 9999999999999999999999999997
Q ss_pred ccCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHH---HHHhCcc----
Q 008365 377 LVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSR---AIEKGTL---- 449 (568)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~---~~~~~~~---- 449 (568)
.+.... ......++..|+|||++.+..++.++|||||||++|+|++|.+||........ .+.....
T Consensus 156 ~~~~~~-------~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (287)
T cd07838 156 IYSFEM-------ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEE 228 (287)
T ss_pred eccCCc-------ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChH
Confidence 763321 11234578999999999999999999999999999999999999965433221 1110000
Q ss_pred -------------ccccCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhH
Q 008365 450 -------------AEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVP 492 (568)
Q Consensus 450 -------------~~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~ 492 (568)
............+..+..+.+++.+||+.+|.+||++.+++.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 229 EWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred hcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 0000000011122456778899999999999999999998854
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=301.58 Aligned_cols=243 Identities=27% Similarity=0.423 Sum_probs=192.2
Q ss_pred cccccceeecccCceeEEEEEe--CCccEEEEEeCcC---hhHhHHHHHHHHHHHHcCCCCceeeeccccCC--CceEEE
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPD---AAQGKRQFQQEVEVLSSIRHPNMVLLLGACPD--YGCLVY 301 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~---~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--~~~lV~ 301 (568)
..|...+.||.|+||.||+|.+ ++..||||.+... .......+.+|+.+++.++|+|++++++++.+ ..++||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 3477778999999999999987 5678999998642 22334567889999999999999999998744 448999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCC
Q 008365 302 EYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPS 381 (568)
Q Consensus 302 E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~ 381 (568)
||+. |+|.+++..... .+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++......
T Consensus 95 e~~~-~~l~~~~~~~~~--~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 168 (308)
T cd06634 95 EYCL-GSASDLLEVHKK--PLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (308)
T ss_pred EccC-CCHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecCc
Confidence 9995 688777754432 3788999999999999999999999 999999999999999999999999998765321
Q ss_pred CCccccccccccccccccCCChhhhh---cCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHH--HHhCccccccCcc
Q 008365 382 VADSVTQYHMTSAAGTFCYIDPEYQQ---TGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRA--IEKGTLAEMLDPA 456 (568)
Q Consensus 382 ~~~~~~~~~~~~~~GT~~Y~APE~~~---~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~--~~~~~~~~~l~~~ 456 (568)
....|++.|+|||++. ...++.++|||||||++|+|++|..||......... +..+.. +.
T Consensus 169 ----------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~-----~~ 233 (308)
T cd06634 169 ----------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES-----PA 233 (308)
T ss_pred ----------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCC-----CC
Confidence 2346889999999874 356888999999999999999999998654332211 111111 11
Q ss_pred CCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 457 VTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 457 ~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
. .+..++..+.+|+.+||..+|.+||++.+++.+.+
T Consensus 234 ~--~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~ 269 (308)
T cd06634 234 L--QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 269 (308)
T ss_pred c--CcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcc
Confidence 1 12345677899999999999999999999986554
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=298.22 Aligned_cols=237 Identities=28% Similarity=0.366 Sum_probs=182.4
Q ss_pred eecccCceeEEEEEe--CCccEEEEEeCcChhH---hHHHHHHHH---HHHHcCCCCceeeeccccCC--CceEEEEecC
Q 008365 236 KIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQ---GKRQFQQEV---EVLSSIRHPNMVLLLGACPD--YGCLVYEYMH 305 (568)
Q Consensus 236 ~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~---~~~~~~~Ev---~iL~~l~HpnIv~l~g~~~~--~~~lV~E~~~ 305 (568)
.||+|+||.||++.+ .++.||||++...... ....+..|. .+++...||||+.+++++.+ ..++||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999986 5679999998654211 112233443 34455689999999998754 4589999999
Q ss_pred CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCCcc
Q 008365 306 NGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADS 385 (568)
Q Consensus 306 ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~~~ 385 (568)
||+|.+++...+ .+++..+..|+.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++..+....
T Consensus 81 g~~L~~~l~~~~---~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~--- 151 (278)
T cd05606 81 GGDLHYHLSQHG---VFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--- 151 (278)
T ss_pred CCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccC---
Confidence 999998886543 4899999999999999999999999 9999999999999999999999999987543211
Q ss_pred ccccccccccccccCCChhhhhcC-CCCCcceehhHHHHHHHHHhCCCCCCCchHHH-HHHHhCccccccCccCCCCChH
Q 008365 386 VTQYHMTSAAGTFCYIDPEYQQTG-MLTTKSDIYSFGIMLLQIITARSPMGLTHHVS-RAIEKGTLAEMLDPAVTDWPAE 463 (568)
Q Consensus 386 ~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~-~~~~~~~~~~~l~~~~~~~p~~ 463 (568)
.....|+..|+|||++.++ .++.++|||||||++|+|++|+.||....... ..+..... .....+|..
T Consensus 152 -----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-----~~~~~~~~~ 221 (278)
T cd05606 152 -----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL-----TMAVELPDS 221 (278)
T ss_pred -----CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhh-----ccCCCCCCc
Confidence 1234799999999988754 68999999999999999999999996542111 01111100 011123444
Q ss_pred HHHHHHHHHHHhhccCCCCCC-----ChHHhHh
Q 008365 464 AAESFSKLAIQCAELRKKDRP-----DLGTVIV 491 (568)
Q Consensus 464 ~~~~l~~li~~Cl~~dP~~RP-----s~~~vl~ 491 (568)
++..+.+++.+|+..+|..|| ++.+++.
T Consensus 222 ~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 222 FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred CCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 567899999999999999999 8888764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=292.47 Aligned_cols=244 Identities=24% Similarity=0.381 Sum_probs=190.4
Q ss_pred cceeecccCceeEEEEEe--CCccEEEEEeCcC-hhHhHHHHHHHHHHHHcCC-CCceeeeccccCC--CceEEEEecCC
Q 008365 233 EAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPD-AAQGKRQFQQEVEVLSSIR-HPNMVLLLGACPD--YGCLVYEYMHN 306 (568)
Q Consensus 233 ~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~-~~~~~~~~~~Ev~iL~~l~-HpnIv~l~g~~~~--~~~lV~E~~~g 306 (568)
.+..||.|+.|.||++.+ .+...|||.+... .....+++...+.++...+ .|+||+.+|+|-. ..++.||.| +
T Consensus 96 ~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM-s 174 (391)
T KOG0983|consen 96 NLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM-S 174 (391)
T ss_pred hHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH-H
Confidence 345799999999999988 4589999998765 3444566777788776665 9999999999843 337889988 4
Q ss_pred CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCCccc
Q 008365 307 GSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSV 386 (568)
Q Consensus 307 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~~~~ 386 (568)
.-++.+|.+.. . ++++.-+-++...++.||.||..++ +|||||+||+|||+|..|++||||||++-.+.++..
T Consensus 175 ~C~ekLlkrik-~-piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkA--- 247 (391)
T KOG0983|consen 175 TCAEKLLKRIK-G-PIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA--- 247 (391)
T ss_pred HHHHHHHHHhc-C-CchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeecccc---
Confidence 55556555533 2 3888888899999999999999987 499999999999999999999999999976654432
Q ss_pred cccccccccccccCCChhhhhcC---CCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHhCccccccC---ccCCCC
Q 008365 387 TQYHMTSAAGTFCYIDPEYQQTG---MLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLD---PAVTDW 460 (568)
Q Consensus 387 ~~~~~~~~~GT~~Y~APE~~~~~---~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~l~---~~~~~~ 460 (568)
.+..+|.+.|||||.+.-. .|+.++||||||+.++||.||+.||.+.+.-...+ ..+++ |.+. .
T Consensus 248 ----htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~l-----tkvln~ePP~L~-~ 317 (391)
T KOG0983|consen 248 ----HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVL-----TKVLNEEPPLLP-G 317 (391)
T ss_pred ----cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHH-----HHHHhcCCCCCC-c
Confidence 2456799999999977643 59999999999999999999999997644322221 11222 2222 1
Q ss_pred ChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 461 PAEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 461 p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
....++.|.+|+..||..|+.+||.+.+++.|.+
T Consensus 318 ~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~F 351 (391)
T KOG0983|consen 318 HMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPF 351 (391)
T ss_pred ccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcc
Confidence 1236778999999999999999999999987655
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=301.63 Aligned_cols=243 Identities=26% Similarity=0.383 Sum_probs=191.5
Q ss_pred cccceeecccCceeEEEEEe--CCccEEEEEeCcCh---hHhHHHHHHHHHHHHcCCCCceeeeccccCC--CceEEEEe
Q 008365 231 FSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDA---AQGKRQFQQEVEVLSSIRHPNMVLLLGACPD--YGCLVYEY 303 (568)
Q Consensus 231 y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--~~~lV~E~ 303 (568)
|...+.||+|+||.||+|++ .+..|+||++.... ......+.+|+.+++.++|||++++++++.+ ..++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 66778899999999999986 56789999986432 2334567889999999999999999998854 35899999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCC
Q 008365 304 MHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVA 383 (568)
Q Consensus 304 ~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~ 383 (568)
+. |+|.+++..... .+++..+..++.||+.||.|||+.+ |+|+||+|+||+++.++.+||+|||++.....
T Consensus 103 ~~-~~l~~~l~~~~~--~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~--- 173 (313)
T cd06633 103 CL-GSASDLLEVHKK--PLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSP--- 173 (313)
T ss_pred CC-CCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCC---
Confidence 95 678787765432 3889999999999999999999999 99999999999999999999999999864221
Q ss_pred ccccccccccccccccCCChhhhh---cCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHhCccccccCccCCCC
Q 008365 384 DSVTQYHMTSAAGTFCYIDPEYQQ---TGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAVTDW 460 (568)
Q Consensus 384 ~~~~~~~~~~~~GT~~Y~APE~~~---~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~l~~~~~~~ 460 (568)
.....|+..|+|||++. ...++.++|||||||++|+|++|..||...+........... . .+.. .
T Consensus 174 -------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~--~-~~~~--~ 241 (313)
T cd06633 174 -------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN--D-SPTL--Q 241 (313)
T ss_pred -------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc--C-CCCC--C
Confidence 12456899999999874 456889999999999999999999999655433322211100 0 0111 1
Q ss_pred ChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 461 PAEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 461 p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
....+..+.+|+.+||+.+|.+||++.+++.+.+
T Consensus 242 ~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~ 275 (313)
T cd06633 242 SNEWTDSFRGFVDYCLQKIPQERPASAELLRHDF 275 (313)
T ss_pred ccccCHHHHHHHHHHccCChhhCcCHHHHhcCcc
Confidence 1234456899999999999999999999986544
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=307.12 Aligned_cols=260 Identities=23% Similarity=0.296 Sum_probs=193.4
Q ss_pred hccccc-ceeecccCceeEEEEEe--CCccEEEEEeCcChhHh--------------HHHHHHHHHHHHcCCCCceeeec
Q 008365 228 TDKFSE-AMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQG--------------KRQFQQEVEVLSSIRHPNMVLLL 290 (568)
Q Consensus 228 ~~~y~~-~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~--------------~~~~~~Ev~iL~~l~HpnIv~l~ 290 (568)
.++|.. .+.||.|+||.||+|.+ .++.||||++....... ...+.+|+.+++.++||||++++
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV 86 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence 455654 46799999999999986 56789999986543221 12467899999999999999999
Q ss_pred cccC--CCceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeE
Q 008365 291 GACP--DYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSK 368 (568)
Q Consensus 291 g~~~--~~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vK 368 (568)
++|. +..++||||+. |+|.+++.... .+++.....++.||+.||.|||+.+ |+|+||+|+|||++.++.+|
T Consensus 87 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~~---~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~k 159 (335)
T PTZ00024 87 DVYVEGDFINLVMDIMA-SDLKKVVDRKI---RLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICK 159 (335)
T ss_pred EEEecCCcEEEEEeccc-cCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEE
Confidence 9874 34589999995 68988886543 3788999999999999999999999 99999999999999999999
Q ss_pred ecccccccccCCCCCcc--------ccccccccccccccCCChhhhhcC-CCCCcceehhHHHHHHHHHhCCCCCCCchH
Q 008365 369 ISDVGLARLVPPSVADS--------VTQYHMTSAAGTFCYIDPEYQQTG-MLTTKSDIYSFGIMLLQIITARSPMGLTHH 439 (568)
Q Consensus 369 L~DFGla~~~~~~~~~~--------~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDvwSlGvil~elltG~~Pf~~~~~ 439 (568)
|+|||++..+....... ..........+++.|+|||++.+. .++.++|||||||++|+|++|.+||.....
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~ 239 (335)
T PTZ00024 160 IADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE 239 (335)
T ss_pred ECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 99999997664211000 001112334678899999988764 478999999999999999999999976544
Q ss_pred HHHHHHh----Cc-----cccc--------c----CccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 440 VSRAIEK----GT-----LAEM--------L----DPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 440 ~~~~~~~----~~-----~~~~--------l----~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
....... +. +... . .+........++..+.+++..||..+|.+||++.+++.+.+
T Consensus 240 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~ 315 (335)
T PTZ00024 240 IDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEY 315 (335)
T ss_pred HHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcc
Confidence 3221100 00 0000 0 00000111234567889999999999999999999986544
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=304.13 Aligned_cols=236 Identities=25% Similarity=0.336 Sum_probs=195.5
Q ss_pred cccccceeecccCceeEEEEEeCCc--cEEEEEeCcChhHh---HHHHHHHHHHHHcCC-CCceeeeccccC--CCceEE
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKLDHT--PVAIKVLRPDAAQG---KRQFQQEVEVLSSIR-HPNMVLLLGACP--DYGCLV 300 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~~~~--~vAvK~l~~~~~~~---~~~~~~Ev~iL~~l~-HpnIv~l~g~~~--~~~~lV 300 (568)
.+|..+.+||+|+||.|.++...|+ .+|||+++++..-. .+--..|-++|.... -|.++.+...|+ +..|+|
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV 428 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV 428 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence 4688899999999999999988665 69999998874322 222346778887765 667888877774 567999
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCC
Q 008365 301 YEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPP 380 (568)
Q Consensus 301 ~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~ 380 (568)
|||+.||+|.-.++..+. +.+..+..++.+|+-||-|||+.+ ||+||||.+|||||.+|++||+|||+++.-
T Consensus 429 MEyvnGGDLMyhiQQ~Gk---FKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEn-- 500 (683)
T KOG0696|consen 429 MEYVNGGDLMYHIQQVGK---FKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN-- 500 (683)
T ss_pred EEEecCchhhhHHHHhcc---cCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeeccccccc--
Confidence 999999999999988775 667788889999999999999999 999999999999999999999999999742
Q ss_pred CCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchH--HHHHHHhCccccccCccCC
Q 008365 381 SVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHH--VSRAIEKGTLAEMLDPAVT 458 (568)
Q Consensus 381 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~--~~~~~~~~~~~~~l~~~~~ 458 (568)
........+++|||.|+|||++...+|+..+|+|||||+|||||.|++||++.+. +.+.|...+ .
T Consensus 501 ----i~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehn---------v 567 (683)
T KOG0696|consen 501 ----IFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHN---------V 567 (683)
T ss_pred ----ccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcc---------C
Confidence 2233345678999999999999999999999999999999999999999987654 333333322 2
Q ss_pred CCChHHHHHHHHHHHHhhccCCCCCCC
Q 008365 459 DWPAEAAESFSKLAIQCAELRKKDRPD 485 (568)
Q Consensus 459 ~~p~~~~~~l~~li~~Cl~~dP~~RPs 485 (568)
.+|..++.+...++...+...|..|-.
T Consensus 568 syPKslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 568 SYPKSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred cCcccccHHHHHHHHHHhhcCCccccC
Confidence 467788888999999999999999864
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=305.24 Aligned_cols=256 Identities=21% Similarity=0.256 Sum_probs=192.2
Q ss_pred ccccceeecccCceeEEEEEeC----CccEEEEEeCcCh--hHhHHHHHHHHHHHHcC-CCCceeeeccccC------CC
Q 008365 230 KFSEAMKIGEGGYGPVYRGKLD----HTPVAIKVLRPDA--AQGKRQFQQEVEVLSSI-RHPNMVLLLGACP------DY 296 (568)
Q Consensus 230 ~y~~~~~IG~G~fg~Vy~~~~~----~~~vAvK~l~~~~--~~~~~~~~~Ev~iL~~l-~HpnIv~l~g~~~------~~ 296 (568)
+|.+.+.||+|+||.||++.+. +..||||++.... ......+.+|+.+++++ +||||+++++.+. ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4788899999999999999874 5589999986432 22245678899999999 5999999998642 12
Q ss_pred ceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEeccccccc
Q 008365 297 GCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLAR 376 (568)
Q Consensus 297 ~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~ 376 (568)
.+++|+|+ +++|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 81 ~~~~~e~~-~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~ 153 (332)
T cd07857 81 LYLYEELM-EADLHQIIRSGQ---PLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLAR 153 (332)
T ss_pred EEEEEecc-cCCHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence 37888988 478988886533 3889999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCCccccccccccccccccCCChhhhhc-CCCCCcceehhHHHHHHHHHhCCCCCCCchHHHH---HHH-------
Q 008365 377 LVPPSVADSVTQYHMTSAAGTFCYIDPEYQQT-GMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSR---AIE------- 445 (568)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~---~~~------- 445 (568)
.+...... .........||+.|+|||++.+ ..++.++|||||||++|+|++|.+||...+.... .+.
T Consensus 154 ~~~~~~~~--~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 231 (332)
T cd07857 154 GFSENPGE--NAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDE 231 (332)
T ss_pred eccccccc--ccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCH
Confidence 66432211 1112234579999999998765 4689999999999999999999999965432111 000
Q ss_pred -------hCc---ccccc----CccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 446 -------KGT---LAEML----DPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 446 -------~~~---~~~~l----~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
... +...+ ...+....+.++..+.+++.+||+.+|.+||++.+++.+.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~ 294 (332)
T cd07857 232 ETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPY 294 (332)
T ss_pred HHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChh
Confidence 000 00000 00001111223567999999999999999999999987655
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=297.61 Aligned_cols=250 Identities=25% Similarity=0.331 Sum_probs=191.5
Q ss_pred cccceeecccCceeEEEEEe--CCccEEEEEeCcChh-HhHHHHHHHHHHHHcCC-CCceeeeccccCC--CceEEEEec
Q 008365 231 FSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAA-QGKRQFQQEVEVLSSIR-HPNMVLLLGACPD--YGCLVYEYM 304 (568)
Q Consensus 231 y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~-~~~~~~~~Ev~iL~~l~-HpnIv~l~g~~~~--~~~lV~E~~ 304 (568)
|.+.+.||.|+||.||+|.. .+..|+||.+..... .......+|+..+++++ ||||++++++|.+ ..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 67788999999999999997 467899999865432 22234557999999999 9999999998855 348999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCCc
Q 008365 305 HNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVAD 384 (568)
Q Consensus 305 ~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~~ 384 (568)
+|+|.+++..... ..+++..+..++.|++.+|.|||+.+ |+|+||+|+||+++.++.++|+|||++.......
T Consensus 81 -~~~l~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~-- 153 (283)
T cd07830 81 -EGNLYQLMKDRKG-KPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP-- 153 (283)
T ss_pred -CCCHHHHHHhccc-ccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCC--
Confidence 8899998876542 24899999999999999999999999 9999999999999999999999999997653321
Q ss_pred cccccccccccccccCCChhhhh-cCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHhCc---------------
Q 008365 385 SVTQYHMTSAAGTFCYIDPEYQQ-TGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGT--------------- 448 (568)
Q Consensus 385 ~~~~~~~~~~~GT~~Y~APE~~~-~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~--------------- 448 (568)
......|+..|+|||++. +..++.++||||||+++|+|++|++||..............
T Consensus 154 -----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (283)
T cd07830 154 -----PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYK 228 (283)
T ss_pred -----CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhh
Confidence 112356889999999764 45589999999999999999999999965433222111000
Q ss_pred cccccCccC--------CCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhH
Q 008365 449 LAEMLDPAV--------TDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVP 492 (568)
Q Consensus 449 ~~~~l~~~~--------~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~ 492 (568)
+...+...+ .......+..+.+++.+||+.+|.+||++.+++.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 229 LASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred hhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 000000000 01111224679999999999999999999998754
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=307.71 Aligned_cols=254 Identities=24% Similarity=0.304 Sum_probs=195.3
Q ss_pred HHHHhcccccceeecccCceeEEEEEe--CCccEEEEEeCcCh--hHhHHHHHHHHHHHHcCCCCceeeeccccCC---C
Q 008365 224 IEEATDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDA--AQGKRQFQQEVEVLSSIRHPNMVLLLGACPD---Y 296 (568)
Q Consensus 224 i~~~~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~--~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~---~ 296 (568)
+..++++|.+.+.||.|+||.||++.+ ++..||||++.... ......+..|+.+++.++||||++++++|.. .
T Consensus 5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 84 (328)
T cd07856 5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLED 84 (328)
T ss_pred eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence 344678999999999999999999986 56789999876432 2234567889999999999999999998743 3
Q ss_pred ceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEeccccccc
Q 008365 297 GCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLAR 376 (568)
Q Consensus 297 ~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~ 376 (568)
.++||||+ +++|.+++... .+++..+..++.||+.||.|||+.+ |+||||+|+|||++.++.+||+|||++.
T Consensus 85 ~~lv~e~~-~~~L~~~~~~~----~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~ 156 (328)
T cd07856 85 IYFVTELL-GTDLHRLLTSR----PLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLAR 156 (328)
T ss_pred EEEEeehh-ccCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCcccccc
Confidence 58999999 67898877532 2778888889999999999999999 9999999999999999999999999987
Q ss_pred ccCCCCCccccccccccccccccCCChhhhhc-CCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHH--H--------
Q 008365 377 LVPPSVADSVTQYHMTSAAGTFCYIDPEYQQT-GMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAI--E-------- 445 (568)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~--~-------- 445 (568)
..... .....++..|+|||++.+ ..++.++|||||||++|+|++|+.||.......... .
T Consensus 157 ~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~ 227 (328)
T cd07856 157 IQDPQ---------MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPD 227 (328)
T ss_pred ccCCC---------cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence 54221 123467889999998765 568999999999999999999999996543321100 0
Q ss_pred -------hCccccccCcc--CC-----CCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 446 -------KGTLAEMLDPA--VT-----DWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 446 -------~~~~~~~l~~~--~~-----~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
.+...+.+... .. ...+.++..+.++|.+||+.+|.+||++.+++.+.+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~ 290 (328)
T cd07856 228 DVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPY 290 (328)
T ss_pred HHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCc
Confidence 00000000000 00 111234578999999999999999999999986544
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=320.50 Aligned_cols=196 Identities=31% Similarity=0.516 Sum_probs=169.4
Q ss_pred ccccceeecccCceeEEEEEe--CCccEEEEEeCcCh-hHhHHHHHHHHHHHHcCCCCceeeeccccCCC--------ce
Q 008365 230 KFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDA-AQGKRQFQQEVEVLSSIRHPNMVLLLGACPDY--------GC 298 (568)
Q Consensus 230 ~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~--------~~ 298 (568)
.|...+.||+||||.||+|++ .|..||||.++... ....+..-+|+++|++|+|||||+++++-++. ..
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v 93 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV 93 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence 355667899999999999986 67899999998753 33456678999999999999999999875332 37
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeecc--CCc--eeEeccccc
Q 008365 299 LVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLD--RNY--VSKISDVGL 374 (568)
Q Consensus 299 lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld--~~~--~vKL~DFGl 374 (568)
+|||||.||||...|..-.+...+++.+.+.++.++..||.|||+++ |+||||||.||++- .+| .-||+|||.
T Consensus 94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 99999999999999988777677999999999999999999999999 99999999999982 223 459999999
Q ss_pred ccccCCCCCccccccccccccccccCCChhhhh-cCCCCCcceehhHHHHHHHHHhCCCCCC
Q 008365 375 ARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQ-TGMLTTKSDIYSFGIMLLQIITARSPMG 435 (568)
Q Consensus 375 a~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~s~ksDvwSlGvil~elltG~~Pf~ 435 (568)
|+-++... ...+.+||..|++||+.. .+.|+.-+|.|||||++|++.||..||.
T Consensus 171 Arel~d~s-------~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~ 225 (732)
T KOG4250|consen 171 ARELDDNS-------LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFI 225 (732)
T ss_pred cccCCCCC-------eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCC
Confidence 99775432 457889999999999888 4889999999999999999999999994
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=295.46 Aligned_cols=250 Identities=25% Similarity=0.357 Sum_probs=194.8
Q ss_pred cccceeecccCceeEEEEEe--CCccEEEEEeCcCh--hHhHHHHHHHHHHHHcCCCCceeeeccccCC--CceEEEEec
Q 008365 231 FSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDA--AQGKRQFQQEVEVLSSIRHPNMVLLLGACPD--YGCLVYEYM 304 (568)
Q Consensus 231 y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~--~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--~~~lV~E~~ 304 (568)
|+....||.|+||.||+|+. +++.||+|++.... ......+..|+.+++.++|+||+++++++.+ ..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 56678899999999999987 46899999987653 2234567889999999999999999998855 458999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCCc
Q 008365 305 HNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVAD 384 (568)
Q Consensus 305 ~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~~ 384 (568)
+ ++|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||+|+||+++.++.+||+|||+++.......
T Consensus 81 ~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~- 153 (282)
T cd07829 81 D-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR- 153 (282)
T ss_pred C-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCcc-
Confidence 6 68999987653 23889999999999999999999999 99999999999999999999999999976543221
Q ss_pred cccccccccccccccCCChhhhhcC-CCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHhCcc------------cc
Q 008365 385 SVTQYHMTSAAGTFCYIDPEYQQTG-MLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTL------------AE 451 (568)
Q Consensus 385 ~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~------------~~ 451 (568)
......++..|+|||++.+. .++.++|||||||++|+|++|.+||............... ..
T Consensus 154 -----~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (282)
T cd07829 154 -----TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTK 228 (282)
T ss_pred -----ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcc
Confidence 12234567889999988776 7899999999999999999999999765433221110000 00
Q ss_pred c--cCccCCC--------CChHHHHHHHHHHHHhhccCCCCCCChHHhHhH
Q 008365 452 M--LDPAVTD--------WPAEAAESFSKLAIQCAELRKKDRPDLGTVIVP 492 (568)
Q Consensus 452 ~--l~~~~~~--------~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~ 492 (568)
. .+..... ..+..+..+.+++..||..+|.+||++.+++.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 229 LPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred cccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 0 0111111 111235679999999999999999999999854
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-37 Score=342.99 Aligned_cols=254 Identities=24% Similarity=0.309 Sum_probs=201.1
Q ss_pred HHhcccccceeecccCceeEEEEEe--CCccEEEEEeCcCh--hHhHHHHHHHHHHHHcCCCCceeeecccc--CCCceE
Q 008365 226 EATDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDA--AQGKRQFQQEVEVLSSIRHPNMVLLLGAC--PDYGCL 299 (568)
Q Consensus 226 ~~~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~--~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~--~~~~~l 299 (568)
..+-+|.....||.|.||.||.|.. +|...|+|.++... ....+.+.+|..+|..|+|||+|++||+- .+..+|
T Consensus 1232 nV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~I 1311 (1509)
T KOG4645|consen 1232 NVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYI 1311 (1509)
T ss_pred cceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHH
Confidence 3455788888999999999999986 67789999876543 23345678999999999999999999975 445689
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccC
Q 008365 300 VYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVP 379 (568)
Q Consensus 300 V~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~ 379 (568)
.||||+||+|.+.+..... .++.....+..|++.||.|||+.| ||||||||.||||+.+|.+|++|||.|..+.
T Consensus 1312 FMEyC~~GsLa~ll~~gri---~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~ 1385 (1509)
T KOG4645|consen 1312 FMEYCEGGSLASLLEHGRI---EDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIK 1385 (1509)
T ss_pred HHHHhccCcHHHHHHhcch---hhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEec
Confidence 9999999999998865432 455556668889999999999999 9999999999999999999999999998886
Q ss_pred CCCCccccccccccccccccCCChhhhhcC---CCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHhCccccccCcc
Q 008365 380 PSVADSVTQYHMTSAAGTFCYIDPEYQQTG---MLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPA 456 (568)
Q Consensus 380 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~---~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~l~~~ 456 (568)
....+. +......+||+.|||||++.+. +-..+.||||||||++||+||+.||...++.....-+ .-...
T Consensus 1386 ~~~~~~--~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~-----V~~gh 1458 (1509)
T KOG4645|consen 1386 NNAQTM--PGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYH-----VAAGH 1458 (1509)
T ss_pred CchhcC--CHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhH-----HhccC
Confidence 553221 1234578999999999988764 3667899999999999999999999644432211110 11122
Q ss_pred CCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhH
Q 008365 457 VTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVP 492 (568)
Q Consensus 457 ~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~ 492 (568)
.+..|..++.+-.+|+.+||..||..|-++.+++.+
T Consensus 1459 ~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1459 KPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred CCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 345677788899999999999999999777776643
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=309.87 Aligned_cols=251 Identities=24% Similarity=0.301 Sum_probs=194.7
Q ss_pred HHhcccccceeecccCceeEEEEEe--CCccEEEEEeCcCh--hHhHHHHHHHHHHHHcCCCCceeeeccccCC--C---
Q 008365 226 EATDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDA--AQGKRQFQQEVEVLSSIRHPNMVLLLGACPD--Y--- 296 (568)
Q Consensus 226 ~~~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~--~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--~--- 296 (568)
.+.++|.+...||.|+||.||+|.+ .+..||||++.... ......+.+|+.+++.++||||+++++++.. .
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 3567899999999999999999988 46789999986532 2233557789999999999999999987632 2
Q ss_pred ---ceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccc
Q 008365 297 ---GCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVG 373 (568)
Q Consensus 297 ---~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFG 373 (568)
.++|+||+ +++|.+++... .+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~~~----~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg 163 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVKCQ----KLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFG 163 (343)
T ss_pred cccEEEEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEcccc
Confidence 48999999 78999888642 3889999999999999999999999 9999999999999999999999999
Q ss_pred cccccCCCCCccccccccccccccccCCChhhhhc-CCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHhCccc--
Q 008365 374 LARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQT-GMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLA-- 450 (568)
Q Consensus 374 la~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~-- 450 (568)
++...... .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||................
T Consensus 164 ~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~ 234 (343)
T cd07851 164 LARHTDDE---------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGT 234 (343)
T ss_pred cccccccc---------ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC
Confidence 99765321 234468899999998765 468899999999999999999999996544322111000000
Q ss_pred ------------------cccC----ccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHH
Q 008365 451 ------------------EMLD----PAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPE 493 (568)
Q Consensus 451 ------------------~~l~----~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~ 493 (568)
..+. +.+.......+..+.+++.+||..+|.+||++.+|+.+.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~ 299 (343)
T cd07851 235 PDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHP 299 (343)
T ss_pred CCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCC
Confidence 0000 000001112356799999999999999999999998543
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=332.35 Aligned_cols=253 Identities=27% Similarity=0.419 Sum_probs=189.6
Q ss_pred HhcccccceeecccCceeEEEEEe--CCccEEEEEeCcCh-hHhHHHHHHHHHHHHcCCCCceeeeccccC---------
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDA-AQGKRQFQQEVEVLSSIRHPNMVLLLGACP--------- 294 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~--------- 294 (568)
...+|+.+..||+||||.||++++ +|+.||||.|.... ...-..+.+|+.+|.+|+|||||++|..+-
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ 556 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVL 556 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccc
Confidence 456789999999999999999986 89999999997664 222345779999999999999996652210
Q ss_pred --------------------------------------------------------------------------------
Q 008365 295 -------------------------------------------------------------------------------- 294 (568)
Q Consensus 295 -------------------------------------------------------------------------------- 294 (568)
T Consensus 557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~ 636 (1351)
T KOG1035|consen 557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS 636 (1351)
T ss_pred cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence
Q ss_pred -----------------------C---------CceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH
Q 008365 295 -----------------------D---------YGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLH 342 (568)
Q Consensus 295 -----------------------~---------~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH 342 (568)
+ ..||-||||+...|.+++.++.... .....++++.+|+.||.|+|
T Consensus 637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLaYIH 714 (1351)
T KOG1035|consen 637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLAYIH 714 (1351)
T ss_pred CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHHHHH
Confidence 0 0146689998888887776654211 34567899999999999999
Q ss_pred HcCCCCcccCCCCCCCeeccCCceeEecccccccccC------------CCCCccccccccccccccccCCChhhhhcCC
Q 008365 343 QAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVP------------PSVADSVTQYHMTSAAGTFCYIDPEYQQTGM 410 (568)
Q Consensus 343 ~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~------------~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~ 410 (568)
+.| ||||||||.|||||.++.|||+|||+|+... ............++.+||.-|+|||++.+..
T Consensus 715 ~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~ 791 (1351)
T KOG1035|consen 715 DQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTS 791 (1351)
T ss_pred hCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccc
Confidence 999 9999999999999999999999999998621 0111111222457889999999999887655
Q ss_pred ---CCCcceehhHHHHHHHHHhCCCCCCCchHHHH---HHHhCccccccCccCCCCChHHHHHHHHHHHHhhccCCCCCC
Q 008365 411 ---LTTKSDIYSFGIMLLQIITARSPMGLTHHVSR---AIEKGTLAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRP 484 (568)
Q Consensus 411 ---~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~---~~~~~~~~~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RP 484 (568)
|+.|+|+|||||||+||+. ||+..-.... .+..+.+... .++.......-..+|.++++.||.+||
T Consensus 792 ~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~-----~~f~~~~~~~e~slI~~Ll~hdP~kRP 863 (1351)
T KOG1035|consen 792 SNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEP-----ADFFDPEHPEEASLIRWLLSHDPSKRP 863 (1351)
T ss_pred cccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCC-----cccccccchHHHHHHHHHhcCCCccCC
Confidence 9999999999999999985 6754322222 2233333222 222333344567899999999999999
Q ss_pred ChHHhHhH
Q 008365 485 DLGTVIVP 492 (568)
Q Consensus 485 s~~~vl~~ 492 (568)
++.++|..
T Consensus 864 tA~eLL~s 871 (1351)
T KOG1035|consen 864 TATELLNS 871 (1351)
T ss_pred CHHHHhhc
Confidence 99999753
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=313.78 Aligned_cols=237 Identities=23% Similarity=0.330 Sum_probs=202.2
Q ss_pred ccccceeecccCceeEEEEEeCCcc--EEEEEeCcChhH---hHHHHHHHHHHHHcCCCCceeeeccccCCCc--eEEEE
Q 008365 230 KFSEAMKIGEGGYGPVYRGKLDHTP--VAIKVLRPDAAQ---GKRQFQQEVEVLSSIRHPNMVLLLGACPDYG--CLVYE 302 (568)
Q Consensus 230 ~y~~~~~IG~G~fg~Vy~~~~~~~~--vAvK~l~~~~~~---~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~--~lV~E 302 (568)
+++++..||-||||.|-++..+++. +|+|++++...- ..+.+..|-+||..++.|+||++|-.|.+.. |+.||
T Consensus 421 dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmE 500 (732)
T KOG0614|consen 421 DLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLME 500 (732)
T ss_pred hhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHH
Confidence 4556678999999999999886654 899999875432 2345778999999999999999999997654 78999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCC
Q 008365 303 YMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSV 382 (568)
Q Consensus 303 ~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~ 382 (568)
-|-||.|+..|..++. |...+...++..++.|+.|||.+| ||+|||||+|++||.+|-+||.|||+|+.+..+
T Consensus 501 aClGGElWTiLrdRg~---Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g- 573 (732)
T KOG0614|consen 501 ACLGGELWTILRDRGS---FDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG- 573 (732)
T ss_pred hhcCchhhhhhhhcCC---cccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhccC-
Confidence 9999999999988774 778888889999999999999999 999999999999999999999999999987543
Q ss_pred CccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHH--HHHhCccccccCccCCCC
Q 008365 383 ADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSR--AIEKGTLAEMLDPAVTDW 460 (568)
Q Consensus 383 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~--~~~~~~~~~~l~~~~~~~ 460 (568)
....++||||.|.|||++.+...+.++|.||||+++||||+|.+||...+.+.. .|-+|. + ...+
T Consensus 574 ------~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGi-----d--~i~~ 640 (732)
T KOG0614|consen 574 ------RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGI-----D--KIEF 640 (732)
T ss_pred ------CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhh-----h--hhhc
Confidence 345789999999999999999999999999999999999999999988877543 333331 1 1246
Q ss_pred ChHHHHHHHHHHHHhhccCCCCCCCh
Q 008365 461 PAEAAESFSKLAIQCAELRKKDRPDL 486 (568)
Q Consensus 461 p~~~~~~l~~li~~Cl~~dP~~RPs~ 486 (568)
|..++....+||.+.|..+|.+|--+
T Consensus 641 Pr~I~k~a~~Lik~LCr~~P~ERLG~ 666 (732)
T KOG0614|consen 641 PRRITKTATDLIKKLCRDNPTERLGY 666 (732)
T ss_pred ccccchhHHHHHHHHHhcCcHhhhcc
Confidence 77778888999999999999999873
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=297.96 Aligned_cols=245 Identities=25% Similarity=0.331 Sum_probs=191.5
Q ss_pred ccccceeecccCceeEEEEEe-----CCccEEEEEeCcChh----HhHHHHHHHHHHHHcC-CCCceeeeccccCCC--c
Q 008365 230 KFSEAMKIGEGGYGPVYRGKL-----DHTPVAIKVLRPDAA----QGKRQFQQEVEVLSSI-RHPNMVLLLGACPDY--G 297 (568)
Q Consensus 230 ~y~~~~~IG~G~fg~Vy~~~~-----~~~~vAvK~l~~~~~----~~~~~~~~Ev~iL~~l-~HpnIv~l~g~~~~~--~ 297 (568)
+|.+.+.||+|+||.||++.. ++..||||+++.... .....+.+|+.++..+ +||||+++++.+... .
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 378889999999999999874 456899999875422 2234678999999999 599999999887543 4
Q ss_pred eEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccc
Q 008365 298 CLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARL 377 (568)
Q Consensus 298 ~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~ 377 (568)
++||||+.+|+|.+++.... .+++..+..++.|++.||.|||+.+ ++||||||.||+++.++.++|+|||+++.
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~ 154 (288)
T cd05583 81 HLILDYVNGGELFTHLYQRE---HFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKE 154 (288)
T ss_pred EEEEecCCCCcHHHHHhhcC---CcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccc
Confidence 89999999999999887543 3788899999999999999999998 99999999999999999999999999876
Q ss_pred cCCCCCccccccccccccccccCCChhhhhcCC--CCCcceehhHHHHHHHHHhCCCCCCCchHH--HHHHHhCcccccc
Q 008365 378 VPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGM--LTTKSDIYSFGIMLLQIITARSPMGLTHHV--SRAIEKGTLAEML 453 (568)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~--~s~ksDvwSlGvil~elltG~~Pf~~~~~~--~~~~~~~~~~~~l 453 (568)
+..... .......|+..|+|||.+.+.. .+.++||||||+++|+|++|..||...... ...+.....
T Consensus 155 ~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~---- 225 (288)
T cd05583 155 FLAEEE-----ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRIL---- 225 (288)
T ss_pred cccccc-----cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHH----
Confidence 533211 1122356899999999887665 788999999999999999999999532211 111111110
Q ss_pred CccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhH
Q 008365 454 DPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVI 490 (568)
Q Consensus 454 ~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl 490 (568)
......+..++..+.+++.+||+.+|.+||++.++.
T Consensus 226 -~~~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~ 261 (288)
T cd05583 226 -KSKPPFPKTMSAEARDFIQKLLEKDPKKRLGANGAD 261 (288)
T ss_pred -ccCCCCCcccCHHHHHHHHHHhcCCHhhccCcchHH
Confidence 111223444566789999999999999999987653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=328.34 Aligned_cols=142 Identities=30% Similarity=0.456 Sum_probs=125.9
Q ss_pred cccccceeecccCceeEEEEEeC--CccEEEEEeCcCh---hHhHHHHHHHHHHHHcCCCCceeeeccccC--CCceEEE
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKLD--HTPVAIKVLRPDA---AQGKRQFQQEVEVLSSIRHPNMVLLLGACP--DYGCLVY 301 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~~--~~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~--~~~~lV~ 301 (568)
++|.++++||+|+||.||+|.+. +..||||+++... ......+..|+.++..++||||+++++++. +..||||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 67999999999999999999985 7899999997542 233467889999999999999999998874 3458999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEeccccccc
Q 008365 302 EYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLAR 376 (568)
Q Consensus 302 E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~ 376 (568)
||+.|++|.+++...+ .+++..++.|+.||+.||.|||..+ ||||||||+||||+.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~~~---~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHIYG---YFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999999987654 3788889999999999999999998 9999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=287.34 Aligned_cols=249 Identities=24% Similarity=0.386 Sum_probs=198.2
Q ss_pred eeecccCceeEEEEEe--CCccEEEEEeCcChhHhHHHHHHHHHHHHcCC-CCceeeeccccCCC--ceEEEEecCCCCH
Q 008365 235 MKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIR-HPNMVLLLGACPDY--GCLVYEYMHNGSL 309 (568)
Q Consensus 235 ~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~-HpnIv~l~g~~~~~--~~lV~E~~~ggsL 309 (568)
+.||+|+|+.|--+.. ++..+|||++.+.....+..+.+|++++..++ |+||+.|+++|++. .|||||-|.||+|
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl 163 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL 163 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence 4799999999998765 78899999999888888888999999999996 99999999999765 4999999999999
Q ss_pred HHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCC---ceeEecccccccccCCCC-Ccc
Q 008365 310 EDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRN---YVSKISDVGLARLVPPSV-ADS 385 (568)
Q Consensus 310 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~---~~vKL~DFGla~~~~~~~-~~~ 385 (568)
...|.++. .|++.++.++..+|+.||.|||.+| |.||||||+|||.... .-||||||.|...+.... ...
T Consensus 164 LshI~~~~---~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~sp 237 (463)
T KOG0607|consen 164 LSHIQKRK---HFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSP 237 (463)
T ss_pred HHHHHHhh---hccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccccccccccCCCCCC
Confidence 99988764 3899999999999999999999999 9999999999998543 467999999986542211 112
Q ss_pred ccccccccccccccCCChhhhh-----cCCCCCcceehhHHHHHHHHHhCCCCCCCc-----------------hHHHHH
Q 008365 386 VTQYHMTSAAGTFCYIDPEYQQ-----TGMLTTKSDIYSFGIMLLQIITARSPMGLT-----------------HHVSRA 443 (568)
Q Consensus 386 ~~~~~~~~~~GT~~Y~APE~~~-----~~~~s~ksDvwSlGvil~elltG~~Pf~~~-----------------~~~~~~ 443 (568)
.......+.+|+..|||||+.. ...|+.++|+||||||+|-||+|++||.+. +.+...
T Consensus 238 astP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFes 317 (463)
T KOG0607|consen 238 ASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFES 317 (463)
T ss_pred CCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHH
Confidence 2333455789999999999543 235999999999999999999999999421 112222
Q ss_pred HHhCccccccCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 444 IEKGTLAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 444 ~~~~~~~~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
|..|.+ +.-+. +| ..++.+..+++...+..++.+|-++.+++.+.+
T Consensus 318 IQEGkY-eFPdk---dW-ahIS~eakdlisnLlvrda~~rlsa~~vlnhPw 363 (463)
T KOG0607|consen 318 IQEGKY-EFPDK---DW-AHISSEAKDLISNLLVRDAKQRLSAAQVLNHPW 363 (463)
T ss_pred HhccCC-cCChh---hh-HHhhHHHHHHHHHHHhccHHhhhhhhhccCCcc
Confidence 333332 11111 22 356778889999999999999999999987544
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=287.47 Aligned_cols=230 Identities=28% Similarity=0.350 Sum_probs=189.5
Q ss_pred ecccCceeEEEEEe--CCccEEEEEeCcChhH---hHHHHHHHHHHHHcCCCCceeeeccccCCC--ceEEEEecCCCCH
Q 008365 237 IGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQ---GKRQFQQEVEVLSSIRHPNMVLLLGACPDY--GCLVYEYMHNGSL 309 (568)
Q Consensus 237 IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~---~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~--~~lV~E~~~ggsL 309 (568)
||.|+||.||++.+ .+..||+|++...... ....+..|+.+++.++||||+++++.+.+. .++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 79999999999987 4679999998765332 345688999999999999999999988554 4899999999999
Q ss_pred HHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCCcccccc
Q 008365 310 EDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQY 389 (568)
Q Consensus 310 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~ 389 (568)
.+++.... .+++..+..++.|++.||.|||..+ ++|+||+|+||+++.++.++|+|||++....... .
T Consensus 81 ~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~------~ 148 (250)
T cd05123 81 FSHLSKEG---RFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG------S 148 (250)
T ss_pred HHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC------C
Confidence 99987654 3789999999999999999999999 9999999999999999999999999997653321 1
Q ss_pred ccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHH--HHHHhCccccccCccCCCCChHHHHH
Q 008365 390 HMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVS--RAIEKGTLAEMLDPAVTDWPAEAAES 467 (568)
Q Consensus 390 ~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~--~~~~~~~~~~~l~~~~~~~p~~~~~~ 467 (568)
......|+..|++||.+.+..++.++|+||||+++|+|++|..||....... ..+.. ....++...+..
T Consensus 149 ~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~---------~~~~~~~~~~~~ 219 (250)
T cd05123 149 RTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK---------DPLRFPEFLSPE 219 (250)
T ss_pred cccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc---------CCCCCCCCCCHH
Confidence 1234568999999999988889999999999999999999999996554311 11111 111234445678
Q ss_pred HHHHHHHhhccCCCCCCChH
Q 008365 468 FSKLAIQCAELRKKDRPDLG 487 (568)
Q Consensus 468 l~~li~~Cl~~dP~~RPs~~ 487 (568)
+.+++.+||..+|.+||++.
T Consensus 220 l~~~i~~~l~~~p~~R~~~~ 239 (250)
T cd05123 220 ARDLISGLLQKDPTKRLGSG 239 (250)
T ss_pred HHHHHHHHhcCCHhhCCCcc
Confidence 89999999999999999994
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=339.68 Aligned_cols=244 Identities=27% Similarity=0.460 Sum_probs=190.8
Q ss_pred HhcccccceeecccCceeEEEEEe--CCccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCceeeeccccCC--CceEEEE
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACPD--YGCLVYE 302 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--~~~lV~E 302 (568)
....|.....||+|+||.||+|.+ ++..||||.+...... ...|+.++++++|||||+++|+|.+ ..++|||
T Consensus 688 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~E 763 (968)
T PLN00113 688 ILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHE 763 (968)
T ss_pred HHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEe
Confidence 345677788999999999999986 6789999998644321 2356889999999999999999854 4589999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCC
Q 008365 303 YMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSV 382 (568)
Q Consensus 303 ~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~ 382 (568)
|+++|+|.+++.. ++|..+..|+.||+.||.|||.....+|+||||||+||+++.++..++. ||.......
T Consensus 764 y~~~g~L~~~l~~------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~-- 834 (968)
T PLN00113 764 YIEGKNLSEVLRN------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT-- 834 (968)
T ss_pred CCCCCcHHHHHhc------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc--
Confidence 9999999999852 7899999999999999999996544459999999999999998888775 666543211
Q ss_pred CccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCch----H-HH---HHHHhCccccccC
Q 008365 383 ADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTH----H-VS---RAIEKGTLAEMLD 454 (568)
Q Consensus 383 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~----~-~~---~~~~~~~~~~~l~ 454 (568)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||+... . +. ...........++
T Consensus 835 --------~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 906 (968)
T PLN00113 835 --------DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWID 906 (968)
T ss_pred --------CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeC
Confidence 122368999999999999999999999999999999999999985321 1 11 1111222333444
Q ss_pred ccCC---CCChHHHHHHHHHHHHhhccCCCCCCChHHhHh
Q 008365 455 PAVT---DWPAEAAESFSKLAIQCAELRKKDRPDLGTVIV 491 (568)
Q Consensus 455 ~~~~---~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~ 491 (568)
+.+. ..+......+.+++.+||+.+|.+||++.+|+.
T Consensus 907 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~ 946 (968)
T PLN00113 907 PSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLK 946 (968)
T ss_pred ccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHH
Confidence 4432 233456667889999999999999999999873
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=304.80 Aligned_cols=243 Identities=25% Similarity=0.414 Sum_probs=203.1
Q ss_pred eeecccCceeEEEEEe--CCccEEEEEeCcCh--hHhHHHHHHHHHHHHcCCCCceeeeccccC--CCceEEEEecCCCC
Q 008365 235 MKIGEGGYGPVYRGKL--DHTPVAIKVLRPDA--AQGKRQFQQEVEVLSSIRHPNMVLLLGACP--DYGCLVYEYMHNGS 308 (568)
Q Consensus 235 ~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~--~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~--~~~~lV~E~~~ggs 308 (568)
+.||.|-||+||-|++ +|+.||||++.+-. .....++++|+.||..+.||.||.+--.|+ +..++|||-+ .|+
T Consensus 570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~GD 648 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-HGD 648 (888)
T ss_pred hhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-cch
Confidence 6899999999998876 78899999996642 233467899999999999999999987774 4568999999 677
Q ss_pred HHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCC---ceeEecccccccccCCCCCcc
Q 008365 309 LEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRN---YVSKISDVGLARLVPPSVADS 385 (568)
Q Consensus 309 L~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~---~~vKL~DFGla~~~~~~~~~~ 385 (568)
+.+.+...... .+++.....++.||+.||.|||.++ |+|+||||+||||... -.+||||||+|+.++...
T Consensus 649 MLEMILSsEkg-RL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks--- 721 (888)
T KOG4236|consen 649 MLEMILSSEKG-RLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS--- 721 (888)
T ss_pred HHHHHHHhhcc-cchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchhh---
Confidence 77766554333 3888888889999999999999999 9999999999999543 579999999999986543
Q ss_pred ccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHhCccccccCccCCCCChHHH
Q 008365 386 VTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAVTDWPAEAA 465 (568)
Q Consensus 386 ~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~l~~~~~~~p~~~~ 465 (568)
...+.+|||.|+|||++.+..|...-|+||+|||+|--|.|..||+-...+..+|....+...-.| | .+++
T Consensus 722 ----FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAaFMyPp~P----W-~eis 792 (888)
T KOG4236|consen 722 ----FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAAFMYPPNP----W-SEIS 792 (888)
T ss_pred ----hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhhccccccCCCc----h-hhcC
Confidence 235679999999999999999999999999999999999999999988888888776655332221 2 4566
Q ss_pred HHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 466 ESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 466 ~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
....+||...|+..-.+|-+...-+.|.|
T Consensus 793 ~~AidlIn~LLqVkm~kRysvdk~lsh~W 821 (888)
T KOG4236|consen 793 PEAIDLINNLLQVKMRKRYSVDKSLSHPW 821 (888)
T ss_pred HHHHHHHHHHHHHHHHHhcchHhhccchh
Confidence 77889999999999999999988876554
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=315.93 Aligned_cols=252 Identities=25% Similarity=0.395 Sum_probs=210.3
Q ss_pred HhcccccceeecccCceeEEEEEe--CCccEEEEEeCcChhHhHHHHHHHHHHHHcC-CCCceeeecccc-------CCC
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQGKRQFQQEVEVLSSI-RHPNMVLLLGAC-------PDY 296 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l-~HpnIv~l~g~~-------~~~ 296 (568)
-++.|++...||.|.+|.||+++. +++.+|||++..+... .+.++.|.+||+.+ .|||++.+||+| .|.
T Consensus 17 p~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~-deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~Dq 95 (953)
T KOG0587|consen 17 PADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE-EEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQ 95 (953)
T ss_pred CCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc-cHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCe
Confidence 457899999999999999998765 7889999998876543 35678899999887 599999999987 345
Q ss_pred ceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEeccccccc
Q 008365 297 GCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLAR 376 (568)
Q Consensus 297 ~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~ 376 (568)
.+||||||.|||.-|++.... ...+.|..+..|++.++.||.+||++. +||||||-.|||++.++.|||+|||++.
T Consensus 96 LWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLvDFGvSa 171 (953)
T KOG0587|consen 96 LWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLVDFGVSA 171 (953)
T ss_pred EEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEEeeeeeee
Confidence 599999999999999887754 345899999999999999999999999 9999999999999999999999999997
Q ss_pred ccCCCCCccccccccccccccccCCChhhhhcC-----CCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHhCcccc
Q 008365 377 LVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTG-----MLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAE 451 (568)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-----~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~ 451 (568)
.+.. +..+..+++|||+|||||++... .|+.++|+||||++..||.-|.+|+...+.+...+..-.
T Consensus 172 Qlds------T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpR--- 242 (953)
T KOG0587|consen 172 QLDS------TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR--- 242 (953)
T ss_pred eeec------ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCC---
Confidence 6643 23344678999999999987643 388899999999999999999999988887655443211
Q ss_pred ccCccCC-CCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 452 MLDPAVT-DWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 452 ~l~~~~~-~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
+|... ..|....+.|.++|..||..|...||++.+++.|.+
T Consensus 243 --NPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpF 284 (953)
T KOG0587|consen 243 --NPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPF 284 (953)
T ss_pred --CCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCc
Confidence 12111 236677889999999999999999999999886544
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=289.31 Aligned_cols=247 Identities=26% Similarity=0.362 Sum_probs=191.1
Q ss_pred ccceeecccCceeEEEEEe--CCccEEEEEeCcChh-HhHHHHHHHHHHHHcC-CCCceeeeccccCCCc--eEEEEecC
Q 008365 232 SEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAA-QGKRQFQQEVEVLSSI-RHPNMVLLLGACPDYG--CLVYEYMH 305 (568)
Q Consensus 232 ~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~-~~~~~~~~Ev~iL~~l-~HpnIv~l~g~~~~~~--~lV~E~~~ 305 (568)
+.+..||.|+||+|++..+ .|+..|||.++.... ...+++..|.++..+- +.||||++||++-.++ +|.||+|
T Consensus 67 qdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM- 145 (361)
T KOG1006|consen 67 QDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM- 145 (361)
T ss_pred HHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH-
Confidence 3345799999999999877 577899999987654 4566788888776554 6999999999864433 7899999
Q ss_pred CCCHHHHHhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCC
Q 008365 306 NGSLEDRLLRR--GNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVA 383 (568)
Q Consensus 306 ggsL~~~l~~~--~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~ 383 (568)
..||+.+...- -....+++.-.-.|....+.||.||..... ||||||||+|||||..|.|||||||++-.+..+..
T Consensus 146 d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lk--iIHRDvKPSNILldr~G~vKLCDFGIcGqLv~SiA 223 (361)
T KOG1006|consen 146 DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELK--IIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSIA 223 (361)
T ss_pred hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhh--hhhccCChhheEEecCCCEeeecccchHhHHHHHH
Confidence 57876654321 122348888888898999999999988653 99999999999999999999999999976644432
Q ss_pred ccccccccccccccccCCChhhhhc--CCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHhCccccccCccCCCCC
Q 008365 384 DSVTQYHMTSAAGTFCYIDPEYQQT--GMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAVTDWP 461 (568)
Q Consensus 384 ~~~~~~~~~~~~GT~~Y~APE~~~~--~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~l~~~~~~~p 461 (568)
.+.-+|...|||||.+.. ..|+.++||||||++|||+.||..|+...+.+..++..-.. -++.....+
T Consensus 224 -------kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~---gdpp~l~~~ 293 (361)
T KOG1006|consen 224 -------KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVI---GDPPILLFD 293 (361)
T ss_pred -------hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHc---CCCCeecCc
Confidence 344579999999997753 35999999999999999999999999877776655432111 012111112
Q ss_pred ---hHHHHHHHHHHHHhhccCCCCCCChHHhHh
Q 008365 462 ---AEAAESFSKLAIQCAELRKKDRPDLGTVIV 491 (568)
Q Consensus 462 ---~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~ 491 (568)
.+.+..+..+|..|+-+|..+||.+.++..
T Consensus 294 ~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 294 KECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred ccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 235677999999999999999999998764
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-34 Score=291.96 Aligned_cols=246 Identities=28% Similarity=0.493 Sum_probs=189.9
Q ss_pred ccccceeecccCceeEEEEEeCCccEEEEEeCcChhHhHHHHHHHHHHHHc--CCCCceeeeccccCC------CceEEE
Q 008365 230 KFSEAMKIGEGGYGPVYRGKLDHTPVAIKVLRPDAAQGKRQFQQEVEVLSS--IRHPNMVLLLGACPD------YGCLVY 301 (568)
Q Consensus 230 ~y~~~~~IG~G~fg~Vy~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~--l~HpnIv~l~g~~~~------~~~lV~ 301 (568)
....+.+||+|.||.||+|++.++.||||++.. ...+.|.+|.+|++. +.|+||++++++-.. ...||+
T Consensus 211 pl~l~eli~~Grfg~V~KaqL~~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt 287 (534)
T KOG3653|consen 211 PLQLLELIGRGRFGCVWKAQLDNRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVT 287 (534)
T ss_pred chhhHHHhhcCccceeehhhccCceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEe
Confidence 345567899999999999999999999999974 445678999999886 579999999987522 347999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCC------CCcccCCCCCCCeeccCCceeEecccccc
Q 008365 302 EYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKP------EPLVHRDLKPANILLDRNYVSKISDVGLA 375 (568)
Q Consensus 302 E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~------~~IiHrDIKp~NILld~~~~vKL~DFGla 375 (568)
+|.+.|+|.++|..+- ++|....+|+.-+++||+|||.-.+ ++|+|||||..||||.+++..-|+|||||
T Consensus 288 ~fh~kGsL~dyL~~nt----isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLA 363 (534)
T KOG3653|consen 288 EFHPKGSLCDYLKANT----ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLA 363 (534)
T ss_pred eeccCCcHHHHHHhcc----ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecccee
Confidence 9999999999998763 9999999999999999999998654 47999999999999999999999999999
Q ss_pred cccCCCCCccccccccccccccccCCChhhhhcCC-CC-----CcceehhHHHHHHHHHhCCC------------CCC--
Q 008365 376 RLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGM-LT-----TKSDIYSFGIMLLQIITARS------------PMG-- 435 (568)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~-~s-----~ksDvwSlGvil~elltG~~------------Pf~-- 435 (568)
..+.+..... .....+||.+|||||++.+.. +. .+.||||+|.|||||++... ||+
T Consensus 364 l~~~p~~~~~----d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~e 439 (534)
T KOG3653|consen 364 LRLEPGKPQG----DTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAE 439 (534)
T ss_pred EEecCCCCCc----chhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHH
Confidence 9887544322 234579999999999987753 22 36899999999999998543 221
Q ss_pred -C----chHHHHHHHhCccccccCccCCC-CC-hHHHHHHHHHHHHhhccCCCCCCChHHhH
Q 008365 436 -L----THHVSRAIEKGTLAEMLDPAVTD-WP-AEAAESFSKLAIQCAELRKKDRPDLGTVI 490 (568)
Q Consensus 436 -~----~~~~~~~~~~~~~~~~l~~~~~~-~p-~~~~~~l~~li~~Cl~~dP~~RPs~~~vl 490 (568)
+ .+.+...+...+ ..|.+++ |- .....-+.+.+..||..|++.|-|+.=+.
T Consensus 440 vG~hPt~e~mq~~VV~kK----~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~ 497 (534)
T KOG3653|consen 440 VGNHPTLEEMQELVVRKK----QRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVE 497 (534)
T ss_pred hcCCCCHHHHHHHHHhhc----cCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHH
Confidence 0 111111111111 1222221 11 13356789999999999999999987553
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=282.07 Aligned_cols=219 Identities=24% Similarity=0.226 Sum_probs=175.7
Q ss_pred cCceeEEEEEe--CCccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCceeeeccccCC--CceEEEEecCCCCHHHHHhh
Q 008365 240 GGYGPVYRGKL--DHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACPD--YGCLVYEYMHNGSLEDRLLR 315 (568)
Q Consensus 240 G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--~~~lV~E~~~ggsL~~~l~~ 315 (568)
|.||.||++.+ +++.||+|++.... .+.+|...+....||||+++++++.+ ..++||||++||+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 89999999987 67789999997653 23345555666679999999998754 44899999999999999876
Q ss_pred cCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCCcccccccccccc
Q 008365 316 RGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAA 395 (568)
Q Consensus 316 ~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~ 395 (568)
.. .+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++..+... .....
T Consensus 79 ~~---~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~---------~~~~~ 143 (237)
T cd05576 79 FL---NIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS---------CDGEA 143 (237)
T ss_pred hc---CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccc---------cccCC
Confidence 53 3889999999999999999999999 999999999999999999999999988654321 12345
Q ss_pred ccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHhCccccccCccCCCCChHHHHHHHHHHHHh
Q 008365 396 GTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAVTDWPAEAAESFSKLAIQC 475 (568)
Q Consensus 396 GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~l~~~~~~~p~~~~~~l~~li~~C 475 (568)
++..|+|||++.+..++.++||||+||++|+|++|..||...... + .. ......|..++..+.+++.+|
T Consensus 144 ~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~---~-----~~---~~~~~~~~~~~~~~~~li~~~ 212 (237)
T cd05576 144 VENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG---I-----NT---HTTLNIPEWVSEEARSLLQQL 212 (237)
T ss_pred cCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh---c-----cc---ccccCCcccCCHHHHHHHHHH
Confidence 677899999998888999999999999999999999987532110 0 00 001123445667899999999
Q ss_pred hccCCCCCCChHHh
Q 008365 476 AELRKKDRPDLGTV 489 (568)
Q Consensus 476 l~~dP~~RPs~~~v 489 (568)
++.||.+||++.+.
T Consensus 213 l~~dp~~R~~~~~~ 226 (237)
T cd05576 213 LQFNPTERLGAGVA 226 (237)
T ss_pred ccCCHHHhcCCCcc
Confidence 99999999997443
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=304.00 Aligned_cols=256 Identities=27% Similarity=0.417 Sum_probs=211.5
Q ss_pred cceeecccCceeEEEEEe--CC----ccEEEEEeCcC-hhHhHHHHHHHHHHHHcCCCCceeeeccccCCC-ceEEEEec
Q 008365 233 EAMKIGEGGYGPVYRGKL--DH----TPVAIKVLRPD-AAQGKRQFQQEVEVLSSIRHPNMVLLLGACPDY-GCLVYEYM 304 (568)
Q Consensus 233 ~~~~IG~G~fg~Vy~~~~--~~----~~vAvK~l~~~-~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~-~~lV~E~~ 304 (568)
..++||.|+||+||+|.+ .+ -+||||++... ..+....+..|+-+|..|+|||+++|+|+|... .-||++||
T Consensus 700 k~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~~qlvtq~m 779 (1177)
T KOG1025|consen 700 KDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLSTLQLVTQLM 779 (1177)
T ss_pred hhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccchHHHHHHhc
Confidence 356899999999999987 33 38999998664 344456789999999999999999999999654 47899999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCCc
Q 008365 305 HNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVAD 384 (568)
Q Consensus 305 ~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~~ 384 (568)
++|.|.|+++.+.. .+-.+..+.|..||++|+.|||... ++||||-..||||..-.++||.|||+++++.+..
T Consensus 780 P~G~LlDyvr~hr~--~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~-- 852 (1177)
T KOG1025|consen 780 PLGCLLDYVREHRD--NIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE-- 852 (1177)
T ss_pred ccchHHHHHHHhhc--cccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCccc--
Confidence 99999999987543 3778889999999999999999999 9999999999999999999999999999886543
Q ss_pred cccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh-CCCCCCCc--hHHHHHHHhCccccccCccCCCCC
Q 008365 385 SVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPMGLT--HHVSRAIEKGTLAEMLDPAVTDWP 461 (568)
Q Consensus 385 ~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~--~~~~~~~~~~~~~~~l~~~~~~~p 461 (568)
..+......-.+-|||-|.+....|+.++|||||||.+||++| |..|++.. ..+...++++.- ...|
T Consensus 853 --~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geR--------LsqP 922 (1177)
T KOG1025|consen 853 --KEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGER--------LSQP 922 (1177)
T ss_pred --ccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhcccc--------CCCC
Confidence 2233334445677999999999999999999999999999999 99998643 345555555432 2457
Q ss_pred hHHHHHHHHHHHHhhccCCCCCCChHHhHhHHHHHHHHHhhhhh
Q 008365 462 AEAAESFSKLAIQCAELRKKDRPDLGTVIVPELNRLKDLGRKLE 505 (568)
Q Consensus 462 ~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l~~L~~l~~~~~ 505 (568)
+.|+..+..++.+||..|+..||.+.++....-..+++..+-+.
T Consensus 923 piCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardpqryl~ 966 (1177)
T KOG1025|consen 923 PICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDPQRYLV 966 (1177)
T ss_pred CCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCcceEee
Confidence 88899999999999999999999999988766666665544443
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=282.47 Aligned_cols=263 Identities=23% Similarity=0.303 Sum_probs=192.5
Q ss_pred HhcccccceeecccCceeEEEEEeC------CccEEEEEeCcChhH--hHHHHHHHHHHHHcCCCCceeeeccccCC---
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKLD------HTPVAIKVLRPDAAQ--GKRQFQQEVEVLSSIRHPNMVLLLGACPD--- 295 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~~------~~~vAvK~l~~~~~~--~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--- 295 (568)
....|+.++.||+|.||.||++.-. ...+|||.++..... .-...-+|+.+++.|+|||||.+..+|-.
T Consensus 22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~ 101 (438)
T KOG0666|consen 22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDK 101 (438)
T ss_pred HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence 3457999999999999999999541 237999998754211 11235689999999999999999988744
Q ss_pred CceEEEEecCCCCHHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCC----ceeEe
Q 008365 296 YGCLVYEYMHNGSLEDRLLRRG--NTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRN----YVSKI 369 (568)
Q Consensus 296 ~~~lV~E~~~ggsL~~~l~~~~--~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~----~~vKL 369 (568)
..+|++||.+ -+|..++..+. ....++...+..|+.||+.|+.|||++. |+||||||.||||..+ |.|||
T Consensus 102 ~v~l~fdYAE-hDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKI 177 (438)
T KOG0666|consen 102 KVWLLFDYAE-HDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKI 177 (438)
T ss_pred eEEEEehhhh-hhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEe
Confidence 3379999995 68888886532 2345888899999999999999999999 9999999999999776 99999
Q ss_pred cccccccccCCCCCccccccccccccccccCCChhhhhcC-CCCCcceehhHHHHHHHHHhCCCCCCCch----------
Q 008365 370 SDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTG-MLTTKSDIYSFGIMLLQIITARSPMGLTH---------- 438 (568)
Q Consensus 370 ~DFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDvwSlGvil~elltG~~Pf~~~~---------- 438 (568)
+|||+++++..... .-+.....+.|.+|.|||.+.|. .|+.+.|||++|||+.|||+-.+-|.+..
T Consensus 178 aDlGlaR~~~~plk---pl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq 254 (438)
T KOG0666|consen 178 ADLGLARLFNNPLK---PLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQ 254 (438)
T ss_pred ecccHHHHhhcccc---ccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCch
Confidence 99999998854332 12233457889999999977765 69999999999999999999988774321
Q ss_pred --HHHHHHHh-CccccccCccCCCCCh--------------H------------HHHHHHHHHHHhhccCCCCCCChHHh
Q 008365 439 --HVSRAIEK-GTLAEMLDPAVTDWPA--------------E------------AAESFSKLAIQCAELRKKDRPDLGTV 489 (568)
Q Consensus 439 --~~~~~~~~-~~~~~~l~~~~~~~p~--------------~------------~~~~l~~li~~Cl~~dP~~RPs~~~v 489 (568)
.+.+.++- |.-.+..-|.+..+|. . -++...+|+..+|..||..|.+..+.
T Consensus 255 ~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qA 334 (438)
T KOG0666|consen 255 HDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQA 334 (438)
T ss_pred HHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHH
Confidence 11111110 0000000000001110 0 11235678999999999999999988
Q ss_pred HhHHHHH
Q 008365 490 IVPELNR 496 (568)
Q Consensus 490 l~~~l~~ 496 (568)
+.+..-+
T Consensus 335 leh~yF~ 341 (438)
T KOG0666|consen 335 LEHPYFT 341 (438)
T ss_pred hcccccc
Confidence 8665533
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=312.35 Aligned_cols=254 Identities=30% Similarity=0.487 Sum_probs=203.6
Q ss_pred cccccceeecccCceeEEEEEeC---------CccEEEEEeCcChh-HhHHHHHHHHHHHHcCC-CCceeeeccccCC--
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKLD---------HTPVAIKVLRPDAA-QGKRQFQQEVEVLSSIR-HPNMVLLLGACPD-- 295 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~~---------~~~vAvK~l~~~~~-~~~~~~~~Ev~iL~~l~-HpnIv~l~g~~~~-- 295 (568)
++..+.+.||.|.||.|++|... ...||||.++.... ...+.+..|+++|+.+. |||||.++|+|..
T Consensus 296 ~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~ 375 (609)
T KOG0200|consen 296 ENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDG 375 (609)
T ss_pred hhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCC
Confidence 34455669999999999998742 34799999986543 45667999999999985 9999999999966
Q ss_pred CceEEEEecCCCCHHHHHhhcC-----CC--------CCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeecc
Q 008365 296 YGCLVYEYMHNGSLEDRLLRRG-----NT--------PVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLD 362 (568)
Q Consensus 296 ~~~lV~E~~~ggsL~~~l~~~~-----~~--------~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld 362 (568)
..++|+||+..|+|.++|.... .. ..++....+.++.||+.|++||++.. +|||||-..||||.
T Consensus 376 ~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaRNVLi~ 452 (609)
T KOG0200|consen 376 PLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAARNVLIT 452 (609)
T ss_pred ceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhhhEEec
Confidence 3489999999999999998765 00 13888999999999999999999999 99999999999999
Q ss_pred CCceeEecccccccccCCCCCccccccccccccc--cccCCChhhhhcCCCCCcceehhHHHHHHHHHh-CCCCCCC---
Q 008365 363 RNYVSKISDVGLARLVPPSVADSVTQYHMTSAAG--TFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPMGL--- 436 (568)
Q Consensus 363 ~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~G--T~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~--- 436 (568)
.+..+||+|||+|+...... .+......| ...|||||.+....|+.++|||||||+||||++ |..||..
T Consensus 453 ~~~~~kIaDFGlar~~~~~~-----~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~ 527 (609)
T KOG0200|consen 453 KNKVIKIADFGLARDHYNKD-----YYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP 527 (609)
T ss_pred CCCEEEEccccceeccCCCC-----ceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc
Confidence 99999999999998653321 122222233 345999999999999999999999999999999 8899965
Q ss_pred chHHHHHHHhCccccccCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHHHHHH
Q 008365 437 THHVSRAIEKGTLAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPELNRLK 498 (568)
Q Consensus 437 ~~~~~~~~~~~~~~~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l~~L~ 498 (568)
...+...+..|. ..+.|..|+.++.++|..||+.+|.+||++.+++...-..|.
T Consensus 528 ~~~l~~~l~~G~--------r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~ 581 (609)
T KOG0200|consen 528 TEELLEFLKEGN--------RMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ 581 (609)
T ss_pred HHHHHHHHhcCC--------CCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence 223333333333 234577788899999999999999999999998755444343
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=277.52 Aligned_cols=259 Identities=23% Similarity=0.355 Sum_probs=196.0
Q ss_pred hcccccceeecccCceeEEEEEe--CCccEEEEEeCcC--hhHhHHHHHHHHHHHHcCCCCceeeeccccCC--------
Q 008365 228 TDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPD--AAQGKRQFQQEVEVLSSIRHPNMVLLLGACPD-------- 295 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~-------- 295 (568)
.+.|....+||+|.||.||+++. .++.||+|+.... ...-.....+|+.+|..|.|+|++.++..|..
T Consensus 16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~ 95 (376)
T KOG0669|consen 16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRD 95 (376)
T ss_pred chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccc
Confidence 35677788999999999999876 5667888864321 11112345689999999999999999988832
Q ss_pred --CceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccc
Q 008365 296 --YGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVG 373 (568)
Q Consensus 296 --~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFG 373 (568)
..++||.+|+ .+|..+|..... .++..++.+++.++..||.|+|... |+|||+||.|+||+.+|.+||+|||
T Consensus 96 r~t~ylVf~~ce-hDLaGlLsn~~v--r~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFG 169 (376)
T KOG0669|consen 96 RATFYLVFDFCE-HDLAGLLSNRKV--RFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFG 169 (376)
T ss_pred cceeeeeHHHhh-hhHHHHhcCccc--cccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeeccc
Confidence 1389999995 688887765432 3888999999999999999999999 9999999999999999999999999
Q ss_pred cccccCCCCCccccccccccccccccCCChhhhhc-CCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHH--H--HhCc
Q 008365 374 LARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQT-GMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRA--I--EKGT 448 (568)
Q Consensus 374 la~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~--~--~~~~ 448 (568)
+++.+..+. .......+..+.|.+|.+||.+.| ..|+++.|||..||||.||++|.+-|.......+. | -.|.
T Consensus 170 lar~fs~~~--n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs 247 (376)
T KOG0669|consen 170 LARAFSTSK--NVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGS 247 (376)
T ss_pred cccceeccc--ccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhcc
Confidence 998774432 333444677888999999996655 56999999999999999999999988654433221 1 1232
Q ss_pred cccccCccCCCCC------------------------hHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 449 LAEMLDPAVTDWP------------------------AEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 449 ~~~~l~~~~~~~p------------------------~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
+..-+-|.+.+.| -.-.+...+|+..++.+||.+|++..+++.|.+
T Consensus 248 ~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~ 317 (376)
T KOG0669|consen 248 ITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDF 317 (376)
T ss_pred CCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhh
Confidence 2222222211111 011236778999999999999999999987655
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-34 Score=302.41 Aligned_cols=238 Identities=24% Similarity=0.320 Sum_probs=194.6
Q ss_pred HhcccccceeecccCceeEEEEEe--CCccEEEEEeCcChhHhHHHHHHHHHHHHcC-CCCceeeeccccCCCc--eEEE
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQGKRQFQQEVEVLSSI-RHPNMVLLLGACPDYG--CLVY 301 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l-~HpnIv~l~g~~~~~~--~lV~ 301 (568)
+++.|.+...||.|+|+.|-.+.+ +++..++|++.... .+..+|+.++... +||||+++.+.|.+.. ++||
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 356788889999999999999987 56789999997652 2335677666665 6999999999997754 8999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeec-cCCceeEecccccccccCC
Q 008365 302 EYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILL-DRNYVSKISDVGLARLVPP 380 (568)
Q Consensus 302 E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILl-d~~~~vKL~DFGla~~~~~ 380 (568)
|++.|+-|.+.+..... +. ..+..|+.+|+.|+.|||..| ||||||||+|||+ +..++++|+|||.++....
T Consensus 396 e~l~g~ell~ri~~~~~---~~-~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~ 468 (612)
T KOG0603|consen 396 ELLDGGELLRRIRSKPE---FC-SEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELER 468 (612)
T ss_pred hhccccHHHHHHHhcch---hH-HHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCch
Confidence 99999998888766542 33 677789999999999999999 9999999999999 6899999999999987644
Q ss_pred CCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchH---HHHHHHhCccccccCccC
Q 008365 381 SVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHH---VSRAIEKGTLAEMLDPAV 457 (568)
Q Consensus 381 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~---~~~~~~~~~~~~~l~~~~ 457 (568)
. ..+.+-|..|.|||++....|+.+|||||||++||+||+|+.||..... +...+..+.
T Consensus 469 ~---------~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~--------- 530 (612)
T KOG0603|consen 469 S---------CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPK--------- 530 (612)
T ss_pred h---------hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCc---------
Confidence 3 1234678899999999999999999999999999999999999953322 222222222
Q ss_pred CCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHHH
Q 008365 458 TDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPELN 495 (568)
Q Consensus 458 ~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l~ 495 (568)
+...++....+|+.+||+.+|.+||++.++..|.+.
T Consensus 531 --~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 531 --FSECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred --cccccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 125667889999999999999999999999877664
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=284.29 Aligned_cols=253 Identities=23% Similarity=0.285 Sum_probs=194.4
Q ss_pred HhcccccceeecccCceeEEEEEeC--CccEEEEEeCcChhHhHHHHHHHHHHHHcCC--CC----ceeeeccccCCC--
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKLD--HTPVAIKVLRPDAAQGKRQFQQEVEVLSSIR--HP----NMVLLLGACPDY-- 296 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~~--~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~--Hp----nIv~l~g~~~~~-- 296 (568)
.+++|.++..+|+|.||.|-.+.+. +..||||+++.-. ...+...-|+++|.++. -| -+|.+.++|.-.
T Consensus 87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrgh 165 (415)
T KOG0671|consen 87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGH 165 (415)
T ss_pred cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCc
Confidence 5789999999999999999999874 4589999987443 33455677999999994 22 367888887544
Q ss_pred ceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeecc--------------
Q 008365 297 GCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLD-------------- 362 (568)
Q Consensus 297 ~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld-------------- 362 (568)
.|||+|.+ |-|+.++|..++.. +++...+..|+.|++.++.|||+.+ ++|-||||+|||+-
T Consensus 166 iCivfell-G~S~~dFlk~N~y~-~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~~ 240 (415)
T KOG0671|consen 166 ICIVFELL-GLSTFDFLKENNYI-PFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKKV 240 (415)
T ss_pred eEEEEecc-ChhHHHHhccCCcc-ccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCcc
Confidence 49999999 77999999876654 4899999999999999999999999 99999999999982
Q ss_pred ------CCceeEecccccccccCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCC
Q 008365 363 ------RNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGL 436 (568)
Q Consensus 363 ------~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~ 436 (568)
++..|+|+|||.|+.-.. .....+.|..|.|||++.+-+++..|||||+||||+|+.+|...|..
T Consensus 241 ~~~r~~ks~~I~vIDFGsAtf~~e---------~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqt 311 (415)
T KOG0671|consen 241 CFIRPLKSTAIKVIDFGSATFDHE---------HHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQT 311 (415)
T ss_pred ceeccCCCcceEEEecCCcceecc---------CcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceeccc
Confidence 134689999999975321 23567899999999999999999999999999999999999999964
Q ss_pred chHHHHH-----H---------HhCccccccCccCCC-------------------------CChHHHHHHHHHHHHhhc
Q 008365 437 THHVSRA-----I---------EKGTLAEMLDPAVTD-------------------------WPAEAAESFSKLAIQCAE 477 (568)
Q Consensus 437 ~~~~~~~-----~---------~~~~~~~~l~~~~~~-------------------------~p~~~~~~l~~li~~Cl~ 477 (568)
.++.+.. + .+....+.+.....+ ........|.+|+..+|.
T Consensus 312 Hen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~ 391 (415)
T KOG0671|consen 312 HENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLE 391 (415)
T ss_pred CCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHc
Confidence 4322110 0 000000000000001 112334568999999999
Q ss_pred cCCCCCCChHHhHhHHH
Q 008365 478 LRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 478 ~dP~~RPs~~~vl~~~l 494 (568)
.||.+|+++.+++.|.+
T Consensus 392 fDP~~RiTl~EAL~HpF 408 (415)
T KOG0671|consen 392 FDPARRITLREALSHPF 408 (415)
T ss_pred cCccccccHHHHhcCHH
Confidence 99999999999987655
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=267.84 Aligned_cols=235 Identities=28% Similarity=0.396 Sum_probs=188.9
Q ss_pred CceeEEEEEeC--CccEEEEEeCcChhHh-HHHHHHHHHHHHcCCCCceeeeccccCC--CceEEEEecCCCCHHHHHhh
Q 008365 241 GYGPVYRGKLD--HTPVAIKVLRPDAAQG-KRQFQQEVEVLSSIRHPNMVLLLGACPD--YGCLVYEYMHNGSLEDRLLR 315 (568)
Q Consensus 241 ~fg~Vy~~~~~--~~~vAvK~l~~~~~~~-~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--~~~lV~E~~~ggsL~~~l~~ 315 (568)
+||.||+|... +..||+|++....... ...+.+|+.+++.++|+||+++++.+.. ..++||||+++++|..++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 68999999984 5899999997665443 5788999999999999999999998854 45899999999999998876
Q ss_pred cCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCCcccccccccccc
Q 008365 316 RGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAA 395 (568)
Q Consensus 316 ~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~ 395 (568)
... +++..+..++.+++.+|.|||+.+ |+|+||+|.||+++.++.++|+|||++....... ......
T Consensus 81 ~~~---~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-------~~~~~~ 147 (244)
T smart00220 81 RGR---LSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-------LLTTFV 147 (244)
T ss_pred ccC---CCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc-------cccccc
Confidence 442 788999999999999999999999 9999999999999999999999999998764431 223456
Q ss_pred ccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHhCccccccCccCCCCChHHHHHHHHHHHHh
Q 008365 396 GTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAVTDWPAEAAESFSKLAIQC 475 (568)
Q Consensus 396 GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~l~~~~~~~p~~~~~~l~~li~~C 475 (568)
|+..|++||.+.+..++.++||||||+++|+|++|..||............... .... .......++..+.+++.+|
T Consensus 148 ~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~-~~~~--~~~~~~~~~~~~~~~i~~~ 224 (244)
T smart00220 148 GTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGK-PKPP--FPPPEWKISPEAKDLIRKL 224 (244)
T ss_pred CCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhc-cCCC--CccccccCCHHHHHHHHHH
Confidence 889999999998888999999999999999999999999663222221111000 0000 0000011556799999999
Q ss_pred hccCCCCCCChHHhHh
Q 008365 476 AELRKKDRPDLGTVIV 491 (568)
Q Consensus 476 l~~dP~~RPs~~~vl~ 491 (568)
+..+|.+||++.+++.
T Consensus 225 l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 225 LVKDPEKRLTAEEALQ 240 (244)
T ss_pred ccCCchhccCHHHHhh
Confidence 9999999999999874
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=278.28 Aligned_cols=244 Identities=24% Similarity=0.319 Sum_probs=188.1
Q ss_pred cccccceeecccCceeEEEEEe--CCccEEEEEeCcChhHh---HHHHHHHHHHHHcC-CCCceeeeccccCCCc--eEE
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQG---KRQFQQEVEVLSSI-RHPNMVLLLGACPDYG--CLV 300 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~---~~~~~~Ev~iL~~l-~HpnIv~l~g~~~~~~--~lV 300 (568)
.+|.++.+||+|+|+.|.++++ +.+.+|+|++++..... ..=.+.|-.+.... +||.+|-+...|+... ++|
T Consensus 250 ~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffv 329 (593)
T KOG0695|consen 250 QDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFV 329 (593)
T ss_pred ccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEE
Confidence 5799999999999999999987 45689999998754332 22345677776554 7999999998886544 889
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCC
Q 008365 301 YEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPP 380 (568)
Q Consensus 301 ~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~ 380 (568)
.||++||+|.-.+.+.. .+|++.+..+..+|..||.|||+.| ||+||||.+|+|||..|++||.|+|+++.-
T Consensus 330 ieyv~ggdlmfhmqrqr---klpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~-- 401 (593)
T KOG0695|consen 330 IEYVNGGDLMFHMQRQR---KLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEG-- 401 (593)
T ss_pred EEEecCcceeeehhhhh---cCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcC--
Confidence 99999999987776544 3889999999999999999999999 999999999999999999999999999742
Q ss_pred CCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchH--HHHHHHhCccccccCccCC
Q 008365 381 SVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHH--VSRAIEKGTLAEMLDPAVT 458 (568)
Q Consensus 381 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~--~~~~~~~~~~~~~l~~~~~ 458 (568)
-.......++||||.|+|||++.+..|+..+|+|+|||+|+||+.|+.||+.... -...-+.--+.-++... .
T Consensus 402 ----l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekq-i 476 (593)
T KOG0695|consen 402 ----LGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQ-I 476 (593)
T ss_pred ----CCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhc-c
Confidence 1122334678999999999999999999999999999999999999999963211 00000000011111111 1
Q ss_pred CCChHHHHHHHHHHHHhhccCCCCCCC
Q 008365 459 DWPAEAAESFSKLAIQCAELRKKDRPD 485 (568)
Q Consensus 459 ~~p~~~~~~l~~li~~Cl~~dP~~RPs 485 (568)
..|..++-....++..-|.+||.+|-.
T Consensus 477 riprslsvkas~vlkgflnkdp~erlg 503 (593)
T KOG0695|consen 477 RIPRSLSVKASHVLKGFLNKDPKERLG 503 (593)
T ss_pred cccceeehhhHHHHHHhhcCCcHHhcC
Confidence 234445556677888899999998853
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=279.49 Aligned_cols=254 Identities=28% Similarity=0.428 Sum_probs=192.9
Q ss_pred HhcccccceeecccCceeEEEEEeCCccEEEEEeCcChhHhHHHHHHHHHHHHc--CCCCceeeecccc-CC-----Cce
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKLDHTPVAIKVLRPDAAQGKRQFQQEVEVLSS--IRHPNMVLLLGAC-PD-----YGC 298 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~--l~HpnIv~l~g~~-~~-----~~~ 298 (568)
...+..+.+.||+|.||.||+|.+.|..||||+|.... ...+.+|.+|++. |+|+||+.++++- .+ ..+
T Consensus 209 iarqI~L~e~IGkGRyGEVwrG~wrGe~VAVKiF~srd---E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLw 285 (513)
T KOG2052|consen 209 IARQIVLQEIIGKGRFGEVWRGRWRGEDVAVKIFSSRD---ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLW 285 (513)
T ss_pred hhheeEEEEEecCccccceeeccccCCceEEEEecccc---hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEE
Confidence 45667888999999999999999999999999997554 3467888888875 6999999999763 22 238
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHH-----cCCCCcccCCCCCCCeeccCCceeEecccc
Q 008365 299 LVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQ-----AKPEPLVHRDLKPANILLDRNYVSKISDVG 373 (568)
Q Consensus 299 lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~-----~~~~~IiHrDIKp~NILld~~~~vKL~DFG 373 (568)
||.+|.+.|||.|+|.+. .++....++++.-+|.||.+||. .|.+.|.|||||..||||.++|..-|+|+|
T Consensus 286 LvTdYHe~GSL~DyL~r~----tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLG 361 (513)
T KOG2052|consen 286 LVTDYHEHGSLYDYLNRN----TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 361 (513)
T ss_pred EeeecccCCcHHHHHhhc----cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeece
Confidence 999999999999999874 38889999999999999999996 345569999999999999999999999999
Q ss_pred cccccCCCCCccccccccccccccccCCChhhhhcCC----C--CCcceehhHHHHHHHHHhC----------CCCCCCc
Q 008365 374 LARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGM----L--TTKSDIYSFGIMLLQIITA----------RSPMGLT 437 (568)
Q Consensus 374 la~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~----~--s~ksDvwSlGvil~elltG----------~~Pf~~~ 437 (568)
||....... + .-....+..+||-+|||||++.... + -..+||||||.|+||+... ++||...
T Consensus 362 LAv~h~~~t-~-~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~ 439 (513)
T KOG2052|consen 362 LAVRHDSDT-D-TIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDV 439 (513)
T ss_pred eeEEecccC-C-cccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccC
Confidence 997665443 1 1222345679999999999887543 1 1257999999999999863 3677421
Q ss_pred ---hHHHHHHHhCccccccCccCCC-C-ChHHHHHHHHHHHHhhccCCCCCCChHHh
Q 008365 438 ---HHVSRAIEKGTLAEMLDPAVTD-W-PAEAAESFSKLAIQCAELRKKDRPDLGTV 489 (568)
Q Consensus 438 ---~~~~~~~~~~~~~~~l~~~~~~-~-p~~~~~~l~~li~~Cl~~dP~~RPs~~~v 489 (568)
+.-.....+--..+.+.|.+++ | ...+...+.+||..||..+|..|-++-.|
T Consensus 440 Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALri 496 (513)
T KOG2052|consen 440 VPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRI 496 (513)
T ss_pred CCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHH
Confidence 1111111111122233343332 2 23566789999999999999999887543
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-32 Score=251.18 Aligned_cols=249 Identities=25% Similarity=0.354 Sum_probs=186.9
Q ss_pred ccccceeecccCceeEEEEEe--CCccEEEEEeCcChh--HhHHHHHHHHHHHHcCCCCceeeeccccCCC--ceEEEEe
Q 008365 230 KFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAA--QGKRQFQQEVEVLSSIRHPNMVLLLGACPDY--GCLVYEY 303 (568)
Q Consensus 230 ~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~--~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~--~~lV~E~ 303 (568)
+|...++||+|.||+||+|+. .+..||+|..+.+.. .......+|+-+|+.+.|.|||+++++.... .-+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 466677899999999999987 556899999866432 2234567999999999999999999987443 4789999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCC
Q 008365 304 MHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVA 383 (568)
Q Consensus 304 ~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~ 383 (568)
| ..+|..++...+. .+.......++.|+++||.|+|+.+ ++|||+||.|+||+.+|.+||+|||+++.++-..
T Consensus 83 c-dqdlkkyfdslng--~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipv- 155 (292)
T KOG0662|consen 83 C-DQDLKKYFDSLNG--DLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPV- 155 (292)
T ss_pred h-hHHHHHHHHhcCC--cCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCce-
Confidence 9 5788888876544 3788888999999999999999999 9999999999999999999999999999765332
Q ss_pred ccccccccccccccccCCChhhhhcC-CCCCcceehhHHHHHHHHHh-CCCCCCCchHHHHHHHh-----CccccccCcc
Q 008365 384 DSVTQYHMTSAAGTFCYIDPEYQQTG-MLTTKSDIYSFGIMLLQIIT-ARSPMGLTHHVSRAIEK-----GTLAEMLDPA 456 (568)
Q Consensus 384 ~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~-----~~~~~~l~~~ 456 (568)
......+.|.+|.+|.++-+. -|+...|+||.|||+.|+.. |++.|-+. .+..++.. |...+---|.
T Consensus 156 -----rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~-dvddqlkrif~~lg~p~ed~wps 229 (292)
T KOG0662|consen 156 -----RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN-DVDDQLKRIFRLLGTPTEDQWPS 229 (292)
T ss_pred -----EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCC-cHHHHHHHHHHHhCCCccccCCc
Confidence 223456789999999977665 48999999999999999998 44445333 33322221 1111111111
Q ss_pred CC---------CCCh---------HHHHHHHHHHHHhhccCCCCCCChHHhHh
Q 008365 457 VT---------DWPA---------EAAESFSKLAIQCAELRKKDRPDLGTVIV 491 (568)
Q Consensus 457 ~~---------~~p~---------~~~~~l~~li~~Cl~~dP~~RPs~~~vl~ 491 (568)
+. -+|. .+...=.++++..+..+|.+|.+++..++
T Consensus 230 ~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 230 MTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred cccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 11 1111 12223457888899999999999987664
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.7e-32 Score=301.20 Aligned_cols=256 Identities=21% Similarity=0.247 Sum_probs=168.5
Q ss_pred HhcccccceeecccCceeEEEEEe--C----CccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCceeeeccc--------
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKL--D----HTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGA-------- 292 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~--~----~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~-------- 292 (568)
..++|.+.++||+|+||.||+|.+ + +..||||++...... +.+..+ .+....+.+++.++..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 346899999999999999999987 3 568999988643221 111111 1122222233222221
Q ss_pred cCCCceEEEEecCCCCHHHHHhhcCCC-----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCC
Q 008365 293 CPDYGCLVYEYMHNGSLEDRLLRRGNT-----------------PVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLK 355 (568)
Q Consensus 293 ~~~~~~lV~E~~~ggsL~~~l~~~~~~-----------------~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIK 355 (568)
..+..+|||||+.+++|.+++...... .......+..|+.||+.||.|||+.+ |+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence 123458999999999999988654310 00112345579999999999999999 9999999
Q ss_pred CCCeeccC-CceeEecccccccccCCCCCccccccccccccccccCCChhhhhcC----------------------CCC
Q 008365 356 PANILLDR-NYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTG----------------------MLT 412 (568)
Q Consensus 356 p~NILld~-~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~----------------------~~s 412 (568)
|+||||+. ++.+||+|||+|+.+.... .+.....+||+.|+|||.+... .++
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~-----~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~ 357 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGI-----NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLP 357 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCcccccccc-----ccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCC
Confidence 99999986 6899999999998653221 1223456899999999965322 244
Q ss_pred CcceehhHHHHHHHHHhCCCCCCCchH-HHHHHHhCcc-----ccccCccCC-C------CChHHHHHHHHHHHHhhccC
Q 008365 413 TKSDIYSFGIMLLQIITARSPMGLTHH-VSRAIEKGTL-----AEMLDPAVT-D------WPAEAAESFSKLAIQCAELR 479 (568)
Q Consensus 413 ~ksDvwSlGvil~elltG~~Pf~~~~~-~~~~~~~~~~-----~~~l~~~~~-~------~p~~~~~~l~~li~~Cl~~d 479 (568)
.++||||||||||||+++..|++.... ....+..... ...+.+... + ..........+|+.+||+.|
T Consensus 358 ~k~DVwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~d 437 (566)
T PLN03225 358 DRFDIYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFK 437 (566)
T ss_pred CCcccHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCC
Confidence 567999999999999998777643211 1111111110 001111100 0 00011224568999999999
Q ss_pred CCCCCChHHhHhHHH
Q 008365 480 KKDRPDLGTVIVPEL 494 (568)
Q Consensus 480 P~~RPs~~~vl~~~l 494 (568)
|.+||++.+++.|.+
T Consensus 438 P~kR~ta~e~L~Hpf 452 (566)
T PLN03225 438 GRQRISAKAALAHPY 452 (566)
T ss_pred cccCCCHHHHhCCcC
Confidence 999999999987655
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=288.74 Aligned_cols=260 Identities=21% Similarity=0.282 Sum_probs=181.3
Q ss_pred HhcccccceeecccCceeEEEEEe------------------CCccEEEEEeCcChhHhHHHH--------------HHH
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKL------------------DHTPVAIKVLRPDAAQGKRQF--------------QQE 274 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~------------------~~~~vAvK~l~~~~~~~~~~~--------------~~E 274 (568)
..++|.+.++||+|+||.||+|.+ .++.||||.+........+.| ..|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 357899999999999999999963 235799999875543322333 346
Q ss_pred HHHHHcCCCCce-----eeeccccC----------CCceEEEEecCCCCHHHHHhhcCC---------------------
Q 008365 275 VEVLSSIRHPNM-----VLLLGACP----------DYGCLVYEYMHNGSLEDRLLRRGN--------------------- 318 (568)
Q Consensus 275 v~iL~~l~HpnI-----v~l~g~~~----------~~~~lV~E~~~ggsL~~~l~~~~~--------------------- 318 (568)
+.++.+++|.++ +.++++|. ...+|||||+++++|.++|.....
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 677777776654 56667663 234899999999999998864321
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCCccccccccccccccc
Q 008365 319 TPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTF 398 (568)
Q Consensus 319 ~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~GT~ 398 (568)
...+++..+..|+.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+..... .......+|+
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-----~~~~~g~~tp 374 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-----FNPLYGMLDP 374 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCc-----cCccccCCCc
Confidence 112456778889999999999999999 99999999999999999999999999975532211 1112234589
Q ss_pred cCCChhhhhcCC--------------------C--CCcceehhHHHHHHHHHhCCC-CCCCchHHHHHHHh--Cccc--c
Q 008365 399 CYIDPEYQQTGM--------------------L--TTKSDIYSFGIMLLQIITARS-PMGLTHHVSRAIEK--GTLA--E 451 (568)
Q Consensus 399 ~Y~APE~~~~~~--------------------~--s~ksDvwSlGvil~elltG~~-Pf~~~~~~~~~~~~--~~~~--~ 451 (568)
.|+|||.+.... | ..+.||||+|||+|+|++|.. ||.........+.. .... .
T Consensus 375 ~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r 454 (507)
T PLN03224 375 RYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWR 454 (507)
T ss_pred ceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHH
Confidence 999999765322 1 234799999999999999986 77533222211111 0000 0
Q ss_pred ccCccCCCC--ChHHHHHHHHHHHHhhccCC---CCCCChHHhHhHHH
Q 008365 452 MLDPAVTDW--PAEAAESFSKLAIQCAELRK---KDRPDLGTVIVPEL 494 (568)
Q Consensus 452 ~l~~~~~~~--p~~~~~~l~~li~~Cl~~dP---~~RPs~~~vl~~~l 494 (568)
.......++ ....+....+|+.+++..+| .+|+++.+++.|.+
T Consensus 455 ~~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~ 502 (507)
T PLN03224 455 MYKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRF 502 (507)
T ss_pred hhcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCC
Confidence 000000111 22356778999999999866 68999999987654
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-32 Score=298.11 Aligned_cols=248 Identities=26% Similarity=0.360 Sum_probs=192.8
Q ss_pred cccceeecccCcee-EEEEEeCCccEEEEEeCcChhHhHHHHHHHHHHHHcCC-CCceeeeccccCCCc--eEEEEecCC
Q 008365 231 FSEAMKIGEGGYGP-VYRGKLDHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIR-HPNMVLLLGACPDYG--CLVYEYMHN 306 (568)
Q Consensus 231 y~~~~~IG~G~fg~-Vy~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~-HpnIv~l~g~~~~~~--~lV~E~~~g 306 (568)
|...+.+|.|+-|+ ||+|.+.++.||||.+-.... ....+|+..|+..+ |||||++|+.-.+.. ||..|+| .
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye~R~VAVKrll~e~~---~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC-~ 586 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYEGREVAVKRLLEEFF---DFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC-A 586 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeCCceehHHHHhhHhH---HHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-h
Confidence 45556799999985 799999999999998754332 24579999999986 999999998876544 8999999 6
Q ss_pred CCHHHHHhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccC-----CceeEecccccccccCC
Q 008365 307 GSLEDRLLRRGNT-PVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDR-----NYVSKISDVGLARLVPP 380 (568)
Q Consensus 307 gsL~~~l~~~~~~-~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~-----~~~vKL~DFGla~~~~~ 380 (568)
.+|.+++...+.. .....-..+.+..|++.||++||+.+ ||||||||.||||+. ...++|+|||+|+.++.
T Consensus 587 ~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~ 663 (903)
T KOG1027|consen 587 CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAG 663 (903)
T ss_pred hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccCC
Confidence 8999999774111 11111334668889999999999999 999999999999965 25789999999998865
Q ss_pred CCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhC-CCCCCCchHHHHHHHhCccccccCccCCC
Q 008365 381 SVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITA-RSPMGLTHHVSRAIEKGTLAEMLDPAVTD 459 (568)
Q Consensus 381 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG-~~Pf~~~~~~~~~~~~~~~~~~l~~~~~~ 459 (568)
+... ..+..+..||-+|+|||++....-+.++||||||||+|+.++| ..||+..-..+..|..+...-..-..
T Consensus 664 ~~sS---~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~~~~~L~~L~~--- 737 (903)
T KOG1027|consen 664 GKSS---FSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILTGNYTLVHLEP--- 737 (903)
T ss_pred Ccch---hhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhcCccceeeecc---
Confidence 4322 2235678899999999999999989999999999999999995 89998665555555555432111111
Q ss_pred CChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 460 WPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 460 ~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
-.++ +..+||.+|+.++|..||++.+|+.|.+
T Consensus 738 -~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~HPl 769 (903)
T KOG1027|consen 738 -LPDC--EAKDLISRMLNPDPQLRPSATDVLNHPL 769 (903)
T ss_pred -CchH--HHHHHHHHhcCCCcccCCCHHHHhCCCc
Confidence 1122 6889999999999999999999987544
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=249.05 Aligned_cols=201 Identities=29% Similarity=0.428 Sum_probs=162.1
Q ss_pred HhcccccceeecccCceeEEEEEe--CCccEEEEEeCcCh-hHhHHHHHHHHHHHHcC-CCCceeeeccccCCCc--eEE
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDA-AQGKRQFQQEVEVLSSI-RHPNMVLLLGACPDYG--CLV 300 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l-~HpnIv~l~g~~~~~~--~lV 300 (568)
..+....+..||+|+||.|-+-++ +|+..|+|.+.... .+..+++.+|+++..+. .+|++|.+||...+.. +|.
T Consensus 44 ~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIc 123 (282)
T KOG0984|consen 44 PADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWIC 123 (282)
T ss_pred chhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEe
Confidence 344556667899999999876665 88999999987653 33445677899887665 6999999999875543 899
Q ss_pred EEecCCCCHHHHHhh-cCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccC
Q 008365 301 YEYMHNGSLEDRLLR-RGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVP 379 (568)
Q Consensus 301 ~E~~~ggsL~~~l~~-~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~ 379 (568)
||.| ..||+.+-.+ ......+++.-+-+|+..++.||.|||++-. |||||+||+|||||.+|+|||||||++-.+.
T Consensus 124 ME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~--vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~ 200 (282)
T KOG0984|consen 124 MELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLS--VIHRDVKPSNILINYDGQVKICDFGISGYLV 200 (282)
T ss_pred HHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhh--hhhccCCcceEEEccCCcEEEcccccceeeh
Confidence 9999 5788766543 1222348999999999999999999999753 9999999999999999999999999998776
Q ss_pred CCCCccccccccccccccccCCChhhhhc----CCCCCcceehhHHHHHHHHHhCCCCCCCc
Q 008365 380 PSVADSVTQYHMTSAAGTFCYIDPEYQQT----GMLTTKSDIYSFGIMLLQIITARSPMGLT 437 (568)
Q Consensus 380 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~----~~~s~ksDvwSlGvil~elltG~~Pf~~~ 437 (568)
++... +-..|.-.|||||.+.. ..|+.++||||||+.++||.+++.||...
T Consensus 201 dSiAk-------t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w 255 (282)
T KOG0984|consen 201 DSIAK-------TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW 255 (282)
T ss_pred hhhHH-------HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence 55433 22468889999997643 46999999999999999999999999643
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-31 Score=278.15 Aligned_cols=264 Identities=21% Similarity=0.310 Sum_probs=203.0
Q ss_pred ccccCHHHHHHHhcccccceeecccCceeEEEEEe--CCccEEEEEeCcChhHhHHHHHHHHHHHHcCC------CCcee
Q 008365 216 YRKYTIEEIEEATDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIR------HPNMV 287 (568)
Q Consensus 216 ~~~~~~~ei~~~~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~------HpnIv 287 (568)
|.++.+.|+ +..+|.+....|+|-|++|..|.+ .+..||||+|..+.... +.=..|++||++|+ --|++
T Consensus 421 YYrv~igE~--LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~-KtGl~EleiLkKL~~AD~Edk~Hcl 497 (752)
T KOG0670|consen 421 YYRVRIGEL--LDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMH-KTGLKELEILKKLNDADPEDKFHCL 497 (752)
T ss_pred eEEEehhhh--hcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHh-hhhhHHHHHHHHhhccCchhhhHHH
Confidence 444555544 678899999999999999999987 46799999998765432 23357999999994 34688
Q ss_pred eeccccC--CCceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCC-
Q 008365 288 LLLGACP--DYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRN- 364 (568)
Q Consensus 288 ~l~g~~~--~~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~- 364 (568)
+|+-.|. +..|||+|-+ ..+|.++|.+.|..-.|....+..++.|++.||..|..++ |+|.||||+||||++.
T Consensus 498 rl~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k 573 (752)
T KOG0670|consen 498 RLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESK 573 (752)
T ss_pred HHHHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCc
Confidence 8887774 4569999998 6899999999888777888999999999999999999999 9999999999999875
Q ss_pred ceeEecccccccccCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchH--HHH
Q 008365 365 YVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHH--VSR 442 (568)
Q Consensus 365 ~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~--~~~ 442 (568)
..+||||||.|..+... .+ +....+..|.|||++.|..|+...|+||+||+||||.||+..|.+..+ +..
T Consensus 574 ~iLKLCDfGSA~~~~en---ei-----tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLr 645 (752)
T KOG0670|consen 574 NILKLCDFGSASFASEN---EI-----TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLR 645 (752)
T ss_pred ceeeeccCccccccccc---cc-----cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHH
Confidence 67899999999766432 22 334566789999999999999999999999999999999998843221 111
Q ss_pred ------------HHHhCcc---------------------------ccccCcc---------CCCCCh---HHHHHHHHH
Q 008365 443 ------------AIEKGTL---------------------------AEMLDPA---------VTDWPA---EAAESFSKL 471 (568)
Q Consensus 443 ------------~~~~~~~---------------------------~~~l~~~---------~~~~p~---~~~~~l~~l 471 (568)
.+.++.| ...+.|. ...+|. .....|.+|
T Consensus 646 l~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdL 725 (752)
T KOG0670|consen 646 LFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDL 725 (752)
T ss_pred HHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHH
Confidence 1111111 0001110 001222 344578899
Q ss_pred HHHhhccCCCCCCChHHhHhHHH
Q 008365 472 AIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 472 i~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
+..|+.+||..|-+..+.|.|.+
T Consensus 726 Ldkml~LdP~KRit~nqAL~HpF 748 (752)
T KOG0670|consen 726 LDKMLILDPEKRITVNQALKHPF 748 (752)
T ss_pred HHHHhccChhhcCCHHHHhcCCc
Confidence 99999999999999998886654
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.6e-32 Score=285.66 Aligned_cols=254 Identities=25% Similarity=0.378 Sum_probs=208.3
Q ss_pred HhcccccceeecccCceeEEEEEe--CCccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCceeeecccc--CCCceEEEE
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGAC--PDYGCLVYE 302 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~--~~~~~lV~E 302 (568)
-.++|+.+..||.|+||.||++++ .+...|||+++.....+...+++|+-+++.++|||||.++|.+ .+..+++||
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME 92 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME 92 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence 457899999999999999999988 5678999999988777777888999999999999999999988 455699999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCC
Q 008365 303 YMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSV 382 (568)
Q Consensus 303 ~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~ 382 (568)
||.||+|.+.-+--+ ++++.++..++++.++||.|||+.+ -+|||||-.|||+++.|.+|++|||.+-.+....
T Consensus 93 ycgggslQdiy~~Tg---plselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitati 166 (829)
T KOG0576|consen 93 YCGGGSLQDIYHVTG---PLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITATI 166 (829)
T ss_pred ecCCCcccceeeecc---cchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhhh
Confidence 999999998755433 4888999999999999999999999 8999999999999999999999999987664433
Q ss_pred CccccccccccccccccCCChhhh---hcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHhCccccccCccCCC
Q 008365 383 ADSVTQYHMTSAAGTFCYIDPEYQ---QTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAVTD 459 (568)
Q Consensus 383 ~~~~~~~~~~~~~GT~~Y~APE~~---~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~l~~~~~~ 459 (568)
. +..++.||++|||||+. ..+.|...||||++|+...|+-.-++|....+.....+-..+ -.+++.-.+
T Consensus 167 ~------KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTk--S~~qpp~lk 238 (829)
T KOG0576|consen 167 A------KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTK--SGFQPPTLK 238 (829)
T ss_pred h------hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhc--cCCCCCccc
Confidence 2 34578999999999954 567799999999999999999999999766665443321110 011222112
Q ss_pred CChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 460 WPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 460 ~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
-+....+.|.+|+..|+..+|.+||+...+|.|.+
T Consensus 239 Dk~kws~~fh~fvK~altknpKkRptaeklL~h~f 273 (829)
T KOG0576|consen 239 DKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPF 273 (829)
T ss_pred CCccchHHHHHHHHHHhcCCCccCCChhhheecee
Confidence 23345678999999999999999999998876544
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.7e-32 Score=259.59 Aligned_cols=250 Identities=23% Similarity=0.318 Sum_probs=187.9
Q ss_pred cccceeecccCceeEEEEEe--CCccEEEEEeCcC--hhHhHHHHHHHHHHHHcCCCCceeeeccccCCC-------ceE
Q 008365 231 FSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPD--AAQGKRQFQQEVEVLSSIRHPNMVLLLGACPDY-------GCL 299 (568)
Q Consensus 231 y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~-------~~l 299 (568)
.+..+.||-|+||+||-+.+ +++.||+|.+... ....-+.+.+|+.+|..++|.|++..+++.+.. .|+
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV 134 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV 134 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence 34557899999999999987 7889999987542 222345678999999999999999998876432 267
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccC
Q 008365 300 VYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVP 379 (568)
Q Consensus 300 V~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~ 379 (568)
|.|+| ..+|..++..-. .++...+.-+.+||++||.|||+.+ |+||||||.|+||+.|..+||||||+++...
T Consensus 135 ~TELm-QSDLHKIIVSPQ---~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee 207 (449)
T KOG0664|consen 135 LTELM-QSDLHKIIVSPQ---ALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWD 207 (449)
T ss_pred HHHHH-HhhhhheeccCC---CCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccc
Confidence 88888 567877765432 3677777889999999999999999 9999999999999999999999999999764
Q ss_pred CCCCccccccccccccccccCCChhhhhcC-CCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHH--------------
Q 008365 380 PSVADSVTQYHMTSAAGTFCYIDPEYQQTG-MLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAI-------------- 444 (568)
Q Consensus 380 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~-------------- 444 (568)
... ...++..+.|-+|.|||++.|. .|+.++||||+|||+.|||..+..|.....+.+..
T Consensus 208 ~d~-----~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaM 282 (449)
T KOG0664|consen 208 QRD-----RLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAM 282 (449)
T ss_pred hhh-----hhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHH
Confidence 432 3345667789999999988775 59999999999999999999998886544433211
Q ss_pred ---HhCccccccCccCC--C--------CChHHHHHHHHHHHHhhccCCCCCCChHHhHhH
Q 008365 445 ---EKGTLAEMLDPAVT--D--------WPAEAAESFSKLAIQCAELRKKDRPDLGTVIVP 492 (568)
Q Consensus 445 ---~~~~~~~~l~~~~~--~--------~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~ 492 (568)
.+|....++..... + .+....-+...+...++..+|+.|.+..+.+.+
T Consensus 283 r~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~ 343 (449)
T KOG0664|consen 283 KYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQH 343 (449)
T ss_pred HHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccc
Confidence 12222222222111 1 122233345667788889999999888776543
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-30 Score=254.77 Aligned_cols=253 Identities=22% Similarity=0.318 Sum_probs=201.4
Q ss_pred hcccccceeecccCceeEEEEEe--CCccEEEEEeCcChhHhHHHHHHHHHHHHcCC-CCceeeec--cccCCCceEEEE
Q 008365 228 TDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIR-HPNMVLLL--GACPDYGCLVYE 302 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~-HpnIv~l~--g~~~~~~~lV~E 302 (568)
.-.|.+.++||+|+||+++.|+. ++.+||||.-.... ...++..|...++.|. .++|...| |-|.-+..||||
T Consensus 27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVid 104 (449)
T KOG1165|consen 27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVID 104 (449)
T ss_pred cccceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhh
Confidence 34799999999999999999986 88999999864332 2357788888888885 67776655 445556789999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccC-----CceeEecccccccc
Q 008365 303 YMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDR-----NYVSKISDVGLARL 377 (568)
Q Consensus 303 ~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~-----~~~vKL~DFGla~~ 377 (568)
++ |.||.|++.-++.. |+.+++..||.|++.-++|+|.++ +|.|||||+|+||.. ...+.|+|||+|+.
T Consensus 105 LL-GPSLEDLFD~CgR~--FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~ 178 (449)
T KOG1165|consen 105 LL-GPSLEDLFDLCGRR--FSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE 178 (449)
T ss_pred hh-CcCHHHHHHHhcCc--ccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence 99 99999999888865 999999999999999999999999 999999999999954 35789999999998
Q ss_pred cCCCCC-ccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchH--HHHHHHh-Ccccccc
Q 008365 378 VPPSVA-DSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHH--VSRAIEK-GTLAEML 453 (568)
Q Consensus 378 ~~~~~~-~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~--~~~~~~~-~~~~~~l 453 (568)
+.+... .........+..||.+||+-.-+.+...+.+.|+-|||-|++++|.|.+||.+... .....++ |....
T Consensus 179 YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr-- 256 (449)
T KOG1165|consen 179 YRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKR-- 256 (449)
T ss_pred hcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccc--
Confidence 855433 33444455678899999999999999999999999999999999999999965432 1111111 11100
Q ss_pred CccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhH
Q 008365 454 DPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVI 490 (568)
Q Consensus 454 ~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl 490 (568)
...+.....+.|.+|...+.....++..+-|+++.+.
T Consensus 257 ~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr 293 (449)
T KOG1165|consen 257 STPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLR 293 (449)
T ss_pred cCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHH
Confidence 0111233456788999999999999999999998764
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8e-31 Score=247.96 Aligned_cols=250 Identities=23% Similarity=0.389 Sum_probs=194.5
Q ss_pred HhcccccceeecccCceeEEEEEe--CCccEEEEEeCcChhHhHHHHHHHHHHHHcCC-CCceeeeccccCCCc----eE
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIR-HPNMVLLLGACPDYG----CL 299 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~-HpnIv~l~g~~~~~~----~l 299 (568)
..++|++.+++|+|.|+.||.|.. ++..++||++++-. .+.+.+|+.||..|. ||||++++++..|.. .|
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL 112 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL 112 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence 347899999999999999999984 67799999998654 346789999999997 999999999986643 79
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccC-CceeEeccccccccc
Q 008365 300 VYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDR-NYVSKISDVGLARLV 378 (568)
Q Consensus 300 V~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~-~~~vKL~DFGla~~~ 378 (568)
|+||+++.+...+.. .++...+..++.+++.||.|+|+.| |+|||+||.|++||. .-.++|+|+|||.++
T Consensus 113 iFE~v~n~Dfk~ly~------tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFY 183 (338)
T KOG0668|consen 113 IFEYVNNTDFKQLYP------TLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 183 (338)
T ss_pred HhhhhccccHHHHhh------hhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhc
Confidence 999999988776542 3677788889999999999999999 999999999999986 467999999999988
Q ss_pred CCCCCccccccccccccccccCCChhhh-hcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHH-------h----
Q 008365 379 PPSVADSVTQYHMTSAAGTFCYIDPEYQ-QTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIE-------K---- 446 (568)
Q Consensus 379 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~-~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~-------~---- 446 (568)
.+... ....+.+..|--||.+ ....|+..-|+|||||+|..|+..+-||...+....++. .
T Consensus 184 Hp~~e-------YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~ 256 (338)
T KOG0668|consen 184 HPGKE-------YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELY 256 (338)
T ss_pred CCCce-------eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHH
Confidence 65432 2345678889999965 456799999999999999999999999953322111110 0
Q ss_pred ---CccccccCccCCC---------CC-------h-HHHHHHHHHHHHhhccCCCCCCChHHhHhHHHH
Q 008365 447 ---GTLAEMLDPAVTD---------WP-------A-EAAESFSKLAIQCAELRKKDRPDLGTVIVPELN 495 (568)
Q Consensus 447 ---~~~~~~l~~~~~~---------~p-------~-~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l~ 495 (568)
....-.+++...+ |. . -..++..+|+...|..|-.+|||+.+.+.|.+-
T Consensus 257 ~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF 325 (338)
T KOG0668|consen 257 AYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYF 325 (338)
T ss_pred HHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchH
Confidence 0011112332211 10 0 123678899999999999999999999876653
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.3e-30 Score=262.73 Aligned_cols=128 Identities=25% Similarity=0.406 Sum_probs=109.1
Q ss_pred cccccceeecccCceeEEEEEe--CCccEEEEEeCcChhHhHHHHHHHHHHHHcCC-----C---CceeeeccccCCC--
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIR-----H---PNMVLLLGACPDY-- 296 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~-----H---pnIv~l~g~~~~~-- 296 (568)
.+|.+.++||.|.|++||++.+ ..+.||+||.+.. ..-.+....|+.+|++++ | .+||+|++.|...
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 6899999999999999999998 4568999998744 333456678999999883 3 3699999999432
Q ss_pred ----ceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeec
Q 008365 297 ----GCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILL 361 (568)
Q Consensus 297 ----~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILl 361 (568)
.|||+|++ |.+|..+|....... ++...+..|+.||+.||.|||... +|||-||||+|||+
T Consensus 157 NG~HVCMVfEvL-GdnLLklI~~s~YrG-lpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 157 NGQHVCMVFEVL-GDNLLKLIKYSNYRG-LPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL 221 (590)
T ss_pred CCcEEEEEehhh-hhHHHHHHHHhCCCC-CcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence 39999999 889999998866543 899999999999999999999976 49999999999998
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.4e-29 Score=237.15 Aligned_cols=206 Identities=33% Similarity=0.556 Sum_probs=178.7
Q ss_pred ecccCceeEEEEEeC--CccEEEEEeCcChhH-hHHHHHHHHHHHHcCCCCceeeeccccCC--CceEEEEecCCCCHHH
Q 008365 237 IGEGGYGPVYRGKLD--HTPVAIKVLRPDAAQ-GKRQFQQEVEVLSSIRHPNMVLLLGACPD--YGCLVYEYMHNGSLED 311 (568)
Q Consensus 237 IG~G~fg~Vy~~~~~--~~~vAvK~l~~~~~~-~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--~~~lV~E~~~ggsL~~ 311 (568)
||.|++|.||++... +..++||++...... ....+.+|+.+++.+.|++|+++++++.. ..++||||+.|++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 689999999999986 789999999766442 34678999999999999999999999865 5589999999999999
Q ss_pred HHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccC-CceeEecccccccccCCCCCccccccc
Q 008365 312 RLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDR-NYVSKISDVGLARLVPPSVADSVTQYH 390 (568)
Q Consensus 312 ~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~-~~~vKL~DFGla~~~~~~~~~~~~~~~ 390 (568)
++.... ..+++..+..++.+++.+|.+||+.+ ++|+||+|.||+++. ++.++|+|||.+........ .
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~------~ 149 (215)
T cd00180 81 LLKENE--GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS------L 149 (215)
T ss_pred HHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc------h
Confidence 987653 23788999999999999999999999 999999999999999 89999999999986643321 1
Q ss_pred cccccccccCCChhhhhcC-CCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHhCccccccCccCCCCChHHHHHHH
Q 008365 391 MTSAAGTFCYIDPEYQQTG-MLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAVTDWPAEAAESFS 469 (568)
Q Consensus 391 ~~~~~GT~~Y~APE~~~~~-~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~l~~~~~~~p~~~~~~l~ 469 (568)
.....+...|++||.+... .++.+.|+|+||+++++| ..+.
T Consensus 150 ~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------------------------------------~~~~ 191 (215)
T cd00180 150 LKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------------------------------------PELK 191 (215)
T ss_pred hhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH--------------------------------------HHHH
Confidence 2335688899999998877 889999999999999999 4688
Q ss_pred HHHHHhhccCCCCCCChHHhHh
Q 008365 470 KLAIQCAELRKKDRPDLGTVIV 491 (568)
Q Consensus 470 ~li~~Cl~~dP~~RPs~~~vl~ 491 (568)
+++..|++.+|.+||++.+++.
T Consensus 192 ~~l~~~l~~~p~~R~~~~~l~~ 213 (215)
T cd00180 192 DLIRKMLQKDPEKRPSAKEILE 213 (215)
T ss_pred HHHHHHhhCCcccCcCHHHHhh
Confidence 9999999999999999998863
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=250.68 Aligned_cols=249 Identities=22% Similarity=0.277 Sum_probs=191.8
Q ss_pred cccccceeecccCceeEEEEEe--CCccEEEEEeCcC--hhHhHHHHHHHHHHHHcCCCCceeeeccccCCC--------
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPD--AAQGKRQFQQEVEVLSSIRHPNMVLLLGACPDY-------- 296 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~-------- 296 (568)
.+|.-+..+|.|.- .|--+.+ .+.+||+|.+... .....+...+|..++..++|+||+.++.+|...
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 56778888999988 5655554 6789999986432 112234567899999999999999999998432
Q ss_pred ceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEeccccccc
Q 008365 297 GCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLAR 376 (568)
Q Consensus 297 ~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~ 376 (568)
.|+||||| ..+|...+... +.-.++..|..|++.|+.|||+.+ |+||||||+||+|+.++.+||+|||+|+
T Consensus 96 ~y~v~e~m-~~nl~~vi~~e-----lDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar 166 (369)
T KOG0665|consen 96 VYLVMELM-DANLCQVILME-----LDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLAR 166 (369)
T ss_pred HHHHHHhh-hhHHHHHHHHh-----cchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhc
Confidence 38999999 68898887633 556788899999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHhCc--------
Q 008365 377 LVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGT-------- 448 (568)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~-------- 448 (568)
.... ...++..+.|..|.|||++.+..|...+||||+||++.||++|..-|.+.+.+.+......
T Consensus 167 ~e~~-------~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~ 239 (369)
T KOG0665|consen 167 TEDT-------DFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPS 239 (369)
T ss_pred ccCc-------ccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHH
Confidence 5322 2456778999999999999998899999999999999999999999876555544322110
Q ss_pred -----------------------cccccCc----cCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 449 -----------------------LAEMLDP----AVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 449 -----------------------~~~~l~~----~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
+.+.+.. ...+.+.-......+++.+||-.+|++|-+..++|.|..
T Consensus 240 F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY 312 (369)
T KOG0665|consen 240 FMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPY 312 (369)
T ss_pred HHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCe
Confidence 0111100 001111112335778999999999999999999986553
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.8e-29 Score=251.21 Aligned_cols=254 Identities=21% Similarity=0.364 Sum_probs=201.5
Q ss_pred HHHHHHhcccccceeecccCceeEEEEEe-------CCccEEEEEeCcChhH-hHHHHHHHHHHHHcCCCCceeeecccc
Q 008365 222 EEIEEATDKFSEAMKIGEGGYGPVYRGKL-------DHTPVAIKVLRPDAAQ-GKRQFQQEVEVLSSIRHPNMVLLLGAC 293 (568)
Q Consensus 222 ~ei~~~~~~y~~~~~IG~G~fg~Vy~~~~-------~~~~vAvK~l~~~~~~-~~~~~~~Ev~iL~~l~HpnIv~l~g~~ 293 (568)
.++.....+++...++-+|.||.||.|.+ +.+.|-+|.++....+ ....+..|.-.|..+.|||+..+.+++
T Consensus 277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ 356 (563)
T KOG1024|consen 277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVS 356 (563)
T ss_pred HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEE
Confidence 34444456788888999999999999954 2235777777654332 234577899999999999999999987
Q ss_pred CC---CceEEEEecCCCCHHHHHhhc-----CCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCc
Q 008365 294 PD---YGCLVYEYMHNGSLEDRLLRR-----GNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNY 365 (568)
Q Consensus 294 ~~---~~~lV~E~~~ggsL~~~l~~~-----~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~ 365 (568)
-+ ..+.+|.++.-|+|..+|..+ .....++-.+...++.|++.|+.|||+.+ |||.||-..|.+||+..
T Consensus 357 ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~L 433 (563)
T KOG1024|consen 357 IEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQL 433 (563)
T ss_pred eeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhhe
Confidence 33 337889999999999999833 22334666778889999999999999999 99999999999999999
Q ss_pred eeEecccccccccCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh-CCCCCCCchHHH--H
Q 008365 366 VSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPMGLTHHVS--R 442 (568)
Q Consensus 366 ~vKL~DFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~--~ 442 (568)
.|||+|=.+++.+-+....... ..-.....||+||.+.+..|+.++|||||||+||||+| |+.|+...+..+ .
T Consensus 434 qVkltDsaLSRDLFP~DYhcLG----DnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ 509 (563)
T KOG1024|consen 434 QVKLTDSALSRDLFPGDYHCLG----DNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEH 509 (563)
T ss_pred eEEeccchhccccCcccccccC----CCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHH
Confidence 9999999999977654433222 12234678999999999999999999999999999999 999996555433 3
Q ss_pred HHHhCccccccCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhH
Q 008365 443 AIEKGTLAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVI 490 (568)
Q Consensus 443 ~~~~~~~~~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl 490 (568)
.+++|. ....|.+||+++..+|..||+..|++||++.+++
T Consensus 510 ylkdGy--------RlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv 549 (563)
T KOG1024|consen 510 YLKDGY--------RLAQPFNCPDELFTVMACCWALLPEERPSFSQLV 549 (563)
T ss_pred HHhccc--------eecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHH
Confidence 333332 2234778999999999999999999999999986
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-29 Score=238.54 Aligned_cols=255 Identities=20% Similarity=0.271 Sum_probs=201.7
Q ss_pred HhcccccceeecccCceeEEEEEe--CCccEEEEEeCcChhHhHHHHHHHHHHHHcCCC-Cceeeecccc--CCCceEEE
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRH-PNMVLLLGAC--PDYGCLVY 301 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~H-pnIv~l~g~~--~~~~~lV~ 301 (568)
...+|.++++||.|+||.+|.|.. .|..||||+-...... .++..|..+...|++ ..|..+..++ .++..+||
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h--pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM 90 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH--PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM 90 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC--cchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence 457899999999999999999986 7889999997665443 467789999998874 4555555444 45668999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccC---CceeEeccccccccc
Q 008365 302 EYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDR---NYVSKISDVGLARLV 378 (568)
Q Consensus 302 E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~---~~~vKL~DFGla~~~ 378 (568)
+++ |.+|.+++.-+... ++.++++.++-|++.-++|+|..+ +|||||||+|+|..- ...+.|+|||||+.+
T Consensus 91 dLL-GPsLEdLfnfC~R~--ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky 164 (341)
T KOG1163|consen 91 DLL-GPSLEDLFNFCSRR--FTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY 164 (341)
T ss_pred ecc-CccHHHHHHHHhhh--hhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhh
Confidence 999 99999998877653 889999999999999999999999 999999999999853 357899999999877
Q ss_pred CCCCCc-cccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHhCccccc-cCcc
Q 008365 379 PPSVAD-SVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEM-LDPA 456 (568)
Q Consensus 379 ~~~~~~-~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~-l~~~ 456 (568)
.+.... ...........||..|.+-..+.+...+.+.|+-|+|++|..+..|..||..........+...+.+. +...
T Consensus 165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~ 244 (341)
T KOG1163|consen 165 RDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTP 244 (341)
T ss_pred ccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCC
Confidence 543322 33333445688999999999999999999999999999999999999999766554443333333222 1222
Q ss_pred CCCCChHHHHHHHHHHHHhhccCCCCCCChHHh
Q 008365 457 VTDWPAEAAESFSKLAIQCAELRKKDRPDLGTV 489 (568)
Q Consensus 457 ~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~v 489 (568)
+...+.+.|.+|.-.+..|..+...+-|++..+
T Consensus 245 ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~yl 277 (341)
T KOG1163|consen 245 IEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYL 277 (341)
T ss_pred HHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHH
Confidence 223344566789999999999999999999755
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.3e-28 Score=234.48 Aligned_cols=196 Identities=33% Similarity=0.549 Sum_probs=168.2
Q ss_pred cccceeecccCceeEEEEEeC--CccEEEEEeCcChhH-hHHHHHHHHHHHHcCCCCceeeeccccC--CCceEEEEecC
Q 008365 231 FSEAMKIGEGGYGPVYRGKLD--HTPVAIKVLRPDAAQ-GKRQFQQEVEVLSSIRHPNMVLLLGACP--DYGCLVYEYMH 305 (568)
Q Consensus 231 y~~~~~IG~G~fg~Vy~~~~~--~~~vAvK~l~~~~~~-~~~~~~~Ev~iL~~l~HpnIv~l~g~~~--~~~~lV~E~~~ 305 (568)
|.+.+.||.|+||.||++... +..+|||.+...... ....+.+|+..+..++|+|++++++++. +..++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 567789999999999999884 578999999876544 5678899999999999999999999875 45589999999
Q ss_pred CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCCcc
Q 008365 306 NGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADS 385 (568)
Q Consensus 306 ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~~~ 385 (568)
+++|.+++...... +++..+..++.+++.+|.|||+.+ ++|+||+|.||+++.++.++|+|||++..+......
T Consensus 81 ~~~L~~~~~~~~~~--~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~- 154 (225)
T smart00221 81 GGDLFDYLRKKGGK--LSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA- 154 (225)
T ss_pred CCCHHHHHHhcccC--CCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc-
Confidence 99999998765421 688899999999999999999998 999999999999999999999999999876443200
Q ss_pred ccccccccccccccCCChhhh-hcCCCCCcceehhHHHHHHHHHhCCCCCCC
Q 008365 386 VTQYHMTSAAGTFCYIDPEYQ-QTGMLTTKSDIYSFGIMLLQIITARSPMGL 436 (568)
Q Consensus 386 ~~~~~~~~~~GT~~Y~APE~~-~~~~~s~ksDvwSlGvil~elltG~~Pf~~ 436 (568)
......++..|++||.+ ....++.++|||+||+++++|++|+.||..
T Consensus 155 ----~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 155 ----LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ----cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 12345688899999988 667788899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7e-29 Score=260.18 Aligned_cols=193 Identities=24% Similarity=0.334 Sum_probs=163.4
Q ss_pred cccccceeecccCceeEEEEEe--CCccEEEEEeCcChhHh--------HHHHHHHHHHHHcCC---CCceeeeccccCC
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQG--------KRQFQQEVEVLSSIR---HPNMVLLLGACPD 295 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~--------~~~~~~Ev~iL~~l~---HpnIv~l~g~~~~ 295 (568)
.+|..++.+|.|+||.|++|.+ +...|+||.+.+...-. .-.+-.|+.||..|+ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 4589999999999999999988 45589999987653211 112457999999998 9999999999976
Q ss_pred C--ceEEEEec-CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEeccc
Q 008365 296 Y--GCLVYEYM-HNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDV 372 (568)
Q Consensus 296 ~--~~lV~E~~-~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DF 372 (568)
. .||+||-- +|-+|.+++..+. .+++.++..|+.||+.|+.+||..+ |||||||-+|+.|+.+|.+||+||
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~kp---~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidf 714 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEFKP---RMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDF 714 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhccC---ccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeec
Confidence 4 47888875 5568888887653 4889999999999999999999999 999999999999999999999999
Q ss_pred ccccccCCCCCccccccccccccccccCCChhhhhcCCC-CCcceehhHHHHHHHHHhCCCCCC
Q 008365 373 GLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGML-TTKSDIYSFGIMLLQIITARSPMG 435 (568)
Q Consensus 373 Gla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~-s~ksDvwSlGvil~elltG~~Pf~ 435 (568)
|.|.+...+. ...++||..|.|||++.|..| +..-|||+||++||.++....||.
T Consensus 715 gsaa~~ksgp--------fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 715 GSAAYTKSGP--------FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred cchhhhcCCC--------cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 9997764432 245789999999999999876 566899999999999999999984
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.3e-28 Score=234.53 Aligned_cols=245 Identities=25% Similarity=0.350 Sum_probs=176.6
Q ss_pred HhcccccceeecccCceeEEEEEeC--CccEEEEEeCcChhHhHHHHHHHHHHHHcCC-CCceeeeccc-cC--CCceEE
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKLD--HTPVAIKVLRPDAAQGKRQFQQEVEVLSSIR-HPNMVLLLGA-CP--DYGCLV 300 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~~--~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~-HpnIv~l~g~-~~--~~~~lV 300 (568)
+.+.|.+.+.||+|.||.+-++.+. ++.+|+|.+.... ....+|.+|...--.|. |.||+.-|++ |+ +..+++
T Consensus 22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~ 100 (378)
T KOG1345|consen 22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV 100 (378)
T ss_pred hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence 4467999999999999999999984 4689999886443 33568889887766664 8999998865 43 445789
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeec-c-CCceeEeccccccccc
Q 008365 301 YEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILL-D-RNYVSKISDVGLARLV 378 (568)
Q Consensus 301 ~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILl-d-~~~~vKL~DFGla~~~ 378 (568)
|||++.|+|..-+...| +-+....+++.|++.||.|+|+.+ +||||||.+|||| + +...|||||||+.+..
T Consensus 101 qE~aP~gdL~snv~~~G----igE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~ 173 (378)
T KOG1345|consen 101 QEFAPRGDLRSNVEAAG----IGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKV 173 (378)
T ss_pred eccCccchhhhhcCccc----ccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeeccccccc
Confidence 99999999988776544 667778889999999999999999 9999999999999 2 3468999999998765
Q ss_pred CCCCCccccccccccccccccCCChhhhhcCC-----CCCcceehhHHHHHHHHHhCCCCCCCchHHHHH-HHhCccccc
Q 008365 379 PPSVADSVTQYHMTSAAGTFCYIDPEYQQTGM-----LTTKSDIYSFGIMLLQIITARSPMGLTHHVSRA-IEKGTLAEM 452 (568)
Q Consensus 379 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~-----~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~-~~~~~~~~~ 452 (568)
+..+ ...--+..|.+||...... ..+.+|||.||+++|.+|||.+||......+.. .+-......
T Consensus 174 g~tV---------~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~r 244 (378)
T KOG1345|consen 174 GTTV---------KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKR 244 (378)
T ss_pred Ccee---------hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcc
Confidence 3322 1122456799999665432 567889999999999999999999621110000 000011111
Q ss_pred cCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHH
Q 008365 453 LDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGT 488 (568)
Q Consensus 453 l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~ 488 (568)
..+.++....-.++.+..+..+-+..++++|--..+
T Consensus 245 k~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~ 280 (378)
T KOG1345|consen 245 KNPALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWT 280 (378)
T ss_pred cCccCchhhcccCHHHHHHHHHhcCCcccccchhHH
Confidence 222332222233456777888889999999844433
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.6e-27 Score=243.98 Aligned_cols=253 Identities=23% Similarity=0.312 Sum_probs=191.8
Q ss_pred ccccceeecccCceeEEEEEeCCc---cEEEEEeCcChhHhHHHHHHHHHHHHcCCC----Cceeeecccc---CCCceE
Q 008365 230 KFSEAMKIGEGGYGPVYRGKLDHT---PVAIKVLRPDAAQGKRQFQQEVEVLSSIRH----PNMVLLLGAC---PDYGCL 299 (568)
Q Consensus 230 ~y~~~~~IG~G~fg~Vy~~~~~~~---~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~H----pnIv~l~g~~---~~~~~l 299 (568)
+|.+.++||+|+||.||++.+... .+|+|+...........+..|+.+|..+.. +++..+++.. ..+.++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 799999999999999999997543 699998866533322367789999988862 4677777665 335699
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCC-----ceeEeccccc
Q 008365 300 VYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRN-----YVSKISDVGL 374 (568)
Q Consensus 300 V~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~-----~~vKL~DFGl 374 (568)
||+.+ |.+|.++..... ...++..+.++|+.|++.+|.+||+.| +|||||||+|+++... ..++|.|||+
T Consensus 99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 99998 999999876655 345999999999999999999999999 9999999999999754 4799999999
Q ss_pred ccccC--CCCCccccccc--cccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHH--HHHHHhCc
Q 008365 375 ARLVP--PSVADSVTQYH--MTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHV--SRAIEKGT 448 (568)
Q Consensus 375 a~~~~--~~~~~~~~~~~--~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~--~~~~~~~~ 448 (568)
++.+. ........... ...+.||..|+++.++.+...+.+.|+||+++++.+++.|..||...... ...+....
T Consensus 174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~ 253 (322)
T KOG1164|consen 174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDP 253 (322)
T ss_pred CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHh
Confidence 98332 22111111111 23567999999999999999999999999999999999999999544321 11111111
Q ss_pred cccccCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHh
Q 008365 449 LAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIV 491 (568)
Q Consensus 449 ~~~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~ 491 (568)
....... .....+..+.++...+-..+..++|++..+..
T Consensus 254 ~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~ 292 (322)
T KOG1164|consen 254 RKLLTDR----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAE 292 (322)
T ss_pred hhhcccc----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHH
Confidence 1111111 23344567888999999999999999998763
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.6e-27 Score=241.83 Aligned_cols=259 Identities=23% Similarity=0.302 Sum_probs=190.9
Q ss_pred HHHhcccccceeecccCceeEEEEEeC-----CccEEEEEeCcChhHhHHHHHHHHHHHHcCC-CCceeeecccc--CCC
Q 008365 225 EEATDKFSEAMKIGEGGYGPVYRGKLD-----HTPVAIKVLRPDAAQGKRQFQQEVEVLSSIR-HPNMVLLLGAC--PDY 296 (568)
Q Consensus 225 ~~~~~~y~~~~~IG~G~fg~Vy~~~~~-----~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~-HpnIv~l~g~~--~~~ 296 (568)
....+.|..+++||.|.|++||++.+. ...||+|.+..... ...+.+|+++|..+. +.||+++.+.+ .+.
T Consensus 32 p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~--p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~ 109 (418)
T KOG1167|consen 32 PFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS--PSRILNELEMLYRLGGSDNIIKLNGCFRNNDQ 109 (418)
T ss_pred hhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC--chHHHHHHHHHHHhccchhhhcchhhhccCCe
Confidence 345567899999999999999999762 35899999865533 345789999999996 99999999987 455
Q ss_pred ceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccC-CceeEecccccc
Q 008365 297 GCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDR-NYVSKISDVGLA 375 (568)
Q Consensus 297 ~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~-~~~vKL~DFGla 375 (568)
.++||||++.....+++.. ++...+..+++.++.||.++|.+| ||||||||+|||.+. -+.-.|+|||||
T Consensus 110 v~ivlp~~~H~~f~~l~~~------l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgLA 180 (418)
T KOG1167|consen 110 VAIVLPYFEHDRFRDLYRS------LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGLA 180 (418)
T ss_pred eEEEecccCccCHHHHHhc------CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechhH
Confidence 6999999999998887754 567788899999999999999999 999999999999975 467789999999
Q ss_pred cccCCCC-----------------C---------------------ccccccccccccccccCCChhhhh-cCCCCCcce
Q 008365 376 RLVPPSV-----------------A---------------------DSVTQYHMTSAAGTFCYIDPEYQQ-TGMLTTKSD 416 (568)
Q Consensus 376 ~~~~~~~-----------------~---------------------~~~~~~~~~~~~GT~~Y~APE~~~-~~~~s~ksD 416 (568)
....... . ...........+||++|.|||++. ....++++|
T Consensus 181 ~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiD 260 (418)
T KOG1167|consen 181 QRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAID 260 (418)
T ss_pred HHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccc
Confidence 6210000 0 000111123468999999999654 566899999
Q ss_pred ehhHHHHHHHHHhCCCCCCCch----------------HHHH-HHHhCc--ccc--------------------ccCc--
Q 008365 417 IYSFGIMLLQIITARSPMGLTH----------------HVSR-AIEKGT--LAE--------------------MLDP-- 455 (568)
Q Consensus 417 vwSlGvil~elltG~~Pf~~~~----------------~~~~-~~~~~~--~~~--------------------~l~~-- 455 (568)
|||.|||++-+++++.||.... .+.. +.-.|. +.+ .+.+
T Consensus 261 iws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~ 340 (418)
T KOG1167|consen 261 IWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSR 340 (418)
T ss_pred eeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccc
Confidence 9999999999999999993211 0110 111122 111 0000
Q ss_pred ----cCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 456 ----AVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 456 ----~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
....+....+..+.+|+.+|+..||.+|.++++.|.|.+
T Consensus 341 q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpF 383 (418)
T KOG1167|consen 341 QPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPF 383 (418)
T ss_pred ccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcC
Confidence 001122223447889999999999999999999987554
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-27 Score=277.01 Aligned_cols=201 Identities=16% Similarity=0.205 Sum_probs=141.0
Q ss_pred cCCC-CceeeeccccC---------CCceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCc
Q 008365 280 SIRH-PNMVLLLGACP---------DYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPL 349 (568)
Q Consensus 280 ~l~H-pnIv~l~g~~~---------~~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~I 349 (568)
.++| +||+.++++|. +..+++|||+ +++|.++|.... ..+++..+..|+.||+.||.|||+++ |
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~g---I 101 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD--RSVDAFECFHVFRQIVEIVNAAHSQG---I 101 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc--ccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 3445 57888888771 1235678887 779999996532 34899999999999999999999999 9
Q ss_pred ccCCCCCCCeeccCC-------------------ceeEecccccccccCCCCCc---c-------ccccccccccccccC
Q 008365 350 VHRDLKPANILLDRN-------------------YVSKISDVGLARLVPPSVAD---S-------VTQYHMTSAAGTFCY 400 (568)
Q Consensus 350 iHrDIKp~NILld~~-------------------~~vKL~DFGla~~~~~~~~~---~-------~~~~~~~~~~GT~~Y 400 (568)
|||||||+||||+.. +.+||+|||+++........ . .........+||++|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 999999999999654 45566666666532110000 0 000111235789999
Q ss_pred CChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHhCccccccCccCCCCChHHHHHHHHHHHHhhccCC
Q 008365 401 IDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAVTDWPAEAAESFSKLAIQCAELRK 480 (568)
Q Consensus 401 ~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP 480 (568)
||||++.+..|+.++|||||||+||||++|.+||.........+... .+.+.. .........++.+||..+|
T Consensus 182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~~~~~~~~----~~~~~~----~~~~~~~~~~~~~~L~~~P 253 (793)
T PLN00181 182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSRTMSSLRHR----VLPPQI----LLNWPKEASFCLWLLHPEP 253 (793)
T ss_pred EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHHHHHHHHh----hcChhh----hhcCHHHHHHHHHhCCCCh
Confidence 99999999999999999999999999999999985332222222111 111111 1112345688899999999
Q ss_pred CCCCChHHhHhHHH
Q 008365 481 KDRPDLGTVIVPEL 494 (568)
Q Consensus 481 ~~RPs~~~vl~~~l 494 (568)
.+||++.+++.+.+
T Consensus 254 ~~Rps~~eil~h~~ 267 (793)
T PLN00181 254 SCRPSMSELLQSEF 267 (793)
T ss_pred hhCcChHHHhhchh
Confidence 99999999986544
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-25 Score=211.91 Aligned_cols=165 Identities=24% Similarity=0.278 Sum_probs=127.0
Q ss_pred CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCCccc
Q 008365 307 GSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSV 386 (568)
Q Consensus 307 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~~~~ 386 (568)
|+|.+++...+. .+++..++.|+.||+.||.|||+.+ ||+|||++.++.+|+ ||+++.....
T Consensus 1 GsL~~~l~~~~~--~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~----- 62 (176)
T smart00750 1 VSLADILEVRGR--PLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPE----- 62 (176)
T ss_pred CcHHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeeccc-----
Confidence 789999976443 3899999999999999999999876 999999999999999 9999765331
Q ss_pred cccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHh--CccccccCccCCCCChHH
Q 008365 387 TQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEK--GTLAEMLDPAVTDWPAEA 464 (568)
Q Consensus 387 ~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~--~~~~~~l~~~~~~~p~~~ 464 (568)
...||+.|+|||++.+..++.++|||||||++|||++|+.||.........+.. .... ...+.....+...
T Consensus 63 ------~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 135 (176)
T smart00750 63 ------QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMP-ADDPRDRSNLESV 135 (176)
T ss_pred ------cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhc-cCCccccccHHHH
Confidence 125899999999999999999999999999999999999999654332221111 0000 0111111122334
Q ss_pred HH--HHHHHHHHhhccCCCCCCChHHhHhHHHHH
Q 008365 465 AE--SFSKLAIQCAELRKKDRPDLGTVIVPELNR 496 (568)
Q Consensus 465 ~~--~l~~li~~Cl~~dP~~RPs~~~vl~~~l~~ 496 (568)
.. .+.+++.+||..+|.+||++.+++.+....
T Consensus 136 ~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 136 SAARSFADFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred HhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence 44 699999999999999999999998776544
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=3e-25 Score=232.52 Aligned_cols=168 Identities=20% Similarity=0.170 Sum_probs=130.0
Q ss_pred HHhcccccceeecccCceeEEEEEe---CCccEEEEEeCcC-----hhHhHHHHHHHHHHHHcCCCCceee-eccccCCC
Q 008365 226 EATDKFSEAMKIGEGGYGPVYRGKL---DHTPVAIKVLRPD-----AAQGKRQFQQEVEVLSSIRHPNMVL-LLGACPDY 296 (568)
Q Consensus 226 ~~~~~y~~~~~IG~G~fg~Vy~~~~---~~~~vAvK~l~~~-----~~~~~~~~~~Ev~iL~~l~HpnIv~-l~g~~~~~ 296 (568)
.+.++|.+.+.||+|+||+||+|.+ +++.||||++... .......|.+|+++|+.++|+||+. +++. ..
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~--~~ 92 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT--GK 92 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc--CC
Confidence 3567899999999999999999986 4567899987533 1223456899999999999999985 5443 45
Q ss_pred ceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCC-CCCCeeccCCceeEecccccc
Q 008365 297 GCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDL-KPANILLDRNYVSKISDVGLA 375 (568)
Q Consensus 297 ~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDI-Kp~NILld~~~~vKL~DFGla 375 (568)
.+||||||+|++|.. +.. .. ...++.+++.||.|||+.+ |+|||| ||+|||++.++.+||+|||+|
T Consensus 93 ~~LVmE~~~G~~L~~-~~~------~~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFGlA 159 (365)
T PRK09188 93 DGLVRGWTEGVPLHL-ARP------HG---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQLA 159 (365)
T ss_pred cEEEEEccCCCCHHH-hCc------cc---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECccc
Confidence 699999999999963 211 11 1457889999999999999 999999 999999999999999999999
Q ss_pred cccCCCCCccc--cccccccccccccCCChhhhhc
Q 008365 376 RLVPPSVADSV--TQYHMTSAAGTFCYIDPEYQQT 408 (568)
Q Consensus 376 ~~~~~~~~~~~--~~~~~~~~~GT~~Y~APE~~~~ 408 (568)
+.+........ .........|++.|+|||++..
T Consensus 160 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 160 SVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred eecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 97754322111 1112246789999999998754
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.6e-24 Score=212.37 Aligned_cols=258 Identities=32% Similarity=0.469 Sum_probs=196.5
Q ss_pred cccceeecccCceeEEEEEeCCccEEEEEeCcChhH---hHHHHHHHHHHHHcCCCC-ceeeeccccCCCc--eEEEEec
Q 008365 231 FSEAMKIGEGGYGPVYRGKLDHTPVAIKVLRPDAAQ---GKRQFQQEVEVLSSIRHP-NMVLLLGACPDYG--CLVYEYM 304 (568)
Q Consensus 231 y~~~~~IG~G~fg~Vy~~~~~~~~vAvK~l~~~~~~---~~~~~~~Ev~iL~~l~Hp-nIv~l~g~~~~~~--~lV~E~~ 304 (568)
|.+...||.|+||.||++.+. ..+++|.+...... ....+.+|+.++..+.|+ +|+.+++.+.... +++++|+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~-~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 80 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR-KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYV 80 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec-cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecC
Confidence 677889999999999999887 88999998765433 356789999999999988 7999999885544 8999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCc-eeEecccccccccCCCCC
Q 008365 305 HNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNY-VSKISDVGLARLVPPSVA 383 (568)
Q Consensus 305 ~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~-~vKL~DFGla~~~~~~~~ 383 (568)
.+++|.+++........++......++.|++.++.|+|..+ ++||||||+||+++..+ .++++|||+++.+.....
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~ 157 (384)
T COG0515 81 DGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGS 157 (384)
T ss_pred CCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCCc
Confidence 99999966655431124788899999999999999999999 99999999999999988 799999999986543321
Q ss_pred ccccccccccccccccCCChhhhhc---CCCCCcceehhHHHHHHHHHhCCCCCCCchH------HHHHHHhCccccccC
Q 008365 384 DSVTQYHMTSAAGTFCYIDPEYQQT---GMLTTKSDIYSFGIMLLQIITARSPMGLTHH------VSRAIEKGTLAEMLD 454 (568)
Q Consensus 384 ~~~~~~~~~~~~GT~~Y~APE~~~~---~~~s~ksDvwSlGvil~elltG~~Pf~~~~~------~~~~~~~~~~~~~l~ 454 (568)
............||..|++||.+.+ ..++...|+||+|++++++++|..||..... ....+..........
T Consensus 158 ~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (384)
T COG0515 158 TSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLAS 237 (384)
T ss_pred cccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCccccc
Confidence 1110013456789999999999887 5789999999999999999999999865542 112221111110000
Q ss_pred ccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhH
Q 008365 455 PAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVP 492 (568)
Q Consensus 455 ~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~ 492 (568)
......+......+.+++..|+..+|..|.+....+.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 238 PLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred ccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 00001111223578899999999999999999887755
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=7.4e-23 Score=200.71 Aligned_cols=170 Identities=18% Similarity=0.173 Sum_probs=133.3
Q ss_pred HhcccccceeecccCceeEEEEEeCCccEEEEEeCcChhHhHH---------HHHHHHHHHHcCCCCceeeeccccC---
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKLDHTPVAIKVLRPDAAQGKR---------QFQQEVEVLSSIRHPNMVLLLGACP--- 294 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~~~~~vAvK~l~~~~~~~~~---------~~~~Ev~iL~~l~HpnIv~l~g~~~--- 294 (568)
+.++|.+.++||.|+||.||+...++..+|||++.+....... .+.+|+..+.++.||+|..+.+++.
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~ 108 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAE 108 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEecCCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecc
Confidence 5679999999999999999998777789999999765332222 2689999999999999988877642
Q ss_pred -------CCceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCcee
Q 008365 295 -------DYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVS 367 (568)
Q Consensus 295 -------~~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~v 367 (568)
...+|||||++|.+|.++.. ++. ....+++.+|..||..| |+||||||+||+++++| +
T Consensus 109 ~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g-i 173 (232)
T PRK10359 109 RKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG-L 173 (232)
T ss_pred cccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-E
Confidence 23589999999999988631 222 24569999999999999 99999999999999988 9
Q ss_pred EecccccccccCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh
Q 008365 368 KISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT 429 (568)
Q Consensus 368 KL~DFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt 429 (568)
+|+|||..+........ .-+.....|+.+.|+|+|||.+..+..
T Consensus 174 ~liDfg~~~~~~e~~a~------------------d~~vler~y~~~~di~~lg~~~~~~~~ 217 (232)
T PRK10359 174 RIIDLSGKRCTAQRKAK------------------DRIDLERHYGIKNEIKDLGYYLLIYKK 217 (232)
T ss_pred EEEECCCcccccchhhH------------------HHHHHHhHhcccccccceeEeehHHHH
Confidence 99999988654221100 114555567789999999998876643
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.6e-22 Score=193.11 Aligned_cols=138 Identities=18% Similarity=0.184 Sum_probs=106.9
Q ss_pred ceeecccCceeEEEEEe-CCccEEEEEeCcChhH--h------------------------HHHHHHHHHHHHcCCCCce
Q 008365 234 AMKIGEGGYGPVYRGKL-DHTPVAIKVLRPDAAQ--G------------------------KRQFQQEVEVLSSIRHPNM 286 (568)
Q Consensus 234 ~~~IG~G~fg~Vy~~~~-~~~~vAvK~l~~~~~~--~------------------------~~~~~~Ev~iL~~l~HpnI 286 (568)
...||+|+||.||+|.+ +|..||||+++..... . ......|+.+|..+.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 45799999999999987 6889999999764211 0 0122459999999987776
Q ss_pred eeeccccCCCceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHH-HHcCCCCcccCCCCCCCeeccCCc
Q 008365 287 VLLLGACPDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFL-HQAKPEPLVHRDLKPANILLDRNY 365 (568)
Q Consensus 287 v~l~g~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yL-H~~~~~~IiHrDIKp~NILld~~~ 365 (568)
.....+.....+|||||++|+++...+.... .++......++.|++.+|.|| |..+ |+||||||+|||++ ++
T Consensus 82 ~~p~~~~~~~~~iVmE~i~g~~l~~~~~~~~---~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~-~~ 154 (190)
T cd05147 82 PCPEPILLKSHVLVMEFIGDDGWAAPRLKDA---PLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH-DG 154 (190)
T ss_pred CCCcEEEecCCEEEEEEeCCCCCcchhhhcC---CCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-CC
Confidence 4333222334589999998887765433322 378889999999999999999 6888 99999999999998 47
Q ss_pred eeEeccccccccc
Q 008365 366 VSKISDVGLARLV 378 (568)
Q Consensus 366 ~vKL~DFGla~~~ 378 (568)
.++|+|||+|...
T Consensus 155 ~v~LiDFG~a~~~ 167 (190)
T cd05147 155 KLYIIDVSQSVEH 167 (190)
T ss_pred cEEEEEccccccC
Confidence 8999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.87 E-value=5.9e-23 Score=228.45 Aligned_cols=254 Identities=20% Similarity=0.270 Sum_probs=183.3
Q ss_pred ccceeecccCceeEEEEEe--CCccEEEEEeC----cCh-h-HhHHHHHHHHHHHHcCCCCceeeeccccCCCc--eEEE
Q 008365 232 SEAMKIGEGGYGPVYRGKL--DHTPVAIKVLR----PDA-A-QGKRQFQQEVEVLSSIRHPNMVLLLGACPDYG--CLVY 301 (568)
Q Consensus 232 ~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~----~~~-~-~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~--~lV~ 301 (568)
....++|.|+||.|+.... ....++.|.+. ... . .....+..|+-+-..|.|||++..+..+.+.. .-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 3556899999998876654 33334444332 211 1 11112556777778889999988877664432 3349
Q ss_pred EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCC
Q 008365 302 EYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPS 381 (568)
Q Consensus 302 E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~ 381 (568)
|||++ +|..++...+. +....+..++.|++.||.|||..| |.||||||+|+++..+|.+||+|||.+..+...
T Consensus 401 E~~~~-Dlf~~~~~~~~---~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~ 473 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSNGK---LTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYP 473 (601)
T ss_pred hcccH-HHHHHHhcccc---cchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccC
Confidence 99999 99998877532 667788889999999999999999 999999999999999999999999999765432
Q ss_pred CCccccccccccccccccCCChhhhhcCCCCC-cceehhHHHHHHHHHhCCCCCCCchHHHHHHHhCccccccCccCC--
Q 008365 382 VADSVTQYHMTSAAGTFCYIDPEYQQTGMLTT-KSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAVT-- 458 (568)
Q Consensus 382 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~-ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~l~~~~~-- 458 (568)
-.. .......++|+..|+|||++.+..|++ ..||||.|++++.|++|+.||.....-...+..............
T Consensus 474 ~e~--~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~ 551 (601)
T KOG0590|consen 474 WEK--NIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPN 551 (601)
T ss_pred cch--hhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChH
Confidence 221 113346789999999999999999887 579999999999999999999654432221101000011111111
Q ss_pred CCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 459 DWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 459 ~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
..-..++.....+|.++|+++|..|-++.+|+...|
T Consensus 552 ~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W 587 (601)
T KOG0590|consen 552 RLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEW 587 (601)
T ss_pred HHHHhchhhHHHHHHHHccCChhheecHHHHhhChH
Confidence 112356777889999999999999999999986555
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=7.6e-22 Score=190.04 Aligned_cols=188 Identities=16% Similarity=0.117 Sum_probs=141.9
Q ss_pred ccceeecccCceeEEEEEeCCccEEEEEeCcChhHh----HHHHHHHHHHHHcCC-CCceeeeccccCCCceEEEEecCC
Q 008365 232 SEAMKIGEGGYGPVYRGKLDHTPVAIKVLRPDAAQG----KRQFQQEVEVLSSIR-HPNMVLLLGACPDYGCLVYEYMHN 306 (568)
Q Consensus 232 ~~~~~IG~G~fg~Vy~~~~~~~~vAvK~l~~~~~~~----~~~~~~Ev~iL~~l~-HpnIv~l~g~~~~~~~lV~E~~~g 306 (568)
.+...|++|+||+||.+...+..++.+.+....... ...+.+|+++|++|. |++|++++++ +..+++|+|+.|
T Consensus 5 ~~~~~l~~~~f~~v~~~~~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~--~~~~lvmeyI~G 82 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRGGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW--DGRHLDRSYLAG 82 (218)
T ss_pred ccceeecCCCcceEEEeecCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE--cCEEEEEeeecC
Confidence 455789999999999888888889988876554322 125789999999995 5788888886 446999999999
Q ss_pred CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCC-CCCCeeccCCceeEecccccccccCCCCC--
Q 008365 307 GSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDL-KPANILLDRNYVSKISDVGLARLVPPSVA-- 383 (568)
Q Consensus 307 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDI-Kp~NILld~~~~vKL~DFGla~~~~~~~~-- 383 (568)
.+|...+.. ....++.|++.+|.++|..| |+|||| ||.|||++.++.++|+|||+|........
T Consensus 83 ~~L~~~~~~----------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~ 149 (218)
T PRK12274 83 AAMYQRPPR----------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWM 149 (218)
T ss_pred ccHHhhhhh----------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHH
Confidence 998654321 11346789999999999999 999999 79999999999999999999986543221
Q ss_pred -----ccccccccccccccccCCChhhhhcC-CCC-CcceehhHHHHHHHHHhCCCCC
Q 008365 384 -----DSVTQYHMTSAAGTFCYIDPEYQQTG-MLT-TKSDIYSFGIMLLQIITARSPM 434 (568)
Q Consensus 384 -----~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s-~ksDvwSlGvil~elltG~~Pf 434 (568)
.+...........++.|++|+...-. ..+ ...++++.|+.+|.++|+..|+
T Consensus 150 r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~ 207 (218)
T PRK12274 150 RLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLH 207 (218)
T ss_pred HHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCc
Confidence 00110111123478899999854332 223 5678999999999999999886
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.1e-22 Score=195.14 Aligned_cols=243 Identities=24% Similarity=0.425 Sum_probs=187.7
Q ss_pred ccceeecccCceeEEEEEeCCccEEEEEeCcChh--HhHHHHHHHHHHHHcCCCCceeeeccccCC--CceEEEEecCCC
Q 008365 232 SEAMKIGEGGYGPVYRGKLDHTPVAIKVLRPDAA--QGKRQFQQEVEVLSSIRHPNMVLLLGACPD--YGCLVYEYMHNG 307 (568)
Q Consensus 232 ~~~~~IG~G~fg~Vy~~~~~~~~vAvK~l~~~~~--~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--~~~lV~E~~~gg 307 (568)
.++.+|.....|..|+|++.|..+++|+++.... ..-+.|..|.-.|+.+.||||+.++|.|.. ...++..||+.|
T Consensus 193 nl~tkl~e~hsgelwrgrwqgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~g 272 (448)
T KOG0195|consen 193 NLITKLAESHSGELWRGRWQGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFG 272 (448)
T ss_pred hhhhhhccCCCcccccccccCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccch
Confidence 3455799999999999999999999999865432 223578899999999999999999999954 447889999999
Q ss_pred CHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccC-CCCCCCeeccCCceeEec--ccccccccCCCCCc
Q 008365 308 SLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHR-DLKPANILLDRNYVSKIS--DVGLARLVPPSVAD 384 (568)
Q Consensus 308 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHr-DIKp~NILld~~~~vKL~--DFGla~~~~~~~~~ 384 (568)
+|...|..... -.+.-.++.+++.+|++|+.|||+..+ +|-| -|....++||++.+++|. |--++.
T Consensus 273 slynvlhe~t~-vvvd~sqav~faldiargmaflhslep--~ipr~~lns~hvmidedltarismad~kfsf-------- 341 (448)
T KOG0195|consen 273 SLYNVLHEQTS-VVVDHSQAVRFALDIARGMAFLHSLEP--MIPRFYLNSKHVMIDEDLTARISMADTKFSF-------- 341 (448)
T ss_pred HHHHHHhcCcc-EEEecchHHHHHHHHHhhHHHHhhcch--hhhhhhcccceEEecchhhhheecccceeee--------
Confidence 99999987543 236677889999999999999999974 5554 588899999999887764 322221
Q ss_pred cccccccccccccccCCChhhhhcCCCC---CcceehhHHHHHHHHHhCCCCCCCchHHHHHHHhCccccccCccCCCCC
Q 008365 385 SVTQYHMTSAAGTFCYIDPEYQQTGMLT---TKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAVTDWP 461 (568)
Q Consensus 385 ~~~~~~~~~~~GT~~Y~APE~~~~~~~s---~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~l~~~~~~~p 461 (568)
.-.+..-.|.||+||.+....-+ .++|+|||.+++|||.|...||.....+.-..+ -.+.......|
T Consensus 342 -----qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmk-----ialeglrv~ip 411 (448)
T KOG0195|consen 342 -----QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMK-----IALEGLRVHIP 411 (448)
T ss_pred -----eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhh-----hhhccccccCC
Confidence 11233457899999988776543 478999999999999999999965544332211 11222233568
Q ss_pred hHHHHHHHHHHHHhhccCCCCCCChHHhHhHHHHH
Q 008365 462 AEAAESFSKLAIQCAELRKKDRPDLGTVIVPELNR 496 (568)
Q Consensus 462 ~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l~~ 496 (568)
++++..+.+|+.-|+..||.+||.+..|+ +.|++
T Consensus 412 pgis~hm~klm~icmnedpgkrpkfdmiv-pilek 445 (448)
T KOG0195|consen 412 PGISRHMNKLMNICMNEDPGKRPKFDMIV-PILEK 445 (448)
T ss_pred CCccHHHHHHHHHHhcCCCCcCCCcceeh-hhHHH
Confidence 88999999999999999999999999876 44443
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.3e-21 Score=186.55 Aligned_cols=139 Identities=20% Similarity=0.179 Sum_probs=109.1
Q ss_pred ceeecccCceeEEEEEe-CCccEEEEEeCcChhH--------------------------hHHHHHHHHHHHHcCCCCce
Q 008365 234 AMKIGEGGYGPVYRGKL-DHTPVAIKVLRPDAAQ--------------------------GKRQFQQEVEVLSSIRHPNM 286 (568)
Q Consensus 234 ~~~IG~G~fg~Vy~~~~-~~~~vAvK~l~~~~~~--------------------------~~~~~~~Ev~iL~~l~HpnI 286 (568)
...||+|+||.||+|.+ +|+.||||+++..... ....+..|...+.++.|++|
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 46899999999999987 5899999998764210 01124679999999999987
Q ss_pred eeeccccCCCceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCCCCcccCCCCCCCeeccCCc
Q 008365 287 VLLLGACPDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQ-AKPEPLVHRDLKPANILLDRNY 365 (568)
Q Consensus 287 v~l~g~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~-~~~~~IiHrDIKp~NILld~~~ 365 (568)
.....+.....+|||||++|+++........ .++......|+.|++.+|.+||+ .| |+||||||+|||++ ++
T Consensus 82 ~~p~~~~~~~~~lVmE~~~g~~~~~~~l~~~---~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~-~~ 154 (190)
T cd05145 82 PVPEPILLKKNVLVMEFIGDDGSPAPRLKDV---PLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH-DG 154 (190)
T ss_pred CCceEEEecCCEEEEEEecCCCchhhhhhhc---cCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-CC
Confidence 4433333334689999998886544322222 26778889999999999999999 88 99999999999999 88
Q ss_pred eeEecccccccccC
Q 008365 366 VSKISDVGLARLVP 379 (568)
Q Consensus 366 ~vKL~DFGla~~~~ 379 (568)
.++|+|||+++.+.
T Consensus 155 ~~~liDFG~a~~~~ 168 (190)
T cd05145 155 KPYIIDVSQAVELD 168 (190)
T ss_pred CEEEEEcccceecC
Confidence 99999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.9e-22 Score=221.70 Aligned_cols=247 Identities=22% Similarity=0.284 Sum_probs=179.1
Q ss_pred ccccceeecccCceeEEEEEeCCccEEEEEeCcCh-hHhHHHHH---HHHHHHHcCCCCceeeeccccC--CCceEEEEe
Q 008365 230 KFSEAMKIGEGGYGPVYRGKLDHTPVAIKVLRPDA-AQGKRQFQ---QEVEVLSSIRHPNMVLLLGACP--DYGCLVYEY 303 (568)
Q Consensus 230 ~y~~~~~IG~G~fg~Vy~~~~~~~~vAvK~l~~~~-~~~~~~~~---~Ev~iL~~l~HpnIv~l~g~~~--~~~~lV~E~ 303 (568)
.|...+.||.+.|=.|.+|++....|+|||+-+.. .-....|. .|++ ...++|||.+++.-+-. ...|||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGLVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCceEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 56777899999999999999977779999985433 22233333 3444 55568999998875542 334888899
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccc--cCCC
Q 008365 304 MHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARL--VPPS 381 (568)
Q Consensus 304 ~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~--~~~~ 381 (568)
+ .-+|.|.|.. .|.+...+...|+.|++.||..+|..| |+|||||.+||||+.-.-+.|+||..-+. ++.+
T Consensus 103 v-khnLyDRlST---RPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD 175 (1431)
T KOG1240|consen 103 V-KHNLYDRLST---RPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPED 175 (1431)
T ss_pred H-hhhhhhhhcc---chHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence 8 5789888854 356788888899999999999999999 99999999999999999999999987643 3333
Q ss_pred CCccccccccccccccccCCChhhhhcC----------C-CCCcceehhHHHHHHHHHh-CCCCCCCchHHHHHHHhCcc
Q 008365 382 VADSVTQYHMTSAAGTFCYIDPEYQQTG----------M-LTTKSDIYSFGIMLLQIIT-ARSPMGLTHHVSRAIEKGTL 449 (568)
Q Consensus 382 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~----------~-~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~ 449 (568)
+..++..+.-+ ...-.+|+|||.+... . .+++.||||+||+++||++ |++||.+.+.....-.....
T Consensus 176 NPadf~fFFDT-SrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~ 254 (1431)
T KOG1240|consen 176 NPADFTFFFDT-SRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNADD 254 (1431)
T ss_pred CcccceEEEec-CCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCccC
Confidence 33333322222 2344589999965431 1 6788999999999999999 89999765543322111111
Q ss_pred ccccCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHh
Q 008365 450 AEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIV 491 (568)
Q Consensus 450 ~~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~ 491 (568)
.+.+-..+.+ ..+.+++..|++.||..|-++++.|.
T Consensus 255 ~e~~Le~Ied------~~~Rnlil~Mi~rdPs~RlSAedyL~ 290 (1431)
T KOG1240|consen 255 PEQLLEKIED------VSLRNLILSMIQRDPSKRLSAEDYLQ 290 (1431)
T ss_pred HHHHHHhCcC------ccHHHHHHHHHccCchhccCHHHHHH
Confidence 1111111111 25899999999999999999998874
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=5.4e-22 Score=212.25 Aligned_cols=223 Identities=27% Similarity=0.328 Sum_probs=177.4
Q ss_pred eecccCceeEEEEE-----eCCccEEEEEeCcChhHh--HHHHHHHHHHHHcCC-CCceeeeccccCCC--ceEEEEecC
Q 008365 236 KIGEGGYGPVYRGK-----LDHTPVAIKVLRPDAAQG--KRQFQQEVEVLSSIR-HPNMVLLLGACPDY--GCLVYEYMH 305 (568)
Q Consensus 236 ~IG~G~fg~Vy~~~-----~~~~~vAvK~l~~~~~~~--~~~~~~Ev~iL~~l~-HpnIv~l~g~~~~~--~~lV~E~~~ 305 (568)
.+|.|+||.|+++. +.+.-+|+|++++..... ......|..++..++ ||.+|++...|+.. .+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37999999999653 456789999987643221 224567888999987 99999998877543 489999999
Q ss_pred CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCCcc
Q 008365 306 NGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADS 385 (568)
Q Consensus 306 ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~~~ 385 (568)
||.|...+..... +.+.....+...++-++..+|..+ |+|||+|++||+++.+|++++.|||+++..-...
T Consensus 81 gg~lft~l~~~~~---f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~--- 151 (612)
T KOG0603|consen 81 GGDLFTRLSKEVM---FDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK--- 151 (612)
T ss_pred cchhhhccccCCc---hHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhh---
Confidence 9999887765443 566666778889999999999999 9999999999999999999999999998653221
Q ss_pred ccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHhCccccccCccCCCCChHHH
Q 008365 386 VTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAVTDWPAEAA 465 (568)
Q Consensus 386 ~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~l~~~~~~~p~~~~ 465 (568)
..|||..|||||++. .....+|+||||++++||++|-.||.. .+...|-+ .-...|....
T Consensus 152 -------~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~--~~~~~Il~---------~~~~~p~~l~ 211 (612)
T KOG0603|consen 152 -------IACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG--DTMKRILK---------AELEMPRELS 211 (612)
T ss_pred -------hcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch--HHHHHHhh---------hccCCchhhh
Confidence 128999999999998 568899999999999999999999976 22222222 1124577788
Q ss_pred HHHHHHHHHhhccCCCCCCChH
Q 008365 466 ESFSKLAIQCAELRKKDRPDLG 487 (568)
Q Consensus 466 ~~l~~li~~Cl~~dP~~RPs~~ 487 (568)
.....++.+++..+|..|--..
T Consensus 212 ~~a~~~~~~l~~r~p~nrLg~~ 233 (612)
T KOG0603|consen 212 AEARSLFRQLFKRNPENRLGAG 233 (612)
T ss_pred HHHHHHHHHHHhhCHHHHhccC
Confidence 8889999999999999887663
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.9e-20 Score=187.74 Aligned_cols=230 Identities=21% Similarity=0.280 Sum_probs=148.0
Q ss_pred ccccceeecccCceeEEEEEeC--CccEEEEEeCcC---hhHhHHHHHHHHHHHHcCCC----------Cc------eee
Q 008365 230 KFSEAMKIGEGGYGPVYRGKLD--HTPVAIKVLRPD---AAQGKRQFQQEVEVLSSIRH----------PN------MVL 288 (568)
Q Consensus 230 ~y~~~~~IG~G~fg~Vy~~~~~--~~~vAvK~l~~~---~~~~~~~~~~Ev~iL~~l~H----------pn------Iv~ 288 (568)
.+.....||.|+|+.||.+.+. ++.+|||++... .....+++++|.-....+.+ -. +++
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 4556778999999999999994 579999997433 22334566666655444322 11 122
Q ss_pred ecc---cc---C---C----CceEEEEecCCCCHHHHHhh---cCCC-CCCCHHHHHHHHHHHHHHHHHHHHcCCCCccc
Q 008365 289 LLG---AC---P---D----YGCLVYEYMHNGSLEDRLLR---RGNT-PVIPWRKRFKIAAEIATALLFLHQAKPEPLVH 351 (568)
Q Consensus 289 l~g---~~---~---~----~~~lV~E~~~ggsL~~~l~~---~~~~-~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiH 351 (568)
+-+ ++ . . +.+++|+-+ -++|.+++.. .... ..+....+..+..|+++.+++||..| |+|
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVH 168 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVH 168 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEE
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEe
Confidence 211 01 0 0 125677777 5788877542 2221 12334555667789999999999999 999
Q ss_pred CCCCCCCeeccCCceeEecccccccccCCCCCccccccccccccccccCCChhhhhcC--------CCCCcceehhHHHH
Q 008365 352 RDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTG--------MLTTKSDIYSFGIM 423 (568)
Q Consensus 352 rDIKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~--------~~s~ksDvwSlGvi 423 (568)
+||+|+|||++.+|.++|+||+.....+... .....+..|.+||..... .++.+.|.|+||++
T Consensus 169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~---------~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ 239 (288)
T PF14531_consen 169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTRY---------RCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGIT 239 (288)
T ss_dssp ST-SGGGEEE-TTS-EEE--GGGEEETTEEE---------EGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHH
T ss_pred cccceeeEEEcCCCCEEEcChHHHeecCcee---------eccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHH
Confidence 9999999999999999999999876543211 113355789999966442 47889999999999
Q ss_pred HHHHHhCCCCCCCchHHHHHHHhCccccccCccCCCCChHHHHHHHHHHHHhhccCCCCC
Q 008365 424 LLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDR 483 (568)
Q Consensus 424 l~elltG~~Pf~~~~~~~~~~~~~~~~~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~R 483 (568)
+|.|+||..||+..... . ..+..+..|. +.|+.+..||..+|+.+|.+|
T Consensus 240 ly~lWC~~lPf~~~~~~------~----~~~~~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 240 LYSLWCGRLPFGLSSPE------A----DPEWDFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHHHHSS-STCCCGGG------S----TSGGGGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HHHHHHccCCCCCCCcc------c----cccccchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 99999999999754321 0 0011345566 889999999999999999987
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=6.8e-20 Score=178.64 Aligned_cols=133 Identities=17% Similarity=0.260 Sum_probs=103.8
Q ss_pred cceeecccCceeEEEEEeCCccEEEEEeCcChhHhHHHHHHHHHHHHcC-----CCCceeeeccccCCC---ce---EEE
Q 008365 233 EAMKIGEGGYGPVYRGKLDHTPVAIKVLRPDAAQGKRQFQQEVEVLSSI-----RHPNMVLLLGACPDY---GC---LVY 301 (568)
Q Consensus 233 ~~~~IG~G~fg~Vy~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l-----~HpnIv~l~g~~~~~---~~---lV~ 301 (568)
-...||+|+||.||....++. .+||++..........+.+|+.+++.+ .||||++++|++... ++ +||
T Consensus 6 ~~~~LG~G~~~~Vy~hp~~~~-k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~ 84 (210)
T PRK10345 6 EQSPLGTGRHRKCYAHPEDAQ-RCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIA 84 (210)
T ss_pred CcceecCCCceEEEECCCCcC-eEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEe
Confidence 346899999999997333333 479998765444556789999999999 679999999998654 23 689
Q ss_pred Ee--cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHH-HHHHHcCCCCcccCCCCCCCeeccC----CceeEeccccc
Q 008365 302 EY--MHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATAL-LFLHQAKPEPLVHRDLKPANILLDR----NYVSKISDVGL 374 (568)
Q Consensus 302 E~--~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL-~yLH~~~~~~IiHrDIKp~NILld~----~~~vKL~DFGl 374 (568)
|| +.+|+|.+++.+.. +++. ..++.+++.++ .|||+.+ ||||||||+|||++. ++.++|+||+.
T Consensus 85 e~~G~~~~tL~~~l~~~~----~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg~G 155 (210)
T PRK10345 85 DFDGKPSITLTEFAEQCR----YEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDNIG 155 (210)
T ss_pred cCCCCcchhHHHHHHccc----ccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence 99 55799999996532 4444 35677888887 9999999 999999999999964 34899999544
Q ss_pred c
Q 008365 375 A 375 (568)
Q Consensus 375 a 375 (568)
+
T Consensus 156 ~ 156 (210)
T PRK10345 156 E 156 (210)
T ss_pred C
Confidence 3
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.6e-19 Score=183.27 Aligned_cols=192 Identities=21% Similarity=0.266 Sum_probs=136.2
Q ss_pred CCCceeeeccccCCC-----------------------------ceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHH
Q 008365 282 RHPNMVLLLGACPDY-----------------------------GCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAA 332 (568)
Q Consensus 282 ~HpnIv~l~g~~~~~-----------------------------~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~ 332 (568)
.|||||+++++|.+. .|+||... ..+|..++.... .+.....-|+.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~~----~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTRH----RSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcCC----CchHHHHHHHH
Confidence 699999999877321 15788776 468888887654 56677788999
Q ss_pred HHHHHHHHHHHcCCCCcccCCCCCCCeec--cCC--ceeEecccccccccCCCCCccc-cccccccccccccCCChhhhh
Q 008365 333 EIATALLFLHQAKPEPLVHRDLKPANILL--DRN--YVSKISDVGLARLVPPSVADSV-TQYHMTSAAGTFCYIDPEYQQ 407 (568)
Q Consensus 333 qia~aL~yLH~~~~~~IiHrDIKp~NILl--d~~--~~vKL~DFGla~~~~~~~~~~~-~~~~~~~~~GT~~Y~APE~~~ 407 (568)
|++.|+.|||..| |.|||+|.+|||| |++ -.+.|+|||.|---. ...-.. .........|....||||+..
T Consensus 349 QlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~-~hGlqlpy~S~~Vd~GGNa~lmAPEi~t 424 (598)
T KOG4158|consen 349 QLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADD-NHGLQLPYESDEVDLGGNAKLMAPEIAT 424 (598)
T ss_pred HHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeecc-ccccccccccccccCCCcceecchhhhh
Confidence 9999999999999 9999999999999 444 467899999873211 100000 011112346888999999886
Q ss_pred cCCC------CCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHhCccccccCccCCCCChHHHHHHHHHHHHhhccCCC
Q 008365 408 TGML------TTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAVTDWPAEAAESFSKLAIQCAELRKK 481 (568)
Q Consensus 408 ~~~~------s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~ 481 (568)
..+- -.+.|.|+.|.+.||+++...||...... .++..++. ...++..|..+++.+.+++...|+.+|.
T Consensus 425 a~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem--~L~~r~Yq---e~qLPalp~~vpp~~rqlV~~lL~r~ps 499 (598)
T KOG4158|consen 425 AVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEM--LLDTRTYQ---ESQLPALPSRVPPVARQLVFDLLKRDPS 499 (598)
T ss_pred cCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchh--eechhhhh---hhhCCCCcccCChHHHHHHHHHhcCCcc
Confidence 5431 23789999999999999999999542110 01111111 1223445667788899999999999999
Q ss_pred CCCChH
Q 008365 482 DRPDLG 487 (568)
Q Consensus 482 ~RPs~~ 487 (568)
+||+..
T Consensus 500 kRvsp~ 505 (598)
T KOG4158|consen 500 KRVSPN 505 (598)
T ss_pred ccCCcc
Confidence 999864
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.79 E-value=8.3e-20 Score=204.06 Aligned_cols=209 Identities=23% Similarity=0.328 Sum_probs=144.7
Q ss_pred cccccceeecccCceeEEEEEeC--CccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCceeeeccccCCCceEEEEecCC
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKLD--HTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACPDYGCLVYEYMHN 306 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~~--~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~lV~E~~~g 306 (568)
++|..++.|..|+||.||.+++. .+.+|+|+ +++..- +++ +|.....|.+|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~li----lRn---ilt~a~npfvv------------------- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQNLI----LRN---ILTFAGNPFVV------------------- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhcc-cccchh----hhc---cccccCCccee-------------------
Confidence 57999999999999999999875 67899954 322111 111 33333333333
Q ss_pred CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCC---
Q 008365 307 GSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVA--- 383 (568)
Q Consensus 307 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~--- 383 (568)
|+=.+.+...+. ++. +++.+++|||+.+ |+|||+||+|.||+.-|++|+.|||+++..-....
T Consensus 136 gDc~tllk~~g~---lPv--------dmvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl 201 (1205)
T KOG0606|consen 136 GDCATLLKNIGP---LPV--------DMVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNL 201 (1205)
T ss_pred chhhhhcccCCC---Ccc--------hhhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhccchh
Confidence 444444544333 332 3378899999999 99999999999999999999999999865321111
Q ss_pred ------ccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchH---HHHHHHhCccccccC
Q 008365 384 ------DSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHH---VSRAIEKGTLAEMLD 454 (568)
Q Consensus 384 ------~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~---~~~~~~~~~~~~~l~ 454 (568)
...........+|||.|+|||++....|+..+|+|++|+|+||++.|..||..... +...+....
T Consensus 202 ~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i------ 275 (1205)
T KOG0606|consen 202 KEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDI------ 275 (1205)
T ss_pred hhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhc------
Confidence 11111122356999999999999999999999999999999999999999975522 112221110
Q ss_pred ccCCCCChHHHHHHHHHHHHhhccCCCCCCC
Q 008365 455 PAVTDWPAEAAESFSKLAIQCAELRKKDRPD 485 (568)
Q Consensus 455 ~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs 485 (568)
.+++-....+.+.++++.+.|..+|..|--
T Consensus 276 -~wpE~dea~p~Ea~dli~~LL~qnp~~Rlg 305 (1205)
T KOG0606|consen 276 -EWPEEDEALPPEAQDLIEQLLRQNPLCRLG 305 (1205)
T ss_pred -cccccCcCCCHHHHHHHHHHHHhChHhhcc
Confidence 111112234567889999999999998864
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.79 E-value=6.1e-19 Score=200.72 Aligned_cols=197 Identities=21% Similarity=0.265 Sum_probs=153.9
Q ss_pred HHHHHhcccccceeecccCceeEEEEEe-CCccEEEEEeCcChhHhHHHHHHHHHHHHcCC---CCceeeecc--ccCCC
Q 008365 223 EIEEATDKFSEAMKIGEGGYGPVYRGKL-DHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIR---HPNMVLLLG--ACPDY 296 (568)
Q Consensus 223 ei~~~~~~y~~~~~IG~G~fg~Vy~~~~-~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~---HpnIv~l~g--~~~~~ 296 (568)
+++....+|.+.+.||+|+||.||+|.. +++.||||+-++...... .-=.+++.+|+ -+.|+.+.. .|.+.
T Consensus 692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEf---YI~~q~~~RLk~~~~~~~~~~~~a~~~~~~ 768 (974)
T KOG1166|consen 692 EFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEF---YICLQVMERLKPQMLPSIMHISSAHVFQNA 768 (974)
T ss_pred eeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceee---eehHHHHHhhchhhhcchHHHHHHHccCCc
Confidence 3444567899999999999999999986 678999999887655421 11223444444 223333332 34677
Q ss_pred ceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeecc-------CCceeEe
Q 008365 297 GCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLD-------RNYVSKI 369 (568)
Q Consensus 297 ~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld-------~~~~vKL 369 (568)
.+||+||.+.|+|.+++.. ...++|.....|+.|++..|..||..+ |||+||||+|+||. ....++|
T Consensus 769 S~lv~ey~~~Gtlld~~N~---~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~l 842 (974)
T KOG1166|consen 769 SVLVSEYSPYGTLLDLINT---NKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYL 842 (974)
T ss_pred ceeeeeccccccHHHhhcc---CCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEE
Confidence 7999999999999999873 335889999999999999999999999 99999999999993 2456899
Q ss_pred cccccccccCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCC
Q 008365 370 SDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARS 432 (568)
Q Consensus 370 ~DFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~ 432 (568)
+|||.+-.+..-. ........++|-.+-.+|+..|..++...|.|.|.-+++-||.|+.
T Consensus 843 IDfG~siDm~lfp----~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 843 IDFGRSIDMKLFP----DGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred EecccceeeeEcC----CCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 9999985432111 1124456789999999999999999999999999999999999863
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.1e-19 Score=191.29 Aligned_cols=178 Identities=25% Similarity=0.364 Sum_probs=132.7
Q ss_pred CceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccc
Q 008365 296 YGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLA 375 (568)
Q Consensus 296 ~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla 375 (568)
+.+|.|++|...+|.++|.+.......++.....++.|++.|+.| ++ .+|+|+||.||++..+..+||+|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhhe
Confidence 357899999999999999866555557888899999999999999 77 999999999999999999999999998
Q ss_pred cccCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh-CCCCCCCchHHHHHHHhCccccccC
Q 008365 376 RLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPMGLTHHVSRAIEKGTLAEMLD 454 (568)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~l~ 454 (568)
................+..+||..||+||.+.+..|+.++||||||+||+|++. -..+|...... .-+..+.+..
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~t~-~d~r~g~ip~--- 479 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIATL-TDIRDGIIPP--- 479 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHHhh-hhhhcCCCCh---
Confidence 766443322222334567899999999999999999999999999999999998 23333111110 1111221110
Q ss_pred ccCCCCChHHHHHHHHHHHHhhccCCCCCCChHH
Q 008365 455 PAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGT 488 (568)
Q Consensus 455 ~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~ 488 (568)
..+.++| .-..|+++++.+.|.+||++..
T Consensus 480 ~~~~d~p-----~e~~ll~~lls~~p~~RP~~~~ 508 (516)
T KOG1033|consen 480 EFLQDYP-----EEYTLLQQLLSPSPEERPSAIE 508 (516)
T ss_pred HHhhcCc-----HHHHHHHHhcCCCcccCchHHH
Confidence 0111222 2357999999999999995443
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.3e-18 Score=169.41 Aligned_cols=132 Identities=23% Similarity=0.336 Sum_probs=109.7
Q ss_pred eeecccCceeEEEEEeCCccEEEEEeCcChh--------HhHHHHHHHHHHHHcCCCCceeeeccc--cCCCceEEEEec
Q 008365 235 MKIGEGGYGPVYRGKLDHTPVAIKVLRPDAA--------QGKRQFQQEVEVLSSIRHPNMVLLLGA--CPDYGCLVYEYM 304 (568)
Q Consensus 235 ~~IG~G~fg~Vy~~~~~~~~vAvK~l~~~~~--------~~~~~~~~Ev~iL~~l~HpnIv~l~g~--~~~~~~lV~E~~ 304 (568)
+.||+|++|.||+|.+.+..|+||+...... .....+.+|+.++..+.|++|+....+ ..+..++||||+
T Consensus 2 ~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 81 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYI 81 (211)
T ss_pred cccccCceEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEe
Confidence 5799999999999999999999998764321 112457789999999999887654444 355668999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccc
Q 008365 305 HNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARL 377 (568)
Q Consensus 305 ~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~ 377 (568)
+|++|.+++.... . .+..++.+++.+|.+||+.+ ++|||++|.|||++ ++.++|+|||++..
T Consensus 82 ~G~~L~~~~~~~~------~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 82 EGEPLKDLINSNG------M-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred CCcCHHHHHHhcc------H-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999886432 2 77889999999999999999 99999999999999 78899999999864
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.6e-18 Score=167.21 Aligned_cols=128 Identities=25% Similarity=0.368 Sum_probs=105.6
Q ss_pred eecccCceeEEEEEeCCccEEEEEeCcCh--------hHhHHHHHHHHHHHHcCCCCce--eeeccccCCCceEEEEecC
Q 008365 236 KIGEGGYGPVYRGKLDHTPVAIKVLRPDA--------AQGKRQFQQEVEVLSSIRHPNM--VLLLGACPDYGCLVYEYMH 305 (568)
Q Consensus 236 ~IG~G~fg~Vy~~~~~~~~vAvK~l~~~~--------~~~~~~~~~Ev~iL~~l~HpnI--v~l~g~~~~~~~lV~E~~~ 305 (568)
.||+|+||.||+|.+.+..|+||+..... ......+.+|++++..+.|+++ ..++....+..++||||++
T Consensus 1 ~ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~ 80 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIE 80 (199)
T ss_pred CCCCCceEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEEC
Confidence 48999999999999999999999965432 1123557789999999988754 4455555666799999999
Q ss_pred CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccc
Q 008365 306 NGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARL 377 (568)
Q Consensus 306 ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~ 377 (568)
|++|.+++.... . .++.+++.+|.+||+.+ ++|+|++|.||+++ ++.++|+|||+++.
T Consensus 81 g~~l~~~~~~~~----~------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 81 GKPLKDVIEEGN----D------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CccHHHHHhhcH----H------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 999998775421 1 68899999999999999 99999999999999 88999999999865
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.6e-18 Score=172.56 Aligned_cols=141 Identities=20% Similarity=0.171 Sum_probs=109.2
Q ss_pred ccccceeecccCceeEEEEE---eCCccEEEEEeCcChhH------------------------hHHHHHHHHHHHHcCC
Q 008365 230 KFSEAMKIGEGGYGPVYRGK---LDHTPVAIKVLRPDAAQ------------------------GKRQFQQEVEVLSSIR 282 (568)
Q Consensus 230 ~y~~~~~IG~G~fg~Vy~~~---~~~~~vAvK~l~~~~~~------------------------~~~~~~~Ev~iL~~l~ 282 (568)
.|.+.+.||+|+||.||+|. .+++.||||+++..... ....+..|+.++.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 47888999999999999998 27889999998753210 1123578999999997
Q ss_pred CCc--eeeeccccCCCceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCee
Q 008365 283 HPN--MVLLLGACPDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANIL 360 (568)
Q Consensus 283 Hpn--Iv~l~g~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NIL 360 (568)
+.+ +..+++. ...+|||||++|++|...+.... .+.......++.||+.+|.+||..+. |+||||||+||+
T Consensus 109 ~~~i~~p~~~~~--~~~~lV~E~~~g~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~LH~~g~--iiH~Dikp~NIl 181 (237)
T smart00090 109 EAGVPVPKPIAW--RRNVLVMEFIGGDGLPAPRLKDV---EPEEEEEFELYDDILEEMRKLYKEGE--LVHGDLSEYNIL 181 (237)
T ss_pred hcCCCCCeeeEe--cCceEEEEEecCCcccccccccC---CcchHHHHHHHHHHHHHHHHHHhcCC--EEeCCCChhhEE
Confidence 533 3344443 24589999999888866543222 24555677899999999999999873 999999999999
Q ss_pred ccCCceeEeccccccccc
Q 008365 361 LDRNYVSKISDVGLARLV 378 (568)
Q Consensus 361 ld~~~~vKL~DFGla~~~ 378 (568)
++ ++.++|+|||++...
T Consensus 182 i~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 182 VH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred EE-CCCEEEEEChhhhcc
Confidence 99 889999999998754
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.9e-18 Score=183.61 Aligned_cols=202 Identities=26% Similarity=0.426 Sum_probs=151.1
Q ss_pred HHcCCCCceeeeccccCCC--ceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCc-ccCCC
Q 008365 278 LSSIRHPNMVLLLGACPDY--GCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPL-VHRDL 354 (568)
Q Consensus 278 L~~l~HpnIv~l~g~~~~~--~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~I-iHrDI 354 (568)
|+.+.|.|+.+++|.+-+. .++|.+||..|+|.|.+..... .+++.-...++.+|+.||.|||... | .|+.+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~--~~d~~F~~s~~rdi~~Gl~ylh~s~---i~~hg~l 75 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDI--KLDYFFILSFIRDISKGLAYLHNSP---IGYHGAL 75 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcccc--CccHHHHHHHHHHHHHHHHHHhcCc---ceeeeee
Confidence 4578899999999998554 4789999999999999987432 3778888889999999999999876 5 99999
Q ss_pred CCCCeeccCCceeEecccccccccCCCCCccccccccccccccccCCChhhhhcCC-------CCCcceehhHHHHHHHH
Q 008365 355 KPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGM-------LTTKSDIYSFGIMLLQI 427 (568)
Q Consensus 355 Kp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~-------~s~ksDvwSlGvil~el 427 (568)
++.|.++|..+.+||+|||+......... ........-..-|.|||.+.+.. .+.+.||||||++++|+
T Consensus 76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~----~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei 151 (484)
T KOG1023|consen 76 KSSNCLVDSRWVLKLTDFGLNSLLEETAE----PEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEI 151 (484)
T ss_pred ccccceeeeeEEEEechhhhccccccccc----ccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHH
Confidence 99999999999999999999876532100 00111122345699999887642 46679999999999999
Q ss_pred HhCCCCCCCchH------HHHHHHhCccccccCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhH
Q 008365 428 ITARSPMGLTHH------VSRAIEKGTLAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVI 490 (568)
Q Consensus 428 ltG~~Pf~~~~~------~~~~~~~~~~~~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl 490 (568)
++...||..... +...+.+ .....+.|.+.... +.++.+..++..||..+|.+||++.+|-
T Consensus 152 ~~r~~~~~~~~~~~~~~eii~~~~~-~~~~~~rP~i~~~~-e~~~~l~~l~~~cw~e~P~~rPs~~~i~ 218 (484)
T KOG1023|consen 152 LFRSGPFDLRNLVEDPDEIILRVKK-GGSNPFRPSIELLN-ELPPELLLLVARCWEEIPEKRPSIEQIR 218 (484)
T ss_pred HhccCccccccccCChHHHHHHHHh-cCCCCcCcchhhhh-hcchHHHHHHHHhcccChhhCccHHHHH
Confidence 999999964221 2222222 12223333333211 4555789999999999999999998874
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.75 E-value=5.2e-18 Score=164.10 Aligned_cols=136 Identities=22% Similarity=0.192 Sum_probs=107.3
Q ss_pred ccccceeecccCceeEEEEEe-CCccEEEEEeCcChh----------------------HhHHHHHHHHHHHHcCCCCc-
Q 008365 230 KFSEAMKIGEGGYGPVYRGKL-DHTPVAIKVLRPDAA----------------------QGKRQFQQEVEVLSSIRHPN- 285 (568)
Q Consensus 230 ~y~~~~~IG~G~fg~Vy~~~~-~~~~vAvK~l~~~~~----------------------~~~~~~~~Ev~iL~~l~Hpn- 285 (568)
.|.+.+.||.|+||.||++.. +++.||||++..... .....+..|..++..+.|++
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 477888999999999999987 688999998764320 01123567899999988774
Q ss_pred -eeeeccccCCCceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCC
Q 008365 286 -MVLLLGACPDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRN 364 (568)
Q Consensus 286 -Iv~l~g~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~ 364 (568)
++..++. ...++||||++|++|...... .....++.+++.++.++|+.+ |+||||||+||+|+.+
T Consensus 96 ~v~~~~~~--~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p~Nill~~~ 161 (198)
T cd05144 96 PVPKPIDW--NRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYKHG---IIHGDLSEFNILVDDD 161 (198)
T ss_pred CCCceeec--CCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHHCC---CCcCCCCcccEEEcCC
Confidence 4444443 345899999999998765321 234568889999999999998 9999999999999999
Q ss_pred ceeEecccccccccC
Q 008365 365 YVSKISDVGLARLVP 379 (568)
Q Consensus 365 ~~vKL~DFGla~~~~ 379 (568)
+.++|+|||++....
T Consensus 162 ~~~~liDfg~~~~~~ 176 (198)
T cd05144 162 EKIYIIDWPQMVSTD 176 (198)
T ss_pred CcEEEEECCccccCC
Confidence 999999999996543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.75 E-value=3.7e-18 Score=189.68 Aligned_cols=136 Identities=22% Similarity=0.299 Sum_probs=110.1
Q ss_pred hcccccceeecccCceeEEEEEeCCccEEEEEeCcCh--------hHhHHHHHHHHHHHHcCCCCceeeecccc--CCCc
Q 008365 228 TDKFSEAMKIGEGGYGPVYRGKLDHTPVAIKVLRPDA--------AQGKRQFQQEVEVLSSIRHPNMVLLLGAC--PDYG 297 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~~~~~~~~vAvK~l~~~~--------~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~--~~~~ 297 (568)
...|...++||+|+||.||+|.+.+..+++|+..... ......+.+|++++..++|++++..+.++ .+..
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~ 411 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK 411 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence 3455678899999999999999877777766542211 11234578999999999999987655443 4467
Q ss_pred eEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccc
Q 008365 298 CLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARL 377 (568)
Q Consensus 298 ~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~ 377 (568)
++||||++|++|.+++. ....++.+++.+|.|||+.+ |+||||||+|||+ .++.++|+|||+++.
T Consensus 412 ~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 412 TIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred EEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 99999999999998874 34568999999999999999 9999999999999 578899999999975
Q ss_pred c
Q 008365 378 V 378 (568)
Q Consensus 378 ~ 378 (568)
.
T Consensus 477 ~ 477 (535)
T PRK09605 477 S 477 (535)
T ss_pred C
Confidence 3
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.2e-16 Score=152.53 Aligned_cols=134 Identities=24% Similarity=0.262 Sum_probs=95.7
Q ss_pred ceeecccCceeEEEEEeC-CccEEEEEeCcChhHh--HHH----------------------HHHHHHHHHcCCCCc--e
Q 008365 234 AMKIGEGGYGPVYRGKLD-HTPVAIKVLRPDAAQG--KRQ----------------------FQQEVEVLSSIRHPN--M 286 (568)
Q Consensus 234 ~~~IG~G~fg~Vy~~~~~-~~~vAvK~l~~~~~~~--~~~----------------------~~~Ev~iL~~l~Hpn--I 286 (568)
.+.||+|+||.||+|.+. +..||||+++...... ... ...|...+..+.+.+ +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 467999999999999885 8899999987542211 111 134566666654432 3
Q ss_pred eeeccccCCCceEEEEecCCCCHHHH-HhhcCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCCCCcccCCCCCCCeeccCC
Q 008365 287 VLLLGACPDYGCLVYEYMHNGSLEDR-LLRRGNTPVIPWRKRFKIAAEIATALLFLHQ-AKPEPLVHRDLKPANILLDRN 364 (568)
Q Consensus 287 v~l~g~~~~~~~lV~E~~~ggsL~~~-l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~-~~~~~IiHrDIKp~NILld~~ 364 (568)
...++. ...++||||++|+.+... +.... .. .....++.+++.++.++|. .+ |+|+||||+||+++ +
T Consensus 82 ~~~~~~--~~~~lv~e~~~g~~~~~~~l~~~~----~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~-~ 150 (187)
T cd05119 82 PKPIDL--NRHVLVMEFIGGDGIPAPRLKDVR----LL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD-D 150 (187)
T ss_pred CceEec--CCCEEEEEEeCCCCccChhhhhhh----hc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-C
Confidence 333332 345899999998543221 11111 11 4567899999999999999 88 99999999999999 8
Q ss_pred ceeEeccccccccc
Q 008365 365 YVSKISDVGLARLV 378 (568)
Q Consensus 365 ~~vKL~DFGla~~~ 378 (568)
+.++|+|||.+...
T Consensus 151 ~~~~liDfg~a~~~ 164 (187)
T cd05119 151 GKVYIIDVPQAVEI 164 (187)
T ss_pred CcEEEEECcccccc
Confidence 99999999999654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.67 E-value=2.3e-16 Score=142.97 Aligned_cols=133 Identities=23% Similarity=0.266 Sum_probs=110.7
Q ss_pred cceeecccCceeEEEEEeCCccEEEEEeCcChhHhHHHHHHHHHHHHcCCC--CceeeeccccCC--CceEEEEecCCCC
Q 008365 233 EAMKIGEGGYGPVYRGKLDHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRH--PNMVLLLGACPD--YGCLVYEYMHNGS 308 (568)
Q Consensus 233 ~~~~IG~G~fg~Vy~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~H--pnIv~l~g~~~~--~~~lV~E~~~ggs 308 (568)
+.+.||.|.++.||++...+..++||+...... ...+..|+.++..+.| ++++++++++.. ..+++|||++|+.
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~ 79 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKDEDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGET 79 (155)
T ss_pred cceecccccccceEEEEecCCeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCee
Confidence 456899999999999999888999999876543 4578899999999976 488888877654 5699999998887
Q ss_pred HHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccc
Q 008365 309 LEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARL 377 (568)
Q Consensus 309 L~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~ 377 (568)
+..+ +......++.+++.+|.+||.....+++|+||+|.|||+++.+.++++|||+++.
T Consensus 80 ~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 80 LDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred cccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 7543 3445667889999999999996444599999999999999999999999999864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.65 E-value=9.3e-16 Score=152.92 Aligned_cols=132 Identities=17% Similarity=0.167 Sum_probs=103.4
Q ss_pred eeec-ccCceeEEEEEeCCccEEEEEeCcCh-------------hHhHHHHHHHHHHHHcCCCCce--eeeccccCC---
Q 008365 235 MKIG-EGGYGPVYRGKLDHTPVAIKVLRPDA-------------AQGKRQFQQEVEVLSSIRHPNM--VLLLGACPD--- 295 (568)
Q Consensus 235 ~~IG-~G~fg~Vy~~~~~~~~vAvK~l~~~~-------------~~~~~~~~~Ev~iL~~l~HpnI--v~l~g~~~~--- 295 (568)
..|| .||.|+||.+...+..+|||.+.... ......+.+|+.++..|.|++| +..++++..
T Consensus 37 ~~lg~~~g~gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~ 116 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHG 116 (239)
T ss_pred ceeecCCCCccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecC
Confidence 4688 89999999999888999999875321 1223457889999999998875 555554321
Q ss_pred ---CceEEEEecCC-CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecc
Q 008365 296 ---YGCLVYEYMHN-GSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISD 371 (568)
Q Consensus 296 ---~~~lV~E~~~g-gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~D 371 (568)
..++||||++| .+|.+++... .++.. .+.+|+.+|.+||+.| |+||||||.|||++.++.++|+|
T Consensus 117 ~~~~~~lV~e~l~G~~~L~~~l~~~----~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LID 185 (239)
T PRK01723 117 LFYRADILIERIEGARDLVALLQEA----PLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLID 185 (239)
T ss_pred cceeeeEEEEecCCCCCHHHHHhcC----CCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEEE
Confidence 12599999997 6898887542 24443 3568999999999999 99999999999999989999999
Q ss_pred cccccc
Q 008365 372 VGLARL 377 (568)
Q Consensus 372 FGla~~ 377 (568)
||.+..
T Consensus 186 fg~~~~ 191 (239)
T PRK01723 186 FDRGEL 191 (239)
T ss_pred CCCccc
Confidence 999864
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.59 E-value=1.7e-16 Score=177.00 Aligned_cols=251 Identities=18% Similarity=0.262 Sum_probs=183.3
Q ss_pred cccccceeecccCceeEEEEEe---CCccEEEEEeCcCh--hHhHHHHHHHHHHHHcCC-CCceeeeccccC--CCceEE
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKL---DHTPVAIKVLRPDA--AQGKRQFQQEVEVLSSIR-HPNMVLLLGACP--DYGCLV 300 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~---~~~~vAvK~l~~~~--~~~~~~~~~Ev~iL~~l~-HpnIv~l~g~~~--~~~~lV 300 (568)
..|.+.+.||+|+|+.|-.... ....+|+|.+.... .........|..+-+.+. |+|++.+++... +..+++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 4678888899999999987765 23356666654332 223344556888888887 999999998864 445889
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH-HcCCCCcccCCCCCCCeeccCCc-eeEeccccccccc
Q 008365 301 YEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLH-QAKPEPLVHRDLKPANILLDRNY-VSKISDVGLARLV 378 (568)
Q Consensus 301 ~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH-~~~~~~IiHrDIKp~NILld~~~-~vKL~DFGla~~~ 378 (568)
++|..|+++.+.+.... ....+....-.++.|+..+|.|+| ..+ +.|+||||+|.+++..+ .++++|||+|..+
T Consensus 100 ~~~s~g~~~f~~i~~~~-~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~~ 175 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISHPD-STGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATAY 175 (601)
T ss_pred cCcccccccccccccCC-ccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhccc
Confidence 99999999988773211 112445556678899999999999 888 99999999999999999 9999999999877
Q ss_pred CCCCCccccccccccccc-cccCCChhhhhc-CCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHhCccccccCcc
Q 008365 379 PPSVADSVTQYHMTSAAG-TFCYIDPEYQQT-GMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPA 456 (568)
Q Consensus 379 ~~~~~~~~~~~~~~~~~G-T~~Y~APE~~~~-~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~l~~~ 456 (568)
.... .........+| ++.|+|||...+ .......|+||.|+++.-+++|..||....... +.+..+....
T Consensus 176 ~~~~---g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~-----~~~~~~~~~~ 247 (601)
T KOG0590|consen 176 RNKN---GAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD-----GRYSSWKSNK 247 (601)
T ss_pred cccC---CcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc-----ccceeecccc
Confidence 5521 11222345677 999999998877 456788999999999999999999997554322 1111111111
Q ss_pred -C--CCCChHHHHHHHHHHHHhhccCCCCCCChHHhHh
Q 008365 457 -V--TDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIV 491 (568)
Q Consensus 457 -~--~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~ 491 (568)
. ............+++..++..+|..|.+..++-.
T Consensus 248 ~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 248 GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred cccccCccccCChhhhhcccccccCCchhccccccccc
Confidence 0 1112344556778889999999999999988753
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.55 E-value=2.8e-14 Score=154.30 Aligned_cols=138 Identities=22% Similarity=0.268 Sum_probs=98.7
Q ss_pred eeecccCceeEEEEEe-CCccEEEEEeCcChhHhH----------------------------------------HHHHH
Q 008365 235 MKIGEGGYGPVYRGKL-DHTPVAIKVLRPDAAQGK----------------------------------------RQFQQ 273 (568)
Q Consensus 235 ~~IG~G~fg~Vy~~~~-~~~~vAvK~l~~~~~~~~----------------------------------------~~~~~ 273 (568)
+.||.|++|.||+|+. +|+.||||+.++...... -.|.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 5799999999999987 789999999877531110 01345
Q ss_pred HHHHHHcC----CCCceee---eccccCCCceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHH-HHHHHHHcC
Q 008365 274 EVEVLSSI----RHPNMVL---LLGACPDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIAT-ALLFLHQAK 345 (568)
Q Consensus 274 Ev~iL~~l----~HpnIv~---l~g~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~-aL~yLH~~~ 345 (568)
|...+.++ .|.+-|. ++..+....+|||||++|++|.++....... + .+..++..++. .+..+|..|
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~--~---~~~~ia~~~~~~~l~ql~~~g 277 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAG--L---DRKALAENLARSFLNQVLRDG 277 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcC--C---CHHHHHHHHHHHHHHHHHhCC
Confidence 66555554 2332233 3332334569999999999998876532111 2 23456666666 468889988
Q ss_pred CCCcccCCCCCCCeeccCCceeEecccccccccCC
Q 008365 346 PEPLVHRDLKPANILLDRNYVSKISDVGLARLVPP 380 (568)
Q Consensus 346 ~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~ 380 (568)
++|+|++|.||+++.++.++|+|||++..+.+
T Consensus 278 ---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 278 ---FFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred ---ceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 99999999999999999999999999987643
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.47 E-value=8.8e-14 Score=130.24 Aligned_cols=130 Identities=20% Similarity=0.178 Sum_probs=99.7
Q ss_pred ceeecccCceeEEEEEeCCccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCce-eeeccccCCCceEEEEecCCCCHHHH
Q 008365 234 AMKIGEGGYGPVYRGKLDHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNM-VLLLGACPDYGCLVYEYMHNGSLEDR 312 (568)
Q Consensus 234 ~~~IG~G~fg~Vy~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnI-v~l~g~~~~~~~lV~E~~~ggsL~~~ 312 (568)
++.|+.|.++.||++...+..|+||+...... ....+..|+.++..+.+.++ .+++.++.+..++||||++|.++.+.
T Consensus 3 ~~~l~~G~~~~vy~~~~~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~~~~~lv~e~i~G~~l~~~ 81 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVANKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDPETGVLITEFIEGSELLTE 81 (170)
T ss_pred eeecCCcccCceEEEEECCeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeCCCCeEEEEecCCCccccc
Confidence 35789999999999999889999999765432 12346789999998865444 34555555567999999999887643
Q ss_pred HhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcC--CCCcccCCCCCCCeeccCCceeEeccccccc
Q 008365 313 LLRRGNTPVIPWRKRFKIAAEIATALLFLHQAK--PEPLVHRDLKPANILLDRNYVSKISDVGLAR 376 (568)
Q Consensus 313 l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~--~~~IiHrDIKp~NILld~~~~vKL~DFGla~ 376 (568)
. .. ...++.+++.+|..||..+ +..++|+|++|.||+++ ++.++|+|||.+.
T Consensus 82 ----~----~~---~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 82 ----D----FS---DPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred ----c----cc---CHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 0 11 1235678999999999987 12249999999999999 6689999999885
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.43 E-value=1.1e-13 Score=138.22 Aligned_cols=203 Identities=26% Similarity=0.329 Sum_probs=139.4
Q ss_pred HHHcCCCCceeeeccccCCCc-------eEEEEecCCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHcCCCC
Q 008365 277 VLSSIRHPNMVLLLGACPDYG-------CLVYEYMHNGSLEDRLLRRG-NTPVIPWRKRFKIAAEIATALLFLHQAKPEP 348 (568)
Q Consensus 277 iL~~l~HpnIv~l~g~~~~~~-------~lV~E~~~ggsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ 348 (568)
-|-++.|-|||++..++.+.. .++.|||..|+|..+|++.. ....+......+|+.||+.||.|||+.. +|
T Consensus 120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~-Pp 198 (458)
T KOG1266|consen 120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD-PP 198 (458)
T ss_pred HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-Cc
Confidence 344567999999998885533 58999999999999998632 2334667777889999999999999997 57
Q ss_pred cccCCCCCCCeeccCCceeEecccccccccCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHH
Q 008365 349 LVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQII 428 (568)
Q Consensus 349 IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ell 428 (568)
|+|+++..+-|++..+|.+||+--.-.. +.+.. ............|-++|.+||+-.....+.++|||+||.+.++|.
T Consensus 199 iihgnlTc~tifiq~ngLIkig~~ap~s-~h~s~-~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema 276 (458)
T KOG1266|consen 199 IIHGNLTCDTIFIQHNGLIKIGSVAPDS-THPSV-NSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA 276 (458)
T ss_pred cccCCcchhheeecCCceEEecccCccc-cchhh-hhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence 9999999999999999999985322111 11111 011111122345778999999877777888999999999999998
Q ss_pred hCCCC-CCCchH--HHHHHHhCccccccCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 429 TARSP-MGLTHH--VSRAIEKGTLAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 429 tG~~P-f~~~~~--~~~~~~~~~~~~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
.|..- -..... +...+.. ....+.. ..-..++..|++..|..||++..++.|.|
T Consensus 277 ilEiq~tnseS~~~~ee~ia~--~i~~len----------~lqr~~i~kcl~~eP~~rp~ar~llfHpl 333 (458)
T KOG1266|consen 277 ILEIQSTNSESKVEVEENIAN--VIIGLEN----------GLQRGSITKCLEGEPNGRPDARLLLFHPL 333 (458)
T ss_pred HheeccCCCcceeehhhhhhh--heeeccC----------ccccCcCcccccCCCCCCcchhhhhcCce
Confidence 87653 211111 1111110 0000000 01234678999999999999998875543
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.42 E-value=1e-12 Score=144.29 Aligned_cols=142 Identities=21% Similarity=0.268 Sum_probs=92.0
Q ss_pred hcccccceeecccCceeEEEEEe-C-CccEEEEEeCcChhHh----------------------------------HH--
Q 008365 228 TDKFSEAMKIGEGGYGPVYRGKL-D-HTPVAIKVLRPDAAQG----------------------------------KR-- 269 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~~~~-~-~~~vAvK~l~~~~~~~----------------------------------~~-- 269 (568)
...|+. +.||.|++|.||+|+. + |+.||||++++..... .+
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 345666 6899999999999987 4 8999999998653111 01
Q ss_pred ----HHHHHHHHHHcCC----CCceeeecccc---CCCceEEEEecCCCCHHHH--HhhcCCC-CCCCHHHHHHHHHHHH
Q 008365 270 ----QFQQEVEVLSSIR----HPNMVLLLGAC---PDYGCLVYEYMHNGSLEDR--LLRRGNT-PVIPWRKRFKIAAEIA 335 (568)
Q Consensus 270 ----~~~~Ev~iL~~l~----HpnIv~l~g~~---~~~~~lV~E~~~ggsL~~~--l~~~~~~-~~l~~~~~~~i~~qia 335 (568)
.|.+|+..+.++. +.+.|.+-.++ ....+|||||++|+.|.++ +...+.. ..+.......++.
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~--- 274 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFT--- 274 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHH---
Confidence 1334444444442 33334333333 3345899999999999874 2222210 0122222222223
Q ss_pred HHHHHHHHcCCCCcccCCCCCCCeeccCCc----eeEecccccccccCC
Q 008365 336 TALLFLHQAKPEPLVHRDLKPANILLDRNY----VSKISDVGLARLVPP 380 (568)
Q Consensus 336 ~aL~yLH~~~~~~IiHrDIKp~NILld~~~----~vKL~DFGla~~~~~ 380 (568)
-+...| ++|+|+||.||+|+.++ .++++|||++..++.
T Consensus 275 ----Qif~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 275 ----QVFRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred ----HHHhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 334566 99999999999999887 999999999987644
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.34 E-value=8.8e-13 Score=141.84 Aligned_cols=248 Identities=21% Similarity=0.275 Sum_probs=175.2
Q ss_pred cccccceeecc--cCceeEEEEEe----CCccEEEEEeCc--ChhHhHHHHHHHHHHHHcCC-CCceeeeccccCCCc--
Q 008365 229 DKFSEAMKIGE--GGYGPVYRGKL----DHTPVAIKVLRP--DAAQGKRQFQQEVEVLSSIR-HPNMVLLLGACPDYG-- 297 (568)
Q Consensus 229 ~~y~~~~~IG~--G~fg~Vy~~~~----~~~~vAvK~l~~--~~~~~~~~~~~Ev~iL~~l~-HpnIv~l~g~~~~~~-- 297 (568)
..|.+.+.+|. |.+|.||.+.. ....+|+|.-+. ........=.+|+...+.++ |+|.|+.+..+....
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence 34677788999 99999998765 456788887322 21122222346777777775 999999887775544
Q ss_pred eEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHH----HHHHHHHcCCCCcccCCCCCCCeeccCC-ceeEeccc
Q 008365 298 CLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIAT----ALLFLHQAKPEPLVHRDLKPANILLDRN-YVSKISDV 372 (568)
Q Consensus 298 ~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~----aL~yLH~~~~~~IiHrDIKp~NILld~~-~~vKL~DF 372 (568)
++-.|+| +.+|..+...... .++....+.+..+... ||..+|..+ |+|-|+||.||++..+ ...+++||
T Consensus 194 fiqtE~~-~~sl~~~~~~~~~--~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df 267 (524)
T KOG0601|consen 194 FIQTELC-GESLQSYCHTPCN--FLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDF 267 (524)
T ss_pred eeeeccc-cchhHHhhhcccc--cCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCc
Confidence 6778888 6788777665443 3677778888888888 999999999 9999999999999988 88999999
Q ss_pred ccccccCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCch-HHHHHHHhCcccc
Q 008365 373 GLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTH-HVSRAIEKGTLAE 451 (568)
Q Consensus 373 Gla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~-~~~~~~~~~~~~~ 451 (568)
|+...+............ ....|...|++||...+ -++...|||++|.++.+..++..+..... .....+..+.+.
T Consensus 268 ~~v~~i~~~~~~~~~~~~-~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip- 344 (524)
T KOG0601|consen 268 GLVSKISDGNFSSVFKVS-KRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIP- 344 (524)
T ss_pred ceeEEccCCccccceeee-ecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCc-
Confidence 999888665433322222 33367888999997764 57889999999999999999876653221 100111111110
Q ss_pred ccCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHh
Q 008365 452 MLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIV 491 (568)
Q Consensus 452 ~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~ 491 (568)
.++.......+...+..+++.+|.-|++...+..
T Consensus 345 ------~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 345 ------LEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred ------hhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 0122222344555889999999999999887653
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.30 E-value=1.8e-11 Score=117.82 Aligned_cols=135 Identities=17% Similarity=0.154 Sum_probs=96.4
Q ss_pred ceeecccCceeEEEEEeC--------CccEEEEEeCcCh----------------------hHhHHHHH----HHHHHHH
Q 008365 234 AMKIGEGGYGPVYRGKLD--------HTPVAIKVLRPDA----------------------AQGKRQFQ----QEVEVLS 279 (568)
Q Consensus 234 ~~~IG~G~fg~Vy~~~~~--------~~~vAvK~l~~~~----------------------~~~~~~~~----~Ev~iL~ 279 (568)
...||.|--+.||.|... +..+|||+.+... ......+. +|...|.
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 357999999999999753 3689999964210 01122333 8999999
Q ss_pred cCCC--CceeeeccccCCCceEEEEecCCCCHHH-HHhhcCCCCCCCHHHHHHHHHHHHHHHHHH-HHcCCCCcccCCCC
Q 008365 280 SIRH--PNMVLLLGACPDYGCLVYEYMHNGSLED-RLLRRGNTPVIPWRKRFKIAAEIATALLFL-HQAKPEPLVHRDLK 355 (568)
Q Consensus 280 ~l~H--pnIv~l~g~~~~~~~lV~E~~~ggsL~~-~l~~~~~~~~l~~~~~~~i~~qia~aL~yL-H~~~~~~IiHrDIK 355 (568)
++.. -++...+++ ...+|||||+.++.+.. .+... .++......+..+++.+|..| |..+ |||+||+
T Consensus 82 rl~~~Gv~vP~pi~~--~~~~lvME~Ig~~~~~~~~Lkd~----~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDLs 152 (197)
T cd05146 82 RMQKAGIPCPEVVVL--KKHVLVMSFIGDDQVPAPKLKDA----KLNDEEMKNAYYQVLSMMKQLYKECN---LVHADLS 152 (197)
T ss_pred HHHHcCCCCCeEEEe--cCCEEEEEEcCCCCccchhhhcc----ccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCCC
Confidence 8853 344455543 56799999996654422 12211 244455667889999999998 8888 9999999
Q ss_pred CCCeeccCCceeEeccccccccc
Q 008365 356 PANILLDRNYVSKISDVGLARLV 378 (568)
Q Consensus 356 p~NILld~~~~vKL~DFGla~~~ 378 (568)
+.|||++ ++.++|+|||.+...
T Consensus 153 ~~NIL~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 153 EYNMLWH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred HHHEEEE-CCcEEEEECCCceeC
Confidence 9999997 467999999988654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.29 E-value=1.4e-12 Score=146.91 Aligned_cols=251 Identities=19% Similarity=0.204 Sum_probs=175.5
Q ss_pred HhcccccceeecccCceeEEEEEe--CCccEEEEEeCcChhHh---HHHHHHHHHHHHcCCCCceeeeccc--cCCCceE
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQG---KRQFQQEVEVLSSIRHPNMVLLLGA--CPDYGCL 299 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~---~~~~~~Ev~iL~~l~HpnIv~l~g~--~~~~~~l 299 (568)
..+.|.+.+-+-.|.|+.++.+.- .+...++|+......-. .+....+-+++-..++|.++...-. |....+|
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L 881 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL 881 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence 446778888999999999998764 33445666554332211 1223344444444567777776655 4556699
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccC
Q 008365 300 VYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVP 379 (568)
Q Consensus 300 V~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~ 379 (568)
||+|+.|++|...|+..+. .+..-....+..+..+++|||... ++|+|++|.|+|+..+|+.++.|||.....+
T Consensus 882 ~~~~~~~~~~~Skl~~~~~---~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg 955 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLHNSGC---LSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKVG 955 (1205)
T ss_pred hhHHhccCCchhhhhcCCC---cccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCccccccccc
Confidence 9999999999998877652 333344456678899999999998 9999999999999999999999999443221
Q ss_pred C---CCCc------------------c-c---cccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCC
Q 008365 380 P---SVAD------------------S-V---TQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPM 434 (568)
Q Consensus 380 ~---~~~~------------------~-~---~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf 434 (568)
- .... . . .........||+.|.+||...+......+|+|++|++++|.++|.+||
T Consensus 956 ~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~ 1035 (1205)
T KOG0606|consen 956 LIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPF 1035 (1205)
T ss_pred cccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCC
Confidence 0 0000 0 0 001234568999999999999999999999999999999999999999
Q ss_pred CCchHHHHHHHhCccccccCccCCCCChHHHHHHHHHHHHhhccCCCCCCChH
Q 008365 435 GLTHHVSRAIEKGTLAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLG 487 (568)
Q Consensus 435 ~~~~~~~~~~~~~~~~~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~ 487 (568)
.....-... +++... +..+..-+...+.....++...+..+|.+|-.+.
T Consensus 1036 na~tpq~~f---~ni~~~-~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1036 NAETPQQIF---ENILNR-DIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCcchhhhh---hccccC-CCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 654432111 111111 2223334556677888999999999999998775
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.27 E-value=3.4e-11 Score=112.83 Aligned_cols=128 Identities=26% Similarity=0.375 Sum_probs=100.5
Q ss_pred eeecccCceeEEEEEeCCccEEEEEeCcC--------hhHhHHHHHHHHHHHHcCCC--CceeeeccccCCCceEEEEec
Q 008365 235 MKIGEGGYGPVYRGKLDHTPVAIKVLRPD--------AAQGKRQFQQEVEVLSSIRH--PNMVLLLGACPDYGCLVYEYM 304 (568)
Q Consensus 235 ~~IG~G~fg~Vy~~~~~~~~vAvK~l~~~--------~~~~~~~~~~Ev~iL~~l~H--pnIv~l~g~~~~~~~lV~E~~ 304 (568)
..|++|+-+.||.+.+-+.++++|.=.+. ..-....-.+|..+|.++.- -+...+|++.++...|+|||+
T Consensus 2 ~~i~~GAEa~i~~~~~~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I 81 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI 81 (204)
T ss_pred chhhCCcceeEEeeeccCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence 35899999999999887777888863222 11122345689999988753 345566777788889999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEeccccccc
Q 008365 305 HNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLAR 376 (568)
Q Consensus 305 ~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~ 376 (568)
+|..|.+.+... ...++..|-.-+.-||..+ |||+||.++||++..++ +.++||||+.
T Consensus 82 ~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~ 139 (204)
T COG3642 82 EGELLKDALEEA----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGE 139 (204)
T ss_pred CChhHHHHHHhc----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCccc
Confidence 999999888654 2346777888888999999 99999999999997765 8999999986
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.24 E-value=7.6e-12 Score=134.66 Aligned_cols=237 Identities=21% Similarity=0.211 Sum_probs=167.3
Q ss_pred hcccccceeecccCceeEEEEEe---CCccEEEEEeCcChhHhHHHH--HHHHHHHHcCC-CCceeeecccc-C-CCceE
Q 008365 228 TDKFSEAMKIGEGGYGPVYRGKL---DHTPVAIKVLRPDAAQGKRQF--QQEVEVLSSIR-HPNMVLLLGAC-P-DYGCL 299 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~~~~---~~~~vAvK~l~~~~~~~~~~~--~~Ev~iL~~l~-HpnIv~l~g~~-~-~~~~l 299 (568)
..+|..+..||.|.|+.|+.... ++..|++|.+.........++ ..|+-+...+. |.+++.++..+ + +..++
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~i 343 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYI 343 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccC
Confidence 35788999999999999998754 466899998766543333332 35777776664 88888877655 3 34478
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCC-ceeEeccccccccc
Q 008365 300 VYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRN-YVSKISDVGLARLV 378 (568)
Q Consensus 300 V~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~-~~vKL~DFGla~~~ 378 (568)
--|||+++++...+.-.. .+....++++..|++.++.++|+.. ++|+|+||+||++..+ +..+++|||+...+
T Consensus 344 p~e~~~~~s~~l~~~~~~---~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t~~ 417 (524)
T KOG0601|consen 344 PLEFCEGGSSSLRSVTSQ---MLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWTRL 417 (524)
T ss_pred chhhhcCcchhhhhHHHH---hcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhcccccccccc
Confidence 889999999876663222 2566778889999999999999999 9999999999999775 78899999998643
Q ss_pred CCCCCccccccccccccccccCC--ChhhhhcCCCCCcceehhHHHHHHHHHhCCC-CCCCchHHHHHHHhCccccccCc
Q 008365 379 PPSVADSVTQYHMTSAAGTFCYI--DPEYQQTGMLTTKSDIYSFGIMLLQIITARS-PMGLTHHVSRAIEKGTLAEMLDP 455 (568)
Q Consensus 379 ~~~~~~~~~~~~~~~~~GT~~Y~--APE~~~~~~~s~ksDvwSlGvil~elltG~~-Pf~~~~~~~~~~~~~~~~~~l~~ 455 (568)
... . ....++-+|+ +|.......+..+.|+||||.-+.+.++|.+ +....+. ..+...
T Consensus 418 ~~~--------~-~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~----------~~i~~~ 478 (524)
T KOG0601|consen 418 AFS--------S-GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQS----------LTIRSG 478 (524)
T ss_pred cee--------c-ccccccccccccchhhccccccccccccccccccccccccCcccCcccccc----------eeeecc
Confidence 211 1 1222333444 5556666678899999999999999999875 2322211 011111
Q ss_pred cCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhH
Q 008365 456 AVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVI 490 (568)
Q Consensus 456 ~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl 490 (568)
.... .......+..+...+...++..||.+.++.
T Consensus 479 ~~p~-~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~ 512 (524)
T KOG0601|consen 479 DTPN-LPGLKLQLQVLLKVMINPDRKRRPSAVELS 512 (524)
T ss_pred cccC-CCchHHhhhhhhhhhcCCccccchhhhhhc
Confidence 1112 223337788888999999999999887654
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.21 E-value=1e-10 Score=127.21 Aligned_cols=163 Identities=22% Similarity=0.259 Sum_probs=122.4
Q ss_pred eCCccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCceeeeccccCCCc--eEEEEecCCCCHHHHHhhcCCCCCCCHHHH
Q 008365 250 LDHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACPDYG--CLVYEYMHNGSLEDRLLRRGNTPVIPWRKR 327 (568)
Q Consensus 250 ~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~--~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~ 327 (568)
.++.+|.|.+.+...........+-++.|+.++||||+++++.+.... |||+|-+ ..|..++.+.+ ....
T Consensus 35 ~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~l~------~~~v 106 (690)
T KOG1243|consen 35 ADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKELG------KEEV 106 (690)
T ss_pred ccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHHhH------HHHH
Confidence 367788888886655433455678889999999999999999886655 9999998 57777777644 3455
Q ss_pred HHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCCccccccccccccccccCCChhhhh
Q 008365 328 FKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQ 407 (568)
Q Consensus 328 ~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~ 407 (568)
...+.||+.||.|||+.+. ++|++|.-+-|+|+..|..||++|.++........ ......---.|..|+.+.
T Consensus 107 ~~Gl~qIl~AL~FL~~d~~--lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~------~~~~~~~~~s~~~P~~~~ 178 (690)
T KOG1243|consen 107 CLGLFQILAALSFLNDDCN--LVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA------PAKSLYLIESFDDPEEID 178 (690)
T ss_pred HHHHHHHHHHHHHHhccCC--eeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc------ccccchhhhcccChhhcC
Confidence 6678999999999986552 99999999999999999999999999864422111 001111122366676554
Q ss_pred cCCCCCcceehhHHHHHHHHHhC
Q 008365 408 TGMLTTKSDIYSFGIMLLQIITA 430 (568)
Q Consensus 408 ~~~~s~ksDvwSlGvil~elltG 430 (568)
... -..|.|-|||++++++.|
T Consensus 179 ~s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 179 PSE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred ccc--cchhhhhHHHHHHHHhCc
Confidence 333 356999999999999999
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.20 E-value=6.4e-11 Score=115.41 Aligned_cols=139 Identities=26% Similarity=0.333 Sum_probs=105.4
Q ss_pred eeecccCceeEEEEEeCC-ccEEEEEeCcChh-HhHHHHHHHHHHHHcCCC--CceeeeccccCC-----CceEEEEecC
Q 008365 235 MKIGEGGYGPVYRGKLDH-TPVAIKVLRPDAA-QGKRQFQQEVEVLSSIRH--PNMVLLLGACPD-----YGCLVYEYMH 305 (568)
Q Consensus 235 ~~IG~G~fg~Vy~~~~~~-~~vAvK~l~~~~~-~~~~~~~~Ev~iL~~l~H--pnIv~l~g~~~~-----~~~lV~E~~~ 305 (568)
+.||.|.++.||++...+ ..++||+...... .....+..|+.++..+.+ .++.+++.++.+ ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 578999999999998765 8999999765432 134567899999999875 335566666544 4489999999
Q ss_pred CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcC----------------------------------------
Q 008365 306 NGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAK---------------------------------------- 345 (568)
Q Consensus 306 ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~---------------------------------------- 345 (568)
|.++.+.+.. ..++......++.+++.+|.+||+..
T Consensus 84 G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 84 GRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred CEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 9888765431 12566677778888888888888532
Q ss_pred -------------CCCcccCCCCCCCeeccC--CceeEecccccccc
Q 008365 346 -------------PEPLVHRDLKPANILLDR--NYVSKISDVGLARL 377 (568)
Q Consensus 346 -------------~~~IiHrDIKp~NILld~--~~~vKL~DFGla~~ 377 (568)
+..++|+|+.|.|||++. ++.+.|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 123799999999999998 67789999998863
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.18 E-value=3e-10 Score=106.06 Aligned_cols=141 Identities=22% Similarity=0.266 Sum_probs=103.8
Q ss_pred cceeecccCceeEEEEEeCCccEEEEEeCc--------ChhHhHHHHHHHHHHHHcCCCCcee--eeccccCCCceEEEE
Q 008365 233 EAMKIGEGGYGPVYRGKLDHTPVAIKVLRP--------DAAQGKRQFQQEVEVLSSIRHPNMV--LLLGACPDYGCLVYE 302 (568)
Q Consensus 233 ~~~~IG~G~fg~Vy~~~~~~~~vAvK~l~~--------~~~~~~~~~~~Ev~iL~~l~HpnIv--~l~g~~~~~~~lV~E 302 (568)
.+..|-+|+-+.|+++.+.|+.++||.=.. +..-......+|+.+|.++.--.|. .++-+-....+|+||
T Consensus 11 ~l~likQGAEArv~~~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME 90 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYME 90 (229)
T ss_pred cceeeeccceeeEeeeccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEE
Confidence 567899999999999999999988886322 1222345677899999988643332 222222345599999
Q ss_pred ecCC-CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCC---ceeEecccccccc
Q 008365 303 YMHN-GSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRN---YVSKISDVGLARL 377 (568)
Q Consensus 303 ~~~g-gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~---~~vKL~DFGla~~ 377 (568)
|++| .++.+++......... ......++..|-..|.-||.++ |||+||..+||+|..+ ..+.|+|||++..
T Consensus 91 ~~~g~~~vk~~i~~~~~~~~~-d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 91 FIDGASTVKDFILSTMEDESE-DEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred eccchhHHHHHHHHHccCccc-chhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence 9976 4788888776544322 2333678889999999999999 9999999999999554 3458999999853
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.97 E-value=7.9e-09 Score=104.65 Aligned_cols=137 Identities=18% Similarity=0.050 Sum_probs=96.6
Q ss_pred eecccCceeEEEEEeCCccEEEEEeCcChhH-hH----------HHHHHHHHHHHcCC-----CCceeeeccc--c--CC
Q 008365 236 KIGEGGYGPVYRGKLDHTPVAIKVLRPDAAQ-GK----------RQFQQEVEVLSSIR-----HPNMVLLLGA--C--PD 295 (568)
Q Consensus 236 ~IG~G~fg~Vy~~~~~~~~vAvK~l~~~~~~-~~----------~~~~~Ev~iL~~l~-----HpnIv~l~g~--~--~~ 295 (568)
.+-......|+++..+|+.|.||........ .. ..+.+|+..+.+|. -|.+|-+... . ..
T Consensus 29 ~v~~~~~rrvvr~~~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~ 108 (268)
T PRK15123 29 VFRELEGRRTLRFELAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATR 108 (268)
T ss_pred EEecCCCceEEEEEECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccc
Confidence 3444444457778888899999977543211 01 13678998888774 3333333211 1 12
Q ss_pred CceEEEEecCCC-CHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccC-------Ccee
Q 008365 296 YGCLVYEYMHNG-SLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDR-------NYVS 367 (568)
Q Consensus 296 ~~~lV~E~~~gg-sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~-------~~~v 367 (568)
..+||||++++. +|.+++..... ...+...+..++.+++..+.-||..| |+|+|+++.||||+. ++.+
T Consensus 109 ~s~LVte~l~~~~sL~~~~~~~~~-~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~~ 184 (268)
T PRK15123 109 TSFIITEDLAPTISLEDYCADWAT-NPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLKL 184 (268)
T ss_pred eeEEEEeeCCCCccHHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCceE
Confidence 358999999876 89998864322 12455667789999999999999999 999999999999975 5789
Q ss_pred Eeccccccc
Q 008365 368 KISDVGLAR 376 (568)
Q Consensus 368 KL~DFGla~ 376 (568)
.|+||+.+.
T Consensus 185 ~LIDl~r~~ 193 (268)
T PRK15123 185 SVIDLHRAQ 193 (268)
T ss_pred EEEECCccc
Confidence 999999885
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.96 E-value=5.1e-08 Score=101.20 Aligned_cols=244 Identities=17% Similarity=0.218 Sum_probs=159.2
Q ss_pred cceeecccCceeEEEEEeCCccEEEEEeCcChhHhHHHHHHHHHHHHcC-CCCceee--------eccccCCC-ceEEEE
Q 008365 233 EAMKIGEGGYGPVYRGKLDHTPVAIKVLRPDAAQGKRQFQQEVEVLSSI-RHPNMVL--------LLGACPDY-GCLVYE 302 (568)
Q Consensus 233 ~~~~IG~G~fg~Vy~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l-~HpnIv~--------l~g~~~~~-~~lV~E 302 (568)
....||+|+-+.+|-.-.-+.. +-|+......-...+ -+..|... .||-+-. ++|--... ..+.|.
T Consensus 15 ~gr~LgqGgea~ly~l~e~~d~-VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP 90 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEVRDQ-VAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMP 90 (637)
T ss_pred CCccccCCccceeeecchhhch-hheeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEecc
Confidence 4568999999999954322223 446665433222222 23333333 4654322 12221111 256777
Q ss_pred ecCCCC-HHHHHh---hcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEeccccccccc
Q 008365 303 YMHNGS-LEDRLL---RRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLV 378 (568)
Q Consensus 303 ~~~ggs-L~~~l~---~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~ 378 (568)
.+.|.. +.+++. +....+...|.-.++.+..++.+...||..| .+-+|+.++||||.+++.|.|.|-..-...
T Consensus 91 ~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfqi~ 167 (637)
T COG4248 91 KVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQIN 167 (637)
T ss_pred cCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcccceeec
Confidence 776642 223222 2334566889999999999999999999999 999999999999999999999885433221
Q ss_pred CCCCCccccccccccccccccCCChhhhh-----cCCCCCcceehhHHHHHHHHHhC-CCCCCCc-------hHHHHHHH
Q 008365 379 PPSVADSVTQYHMTSAAGTFCYIDPEYQQ-----TGMLTTKSDIYSFGIMLLQIITA-RSPMGLT-------HHVSRAIE 445 (568)
Q Consensus 379 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-----~~~~s~ksDvwSlGvil~elltG-~~Pf~~~-------~~~~~~~~ 445 (568)
.........+|...|++||... +..-+...|.|.||++++++|.| +.||.+. ...+..|.
T Consensus 168 -------~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia 240 (637)
T COG4248 168 -------ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIA 240 (637)
T ss_pred -------cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhh
Confidence 1122234568999999999655 34456789999999999999996 9999542 23444555
Q ss_pred hCccccccCccC------CCCC-hHHHHHHHHHHHHhhcc--CCCCCCChHHhH
Q 008365 446 KGTLAEMLDPAV------TDWP-AEAAESFSKLAIQCAEL--RKKDRPDLGTVI 490 (568)
Q Consensus 446 ~~~~~~~l~~~~------~~~p-~~~~~~l~~li~~Cl~~--dP~~RPs~~~vl 490 (568)
.+.+...-+... ..+| ..+++.+..|..+|+.. ++.-||+....+
T Consensus 241 ~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~ 294 (637)
T COG4248 241 HGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWV 294 (637)
T ss_pred cceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHH
Confidence 555544433222 2233 24567889999999986 356899998765
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.95 E-value=2.8e-09 Score=102.18 Aligned_cols=124 Identities=24% Similarity=0.249 Sum_probs=80.3
Q ss_pred eEEEEEe-CCccEEEEEeCcCh--------------------------hHhHHHHHHHHHHHHcCCCC--ceeeeccccC
Q 008365 244 PVYRGKL-DHTPVAIKVLRPDA--------------------------AQGKRQFQQEVEVLSSIRHP--NMVLLLGACP 294 (568)
Q Consensus 244 ~Vy~~~~-~~~~vAvK~l~~~~--------------------------~~~~~~~~~Ev~iL~~l~Hp--nIv~l~g~~~ 294 (568)
.||.|.. ++..+|||+.+... .......++|.+.|.++..- ++.+.+++
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~-- 78 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY-- 78 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence 4899987 67899999975321 00112356899999999755 34555543
Q ss_pred CCceEEEEecC--CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHH-HHHcCCCCcccCCCCCCCeeccCCceeEecc
Q 008365 295 DYGCLVYEYMH--NGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLF-LHQAKPEPLVHRDLKPANILLDRNYVSKISD 371 (568)
Q Consensus 295 ~~~~lV~E~~~--ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~y-LH~~~~~~IiHrDIKp~NILld~~~~vKL~D 371 (568)
...+|||||++ |..+..+. ... ++......++.+++..+.. +|..| |||+||.+.|||++++ .+.|+|
T Consensus 79 ~~~~ivME~I~~~G~~~~~l~-~~~----~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~iID 149 (188)
T PF01163_consen 79 NRNVIVMEYIGEDGVPLPRLK-DVD----LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYIID 149 (188)
T ss_dssp ETTEEEEE--EETTEEGGCHH-HCG----GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE--
T ss_pred eCCEEEEEecCCCccchhhHH-hcc----ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEEEe
Confidence 35689999998 55554432 221 1123445677788885555 57888 9999999999999887 899999
Q ss_pred ccccccc
Q 008365 372 VGLARLV 378 (568)
Q Consensus 372 FGla~~~ 378 (568)
||.+...
T Consensus 150 f~qav~~ 156 (188)
T PF01163_consen 150 FGQAVDS 156 (188)
T ss_dssp GTTEEET
T ss_pred cCcceec
Confidence 9988643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.91 E-value=2.4e-08 Score=105.96 Aligned_cols=210 Identities=18% Similarity=0.255 Sum_probs=142.7
Q ss_pred ceeEEEEEe--CCccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCceeeeccccCC------CceEEEEecCC-CCHHHH
Q 008365 242 YGPVYRGKL--DHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACPD------YGCLVYEYMHN-GSLEDR 312 (568)
Q Consensus 242 fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~------~~~lV~E~~~g-gsL~~~ 312 (568)
-.+.|++.. +|..|++|.++.+..........-+++++++.|+|||++.++|.. ..+|||+|.++ ++|.++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 357888875 788999999955433333233456889999999999999988752 23799999986 578776
Q ss_pred HhhcC------------CCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCC
Q 008365 313 LLRRG------------NTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPP 380 (568)
Q Consensus 313 l~~~~------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~ 380 (568)
..... .....++..+|.++.|+..||.++|+.| +.-+-|.|.+||++.+..++|...|+...+..
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 54321 1233678899999999999999999999 99999999999999999999998888765533
Q ss_pred CCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHhCccccccCccCCCC
Q 008365 381 SVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAVTDW 460 (568)
Q Consensus 381 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~l~~~~~~~ 460 (568)
+. .+| +. --.+-|.=-||.+++.|.||..--...+..... . ....
T Consensus 446 d~------------------~~~--le---~~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s----~--------~~~I 490 (655)
T KOG3741|consen 446 DP------------------TEP--LE---SQQQNDLRDLGLLLLALATGTENSNRTDSTQSS----H--------LTRI 490 (655)
T ss_pred CC------------------Ccc--hh---HHhhhhHHHHHHHHHHHhhcccccccccchHHH----H--------HHHh
Confidence 21 011 11 123568899999999999985421000000000 0 0001
Q ss_pred ChHHHHHHHHHHHHhhccCCCCCCChHHhH
Q 008365 461 PAEAAESFSKLAIQCAELRKKDRPDLGTVI 490 (568)
Q Consensus 461 p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl 490 (568)
....+.++.+++......++++ -++.+++
T Consensus 491 ~~~yS~D~rn~v~yl~s~~~~~-ksI~~ll 519 (655)
T KOG3741|consen 491 TTTYSTDLRNVVEYLESLNFRE-KSIQDLL 519 (655)
T ss_pred hhhhhHHHHHHHHHHHhcCccc-ccHHHHH
Confidence 2234455667777777777765 4555443
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.75 E-value=4e-08 Score=97.49 Aligned_cols=133 Identities=22% Similarity=0.157 Sum_probs=95.3
Q ss_pred cccceeecccCceeEEEEEe-CCccEEEEEeCcChh----------------------HhHHHHHHHHHHHHcCCCC--c
Q 008365 231 FSEAMKIGEGGYGPVYRGKL-DHTPVAIKVLRPDAA----------------------QGKRQFQQEVEVLSSIRHP--N 285 (568)
Q Consensus 231 y~~~~~IG~G~fg~Vy~~~~-~~~~vAvK~l~~~~~----------------------~~~~~~~~Ev~iL~~l~Hp--n 285 (568)
+.+..+||-|--+.||.|.+ .+.++|||..+.... -.+...++|.++|.+|... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 45678999999999999998 588999998643210 1122356899999988644 4
Q ss_pred eeeeccccCCCceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCc
Q 008365 286 MVLLLGACPDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNY 365 (568)
Q Consensus 286 Iv~l~g~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~ 365 (568)
+..-++ .+..++||||++|-.|...-. .....-.|+..|+.-+.-+-..| |||+|+.+-||||+++|
T Consensus 173 VP~P~~--~nRHaVvMe~ieG~eL~~~r~--------~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~~dg 239 (304)
T COG0478 173 VPKPIA--WNRHAVVMEYIEGVELYRLRL--------DVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVTEDG 239 (304)
T ss_pred CCCccc--cccceeeeehcccceeecccC--------cccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEecCC
Confidence 444444 345589999999877754321 12223335555666555555778 99999999999999999
Q ss_pred eeEeccccccc
Q 008365 366 VSKISDVGLAR 376 (568)
Q Consensus 366 ~vKL~DFGla~ 376 (568)
.+.++||--+.
T Consensus 240 ~~~vIDwPQ~v 250 (304)
T COG0478 240 DIVVIDWPQAV 250 (304)
T ss_pred CEEEEeCcccc
Confidence 99999997664
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.70 E-value=5.2e-08 Score=95.02 Aligned_cols=104 Identities=22% Similarity=0.264 Sum_probs=77.9
Q ss_pred HHHHHHHHHHHcCCCCce--eeeccccC------CCceEEEEecCCC-CHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHH
Q 008365 269 RQFQQEVEVLSSIRHPNM--VLLLGACP------DYGCLVYEYMHNG-SLEDRLLRRGNTPVIPWRKRFKIAAEIATALL 339 (568)
Q Consensus 269 ~~~~~Ev~iL~~l~HpnI--v~l~g~~~------~~~~lV~E~~~gg-sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~ 339 (568)
....+|...+..|..-+| ...+++.. ...+||+|++++. +|.+++..... .+......++.+++..+.
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~---~~~~~~~~ll~~l~~~i~ 132 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ---LDPSQRRELLRALARLIA 132 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc---cchhhHHHHHHHHHHHHH
Confidence 456788888777643222 22332221 2348999999874 79998876332 445567789999999999
Q ss_pred HHHHcCCCCcccCCCCCCCeeccCCc---eeEeccccccccc
Q 008365 340 FLHQAKPEPLVHRDLKPANILLDRNY---VSKISDVGLARLV 378 (568)
Q Consensus 340 yLH~~~~~~IiHrDIKp~NILld~~~---~vKL~DFGla~~~ 378 (568)
-||..| |+|+|+++.||||+.++ .+.|+||+-++..
T Consensus 133 ~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 133 KLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 999999 99999999999998876 8999999988653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.69 E-value=1.2e-07 Score=91.76 Aligned_cols=136 Identities=15% Similarity=0.107 Sum_probs=102.1
Q ss_pred ecccCceeEEEEEeCCccEEEEEeCcCh------hHhHHHHHHHHHHHHcCCCCc--eeeeccccC---C----CceEEE
Q 008365 237 IGEGGYGPVYRGKLDHTPVAIKVLRPDA------AQGKRQFQQEVEVLSSIRHPN--MVLLLGACP---D----YGCLVY 301 (568)
Q Consensus 237 IG~G~fg~Vy~~~~~~~~vAvK~l~~~~------~~~~~~~~~Ev~iL~~l~Hpn--Iv~l~g~~~---~----~~~lV~ 301 (568)
-|+||.+-|+.....|..+-||.-.... ......|.+|+..|..|..-+ +.... ++. . ..+||+
T Consensus 26 ~~rgG~SgV~r~~~~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 26 YRRNGMSGVQCVERNGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLVT 104 (216)
T ss_pred cCCCCcceEEEEEeCCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEEE
Confidence 5789999999998888888888754110 234567999999999885333 33333 221 1 237999
Q ss_pred EecCC-CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCce--eEecccccccc
Q 008365 302 EYMHN-GSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYV--SKISDVGLARL 377 (568)
Q Consensus 302 E~~~g-gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~--vKL~DFGla~~ 377 (568)
|-+.| -+|.+++....-. ..+...+..++.+|+..|.-||..| +.|+|+.+.|||++.++. ++++||.-++.
T Consensus 105 e~L~g~~~L~~~l~~~~~~-~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVS-PYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhcCCcC-CcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 98854 5888887654322 3566777889999999999999999 999999999999986666 99999997753
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.61 E-value=2.2e-07 Score=101.86 Aligned_cols=138 Identities=21% Similarity=0.293 Sum_probs=91.4
Q ss_pred eeecccCceeEEEEEeC-CccEEEEEeCcChhHhH------------------------------H----------HHHH
Q 008365 235 MKIGEGGYGPVYRGKLD-HTPVAIKVLRPDAAQGK------------------------------R----------QFQQ 273 (568)
Q Consensus 235 ~~IG~G~fg~Vy~~~~~-~~~vAvK~l~~~~~~~~------------------------------~----------~~~~ 273 (568)
..|+.++-|.||+|+.. |+.||||+.+++..... . ++.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 57999999999999984 89999999887532210 0 1234
Q ss_pred HHHHHHcCC-----CCce--eeeccccCCCceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHH-HHHHHcC
Q 008365 274 EVEVLSSIR-----HPNM--VLLLGACPDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATAL-LFLHQAK 345 (568)
Q Consensus 274 Ev~iL~~l~-----HpnI--v~l~g~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL-~yLH~~~ 345 (568)
|...+.+++ .|+| .++|--+.....|+|||++|-.+.+........ ++.+ .|+..++.+. .-+=..|
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g--~d~k---~ia~~~~~~f~~q~~~dg 285 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAG--IDRK---ELAELLVRAFLRQLLRDG 285 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcC--CCHH---HHHHHHHHHHHHHHHhcC
Confidence 555554442 3332 223322334558999999999998874322211 3322 3444444432 2233355
Q ss_pred CCCcccCCCCCCCeeccCCceeEecccccccccCC
Q 008365 346 PEPLVHRDLKPANILLDRNYVSKISDVGLARLVPP 380 (568)
Q Consensus 346 ~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~ 380 (568)
++|.|..|.||+++.+|.+.+.|||+...+++
T Consensus 286 ---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 286 ---FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred ---ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 99999999999999999999999999976644
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.60 E-value=3e-07 Score=89.47 Aligned_cols=135 Identities=21% Similarity=0.207 Sum_probs=93.4
Q ss_pred HhcccccceeecccCceeEEEEEeCCccEEEEEeCcChhHhHHHH---------HHHHHHHHcCCC---Cceeeeccc--
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKLDHTPVAIKVLRPDAAQGKRQF---------QQEVEVLSSIRH---PNMVLLLGA-- 292 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~~~~~vAvK~l~~~~~~~~~~~---------~~Ev~iL~~l~H---pnIv~l~g~-- 292 (568)
...+|.+.+.+-.....-|.+-..++..+++|+.+.......+.| .+.+..+..+.. -.+..++-+
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~e 108 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAE 108 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeee
Confidence 456788888888888888999888999999999876543322222 233443333321 222222211
Q ss_pred -----cCCCceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCcee
Q 008365 293 -----CPDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVS 367 (568)
Q Consensus 293 -----~~~~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~v 367 (568)
+....+|||||++|..|.+... ++. .++..|+.++.-||..| ++|+|+.|.||++.+++ +
T Consensus 109 kk~~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~~-i 173 (229)
T PF06176_consen 109 KKIFRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNNG-I 173 (229)
T ss_pred eeeccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECCc-E
Confidence 1233368999999988876532 222 24456778899999999 99999999999998665 8
Q ss_pred Eeccccccc
Q 008365 368 KISDVGLAR 376 (568)
Q Consensus 368 KL~DFGla~ 376 (568)
+++||+..+
T Consensus 174 ~iID~~~k~ 182 (229)
T PF06176_consen 174 RIIDTQGKR 182 (229)
T ss_pred EEEECcccc
Confidence 999998765
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.60 E-value=1.4e-08 Score=111.28 Aligned_cols=153 Identities=18% Similarity=0.324 Sum_probs=106.5
Q ss_pred HHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCCccccccc---cccccccccCCChhhhhc
Q 008365 332 AEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYH---MTSAAGTFCYIDPEYQQT 408 (568)
Q Consensus 332 ~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~---~~~~~GT~~Y~APE~~~~ 408 (568)
.+++.||.|+|..- .+||++|.|++|.++.++..||+.|+.+........-....+. .....-...|.|||++.+
T Consensus 106 ~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 35569999999875 3999999999999999999999999998655432221111111 112345678999999999
Q ss_pred CCCCCcceehhHHHHHHHHHh-CCCCCCCch-HHHHHHHhCccccccCccCCCCChHHHHHHHHHHHHhhccCCCCCCCh
Q 008365 409 GMLTTKSDIYSFGIMLLQIIT-ARSPMGLTH-HVSRAIEKGTLAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDL 486 (568)
Q Consensus 409 ~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~-~~~~~~~~~~~~~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~ 486 (568)
...+.++|+||+||++|.+.. |+.-+.... .....+... .++-....++..+|.++.+=+.+.+..+..-||++
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~----~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~ 259 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRN----LLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTL 259 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhc----ccccccccccccCcHHHHHHHHHHhcCCcccCcch
Confidence 889999999999999999995 444443221 111111111 11112223446677888999999999999999977
Q ss_pred HHhH
Q 008365 487 GTVI 490 (568)
Q Consensus 487 ~~vl 490 (568)
..+.
T Consensus 260 ~~l~ 263 (700)
T KOG2137|consen 260 DLLL 263 (700)
T ss_pred hhhh
Confidence 6554
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.45 E-value=6.6e-07 Score=87.42 Aligned_cols=141 Identities=24% Similarity=0.271 Sum_probs=82.9
Q ss_pred ceeecccCceeEEEEEeCCccEEEEEeCcChhHhHHHHHHHHHHHHcCCCC--ceeeecccc-----CCCceEEEEecCC
Q 008365 234 AMKIGEGGYGPVYRGKLDHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHP--NMVLLLGAC-----PDYGCLVYEYMHN 306 (568)
Q Consensus 234 ~~~IG~G~fg~Vy~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~Hp--nIv~l~g~~-----~~~~~lV~E~~~g 306 (568)
++.|+.|..+.||+....+..++||+.... .....+.+|+.++..+... .+..++..+ ....+++|++++|
T Consensus 2 i~~l~~G~~n~~~~v~~~~~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g 79 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDDGRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG 79 (239)
T ss_dssp EEEEEESSSSEEEEEEETTSEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred CccCCCCCeeeEEEEEECCcEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence 457999999999999987789999997655 4456677888888877532 234455422 1123789999999
Q ss_pred CCHHH----------------HHh---hc-CCCCCCCHHH---------HHHH------------HHHHHH-HHHHHHHc
Q 008365 307 GSLED----------------RLL---RR-GNTPVIPWRK---------RFKI------------AAEIAT-ALLFLHQA 344 (568)
Q Consensus 307 gsL~~----------------~l~---~~-~~~~~l~~~~---------~~~i------------~~qia~-aL~yLH~~ 344 (568)
..+.. .+. .. .....+.... .... ...+.. .+..++..
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (239)
T PF01636_consen 80 RPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEAL 159 (239)
T ss_dssp EEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhh
Confidence 88777 111 11 0111111111 0000 011222 33333332
Q ss_pred ----CCCCcccCCCCCCCeecc-CCceeEeccccccc
Q 008365 345 ----KPEPLVHRDLKPANILLD-RNYVSKISDVGLAR 376 (568)
Q Consensus 345 ----~~~~IiHrDIKp~NILld-~~~~vKL~DFGla~ 376 (568)
.+..++|+|+.|.|||++ .++.+.|+||+.+.
T Consensus 160 ~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 160 LPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred hccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 234499999999999999 66777899999875
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.42 E-value=1.4e-06 Score=86.15 Aligned_cols=137 Identities=16% Similarity=0.227 Sum_probs=78.8
Q ss_pred eeecccCceeEEEEEeCCccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCce--eeeccccC--CCceEEEEecCCCC-H
Q 008365 235 MKIGEGGYGPVYRGKLDHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNM--VLLLGACP--DYGCLVYEYMHNGS-L 309 (568)
Q Consensus 235 ~~IG~G~fg~Vy~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnI--v~l~g~~~--~~~~lV~E~~~ggs-L 309 (568)
..||.|..+.||+. .+..+++|+..... ......+|.+++..+..-++ .+.++++. +...+|||+++|.. +
T Consensus 7 ~~i~~G~t~~~y~~--~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~ 82 (226)
T TIGR02172 7 TQTGEGGNGESYTH--KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSF 82 (226)
T ss_pred eeecCCCCcceeEe--cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccch
Confidence 57999999999984 25568899986543 23456889999988753322 34444432 23478999998863 2
Q ss_pred HHHH--------------hh----cCCC--CCCCHHHHH-HHHH----------HHHHH-HHHHHHc-CCCCcccCCCCC
Q 008365 310 EDRL--------------LR----RGNT--PVIPWRKRF-KIAA----------EIATA-LLFLHQA-KPEPLVHRDLKP 356 (568)
Q Consensus 310 ~~~l--------------~~----~~~~--~~l~~~~~~-~i~~----------qia~a-L~yLH~~-~~~~IiHrDIKp 356 (568)
...+ .. -... +........ .+.. .+... ..+|... ....++|+|+.|
T Consensus 83 ~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~~ 162 (226)
T TIGR02172 83 SRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQI 162 (226)
T ss_pred hhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCCC
Confidence 1111 00 0000 001111100 0000 01111 1222211 122468999999
Q ss_pred CCeeccCCceeEeccccccc
Q 008365 357 ANILLDRNYVSKISDVGLAR 376 (568)
Q Consensus 357 ~NILld~~~~vKL~DFGla~ 376 (568)
.||++++++ +.|+||+.+.
T Consensus 163 ~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 163 GNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CcEEEcCCC-cEEEechhcC
Confidence 999999888 9999999875
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.41 E-value=9.3e-07 Score=82.65 Aligned_cols=129 Identities=19% Similarity=0.223 Sum_probs=93.2
Q ss_pred ccceeecccCceeEEEEEeCCccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCcee-eeccccCCCceEEEEecCCCCHH
Q 008365 232 SEAMKIGEGGYGPVYRGKLDHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMV-LLLGACPDYGCLVYEYMHNGSLE 310 (568)
Q Consensus 232 ~~~~~IG~G~fg~Vy~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv-~l~g~~~~~~~lV~E~~~ggsL~ 310 (568)
.+.+.||+|++|.||+|.+.+..+|+|+-+.++. +..+..|+++|..+.--++- .+|.+ +..++.|||+.|-.|.
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~~~~~~a~Kvrr~ds~--r~~l~kEakiLeil~g~~~~p~vy~y--g~~~i~me~i~G~~L~ 100 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEWRGGEVALKVRRRDSP--RRNLEKEAKILEILAGEGVTPEVYFY--GEDFIRMEYIDGRPLG 100 (201)
T ss_pred hhhhhhhcccccEEEEeeccCceEEEEEecCCcc--hhhHHHHHHHHHHhhhcCCCceEEEe--chhhhhhhhhcCcchh
Confidence 3456799999999999999999999999876654 35788999999988765553 33332 3345669999998987
Q ss_pred HHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCC-CCCeeccCCceeEecccccccc
Q 008365 311 DRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLK-PANILLDRNYVSKISDVGLARL 377 (568)
Q Consensus 311 ~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIK-p~NILld~~~~vKL~DFGla~~ 377 (568)
+.-... . .+-...++..-.-|...| |-|+.|. |..++|-+++.+.|+||..|+.
T Consensus 101 ~~~~~~------~----rk~l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 101 KLEIGG------D----RKHLLRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hhhhcc------c----HHHHHHHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 754321 1 122335666666677788 9999995 5544454555999999999863
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.40 E-value=3.1e-06 Score=81.29 Aligned_cols=104 Identities=24% Similarity=0.271 Sum_probs=83.2
Q ss_pred HHHHHHHHcCCC-CceeeeccccCCCceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcc
Q 008365 272 QQEVEVLSSIRH-PNMVLLLGACPDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLV 350 (568)
Q Consensus 272 ~~Ev~iL~~l~H-pnIv~l~g~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~Ii 350 (568)
..|.-+|+.+.+ +++++++|+|.+ ++|.||+..+++.............+|..+.+|+.+++..+.+|++.....+.
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~--~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~~ 84 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR--FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFFY 84 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC--EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcEE
Confidence 468888888875 699999999965 78999998776643210001111268999999999999999999997666688
Q ss_pred cCCCCCCCeeccCCceeEecccccccc
Q 008365 351 HRDLKPANILLDRNYVSKISDVGLARL 377 (568)
Q Consensus 351 HrDIKp~NILld~~~~vKL~DFGla~~ 377 (568)
-.|++|+||-|+++|.+|++|...+..
T Consensus 85 lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 85 LCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred EeecchHHeEEeCCCcEEEEechhcch
Confidence 899999999999999999999987754
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.38 E-value=3.4e-06 Score=83.15 Aligned_cols=154 Identities=23% Similarity=0.227 Sum_probs=98.6
Q ss_pred cccccCHHHHHHHhccccccee---ecccCceeEEEEEe-CCccEEEEEeCcChhHhH-------------------HH-
Q 008365 215 RYRKYTIEEIEEATDKFSEAMK---IGEGGYGPVYRGKL-DHTPVAIKVLRPDAAQGK-------------------RQ- 270 (568)
Q Consensus 215 ~~~~~~~~ei~~~~~~y~~~~~---IG~G~fg~Vy~~~~-~~~~vAvK~l~~~~~~~~-------------------~~- 270 (568)
.++..+...+..+.....+... |+.|--+.||+|.. ++..||||+++....... .+
T Consensus 31 v~D~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~l 110 (268)
T COG1718 31 VFDKRTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKL 110 (268)
T ss_pred hhhhHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHH
Confidence 3455566666666666655554 55677778999876 578999999865422211 11
Q ss_pred ----HHHHHHHHHcCC--CCceeeeccccCCCceEEEEecCCCC-HHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHH
Q 008365 271 ----FQQEVEVLSSIR--HPNMVLLLGACPDYGCLVYEYMHNGS-LEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQ 343 (568)
Q Consensus 271 ----~~~Ev~iL~~l~--HpnIv~l~g~~~~~~~lV~E~~~ggs-L~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~ 343 (568)
..+|+..|+++. +-.+.+-+++. .+.|||||+.... -.-.|... .+.......+..++++.+.-|-.
T Consensus 111 v~~W~~kEf~NL~R~~eAGVrvP~Pi~~~--~nVLvMEfIg~~g~pAP~LkDv----~~e~~e~~~~~~~~v~~~~~l~~ 184 (268)
T COG1718 111 VFAWARKEFRNLKRAYEAGVRVPEPIAFR--NNVLVMEFIGDDGLPAPRLKDV----PLELEEAEGLYEDVVEYMRRLYK 184 (268)
T ss_pred HHHHHHHHHHHHHHHHHcCCCCCCceeec--CCeEEEEeccCCCCCCCCcccC----CcCchhHHHHHHHHHHHHHHHHH
Confidence 135777776663 22223333322 3479999994321 00111111 12222466677788888888777
Q ss_pred -cCCCCcccCCCCCCCeeccCCceeEeccccccccc
Q 008365 344 -AKPEPLVHRDLKPANILLDRNYVSKISDVGLARLV 378 (568)
Q Consensus 344 -~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~ 378 (568)
.+ +||+||..=|||+. ++.+.|+|||-|...
T Consensus 185 ~a~---LVHgDLSEyNiL~~-~~~p~iID~~QaV~~ 216 (268)
T COG1718 185 EAG---LVHGDLSEYNILVH-DGEPYIIDVSQAVTI 216 (268)
T ss_pred hcC---cccccchhhheEEE-CCeEEEEECcccccc
Confidence 67 99999999999999 889999999988654
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.37 E-value=1.4e-06 Score=95.46 Aligned_cols=137 Identities=23% Similarity=0.308 Sum_probs=89.3
Q ss_pred eeecccCceeEEEEEe-CCccEEEEEeCcChhHhH-------------------------------H------HHHHHHH
Q 008365 235 MKIGEGGYGPVYRGKL-DHTPVAIKVLRPDAAQGK-------------------------------R------QFQQEVE 276 (568)
Q Consensus 235 ~~IG~G~fg~Vy~~~~-~~~~vAvK~l~~~~~~~~-------------------------------~------~~~~Ev~ 276 (568)
+.||.-+.|.||+|+. +|..|||||-++...... + +|.+|.+
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 4799999999999987 678899999776432210 0 1334444
Q ss_pred HHHc----CCCCc------eeeeccccCCCceEEEEecCCCCHHHH--HhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHc
Q 008365 277 VLSS----IRHPN------MVLLLGACPDYGCLVYEYMHNGSLEDR--LLRRGNTPVIPWRKRFKIAAEIATALLFLHQA 344 (568)
Q Consensus 277 iL~~----l~Hpn------Iv~l~g~~~~~~~lV~E~~~ggsL~~~--l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~ 344 (568)
...+ +.|-+ |.++|-.+.....|+||||+|..+.|. |.+.+ ++... |+..+.++ |++..
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~g----i~~~~---i~~~l~~~--~~~qI 317 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKRG----ISPHD---ILNKLVEA--YLEQI 317 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHcC----CCHHH---HHHHHHHH--HHHHH
Confidence 3332 34555 444554445566999999999877664 33333 44443 33344443 22222
Q ss_pred CCCCcccCCCCCCCeecc----CCceeEecccccccccCC
Q 008365 345 KPEPLVHRDLKPANILLD----RNYVSKISDVGLARLVPP 380 (568)
Q Consensus 345 ~~~~IiHrDIKp~NILld----~~~~vKL~DFGla~~~~~ 380 (568)
-..+++|+|-.|.||++. .++.+.+.|||+...+.+
T Consensus 318 f~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 318 FKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred HhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 222399999999999998 367899999999976644
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.28 E-value=3.9e-06 Score=83.63 Aligned_cols=138 Identities=17% Similarity=0.161 Sum_probs=81.5
Q ss_pred eecccCc-eeEEEEEeCCccEEEEEeCcChhHhHHHHHHHHHHHHcCC-CCceeeeccccCC--CceEEEEecCCCCHHH
Q 008365 236 KIGEGGY-GPVYRGKLDHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIR-HPNMVLLLGACPD--YGCLVYEYMHNGSLED 311 (568)
Q Consensus 236 ~IG~G~f-g~Vy~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~-HpnIv~l~g~~~~--~~~lV~E~~~ggsL~~ 311 (568)
.|-.|.+ ..||+....+..++||+..... ...+.+|+.+++.+. +--+.++++++.. ..++||++++|.+|..
T Consensus 5 ~~~~g~~~~~v~~~~~~~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~ 81 (244)
T cd05150 5 RVTEGQSGATVYRLDGKNPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAA 81 (244)
T ss_pred ecCCCCCcCeEEEEcCCCCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhH
Confidence 3445555 7899998777789999876543 235677888888774 3334455655543 4689999999987764
Q ss_pred HHh----------------hcCCCC----CCCH--HHHHHHHH--------------------HHHHHHHHHHHc----C
Q 008365 312 RLL----------------RRGNTP----VIPW--RKRFKIAA--------------------EIATALLFLHQA----K 345 (568)
Q Consensus 312 ~l~----------------~~~~~~----~l~~--~~~~~i~~--------------------qia~aL~yLH~~----~ 345 (568)
... .-...+ .+.. ........ .+...+..|-.. .
T Consensus 82 ~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 161 (244)
T cd05150 82 LWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEE 161 (244)
T ss_pred hhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcC
Confidence 321 000000 0100 00000000 011112222111 1
Q ss_pred CCCcccCCCCCCCeeccCCceeEeccccccc
Q 008365 346 PEPLVHRDLKPANILLDRNYVSKISDVGLAR 376 (568)
Q Consensus 346 ~~~IiHrDIKp~NILld~~~~vKL~DFGla~ 376 (568)
+..++|+|+.|.|||+++++.+.|+||+.+.
T Consensus 162 ~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 162 DLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred ceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 1238999999999999998888999999875
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.17 E-value=8.6e-06 Score=80.89 Aligned_cols=71 Identities=14% Similarity=0.225 Sum_probs=45.1
Q ss_pred eeecccCce-eEEEEEeCCccEEEEEeCcChhHhHHHHHHHHHHHHcCCCC---ceeeeccccCC-----CceEEEEecC
Q 008365 235 MKIGEGGYG-PVYRGKLDHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHP---NMVLLLGACPD-----YGCLVYEYMH 305 (568)
Q Consensus 235 ~~IG~G~fg-~Vy~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~Hp---nIv~l~g~~~~-----~~~lV~E~~~ 305 (568)
..|+.||.. .||+. +..+++|+..... ....+.+|..+|..+... .+..+++.... ..++||++++
T Consensus 3 ~~~~~gG~~n~vy~~---~~~~VlR~~~~~~--~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i~ 77 (235)
T cd05155 3 EPVDSGGTDNATFRL---GDDMSVRLPSAAG--YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWLE 77 (235)
T ss_pred eeccCCCcccceEEc---CCceEEEcCCccc--hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEeec
Confidence 467877776 59975 3467888765432 234688899999877521 23333333322 2378999999
Q ss_pred CCCHH
Q 008365 306 NGSLE 310 (568)
Q Consensus 306 ggsL~ 310 (568)
|.++.
T Consensus 78 G~~l~ 82 (235)
T cd05155 78 GETAT 82 (235)
T ss_pred CCCCC
Confidence 87663
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.15 E-value=3.3e-07 Score=99.73 Aligned_cols=185 Identities=18% Similarity=0.145 Sum_probs=128.5
Q ss_pred hcccccceeecccCceeEEEEEeCCc-cEEEEEeCcChhHhHHHHHHHHHHHHcCCCCc-eeeecccc--CCCceEEEEe
Q 008365 228 TDKFSEAMKIGEGGYGPVYRGKLDHT-PVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPN-MVLLLGAC--PDYGCLVYEY 303 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~~~~~~~-~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~Hpn-Iv~l~g~~--~~~~~lV~E~ 303 (568)
+.-|...+-+++|+++.+|+.+...+ ....+++... ....-++++|.+++||| .+..++.+ +++..++|++
T Consensus 241 ~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i 315 (829)
T KOG0576|consen 241 TKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRI 315 (829)
T ss_pred ccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhh
Confidence 33455566789999999999876443 3334544322 23456889999999999 66666655 3455789999
Q ss_pred cCCC-CHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCC
Q 008365 304 MHNG-SLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSV 382 (568)
Q Consensus 304 ~~gg-sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~ 382 (568)
+.++ +........ ...+..-+...+...-+++|+|||+.. -+|+| ||+..+ +..|.+||+....+....
T Consensus 316 ~s~~rs~~~~~~~s--e~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~ 385 (829)
T KOG0576|consen 316 CSTGRSSALEMTVS--EIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRTM 385 (829)
T ss_pred hcCCccccccCChh--hHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCccc
Confidence 9777 221111000 001222233345666778899999875 58999 777755 678999999987664322
Q ss_pred CccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCC
Q 008365 383 ADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPM 434 (568)
Q Consensus 383 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf 434 (568)
......+|+.++|||+...+.+....|+|++|+--.++--|-+|-
T Consensus 386 -------~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 386 -------KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred -------ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 335678999999999999999999999999998777777776664
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.14 E-value=1.1e-05 Score=94.46 Aligned_cols=145 Identities=19% Similarity=0.315 Sum_probs=89.6
Q ss_pred ceeecccCceeEEEEEeCC----ccEEEEEeCcCh-hHhHHHHHHHHHHHHcCC-CCce--eeeccccCC-----CceEE
Q 008365 234 AMKIGEGGYGPVYRGKLDH----TPVAIKVLRPDA-AQGKRQFQQEVEVLSSIR-HPNM--VLLLGACPD-----YGCLV 300 (568)
Q Consensus 234 ~~~IG~G~fg~Vy~~~~~~----~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l~-HpnI--v~l~g~~~~-----~~~lV 300 (568)
+..|+.|.++.+|+....+ ..+++|+..... ......+.+|+.+|+.+. |+++ .+++.+|.+ ..|+|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 5678999999999887643 367888764432 122346889999999995 6664 677777755 34899
Q ss_pred EEecCCCCHHH--------------------HHh---hcCCC--------CCCCH--HHHHHHH---------------H
Q 008365 301 YEYMHNGSLED--------------------RLL---RRGNT--------PVIPW--RKRFKIA---------------A 332 (568)
Q Consensus 301 ~E~~~ggsL~~--------------------~l~---~~~~~--------~~l~~--~~~~~i~---------------~ 332 (568)
|||++|..+.+ .|. ..... ....+ .++..+. .
T Consensus 123 ME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~ 202 (822)
T PLN02876 123 MEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNP 202 (822)
T ss_pred EEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCCh
Confidence 99998764321 111 10000 00001 1111111 1
Q ss_pred HHHHHHHHHHHcCCC--------CcccCCCCCCCeeccC--CceeEeccccccccc
Q 008365 333 EIATALLFLHQAKPE--------PLVHRDLKPANILLDR--NYVSKISDVGLARLV 378 (568)
Q Consensus 333 qia~aL~yLH~~~~~--------~IiHrDIKp~NILld~--~~~vKL~DFGla~~~ 378 (568)
.+...+.+|..+-+. .+||+|+++.|||++. ...+-|.||+++..-
T Consensus 203 ~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~G 258 (822)
T PLN02876 203 KMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLG 258 (822)
T ss_pred hHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccC
Confidence 123345667554332 3999999999999975 234679999998653
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=98.02 E-value=1.1e-05 Score=81.02 Aligned_cols=139 Identities=12% Similarity=0.052 Sum_probs=79.9
Q ss_pred eecccCceeEEEEEeCCccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCce-eeeccccCCCceEEEEecCCCCHHH---
Q 008365 236 KIGEGGYGPVYRGKLDHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNM-VLLLGACPDYGCLVYEYMHNGSLED--- 311 (568)
Q Consensus 236 ~IG~G~fg~Vy~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnI-v~l~g~~~~~~~lV~E~~~ggsL~~--- 311 (568)
.+..|-.+.+|+...++..+++|+.........-...+|..+++.+..-++ .+++..+ ..++||||++|..+..
T Consensus 3 ~~~~G~tn~~y~~~~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~~~~v~e~i~G~~~~~~~~ 80 (256)
T TIGR02721 3 TLSGGLTNRSWRIEHPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN--EHWLLVEWLEGEVITLDQF 80 (256)
T ss_pred cCCCcCcCCeEEEEeCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe--CCEEEEEeccCcccccccc
Confidence 356688889999988888899998654322211134678888888853323 2333333 3579999999866531
Q ss_pred -----------HHhhcCCC----CCCCHHH-HHHHHHH---------HHHHHHHHHHcC-----CCCcccCCCCCCCeec
Q 008365 312 -----------RLLRRGNT----PVIPWRK-RFKIAAE---------IATALLFLHQAK-----PEPLVHRDLKPANILL 361 (568)
Q Consensus 312 -----------~l~~~~~~----~~l~~~~-~~~i~~q---------ia~aL~yLH~~~-----~~~IiHrDIKp~NILl 361 (568)
.+.+-... ..+.... ...+..+ +...+..+-... +..++|+|+.|.||++
T Consensus 81 ~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Nil~ 160 (256)
T TIGR02721 81 VALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNLVV 160 (256)
T ss_pred cCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcEEE
Confidence 11111110 1112111 1111111 111122222211 1238999999999999
Q ss_pred cCCceeEecccccccc
Q 008365 362 DRNYVSKISDVGLARL 377 (568)
Q Consensus 362 d~~~~vKL~DFGla~~ 377 (568)
++++ +.|+||+.|..
T Consensus 161 ~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 161 TPQG-LKLIDWEYASD 175 (256)
T ss_pred eCCC-CEEEeccccCc
Confidence 9877 78999998853
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.94 E-value=2.5e-05 Score=77.22 Aligned_cols=73 Identities=12% Similarity=0.175 Sum_probs=48.6
Q ss_pred ceeecccCceeEEEEEeC---CccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCc-eeeeccccCCCceEEEEecCCCCH
Q 008365 234 AMKIGEGGYGPVYRGKLD---HTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPN-MVLLLGACPDYGCLVYEYMHNGSL 309 (568)
Q Consensus 234 ~~~IG~G~fg~Vy~~~~~---~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~Hpn-Iv~l~g~~~~~~~lV~E~~~ggsL 309 (568)
++.|..|-...||+.... +..|++|+....... .-...+|+.+++.+...+ .+++++.+. ..+||||++|.++
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~~~l~e~i~G~~l 79 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ--NGLIYEFIPGRTL 79 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC--CcEEEEeeCCCcC
Confidence 356888888999998765 468999987643221 122347888888875322 344444443 3589999998765
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.91 E-value=4.3e-05 Score=78.38 Aligned_cols=140 Identities=16% Similarity=0.171 Sum_probs=84.9
Q ss_pred ceeecccCceeEEEEEeCCccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCc--eeeecccc--------CCCceEEEEe
Q 008365 234 AMKIGEGGYGPVYRGKLDHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPN--MVLLLGAC--------PDYGCLVYEY 303 (568)
Q Consensus 234 ~~~IG~G~fg~Vy~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~Hpn--Iv~l~g~~--------~~~~~lV~E~ 303 (568)
...|..|....+|+...++..+++|+.... ....+..|+.++..|.+-+ +.+++... .+..++||+|
T Consensus 19 i~~i~~G~~n~~y~v~~~~~~~vLr~~~~~---~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~ 95 (296)
T cd05153 19 FEGISAGIENTNYFVTTDSGRYVLTLFEKV---SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEF 95 (296)
T ss_pred eecccCccccceEEEEeCCCcEEEEEcCCC---ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEe
Confidence 456888888999998877778999998652 2345667888877774322 34443321 2234789999
Q ss_pred cCCCCHHH-----------H---HhhcCC--C------CCCCHHHHH----------HHHHHHHHHHHHHHHc----CCC
Q 008365 304 MHNGSLED-----------R---LLRRGN--T------PVIPWRKRF----------KIAAEIATALLFLHQA----KPE 347 (568)
Q Consensus 304 ~~ggsL~~-----------~---l~~~~~--~------~~l~~~~~~----------~i~~qia~aL~yLH~~----~~~ 347 (568)
++|..+.. . |+.... . ....|.... .....+..++.++... -+.
T Consensus 96 i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~ 175 (296)
T cd05153 96 LAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPR 175 (296)
T ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCC
Confidence 99876421 1 111100 0 011121110 0111233445555531 223
Q ss_pred CcccCCCCCCCeeccCCceeEeccccccc
Q 008365 348 PLVHRDLKPANILLDRNYVSKISDVGLAR 376 (568)
Q Consensus 348 ~IiHrDIKp~NILld~~~~vKL~DFGla~ 376 (568)
.++|+|+.|.|||+++++.+.|+||+.+.
T Consensus 176 ~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 176 GVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred cCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 49999999999999998888999999875
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.90 E-value=6.1e-05 Score=72.67 Aligned_cols=123 Identities=23% Similarity=0.337 Sum_probs=89.3
Q ss_pred cccccceeecccCc-eeEEEEEeCCccEEEEEeCc---Ch--------h----------HhHHHHHHHHHHHHcCC---C
Q 008365 229 DKFSEAMKIGEGGY-GPVYRGKLDHTPVAIKVLRP---DA--------A----------QGKRQFQQEVEVLSSIR---H 283 (568)
Q Consensus 229 ~~y~~~~~IG~G~f-g~Vy~~~~~~~~vAvK~l~~---~~--------~----------~~~~~~~~Ev~iL~~l~---H 283 (568)
.+++.++.||.|.- |.||+++.+|..+|||+++. .. . ....-|..|.+...+|+ +
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~ 116 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEIDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGR 116 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhccc
Confidence 67899999999999 99999999999999999422 00 0 11123678888877764 4
Q ss_pred Cce--eeecccc--C-C-------------C----ceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHH
Q 008365 284 PNM--VLLLGAC--P-D-------------Y----GCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFL 341 (568)
Q Consensus 284 pnI--v~l~g~~--~-~-------------~----~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yL 341 (568)
.++ |+++|+. . + . ..||.||++... .+... -+.+|.+-|..+
T Consensus 117 e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~~~----~~~~~~~dl~~~ 180 (207)
T PF13095_consen 117 EGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQIR----DIPQMLRDLKIL 180 (207)
T ss_pred cCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccchh----HHHHHHHHHHHH
Confidence 455 8888876 1 0 0 147888876544 02222 345677888999
Q ss_pred HHcCCCCcccCCCCCCCeeccCCceeEecccccc
Q 008365 342 HQAKPEPLVHRDLKPANILLDRNYVSKISDVGLA 375 (568)
Q Consensus 342 H~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla 375 (568)
|..| |+-+|+++.|.. .-||+|||.+
T Consensus 181 ~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 181 HKLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHCC---eeeccCcccccc-----CCEEEecccC
Confidence 9999 999999999987 3489999964
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.88 E-value=0.00015 Score=70.26 Aligned_cols=130 Identities=25% Similarity=0.357 Sum_probs=87.8
Q ss_pred ceeecccCceeEEEEEeCCccEEEEEeCcCh----------------hHhHHHHHHHHHHHHcCC------CCceeeecc
Q 008365 234 AMKIGEGGYGPVYRGKLDHTPVAIKVLRPDA----------------AQGKRQFQQEVEVLSSIR------HPNMVLLLG 291 (568)
Q Consensus 234 ~~~IG~G~fg~Vy~~~~~~~~vAvK~l~~~~----------------~~~~~~~~~Ev~iL~~l~------HpnIv~l~g 291 (568)
...||.|+.=.||.--. .....||+..+.. .....+..+|+.-...+. +.+|.+++|
T Consensus 6 ~~~i~~G~~R~cy~HP~-dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G 84 (199)
T PF10707_consen 6 SDLIAQGGERDCYQHPD-DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYG 84 (199)
T ss_pred CcccccCCCceEEECCC-CCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeE
Confidence 34799999999996543 3457789987665 112345566776666555 778899999
Q ss_pred ccCCCc--eEEEEecCC------CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccC
Q 008365 292 ACPDYG--CLVYEYMHN------GSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDR 363 (568)
Q Consensus 292 ~~~~~~--~lV~E~~~g------gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~ 363 (568)
+.+... .+|+|.+.+ .+|.+++.... ++. . +...+-.-..||-..+ |+.+||+|.||++..
T Consensus 85 ~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~----~~~-~---~~~~L~~f~~~l~~~~---Iv~~dl~~~NIv~~~ 153 (199)
T PF10707_consen 85 FVETNLGLGLVVELIRDADGNISPTLEDYLKEGG----LTE-E---LRQALDEFKRYLLDHH---IVIRDLNPHNIVVQR 153 (199)
T ss_pred EEecCCceEEEEEEEECCCCCcCccHHHHHHcCC----ccH-H---HHHHHHHHHHHHHHcC---CeecCCCcccEEEEe
Confidence 886543 678887643 35777775433 443 2 3333444456778888 999999999999943
Q ss_pred C---c-eeEecc-cccc
Q 008365 364 N---Y-VSKISD-VGLA 375 (568)
Q Consensus 364 ~---~-~vKL~D-FGla 375 (568)
. . .+.|+| ||-.
T Consensus 154 ~~~~~~~lvlIDG~G~~ 170 (199)
T PF10707_consen 154 RDSGEFRLVLIDGLGEK 170 (199)
T ss_pred cCCCceEEEEEeCCCCc
Confidence 2 2 678888 5544
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.87 E-value=9.2e-05 Score=76.39 Aligned_cols=74 Identities=19% Similarity=0.090 Sum_probs=53.7
Q ss_pred ceeecccCceeEEEEEeCCccEEEEEeCcChhHhHHHHHHHHHHHHcCCC---CceeeeccccC-----CCceEEEEecC
Q 008365 234 AMKIGEGGYGPVYRGKLDHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRH---PNMVLLLGACP-----DYGCLVYEYMH 305 (568)
Q Consensus 234 ~~~IG~G~fg~Vy~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~H---pnIv~l~g~~~-----~~~~lV~E~~~ 305 (568)
...||.|..+.||.....+..+++|+.+... ....+..|...|+.|.- ..+.+++++|. +..+||||+++
T Consensus 19 ~~~i~~G~~~~vy~~~~~~~~~~~k~~~~~~--~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~ 96 (297)
T PRK10593 19 VECISEQPYAALWALYDSQGNPMPLMARSFS--TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLR 96 (297)
T ss_pred eeecCCccceeEEEEEcCCCCEEEEEecccc--cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccC
Confidence 3579999999999987755567888854311 23478899999988752 35667776653 33599999999
Q ss_pred CCCH
Q 008365 306 NGSL 309 (568)
Q Consensus 306 ggsL 309 (568)
|+++
T Consensus 97 G~~~ 100 (297)
T PRK10593 97 GVSV 100 (297)
T ss_pred CEec
Confidence 8764
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.86 E-value=0.00012 Score=78.22 Aligned_cols=75 Identities=19% Similarity=0.154 Sum_probs=54.7
Q ss_pred ceeecccCceeEEEEEeCC--ccEEEEEeCcCh-------hHhHHHHHHHHHHHHcCC---CCceeeeccccCCCceEEE
Q 008365 234 AMKIGEGGYGPVYRGKLDH--TPVAIKVLRPDA-------AQGKRQFQQEVEVLSSIR---HPNMVLLLGACPDYGCLVY 301 (568)
Q Consensus 234 ~~~IG~G~fg~Vy~~~~~~--~~vAvK~l~~~~-------~~~~~~~~~Ev~iL~~l~---HpnIv~l~g~~~~~~~lV~ 301 (568)
.+.||.|.+..||++...+ +.|+||.-.+.. ......+..|.+.|..+. ..++.+++.+..+..++||
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~~~~~lVM 110 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDEELAVTVM 110 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECCCCCEEEE
Confidence 3579999999999998854 389999843211 123456677888888763 3467778887777789999
Q ss_pred EecCCCC
Q 008365 302 EYMHNGS 308 (568)
Q Consensus 302 E~~~ggs 308 (568)
||+++..
T Consensus 111 E~L~~~~ 117 (401)
T PRK09550 111 EDLSDHK 117 (401)
T ss_pred ecCCCcc
Confidence 9998644
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.84 E-value=0.00049 Score=71.42 Aligned_cols=155 Identities=16% Similarity=0.211 Sum_probs=82.4
Q ss_pred cCHHHHHHHhccccc-----ceeecccCceeEEEEEeCCccEEEEEeCcChhHhHHHHHHHHHHHHcC-----CCCceee
Q 008365 219 YTIEEIEEATDKFSE-----AMKIGEGGYGPVYRGKLDHTPVAIKVLRPDAAQGKRQFQQEVEVLSSI-----RHPNMVL 288 (568)
Q Consensus 219 ~~~~ei~~~~~~y~~-----~~~IG~G~fg~Vy~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l-----~HpnIv~ 288 (568)
.+..++......|.+ .+.|+.|....+|+...++..+++|++.... ...+..|+.++..| ..|.++.
T Consensus 7 ls~~~l~~~l~~y~~~~~~~~~~l~~G~~n~~y~v~t~~g~~vLK~~~~~~---~~~l~~~~~~l~~L~~~glpvP~~i~ 83 (319)
T PRK05231 7 VSDDELAAFLAPYDLGELLSLKGIAEGIENSNFFLTTTQGEYVLTLFERLT---AEDLPFFLGLMQHLAARGVPVPAPVA 83 (319)
T ss_pred CCHHHHHHHHHhcCCchhhccchhccccccceEEEEeCCCcEEEEEeccCC---hHHhHHHHHHHHHHHHCCCCCCccee
Confidence 334444444444543 3457778888999988766689999986212 22333455555444 2333332
Q ss_pred ec-----cccCCCceEEEEecCCCCHH-----------HHHh---hcCCC--------CCCCH-HHHHH-----------
Q 008365 289 LL-----GACPDYGCLVYEYMHNGSLE-----------DRLL---RRGNT--------PVIPW-RKRFK----------- 329 (568)
Q Consensus 289 l~-----g~~~~~~~lV~E~~~ggsL~-----------~~l~---~~~~~--------~~l~~-~~~~~----------- 329 (568)
-. ....+..+++|+|++|..+. ..|. ..... ..+.| .....
T Consensus 84 ~~~G~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (319)
T PRK05231 84 RRDGAALGELAGKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQA 163 (319)
T ss_pred CCCCCEeeeeCCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHH
Confidence 11 11123347899999887431 1111 11100 00111 11111
Q ss_pred -HHHH-HHHHHHHHHHc----CCCCcccCCCCCCCeeccCCceeEeccccccc
Q 008365 330 -IAAE-IATALLFLHQA----KPEPLVHRDLKPANILLDRNYVSKISDVGLAR 376 (568)
Q Consensus 330 -i~~q-ia~aL~yLH~~----~~~~IiHrDIKp~NILld~~~~vKL~DFGla~ 376 (568)
.+.+ +...+..+... -+.++||+|+.|.|||++.+..+-|+||+.+.
T Consensus 164 ~~l~~~~~~~~~~~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 164 ALLEAELAAQLAFLASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred HHHHHHHHHHHHhhhccccccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 1111 11122233211 23459999999999999977667899999875
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.72 E-value=1.5e-05 Score=94.01 Aligned_cols=174 Identities=14% Similarity=0.085 Sum_probs=121.9
Q ss_pred EEEEEeCcChhHh-----HHHHHHHHHHHHcCCCCceeeeccccCC----CceEEEEecCCCCHHHHHhhcCCC-CCCCH
Q 008365 255 VAIKVLRPDAAQG-----KRQFQQEVEVLSSIRHPNMVLLLGACPD----YGCLVYEYMHNGSLEDRLLRRGNT-PVIPW 324 (568)
Q Consensus 255 vAvK~l~~~~~~~-----~~~~~~Ev~iL~~l~HpnIv~l~g~~~~----~~~lV~E~~~ggsL~~~l~~~~~~-~~l~~ 324 (568)
+-+|+.+....+. ++....|++-++...|++++..+.-.++ ..+.+++|+.+|.+.+.|.+.... +.+..
T Consensus 1255 Fk~~I~ke~d~e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~ 1334 (2724)
T KOG1826|consen 1255 FKFSIYKEYDFENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDR 1334 (2724)
T ss_pred eEEEeehhhhHHHHhhHHHHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchh
Confidence 4556655433222 2234456666777889999887765533 338899999999999998765432 22322
Q ss_pred HHHHHHHHHHHHHHHHHHHcC--CCCcccCCCCCCCeeccCCceeEecccccccccCCCCCccccccccccccccccCCC
Q 008365 325 RKRFKIAAEIATALLFLHQAK--PEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYID 402 (568)
Q Consensus 325 ~~~~~i~~qia~aL~yLH~~~--~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~A 402 (568)
.-......+.+....-+|... ..-.+|+++|+-|.+|..+..+|++++|+.+...+.. ...+..++++.|+.
T Consensus 1335 ~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~------sf~Gl~l~sp~~v~ 1408 (2724)
T KOG1826|consen 1335 SPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVL------SFFGLELCSPIYVL 1408 (2724)
T ss_pred chHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCcccccccccccccCchH------hhhhhhhCCHHHHH
Confidence 222222223244555545433 2347899999999999999999999999998433221 12345678899999
Q ss_pred hhhhhcCCCCCcceehhHHHHHHHHHhCCCCC
Q 008365 403 PEYQQTGMLTTKSDIYSFGIMLLQIITARSPM 434 (568)
Q Consensus 403 PE~~~~~~~s~ksDvwSlGvil~elltG~~Pf 434 (568)
|++...-.++.++|+|..|+.+|+.-.|..+|
T Consensus 1409 qli~N~ik~t~rsdilr~s~~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1409 QLIKNEIKFTKRSDILRRSLSLYLRSDGNAYF 1440 (2724)
T ss_pred HHHHHHHhhhhHHHHHHHHHHHHHHhcccHHH
Confidence 99999889999999999999999998898887
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.69 E-value=0.00088 Score=69.27 Aligned_cols=141 Identities=17% Similarity=0.231 Sum_probs=80.7
Q ss_pred ceeecccCceeEEEEEeCCccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCc--eeeecccc--------CCCceEEEEe
Q 008365 234 AMKIGEGGYGPVYRGKLDHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPN--MVLLLGAC--------PDYGCLVYEY 303 (568)
Q Consensus 234 ~~~IG~G~fg~Vy~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~Hpn--Iv~l~g~~--------~~~~~lV~E~ 303 (568)
+..|+.|....||+...++..+++|+...... ...+..|++++..|...+ +.+++... .+..++||+|
T Consensus 27 i~~~~~G~~n~~y~v~t~~~~~vLK~~~~~~~--~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e~ 104 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTDVGRYILTLYEKRVK--AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVEF 104 (307)
T ss_pred ccccCCccccceEEEEeCCCcEEEEEecCCCC--HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEEe
Confidence 45677777789999877666788998755321 233455667776663222 33333321 2234789999
Q ss_pred cCCCCHH-----------HH---HhhcCCC---C------CCCHHHHHH------------HHHHHHHHHHHHHH----c
Q 008365 304 MHNGSLE-----------DR---LLRRGNT---P------VIPWRKRFK------------IAAEIATALLFLHQ----A 344 (568)
Q Consensus 304 ~~ggsL~-----------~~---l~~~~~~---~------~l~~~~~~~------------i~~qia~aL~yLH~----~ 344 (568)
++|..+. .. ++..... + .-.|..... ....+...+.++.. .
T Consensus 105 i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~~ 184 (307)
T TIGR00938 105 LQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPRD 184 (307)
T ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhhc
Confidence 9885431 11 1111110 0 011111100 01123334555543 2
Q ss_pred CCCCcccCCCCCCCeeccCCceeEeccccccc
Q 008365 345 KPEPLVHRDLKPANILLDRNYVSKISDVGLAR 376 (568)
Q Consensus 345 ~~~~IiHrDIKp~NILld~~~~vKL~DFGla~ 376 (568)
.+..+||+|+.+.||+++.++.+.|+||+.+.
T Consensus 185 ~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 185 LPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred CCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 23459999999999999998878999999874
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.53 E-value=0.00018 Score=74.12 Aligned_cols=73 Identities=22% Similarity=0.295 Sum_probs=48.0
Q ss_pred eeecccCceeEEEEEeC--------CccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCce-eeeccccCCCceEEEEecC
Q 008365 235 MKIGEGGYGPVYRGKLD--------HTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNM-VLLLGACPDYGCLVYEYMH 305 (568)
Q Consensus 235 ~~IG~G~fg~Vy~~~~~--------~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnI-v~l~g~~~~~~~lV~E~~~ 305 (568)
+.|..|-...||+.... +..+++|+...... ......+|+.++..+...++ .++++++. ..+||+|++
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~r~~E~~~~~~l~~~g~~P~~~~~~~--~~~v~e~i~ 80 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE-LLIDRERELVVFARLSERNLGPKLYGIFP--NGRIEEFIP 80 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc-ceechHHHHHHHHHHHhCCCCCceEEEeC--CCchhheeC
Confidence 45677777899988764 36899999765432 22345678888887753222 34455554 356899998
Q ss_pred CCCHH
Q 008365 306 NGSLE 310 (568)
Q Consensus 306 ggsL~ 310 (568)
|..+.
T Consensus 81 G~~l~ 85 (302)
T cd05156 81 SRTLT 85 (302)
T ss_pred CCcCC
Confidence 87653
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=97.51 E-value=0.0007 Score=72.27 Aligned_cols=80 Identities=16% Similarity=0.101 Sum_probs=56.7
Q ss_pred ceeecccCceeEEEEEeCCccEEEEEeCcChh-------HhHHHHHHHHHHHHcCC---CCceeeeccccCCCceEEEEe
Q 008365 234 AMKIGEGGYGPVYRGKLDHTPVAIKVLRPDAA-------QGKRQFQQEVEVLSSIR---HPNMVLLLGACPDYGCLVYEY 303 (568)
Q Consensus 234 ~~~IG~G~fg~Vy~~~~~~~~vAvK~l~~~~~-------~~~~~~~~Ev~iL~~l~---HpnIv~l~g~~~~~~~lV~E~ 303 (568)
.+.||.|....||+....+..|+||.-.+... .....-..|...|+.+. ..++.++|.++.+..++||||
T Consensus 37 ~~eiggGn~N~VyrV~~~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded~~vlvME~ 116 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSSSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRTMALIGMRY 116 (418)
T ss_pred EEEcCCCceeeEEEEEcCCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCCCCEEEEee
Confidence 46799999999999988777899998542111 12333345677776654 347888999999999999999
Q ss_pred cCC--CCHHHHH
Q 008365 304 MHN--GSLEDRL 313 (568)
Q Consensus 304 ~~g--gsL~~~l 313 (568)
+++ ..+.+.+
T Consensus 117 L~~~~~ilr~~L 128 (418)
T PLN02756 117 LEPPHIILRKGL 128 (418)
T ss_pred cCCcceehhhhh
Confidence 976 2444433
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.50 E-value=7.1e-05 Score=76.35 Aligned_cols=134 Identities=15% Similarity=0.162 Sum_probs=93.0
Q ss_pred ccccceeecccCceeEEEEEe-CCccEEEEEeCcChh-----H-----------------hHHHHHHHHHHHHcCC-CCc
Q 008365 230 KFSEAMKIGEGGYGPVYRGKL-DHTPVAIKVLRPDAA-----Q-----------------GKRQFQQEVEVLSSIR-HPN 285 (568)
Q Consensus 230 ~y~~~~~IG~G~fg~Vy~~~~-~~~~vAvK~l~~~~~-----~-----------------~~~~~~~Ev~iL~~l~-Hpn 285 (568)
-+.+++.||-|--+.||.+-+ .|++.++|+.+.... . .+-...+|...|+.|. |..
T Consensus 93 v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 467889999999999999988 589999997542110 0 0112346777777774 322
Q ss_pred -eeeeccccCCCceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCC
Q 008365 286 -MVLLLGACPDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRN 364 (568)
Q Consensus 286 -Iv~l~g~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~ 364 (568)
+.+.+++ +..|+|||++.|-.|...-.- .. ...+...+..-+--|-..| +||+|..--||+|+++
T Consensus 173 pVPkpiD~--~RH~Vvmelv~g~Pl~~v~~v------~d---~~~ly~~lm~~Iv~la~~G---lIHgDFNEFNimv~dd 238 (465)
T KOG2268|consen 173 PVPKPIDH--NRHCVVMELVDGYPLRQVRHV------ED---PPTLYDDLMGLIVRLANHG---LIHGDFNEFNIMVKDD 238 (465)
T ss_pred CCCCcccc--cceeeHHHhhcccceeeeeec------CC---hHHHHHHHHHHHHHHHHcC---ceecccchheeEEecC
Confidence 2233332 234899999998887653211 11 1234445566667788888 9999999999999999
Q ss_pred ceeEecccccccc
Q 008365 365 YVSKISDVGLARL 377 (568)
Q Consensus 365 ~~vKL~DFGla~~ 377 (568)
+.++++||--+..
T Consensus 239 ~~i~vIDFPQmvS 251 (465)
T KOG2268|consen 239 DKIVVIDFPQMVS 251 (465)
T ss_pred CCEEEeechHhhc
Confidence 9999999986643
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.45 E-value=0.00084 Score=69.51 Aligned_cols=139 Identities=21% Similarity=0.290 Sum_probs=82.6
Q ss_pred cceeecccCceeEEEEEeCCccEEEEEeCc--ChhHhHHHHHHHHHHHHcCCC--CceeeeccccCCCc----eEEEEec
Q 008365 233 EAMKIGEGGYGPVYRGKLDHTPVAIKVLRP--DAAQGKRQFQQEVEVLSSIRH--PNMVLLLGACPDYG----CLVYEYM 304 (568)
Q Consensus 233 ~~~~IG~G~fg~Vy~~~~~~~~vAvK~l~~--~~~~~~~~~~~Ev~iL~~l~H--pnIv~l~g~~~~~~----~lV~E~~ 304 (568)
+...+-.|-...+|.....++.+++. ... ..........+|..+|+.+.- .-+...++.|.+.. +.||+|+
T Consensus 29 ~v~~~~~G~sn~t~~~~~~~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~v 107 (321)
T COG3173 29 IVEEISGGWSNDTFRLGDTGQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWV 107 (321)
T ss_pred eeeeccCCcccceEEEecCCceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEe
Confidence 33444344444566655567888888 321 222333456678888887653 22345567776655 8999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHH-HHHHHHH---------------------------------------------
Q 008365 305 HNGSLEDRLLRRGNTPVIPWRKRFKIA-AEIATAL--------------------------------------------- 338 (568)
Q Consensus 305 ~ggsL~~~l~~~~~~~~l~~~~~~~i~-~qia~aL--------------------------------------------- 338 (568)
+|..+.+.+... +.. .+++ ..++..|
T Consensus 108 eGe~~~~~~~~~------~~~--~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~ 179 (321)
T COG3173 108 EGEVVWSALPPE------SLG--RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPL 179 (321)
T ss_pred cceeccCcCCcc------cch--HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCch
Confidence 884332211110 000 0111 1333333
Q ss_pred -----HHHHHcCC-----CCcccCCCCCCCeeccCCceeEecccccccccCC
Q 008365 339 -----LFLHQAKP-----EPLVHRDLKPANILLDRNYVSKISDVGLARLVPP 380 (568)
Q Consensus 339 -----~yLH~~~~-----~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~ 380 (568)
.+|+.+-+ ..++|+|+.+.||+|++++.+=|.||+++.+-.+
T Consensus 180 ~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP 231 (321)
T COG3173 180 ADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGDP 231 (321)
T ss_pred HHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCCc
Confidence 34444332 3589999999999999988899999999975433
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.36 E-value=0.00054 Score=79.87 Aligned_cols=197 Identities=18% Similarity=0.180 Sum_probs=137.1
Q ss_pred HHHHHHHHHcCCCCceeeeccccCCCc------eEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHc
Q 008365 271 FQQEVEVLSSIRHPNMVLLLGACPDYG------CLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQA 344 (568)
Q Consensus 271 ~~~Ev~iL~~l~HpnIv~l~g~~~~~~------~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~ 344 (568)
..-|...+..+.|+|++.++.+.-... .+..++|..-++...+...+. ++..+.+.+..++..||.|+|..
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~---i~~~~~r~~~~~~~~GL~~~h~~ 305 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGS---IPLETLRILHQKLLEGLAYLHSL 305 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccc---cCHHHHHHHHHHHhhhHHHHHHh
Confidence 445777788899999999987753322 234578888888887776553 77788888999999999999999
Q ss_pred CCCCcccCCCCCC---CeeccCCceeEec--ccccccccCCCCCccccccccccccccccCCChhhhhcCCCCCc--cee
Q 008365 345 KPEPLVHRDLKPA---NILLDRNYVSKIS--DVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTK--SDI 417 (568)
Q Consensus 345 ~~~~IiHrDIKp~---NILld~~~~vKL~--DFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~k--sDv 417 (568)
. ..|.-+..+ +..++..+.+.++ ||+.++.++..... ....-+..|.+||......+..+ .|+
T Consensus 306 ~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~-------~~~~~~~~~~~~e~~~~~~~~~~r~~dL 375 (1351)
T KOG1035|consen 306 S---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS-------FSDLLAEIRNADEDLKENTAKKSRLTDL 375 (1351)
T ss_pred c---cceeEEecccccccccCccceeecchhhhcccccCCCcccc-------hhhcCccccccccccccccchhhhhhHH
Confidence 7 777766655 5666777888877 99988766443211 22334556778887666655544 799
Q ss_pred hhHHHHHHHHHhCCCCCCCchHHHHHHHhCccccccCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHHHH
Q 008365 418 YSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPELNR 496 (568)
Q Consensus 418 wSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l~~ 496 (568)
|++|..+..+..|..+-.....+. ..+ +.........+...|+.-+++.|+...+++.+.+.+
T Consensus 376 ~~lgll~~~~~~~~~i~~~~~~~~---------~~l-------~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~ 438 (1351)
T KOG1035|consen 376 WCLGLLLLQLSQGEDISEKSAVPV---------SLL-------DVLSTSELLDALPKCLDEDSEERLSALELLTHPFLR 438 (1351)
T ss_pred HHHHHHHhhhhhcCcccccccchh---------hhh-------ccccchhhhhhhhhhcchhhhhccchhhhhhchhcc
Confidence 999999999998876532111100 011 111111466778899999999999999988655543
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.16 E-value=0.0012 Score=69.69 Aligned_cols=141 Identities=18% Similarity=0.238 Sum_probs=80.8
Q ss_pred ceeecccCceeEEEEEeC------CccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCce-eeeccccCCCceEEEEecCC
Q 008365 234 AMKIGEGGYGPVYRGKLD------HTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNM-VLLLGACPDYGCLVYEYMHN 306 (568)
Q Consensus 234 ~~~IG~G~fg~Vy~~~~~------~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnI-v~l~g~~~~~~~lV~E~~~g 306 (568)
+..|-.|-...+|+.... +..|++|+......... .-.+|..+++.+..-++ .++++.+.+. .|++|+++
T Consensus 41 i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~i-dR~~E~~~~~~l~~~gl~P~~~~~~~~g--~v~efi~g 117 (344)
T PLN02236 41 VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFF-DRDDEIRTFECMSRHGQGPRLLGRFPNG--RVEEFIHA 117 (344)
T ss_pred EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeee-chHHHHHHHHHHHHcCCCCceEEEECCc--eEEEeeCC
Confidence 345656888899998642 25799998765432221 22578888887753333 3455666443 78999987
Q ss_pred CCHHHH--------------H---hhcC---CCCCCCHHHHHHHHHHH-----------------HHHHHHH----HH-c
Q 008365 307 GSLEDR--------------L---LRRG---NTPVIPWRKRFKIAAEI-----------------ATALLFL----HQ-A 344 (568)
Q Consensus 307 gsL~~~--------------l---~~~~---~~~~l~~~~~~~i~~qi-----------------a~aL~yL----H~-~ 344 (568)
.+|... + +... ......+.++..+..++ ...+..| .. .
T Consensus 118 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~ 197 (344)
T PLN02236 118 RTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDD 197 (344)
T ss_pred CCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccC
Confidence 665321 1 1111 00011233333332111 1112222 11 1
Q ss_pred CCCCcccCCCCCCCeeccC-CceeEecccccccc
Q 008365 345 KPEPLVHRDLKPANILLDR-NYVSKISDVGLARL 377 (568)
Q Consensus 345 ~~~~IiHrDIKp~NILld~-~~~vKL~DFGla~~ 377 (568)
.+..++|+|+++.|||+++ ++.+.|+||..|..
T Consensus 198 ~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 198 QEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred CCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 1224899999999999976 57899999998863
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.13 E-value=0.0021 Score=67.54 Aligned_cols=78 Identities=14% Similarity=0.109 Sum_probs=51.5
Q ss_pred eecccCceeEEEEEeCC--ccEEEEEeCcC-------hhHhHHHHHHHHHHHHcCC--CC-ceeeeccccCCCceEEEEe
Q 008365 236 KIGEGGYGPVYRGKLDH--TPVAIKVLRPD-------AAQGKRQFQQEVEVLSSIR--HP-NMVLLLGACPDYGCLVYEY 303 (568)
Q Consensus 236 ~IG~G~fg~Vy~~~~~~--~~vAvK~l~~~-------~~~~~~~~~~Ev~iL~~l~--Hp-nIv~l~g~~~~~~~lV~E~ 303 (568)
.||.|....||++...+ +.|+||.-.+. -.....+..-|...|+... -| .+.++|.+-.+...+|||+
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~D~e~~~~vMEd 81 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHFDTEMAVTVMED 81 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEEccccceehHhh
Confidence 58999999999998754 47999974321 1222344556777777653 34 4556776666677899999
Q ss_pred cCCC-CHHHHH
Q 008365 304 MHNG-SLEDRL 313 (568)
Q Consensus 304 ~~gg-sL~~~l 313 (568)
++.. .|.+.|
T Consensus 82 L~~~~ilR~~L 92 (370)
T TIGR01767 82 LSHHKIARKGL 92 (370)
T ss_pred CccchHHHHHH
Confidence 9543 343444
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.03 E-value=0.003 Score=64.49 Aligned_cols=29 Identities=41% Similarity=0.653 Sum_probs=24.8
Q ss_pred cccCCCCCCCeeccCCc-eeEecccccccc
Q 008365 349 LVHRDLKPANILLDRNY-VSKISDVGLARL 377 (568)
Q Consensus 349 IiHrDIKp~NILld~~~-~vKL~DFGla~~ 377 (568)
++|+|+.|.|||+++++ .+-|+||+.+..
T Consensus 187 lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 187 LVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 89999999999998744 457999998853
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.83 E-value=0.0029 Score=67.26 Aligned_cols=81 Identities=20% Similarity=0.231 Sum_probs=53.9
Q ss_pred ceeecccCceeEEEEEeC--CccEEEEEeCc------ChhHhHHHHHHHHHHHHcCC--CC-ceeeeccccCCCceEEEE
Q 008365 234 AMKIGEGGYGPVYRGKLD--HTPVAIKVLRP------DAAQGKRQFQQEVEVLSSIR--HP-NMVLLLGACPDYGCLVYE 302 (568)
Q Consensus 234 ~~~IG~G~fg~Vy~~~~~--~~~vAvK~l~~------~~~~~~~~~~~Ev~iL~~l~--Hp-nIv~l~g~~~~~~~lV~E 302 (568)
...||-|.-..||++.+. ++.|+||.-.+ +-.-...+..-|.++|+.+. -| .+.++|.+-.+...+|||
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~D~e~~~~vME 113 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLFDSVMNCCVME 113 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEECcHHhhHHHH
Confidence 468999999999999874 56899996422 11223455667788887664 34 455676665666788999
Q ss_pred ecCCC-CHHHHHh
Q 008365 303 YMHNG-SLEDRLL 314 (568)
Q Consensus 303 ~~~gg-sL~~~l~ 314 (568)
+++.. .|.+.|.
T Consensus 114 dL~~~~ilR~~Li 126 (409)
T PRK12396 114 DLSDHTILRTALI 126 (409)
T ss_pred hCcccHHHHHHHH
Confidence 98543 3444443
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.74 E-value=0.0076 Score=62.89 Aligned_cols=135 Identities=20% Similarity=0.164 Sum_probs=88.2
Q ss_pred ceeecccCceeEEEEEe-CCccEEEEEeCcCh-------------------------hHhHHH-HHHHHHHHHcCCCCce
Q 008365 234 AMKIGEGGYGPVYRGKL-DHTPVAIKVLRPDA-------------------------AQGKRQ-FQQEVEVLSSIRHPNM 286 (568)
Q Consensus 234 ~~~IG~G~fg~Vy~~~~-~~~~vAvK~l~~~~-------------------------~~~~~~-~~~Ev~iL~~l~HpnI 286 (568)
...|..|--+.||.+.. +|..+|||+++-.. ..-.+. ...|+..|++|+.-.|
T Consensus 149 nGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGI 228 (520)
T KOG2270|consen 149 NGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGI 228 (520)
T ss_pred ccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCC
Confidence 34688899999999876 78889999875321 000011 2468888888765443
Q ss_pred eeeccccCCCceEEEEecCCCCHH--HHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCC
Q 008365 287 VLLLGACPDYGCLVYEYMHNGSLE--DRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRN 364 (568)
Q Consensus 287 v~l~g~~~~~~~lV~E~~~ggsL~--~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~ 364 (568)
..---+......|||+|+. ++=+ -.|.. -.++...+..+-.+++.-+.-|-+.+. +||.||.=-|+|+. +
T Consensus 229 P~PePIlLk~hVLVM~FlG-rdgw~aPkLKd----~~ls~~ka~~~Y~~~v~~MR~lY~~c~--LVHADLSEfN~Lyh-d 300 (520)
T KOG2270|consen 229 PCPEPILLKNHVLVMEFLG-RDGWAAPKLKD----ASLSTSKARELYQQCVRIMRRLYQKCR--LVHADLSEFNLLYH-D 300 (520)
T ss_pred CCCCceeeecceEeeeecc-CCCCcCccccc----ccCChHHHHHHHHHHHHHHHHHHHHhc--eeccchhhhhheEE-C
Confidence 3211122234479999993 3311 11211 125555666777788888877766542 99999999999985 5
Q ss_pred ceeEeccccccc
Q 008365 365 YVSKISDVGLAR 376 (568)
Q Consensus 365 ~~vKL~DFGla~ 376 (568)
|.++|+|.+-+.
T Consensus 301 G~lyiIDVSQSV 312 (520)
T KOG2270|consen 301 GKLYIIDVSQSV 312 (520)
T ss_pred CEEEEEEccccc
Confidence 789999998764
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.64 E-value=0.022 Score=59.61 Aligned_cols=138 Identities=23% Similarity=0.315 Sum_probs=82.1
Q ss_pred eecccCceeEEEEEeCCccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCc---eeee-------ccccCC--CceEEEEe
Q 008365 236 KIGEGGYGPVYRGKLDHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPN---MVLL-------LGACPD--YGCLVYEY 303 (568)
Q Consensus 236 ~IG~G~fg~Vy~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~Hpn---Iv~l-------~g~~~~--~~~lV~E~ 303 (568)
.|.. .-..||+....+..+++|+.... ....++.-|...|..|.-.+ .+++ +..... +.+-|++|
T Consensus 33 ~l~s-~eN~~f~~~~~~g~~iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~ 109 (331)
T COG2334 33 GLNS-EENSNFRVQTEDGRYILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEY 109 (331)
T ss_pred cccc-ccCceEEEEecCCCeEEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEe
Confidence 3444 45678988887777799999876 33456677788877763222 2221 222333 55678999
Q ss_pred cCCCCHHH------------H---HhhcCC---------CCCCCHHH---H----------HHHHHHHHHHHHHHHHcC-
Q 008365 304 MHNGSLED------------R---LLRRGN---------TPVIPWRK---R----------FKIAAEIATALLFLHQAK- 345 (568)
Q Consensus 304 ~~ggsL~~------------~---l~~~~~---------~~~l~~~~---~----------~~i~~qia~aL~yLH~~~- 345 (568)
++|..+.. + |+.... .....|.. . .....++...+..+...-
T Consensus 110 l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~ 189 (331)
T COG2334 110 LPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLP 189 (331)
T ss_pred cCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhch
Confidence 99887762 1 111110 00122320 0 012233444444444432
Q ss_pred ---CCC---cccCCCCCCCeeccCCc-eeEeccccccc
Q 008365 346 ---PEP---LVHRDLKPANILLDRNY-VSKISDVGLAR 376 (568)
Q Consensus 346 ---~~~---IiHrDIKp~NILld~~~-~vKL~DFGla~ 376 (568)
+.. +||+|+.|+|||++.+. .+-++|||-|.
T Consensus 190 ~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 190 AHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred hhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 233 89999999999999887 48999999875
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=96.56 E-value=0.0066 Score=59.18 Aligned_cols=116 Identities=16% Similarity=0.160 Sum_probs=71.6
Q ss_pred cCceeEEEEEeCCccEEEEEeCcChhH-hHHHHHHHHHHHHcCCCCceeeeccccCCCceEEEEecCCCCHHHHHhhcCC
Q 008365 240 GGYGPVYRGKLDHTPVAIKVLRPDAAQ-GKRQFQQEVEVLSSIRHPNMVLLLGACPDYGCLVYEYMHNGSLEDRLLRRGN 318 (568)
Q Consensus 240 G~fg~Vy~~~~~~~~vAvK~l~~~~~~-~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~lV~E~~~ggsL~~~l~~~~~ 318 (568)
||.++.-.++.+--+..+|.+..-... ...-|.++..++.++. .|+++..--.....++.|+|-....
T Consensus 73 ~gNsTl~~~kt~iG~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~NDn~~~yGvIlE~Cy~~~i--------- 141 (308)
T PF07387_consen 73 NGNSTLLIGKTKIGPLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKNDNNYKYGVILERCYKIKI--------- 141 (308)
T ss_pred CCceEEEEeccccchhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecCCCceeEEEEeeccCccc---------
Confidence 334444444333334556666544333 3445788899998875 5788774311122588899832211
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEeccccc
Q 008365 319 TPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGL 374 (568)
Q Consensus 319 ~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGl 374 (568)
.. ..++.-=+.+|.-.|+.+ ...+|+|-.|+||+-|+.|.+||.|=+.
T Consensus 142 ---~~----~N~i~agi~~L~~fH~~~-~~~lHGD~np~NiM~D~~G~lKlVDP~~ 189 (308)
T PF07387_consen 142 ---NF----SNFITAGIKDLMDFHSEN-QHCLHGDCNPDNIMCDKFGYLKLVDPVC 189 (308)
T ss_pred ---ch----hHHHHHhHHHHHHhhccC-CCeecCCCChhheeecCCCCEEecChhh
Confidence 00 012222246678888554 2499999999999999999999999774
|
The function of this family is unknown. |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.40 E-value=0.02 Score=58.86 Aligned_cols=29 Identities=24% Similarity=0.287 Sum_probs=25.1
Q ss_pred CCcccCCCCCCCeeccCCceeEeccccccc
Q 008365 347 EPLVHRDLKPANILLDRNYVSKISDVGLAR 376 (568)
Q Consensus 347 ~~IiHrDIKp~NILld~~~~vKL~DFGla~ 376 (568)
.+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 34899999999999987 568899999764
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.38 E-value=0.0084 Score=61.50 Aligned_cols=72 Identities=21% Similarity=0.298 Sum_probs=44.8
Q ss_pred cceeecccCceeEEEEEeCCccEEEEEeCcChhHhHHHHHHHHHHHHcCC---CCceeeeccc--cCCCceEEEEecCCC
Q 008365 233 EAMKIGEGGYGPVYRGKLDHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIR---HPNMVLLLGA--CPDYGCLVYEYMHNG 307 (568)
Q Consensus 233 ~~~~IG~G~fg~Vy~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~---HpnIv~l~g~--~~~~~~lV~E~~~gg 307 (568)
....||.|....+|+...++..+.||+-. ......|..|..-|+.|. --.+.+.+++ +.+..+|||||++.+
T Consensus 21 ~~~~v~GG~i~~a~~~~~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~ 97 (288)
T PF03881_consen 21 SIEPVSGGDINEAYRLDTDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG 97 (288)
T ss_dssp EEEEE--SSSSEEEEEETTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred eeEecCCCChhheEEEECCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence 34579999999999999888899999975 222346788888888773 2234455543 456669999999876
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.36 E-value=0.0035 Score=61.06 Aligned_cols=29 Identities=34% Similarity=0.579 Sum_probs=20.9
Q ss_pred cccCCCCCCCeec-cCCceeEecccccccc
Q 008365 349 LVHRDLKPANILL-DRNYVSKISDVGLARL 377 (568)
Q Consensus 349 IiHrDIKp~NILl-d~~~~vKL~DFGla~~ 377 (568)
++|.|+.|.|||+ +.++.++|+||..|..
T Consensus 145 ~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 145 FCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred EeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 7899999999999 8889999999998853
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.19 E-value=0.011 Score=62.01 Aligned_cols=140 Identities=16% Similarity=0.289 Sum_probs=78.3
Q ss_pred eeecccCceeEEEEEeCC-----ccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCce-eeeccccCCCceEEEEecCCCC
Q 008365 235 MKIGEGGYGPVYRGKLDH-----TPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNM-VLLLGACPDYGCLVYEYMHNGS 308 (568)
Q Consensus 235 ~~IG~G~fg~Vy~~~~~~-----~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnI-v~l~g~~~~~~~lV~E~~~ggs 308 (568)
+.|..|=...+|+....+ ..|++|+........ -.-.+|..+++.+..-++ .++++++.. .+|.+|++|..
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~-IdR~~E~~il~~l~~~gl~P~~l~~~~~--G~i~~fi~g~~ 96 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYV-IDRERELQAIKYLSAAGFGAKLLGVFGN--GMIQSFINART 96 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeE-echHHHHHHHHHHHhcCCCCceeEEeCC--cEeehhhcCCC
Confidence 456557778899886543 278999876543221 123578888888764333 345555532 35899997765
Q ss_pred HHH--------------HHhhcCCCC------CCCHHHHHHHHHHH----------------------HHHHHHHHH---
Q 008365 309 LED--------------RLLRRGNTP------VIPWRKRFKIAAEI----------------------ATALLFLHQ--- 343 (568)
Q Consensus 309 L~~--------------~l~~~~~~~------~l~~~~~~~i~~qi----------------------a~aL~yLH~--- 343 (568)
|.. .+.+-...+ ...|..+..+..++ ..-+..+..
T Consensus 97 l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~~~ 176 (330)
T PLN02421 97 LTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEITD 176 (330)
T ss_pred CChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHHhc
Confidence 421 111100000 11233332222211 111222211
Q ss_pred -cC-CCCcccCCCCCCCeeccC-CceeEecccccccc
Q 008365 344 -AK-PEPLVHRDLKPANILLDR-NYVSKISDVGLARL 377 (568)
Q Consensus 344 -~~-~~~IiHrDIKp~NILld~-~~~vKL~DFGla~~ 377 (568)
.+ +.-++|.|+.+.|||+++ ++.++++||..|..
T Consensus 177 ~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 177 SLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred cCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 11 123799999999999974 57899999999853
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.10 E-value=0.034 Score=57.52 Aligned_cols=31 Identities=23% Similarity=0.235 Sum_probs=27.9
Q ss_pred CCcccCCCCCCCeeccCCceeEecccccccc
Q 008365 347 EPLVHRDLKPANILLDRNYVSKISDVGLARL 377 (568)
Q Consensus 347 ~~IiHrDIKp~NILld~~~~vKL~DFGla~~ 377 (568)
..++|+|+.++|||+++++.+.|+||..+..
T Consensus 196 ~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 196 TVLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 3599999999999999999999999998863
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PF04655 APH_6_hur: Aminoglycoside/hydroxyurea antibiotic resistance kinase; InterPro: IPR006748 The aminoglycosides are a large group of biologically active bacterial secondary metabolites, best known for their antibiotic properties [] | Back alignment and domain information |
|---|
Probab=95.93 E-value=0.028 Score=56.57 Aligned_cols=74 Identities=27% Similarity=0.290 Sum_probs=56.5
Q ss_pred eeecccCceeEEEEEe-CCccEEEEEeCcChhHhHHHHHHHH---HHHHcCCCCceeeeccccCCCceEEEEec-CCCCH
Q 008365 235 MKIGEGGYGPVYRGKL-DHTPVAIKVLRPDAAQGKRQFQQEV---EVLSSIRHPNMVLLLGACPDYGCLVYEYM-HNGSL 309 (568)
Q Consensus 235 ~~IG~G~fg~Vy~~~~-~~~~vAvK~l~~~~~~~~~~~~~Ev---~iL~~l~HpnIv~l~g~~~~~~~lV~E~~-~ggsL 309 (568)
..+..|..+.|+.++. +|+++++|+..+.... ..|. ..|+..+-...|++++.-.+...|++|.+ ++.+|
T Consensus 8 ~~~~~g~~s~V~pv~~~dG~~avLKl~~p~~~~-----~~E~~g~~~L~~w~G~GaVrll~~d~~~~AlLLErl~~g~~L 82 (253)
T PF04655_consen 8 GPPAHGSSSLVVPVRRADGTPAVLKLAPPHAEA-----EHEARGEAALRWWNGRGAVRLLAADPERGALLLERLDPGRSL 82 (253)
T ss_pred CCCCCCcceEEEEEEcCCCCeEEEEecCCcccc-----hhhhhHHhHhheeCCCCceeeeccccccchhhhhhccCCCch
Confidence 4567799999999975 7899999998755422 2233 55888888889999998888889999999 55577
Q ss_pred HHHH
Q 008365 310 EDRL 313 (568)
Q Consensus 310 ~~~l 313 (568)
.++.
T Consensus 83 ~~~~ 86 (253)
T PF04655_consen 83 ASLP 86 (253)
T ss_pred hhcc
Confidence 6544
|
Aminoglycoside phosphotransferases achieve inactivation of these enzymes by phosphorylation, utilising ATP. Likewise, hydroxyurea is inactivated by phosphorylation of the hydroxy group in the hydroxylamine moiety.; GO: 0016773 phosphotransferase activity, alcohol group as acceptor, 0006468 protein phosphorylation, 0019748 secondary metabolic process |
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.84 E-value=0.026 Score=59.77 Aligned_cols=58 Identities=29% Similarity=0.284 Sum_probs=41.2
Q ss_pred eEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCCCCcccCCCCCCCeecc
Q 008365 298 CLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQ-AKPEPLVHRDLKPANILLD 362 (568)
Q Consensus 298 ~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~-~~~~~IiHrDIKp~NILld 362 (568)
.||=+|+.|-++..++...+ .++....+++.-.++||.-+-- .+ ++|.|+.|.||++-
T Consensus 321 vl~E~~~~Gl~v~~~v~~~~----~pe~l~kkva~lg~~AllkMl~vDN---FvHaDlHPGNVlir 379 (565)
T KOG1236|consen 321 VLVETYERGLSVLRFVKWKS----QPEALVKKVAKLGVNALLKMLIVDN---FVHADLHPGNVLIR 379 (565)
T ss_pred eeeeeccccccHHhhhhccc----ChHHHHHHHHHHHHHHHHHHHHhhc---ceecccCCCcEEEE
Confidence 46667888889888876554 3445556666666666544333 34 99999999999993
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.82 E-value=0.17 Score=52.87 Aligned_cols=94 Identities=16% Similarity=0.142 Sum_probs=54.4
Q ss_pred ccccccCHHHHHHHhcccccc---e-eecccCceeEEEEEe-CCccEEEEEeCcChhHhHHHHHHHHHHHHcCCCC--ce
Q 008365 214 VRYRKYTIEEIEEATDKFSEA---M-KIGEGGYGPVYRGKL-DHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHP--NM 286 (568)
Q Consensus 214 ~~~~~~~~~ei~~~~~~y~~~---~-~IG~G~fg~Vy~~~~-~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~Hp--nI 286 (568)
..|...+...+..+...+-+. . ..-.+.-..||+... ++..+++|+.++.. ....++..|+..+..|... .+
T Consensus 6 ~~~~~l~p~~~~~a~~~~g~~~~~~~~~l~s~eN~vy~v~~~~~~~~vlKv~r~~~-~~~~~i~~E~~~l~~L~~~gipv 84 (325)
T PRK11768 6 FPFQTLTPDLILDALESLGLRVDGRLLALNSYENRVYQFGDEDGRRVVAKFYRPER-WSDAQILEEHAFALELAEAEIPV 84 (325)
T ss_pred CCCCCCChHHHHHHHHHcCCCCccceEeeccccceEEEEecCCCCEEEEEEcCccc-CCHHHHHHHHHHHHHHHHCCCCC
Confidence 456677777777776665332 0 122345567898876 46689999986442 2345666778777766321 12
Q ss_pred eeec---c----ccCCCceEEEEecCCCC
Q 008365 287 VLLL---G----ACPDYGCLVYEYMHNGS 308 (568)
Q Consensus 287 v~l~---g----~~~~~~~lV~E~~~ggs 308 (568)
+... | .+....+.|+++++|..
T Consensus 85 ~~p~~~~G~~~~~~~g~~~~l~~~~~G~~ 113 (325)
T PRK11768 85 VAPLAFNGQTLHEHQGFRFALFPRRGGRA 113 (325)
T ss_pred CCCccCCCCEEEEECCEEEEEEeeeCCCC
Confidence 2211 1 11223467899998764
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.40 E-value=0.052 Score=58.01 Aligned_cols=74 Identities=16% Similarity=0.207 Sum_probs=45.0
Q ss_pred ceeecccCceeEEEEEeCC---cc-----EEEEEeCcChhHhHHHHHHHHHHHHcCCCCce-eeeccccCCCceEEEEec
Q 008365 234 AMKIGEGGYGPVYRGKLDH---TP-----VAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNM-VLLLGACPDYGCLVYEYM 304 (568)
Q Consensus 234 ~~~IG~G~fg~Vy~~~~~~---~~-----vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnI-v~l~g~~~~~~~lV~E~~ 304 (568)
++.|..|-...+|++...+ .. |.+++.-...... -.-.+|+.+++.+...++ .++++.+.+ ++|+||+
T Consensus 55 i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~-IdR~~E~~i~~~Ls~~glgP~l~~~f~~--g~l~efI 131 (383)
T PTZ00384 55 IKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLV-IDNDLQYNIAKLLGDNNFGPKIIGRFGD--FTIQEWV 131 (383)
T ss_pred EEEeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceE-eccHHHHHHHHHHHhCCCCCeEEEecCC--EEEEEEe
Confidence 4466668889999986532 12 4444422111111 122568899988864444 566676653 6999999
Q ss_pred CCCCHH
Q 008365 305 HNGSLE 310 (568)
Q Consensus 305 ~ggsL~ 310 (568)
+|..|.
T Consensus 132 eGr~l~ 137 (383)
T PTZ00384 132 EGNTMG 137 (383)
T ss_pred ccccCC
Confidence 987653
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.25 E-value=0.057 Score=58.83 Aligned_cols=73 Identities=18% Similarity=0.213 Sum_probs=45.6
Q ss_pred ceeecccCceeEEEEEeC----------CccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCce-eeeccccCCCceEEEE
Q 008365 234 AMKIGEGGYGPVYRGKLD----------HTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNM-VLLLGACPDYGCLVYE 302 (568)
Q Consensus 234 ~~~IG~G~fg~Vy~~~~~----------~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnI-v~l~g~~~~~~~lV~E 302 (568)
++.|..|=.-.+|++... +..|.+++.-.....-. .-..|..+++.+..-+| .++++.+. +..|.+
T Consensus 110 i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~lI-dR~~E~~v~~~ls~~gi~P~l~~~f~--gg~I~e 186 (442)
T PTZ00296 110 VNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDELY-NPISEFEVYKTMSKYRIAPQLLNTFS--GGRIEE 186 (442)
T ss_pred EEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCcccee-CHHHHHHHHHHHHHCCCCCceEEEeC--CCEEEE
Confidence 456777777888988643 35788998755432211 23457777776653333 24555553 567899
Q ss_pred ecCCCCH
Q 008365 303 YMHNGSL 309 (568)
Q Consensus 303 ~~~ggsL 309 (568)
|++|..|
T Consensus 187 fi~g~~l 193 (442)
T PTZ00296 187 WLYGDPL 193 (442)
T ss_pred eeCCccC
Confidence 9998744
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.24 E-value=0.042 Score=57.43 Aligned_cols=104 Identities=18% Similarity=0.141 Sum_probs=71.2
Q ss_pred CceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccc
Q 008365 296 YGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLA 375 (568)
Q Consensus 296 ~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla 375 (568)
+.|++|++- |++|.- +. ...+.+...|+.+.+..+.-+...- ++-|||+..+||||+ +|+|-|+||-++
T Consensus 300 y~yl~~kdh-gt~is~-ik------~~~~~e~lsff~s~~sil~~lekkf--~fehrnlt~~niLId-~GnvtLIDfkls 368 (488)
T COG5072 300 YLYLHFKDH-GTPISI-IK------ADRSEEELSFFWSCISILDILEKKF--PFEHRNLTLDNILID-EGNVTLIDFKLS 368 (488)
T ss_pred EEEEEEecC-Cceeee-ee------cccHHHHHHHHHHHHHHHhhhhhcC--Ccccccccccceeee-cCceEEEEeeee
Confidence 346778775 666532 11 2457888899999998888887765 499999999999999 999999999999
Q ss_pred cccCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHH
Q 008365 376 RLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGI 422 (568)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGv 422 (568)
|+-.... .+--..+--|-++.|.. +..-|||-+--
T Consensus 369 Rl~~~q~-----------~isy~rldhp~lF~G~d-d~QFeIYrlMr 403 (488)
T COG5072 369 RLSYSQG-----------IISYNRLDHPDLFNGVD-DYQFEIYRLMR 403 (488)
T ss_pred ecccCCc-----------eeeccccCchhhhcCcc-ceeeeHHHHHH
Confidence 8532111 11111233566666443 66677776543
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=94.89 E-value=0.16 Score=61.15 Aligned_cols=31 Identities=32% Similarity=0.455 Sum_probs=25.7
Q ss_pred CCCcccCCCCCCCeeccCCc--eeE-eccccccc
Q 008365 346 PEPLVHRDLKPANILLDRNY--VSK-ISDVGLAR 376 (568)
Q Consensus 346 ~~~IiHrDIKp~NILld~~~--~vK-L~DFGla~ 376 (568)
+..+||+|+.+.|||++.++ .+. |+|||.+.
T Consensus 202 p~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~ 235 (1013)
T PRK06148 202 PAQVIHNDANDYNILVDADDGERISGLIDFGDAV 235 (1013)
T ss_pred CcceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence 34599999999999998775 454 99999875
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 568 | ||||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-44 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-43 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 4e-43 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 4e-42 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 5e-42 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 3e-40 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 7e-38 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 4e-36 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-29 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 8e-29 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 8e-26 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 3e-24 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 3e-24 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-22 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-22 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-22 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-22 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-22 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-22 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-22 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-22 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 3e-22 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 3e-22 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 3e-22 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 4e-22 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 4e-22 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 4e-22 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 4e-22 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 9e-22 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 9e-22 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-21 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-21 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-21 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-21 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-21 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-21 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-21 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-21 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 3e-21 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 4e-21 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 4e-21 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 4e-21 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 5e-21 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 5e-21 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 5e-21 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-21 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 5e-21 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 6e-21 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 6e-21 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 7e-21 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-21 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 7e-21 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 7e-21 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 7e-21 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 8e-21 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 8e-21 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 9e-21 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 9e-21 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-20 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-20 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-20 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-20 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-20 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-20 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-20 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-20 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-20 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 3e-20 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 3e-20 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 3e-20 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 3e-20 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 3e-20 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 3e-20 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 3e-20 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 3e-20 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 4e-20 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 4e-20 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-20 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-20 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 5e-20 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 6e-20 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 6e-20 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 6e-20 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-19 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-19 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-19 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-19 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-19 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 3e-19 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 5e-19 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 8e-19 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-18 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 3e-18 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 3e-18 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 4e-18 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 5e-18 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 6e-18 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 6e-18 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 7e-18 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 8e-18 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 9e-18 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-17 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 1e-17 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 1e-17 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-17 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-17 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-17 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-17 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-17 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-17 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 1e-17 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-17 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-17 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-17 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-17 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 2e-17 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-17 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-17 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-17 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-17 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-17 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-17 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-17 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 3e-17 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 3e-17 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 3e-17 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 3e-17 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 3e-17 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 3e-17 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-17 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 4e-17 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 4e-17 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 4e-17 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 4e-17 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 4e-17 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 4e-17 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 4e-17 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 5e-17 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 7e-17 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-17 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-16 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-16 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-16 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-16 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 3e-16 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-16 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 3e-16 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 4e-16 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 4e-16 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 4e-16 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 5e-16 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 6e-16 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 7e-16 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 7e-16 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 7e-16 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 8e-16 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 8e-16 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 8e-16 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 8e-16 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 8e-16 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 9e-16 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-15 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-15 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-15 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-15 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-15 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-15 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-15 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-15 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 1e-15 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-15 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-15 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-15 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-15 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-15 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-15 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-15 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-15 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-15 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 3e-15 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 3e-15 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 3e-15 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 3e-15 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 3e-15 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 3e-15 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-15 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 3e-15 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 3e-15 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-15 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 3e-15 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 4e-15 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 4e-15 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 4e-15 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 4e-15 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 4e-15 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-15 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 4e-15 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 5e-15 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 5e-15 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 5e-15 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 5e-15 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 5e-15 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 6e-15 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 6e-15 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 6e-15 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 7e-15 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 8e-15 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 9e-15 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 9e-15 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 9e-15 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-14 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-14 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-14 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-14 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-14 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-14 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-14 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-14 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-14 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-14 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-14 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-14 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-14 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-14 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-14 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-14 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-14 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-14 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-14 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-14 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-14 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-14 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-14 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-14 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-14 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-14 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-14 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-14 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-14 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-14 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-14 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-14 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 3e-14 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-14 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-14 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-14 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 3e-14 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 4e-14 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-14 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 4e-14 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 5e-14 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 5e-14 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-14 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 7e-14 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 7e-14 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 8e-14 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 8e-14 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 9e-14 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 9e-14 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 9e-14 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 9e-14 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-13 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-13 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-13 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-13 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-13 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-13 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-13 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-13 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-13 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-13 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-13 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-13 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-13 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-13 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-13 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-13 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-13 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-13 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-13 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-13 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 3e-13 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 3e-13 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 3e-13 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 3e-13 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-13 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 4e-13 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 4e-13 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 4e-13 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-13 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-13 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 5e-13 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 5e-13 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 5e-13 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 5e-13 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 5e-13 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 6e-13 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-13 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-13 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 6e-13 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-13 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-13 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 6e-13 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 6e-13 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 6e-13 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-13 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 6e-13 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 7e-13 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-13 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 7e-13 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 7e-13 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 7e-13 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 7e-13 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 7e-13 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 7e-13 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 7e-13 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 7e-13 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 7e-13 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 7e-13 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 7e-13 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 7e-13 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-13 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 8e-13 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-13 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 8e-13 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-13 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-13 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 9e-13 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-12 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-12 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-12 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-12 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-12 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-12 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-12 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-12 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-12 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-12 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-12 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-12 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-12 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-12 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-12 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-12 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-12 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-12 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-12 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-12 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-12 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-12 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-12 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-12 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-12 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-12 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-12 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-12 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-12 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-12 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-12 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-12 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-12 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-12 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-12 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-12 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-12 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 2e-12 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-12 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-12 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-12 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-12 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-12 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 3e-12 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 3e-12 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-12 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 3e-12 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-12 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 3e-12 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 3e-12 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 3e-12 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 3e-12 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-12 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 3e-12 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 3e-12 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 3e-12 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 4e-12 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 4e-12 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 4e-12 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 4e-12 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 4e-12 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-12 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 5e-12 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-12 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 5e-12 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 5e-12 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 5e-12 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 5e-12 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 5e-12 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 6e-12 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 6e-12 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-12 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 6e-12 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 6e-12 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 6e-12 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 6e-12 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-12 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 7e-12 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 7e-12 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-12 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 7e-12 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 7e-12 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 8e-12 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 8e-12 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 8e-12 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 8e-12 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 8e-12 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 8e-12 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 9e-12 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 9e-12 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 9e-12 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-11 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-11 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-11 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-11 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-11 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-11 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-11 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-11 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 1e-11 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-11 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-11 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-11 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-11 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-11 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-11 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-11 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-11 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-11 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-11 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-11 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-11 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-11 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-11 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-11 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-11 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-11 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 3e-11 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 3e-11 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-11 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-11 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-11 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-11 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 3e-11 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 3e-11 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 3e-11 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-11 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-11 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 3e-11 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 3e-11 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-11 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 4e-11 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 4e-11 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 4e-11 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 4e-11 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 4e-11 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 4e-11 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 4e-11 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 4e-11 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 4e-11 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 4e-11 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 4e-11 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-11 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 4e-11 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-11 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 4e-11 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 4e-11 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-11 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 4e-11 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 4e-11 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 5e-11 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 5e-11 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 5e-11 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 5e-11 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-11 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 5e-11 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-11 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 6e-11 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 6e-11 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-11 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 6e-11 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 6e-11 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 6e-11 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 8e-11 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 9e-11 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 9e-11 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-11 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 9e-11 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-10 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-10 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-10 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-10 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-10 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-10 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-10 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-10 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-10 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-10 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-10 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 1e-10 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-10 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-10 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-10 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-10 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-10 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-10 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-10 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-10 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-10 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-10 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-10 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-10 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-10 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 2e-10 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-10 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-10 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-10 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-10 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-10 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-10 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-10 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-10 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-10 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-10 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-10 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-10 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-10 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-10 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-10 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-10 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-10 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 3e-10 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 3e-10 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 3e-10 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 3e-10 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-10 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 3e-10 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 3e-10 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 3e-10 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 3e-10 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 3e-10 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 3e-10 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 4e-10 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 4e-10 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 4e-10 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 4e-10 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 4e-10 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-10 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-10 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 4e-10 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-10 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-10 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 4e-10 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-10 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 5e-10 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 5e-10 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 5e-10 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 5e-10 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 5e-10 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 6e-10 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 6e-10 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 6e-10 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 6e-10 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-10 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 6e-10 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 6e-10 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 7e-10 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 7e-10 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 7e-10 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 7e-10 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 7e-10 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 8e-10 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 8e-10 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 8e-10 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-10 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 8e-10 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 8e-10 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 9e-10 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 9e-10 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 9e-10 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-09 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-09 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-09 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-09 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-09 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-09 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-09 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-09 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-09 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-09 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 1e-09 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-09 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 1e-09 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 1e-09 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-09 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 1e-09 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-09 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-09 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-09 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-09 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-09 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-09 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-09 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-09 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-09 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-09 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-09 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-09 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-09 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-09 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-09 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-09 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-09 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-09 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 3e-09 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-09 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-09 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 3e-09 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-09 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 3e-09 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 3e-09 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 3e-09 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 3e-09 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 3e-09 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-09 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 4e-09 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-09 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 4e-09 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 4e-09 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 4e-09 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 4e-09 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 4e-09 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 4e-09 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 4e-09 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 4e-09 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 4e-09 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 4e-09 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 4e-09 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 4e-09 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 4e-09 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 4e-09 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 4e-09 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 4e-09 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 4e-09 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 4e-09 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 4e-09 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 4e-09 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 4e-09 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 4e-09 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 4e-09 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-09 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 4e-09 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 4e-09 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 4e-09 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 4e-09 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 5e-09 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 5e-09 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 5e-09 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 5e-09 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 5e-09 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 5e-09 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 5e-09 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 5e-09 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-09 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 5e-09 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-09 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-09 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 6e-09 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 6e-09 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 6e-09 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 6e-09 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 6e-09 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 6e-09 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 6e-09 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 6e-09 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-09 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 6e-09 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 6e-09 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 6e-09 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 7e-09 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 7e-09 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 8e-09 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 8e-09 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 8e-09 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 9e-09 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 9e-09 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 9e-09 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 9e-09 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 9e-09 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 9e-09 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 9e-09 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 9e-09 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 9e-09 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 9e-09 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 9e-09 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-09 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-08 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-08 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-08 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-08 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-08 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-08 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-08 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-08 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-08 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-08 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-08 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-08 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-08 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-08 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-08 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-08 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-08 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-08 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-08 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-08 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-08 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-08 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-08 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 3e-08 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 3e-08 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 3e-08 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 3e-08 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 4e-08 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 4e-08 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 4e-08 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 5e-08 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 5e-08 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 5e-08 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 5e-08 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 6e-08 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 7e-08 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 7e-08 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 8e-08 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 8e-08 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 8e-08 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 8e-08 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 9e-08 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-07 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-07 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-07 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-07 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-07 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-07 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-07 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-07 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-07 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-07 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-07 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-07 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-07 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-07 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-07 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-07 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-07 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-07 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-07 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-07 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-07 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-07 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-07 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-07 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-07 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-07 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-07 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-07 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-07 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-07 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-07 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-07 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-07 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-07 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-07 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-07 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-07 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-07 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-07 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-07 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-07 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-07 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-07 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-07 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 3e-07 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-07 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 3e-07 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 3e-07 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 3e-07 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 3e-07 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 3e-07 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 3e-07 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 3e-07 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 3e-07 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 3e-07 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 3e-07 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 3e-07 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 3e-07 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 3e-07 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 3e-07 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 3e-07 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 3e-07 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 3e-07 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-07 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 3e-07 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 4e-07 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 4e-07 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 4e-07 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 4e-07 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-07 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 4e-07 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 4e-07 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 4e-07 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-07 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 4e-07 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 4e-07 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-07 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-07 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 4e-07 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 5e-07 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 5e-07 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 5e-07 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 5e-07 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 5e-07 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 6e-07 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 6e-07 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 7e-07 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 7e-07 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 7e-07 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 8e-07 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 9e-07 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 9e-07 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-06 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-06 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-06 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-06 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-06 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-06 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-06 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-06 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-06 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-06 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-06 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-06 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-06 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-06 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-06 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-06 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-06 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-06 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 3e-06 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 3e-06 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 3e-06 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 3e-06 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-06 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 3e-06 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-06 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 4e-06 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 4e-06 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-06 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 4e-06 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 4e-06 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 4e-06 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 4e-06 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 5e-06 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 5e-06 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 5e-06 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-06 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 7e-06 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 7e-06 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 7e-06 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 8e-06 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 9e-06 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 9e-06 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 9e-06 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 9e-06 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 9e-06 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 9e-06 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 9e-06 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-05 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 1e-05 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-05 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 1e-05 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-05 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 1e-05 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-05 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 1e-05 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 1e-05 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 1e-05 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 1e-05 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-05 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 1e-05 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-05 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 1e-05 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 1e-05 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 1e-05 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-05 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-05 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-05 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 1e-05 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-05 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 2e-05 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-05 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 2e-05 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-05 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-05 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-05 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-05 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-05 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-05 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-05 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 2e-05 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-05 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 2e-05 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-05 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-05 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-05 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-05 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-05 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-05 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 2e-05 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-05 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-05 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 3e-05 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 3e-05 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 3e-05 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 3e-05 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 3e-05 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 3e-05 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 3e-05 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 4e-05 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 4e-05 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 4e-05 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-05 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 5e-05 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 6e-05 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 6e-05 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 6e-05 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 6e-05 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 8e-05 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 8e-05 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 9e-05 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 9e-05 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 1e-04 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 1e-04 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 1e-04 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-04 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 2e-04 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-04 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 2e-04 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-04 | ||
| 4hgl_A | 330 | Crystal Structure Of Ck1g3 With Compound 1 Length = | 2e-04 | ||
| 2wb8_A | 352 | Crystal Structure Of Haspin Kinase Length = 352 | 2e-04 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-04 | ||
| 3dlz_A | 357 | Crystal Structure Of Human Haspin In Complex With A | 2e-04 | ||
| 2vuw_A | 336 | Structure Of Human Haspin Kinase Domain Length = 33 | 2e-04 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 2e-04 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 3e-04 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 3e-04 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-04 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 3e-04 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-04 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 4e-04 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 4e-04 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-04 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 5e-04 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-04 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 5e-04 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 5e-04 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 5e-04 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 5e-04 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 6e-04 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 6e-04 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 6e-04 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 6e-04 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 6e-04 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 6e-04 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 6e-04 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 6e-04 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 6e-04 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 6e-04 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 6e-04 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 7e-04 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 7e-04 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 7e-04 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 7e-04 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-04 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 7e-04 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-04 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-04 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 7e-04 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 8e-04 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 8e-04 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 8e-04 |
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|4HGL|A Chain A, Crystal Structure Of Ck1g3 With Compound 1 Length = 330 | Back alignment and structure |
|
| >pdb|2WB8|A Chain A, Crystal Structure Of Haspin Kinase Length = 352 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3DLZ|A Chain A, Crystal Structure Of Human Haspin In Complex With Amp Length = 357 | Back alignment and structure |
|
| >pdb|2VUW|A Chain A, Structure Of Human Haspin Kinase Domain Length = 336 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 312 bits (802), Expect = e-103
Identities = 105/311 (33%), Positives = 161/311 (51%), Gaps = 21/311 (6%)
Query: 194 KAKREAEEKNRALTALANNDVRYRKYTIEEIEEATDKFSEAMKIGEGGYGPVYRGKL-DH 252
K + N AL++ + + ++EEAT+ F IG G +G VY+G L D
Sbjct: 4 KYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDG 63
Query: 253 TPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACPDYG--CLVYEYMHNGSLE 310
VA+K P+++QG +F+ E+E LS RHP++V L+G C + L+Y+YM NG+L+
Sbjct: 64 AKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLK 123
Query: 311 DRLLRRGN-TPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKI 369
L T + W +R +I A L +LH ++HRD+K NILLD N+V KI
Sbjct: 124 RHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKI 180
Query: 370 SDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT 429
+D G+++ ++ T GT YIDPEY G LT KSD+YSFG++L +++
Sbjct: 181 TDFGISKKGTELDQTHLS----TVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLC 236
Query: 430 ARSPM---------GLTHHVSRAIEKGTLAEMLDPA-VTDWPAEAAESFSKLAIQCAELR 479
ARS + L + G L +++DP E+ F A++C L
Sbjct: 237 ARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALS 296
Query: 480 KKDRPDLGTVI 490
+DRP +G V+
Sbjct: 297 SEDRPSMGDVL 307
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 305 bits (784), Expect = e-100
Identities = 114/311 (36%), Positives = 164/311 (52%), Gaps = 31/311 (9%)
Query: 208 ALANNDVRYRKYTIEEIEEATDKFSEAM------KIGEGGYGPVYRGKLDHTPVAIKVLR 261
+L +D R+ ++ E++ T+ F E K+GEGG+G VY+G +++T VA+K L
Sbjct: 4 SLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLA 63
Query: 262 ----PDAAQGKRQFQQEVEVLSSIRHPNMVLLLGAC--PDYGCLVYEYMHNGSLEDRLLR 315
+ K+QF QE++V++ +H N+V LLG D CLVY YM NGSL DRL
Sbjct: 64 AMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSC 123
Query: 316 RGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLA 375
TP + W R KIA A + FLH+ +HRD+K ANILLD + +KISD GLA
Sbjct: 124 LDGTPPLSWHMRCKIAQGAANGINFLHE---NHHIHRDIKSANILLDEAFTAKISDFGLA 180
Query: 376 RLVPPSVADSVTQYHMTSA-AGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPM 434
R + T MTS GT Y+ PE G +T KSDIYSFG++LL+IIT +
Sbjct: 181 RASE---KFAQT--VMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAV 234
Query: 435 GLTHH----VSRA----IEKGTLAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDL 486
+ E+ T+ + +D + D + + E+ +A QC +K RPD+
Sbjct: 235 DEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDI 294
Query: 487 GTVIVPELNRL 497
V L +
Sbjct: 295 KKV-QQLLQEM 304
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 292 bits (750), Expect = 4e-95
Identities = 101/293 (34%), Positives = 161/293 (54%), Gaps = 26/293 (8%)
Query: 217 RKYTIEEIEEATDKFSEAMKIGEGGYGPVYRGKL-DHTPVAIKVLRPDAAQG-KRQFQQE 274
+++++ E++ A+D FS +G GG+G VY+G+L D T VA+K L+ + QG + QFQ E
Sbjct: 18 KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTE 77
Query: 275 VEVLSSIRHPNMVLLLGAC--PDYGCLVYEYMHNGSLEDRLL-RRGNTPVIPWRKRFKIA 331
VE++S H N++ L G C P LVY YM NGS+ L R + P + W KR +IA
Sbjct: 78 VEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIA 137
Query: 332 AEIATALLFLH-QAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYH 390
A L +LH P ++HRD+K ANILLD + + + D GLA+L+ T H
Sbjct: 138 LGSARGLAYLHDHCDP-KIIHRDVKAANILLDEEFEAVVGDFGLAKLMD----YKDT--H 190
Query: 391 MTSA-AGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPM-----------GLTH 438
+T+A GT +I PEY TG + K+D++ +G+MLL++IT + L
Sbjct: 191 VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLD 250
Query: 439 HVSRAIEKGTLAEMLDPAV-TDWPAEAAESFSKLAIQCAELRKKDRPDLGTVI 490
V +++ L ++D + ++ E E ++A+ C + +RP + V+
Sbjct: 251 WVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVV 303
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 229 bits (586), Expect = 4e-71
Identities = 79/284 (27%), Positives = 123/284 (43%), Gaps = 27/284 (9%)
Query: 220 TIEEIEEATDKFSEAMKIGEGGYGPVYRGKLDHTPVAIKVLRPDAAQGKRQFQQEVEVLS 279
++ I+ + +G G +G V + K VAIK + + ++ F E+ LS
Sbjct: 1 SLHMIDY--KEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESE--SERKAFIVELRQLS 56
Query: 280 SIRHPNMVLLLGACPDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALL 339
+ HPN+V L GAC + CLV EY GSL + L P + + +
Sbjct: 57 RVNHPNIVKLYGACLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVA 116
Query: 340 FLHQAKPEPLVHRDLKPANILLDRNY-VSKISDVGLARLVPPSVADSVTQYHMTSAAGTF 398
+LH +P+ L+HRDLKP N+LL V KI D G A + Q HMT+ G+
Sbjct: 117 YLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI---------QTHMTNNKGSA 167
Query: 399 CYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSP----MGLTHHVSRAIEKGTLAEMLD 454
++ PE + + K D++S+GI+L ++IT R P G + A+ G
Sbjct: 168 AWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNG-----TR 222
Query: 455 PAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPELNRLK 498
P + + L +C RP + IV + L
Sbjct: 223 PPL---IKNLPKPIESLMTRCWSKDPSQRPSM-EEIVKIMTHLM 262
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 220 bits (562), Expect = 2e-67
Identities = 82/267 (30%), Positives = 129/267 (48%), Gaps = 19/267 (7%)
Query: 236 KIGEGGYGPVYRGKLDHTPVAIKVLRPD--AAQGKRQFQQEVEVLSSIRHPNMVLLLGAC 293
KIG G +G V+R + + VA+K+L A+ +F +EV ++ +RHPN+VL +GA
Sbjct: 44 KIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 294 --PDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVH 351
P +V EY+ GSL L + G + R+R +A ++A + +LH P P+VH
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNP-PIVH 162
Query: 352 RDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGML 411
R+LK N+L+D+ Y K+ D GL+RL + T SAAGT ++ PE +
Sbjct: 163 RNLKSPNLLVDKKYTVKVCDFGLSRLK------ASTFLSSKSAAGTPEWMAPEVLRDEPS 216
Query: 412 TTKSDIYSFGIMLLQIITARSP-MGLTHHVSRAIEKGTLAEMLDPAVTDWPAEAAESFSK 470
KSD+YSFG++L ++ T + P L + + + P +
Sbjct: 217 NEKSDVYSFGVILWELATLQQPWGNLN---PAQVVAAVGFKCKRLEI---PRNLNPQVAA 270
Query: 471 LAIQCAELRKKDRPDLGTVIVPELNRL 497
+ C RP T I+ L L
Sbjct: 271 IIEGCWTNEPWKRPSFAT-IMDLLRPL 296
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 216 bits (552), Expect = 6e-66
Identities = 65/318 (20%), Positives = 116/318 (36%), Gaps = 49/318 (15%)
Query: 220 TIEEIEEATDKFSEAMKIGEGGYGPVYRGKLDHTPVAIKVLRPDAAQGKRQFQQEVEVLS 279
E + + G +G V++ +L + VA+K+ Q Q + EV L
Sbjct: 15 GTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQDKQSW-QNEYEVYSLP 73
Query: 280 SIRHPNMVLLLGAC--PDYG----CLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAE 333
++H N++ +GA L+ + GSL D L V+ W + IA
Sbjct: 74 GMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN----VVSWNELCHIAET 129
Query: 334 IATALLFLHQ--------AKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADS 385
+A L +LH+ KP + HRD+K N+LL N + I+D GLA
Sbjct: 130 MARGLAYLHEDIPGLKDGHKP-AISHRDIKSKNVLLKNNLTACIADFGLALKFEA----G 184
Query: 386 VTQYHMTSAAGTFCYIDPEYQQTGMLTT-----KSDIYSFGIMLLQIITARSPMGLTHHV 440
+ GT Y+ PE + + + D+Y+ G++L ++ + +
Sbjct: 185 KSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDE 244
Query: 441 SRAI------EKGTLAEM--------LDPAVTDW--PAEAAESFSKLAIQCAELRKKDRP 484
+ +L +M P + D+ + +C + + R
Sbjct: 245 YMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARL 304
Query: 485 DLGTVIVPELNRLKDLGR 502
G V R+ + R
Sbjct: 305 SAGCVGE----RITQMQR 318
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 212 bits (542), Expect = 7e-65
Identities = 77/278 (27%), Positives = 131/278 (47%), Gaps = 32/278 (11%)
Query: 236 KIGEGGYGPVYRGKLDH--TPVAIKVLRPDAAQGK-------RQFQQEVEVLSSIRHPNM 286
+IG+GG+G V++G+L + VAIK L ++G+ ++FQ+EV ++S++ HPN+
Sbjct: 26 QIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNI 85
Query: 287 VLLLGACPDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKP 346
V L G + +V E++ G L RLL + + I W + ++ +IA + ++ P
Sbjct: 86 VKLYGLMHNPPRMVMEFVPCGDLYHRLLDKAHP--IKWSVKLRLMLDIALGIEYMQNQNP 143
Query: 347 EPLVHRDLKPANILLD-----RNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYI 401
P+VHRDL+ NI L +K++D GL++ + + ++ G F ++
Sbjct: 144 -PIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ---------QSVHSVSGLLGNFQWM 193
Query: 402 DPE--YQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAVTD 459
PE + T K+D YSF ++L I+T P + E L P +
Sbjct: 194 APETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTI-- 251
Query: 460 WPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPELNRL 497
P + + C K RP IV EL+ L
Sbjct: 252 -PEDCPPRLRNVIELCWSGDPKKRPHFSY-IVKELSEL 287
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 210 bits (538), Expect = 2e-64
Identities = 62/274 (22%), Positives = 115/274 (41%), Gaps = 30/274 (10%)
Query: 236 KIGEGGYGPVYRGKLDHTPVAIKVLRPD--AAQGKRQFQQEVEVLSSIRHPNMVLLLGAC 293
K+ E G +++G+ + +KVL+ + + R F +E L HPN++ +LGAC
Sbjct: 17 KLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGAC 76
Query: 294 ----PDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPL 349
+ L+ +M GSL + +L G V+ + K A ++A + FLH +P +
Sbjct: 77 QSPPAPHPTLITHWMPYGSLYN-VLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEP-LI 134
Query: 350 VHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPE---YQ 406
L ++++D + ++IS + + ++ PE +
Sbjct: 135 PRHALNSRSVMIDEDMTARISMADVKFS-----------FQSPGRMYAPAWVAPEALQKK 183
Query: 407 QTGMLTTKSDIYSFGIMLLQIITARSP-MGLTHHVSRAIEKGTLAEMLDPAVTDWPAEAA 465
+D++SF ++L +++T P L+ + I E L P + P +
Sbjct: 184 PEDTNRRSADMWSFAVLLWELVTREVPFADLS---NMEIGMKVALEGLRPTI---PPGIS 237
Query: 466 ESFSKLAIQCAELRKKDRPDLGTVIVPELNRLKD 499
SKL C RP IVP L +++D
Sbjct: 238 PHVSKLMKICMNEDPAKRPKFDM-IVPILEKMQD 270
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 209 bits (534), Expect = 8e-64
Identities = 78/279 (27%), Positives = 122/279 (43%), Gaps = 38/279 (13%)
Query: 236 KIGEGGYGPVYRGKLDHTPVAIKVLRP----DAAQGKRQFQQEVEVLSSIRHPNMVLLLG 291
IG GG+G VYR VA+K R D +Q +QE ++ + ++HPN++ L G
Sbjct: 14 IIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73
Query: 292 AC--PDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPL 349
C CLV E+ G L L + IP A +IA + +LH P+
Sbjct: 74 VCLKEPNLCLVMEFARGGPLNRVLSGK----RIPPDILVNWAVQIARGMNYLHDEAIVPI 129
Query: 350 VHRDLKPANILLDR--------NYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYI 401
+HRDLK +NIL+ + N + KI+D GLAR + SAAG + ++
Sbjct: 130 IHRDLKSSNILILQKVENGDLSNKILKITDFGLARE--------WHRTTKMSAAGAYAWM 181
Query: 402 DPEYQQTGMLTTKSDIYSFGIMLLQIITARSP---MGLTHHVSRAIEKGTLAEMLDPAVT 458
PE + M + SD++S+G++L +++T P + L +
Sbjct: 182 APEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNK-----LALPI- 235
Query: 459 DWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPELNRL 497
P+ E F+KL C RP I+ +L +
Sbjct: 236 --PSTCPEPFAKLMEDCWNPDPHSRPSFTN-ILDQLTTI 271
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 208 bits (531), Expect = 4e-63
Identities = 72/278 (25%), Positives = 132/278 (47%), Gaps = 29/278 (10%)
Query: 236 KIGEGGYGPVYRGKLDHTPVAIKVLRPDAAQGK--RQFQQEVEVLSSIRHPNMVLLLGAC 293
+IG G +G VY+GK H VA+K+L A + + F+ EV VL RH N++L +G
Sbjct: 31 RIGSGSFGTVYKGKW-HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 294 --PDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVH 351
P +V ++ SL L +K IA + A + +LH + ++H
Sbjct: 90 TAPQL-AIVTQWCEGSSLYHHLHASETK--FEMKKLIDIARQTARGMDYLHA---KSIIH 143
Query: 352 RDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPE---YQQT 408
RDLK NI L + KI D GLA + + +G+ ++ PE Q +
Sbjct: 144 RDLKSNNIFLHEDNTVKIGDFGLATE----KSRWSGSHQFEQLSGSILWMAPEVIRMQDS 199
Query: 409 GMLTTKSDIYSFGIMLLQIITARSP-MGLTHH--VSRAIEKGTLAEMLDPAVTDWPAEAA 465
+ +SD+Y+FGI+L +++T + P + + + + +G+L+ P ++ +
Sbjct: 200 NPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLS----PDLSKVRSNCP 255
Query: 466 ESFSKLAIQCAELRKKDRPDLGTVIVPELNRLKDLGRK 503
+ +L +C + ++ +RP + L +++L R+
Sbjct: 256 KRMKRLMAECLKKKRDERPSFPRI----LAEIEELARE 289
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 200 bits (509), Expect = 2e-59
Identities = 74/342 (21%), Positives = 114/342 (33%), Gaps = 54/342 (15%)
Query: 222 EEIEEATDKFSEAMKIGEGGYGPVYRGKLDHTPVAIKVLRPDAAQGKRQFQQEVEV--LS 279
E D IG G YG VY+G LD PVA+KV ++ F E + +
Sbjct: 6 SEPSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSF---ANRQNFINEKNIYRVP 62
Query: 280 SIRHPNMVLLLGACPDYG-------CLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAA 332
+ H N+ + LV EY NGSL L + W ++A
Sbjct: 63 LMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL----SLHTSDWVSSCRLAH 118
Query: 333 EIATALLFLHQAKPE------PLVHRDLKPANILLDRNYVSKISDVGLARLVPPS--VAD 384
+ L +LH P + HRDL N+L+ + ISD GL+ + + V
Sbjct: 119 SVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRP 178
Query: 385 SVTQYHMTSAAGTFCYIDPEY-------QQTGMLTTKSDIYSFGIMLLQIITARSPMGLT 437
S GT Y+ PE + + D+Y+ G++ +I + +
Sbjct: 179 GEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPG 238
Query: 438 HHV--------SRAIEKGTLAEMLDPAVTD---------WP--AEAAESFSKLAIQCAEL 478
V + T +M + W + A S + C +
Sbjct: 239 ESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQ 298
Query: 479 RKKDRPDLGTVIVPELNRLKDLGRKLESNKSYGYAKREGHSH 520
+ R R+ +L E NKS H H
Sbjct: 299 DAEARLTAQXAEE----RMAELMMIWERNKSVSPTAHHHHHH 336
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 199 bits (508), Expect = 2e-59
Identities = 63/284 (22%), Positives = 113/284 (39%), Gaps = 31/284 (10%)
Query: 236 KIGEGGYGPVYRGKLDHTPVAIKVLRP--DAAQGKRQFQQEVEVLSSIRHPNMVLLLGAC 293
IG+G +G VY G+ H VAI+++ D + F++EV RH N+VL +GAC
Sbjct: 40 LIGKGRFGQVYHGRW-HGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGAC 98
Query: 294 --PDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVH 351
P + ++ +L + R V+ K +IA EI + +LH + ++H
Sbjct: 99 MSPPHLAIITSLCKGRTLYSVV--RDAKIVLDVNKTRQIAQEIVKGMGYLHA---KGILH 153
Query: 352 RDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGML 411
+DLK N+ D V I+D GL + A + G C++ PE +
Sbjct: 154 KDLKSKNVFYDNGKV-VITDFGLFSISGVLQAGRREDK-LRIQNGWLCHLAPEIIRQLSP 211
Query: 412 ---------TTKSDIYSFGIMLLQIITARSP-MGLTHH-VSRAIEKGTLAEMLDPAVTDW 460
+ SD+++ G + ++ P + + G
Sbjct: 212 DTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMK--PNLS----- 264
Query: 461 PAEAAESFSKLAIQCAELRKKDRPDLGTVIVPELNRLKDLGRKL 504
+ S + + C +++RP ++ L +L R+L
Sbjct: 265 QIGMGKEISDILLFCWAFEQEERPTFTK-LMDMLEKLPKRNRRL 307
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 196 bits (501), Expect = 1e-58
Identities = 64/301 (21%), Positives = 121/301 (40%), Gaps = 35/301 (11%)
Query: 223 EIEEATDKFSEAMKIGEGGYGPVYRGKLDHT--PVAIKVLRPDAAQGKRQFQQEVEVLSS 280
+ E +G+G +G + T + +K L + +R F +EV+V+
Sbjct: 6 IFRPSDLIHGE--VLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRC 63
Query: 281 IRHPNMVLLLGAC--PDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATAL 338
+ HPN++ +G + EY+ G+L +++ ++ PW +R A +IA+ +
Sbjct: 64 LEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRG-IIKSMDSQ-YPWSQRVSFAKDIASGM 121
Query: 339 LFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVP--------PSVADSVTQYH 390
+LH ++HRDL N L+ N ++D GLARL+ +
Sbjct: 122 AYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKK 178
Query: 391 MTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSP----MGLTHHVSRAIEK 446
+ G ++ PE K D++SFGI+L +II + + T +
Sbjct: 179 RYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRG 238
Query: 447 GTLAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPELNRLKDLGRKLES 506
+ + P SF + ++C +L + RP + + L+ L L
Sbjct: 239 F--LDR--YCPPNCP----PSFFPITVRCCDLDPEKRPSFVKLE----HWLETLRMHLAG 286
Query: 507 N 507
+
Sbjct: 287 H 287
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 5e-54
Identities = 57/220 (25%), Positives = 92/220 (41%), Gaps = 30/220 (13%)
Query: 236 KIGEGGYGPVYRGKLDHTPVAIKVLRPDAAQGKRQFQQEVEV--LSSIRHPNMVLLLGAC 293
+G+G YG V+RG VA+K+ + ++ + +E E+ +RH N++ + +
Sbjct: 15 CVGKGRYGEVWRGSWQGENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGFIASD 71
Query: 294 ------PDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLH----- 342
L+ Y GSL D L + +I IA+ L LH
Sbjct: 72 MTSRHSSTQLWLITHYHEMGSLYDYL----QLTTLDTVSCLRIVLSIASGLAHLHIEIFG 127
Query: 343 -QAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYI 401
Q KP + HRDLK NIL+ +N I+D+GLA + S + GT Y+
Sbjct: 128 TQGKP-AIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQS--TNQLDVGNNPRVGTKRYM 184
Query: 402 DPE------YQQTGMLTTKSDIYSFGIMLLQIITARSPMG 435
PE + DI++FG++L ++ G
Sbjct: 185 APEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNG 224
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 3e-52
Identities = 68/272 (25%), Positives = 107/272 (39%), Gaps = 48/272 (17%)
Query: 236 KIGEGGYGPVYRGKLDHTPVAIKVLRPDAAQGKRQFQQEVEV--LSSIRHPNMVLLLGAC 293
+IG+G YG V+ GK VA+KV + + +E E+ +RH N++ + A
Sbjct: 44 QIGKGRYGEVWMGKWRGEKVAVKVFFT---TEEASWFRETEIYQTVLMRHENILGFIAAD 100
Query: 294 -------PDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLH---- 342
L+ +Y NGSL D L + + + K+A + L LH
Sbjct: 101 IKGTGSWTQL-YLITDYHENGSLYDYL----KSTTLDAKSMLKLAYSSVSGLCHLHTEIF 155
Query: 343 --QAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCY 400
Q KP + HRDLK NIL+ +N I+D+GLA + + GT Y
Sbjct: 156 STQGKP-AIAHRDLKSKNILVKKNGTCCIADLGLAVKFISD--TNEVDIPPNTRVGTKRY 212
Query: 401 IDPE------YQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLD 454
+ PE + +D+YSFG++L ++ R + G + E
Sbjct: 213 MPPEVLDESLNRNHFQSYIMADMYSFGLILWEVAR------------RCVSGGIVEEYQL 260
Query: 455 PAVTDWPAEAAESFSKLAIQCAELRKKDRPDL 486
P + S ++ KK RP
Sbjct: 261 P----YHDLVPSDPSYEDMREIVCIKKLRPSF 288
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 176 bits (447), Expect = 2e-50
Identities = 62/220 (28%), Positives = 95/220 (43%), Gaps = 30/220 (13%)
Query: 236 KIGEGGYGPVYRGKLDHTPVAIKVLRPDAAQGKRQFQQEVEV--LSSIRHPNMVLLLGAC 293
IG+G +G V+RGK VA+K+ + +R + +E E+ +RH N++ + A
Sbjct: 49 SIGKGRFGEVWRGKWRGEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFIAAD 105
Query: 294 PDYG------CLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLH----- 342
LV +Y +GSL D L N + K+A A+ L LH
Sbjct: 106 NKDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEIVG 161
Query: 343 -QAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYI 401
Q KP + HRDLK NIL+ +N I+D+GLA + GT Y+
Sbjct: 162 TQGKP-AIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSA--TDTIDIAPNHRVGTKRYM 218
Query: 402 DPE------YQQTGMLTTKSDIYSFGIMLLQIITARSPMG 435
PE + ++DIY+ G++ +I S G
Sbjct: 219 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG 258
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 4e-42
Identities = 71/278 (25%), Positives = 114/278 (41%), Gaps = 33/278 (11%)
Query: 236 KIGEGGYGPVYRGKL--DHTPVAIKVLRPDA-AQGKRQFQQEVEVLSSIRHPNMVLLLGA 292
+IG G +G V+ G+L D+T VA+K R K +F QE +L HPN+V L+G
Sbjct: 121 QIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 180
Query: 293 CPDYG--CLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLV 350
C +V E + G L R + + ++ + A + +L +
Sbjct: 181 CTQKQPIYIVMELVQGGDFLTFL--RTEGARLRVKTLLQMVGDAAAGMEYLESKC---CI 235
Query: 351 HRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCY--IDPEYQQT 408
HRDL N L+ V KISD G++R Y + PE
Sbjct: 236 HRDLAARNCLVTEKNVLKISDFGMSREEAD------GVYAASGGLRQVPVKWTAPEALNY 289
Query: 409 GMLTTKSDIYSFGIMLLQIIT-ARSP-MGLTHH-VSRAIEKGTLAEMLDPAVTDWPAEAA 465
G +++SD++SFGI+L + + SP L++ +EKG L P
Sbjct: 290 GRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKG---GRLPC-----PELCP 341
Query: 466 ESFSKLAIQCAELRKKDRPDLGTVIVPELNRLKDLGRK 503
++ +L QC RP T+ L+ + ++
Sbjct: 342 DAVFRLMEQCWAYEPGQRPSFSTI----YQELQSIRKR 375
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 3e-40
Identities = 59/218 (27%), Positives = 103/218 (47%), Gaps = 22/218 (10%)
Query: 223 EIEEATDKFSEAMKIGEGGYGPVYRGKLD------HTPVAIKVLRPDAAQGKRQFQQEVE 276
+ EE KF + ++G+G +G V + D VA+K L+ + R F++E+E
Sbjct: 6 QFEERHLKFLQ--QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIE 63
Query: 277 VLSSIRHPNMVLLLGACPDYG----CLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAA 332
+L S++H N+V G C G L+ EY+ GSL D L + + I K + +
Sbjct: 64 ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTS 121
Query: 333 EIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMT 392
+I + +L + +HRDL NIL++ KI D GL +++P + +
Sbjct: 122 QICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLP----QDKEFFKVK 174
Query: 393 SAAGT-FCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT 429
+ + PE + SD++SFG++L ++ T
Sbjct: 175 EPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 151 bits (382), Expect = 5e-40
Identities = 78/259 (30%), Positives = 120/259 (46%), Gaps = 31/259 (11%)
Query: 236 KIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGAC 293
K+G G YG VY G VA+K L+ D + +F +E V+ I+HPN+V LLG C
Sbjct: 227 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 285
Query: 294 PDYG--CLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVH 351
++ E+M G+L D LR N + +A +I++A+ +L + +H
Sbjct: 286 TREPPFYIITEFMTYGNLLD-YLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIH 341
Query: 352 RDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYID---PEYQQT 408
R+L N L+ N++ K++D GL+RL+ Y T+ AG I PE
Sbjct: 342 RNLAARNCLVGENHLVKVADFGLSRLMTGD------TY--TAHAGAKFPIKWTAPESLAY 393
Query: 409 GMLTTKSDIYSFGIMLLQIIT-ARSPM-GLTHH-VSRAIEKGTLAEMLDPAVTDWPAEAA 465
+ KSD+++FG++L +I T SP G+ V +EK E P
Sbjct: 394 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER--------PEGCP 445
Query: 466 ESFSKLAIQCAELRKKDRP 484
E +L C + DRP
Sbjct: 446 EKVYELMRACWQWNPSDRP 464
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 1e-39
Identities = 60/218 (27%), Positives = 103/218 (47%), Gaps = 22/218 (10%)
Query: 223 EIEEATDKFSEAMKIGEGGYGPVYRGKLD------HTPVAIKVLRPDAAQGKRQFQQEVE 276
+ EE KF + ++G+G +G V + D VA+K L+ + R F++E+E
Sbjct: 37 QFEERHLKFLQ--QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIE 94
Query: 277 VLSSIRHPNMVLLLGACPDYG----CLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAA 332
+L S++H N+V G C G L+ EY+ GSL D L + + I K + +
Sbjct: 95 ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTS 152
Query: 333 EIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMT 392
+I + +L + +HRDL NIL++ KI D GL +++P Y +
Sbjct: 153 QICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLP----QDKEYYKVK 205
Query: 393 SAAGT-FCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT 429
+ + PE + SD++SFG++L ++ T
Sbjct: 206 EPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 243
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 2e-39
Identities = 56/218 (25%), Positives = 101/218 (46%), Gaps = 22/218 (10%)
Query: 223 EIEEATDKFSEAMKIGEGGYGPVYRGKLD------HTPVAIKVLRPDAAQGKRQFQQEVE 276
EE K+ ++G+G +G V + D VA+K L+ +R FQ+E++
Sbjct: 19 IFEERHLKYIS--QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQ 76
Query: 277 VLSSIRHPNMVLLLGACPDYG----CLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAA 332
+L ++ +V G G LV EY+ +G L D L + + + + ++
Sbjct: 77 ILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSS 134
Query: 333 EIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMT 392
+I + +L + VHRDL NIL++ KI+D GLA+L+P Y +
Sbjct: 135 QICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLLP----LDKDYYVVR 187
Query: 393 SAAGT-FCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT 429
+ + PE + + +SD++SFG++L ++ T
Sbjct: 188 EPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 225
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 4e-39
Identities = 84/257 (32%), Positives = 125/257 (48%), Gaps = 29/257 (11%)
Query: 236 KIGEGGYGPVYRGKL-DHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACP 294
K+G+G +G V+ G T VAIK L+P F QE +V+ +RH +V L
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 295 DYG-CLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRD 353
+ +V EYM GSL D L+ + + +AA+IA+ + ++ + VHRD
Sbjct: 250 EEPIYIVTEYMSKGSLLD-FLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRD 305
Query: 354 LKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYID---PEYQQTGM 410
L+ ANIL+ N V K++D GLARL+ + +Y T+ G I PE G
Sbjct: 306 LRAANILVGENLVCKVADFGLARLIEDN------EY--TARQGAKFPIKWTAPEAALYGR 357
Query: 411 LTTKSDIYSFGIMLLQIIT-ARSP-MGLTHH-VSRAIEKGTLAEMLDPAVTDWPAEAAES 467
T KSD++SFGI+L ++ T R P G+ + V +E+G + P E ES
Sbjct: 358 FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG---YRMPC-----PPECPES 409
Query: 468 FSKLAIQCAELRKKDRP 484
L QC ++RP
Sbjct: 410 LHDLMCQCWRKEPEERP 426
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 6e-39
Identities = 56/220 (25%), Positives = 101/220 (45%), Gaps = 25/220 (11%)
Query: 223 EIEEATDKFSEAMKIGEGGYGPVYRGKLD------HTPVAIKVLRPDA-AQGKRQFQQEV 275
E+ K +GEG +G V + D VA+K L+P++ ++E+
Sbjct: 17 HFEKRFLKRIR--DLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEI 74
Query: 276 EVLSSIRHPNMVLLLGACPDYG----CLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIA 331
E+L ++ H N+V G C + G L+ E++ +GSL++ L N I +++ K A
Sbjct: 75 EILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYA 132
Query: 332 AEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHM 391
+I + +L + VHRDL N+L++ + KI D GL + + + +Y+
Sbjct: 133 VQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIE-----TDKEYYT 184
Query: 392 TSAAGTF--CYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT 429
+ PE SD++SFG+ L +++T
Sbjct: 185 VKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLT 224
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 8e-39
Identities = 66/307 (21%), Positives = 111/307 (36%), Gaps = 39/307 (12%)
Query: 229 DKFSEAMKIGEGGYGPVY--RGKLDHTPVAIKVLR-PDAAQGKRQFQQEVEVLSSIRHPN 285
F +G GG+G V+ + K+D AIK +R P+ + + +EV+ L+ + HP
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 286 MVLLLGA--------------CPDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIA 331
+V A Y + + +L+D + R I
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 332 AEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHM 391
+IA A+ FLH L+HRDLKP+NI + V K+ D GL + + M
Sbjct: 125 LQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181
Query: 392 ------TSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIE 445
T GT Y+ PE + K DI+S G++L +++ S +
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVR 241
Query: 446 KGTLAEMLDPAVTDWPAEAAESFSKLAIQCAELRK--KDRPDLGTVI-VPELNRLKDLGR 502
+ + + L +RP+ +I L G+
Sbjct: 242 NLKFPPL--------FTQKYPCEYVMVQDM--LSPSPMERPEAINIIENAVFEDLDFPGK 291
Query: 503 KLESNKS 509
+ +S
Sbjct: 292 TVLRQRS 298
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 9e-39
Identities = 68/220 (30%), Positives = 103/220 (46%), Gaps = 25/220 (11%)
Query: 236 KIGEGGYGPVYRGKLDHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACPD 295
IG+G +G V G VA+K ++ DA + F E V++ +RH N+V LLG +
Sbjct: 28 TIGKGEFGDVMLGDYRGNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVIVE 85
Query: 296 YGCLVY---EYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHR 352
+Y EYM GSL D LR V+ K + ++ A+ +L VHR
Sbjct: 86 EKGGLYIVTEYMAKGSLVD-YLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHR 141
Query: 353 DLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTF--CYIDPEYQQTGM 410
DL N+L+ + V+K+SD GL + + T G + PE +
Sbjct: 142 DLAARNVLVSEDNVAKVSDFGLTK-----------EASSTQDTGKLPVKWTAPEALREKK 190
Query: 411 LTTKSDIYSFGIMLLQIIT-ARSP-MGLTHH-VSRAIEKG 447
+TKSD++SFGI+L +I + R P + V +EKG
Sbjct: 191 FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG 230
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 1e-38
Identities = 73/257 (28%), Positives = 110/257 (42%), Gaps = 33/257 (12%)
Query: 236 KIGEGGYGPVYRGKLDHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACPD 295
IG+G +G V G VA+K ++ DA + F E V++ +RH N+V LLG +
Sbjct: 200 TIGKGEFGDVMLGDYRGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVE 257
Query: 296 YGCLVY---EYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHR 352
+Y EYM GSL D LR V+ K + ++ A+ +L VHR
Sbjct: 258 EKGGLYIVTEYMAKGSLVD-YLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHR 313
Query: 353 DLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCY--IDPEYQQTGM 410
DL N+L+ + V+K+SD GL + + T G PE +
Sbjct: 314 DLAARNVLVSEDNVAKVSDFGLTK-----------EASSTQDTGKLPVKWTAPEALREKK 362
Query: 411 LTTKSDIYSFGIMLLQIIT-ARSP-MGLTHH-VSRAIEKGTLAEMLDPAVTDWPAEAAES 467
+TKSD++SFGI+L +I + R P + V +EKG + P +
Sbjct: 363 FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDA--------PDGCPPA 414
Query: 468 FSKLAIQCAELRKKDRP 484
+ C L RP
Sbjct: 415 VYDVMKNCWHLDAATRP 431
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 3e-38
Identities = 74/222 (33%), Positives = 113/222 (50%), Gaps = 25/222 (11%)
Query: 236 KIGEGGYGPVYRGKL-DHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGAC- 293
++G G +G V+ G HT VA+K L+ + F E ++ ++H +V L
Sbjct: 20 RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAVVT 78
Query: 294 --PDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVH 351
P Y ++ EYM NGSL D L+ + + K +AA+IA + F+ + +H
Sbjct: 79 QEPIY--IITEYMENGSLVD-FLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIH 132
Query: 352 RDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYID---PEYQQT 408
RDL+ ANIL+ KI+D GLARL+ +Y T+ G I PE
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLIED------NEY--TAREGAKFPIKWTAPEAINY 184
Query: 409 GMLTTKSDIYSFGIMLLQIIT-ARSP-MGLTHH-VSRAIEKG 447
G T KSD++SFGI+L +I+T R P G+T+ V + +E+G
Sbjct: 185 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG 226
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 3e-38
Identities = 68/221 (30%), Positives = 107/221 (48%), Gaps = 21/221 (9%)
Query: 236 KIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGAC 293
K+G G YG VY G VA+K L+ D + +F +E V+ I+HPN+V LLG C
Sbjct: 20 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 78
Query: 294 PDYG--CLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVH 351
++ E+M G+L D LR N + +A +I++A+ +L + +H
Sbjct: 79 TREPPFYIITEFMTYGNLLD-YLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIH 134
Query: 352 RDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCY--IDPEYQQTG 409
RDL N L+ N++ K++D GL+RL+ + A F PE
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMT-------GDTYTAHAGAKFPIKWTAPESLAYN 187
Query: 410 MLTTKSDIYSFGIMLLQIIT-ARSP-MGLTHH-VSRAIEKG 447
+ KSD+++FG++L +I T SP G+ V +EK
Sbjct: 188 KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD 228
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 3e-38
Identities = 66/221 (29%), Positives = 106/221 (47%), Gaps = 23/221 (10%)
Query: 236 KIGEGGYGPVYRGKL-DHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACP 294
+IG G +G V+ G + VAIK +R A + F +E EV+ + HP +V L G C
Sbjct: 15 EIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLVQLYGVCL 73
Query: 295 DYG--CLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHR 352
+ CLV E+M +G L D L R + + ++ + +L +A ++HR
Sbjct: 74 EQAPICLVTEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHR 128
Query: 353 DLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYID---PEYQQTG 409
DL N L+ N V K+SD G+ R V QY TS+ GT + PE
Sbjct: 129 DLAARNCLVGENQVIKVSDFGMTRFVLDD------QY--TSSTGTKFPVKWASPEVFSFS 180
Query: 410 MLTTKSDIYSFGIMLLQIIT-ARSP-MGLTHH-VSRAIEKG 447
++KSD++SFG+++ ++ + + P ++ V I G
Sbjct: 181 RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG 221
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 4e-38
Identities = 66/258 (25%), Positives = 119/258 (46%), Gaps = 31/258 (12%)
Query: 236 KIGEGGYGPVYRGKL-DHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACP 294
++G G +G V GK VAIK+++ + + +F +E +V+ ++ H +V L G C
Sbjct: 31 ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQLYGVCT 89
Query: 295 DYG--CLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHR 352
++ EYM NG L + L R ++ ++ ++ A+ +L + +HR
Sbjct: 90 KQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHR 144
Query: 353 DLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYID---PEYQQTG 409
DL N L++ V K+SD GL+R V +Y TS+ G+ + PE
Sbjct: 145 DLAARNCLVNDQGVVKVSDFGLSRYVLD------DEY--TSSVGSKFPVRWSPPEVLMYS 196
Query: 410 MLTTKSDIYSFGIMLLQIIT-ARSP-MGLTHH-VSRAIEKGTLAEMLDPAVTDWPAEAAE 466
++KSDI++FG+++ +I + + P T+ + I +G L P A+E
Sbjct: 197 KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG---LRLYR-----PHLASE 248
Query: 467 SFSKLAIQCAELRKKDRP 484
+ C + +RP
Sbjct: 249 KVYTIMYSCWHEKADERP 266
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 141 bits (359), Expect = 4e-38
Identities = 67/283 (23%), Positives = 116/283 (40%), Gaps = 49/283 (17%)
Query: 236 KIGEGGYGPVYRGKL------DHTPVAIKVLRPDA-AQGKRQFQQEVEVLSSIRHPNMVL 288
+G G +G VY+G PVAIK LR + ++ E V++S+ +P++
Sbjct: 22 VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 289 LLGAC---PDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAK 345
LLG C L+ + M G L D + R + I + +IA + +L +
Sbjct: 82 LLGICLTSTVQ--LITQLMPFGCLLDYV--REHKDNIGSQYLLNWCVQIAKGMNYLEDRR 137
Query: 346 PEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSA--------AGT 397
LVHRDL N+L+ KI+D GLA+L+ + + A
Sbjct: 138 ---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE-----EKEYHAEGGKVPIKWMA-- 187
Query: 398 FCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSP-MGLTHH-VSRAIEKGTLAEMLD 454
E + T +SD++S+G+ + +++T P G+ +S +EKG E L
Sbjct: 188 -----LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG---ERLP 239
Query: 455 PAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPELNRL 497
P + +C + RP ++ E +++
Sbjct: 240 Q-----PPICTIDVYMIMRKCWMIDADSRPKFRE-LIIEFSKM 276
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 5e-38
Identities = 64/226 (28%), Positives = 99/226 (43%), Gaps = 39/226 (17%)
Query: 223 EIEEATDKFSEAMKIGEGGYGPVYRGKLD------HTPVAIKVLRPDA-AQGKRQFQQEV 275
+ K +GEG +G V D VA+K L+ DA Q + ++QE+
Sbjct: 27 VFHKRYLKKIR--DLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEI 84
Query: 276 EVLSSIRHPNMVLLLGACPDYG----CLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIA 331
++L ++ H +++ G C D G LV EY+ GSL D L R I + A
Sbjct: 85 DILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS----IGLAQLLLFA 140
Query: 332 AEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHM 391
+I + +LH +HRDL N+LLD + + KI D GLA+ VP + Y +
Sbjct: 141 QQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP----EGHEYYRV 193
Query: 392 TSA--------AGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT 429
A PE + SD++SFG+ L +++T
Sbjct: 194 REDGDSPVFWYA-------PECLKEYKFYYASDVWSFGVTLYELLT 232
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 5e-38
Identities = 64/258 (24%), Positives = 117/258 (45%), Gaps = 31/258 (12%)
Query: 236 KIGEGGYGPVYRGKL-DHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACP 294
++G G +G V GK VA+K+++ + + +F QE + + + HP +V G C
Sbjct: 15 ELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS-EDEFFQEAQTMMKLSHPKLVKFYGVCS 73
Query: 295 DYG--CLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHR 352
+V EY+ NG L + L R + + + ++ ++ + FL + +HR
Sbjct: 74 KEYPIYIVTEYISNGCLLNYL--RSHGKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHR 128
Query: 353 DLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYID---PEYQQTG 409
DL N L+DR+ K+SD G+ R V QY S+ GT + PE
Sbjct: 129 DLAARNCLVDRDLCVKVSDFGMTRYVLD------DQY--VSSVGTKFPVKWSAPEVFHYF 180
Query: 410 MLTTKSDIYSFGIMLLQIIT-ARSP-MGLTHH-VSRAIEKGTLAEMLDPAVTDWPAEAAE 466
++KSD+++FGI++ ++ + + P T+ V + +G L P A++
Sbjct: 181 KYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQG---HRLYR-----PHLASD 232
Query: 467 SFSKLAIQCAELRKKDRP 484
+ ++ C + RP
Sbjct: 233 TIYQIMYSCWHELPEKRP 250
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 7e-38
Identities = 79/258 (30%), Positives = 126/258 (48%), Gaps = 31/258 (12%)
Query: 236 KIGEGGYGPVYRGKL-DHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGAC- 293
K+G G +G V+ HT VA+K ++P + F E V+ +++H +V L
Sbjct: 195 KLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVKLHAVVT 253
Query: 294 --PDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVH 351
P Y ++ E+M GSL D L+ P K +A+IA + F+ Q +H
Sbjct: 254 KEPIY--IITEFMAKGSLLD-FLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIH 307
Query: 352 RDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCY--IDPEYQQTG 409
RDL+ ANIL+ + V KI+D GLAR++ + +Y F PE G
Sbjct: 308 RDLRAANILVSASLVCKIADFGLARVIEDN------EY-TAREGAKFPIKWTAPEAINFG 360
Query: 410 MLTTKSDIYSFGIMLLQIIT-ARSP-MGLTHH-VSRAIEKGTLAEMLDPAVTDWPAEAAE 466
T KSD++SFGI+L++I+T R P G+++ V RA+E+G + P E
Sbjct: 361 SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG---YRMPR-----PENCPE 412
Query: 467 SFSKLAIQCAELRKKDRP 484
+ ++C + R ++RP
Sbjct: 413 ELYNIMMRCWKNRPEERP 430
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 1e-37
Identities = 83/257 (32%), Positives = 123/257 (47%), Gaps = 29/257 (11%)
Query: 236 KIGEGGYGPVYRGKL-DHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACP 294
K+G+G +G V+ G T VAIK L+P F QE +V+ +RH +V L
Sbjct: 274 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS 332
Query: 295 DYG-CLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRD 353
+ +V EYM GSL D L+ + + +AA+IA+ + ++ + VHRD
Sbjct: 333 EEPIYIVTEYMSKGSLLD-FLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRD 388
Query: 354 LKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYID---PEYQQTGM 410
L+ ANIL+ N V K++D GLARL+ + T+ G I PE G
Sbjct: 389 LRAANILVGENLVCKVADFGLARLIEDN--------EYTARQGAKFPIKWTAPEAALYGR 440
Query: 411 LTTKSDIYSFGIMLLQIIT-ARSP-MGLTHH-VSRAIEKGTLAEMLDPAVTDWPAEAAES 467
T KSD++SFGI+L ++ T R P G+ + V +E+G + P E ES
Sbjct: 441 FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG---YRMPC-----PPECPES 492
Query: 468 FSKLAIQCAELRKKDRP 484
L QC ++RP
Sbjct: 493 LHDLMCQCWRKEPEERP 509
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 2e-37
Identities = 66/264 (25%), Positives = 106/264 (40%), Gaps = 38/264 (14%)
Query: 236 KIGEGGYGPVYRGKL-----DHTPVAIKVLRPDA-AQGKRQFQQEVEVLSSIRHPNMVLL 289
+GEG +G VY G + VA+K + D K +F E ++ ++ HP++V L
Sbjct: 19 ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78
Query: 290 LGAC---PDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKP 346
+G P + ++ E G L L N + + +I A+ +L
Sbjct: 79 IGIIEEEPTW--IIMELYPYGELGHYL--ERNKNSLKVLTLVLYSLQICKAMAYLESIN- 133
Query: 347 EPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYID---P 403
VHRD+ NIL+ K+ D GL+R + D Y A+ T I P
Sbjct: 134 --CVHRDIAVRNILVASPECVKLGDFGLSRYI----EDE--DY--YKASVTRLPIKWMSP 183
Query: 404 EYQQTGMLTTKSDIYSFGIMLLQIIT-ARSP-MGLTHH-VSRAIEKGTLAEMLDPAVTDW 460
E TT SD++ F + + +I++ + P L + V +EKG + L
Sbjct: 184 ESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKG---DRLPK----- 235
Query: 461 PAEAAESFSKLAIQCAELRKKDRP 484
P L +C + DRP
Sbjct: 236 PDLCPPVLYTLMTRCWDYDPSDRP 259
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 3e-37
Identities = 70/310 (22%), Positives = 124/310 (40%), Gaps = 53/310 (17%)
Query: 217 RKYTIEEIEEATDKFSEAMKIGEGGYGPVYRGKL----DHTPVAIKVLRPDA-AQGKRQF 271
+K ++ +++G G +G V +G VAIKVL+ +
Sbjct: 2 KKLFLKRDNLLIAD----IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEM 57
Query: 272 QQEVEVLSSIRHPNMVLLLGAC---PDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRF 328
+E +++ + +P +V L+G C LV E G L L G IP
Sbjct: 58 MREAQIMHQLDNPYIVRLIGVCQAEALM--LVMEMAGGGPLHKFL--VGKREEIPVSNVA 113
Query: 329 KIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQ 388
++ +++ + +L + VHRDL N+LL + +KISD GL++ + +
Sbjct: 114 ELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALG----ADDSY 166
Query: 389 YHMTSA--------AGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSP-MGLTH 438
Y SA A PE +++SD++S+G+ + + ++ + P +
Sbjct: 167 YTARSAGKWPLKWYA-------PECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG 219
Query: 439 H-VSRAIEKGTLAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPELNRL 497
V IE+G + ++ P E L C + +DRPD TV R+
Sbjct: 220 PEVMAFIEQG---KRMEC-----PPECPPELYALMSDCWIYKWEDRPDFLTV----EQRM 267
Query: 498 KDLGRKLESN 507
+ L S
Sbjct: 268 RACYYSLASK 277
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 4e-37
Identities = 72/288 (25%), Positives = 120/288 (41%), Gaps = 45/288 (15%)
Query: 190 QAELKAKREAEEKNRALTALANNDVRYRKYTIEEIEEATDKFSEAMKIGEGGYGPVYRG- 248
Q E +++ E+ +ND R+ K+ I +IG G + VY+G
Sbjct: 1 QEERNQQQDDIEELETKAVGMSNDGRFLKFDI--------------EIGRGSFKTVYKGL 46
Query: 249 -KLDHTPVAIKV--LRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACPDYG------CL 299
VA R +++F++E E+L ++HPN+V + L
Sbjct: 47 DTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106
Query: 300 VYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANI 359
V E M +G+L+ L R + R +I L FLH P P++HRDLK NI
Sbjct: 107 VTELMTSGTLKTYLKRFKVMKIKVLR---SWCRQILKGLQFLHTRTP-PIIHRDLKCDNI 162
Query: 360 LLDRNY-VSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIY 418
+ KI D+GLA L S A +V GT ++ PE + D+Y
Sbjct: 163 FITGPTGSVKIGDLGLATLKRASFAKAV--------IGTPEFMAPEMYEEK-YDESVDVY 213
Query: 419 SFGIMLLQIITARSP-------MGLTHHVSRAIEKGTLAEMLDPAVTD 459
+FG+ +L++ T+ P + V+ ++ + ++ P V +
Sbjct: 214 AFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKE 261
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 7e-37
Identities = 67/264 (25%), Positives = 106/264 (40%), Gaps = 38/264 (14%)
Query: 236 KIGEGGYGPVYRGKL-----DHTPVAIKVLRPDA-AQGKRQFQQEVEVLSSIRHPNMVLL 289
IGEG +G V++G VAIK + + +F QE + HP++V L
Sbjct: 22 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 81
Query: 290 LGAC---PDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKP 346
+G P + ++ E G L L + + A +++TAL +L +
Sbjct: 82 IGVITENPVW--IIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESKR- 136
Query: 347 EPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYID---P 403
VHRD+ N+L+ N K+ D GL+R + DS Y A+ I P
Sbjct: 137 --FVHRDIAARNVLVSSNDCVKLGDFGLSRY----MEDS--TY--YKASKGKLPIKWMAP 186
Query: 404 EYQQTGMLTTKSDIYSFGIMLLQIIT-ARSP-MGLTHH-VSRAIEKGTLAEMLDPAVTDW 460
E T+ SD++ FG+ + +I+ P G+ ++ V IE G E L
Sbjct: 187 ESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG---ERLPM----- 238
Query: 461 PAEAAESFSKLAIQCAELRKKDRP 484
P + L +C RP
Sbjct: 239 PPNCPPTLYSLMTKCWAYDPSRRP 262
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 8e-37
Identities = 64/310 (20%), Positives = 115/310 (37%), Gaps = 42/310 (13%)
Query: 236 KIGEGGYGPVYRGKL-----DHTPVAIKVLRPDAA--QGKRQFQQEVEVLSSIRHPNMVL 288
+G+G +G V +L VA+K+L+ D +F +E + HP++
Sbjct: 30 MLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAK 89
Query: 289 LLGACPDYG--------CLVYEYMHNGSLED--RLLRRGNTPVIPWRKRF-KIAAEIATA 337
L+G ++ +M +G L R G P + + +IA
Sbjct: 90 LVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACG 149
Query: 338 LLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGT 397
+ +L +HRDL N +L + ++D GL+R + Y+ A
Sbjct: 150 MEYLSSRN---FIHRDLAARNCMLAEDMTVCVADFGLSRKI------YSGDYYRQGCASK 200
Query: 398 F--CYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSP-MGLTHH-VSRAIEKGTLAEM 452
++ E + T SD+++FG+ + +I+T ++P G+ + + + G
Sbjct: 201 LPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGG---NR 257
Query: 453 LDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPELNRLKDLGRKLESNKSYGY 512
L P E E L QC K RP + EL + L +++ Y
Sbjct: 258 LKQ-----PPECMEEVYDLMYQCWSADPKQRPSFTC-LRMELENILGHLSVLSTSQDPLY 311
Query: 513 A-KREGHSHS 521
H H
Sbjct: 312 INIERAHHHH 321
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 1e-36
Identities = 71/294 (24%), Positives = 119/294 (40%), Gaps = 44/294 (14%)
Query: 223 EIEEATDKFSEAMKIGEGGYGPVYRGKL-----DHTPVAIKVLRPDA-AQGKRQFQQEVE 276
F+E IG G +G VY G L A+K L QF E
Sbjct: 21 GPSSLIVHFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGI 78
Query: 277 VLSSIRHPNMVLLLGACPDYG---CLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAE 333
++ HPN++ LLG C +V YM +G L + + R T + +
Sbjct: 79 IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQ 136
Query: 334 IATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTS 393
+A + +L K VHRDL N +LD + K++D GLAR + + + ++ T
Sbjct: 137 VAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDM--YDKEYYSVHNKTG 191
Query: 394 A-------AGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSP-MGLTHH-VSRA 443
A A E QT TTKSD++SFG++L +++T P + ++
Sbjct: 192 AKLPVKWMA-------LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY 244
Query: 444 IEKGTLAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPELNRL 497
+ +G L P + ++ ++C + + RP +V ++ +
Sbjct: 245 LLQG---RRLLQ-----PEYCPDPLYEVMLKCWHPKAEMRPSFSE-LVSRISAI 289
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 136 bits (346), Expect = 1e-36
Identities = 56/210 (26%), Positives = 90/210 (42%), Gaps = 28/210 (13%)
Query: 236 KIGEGGYGPVYRGKLDHT---PVAIKVLRPDAAQGK---RQFQQEVEVLSSIRHPNMVLL 289
K+G GG VY + D VAIK + + + ++F++EV S + H N+V +
Sbjct: 18 KLGGGGMSTVYLAE-DTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSM 76
Query: 290 LGACPDYGC------LVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQ 343
+ D LV EY+ +L + + G + +I + H
Sbjct: 77 I----DVDEEDDCYYLVMEYIEGPTLSEYIESHG---PLSVDTAINFTNQILDGIKHAHD 129
Query: 344 AKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDP 403
+ +VHRD+KP NIL+D N KI D G+A+ + + GT Y P
Sbjct: 130 MR---IVHRDIKPQNILIDSNKTLKIFDFGIAKAL-----SETSLTQTNHVLGTVQYFSP 181
Query: 404 EYQQTGMLTTKSDIYSFGIMLLQIITARSP 433
E + +DIYS GI+L +++ P
Sbjct: 182 EQAKGEATDECTDIYSIGIVLYEMLVGEPP 211
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 1e-36
Identities = 74/295 (25%), Positives = 122/295 (41%), Gaps = 51/295 (17%)
Query: 236 KIGEGGYGPVYRGKL-----DHTPVAIKVLRPDA-AQGKRQFQQEVEVLSSIRHPNMVLL 289
IG G G V G+L PVAIK L+ + +R F E ++ HPN++ L
Sbjct: 56 IIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRL 115
Query: 290 LGAC----PDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAK 345
G +V EYM NGSL+ L R + + + + + +L
Sbjct: 116 EGVVTRGRLAM--IVTEYMENGSLDTFL--RTHDGQFTIMQLVGMLRGVGAGMRYLSDLG 171
Query: 346 PEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTS--------AAGT 397
VHRDL N+L+D N V K+SD GL+R+ + D + T+ A
Sbjct: 172 ---YVHRDLAARNVLVDSNLVCKVSDFGLSRV----LEDDPDAAYTTTGGKIPIRWTA-- 222
Query: 398 FCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSP-MGLTHH-VSRAIEKGTLAEMLD 454
PE ++ SD++SFG+++ +++ P +T+ V ++E+G L
Sbjct: 223 -----PEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEG---YRLP 274
Query: 455 PAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPELNRLKDLGRKLESNKS 509
P + +L + C + RP + ++ L L R ES ++
Sbjct: 275 A-----PMGCPHALHQLMLDCWHKDRAQRPRFSQI----VSVLDALIRSPESLRA 320
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 2e-36
Identities = 69/290 (23%), Positives = 116/290 (40%), Gaps = 34/290 (11%)
Query: 223 EIEEATDKFSEAMKIGEGGYGPVYRGKL-----DHTPVAIKVLRPDA-AQGKRQFQQEVE 276
I IG+G +G VY G+ + AIK L Q F +E
Sbjct: 15 LIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGL 74
Query: 277 VLSSIRHPNMVLLLGACPDYGCLVY---EYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAE 333
++ + HPN++ L+G L + YM +G L + R + +
Sbjct: 75 LMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFI--RSPQRNPTVKDLISFGLQ 132
Query: 334 IATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTS 393
+A + +L + K VHRDL N +LD ++ K++D GLAR + Y +
Sbjct: 133 VARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDI-----LDREYYSVQQ 184
Query: 394 AAGTFCYID---PEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSP-MGLTHH-VSRAIEKG 447
+ E QT TTKSD++SFG++L +++T P + ++ + +G
Sbjct: 185 HRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQG 244
Query: 448 TLAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPELNRL 497
L P +S ++ QC E RP +V E+ ++
Sbjct: 245 ---RRLPQ-----PEYCPDSLYQVMQQCWEADPAVRPTFRV-LVGEVEQI 285
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 2e-36
Identities = 64/246 (26%), Positives = 100/246 (40%), Gaps = 32/246 (13%)
Query: 228 TDKFSEAMKIGEGGYGPVY--RGKLDHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPN 285
F E +G+G +G V R LD AIK +R + EV +L+S+ H
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQY 63
Query: 286 MVLLLGA---------------CPDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKI 330
+V A + EY NG+L D + + +++
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLN--QQRDEYWRL 121
Query: 331 AAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQY- 389
+I AL ++H ++HRDLKP NI +D + KI D GLA+ V S+
Sbjct: 122 FRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQ 178
Query: 390 -------HMTSAAGTFCYIDPE-YQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVS 441
++TSA GT Y+ E TG K D+YS GI+ ++I S ++
Sbjct: 179 NLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGMERVNIL 238
Query: 442 RAIEKG 447
+ +
Sbjct: 239 KKLRSV 244
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 3e-36
Identities = 64/295 (21%), Positives = 118/295 (40%), Gaps = 51/295 (17%)
Query: 236 KIGEGGYGPVYRGKL----DHTPVAIKVLRPDA--AQGKRQFQQEVEVLSSIRHPNMVLL 289
++G G +G V +G VA+K+L+ +A K + E V+ + +P +V +
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 290 LGAC---PDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKP 346
+G C LV E G L L + + ++ +++ + +L ++
Sbjct: 84 IGICEAESWM--LVMEMAELGPLNKYLQQNRHVKDK---NIIELVHQVSMGMKYLEESN- 137
Query: 347 EPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSA--------AGTF 398
VHRDL N+LL + +KISD GL++ + Y + A
Sbjct: 138 --FVHRDLAARNVLLVTQHYAKISDFGLSKALR----ADENYYKAQTHGKWPVKWYA--- 188
Query: 399 CYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSP-MGLTHH-VSRAIEKGTLAEMLDP 455
PE ++KSD++SFG+++ + + + P G+ V+ +EKG E +
Sbjct: 189 ----PECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG---ERMGC 241
Query: 456 AVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPELNRLKDLGRKLESNKSY 510
PA L C ++RP V RL++ + + +
Sbjct: 242 -----PAGCPREMYDLMNLCWTYDVENRPGFAAV----ELRLRNYYYDVVNEGHH 287
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 5e-36
Identities = 67/239 (28%), Positives = 113/239 (47%), Gaps = 36/239 (15%)
Query: 236 KIGEGGYGPVYRGKL-------DHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVL 288
++GEG +G V+ + D VA+K L+ ++ FQ+E E+L++++H ++V
Sbjct: 22 ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 81
Query: 289 LLGACPDYG--CLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFK-------------IAAE 333
G C D +V+EYM +G L L G +I + + IA++
Sbjct: 82 FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 141
Query: 334 IATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTS 393
IA+ +++L VHRDL N L+ N + KI D G++R V T Y+
Sbjct: 142 IASGMVYLASQH---FVHRDLATRNCLVGANLLVKIGDFGMSRDV------YSTDYYRVG 192
Query: 394 AAGTF--CYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSP-MGLTHH-VSRAIEKG 447
++ PE TT+SD++SFG++L +I T + P L++ V I +G
Sbjct: 193 GHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQG 251
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 6e-36
Identities = 78/358 (21%), Positives = 138/358 (38%), Gaps = 58/358 (16%)
Query: 223 EIEEATDKFSEAMKIGEGGYGPVYRGKL------DHTPVAIKVLRPDA-AQGKRQFQQEV 275
+E + + +G G +G V++G PV IKV+ + Q + +
Sbjct: 9 IFKETELRKLK--VLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHM 66
Query: 276 EVLSSIRHPNMVLLLGAC---PDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAA 332
+ S+ H ++V LLG C LV +Y+ GSL D + R + + +
Sbjct: 67 LAIGSLDHAHIVRLLGLCPGSSLQ--LVTQYLPLGSLLDHV--RQHRGALGPQLLLNWGV 122
Query: 333 EIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMT 392
+IA + +L + +VHR+L N+LL +++D G+A L+PP + +
Sbjct: 123 QIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPD-----DKQLLY 174
Query: 393 SAAGT-FCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSP-MGLTHH-VSRAIEKGT 448
S A T ++ E G T +SD++S+G+ + +++T P GL V +EKG
Sbjct: 175 SEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKG- 233
Query: 449 LAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPELNRLKDLGRKLESNK 508
E L P + ++C + + RP + E R+
Sbjct: 234 --ERLAQ-----PQICTIDVYMVMVKCWMIDENIRPTFKE-LANEFTRM------ARDPP 279
Query: 509 SYGYAKREGHSHSGSGRTSHTRSNVPRSPPPLSSSSYSNSRISNPSSSQMEDSSIEHE 566
Y KRE + P P +N ++ D ++ E
Sbjct: 280 RYLVIKRE---------------SGPGIAPGPEPHGLTNKKLEEVELEPELDLDLDLE 322
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 9e-36
Identities = 70/321 (21%), Positives = 127/321 (39%), Gaps = 41/321 (12%)
Query: 236 KIGEGGYGPVYRGKL------DHTPVAIKVLRPDA-AQGKRQFQQEVEVLSSIRHPNMVL 288
+G G +G VY+G PVAIK LR + ++ E V++S+ +P++
Sbjct: 22 VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 289 LLGAC---PDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAK 345
LLG C L+ + M G L D + R + I + +IA + +L +
Sbjct: 82 LLGICLTSTVQ--LITQLMPFGCLLDYV--REHKDNIGSQYLLNWCVQIAKGMNYLEDRR 137
Query: 346 PEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGT-FCYIDPE 404
LVHRDL N+L+ KI+D GLA+L+ + + ++ E
Sbjct: 138 ---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE-----EKEYHAEGGKVPIKWMALE 189
Query: 405 YQQTGMLTTKSDIYSFGIMLLQIIT-ARSP-MGLTHH-VSRAIEKGTLAEMLDPAVTDWP 461
+ T +SD++S+G+ + +++T P G+ +S +EKG E L P
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG---ERLPQ-----P 241
Query: 462 AEAAESFSKLAIQCAELRKKDRPDLGTVIVPELNRLKDLGRKLESNKSYGYAKREGHSHS 521
+ ++C + RP ++ E +++ + Y + + H
Sbjct: 242 PICTIDVYMIMVKCWMIDADSRPKFRE-LIIEFSKM------ARDPQRYLVIQGDERMHL 294
Query: 522 GSGRTSHTRSNVPRSPPPLSS 542
S S+ +
Sbjct: 295 PSPTDSNFYRALMDEEDMDDV 315
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 1e-35
Identities = 65/233 (27%), Positives = 100/233 (42%), Gaps = 40/233 (17%)
Query: 236 KIGEGGYGPVYRGKL-----DHTPVAIKVLRPDA---AQGKRQFQQEVEVLSSIRHPNMV 287
K+G+G +G V RG+ VA+K L+PD + F +EV + S+ H N++
Sbjct: 25 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84
Query: 288 LLLGAC---PDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQA 344
L G P +V E GSL DRL R + + A ++A + +L
Sbjct: 85 RLYGVVLTPPMK--MVTELAPLGSLLDRL--RKHQGHFLLGTLSRYAVQVAEGMGYLESK 140
Query: 345 KPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSA--------AG 396
+ +HRDL N+LL + KI D GL R +P + Y M A
Sbjct: 141 R---FIHRDLAARNLLLATRDLVKIGDFGLMRALP----QNDDHYVMQEHRKVPFAWCA- 192
Query: 397 TFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSP-MGLTHH-VSRAIEK 446
PE +T + SD + FG+ L ++ T + P +GL + I+K
Sbjct: 193 ------PESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK 239
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 1e-35
Identities = 55/235 (23%), Positives = 94/235 (40%), Gaps = 38/235 (16%)
Query: 236 KIGEGGYGPVYRGKL---------DHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNM 286
+G+G + +++G T V +KVL F + ++S + H ++
Sbjct: 15 SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHL 74
Query: 287 VLLLGACPDYG--CLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQA 344
VL G C LV E++ GSL+ L + N I W + ++A ++A A+ FL +
Sbjct: 75 VLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILW--KLEVAKQLAAAMHFLEEN 132
Query: 345 KPEPLVHRDLKPANILLDR--------NYVSKISDVGLARLVPPSVADSVTQYHMTSAAG 396
L+H ++ NILL R K+SD G++ V + + Q +
Sbjct: 133 T---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITV---LPKDILQERIPWVP- 185
Query: 397 TFCYIDPE-YQQTGMLTTKSDIYSFGIMLLQIIT-ARSP-MGLTHH-VSRAIEKG 447
PE + L +D +SFG L +I + P L + E
Sbjct: 186 ------PECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDR 234
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 2e-35
Identities = 67/234 (28%), Positives = 105/234 (44%), Gaps = 31/234 (13%)
Query: 236 KIGEGGYGPVYRGKL-------DHTPVAIKVLRPDAAQGKRQ-FQQEVEVLSSIRHPNMV 287
++G+G +G VY G T VAIK + A+ +R F E V+ ++V
Sbjct: 32 ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 91
Query: 288 LLLGACPDYG--CLVYEYMHNGSLEDRLL-RRGNTPVIPWRKRF------KIAAEIATAL 338
LLG ++ E M G L+ L R P ++A EIA +
Sbjct: 92 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGM 151
Query: 339 LFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTF 398
+L+ K VHRDL N ++ ++ KI D G+ R + T Y+ G
Sbjct: 152 AYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDI------YETDYYRKGGKGLL 202
Query: 399 --CYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSP-MGLTHH-VSRAIEKG 447
++ PE + G+ TT SD++SFG++L +I T A P GL++ V R + +G
Sbjct: 203 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEG 256
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 2e-35
Identities = 76/271 (28%), Positives = 117/271 (43%), Gaps = 48/271 (17%)
Query: 236 KIGEGGYGPVYRGKL------DHTPVAIKVLRPDA-AQGKRQFQQEVEVLSSIRHPNMVL 288
IG G +G VY+G L PVAIK L+ + + F E ++ H N++
Sbjct: 51 VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIR 110
Query: 289 LLGAC----PDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQA 344
L G P ++ EYM NG+L+ L R + + IA + +L
Sbjct: 111 LEGVISKYKPMM--IITEYMENGALDKFL--REKDGEFSVLQLVGMLRGIAAGMKYLANM 166
Query: 345 KPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTS--------AAG 396
VHRDL NIL++ N V K+SD GL+R+ + D + TS A
Sbjct: 167 N---YVHRDLAARNILVNSNLVCKVSDFGLSRV----LEDDPEATYTTSGGKIPIRWTA- 218
Query: 397 TFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSP-MGLTHH-VSRAIEKGTLAEML 453
PE T+ SD++SFGI++ +++T P L++H V +AI G L
Sbjct: 219 ------PEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDG---FRL 269
Query: 454 DPAVTDWPAEAAESFSKLAIQCAELRKKDRP 484
P + + +L +QC + + RP
Sbjct: 270 PT-----PMDCPSAIYQLMMQCWQQERARRP 295
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 3e-35
Identities = 66/228 (28%), Positives = 106/228 (46%), Gaps = 29/228 (12%)
Query: 236 KIGEGGYGPVYRGKL-----DHTPVAIKVLRPDA-AQGKRQFQQEVEVLSSIRHPNMVLL 289
+G G +G V G+L VAIK L+ + +R F E ++ HPN++ L
Sbjct: 52 VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL 111
Query: 290 LGAC----PDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAK 345
G P +V EYM NGSL+ L R + + + IA+ + +L
Sbjct: 112 EGVVTKSKPVM--IVTEYMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGMKYLSDMG 167
Query: 346 PEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYID--- 402
VHRDL NIL++ N V K+SD GL R+ + D + T G I
Sbjct: 168 ---YVHRDLAARNILINSNLVCKVSDFGLGRV----LEDDPEAAYTTR--GGKIPIRWTS 218
Query: 403 PEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSP-MGLTHH-VSRAIEKG 447
PE T+ SD++S+GI+L ++++ P +++ V +A+++G
Sbjct: 219 PEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG 266
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 4e-35
Identities = 65/215 (30%), Positives = 107/215 (49%), Gaps = 32/215 (14%)
Query: 236 KIGEGGYGPVYRGKLDHT---PVAIKVLRPDAAQGK---RQFQQEVEVLSSIRHPNMVLL 289
+G GG V+ + D VA+KVLR D A+ +F++E + +++ HP +V +
Sbjct: 19 ILGFGGMSEVHLAR-DLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 77
Query: 290 LGACPDYGC----------LVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALL 339
D G +V EY+ +L D + G + ++ ++ A+ AL
Sbjct: 78 Y----DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALN 130
Query: 340 FLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAA-GTF 398
F HQ ++HRD+KPANI++ K+ D G+AR + S SVTQ T+A GT
Sbjct: 131 FSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGN-SVTQ---TAAVIGTA 183
Query: 399 CYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSP 433
Y+ PE + + +SD+YS G +L +++T P
Sbjct: 184 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 4e-35
Identities = 61/238 (25%), Positives = 108/238 (45%), Gaps = 35/238 (14%)
Query: 236 KIGEGGYGPVYRGKL-------DHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVL 288
++GEG +G V+ + D VA+K L+ + ++ FQ+E E+L+ ++H ++V
Sbjct: 48 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 107
Query: 289 LLGACPDYG--CLVYEYMHNGSLEDRLLRRGNTPVIPWRKR------------FKIAAEI 334
G C + +V+EYM +G L L G + +A+++
Sbjct: 108 FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 167
Query: 335 ATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSA 394
A +++L VHRDL N L+ + V KI D G++R + T Y+
Sbjct: 168 AAGMVYLAGLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIY------STDYYRVGG 218
Query: 395 AGTF--CYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSP-MGLTHH-VSRAIEKG 447
++ PE TT+SD++SFG++L +I T + P L++ I +G
Sbjct: 219 RTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQG 276
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 4e-35
Identities = 52/217 (23%), Positives = 83/217 (38%), Gaps = 29/217 (13%)
Query: 236 KIGEGGYGPVYRG--KLDHTPVAIKVLRPDAAQGKRQ-FQQEVEVLSSIRHPNMVLLL-- 290
+G+G V+RG K AIKV + +E EVL + H N+V L
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 291 --GACPDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEP 348
+ L+ E+ GSL L N +P + + ++ + L +
Sbjct: 76 EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--- 132
Query: 349 LVHRDLKPANILL----DRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPE 404
+VHR++KP NI+ D V K++D G AR + S GT Y+ P+
Sbjct: 133 IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE-------QFVSLYGTEEYLHPD 185
Query: 405 YQQTGMLTT--------KSDIYSFGIMLLQIITARSP 433
+ +L D++S G+ T P
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 5e-35
Identities = 68/282 (24%), Positives = 110/282 (39%), Gaps = 44/282 (15%)
Query: 236 KIGEGGYGPVYRGKL-----DHTPVAIKVLRPDA-AQGKRQFQQEVEVLSSIRHPNMVLL 289
IG G +G VY G L A+K L QF E ++ HPN++ L
Sbjct: 96 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 155
Query: 290 LGACPDYGCLVY---EYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKP 346
LG C YM +G L + + R T + ++A + FL K
Sbjct: 156 LGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMKFLASKK- 212
Query: 347 EPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSA--------AGTF 398
VHRDL N +LD + K++D GLAR + H + A
Sbjct: 213 --FVHRDLAARNCMLDEKFTVKVADFGLARDM---YDKEFDSVHNKTGAKLPVKWMA--- 264
Query: 399 CYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSP-MGLTHH-VSRAIEKGTLAEMLDP 455
E QT TTKSD++SFG++L +++T P + ++ + +G L
Sbjct: 265 ----LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG---RRLLQ 317
Query: 456 AVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPELNRL 497
P + ++ ++C + + RP +V ++ +
Sbjct: 318 -----PEYCPDPLYEVMLKCWHPKAEMRPSFSE-LVSRISAI 353
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 6e-35
Identities = 60/246 (24%), Positives = 102/246 (41%), Gaps = 49/246 (19%)
Query: 236 KIGEGGYGPVYRGKL-------DHTPVAIKVLRPDA-AQGKRQFQQEVEVLSSIRHPNMV 287
++GE +G VY+G L VAIK L+ A + +F+ E + + ++HPN+V
Sbjct: 16 ELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVV 75
Query: 288 LLLGACPDYG--CLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFK-------------IAA 332
LLG +++ Y +G L + L+ R + + + A
Sbjct: 76 CLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVA 135
Query: 333 EIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMT 392
+IA + +L +VH+DL N+L+ KISD+GL R V + Y +
Sbjct: 136 QIAAGMEYLSSHH---VVHKDLATRNVLVYDKLNVKISDLGLFREV-----YAADYYKLL 187
Query: 393 SA--------AGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSP-MGLTHH-VS 441
A PE G + SDI+S+G++L ++ + P G ++ V
Sbjct: 188 GNSLLPIRWMA-------PEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVV 240
Query: 442 RAIEKG 447
I
Sbjct: 241 EMIRNR 246
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 6e-35
Identities = 64/261 (24%), Positives = 106/261 (40%), Gaps = 32/261 (12%)
Query: 236 KIGEGGYGPVYRGKL-----DHTPVAIKVLRPDA-AQGKRQFQQEVEVLSSIRHPNMVLL 289
IGEG +G V++G VAIK + + +F QE + HP++V L
Sbjct: 397 CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 456
Query: 290 LGAC---PDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKP 346
+G P + ++ E G L L + + A +++TAL +L +
Sbjct: 457 IGVITENPVW--IIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYLESKR- 511
Query: 347 EPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQ 406
VHRD+ N+L+ N K+ D GL+R + + T Y + ++ PE
Sbjct: 512 --FVHRDIAARNVLVSSNDCVKLGDFGLSRYM-----EDSTYYKASKGKLPIKWMAPESI 564
Query: 407 QTGMLTTKSDIYSFGIMLLQIIT-ARSP-MGLTHH-VSRAIEKGTLAEMLDPAVTDWPAE 463
T+ SD++ FG+ + +I+ P G+ ++ V IE G E L P
Sbjct: 565 NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG---ERLPM-----PPN 616
Query: 464 AAESFSKLAIQCAELRKKDRP 484
+ L +C RP
Sbjct: 617 CPPTLYSLMTKCWAYDPSRRP 637
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 6e-35
Identities = 64/290 (22%), Positives = 111/290 (38%), Gaps = 52/290 (17%)
Query: 236 KIGEGGYGPVYRGKL-----DHTPVAIKVLRPDAA--QGKRQFQQEVEVLSSIRHPNMVL 288
+GEG +G V G L VA+K ++ D + + +F E + HPN++
Sbjct: 41 ILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIR 100
Query: 289 LLGACPDYGC-------LVYEYMHNGSLEDRLLRR---GNTPVIPWRKRFKIAAEIATAL 338
LLG C + ++ +M G L LL IP + K +IA +
Sbjct: 101 LLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGM 160
Query: 339 LFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSA---- 394
+L +HRDL N +L + ++D GL++ + S Y
Sbjct: 161 EYLSNRN---FLHRDLAARNCMLRDDMTVCVADFGLSKKI-----YSGDYYRQGRIAKMP 212
Query: 395 ----AGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSP-MGLTHH-VSRAIEKG 447
A E + T+KSD+++FG+ + +I T +P G+ +H + + G
Sbjct: 213 VKWIA-------IESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHG 265
Query: 448 TLAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPELNRL 497
L P + + ++ C DRP + +L +L
Sbjct: 266 ---HRLKQ-----PEDCLDELYEIMYSCWRTDPLDRPTFSV-LRLQLEKL 306
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 8e-35
Identities = 55/234 (23%), Positives = 92/234 (39%), Gaps = 31/234 (13%)
Query: 236 KIGEGGYGPVYRGKL-------DHTPVAIKVLRPDA-AQGKRQFQQEVEVLSSIRHPNMV 287
+G G +G VY G++ VA+K L Q + F E ++S H N+V
Sbjct: 37 GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 96
Query: 288 LLLGACPDYG--CLVYEYMHNGSLEDRLLRR----GNTPVIPWRKRFKIAAEIATALLFL 341
+G ++ E M G L+ L + +A +IA +L
Sbjct: 97 RCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 156
Query: 342 HQAKPEPLVHRDLKPANILLDR---NYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTF 398
+ +HRD+ N LL V+KI D G+AR + Y+
Sbjct: 157 EENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY------RASYYRKGGCAML 207
Query: 399 --CYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSP-MGLTHH-VSRAIEKG 447
++ PE G+ T+K+D +SFG++L +I + P ++ V + G
Sbjct: 208 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG 261
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 2e-34
Identities = 66/286 (23%), Positives = 123/286 (43%), Gaps = 37/286 (12%)
Query: 235 MKIGEGGYGPVYRGKL----DHTPVAIKVLRPDAAQGKRQ-FQQEVEVLSSIRHPNMVLL 289
+++G G +G V +G VAIKVL+ + + +E +++ + +P +V L
Sbjct: 342 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRL 401
Query: 290 LGAC---PDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKP 346
+G C LV E G L L+ + IP ++ +++ + +L +
Sbjct: 402 IGVCQAEALM--LVMEMAGGGPLHKFLVGKREE--IPVSNVAELLHQVSMGMKYLEEKN- 456
Query: 347 EPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCY--IDPE 404
VHR+L N+LL + +KISD GL++ + Y+ +AG + PE
Sbjct: 457 --FVHRNLAARNVLLVNRHYAKISDFGLSKALGAD-----DSYYTARSAGKWPLKWYAPE 509
Query: 405 YQQTGMLTTKSDIYSFGIMLLQIIT-ARSP-MGLTHH-VSRAIEKGTLAEMLDPAVTDWP 461
+++SD++S+G+ + + ++ + P + V IE+G + ++ P
Sbjct: 510 CINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG---KRMEC-----P 561
Query: 462 AEAAESFSKLAIQCAELRKKDRPDLGTVIVPELNRLKDLGRKLESN 507
E L C + +DRPD TV R++ L S
Sbjct: 562 PECPPELYALMSDCWIYKWEDRPDFLTV----EQRMRACYYSLASK 603
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 2e-34
Identities = 65/263 (24%), Positives = 105/263 (39%), Gaps = 75/263 (28%)
Query: 236 KIGEGGYGPVYRGKL-------DHTPVAIKVLRPDAAQGKRQ-FQQEVEVLSSIRHPNMV 287
+GEG +G V + +T VA+K+L+ +A+ + + E VL + HP+++
Sbjct: 30 TLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVI 89
Query: 288 LLLGACPDYG--CLVYEYMHNGSLEDRLLRR---------------------GNTPVIPW 324
L GAC G L+ EY GSL L + +
Sbjct: 90 KLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTM 149
Query: 325 RKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVAD 384
A +I+ + +L + K LVHRDL NIL+ KISD GL+R V
Sbjct: 150 GDLISFAWQISQGMQYLAEMK---LVHRDLAARNILVAEGRKMKISDFGLSRDV------ 200
Query: 385 SVTQYHMTSAAGTFCYIDPEYQQT--GML---------------TTKSDIYSFGIMLLQI 427
Y + Y + G + TT+SD++SFG++L +I
Sbjct: 201 ---------------YEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEI 245
Query: 428 IT-ARSP-MGLTHH-VSRAIEKG 447
+T +P G+ + ++ G
Sbjct: 246 VTLGGNPYPGIPPERLFNLLKTG 268
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 2e-34
Identities = 83/301 (27%), Positives = 132/301 (43%), Gaps = 53/301 (17%)
Query: 236 KIGEGGYGPVYRGKLD----HTPVAIKVLRPDA-AQGKRQFQQEVEVLSSI-RHPNMVLL 289
IGEG +G V + ++ AIK ++ A R F E+EVL + HPN++ L
Sbjct: 32 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 91
Query: 290 LGACPDYG--CLVYEYMHNGSLEDRLLRRGNTPVIPWRKRF-------------KIAAEI 334
LGAC G L EY +G+L D L + P AA++
Sbjct: 92 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 151
Query: 335 ATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSA 394
A + +L Q + +HRDL NIL+ NYV+KI+D GL+R + ++
Sbjct: 152 ARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSR---------GQEVYVKKT 199
Query: 395 AGTF--CYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSP-MGLTHH-VSRAIEKGTL 449
G ++ E + TT SD++S+G++L +I++ +P G+T + + +G
Sbjct: 200 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG-- 257
Query: 450 AEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPELNRLKDLGRKLESNKS 509
L+ P + L QC + +RP I+ LNR+ LE K+
Sbjct: 258 -YRLEK-----PLNCDDEVYDLMRQCWREKPYERPSFAQ-ILVSLNRM------LEERKT 304
Query: 510 Y 510
Y
Sbjct: 305 Y 305
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 2e-34
Identities = 57/277 (20%), Positives = 109/277 (39%), Gaps = 50/277 (18%)
Query: 236 KIGEGGYGPVYRG--KLDHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGAC 293
IG GG+G V++ ++D IK ++ + ++EV+ L+ + H N+V G
Sbjct: 18 LIGSGGFGQVFKAKHRIDGKTYVIKRVK----YNNEKAEREVKALAKLDHVNIVHYNGCW 73
Query: 294 PDYG------------------CLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIA 335
+ + E+ G+LE + +R + ++ +I
Sbjct: 74 DGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEK-LDKVLALELFEQIT 132
Query: 336 TALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAA 395
+ ++H K L++RDLKP+NI L KI D GL + T +
Sbjct: 133 KGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGK-------RTRSK 182
Query: 396 GTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDP 455
GT Y+ PE + + D+Y+ G++L +++ T + G ++++ D
Sbjct: 183 GTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDK 242
Query: 456 AVTDWPAEAAESFSKLAIQCAELRK--KDRPDLGTVI 490
L + L K +DRP+ ++
Sbjct: 243 K-----------EKTLLQKL--LSKKPEDRPNTSEIL 266
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 2e-34
Identities = 63/259 (24%), Positives = 99/259 (38%), Gaps = 71/259 (27%)
Query: 236 KIGEGGYGPVYRGKL-------DHTPVAIKVLRPDAAQGKRQ-FQQEVEVLSSI-RHPNM 286
+G G +G V VA+K+L+P A +R+ E++VLS + H N+
Sbjct: 30 TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNI 89
Query: 287 VLLLGACPDYG--CLVYEYMHNGSLEDRLLRR---------------GNTPVIPWRKRFK 329
V LLGAC G ++ EY G L + L R+ + +
Sbjct: 90 VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 149
Query: 330 IAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQY 389
+ ++A + FL +HRDL NILL ++KI D GLAR +
Sbjct: 150 FSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDI----------- 195
Query: 390 HMTSAAGTFCYIDPEYQQT--GML---------------TTKSDIYSFGIMLLQIIT-AR 431
D Y L T +SD++S+GI L ++ +
Sbjct: 196 ----------KNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGS 245
Query: 432 SP---MGLTHHVSRAIEKG 447
SP M + + I++G
Sbjct: 246 SPYPGMPVDSKFYKMIKEG 264
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 3e-34
Identities = 62/258 (24%), Positives = 105/258 (40%), Gaps = 70/258 (27%)
Query: 236 KIGEGGYGPVYRGKL---------DHTPVAIKVLRPDAAQGKRQ-FQQEVEVLSSI-RHP 284
+GEG +G V + + VA+K+L+ DA + E+E++ I +H
Sbjct: 42 PLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 101
Query: 285 NMVLLLGACPDYG--CLVYEYMHNGSLEDRLLRRGNTPVIPWRKR-------------FK 329
N++ LLGAC G ++ EY G+L + L R +
Sbjct: 102 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 330 IAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQY 389
++A + +L K +HRDL N+L+ N V KI+D GLAR +
Sbjct: 162 CTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLARDI----------- 207
Query: 390 HMTSAAGTFCYIDPEYQQT--GML---------------TTKSDIYSFGIMLLQIIT-AR 431
Y++T G L T +SD++SFG+++ +I T
Sbjct: 208 ----------NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGG 257
Query: 432 SP-MGLTHH-VSRAIEKG 447
SP G+ + + +++G
Sbjct: 258 SPYPGIPVEELFKLLKEG 275
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 3e-34
Identities = 50/216 (23%), Positives = 89/216 (41%), Gaps = 30/216 (13%)
Query: 236 KIGEGGYGPVYRGKLDHT-PVAIKVLRPDAAQGK--RQFQQEVEVLSSIRHPNM--VLLL 290
+IG GG V++ + AIK + + A + ++ E+ L+ ++ + + L
Sbjct: 35 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 94
Query: 291 GAC--PDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEP 348
Y +V E N L L ++ + I +R + A+ +HQ
Sbjct: 95 DYEITDQYIYMVMEC-GNIDLNSWLKKKKS---IDPWERKSYWKNMLEAVHTIHQHG--- 147
Query: 349 LVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPE---- 404
+VH DLKPAN L+ + K+ D G+A + T S GT Y+ PE
Sbjct: 148 IVHSDLKPANFLIVDGML-KLIDFGIANQMQ----PDTTSVVKDSQVGTVNYMPPEAIKD 202
Query: 405 -------YQQTGMLTTKSDIYSFGIMLLQIITARSP 433
+ ++ KSD++S G +L + ++P
Sbjct: 203 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 238
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 4e-34
Identities = 65/341 (19%), Positives = 128/341 (37%), Gaps = 32/341 (9%)
Query: 229 DKFSEAMKIGEGGYGPVYRG--KLDHTPVAIKVLRPDA--AQGKRQFQQEVEVLSSIRHP 284
+K+ KIGEG +G D IK + ++ + + ++EV VL++++HP
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 285 NMVLLLGACPDYGCL--VYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLH 342
N+V + + G L V +Y G L R+ + + +I AL +H
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVL-FQEDQILDWFVQICLALKHVH 142
Query: 343 QAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYID 402
K ++HRD+K NI L ++ ++ D G+AR++ + T + GT Y+
Sbjct: 143 DRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVL------NSTVELARACIGTPYYLS 193
Query: 403 PEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVS--RAIEKGTLAEMLDPAVTDW 460
PE + KSDI++ G +L ++ T + + I G+
Sbjct: 194 PEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGS--------FPPV 245
Query: 461 PAEAAESFSKLAIQCAELRK--KDRPDLGTVI-VPEL-NRLKDLGRKLESNKSYGYAKRE 516
+ L Q ++ +DRP + +++ + R++ + +
Sbjct: 246 SLHYSYDLRSLVSQL--FKRNPRDRPSVNSILEKGFIAKRIEKFLSPQLIAEEFCLKTFS 303
Query: 517 GHSHSGSGRTSHTRSNVPRSPPPLSSSSYSNSRISNPSSSQ 557
S P + ++ P + +
Sbjct: 304 KFGSQPIPAKRPASGQNSISVMPAQKITKPAAKYGIPLAYK 344
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 5e-34
Identities = 63/258 (24%), Positives = 98/258 (37%), Gaps = 70/258 (27%)
Query: 236 KIGEGGYGPVYRGKL-------DHTPVAIKVLRPDA-AQGKRQFQQEVEVLSSI-RHPNM 286
+G G +G V VA+K+L+ A R E+++L I H N+
Sbjct: 34 PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 93
Query: 287 VLLLGACPDYG---CLVYEYMHNGSLEDRLLRR-------------GNTPVIPWRKRFKI 330
V LLGAC G ++ E+ G+L L + +
Sbjct: 94 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 153
Query: 331 AAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYH 390
+ ++A + FL K +HRDL NILL V KI D GLAR +
Sbjct: 154 SFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDI------------ 198
Query: 391 MTSAAGTFCYIDPEYQQT--GML---------------TTKSDIYSFGIMLLQIIT-ARS 432
Y DP+Y + L T +SD++SFG++L +I + S
Sbjct: 199 ---------YKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS 249
Query: 433 P---MGLTHHVSRAIEKG 447
P + + R +++G
Sbjct: 250 PYPGVKIDEEFCRRLKEG 267
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 6e-34
Identities = 51/216 (23%), Positives = 87/216 (40%), Gaps = 30/216 (13%)
Query: 236 KIGEGGYGPVYRGKLDHT-PVAIKV--LRPDAAQGKRQFQQEVEVLSSIRHPNM--VLLL 290
+IG GG V++ + AIK L Q ++ E+ L+ ++ + + L
Sbjct: 16 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 75
Query: 291 GAC--PDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEP 348
Y +V E N L L ++ + I +R + A+ +HQ
Sbjct: 76 DYEITDQYIYMVMEC-GNIDLNSWLKKKKS---IDPWERKSYWKNMLEAVHTIHQHG--- 128
Query: 349 LVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPE---- 404
+VH DLKPAN L+ + K+ D G+A + T S GT Y+ PE
Sbjct: 129 IVHSDLKPANFLIVDGML-KLIDFGIANQMQ----PDTTSVVKDSQVGTVNYMPPEAIKD 183
Query: 405 -------YQQTGMLTTKSDIYSFGIMLLQIITARSP 433
+ ++ KSD++S G +L + ++P
Sbjct: 184 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 219
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 6e-34
Identities = 58/238 (24%), Positives = 93/238 (39%), Gaps = 64/238 (26%)
Query: 236 KIGEGGYGPVYRGKL-------DHTPVAIKVLRPDA-AQGKRQFQQEVEVLSSI-RHPNM 286
+G G +G V VA+K+L+ A A K E++++S + +H N+
Sbjct: 53 TLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENI 112
Query: 287 VLLLGACPDYG--CLVYEYMHNGSLEDRLLRRGNT-----------PVIPWRKRFKIAAE 333
V LLGAC G ++ EY G L + L R+ R +++
Sbjct: 113 VNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQ 172
Query: 334 IATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTS 393
+A + FL +HRD+ N+LL +V+KI D GLAR +
Sbjct: 173 VAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLARDI--------------- 214
Query: 394 AAGTFCYIDPEYQQT--GML---------------TTKSDIYSFGIMLLQIIT-ARSP 433
D Y L T +SD++S+GI+L +I + +P
Sbjct: 215 ------MNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 266
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 9e-34
Identities = 49/232 (21%), Positives = 87/232 (37%), Gaps = 30/232 (12%)
Query: 217 RKYTIEEIEEATDKFSEAMKIGEGGYGPVY--RGKLDHTPVAIKVLRPDAAQGKRQFQQE 274
+ Y + K+GEGG+ V G D A+K + Q + + Q+E
Sbjct: 29 KHYLFIQ------------KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQRE 76
Query: 275 VEVLSSIRHPNMVLLLGACPDYG------CLVYEYMHNGSLEDRLLRRG-NTPVIPWRKR 327
++ HPN++ L+ C L+ + G+L + + R + +
Sbjct: 77 ADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQI 136
Query: 328 FKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLV---PPSVAD 384
+ I L +H + HRDLKP NILL + D+G
Sbjct: 137 LWLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQ 193
Query: 385 SVTQYHMTSAAGTFCYIDPE---YQQTGMLTTKSDIYSFGIMLLQIITARSP 433
++T + T Y PE Q ++ ++D++S G +L ++ P
Sbjct: 194 ALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGP 245
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-33
Identities = 66/312 (21%), Positives = 112/312 (35%), Gaps = 82/312 (26%)
Query: 194 KAKREAEEKNRALTALANNDVRYRKYTIEEIEEAT------DKFSEAMKIGEGGYGPVYR 247
K + E + + + ++D Y E E + +G G +G V
Sbjct: 4 KKQFRYESQLQMVQVTGSSDNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMN 63
Query: 248 GKL-------DHTPVAIKVLRPDA-AQGKRQFQQEVEVLSSI-RHPNMVLLLGACPDYG- 297
VA+K+L+ A + + E+++++ + H N+V LLGAC G
Sbjct: 64 ATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 123
Query: 298 -CLVYEYMHNGSLEDRLLRR--------------------GNTPVIPWRKRFKIAAEIAT 336
L++EY G L + L + + V+ + A ++A
Sbjct: 124 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAK 183
Query: 337 ALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAG 396
+ FL VHRDL N+L+ V KI D GLAR +
Sbjct: 184 GMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARDI------------------ 222
Query: 397 TFCYIDPEYQQT--GML---------------TTKSDIYSFGIMLLQIIT-ARSP---MG 435
D Y L T KSD++S+GI+L +I + +P +
Sbjct: 223 ---MSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 279
Query: 436 LTHHVSRAIEKG 447
+ + + I+ G
Sbjct: 280 VDANFYKLIQNG 291
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 1e-33
Identities = 52/217 (23%), Positives = 83/217 (38%), Gaps = 29/217 (13%)
Query: 236 KIGEGGYGPVYRG--KLDHTPVAIKVLRPDAAQGKRQ-FQQEVEVLSSIRHPNMVLLL-- 290
+G+G V+RG K AIKV + +E EVL + H N+V L
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 291 --GACPDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEP 348
+ L+ E+ GSL L N +P + + ++ + L +
Sbjct: 76 EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--- 132
Query: 349 LVHRDLKPANILL----DRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPE 404
+VHR++KP NI+ D V K++D G AR + S GT Y+ P+
Sbjct: 133 IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE-------QFVSLYGTEEYLHPD 185
Query: 405 YQQTGMLTT--------KSDIYSFGIMLLQIITARSP 433
+ +L D++S G+ T P
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 4e-33
Identities = 62/258 (24%), Positives = 105/258 (40%), Gaps = 70/258 (27%)
Query: 236 KIGEGGYGPVYRGKL---------DHTPVAIKVLRPDA-AQGKRQFQQEVEVLSSI-RHP 284
+GEG +G V + + VA+K+L+ DA + E+E++ I +H
Sbjct: 88 PLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 147
Query: 285 NMVLLLGACPDYG--CLVYEYMHNGSLEDRLLRRGNTPVIPWRKR-------------FK 329
N++ LLGAC G ++ EY G+L + L R +
Sbjct: 148 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 207
Query: 330 IAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQY 389
++A + +L K +HRDL N+L+ N V KI+D GLAR +
Sbjct: 208 CTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLARDI----------- 253
Query: 390 HMTSAAGTFCYIDPEYQQT--GML---------------TTKSDIYSFGIMLLQIIT-AR 431
Y++T G L T +SD++SFG+++ +I T
Sbjct: 254 ----------NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGG 303
Query: 432 SP-MGLTHH-VSRAIEKG 447
SP G+ + + +++G
Sbjct: 304 SPYPGIPVEELFKLLKEG 321
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 4e-33
Identities = 54/234 (23%), Positives = 92/234 (39%), Gaps = 31/234 (13%)
Query: 236 KIGEGGYGPVYRGKL-------DHTPVAIKVLRPDAAQGKRQ-FQQEVEVLSSIRHPNMV 287
+G G +G VY G++ VA+K L ++ F E ++S H N+V
Sbjct: 78 GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 137
Query: 288 LLLGACPDYG--CLVYEYMHNGSLEDRLLRR----GNTPVIPWRKRFKIAAEIATALLFL 341
+G ++ E M G L+ L + +A +IA +L
Sbjct: 138 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 197
Query: 342 HQAKPEPLVHRDLKPANILLDR---NYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTF 398
+ +HRD+ N LL V+KI D G+AR + Y+
Sbjct: 198 EENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY------RAGYYRKGGCAML 248
Query: 399 --CYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSP-MGLTHH-VSRAIEKG 447
++ PE G+ T+K+D +SFG++L +I + P ++ V + G
Sbjct: 249 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG 302
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 5e-33
Identities = 51/213 (23%), Positives = 88/213 (41%), Gaps = 34/213 (15%)
Query: 236 KIGEGGYGPVYRGKLDHT---PVAIKVLRPDAAQG---KRQFQQEVEVLSSIRHPNMVLL 289
+G GG G VY + D VA+K++ + + + Q+E ++ P++V
Sbjct: 41 LVGRGGMGDVYEAE-DTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVV-- 97
Query: 290 LGACPDYGC------LVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQ 343
D+G + ++ L L R+G + + I +I +AL H
Sbjct: 98 --PIHDFGEIDGQLYVDMRLINGVDLAAMLRRQG---PLAPPRAVAIVRQIGSALDAAHA 152
Query: 344 AKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAA---GTFCY 400
A HRD+KP NIL+ + + + D G+A + T +T GT Y
Sbjct: 153 AG---ATHRDVKPENILVSADDFAYLVDFGIAS--------ATTDEKLTQLGNTVGTLYY 201
Query: 401 IDPEYQQTGMLTTKSDIYSFGIMLLQIITARSP 433
+ PE T ++DIY+ +L + +T P
Sbjct: 202 MAPERFSESHATYRADIYALTCVLYECLTGSPP 234
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 5e-33
Identities = 64/243 (26%), Positives = 110/243 (45%), Gaps = 40/243 (16%)
Query: 236 KIGEGGYGPVYRGKL---------DHTPVAIKVLRPDA-AQGKRQFQQEVEVLSSI-RHP 284
+GEG +G V + T VA+K+L+ DA + E+E++ I +H
Sbjct: 76 PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 135
Query: 285 NMVLLLGACPDYG--CLVYEYMHNGSLEDRLLRR-------------GNTPVIPWRKRFK 329
N++ LLGAC G ++ EY G+L + L R + +
Sbjct: 136 NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 195
Query: 330 IAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQY 389
A ++A + +L K +HRDL N+L+ + V KI+D GLAR + Y
Sbjct: 196 CAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDI------HHIDY 246
Query: 390 HMTSAAGTF--CYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSP-MGLTHH-VSRAI 444
+ + G ++ PE + T +SD++SFG++L +I T SP G+ + + +
Sbjct: 247 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL 306
Query: 445 EKG 447
++G
Sbjct: 307 KEG 309
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 1e-32
Identities = 61/213 (28%), Positives = 95/213 (44%), Gaps = 17/213 (7%)
Query: 229 DKFSEAMKIGEGGYGPVYRG--KLDHTPVAIK---VLRPDAAQGKRQFQQEVEVLSSIRH 283
F KIG G + VYR LD PVA+K + A+ + +E+++L + H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 284 PNMVLLLGACPDYGCL--VYEYMHNGSLEDRLLRRGNTPV-IPWRKRFKIAAEIATALLF 340
PN++ + + L V E G L + IP R +K ++ +AL
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 341 LHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCY 400
+H + ++HRD+KPAN+ + V K+ D+GL R S S GT Y
Sbjct: 152 MHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFF------SSKTTAAHSLVGTPYY 202
Query: 401 IDPEYQQTGMLTTKSDIYSFGIMLLQIITARSP 433
+ PE KSDI+S G +L ++ +SP
Sbjct: 203 MSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 235
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 3e-32
Identities = 67/342 (19%), Positives = 122/342 (35%), Gaps = 45/342 (13%)
Query: 236 KIGEGGYGPVYRGKLDHT-PVAIKV--LRPDAAQGKRQFQQEVEVLSSIRHPNM--VLLL 290
+IG GG V++ + AIK L Q ++ E+ L+ ++ + + L
Sbjct: 63 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 122
Query: 291 GAC--PDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEP 348
Y +V E N L L ++ + I +R + A+ +HQ
Sbjct: 123 DYEITDQYIYMVMEC-GNIDLNSWLKKKKS---IDPWERKSYWKNMLEAVHTIHQHG--- 175
Query: 349 LVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPE---- 404
+VH DLKPAN L+ + K+ D G+A + T S G Y+ PE
Sbjct: 176 IVHSDLKPANFLIVDGML-KLIDFGIANQMQ----PDTTSVVKDSQVGAVNYMPPEAIKD 230
Query: 405 -------YQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAV 457
+ ++ KSD++S G +L + ++P + I K L ++DP
Sbjct: 231 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF---QQIINQISK--LHAIIDPNH 285
Query: 458 T-DWPAEAAESFSKLAIQCAELRKKDRPD---------LGTVIVPELNRLKDLGRKLESN 507
++P + + C + K R + P K +++
Sbjct: 286 EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMKYV 345
Query: 508 KSYGYAKREGHSHSGSGRTSHTRSNVPRSPPPLSSSSYSNSR 549
+S + +T + + S SS ++ R
Sbjct: 346 LGQLVGLNSPNSILKAAKTLYEHYSGGESHNSSSSKTFEKKR 387
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 5e-32
Identities = 56/217 (25%), Positives = 86/217 (39%), Gaps = 19/217 (8%)
Query: 229 DKFSEAMKIGEGGYGPVY--RGKLDHTPVAIKVLRPDA--AQGKRQFQQEVEVLSSIRHP 284
+ + IG G YG R K D + K L + K+ EV +L ++HP
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 285 NMVLLLGACPDYG----CLVYEYMHNGSLEDRL--LRRGNTPVIPWRKRFKIAAEIATAL 338
N+V D +V EY G L + + + ++ ++ AL
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQY-LDEEFVLRVMTQLTLAL 124
Query: 339 LFLHQAKPEPL--VHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAG 396
H+ +HRDLKPAN+ LD K+ D GLAR++ + + G
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL------NHDTSFAKTFVG 178
Query: 397 TFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSP 433
T Y+ PE KSDI+S G +L ++ P
Sbjct: 179 TPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP 215
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 5e-32
Identities = 65/263 (24%), Positives = 109/263 (41%), Gaps = 75/263 (28%)
Query: 236 KIGEGGYGPVYRGKLDH-------TPVAIKVLRPDAAQGKRQ-FQQEVEVLSSIRHPNMV 287
IGEG +G V++ + T VA+K+L+ +A+ + FQ+E +++ +PN+V
Sbjct: 54 DIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIV 113
Query: 288 LLLGACPDYG--CLVYEYMHNGSLEDRLLRR---------------------GNTPVIPW 324
LLG C CL++EYM G L + L P +
Sbjct: 114 KLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSC 173
Query: 325 RKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVAD 384
++ IA ++A + +L + K VHRDL N L+ N V KI+D GL+R +
Sbjct: 174 AEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNI------ 224
Query: 385 SVTQYHMTSAAGTFCYIDPEYQQT--GML---------------TTKSDIYSFGIMLLQI 427
Y Y+ + TT+SD++++G++L +I
Sbjct: 225 ---------------YSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEI 269
Query: 428 IT-ARSP-MGLTHH-VSRAIEKG 447
+ P G+ H V + G
Sbjct: 270 FSYGLQPYYGMAHEEVIYYVRDG 292
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 5e-32
Identities = 39/239 (16%), Positives = 73/239 (30%), Gaps = 35/239 (14%)
Query: 220 TIEEIEEATDKFSEAMKIGEGGYGPVYRGKLDHTP-------VAIKVLRPDAAQGKRQFQ 272
E + + +GEG + VY +KV +P
Sbjct: 56 PKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGT 115
Query: 273 QEVEVLSSIRHPNMVLLLGAC--PDYGCLVYEYMHNGSLEDRLLRRGNTP--VIPWRKRF 328
Q +E L + A + LV E G+L + + NTP V+P
Sbjct: 116 QLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVI 175
Query: 329 KIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVS-----------KISDVGLA-- 375
A + + +H + ++H D+KP N +L ++ + D+G +
Sbjct: 176 SFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSID 232
Query: 376 -RLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSP 433
+L P T+ T + E + D + + ++
Sbjct: 233 MKLFPKGTI-------FTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM 284
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 5e-31
Identities = 54/213 (25%), Positives = 80/213 (37%), Gaps = 23/213 (10%)
Query: 229 DKFSEAMKIGEGGYGPVYRG--KLDHTPVAIKVLRPDAAQGK--RQFQQEVEVLSSI-RH 283
F ++G G YG V++ K D A+K K + EV + +H
Sbjct: 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116
Query: 284 PNMVLLLGACPDYGCL--VYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFL 341
P V L A + G L E SL+ G + +P + + + AL L
Sbjct: 117 PCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGAS--LPEAQVWGYLRDTLLALAHL 173
Query: 342 HQAKPEPLVHRDLKPANILLDRNYVSKISDVGLAR-LVPPSVADSVTQYHMTSAAGTFCY 400
H LVH D+KPANI L K+ D GL L + G Y
Sbjct: 174 HSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQE--------GDPRY 222
Query: 401 IDPEYQQTGMLTTKSDIYSFGIMLLQIITARSP 433
+ PE Q T +D++S G+ +L++
Sbjct: 223 MAPELLQGS-YGTAADVFSLGLTILEVACNMEL 254
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 5e-31
Identities = 50/209 (23%), Positives = 81/209 (38%), Gaps = 31/209 (14%)
Query: 236 KIGEGGYGPVYRGK---LDHTPVAIKVLRPDA-AQGKRQFQQEVEVLSSIRHPNMVLLL- 290
I GG G +Y ++ PV +K L A+ + E + L+ + HP++V +
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146
Query: 291 -GACPDYGC-----LVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQA 344
D +V EY+ SL+ ++ +P + EI AL +LH
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK-----LPVAEAIAYLLEILPALSYLHSI 201
Query: 345 KPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPE 404
LV+ DLKP NI+L + K+ D+G + + GT + PE
Sbjct: 202 ---GLVYNDLKPENIMLTEEQL-KLIDLGAVS--------RINSFGY--LYGTPGFQAPE 247
Query: 405 YQQTGMLTTKSDIYSFGIMLLQIITARSP 433
T +DIY+ G L +
Sbjct: 248 -IVRTGPTVATDIYTVGRTLAALTLDLPT 275
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 8e-31
Identities = 59/212 (27%), Positives = 95/212 (44%), Gaps = 24/212 (11%)
Query: 236 KIGEGGYGPVYRG--KLDHTPVAIKVLRPDAAQGKRQ-FQQEVEVLSSIRHPNMVLLL-- 290
++G GG+G V R + VAIK R + + R+ + E++++ + HPN+V
Sbjct: 21 RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREV 80
Query: 291 ------GACPDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQA 344
A D L EY G L L + N + + ++I++AL +LH+
Sbjct: 81 PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN 140
Query: 345 KPEPLVHRDLKPANILLDRN---YVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYI 401
+ ++HRDLKP NI+L + KI D+G A+ + T GT Y+
Sbjct: 141 R---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQ-------GELCTEFVGTLQYL 190
Query: 402 DPEYQQTGMLTTKSDIYSFGIMLLQIITARSP 433
PE + T D +SFG + + IT P
Sbjct: 191 APELLEQKKYTVTVDYWSFGTLAFECITGFRP 222
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 4e-30
Identities = 45/195 (23%), Positives = 78/195 (40%), Gaps = 19/195 (9%)
Query: 237 IGEGGYGPVYRGKLDHT--PVAIKVLRPDAAQGKR---QFQQEVEVLSSIRHPNMVLLLG 291
+G+GG+ + T A K++ + E+ + S+ H ++V G
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 292 --ACPDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPL 349
D+ +V E SL + RR R + +I +LH+ + +
Sbjct: 83 FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR---QIVLGCQYLHRNR---V 136
Query: 350 VHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTG 409
+HRDLK N+ L+ + KI D GLA V + + GT YI PE
Sbjct: 137 IHRDLKLGNLFLNEDLEVKIGDFGLATKV-----EYDGERKKVL-CGTPNYIAPEVLSKK 190
Query: 410 MLTTKSDIYSFGIML 424
+ + D++S G ++
Sbjct: 191 GHSFEVDVWSIGCIM 205
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 5e-30
Identities = 52/238 (21%), Positives = 86/238 (36%), Gaps = 34/238 (14%)
Query: 217 RKYTIEEIEEATDKFSEAMKIGEGGYGPVY--RGKLDHTPVAIKVLRPDAAQGKRQFQQE 274
+ + + EGG+ VY + A+K L + + R QE
Sbjct: 28 LRLRVRR------------VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQE 75
Query: 275 VEVLSSIR-HPNMVLLLGAC---------PDYGCLVYEYMHNGSLEDRLLRRGNTPVIPW 324
V + + HPN+V A L+ + G L + L + + +
Sbjct: 76 VCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSC 135
Query: 325 RKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARL--VPPSV 382
KI + A+ +H+ KP P++HRDLK N+LL K+ D G A P
Sbjct: 136 DTVLKIFYQTCRAVQHMHRQKP-PIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDY 194
Query: 383 ADSVTQYHMTSAAGTFC----YIDPE---YQQTGMLTTKSDIYSFGIMLLQIITARSP 433
+ S + + T Y PE + K DI++ G +L + + P
Sbjct: 195 SWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP 252
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 5e-30
Identities = 56/203 (27%), Positives = 89/203 (43%), Gaps = 37/203 (18%)
Query: 237 IGEGGYGPVYRGKLDHT--PVAIKVLRPDAAQGKRQFQQ---EVEVLSSIRHPNMVLLLG 291
+G+G +G VY + + +A+KVL + Q EVE+ S +RHPN++ L G
Sbjct: 17 LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 292 ACPD----YGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRF------KIAAEIATALLFL 341
D Y L+ EY G++ L + +F E+A AL +
Sbjct: 77 YFHDATRVY--LILEYAPLGTVYRELQKLS---------KFDEQRTATYITELANALSYC 125
Query: 342 HQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYI 401
H + ++HRD+KP N+LL KI+D G + P + GT Y+
Sbjct: 126 HSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP-------SSRRTDL-CGTLDYL 174
Query: 402 DPEYQQTGMLTTKSDIYSFGIML 424
PE + M K D++S G++
Sbjct: 175 PPEMIEGRMHDEKVDLWSLGVLC 197
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 6e-30
Identities = 59/267 (22%), Positives = 103/267 (38%), Gaps = 44/267 (16%)
Query: 236 KIGEGGYGPV-YRGKLDHTPVAIKVLRPDAAQGKRQFQQEVEVLS-SIRHPNMVLLLGAC 293
+G G G V ++G PVA+K + D E+++L+ S HPN++ +
Sbjct: 22 ILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCD---IALMEIKLLTESDDHPNVIRYYCSE 78
Query: 294 --PDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAE----IATALLFLHQAKPE 347
+ + E N +L+D + + + ++ IA+ + LH K
Sbjct: 79 TTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK-- 135
Query: 348 PLVHRDLKPANILLD-------------RNYVSKISDVGLARLVPPSVADSVTQYHMTSA 394
++HRDLKP NIL+ N ISD GL + + S + ++ +
Sbjct: 136 -IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSG--QSSFRTNLNNP 192
Query: 395 AGTFCYIDPE-------YQQTGMLTTKSDIYSFGIMLLQIITA-RSPMGLTHHVSRAIEK 446
+GT + PE Q LT DI+S G + I++ + P G + I +
Sbjct: 193 SGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIR 252
Query: 447 GTLAEMLDPAVTDWPAEAAESFSKLAI 473
G ++ + S A
Sbjct: 253 G------IFSLDEMKCLHDRSLIAEAT 273
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 8e-30
Identities = 52/216 (24%), Positives = 86/216 (39%), Gaps = 24/216 (11%)
Query: 230 KFSEAMKIGEGGYGP-VYRGKLDHTPVAIKVLRPDAAQGKRQFQQEVEVLS-SIRHPNMV 287
F +G G G VYRG D+ VA+K + P+ + EV++L S HPN++
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADR---EVQLLRESDEHPNVI 81
Query: 288 LLLGAC--PDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAK 345
+ + E +L++ + ++ + + + + L LH
Sbjct: 82 RYFCTEKDRQFQYIAIELC-AATLQEYVEQKDFAH--LGLEPITLLQQTTSGLAHLHSLN 138
Query: 346 PEPLVHRDLKPANILL-----DRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCY 400
+VHRDLKP NIL+ + ISD GL + + + + GT +
Sbjct: 139 ---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAV---GRHSFSRRSGVPGTEGW 192
Query: 401 IDPEY---QQTGMLTTKSDIYSFGIMLLQIITARSP 433
I PE T DI+S G + +I+ S
Sbjct: 193 IAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH 228
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-29
Identities = 42/221 (19%), Positives = 82/221 (37%), Gaps = 48/221 (21%)
Query: 236 KIGEGGYGPVYRGKLDHTPVAIKVL-----------------RPDAAQGKRQFQQEVEVL 278
+ +G + + + D+ A+K + F+ E++++
Sbjct: 38 TLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 279 SSIRHPNMVLLLG--ACPDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRF------KI 330
+ I++ + G D ++YEYM N S+ I
Sbjct: 98 TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNY-TCFIPIQVIKCI 156
Query: 331 AAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYH 390
+ + ++H K + HRD+KP+NIL+D+N K+SD G + +
Sbjct: 157 IKSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK--------K 206
Query: 391 MTSAAGTFCYIDPEYQQTGMLTTK-------SDIYSFGIML 424
+ + GT+ ++ PE + + DI+S GI L
Sbjct: 207 IKGSRGTYEFMPPE-----FFSNESSYNGAKVDIWSLGICL 242
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-29
Identities = 54/256 (21%), Positives = 92/256 (35%), Gaps = 33/256 (12%)
Query: 187 RRKQAELKAKREAEEKNRALTALANNDVRYRKYTIEEIEEATDKFSEAMKIGEGGYGPVY 246
K L + E E L D YR E + ++G G +G V+
Sbjct: 24 SAKLQRLGPETEDNEGVLLTEKLKPVDYEYR--------EEVHWMTHQPRVGRGSFGEVH 75
Query: 247 RGKLDHT--PVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACPDYGCL--VYE 302
R K T A+K +R + + +E+ + + P +V L GA + + E
Sbjct: 76 RMKDKQTGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGAVREGPWVNIFME 130
Query: 303 YMHNGSLEDRLLRRGNT---PVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANI 359
+ GSL L+++ + L +LH + ++H D+K N+
Sbjct: 131 LLEGGSLGQ-LIKQMGCLPEDRAL-----YYLGQALEGLEYLHTRR---ILHGDVKADNV 181
Query: 360 LLDRNYVS-KISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPE-YQQTGMLTTKSDI 417
LL + + D G A + P + GT ++ PE K DI
Sbjct: 182 LLSSDGSRAALCDFGHALCLQPDGLGK-SLLTGDYIPGTETHMAPEVVMGKP-CDAKVDI 239
Query: 418 YSFGIMLLQIITARSP 433
+S M+L ++ P
Sbjct: 240 WSSCCMMLHMLNGCHP 255
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-29
Identities = 66/291 (22%), Positives = 126/291 (43%), Gaps = 30/291 (10%)
Query: 185 AQRRKQAELKAKREAEEKNRALTALANNDVRYRKYTIEEIEEATDKFSEAMKIGEGGYGP 244
++ ++ EL E++ + L A + + ++ E+ + ++G G G
Sbjct: 1 GKKLEELELD-----EQQRKRLEAFLTQKQKVGELKDDDFEKIS-------ELGAGNGGV 48
Query: 245 VYRG--KLDHTPVAIKVLRPDAAQGKR-QFQQEVEVLSSIRHPNMVLLLGACPDYGCLVY 301
V++ K +A K++ + R Q +E++VL P +V GA G +
Sbjct: 49 VFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 108
Query: 302 --EYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANI 359
E+M GSL+ +L++ IP + K++ + L +L + ++HRD+KP+NI
Sbjct: 109 CMEHMDGGSLDQ-VLKKAGR--IPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNI 163
Query: 360 LLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYS 419
L++ K+ D G++ + S+A+S GT Y+ PE Q + +SDI+S
Sbjct: 164 LVNSRGEIKLCDFGVSGQLIDSMANSF--------VGTRSYMSPERLQGTHYSVQSDIWS 215
Query: 420 FGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAVTDWPAEAAESFSK 470
G+ L+++ R P+ + G E P +K
Sbjct: 216 MGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNK 266
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 3e-29
Identities = 45/195 (23%), Positives = 78/195 (40%), Gaps = 19/195 (9%)
Query: 237 IGEGGYGPVYRGKLDHT--PVAIKVLRPDAAQGKR---QFQQEVEVLSSIRHPNMVLLLG 291
+G+GG+ + T A K++ + E+ + S+ H ++V G
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 292 --ACPDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPL 349
D+ +V E SL + RR R + +I +LH+ + +
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR---QIVLGCQYLHRNR---V 162
Query: 350 VHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTG 409
+HRDLK N+ L+ + KI D GLA V + + GT YI PE
Sbjct: 163 IHRDLKLGNLFLNEDLEVKIGDFGLATKV-----EYDGERKKVL-CGTPNYIAPEVLSKK 216
Query: 410 MLTTKSDIYSFGIML 424
+ + D++S G ++
Sbjct: 217 GHSFEVDVWSIGCIM 231
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 4e-29
Identities = 58/275 (21%), Positives = 103/275 (37%), Gaps = 30/275 (10%)
Query: 228 TDKFSEAMKIGEGGYGPVYRG--KLDHTPVAIK-VLRPDAAQGKRQFQ-QEVEVLSSI-R 282
T +F E KIG G +G V++ +LD AIK +P A Q +EV + + +
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 283 HPNMVLLLGACPDYGCL--VYEYMHNGSLEDRLLRRGNTP-VIPWRKRFKIAAEIATALL 339
H ++V A + + EY + GSL D + + + ++ L
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129
Query: 340 FLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPS------VAD--SVTQY-H 390
++H LVH D+KP+NI + R + + S + D VT+
Sbjct: 130 YIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS 186
Query: 391 MTSAAGTFCYIDPE-YQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTL 449
G ++ E Q+ K+DI++ + ++ A I +G L
Sbjct: 187 PQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQW-HEIRQGRL 245
Query: 450 AEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRP 484
+ P ++ F++L + RP
Sbjct: 246 PRI--------PQVLSQEFTELLKVMIHPDPERRP 272
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-28
Identities = 63/212 (29%), Positives = 93/212 (43%), Gaps = 52/212 (24%)
Query: 237 IGEGGYGPVYRGKLDHT--PVAIKVL---RPDAAQGKRQFQQEVEVLSSIRHPNMVLLLG 291
+G+G + VYR + HT VAIK++ A ++ Q EV++ ++HP+++ L
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILEL-- 76
Query: 292 ACPDYGC--------LVYEYMHNGSLEDRLLRRGNTPVIPWRKRF------KIAAEIATA 337
Y LV E HNG + L R K F +I T
Sbjct: 77 ----YNYFEDSNYVYLVLEMCHNGEMNRYLKNRV--------KPFSENEARHFMHQIITG 124
Query: 338 LLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGT 397
+L+LH ++HRDL +N+LL RN KI+D GLA + + H T GT
Sbjct: 125 MLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLA-----TQLKMPHEKHYTL-CGT 175
Query: 398 FCYIDPEYQQTGMLT-----TKSDIYSFGIML 424
YI PE + T +SD++S G M
Sbjct: 176 PNYISPE-----IATRSAHGLESDVWSLGCMF 202
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 3e-28
Identities = 56/203 (27%), Positives = 92/203 (45%), Gaps = 37/203 (18%)
Query: 237 IGEGGYGPVY--RGKLDHTPVAIKVLRPDAAQGKR---QFQQEVEVLSSIRHPNMVLLLG 291
+G+G +G VY R K + +A+KVL + + Q ++E+E+ S +RHPN++ +
Sbjct: 22 LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81
Query: 292 ACPD----YGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRF------KIAAEIATALLFL 341
D Y L+ E+ G L L + G RF E+A AL +
Sbjct: 82 YFHDRKRIY--LMLEFAPRGELYKELQKHG---------RFDEQRSATFMEELADALHYC 130
Query: 342 HQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYI 401
H+ K ++HRD+KP N+L+ KI+D G + P + T GT Y+
Sbjct: 131 HERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAP-------SLRRRTM-CGTLDYL 179
Query: 402 DPEYQQTGMLTTKSDIYSFGIML 424
PE + K D++ G++
Sbjct: 180 PPEMIEGKTHDEKVDLWCAGVLC 202
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 6e-28
Identities = 56/294 (19%), Positives = 99/294 (33%), Gaps = 71/294 (24%)
Query: 229 DKFSEAMKIGEGGYGPVY--RGKLDHTPVAIKVLR-PDAAQGKRQFQQEVEVLSSIRHPN 285
F +G GG+G V+ + K+D AIK +R P+ + + +EV+ L+ + HP
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 286 MVLLLGACPDYGCLVYEYMHNGSL---------------------EDRLLRRGNTPVIPW 324
+V A + ++ + + R + +T
Sbjct: 66 IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125
Query: 325 RKRF--------------------------------------KIAAEIATALLFLHQAKP 346
+ + I +IA A+ FLH
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG- 184
Query: 347 EPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQY------HMTSAAGTFCY 400
L+HRDLKP+NI + V K+ D GL + + T GT Y
Sbjct: 185 --LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242
Query: 401 IDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLD 454
+ PE + K DI+S G++L +++ + S + + +
Sbjct: 243 MSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVRIITDVRNLKFPLLFT 296
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-27
Identities = 54/211 (25%), Positives = 90/211 (42%), Gaps = 17/211 (8%)
Query: 236 KIGEGGYGPVYRG--KLDHTPVAIKVLRPDAAQGKRQ-FQQEVEVLSSIRHPNMVLLLGA 292
IG G V VAIK + + Q +E++ +S HPN+V +
Sbjct: 22 VIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTS 81
Query: 293 --CPDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFK---IAA---EIATALLFLHQA 344
D LV + + GS+ D +++ IA E+ L +LH+
Sbjct: 82 FVVKDELWLVMKLLSGGSVLD-IIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN 140
Query: 345 KPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPE 404
+HRD+K NILL + +I+D G++ + + + T GT C++ PE
Sbjct: 141 G---QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTF-VGTPCWMAPE 196
Query: 405 -YQQTGMLTTKSDIYSFGIMLLQIITARSPM 434
+Q K+DI+SFGI +++ T +P
Sbjct: 197 VMEQVRGYDFKADIWSFGITAIELATGAAPY 227
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 4e-27
Identities = 70/268 (26%), Positives = 112/268 (41%), Gaps = 37/268 (13%)
Query: 236 KIGEGGYGPVYRG--KLDHTPVAIKVLRPDAAQGKR-QFQQEVEV-LSSIRHPNMVLLLG 291
+IG G YG V + K +A+K +R + ++ Q +++V + S P +V G
Sbjct: 29 EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYG 88
Query: 292 ACPDYGCL--VYEYMHNGSLEDRLLRRGNTPVIPWRKRF--KIAAEIATALLFLHQAKPE 347
A G E M + S + + + KI AL L +
Sbjct: 89 ALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK- 146
Query: 348 PLVHRDLKPANILLDRNYVSKISDVGL-ARLVPPSVADSVTQYHMTSAAGTFCY-----I 401
++HRD+KP+NILLDR+ K+ D G+ +LV DS+ + T AG Y I
Sbjct: 147 -IIHRDIKPSNILLDRSGNIKLCDFGISGQLV-----DSIAK---TRDAGCRPYMAPERI 197
Query: 402 DPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRA---IEKGTLAEMLDPAVT 458
DP + G +SD++S GI L ++ T R P + V + KG ++ +
Sbjct: 198 DPSASRQGY-DVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEER 256
Query: 459 DWPAEAAESFSKLAIQCAELRK--KDRP 484
++ +F C L K RP
Sbjct: 257 EFSPS-FINFVN---LC--LTKDESKRP 278
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 4e-27
Identities = 53/206 (25%), Positives = 97/206 (47%), Gaps = 20/206 (9%)
Query: 237 IGEGGYGPVYRGKLDHT--PVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACP 294
+G+G YG VY G+ +AIK + ++ + +E+ + ++H N+V LG+
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 295 DYGCL--VYEYMHNGSLEDRLLRRGNTPVIPWRKRF--KIAAEIATALLFLHQAKPEPLV 350
+ G + E + GSL LLR P + ++ +I L +LH + +V
Sbjct: 90 ENGFIKIFMEQVPGGSLSA-LLRSKWGP-LKDNEQTIGFYTKQILEGLKYLHDNQ---IV 144
Query: 351 HRDLKPANILLD-RNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPE--YQQ 407
HRD+K N+L++ + V KISD G ++ + + + GT Y+ PE +
Sbjct: 145 HRDIKGDNVLINTYSGVLKISDFGTSKRL------AGINPCTETFTGTLQYMAPEIIDKG 198
Query: 408 TGMLTTKSDIYSFGIMLLQIITARSP 433
+DI+S G ++++ T + P
Sbjct: 199 PRGYGKAADIWSLGCTIIEMATGKPP 224
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 5e-27
Identities = 54/217 (24%), Positives = 91/217 (41%), Gaps = 25/217 (11%)
Query: 229 DKFSEAMKIGEGGYGPVYRG--KLDHTPVAIKVLRPDAAQGKR-QFQQEVEVL-SSIRHP 284
+ ++G G G V++ + +A+K +R + + + +++V+ S P
Sbjct: 25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCP 84
Query: 285 NMVLLLGACPDYGCL--VYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLH 342
+V G + E M E R IP R K+ I AL +L
Sbjct: 85 YIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQGP--IPERILGKMTVAIVKALYYLK 141
Query: 343 QAKPEPLVHRDLKPANILLDRNYVSKISDVGL-ARLVPPSVADSVTQYHMTSAAGTFCY- 400
+ ++HRD+KP+NILLD K+ D G+ RLV D + +AG Y
Sbjct: 142 EKHG--VIHRDVKPSNILLDERGQIKLCDFGISGRLV-----DDKAK---DRSAGCAAYM 191
Query: 401 ----IDPEYQQTGMLTTKSDIYSFGIMLLQIITARSP 433
IDP ++D++S GI L+++ T + P
Sbjct: 192 APERIDPPDPTKPDYDIRADVWSLGISLVELATGQFP 228
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 57/214 (26%), Positives = 93/214 (43%), Gaps = 37/214 (17%)
Query: 237 IGEGGYGPVY--RGKLDHTPVAIKVLRPDAAQGKRQFQQ---EVEVLSSIRHPNMVLLLG 291
+GEG + V R AIK+L + + E +V+S + HP V L
Sbjct: 38 LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 97
Query: 292 AC--PDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPL 349
+ Y NG L + + G+ RF AEI +AL +LH +
Sbjct: 98 TFQDDEKLYFGLSYAKNGELLKYIRKIGSFD--ETCTRF-YTAEIVSALEYLHGKG---I 151
Query: 350 VHRDLKPANILLDRN-YVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFC----YIDPE 404
+HRDLKP NILL+ + ++ +I+D G A+++ P + +F Y+ PE
Sbjct: 152 IHRDLKPENILLNEDMHI-QITDFGTAKVLSPESKQARAN--------SFVGTAQYVSPE 202
Query: 405 YQQTGMLTTK-----SDIYSFGIMLLQIITARSP 433
+LT K SD+++ G ++ Q++ P
Sbjct: 203 -----LLTEKSACKSSDLWALGCIIYQLVAGLPP 231
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 1e-26
Identities = 70/269 (26%), Positives = 121/269 (44%), Gaps = 43/269 (15%)
Query: 236 KIGEGGYGPVYRG--KLDHTPVAIKVLRPDAAQGKR-QFQQEVEV-LSSIRHPNMVLLLG 291
++G G YG V + +A+K +R ++ + ++++ + ++ P V G
Sbjct: 14 ELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYG 73
Query: 292 ACPDYGCL--VYEYMHNGSLED---RLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKP 346
A G + E M + SL+ +++ +G T IP KIA I AL LH
Sbjct: 74 ALFREGDVWICMELM-DTSLDKFYKQVIDKGQT--IPEDILGKIAVSIVKALEHLHSKLS 130
Query: 347 EPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCY-----I 401
++HRD+KP+N+L++ K+ D G++ + VA AG Y I
Sbjct: 131 --VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVA-------KDIDAGCKPYMAPERI 181
Query: 402 DPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAVTDWP 461
+PE Q G + KSDI+S GI ++++ R P + ++ + +P+ P
Sbjct: 182 NPELNQKGY-SVKSDIWSLGITMIELAILRFPYDSWGTPFQQLK----QVVEEPS----P 232
Query: 462 AEAAESFSKLAI----QCAELRK--KDRP 484
A+ FS + QC L+K K+RP
Sbjct: 233 QLPADKFSAEFVDFTSQC--LKKNSKERP 259
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 3e-26
Identities = 39/327 (11%), Positives = 80/327 (24%), Gaps = 57/327 (17%)
Query: 174 AEKAQKLADAEAQRRKQAELKAKREAEEKNRALTALANNDVRYRKYTIEEIEEATDKFSE 233
+ ++ + R++A K A + + ++ E K E
Sbjct: 12 RDLLKREEELIGYCREEAL---KEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVE 68
Query: 234 AMKIGEGGYGPVYRGKLDHT--PVAIKVLRPDAAQGK---RQFQQEVEVLSSIRHPN--- 285
+ G V+ + A+KV A + + + + + +
Sbjct: 69 --PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEE 126
Query: 286 ---------------------MVLLLGACPDYG----CLVYEYMHNGSLEDRLLRRGNTP 320
L DY L+ LE
Sbjct: 127 ARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVY 185
Query: 321 V----IPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLAR 376
V + A++ L LVH P N+ + + + DV
Sbjct: 186 VFRGDEGILALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALW 242
Query: 377 LVPPSVADSVTQYHMTSAAGTFCYIDPEY--QQTGMLTTKSDIYSFGIMLLQIITARSPM 434
V +++ Y E+ T T + + G+ + ++ P
Sbjct: 243 KVGTR---------GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPF 293
Query: 435 GLTHHVSRAIEKGTLAEMLDPAVTDWP 461
GL + K + +
Sbjct: 294 GLVTPGIKGSWKRPSLRVPGTDSLAFG 320
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 55/266 (20%), Positives = 105/266 (39%), Gaps = 24/266 (9%)
Query: 186 QRRKQAELKAKREAEEKNRALTALANNDVRYRKYTIEEIEEATDKFSEAMKIGEGGYGPV 245
E + + + + + + +KIGEG G V
Sbjct: 2 HHHHHHSSGVDLGTENLYFQSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIV 61
Query: 246 YRGKLDHT--PVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACPDYGCL--VY 301
+ H+ VA+K++ Q + EV ++ +H N+V + + L +
Sbjct: 62 CLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLM 121
Query: 302 EYMHNGSLEDRLLRRG--NTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANI 359
E++ G+L D ++ + N I + + AL +LH ++HRD+K +I
Sbjct: 122 EFLQGGALTD-IVSQVRLNEEQIA-----TVCEAVLQALAYLHAQG---VIHRDIKSDSI 172
Query: 360 LLDRNYVSKISDVGL-ARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIY 418
LL + K+SD G A++ S GT ++ PE + T+ DI+
Sbjct: 173 LLTLDGRVKLSDFGFCAQISK-------DVPKRKSLVGTPYWMAPEVISRSLYATEVDIW 225
Query: 419 SFGIMLLQIITARSPMGLTHHVSRAI 444
S GIM+++++ P + +A+
Sbjct: 226 SLGIMVIEMVDGEPPY-FSDSPVQAM 250
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 53/202 (26%), Positives = 90/202 (44%), Gaps = 33/202 (16%)
Query: 236 KIGEGGYGPVYRG--KLDHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGA- 292
+G G + V+ +L A+K ++ A + E+ VL I+H N+V L
Sbjct: 16 VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75
Query: 293 -CPDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRF--KIAAE----IATALLFLHQAK 345
+ LV + + G L DR+L RG + K A+ + +A+ +LH+
Sbjct: 76 ESTTHYYLVMQLVSGGELFDRILERG---------VYTEKDASLVIQQVLSAVKYLHENG 126
Query: 346 PEPLVHRDLKPANILL---DRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYID 402
+VHRDLKP N+L + N I+D GL+++ + M++A GT Y+
Sbjct: 127 ---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI--------MSTACGTPGYVA 175
Query: 403 PEYQQTGMLTTKSDIYSFGIML 424
PE + D +S G++
Sbjct: 176 PEVLAQKPYSKAVDCWSIGVIT 197
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-25
Identities = 64/224 (28%), Positives = 99/224 (44%), Gaps = 24/224 (10%)
Query: 228 TDKFSEAMKIGEGGYGPVYRGKLDHT--PVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPN 285
K++ KIG+G G VY T VAI+ + K E+ V+ ++PN
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 286 MVLLLGACPDYGCL--VYEYMHNGSLEDRLLRRG--NTPVIPWRKRFKIAAEIATALLFL 341
+V L + L V EY+ GSL D ++ + I + E AL FL
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIA-----AVCRECLQALEFL 132
Query: 342 HQAKPEPLVHRDLKPANILLDRNYVSKISDVGL-ARLVPPSVADSVTQYHMTSAAGTFCY 400
H + ++HRD+K NILL + K++D G A++ P Q ++ GT +
Sbjct: 133 HSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITP-------EQSKRSTMVGTPYW 182
Query: 401 IDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAI 444
+ PE K DI+S GIM +++I P L + RA+
Sbjct: 183 MAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPY-LNENPLRAL 225
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 3e-25
Identities = 64/218 (29%), Positives = 103/218 (47%), Gaps = 22/218 (10%)
Query: 228 TDKFSEAMKIGEGGYGPVYRG--KLDHTPVAIKVLRPDAAQGKRQ-FQQEVEVLSSIRHP 284
+ F++ KIG+G +G V++G VAIK++ + A+ + + QQE+ VLS P
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80
Query: 285 NMVLLLGACPDYGCL--VYEYMHNGSLEDRLLRRG--NTPVIPWRKRFKIAAEIATALLF 340
+ G+ L + EY+ GS D LL G + I I EI L +
Sbjct: 81 YVTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIAT-----ILREILKGLDY 134
Query: 341 LHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCY 400
LH K +HRD+K AN+LL + K++D G+A + + TQ + GT +
Sbjct: 135 LHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQL------TDTQIKRNTFVGTPFW 185
Query: 401 IDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTH 438
+ PE + +K+DI+S GI +++ P H
Sbjct: 186 MAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELH 223
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 4e-25
Identities = 56/239 (23%), Positives = 89/239 (37%), Gaps = 55/239 (23%)
Query: 236 KIGEGGYGPVYRG--KLDHTPVAIKV-----LRPDAAQGKRQFQQEVEVLSSIRHPNMVL 288
IG+G YG V AIK+ +R + + + EV ++ + HPN+
Sbjct: 33 AIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIAR 92
Query: 289 LLGAC--PDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRF------------------ 328
L Y CLV E H G L D+L +
Sbjct: 93 LYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAING 152
Query: 329 ---------------KIAAE----IATALLFLHQAKPEPLVHRDLKPANILL--DRNYVS 367
K+ + I +AL +LH + HRD+KP N L ++++
Sbjct: 153 SIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG---ICHRDIKPENFLFSTNKSFEI 209
Query: 368 KISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPE--YQQTGMLTTKSDIYSFGIML 424
K+ D GL++ ++ Y MT+ AGT ++ PE K D +S G++L
Sbjct: 210 KLVDFGLSKEFYKL--NNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLL 266
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 4e-25
Identities = 52/207 (25%), Positives = 82/207 (39%), Gaps = 43/207 (20%)
Query: 236 KIGEGGYGPVYRG--KLDHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGAC 293
IG G +G V K A K + + +F+QE+E++ S+ HPN++ L
Sbjct: 16 TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETF 75
Query: 294 --PDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRF--KIAAE----IATALLFLHQAK 345
LV E G L +R++ + F AA + +A+ + H+
Sbjct: 76 EDNTDIYLVMELCTGGELFERVVHKR---------VFRESDAARIMKDVLSAVAYCHKLN 126
Query: 346 PEPLVHRDLKPANILL---DRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYID 402
+ HRDLKP N L + K+ D GLA P M + GT Y+
Sbjct: 127 ---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM-------MRTKVGTPYYVS 176
Query: 403 PE-----YQQTGMLTTKSDIYSFGIML 424
P+ Y + D +S G+M+
Sbjct: 177 PQVLEGLY------GPECDEWSAGVMM 197
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 5e-25
Identities = 61/226 (26%), Positives = 101/226 (44%), Gaps = 26/226 (11%)
Query: 236 KIGEGGYGPVYRG--KLDHTPVAIKVLRPDAAQGK---RQFQQEVEVLSSIRHPNMVLLL 290
+G+G +G V K+ A+KV+ + K +EV++L + HPN++ L
Sbjct: 33 VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 92
Query: 291 GACPDYGC--LVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEP 348
D G LV E G L D ++ R +I ++ + + ++H+ K
Sbjct: 93 EFFEDKGYFYLVGEVYTGGELFDEIISRKR---FSEVDAARIIRQVLSGITYMHKNK--- 146
Query: 349 LVHRDLKPANILL---DRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEY 405
+VHRDLKP N+LL ++ +I D GL+ S M GT YI PE
Sbjct: 147 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK-------KMKDKIGTAYYIAPEV 199
Query: 406 QQTGMLTTKSDIYSFGIMLLQIITARSP-MGLTHH-VSRAIEKGTL 449
G K D++S G++L +++ P G + + + +EKG
Sbjct: 200 LH-GTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKY 244
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 5e-25
Identities = 64/225 (28%), Positives = 99/225 (44%), Gaps = 25/225 (11%)
Query: 236 KIGEGGYGPVYRG--KLDHTPVAIKVL--RPDAAQGKRQFQQEVEVLSSIRHPNMVLLLG 291
K+G G YG V K+ H AIK++ + + +EV VL + HPN++ L
Sbjct: 44 KLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYD 103
Query: 292 ACPDYGC--LVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPL 349
D LV E G L D ++ R I ++ + + +LH+ +
Sbjct: 104 FFEDKRNYYLVMECYKGGELFDEIIHRMK---FNEVDAAVIIKQVLSGVTYLHKHN---I 157
Query: 350 VHRDLKPANILL---DRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQ 406
VHRDLKP N+LL +++ + KI D GL+ + M GT YI PE
Sbjct: 158 VHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKK-------MKERLGTAYYIAPEVL 210
Query: 407 QTGMLTTKSDIYSFGIMLLQIITARSP-MGLTHH-VSRAIEKGTL 449
+ K D++S G++L ++ P G T + R +EKG
Sbjct: 211 R-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKY 254
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 54/230 (23%), Positives = 102/230 (44%), Gaps = 29/230 (12%)
Query: 228 TDKFSEAMKIGEGGYGPVYRG--KLDHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPN 285
+ + ++G+G +G VY+ K A KV+ + + + E+E+L++ HP
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77
Query: 286 MVLLLGACPDYGCL--VYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAA---EIATALLF 340
+V LLGA G L + E+ G+++ ++ + + +I ++ AL F
Sbjct: 78 IVKLLGAYYHDGKLWIMIEFCPGGAVDA-IMLELDRGL----TEPQIQVVCRQMLEALNF 132
Query: 341 LHQAKPEPLVHRDLKPANILLDRNYVSKISDVGL-ARLVPPSVADSVTQYHMTSAAGTFC 399
LH + ++HRDLK N+L+ +++D G+ A+ T S GT
Sbjct: 133 LHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKN-------LKTLQKRDSFIGTPY 182
Query: 400 YIDPE-----YQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAI 444
++ PE + K+DI+S GI L+++ P + R +
Sbjct: 183 WMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPH-HELNPMRVL 231
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 52/194 (26%), Positives = 85/194 (43%), Gaps = 16/194 (8%)
Query: 237 IGEGGYGPVYRGK--LDHTPVAIKVL-RPDAAQGKRQFQQEVEVLSSIRHPNMVLLLG-- 291
+GEG YG V + VA+K++ A ++E+ + + H N+V G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 292 ACPDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVH 351
+ L EY G L DR+ P ++ F ++ +++LH + H
Sbjct: 75 REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH---QLMAGVVYLHGIG---ITH 128
Query: 352 RDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPE-YQQTGM 410
RD+KP N+LLD KISD GLA + + + + GT Y+ PE ++
Sbjct: 129 RDIKPENLLLDERDNLKISDFGLATVFRYNNRER----LLNKMCGTLPYVAPELLKRREF 184
Query: 411 LTTKSDIYSFGIML 424
D++S GI+L
Sbjct: 185 HAEPVDVWSCGIVL 198
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 105 bits (262), Expect = 2e-24
Identities = 29/239 (12%), Positives = 64/239 (26%), Gaps = 50/239 (20%)
Query: 237 IGEGGYGPVYRG--KLDHTPVAIKVLR----------------------------PDAAQ 266
+G+ + + V A+
Sbjct: 86 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145
Query: 267 GKRQFQQEVEVLSSIRHPNMVLLLGACPDYG----CLVYEYMH--NGSLEDRLLRRGNTP 320
+F +++ + M+ + D +Y M + + LL +T
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205
Query: 321 -VIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVP 379
+ R ++ ++ L LH LVH L+P +I+LD+ ++
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLV--- 259
Query: 380 PSVADSVTQYHMTSAAGTFCYIDPE-----YQQTGMLTTKSDIYSFGIMLLQIITARSP 433
+ + ++T D ++ G+ + I A P
Sbjct: 260 --RDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP 316
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-24
Identities = 51/242 (21%), Positives = 97/242 (40%), Gaps = 36/242 (14%)
Query: 205 ALTALANNDVRYRKYTIEEIEEATDKFSE----AMKIGEGGYGPVYRG--KLDHTPVAIK 258
AL+ N + T+++ + + +G G G V + VAI+
Sbjct: 107 ALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIR 166
Query: 259 VLRPDAAQGKR--------QFQQEVEVLSSIRHPNMVLLLGAC--PDYGCLVYEYMHNGS 308
++ + E+E+L + HP ++ + DY +V E M G
Sbjct: 167 IISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGE 225
Query: 309 LEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILL---DRNY 365
L D+++ + ++ A+ +LH+ ++HRDLKP N+LL + +
Sbjct: 226 LFDKVVGNKR---LKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDC 279
Query: 366 VSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPE---YQQTGMLTTKSDIYSFGI 422
+ KI+D G ++++ + M + GT Y+ PE T D +S G+
Sbjct: 280 LIKITDFGHSKILGETSL-------MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGV 332
Query: 423 ML 424
+L
Sbjct: 333 IL 334
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 45/215 (20%), Positives = 78/215 (36%), Gaps = 25/215 (11%)
Query: 236 KIGEG--GYGPVYRGKLDHTP----VAIKVLRPDAAQGKR--QFQQEVEVLSSIRHPNMV 287
IG+G V + + P V ++ + +A + Q E+ V HPN+V
Sbjct: 32 VIGKGFEDLMTVNLAR--YKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIV 89
Query: 288 LLLGA--CPDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAA---EIATALLFLH 342
+ +V +M GS +D L+ + IA + AL ++H
Sbjct: 90 PYRATFIADNELWVVTSFMAYGSAKD-LICTHFMDGMN---ELAIAYILQGVLKALDYIH 145
Query: 343 QAKPEPLVHRDLKPANILLDRNYVSKISDVG-LARLVPPSVADSVTQYHMTSAAGTFCYI 401
VHR +K ++IL+ + +S + ++ V + ++
Sbjct: 146 HMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWL 202
Query: 402 DPE--YQQTGMLTTKSDIYSFGIMLLQIITARSPM 434
PE Q KSDIYS GI ++ P
Sbjct: 203 SPEVLQQNLQGYDAKSDIYSVGITACELANGHVPF 237
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 3e-24
Identities = 61/203 (30%), Positives = 91/203 (44%), Gaps = 30/203 (14%)
Query: 236 KIGEGGYGPVYRG--KLDHTPVAIKVLRPDAAQGKRQ-FQQEVEVLSSIRHPNMVLLLGA 292
K+G G +G V+ + IK + D +Q + + E+EVL S+ HPN++ +
Sbjct: 29 KLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEV 88
Query: 293 CPDYGC--LVYEYMHNGSLEDRLLRRGNTPVIPWRKRF--KIAAE----IATALLFLHQA 344
DY +V E G L +R++ K AE + AL + H
Sbjct: 89 FEDYHNMYIVMETCEGGELLERIVSAQAR-----GKALSEGYVAELMKQMMNALAYFHSQ 143
Query: 345 KPEPLVHRDLKPANILL---DRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYI 401
+VH+DLKP NIL + KI D GLA L H T+AAGT Y+
Sbjct: 144 H---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE-------HSTNAAGTALYM 193
Query: 402 DPEYQQTGMLTTKSDIYSFGIML 424
PE + +T K DI+S G+++
Sbjct: 194 APEVFK-RDVTFKCDIWSAGVVM 215
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 5e-24
Identities = 58/209 (27%), Positives = 93/209 (44%), Gaps = 45/209 (21%)
Query: 236 KIGEGGYGPVYRG--KLDHTPVAIKVLRPDAAQGKRQ--FQQEVEVLSSIRHPNMVLLLG 291
+G+G +G V + ++ A+KV+ +A+ K +EVE+L + HPN++ L
Sbjct: 29 MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 292 ACPDYGC--LVYEYMHNGSLEDRLLRRGNTPVIPWRKRF--KIAAE----IATALLFLHQ 343
D +V E G L D +++R RF AA + + + ++H+
Sbjct: 89 ILEDSSSFYIVGELYTGGELFDEIIKRK---------RFSEHDAARIIKQVFSGITYMHK 139
Query: 344 AKPEPLVHRDLKPANILL---DRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCY 400
+VHRDLKP NILL +++ KI D GL+ + M GT Y
Sbjct: 140 HN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK-------MKDRIGTAYY 189
Query: 401 IDPE-----YQQTGMLTTKSDIYSFGIML 424
I PE Y K D++S G++L
Sbjct: 190 IAPEVLRGTY------DEKCDVWSAGVIL 212
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 103 bits (257), Expect = 5e-24
Identities = 31/245 (12%), Positives = 70/245 (28%), Gaps = 61/245 (24%)
Query: 237 IGEGGYGPVYRG--KLDHTPVAIKVLR----------------------------PDAAQ 266
+G+ + + V A+
Sbjct: 81 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140
Query: 267 GKRQFQQEVEVLSSIRHPNMVLLLGACPDYG----CLVYEYMH--NGSLEDRLLRRGNT- 319
+F +++ + M+ + D +Y M + + LL +T
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200
Query: 320 PVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVP 379
+ R ++ ++ L LH LVH L+P +I+LD+ ++
Sbjct: 201 KSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 257
Query: 380 PSVADSVTQYHMTSAAGTFCYIDPEY-----------QQTGMLTTKSDIYSFGIMLLQII 428
++ + + PE + ++T D ++ G+++ I
Sbjct: 258 ----------ARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIW 307
Query: 429 TARSP 433
A P
Sbjct: 308 CADLP 312
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 8e-24
Identities = 60/225 (26%), Positives = 98/225 (43%), Gaps = 26/225 (11%)
Query: 228 TDKFSEAMKIGEGGYGPVYRG--KLDHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPN 285
+ F K+GEG YG VY+ K VAIK + ++ +E+ ++ P+
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQV--PVESDLQEIIKEISIMQQCDSPH 85
Query: 286 MVLLLGACPDYGCL--VYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAA---EIATALLF 340
+V G+ L V EY GS+ D ++R N + +IA L +
Sbjct: 86 VVKYYGSYFKNTDLWIVMEYCGAGSVSD-IIRLRNKTL----TEDEIATILQSTLKGLEY 140
Query: 341 LHQAKPEPLVHRDLKPANILLDRNYVSKISDVGL-ARLVPPSVADSVTQYHMTSAAGTFC 399
LH + +HRD+K NILL+ +K++D G+ +L + T + GT
Sbjct: 141 LHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQL-------TDTMAKRNTVIGTPF 190
Query: 400 YIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAI 444
++ PE Q +DI+S GI +++ + P H RAI
Sbjct: 191 WMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPY-ADIHPMRAI 234
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 8e-24
Identities = 55/203 (27%), Positives = 92/203 (45%), Gaps = 33/203 (16%)
Query: 236 KIGEGGYGPVYRG--KLDHTPVAIKVLRPDAAQGK--RQFQQEVEVLSSIRHPNMVLLLG 291
+G+G +G V + ++ A+KV+ +A+ K +EVE+L + HPN++ L
Sbjct: 29 MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 292 ACPDYGC--LVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPL 349
D +V E G L D +++R +I ++ + + ++H+ +
Sbjct: 89 ILEDSSSFYIVGELYTGGELFDEIIKRKR---FSEHDAARIIKQVFSGITYMHKHN---I 142
Query: 350 VHRDLKPANILL---DRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPE-- 404
VHRDLKP NILL +++ KI D GL+ + M GT YI PE
Sbjct: 143 VHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT-------KMKDRIGTAYYIAPEVL 195
Query: 405 ---YQQTGMLTTKSDIYSFGIML 424
Y K D++S G++L
Sbjct: 196 RGTY------DEKCDVWSAGVIL 212
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-23
Identities = 56/218 (25%), Positives = 91/218 (41%), Gaps = 34/218 (15%)
Query: 236 KIGEGGYGPVYRG--KLDHTPVAIKVLR-------------PDAAQGKRQFQQEVEVLSS 280
K+G G YG V K H+ AIKV++ + + + E+ +L S
Sbjct: 43 KLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKS 102
Query: 281 IRHPNMVLLLGACPDYGC--LVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATAL 338
+ HPN++ L D LV E+ G L ++++ R I +I + +
Sbjct: 103 LDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHK---FDECDAANIMKQILSGI 159
Query: 339 LFLHQAKPEPLVHRDLKPANILL---DRNYVSKISDVGLARLVPPSVADSVTQYHMTSAA 395
+LH+ +VHRD+KP NILL + KI D GL+ +
Sbjct: 160 CYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDY-------KLRDRL 209
Query: 396 GTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSP 433
GT YI PE + K D++S G+++ ++ P
Sbjct: 210 GTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPP 246
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 52/194 (26%), Positives = 85/194 (43%), Gaps = 16/194 (8%)
Query: 237 IGEGGYGPVYRGK--LDHTPVAIKVL-RPDAAQGKRQFQQEVEVLSSIRHPNMVLLLG-- 291
+GEG YG V + VA+K++ A ++E+ + + H N+V G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 292 ACPDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVH 351
+ L EY G L DR+ P ++ F ++ +++LH + H
Sbjct: 75 REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH---QLMAGVVYLHGIG---ITH 128
Query: 352 RDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPE-YQQTGM 410
RD+KP N+LLD KISD GLA + + + + GT Y+ PE ++
Sbjct: 129 RDIKPENLLLDERDNLKISDFGLATVFRYNNRER----LLNKMCGTLPYVAPELLKRREF 184
Query: 411 LTTKSDIYSFGIML 424
D++S GI+L
Sbjct: 185 HAEPVDVWSCGIVL 198
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 53/205 (25%), Positives = 91/205 (44%), Gaps = 20/205 (9%)
Query: 237 IGEGGYGPVYRGK--LDHTPVAIKVLRPDA--AQGKRQFQQEVEVLSSIRHPNMVLLLG- 291
IG+G + V + L VAIK++ ++ +EV ++ + HPN+V L
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 292 -ACPDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLV 350
L+ EY G + D L+ G R +F+ +I +A+ + HQ + +V
Sbjct: 83 IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFR---QIVSAVQYCHQKR---IV 136
Query: 351 HRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPE-YQQTG 409
HRDLK N+LLD + KI+D G + + + G Y PE +Q
Sbjct: 137 HRDLKAENLLLDADMNIKIADFGFSNEFTV-------GGKLDAFCGAPPYAAPELFQGKK 189
Query: 410 MLTTKSDIYSFGIMLLQIITARSPM 434
+ D++S G++L +++ P
Sbjct: 190 YDGPEVDVWSLGVILYTLVSGSLPF 214
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 6e-23
Identities = 49/208 (23%), Positives = 87/208 (41%), Gaps = 32/208 (15%)
Query: 237 IGEGGYGPVYRG--KLDHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIR-HPNMVLLLGAC 293
+GEG + V + A+K++ + + +EVE+L + H N++ L+
Sbjct: 21 LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF 80
Query: 294 PDYGC--LVYEYMHNGSLEDRLLRRGNTPVIPWRKRF--KIAAE----IATALLFLHQAK 345
+ LV+E M GS+ + +R + F A+ +A+AL FLH
Sbjct: 81 EEEDRFYLVFEKMRGGSILSHIHKRRH---------FNELEASVVVQDVASALDFLHNKG 131
Query: 346 PEPLVHRDLKPANILL---DRNYVSKISDVGLARLVPP-SVADSVTQYHMTSAAGTFCYI 401
+ HRDLKP NIL ++ KI D L + ++ + + G+ Y+
Sbjct: 132 ---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYM 188
Query: 402 DPEYQQTGMLTTKS-----DIYSFGIML 424
PE + D++S G++L
Sbjct: 189 APEVVEAFSEEASIYDKRCDLWSLGVIL 216
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 7e-23
Identities = 56/295 (18%), Positives = 116/295 (39%), Gaps = 34/295 (11%)
Query: 137 QWKIEEAQRFEEARMAEETALAIAEMEKAKCRAAIEAAEKAQKLADAEAQRRKQAELKAK 196
+++I + +++ E TA + ++ K R + E+ + +
Sbjct: 79 EFRIIAENKHGQSKPCEPTAPVLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFD 138
Query: 197 REAEEKNRALTALANNDVRYRKYTIEEIEEATDKFSEAMKIGEGGYGPVYRG--KLDHTP 254
+ + + + ++ V Y I E ++G G +G V+R +
Sbjct: 139 IWKQYYPQPVE-IKHDHVL-DHYDIHE------------ELGTGAFGVVHRVTERATGNN 184
Query: 255 VAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGAC--PDYGCLVYEYMHNGSLEDR 312
A K + K ++E++ +S +RHP +V L A + ++YE+M G L ++
Sbjct: 185 FAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEK 244
Query: 313 LLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILL---DRNYVSKI 369
+ N + + + ++ L +H+ VH DLKP NI+ N + K+
Sbjct: 245 VADEHNK--MSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNEL-KL 298
Query: 370 SDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIML 424
D GL + P + GT + PE + + +D++S G++
Sbjct: 299 IDFGLTAHLDPKQ-------SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLS 346
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 1e-22
Identities = 49/204 (24%), Positives = 92/204 (45%), Gaps = 34/204 (16%)
Query: 236 KIGEGGYGPVYRG--KLDHTPVAIKVL--RPDAAQGKRQFQQEVEVLSSIRHPNMVLLLG 291
++G+G + V R K A K++ + +A+ ++ ++E + ++HPN+V L
Sbjct: 13 ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 72
Query: 292 ACPDYGC--LVYEYMHNGSLEDRLLRRGNTPVIPWRKRF--KIAAE----IATALLFLHQ 343
+ + LV++ + G L + ++ R + A+ I ++ + H
Sbjct: 73 SIQEESFHYLVFDLVTGGELFEDIVARE---------FYSEADASHCIQQILESIAYCHS 123
Query: 344 AKPEPLVHRDLKPANILL---DRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCY 400
+VHR+LKP N+LL + K++D GLA V S A AGT Y
Sbjct: 124 NG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA-------WHGFAGTPGY 173
Query: 401 IDPEYQQTGMLTTKSDIYSFGIML 424
+ PE + + DI++ G++L
Sbjct: 174 LSPEVLKKDPYSKPVDIWACGVIL 197
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 1e-22
Identities = 56/211 (26%), Positives = 87/211 (41%), Gaps = 25/211 (11%)
Query: 237 IGEGGYGPVYRGK--LDHTPVAIKVLR----PDAAQGKRQFQQEVEVLSSIRHPNMVLL- 289
+GEG YG V A+K+L+ G+ ++E+++L +RH N++ L
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 290 ---LGACPDYGCLVYEYMHNGSLE--DRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQA 344
+V EY G E D + PV F ++ L +LH
Sbjct: 73 DVLYNEEKQKMYMVMEYCVCGMQEMLDSVPE-KRFPVCQAHGYFC---QLIDGLEYLHSQ 128
Query: 345 KPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPE 404
+VH+D+KP N+LL KIS +G+A + P AD ++ G+ + PE
Sbjct: 129 G---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADD----TCRTSQGSPAFQPPE 181
Query: 405 --YQQTGMLTTKSDIYSFGIMLLQIITARSP 433
K DI+S G+ L I T P
Sbjct: 182 IANGLDTFSGFKVDIWSAGVTLYNITTGLYP 212
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 2e-22
Identities = 51/235 (21%), Positives = 87/235 (37%), Gaps = 57/235 (24%)
Query: 216 YRKYTIEEIEEATDKFSEAMKIGEGGYGPVYRG--KLDHTPVAIKVL---------RPDA 264
Y Y +E +G G V R K A+K++ +
Sbjct: 16 YENYEPKE------------ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEV 63
Query: 265 AQGKRQFQQEVEVLSSI-RHPNMVLLLGAC--PDYGCLVYEYMHNGSLEDRLLRRGNTPV 321
+ + +EV++L + HPN++ L + LV++ M G L D L +
Sbjct: 64 QELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV---- 119
Query: 322 IPWRKRF--KIAAE----IATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLA 375
K + + + LH+ +VHRDLKP NILLD + K++D G +
Sbjct: 120 -----TLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFS 171
Query: 376 RLVPPSVADSVTQYHMTSAAGTFCYIDPE------YQQTGMLTTKSDIYSFGIML 424
+ P + GT Y+ PE + D++S G+++
Sbjct: 172 CQLDPGEK-------LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 2e-22
Identities = 42/207 (20%), Positives = 81/207 (39%), Gaps = 32/207 (15%)
Query: 236 KIGEGGYGPVYRG--KLDHTPVAIKV-----LRPDAAQGKRQFQQEVEVLSSIRHPNMVL 288
IG+G + V R + A+K+ ++E + ++HP++V
Sbjct: 31 VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 289 LLGACPDYGC--LVYEYMHNGSLEDRLLRRGNTPVIPWRKRF--KIAAE----IATALLF 340
LL G +V+E+M L +++R + + +A+ I AL +
Sbjct: 91 LLETYSSDGMLYMVFEFMDGADLCFEIVKRADAG-----FVYSEAVASHYMRQILEALRY 145
Query: 341 LHQAKPEPLVHRDLKPANILL---DRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGT 397
H ++HRD+KP +LL + + K+ G+A + S GT
Sbjct: 146 CHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGES------GLVAGGRVGT 196
Query: 398 FCYIDPEYQQTGMLTTKSDIYSFGIML 424
++ PE + D++ G++L
Sbjct: 197 PHFMAPEVVKREPYGKPVDVWGCGVIL 223
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 2e-22
Identities = 49/213 (23%), Positives = 85/213 (39%), Gaps = 44/213 (20%)
Query: 236 KIGEGGYGPVYRG--KLDHTPVAIKVLRPDAAQGK--------RQFQQEVEVLSSIRHPN 285
+G G G V + VAIK++ + E+E+L + HP
Sbjct: 17 TLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 76
Query: 286 MVLLLGA--CPDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRF--KIAAE----IATA 337
++ + DY +V E M G L D+++ R + A
Sbjct: 77 IIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNK---------RLKEATCKLYFYQMLLA 126
Query: 338 LLFLHQAKPEPLVHRDLKPANILL---DRNYVSKISDVGLARLVPPSVADSVTQYHMTSA 394
+ +LH+ ++HRDLKP N+LL + + + KI+D G ++++ + M +
Sbjct: 127 VQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL-------MRTL 176
Query: 395 AGTFCYIDPE---YQQTGMLTTKSDIYSFGIML 424
GT Y+ PE T D +S G++L
Sbjct: 177 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 98.0 bits (243), Expect = 2e-22
Identities = 44/195 (22%), Positives = 69/195 (35%), Gaps = 47/195 (24%)
Query: 227 ATDKFSEAMKIGEGGYGPVYRGKLDHTPVAIKVLR---PDAAQGKRQ-----------FQ 272
T+K KIGEG +G V++ DHTPVAIK++ PD G Q
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIIS 77
Query: 273 QEVEVLSSI---RHPNMVLLL------GACPDYGCLVYEYMH--NGSLEDRL-------- 313
+E+ +LS R + L G+ P +++ + GS DR
Sbjct: 78 KELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQL 137
Query: 314 ------------LRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILL 361
L + T + I ++ +L HRDL N+LL
Sbjct: 138 FIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAE--ASLRFEHRDLHWGNVLL 195
Query: 362 DRNYVSKISDVGLAR 376
+ + K+ +
Sbjct: 196 KKTSLKKLHYTLNGK 210
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 2e-22
Identities = 54/196 (27%), Positives = 98/196 (50%), Gaps = 21/196 (10%)
Query: 237 IGEGGYGPVYRGKLDHT--PVAIKVL---RPDAAQGKRQFQQEVEVLSSIRHPNMVLLLG 291
+G G +G V G+ T VA+K+L + + + ++E++ L RHP+++ L
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 292 --ACPDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPL 349
+ P +V EY+ G L D + + G + R+ F+ +I +A+ + H+ +
Sbjct: 79 VISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQ---QILSAVDYCHRHM---V 132
Query: 350 VHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPE-YQQT 408
VHRDLKP N+LLD + +KI+D GL+ ++ + ++ G+ Y PE
Sbjct: 133 VHRDLKPENVLLDAHMNAKIADFGLSNMMSD-------GEFLRTSCGSPNYAAPEVISGR 185
Query: 409 GMLTTKSDIYSFGIML 424
+ DI+S G++L
Sbjct: 186 LYAGPEVDIWSCGVIL 201
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 3e-22
Identities = 45/255 (17%), Positives = 87/255 (34%), Gaps = 34/255 (13%)
Query: 186 QRRKQAELKAKREAEEKNRALTALANNDVRYRKYTIEEIEEATDKFSE----AMKIGEGG 241
R + + + ++KY + +E + ++G G
Sbjct: 4 SHHHHHHGSKVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGA 63
Query: 242 YGPVYRG--KLDHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGAC--PDYG 297
+G V+R K K + K + E+ +++ + HP ++ L A
Sbjct: 64 FGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEM 123
Query: 298 CLVYEYMHNGSLEDRLLRRGNTPVIPWRKRF--KIAAE----IATALLFLHQAKPEPLVH 351
L+ E++ G L DR+ + L +H+ +VH
Sbjct: 124 VLILEFLSGGELFDRIAAEDY--------KMSEAEVINYMRQACEGLKHMHEHS---IVH 172
Query: 352 RDLKPANILLDRNYVS--KISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTG 409
D+KP NI+ + S KI D GLA + P + T + PE
Sbjct: 173 LDIKPENIMCETKKASSVKIIDFGLATKLNPDEI-------VKVTTATAEFAAPEIVDRE 225
Query: 410 MLTTKSDIYSFGIML 424
+ +D+++ G++
Sbjct: 226 PVGFYTDMWAIGVLG 240
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 3e-22
Identities = 62/213 (29%), Positives = 96/213 (45%), Gaps = 34/213 (15%)
Query: 225 EEATDKFSEAMKIGEGGYGPVYRG--KLDHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIR 282
+ +D F ++G G VYR K P A+KVL K+ + E+ VL +
Sbjct: 49 DALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVL--KKTVDKKIVRTEIGVLLRLS 106
Query: 283 HPNMVLLLGAC--PDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRF--KIAAE----I 334
HPN++ L P LV E + G L DR++ +G + + AA+ I
Sbjct: 107 HPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKG---------YYSERDAADAVKQI 157
Query: 335 ATALLFLHQAKPEPLVHRDLKPANILL---DRNYVSKISDVGLARLVPPSVADSVTQYHM 391
A+ +LH+ +VHRDLKP N+L + KI+D GL+++V V M
Sbjct: 158 LEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL-------M 207
Query: 392 TSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIML 424
+ GT Y PE + + D++S GI+
Sbjct: 208 KTVCGTPGYCAPEILRGCAYGPEVDMWSVGIIT 240
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 5e-22
Identities = 49/204 (24%), Positives = 92/204 (45%), Gaps = 34/204 (16%)
Query: 236 KIGEGGYGPVYRG--KLDHTPVAIKVL--RPDAAQGKRQFQQEVEVLSSIRHPNMVLLLG 291
++G+G + V R K A K++ + +A+ ++ ++E + ++HPN+V L
Sbjct: 36 ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 95
Query: 292 ACPDYGC--LVYEYMHNGSLEDRLLRRGNTPVIPWRKRF--KIAAE----IATALLFLHQ 343
+ + LV++ + G L + ++ R + A+ I ++ + H
Sbjct: 96 SIQEESFHYLVFDLVTGGELFEDIVARE---------FYSEADASHCIQQILESIAYCHS 146
Query: 344 AKPEPLVHRDLKPANILL---DRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCY 400
+VHR+LKP N+LL + K++D GLA V S A AGT Y
Sbjct: 147 NG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA-------WHGFAGTPGY 196
Query: 401 IDPEYQQTGMLTTKSDIYSFGIML 424
+ PE + + DI++ G++L
Sbjct: 197 LSPEVLKKDPYSKPVDIWACGVIL 220
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 5e-22
Identities = 49/204 (24%), Positives = 91/204 (44%), Gaps = 33/204 (16%)
Query: 236 KIGEGGYGPVYRG--KLDHTPVAIKVL--RPDAAQGKRQFQQEVEVLSSIRHPNMVLLLG 291
++G+G + V R L A ++ + +A+ ++ ++E + ++HPN+V L
Sbjct: 18 ELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHD 77
Query: 292 ACPDYGC--LVYEYMHNGSLEDRLLRRGNTPVIPWRKRF--KIAAE----IATALLFLHQ 343
+ + G L+++ + G L + ++ R + A+ I A+L HQ
Sbjct: 78 SISEEGHHYLIFDLVTGGELFEDIVARE---------YYSEADASHCIQQILEAVLHCHQ 128
Query: 344 AKPEPLVHRDLKPANILL---DRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCY 400
+VHR+LKP N+LL + K++D GLA V Q AGT Y
Sbjct: 129 MG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE------QQAWFGFAGTPGY 179
Query: 401 IDPEYQQTGMLTTKSDIYSFGIML 424
+ PE + D+++ G++L
Sbjct: 180 LSPEVLRKDPYGKPVDLWACGVIL 203
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 6e-22
Identities = 53/205 (25%), Positives = 78/205 (38%), Gaps = 31/205 (15%)
Query: 237 IGEGGYGPVYRGK--LDHTPVAIKVL------RPDAAQGKRQFQQEVEVLSSIR----HP 284
+G+GG+G V+ G D VAIKV+ EV +L + HP
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 285 NMVLLLG--ACPDYGCLVYEYMHNGS-LEDRLLRRGNTPVIPWRKRFKIAAEIATALLFL 341
++ LL + LV E L D + +G P R F ++ A+
Sbjct: 99 GVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFG---QVVAAIQHC 155
Query: 342 HQAKPEPLVHRDLKPANILLDRNYVS-KISDVGLARLVPPSVADSVTQYHMTSAAGTFCY 400
H +VHRD+K NIL+D K+ D G L+ T GT Y
Sbjct: 156 HSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDE--------PYTDFDGTRVY 204
Query: 401 IDPEYQQTGMLT-TKSDIYSFGIML 424
PE+ + ++S GI+L
Sbjct: 205 SPPEWISRHQYHALPATVWSLGILL 229
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 7e-22
Identities = 59/269 (21%), Positives = 102/269 (37%), Gaps = 34/269 (12%)
Query: 172 EAAEKAQKLADAEAQRRKQAELKAKREAEEKNRALTALANNDVRYRKYTIEEIEEATDKF 231
+ K + A ++ +K+KR + A D R +
Sbjct: 33 RSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSFYT-V 91
Query: 232 SEAMKIGEGGYGPVYRG--KLDHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLL 289
S+ +G G +G V++ +A K+++ + K + + E+ V++ + H N++ L
Sbjct: 92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQL 151
Query: 290 LGA--CPDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRF--KIAAE----IATALLFL 341
A + LV EY+ G L DR++ I + +
Sbjct: 152 YDAFESKNDIVLVMEYVDGGELFDRIIDESY--------NLTELDTILFMKQICEGIRHM 203
Query: 342 HQAKPEPLVHRDLKPANILLDRNYVS--KISDVGLARLVPPSVADSVTQYHMTSAAGTFC 399
HQ ++H DLKP NIL KI D GLAR P + GT
Sbjct: 204 HQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK-------LKVNFGTPE 253
Query: 400 YIDPEYQQTGMLTTKSDIYSFGI---MLL 425
++ PE ++ +D++S G+ MLL
Sbjct: 254 FLAPEVVNYDFVSFPTDMWSVGVIAYMLL 282
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 7e-22
Identities = 55/215 (25%), Positives = 84/215 (39%), Gaps = 35/215 (16%)
Query: 237 IGEGGYGPVYRGK--LDHTPVAIKVL------RPDAAQGKRQFQQEVEVLSSIRH--PNM 286
+G GG+G VY G D+ PVAIK + + EV +L + +
Sbjct: 51 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 287 VLLLG--ACPDYGCLVYEYMHN-GSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQ 343
+ LL PD L+ E L D + RG R F ++ A+ H
Sbjct: 111 IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFW---QVLEAVRHCHN 167
Query: 344 AKPEPLVHRDLKPANILLDRNYVS-KISDVGLARLVPPSVADSVTQYHMTSAAGTFCYID 402
++HRD+K NIL+D N K+ D G L+ + T GT Y
Sbjct: 168 CG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--------VYTDFDGTRVYSP 216
Query: 403 PEYQQ----TGMLTTKSDIYSFGIMLLQIITARSP 433
PE+ + G + ++S GI+L ++ P
Sbjct: 217 PEWIRYHRYHG---RSAAVWSLGILLYDMVCGDIP 248
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 9e-22
Identities = 57/266 (21%), Positives = 104/266 (39%), Gaps = 49/266 (18%)
Query: 185 AQRRKQAELKAKREAEEKNRALTALANNDVRYRKYTIEEIEEATDKFSEAMKIGEGGYGP 244
A +K +E ++ +E K + +++ F +G G +G
Sbjct: 4 AAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQ-------FDRIKTLGTGSFGR 56
Query: 245 VY--RGKLDHTPVAIKVLRPDAAQGKRQFQ---QEVEVLSSIRHPNMVLLLGAC--PDYG 297
V + K A+K+L +Q + E +L ++ P +V L +
Sbjct: 57 VMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNL 116
Query: 298 CLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPA 357
+V EY+ G + L R G RF AA+I +LH L++RDLKP
Sbjct: 117 YMVMEYVAGGEMFSHLRRIGRFS--EPHARF-YAAQIVLTFEYLHSLD---LIYRDLKPE 170
Query: 358 NILLDRN-YVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFC----YIDPEYQQTGMLT 412
N+L+D+ Y+ +++D G A+ V T T C + PE ++
Sbjct: 171 NLLIDQQGYI-QVTDFGFAKRV-----KGRTW--------TLCGTPEALAPE-----IIL 211
Query: 413 TKS-----DIYSFGIMLLQIITARSP 433
+K D ++ G+++ ++ P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP 237
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 9e-22
Identities = 60/233 (25%), Positives = 94/233 (40%), Gaps = 33/233 (14%)
Query: 221 IEEIEEATDKFSEAMKIGEGGYGPVYRGKLDHT--PVAIKVLRPDAAQGKRQFQQEVEVL 278
+ + + F +G G YG VY+G+ T AIKV+ + + +QE+ +L
Sbjct: 16 LSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINML 74
Query: 279 SSI-RHPNMVLLLGA--------CPDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFK 329
H N+ GA D LV E+ GS+ D + + K
Sbjct: 75 KKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTL----KEEW 130
Query: 330 IAA---EIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSV 386
IA EI L LHQ K ++HRD+K N+LL N K+ D G++ +
Sbjct: 131 IAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQL------DR 181
Query: 387 TQYHMTSAAGTFCYIDPE-----YQQTGMLTTKSDIYSFGIMLLQIITARSPM 434
T + GT ++ PE KSD++S GI +++ P+
Sbjct: 182 TVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 234
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 2e-21
Identities = 50/214 (23%), Positives = 95/214 (44%), Gaps = 37/214 (17%)
Query: 237 IGEGGYGPVY--RGKLDHTPVAIKVLRPDAAQGKRQFQ---QEVEVLSSIRHPNMVLLLG 291
IG+G +G V + A+K + + + + +E++++ + HP +V L
Sbjct: 23 IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWY 82
Query: 292 A--CPDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKI------AAEIATALLFLHQ 343
+ + +V + + G L L + FK E+ AL +L
Sbjct: 83 SFQDEEDMFMVVDLLLGGDLRYHLQQNV---------HFKEETVKLFICELVMALDYLQN 133
Query: 344 AKPEPLVHRDLKPANILLDRN-YVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYID 402
+ ++HRD+KP NILLD + +V I+D +A ++P ++ T+ AGT Y+
Sbjct: 134 QR---IIHRDMKPDNILLDEHGHV-HITDFNIAAMLPR---ETQI----TTMAGTKPYMA 182
Query: 403 PE--YQQTGMLTTKS-DIYSFGIMLLQIITARSP 433
PE + G + + D +S G+ +++ R P
Sbjct: 183 PEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 2e-21
Identities = 59/303 (19%), Positives = 107/303 (35%), Gaps = 49/303 (16%)
Query: 147 EEARMAEETALAIAEMEKAKCRAAIEAAEKAQKLADAEAQRRKQAELKAKREAEEKNRAL 206
+E R A + + + + RA I + + K+ + E
Sbjct: 17 KERRRARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQS 76
Query: 207 TALANNDVRYRKYTIEEIEEATDKFSEAMKIGEGGYGPVYRG--KLDHTPVAIKVL---- 260
+ + +E K+ IG G V R + A+K++
Sbjct: 77 MGPEDELPDWAA-----AKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTA 131
Query: 261 ----RPDAAQGKRQFQQEVEVLSSIR-HPNMVLLLGAC--PDYGCLVYEYMHNGSLEDRL 313
+ + ++E +L + HP+++ L+ + + LV++ M G L D L
Sbjct: 132 ERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYL 191
Query: 314 LRRGNTPVIPWRKRF--KIAAE----IATALLFLHQAKPEPLVHRDLKPANILLDRNYVS 367
+ K + A+ FLH +VHRDLKP NILLD N
Sbjct: 192 TEKV---------ALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQI 239
Query: 368 KISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPE------YQQTGMLTTKSDIYSFG 421
++SD G + + P + GT Y+ PE + + D+++ G
Sbjct: 240 RLSDFGFSCHLEPGEK-------LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACG 292
Query: 422 IML 424
++L
Sbjct: 293 VIL 295
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 93.0 bits (232), Expect = 3e-21
Identities = 47/209 (22%), Positives = 84/209 (40%), Gaps = 39/209 (18%)
Query: 236 KIGEGGYGPVYRG--KLDHTPVAIKVLR------PDAAQGKRQFQQEVEVLSSIRHPNMV 287
++G G + V + K A K ++ + + ++EV +L IRHPN++
Sbjct: 12 ELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 71
Query: 288 LLLGAC--PDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRF--KIAAE----IATALL 339
L L+ E + G L D L + + A + I +
Sbjct: 72 TLHDIFENKTDVVLILELVSGGELFDFLAEKES---------LTEDEATQFLKQILDGVH 122
Query: 340 FLHQAKPEPLVHRDLKPANILL-DRNYVS---KISDVGLARLVPPSVADSVTQYHMTSAA 395
+LH + + H DLKP NI+L D+N + K+ D G+A + +
Sbjct: 123 YLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE-------FKNIF 172
Query: 396 GTFCYIDPEYQQTGMLTTKSDIYSFGIML 424
GT ++ PE L ++D++S G++
Sbjct: 173 GTPEFVAPEIVNYEPLGLEADMWSIGVIT 201
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 96.4 bits (240), Expect = 3e-21
Identities = 61/217 (28%), Positives = 95/217 (43%), Gaps = 28/217 (12%)
Query: 229 DKFSEAMKIGEGGYGPVYRGKLDHTPV--AIKVLRPDAAQGKRQFQQ---EVEVLSSIRH 283
+ F + +G+GG+G V ++ T A K L + ++ E ++L +
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 284 PNMVLLLGA--CPDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFL 341
+V L A D CLV M+ G L+ + G R F AAEI L L
Sbjct: 244 RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVF-YAAEICCGLEDL 302
Query: 342 HQAKPEPLVHRDLKPANILLDRN-YVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFC- 399
H+ + +V+RDLKP NILLD + ++ +ISD+GLA VP
Sbjct: 303 HRER---IVYRDLKPENILLDDHGHI-RISDLGLAVHVPEG-----------QTIKGRVG 347
Query: 400 ---YIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSP 433
Y+ PE + T D ++ G +L ++I +SP
Sbjct: 348 TVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 384
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 4e-21
Identities = 62/217 (28%), Positives = 99/217 (45%), Gaps = 48/217 (22%)
Query: 237 IGEGGYGPVY--RGKLDHTPVAIKVLRPDAAQGKRQFQ---QEVEVLSSIRHPNMVLLLG 291
+G G +G V+ R + + A+KVL+ + +Q + E +LS + HP ++ + G
Sbjct: 14 LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWG 73
Query: 292 AC--PDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKI------AAEIATALLFLHQ 343
++ +Y+ G L L + RF AAE+ AL +LH
Sbjct: 74 TFQDAQQIFMIMDYIEGGELFSLLRKSQ---------RFPNPVAKFYAAEVCLALEYLHS 124
Query: 344 AKPEPLVHRDLKPANILLDRN-YVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFC--- 399
+++RDLKP NILLD+N ++ KI+D G A+ V VT T C
Sbjct: 125 KD---IIYRDLKPENILLDKNGHI-KITDFGFAKYV-----PDVTY--------TLCGTP 167
Query: 400 -YIDPE-YQQTGMLTTKS-DIYSFGIMLLQIITARSP 433
YI PE KS D +SFGI++ +++ +P
Sbjct: 168 DYIAPEVVSTKPY--NKSIDWWSFGILIYEMLAGYTP 202
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 4e-21
Identities = 54/206 (26%), Positives = 85/206 (41%), Gaps = 41/206 (19%)
Query: 236 KIGEGGYGPVYRG--KLDHTPVAIKVLRPDAAQGKRQF---QQEVEVLSSIR-HPNMVLL 289
+GEG + + K + A+K++ KR Q+E+ L HPN+V L
Sbjct: 18 PLGEGSFSICRKCVHKKSNQAFAVKIIS------KRMEANTQKEITALKLCEGHPNIVKL 71
Query: 290 LGACPDYGC--LVYEYMHNGSLEDRLLRRGNTPVIPWRKRF--KIAAE----IATALLFL 341
D LV E ++ G L +R+ ++ + F A+ + +A+ +
Sbjct: 72 HEVFHDQLHTFLVMELLNGGELFERIKKKKH---------FSETEASYIMRKLVSAVSHM 122
Query: 342 HQAKPEPLVHRDLKPANILL---DRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTF 398
H +VHRDLKP N+L + N KI D G ARL PP + + T
Sbjct: 123 HDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD------NQPLKTPCFTL 173
Query: 399 CYIDPEYQQTGMLTTKSDIYSFGIML 424
Y PE D++S G++L
Sbjct: 174 HYAAPELLNQNGYDESCDLWSLGVIL 199
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 7e-21
Identities = 60/239 (25%), Positives = 102/239 (42%), Gaps = 40/239 (16%)
Query: 215 RYRKYTIEEIEEAT-DKFSEAMKIGEGGYGPVY--RGKLDHTPVAIKVLRPDAAQGKRQF 271
R+ ++ E + D F + +G GG+G V+ + K A K L + ++ +
Sbjct: 170 RFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGY 229
Query: 272 Q---QEVEVLSSIRHPNMVLLLGA--CPDYGCLVYEYMHNGSLEDRLLRRGNTPVI--PW 324
Q E ++L+ + +V L A CLV M+ G + +
Sbjct: 230 QGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEP 289
Query: 325 RKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRN-YVSKISDVGLARLVPPSVA 383
R F A+I + L LHQ +++RDLKP N+LLD + V +ISD+GLA +
Sbjct: 290 RAIF-YTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNV-RISDLGLAVELKAG-- 342
Query: 384 DSVTQYHMTSAAGTFC----YIDPEYQQTGMLT----TKS-DIYSFGIMLLQIITARSP 433
+ T+ + ++ PE +L S D ++ G+ L ++I AR P
Sbjct: 343 QTKTK--------GYAGTPGFMAPE-----LLLGEEYDFSVDYFALGVTLYEMIAARGP 388
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 7e-21
Identities = 40/202 (19%), Positives = 77/202 (38%), Gaps = 27/202 (13%)
Query: 237 IGEGGYGPVYRG--KLDHTPVAIKVL--------RPDAAQGKRQFQQEVEVLSSIRHPNM 286
+G G +G V+ K + V +K + + E+ +LS + H N+
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 287 VLLLG--ACPDYGCLVYEYMHNGS-LEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQ 343
+ +L + LV E +G L + R F+ ++ +A+ +L
Sbjct: 92 IKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFR---QLVSAVGYLRL 148
Query: 344 AKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDP 403
++HRD+K NI++ ++ K+ D G A + + GT Y P
Sbjct: 149 KD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLER-------GKLFYTFCGTIEYCAP 198
Query: 404 E-YQQTGMLTTKSDIYSFGIML 424
E + +++S G+ L
Sbjct: 199 EVLMGNPYRGPELEMWSLGVTL 220
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 95.3 bits (237), Expect = 9e-21
Identities = 66/208 (31%), Positives = 93/208 (44%), Gaps = 25/208 (12%)
Query: 237 IGEGGYGPVYRGKLDHTPV--AIKVLRPDAAQGKRQFQ---QEVEVL---SSIRHPNMVL 288
IG GG+G VY + T A+K L + K+ E +L S+ P +V
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 256
Query: 289 LLGA--CPDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKP 346
+ A PD + + M+ G L L + G RF AAEI L +H
Sbjct: 257 MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS--EADMRF-YAAEIILGLEHMHNRF- 312
Query: 347 EPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQ 406
+V+RDLKPANILLD + +ISD+GLA ++ GT Y+ PE
Sbjct: 313 --VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP--------HASVGTHGYMAPEVL 362
Query: 407 QTGMLTTKS-DIYSFGIMLLQIITARSP 433
Q G+ S D +S G ML +++ SP
Sbjct: 363 QKGVAYDSSADWFSLGCMLFKLLRGHSP 390
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 1e-20
Identities = 42/212 (19%), Positives = 85/212 (40%), Gaps = 31/212 (14%)
Query: 225 EEATDKFSEAMKIGEGGYGPVYRG--KLDHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIR 282
+E +K+ A +G G +G V+R K ++ + ++E+ +L+ R
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV-KGTDQVLVKKEISILNIAR 59
Query: 283 HPNMVLLLGAC--PDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRF--KIAAE----I 334
H N++ L + + +++E++ + +R+ + +
Sbjct: 60 HRNILHLHESFESMEELVMIFEFISGLDIFERINTSAF--------ELNEREIVSYVHQV 111
Query: 335 ATALLFLHQAKPEPLVHRDLKPANILL--DRNYVSKISDVGLARLVPPSVADSVTQYHMT 392
AL FLH + H D++P NI+ R+ KI + G AR + P
Sbjct: 112 CEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN-------FR 161
Query: 393 SAAGTFCYIDPEYQQTGMLTTKSDIYSFGIML 424
Y PE Q +++T +D++S G ++
Sbjct: 162 LLFTAPEYYAPEVHQHDVVSTATDMWSLGTLV 193
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 2e-20
Identities = 53/225 (23%), Positives = 88/225 (39%), Gaps = 39/225 (17%)
Query: 220 TIEEIEEATDKFSEAMKIGEGGYGPVYRG--KLDHTPVAIKVLR------PDAAQGKRQF 271
T+ E D + ++G G + V + K A K ++ +
Sbjct: 2 TVFRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDI 61
Query: 272 QQEVEVLSSIRHPNMVLLLGA--CPDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRF- 328
++EV +L I+HPN++ L L+ E + G L D L + +
Sbjct: 62 EREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---------LT 112
Query: 329 -KIAAE----IATALLFLHQAKPEPLVHRDLKPANILL-DRNYVS---KISDVGLARLVP 379
+ A E I + +LH + + H DLKP NI+L DRN KI D GLA +
Sbjct: 113 EEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID 169
Query: 380 PSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIML 424
+ GT ++ PE L ++D++S G++
Sbjct: 170 FGNE-------FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 207
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 2e-20
Identities = 61/230 (26%), Positives = 92/230 (40%), Gaps = 33/230 (14%)
Query: 228 TDKFSEAMKIGEGGYGPVYRGKLDHT--PVAIKVLRPDAAQGKRQF---QQEVEVLSSIR 282
FS+ +IG G +G VY + VAIK + Q ++ +EV L +R
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112
Query: 283 HPNMVLLLGACPDYGCL--VYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAA---EIATA 337
HPN + G V EY GS D LL P+ + +IAA
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYC-LGSASD-LLEVHKKPL----QEVEIAAVTHGALQG 166
Query: 338 LLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGT 397
L +LH ++HRD+K NILL + K+ D G A + S GT
Sbjct: 167 LAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFG--------SASIMAP--ANSFVGT 213
Query: 398 FCYIDPE---YQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAI 444
++ PE G K D++S GI +++ + P+ + A+
Sbjct: 214 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL-FNMNAMSAL 262
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 3e-20
Identities = 53/196 (27%), Positives = 90/196 (45%), Gaps = 22/196 (11%)
Query: 237 IGEGGYGPVYRGK--LDHTPVAIKVL---RPDAAQGKRQFQQEVEVLSSIRHPNMVLLLG 291
+GEG +G V VA+K + + + ++E+ L +RHP+++ L
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 292 --ACPDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPL 349
P +V EY G L D ++ + R+ F+ +I A+ + H+ K +
Sbjct: 77 VITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQ---QIICAIEYCHRHK---I 129
Query: 350 VHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPE-YQQT 408
VHRDLKP N+LLD N KI+D GL+ ++ + ++ G+ Y PE
Sbjct: 130 VHRDLKPENLLLDDNLNVKIADFGLSNIMTDG-------NFLKTSCGSPNYAAPEVINGK 182
Query: 409 GMLTTKSDIYSFGIML 424
+ D++S GI+L
Sbjct: 183 LYAGPEVDVWSCGIVL 198
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 3e-20
Identities = 44/203 (21%), Positives = 81/203 (39%), Gaps = 27/203 (13%)
Query: 236 KIGEGGYGPVYRG--KLDHTPVAIKVLR------PDAAQGKRQFQQEVEVLSSIRHPNMV 287
++G G + V + K A K ++ + + ++EV +L + H N++
Sbjct: 19 ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78
Query: 288 LLLGA--CPDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAK 345
L L+ E + G L D L ++ + + + +I + +LH K
Sbjct: 79 TLHDVYENRTDVVLILELVSGGELFDFLAQKES---LSEEEATSFIKQILDGVNYLHTKK 135
Query: 346 PEPLVHRDLKPANILL----DRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYI 401
+ H DLKP NI+L K+ D GLA + V + GT ++
Sbjct: 136 ---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-------FKNIFGTPEFV 185
Query: 402 DPEYQQTGMLTTKSDIYSFGIML 424
PE L ++D++S G++
Sbjct: 186 APEIVNYEPLGLEADMWSIGVIT 208
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 3e-20
Identities = 32/206 (15%), Positives = 58/206 (28%), Gaps = 50/206 (24%)
Query: 236 KIGEGGYGPVYRG---KLDHTPVAIKVLRPD---AAQGKRQFQQEVEVLSSIRHPNMVLL 289
G ++ LD VA+ + P ++ LS I P + +
Sbjct: 38 FHGGVPPLQFWQALDTALD-RQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV 96
Query: 290 L--GACPDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPE 347
L G +V E++ GSL++ + +P + +A A H+A
Sbjct: 97 LDVVHTRAGGLVVAEWIRGGSLQE-VADTSPSP----VGAIRAMQSLAAAADAAHRA--- 148
Query: 348 PLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQ 407
+ P+ + +S G L +
Sbjct: 149 GVALSIDHPSRVR--------VSIDGDVVL------------------AYPATMPDA--- 179
Query: 408 TGMLTTKSDIYSFGIMLLQIITARSP 433
+ DI G L ++ R P
Sbjct: 180 ----NPQDDIRGIGASLYALLVNRWP 201
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 3e-20
Identities = 49/208 (23%), Positives = 85/208 (40%), Gaps = 43/208 (20%)
Query: 236 KIGEGGYGPVYRG--KLDHTPVAIKVLRPDAAQGKRQ-FQQEVEVL-SSIRHPNMVLLLG 291
+G G G V + A+K+L +QEV+ + P++V +L
Sbjct: 36 VLGLGVNGKVLECFHRRTGQKCALKLLY------DSPKARQEVDHHWQASGGPHIVCILD 89
Query: 292 ACPDYGC------LVYEYMHNGSLEDRLLRRGNTPVIPWRKRF--KIAAE----IATALL 339
+ ++ E M G L R+ RG+ + F + AAE I TA+
Sbjct: 90 VYENMHHGKRCLLIIMECMEGGELFSRIQERGD-------QAFTEREAAEIMRDIGTAIQ 142
Query: 340 FLHQAKPEPLVHRDLKPANILL---DRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAG 396
FLH + HRD+KP N+L +++ V K++D G A+ + + +
Sbjct: 143 FLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA--------LQTPCY 191
Query: 397 TFCYIDPEYQQTGMLTTKSDIYSFGIML 424
T Y+ PE D++S G+++
Sbjct: 192 TPYYVAPEVLGPEKYDKSCDMWSLGVIM 219
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 4e-20
Identities = 45/203 (22%), Positives = 82/203 (40%), Gaps = 27/203 (13%)
Query: 236 KIGEGGYGPVYRG--KLDHTPVAIKVLR------PDAAQGKRQFQQEVEVLSSIRHPNMV 287
++G G + V + K A K ++ + + ++EV +L + HPN++
Sbjct: 19 ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNII 78
Query: 288 LLLGA--CPDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAK 345
L L+ E + G L D L ++ + + + +I + +LH K
Sbjct: 79 TLHDVYENRTDVVLILELVSGGELFDFLAQKES---LSEEEATSFIKQILDGVNYLHTKK 135
Query: 346 PEPLVHRDLKPANILL----DRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYI 401
+ H DLKP NI+L K+ D GLA + V + GT ++
Sbjct: 136 ---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-------FKNIFGTPEFV 185
Query: 402 DPEYQQTGMLTTKSDIYSFGIML 424
PE L ++D++S G++
Sbjct: 186 APEIVNYEPLGLEADMWSIGVIT 208
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 5e-20
Identities = 51/223 (22%), Positives = 93/223 (41%), Gaps = 48/223 (21%)
Query: 237 IGEGGYGPVYRGK--LDHTPVAIKVL---------------RPDAAQGKR---------- 269
IG+G YG V D+T A+KVL P +
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 270 -QFQQEVEVLSSIRHPNMVLLL----GACPDYGCLVYEYMHNGSLEDRLLRRGNTPVIPW 324
Q QE+ +L + HPN+V L+ D+ +V+E ++ G + + +
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVME-VPTLKPLSEDQA 139
Query: 325 RKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVAD 384
R F+ ++ + +LH K ++HRD+KP+N+L+ + KI+D G++ S A
Sbjct: 140 RFYFQ---DLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDA- 192
Query: 385 SVTQYHMTSAAGTFCYIDPE---YQQTGMLTTKSDIYSFGIML 424
+++ GT ++ PE + D+++ G+ L
Sbjct: 193 -----LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTL 230
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 6e-20
Identities = 55/213 (25%), Positives = 87/213 (40%), Gaps = 33/213 (15%)
Query: 237 IGEGGYGPVY--RGKLDHTPVAIKVLRPDAAQGKRQ---FQQEVEVLSSIRHPNMVLLLG 291
IG G +G V R K A+K+L + F +E ++++ P +V L
Sbjct: 77 IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY 136
Query: 292 A--CPDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPL 349
A Y +V EYM G L L+ + P RF AE+ AL +H
Sbjct: 137 AFQDDRYLYMVMEYMPGGDLV-NLMSNYDVP--EKWARF-YTAEVVLALDAIHSMG---F 189
Query: 350 VHRDLKPANILLDRN-YVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFC----YIDPE 404
+HRD+KP N+LLD++ ++ K++D G + T YI PE
Sbjct: 190 IHRDVKPDNMLLDKSGHL-KLADFGTCMKMNKEGMVR---------CDTAVGTPDYISPE 239
Query: 405 ---YQQTGMLTTKS-DIYSFGIMLLQIITARSP 433
Q + D +S G+ L +++ +P
Sbjct: 240 VLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 6e-20
Identities = 52/214 (24%), Positives = 86/214 (40%), Gaps = 32/214 (14%)
Query: 237 IGEGGYGPVY--RGKLDHTPVAIKVLRPDAAQGKRQ---FQQEVEVLSSIRHPNMVLLLG 291
IG G +G V + K A+K+L + + F++E +VL + + L
Sbjct: 82 IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHY 141
Query: 292 A--CPDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPL 349
A + LV +Y G L LL + + RF AE+ A+ +HQ
Sbjct: 142 AFQDDNNLYLVMDYYVGGDLL-TLLSKFEDRLPEEMARF-YLAEMVIAIDSVHQLH---Y 196
Query: 350 VHRDLKPANILLDRN-YVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFC----YIDPE 404
VHRD+KP NIL+D N ++ +++D G + T + YI PE
Sbjct: 197 VHRDIKPDNILMDMNGHI-RLADFGSCLKLMEDG---------TVQSSVAVGTPDYISPE 246
Query: 405 YQQTGMLTTKS-----DIYSFGIMLLQIITARSP 433
Q D +S G+ + +++ +P
Sbjct: 247 ILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 91.8 bits (228), Expect = 6e-20
Identities = 54/198 (27%), Positives = 96/198 (48%), Gaps = 25/198 (12%)
Query: 237 IGEGGYGPVYRGKLDHTP----VAIKVL---RPDAAQGKRQFQQEVEVLSSIRHPNMVLL 289
+G G +G V GK H VA+K+L + + + ++E++ L RHP+++ L
Sbjct: 24 LGVGTFGKVKVGK--HELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL 81
Query: 290 LG--ACPDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPE 347
+ P +V EY+ G L D + + G R+ F+ +I + + + H+
Sbjct: 82 YQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQ---QILSGVDYCHRHM-- 136
Query: 348 PLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPE-YQ 406
+VHRDLKP N+LLD + +KI+D GL+ ++ + ++ G+ Y PE
Sbjct: 137 -VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-------EFLRTSCGSPNYAAPEVIS 188
Query: 407 QTGMLTTKSDIYSFGIML 424
+ DI+S G++L
Sbjct: 189 GRLYAGPEVDIWSSGVIL 206
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 7e-20
Identities = 44/162 (27%), Positives = 78/162 (48%), Gaps = 20/162 (12%)
Query: 227 ATDKFSEAMKIGEGGYGPVYRGKLDHT--PVAIKVLRPDAAQGK-----RQFQQEVEVLS 279
++ +F + K+G G Y VY+G T VA+K ++ D+ +G R E+ ++
Sbjct: 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIR----EISLMK 58
Query: 280 SIRHPNMVLLLGACPDYGC--LVYEYMHN---GSLEDRLLRRGNTPVIPWRKRFKIAAEI 334
++H N+V L LV+E+M N ++ R + + + ++
Sbjct: 59 ELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVK-YFQWQL 117
Query: 335 ATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLAR 376
L F H+ K ++HRDLKP N+L+++ K+ D GLAR
Sbjct: 118 LQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLAR 156
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 8e-20
Identities = 63/214 (29%), Positives = 99/214 (46%), Gaps = 39/214 (18%)
Query: 237 IGEGGYGPVY--RGKLDHTPVAIKVLRPDAAQGKRQF---QQEVEVLSSIRHPNMVLLLG 291
+G+G +G V R K A+K+LR + K + E VL + RHP + L
Sbjct: 13 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 72
Query: 292 A--CPDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPL 349
A D C V EY + G L L R R RF AEI +AL +LH +
Sbjct: 73 AFQTHDRLCFVMEYANGGELFFHLSRERVFTEE--RARF-YGAEIVSALEYLHSRD---V 126
Query: 350 VHRDLKPANILLDRN-YVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFC----YIDPE 404
V+RD+K N++LD++ ++ KI+D GL + ++D T TFC Y+ PE
Sbjct: 127 VYRDIKLENLMLDKDGHI-KITDFGLCKE---GISDGAT-------MKTFCGTPEYLAPE 175
Query: 405 YQQTGMLT----TKS-DIYSFGIMLLQIITARSP 433
+L ++ D + G+++ +++ R P
Sbjct: 176 -----VLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 1e-19
Identities = 55/195 (28%), Positives = 84/195 (43%), Gaps = 21/195 (10%)
Query: 237 IGEGGYGPVY--RGKLDHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLL--LGA 292
IG G +G R KL VA+K + A Q+E+ S+RHPN+V +
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYI-ERGAAIDENVQREIINHRSLRHPNIVRFKEVIL 86
Query: 293 CPDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHR 352
P + ++ EY G L +R+ G R F+ ++ + + + H + + HR
Sbjct: 87 TPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQ---QLLSGVSYCHSMQ---ICHR 140
Query: 353 DLKPANILLDRNYVS--KISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPE-YQQTG 409
DLK N LLD + KI D G ++ SV S GT YI PE +
Sbjct: 141 DLKLENTLLDGSPAPRLKICDFGYSKS-------SVLHSQPKSTVGTPAYIAPEVLLRQE 193
Query: 410 MLTTKSDIYSFGIML 424
+D++S G+ L
Sbjct: 194 YDGKIADVWSCGVTL 208
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 90.6 bits (225), Expect = 1e-19
Identities = 69/273 (25%), Positives = 110/273 (40%), Gaps = 33/273 (12%)
Query: 172 EAAEKAQKLADAEAQRRKQAELKAKREAEEKNRALTALANNDVRYRKYTIEEIEEATDKF 231
E Q +AD ++ + + A + + T+ E F
Sbjct: 98 EWTTAIQTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNE-------F 150
Query: 232 SEAMKIGEGGYGPVY--RGKLDHTPVAIKVLRPDAAQGKRQFQQ---EVEVLSSIRHPNM 286
+G+G +G V + K A+K+L+ + K + E VL + RHP +
Sbjct: 151 EYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFL 210
Query: 287 VLLLGA--CPDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQA 344
L + D C V EY + G L L R R RF AEI +AL +LH
Sbjct: 211 TALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSE--DRARF-YGAEIVSALDYLHSE 267
Query: 345 KPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFC----Y 400
K +V+RDLK N++LD++ KI+D GL + + D T TFC Y
Sbjct: 268 KN--VVYRDLKLENLMLDKDGHIKITDFGLCKE---GIKDGAT-------MKTFCGTPEY 315
Query: 401 IDPEYQQTGMLTTKSDIYSFGIMLLQIITARSP 433
+ PE + D + G+++ +++ R P
Sbjct: 316 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 348
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 2e-19
Identities = 57/230 (24%), Positives = 99/230 (43%), Gaps = 31/230 (13%)
Query: 216 YRKYTIEEIE-EATDKFSEAMKIGEGGYGPVYRG--KLDHTPVAIKVLRPDAAQG-KRQF 271
Y Y +E D + K+G G Y V+ ++ V +K+L+P + KR
Sbjct: 22 YWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKR-- 79
Query: 272 QQEVEVLSSIR-HPNMVLLLGACPDYG----CLVYEYMHNGSLEDRLLRRGNTPVIPWRK 326
E+++L ++R PN++ L D LV+E+++N + +L + I
Sbjct: 80 --EIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFK-QLYQTLTDYDI---- 132
Query: 327 RFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDR-NYVSKISDVGLARLVPPSVADS 385
RF + EI AL + H ++HRD+KP N+++D + ++ D GLA P
Sbjct: 133 RFYMY-EILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE-- 186
Query: 386 VTQYHMTSAAGTFCYIDPEYQQTGMLTTKS-DIYSFGIMLLQIITARSPM 434
+ + PE + S D++S G ML +I + P
Sbjct: 187 -----YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 231
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 2e-19
Identities = 46/157 (29%), Positives = 76/157 (48%), Gaps = 19/157 (12%)
Query: 229 DKFSEAMKIGEGGYGPVYRGKLDHT--PVAIKVLRPDAAQGK-----RQFQQEVEVLSSI 281
+ + + K+GEG Y VY+GK T VA+K +R + +G R EV +L +
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIR----EVSLLKDL 57
Query: 282 RHPNMVLLLGACPDYGC--LVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALL 339
+H N+V L LV+EY+ L+ + L + + ++ L
Sbjct: 58 KHANIVTLHDIIHTEKSLTLVFEYLDK-DLK-QYLDDCGNIINMHNVK-LFLFQLLRGLA 114
Query: 340 FLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLAR 376
+ H+ K ++HRDLKP N+L++ K++D GLAR
Sbjct: 115 YCHRQK---VLHRDLKPQNLLINERGELKLADFGLAR 148
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 2e-19
Identities = 55/212 (25%), Positives = 85/212 (40%), Gaps = 26/212 (12%)
Query: 237 IGEGGYGPVY--RGKLDHTPVAIKVLRPDAAQGKRQ---FQQEVEVLSSIRHPNMVLLLG 291
IG G + V + K A+K++ + + F++E +VL + + L
Sbjct: 69 IGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHF 128
Query: 292 A--CPDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPL 349
A +Y LV EY G L L + G RF AEI A+ +H+
Sbjct: 129 AFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAE-MARF-YLAEIVMAIDSVHRLG---Y 183
Query: 350 VHRDLKPANILLDRNYVSKISDVGLA-RLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQT 408
VHRD+KP NILLDR +++D G +L S A GT Y+ PE Q
Sbjct: 184 VHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRS------LVAVGTPDYLSPEILQA 237
Query: 409 GMLTTKSDIY-------SFGIMLLQIITARSP 433
+ Y + G+ ++ ++P
Sbjct: 238 VGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 3e-19
Identities = 51/260 (19%), Positives = 100/260 (38%), Gaps = 47/260 (18%)
Query: 184 EAQRRKQAELKAKREAEEKNRALTALANNDVRYRKYTIEEIEEATDKFSEAMKIGEGGYG 243
+ A+ + + ++ +K I + + T + +G G G
Sbjct: 22 QPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQ-----VLGLGING 76
Query: 244 PVYRG--KLDHTPVAIKVLRPDAAQGKRQ-FQQEVEVLSSI-RHPNMVLLLGACPDYGC- 298
V + K A+K+L+ ++EVE+ + P++V ++ +
Sbjct: 77 KVLQIFNKRTQEKFALKMLQ------DCPKARREVELHWRASQCPHIVRIVDVYENLYAG 130
Query: 299 -----LVYEYMHNGSLEDRLLRRGNTPVIPWRKRF--KIAAE----IATALLFLHQAKPE 347
+V E + G L R+ RG+ + F + A+E I A+ +LH
Sbjct: 131 RKCLLIVMECLDGGELFSRIQDRGD-------QAFTEREASEIMKSIGEAIQYLHSIN-- 181
Query: 348 PLVHRDLKPANILL---DRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPE 404
+ HRD+KP N+L N + K++D G A+ + +T+ T Y+ PE
Sbjct: 182 -IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS-------LTTPCYTPYYVAPE 233
Query: 405 YQQTGMLTTKSDIYSFGIML 424
D++S G+++
Sbjct: 234 VLGPEKYDKSCDMWSLGVIM 253
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 87.6 bits (218), Expect = 3e-19
Identities = 49/158 (31%), Positives = 75/158 (47%), Gaps = 19/158 (12%)
Query: 229 DKFSEAMKIGEGGYGPVYRGKLDHT--PVAIKVLRPDAAQ------GKRQFQQEVEVLSS 280
+ F + KIGEG YG VY+ + T VA+K +R D R E+ +L
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR----EISLLKE 58
Query: 281 IRHPNMVLLLGACPDYGC--LVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATAL 338
+ HPN+V LL LV+E++H L+ + + IP ++ L
Sbjct: 59 LNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLK-KFMDASALTGIPLPLIKSYLFQLLQGL 116
Query: 339 LFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLAR 376
F H + ++HRDLKP N+L++ K++D GLAR
Sbjct: 117 AFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR 151
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 87.6 bits (218), Expect = 3e-19
Identities = 48/154 (31%), Positives = 75/154 (48%), Gaps = 12/154 (7%)
Query: 229 DKFSEAMKIGEGGYGPVYRGKLDHT--PVAIKVLRPDAAQG--KRQFQQEVEVLSSIRHP 284
+K+ + KIGEG YG V++ + T VAIK K+ +E+ +L ++HP
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62
Query: 285 NMVLLLGACPDYGC--LVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLH 342
N+V LL LV+EY + ++ L R V + I + A+ F H
Sbjct: 63 NLVNLLEVFRRKRRLHLVFEYCDH-TVL-HELDRYQRGVPEHLVK-SITWQTLQAVNFCH 119
Query: 343 QAKPEPLVHRDLKPANILLDRNYVSKISDVGLAR 376
+ +HRD+KP NIL+ ++ V K+ D G AR
Sbjct: 120 KHN---CIHRDVKPENILITKHSVIKLCDFGFAR 150
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 86.8 bits (216), Expect = 4e-19
Identities = 43/158 (27%), Positives = 75/158 (47%), Gaps = 21/158 (13%)
Query: 229 DKFSEAMKIGEGGYGPVYRGKLDHT--PVAIKVLRPDAAQ------GKRQFQQEVEVLSS 280
+K+ KIGEG YG VY+ + ++ A+K +R + R E+ +L
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQ-NNYGETFALKKIRLEKEDEGIPSTTIR----EISILKE 56
Query: 281 IRHPNMVLLLGACPDYG--CLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATAL 338
++H N+V L LV+E++ L+ +LL + + ++ +
Sbjct: 57 LKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLK-KLLDVCEGGLESVTAK-SFLLQLLNGI 113
Query: 339 LFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLAR 376
+ H + ++HRDLKP N+L++R KI+D GLAR
Sbjct: 114 AYCHDRR---VLHRDLKPQNLLINREGELKIADFGLAR 148
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 87.6 bits (218), Expect = 4e-19
Identities = 57/222 (25%), Positives = 100/222 (45%), Gaps = 53/222 (23%)
Query: 237 IGEGGYGPVY-----RGKLDHTPVAIKVLRPDAAQGKRQFQQEVE--VLSSIRHPNMVLL 289
+G+G +G V+ G A+KVL+ + + + + ++E +L + HP +V L
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91
Query: 290 LGA--CPDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKI------AAEIATALLFL 341
A L+ +++ G L RL + F AE+A AL L
Sbjct: 92 HYAFQTEGKLYLILDFLRGGDLFTRLSKEV---------MFTEEDVKFYLAELALALDHL 142
Query: 342 HQAKPEPLVHRDLKPANILLDRN-YVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFC- 399
H +++RDLKP NILLD ++ K++D GL++ S+ +FC
Sbjct: 143 HSLG---IIYRDLKPENILLDEEGHI-KLTDFGLSKE-------SIDHEKKAY---SFCG 188
Query: 400 ---YIDPEYQQTGMLT----TKS-DIYSFGIMLLQIITARSP 433
Y+ PE ++ T+S D +SFG+++ +++T P
Sbjct: 189 TVEYMAPE-----VVNRRGHTQSADWWSFGVLMFEMLTGTLP 225
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 4e-19
Identities = 61/215 (28%), Positives = 97/215 (45%), Gaps = 40/215 (18%)
Query: 237 IGEGGYGPVY--RGKLDHTPVAIKVLRPDAAQGKRQF---QQEVEVLS-SIRHPNMVLLL 290
+G+G +G V+ K + AIK L+ D E VLS + HP + +
Sbjct: 25 LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMF 84
Query: 291 GA--CPDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEP 348
+ V EY++ G L + + R F AAEI L FLH
Sbjct: 85 CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLS--RATF-YAAEIILGLQFLHSKG--- 138
Query: 349 LVHRDLKPANILLDRN-YVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFC----YIDP 403
+V+RDLK NILLD++ ++ KI+D G+ + +++ T+ TFC YI P
Sbjct: 139 IVYRDLKLDNILLDKDGHI-KIADFGMCK-------ENMLGDAKTN---TFCGTPDYIAP 187
Query: 404 EYQQTGMLTTKS-----DIYSFGIMLLQIITARSP 433
E +L + D +SFG++L +++ +SP
Sbjct: 188 E-----ILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 5e-19
Identities = 48/205 (23%), Positives = 76/205 (37%), Gaps = 33/205 (16%)
Query: 236 KIGEGGYGPVYRG--KLDHTPVAIKVL--RPDAAQGKRQFQQEVEVLSSIRH-PNMVLLL 290
++G G + V + K A K L R + + E+ VL + P ++ L
Sbjct: 36 ELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH 95
Query: 291 GA--CPDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRF--KIAAE----IATALLFLH 342
L+ EY G + L + I + +LH
Sbjct: 96 EVYENTSEIILILEYAAGGEIFSLCLPELA-------EMVSENDVIRLIKQILEGVYYLH 148
Query: 343 QAKPEPLVHRDLKPANILLDRNYVS---KISDVGLARLVPPSVADSVTQYHMTSAAGTFC 399
Q +VH DLKP NILL Y KI D G++R + + + GT
Sbjct: 149 QNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE-------LREIMGTPE 198
Query: 400 YIDPEYQQTGMLTTKSDIYSFGIML 424
Y+ PE +TT +D+++ GI+
Sbjct: 199 YLAPEILNYDPITTATDMWNIGIIA 223
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 86.8 bits (216), Expect = 8e-19
Identities = 61/227 (26%), Positives = 96/227 (42%), Gaps = 61/227 (26%)
Query: 237 IGEGGYGPVY-----RGKLDHTPVAIKVLRPDAAQGKRQFQQEVE-------VLSSIRHP 284
+G+GGYG V+ G A+KVL+ ++ +L ++HP
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRN---AKDTAHTKAERNILEEVKHP 81
Query: 285 NMVLLLGA--CPDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKI------AAEIAT 336
+V L+ A L+ EY+ G L +L R G F AEI+
Sbjct: 82 FIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREG---------IFMEDTACFYLAEISM 132
Query: 337 ALLFLHQAKPEPLVHRDLKPANILLDRN-YVSKISDVGLARLVPPSVADSVTQYHMTSAA 395
AL LHQ +++RDLKP NI+L+ +V K++D GL + S+ D
Sbjct: 133 ALGHLHQKG---IIYRDLKPENIMLNHQGHV-KLTDFGLCKE---SIHDGTV-------T 178
Query: 396 GTFC----YIDPEYQQTGMLT----TKS-DIYSFGIMLLQIITARSP 433
TFC Y+ PE +L ++ D +S G ++ ++T P
Sbjct: 179 HTFCGTIEYMAPE-----ILMRSGHNRAVDWWSLGALMYDMLTGAPP 220
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 86.0 bits (214), Expect = 9e-19
Identities = 47/158 (29%), Positives = 74/158 (46%), Gaps = 20/158 (12%)
Query: 229 DKFSEAMKIGEGGYGPVYRGKLDHT--PVAIKVLRPDAAQ------GKRQFQQEVEVLSS 280
K+ + KIGEG YG V++ K T VA+K +R D R E+ +L
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR----EICLLKE 57
Query: 281 IRHPNMVLLLGACPDYGC--LVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATAL 338
++H N+V L LV+E+ L+ + N + P + ++ L
Sbjct: 58 LKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLK-KYFDSCNGDLDPEIVK-SFLFQLLKGL 114
Query: 339 LFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLAR 376
F H ++HRDLKP N+L++RN K+++ GLAR
Sbjct: 115 GFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLAR 149
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 9e-19
Identities = 50/204 (24%), Positives = 79/204 (38%), Gaps = 37/204 (18%)
Query: 236 KIGEGGYGPVYRG--KLDHTPVAIKVLRPDAAQGKRQFQQEVEVL-SSIRHPNMVLLLGA 292
IG G Y R K + A+K++ E+E+L +HPN++ L
Sbjct: 29 DIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTE----EIEILLRYGQHPNIITLKDV 84
Query: 293 CPDYGC--LVYEYMHNGSLEDRLLRRGNTPVIPWRKRF------KIAAEIATALLFLHQA 344
D +V E M G L D++LR+ F + I + +LH
Sbjct: 85 YDDGKYVYVVTELMKGGELLDKILRQKF---------FSEREASAVLFTITKTVEYLHAQ 135
Query: 345 KPEPLVHRDLKPANILL----DRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCY 400
+VHRDLKP+NIL +I D G A+ + + + T +
Sbjct: 136 G---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA------ENGLLMTPCYTANF 186
Query: 401 IDPEYQQTGMLTTKSDIYSFGIML 424
+ PE + DI+S G++L
Sbjct: 187 VAPEVLERQGYDAACDIWSLGVLL 210
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 1e-18
Identities = 44/154 (28%), Positives = 72/154 (46%), Gaps = 12/154 (7%)
Query: 229 DKFSEAMKIGEGGYGPVYRGKLDHT--PVAIKVLRPDAAQG--KRQFQQEVEVLSSIRHP 284
+K+ +GEG YG V + + T VAIK K+ +E+++L +RH
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHE 84
Query: 285 NMVLLLGACPDYGC--LVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLH 342
N+V LL C LV+E++ + ++ L + + K +I + F H
Sbjct: 85 NLVNLLEVCKKKKRWYLVFEFVDH-TIL-DDLELFPNGLDYQVVQ-KYLFQIINGIGFCH 141
Query: 343 QAKPEPLVHRDLKPANILLDRNYVSKISDVGLAR 376
+HRD+KP NIL+ ++ V K+ D G AR
Sbjct: 142 SHNI---IHRDIKPENILVSQSGVVKLCDFGFAR 172
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 1e-18
Identities = 51/169 (30%), Positives = 74/169 (43%), Gaps = 26/169 (15%)
Query: 227 ATDKFSEAMKIGEGGYGPVYRGKLDHT--PVAIKVLRPDAAQ-GKRQFQQ----EVEVL- 278
AT ++ +IG G YG VY+ + H+ VA+K +R G EV +L
Sbjct: 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 279 --SSIRHPNMVLLLGACPDYGC-------LVYEYMHNGSLED--RLLRRGNTPVIPWRKR 327
+ HPN+V L+ C LV+E++ D L + P +P
Sbjct: 67 RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ----DLRTYLDKAPPPGLPAETI 122
Query: 328 FKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLAR 376
+ + L FLH +VHRDLKP NIL+ K++D GLAR
Sbjct: 123 KDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLAR 168
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 2e-18
Identities = 49/158 (31%), Positives = 81/158 (51%), Gaps = 21/158 (13%)
Query: 229 DKFSEAMKIGEGGYGPVYRGKLDHT--PVAIKVLRPDAAQ------GKRQFQQEVEVLSS 280
+K+ + K+GEG YG VY+ K D VA+K +R DA R E+ +L
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAK-DSQGRIVALKRIRLDAEDEGIPSTAIR----EISLLKE 75
Query: 281 IRHPNMVLLLGACPDYGC--LVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATAL 338
+ HPN+V L+ C LV+E+M L+ ++L T + + + ++ +
Sbjct: 76 LHHPNIVSLIDVIHSERCLTLVFEFMEK-DLK-KVLDENKTGLQDSQIK-IYLYQLLRGV 132
Query: 339 LFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLAR 376
HQ + ++HRDLKP N+L++ + K++D GLAR
Sbjct: 133 AHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLAR 167
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 6e-18
Identities = 66/215 (30%), Positives = 102/215 (47%), Gaps = 40/215 (18%)
Query: 237 IGEGGYGPVY--RGKLDHTPVAIKVLRPDAAQGKRQF---QQEVEVLS-SIRHPNMVLLL 290
IG+G +G V R K + A+KVL+ A K++ E VL +++HP +V L
Sbjct: 46 IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 105
Query: 291 GA--CPDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEP 348
+ D V +Y++ G L L R R RF AAEIA+AL +LH
Sbjct: 106 FSFQTADKLYFVLDYINGGELFYHLQRERCFLEP--RARF-YAAEIASALGYLHSLN--- 159
Query: 349 LVHRDLKPANILLDRN-YVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFC----YIDP 403
+V+RDLKP NILLD ++ ++D GL + +++ TS TFC Y+ P
Sbjct: 160 IVYRDLKPENILLDSQGHI-VLTDFGLCK-------ENIEHNSTTS---TFCGTPEYLAP 208
Query: 404 EYQQTGMLT----TKS-DIYSFGIMLLQIITARSP 433
E +L ++ D + G +L +++ P
Sbjct: 209 E-----VLHKQPYDRTVDWWCLGAVLYEMLYGLPP 238
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 7e-18
Identities = 56/215 (26%), Positives = 93/215 (43%), Gaps = 40/215 (18%)
Query: 237 IGEGGYGPVY--RGKLDHTPVAIKVLRPDAAQGKRQF---QQEVEVLSSI-RHPNMVLLL 290
+G+G +G V K A+K+L+ D E VL+ + P + L
Sbjct: 28 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 87
Query: 291 GA--CPDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEP 348
D V EY++ G L + + G F AAEIA L FL
Sbjct: 88 SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEP--HAVF-YAAEIAIGLFFLQSKG--- 141
Query: 349 LVHRDLKPANILLDRN-YVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFC----YIDP 403
+++RDLK N++LD ++ KI+D G+ + +++ T TFC YI P
Sbjct: 142 IIYRDLKLDNVMLDSEGHI-KIADFGMCK-------ENIWDGVTTK---TFCGTPDYIAP 190
Query: 404 EYQQTGMLT----TKS-DIYSFGIMLLQIITARSP 433
E ++ KS D ++FG++L +++ ++P
Sbjct: 191 E-----IIAYQPYGKSVDWWAFGVLLYEMLAGQAP 220
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 8e-18
Identities = 43/181 (23%), Positives = 82/181 (45%), Gaps = 32/181 (17%)
Query: 229 DKFSEAMKIGEGGYGPVYRGKLDHT--PVAIKVLRPDAAQ------GKRQFQQEVEVLSS 280
K+ + KIG+G +G V++ + T VA+K + + + R E+++L
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR----EIKILQL 72
Query: 281 IRHPNMVLLLGACPDYGC----------LVYEYMHNGSLED--RLLRRGNTPVIPWRKRF 328
++H N+V L+ C LV+++ + D LL +
Sbjct: 73 LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH----DLAGLLSNVLVKFTLSEIK- 127
Query: 329 KIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQ 388
++ + L ++H+ K ++HRD+K AN+L+ R+ V K++D GLAR + +
Sbjct: 128 RVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNR 184
Query: 389 Y 389
Y
Sbjct: 185 Y 185
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 1e-17
Identities = 61/216 (28%), Positives = 96/216 (44%), Gaps = 42/216 (19%)
Query: 237 IGEGGYGPVY--RGKLDHTPVAIKVLRPDAAQGKRQF---QQEVEVLSSI-RHPNMVLLL 290
IG G Y V R K A+KV++ + Q E V HP +V L
Sbjct: 17 IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 76
Query: 291 GAC---PDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPE 347
+C V EY++ G L + R+ P RF +AEI+ AL +LH+
Sbjct: 77 -SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEE--HARF-YSAEISLALNYLHERG-- 130
Query: 348 PLVHRDLKPANILLDRN-YVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFC----YID 402
+++RDLK N+LLD ++ K++D G+ + + + TS TFC YI
Sbjct: 131 -IIYRDLKLDNVLLDSEGHI-KLTDYGMCK-------EGLRPGDTTS---TFCGTPNYIA 178
Query: 403 PEYQQTGMLT----TKS-DIYSFGIMLLQIITARSP 433
PE +L S D ++ G+++ +++ RSP
Sbjct: 179 PE-----ILRGEDYGFSVDWWALGVLMFEMMAGRSP 209
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 1e-17
Identities = 59/215 (27%), Positives = 95/215 (44%), Gaps = 40/215 (18%)
Query: 237 IGEGGYGPVY--RGKLDHTPVAIKVLRPDAAQGKRQF---QQEVEVLSSI-RHPNMVLLL 290
+G+G +G V R K A+KVL+ D E +LS HP + L
Sbjct: 31 LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLF 90
Query: 291 GAC--PDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEP 348
PD V E+++ G L + + R RF AAEI +AL+FLH
Sbjct: 91 CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEA--RARF-YAAEIISALMFLHDKG--- 144
Query: 349 LVHRDLKPANILLDRN-YVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFC----YIDP 403
+++RDLK N+LLD + K++D G+ + + + T+ TFC YI P
Sbjct: 145 IIYRDLKLDNVLLDHEGHC-KLADFGMCK-------EGICNGVTTA---TFCGTPDYIAP 193
Query: 404 EYQQTGMLT----TKS-DIYSFGIMLLQIITARSP 433
E +L + D ++ G++L +++ +P
Sbjct: 194 E-----ILQEMLYGPAVDWWAMGVLLYEMLCGHAP 223
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 2e-17
Identities = 47/161 (29%), Positives = 76/161 (47%), Gaps = 37/161 (22%)
Query: 236 KIGEGGYGPVYRGKLDHT--PVAIKVLRPDAAQGK---------RQFQQEVEVLSSIRHP 284
+GEG + VY+ + +T VAIK ++ R E+++L + HP
Sbjct: 17 FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALR----EIKLLQELSHP 72
Query: 285 NMVLLLGACPDYGC--LVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIAT------ 336
N++ LL A LV+++M LE +++ + + P + I
Sbjct: 73 NIIGLLDAFGHKSNISLVFDFMET-DLE-VIIKDNSLVLTP--------SHIKAYMLMTL 122
Query: 337 -ALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLAR 376
L +LHQ ++HRDLKP N+LLD N V K++D GLA+
Sbjct: 123 QGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAK 160
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 2e-17
Identities = 60/230 (26%), Positives = 95/230 (41%), Gaps = 64/230 (27%)
Query: 225 EEATDKFSEAMKIGEGGYGPVYRGKLDHT-PVAIKVLRPDAAQGKRQFQQEVEVLSSIRH 283
E+ ++ IG G +G V++ KL + VAIK + D R E++++ ++H
Sbjct: 36 EQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNR----ELQIMRIVKH 91
Query: 284 PNMVLLL------GACPDYGC--LVYEYMHNGSLED--RLLRRGNTPVIPWRKRFKIAAE 333
PN+V L G D LV EY+ E R R + + +
Sbjct: 92 PNVVDLKAFFYSNGDKKDEVFLNLVLEYVP----ETVYRASRH------YAKLKQTMPML 141
Query: 334 --------IATALLFLHQAKPEPLVHRDLKPANILLDRN-YVSKISDVGLAR-LVP--PS 381
+ +L ++H + HRD+KP N+LLD V K+ D G A+ L+ P+
Sbjct: 142 LIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPN 198
Query: 382 VADSVTQYHMTSAAGTFCYIDPE-------YQQTGMLTTKSDIYSFG-IM 423
V+ ++Y Y PE Y TT DI+S G +M
Sbjct: 199 VSYICSRY----------YRAPELIFGATNY------TTNIDIWSTGCVM 232
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 84.7 bits (209), Expect = 2e-17
Identities = 58/210 (27%), Positives = 91/210 (43%), Gaps = 30/210 (14%)
Query: 237 IGEGGYGPVY--RGKLDHTPVAIKVLRPDAAQGKRQFQQ---EVEVLSSI-RHPNMVLLL 290
+G+G +G V K A+K+L+ D + E VL+ + P + L
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 408
Query: 291 GA--CPDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEP 348
D V EY++ G L + + G F AAEIA L FL
Sbjct: 409 SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEP--HAVF-YAAEIAIGLFFLQSKG--- 462
Query: 349 LVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFC----YIDPE 404
+++RDLK N++LD KI+D G+ + ++ D VT TFC YI PE
Sbjct: 463 IIYRDLKLDNVMLDSEGHIKIADFGMCKE---NIWDGVT-------TKTFCGTPDYIAPE 512
Query: 405 YQQTGMLTTKS-DIYSFGIMLLQIITARSP 433
KS D ++FG++L +++ ++P
Sbjct: 513 IIA-YQPYGKSVDWWAFGVLLYEMLAGQAP 541
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 4e-17
Identities = 60/215 (27%), Positives = 94/215 (43%), Gaps = 40/215 (18%)
Query: 237 IGEGGYGPVY--RGKLDHTPVAIKVLRPDAAQGKRQF---QQEVEVLSSI-RHPNMVLLL 290
IG G Y V R K A++V++ + Q E V HP +V L
Sbjct: 60 IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 119
Query: 291 GAC---PDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPE 347
+C V EY++ G L + R+ P RF +AEI+ AL +LH+
Sbjct: 120 -SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEE--HARF-YSAEISLALNYLHERG-- 173
Query: 348 PLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFC----YIDP 403
+++RDLK N+LLD K++D G+ + + + TS TFC YI P
Sbjct: 174 -IIYRDLKLDNVLLDSEGHIKLTDYGMCK-------EGLRPGDTTS---TFCGTPNYIAP 222
Query: 404 EYQQTGMLT----TKS-DIYSFGIMLLQIITARSP 433
E +L S D ++ G+++ +++ RSP
Sbjct: 223 E-----ILRGEDYGFSVDWWALGVLMFEMMAGRSP 252
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 82.5 bits (204), Expect = 4e-17
Identities = 46/187 (24%), Positives = 78/187 (41%), Gaps = 31/187 (16%)
Query: 213 DVRYRKYTIEEIEEATDKFS-EAMKIGEGGYGPVYRGKLDHTP----VAIKVLR----PD 263
D ++ E E D F E K+G G YG VY+ K A+K +
Sbjct: 4 DYDFKVKLSSERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISM 63
Query: 264 AAQGKRQFQQEVEVLSSIRHPNMVLLLGACPDYG----CLVYEYMHN---GSLEDRLLRR 316
+A E+ +L ++HPN++ L + L+++Y + ++ +
Sbjct: 64 SACR------EIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASK 117
Query: 317 GNTPVIPWRKRF--KIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVS----KIS 370
N + + + +I + +LH ++HRDLKPANIL+ KI+
Sbjct: 118 ANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIA 174
Query: 371 DVGLARL 377
D+G ARL
Sbjct: 175 DMGFARL 181
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 5e-17
Identities = 55/222 (24%), Positives = 87/222 (39%), Gaps = 40/222 (18%)
Query: 222 EEIEEATDKFSEAMKIGEGGYGPVYRGKLDHT--PVAIKVLRPDAAQGKRQFQQEVEVLS 279
E + D+F G+G +G V GK T VAIK + D R+ Q ++ L+
Sbjct: 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNREL-QIMQDLA 74
Query: 280 SIRHPNMVLLL------GACPD---YGCLVYEYMHNGSLED-----RLLRRGNTPVIPWR 325
+ HPN+V L G Y +V EY+ + R R P
Sbjct: 75 VLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP----DTLHRCCRNYYRRQVAPPPIL 130
Query: 326 KRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDR-NYVSKISDVGLARLVPPSVAD 384
+ ++ ++ LH + HRD+KP N+L++ + K+ D G A+ + PS
Sbjct: 131 IKV-FLFQLIRSIGCLHLPSVN-VCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEP- 187
Query: 385 SVTQYHMTSAAGTFCYIDPEYQQTGML-----TTKSDIYSFG 421
+ + Y PE + TT DI+S G
Sbjct: 188 ------NVAYICSRYYRAPEL----IFGNQHYTTAVDIWSVG 219
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 9e-17
Identities = 47/174 (27%), Positives = 70/174 (40%), Gaps = 42/174 (24%)
Query: 229 DKFSEAMKIGEGGYGPVYRG---KLDHTPVAIKVLRPDAAQGKRQFQQEVE--------- 276
++ +IGEG YG V++ K VA+K +R E
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQ---------TGEEGMPLSTIRE 61
Query: 277 -----VLSSIRHPNMVLLLGACPDYGC-------LVYEYMHNGSLED--RLLRRGNTPVI 322
L + HPN+V L C LV+E++ D L + P +
Sbjct: 62 VAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ----DLTTYLDKVPEPGV 117
Query: 323 PWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLAR 376
P + ++ L FLH + +VHRDLKP NIL+ + K++D GLAR
Sbjct: 118 PTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLAR 168
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 9e-17
Identities = 48/163 (29%), Positives = 74/163 (45%), Gaps = 26/163 (15%)
Query: 229 DKFSEAMKIGEGGYGPVYRGKLDHT--PVAIKVLRPDAAQ------GKRQFQQEVEVLSS 280
D++ K+GEG YG VY+ T VAIK +R + + R EV +L
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIR----EVSLLKE 89
Query: 281 IRHPNMVLLLGACPDYGC--LVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATAL 338
++H N++ L L++EY N L+ + + + + K F ++ +
Sbjct: 90 LQHRNIIELKSVIHHNHRLHLIFEYAEN-DLK-KYMDKNPDVSMRVIKSF--LYQLINGV 145
Query: 339 LFLHQAKPEPLVHRDLKPANILLDRNYVS-----KISDVGLAR 376
F H + +HRDLKP N+LL + S KI D GLAR
Sbjct: 146 NFCHSRRC---LHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 1e-16
Identities = 39/161 (24%), Positives = 70/161 (43%), Gaps = 33/161 (20%)
Query: 236 KIGEGGYGPVYRG--KLDHTPVAIKVLRPDAAQGKRQFQQEVEVLSSI-RHPNMVLLLGA 292
+G G G V + K A+K+L+ + ++EVE+ + P++V ++
Sbjct: 25 VLGLGINGKVLQIFNKRTQEKFALKMLQ-----DCPKARREVELHWRASQCPHIVRIVDV 79
Query: 293 CPDYGC------LVYEYMHNGSLEDRLLRRGNTPVIPWRKRF--KIAAE----IATALLF 340
+ +V E + G L R+ RG+ + F + A+E I A+ +
Sbjct: 80 YENLYAGRKCLLIVMECLDGGELFSRIQDRGD-------QAFTEREASEIMKSIGEAIQY 132
Query: 341 LHQAKPEPLVHRDLKPANILL---DRNYVSKISDVGLARLV 378
LH + HRD+KP N+L N + K++D G A+
Sbjct: 133 LHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKET 170
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 1e-16
Identities = 55/218 (25%), Positives = 92/218 (42%), Gaps = 39/218 (17%)
Query: 237 IGEGGYGPVY-----RGKLDHTPVAIKVLRPDA-AQGKRQFQQ---EVEVLSSIRHPNMV 287
+G G YG V+ G A+KVL+ Q + + E +VL IR +
Sbjct: 62 LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 121
Query: 288 LLLGAC---PDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQA 344
+ L L+ +Y++ G L L +R + EI AL LH+
Sbjct: 122 VTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEH--EVQI-YVGEIVLALEHLHKL 178
Query: 345 KPEPLVHRDLKPANILLDRN-YVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFC---- 399
+++RD+K NILLD N +V ++D GL++ + A FC
Sbjct: 179 G---IIYRDIKLENILLDSNGHV-VLTDFGLSKEFVADETER---------AYDFCGTIE 225
Query: 400 YIDPE---YQQTGMLTTKS-DIYSFGIMLLQIITARSP 433
Y+ P+ +G K+ D +S G+++ +++T SP
Sbjct: 226 YMAPDIVRGGDSGH--DKAVDWWSLGVLMYELLTGASP 261
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 4e-16
Identities = 56/234 (23%), Positives = 92/234 (39%), Gaps = 31/234 (13%)
Query: 212 NDVRYRKYTIEEIE-EATDKFSEAMKIGEGGYGPVYRGKLDHT--PVAIK-VLRP--DAA 265
D + I + ++ IG G G V VAIK + RP +
Sbjct: 7 RDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQT 66
Query: 266 QGKRQFQQEVEVLSSIRHPNMVLLLGA-CPDYGC-------LVYEYMHNGSLEDRLLRRG 317
KR ++ E+ ++ + H N++ LL P +V E M +L ++++
Sbjct: 67 HAKRAYR-ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLC-QVIQME 123
Query: 318 NTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARL 377
R + + ++ + LH A ++HRDLKP+NI++ + KI D GLAR
Sbjct: 124 LDHE---RMSY-LLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART 176
Query: 378 VPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITAR 431
S MT T Y PE DI+S G ++ ++I
Sbjct: 177 AGTSF-------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 79.9 bits (197), Expect = 5e-16
Identities = 55/259 (21%), Positives = 98/259 (37%), Gaps = 34/259 (13%)
Query: 169 AAIEAAEKAQKLADAEAQRRKQAELKAKREAEEKNRALTALANNDVRYRKYTIEEIEEAT 228
++ EAA Q + + + +R+ ++ ++ + +
Sbjct: 2 SSHEAAAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDW---------QIP 52
Query: 229 DKFSEAMKIGEGGYGPVYRG--KLDHTPVAIK-VLRP--DAAQGKRQFQQEVEVLSSIRH 283
D++ IG G YG V KL+ VAIK +LR D KR + E+ +L+ + H
Sbjct: 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILR-EIAILNRLNH 111
Query: 284 PNMVLLLGACPDYGC-------LVYEYMHNGSLED--RLLRRGNTPVIPWRKRFKIAAEI 334
++V +L +V E + D +L R + + + +
Sbjct: 112 DHVVKVLDIVIPKDVEKFDELYVVLEIADS----DFKKLFRTPV-YLTELHIKT-LLYNL 165
Query: 335 ATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLV-PPSVADSVTQYHMTS 393
+ ++H A ++HRDLKPAN L++++ K+ D GLAR V P +S
Sbjct: 166 LVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPRE 222
Query: 394 AAGTFCYIDPEYQQTGMLT 412
LT
Sbjct: 223 DDMNLVTFPHTKNLKRQLT 241
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 6e-16
Identities = 52/218 (23%), Positives = 88/218 (40%), Gaps = 45/218 (20%)
Query: 228 TDKFSEAMKIGEGGYGPVYRGKLDHT--PVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPN 285
+++ IG G +G VY+ KL + VAIK + D R E++++ + H N
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCN 108
Query: 286 MVLLL------GACPD--YGCLVYEYMHNGSLED-----RLLRRGNTPVIPWRKRFKIAA 332
+V L G D Y LV +Y+ E R R + +
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYVP----ETVYRVARHYSRAKQTLPVIYVKL-YMY 163
Query: 333 EIATALLFLHQAKPEPLVHRDLKPANILLDRN-YVSKISDVGLARLVPPSVADSVTQYHM 391
++ +L ++H + HRD+KP N+LLD + V K+ D G A+ +
Sbjct: 164 QLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP-------N 213
Query: 392 TSAAGTFCYIDPEYQQTGML-----TTKSDIYSFG-IM 423
S + Y PE + T+ D++S G ++
Sbjct: 214 VSYICSRYYRAPEL----IFGATDYTSSIDVWSAGCVL 247
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 6e-16
Identities = 58/288 (20%), Positives = 99/288 (34%), Gaps = 46/288 (15%)
Query: 211 NNDVRYRKYTIEEIE-EATDKFSEAMKIGEGGYGPVYRGKLDHT--PVAIK-VLRP--DA 264
++ R Y D + IG G YG VY +T VAIK V R D
Sbjct: 7 HSSGRENLYFQGIKNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDL 66
Query: 265 AQGKRQFQQEVEVLSSIRHPNMVLLLGACPDYGC-------LVYEYM----HNGSLEDRL 313
KR + E+ +L+ ++ ++ L +V E +L
Sbjct: 67 IDCKRILR-EITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLK------KL 119
Query: 314 LRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVG 373
+ + + I + F+H++ ++HRDLKPAN LL+++ K+ D G
Sbjct: 120 FKTPI-FLTEEHIKT-ILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFG 174
Query: 374 LARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTG------------MLT----TKS-D 416
LAR + ++ + + + Q T +L TKS D
Sbjct: 175 LARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSID 234
Query: 417 IYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAVTDWPAEA 464
I+S G + +++ + G+ L P
Sbjct: 235 IWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHE 282
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 2e-15
Identities = 56/233 (24%), Positives = 99/233 (42%), Gaps = 36/233 (15%)
Query: 215 RYRKYTIEEIE-EATDKFSEAMKIGEGGYGPVYRG--KLDHTPVAIK-VLRP--DAAQGK 268
+ K + + E + +G G YG V K VAIK + RP K
Sbjct: 9 GFYKQDVNKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAK 68
Query: 269 RQFQQEVEVLSSIRHPNMVLLLGA-CPDYGC-------LVYEYMHNGSLEDRLLRRGNTP 320
R ++ E+ +L ++H N++ LL P LV +M + L +
Sbjct: 69 RAYR-ELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFM-----QTDLQKIMGLK 122
Query: 321 VIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPP 380
+ ++ + ++ L ++H A +VHRDLKP N+ ++ + KI D GLAR
Sbjct: 123 FSEEKIQY-LVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADA 178
Query: 381 SVADSV-TQYHMTSAAGTFCYIDPEYQQTGMLTTKS-DIYSFGIMLLQIITAR 431
+ V T++ Y PE + M ++ DI+S G ++ +++T +
Sbjct: 179 EMTGYVVTRW----------YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 78.0 bits (192), Expect = 2e-15
Identities = 55/234 (23%), Positives = 93/234 (39%), Gaps = 31/234 (13%)
Query: 212 NDVRYRKYTIEEIE-EATDKFSEAMKIGEGGYGPVYRGKLDHT--PVAIK-VLRP--DAA 265
D ++ + + ++ IG G G V VAIK + RP +
Sbjct: 44 VDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQT 103
Query: 266 QGKRQFQQEVEVLSSIRHPNMVLLLGA-CPDYGC-------LVYEYMHNGSLEDRLLRRG 317
KR ++ E+ ++ + H N++ LL P LV E M + L +
Sbjct: 104 HAKRAYR-ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLCQVI 157
Query: 318 NTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARL 377
+ R + + ++ + LH A ++HRDLKP+NI++ + KI D GLAR
Sbjct: 158 QMELDHERMSY-LLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART 213
Query: 378 VPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITAR 431
T + MT T Y PE DI+S G ++ +++ +
Sbjct: 214 AG-------TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 3e-15
Identities = 47/200 (23%), Positives = 68/200 (34%), Gaps = 38/200 (19%)
Query: 215 RYRKYTI-EEIEEATDKFSEAMKIGEGGYGPVYRGKLDHT--PVAIK--VLRPDAAQGKR 269
+ E+ ++ I G YG V G +D PVAIK +
Sbjct: 7 EAAMRDLIAELHAMQSPYTVQRFISSGSYGAVCAG-VDSEGIPVAIKRVFNTVSDGRTVN 65
Query: 270 QFQQ---------EVEVLSSIRHPNMVLLLGACPDYGC-------LVYEYM----HNGSL 309
E+ +L+ HPN++ L + LV E M
Sbjct: 66 ILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLA---- 121
Query: 310 EDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKI 369
+++ + P ++ I L LH+A +VHRDL P NILL N I
Sbjct: 122 --QVIHDQRIVISPQHIQY-FMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITI 175
Query: 370 SDVGLARLVPPSVADSVTQY 389
D LAR + T Y
Sbjct: 176 CDFNLAREDTAD--ANKTHY 193
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 5e-15
Identities = 56/230 (24%), Positives = 93/230 (40%), Gaps = 41/230 (17%)
Query: 226 EATDKFSEAMKIGEGGYGPVYRG--KLDHTPVAIKVLRP--DAAQGKRQFQQEVEVLSSI 281
+ F +GEG YG V K VAIK + P R + E+++L
Sbjct: 8 NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR-EIKILKHF 66
Query: 282 RHPNMVLLLGACPDYGC-------LVYEYM----HNGSLEDRLLRRGNTPVIPWRKRFKI 330
+H N++ + ++ E M H R++ + ++
Sbjct: 67 KHENIITIFNIQRPDSFENFNEVYIIQELMQTDLH------RVIS--TQMLSDDHIQY-F 117
Query: 331 AAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSV---- 386
+ A+ LH + ++HRDLKP+N+L++ N K+ D GLAR++ S AD+
Sbjct: 118 IYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTG 174
Query: 387 TQYHMTSAAGTFCYIDPEYQQTGML-----TTKSDIYSFGIMLLQIITAR 431
Q M T Y PE ML + D++S G +L ++ R
Sbjct: 175 QQSGMVEFVATRWYRAPEV----MLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 7e-15
Identities = 58/226 (25%), Positives = 92/226 (40%), Gaps = 40/226 (17%)
Query: 226 EATDKFSEAMKIGEGGYGPVYRG--KLDHTPVAIKVLRP--DAAQGKRQFQQEVEVLSSI 281
+ +++ IGEG YG V L+ VAIK + P +R + E+++L
Sbjct: 24 DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRF 82
Query: 282 RHPNMVLLLGACPDYGC-------LVYEYM--------HNGSLEDRLLRRGNTPVIPWRK 326
RH N++ + +V + M L +
Sbjct: 83 RHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND------------HI 130
Query: 327 RFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSV 386
+ +I L ++H A ++HRDLKP+N+LL+ KI D GLAR+ P D
Sbjct: 131 CY-FLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADP---DHD 183
Query: 387 TQYHMTSAAGTFCYIDPEYQQTGMLTTKS-DIYSFGIMLLQIITAR 431
+T T Y PE TKS DI+S G +L ++++ R
Sbjct: 184 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 3e-14
Identities = 59/239 (24%), Positives = 98/239 (41%), Gaps = 49/239 (20%)
Query: 216 YRKYTIEEIE-EATDKFSEAMKIGEGGYGPVY--RGKLDHTPVAIK-VLRP--DAAQGKR 269
+ + + + E +++ +G G YG V VA+K + RP KR
Sbjct: 15 FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR 74
Query: 270 QFQQEVEVLSSIRHPNMVLLLGA-CPDYGC-------LVYEYM--------HNGSLEDRL 313
++ E+ +L ++H N++ LL P LV M L D
Sbjct: 75 TYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDD- 132
Query: 314 LRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVG 373
+F + +I L ++H A ++HRDLKP+N+ ++ + KI D G
Sbjct: 133 -----------HVQF-LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFG 177
Query: 374 LARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKS-DIYSFGIMLLQIITAR 431
LAR AD +T Y T Y PE M ++ DI+S G ++ +++T R
Sbjct: 178 LAR----HTADEMTGYVATRW-----YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 3e-14
Identities = 45/245 (18%), Positives = 84/245 (34%), Gaps = 66/245 (26%)
Query: 225 EEATDKFSEAMKIGEGGYGPVYRGKLDHT--PVAIKVLRPDAAQGKRQFQQEVEVLSSIR 282
E ++ K+S +G G +G V + A+K + D R E++++ +
Sbjct: 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNR----ELDIMKVLD 58
Query: 283 HPNMVLLL------GACPDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFK---IAAE 333
H N++ L+ G + + ++ + + VI + K + E
Sbjct: 59 HVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIME 118
Query: 334 -------------------------------IATALLFLHQAKPEPLVHRDLKPANILLD 362
+ A+ F+H + HRD+KP N+L++
Sbjct: 119 YVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG---ICHRDIKPQNLLVN 175
Query: 363 RN-YVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGML-----TTKSD 416
K+ D G A+ + PS + + Y PE ML T D
Sbjct: 176 SKDNTLKLCDFGSAKKLIPSEP-------SVAYICSRFYRAPEL----MLGATEYTPSID 224
Query: 417 IYSFG 421
++S G
Sbjct: 225 LWSIG 229
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 6e-14
Identities = 58/243 (23%), Positives = 97/243 (39%), Gaps = 57/243 (23%)
Query: 216 YRKYTIEEIE-EATDKFSEAMKIGEGGYGPVYRG--KLDHTPVAIK-VLRP--DAAQGKR 269
+ + + + E + + +G G YG V VAIK + RP KR
Sbjct: 11 FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 70
Query: 270 QFQQEVEVLSSIRHPNMVLLL---GACPDYGC-----LVYEYM--------HNGSLEDRL 313
++ E+ +L +RH N++ LL LV +M + L +
Sbjct: 71 AYR-ELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGED- 128
Query: 314 LRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVG 373
R +F + ++ L ++H A ++HRDLKP N+ ++ + KI D G
Sbjct: 129 -----------RIQF-LVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFG 173
Query: 374 LARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGML-----TTKSDIYSFGIMLLQII 428
LAR +T Y +T Y PE +L T DI+S G ++ ++I
Sbjct: 174 LAR----QADSEMTGYVVTRW-----YRAPEV----ILNWMRYTQTVDIWSVGCIMAEMI 220
Query: 429 TAR 431
T +
Sbjct: 221 TGK 223
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 2e-13
Identities = 47/207 (22%), Positives = 84/207 (40%), Gaps = 44/207 (21%)
Query: 226 EATDKFSEAMKIGEGGYGPVYRG--KLDHTPVAIK-VLRP--DAAQGKRQFQQEVEVLSS 280
K+ K+G+G YG V++ + VA+K + ++ +R F+ E+ +L+
Sbjct: 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFR-EIMILTE 64
Query: 281 IR-HPNMVLLLGAC-PD-----YGCLVYEYM--------HNGSLEDRLLRRGNTPVIPWR 325
+ H N+V LL D Y LV++YM LE
Sbjct: 65 LSGHENIVNLLNVLRADNDRDVY--LVFDYMETDLHAVIRANILEPV------------H 110
Query: 326 KRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADS 385
K++ + ++ + +LH L+HRD+KP+NILL+ K++D GL+R +
Sbjct: 111 KQY-VVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVT 166
Query: 386 VTQYHMTSAAGTFCYIDPEYQQTGMLT 412
+ + +LT
Sbjct: 167 NNIPLSINENT-----ENFDDDQPILT 188
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 3e-13
Identities = 53/235 (22%), Positives = 98/235 (41%), Gaps = 49/235 (20%)
Query: 226 EATDKFSEAMKIGEGGYGPVYRG--KLDHTPVAIK-VLRPDAAQGKRQFQQEVEVLSSIR 282
+ ++ + +G GG G V+ VAIK ++ D K + E++++ +
Sbjct: 8 DLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALR-EIKIIRRLD 66
Query: 283 HPNMVLLLGA-CPDYGC---------------LVYEYM----HNGSLEDRLLRRGNTPVI 322
H N+V + P +V EYM +L +G P++
Sbjct: 67 HDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLA------NVLEQG--PLL 118
Query: 323 PWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLD-RNYVSKISDVGLARLVPPS 381
R ++ L ++H A ++HRDLKPAN+ ++ + V KI D GLAR++ P
Sbjct: 119 EEHARL-FMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDP- 173
Query: 382 VADSVTQYHMTSAAGTFCYIDPEYQQTGML-----TTKSDIYSFGIMLLQIITAR 431
+ H++ T Y P +L T D+++ G + +++T +
Sbjct: 174 --HYSHKGHLSEGLVTKWYRSPRL----LLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 68.8 bits (168), Expect = 1e-12
Identities = 35/126 (27%), Positives = 58/126 (46%), Gaps = 15/126 (11%)
Query: 329 KIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQ 388
+ ++A + FL K +HRDL NILL V KI D GLAR +
Sbjct: 197 CYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDI------YKDP 247
Query: 389 YHMTSAAGTF--CYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSP---MGLTHHVSR 442
++ ++ PE + T +SD++SFG++L +I + SP + + R
Sbjct: 248 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 307
Query: 443 AIEKGT 448
+++GT
Sbjct: 308 RLKEGT 313
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 66.9 bits (163), Expect = 4e-12
Identities = 28/101 (27%), Positives = 42/101 (41%), Gaps = 12/101 (11%)
Query: 236 KIGEGGYGPVYRGKL-------DHTPVAIKVLRPDA-AQGKRQFQQEVEVLSSI-RHPNM 286
+G G +G V VA+K+L+ A R E+++L I H N+
Sbjct: 29 PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 88
Query: 287 VLLLGACPDYG---CLVYEYMHNGSLEDRLLRRGNTPVIPW 324
V LLGAC G ++ E+ G+L L + N V
Sbjct: 89 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYK 129
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 3e-12
Identities = 46/225 (20%), Positives = 95/225 (42%), Gaps = 51/225 (22%)
Query: 236 KIGEGGYGPVYRGK--LDHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIR----------- 282
K+G G + V+ K +++T VA+K++R + E+++L +
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVR-GDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 84
Query: 283 HPNMVLLL------GACPDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIAT 336
+++ LL G + +V+E + +L L+++ IP +I+ ++
Sbjct: 85 ANHILKLLDHFNHKGPNGVHVVMVFEVLGE-NLLA-LIKKYEHRGIPLIYVKQISKQLLL 142
Query: 337 ALLFLHQAKPEPLVHRDLKPANILLDRNYVS------KISDVGLARLVPPSVADSVTQYH 390
L ++H + ++H D+KP N+L++ KI+D+G A H
Sbjct: 143 GLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA---------CWYDEH 191
Query: 391 MTSAAGTFCYIDPE------YQQTGMLTTKSDIYSFGIMLLQIIT 429
T++ T Y PE + +DI+S ++ ++IT
Sbjct: 192 YTNSIQTREYRSPEVLLGAPW------GCGADIWSTACLIFELIT 230
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 63.4 bits (154), Expect = 6e-11
Identities = 52/277 (18%), Positives = 94/277 (33%), Gaps = 65/277 (23%)
Query: 236 KIGEGGYGPVY--RGKLDHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIR-----HPN--- 285
K+G G + V+ VA+KV++ A E+ +L S+R PN
Sbjct: 44 KLGWGHFSTVWLSWDIQGKKFVAMKVVK-SAEHYTETALDEIRLLKSVRNSDPNDPNREM 102
Query: 286 MVLLL------GACPDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALL 339
+V LL G + C+V+E + + L + + N +P KI ++ L
Sbjct: 103 VVQLLDDFKISGVNGTHICMVFEVLGH-HLLK-WIIKSNYQGLPLPCVKKIIQQVLQGLD 160
Query: 340 FLH-QAKPEPLVHRDLKPANILL------------------------------------- 361
+LH + + ++H D+KP NILL
Sbjct: 161 YLHTKCR---IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATA 217
Query: 362 ----DRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDI 417
K ++ ++ A V ++ T T Y E T +DI
Sbjct: 218 GNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF-TEDIQTRQYRSLEVLIGSGYNTPADI 276
Query: 418 YSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLD 454
+S M ++ T ++ +A +++
Sbjct: 277 WSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIE 313
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 62.6 bits (151), Expect = 3e-10
Identities = 67/433 (15%), Positives = 136/433 (31%), Gaps = 118/433 (27%)
Query: 100 LEAEMRRLKLELRQTMEMYSTACKEALNAKKKAKELNQ-WKIEEAQRFEEARMAEETALA 158
++ E + + + + ++ A + + K EE ++ A L
Sbjct: 7 MDFETGEHQYQYKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTLR 66
Query: 159 IAEMEKAKCRAAIEAA--EKAQK----LADAEAQRRKQAELKAKREAEEKNRALTALANN 212
+ +K ++ E + L ++Q + + E+++R L N+
Sbjct: 67 LFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDR----LYND 122
Query: 213 DVRYRKYTI------EEIEEATDKFSEAMKI---GEGGYGPVYRGKLDHTPVAIKVLRPD 263
+ + KY + ++ +A + A + G G G K T VA+ V
Sbjct: 123 NQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSG-----K---TWVALDVCLSY 174
Query: 264 AAQGKRQFQ-------------QEVEVLSSIRHPNMVLLLGACPDYGCLVYEYMHNGSLE 310
Q K F+ +E+L + + + + D+ + +H S++
Sbjct: 175 KVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLY-QIDPNWTSRSDHSSNIKLRIH--SIQ 231
Query: 311 DRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKIS 370
L R + K ++ LL L +++ A N KI
Sbjct: 232 AELRR------LLKSKPYE------NCLLVL----------LNVQNAKAWNAFNLSCKI- 268
Query: 371 DVGLARLV---PPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKS-DIYS--FGI-- 422
L+ V D ++ A T +I ++ + + +
Sbjct: 269 ------LLTTRFKQVTDFLS-------AATTTHISLDHHSMTLTPDEVKSLLLKYLDCRP 315
Query: 423 ------------MLLQIITARSPMGLTH-----HV-----SRAIEKGTLAEMLDPAVTDW 460
L II GL HV + IE +L +L+PA
Sbjct: 316 QDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIES-SL-NVLEPA---- 369
Query: 461 PAEAAESFSKLAI 473
E + F +L++
Sbjct: 370 --EYRKMFDRLSV 380
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 56.0 bits (134), Expect = 3e-08
Identities = 59/437 (13%), Positives = 134/437 (30%), Gaps = 100/437 (22%)
Query: 35 STLALDT-----IESTLPGR---RSTGRDSFSDESDYSGPLAMGSLDISSKNLDFSSVPV 86
+ +ALD ++ + + + + S E+ L M L +D +
Sbjct: 164 TWVALDVCLSYKVQCKMDFKIFWLNLKNCN-SPETV----LEM--LQKLLYQIDPNWTSR 216
Query: 87 SPRVSSASQSSRDLEAEMRRLKLELRQTMEMYSTACKEALNAKKKAKEL---NQWKIEEA 143
S S+ ++AE+RRL L+ + Y + L L N +
Sbjct: 217 SDHSSNIKLRIHSIQAELRRL-LKSKP----Y----ENCL--------LVLLNVQNAKAW 259
Query: 144 QRFE-EARMAEETA-LAIAEMEKAKCRAAIEAAEKAQKLADAEAQR--RKQAELKAK--- 196
F ++ T + + A I + L E + K + + +
Sbjct: 260 NAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLP 319
Query: 197 REAEEKN-RALT---ALANNDV----RYRKYTIEEIEEATDKFSEAMKIGEGGYGPVYRG 248
RE N R L+ + + ++ +++ + ++ E Y ++
Sbjct: 320 REVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAE--YRKMFD- 376
Query: 249 KL----DHTPVAIKVL----RPDAAQGKRQFQQEVEVLSSI-RHPN-------MVLLLGA 292
+L + +L ++ S + + P + L
Sbjct: 377 RLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELK 436
Query: 293 CPDYGCLVYEYMHNGSLEDRLLRRG---NTPVIPWRKRFKIAAEIATALLFLHQAKPEPL 349
+H ++ + + + + P+ ++ + I H E
Sbjct: 437 VK---LENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQY-FYSHIG-----HHLKNIEHP 487
Query: 350 VHRDLKPANILLDRNYV-SKISDVGLARLVPPSVADSVTQ---Y--HMTSAAGTFCYIDP 403
L + LD ++ KI A S+ +++ Q Y ++ DP
Sbjct: 488 ERMTLFR-MVFLDFRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICD-------NDP 539
Query: 404 EYQQTGMLTTKSDIYSF 420
+Y++ ++ + I F
Sbjct: 540 KYER--LV---NAILDF 551
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 4e-10
Identities = 43/178 (24%), Positives = 78/178 (43%), Gaps = 34/178 (19%)
Query: 212 NDVRYRKYTIEEIEEATDKFSEAMKIGEGGYGPVYRGKLDH---TPVAIKVLRPDAAQGK 268
+D +Y + ++ IG+G +G V + DH VA+K++R +
Sbjct: 92 HDHVAYRYEVLKV------------IGKGSFGQVVKAY-DHKVHQHVALKMVRNEKRF-H 137
Query: 269 RQFQQEVEVLSSIRH------PNMVLLLGACPDYG--CLVYEYMHNGSLEDRLLRRGNTP 320
RQ +E+ +L +R N++ +L C+ +E + +L + L+++
Sbjct: 138 RQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSM-NLYE-LIKKNKFQ 195
Query: 321 VIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILL---DRNYVSKISDVGLA 375
K A I L LH+ + ++H DLKP NILL R+ + K+ D G +
Sbjct: 196 GFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGI-KVIDFGSS 249
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 4e-10
Identities = 42/159 (26%), Positives = 63/159 (39%), Gaps = 34/159 (21%)
Query: 236 KIGEGGYGPVYRGK--LDHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRH----PNMVLL 289
KIG G +G + GK + VAIK+ + Q E + P V
Sbjct: 16 KIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQ-VYY 72
Query: 290 LGACPDYGCLVYEYMHNG-SLEDRLLRRGNTPVIPWRKRF------KIAAEIATALLFLH 342
G C Y +V E + G SLED L + + F IA ++ + + ++H
Sbjct: 73 FGPCGKYNAMVLELL--GPSLED-LFDLCD-------RTFSLKTVLMIAIQLISRMEYVH 122
Query: 343 QAKPEPLVHRDLKPANILLDRNYVSK-----ISDVGLAR 376
L++RD+KP N L+ R I D LA+
Sbjct: 123 SKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 9e-10
Identities = 41/157 (26%), Positives = 64/157 (40%), Gaps = 32/157 (20%)
Query: 236 KIGEGGYGPVYRGK--LDHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRH----PNMVLL 289
KIG G +G +Y G VAIK+ Q E ++ ++ P +
Sbjct: 16 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPT-IRW 72
Query: 290 LGACPDYGCLVYEYMHNG-SLEDRLLRRGNTPVIPWRKRF------KIAAEIATALLFLH 342
GA DY +V E + G SLED L ++F +A ++ + + ++H
Sbjct: 73 CGAEGDYNVMVMELL--GPSLED--LFNFC------SRKFSLKTVLLLADQMISRIEYIH 122
Query: 343 QAKPEPLVHRDLKPANILLDRNYVSK---ISDVGLAR 376
+HRD+KP N L+ I D GLA+
Sbjct: 123 SKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 9e-10
Identities = 40/159 (25%), Positives = 65/159 (40%), Gaps = 34/159 (21%)
Query: 236 KIGEGGYGPVYRGK--LDHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRH----PNMVLL 289
+IGEG +G ++ G L++ VAIK + Q + E + PN V
Sbjct: 17 RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPN-VYY 73
Query: 290 LGACPDYGCLVYEYMHNG-SLEDRLLRRGNTPVIPWRKRF------KIAAEIATALLFLH 342
G + LV + + G SLED LL ++F A ++ + +H
Sbjct: 74 FGQEGLHNVLVIDLL--GPSLED-LLDLCG-------RKFSVKTVAMAAKQMLARVQSIH 123
Query: 343 QAKPEPLVHRDLKPANILLDRNYVSK-----ISDVGLAR 376
+ LV+RD+KP N L+ R + D G+ +
Sbjct: 124 EKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 3e-09
Identities = 41/171 (23%), Positives = 64/171 (37%), Gaps = 31/171 (18%)
Query: 212 NDVRYRKYTIEEIEEATDKFSEAMKIGEGGYGPVYRGKLDH---TPVAIKVLRPDAAQGK 268
+ + + +G+G +G V + A+KV+R
Sbjct: 30 GMLLNNAFLVIRK------------MGDGTFGRVLLCQ-HIDNKKYYAVKVVRNIKKY-T 75
Query: 269 RQFQQEVEVLSSIRH-----PNMVLLLGACPDYG---CLVYEYMHNGSLEDRLLRRGNTP 320
R + E ++L I++ N+V G Y CL++E + SL + ++ R N
Sbjct: 76 RSAKIEADILKKIQNDDINNNNIVKYHG-KFMYYDHMCLIFEPLGP-SLYE-IITRNNYN 132
Query: 321 VIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISD 371
EI AL +L + L H DLKP NILLD Y K
Sbjct: 133 GFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFEKSLI 180
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 3e-09
Identities = 38/177 (21%), Positives = 67/177 (37%), Gaps = 31/177 (17%)
Query: 212 NDVRYRKYTIEEIEEATDKFSEAMKIGEGGYGPVYR---GKLDHTPVAIKVLRPDAAQGK 268
D +Y I +GEG +G V + VA+K++R +
Sbjct: 14 GDWLQERYEIVGN------------LGEGTFGKVVECLDHARGKSQVALKIIRNVGKY-R 60
Query: 269 RQFQQEVEVLSSIRHP------NMVLLLGACPDYG---CLVYEYMHNGSLEDRLLRRGNT 319
+ E+ VL I+ VL+ ++ C+ +E + + + L+ N
Sbjct: 61 EAARLEINVLKKIKEKDKENKFLCVLMSD-WFNFHGHMCIAFELLGK-NTFE-FLKENNF 117
Query: 320 PVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLAR 376
P +A ++ AL FLH+ + L H DLKP NIL + + + +
Sbjct: 118 QPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSC 171
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 4e-09
Identities = 52/171 (30%), Positives = 77/171 (45%), Gaps = 20/171 (11%)
Query: 219 YTIEEIEEATDKFSEAMKIGEGGYGPVYRGKLDHT---PVAIKVLRPDAAQGKRQFQQEV 275
Y ++ E+ D++ IG+G +G V + D VAIK+++ A Q Q EV
Sbjct: 44 YIVKNGEKWMDRYEIDSLIGKGSFGQVVKAY-DRVEQEWVAIKIIKNKKAF-LNQAQIEV 101
Query: 276 EVLSSIRHP------NMVLLLGACPDYG--CLVYEYMHNGSLEDRLLRRGNTPVIPWRKR 327
+L + +V L CLV+E + +L D L V R
Sbjct: 102 RLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTR 160
Query: 328 FKIAAEIATALLFLHQAKPEPLVHRDLKPANILL---DRNYVSKISDVGLA 375
K A ++ TALLFL + ++H DLKP NILL R+ + KI D G +
Sbjct: 161 -KFAQQMCTALLFLATPELS-IIHCDLKPENILLCNPKRSAI-KIVDFGSS 208
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 5e-09
Identities = 40/177 (22%), Positives = 70/177 (39%), Gaps = 31/177 (17%)
Query: 212 NDVRYRKYTIEEIEEATDKFSEAMKIGEGGYGPVYRG---KLDHTPVAIKVLRPDAAQGK 268
DV +Y I + +GEG +G V K VA+K+++
Sbjct: 9 GDVLSARYEIVDT------------LGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRY-C 55
Query: 269 RQFQQEVEVLSSIRHP------NMVLLLGACPDYG---CLVYEYMHNGSLEDRLLRRGNT 319
+ E++VL + V +L ++ C+V+E + S D ++
Sbjct: 56 EAARSEIQVLEHLNTTDPNSTFRCVQMLE-WFEHHGHICIVFELLGL-STYD-FIKENGF 112
Query: 320 PVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLAR 376
K+A +I ++ FLH K L H DLKP NIL ++ ++ + + R
Sbjct: 113 LPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKR 166
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 1e-08
Identities = 35/227 (15%), Positives = 63/227 (27%), Gaps = 61/227 (26%)
Query: 182 DAEAQRRKQAELKAKREAEEKNRALTALANNDVRYRKYTIEEIEEATDKFSEAMKIGEGG 241
D + + EA LT D R++ ++
Sbjct: 12 DLGTENLYFQSMTTSLEALPTGTVLT-----DKSGRQWKLKS------------FQTRDN 54
Query: 242 YGPVYRG----------KLDHTPVAIKV----------LRPDAAQGKRQFQQEVEVLSSI 281
G +Y ++K+ K + + L S
Sbjct: 55 QGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWKKLYST 114
Query: 282 RHPNMVLLLG---ACPDYGCLVYEYMHNG-SLEDRLLRRGNTPVIPWRKRF------KIA 331
+ +G Y LV + G SL+ L + ++A
Sbjct: 115 PLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQS-ALDVSP------KHVLSERSVLQVA 165
Query: 332 AEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKI--SDVGLAR 376
+ AL FLH+ + VH ++ NI +D S++ + G A
Sbjct: 166 CRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 54.0 bits (130), Expect = 5e-08
Identities = 31/173 (17%), Positives = 58/173 (33%), Gaps = 47/173 (27%)
Query: 236 KIGEGGYGPVYRGK--LDHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMV------ 287
KIG GG+G +Y A V++ + Q E++ + + +
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVKVEY-QENGPLFSELKFYQRVAKKDCIKKWIER 102
Query: 288 ---------------LLLGACPDYGCLVYEYMHNG-SLEDRLLRRGNTPVIPWRKRF--- 328
L Y +V E + G L+ + F
Sbjct: 103 KQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQK-ISG--------QNGTFKKS 151
Query: 329 ---KIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKI--SDVGLAR 376
++ + L ++H+ + VH D+K AN+LL ++ +D GL+
Sbjct: 152 TVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSY 201
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 53.9 bits (129), Expect = 9e-08
Identities = 42/151 (27%), Positives = 65/151 (43%), Gaps = 20/151 (13%)
Query: 236 KIGEGGYGPVYRGK--LDHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRH----PNMVLL 289
KIG G +G +Y G + VAIK+ Q E ++ ++ PN V
Sbjct: 14 KIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLLYESKIYRILQGGTGIPN-VRW 70
Query: 290 LGACPDYGCLVYEYMHNG-SLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEP 348
G DY LV + + G SLED L + + + +A ++ + F+H
Sbjct: 71 FGVEGDYNVLVMDLL--GPSLED--LFNFCSRKLSLKTVLMLADQMINRVEFVHSKS--- 123
Query: 349 LVHRDLKPANILLDRNYVSK---ISDVGLAR 376
+HRD+KP N L+ + I D GLA+
Sbjct: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 1e-07
Identities = 32/172 (18%), Positives = 61/172 (35%), Gaps = 42/172 (24%)
Query: 236 KIGEGGYGPVYRGKL-------DHTPVAIKVLRPDAAQGKRQFQ-----QEVEVLSSIRH 283
IG+GG+G +Y + P +KV D + + + E +
Sbjct: 42 PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101
Query: 284 PNMVLLLGACPDYGCLVYEYMHNG-----------SLEDRLLRRGNTPVIPWRKRF---- 328
+ LG +G +++ L+ + KRF
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQK-IYEANA-------KRFSRKT 153
Query: 329 --KIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKI--SDVGLAR 376
+++ I L ++H+ + VH D+K +N+LL+ ++ D GLA
Sbjct: 154 VLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
| >2zuo_A MVP, major vault protein; repeat domains, protein-protein complex, cytoplasm, ribonucleoprotein, structural protein; 3.50A {Rattus norvegicus} PDB: 2zv4_N 2zv5_a 2qzv_A Length = 861 | Back alignment and structure |
|---|
Score = 51.0 bits (121), Expect = 1e-06
Identities = 30/150 (20%), Positives = 52/150 (34%), Gaps = 7/150 (4%)
Query: 95 QSSRDLEAEMRRLKLELRQTMEMYSTACKEALNAKKKAKELNQWKIE-EAQRFEEARMAE 153
QS ++ R Q +T +EA + + + + E Q+ + AE
Sbjct: 641 QSVEPVDQRTRDALQRSVQLAIEITTNSQEAAAKHEAQRLEQEARGRLERQKILDQSEAE 700
Query: 154 ETALAIAEMEKAKCRAAIEAAEKAQKLADAEAQRR------KQAELKAKREAEEKNRALT 207
+ + E+E KA+ + AEA R QA+LKA+ A E L
Sbjct: 701 KARKELLELEAMSMAVESTGNAKAEAESRAEAARIEGEGSVLQAKLKAQALAIETEAELE 760
Query: 208 ALANNDVRYRKYTIEEIEEATDKFSEAMKI 237
+ Y ++E K + +
Sbjct: 761 RVKKVREMELIYARAQLELEVSKAQQLANV 790
|
| >2zuo_A MVP, major vault protein; repeat domains, protein-protein complex, cytoplasm, ribonucleoprotein, structural protein; 3.50A {Rattus norvegicus} PDB: 2zv4_N 2zv5_a 2qzv_A Length = 861 | Back alignment and structure |
|---|
Score = 49.4 bits (117), Expect = 2e-06
Identities = 20/109 (18%), Positives = 41/109 (37%)
Query: 95 QSSRDLEAEMRRLKLELRQTMEMYSTACKEALNAKKKAKELNQWKIEEAQRFEEARMAEE 154
+ EAE R +L + M M + A + E + + E + + +
Sbjct: 692 KILDQSEAEKARKELLELEAMSMAVESTGNAKAEAESRAEAARIEGEGSVLQAKLKAQAL 751
Query: 155 TALAIAEMEKAKCRAAIEAAEKAQKLADAEAQRRKQAELKAKREAEEKN 203
AE+E+ K +E +L ++ ++ A ++AK+ E
Sbjct: 752 AIETEAELERVKKVREMELIYARAQLELEVSKAQQLANVEAKKFKEMTE 800
|
| >3lvg_D LCB, clathrin light chain B; SELF assembly, coated PIT, cytoplasmic vesicle, membrane, Ca structural protein; 7.94A {Bos taurus} Length = 190 | Back alignment and structure |
|---|
Score = 48.2 bits (114), Expect = 1e-06
Identities = 18/66 (27%), Positives = 31/66 (46%), Gaps = 7/66 (10%)
Query: 141 EEAQRFEEARMAEETALAIAEMEKAKCRAAIEAAEKAQK-LADAEAQRRKQAELKAK--- 196
+E + + R EE + E++ A E EKA+K L + ++ +Q E K K
Sbjct: 82 QEPESIRKWR--EEQRKRLQELDAASKVMEQEWREKAKKDLEEWNQRQSEQVE-KNKINN 138
Query: 197 REAEEK 202
R A++
Sbjct: 139 RIADKA 144
|
| >3lvg_D LCB, clathrin light chain B; SELF assembly, coated PIT, cytoplasmic vesicle, membrane, Ca structural protein; 7.94A {Bos taurus} Length = 190 | Back alignment and structure |
|---|
Score = 42.5 bits (99), Expect = 1e-04
Identities = 13/77 (16%), Positives = 30/77 (38%), Gaps = 9/77 (11%)
Query: 124 EALNAKKKAKELNQWKIEEAQRFEEARMAEETALAIAEMEKAKCRAAIEAAEKAQKLADA 183
E++ +K +E + +++E + E A ++E+ R + E EK +
Sbjct: 85 ESI---RKWREEQRKRLQELDAASKVMEQEWREKAKKDLEEWNQRQS-EQVEKNKI---- 136
Query: 184 EAQRRKQAELKAKREAE 200
R + +A+
Sbjct: 137 -NNRIADKAFYQQPDAD 152
|
| >1i84_S Smooth muscle myosin heavy chain; muscle protein, myosin subfragment 2, heavy meromyosin, essential light chain, motor protein; HET: MLY; 20.00A {Gallus gallus} SCOP: i.15.1.1 PDB: 3j04_A 3dtp_B 3dtp_A Length = 1184 | Back alignment and structure |
|---|
Score = 47.5 bits (113), Expect = 1e-05
Identities = 23/116 (19%), Positives = 47/116 (40%), Gaps = 6/116 (5%)
Query: 89 RVSSASQSSRDLEAEMRRLKLELRQTMEMYSTACKEALNAKKKAKELNQWKIEEAQRFEE 148
+++ +L+A++ + + EL+ + + NA KK +EL I + +
Sbjct: 1075 QIAELQAQIAELKAQLAKKEEELQAALARLEDETSQKNNALKKIRELES-HISDL----Q 1129
Query: 149 ARMAEETALAIAEMEKAKCRAAIEAAEKAQKLADAEAQRRKQAELKAKREAEEKNR 204
+ E A A + EK K + E +L D Q EL+ ++ ++
Sbjct: 1130 EDLESEKA-ARNKAEKQKRDLSEELEALKTELEDTLDTTATQQELRGSDYKDDDDK 1184
|
| >1i84_S Smooth muscle myosin heavy chain; muscle protein, myosin subfragment 2, heavy meromyosin, essential light chain, motor protein; HET: MLY; 20.00A {Gallus gallus} SCOP: i.15.1.1 PDB: 3j04_A 3dtp_B 3dtp_A Length = 1184 | Back alignment and structure |
|---|
Score = 42.1 bits (99), Expect = 5e-04
Identities = 27/146 (18%), Positives = 61/146 (41%), Gaps = 10/146 (6%)
Query: 89 RVSSASQSSRDLEAEMRRLKLELRQTMEMYSTACKEALNAKKKAKELNQWKIE-EAQRFE 147
+ + L E + L+ + + ++KAK L + K + E+ E
Sbjct: 991 DILIMEDQNNKLTKERKLLEERVSDLTTNLAEE-------EEKAKNLTKLKNKHESMISE 1043
Query: 148 EARMAEETALAIAEMEKAKCRAAIEAAEKAQKLADAEAQRRKQAELKAKREAEEKNRALT 207
++ + E+EK K + E+++ +++A+ +AQ + AK+E E +A
Sbjct: 1044 LEVRLKKEEKSRQELEKIKRKLEGESSDLHEQIAELQAQIAELKAQLAKKEEE--LQAAL 1101
Query: 208 ALANNDVRYRKYTIEEIEEATDKFSE 233
A ++ + +++I E S+
Sbjct: 1102 ARLEDETSQKNNALKKIRELESHISD 1127
|
| >2dfs_A Myosin-5A; myosin-V, inhibited state, cryoelectron tomograp contractIle protein-transport protein complex; 24.00A {Gallus gallus} Length = 1080 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 3e-04
Identities = 25/149 (16%), Positives = 49/149 (32%), Gaps = 11/149 (7%)
Query: 89 RVSSASQSSRDLEAEMRRLKLELRQTMEMYSTACKEALNAKKKA-KELNQWK------IE 141
V + LE ++ +L++ ++ + K L + +E
Sbjct: 915 SVERYKKLHIGLENKIM----QLQRKIDEQNKEYKSLLEKMNNLEITYSTETEKLRSDVE 970
Query: 142 EAQRFEEARMAEETALAIAEMEKAKCRAAIEAAEKAQKLADAEAQRRKQAELKAKREAEE 201
+ EE + + E AK R + + +K + A + K + E +E
Sbjct: 971 RLRMSEEEAKNATNRVLSLQEEIAKLRKELHQTQTEKKTIEEWADKYKHETEQLVSELKE 1030
Query: 202 KNRALTALANNDVRYRKYTIEEIEEATDK 230
+N L R +EI E +K
Sbjct: 1031 QNTLLKTEKEELNRRIHDQAKEITETMEK 1059
|
| >3iyk_A VP5; icosahedral virus; HET: MNA; 7.00A {Bluetongue virus} Length = 526 | Back alignment and structure |
|---|
Score = 42.3 bits (99), Expect = 4e-04
Identities = 31/150 (20%), Positives = 51/150 (34%), Gaps = 10/150 (6%)
Query: 79 LDFSSVPVSPRVSSASQSSRDLEAEMRRLKLELRQTMEMYSTACKEALNAKKKAKELNQW 138
+ P+SP ++LE E R + L+ ++ KE
Sbjct: 81 GEEIPDPLSPGERGIQAKLKELEDEQRNELVRLKYNDKIKEKFGKELEEVYNFMNGEANA 140
Query: 139 KIEEAQRFEEARMAEETALAIAEMEKAKCRAAIEAAEKAQKLADAEAQRRKQAELKAKRE 198
+IE+ ++F+ A + I E + R A +K E R AE +E
Sbjct: 141 EIEDEKQFDILNKAVTSYNKILTEEDLQMRRLATALQK-------EIGERTHAETVMVKE 193
Query: 199 AEEKNRALTALANNDVRYRKYTIEEIEEAT 228
+K + AL N R EE +
Sbjct: 194 YRDK---IDALKNAIEVERDGMQEEAIQEI 220
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 568 | |||
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.95 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.91 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.85 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.71 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.42 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.21 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.18 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.15 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.91 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.65 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.52 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.44 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.43 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.43 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.4 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.21 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 98.14 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.89 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.85 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.82 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.79 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.6 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.5 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.48 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.4 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.3 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.27 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.63 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.62 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.62 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.86 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.74 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 83.85 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 82.43 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 80.02 |
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-56 Score=465.99 Aligned_cols=248 Identities=24% Similarity=0.392 Sum_probs=204.4
Q ss_pred cccccceeecccCceeEEEEEe--CCccEEEEEeCcCh--hHhHHHHHHHHHHHHcCCCCceeeeccccCCC--ceEEEE
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDA--AQGKRQFQQEVEVLSSIRHPNMVLLLGACPDY--GCLVYE 302 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~--~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~--~~lV~E 302 (568)
++|++++.||+|+||.||+|++ +++.||||++.... ....+.|.+|+.+|+.|+|||||+++++|.+. .|||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 6899999999999999999987 57899999997542 34456799999999999999999999998654 489999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCC
Q 008365 303 YMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSV 382 (568)
Q Consensus 303 ~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~ 382 (568)
||+||+|.++|...+.. .+++..++.|+.||+.||.|||+++ ||||||||+||||+.+|.+||+|||+|+.+...
T Consensus 104 y~~gg~L~~~i~~~~~~-~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~- 178 (350)
T 4b9d_A 104 YCEGGDLFKRINAQKGV-LFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST- 178 (350)
T ss_dssp CCTTCBHHHHHHHTTTC-CCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHH-
T ss_pred CCCCCcHHHHHHHcCCC-CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCC-
Confidence 99999999999765432 3788999999999999999999999 999999999999999999999999999865321
Q ss_pred CccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHH--HHHHhCccccccCccCCCC
Q 008365 383 ADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVS--RAIEKGTLAEMLDPAVTDW 460 (568)
Q Consensus 383 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~--~~~~~~~~~~~l~~~~~~~ 460 (568)
.......+||+.|||||++.+..|+.++|||||||+||||++|++||....... ..+..+.+ ...
T Consensus 179 -----~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~--------~~~ 245 (350)
T 4b9d_A 179 -----VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSF--------PPV 245 (350)
T ss_dssp -----HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC--------CCC
T ss_pred -----cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC--------CCC
Confidence 122345789999999999999999999999999999999999999997654422 22333321 233
Q ss_pred ChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 461 PAEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 461 p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
+..++..+.+||.+||+.||.+||++.+++.|.+
T Consensus 246 ~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~ 279 (350)
T 4b9d_A 246 SLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGF 279 (350)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHH
T ss_pred CccCCHHHHHHHHHHccCChhHCcCHHHHhcCHH
Confidence 4556778999999999999999999999998766
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-55 Score=448.99 Aligned_cols=250 Identities=25% Similarity=0.473 Sum_probs=203.5
Q ss_pred hcccccceeecccCceeEEEEEeCCccEEEEEeCcC--hhHhHHHHHHHHHHHHcCCCCceeeeccccCC-CceEEEEec
Q 008365 228 TDKFSEAMKIGEGGYGPVYRGKLDHTPVAIKVLRPD--AAQGKRQFQQEVEVLSSIRHPNMVLLLGACPD-YGCLVYEYM 304 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~~~~~~~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~-~~~lV~E~~ 304 (568)
.++|.+.++||+|+||+||+|++.+ .||||+++.. .....+.|.+|+.+|++++|||||+++|+|.+ ..+||||||
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~iVmEy~ 113 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWHG-DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWC 113 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESSS-EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEEECC
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECC-cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEECCeEEEEEEcC
Confidence 3567889999999999999998765 5999998753 33445789999999999999999999999854 458999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCCc
Q 008365 305 HNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVAD 384 (568)
Q Consensus 305 ~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~~ 384 (568)
+||+|.++|..... .+++..+..|+.||+.||.|||+.+ ||||||||+||||+.++.+||+|||+|+.......
T Consensus 114 ~gGsL~~~l~~~~~--~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~- 187 (307)
T 3omv_A 114 EGSSLYKHLHVQET--KFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSG- 187 (307)
T ss_dssp SSCBHHHHHHTSCC--CCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC-------
T ss_pred CCCCHHHHHhhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccCCc-
Confidence 99999999976543 3899999999999999999999999 99999999999999999999999999987543221
Q ss_pred cccccccccccccccCCChhhhhc---CCCCCcceehhHHHHHHHHHhCCCCCCCchH---HHHHHHhCccccccCccCC
Q 008365 385 SVTQYHMTSAAGTFCYIDPEYQQT---GMLTTKSDIYSFGIMLLQIITARSPMGLTHH---VSRAIEKGTLAEMLDPAVT 458 (568)
Q Consensus 385 ~~~~~~~~~~~GT~~Y~APE~~~~---~~~s~ksDvwSlGvil~elltG~~Pf~~~~~---~~~~~~~~~~~~~l~~~~~ 458 (568)
.......+||+.|||||++.+ +.|+.++|||||||+||||+||+.||..... +...+..+ ...+.+.
T Consensus 188 ---~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~----~~~p~~~ 260 (307)
T 3omv_A 188 ---SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRG----YASPDLS 260 (307)
T ss_dssp ---------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTT----CCCCCST
T ss_pred ---ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcC----CCCCCcc
Confidence 122345789999999999864 4589999999999999999999999965432 22223222 2234444
Q ss_pred CCChHHHHHHHHHHHHhhccCCCCCCChHHhHh
Q 008365 459 DWPAEAAESFSKLAIQCAELRKKDRPDLGTVIV 491 (568)
Q Consensus 459 ~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~ 491 (568)
..+.+++..+.+|+.+||+.+|.+||++.+|+.
T Consensus 261 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~ 293 (307)
T 3omv_A 261 KLYKNCPKAMKRLVADCVKKVKEERPLFPQILS 293 (307)
T ss_dssp TSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHH
T ss_pred cccccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 566778889999999999999999999999874
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-55 Score=450.89 Aligned_cols=247 Identities=26% Similarity=0.458 Sum_probs=207.3
Q ss_pred cccccceeecccCceeEEEEEe-------CCccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCceeeeccccCC--CceE
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKL-------DHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACPD--YGCL 299 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~-------~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--~~~l 299 (568)
++|.+.++||+|+||.||+|++ ++..||||+++.......+.|.+|+.+|++|+|||||+++|+|.+ ..+|
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 5788999999999999999986 256899999988777777889999999999999999999999965 4489
Q ss_pred EEEecCCCCHHHHHhhcC----------CCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEe
Q 008365 300 VYEYMHNGSLEDRLLRRG----------NTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKI 369 (568)
Q Consensus 300 V~E~~~ggsL~~~l~~~~----------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL 369 (568)
|||||+||+|.++|...+ ....++|..++.|+.||+.||.|||+.+ ||||||||+||||+.++.+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEE
Confidence 999999999999997643 2235899999999999999999999999 999999999999999999999
Q ss_pred cccccccccCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh-CCCCCCCchH--HHHHHHh
Q 008365 370 SDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPMGLTHH--VSRAIEK 446 (568)
Q Consensus 370 ~DFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~--~~~~~~~ 446 (568)
+|||+|+...... ........+||+.|||||++.+..|+.++|||||||+||||+| |+.||..... +...+..
T Consensus 170 ~DFGla~~~~~~~----~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~ 245 (299)
T 4asz_A 170 GDFGMSRDVYSTD----YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQ 245 (299)
T ss_dssp CCCSCHHHHTGGG----CEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHH
T ss_pred CCcccceecCCCC----ceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 9999998653321 1112234579999999999999999999999999999999998 9999975443 3333333
Q ss_pred CccccccCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhH
Q 008365 447 GTLAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVI 490 (568)
Q Consensus 447 ~~~~~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl 490 (568)
+. ....|..+++.+.+|+.+||+.||.+||++.+|+
T Consensus 246 ~~--------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~ 281 (299)
T 4asz_A 246 GR--------VLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIH 281 (299)
T ss_dssp TC--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CC--------CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 32 2234667778899999999999999999999985
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-54 Score=450.71 Aligned_cols=248 Identities=25% Similarity=0.428 Sum_probs=202.8
Q ss_pred cccccceeecccCceeEEEEEeC-------CccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCceeeeccccCCC--ceE
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKLD-------HTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACPDY--GCL 299 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~~-------~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~--~~l 299 (568)
++|.+.++||+|+||.||+|++. ++.||||+++.......+.|.+|+.+|++|+|||||+++|+|.+. .||
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 56888899999999999999863 568999999887777778899999999999999999999999654 489
Q ss_pred EEEecCCCCHHHHHhhcCC------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCcee
Q 008365 300 VYEYMHNGSLEDRLLRRGN------------TPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVS 367 (568)
Q Consensus 300 V~E~~~ggsL~~~l~~~~~------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~v 367 (568)
|||||++|+|.++|..... ...++|.+++.|+.||+.||.|||+.+ ||||||||+||||+.++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcE
Confidence 9999999999999976532 235899999999999999999999999 9999999999999999999
Q ss_pred EecccccccccCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh-CCCCCCCchHH--HHHH
Q 008365 368 KISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPMGLTHHV--SRAI 444 (568)
Q Consensus 368 KL~DFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~--~~~~ 444 (568)
||+|||+|+.+..... ....+..+||+.|||||++.+..|+.++|||||||+||||+| |+.||...... ...+
T Consensus 198 Ki~DFGla~~~~~~~~----~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i 273 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDY----YRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCI 273 (329)
T ss_dssp EECCCC--------------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHH
T ss_pred EEcccccceeccCCCc----ceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 9999999986643211 112245689999999999999999999999999999999999 99999754432 2233
Q ss_pred HhCccccccCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHh
Q 008365 445 EKGTLAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIV 491 (568)
Q Consensus 445 ~~~~~~~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~ 491 (568)
..+. ....|..+++.+.+|+.+||+.||.+||++.+|+.
T Consensus 274 ~~g~--------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~ 312 (329)
T 4aoj_A 274 TQGR--------ELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHA 312 (329)
T ss_dssp HHTC--------CCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHH
T ss_pred HcCC--------CCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence 3322 12345667788999999999999999999999874
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-54 Score=446.77 Aligned_cols=247 Identities=26% Similarity=0.419 Sum_probs=205.2
Q ss_pred cccccceeecccCceeEEEEEe-------CCccEEEEEeCcCh-hHhHHHHHHHHHHHHcCCCCceeeeccccCC--Cce
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKL-------DHTPVAIKVLRPDA-AQGKRQFQQEVEVLSSIRHPNMVLLLGACPD--YGC 298 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~-------~~~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--~~~ 298 (568)
.++++.++||+|+||.||+|.+ +++.||||+++... ....+.|.+|+.+|++|+|||||+++|+|.+ ..+
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 4577889999999999999986 34689999997543 2335689999999999999999999999955 458
Q ss_pred EEEEecCCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCc
Q 008365 299 LVYEYMHNGSLEDRLLRRGN-------------TPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNY 365 (568)
Q Consensus 299 lV~E~~~ggsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~ 365 (568)
||||||++|+|.++|..... ...++|..++.|+.||+.||.|||+.+ ||||||||+||||+.++
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKL 182 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGG
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCC
Confidence 99999999999999975432 134899999999999999999999999 99999999999999999
Q ss_pred eeEecccccccccCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh-CCCCCCCchH--HHH
Q 008365 366 VSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPMGLTHH--VSR 442 (568)
Q Consensus 366 ~vKL~DFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~--~~~ 442 (568)
.+||+|||+|+.+.... .....+..+||+.|||||++.++.|+.++|||||||+||||+| |..||..... +..
T Consensus 183 ~~Ki~DFGlar~~~~~~----~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~ 258 (308)
T 4gt4_A 183 NVKISDLGLFREVYAAD----YYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVE 258 (308)
T ss_dssp CEEECCSCCBCGGGGGG----CBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHH
T ss_pred CEEECCcccceeccCCC----ceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 99999999998653221 1122345689999999999999999999999999999999998 8999975443 223
Q ss_pred HHHhCccccccCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhH
Q 008365 443 AIEKGTLAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVI 490 (568)
Q Consensus 443 ~~~~~~~~~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl 490 (568)
.+..+ .....|.+++..+.+|+.+||+.+|.+||++.+|+
T Consensus 259 ~i~~~--------~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~ 298 (308)
T 4gt4_A 259 MIRNR--------QVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIH 298 (308)
T ss_dssp HHHTT--------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred HHHcC--------CCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 33332 22345667788899999999999999999999986
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-55 Score=453.67 Aligned_cols=247 Identities=22% Similarity=0.307 Sum_probs=208.8
Q ss_pred cccccceeecccCceeEEEEEe--CCccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCceeeeccccCC--CceEEEEec
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACPD--YGCLVYEYM 304 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--~~~lV~E~~ 304 (568)
..|+++++||+|+||.||+|++ +++.||||++........+.+.+|+.+|+.++|||||+++++|.+ ..|||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 5699999999999999999998 578999999976655555678899999999999999999999854 458999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCCc
Q 008365 305 HNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVAD 384 (568)
Q Consensus 305 ~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~~ 384 (568)
+||+|.+++... .+++..+..|+.||+.||.|||+++ ||||||||+||||+.+|.+||+|||+|+.+....
T Consensus 154 ~gg~L~~~l~~~----~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-- 224 (346)
T 4fih_A 154 EGGALTDIVTHT----RMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-- 224 (346)
T ss_dssp TTEEHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSS--
T ss_pred CCCcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCC--
Confidence 999999988753 2899999999999999999999999 9999999999999999999999999998764322
Q ss_pred cccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHH--HHHhCccccccCccCCCCCh
Q 008365 385 SVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSR--AIEKGTLAEMLDPAVTDWPA 462 (568)
Q Consensus 385 ~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~--~~~~~~~~~~l~~~~~~~p~ 462 (568)
......+||+.|||||++.+..|+.++||||||||||||++|++||........ .+..+ ..+.+ ..+.
T Consensus 225 ----~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~-----~~~~~-~~~~ 294 (346)
T 4fih_A 225 ----PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDN-----LPPRL-KNLH 294 (346)
T ss_dssp ----CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS-----SCCCC-SCGG
T ss_pred ----CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcC-----CCCCC-Cccc
Confidence 123567999999999999999999999999999999999999999976544322 22221 11222 2234
Q ss_pred HHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 463 EAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 463 ~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
.+++.+.+||.+||..||.+||++.+++.|.+
T Consensus 295 ~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~ 326 (346)
T 4fih_A 295 KVSPSLKGFLDRLLVRDPAQRATAAELLKHPF 326 (346)
T ss_dssp GSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGG
T ss_pred cCCHHHHHHHHHHcCCChhHCcCHHHHhcCHh
Confidence 56778999999999999999999999986544
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-54 Score=443.45 Aligned_cols=245 Identities=26% Similarity=0.356 Sum_probs=208.8
Q ss_pred cccccceeecccCceeEEEEEe--CCccEEEEEeCcChh---HhHHHHHHHHHHHHcCCCCceeeeccccCCCc--eEEE
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAA---QGKRQFQQEVEVLSSIRHPNMVLLLGACPDYG--CLVY 301 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~---~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~--~lV~ 301 (568)
++|++++.||+|+||+||+|++ +++.||||++.+... ...+.+.+|+++|+.|+|||||+++++|.+.. ||||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 5799999999999999999987 577999999976432 23467899999999999999999999996654 8999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCC
Q 008365 302 EYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPS 381 (568)
Q Consensus 302 E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~ 381 (568)
|||+||+|.+++.+.+. +++..+..|+.||+.||.|||+++ ||||||||+||||+.+|.+||+|||+|+.+...
T Consensus 112 Ey~~gG~L~~~i~~~~~---l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~ 185 (311)
T 4aw0_A 112 SYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185 (311)
T ss_dssp CCCTTEEHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred ecCCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence 99999999999987653 899999999999999999999999 999999999999999999999999999977543
Q ss_pred CCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchH--HHHHHHhCccccccCccCCC
Q 008365 382 VADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHH--VSRAIEKGTLAEMLDPAVTD 459 (568)
Q Consensus 382 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~--~~~~~~~~~~~~~l~~~~~~ 459 (568)
.. .....+.+||+.|||||++.+..|+.++|||||||+||+|++|++||...+. +...+..+.+ .
T Consensus 186 ~~----~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~---------~ 252 (311)
T 4aw0_A 186 SK----QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEY---------D 252 (311)
T ss_dssp TT----CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC---------C
T ss_pred CC----cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC---------C
Confidence 21 1233567999999999999999999999999999999999999999975543 2233333321 3
Q ss_pred CChHHHHHHHHHHHHhhccCCCCCCChHHhHhH
Q 008365 460 WPAEAAESFSKLAIQCAELRKKDRPDLGTVIVP 492 (568)
Q Consensus 460 ~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~ 492 (568)
+|..+++.+.+||.+||..||.+||++.+++.+
T Consensus 253 ~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~ 285 (311)
T 4aw0_A 253 FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY 285 (311)
T ss_dssp CCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCH
T ss_pred CCcccCHHHHHHHHHHccCCHhHCcChHHHcCC
Confidence 455567789999999999999999999987644
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-54 Score=446.02 Aligned_cols=254 Identities=20% Similarity=0.267 Sum_probs=205.4
Q ss_pred hcccccceeecccCceeEEEEEe--CCccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCceeeeccccCCC--ceEEEEe
Q 008365 228 TDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACPDY--GCLVYEY 303 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~--~~lV~E~ 303 (568)
.+.|.+.++||+|+||.||+|++ +++.||||+++.... +.+|+.+|+.|+|||||+++++|.+. .||||||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 131 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL 131 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 35688999999999999999997 578999999976432 24799999999999999999998554 4899999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCc-eeEecccccccccCCCC
Q 008365 304 MHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNY-VSKISDVGLARLVPPSV 382 (568)
Q Consensus 304 ~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~-~vKL~DFGla~~~~~~~ 382 (568)
|+||+|.++|...+ .+++..+..|+.||+.||.|||+++ ||||||||+||||+.+| .+||+|||+|+.+....
T Consensus 132 ~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~ 205 (336)
T 4g3f_A 132 LEGGSLGQLIKQMG---CLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG 205 (336)
T ss_dssp CTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred cCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence 99999999998765 3899999999999999999999999 99999999999999987 69999999998775432
Q ss_pred CccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchH--HHHHHHhCccccccCccCCCC
Q 008365 383 ADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHH--VSRAIEKGTLAEMLDPAVTDW 460 (568)
Q Consensus 383 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~--~~~~~~~~~~~~~l~~~~~~~ 460 (568)
.. .........+||+.|||||++.+..|+.++|||||||+||||++|++||..... +...+..+. +.....
T Consensus 206 ~~-~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~------~~~~~~ 278 (336)
T 4g3f_A 206 LG-KSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEP------PPIREI 278 (336)
T ss_dssp ---------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSC------CGGGGS
T ss_pred cc-cceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCC------CCchhc
Confidence 11 111122346899999999999999999999999999999999999999964322 222222221 122244
Q ss_pred ChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHHHHHHH
Q 008365 461 PAEAAESFSKLAIQCAELRKKDRPDLGTVIVPELNRLKD 499 (568)
Q Consensus 461 p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l~~L~~ 499 (568)
|+.+++.+.+||.+||+.||.+||++.+++.++...|++
T Consensus 279 ~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~ 317 (336)
T 4g3f_A 279 PPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQE 317 (336)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhh
Confidence 667788899999999999999999999998765555544
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-53 Score=435.45 Aligned_cols=244 Identities=27% Similarity=0.447 Sum_probs=198.6
Q ss_pred cccceeecccCceeEEEEEe--CCccEEEEEeCcC--hhHhHHHHHHHHHHHHcCCCCceeeeccccCC------CceEE
Q 008365 231 FSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPD--AAQGKRQFQQEVEVLSSIRHPNMVLLLGACPD------YGCLV 300 (568)
Q Consensus 231 y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~------~~~lV 300 (568)
|++.++||+|+||.||+|.+ ++..||||++... .....+.|.+|+.+|+.|+|||||+++++|.+ ..|||
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence 35667899999999999998 4668999998654 23345679999999999999999999998843 24899
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccC-CceeEecccccccccC
Q 008365 301 YEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDR-NYVSKISDVGLARLVP 379 (568)
Q Consensus 301 ~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~-~~~vKL~DFGla~~~~ 379 (568)
||||+||+|.+++.+.+ .+++..+..|+.||+.||.|||+++ .+||||||||+||||+. +|.+||+|||+|+...
T Consensus 108 mEy~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~ 183 (290)
T 3fpq_A 108 TELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp EECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EeCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence 99999999999998764 3899999999999999999999986 35999999999999974 7999999999998643
Q ss_pred CCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHH---HHHHhCccccccCcc
Q 008365 380 PSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVS---RAIEKGTLAEMLDPA 456 (568)
Q Consensus 380 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~---~~~~~~~~~~~l~~~ 456 (568)
.. ...+.+||+.|||||++.+ .|+.++|||||||+||||+||+.||....... ..+..+.. +
T Consensus 184 ~~--------~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~-----~- 248 (290)
T 3fpq_A 184 AS--------FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK-----P- 248 (290)
T ss_dssp TT--------SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC-----C-
T ss_pred CC--------ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCC-----C-
Confidence 22 2245789999999998865 69999999999999999999999996543322 22222211 1
Q ss_pred CCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 457 VTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 457 ~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
..++..+++++.+||.+||+.||.+||++.+++.|.+
T Consensus 249 -~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~ 285 (290)
T 3fpq_A 249 -ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAF 285 (290)
T ss_dssp -GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred -CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCcc
Confidence 1123334567899999999999999999999986644
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-53 Score=453.93 Aligned_cols=248 Identities=22% Similarity=0.310 Sum_probs=209.3
Q ss_pred hcccccceeecccCceeEEEEEe--CCccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCceeeeccccCC--CceEEEEe
Q 008365 228 TDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACPD--YGCLVYEY 303 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--~~~lV~E~ 303 (568)
.+.|+++++||+|+||.||+|++ +|+.||||++........+.+.+|+.+|+.|+|||||+++++|.+ ..||||||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence 35699999999999999999998 578999999976655555678999999999999999999999854 45899999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCC
Q 008365 304 MHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVA 383 (568)
Q Consensus 304 ~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~ 383 (568)
|+||+|.+++.... +++..+..|+.||+.||.|||+++ ||||||||+||||+.+|.+||+|||+|+.+....
T Consensus 230 ~~gG~L~~~i~~~~----l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~- 301 (423)
T 4fie_A 230 LEGGALTDIVTHTR----MNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV- 301 (423)
T ss_dssp CTTEEHHHHHHHSC----CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSC-
T ss_pred CCCCcHHHHHhccC----CCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCC-
Confidence 99999999886542 899999999999999999999999 9999999999999999999999999998764322
Q ss_pred ccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHH--HHHHhCccccccCccCCCCC
Q 008365 384 DSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVS--RAIEKGTLAEMLDPAVTDWP 461 (568)
Q Consensus 384 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~--~~~~~~~~~~~l~~~~~~~p 461 (568)
......+||+.|||||++.+..|+.++||||||||+|||++|++||....... ..+..+ ..+.+. .+
T Consensus 302 -----~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~-----~~~~~~-~~ 370 (423)
T 4fie_A 302 -----PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDN-----LPPRLK-NL 370 (423)
T ss_dssp -----CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS-----CCCCCS-CT
T ss_pred -----ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcC-----CCCCCc-cc
Confidence 12356789999999999999999999999999999999999999997654432 222221 112221 23
Q ss_pred hHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 462 AEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 462 ~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
..++..+.+||.+||..||.+||++.+++.|.+
T Consensus 371 ~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~ 403 (423)
T 4fie_A 371 HKVSPSLKGFLDRLLVRDPAQRATAAELLKHPF 403 (423)
T ss_dssp TSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGG
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHH
Confidence 456678999999999999999999999986544
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-53 Score=426.51 Aligned_cols=244 Identities=23% Similarity=0.391 Sum_probs=193.6
Q ss_pred cccccceeecccCceeEEEEEe--CCccEEEEEeCcChh---HhHHHHHHHHHHHHcCCCCceeeeccccCCC--ceEEE
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAA---QGKRQFQQEVEVLSSIRHPNMVLLLGACPDY--GCLVY 301 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~---~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~--~~lV~ 301 (568)
++|++.+.||+|+||.||+|.+ +++.||||++.+... .....+.+|+.+|+.++|||||+++++|.+. .||||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 6899999999999999999987 578999999976432 2345789999999999999999999998654 48999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCC
Q 008365 302 EYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPS 381 (568)
Q Consensus 302 E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~ 381 (568)
||| +|+|.+++...+ .+++..+..|+.||+.||.|||+++ ||||||||+||||+.++.+||+|||+|+.....
T Consensus 93 Ey~-~g~L~~~l~~~~---~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 165 (275)
T 3hyh_A 93 EYA-GNELFDYIVQRD---KMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG 165 (275)
T ss_dssp ECC-CEEHHHHHHHSC---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred eCC-CCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence 999 789999998765 3899999999999999999999999 999999999999999999999999999865332
Q ss_pred CCccccccccccccccccCCChhhhhcCCC-CCcceehhHHHHHHHHHhCCCCCCCchH--HHHHHHhCccccccCccCC
Q 008365 382 VADSVTQYHMTSAAGTFCYIDPEYQQTGML-TTKSDIYSFGIMLLQIITARSPMGLTHH--VSRAIEKGTLAEMLDPAVT 458 (568)
Q Consensus 382 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~-s~ksDvwSlGvil~elltG~~Pf~~~~~--~~~~~~~~~~~~~l~~~~~ 458 (568)
....+.+||+.|||||++.+..| +.++|||||||++|+|++|+.||..... +...+..+. .
T Consensus 166 -------~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~---------~ 229 (275)
T 3hyh_A 166 -------NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGV---------Y 229 (275)
T ss_dssp ----------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC---------C
T ss_pred -------CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCC---------C
Confidence 12345789999999999998876 5799999999999999999999975433 222333322 1
Q ss_pred CCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHHH
Q 008365 459 DWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPELN 495 (568)
Q Consensus 459 ~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l~ 495 (568)
.+|..+++.+.+|+.+||+.||.+||++.+++.|.+-
T Consensus 230 ~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~ 266 (275)
T 3hyh_A 230 TLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWF 266 (275)
T ss_dssp CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHH
T ss_pred CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCccc
Confidence 2345567789999999999999999999999987764
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-52 Score=439.13 Aligned_cols=265 Identities=27% Similarity=0.401 Sum_probs=214.9
Q ss_pred cCHHHHHHHhcccccceeecccCceeEEEEEeCC-------ccEEEEEeCcChh-HhHHHHHHHHHHHHcCCC-Cceeee
Q 008365 219 YTIEEIEEATDKFSEAMKIGEGGYGPVYRGKLDH-------TPVAIKVLRPDAA-QGKRQFQQEVEVLSSIRH-PNMVLL 289 (568)
Q Consensus 219 ~~~~ei~~~~~~y~~~~~IG~G~fg~Vy~~~~~~-------~~vAvK~l~~~~~-~~~~~~~~Ev~iL~~l~H-pnIv~l 289 (568)
|...+.+...++|++.++||+|+||.||+|.+.+ +.||||+++.... ...+.|.+|+.+|.+++| ||||++
T Consensus 54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l 133 (353)
T 4ase_A 54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 133 (353)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence 3344444456889999999999999999998643 4699999976543 345679999999999975 899999
Q ss_pred ccccCC---CceEEEEecCCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCC
Q 008365 290 LGACPD---YGCLVYEYMHNGSLEDRLLRRGN-------------TPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRD 353 (568)
Q Consensus 290 ~g~~~~---~~~lV~E~~~ggsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrD 353 (568)
+|+|.+ ..+||||||++|+|.++|..... ...+++..+..|+.||+.||.|||+.+ |||||
T Consensus 134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRD 210 (353)
T 4ase_A 134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD 210 (353)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCc
Confidence 999843 35899999999999999976421 234899999999999999999999999 99999
Q ss_pred CCCCCeeccCCceeEecccccccccCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh-CCC
Q 008365 354 LKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARS 432 (568)
Q Consensus 354 IKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-G~~ 432 (568)
|||+||||+.++.+||+|||+|+.+.... ........+||+.|||||++.+..|+.++|||||||+||||+| |+.
T Consensus 211 LK~~NILl~~~~~vKi~DFGlar~~~~~~----~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~ 286 (353)
T 4ase_A 211 LAARNILLSEKNVVKICDFGLARDIYKDP----DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS 286 (353)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCT----TSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCC
T ss_pred cCccceeeCCCCCEEECcchhhhhcccCC----CceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCC
Confidence 99999999999999999999998764322 1123345789999999999999999999999999999999998 999
Q ss_pred CCCCc---hHHHHHHHhCccccccCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHHHHHH
Q 008365 433 PMGLT---HHVSRAIEKGTLAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPELNRLK 498 (568)
Q Consensus 433 Pf~~~---~~~~~~~~~~~~~~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l~~L~ 498 (568)
||... ..+...+..+. ....|..+++++.+|+..||+.||.+||++.+|+.++-+-|+
T Consensus 287 Pf~~~~~~~~~~~~i~~g~--------~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq 347 (353)
T 4ase_A 287 PYPGVKIDEEFCRRLKEGT--------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 347 (353)
T ss_dssp SSTTCCCSHHHHHHHHHTC--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHcCC--------CCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHH
Confidence 99643 23334443332 123455667889999999999999999999999866444333
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-53 Score=435.71 Aligned_cols=244 Identities=25% Similarity=0.320 Sum_probs=197.4
Q ss_pred cccccceeecccCceeEEEEEe-----CCccEEEEEeCcChh--HhHHHHHHHHHHHHcCCCCceeeeccccCCC--ceE
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKL-----DHTPVAIKVLRPDAA--QGKRQFQQEVEVLSSIRHPNMVLLLGACPDY--GCL 299 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~-----~~~~vAvK~l~~~~~--~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~--~~l 299 (568)
++|++++.||+|+||+||+|++ .++.||||++++... .....+.+|+.+|+.++|||||+++++|.+. .||
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 5799999999999999999976 356799999975422 2234678999999999999999999998554 489
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccC
Q 008365 300 VYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVP 379 (568)
Q Consensus 300 V~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~ 379 (568)
|||||+||+|.++|.+.+ .+++..+..|+.||+.||.|||+++ ||||||||+||||+.+|.+||+|||+|+...
T Consensus 104 vmEy~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 177 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKEV---MFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESI 177 (304)
T ss_dssp EECCCTTCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred EEEcCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence 999999999999998765 3899999999999999999999999 9999999999999999999999999998653
Q ss_pred CCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHH--HHHHhCccccccCccC
Q 008365 380 PSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVS--RAIEKGTLAEMLDPAV 457 (568)
Q Consensus 380 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~--~~~~~~~~~~~l~~~~ 457 (568)
... ....+.+||+.|||||++.+..|+.++|||||||+||||++|+.||...+... ..+..+.
T Consensus 178 ~~~------~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~--------- 242 (304)
T 3ubd_A 178 DHE------KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAK--------- 242 (304)
T ss_dssp ---------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC---------
T ss_pred CCC------ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCC---------
Confidence 221 12346789999999999999999999999999999999999999997654422 2232222
Q ss_pred CCCChHHHHHHHHHHHHhhccCCCCCCCh-----HHhHhHH
Q 008365 458 TDWPAEAAESFSKLAIQCAELRKKDRPDL-----GTVIVPE 493 (568)
Q Consensus 458 ~~~p~~~~~~l~~li~~Cl~~dP~~RPs~-----~~vl~~~ 493 (568)
..+|..+++.+.+|+.+||+.||.+||++ .+++.|.
T Consensus 243 ~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp 283 (304)
T 3ubd_A 243 LGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHS 283 (304)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSG
T ss_pred CCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCc
Confidence 13455677889999999999999999995 4665443
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-52 Score=428.05 Aligned_cols=254 Identities=24% Similarity=0.367 Sum_probs=191.5
Q ss_pred cccccceeecccCceeEEEEEe--CCccEEEEEeCcCh-hHhHHHHHHHHHHHHcCCCCceeeeccccCC----------
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDA-AQGKRQFQQEVEVLSSIRHPNMVLLLGACPD---------- 295 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~---------- 295 (568)
++|++++.||+|+||.||+|++ +++.||||+++... ....+.+.+|+.+|+.|+|||||+++++|.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 4699999999999999999987 57899999986543 3345678999999999999999999998732
Q ss_pred ----CceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecc
Q 008365 296 ----YGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISD 371 (568)
Q Consensus 296 ----~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~D 371 (568)
+.|||||||+||+|.+++...+.....++..++.|+.||+.||.|||+++ ||||||||+||||+.++.+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEcc
Confidence 13799999999999999987665444667778899999999999999999 99999999999999999999999
Q ss_pred cccccccCCCCCccc------cccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHH
Q 008365 372 VGLARLVPPSVADSV------TQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIE 445 (568)
Q Consensus 372 FGla~~~~~~~~~~~------~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~ 445 (568)
||+|+.+........ .....++.+||+.|||||++.+..|+.++|||||||+||||++ ||.........+.
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~~ 238 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLT 238 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHH
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHHH
Confidence 999987754322111 1122345789999999999999999999999999999999996 8865433222211
Q ss_pred hCccccccCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHH
Q 008365 446 KGTLAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPE 493 (568)
Q Consensus 446 ~~~~~~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~ 493 (568)
.. .....+..+...++.+.+|+.+||+.||.+||++.+++.|.
T Consensus 239 ~~-----~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~ 281 (299)
T 4g31_A 239 DV-----RNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENA 281 (299)
T ss_dssp HH-----HTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred HH-----hcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCH
Confidence 10 01111111233445678899999999999999999998543
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-52 Score=428.09 Aligned_cols=256 Identities=25% Similarity=0.336 Sum_probs=194.7
Q ss_pred cccccceeecccCceeEEEEEeCCccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCceeeeccccCCC------ceEEEE
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKLDHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACPDY------GCLVYE 302 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~------~~lV~E 302 (568)
.+|.+.++||+|+||.||+|+++|+.||||++...... ...++.|+.++..++|||||+++|+|.+. .|||||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~E 81 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD 81 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEec
Confidence 46888899999999999999999999999999765432 22344566777789999999999998532 389999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcC-----CCCcccCCCCCCCeeccCCceeEecccccccc
Q 008365 303 YMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAK-----PEPLVHRDLKPANILLDRNYVSKISDVGLARL 377 (568)
Q Consensus 303 ~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~-----~~~IiHrDIKp~NILld~~~~vKL~DFGla~~ 377 (568)
||+||+|.++|.... ++|..+.+|+.|++.||.|||+.. ..+||||||||+||||+.++.+||+|||+|+.
T Consensus 82 y~~~gsL~~~l~~~~----l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~ 157 (303)
T 3hmm_A 82 YHEHGSLFDYLNRYT----VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp CCTTCBHHHHHHHCC----BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred CCCCCcHHHHHHhCC----CCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcc
Confidence 999999999997643 899999999999999999999871 12399999999999999999999999999987
Q ss_pred cCCCCCccccccccccccccccCCChhhhhcC------CCCCcceehhHHHHHHHHHhCCCCCCCchH------------
Q 008365 378 VPPSVADSVTQYHMTSAAGTFCYIDPEYQQTG------MLTTKSDIYSFGIMLLQIITARSPMGLTHH------------ 439 (568)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~------~~s~ksDvwSlGvil~elltG~~Pf~~~~~------------ 439 (568)
....... ........+||+.|||||++.+. .|+.++|||||||+||||+||.+||.....
T Consensus 158 ~~~~~~~--~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~ 235 (303)
T 3hmm_A 158 HDSATDT--IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235 (303)
T ss_dssp EETTTTE--ESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred ccCCCCc--eeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccccc
Confidence 6433211 11122356899999999998764 367899999999999999999877632110
Q ss_pred -HHHHHHhCccccccCccCCCC--ChHHHHHHHHHHHHhhccCCCCCCChHHhHh
Q 008365 440 -VSRAIEKGTLAEMLDPAVTDW--PAEAAESFSKLAIQCAELRKKDRPDLGTVIV 491 (568)
Q Consensus 440 -~~~~~~~~~~~~~l~~~~~~~--p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~ 491 (568)
....+........+++.++.. +.+++..+.+|+.+||+.||.+||++.+|+.
T Consensus 236 ~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~ 290 (303)
T 3hmm_A 236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290 (303)
T ss_dssp CCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred chHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 001111111122233333321 2357788999999999999999999999874
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=424.06 Aligned_cols=258 Identities=23% Similarity=0.308 Sum_probs=202.0
Q ss_pred hcccccceeecccCceeEEEEEe--CCccEEEEEeCcCh--hHhHHHHHHHHHHHHcCCCCceeeeccccCC--------
Q 008365 228 TDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDA--AQGKRQFQQEVEVLSSIRHPNMVLLLGACPD-------- 295 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~--~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~-------- 295 (568)
.++|++++.||+|+||+||+|.+ +|+.||||+++... ....+.+.+|+.+|+.|+|||||++++++..
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 46899999999999999999987 57899999997542 3345678899999999999999999998642
Q ss_pred CceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccc
Q 008365 296 YGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLA 375 (568)
Q Consensus 296 ~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla 375 (568)
..|||||||+ |+|.+++...+ .+++..+..|+.||+.||.|||+++ ||||||||+||||+.+|.+||+|||+|
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~~~---~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla 205 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHSSQ---PLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMA 205 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTSSS---CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEEeCCC-CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeeccee
Confidence 3489999995 78999887654 4899999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCccccccccccccccccCCChhhhhcC-CCCCcceehhHHHHHHHHHhCCCCCCCchHHHHH--HH--hCccc
Q 008365 376 RLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTG-MLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRA--IE--KGTLA 450 (568)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~--~~--~~~~~ 450 (568)
+.+..... .......+.+||+.|||||++.+. .|+.++||||+|||+|||++|++||...+..... +. .+...
T Consensus 206 ~~~~~~~~--~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~ 283 (398)
T 4b99_A 206 RGLCTSPA--EHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPS 283 (398)
T ss_dssp BCC---------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred eecccCcc--ccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 87643221 122234567999999999988775 5799999999999999999999999765543322 11 11110
Q ss_pred cc----------------cCccCC----CCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 451 EM----------------LDPAVT----DWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 451 ~~----------------l~~~~~----~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
.. +.+... ...+.++..+.+||.+||..||.+||++.+++.|.+
T Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~ 347 (398)
T 4b99_A 284 PAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPF 347 (398)
T ss_dssp GGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGG
T ss_pred hHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHh
Confidence 00 000000 001234567899999999999999999999986654
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-48 Score=407.46 Aligned_cols=258 Identities=22% Similarity=0.319 Sum_probs=195.8
Q ss_pred HHhcccccceeecccCceeEEEEEe-----CCccEEEEEeCcChhHhHHHHHHHHHHHHcC-CCCceeeeccccCC--Cc
Q 008365 226 EATDKFSEAMKIGEGGYGPVYRGKL-----DHTPVAIKVLRPDAAQGKRQFQQEVEVLSSI-RHPNMVLLLGACPD--YG 297 (568)
Q Consensus 226 ~~~~~y~~~~~IG~G~fg~Vy~~~~-----~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l-~HpnIv~l~g~~~~--~~ 297 (568)
...++|++.++||+|+||+||+|++ .++.||||++..... ...+.+|+++|+.+ +|||||+++++|.+ ..
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~--~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~ 95 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH--PIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV 95 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC--HHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC--HHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence 3567899999999999999999975 246899999865532 34678999999998 69999999999854 45
Q ss_pred eEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCC-ceeEeccccccc
Q 008365 298 CLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRN-YVSKISDVGLAR 376 (568)
Q Consensus 298 ~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~-~~vKL~DFGla~ 376 (568)
|||||||+||+|.+++. .+++..+..|+.||+.||.|||++| ||||||||+||||+.+ +.+||+|||+|+
T Consensus 96 ~lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla~ 166 (361)
T 4f9c_A 96 VIAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQ 166 (361)
T ss_dssp EEEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCCc
Confidence 89999999999999883 2889999999999999999999999 9999999999999876 899999999998
Q ss_pred ccCCCCCccc----------------------cccccccccccccCCChhhhhcC-CCCCcceehhHHHHHHHHHhCCCC
Q 008365 377 LVPPSVADSV----------------------TQYHMTSAAGTFCYIDPEYQQTG-MLTTKSDIYSFGIMLLQIITARSP 433 (568)
Q Consensus 377 ~~~~~~~~~~----------------------~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDvwSlGvil~elltG~~P 433 (568)
.......... .....+..+||+.|+|||++.+. .|+.++||||+|||+|||++|+.|
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~P 246 (361)
T 4f9c_A 167 GTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYP 246 (361)
T ss_dssp ECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSS
T ss_pred ccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCC
Confidence 7644321110 01123456899999999988775 599999999999999999999999
Q ss_pred CCCch-HHHHH--H-H-hCc---------cc------------------c---ccCccC-------------CCCChHHH
Q 008365 434 MGLTH-HVSRA--I-E-KGT---------LA------------------E---MLDPAV-------------TDWPAEAA 465 (568)
Q Consensus 434 f~~~~-~~~~~--~-~-~~~---------~~------------------~---~l~~~~-------------~~~p~~~~ 465 (568)
|.... ..... + . .|. +. + ..+... ......++
T Consensus 247 f~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is 326 (361)
T 4f9c_A 247 FYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVP 326 (361)
T ss_dssp SSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCC
T ss_pred CCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCC
Confidence 95322 11110 0 0 000 00 0 000000 00112345
Q ss_pred HHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 466 ESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 466 ~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
+++.+|+.+||..||.+||++.+++.|.+
T Consensus 327 ~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~ 355 (361)
T 4f9c_A 327 DEAYDLLDKLLDLNPASRITAEEALLHPF 355 (361)
T ss_dssp HHHHHHHHHHTCSCTTTSCCHHHHHTSGG
T ss_pred HHHHHHHHHHCcCChhHCcCHHHHhcCcc
Confidence 67889999999999999999999987654
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-48 Score=430.25 Aligned_cols=250 Identities=21% Similarity=0.345 Sum_probs=209.6
Q ss_pred hcccccceeecccCceeEEEEEe--CCccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCceeeeccccCCCc--eEEEEe
Q 008365 228 TDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACPDYG--CLVYEY 303 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~--~lV~E~ 303 (568)
.++|++++.||+|+||.||+|.+ +++.||||++........+.+.+|+.+|+.|+|||||+++++|.+.. ||||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 47899999999999999999987 57899999998776666778999999999999999999999996654 899999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCC--ceeEecccccccccCCC
Q 008365 304 MHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRN--YVSKISDVGLARLVPPS 381 (568)
Q Consensus 304 ~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~--~~vKL~DFGla~~~~~~ 381 (568)
|+||+|.++|..... .+++..+..|+.||+.||.|||+++ |+||||||+||||+.+ +.+||+|||+|+.+...
T Consensus 236 ~~gg~L~~~i~~~~~--~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~ 310 (573)
T 3uto_A 236 MSGGELFEKVADEHN--KMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 310 (573)
T ss_dssp CCCCBHHHHHTCTTS--CEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred cCCCcHHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence 999999999865432 3899999999999999999999999 9999999999999754 89999999999877432
Q ss_pred CCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHH--HHHHhCccccccCccCCC
Q 008365 382 VADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVS--RAIEKGTLAEMLDPAVTD 459 (568)
Q Consensus 382 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~--~~~~~~~~~~~l~~~~~~ 459 (568)
. .....+||+.|||||++.+..|+.++|||||||+||||++|.+||....... ..+..+... +. ..
T Consensus 311 ~-------~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~--~~---~~ 378 (573)
T 3uto_A 311 Q-------SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWN--MD---DS 378 (573)
T ss_dssp S-------EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCC--CC---SG
T ss_pred C-------ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCC--CC---cc
Confidence 1 2345689999999999999999999999999999999999999997655432 223222211 11 11
Q ss_pred CChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 460 WPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 460 ~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
.+..++..+.+||.+||..||.+||++.+++.|.+
T Consensus 379 ~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw 413 (573)
T 3uto_A 379 AFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPW 413 (573)
T ss_dssp GGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTT
T ss_pred cccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcC
Confidence 12345677899999999999999999999987654
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=426.82 Aligned_cols=244 Identities=26% Similarity=0.330 Sum_probs=200.1
Q ss_pred hcccccceeecccCceeEEEEEe--CCccEEEEEeCcChhH---hHHHH---HHHHHHHHcCCCCceeeeccccCCC--c
Q 008365 228 TDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQ---GKRQF---QQEVEVLSSIRHPNMVLLLGACPDY--G 297 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~---~~~~~---~~Ev~iL~~l~HpnIv~l~g~~~~~--~ 297 (568)
.++|+++++||+|+||.||+|++ +++.||||++.+.... ....+ ..++.+++.++|||||+++++|.+. .
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 36799999999999999999987 6789999999754321 12223 3446777888999999999999654 4
Q ss_pred eEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccc
Q 008365 298 CLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARL 377 (568)
Q Consensus 298 ~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~ 377 (568)
|||||||+||+|.++|.+.+. +++..+..|+.||+.||.|||+++ ||||||||+||||+.+|++||+|||+|+.
T Consensus 268 ylVmEy~~GGdL~~~l~~~~~---l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~ 341 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQHGV---FSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACD 341 (689)
T ss_dssp EEEECCCCSCBHHHHHHHHCC---CCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEecCCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeee
Confidence 899999999999999987653 899999999999999999999999 99999999999999999999999999987
Q ss_pred cCCCCCccccccccccccccccCCChhhhh-cCCCCCcceehhHHHHHHHHHhCCCCCCCchH-----HHHHHHhCcccc
Q 008365 378 VPPSVADSVTQYHMTSAAGTFCYIDPEYQQ-TGMLTTKSDIYSFGIMLLQIITARSPMGLTHH-----VSRAIEKGTLAE 451 (568)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~-----~~~~~~~~~~~~ 451 (568)
+... ...+.+||+.|||||++. +..|+.++|||||||+||||++|++||..... +...+...
T Consensus 342 ~~~~--------~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~---- 409 (689)
T 3v5w_A 342 FSKK--------KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM---- 409 (689)
T ss_dssp CSSC--------CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHC----
T ss_pred cCCC--------CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCC----
Confidence 6432 234578999999999986 45799999999999999999999999964321 11111111
Q ss_pred ccCccCCCCChHHHHHHHHHHHHhhccCCCCCCC-----hHHhHhHHH
Q 008365 452 MLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPD-----LGTVIVPEL 494 (568)
Q Consensus 452 ~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs-----~~~vl~~~l 494 (568)
...+|..++.++.+||.+||..||.+|++ +.+|+.|.+
T Consensus 410 -----~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~Hpf 452 (689)
T 3v5w_A 410 -----AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPF 452 (689)
T ss_dssp -----CCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGG
T ss_pred -----CCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCcc
Confidence 12345667788999999999999999998 577776554
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=376.37 Aligned_cols=251 Identities=25% Similarity=0.367 Sum_probs=209.2
Q ss_pred HhcccccceeecccCceeEEEEEe--CCccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCceeeeccccCC--CceEEEE
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACPD--YGCLVYE 302 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--~~~lV~E 302 (568)
..++|.+.+.||+|+||.||+|.+ +++.||||++........+.+.+|+.+++.++|||||+++++|.+ ..++|||
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 97 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence 346899999999999999999986 677999999976655556778999999999999999999998843 4589999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCC
Q 008365 303 YMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSV 382 (568)
Q Consensus 303 ~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~ 382 (568)
|++||+|.+++.... +++..+..|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++..+....
T Consensus 98 ~~~~~~L~~~~~~~~----~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 170 (297)
T 3fxz_A 98 YLAGGSLTDVVTETC----MDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (297)
T ss_dssp CCTTCBHHHHHHHSC----CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred CCCCCCHHHHHhhcC----CCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc
Confidence 999999999987653 889999999999999999999999 9999999999999999999999999998764332
Q ss_pred CccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHhCccccccCccCCCCCh
Q 008365 383 ADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAVTDWPA 462 (568)
Q Consensus 383 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~l~~~~~~~p~ 462 (568)
. .....+||+.|+|||++.+..++.++|||||||++|+|++|..||............... .......+.
T Consensus 171 ~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~----~~~~~~~~~ 240 (297)
T 3fxz_A 171 S------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN----GTPELQNPE 240 (297)
T ss_dssp C------CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHH----CSCCCSCGG
T ss_pred c------ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC----CCCCCCCcc
Confidence 1 234568999999999999999999999999999999999999999765543322111000 000112345
Q ss_pred HHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 463 EAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 463 ~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
.++..+.+|+.+||+.||.+||++.+++.+.+
T Consensus 241 ~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~ 272 (297)
T 3fxz_A 241 KLSAIFRDFLNRCLEMDVEKRGSAKELLQHQF 272 (297)
T ss_dssp GSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGG
T ss_pred ccCHHHHHHHHHHccCChhHCcCHHHHhhChh
Confidence 66778999999999999999999999986554
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-45 Score=375.03 Aligned_cols=252 Identities=31% Similarity=0.514 Sum_probs=200.3
Q ss_pred HhcccccceeecccCceeEEEEEeCCccEEEEEeCcCh--hHhHHHHHHHHHHHHcCCCCceeeeccccCCC--ceEEEE
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKLDHTPVAIKVLRPDA--AQGKRQFQQEVEVLSSIRHPNMVLLLGACPDY--GCLVYE 302 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~~~~~vAvK~l~~~~--~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~--~~lV~E 302 (568)
..++|.+.+.||+|+||.||+|.+.++.||||++.... ......+.+|+.+|+.++||||++++++|.+. .++|||
T Consensus 35 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 114 (309)
T 3p86_A 35 PWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTE 114 (309)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEE
T ss_pred ChhHceeeeEeecCCCeEEEEEEECCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEe
Confidence 45789999999999999999999999999999997653 33456789999999999999999999998554 489999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCC
Q 008365 303 YMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSV 382 (568)
Q Consensus 303 ~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~ 382 (568)
|+++|+|.+++...+....+++..++.|+.||+.||.|||+.+ .+|+||||||+||||+.++.+||+|||+++......
T Consensus 115 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~ 193 (309)
T 3p86_A 115 YLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTF 193 (309)
T ss_dssp CCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC---------
T ss_pred cCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCccccccc
Confidence 9999999999976543334889999999999999999999986 359999999999999999999999999997543221
Q ss_pred CccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHhCccccccCccCCCCCh
Q 008365 383 ADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAVTDWPA 462 (568)
Q Consensus 383 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~l~~~~~~~p~ 462 (568)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||.............. .......|.
T Consensus 194 ------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~-----~~~~~~~~~ 262 (309)
T 3p86_A 194 ------LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGF-----KCKRLEIPR 262 (309)
T ss_dssp --------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHH-----SCCCCCCCT
T ss_pred ------cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-----cCCCCCCCc
Confidence 122456799999999999999999999999999999999999999976544322211100 111123455
Q ss_pred HHHHHHHHHHHHhhccCCCCCCChHHhH
Q 008365 463 EAAESFSKLAIQCAELRKKDRPDLGTVI 490 (568)
Q Consensus 463 ~~~~~l~~li~~Cl~~dP~~RPs~~~vl 490 (568)
.++..+.+|+.+||+.+|.+||++.+++
T Consensus 263 ~~~~~l~~li~~~l~~dP~~Rps~~~ll 290 (309)
T 3p86_A 263 NLNPQVAAIIEGCWTNEPWKRPSFATIM 290 (309)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred cCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 6677899999999999999999999987
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-45 Score=377.40 Aligned_cols=268 Identities=37% Similarity=0.664 Sum_probs=219.2
Q ss_pred cCHHHHHHHhcccccceeecccCceeEEEEEe-CCccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCceeeeccccCC--
Q 008365 219 YTIEEIEEATDKFSEAMKIGEGGYGPVYRGKL-DHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACPD-- 295 (568)
Q Consensus 219 ~~~~ei~~~~~~y~~~~~IG~G~fg~Vy~~~~-~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~-- 295 (568)
+...++...+++|.+.+.||+|+||.||+|.+ ++..||||++..........+.+|+.+++.++||||++++++|.+
T Consensus 29 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 108 (321)
T 2qkw_B 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERN 108 (321)
T ss_dssp -CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTT
T ss_pred ecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence 33344556788999999999999999999997 478999999987766667789999999999999999999999855
Q ss_pred CceEEEEecCCCCHHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEeccccc
Q 008365 296 YGCLVYEYMHNGSLEDRLLRRGN-TPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGL 374 (568)
Q Consensus 296 ~~~lV~E~~~ggsL~~~l~~~~~-~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGl 374 (568)
..++||||+++|+|.+++..... ...+++..++.|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~ 185 (321)
T 2qkw_B 109 EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGI 185 (321)
T ss_dssp CCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTT
T ss_pred eEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeeccc
Confidence 44899999999999998865432 234899999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCch------HH---HHHHH
Q 008365 375 ARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTH------HV---SRAIE 445 (568)
Q Consensus 375 a~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~------~~---~~~~~ 445 (568)
++....... ........||+.|+|||++.+..++.++|||||||++|+|++|+.||.... .. .....
T Consensus 186 ~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~ 261 (321)
T 2qkw_B 186 SKKGTELDQ----THLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHN 261 (321)
T ss_dssp CEECSSSSC----CCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHT
T ss_pred ccccccccc----cccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccc
Confidence 986532211 111234569999999999999999999999999999999999999995321 11 11223
Q ss_pred hCccccccCccCC-CCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHH
Q 008365 446 KGTLAEMLDPAVT-DWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPE 493 (568)
Q Consensus 446 ~~~~~~~l~~~~~-~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~ 493 (568)
.+.+...+++... ..+..++..+.+++.+||+.+|.+||++.+++.++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 310 (321)
T 2qkw_B 262 NGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310 (321)
T ss_dssp TTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred cccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 3444455555443 45778999999999999999999999999987443
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-44 Score=365.53 Aligned_cols=270 Identities=40% Similarity=0.646 Sum_probs=224.5
Q ss_pred ccccccCHHHHHHHhcccccc------eeecccCceeEEEEEeCCccEEEEEeCcC----hhHhHHHHHHHHHHHHcCCC
Q 008365 214 VRYRKYTIEEIEEATDKFSEA------MKIGEGGYGPVYRGKLDHTPVAIKVLRPD----AAQGKRQFQQEVEVLSSIRH 283 (568)
Q Consensus 214 ~~~~~~~~~ei~~~~~~y~~~------~~IG~G~fg~Vy~~~~~~~~vAvK~l~~~----~~~~~~~~~~Ev~iL~~l~H 283 (568)
..+..|...++..++++|... +.||+|+||.||+|.++++.||||++... .......+.+|+.+++.++|
T Consensus 10 ~~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 89 (307)
T 2nru_A 10 TRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH 89 (307)
T ss_dssp -CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEESSSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred CCCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEECCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence 356789999999999988877 89999999999999999999999998653 23345678999999999999
Q ss_pred CceeeeccccCC--CceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeec
Q 008365 284 PNMVLLLGACPD--YGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILL 361 (568)
Q Consensus 284 pnIv~l~g~~~~--~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILl 361 (568)
|||+++++++.+ ..++||||+++|+|.+++........+++..++.|+.||+.||.|||+.+ |+||||||+||||
T Consensus 90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili 166 (307)
T 2nru_A 90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILL 166 (307)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEE
Confidence 999999999854 45899999999999999976554456899999999999999999999999 9999999999999
Q ss_pred cCCceeEecccccccccCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCch---
Q 008365 362 DRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTH--- 438 (568)
Q Consensus 362 d~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~--- 438 (568)
+.++.+||+|||+++....... ........||+.|+|||++.+ .++.++|||||||++|+|++|..||....
T Consensus 167 ~~~~~~kl~Dfg~~~~~~~~~~----~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~ 241 (307)
T 2nru_A 167 DEAFTAKISDFGLARASEKFAQ----TVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQ 241 (307)
T ss_dssp CTTCCEEECCCTTCEECCSCSS----CEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSS
T ss_pred cCCCcEEEeecccccccccccc----cccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchH
Confidence 9999999999999986643221 112234679999999998865 48999999999999999999999996432
Q ss_pred ---HHHHHHHh--CccccccCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHh
Q 008365 439 ---HVSRAIEK--GTLAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIV 491 (568)
Q Consensus 439 ---~~~~~~~~--~~~~~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~ 491 (568)
.+...+.. ..+...+++.+...+..++..+.+++..||+.+|.+||++.+|+.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~ 299 (307)
T 2nru_A 242 LLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQ 299 (307)
T ss_dssp BTTHHHHHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHhhhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 12222221 223445566666778889999999999999999999999999873
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-45 Score=376.60 Aligned_cols=269 Identities=36% Similarity=0.638 Sum_probs=219.4
Q ss_pred cccccCHHHHHHHhcccccceeecccCceeEEEEEe-CCccEEEEEeCcChhH-hHHHHHHHHHHHHcCCCCceeeeccc
Q 008365 215 RYRKYTIEEIEEATDKFSEAMKIGEGGYGPVYRGKL-DHTPVAIKVLRPDAAQ-GKRQFQQEVEVLSSIRHPNMVLLLGA 292 (568)
Q Consensus 215 ~~~~~~~~ei~~~~~~y~~~~~IG~G~fg~Vy~~~~-~~~~vAvK~l~~~~~~-~~~~~~~Ev~iL~~l~HpnIv~l~g~ 292 (568)
....|+..++....++|.+.+.||+|+||.||+|.+ +++.||||++...... ....+.+|+.+++.++||||++++++
T Consensus 16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 95 (326)
T 3uim_A 16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 95 (326)
T ss_dssp CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEE
T ss_pred ccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEE
Confidence 356788899999999999999999999999999987 5789999999765322 22368899999999999999999999
Q ss_pred cCC--CceEEEEecCCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHc---CCCCcccCCCCCCCeeccCCce
Q 008365 293 CPD--YGCLVYEYMHNGSLEDRLLRRG-NTPVIPWRKRFKIAAEIATALLFLHQA---KPEPLVHRDLKPANILLDRNYV 366 (568)
Q Consensus 293 ~~~--~~~lV~E~~~ggsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~---~~~~IiHrDIKp~NILld~~~~ 366 (568)
|.+ ..++||||+++|+|.+++.... ....+++..+..|+.||+.||.|||+. + |+||||||+||||+.++.
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~---ivH~Dlkp~Nil~~~~~~ 172 (326)
T 3uim_A 96 CMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPK---IIHRDVKAANILLDEEFE 172 (326)
T ss_dssp ECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSC---EECCCCSGGGEEECTTCC
T ss_pred EecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC---eEeCCCchhhEEECCCCC
Confidence 855 4489999999999999998654 234589999999999999999999999 7 999999999999999999
Q ss_pred eEecccccccccCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchH-------
Q 008365 367 SKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHH------- 439 (568)
Q Consensus 367 vKL~DFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~------- 439 (568)
+||+|||+++.+..... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.....
T Consensus 173 ~kl~Dfg~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~ 247 (326)
T 3uim_A 173 AVVGDFGLAKLMDYKDT-----HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVM 247 (326)
T ss_dssp EEECCCSSCEECCSSSS-----CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSB
T ss_pred EEeccCccccccCcccc-----cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchh
Confidence 99999999987643221 122445699999999999999999999999999999999999999952211
Q ss_pred HHHH----HHhCccccccCccC-CCCChHHHHHHHHHHHHhhccCCCCCCChHHhHh
Q 008365 440 VSRA----IEKGTLAEMLDPAV-TDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIV 491 (568)
Q Consensus 440 ~~~~----~~~~~~~~~l~~~~-~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~ 491 (568)
.... .....+...++... ..++...+..+.+++..||+.+|.+||++.+|+.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~ 304 (326)
T 3uim_A 248 LLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVR 304 (326)
T ss_dssp HHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHH
T ss_pred HHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHH
Confidence 1111 11122233333333 2456788899999999999999999999999874
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-45 Score=378.92 Aligned_cols=245 Identities=23% Similarity=0.373 Sum_probs=206.0
Q ss_pred HhcccccceeecccCceeEEEEEe--CCccEEEEEeCcC--hhHhHHHHHHHHHHHHcCCCCceeeeccccCCC--ceEE
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPD--AAQGKRQFQQEVEVLSSIRHPNMVLLLGACPDY--GCLV 300 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~--~~lV 300 (568)
..++|.+.+.||+|+||.||+|.+ +++.||||++... .......+.+|+.+|+.++||||+++++++.+. .++|
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 92 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI 92 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence 346899999999999999999997 6789999999654 234456788999999999999999999998554 4899
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCC
Q 008365 301 YEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPP 380 (568)
Q Consensus 301 ~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~ 380 (568)
|||++||+|.+++...+. +++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+..
T Consensus 93 ~e~~~~~~L~~~l~~~~~---l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 166 (328)
T 3fe3_A 93 MEYASGGEVFDYLVAHGR---MKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTV 166 (328)
T ss_dssp ECCCTTCBHHHHHHHHCC---CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSS
T ss_pred EECCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCC
Confidence 999999999999977653 889999999999999999999999 99999999999999999999999999986543
Q ss_pred CCCccccccccccccccccCCChhhhhcCCCC-CcceehhHHHHHHHHHhCCCCCCCchH--HHHHHHhCccccccCccC
Q 008365 381 SVADSVTQYHMTSAAGTFCYIDPEYQQTGMLT-TKSDIYSFGIMLLQIITARSPMGLTHH--VSRAIEKGTLAEMLDPAV 457 (568)
Q Consensus 381 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s-~ksDvwSlGvil~elltG~~Pf~~~~~--~~~~~~~~~~~~~l~~~~ 457 (568)
.. .....+||+.|+|||++.+..++ .++|||||||++|+|++|+.||..... +...+..+..
T Consensus 167 ~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-------- 231 (328)
T 3fe3_A 167 GG-------KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY-------- 231 (328)
T ss_dssp SC-------GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC--------
T ss_pred CC-------ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC--------
Confidence 21 23456899999999999888875 799999999999999999999976543 2222333221
Q ss_pred CCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHH
Q 008365 458 TDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPE 493 (568)
Q Consensus 458 ~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~ 493 (568)
..|..++..+.+|+.+||..||.+||++.+++.|.
T Consensus 232 -~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~ 266 (328)
T 3fe3_A 232 -RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDR 266 (328)
T ss_dssp -CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCT
T ss_pred -CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCH
Confidence 23445567789999999999999999999998543
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=365.35 Aligned_cols=256 Identities=23% Similarity=0.384 Sum_probs=203.3
Q ss_pred hcccccceeecccCceeEEEEEe------CCccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCceeeeccccC----CCc
Q 008365 228 TDKFSEAMKIGEGGYGPVYRGKL------DHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACP----DYG 297 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~~~~------~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~----~~~ 297 (568)
.++|++.+.||+|+||.||+|++ +++.||||++........+.+.+|+.+|+.++||||++++++|. ...
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 46899999999999999999984 56789999998877776778999999999999999999999874 335
Q ss_pred eEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccc
Q 008365 298 CLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARL 377 (568)
Q Consensus 298 ~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~ 377 (568)
++||||+++|+|.+++..... .+++..++.|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~ 163 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKHKE--RIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV 163 (295)
T ss_dssp EEEEECCTTCBHHHHHHHCGG--GCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred EEEEEeCCCCCHHHHHHhccc--ccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCccccc
Confidence 899999999999999977543 3889999999999999999999999 99999999999999999999999999987
Q ss_pred cCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHH-HHhC--------c
Q 008365 378 VPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRA-IEKG--------T 448 (568)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~-~~~~--------~ 448 (568)
+..... .........||+.|+|||++.+..++.++|||||||++|+|++|..||......... +... .
T Consensus 164 ~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (295)
T 3ugc_A 164 LPQDKE---FFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 240 (295)
T ss_dssp ---------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHH
T ss_pred ccCCcc---eeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHH
Confidence 643221 111223456888999999999999999999999999999999999998654321111 1000 0
Q ss_pred c-ccccCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHh
Q 008365 449 L-AEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIV 491 (568)
Q Consensus 449 ~-~~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~ 491 (568)
+ ...........+..++..+.+|+.+||+.+|.+||++.+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 241 LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 0 001111122345667788999999999999999999999873
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=367.38 Aligned_cols=261 Identities=24% Similarity=0.407 Sum_probs=205.2
Q ss_pred hcccccceeecccCceeEEEEEe--CCccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCceeeeccccCCC--ceEEEEe
Q 008365 228 TDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACPDY--GCLVYEY 303 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~--~~lV~E~ 303 (568)
.++|.+.++||+|+||.||+|.+ ++..||||++..........|.+|+.+|+.++||||++++++|.+. .++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 36799999999999999999997 4778999999777667778899999999999999999999998543 4899999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCC
Q 008365 304 MHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVA 383 (568)
Q Consensus 304 ~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~ 383 (568)
+++|+|.+++..... .+++..+..|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+.....
T Consensus 89 ~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 163 (310)
T 3s95_A 89 IKGGTLRGIIKSMDS--QYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT 163 (310)
T ss_dssp CTTCBHHHHHHHCCT--TSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred cCCCcHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence 999999999987543 3899999999999999999999999 99999999999999999999999999987643322
Q ss_pred ccc--------cccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHhCccccccCc
Q 008365 384 DSV--------TQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDP 455 (568)
Q Consensus 384 ~~~--------~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~l~~ 455 (568)
... ........+||+.|+|||++.+..++.++|||||||++|+|++|..||.......... .......++
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~-~~~~~~~~~- 241 (310)
T 3s95_A 164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDF-GLNVRGFLD- 241 (310)
T ss_dssp ----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTS-SBCHHHHHH-
T ss_pred cccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHH-hhhhhcccc-
Confidence 110 0111125689999999999999999999999999999999999999984321100000 000000000
Q ss_pred cCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHHHHHH
Q 008365 456 AVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPELNRLK 498 (568)
Q Consensus 456 ~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l~~L~ 498 (568)
...+..++..+.+|+.+||+.+|.+||++.+++. .|+.++
T Consensus 242 --~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~-~L~~l~ 281 (310)
T 3s95_A 242 --RYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH-WLETLR 281 (310)
T ss_dssp --HTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH-HHHHHH
T ss_pred --ccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH-HHHHHH
Confidence 0124455567999999999999999999999873 334443
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-45 Score=375.24 Aligned_cols=249 Identities=22% Similarity=0.314 Sum_probs=199.2
Q ss_pred hcccccceeecccCceeEEEEEe--CCccEEEEEeCcChh-HhHHHHHHHHHHHHcCCCCceeeeccccCCCc--eEEEE
Q 008365 228 TDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAA-QGKRQFQQEVEVLSSIRHPNMVLLLGACPDYG--CLVYE 302 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~-~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~--~lV~E 302 (568)
.++|++.+.||+|+||.||+|.+ +++.||||++..... ...+.+.+|+.+++.++|||||++++++.+.. ++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 46899999999999999999987 577999999865432 23456889999999999999999999986543 89999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCC
Q 008365 303 YMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSV 382 (568)
Q Consensus 303 ~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~ 382 (568)
||+||+|.+++.... .+++..+..|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+....
T Consensus 86 ~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 159 (323)
T 3tki_A 86 YCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (323)
T ss_dssp CCTTEEGGGGSBTTT---BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred cCCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCC
Confidence 999999999886543 3899999999999999999999999 9999999999999999999999999998653221
Q ss_pred CccccccccccccccccCCChhhhhcCCC-CCcceehhHHHHHHHHHhCCCCCCCchHH---HHHHHhCccccccCccCC
Q 008365 383 ADSVTQYHMTSAAGTFCYIDPEYQQTGML-TTKSDIYSFGIMLLQIITARSPMGLTHHV---SRAIEKGTLAEMLDPAVT 458 (568)
Q Consensus 383 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~-s~ksDvwSlGvil~elltG~~Pf~~~~~~---~~~~~~~~~~~~l~~~~~ 458 (568)
........+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...... ...+.... ...
T Consensus 160 ----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~-------~~~ 228 (323)
T 3tki_A 160 ----RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK-------TYL 228 (323)
T ss_dssp ----EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTC-------TTS
T ss_pred ----cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhccc-------ccC
Confidence 1122345689999999999988775 77899999999999999999999654321 11111110 001
Q ss_pred CCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHH
Q 008365 459 DWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPE 493 (568)
Q Consensus 459 ~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~ 493 (568)
.....++..+.+|+.+||..||.+||++.+++.+.
T Consensus 229 ~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~ 263 (323)
T 3tki_A 229 NPWKKIDSAPLALLHKILVENPSARITIPDIKKDR 263 (323)
T ss_dssp TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCT
T ss_pred CccccCCHHHHHHHHHHccCChhhCcCHHHHhhCh
Confidence 11234567789999999999999999999997543
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-45 Score=373.04 Aligned_cols=255 Identities=24% Similarity=0.349 Sum_probs=202.4
Q ss_pred HhcccccceeecccCceeEEEEEe--CCccEEEEEeCcCh-hHhHHHHHHHHHHHHcCCCCceeeeccccCC--------
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDA-AQGKRQFQQEVEVLSSIRHPNMVLLLGACPD-------- 295 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~-------- 295 (568)
..++|++.+.||+|+||.||+|++ +++.||||++.... ....+.+.+|+.+|+.++|||||+++++|.+
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 83 (332)
T 3qd2_B 4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE 83 (332)
T ss_dssp HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence 456899999999999999999988 57899999986543 3345678999999999999999999987622
Q ss_pred ---------------------------------------------------CceEEEEecCCCCHHHHHhhcCCCCCCCH
Q 008365 296 ---------------------------------------------------YGCLVYEYMHNGSLEDRLLRRGNTPVIPW 324 (568)
Q Consensus 296 ---------------------------------------------------~~~lV~E~~~ggsL~~~l~~~~~~~~l~~ 324 (568)
..++|||||++|+|.+++.........++
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~ 163 (332)
T 3qd2_B 84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH 163 (332)
T ss_dssp HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCH
T ss_pred hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhh
Confidence 14899999999999999988766555677
Q ss_pred HHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCCcccc------ccccccccccc
Q 008365 325 RKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVT------QYHMTSAAGTF 398 (568)
Q Consensus 325 ~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~------~~~~~~~~GT~ 398 (568)
..++.|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+......... .......+||+
T Consensus 164 ~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 240 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred HHHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence 788999999999999999999 999999999999999999999999999877543211110 11234567999
Q ss_pred cCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHhCccccccCccCCCCChHHHHHHHHHHHHhhcc
Q 008365 399 CYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAVTDWPAEAAESFSKLAIQCAEL 478 (568)
Q Consensus 399 ~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~l~~~~~~~p~~~~~~l~~li~~Cl~~ 478 (568)
.|+|||++.+..++.++|||||||++|+|++|..|+.........+.... ....+...+..+.+|+.+||+.
T Consensus 241 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~li~~~l~~ 312 (332)
T 3qd2_B 241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVRIITDVRNLK--------FPLLFTQKYPQEHMMVQDMLSP 312 (332)
T ss_dssp GGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHHHHHHHHHTTC--------CCHHHHHHCHHHHHHHHHHHCS
T ss_pred CccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHHHHHHHhhccC--------CCcccccCChhHHHHHHHHccC
Confidence 99999999999999999999999999999999887632222222222211 1111234556789999999999
Q ss_pred CCCCCCChHHhHhH
Q 008365 479 RKKDRPDLGTVIVP 492 (568)
Q Consensus 479 dP~~RPs~~~vl~~ 492 (568)
+|.+||++.+++.+
T Consensus 313 ~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 313 SPTERPEATDIIEN 326 (332)
T ss_dssp SGGGSCCHHHHHHS
T ss_pred CCCcCCCHHHHhhc
Confidence 99999999999854
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=373.82 Aligned_cols=251 Identities=23% Similarity=0.337 Sum_probs=199.1
Q ss_pred hcccccceeecccCceeEEEEEeCCccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCceeeeccccCCC------ceEEE
Q 008365 228 TDKFSEAMKIGEGGYGPVYRGKLDHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACPDY------GCLVY 301 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~------~~lV~ 301 (568)
.++|++.++||+|+||.||+|++.++.||||++...... ...+..|+.+|+.++|||||+++++|.+. .++||
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~ 101 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQDKQ-SWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLIT 101 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEETTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred hhhchhhheecccCceEEEEEEECCCEEEEEEeecCchH-HHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEE
Confidence 468999999999999999999999999999999765433 34566799999999999999999998542 38999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHc----------CCCCcccCCCCCCCeeccCCceeEecc
Q 008365 302 EYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQA----------KPEPLVHRDLKPANILLDRNYVSKISD 371 (568)
Q Consensus 302 E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~----------~~~~IiHrDIKp~NILld~~~~vKL~D 371 (568)
||+++|+|.+++.... +++..+..|+.||+.||.|||+. + |+||||||+||||+.++.+||+|
T Consensus 102 e~~~~g~L~~~l~~~~----~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~kL~D 174 (322)
T 3soc_A 102 AFHEKGSLSDFLKANV----VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTACIAD 174 (322)
T ss_dssp ECCTTCBHHHHHHHCC----BCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEEECC
T ss_pred ecCCCCCHHHHHHhcC----CCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEEEcc
Confidence 9999999999997643 89999999999999999999998 8 99999999999999999999999
Q ss_pred cccccccCCCCCccccccccccccccccCCChhhhhcC-----CCCCcceehhHHHHHHHHHhCCCCCCCchH-----HH
Q 008365 372 VGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTG-----MLTTKSDIYSFGIMLLQIITARSPMGLTHH-----VS 441 (568)
Q Consensus 372 FGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-----~~s~ksDvwSlGvil~elltG~~Pf~~~~~-----~~ 441 (568)
||+++.+..... .......+||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ..
T Consensus 175 Fg~a~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~ 250 (322)
T 3soc_A 175 FGLALKFEAGKS----AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFE 250 (322)
T ss_dssp CTTCEEECTTSC----CCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTH
T ss_pred CCcccccccccC----ccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchh
Confidence 999987644321 1122346799999999998873 456788999999999999999999953210 00
Q ss_pred ---------HHHHhCccccccCccCCC--CChHHHHHHHHHHHHhhccCCCCCCChHHhH
Q 008365 442 ---------RAIEKGTLAEMLDPAVTD--WPAEAAESFSKLAIQCAELRKKDRPDLGTVI 490 (568)
Q Consensus 442 ---------~~~~~~~~~~~l~~~~~~--~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl 490 (568)
..+..........+.+.. ....++..+.+|+.+||+.||.+||++.+|+
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell 310 (322)
T 3soc_A 251 EEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVG 310 (322)
T ss_dssp HHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred hhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHH
Confidence 000000011111121111 1235677899999999999999999999987
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=372.20 Aligned_cols=247 Identities=26% Similarity=0.473 Sum_probs=201.5
Q ss_pred hcccccceeecccCceeEEEEEeC-----CccEEEEEeCcC-hhHhHHHHHHHHHHHHcCCCCceeeeccccCCC--ceE
Q 008365 228 TDKFSEAMKIGEGGYGPVYRGKLD-----HTPVAIKVLRPD-AAQGKRQFQQEVEVLSSIRHPNMVLLLGACPDY--GCL 299 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~~~~~-----~~~vAvK~l~~~-~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~--~~l 299 (568)
.++|.+.+.||+|+||.||+|.+. +..||||+++.. .......|.+|+.+|+.++||||++++++|.+. .++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 467999999999999999999873 335999999765 344456799999999999999999999998653 489
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccC
Q 008365 300 VYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVP 379 (568)
Q Consensus 300 V~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~ 379 (568)
||||++||+|.+++..... .+++..++.|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+.
T Consensus 128 v~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 202 (325)
T 3kul_A 128 VTEYMENGSLDTFLRTHDG--QFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLE 202 (325)
T ss_dssp EEECCTTCBHHHHHHTTTT--CSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EeeCCCCCcHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence 9999999999999965432 3899999999999999999999999 9999999999999999999999999998765
Q ss_pred CCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh-CCCCCCCchHHH--HHHHhCccccccCcc
Q 008365 380 PSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPMGLTHHVS--RAIEKGTLAEMLDPA 456 (568)
Q Consensus 380 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~--~~~~~~~~~~~l~~~ 456 (568)
..... ........+|+.|+|||++.+..++.++|||||||++|+|++ |..||....... ..+..+ .
T Consensus 203 ~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~--------~ 271 (325)
T 3kul_A 203 DDPDA---AYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEG--------Y 271 (325)
T ss_dssp ----C---CEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTT--------C
T ss_pred cCccc---eeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcC--------C
Confidence 43211 122234567889999999999999999999999999999999 999996544322 222222 1
Q ss_pred CCCCChHHHHHHHHHHHHhhccCCCCCCChHHhH
Q 008365 457 VTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVI 490 (568)
Q Consensus 457 ~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl 490 (568)
....+..++..+.+|+..||..+|.+||++.+|+
T Consensus 272 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil 305 (325)
T 3kul_A 272 RLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIV 305 (325)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 1223455677899999999999999999999987
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-44 Score=376.86 Aligned_cols=250 Identities=27% Similarity=0.433 Sum_probs=205.1
Q ss_pred hcccccceeecccCceeEEEEEeC---------CccEEEEEeCcCh-hHhHHHHHHHHHHHHcC-CCCceeeeccccCC-
Q 008365 228 TDKFSEAMKIGEGGYGPVYRGKLD---------HTPVAIKVLRPDA-AQGKRQFQQEVEVLSSI-RHPNMVLLLGACPD- 295 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~~~~~---------~~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l-~HpnIv~l~g~~~~- 295 (568)
.++|.+.+.||+|+||.||+|.+. +..||||+++... ......+.+|+.+|+.+ +|||||+++++|.+
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 468999999999999999999862 2369999997653 34456789999999999 89999999999855
Q ss_pred -CceEEEEecCCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeec
Q 008365 296 -YGCLVYEYMHNGSLEDRLLRRGN-------------TPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILL 361 (568)
Q Consensus 296 -~~~lV~E~~~ggsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILl 361 (568)
..++||||+++|+|.+++..... ...+++..++.|+.||+.||.|||+.+ |+||||||+||||
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEE
Confidence 44899999999999999987542 124789999999999999999999999 9999999999999
Q ss_pred cCCceeEecccccccccCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh-CCCCCCCchH-
Q 008365 362 DRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPMGLTHH- 439 (568)
Q Consensus 362 d~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~- 439 (568)
+.++.+||+|||+++.+..... ........||+.|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~----~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~ 312 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDY----YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 312 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCT----TCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG
T ss_pred CCCCCEEEccccCCcccCcccc----eecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 9999999999999986643221 112234568899999999999999999999999999999999 9999964322
Q ss_pred -HHHHHHhCccccccCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhH
Q 008365 440 -VSRAIEKGTLAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVP 492 (568)
Q Consensus 440 -~~~~~~~~~~~~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~ 492 (568)
+...+..+. ....|..++..+.+|+.+||+.+|.+||++.+++..
T Consensus 313 ~~~~~~~~~~--------~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 313 ELFKLLKEGH--------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp GHHHHHHTTC--------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHhcCC--------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 222222221 123455667789999999999999999999998743
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=375.85 Aligned_cols=246 Identities=26% Similarity=0.334 Sum_probs=205.8
Q ss_pred hcccccceeecccCceeEEEEEe--CCccEEEEEeCcCh---hHhHHHHHHHHHHHHcCCCCceeeeccccCCC--ceEE
Q 008365 228 TDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDA---AQGKRQFQQEVEVLSSIRHPNMVLLLGACPDY--GCLV 300 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~--~~lV 300 (568)
.++|++++.||+|+||.||+|++ +++.||||++++.. ......+.+|+.+|+.++||||++++++|.+. .|+|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 36799999999999999999987 57899999997642 22345688999999999999999999998654 4899
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCC
Q 008365 301 YEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPP 380 (568)
Q Consensus 301 ~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~ 380 (568)
|||++||+|.+++...+ .+++..+..++.||+.||.|||+.+ |+||||||+||||+.+|.+||+|||+++....
T Consensus 84 ~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 157 (337)
T 1o6l_A 84 MEYANGGELFFHLSRER---VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp EECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred EeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhccc
Confidence 99999999999987754 3889999999999999999999999 99999999999999999999999999975422
Q ss_pred CCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchH--HHHHHHhCccccccCccCC
Q 008365 381 SVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHH--VSRAIEKGTLAEMLDPAVT 458 (568)
Q Consensus 381 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~--~~~~~~~~~~~~~l~~~~~ 458 (568)
.. ......+||+.|+|||++.+..++.++|||||||++|||++|..||..... +...+..+. .
T Consensus 158 ~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~---------~ 222 (337)
T 1o6l_A 158 DG------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE---------I 222 (337)
T ss_dssp TT------CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC---------C
T ss_pred CC------CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCC---------C
Confidence 11 123456899999999999999999999999999999999999999965443 222222221 1
Q ss_pred CCChHHHHHHHHHHHHhhccCCCCCC-----ChHHhHhHHH
Q 008365 459 DWPAEAAESFSKLAIQCAELRKKDRP-----DLGTVIVPEL 494 (568)
Q Consensus 459 ~~p~~~~~~l~~li~~Cl~~dP~~RP-----s~~~vl~~~l 494 (568)
.+|..++..+.+|+.+||+.+|.+|| ++.+|+.|.+
T Consensus 223 ~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~ 263 (337)
T 1o6l_A 223 RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRF 263 (337)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGG
T ss_pred CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCC
Confidence 24556677899999999999999999 8888886654
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=362.61 Aligned_cols=243 Identities=29% Similarity=0.499 Sum_probs=197.6
Q ss_pred cccccceeecccCceeEEEEEeCCccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCceeeeccccCCCceEEEEecCCCC
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKLDHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACPDYGCLVYEYMHNGS 308 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~lV~E~~~ggs 308 (568)
++|++.+.||+|+||.||+|.+.++.||||++.... ..+.|.+|+.+|+.++||||+++++++.+..++||||+++|+
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~lv~e~~~~~~ 85 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESES--ERKAFIVELRQLSRVNHPNIVKLYGACLNPVCLVMEYAEGGS 85 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEETTEEEEEEECSSTT--HHHHHHHHHHHHHHCCCTTBCCEEEBCTTTTEEEEECCTTCB
T ss_pred hHeeeeeEeecCCCceEEEEEECCeeEEEEEecChh--HHHHHHHHHHHHhcCCCCCcCeEEEEEcCCcEEEEEcCCCCC
Confidence 578999999999999999999999999999997543 346789999999999999999999999988999999999999
Q ss_pred HHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCce-eEecccccccccCCCCCcccc
Q 008365 309 LEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYV-SKISDVGLARLVPPSVADSVT 387 (568)
Q Consensus 309 L~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~-vKL~DFGla~~~~~~~~~~~~ 387 (568)
|.+++......+.+++..++.++.||+.||.|||+.++.+|+||||||+||||+.++. +||+|||++..+...
T Consensus 86 L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~------ 159 (307)
T 2eva_A 86 LYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH------ 159 (307)
T ss_dssp HHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-------------
T ss_pred HHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc------
Confidence 9999987655455788999999999999999999943233999999999999988775 799999999754321
Q ss_pred ccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchH----HHHHHHhCccccccCccCCCCChH
Q 008365 388 QYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHH----VSRAIEKGTLAEMLDPAVTDWPAE 463 (568)
Q Consensus 388 ~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~----~~~~~~~~~~~~~l~~~~~~~p~~ 463 (568)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||..... +...+..+ .....+..
T Consensus 160 ---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~--------~~~~~~~~ 228 (307)
T 2eva_A 160 ---MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNG--------TRPPLIKN 228 (307)
T ss_dssp --------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTT--------CCCCCBTT
T ss_pred ---cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcC--------CCCCcccc
Confidence 1334699999999999999999999999999999999999999964321 11111111 11223345
Q ss_pred HHHHHHHHHHHhhccCCCCCCChHHhH
Q 008365 464 AAESFSKLAIQCAELRKKDRPDLGTVI 490 (568)
Q Consensus 464 ~~~~l~~li~~Cl~~dP~~RPs~~~vl 490 (568)
++..+.+|+.+||+.+|.+||++.+++
T Consensus 229 ~~~~l~~li~~~l~~dp~~Rps~~ell 255 (307)
T 2eva_A 229 LPKPIESLMTRCWSKDPSQRPSMEEIV 255 (307)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred cCHHHHHHHHHHhcCChhhCcCHHHHH
Confidence 567799999999999999999999987
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=377.75 Aligned_cols=250 Identities=20% Similarity=0.318 Sum_probs=206.0
Q ss_pred HhcccccceeecccCceeEEEEEe--CCccEEEEEeCcChhH------hHHHHHHHHHHHHcCCCCceeeeccccCCC--
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQ------GKRQFQQEVEVLSSIRHPNMVLLLGACPDY-- 296 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~------~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~-- 296 (568)
+.+.|.+.+.||+|+||.||+|.+ ++..||||+++..... ....+.+|+.+|+.++|||||+++++|.+.
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 457899999999999999999987 5779999999764322 246789999999999999999999998654
Q ss_pred ceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCc----eeEeccc
Q 008365 297 GCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNY----VSKISDV 372 (568)
Q Consensus 297 ~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~----~vKL~DF 372 (568)
.++||||++||+|.+++...+ .+++..+..|+.||+.||.|||+.+ |+||||||+||||+.++ .+||+||
T Consensus 90 ~~lv~e~~~gg~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DF 163 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQKE---SLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (361)
T ss_dssp EEEEEECCCSCBHHHHHTTCS---CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEec
Confidence 489999999999999996543 4899999999999999999999999 99999999999998776 7999999
Q ss_pred ccccccCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHH--HHHHhCccc
Q 008365 373 GLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVS--RAIEKGTLA 450 (568)
Q Consensus 373 Gla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~--~~~~~~~~~ 450 (568)
|+++.+.... .....+||+.|+|||++.+..++.++|||||||++|+|++|..||....... ..+..+..
T Consensus 164 G~a~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~- 235 (361)
T 2yab_A 164 GLAHEIEDGV-------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSY- 235 (361)
T ss_dssp SSCEECCTTC-------CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCC-
T ss_pred CCceEcCCCC-------ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC-
Confidence 9998764321 2245679999999999999999999999999999999999999997554322 22222211
Q ss_pred cccCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 451 EMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 451 ~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
.+++ .++..++..+.+||.+||..||.+||++.+++.|.+
T Consensus 236 -~~~~---~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 275 (361)
T 2yab_A 236 -DFDE---EFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPW 275 (361)
T ss_dssp -CCCH---HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTT
T ss_pred -CCCc---hhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcC
Confidence 0110 111234567899999999999999999999987655
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-44 Score=368.35 Aligned_cols=258 Identities=21% Similarity=0.321 Sum_probs=210.9
Q ss_pred ccCHHHHHHHhc----------ccccceeecccCceeEEEEEe--CCccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCc
Q 008365 218 KYTIEEIEEATD----------KFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPN 285 (568)
Q Consensus 218 ~~~~~ei~~~~~----------~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~Hpn 285 (568)
.++..++..+++ .|...+.||+|+||.||+|.+ +++.||||++........+.+.+|+.+++.++|||
T Consensus 24 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n 103 (321)
T 2c30_A 24 VVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103 (321)
T ss_dssp -CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTT
T ss_pred cCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCC
Confidence 455566655554 377888999999999999987 57899999998766556678899999999999999
Q ss_pred eeeeccccCC--CceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccC
Q 008365 286 MVLLLGACPD--YGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDR 363 (568)
Q Consensus 286 Iv~l~g~~~~--~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~ 363 (568)
|++++++|.. ..++||||++||+|.+++... .+++..+..|+.||+.||.|||+.+ |+||||||+||||+.
T Consensus 104 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~ 176 (321)
T 2c30_A 104 VVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV----RLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTL 176 (321)
T ss_dssp BCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECT
T ss_pred cceEEEEEEECCEEEEEEecCCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECC
Confidence 9999998843 458999999999999988643 3899999999999999999999999 999999999999999
Q ss_pred CceeEecccccccccCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHH
Q 008365 364 NYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRA 443 (568)
Q Consensus 364 ~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~ 443 (568)
++.+||+|||+++.+..... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.........
T Consensus 177 ~~~~kl~Dfg~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~ 250 (321)
T 2c30_A 177 DGRVKLSDFGFCAQISKDVP------KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM 250 (321)
T ss_dssp TCCEEECCCTTCEECCSSSC------CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH
T ss_pred CCcEEEeeeeeeeecccCcc------ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 99999999999987643221 124567999999999999999999999999999999999999999765443221
Q ss_pred --HHhCccccccCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 444 --IEKGTLAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 444 --~~~~~~~~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
+... ..+.. ..+..++..+.+|+.+||+.+|.+||++.+++.+.+
T Consensus 251 ~~~~~~-----~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~ 297 (321)
T 2c30_A 251 KRLRDS-----PPPKL-KNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPF 297 (321)
T ss_dssp HHHHHS-----SCCCC-TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGG
T ss_pred HHHhcC-----CCCCc-CccccCCHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence 1111 11111 113345677999999999999999999999986543
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-44 Score=364.37 Aligned_cols=255 Identities=26% Similarity=0.412 Sum_probs=201.0
Q ss_pred HhcccccceeecccCceeEEEEEe--CCccEEEEEeCcC---hhHhHHHHHHHHHHHHcCCCCceeeeccccCCCc--eE
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPD---AAQGKRQFQQEVEVLSSIRHPNMVLLLGACPDYG--CL 299 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~---~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~--~l 299 (568)
..++|++.+.||+|+||.||+|.+ .+..||||++... .......+.+|+.+++.++||||+++++++.+.. ++
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 88 (294)
T 4eqm_A 9 INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYL 88 (294)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEE
T ss_pred hhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEE
Confidence 346899999999999999999987 5678999998543 3344567899999999999999999999986544 89
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccC
Q 008365 300 VYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVP 379 (568)
Q Consensus 300 V~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~ 379 (568)
||||++||+|.+++...+ .+++..+..|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+.
T Consensus 89 v~e~~~g~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 162 (294)
T 4eqm_A 89 VMEYIEGPTLSEYIESHG---PLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALS 162 (294)
T ss_dssp EEECCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC-
T ss_pred EEeCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCccccc
Confidence 999999999999998764 3899999999999999999999999 9999999999999999999999999998654
Q ss_pred CCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHhCccccccCccCCC
Q 008365 380 PSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAVTD 459 (568)
Q Consensus 380 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~l~~~~~~ 459 (568)
... .......+||+.|+|||++.+..++.++|||||||++|+|++|+.||............ +..........
T Consensus 163 ~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~--~~~~~~~~~~~ 235 (294)
T 4eqm_A 163 ETS-----LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKH--IQDSVPNVTTD 235 (294)
T ss_dssp -----------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHH--HSSCCCCHHHH
T ss_pred ccc-----ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH--hhccCCCcchh
Confidence 321 11223467999999999999999999999999999999999999999766554332211 11111111112
Q ss_pred CChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 460 WPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 460 ~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
.+..++..+.+++.+||+.+|.+||+..+.+.+.|
T Consensus 236 ~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l 270 (294)
T 4eqm_A 236 VRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDL 270 (294)
T ss_dssp SCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHH
T ss_pred cccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHH
Confidence 34456678999999999999999996555554333
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-44 Score=376.04 Aligned_cols=247 Identities=23% Similarity=0.314 Sum_probs=200.7
Q ss_pred HhcccccceeecccCceeEEEEEe--CCccEEEEEeCcCh---hHhHHHHHHHHHHHHcC-CCCceeeeccccCCC--ce
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDA---AQGKRQFQQEVEVLSSI-RHPNMVLLLGACPDY--GC 298 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l-~HpnIv~l~g~~~~~--~~ 298 (568)
..++|++++.||+|+||.||+|++ +++.||||++++.. ......+.+|+.+|..+ +|||||+++++|.+. .|
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 100 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF 100 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence 347899999999999999999987 56799999997642 22345678999999988 699999999998654 48
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEeccccccccc
Q 008365 299 LVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLV 378 (568)
Q Consensus 299 lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~ 378 (568)
||||||+||+|.+++...+. +++..+..|+.||+.||.|||+.+ |+||||||+||||+.+|.+||+|||+|+..
T Consensus 101 lv~E~~~gg~L~~~l~~~~~---~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~ 174 (353)
T 3txo_A 101 FVMEFVNGGDLMFHIQKSRR---FDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEG 174 (353)
T ss_dssp EEEECCCSCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred EEEeCCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeec
Confidence 99999999999999987643 899999999999999999999999 999999999999999999999999999753
Q ss_pred CCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHH--HHHHHhCccccccCcc
Q 008365 379 PPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHV--SRAIEKGTLAEMLDPA 456 (568)
Q Consensus 379 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~--~~~~~~~~~~~~l~~~ 456 (568)
... .......+||+.|+|||++.+..++.++|||||||++|||++|+.||...... ...+..+.
T Consensus 175 ~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~-------- 240 (353)
T 3txo_A 175 ICN------GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDE-------- 240 (353)
T ss_dssp CC---------------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--------
T ss_pred ccC------CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCC--------
Confidence 221 12234578999999999999999999999999999999999999999765432 22232221
Q ss_pred CCCCChHHHHHHHHHHHHhhccCCCCCCCh------HHhHhHHH
Q 008365 457 VTDWPAEAAESFSKLAIQCAELRKKDRPDL------GTVIVPEL 494 (568)
Q Consensus 457 ~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~------~~vl~~~l 494 (568)
..+|..++..+.+|+.+||..+|.+||++ .+++.|.+
T Consensus 241 -~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~ 283 (353)
T 3txo_A 241 -VVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPF 283 (353)
T ss_dssp -CCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGG
T ss_pred -CCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCc
Confidence 12344566779999999999999999998 66765544
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=368.91 Aligned_cols=259 Identities=25% Similarity=0.416 Sum_probs=201.1
Q ss_pred HhcccccceeecccCceeEEEEEe--CCccEEEEEeCcCh---hHhHHHHHHHHHHHHcCCCCceeeeccccCCC--c--
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDA---AQGKRQFQQEVEVLSSIRHPNMVLLLGACPDY--G-- 297 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~--~-- 297 (568)
..++|++.+.||+|+||.||+|.+ +++.||||++.... ......+.+|+.+++.++||||+++++++... .
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 89 (311)
T 3ork_A 10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 89 (311)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence 457899999999999999999996 67799999997653 23345788999999999999999999987432 2
Q ss_pred --eEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccc
Q 008365 298 --CLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLA 375 (568)
Q Consensus 298 --~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla 375 (568)
|+||||++||+|.+++...+ .+++..++.|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++
T Consensus 90 ~~~lv~e~~~g~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a 163 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIA 163 (311)
T ss_dssp EEEEEEECCCEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred ccEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence 89999999999999998764 3889999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHhCccccccCc
Q 008365 376 RLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDP 455 (568)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~l~~ 455 (568)
+.+..... .........||+.|+|||++.+..++.++|||||||++|+|++|+.||............... ....+
T Consensus 164 ~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~-~~~~~ 239 (311)
T 3ork_A 164 RAIADSGN---SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVRE-DPIPP 239 (311)
T ss_dssp ---------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHC-CCCCH
T ss_pred cccccccc---ccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcC-CCCCc
Confidence 86643221 111223467999999999999999999999999999999999999999765543322111000 00000
Q ss_pred cCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHHHHH
Q 008365 456 AVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPELNRL 497 (568)
Q Consensus 456 ~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l~~L 497 (568)
...+..++..+.+|+.+||+.||.+||+..+++.+.+.++
T Consensus 240 --~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 240 --SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp --HHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred --ccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 0012235667999999999999999999999987776554
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-44 Score=368.84 Aligned_cols=249 Identities=29% Similarity=0.480 Sum_probs=204.9
Q ss_pred HhcccccceeecccCceeEEEEEeCC-------ccEEEEEeCcCh-hHhHHHHHHHHHHHHcCCCCceeeeccccCC--C
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKLDH-------TPVAIKVLRPDA-AQGKRQFQQEVEVLSSIRHPNMVLLLGACPD--Y 296 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~~~-------~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--~ 296 (568)
..++|.+.+.||+|+||.||+|.+.+ +.||||+++... ......+.+|+.+++.++||||++++++|.+ .
T Consensus 45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 124 (343)
T 1luf_A 45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 124 (343)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCc
Confidence 45789999999999999999998754 689999997653 3345678999999999999999999999854 4
Q ss_pred ceEEEEecCCCCHHHHHhhcCC---------------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCC
Q 008365 297 GCLVYEYMHNGSLEDRLLRRGN---------------------TPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLK 355 (568)
Q Consensus 297 ~~lV~E~~~ggsL~~~l~~~~~---------------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIK 355 (568)
.++||||+++|+|.+++..... ...+++..++.|+.||+.||.|||+.+ |+|||||
T Consensus 125 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlk 201 (343)
T 1luf_A 125 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLA 201 (343)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCS
T ss_pred eEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCC
Confidence 5899999999999999987432 135899999999999999999999999 9999999
Q ss_pred CCCeeccCCceeEecccccccccCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh-CCCCC
Q 008365 356 PANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPM 434 (568)
Q Consensus 356 p~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf 434 (568)
|+||||+.++.+||+|||+++.+.... .........||+.|+|||++.+..++.++|||||||++|+|++ |..||
T Consensus 202 p~NIl~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 277 (343)
T 1luf_A 202 TRNCLVGENMVVKIADFGLSRNIYSAD----YYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 277 (343)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGG----CBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred cceEEECCCCeEEEeecCCCcccccCc----cccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcC
Confidence 999999999999999999997653221 1112234578999999999999999999999999999999999 99999
Q ss_pred CCchH--HHHHHHhCccccccCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhH
Q 008365 435 GLTHH--VSRAIEKGTLAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVI 490 (568)
Q Consensus 435 ~~~~~--~~~~~~~~~~~~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl 490 (568)
..... +...+..+. ....|..++..+.+|+.+||+.+|.+||++.+++
T Consensus 278 ~~~~~~~~~~~~~~~~--------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~ 327 (343)
T 1luf_A 278 YGMAHEEVIYYVRDGN--------ILACPENCPLELYNLMRLCWSKLPADRPSFCSIH 327 (343)
T ss_dssp TTSCHHHHHHHHHTTC--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CCCChHHHHHHHhCCC--------cCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHH
Confidence 65443 222222222 2234556677899999999999999999999986
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=357.86 Aligned_cols=251 Identities=24% Similarity=0.381 Sum_probs=195.3
Q ss_pred HhcccccceeecccCceeEEEEEeC-----CccEEEEEeCcCh-hHhHHHHHHHHHHHHcCCCCceeeeccccCC-CceE
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKLD-----HTPVAIKVLRPDA-AQGKRQFQQEVEVLSSIRHPNMVLLLGACPD-YGCL 299 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~~-----~~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~-~~~l 299 (568)
..++|++.+.||+|+||.||+|.+. +..||||++.... ....+.+.+|+.+++.++||||+++++++.+ ..++
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~l 92 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWI 92 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSCEE
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEccCccEE
Confidence 4578999999999999999999873 3469999987643 3445678999999999999999999999854 4489
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccC
Q 008365 300 VYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVP 379 (568)
Q Consensus 300 V~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~ 379 (568)
||||+++|+|.+++..... .+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+.
T Consensus 93 v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 167 (281)
T 1mp8_A 93 IMELCTLGELRSFLQVRKY--SLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME 167 (281)
T ss_dssp EEECCTTEEHHHHHHHTTT--TSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EEecCCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccccccccC
Confidence 9999999999999976542 3889999999999999999999999 9999999999999999999999999998764
Q ss_pred CCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh-CCCCCCCchH--HHHHHHhCccccccCcc
Q 008365 380 PSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPMGLTHH--VSRAIEKGTLAEMLDPA 456 (568)
Q Consensus 380 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~--~~~~~~~~~~~~~l~~~ 456 (568)
... ........+|+.|+|||++.+..++.++|||||||++|+|++ |..||..... ....+..+.
T Consensus 168 ~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~-------- 234 (281)
T 1mp8_A 168 DST-----YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE-------- 234 (281)
T ss_dssp ----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC--------
T ss_pred ccc-----ccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCC--------
Confidence 321 112234567889999999999999999999999999999997 9999965432 222222221
Q ss_pred CCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHHH
Q 008365 457 VTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPELN 495 (568)
Q Consensus 457 ~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l~ 495 (568)
....+..++..+.+++.+||+.+|.+||++.+++..+..
T Consensus 235 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~ 273 (281)
T 1mp8_A 235 RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLST 273 (281)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 123345667789999999999999999999998754433
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-44 Score=371.83 Aligned_cols=264 Identities=27% Similarity=0.407 Sum_probs=211.4
Q ss_pred cCHHHHHHHhcccccceeecccCceeEEEEEe-------CCccEEEEEeCcCh-hHhHHHHHHHHHHHHcC-CCCceeee
Q 008365 219 YTIEEIEEATDKFSEAMKIGEGGYGPVYRGKL-------DHTPVAIKVLRPDA-AQGKRQFQQEVEVLSSI-RHPNMVLL 289 (568)
Q Consensus 219 ~~~~ei~~~~~~y~~~~~IG~G~fg~Vy~~~~-------~~~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l-~HpnIv~l 289 (568)
+...+.+...++|.+.+.||+|+||.||+|.+ .++.||||+++... ......+.+|+.+|..+ +|||||++
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence 44455555678999999999999999999984 23689999997653 33456789999999999 79999999
Q ss_pred ccccCCC---ceEEEEecCCCCHHHHHhhcCC------------------------------------------------
Q 008365 290 LGACPDY---GCLVYEYMHNGSLEDRLLRRGN------------------------------------------------ 318 (568)
Q Consensus 290 ~g~~~~~---~~lV~E~~~ggsL~~~l~~~~~------------------------------------------------ 318 (568)
+++|.+. .++|||||++|+|.+++.....
T Consensus 92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (359)
T 3vhe_A 92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171 (359)
T ss_dssp EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence 9998542 5899999999999999976542
Q ss_pred ---------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCC
Q 008365 319 ---------------TPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVA 383 (568)
Q Consensus 319 ---------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~ 383 (568)
...+++..++.|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+....
T Consensus 172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~- 247 (359)
T 3vhe_A 172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDP- 247 (359)
T ss_dssp ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT-
T ss_pred ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeecccc-
Confidence 122889999999999999999999999 9999999999999999999999999998653322
Q ss_pred ccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh-CCCCCCCch---HHHHHHHhCccccccCccCCC
Q 008365 384 DSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPMGLTH---HVSRAIEKGTLAEMLDPAVTD 459 (568)
Q Consensus 384 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~---~~~~~~~~~~~~~~l~~~~~~ 459 (568)
.........||+.|+|||++.+..++.++|||||||++|+|++ |..||.... .+...+..+. ...
T Consensus 248 ---~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~--------~~~ 316 (359)
T 3vhe_A 248 ---DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT--------RMR 316 (359)
T ss_dssp ---TCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTC--------CCC
T ss_pred ---cchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCC--------CCC
Confidence 1122345678999999999999999999999999999999998 999996532 2222222221 112
Q ss_pred CChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHHHHH
Q 008365 460 WPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPELNRL 497 (568)
Q Consensus 460 ~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l~~L 497 (568)
.+..++..+.+++..||+.+|.+||++.+|+.++-..+
T Consensus 317 ~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 354 (359)
T 3vhe_A 317 APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 354 (359)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence 34455677999999999999999999999986544333
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-43 Score=361.49 Aligned_cols=259 Identities=21% Similarity=0.277 Sum_probs=208.4
Q ss_pred hcccccceeecccCceeEEEEEeC--CccEEEEEeCcCh-hHhHHHHHHHHHHHHcCCCCceeeeccccCC----CceEE
Q 008365 228 TDKFSEAMKIGEGGYGPVYRGKLD--HTPVAIKVLRPDA-AQGKRQFQQEVEVLSSIRHPNMVLLLGACPD----YGCLV 300 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~~~~~--~~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~----~~~lV 300 (568)
.++|.+.+.||+|+||.||+|.+. ++.||||++.... ......+.+|+.+|+.++||||+++++++.+ ..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 467999999999999999999984 7799999997643 2335667899999999999999999998743 34899
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeec----cCCceeEeccccccc
Q 008365 301 YEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILL----DRNYVSKISDVGLAR 376 (568)
Q Consensus 301 ~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILl----d~~~~vKL~DFGla~ 376 (568)
|||+++|+|.+++........+++..++.|+.||+.||.|||+.+ |+||||||+|||| +.++.+||+|||+++
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 999999999999987655445899999999999999999999999 9999999999999 888999999999998
Q ss_pred ccCCCCCccccccccccccccccCCChhhhh--------cCCCCCcceehhHHHHHHHHHhCCCCCCCch------HHHH
Q 008365 377 LVPPSVADSVTQYHMTSAAGTFCYIDPEYQQ--------TGMLTTKSDIYSFGIMLLQIITARSPMGLTH------HVSR 442 (568)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~--------~~~~s~ksDvwSlGvil~elltG~~Pf~~~~------~~~~ 442 (568)
.+.... ......||+.|+|||++. +..++.++|||||||++|+|++|+.||.... .+..
T Consensus 165 ~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~ 237 (319)
T 4euu_A 165 ELEDDE-------QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMY 237 (319)
T ss_dssp ECCTTC-------CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHH
T ss_pred ecCCCC-------ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHH
Confidence 764332 123457999999999886 5779999999999999999999999995211 1111
Q ss_pred HHHhCccccc----------------cCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHHHH
Q 008365 443 AIEKGTLAEM----------------LDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPELNR 496 (568)
Q Consensus 443 ~~~~~~~~~~----------------l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l~~ 496 (568)
.+..+..... .-+.....+..++..+.+|+.+||+.||.+||++.+++.+..+.
T Consensus 238 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~ 307 (319)
T 4euu_A 238 KIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (319)
T ss_dssp HHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred HHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence 1211111000 00111134578889999999999999999999999998776543
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=354.76 Aligned_cols=246 Identities=27% Similarity=0.472 Sum_probs=204.0
Q ss_pred hcccccceeecccCceeEEEEEe-CCccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCceeeeccccCCC--ceEEEEec
Q 008365 228 TDKFSEAMKIGEGGYGPVYRGKL-DHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACPDY--GCLVYEYM 304 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~~~~-~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~--~~lV~E~~ 304 (568)
.++|++.+.||+|+||.||+|.+ ++..||||++...... .+.+.+|+.++++++||||++++++|.+. .++||||+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 87 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBC-HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccC-HHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence 36799999999999999999998 6678999999865433 35789999999999999999999998654 48999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCCc
Q 008365 305 HNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVAD 384 (568)
Q Consensus 305 ~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~~ 384 (568)
++++|.+++..... .+++..++.|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 88 ~~~~L~~~l~~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-- 160 (269)
T 4hcu_A 88 EHGCLSDYLRTQRG--LFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-- 160 (269)
T ss_dssp TTCBHHHHHHTTTT--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH--
T ss_pred CCCcHHHHHHhcCc--ccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEeccccccccccccc--
Confidence 99999999976443 4899999999999999999999999 9999999999999999999999999998653321
Q ss_pred cccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh-CCCCCCCchHHH--HHHHhCccccccCccCCCCC
Q 008365 385 SVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPMGLTHHVS--RAIEKGTLAEMLDPAVTDWP 461 (568)
Q Consensus 385 ~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~--~~~~~~~~~~~l~~~~~~~p 461 (568)
........||+.|+|||++.+..++.++|||||||++|+|++ |..||....... ..+..+ .....+
T Consensus 161 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~--------~~~~~~ 229 (269)
T 4hcu_A 161 ---YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG--------FRLYKP 229 (269)
T ss_dssp ---HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT--------CCCCCC
T ss_pred ---cccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcC--------ccCCCC
Confidence 112234567889999999999999999999999999999999 999997554322 222221 111223
Q ss_pred hHHHHHHHHHHHHhhccCCCCCCChHHhHhH
Q 008365 462 AEAAESFSKLAIQCAELRKKDRPDLGTVIVP 492 (568)
Q Consensus 462 ~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~ 492 (568)
..++..+.+++..||+.+|.+||++.+++.+
T Consensus 230 ~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 230 RLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CcCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 4456779999999999999999999998743
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-44 Score=368.44 Aligned_cols=250 Identities=20% Similarity=0.307 Sum_probs=204.4
Q ss_pred HhcccccceeecccCceeEEEEEe--CCccEEEEEeCcChhH------hHHHHHHHHHHHHcCCCCceeeeccccCCC--
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQ------GKRQFQQEVEVLSSIRHPNMVLLLGACPDY-- 296 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~------~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~-- 296 (568)
..+.|.+.+.||+|+||.||+|.+ ++..||||++...... ....+.+|+.+|+.++|||||+++++|.+.
T Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 88 (326)
T 2y0a_A 9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 88 (326)
T ss_dssp HHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 456799999999999999999987 4779999998654321 356789999999999999999999998654
Q ss_pred ceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCc----eeEeccc
Q 008365 297 GCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNY----VSKISDV 372 (568)
Q Consensus 297 ~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~----~vKL~DF 372 (568)
.++||||+++|+|.+++...+ .+++..+..|+.||+.||.|||+.+ |+||||||+||||+.++ .+||+||
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Df 162 (326)
T 2y0a_A 89 VILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDF 162 (326)
T ss_dssp EEEEEECCCSCBHHHHHTTSS---CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEEEcCCCCCHHHHHHhcC---CcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEEC
Confidence 489999999999999986543 4899999999999999999999999 99999999999998877 8999999
Q ss_pred ccccccCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHH--HHHHhCccc
Q 008365 373 GLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVS--RAIEKGTLA 450 (568)
Q Consensus 373 Gla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~--~~~~~~~~~ 450 (568)
|+++.+.... .....+||+.|+|||++.+..++.++|||||||++|+|++|..||....... ..+.....
T Consensus 163 g~a~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~- 234 (326)
T 2y0a_A 163 GLAHKIDFGN-------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNY- 234 (326)
T ss_dssp TTCEECCTTS-------CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCC-
T ss_pred CCCeECCCCC-------ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCC-
Confidence 9998764321 1234679999999999999999999999999999999999999996544322 12222111
Q ss_pred cccCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 451 EMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 451 ~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
.+.. ..+..++..+.+|+.+||..+|.+||++.+++.|.+
T Consensus 235 -~~~~---~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~ 274 (326)
T 2y0a_A 235 -EFED---EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPW 274 (326)
T ss_dssp -CCCH---HHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTT
T ss_pred -CcCc---cccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence 0000 111234567899999999999999999999987554
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=370.94 Aligned_cols=255 Identities=21% Similarity=0.288 Sum_probs=204.8
Q ss_pred HhcccccceeecccCceeEEEEEe--CCccEEEEEeCcChhH-----hHHHHHHHHHHHHcCCCCceeeeccccCCC--c
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQ-----GKRQFQQEVEVLSSIRHPNMVLLLGACPDY--G 297 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~-----~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~--~ 297 (568)
..+.|++.+.||+|+||.||+|.+ +++.||||++...... ....+.+|+.+++.++|||||+++++|.+. .
T Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 101 (351)
T 3c0i_A 22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGML 101 (351)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 446799999999999999999987 5789999998643221 356789999999999999999999998543 4
Q ss_pred eEEEEecCCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCc---eeEecccc
Q 008365 298 CLVYEYMHNGSLEDRLLRRG-NTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNY---VSKISDVG 373 (568)
Q Consensus 298 ~lV~E~~~ggsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~---~vKL~DFG 373 (568)
++|||||+||+|.+.+.... ....+++..+..|+.||+.||.|||+.+ |+||||||+||||+.++ .+||+|||
T Consensus 102 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg 178 (351)
T 3c0i_A 102 YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFG 178 (351)
T ss_dssp EEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCT
T ss_pred EEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCc
Confidence 89999999999988876532 2234889999999999999999999999 99999999999997654 49999999
Q ss_pred cccccCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchH-HHHHHHhCccccc
Q 008365 374 LARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHH-VSRAIEKGTLAEM 452 (568)
Q Consensus 374 la~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~-~~~~~~~~~~~~~ 452 (568)
+++.+.... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||..... +...+..+...
T Consensus 179 ~a~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~i~~~~~~-- 250 (351)
T 3c0i_A 179 VAIQLGESG------LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGKYK-- 250 (351)
T ss_dssp TCEECCTTS------CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHHHHHHHHHTCCC--
T ss_pred ceeEecCCC------eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHHHHHHHHcCCCC--
Confidence 998764321 122456799999999999999999999999999999999999999976433 22222222211
Q ss_pred cCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHHH
Q 008365 453 LDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPELN 495 (568)
Q Consensus 453 l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l~ 495 (568)
+.+. ....++..+.+|+.+||..||.+||++.+++.|.+-
T Consensus 251 ~~~~---~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~ 290 (351)
T 3c0i_A 251 MNPR---QWSHISESAKDLVRRMLMLDPAERITVYEALNHPWL 290 (351)
T ss_dssp CCHH---HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred CCcc---ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhh
Confidence 0000 012345679999999999999999999999987653
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=368.40 Aligned_cols=246 Identities=23% Similarity=0.304 Sum_probs=202.4
Q ss_pred hcccccceeecccCceeEEEEEe--CCccEEEEEeCcCh---hHhHHHHHHHHHHHHcC-CCCceeeeccccCCC--ceE
Q 008365 228 TDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDA---AQGKRQFQQEVEVLSSI-RHPNMVLLLGACPDY--GCL 299 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l-~HpnIv~l~g~~~~~--~~l 299 (568)
.++|.+++.||+|+||.||+|++ +++.||||++++.. ......+.+|+.+|..+ +|||||+++++|.+. .++
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 87 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 87 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence 35799999999999999999987 46789999997642 33345688999999987 899999999998654 489
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccC
Q 008365 300 VYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVP 379 (568)
Q Consensus 300 V~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~ 379 (568)
||||++||+|.+++...+ .+++..+..++.||+.||.|||+.+ |+||||||+||||+.+|.+||+|||+++...
T Consensus 88 v~e~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~ 161 (345)
T 3a8x_A 88 VIEYVNGGDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 161 (345)
T ss_dssp EECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSC
T ss_pred EEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEecccccccc
Confidence 999999999999997754 3899999999999999999999999 9999999999999999999999999997532
Q ss_pred CCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCch-----------HHHHHHHhCc
Q 008365 380 PSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTH-----------HVSRAIEKGT 448 (568)
Q Consensus 380 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~-----------~~~~~~~~~~ 448 (568)
... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.... .+...+...
T Consensus 162 ~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~- 234 (345)
T 3a8x_A 162 RPG------DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK- 234 (345)
T ss_dssp CTT------CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHC-
T ss_pred CCC------CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcC-
Confidence 211 12345689999999999999999999999999999999999999996421 111222221
Q ss_pred cccccCccCCCCChHHHHHHHHHHHHhhccCCCCCCCh------HHhHhHHH
Q 008365 449 LAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDL------GTVIVPEL 494 (568)
Q Consensus 449 ~~~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~------~~vl~~~l 494 (568)
...+|..++..+.+|+.+||..+|.+||++ .+++.|.+
T Consensus 235 --------~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~ 278 (345)
T 3a8x_A 235 --------QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPF 278 (345)
T ss_dssp --------CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGG
T ss_pred --------CCCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCc
Confidence 123455667789999999999999999996 56665443
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=370.94 Aligned_cols=251 Identities=22% Similarity=0.328 Sum_probs=206.3
Q ss_pred HHhcccccceeecccCceeEEEEEe--CCccEEEEEeCcCh--hHhHHHHHHHHHHHHcCCCCceeeeccccCCC--ceE
Q 008365 226 EATDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDA--AQGKRQFQQEVEVLSSIRHPNMVLLLGACPDY--GCL 299 (568)
Q Consensus 226 ~~~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~--~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~--~~l 299 (568)
.+.++|.+.+.||+|+||.||+|.+ ++..||||++.... ......+.+|+.+|+.++|||||+++++|.+. .++
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l 105 (362)
T 2bdw_A 26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 105 (362)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 3567899999999999999999987 47799999996542 33456788999999999999999999998654 489
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCC---ceeEeccccccc
Q 008365 300 VYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRN---YVSKISDVGLAR 376 (568)
Q Consensus 300 V~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~---~~vKL~DFGla~ 376 (568)
|||||+||+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+||||+.+ +.+||+|||+++
T Consensus 106 v~e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~ 179 (362)
T 2bdw_A 106 VFDLVTGGELFEDIVARE---FYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAI 179 (362)
T ss_dssp EECCCCSCBHHHHHTTCS---CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCB
T ss_pred EEecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcce
Confidence 999999999999887643 3889999999999999999999999 9999999999999754 469999999998
Q ss_pred ccCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchH--HHHHHHhCccccccC
Q 008365 377 LVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHH--VSRAIEKGTLAEMLD 454 (568)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~--~~~~~~~~~~~~~l~ 454 (568)
.+.... .....+||+.|+|||++.+..++.++|||||||++|+|++|.+||..... +...+..+.... ..
T Consensus 180 ~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~-~~ 251 (362)
T 2bdw_A 180 EVNDSE-------AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDY-PS 251 (362)
T ss_dssp CCTTCC-------SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC-CT
T ss_pred EecCCc-------ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCC-Cc
Confidence 664321 12356899999999999999999999999999999999999999965443 223333332210 00
Q ss_pred ccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 455 PAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 455 ~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
+ ....++..+.+|+.+||..||.+||++.+++.+.+
T Consensus 252 ~----~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 287 (362)
T 2bdw_A 252 P----EWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPW 287 (362)
T ss_dssp T----GGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHH
T ss_pred c----cccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcc
Confidence 1 11345677999999999999999999999987755
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=366.24 Aligned_cols=243 Identities=27% Similarity=0.370 Sum_probs=204.8
Q ss_pred hcccccceeecccCceeEEEEEe--CCccEEEEEeCcChh---HhHHHHHHHHHHHHcCCCCceeeeccccCCC--ceEE
Q 008365 228 TDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAA---QGKRQFQQEVEVLSSIRHPNMVLLLGACPDY--GCLV 300 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~---~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~--~~lV 300 (568)
.++|++.+.||+|+||.||+|++ +++.||||++++... .....+.+|+.+|+.++|||||+++++|.+. .++|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 36799999999999999999987 578999999976432 2345678999999999999999999998654 4899
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCC
Q 008365 301 YEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPP 380 (568)
Q Consensus 301 ~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~ 380 (568)
|||++||+|.+++...+ .+++..+..++.||+.||.|||+.+ |+||||||+||||+.+|.+||+|||+++....
T Consensus 85 ~e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~ 158 (318)
T 1fot_A 85 MDYIEGGELFSLLRKSQ---RFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD 158 (318)
T ss_dssp ECCCCSCBHHHHHHHTS---SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred EeCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence 99999999999998754 3889999999999999999999999 99999999999999999999999999986532
Q ss_pred CCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHH--HHHHhCccccccCccCC
Q 008365 381 SVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVS--RAIEKGTLAEMLDPAVT 458 (568)
Q Consensus 381 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~--~~~~~~~~~~~l~~~~~ 458 (568)
. ....+||+.|+|||++.+..++.++|||||||++|||++|..||....... ..+..+. .
T Consensus 159 ~---------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~---------~ 220 (318)
T 1fot_A 159 V---------TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAE---------L 220 (318)
T ss_dssp C---------BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCC---------C
T ss_pred c---------cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC---------C
Confidence 1 235689999999999999999999999999999999999999997554322 2222221 1
Q ss_pred CCChHHHHHHHHHHHHhhccCCCCCC-----ChHHhHhHHH
Q 008365 459 DWPAEAAESFSKLAIQCAELRKKDRP-----DLGTVIVPEL 494 (568)
Q Consensus 459 ~~p~~~~~~l~~li~~Cl~~dP~~RP-----s~~~vl~~~l 494 (568)
.+|..++..+.+|+.+||..+|.+|| ++.+++.|.+
T Consensus 221 ~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~ 261 (318)
T 1fot_A 221 RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPW 261 (318)
T ss_dssp CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGG
T ss_pred CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCcc
Confidence 23455667899999999999999999 7888876544
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=377.21 Aligned_cols=246 Identities=23% Similarity=0.308 Sum_probs=201.5
Q ss_pred hcccccceeecccCceeEEEEEe--CCccEEEEEeCcChhH---hHHHHHHHHHHHHcC-CCCceeeeccccCCC--ceE
Q 008365 228 TDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQ---GKRQFQQEVEVLSSI-RHPNMVLLLGACPDY--GCL 299 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~---~~~~~~~Ev~iL~~l-~HpnIv~l~g~~~~~--~~l 299 (568)
.++|+++++||+|+||.||+|++ +++.||||++++.... ....+..|..+|..+ +|||||+++++|.+. .+|
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 46799999999999999999987 4678999999765322 234578899999876 899999999998654 489
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccC
Q 008365 300 VYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVP 379 (568)
Q Consensus 300 V~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~ 379 (568)
|||||+||+|.+++...+ .+++..+..|+.||+.||.|||+.+ |+||||||+||||+.+|.+||+|||+|+...
T Consensus 131 V~E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~ 204 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 204 (396)
T ss_dssp EEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEcCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence 999999999999998764 3899999999999999999999999 9999999999999999999999999997532
Q ss_pred CCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchH-----------HHHHHHhCc
Q 008365 380 PSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHH-----------VSRAIEKGT 448 (568)
Q Consensus 380 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~-----------~~~~~~~~~ 448 (568)
.. .......+||+.|+|||++.+..++.++|||||||++|||++|+.||..... +...+...
T Consensus 205 ~~------~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~- 277 (396)
T 4dc2_A 205 RP------GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK- 277 (396)
T ss_dssp CT------TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHC-
T ss_pred cC------CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcc-
Confidence 21 1123467899999999999999999999999999999999999999953211 11222211
Q ss_pred cccccCccCCCCChHHHHHHHHHHHHhhccCCCCCCCh------HHhHhHHH
Q 008365 449 LAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDL------GTVIVPEL 494 (568)
Q Consensus 449 ~~~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~------~~vl~~~l 494 (568)
...+|..++..+.+||.+||+.||.+||++ .+|+.|.+
T Consensus 278 --------~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpf 321 (396)
T 4dc2_A 278 --------QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPF 321 (396)
T ss_dssp --------CCCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTT
T ss_pred --------ccCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCcc
Confidence 123455677789999999999999999995 56654443
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-44 Score=368.62 Aligned_cols=251 Identities=19% Similarity=0.280 Sum_probs=206.1
Q ss_pred HhcccccceeecccCceeEEEEEe--CCccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCceeeeccccCC--CceEEEE
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACPD--YGCLVYE 302 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--~~~lV~E 302 (568)
+.++|.+.+.||+|+||.||+|.+ ++..||+|++.... .....+.+|+.+|+.++||||++++++|.+ ..++|||
T Consensus 3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 81 (321)
T 1tki_A 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEE
Confidence 357899999999999999999987 46789999997654 334568899999999999999999999854 4489999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccC--CceeEecccccccccCC
Q 008365 303 YMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDR--NYVSKISDVGLARLVPP 380 (568)
Q Consensus 303 ~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~--~~~vKL~DFGla~~~~~ 380 (568)
||+||+|.+++..... .+++..+..|+.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+++.+..
T Consensus 82 ~~~g~~L~~~l~~~~~--~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~ 156 (321)
T 1tki_A 82 FISGLDIFERINTSAF--ELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp CCCCCBHHHHHTSSSC--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred eCCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCC
Confidence 9999999999865432 3899999999999999999999999 999999999999987 78999999999987643
Q ss_pred CCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHH--HHHHHhCccccccCccCC
Q 008365 381 SVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHV--SRAIEKGTLAEMLDPAVT 458 (568)
Q Consensus 381 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~--~~~~~~~~~~~~l~~~~~ 458 (568)
.. ......||+.|+|||++.+..++.++|||||||++|+|++|..||...... ...+..+... ++.
T Consensus 157 ~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~--~~~--- 224 (321)
T 1tki_A 157 GD-------NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYT--FDE--- 224 (321)
T ss_dssp TC-------EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCC--CCH---
T ss_pred CC-------ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCC--CCh---
Confidence 21 123467999999999999988999999999999999999999999654432 2222222210 000
Q ss_pred CCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHHH
Q 008365 459 DWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPELN 495 (568)
Q Consensus 459 ~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l~ 495 (568)
.....++..+.+|+.+||..||.+||++.+++.|.+-
T Consensus 225 ~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~ 261 (321)
T 1tki_A 225 EAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWL 261 (321)
T ss_dssp HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHH
T ss_pred hhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhh
Confidence 0012345679999999999999999999999987763
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-44 Score=371.60 Aligned_cols=247 Identities=23% Similarity=0.353 Sum_probs=205.2
Q ss_pred hcccccceeecccCceeEEEEEe--CCccEEEEEeCcChhH---hHHHHHHHHHHHHcCCCCceeeeccccCCC--ceEE
Q 008365 228 TDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQ---GKRQFQQEVEVLSSIRHPNMVLLLGACPDY--GCLV 300 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~---~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~--~~lV 300 (568)
.++|.+.+.||+|+||.||+|.+ +++.||||++...... ....+.+|+.+|+.++||||++++++|.+. .++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 46899999999999999999997 6779999998754322 234688999999999999999999998654 4899
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCC
Q 008365 301 YEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPP 380 (568)
Q Consensus 301 ~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~ 380 (568)
|||+ +|+|.+++...+ .+++..+..|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++..+..
T Consensus 88 ~E~~-~g~l~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~ 160 (336)
T 3h4j_B 88 IEYA-GGELFDYIVEKK---RMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTD 160 (336)
T ss_dssp ECCC-CEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTT
T ss_pred EECC-CCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccC
Confidence 9999 789999887764 3899999999999999999999999 99999999999999999999999999986543
Q ss_pred CCCccccccccccccccccCCChhhhhcCCC-CCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHhCccccccCccCCC
Q 008365 381 SVADSVTQYHMTSAAGTFCYIDPEYQQTGML-TTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAVTD 459 (568)
Q Consensus 381 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~-s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~l~~~~~~ 459 (568)
.. .....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||..... ..+...+......
T Consensus 161 ~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~-------~~~~~~i~~~~~~ 226 (336)
T 3h4j_B 161 GN-------FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFI-------PNLFKKVNSCVYV 226 (336)
T ss_dssp SB-------TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSS-------TTCBCCCCSSCCC
T ss_pred Cc-------ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccH-------HHHHHHHHcCCCC
Confidence 21 2245679999999999988776 7899999999999999999999954321 1112222222234
Q ss_pred CChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHHH
Q 008365 460 WPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPELN 495 (568)
Q Consensus 460 ~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l~ 495 (568)
.|..++..+.+|+.+||..||.+||++.+++.+.+-
T Consensus 227 ~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~ 262 (336)
T 3h4j_B 227 MPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWF 262 (336)
T ss_dssp CCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHH
T ss_pred CcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhh
Confidence 466677889999999999999999999999987764
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=370.25 Aligned_cols=243 Identities=22% Similarity=0.327 Sum_probs=205.6
Q ss_pred hcccccceeecccCceeEEEEEe--CCccEEEEEeCcChh---HhHHHHHHHHHHHHcCCCCceeeeccccCCC--ceEE
Q 008365 228 TDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAA---QGKRQFQQEVEVLSSIRHPNMVLLLGACPDY--GCLV 300 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~---~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~--~~lV 300 (568)
.++|.+++.||+|+||.||+|++ ++..||||++.+... .....+.+|+.+|+.++||||++++++|.+. .++|
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 36799999999999999999987 577999999975432 2345688999999999999999999998654 4899
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCC
Q 008365 301 YEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPP 380 (568)
Q Consensus 301 ~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~ 380 (568)
|||++||+|.+++...+. +++..+..|+.||+.||.|||+.+ |+||||||+||||+.+|.+||+|||+++.+..
T Consensus 120 ~e~~~gg~L~~~l~~~~~---~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~ 193 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp EECCTTCBHHHHHHHHCC---CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EcCCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccC
Confidence 999999999999987643 889999999999999999999999 99999999999999999999999999986532
Q ss_pred CCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHH--HHHHHhCccccccCccCC
Q 008365 381 SVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHV--SRAIEKGTLAEMLDPAVT 458 (568)
Q Consensus 381 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~--~~~~~~~~~~~~l~~~~~ 458 (568)
. ....+||+.|+|||++.+..++.++|||||||++|+|++|..||...... ...+..+. .
T Consensus 194 ~---------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~---------~ 255 (350)
T 1rdq_E 194 R---------TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK---------V 255 (350)
T ss_dssp C---------BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC---------C
T ss_pred C---------cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCC---------C
Confidence 2 23467999999999999999999999999999999999999999755432 22233322 1
Q ss_pred CCChHHHHHHHHHHHHhhccCCCCCCC-----hHHhHhHHH
Q 008365 459 DWPAEAAESFSKLAIQCAELRKKDRPD-----LGTVIVPEL 494 (568)
Q Consensus 459 ~~p~~~~~~l~~li~~Cl~~dP~~RPs-----~~~vl~~~l 494 (568)
.+|..++..+.+|+.+||+.||.+||+ +.+|+.|.+
T Consensus 256 ~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~ 296 (350)
T 1rdq_E 256 RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKW 296 (350)
T ss_dssp CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGG
T ss_pred CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcC
Confidence 234556678999999999999999998 788775544
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=357.41 Aligned_cols=250 Identities=27% Similarity=0.507 Sum_probs=194.8
Q ss_pred HhcccccceeecccCceeEEEEEeCCccEEEEEeCcCh--hHhHHHHHHHHHHHHcCCCCceeeeccccCC-CceEEEEe
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKLDHTPVAIKVLRPDA--AQGKRQFQQEVEVLSSIRHPNMVLLLGACPD-YGCLVYEY 303 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~~~~~vAvK~l~~~~--~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~-~~~lV~E~ 303 (568)
..++|.+.++||+|+||.||+|.+.+ .||||+++... ....+.|.+|+.+|+.++||||+++++++.+ ..++||||
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~~-~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~lv~e~ 100 (289)
T 3og7_A 22 PDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQLAIVTQW 100 (289)
T ss_dssp CTTSCEEEEEEEECSSEEEEEEESSS-EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEEEC
T ss_pred CccceeeeeEecCCCCeEEEEEEEcC-ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeeccCCccEEEEEe
Confidence 45689999999999999999998765 49999997543 3445678999999999999999999998754 44899999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCC
Q 008365 304 MHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVA 383 (568)
Q Consensus 304 ~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~ 383 (568)
+++++|.+++..... .+++..++.|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++......
T Consensus 101 ~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 174 (289)
T 3og7_A 101 CEGSSLYHHLHASET--KFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWS- 174 (289)
T ss_dssp CCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC----------
T ss_pred cCCCcHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceecccccccc-
Confidence 999999999865432 4899999999999999999999999 9999999999999999999999999997653221
Q ss_pred ccccccccccccccccCCChhhhh---cCCCCCcceehhHHHHHHHHHhCCCCCCCchH---HHHHHHhCccccccCccC
Q 008365 384 DSVTQYHMTSAAGTFCYIDPEYQQ---TGMLTTKSDIYSFGIMLLQIITARSPMGLTHH---VSRAIEKGTLAEMLDPAV 457 (568)
Q Consensus 384 ~~~~~~~~~~~~GT~~Y~APE~~~---~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~---~~~~~~~~~~~~~l~~~~ 457 (568)
.........||+.|+|||++. +..++.++|||||||++|+|++|+.||..... +...+..+.. .+..
T Consensus 175 ---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~----~~~~ 247 (289)
T 3og7_A 175 ---GSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSL----SPDL 247 (289)
T ss_dssp ------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSC----CCCT
T ss_pred ---ccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhccccc----Ccch
Confidence 111224467999999999886 66788999999999999999999999965433 2233333322 2233
Q ss_pred CCCChHHHHHHHHHHHHhhccCCCCCCChHHhH
Q 008365 458 TDWPAEAAESFSKLAIQCAELRKKDRPDLGTVI 490 (568)
Q Consensus 458 ~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl 490 (568)
...+..++..+.+|+.+||+.+|.+||++.+++
T Consensus 248 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell 280 (289)
T 3og7_A 248 SKVRSNCPKRMKRLMAECLKKKRDERPSFPRIL 280 (289)
T ss_dssp TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred hhccccCCHHHHHHHHHHccCChhhCCCHHHHH
Confidence 334456677899999999999999999999986
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=352.44 Aligned_cols=245 Identities=31% Similarity=0.521 Sum_probs=195.0
Q ss_pred hcccccceeecccCceeEEEEEeCCccEEEEEeCcChh----HhHHHHHHHHHHHHcCCCCceeeeccccCCC--ceEEE
Q 008365 228 TDKFSEAMKIGEGGYGPVYRGKLDHTPVAIKVLRPDAA----QGKRQFQQEVEVLSSIRHPNMVLLLGACPDY--GCLVY 301 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~~~~~~~~vAvK~l~~~~~----~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~--~~lV~ 301 (568)
.++|.+.+.||+|+||.||+|.+.++.||||+++.... ...+.+.+|+.+++.++||||++++++|.+. .++||
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVM 85 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEETTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEcCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEE
Confidence 36799999999999999999999999999999876432 2246788999999999999999999998654 48999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccC--------CceeEecccc
Q 008365 302 EYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDR--------NYVSKISDVG 373 (568)
Q Consensus 302 E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~--------~~~vKL~DFG 373 (568)
||+++++|.+++... .+++..+..|+.||+.||.|||+.+..+|+||||||+||||+. ++.+||+|||
T Consensus 86 e~~~~~~L~~~~~~~----~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg 161 (271)
T 3dtc_A 86 EFARGGPLNRVLSGK----RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG 161 (271)
T ss_dssp ECCTTEEHHHHHTSS----CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCC
T ss_pred EcCCCCCHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCC
Confidence 999999999988532 3899999999999999999999998555889999999999986 7789999999
Q ss_pred cccccCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHH--HhCcccc
Q 008365 374 LARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAI--EKGTLAE 451 (568)
Q Consensus 374 la~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~--~~~~~~~ 451 (568)
+++.+.... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.......... ....
T Consensus 162 ~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--- 230 (271)
T 3dtc_A 162 LAREWHRTT--------KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNK--- 230 (271)
T ss_dssp C---------------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSC---
T ss_pred ccccccccc--------ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCC---
Confidence 997653321 124579999999999999999999999999999999999999997654432221 1111
Q ss_pred ccCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHh
Q 008365 452 MLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIV 491 (568)
Q Consensus 452 ~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~ 491 (568)
.....+..++..+.+++.+||+.+|.+||++.+++.
T Consensus 231 ----~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 266 (271)
T 3dtc_A 231 ----LALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILD 266 (271)
T ss_dssp ----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----CCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 112234556678999999999999999999999874
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=355.70 Aligned_cols=251 Identities=24% Similarity=0.412 Sum_probs=202.6
Q ss_pred HhcccccceeecccCceeEEEEEeCC-ccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCceeeeccccCCC--ceEEEEe
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKLDH-TPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACPDY--GCLVYEY 303 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~~~-~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~--~~lV~E~ 303 (568)
..++|.+.+.||+|+||.||+|.+.+ ..||||++...... ...+.+|+.+++.++||||++++++|.+. .++||||
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 100 (283)
T 3gen_A 22 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 100 (283)
T ss_dssp CGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBC-HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECC
T ss_pred CHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCC-HHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEec
Confidence 34689999999999999999998854 58999999865433 35788999999999999999999998654 4899999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCC
Q 008365 304 MHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVA 383 (568)
Q Consensus 304 ~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~ 383 (568)
+++|+|.+++..... .+++..++.|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++......
T Consensus 101 ~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~- 174 (283)
T 3gen_A 101 MANGCLLNYLREMRH--RFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE- 174 (283)
T ss_dssp CTTCBHHHHHHCGGG--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH-
T ss_pred cCCCcHHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEccccccccccccc-
Confidence 999999999976332 3899999999999999999999999 9999999999999999999999999998653321
Q ss_pred ccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh-CCCCCCCchHHHH--HHHhCccccccCccCCCC
Q 008365 384 DSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPMGLTHHVSR--AIEKGTLAEMLDPAVTDW 460 (568)
Q Consensus 384 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~~--~~~~~~~~~~l~~~~~~~ 460 (568)
........||+.|+|||++.+..++.++|||||||++|+|++ |+.||........ .+..+ . ....
T Consensus 175 ----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~-----~---~~~~ 242 (283)
T 3gen_A 175 ----YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG-----L---RLYR 242 (283)
T ss_dssp ----HHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTT-----C---CCCC
T ss_pred ----cccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcc-----c---CCCC
Confidence 112234567889999999999999999999999999999998 9999975543222 22221 1 1122
Q ss_pred ChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHHHH
Q 008365 461 PAEAAESFSKLAIQCAELRKKDRPDLGTVIVPELNR 496 (568)
Q Consensus 461 p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l~~ 496 (568)
+..++..+.+|+.+||+.+|.+||++.+++.++.+.
T Consensus 243 ~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~ 278 (283)
T 3gen_A 243 PHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 278 (283)
T ss_dssp CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 334457799999999999999999999998655443
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=364.31 Aligned_cols=252 Identities=22% Similarity=0.399 Sum_probs=191.5
Q ss_pred HhcccccceeecccCceeEEEEEeCCc-----cEEEEEeCcC--hhHhHHHHHHHHHHHHcCCCCceeeeccccCCC--c
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKLDHT-----PVAIKVLRPD--AAQGKRQFQQEVEVLSSIRHPNMVLLLGACPDY--G 297 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~~~~-----~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~--~ 297 (568)
..++|.+.+.||+|+||.||+|.+... .||||+++.. .......+.+|+.+++.++||||+++++++.+. .
T Consensus 21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (323)
T 3qup_A 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK 100 (323)
T ss_dssp C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence 456899999999999999999987432 7999999765 234456789999999999999999999988432 2
Q ss_pred ------eEEEEecCCCCHHHHHhhcCC---CCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeE
Q 008365 298 ------CLVYEYMHNGSLEDRLLRRGN---TPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSK 368 (568)
Q Consensus 298 ------~lV~E~~~ggsL~~~l~~~~~---~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vK 368 (568)
++||||+++|+|.+++..... ...+++..+..|+.||+.||.|||+.+ |+||||||+||||+.++.+|
T Consensus 101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~~k 177 (323)
T 3qup_A 101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVC 177 (323)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEE
T ss_pred cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCCEE
Confidence 899999999999999865421 224899999999999999999999999 99999999999999999999
Q ss_pred ecccccccccCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh-CCCCCCCchH--HHHHHH
Q 008365 369 ISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPMGLTHH--VSRAIE 445 (568)
Q Consensus 369 L~DFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~--~~~~~~ 445 (568)
|+|||+++.+..... ........+|+.|+|||.+.+..++.++|||||||++|+|++ |..||..... +...+.
T Consensus 178 l~Dfg~a~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~ 253 (323)
T 3qup_A 178 VADFGLSRKIYSGDY----YRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLI 253 (323)
T ss_dssp ECCCCC---------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH
T ss_pred Eeecccccccccccc----ccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHh
Confidence 999999986543221 112234567889999999999999999999999999999999 9999965432 222222
Q ss_pred hCccccccCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHH
Q 008365 446 KGTLAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPE 493 (568)
Q Consensus 446 ~~~~~~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~ 493 (568)
.+. ....+..++..+.+|+.+||+.+|.+||++.+++..+
T Consensus 254 ~~~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l 293 (323)
T 3qup_A 254 GGN--------RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMEL 293 (323)
T ss_dssp TTC--------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred cCC--------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 211 1233455667899999999999999999999987433
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=364.61 Aligned_cols=251 Identities=20% Similarity=0.249 Sum_probs=198.8
Q ss_pred hcccccceeecccCceeEEEEEe--CCccEEEEEeCcChhHhHHHHHHHHHHHHcC-CCCceeeeccccCC--CceEEEE
Q 008365 228 TDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQGKRQFQQEVEVLSSI-RHPNMVLLLGACPD--YGCLVYE 302 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l-~HpnIv~l~g~~~~--~~~lV~E 302 (568)
.++|.+.+.||+|+||.||+|.+ +++.||||++..... ...+.+|+.+++.+ +||||+++++++.+ ..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 46899999999999999999995 678999999865432 23578999999999 89999999998754 3489999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCce-----eEecccccccc
Q 008365 303 YMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYV-----SKISDVGLARL 377 (568)
Q Consensus 303 ~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~-----vKL~DFGla~~ 377 (568)
|+ +++|.+++..... .+++..++.|+.||+.||.|||+.+ |+||||||+||||+.++. +||+|||+++.
T Consensus 86 ~~-~~~L~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~ 159 (330)
T 2izr_A 86 LL-GPSLEDLFDLCDR--TFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159 (330)
T ss_dssp CC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred eC-CCCHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence 99 9999999986532 4899999999999999999999999 999999999999998887 99999999987
Q ss_pred cCCCCCcc-ccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCch--HHH---HHHHhCcccc
Q 008365 378 VPPSVADS-VTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTH--HVS---RAIEKGTLAE 451 (568)
Q Consensus 378 ~~~~~~~~-~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~--~~~---~~~~~~~~~~ 451 (568)
+....... .........+||+.|+|||++.+..++.++|||||||++|||++|..||.... ... ..+.......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~ 239 (330)
T 2izr_A 160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRAT 239 (330)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHS
T ss_pred eecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccC
Confidence 64432211 11112346789999999999999999999999999999999999999996521 111 1111111100
Q ss_pred ccCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHh
Q 008365 452 MLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIV 491 (568)
Q Consensus 452 ~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~ 491 (568)
... .....++ .+.+|+..||+.+|.+||++.+|+.
T Consensus 240 ~~~----~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 240 PIE----VLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp CHH----HHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred CHH----HHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 000 0011234 7999999999999999999999874
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=375.42 Aligned_cols=250 Identities=18% Similarity=0.300 Sum_probs=206.9
Q ss_pred HhcccccceeecccCceeEEEEEe--CCccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCceeeeccccCCC--ceEEEE
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACPDY--GCLVYE 302 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~--~~lV~E 302 (568)
..++|.+.+.||+|+||.||+|.+ ++..||+|++..........+.+|+.+|+.++|||||+++++|.+. .++|||
T Consensus 49 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E 128 (387)
T 1kob_A 49 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE 128 (387)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred cccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEE
Confidence 457899999999999999999987 5678999999876655667889999999999999999999998654 489999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccC--CceeEecccccccccCC
Q 008365 303 YMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDR--NYVSKISDVGLARLVPP 380 (568)
Q Consensus 303 ~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~--~~~vKL~DFGla~~~~~ 380 (568)
||+||+|.+++..... .+++..+..|+.||+.||.|||+.+ |+||||||+||||+. ++.+||+|||+++.+..
T Consensus 129 ~~~gg~L~~~l~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~ 203 (387)
T 1kob_A 129 FLSGGELFDRIAAEDY--KMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 203 (387)
T ss_dssp CCCCCBHHHHTTCTTC--CBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred cCCCCcHHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCC
Confidence 9999999998865432 3899999999999999999999999 999999999999974 57899999999987643
Q ss_pred CCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHH--HHHhCccccccCccCC
Q 008365 381 SVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSR--AIEKGTLAEMLDPAVT 458 (568)
Q Consensus 381 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~--~~~~~~~~~~l~~~~~ 458 (568)
.. .....+||+.|+|||++.+..++.++|||||||++|+|++|..||........ .+..... .++ .
T Consensus 204 ~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~--~~~---~ 271 (387)
T 1kob_A 204 DE-------IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDW--EFD---E 271 (387)
T ss_dssp TS-------CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCC--CCC---S
T ss_pred Cc-------ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC--CCC---c
Confidence 21 12345799999999999999999999999999999999999999976554322 2222211 111 1
Q ss_pred CCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHH
Q 008365 459 DWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPE 493 (568)
Q Consensus 459 ~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~ 493 (568)
.....++..+.+||.+||..||.+||++.+++.+.
T Consensus 272 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp 306 (387)
T 1kob_A 272 DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHP 306 (387)
T ss_dssp STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTST
T ss_pred cccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCc
Confidence 12234567799999999999999999999998544
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=357.49 Aligned_cols=245 Identities=29% Similarity=0.528 Sum_probs=200.8
Q ss_pred hcccccceeecccCceeEEEEEe--CCccEEEEEeCcChhHh-------HHHHHHHHHHHHcCCCCceeeeccccCCCce
Q 008365 228 TDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQG-------KRQFQQEVEVLSSIRHPNMVLLLGACPDYGC 298 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~-------~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~ 298 (568)
.++|.+.+.||+|+||.||+|.+ +++.||||++....... .+.+.+|+.+++.++||||+++++++.+..+
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 97 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPR 97 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTTE
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCCe
Confidence 46899999999999999999988 57789999986543211 1578899999999999999999999998889
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCce-----eEecccc
Q 008365 299 LVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYV-----SKISDVG 373 (568)
Q Consensus 299 lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~-----vKL~DFG 373 (568)
+||||+++|+|.+++..... .+++..+..|+.||+.||.|||+.+ .+|+||||||+||||+.++. +||+|||
T Consensus 98 lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg 174 (287)
T 4f0f_A 98 MVMEFVPCGDLYHRLLDKAH--PIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADFG 174 (287)
T ss_dssp EEEECCTTCBHHHHHHCTTS--CCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECCCT
T ss_pred EEEEecCCCCHHHHHhcccC--CccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCCCC
Confidence 99999999999998876543 4899999999999999999999986 35999999999999987776 9999999
Q ss_pred cccccCCCCCccccccccccccccccCCChhhh--hcCCCCCcceehhHHHHHHHHHhCCCCCCCchH--H--HHHHHhC
Q 008365 374 LARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQ--QTGMLTTKSDIYSFGIMLLQIITARSPMGLTHH--V--SRAIEKG 447 (568)
Q Consensus 374 la~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~--~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~--~--~~~~~~~ 447 (568)
+++.... ......||+.|+|||++ ....++.++|||||||++|+|++|+.||..... . ...+...
T Consensus 175 ~~~~~~~---------~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~ 245 (287)
T 4f0f_A 175 LSQQSVH---------SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREE 245 (287)
T ss_dssp TCBCCSS---------CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHS
T ss_pred ccccccc---------cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhcc
Confidence 9974422 12346799999999988 445578999999999999999999999964322 1 1111111
Q ss_pred ccccccCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHh
Q 008365 448 TLAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIV 491 (568)
Q Consensus 448 ~~~~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~ 491 (568)
.. ....+..++..+.+|+..||+.+|.+||++.+++.
T Consensus 246 ~~-------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 246 GL-------RPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp CC-------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CC-------CCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 11 12334566778999999999999999999999873
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-44 Score=373.28 Aligned_cols=247 Identities=25% Similarity=0.316 Sum_probs=204.8
Q ss_pred HhcccccceeecccCceeEEEEEe--CCccEEEEEeCcChh---HhHHHHHHHHHHHHcC-CCCceeeeccccCCC--ce
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAA---QGKRQFQQEVEVLSSI-RHPNMVLLLGACPDY--GC 298 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~---~~~~~~~~Ev~iL~~l-~HpnIv~l~g~~~~~--~~ 298 (568)
..++|.+.+.||+|+||.||+|++ +++.||||++++... .....+..|..+|..+ +||||++++++|.+. .|
T Consensus 15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~ 94 (345)
T 1xjd_A 15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLF 94 (345)
T ss_dssp -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEE
Confidence 457899999999999999999997 567899999976432 2345677899999876 899999999998654 48
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEeccccccccc
Q 008365 299 LVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLV 378 (568)
Q Consensus 299 lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~ 378 (568)
+||||++||+|.+++...+ .+++..+..++.||+.||.|||+.+ |+||||||+||||+.+|.+||+|||+++..
T Consensus 95 lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 168 (345)
T 1xjd_A 95 FVMEYLNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKEN 168 (345)
T ss_dssp EEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhhhc
Confidence 9999999999999998754 3889999999999999999999999 999999999999999999999999999754
Q ss_pred CCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHH--HHHHHhCccccccCcc
Q 008365 379 PPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHV--SRAIEKGTLAEMLDPA 456 (568)
Q Consensus 379 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~--~~~~~~~~~~~~l~~~ 456 (568)
.... ......+||+.|+|||++.+..++.++|||||||++|||++|..||...... ...+..+.
T Consensus 169 ~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~-------- 234 (345)
T 1xjd_A 169 MLGD------AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN-------- 234 (345)
T ss_dssp CCTT------CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--------
T ss_pred ccCC------CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCC--------
Confidence 3211 1234578999999999999999999999999999999999999999755432 22222221
Q ss_pred CCCCChHHHHHHHHHHHHhhccCCCCCCChH-HhHhHHH
Q 008365 457 VTDWPAEAAESFSKLAIQCAELRKKDRPDLG-TVIVPEL 494 (568)
Q Consensus 457 ~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~-~vl~~~l 494 (568)
..+|..++..+.+|+.+||..+|.+||++. +|+.|.+
T Consensus 235 -~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~ 272 (345)
T 1xjd_A 235 -PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPL 272 (345)
T ss_dssp -CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGG
T ss_pred -CCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCcc
Confidence 123455667899999999999999999998 7765543
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=365.03 Aligned_cols=248 Identities=26% Similarity=0.458 Sum_probs=197.8
Q ss_pred hcccccceeecccCceeEEEEEe--CCc----cEEEEEeCcCh-hHhHHHHHHHHHHHHcCCCCceeeeccccCCC-ceE
Q 008365 228 TDKFSEAMKIGEGGYGPVYRGKL--DHT----PVAIKVLRPDA-AQGKRQFQQEVEVLSSIRHPNMVLLLGACPDY-GCL 299 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~~~~--~~~----~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~-~~l 299 (568)
.++|.+.+.||+|+||.||+|.+ ++. .||+|.+.... ......|.+|+.+++.++|||||+++++|.+. .++
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 93 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQL 93 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSSEEE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEE
Confidence 36799999999999999999987 333 36888875432 23456789999999999999999999998554 479
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccC
Q 008365 300 VYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVP 379 (568)
Q Consensus 300 V~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~ 379 (568)
||+|+.+|+|.+++..... .+++..++.|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+.
T Consensus 94 v~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 168 (327)
T 3poz_A 94 ITQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp EEECCTTCBHHHHHHHSTT--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred EEEecCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence 9999999999999987543 3899999999999999999999999 9999999999999999999999999998764
Q ss_pred CCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh-CCCCCCCch--HHHHHHHhCccccccCcc
Q 008365 380 PSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPMGLTH--HVSRAIEKGTLAEMLDPA 456 (568)
Q Consensus 380 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~--~~~~~~~~~~~~~~l~~~ 456 (568)
.... ........||+.|+|||++.+..++.++|||||||++|+|++ |..||.... .+...+..+.
T Consensus 169 ~~~~----~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~-------- 236 (327)
T 3poz_A 169 AEEK----EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE-------- 236 (327)
T ss_dssp TTCC-----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC--------
T ss_pred CCcc----cccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCC--------
Confidence 4321 122234567899999999999999999999999999999999 999996533 2333333221
Q ss_pred CCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhH
Q 008365 457 VTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVP 492 (568)
Q Consensus 457 ~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~ 492 (568)
....+..++..+.+|+.+||+.+|.+||++.+++.+
T Consensus 237 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 237 RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp CCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred CCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 112345566789999999999999999999998754
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=379.53 Aligned_cols=252 Identities=21% Similarity=0.329 Sum_probs=206.3
Q ss_pred HHhcccccceeecccCceeEEEEEe--CCccEEEEEeCcCh--hHhHHHHHHHHHHHHcCCCCceeeeccccCCC--ceE
Q 008365 226 EATDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDA--AQGKRQFQQEVEVLSSIRHPNMVLLLGACPDY--GCL 299 (568)
Q Consensus 226 ~~~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~--~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~--~~l 299 (568)
...++|.+.+.||+|+||.||+|.+ ++..||+|++.... ......+.+|+.+|+.++|||||+++++|.+. .++
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 87 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL 87 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence 3567899999999999999999987 67899999986543 33456789999999999999999999998654 489
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeecc---CCceeEeccccccc
Q 008365 300 VYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLD---RNYVSKISDVGLAR 376 (568)
Q Consensus 300 V~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld---~~~~vKL~DFGla~ 376 (568)
|||||+||+|.+.+...+ .+++..+..|+.||+.||.|||+.+ |+||||||+||||+ .++.+||+|||+++
T Consensus 88 v~E~~~gg~L~~~i~~~~---~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~ 161 (444)
T 3soa_A 88 IFDLVTGGELFEDIVARE---YYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAI 161 (444)
T ss_dssp EECCCBCCBHHHHHHHCS---CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCB
T ss_pred EEEeCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeE
Confidence 999999999999988764 3899999999999999999999999 99999999999998 46889999999998
Q ss_pred ccCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchH--HHHHHHhCccccccC
Q 008365 377 LVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHH--VSRAIEKGTLAEMLD 454 (568)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~--~~~~~~~~~~~~~l~ 454 (568)
.+.... ......+||+.|+|||++.+..++.++|||||||++|+|++|.+||..... +...+..+... ...
T Consensus 162 ~~~~~~------~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~-~~~ 234 (444)
T 3soa_A 162 EVEGEQ------QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYD-FPS 234 (444)
T ss_dssp CCCTTC------CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC-CCT
T ss_pred EecCCC------ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCC-CCc
Confidence 664321 122456899999999999999999999999999999999999999965443 33333333221 111
Q ss_pred ccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 455 PAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 455 ~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
+ . ...++..+.+|+..||+.||.+||++.+++.|.+
T Consensus 235 ~---~-~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~ 270 (444)
T 3soa_A 235 P---E-WDTVTPEAKDLINKMLTINPSKRITAAEALKHPW 270 (444)
T ss_dssp T---T-TTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCT
T ss_pred c---c-cccCCHHHHHHHHHHcCCChhHCCCHHHHhcCcc
Confidence 1 1 1245677999999999999999999999987654
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-44 Score=362.05 Aligned_cols=248 Identities=24% Similarity=0.370 Sum_probs=195.0
Q ss_pred HhcccccceeecccCceeEEEEEeCCccEEEEEeCcChhHhHHHHHHHHHHHHc--CCCCceeeeccccCC------Cce
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKLDHTPVAIKVLRPDAAQGKRQFQQEVEVLSS--IRHPNMVLLLGACPD------YGC 298 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~--l~HpnIv~l~g~~~~------~~~ 298 (568)
..++|.+.+.||+|+||.||+|.++++.||||++.... ...+..|.+++.. ++||||+++++++.+ ..+
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~ 82 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRD---EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW 82 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEETTEEEEEEEECGGG---HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEECCEEEEEEEecccc---chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence 45789999999999999999999999999999997543 3445566777666 899999999988632 248
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH--------HcCCCCcccCCCCCCCeeccCCceeEec
Q 008365 299 LVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLH--------QAKPEPLVHRDLKPANILLDRNYVSKIS 370 (568)
Q Consensus 299 lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH--------~~~~~~IiHrDIKp~NILld~~~~vKL~ 370 (568)
+||||+++|+|.+++... .+++..++.|+.||+.||.||| +.+ |+||||||+||||+.++.+||+
T Consensus 83 lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl~ 155 (301)
T 3q4u_A 83 LITHYHEMGSLYDYLQLT----TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCIA 155 (301)
T ss_dssp EEECCCTTCBHHHHHTTC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEEC
T ss_pred EehhhccCCCHHHHHhhc----ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEEe
Confidence 999999999999999543 3899999999999999999999 777 9999999999999999999999
Q ss_pred ccccccccCCCCCccccccccccccccccCCChhhhhcC------CCCCcceehhHHHHHHHHHhC----------CCCC
Q 008365 371 DVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTG------MLTTKSDIYSFGIMLLQIITA----------RSPM 434 (568)
Q Consensus 371 DFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~------~~s~ksDvwSlGvil~elltG----------~~Pf 434 (568)
|||+++........ ........+||+.|+|||++.+. .++.++|||||||++|||++| ..||
T Consensus 156 Dfg~a~~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf 233 (301)
T 3q4u_A 156 DLGLAVMHSQSTNQ--LDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPF 233 (301)
T ss_dssp CCTTCEEEETTTTE--EECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred eCCCeeeccccccc--ccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccc
Confidence 99999765433211 11122345899999999999877 455799999999999999999 8888
Q ss_pred CCc-------hHHHHHHHhCccccccCccCC--CCChHHHHHHHHHHHHhhccCCCCCCChHHhH
Q 008365 435 GLT-------HHVSRAIEKGTLAEMLDPAVT--DWPAEAAESFSKLAIQCAELRKKDRPDLGTVI 490 (568)
Q Consensus 435 ~~~-------~~~~~~~~~~~~~~~l~~~~~--~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl 490 (568)
... ......+... ...+... ..+..++..+.+|+.+||+.+|.+||++.+|+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~ 294 (301)
T 3q4u_A 234 YDVVPNDPSFEDMRKVVCVD----QQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIK 294 (301)
T ss_dssp TTTSCSSCCHHHHHHHHTTS----CCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHH
T ss_pred cccCCCCcchhhhhHHHhcc----CCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHH
Confidence 432 1111111111 1111111 12345788999999999999999999999987
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-44 Score=375.90 Aligned_cols=247 Identities=28% Similarity=0.439 Sum_probs=203.0
Q ss_pred HhcccccceeecccCceeEEEEEe--CCccEEEEEeCcCh-hHhHHHHHHHHHHHHcCCCCceeeeccccCC--CceEEE
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDA-AQGKRQFQQEVEVLSSIRHPNMVLLLGACPD--YGCLVY 301 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--~~~lV~ 301 (568)
..++|.+.+.||+|+||.||+|.+ +++.||||+++... ......|.+|+.+|+.++|||||+++++|.+ ..++||
T Consensus 112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 191 (377)
T 3cbl_A 112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVM 191 (377)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEE
Confidence 346899999999999999999998 47899999997653 2334568899999999999999999999865 358999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCC
Q 008365 302 EYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPS 381 (568)
Q Consensus 302 E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~ 381 (568)
||+++|+|.+++...+. .+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.....
T Consensus 192 e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~ 266 (377)
T 3cbl_A 192 ELVQGGDFLTFLRTEGA--RLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADG 266 (377)
T ss_dssp ECCTTCBHHHHHHHHGG--GCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTTS
T ss_pred EcCCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCCC
Confidence 99999999999976543 3889999999999999999999999 999999999999999999999999999864322
Q ss_pred CCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh-CCCCCCCchH--HHHHHHhCccccccCccCC
Q 008365 382 VADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPMGLTHH--VSRAIEKGTLAEMLDPAVT 458 (568)
Q Consensus 382 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~--~~~~~~~~~~~~~l~~~~~ 458 (568)
.. ........+++.|+|||++.++.++.++|||||||++|||++ |..||..... +...+..+. ..
T Consensus 267 ~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~--------~~ 334 (377)
T 3cbl_A 267 VY----AASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGG--------RL 334 (377)
T ss_dssp EE----ECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTC--------CC
T ss_pred ce----eecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC--------CC
Confidence 11 111122346788999999999999999999999999999998 9999975443 222222221 12
Q ss_pred CCChHHHHHHHHHHHHhhccCCCCCCChHHhH
Q 008365 459 DWPAEAAESFSKLAIQCAELRKKDRPDLGTVI 490 (568)
Q Consensus 459 ~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl 490 (568)
..|..++..+.+|+.+||+.+|.+||++.+|+
T Consensus 335 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~ 366 (377)
T 3cbl_A 335 PCPELCPDAVFRLMEQCWAYEPGQRPSFSTIY 366 (377)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHH
Confidence 23555677899999999999999999999986
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=373.05 Aligned_cols=251 Identities=24% Similarity=0.389 Sum_probs=203.2
Q ss_pred hcccccceeecccCceeEEEEEe-------CCccEEEEEeCcC-hhHhHHHHHHHHHHHHcCCCCceeeeccccCC--Cc
Q 008365 228 TDKFSEAMKIGEGGYGPVYRGKL-------DHTPVAIKVLRPD-AAQGKRQFQQEVEVLSSIRHPNMVLLLGACPD--YG 297 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~~~~-------~~~~vAvK~l~~~-~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--~~ 297 (568)
.++|.+.+.||+|+||.||+|.+ .+..||||+++.. .......+.+|+.+++.++|||||+++++|.+ ..
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 46799999999999999999984 3457999999754 34445578899999999999999999999855 34
Q ss_pred eEEEEecCCCCHHHHHhhcCC----CCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCc---eeEec
Q 008365 298 CLVYEYMHNGSLEDRLLRRGN----TPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNY---VSKIS 370 (568)
Q Consensus 298 ~lV~E~~~ggsL~~~l~~~~~----~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~---~vKL~ 370 (568)
++|||||+||+|.+++..... ...+++..++.|+.||+.||.|||+.+ |+||||||+||||+.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEEC
Confidence 899999999999999987542 234889999999999999999999999 99999999999998544 59999
Q ss_pred ccccccccCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh-CCCCCCCchHH--HHHHHhC
Q 008365 371 DVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPMGLTHHV--SRAIEKG 447 (568)
Q Consensus 371 DFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~--~~~~~~~ 447 (568)
|||+++.+.... .........||+.|+|||++.+..++.++|||||||++|||++ |..||...... ...+..+
T Consensus 227 DFG~a~~~~~~~----~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~ 302 (367)
T 3l9p_A 227 DFGMARDIYRAG----YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG 302 (367)
T ss_dssp CCHHHHHHHHHS----SCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT
T ss_pred CCcccccccccc----ccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence 999997542111 1112234578999999999999999999999999999999998 99999755432 2222222
Q ss_pred ccccccCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHH
Q 008365 448 TLAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPE 493 (568)
Q Consensus 448 ~~~~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~ 493 (568)
. ....+..++..+.+|+.+||+.+|.+||++.+|+.++
T Consensus 303 ~--------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l 340 (367)
T 3l9p_A 303 G--------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 340 (367)
T ss_dssp C--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred C--------CCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHH
Confidence 1 1223455667899999999999999999999997543
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=372.22 Aligned_cols=248 Identities=27% Similarity=0.482 Sum_probs=191.3
Q ss_pred hcccccceeecccCceeEEEEEeC-----CccEEEEEeCcC-hhHhHHHHHHHHHHHHcCCCCceeeeccccCCC--ceE
Q 008365 228 TDKFSEAMKIGEGGYGPVYRGKLD-----HTPVAIKVLRPD-AAQGKRQFQQEVEVLSSIRHPNMVLLLGACPDY--GCL 299 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~~~~~-----~~~vAvK~l~~~-~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~--~~l 299 (568)
.++|.+.+.||+|+||.||+|++. +..||||+++.. .......|.+|+.+|+.++|||||+++++|.+. .++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 357999999999999999999863 557999999765 334456799999999999999999999998654 489
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccC
Q 008365 300 VYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVP 379 (568)
Q Consensus 300 V~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~ 379 (568)
||||+++|+|.+++...+. .+++..++.|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+.
T Consensus 124 v~e~~~~~sL~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 198 (373)
T 2qol_A 124 VTEYMENGSLDSFLRKHDA--QFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLE 198 (373)
T ss_dssp EEECCTTCBHHHHHHTTTT--CSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEeCCCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence 9999999999999976542 3899999999999999999999999 9999999999999999999999999998764
Q ss_pred CCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh-CCCCCCCchH--HHHHHHhCccccccCcc
Q 008365 380 PSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPMGLTHH--VSRAIEKGTLAEMLDPA 456 (568)
Q Consensus 380 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~--~~~~~~~~~~~~~l~~~ 456 (568)
..... ........+|+.|+|||++.+..++.++|||||||++|||++ |+.||..... +...+..+.
T Consensus 199 ~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~-------- 267 (373)
T 2qol_A 199 DDPEA---AYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGY-------- 267 (373)
T ss_dssp ------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTE--------
T ss_pred cCCcc---ceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC--------
Confidence 32211 111223456789999999999999999999999999999998 9999965433 222222221
Q ss_pred CCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHh
Q 008365 457 VTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIV 491 (568)
Q Consensus 457 ~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~ 491 (568)
....+..++..+.+|+..||+.+|.+||++.+|+.
T Consensus 268 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 268 RLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp ECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence 11224456678999999999999999999999874
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=382.24 Aligned_cols=252 Identities=22% Similarity=0.273 Sum_probs=194.6
Q ss_pred HhcccccceeecccCceeEEEEEe--CCccEEEEEeCcC--hhHhHHHHHHHHHHHHcCCCCceeeeccccCCC------
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPD--AAQGKRQFQQEVEVLSSIRHPNMVLLLGACPDY------ 296 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~------ 296 (568)
..++|++++.||+|+||.||+|.+ +++.||||++... .......+.+|+.+|+.++|||||+++++|...
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence 347899999999999999999987 5778999999754 233456788999999999999999999998432
Q ss_pred --ceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEeccccc
Q 008365 297 --GCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGL 374 (568)
Q Consensus 297 --~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGl 374 (568)
.|||||||++ +|.+.+.. .+++..+..|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+
T Consensus 140 ~~~~lv~E~~~~-~l~~~~~~-----~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~ 210 (464)
T 3ttj_A 140 QDVYLVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 210 (464)
T ss_dssp CEEEEEEECCSE-EHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCC
T ss_pred CeEEEEEeCCCC-CHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEe
Confidence 2899999965 56666642 2889999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHh----Cc--
Q 008365 375 ARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEK----GT-- 448 (568)
Q Consensus 375 a~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~----~~-- 448 (568)
++..... ......+||+.|+|||++.+..|+.++|||||||++|||++|++||...+........ +.
T Consensus 211 a~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~ 283 (464)
T 3ttj_A 211 ARTAGTS-------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPC 283 (464)
T ss_dssp C-----C-------CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCC
T ss_pred eeecCCC-------cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 9865432 1234578999999999999999999999999999999999999999765543322110 00
Q ss_pred ------c-------------------ccccCccCC----CCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 449 ------L-------------------AEMLDPAVT----DWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 449 ------~-------------------~~~l~~~~~----~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
+ ...+...+. ......+..+.+|+.+||..||.+||++.+++.|.+
T Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~ 358 (464)
T 3ttj_A 284 PEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPY 358 (464)
T ss_dssp HHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTT
T ss_pred HHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChh
Confidence 0 000000000 000122677999999999999999999999997765
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=367.03 Aligned_cols=247 Identities=24% Similarity=0.411 Sum_probs=197.5
Q ss_pred cccccceeecccCceeEEEEEe--CCcc----EEEEEeCcCh-hHhHHHHHHHHHHHHcCCCCceeeeccccCCC-ceEE
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKL--DHTP----VAIKVLRPDA-AQGKRQFQQEVEVLSSIRHPNMVLLLGACPDY-GCLV 300 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~--~~~~----vAvK~l~~~~-~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~-~~lV 300 (568)
++|++.+.||+|+||.||+|.+ ++.. ||+|++.... ......+.+|+.+++.++||||++++++|.+. .++|
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v 92 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPGSSLQLV 92 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECBSSEEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCccEEE
Confidence 5799999999999999999987 3343 7888875432 22234567899999999999999999998654 4899
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCC
Q 008365 301 YEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPP 380 (568)
Q Consensus 301 ~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~ 380 (568)
|||+++|+|.+++.... ..+++..+..|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+..
T Consensus 93 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 167 (325)
T 3kex_A 93 TQYLPLGSLLDHVRQHR--GALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPP 167 (325)
T ss_dssp EECCTTCBSHHHHHSSG--GGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGSCC
T ss_pred EEeCCCCCHHHHHHHcc--ccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcccccCc
Confidence 99999999999987642 24888999999999999999999999 99999999999999999999999999987754
Q ss_pred CCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh-CCCCCCCch--HHHHHHHhCccccccCccC
Q 008365 381 SVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPMGLTH--HVSRAIEKGTLAEMLDPAV 457 (568)
Q Consensus 381 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~--~~~~~~~~~~~~~~l~~~~ 457 (568)
.... .......||+.|+|||++.+..++.++|||||||++|+|++ |..||.... .+...+..+..
T Consensus 168 ~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~-------- 235 (325)
T 3kex_A 168 DDKQ----LLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGER-------- 235 (325)
T ss_dssp CTTC----CC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCB--------
T ss_pred cccc----ccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCC--------
Confidence 3211 12245678889999999999999999999999999999999 999996543 23333333211
Q ss_pred CCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhH
Q 008365 458 TDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVP 492 (568)
Q Consensus 458 ~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~ 492 (568)
...+..++..+.+|+.+||..+|.+||++.+++.+
T Consensus 236 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 236 LAQPQICTIDVYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp CCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred CCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 12233445568899999999999999999998743
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=380.37 Aligned_cols=240 Identities=30% Similarity=0.481 Sum_probs=202.5
Q ss_pred hcccccceeecccCceeEEEEEeCCccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCceeeeccccCC---CceEEEEec
Q 008365 228 TDKFSEAMKIGEGGYGPVYRGKLDHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACPD---YGCLVYEYM 304 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~---~~~lV~E~~ 304 (568)
.++|.+.+.||+|+||.||+|.+.++.||||+++... ..+.|.+|+.+|+.++|||||+++++|.+ ..+||||||
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~ 269 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 269 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECC
T ss_pred hHHeEEEeeecCcCCeeEEEEEecCCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEec
Confidence 4678999999999999999999999999999998664 34678999999999999999999998733 358999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCCc
Q 008365 305 HNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVAD 384 (568)
Q Consensus 305 ~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~~ 384 (568)
++|+|.+++...+.. .+++..++.|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.....
T Consensus 270 ~~g~L~~~l~~~~~~-~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--- 342 (450)
T 1k9a_A 270 AKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--- 342 (450)
T ss_dssp TTCBHHHHHHHHCTT-TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred CCCcHHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccccccc---
Confidence 999999999876532 3789999999999999999999999 999999999999999999999999999854221
Q ss_pred cccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh-CCCCCCCch--HHHHHHHhCccccccCccCCCCC
Q 008365 385 SVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPMGLTH--HVSRAIEKGTLAEMLDPAVTDWP 461 (568)
Q Consensus 385 ~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~--~~~~~~~~~~~~~~l~~~~~~~p 461 (568)
.....+|+.|+|||++.+..++.++|||||||++|||++ |..||.... .+...+..+. ....|
T Consensus 343 ------~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~--------~~~~p 408 (450)
T 1k9a_A 343 ------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY--------KMDAP 408 (450)
T ss_dssp ----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTC--------CCCCC
T ss_pred ------ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC--------CCCCC
Confidence 122367899999999999999999999999999999998 999996432 2333333321 12345
Q ss_pred hHHHHHHHHHHHHhhccCCCCCCChHHhH
Q 008365 462 AEAAESFSKLAIQCAELRKKDRPDLGTVI 490 (568)
Q Consensus 462 ~~~~~~l~~li~~Cl~~dP~~RPs~~~vl 490 (568)
..++..+.+||..||+.+|.+||++.+|+
T Consensus 409 ~~~~~~l~~li~~cl~~dp~~Rpt~~~l~ 437 (450)
T 1k9a_A 409 DGCPPAVYDVMKNCWHLDAATRPTFLQLR 437 (450)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CcCCHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 66778899999999999999999999987
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=352.83 Aligned_cols=247 Identities=23% Similarity=0.418 Sum_probs=203.4
Q ss_pred hcccccceeecccCceeEEEEEeCC-ccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCceeeeccccCCC--ceEEEEec
Q 008365 228 TDKFSEAMKIGEGGYGPVYRGKLDH-TPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACPDY--GCLVYEYM 304 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~~~~~~-~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~--~~lV~E~~ 304 (568)
.++|.+.+.||+|+||.||+|.+.+ ..||||++...... ...+.+|+.++..++||||++++++|.+. .++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS-EDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI 85 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBC-HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCc-HHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence 4689999999999999999998854 47999999765433 35689999999999999999999998654 48999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCCc
Q 008365 305 HNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVAD 384 (568)
Q Consensus 305 ~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~~ 384 (568)
++++|.+++...+. .+++..++.|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 86 ~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~- 159 (268)
T 3sxs_A 86 SNGCLLNYLRSHGK--GLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY- 159 (268)
T ss_dssp TTCBHHHHHHHHGG--GCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE-
T ss_pred CCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhhh-
Confidence 99999999977543 3889999999999999999999999 99999999999999999999999999987643321
Q ss_pred cccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh-CCCCCCCchHHHHHHHhCccccccCccCCCCChH
Q 008365 385 SVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPMGLTHHVSRAIEKGTLAEMLDPAVTDWPAE 463 (568)
Q Consensus 385 ~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~l~~~~~~~p~~ 463 (568)
.......||+.|+|||++.+..++.++|||||||++|+|++ |..||.............. ......|..
T Consensus 160 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~------~~~~~~~~~ 229 (268)
T 3sxs_A 160 ----VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQ------GHRLYRPHL 229 (268)
T ss_dssp ----EECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHT------TCCCCCCTT
T ss_pred ----hcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHc------CCCCCCCCc
Confidence 12234567888999999999999999999999999999999 9999976544332211111 111122334
Q ss_pred HHHHHHHHHHHhhccCCCCCCChHHhHh
Q 008365 464 AAESFSKLAIQCAELRKKDRPDLGTVIV 491 (568)
Q Consensus 464 ~~~~l~~li~~Cl~~dP~~RPs~~~vl~ 491 (568)
++..+.+++..||+.+|.+||++.+++.
T Consensus 230 ~~~~l~~li~~~l~~~p~~Rps~~~ll~ 257 (268)
T 3sxs_A 230 ASDTIYQIMYSCWHELPEKRPTFQQLLS 257 (268)
T ss_dssp SCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred ChHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 5567999999999999999999999873
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=362.26 Aligned_cols=256 Identities=24% Similarity=0.332 Sum_probs=197.7
Q ss_pred HhcccccceeecccCceeEEEEEe-CCccEEEEEeCcChhH--hHHHHHHHHHHHHcCCCCceeeeccccCCCc--eEEE
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKL-DHTPVAIKVLRPDAAQ--GKRQFQQEVEVLSSIRHPNMVLLLGACPDYG--CLVY 301 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~-~~~~vAvK~l~~~~~~--~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~--~lV~ 301 (568)
..++|+++++||+|+||.||+|.+ +++.||||++...... ....+.+|+.+|+.++|||||+++++|.+.. ++||
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 98 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF 98 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence 457899999999999999999998 6789999999754322 2456889999999999999999999986544 8999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCC
Q 008365 302 EYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPS 381 (568)
Q Consensus 302 E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~ 381 (568)
||++ |+|.+++..... .+++..+..|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+...
T Consensus 99 e~~~-~~l~~~~~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 172 (311)
T 3niz_A 99 EFME-KDLKKVLDENKT--GLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIP 172 (311)
T ss_dssp ECCS-EEHHHHHHTCTT--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSC
T ss_pred cCCC-CCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCC
Confidence 9996 588888766442 3899999999999999999999999 999999999999999999999999999876432
Q ss_pred CCccccccccccccccccCCChhhhhc-CCCCCcceehhHHHHHHHHHhCCCCCCCchH---HHHHHHh-Cccc------
Q 008365 382 VADSVTQYHMTSAAGTFCYIDPEYQQT-GMLTTKSDIYSFGIMLLQIITARSPMGLTHH---VSRAIEK-GTLA------ 450 (568)
Q Consensus 382 ~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDvwSlGvil~elltG~~Pf~~~~~---~~~~~~~-~~~~------ 450 (568)
. ......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||..... ....... +...
T Consensus 173 ~------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 246 (311)
T 3niz_A 173 V------RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQ 246 (311)
T ss_dssp C------C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGG
T ss_pred c------ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhh
Confidence 1 12234578999999998876 5689999999999999999999999964322 1111110 0000
Q ss_pred ------------cccCc-cCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 451 ------------EMLDP-AVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 451 ------------~~l~~-~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
..+.. ......+.++.++.+|+.+||+.||.+||++.+++.|.+
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 303 (311)
T 3niz_A 247 VQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPY 303 (311)
T ss_dssp GTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGG
T ss_pred hhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcc
Confidence 00000 000011234567899999999999999999999986543
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-43 Score=348.58 Aligned_cols=243 Identities=22% Similarity=0.371 Sum_probs=201.0
Q ss_pred hcccccceeecccCceeEEEEEeCCccEEEEEeCcCh--hHhHHHHHHHHHHHHcCCCCceeeeccccCCC----ceEEE
Q 008365 228 TDKFSEAMKIGEGGYGPVYRGKLDHTPVAIKVLRPDA--AQGKRQFQQEVEVLSSIRHPNMVLLLGACPDY----GCLVY 301 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~~~~~~~~vAvK~l~~~~--~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~----~~lV~ 301 (568)
.++|.+.+.||+|+||.||+|.+.++.||||++.... ....+.+.+|+.+++.++||||++++++|.+. .++||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT 88 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEETTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEECCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence 3679999999999999999999999999999997653 34456799999999999999999999998543 48999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCC
Q 008365 302 EYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPS 381 (568)
Q Consensus 302 E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~ 381 (568)
||+++|+|.+++..... ..+++..++.|+.||+.||.|||+.+ .+|+||||||+|||++.++.++|+|||++....
T Consensus 89 e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~-- 164 (271)
T 3kmu_A 89 HWMPYGSLYNVLHEGTN-FVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQ-- 164 (271)
T ss_dssp ECCTTCBHHHHHHSCSS-CCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS--
T ss_pred cccCCCcHHHHHhhccc-CCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeec--
Confidence 99999999999976543 24899999999999999999999876 359999999999999999999999988875321
Q ss_pred CCccccccccccccccccCCChhhhhcCCCCC---cceehhHHHHHHHHHhCCCCCCCchHHHHH--HHhCccccccCcc
Q 008365 382 VADSVTQYHMTSAAGTFCYIDPEYQQTGMLTT---KSDIYSFGIMLLQIITARSPMGLTHHVSRA--IEKGTLAEMLDPA 456 (568)
Q Consensus 382 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~---ksDvwSlGvil~elltG~~Pf~~~~~~~~~--~~~~~~~~~l~~~ 456 (568)
.....||+.|+|||++.+..++. ++|||||||++|+|++|+.||......... +.... .
T Consensus 165 ---------~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-------~ 228 (271)
T 3kmu_A 165 ---------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEG-------L 228 (271)
T ss_dssp ---------CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSC-------C
T ss_pred ---------ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcC-------C
Confidence 12356899999999998765554 799999999999999999999755443221 11111 1
Q ss_pred CCCCChHHHHHHHHHHHHhhccCCCCCCChHHhH
Q 008365 457 VTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVI 490 (568)
Q Consensus 457 ~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl 490 (568)
....+..++..+.+++..||+.+|.+||++.+++
T Consensus 229 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il 262 (271)
T 3kmu_A 229 RPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIV 262 (271)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHH
Confidence 1233456677899999999999999999999987
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=360.69 Aligned_cols=247 Identities=22% Similarity=0.325 Sum_probs=196.1
Q ss_pred hcccccceeecccCceeEEEEEe--CCccEEEEEeCcChhH--------------------------hHHHHHHHHHHHH
Q 008365 228 TDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQ--------------------------GKRQFQQEVEVLS 279 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~--------------------------~~~~~~~Ev~iL~ 279 (568)
.++|.+.+.||+|+||.||+|.+ +++.||||++...... ..+.+.+|+.+|+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 46899999999999999999987 5678999998654321 1245889999999
Q ss_pred cCCCCceeeeccccCC----CceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCC
Q 008365 280 SIRHPNMVLLLGACPD----YGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLK 355 (568)
Q Consensus 280 ~l~HpnIv~l~g~~~~----~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIK 355 (568)
.++||||+++++++.+ ..++||||+++++|.+++.. ..+++..+..++.||+.||.|||+.+ |+|||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlk 164 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL----KPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIK 164 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCC
Confidence 9999999999999854 24899999999999875432 24899999999999999999999999 9999999
Q ss_pred CCCeeccCCceeEecccccccccCCCCCccccccccccccccccCCChhhhhcCC---CCCcceehhHHHHHHHHHhCCC
Q 008365 356 PANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGM---LTTKSDIYSFGIMLLQIITARS 432 (568)
Q Consensus 356 p~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~---~s~ksDvwSlGvil~elltG~~ 432 (568)
|+||||+.++.+||+|||+++.+.... .......||+.|+|||++.+.. ++.++|||||||++|+|++|..
T Consensus 165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~ 238 (298)
T 2zv2_A 165 PSNLLVGEDGHIKIADFGVSNEFKGSD------ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQC 238 (298)
T ss_dssp GGGEEECTTSCEEECCCTTCEECSSSS------CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSC
T ss_pred HHHEEECCCCCEEEecCCCcccccccc------ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCC
Confidence 999999999999999999998764321 1123467999999999987765 4788999999999999999999
Q ss_pred CCCCchHHH--HHHHhCccccccCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 433 PMGLTHHVS--RAIEKGTLAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 433 Pf~~~~~~~--~~~~~~~~~~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
||....... ..+...... .+ ....++..+.+|+.+||+.||.+||++.+++.|.+
T Consensus 239 pf~~~~~~~~~~~~~~~~~~---~~----~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~ 295 (298)
T 2zv2_A 239 PFMDERIMCLHSKIKSQALE---FP----DQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPW 295 (298)
T ss_dssp SSCCSSHHHHHHHHHHCCCC---CC----SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHH
T ss_pred CCCCccHHHHHHHHhcccCC---CC----CccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcc
Confidence 997554322 222222111 01 12245567999999999999999999999987655
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=363.57 Aligned_cols=246 Identities=26% Similarity=0.359 Sum_probs=195.1
Q ss_pred hcccccceeecccCceeEEEEEe-----CCccEEEEEeCcCh----hHhHHHHHHHHHHHHcCCCCceeeeccccCC--C
Q 008365 228 TDKFSEAMKIGEGGYGPVYRGKL-----DHTPVAIKVLRPDA----AQGKRQFQQEVEVLSSIRHPNMVLLLGACPD--Y 296 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~~~~-----~~~~vAvK~l~~~~----~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--~ 296 (568)
.++|++.+.||+|+||.||++++ .++.||||+++... ......+.+|+.+|+.++|||||+++++|.+ .
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 46899999999999999999986 56789999997653 2234557899999999999999999999855 3
Q ss_pred ceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEeccccccc
Q 008365 297 GCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLAR 376 (568)
Q Consensus 297 ~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~ 376 (568)
.++||||++||+|.+++...+ .+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 169 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLEREG---IFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK 169 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred EEEEEeCCCCCcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCccc
Confidence 489999999999999998754 3788999999999999999999999 9999999999999999999999999997
Q ss_pred ccCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHH--HHHHhCccccccC
Q 008365 377 LVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVS--RAIEKGTLAEMLD 454 (568)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~--~~~~~~~~~~~l~ 454 (568)
...... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||....... ..+....
T Consensus 170 ~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~------ 237 (327)
T 3a62_A 170 ESIHDG------TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCK------ 237 (327)
T ss_dssp ---------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC------
T ss_pred ccccCC------ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCC------
Confidence 542211 12245679999999999999999999999999999999999999997654322 2222211
Q ss_pred ccCCCCChHHHHHHHHHHHHhhccCCCCCC-----ChHHhHhHHH
Q 008365 455 PAVTDWPAEAAESFSKLAIQCAELRKKDRP-----DLGTVIVPEL 494 (568)
Q Consensus 455 ~~~~~~p~~~~~~l~~li~~Cl~~dP~~RP-----s~~~vl~~~l 494 (568)
..+|..++..+.+|+.+||..+|.+|| ++.+++.|.+
T Consensus 238 ---~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~ 279 (327)
T 3a62_A 238 ---LNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPF 279 (327)
T ss_dssp ---CCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGG
T ss_pred ---CCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCc
Confidence 123455667899999999999999999 6777775544
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-43 Score=357.06 Aligned_cols=251 Identities=27% Similarity=0.428 Sum_probs=205.9
Q ss_pred HhcccccceeecccCceeEEEEEe-------CCccEEEEEeCcCh-hHhHHHHHHHHHHHHcCCCCceeeeccccCC--C
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKL-------DHTPVAIKVLRPDA-AQGKRQFQQEVEVLSSIRHPNMVLLLGACPD--Y 296 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~-------~~~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--~ 296 (568)
..++|.+.+.||+|+||.||+|.+ .+..||||++.... ....+.+.+|+.+|+.++||||++++++|.+ .
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 100 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP 100 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence 357899999999999999999976 23689999997643 3445678999999999999999999999855 3
Q ss_pred ceEEEEecCCCCHHHHHhhcCC---------------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCC
Q 008365 297 GCLVYEYMHNGSLEDRLLRRGN---------------------TPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLK 355 (568)
Q Consensus 297 ~~lV~E~~~ggsL~~~l~~~~~---------------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIK 355 (568)
.++||||+++|+|.+++..... ...+++..++.|+.||+.||.|||+.+ |+|||||
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dik 177 (314)
T 2ivs_A 101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLA 177 (314)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCS
T ss_pred eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccccccc
Confidence 4899999999999999987543 123889999999999999999999999 9999999
Q ss_pred CCCeeccCCceeEecccccccccCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh-CCCCC
Q 008365 356 PANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPM 434 (568)
Q Consensus 356 p~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf 434 (568)
|+||||+.++.+||+|||+++.+..... ........||+.|+|||++.+..++.++|||||||++|+|++ |..||
T Consensus 178 p~NIli~~~~~~kl~Dfg~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 253 (314)
T 2ivs_A 178 ARNILVAEGRKMKISDFGLSRDVYEEDS----YVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY 253 (314)
T ss_dssp GGGEEEETTTEEEECCCTTCEECTTTSC----EECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred hheEEEcCCCCEEEcccccccccccccc----ceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCC
Confidence 9999999999999999999987643221 112234568899999999999999999999999999999999 99999
Q ss_pred CCch--HHHHHHHhCccccccCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhH
Q 008365 435 GLTH--HVSRAIEKGTLAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVP 492 (568)
Q Consensus 435 ~~~~--~~~~~~~~~~~~~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~ 492 (568)
.... .+...+..+. ....+..++..+.+|+.+||+.+|.+||++.+++..
T Consensus 254 ~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 254 PGIPPERLFNLLKTGH--------RMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305 (314)
T ss_dssp TTCCGGGHHHHHHTTC--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCHHHHHHHhhcCC--------cCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 6433 2222232221 122345566789999999999999999999998744
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=376.41 Aligned_cols=245 Identities=23% Similarity=0.372 Sum_probs=200.2
Q ss_pred hcccccceeecccCceeEEEEEe--CCccEEEEEeCcChh---HhHHHHHHHHHHHHcCCCCceeeeccccCCC--ceEE
Q 008365 228 TDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAA---QGKRQFQQEVEVLSSIRHPNMVLLLGACPDY--GCLV 300 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~---~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~--~~lV 300 (568)
.++|.+++.||+|+||.||++.+ +++.||||++..... .....+.+|+.+|+.++|||||+++++|.+. .++|
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 36799999999999999999987 467899999975432 2345688999999999999999999998654 4899
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCC
Q 008365 301 YEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPP 380 (568)
Q Consensus 301 ~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~ 380 (568)
|||+.||+|.+++...+ .+++..+..|+.||+.||.|||+.+ |+||||||+||||+.+|.+||+|||+++.+..
T Consensus 94 ~e~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 167 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQQNV---HFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPR 167 (384)
T ss_dssp ECCCTTEEHHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence 99999999999987643 3899999999999999999999999 99999999999999999999999999987643
Q ss_pred CCCccccccccccccccccCCChhhhhc---CCCCCcceehhHHHHHHHHHhCCCCCCCchH--HHHHHHhCccccccCc
Q 008365 381 SVADSVTQYHMTSAAGTFCYIDPEYQQT---GMLTTKSDIYSFGIMLLQIITARSPMGLTHH--VSRAIEKGTLAEMLDP 455 (568)
Q Consensus 381 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~---~~~s~ksDvwSlGvil~elltG~~Pf~~~~~--~~~~~~~~~~~~~l~~ 455 (568)
.. .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||..... ....+.. +..
T Consensus 168 ~~-------~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~------~~~ 234 (384)
T 4fr4_A 168 ET-------QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHT------FET 234 (384)
T ss_dssp TC-------CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHH------HHH
T ss_pred CC-------ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHH------Hhh
Confidence 21 2345789999999998864 4589999999999999999999999964321 1111110 011
Q ss_pred cCCCCChHHHHHHHHHHHHhhccCCCCCCC-hHHhHh
Q 008365 456 AVTDWPAEAAESFSKLAIQCAELRKKDRPD-LGTVIV 491 (568)
Q Consensus 456 ~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs-~~~vl~ 491 (568)
....+|..++..+.+||.+||+.+|.+||+ +.+|+.
T Consensus 235 ~~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 235 TVVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp CCCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred cccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 122345566778999999999999999999 666553
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=371.68 Aligned_cols=259 Identities=17% Similarity=0.225 Sum_probs=198.5
Q ss_pred HhcccccceeecccCceeEEEEEeC-------CccEEEEEeCcChhHhH-----------HHHHHHHHHHHcCCCCceee
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKLD-------HTPVAIKVLRPDAAQGK-----------RQFQQEVEVLSSIRHPNMVL 288 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~~-------~~~vAvK~l~~~~~~~~-----------~~~~~Ev~iL~~l~HpnIv~ 288 (568)
..++|.+.++||+|+||.||+|.+. ++.||||++........ ..+..|+..+..++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 3458999999999999999999873 36899999876542211 12345677788889999999
Q ss_pred eccccCCC------ceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeecc
Q 008365 289 LLGACPDY------GCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLD 362 (568)
Q Consensus 289 l~g~~~~~------~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld 362 (568)
++++|... .+|||||| |++|.+++..... .+++..++.|+.||+.||.|||+.+ |+||||||+||||+
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~--~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~ 186 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAK--RFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLN 186 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEE
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEe
Confidence 99988432 58999999 9999999977532 3899999999999999999999999 99999999999998
Q ss_pred --CCceeEecccccccccCCCCCcc-ccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCch-
Q 008365 363 --RNYVSKISDVGLARLVPPSVADS-VTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTH- 438 (568)
Q Consensus 363 --~~~~vKL~DFGla~~~~~~~~~~-~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~- 438 (568)
.++.+||+|||+++.+....... .........+||+.|+|||++.+..++.++|||||||++|+|++|+.||....
T Consensus 187 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~ 266 (364)
T 3op5_A 187 YKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLK 266 (364)
T ss_dssp SSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred cCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence 88999999999998764322111 11112245679999999999999999999999999999999999999996421
Q ss_pred -HHHHHHH----hCccccccCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHH
Q 008365 439 -HVSRAIE----KGTLAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPE 493 (568)
Q Consensus 439 -~~~~~~~----~~~~~~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~ 493 (568)
....... ...+...+++.+. +..++..+.+|+..||+.+|.+||++.+|+..+
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l 324 (364)
T 3op5_A 267 DPKYVRDSKIRYRENIASLMDKCFP--AANAPGEIAKYMETVKLLDYTEKPLYENLRDIL 324 (364)
T ss_dssp CHHHHHHHHHHHHHCHHHHHHHHSC--TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHH
T ss_pred CHHHHHHHHHHhhhhHHHHHHHhcc--cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHH
Confidence 1111111 1122222222221 123457799999999999999999999987433
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-43 Score=367.91 Aligned_cols=246 Identities=22% Similarity=0.298 Sum_probs=203.2
Q ss_pred HhcccccceeecccCceeEEEEEeC--CccEEEEEeCcChh---HhHHHHHHHHHHHHcC-CCCceeeeccccCCC--ce
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKLD--HTPVAIKVLRPDAA---QGKRQFQQEVEVLSSI-RHPNMVLLLGACPDY--GC 298 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~~--~~~vAvK~l~~~~~---~~~~~~~~Ev~iL~~l-~HpnIv~l~g~~~~~--~~ 298 (568)
..++|.+++.||+|+||.||+|++. ++.||||++++... .....+..|..+|..+ +||||++++++|.+. .|
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 3468999999999999999999984 56899999976432 2345678999999988 799999999998654 48
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEeccccccccc
Q 008365 299 LVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLV 378 (568)
Q Consensus 299 lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~ 378 (568)
+||||++||+|.+++...+. +++..+..++.||+.||.|||+.+ |+||||||+||||+.+|.+||+|||+++..
T Consensus 98 lv~E~~~gg~L~~~l~~~~~---~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 171 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQVGR---FKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 171 (353)
T ss_dssp EEEECCCSCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEeCCCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence 99999999999999987543 889999999999999999999999 999999999999999999999999999754
Q ss_pred CCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchH--HHHHHHhCccccccCcc
Q 008365 379 PPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHH--VSRAIEKGTLAEMLDPA 456 (568)
Q Consensus 379 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~--~~~~~~~~~~~~~l~~~ 456 (568)
.... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||..... +...+..+.
T Consensus 172 ~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~-------- 237 (353)
T 2i0e_A 172 IWDG------VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN-------- 237 (353)
T ss_dssp CCTT------CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--------
T ss_pred ccCC------cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCC--------
Confidence 2211 123457899999999999999999999999999999999999999975543 222222221
Q ss_pred CCCCChHHHHHHHHHHHHhhccCCCCCCCh-----HHhHhHH
Q 008365 457 VTDWPAEAAESFSKLAIQCAELRKKDRPDL-----GTVIVPE 493 (568)
Q Consensus 457 ~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~-----~~vl~~~ 493 (568)
..+|..++..+.+|+.+||..+|.+||+. .+|+.|.
T Consensus 238 -~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~ 278 (353)
T 2i0e_A 238 -VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHA 278 (353)
T ss_dssp -CCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSG
T ss_pred -CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCc
Confidence 12455667789999999999999999964 6666543
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=372.44 Aligned_cols=264 Identities=20% Similarity=0.232 Sum_probs=202.2
Q ss_pred Hhcccccceeeccc--CceeEEEEEe--CCccEEEEEeCcCh--hHhHHHHHHHHHHHHcCCCCceeeeccccCCC--ce
Q 008365 227 ATDKFSEAMKIGEG--GYGPVYRGKL--DHTPVAIKVLRPDA--AQGKRQFQQEVEVLSSIRHPNMVLLLGACPDY--GC 298 (568)
Q Consensus 227 ~~~~y~~~~~IG~G--~fg~Vy~~~~--~~~~vAvK~l~~~~--~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~--~~ 298 (568)
..++|++.++||+| +||.||+|.+ ++..||||++.... ......+.+|+.+|+.++|||||+++++|.+. .+
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 102 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW 102 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEE
Confidence 34789999999999 9999999998 47899999997543 33456788999999999999999999998544 48
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEeccccccccc
Q 008365 299 LVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLV 378 (568)
Q Consensus 299 lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~ 378 (568)
+|||||++|+|.+++...... .+++..+..|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++...
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~ 178 (389)
T 3gni_B 103 VVTSFMAYGSAKDLICTHFMD-GMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSM 178 (389)
T ss_dssp EEEECCTTCBHHHHHHHTCTT-CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEEEccCCCCHHHHHhhhccc-CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceee
Confidence 999999999999999775332 3899999999999999999999999 999999999999999999999999998654
Q ss_pred CCCCCc-cccccccccccccccCCChhhhhc--CCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHH--hCcccccc
Q 008365 379 PPSVAD-SVTQYHMTSAAGTFCYIDPEYQQT--GMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIE--KGTLAEML 453 (568)
Q Consensus 379 ~~~~~~-~~~~~~~~~~~GT~~Y~APE~~~~--~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~--~~~~~~~l 453 (568)
...... ..........+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........... .+.....+
T Consensus 179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 258 (389)
T 3gni_B 179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLL 258 (389)
T ss_dssp EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC---------
T ss_pred ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccc
Confidence 221110 111111234579999999999987 5799999999999999999999999964322111110 11110000
Q ss_pred Cc-------------------------------------cCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 454 DP-------------------------------------AVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 454 ~~-------------------------------------~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
+. ....++..++..+.+|+.+||+.||.+||++.+++.|.+
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~ 336 (389)
T 3gni_B 259 DTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSF 336 (389)
T ss_dssp -----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGG
T ss_pred cccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHH
Confidence 00 000123345677999999999999999999999986544
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=367.70 Aligned_cols=251 Identities=27% Similarity=0.426 Sum_probs=206.1
Q ss_pred HhcccccceeecccCceeEEEEEeCC---------ccEEEEEeCcCh-hHhHHHHHHHHHHHHcC-CCCceeeeccccCC
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKLDH---------TPVAIKVLRPDA-AQGKRQFQQEVEVLSSI-RHPNMVLLLGACPD 295 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~~~---------~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l-~HpnIv~l~g~~~~ 295 (568)
..++|.+.+.||+|+||.||+|.+.+ ..||||+++... ......+.+|+.+++.+ +|||||+++++|.+
T Consensus 67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 146 (382)
T 3tt0_A 67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146 (382)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence 45789999999999999999998632 469999997653 33456789999999999 89999999999865
Q ss_pred C--ceEEEEecCCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCee
Q 008365 296 Y--GCLVYEYMHNGSLEDRLLRRGN-------------TPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANIL 360 (568)
Q Consensus 296 ~--~~lV~E~~~ggsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NIL 360 (568)
. .++||||+++|+|.+++..... ...+++..++.|+.||+.||.|||+.+ |+||||||+|||
T Consensus 147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl 223 (382)
T 3tt0_A 147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVL 223 (382)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEE
T ss_pred CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEE
Confidence 4 4899999999999999987542 234899999999999999999999999 999999999999
Q ss_pred ccCCceeEecccccccccCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh-CCCCCCCchH
Q 008365 361 LDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPMGLTHH 439 (568)
Q Consensus 361 ld~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~ 439 (568)
|+.++.+||+|||+++.+..... ........||+.|+|||++.+..++.++|||||||++|+|++ |..||.....
T Consensus 224 l~~~~~~kL~DFG~a~~~~~~~~----~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~ 299 (382)
T 3tt0_A 224 VTEDNVMKIADFGLARDIHHIDY----YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 299 (382)
T ss_dssp ECTTCCEEECSCSCCCCSSCCCT----TCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred EcCCCcEEEcccCcccccccccc----cccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 99999999999999986643221 112234568899999999999999999999999999999999 9999965433
Q ss_pred --HHHHHHhCccccccCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhH
Q 008365 440 --VSRAIEKGTLAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVP 492 (568)
Q Consensus 440 --~~~~~~~~~~~~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~ 492 (568)
+...+..+. ....+..++..+.+|+.+||+.+|.+||++.+|+..
T Consensus 300 ~~~~~~~~~~~--------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 300 EELFKLLKEGH--------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp HHHHHHHHTTC--------CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHcCC--------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 222222221 122344566789999999999999999999998743
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-43 Score=355.49 Aligned_cols=253 Identities=24% Similarity=0.327 Sum_probs=196.9
Q ss_pred cccccceeecccCceeEEEEEe-CCccEEEEEeCcChhH--hHHHHHHHHHHHHcCCCCceeeeccccCC--CceEEEEe
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKL-DHTPVAIKVLRPDAAQ--GKRQFQQEVEVLSSIRHPNMVLLLGACPD--YGCLVYEY 303 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~-~~~~vAvK~l~~~~~~--~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--~~~lV~E~ 303 (568)
++|.+++.||+|+||.||+|.+ .++.||||++...... ....+.+|+.+++.++||||+++++++.+ ..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 5799999999999999999998 4778999999755322 23568899999999999999999999854 44899999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCC
Q 008365 304 MHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVA 383 (568)
Q Consensus 304 ~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~ 383 (568)
++ ++|.+++..... .+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+....
T Consensus 82 ~~-~~l~~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 154 (288)
T 1ob3_A 82 LD-QDLKKLLDVCEG--GLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPV- 154 (288)
T ss_dssp CS-EEHHHHHHTSTT--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred cC-CCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCccc-
Confidence 96 599998876432 3889999999999999999999999 9999999999999999999999999998654221
Q ss_pred ccccccccccccccccCCChhhhhcC-CCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHh----Cccc--------
Q 008365 384 DSVTQYHMTSAAGTFCYIDPEYQQTG-MLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEK----GTLA-------- 450 (568)
Q Consensus 384 ~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~----~~~~-------- 450 (568)
.......||+.|+|||++.+. .++.++|||||||++|+|++|..||............ +...
T Consensus 155 -----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (288)
T 1ob3_A 155 -----RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVT 229 (288)
T ss_dssp ------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGG
T ss_pred -----cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhh
Confidence 122345789999999988764 5899999999999999999999999765433221110 0000
Q ss_pred --cccCccC--------CCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHH
Q 008365 451 --EMLDPAV--------TDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPE 493 (568)
Q Consensus 451 --~~l~~~~--------~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~ 493 (568)
..+++.. ..+...++..+.+|+.+||+.||.+||++.+++.|.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp 282 (288)
T 1ob3_A 230 ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHA 282 (288)
T ss_dssp GSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSG
T ss_pred cccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCc
Confidence 0001111 111234567889999999999999999999998654
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-43 Score=351.88 Aligned_cols=248 Identities=25% Similarity=0.409 Sum_probs=201.5
Q ss_pred HhcccccceeecccCceeEEEEEeCC-----ccEEEEEeCcC-hhHhHHHHHHHHHHHHcCCCCceeeeccccCCC-ceE
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKLDH-----TPVAIKVLRPD-AAQGKRQFQQEVEVLSSIRHPNMVLLLGACPDY-GCL 299 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~~~-----~~vAvK~l~~~-~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~-~~l 299 (568)
..++|.+.+.||+|+||.||+|.+.+ ..||||++... .....+.+.+|+.+++.++||||+++++++.+. .++
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 89 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEEPTWI 89 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSSSCEE
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCEE
Confidence 35789999999999999999998632 25999999765 334467799999999999999999999998654 489
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccC
Q 008365 300 VYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVP 379 (568)
Q Consensus 300 V~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~ 379 (568)
||||+++++|.+++..... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 90 v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 164 (281)
T 3cc6_A 90 IMELYPYGELGHYLERNKN--SLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYIE 164 (281)
T ss_dssp EEECCTTCBHHHHHHHHTT--TCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC-
T ss_pred EEecCCCCCHHHHHHhccc--cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCcccc
Confidence 9999999999999977543 3889999999999999999999999 9999999999999999999999999998654
Q ss_pred CCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh-CCCCCCCch--HHHHHHHhCccccccCcc
Q 008365 380 PSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPMGLTH--HVSRAIEKGTLAEMLDPA 456 (568)
Q Consensus 380 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~--~~~~~~~~~~~~~~l~~~ 456 (568)
... ........||+.|+|||++.+..++.++|||||||++|+|++ |+.||.... .....+..+..
T Consensus 165 ~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~------- 232 (281)
T 3cc6_A 165 DED-----YYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDR------- 232 (281)
T ss_dssp -------------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCC-------
T ss_pred ccc-----ccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCC-------
Confidence 321 112234567899999999999999999999999999999998 999995332 22233322211
Q ss_pred CCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhH
Q 008365 457 VTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVP 492 (568)
Q Consensus 457 ~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~ 492 (568)
...+..++..+.+++.+||..+|.+||++.+++..
T Consensus 233 -~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 233 -LPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp -CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -CCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence 12234456779999999999999999999999754
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-44 Score=383.40 Aligned_cols=257 Identities=24% Similarity=0.270 Sum_probs=205.3
Q ss_pred HHHHhcccccceeecccCceeEEEEEe--CCccEEEEEeCcChhHh---HHHHHHHHHHHHcCCCCceeeeccccCCCc-
Q 008365 224 IEEATDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQG---KRQFQQEVEVLSSIRHPNMVLLLGACPDYG- 297 (568)
Q Consensus 224 i~~~~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~---~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~- 297 (568)
+....++|++.++||+|+||.||+|++ .++.||||++.+..... ...+.+|+.+|..++|||||+++++|.+..
T Consensus 69 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~ 148 (437)
T 4aw2_A 69 MRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNN 148 (437)
T ss_dssp HSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSE
T ss_pred ccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCE
Confidence 334567899999999999999999998 45789999997543221 223789999999999999999999986644
Q ss_pred -eEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEeccccccc
Q 008365 298 -CLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLAR 376 (568)
Q Consensus 298 -~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~ 376 (568)
|||||||+||+|.+++..... .+++..+..|+.||+.||.|||+.+ ||||||||+||||+.++.+||+|||+|+
T Consensus 149 ~~lV~Ey~~gg~L~~~l~~~~~--~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DFGla~ 223 (437)
T 4aw2_A 149 LYLVMDYYVGGDLLTLLSKFED--RLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCL 223 (437)
T ss_dssp EEEEECCCTTCBHHHHHHTTTT--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEEecCCCCcHHHHHHHccC--CCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcchhhhh
Confidence 899999999999999976432 3899999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCCccccccccccccccccCCChhhhh-----cCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHH--HHHhCcc
Q 008365 377 LVPPSVADSVTQYHMTSAAGTFCYIDPEYQQ-----TGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSR--AIEKGTL 449 (568)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-----~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~--~~~~~~~ 449 (568)
.+.... .......+||+.|+|||++. ...|+.++|||||||++|||++|+.||........ .+.....
T Consensus 224 ~~~~~~-----~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~ 298 (437)
T 4aw2_A 224 KLMEDG-----TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKE 298 (437)
T ss_dssp ECCTTS-----CEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH
T ss_pred hcccCC-----CcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccc
Confidence 664322 11234568999999999887 45689999999999999999999999976543322 2211110
Q ss_pred ccccCccCCCCChHHHHHHHHHHHHhhccCCCC--CCChHHhHhHHH
Q 008365 450 AEMLDPAVTDWPAEAAESFSKLAIQCAELRKKD--RPDLGTVIVPEL 494 (568)
Q Consensus 450 ~~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~--RPs~~~vl~~~l 494 (568)
. ...+..+..++..+.+||.+||..+|.. ||++.+++.|.+
T Consensus 299 ~----~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpf 341 (437)
T 4aw2_A 299 R----FQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPF 341 (437)
T ss_dssp H----CCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGG
T ss_pred c----ccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCc
Confidence 0 1111222345677899999999888887 999999987655
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=381.70 Aligned_cols=246 Identities=30% Similarity=0.509 Sum_probs=204.3
Q ss_pred HhcccccceeecccCceeEEEEEeC-CccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCceeeeccccCC-CceEEEEec
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKLD-HTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACPD-YGCLVYEYM 304 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~~-~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~-~~~lV~E~~ 304 (568)
..++|.+.+.||+|+||.||+|.+. +..||||+++.... ..+.|.+|+.+|+.++|||||++++++.+ ..++|||||
T Consensus 186 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~lv~e~~ 264 (454)
T 1qcf_A 186 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM-SVEAFLAEANVMKTLQHDKLVKLHAVVTKEPIYIITEFM 264 (454)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEECCC
T ss_pred chHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCc-cHHHHHHHHHHHhhCCCCCEeeEEEEEeCCccEEEEeec
Confidence 4578999999999999999999984 67899999986543 35789999999999999999999999854 458999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCCc
Q 008365 305 HNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVAD 384 (568)
Q Consensus 305 ~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~~ 384 (568)
++|+|.+++..... ..+++..++.|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+....
T Consensus 265 ~~g~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~-- 338 (454)
T 1qcf_A 265 AKGSLLDFLKSDEG-SKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNE-- 338 (454)
T ss_dssp TTCBHHHHHHSHHH-HTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHH--
T ss_pred CCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCc--
Confidence 99999999975422 13788899999999999999999999 9999999999999999999999999998763211
Q ss_pred cccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh-CCCCCCCchH--HHHHHHhCccccccCccCCCCC
Q 008365 385 SVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPMGLTHH--VSRAIEKGTLAEMLDPAVTDWP 461 (568)
Q Consensus 385 ~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~--~~~~~~~~~~~~~l~~~~~~~p 461 (568)
........+|+.|+|||++.+..++.++|||||||+||||++ |+.||..... +...+..+. ....|
T Consensus 339 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~--------~~~~~ 407 (454)
T 1qcf_A 339 ---YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGY--------RMPRP 407 (454)
T ss_dssp ---HHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTC--------CCCCC
T ss_pred ---eeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC--------CCCCC
Confidence 111234457889999999999999999999999999999999 9999965433 222232221 11234
Q ss_pred hHHHHHHHHHHHHhhccCCCCCCChHHhH
Q 008365 462 AEAAESFSKLAIQCAELRKKDRPDLGTVI 490 (568)
Q Consensus 462 ~~~~~~l~~li~~Cl~~dP~~RPs~~~vl 490 (568)
..++..+.+||.+||+.+|.+||++.+|+
T Consensus 408 ~~~~~~l~~li~~cl~~dp~~RPt~~~i~ 436 (454)
T 1qcf_A 408 ENCPEELYNIMMRCWKNRPEERPTFEYIQ 436 (454)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CCCCHHHHHHHHHHccCChhHCcCHHHHH
Confidence 56678899999999999999999999986
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-43 Score=366.35 Aligned_cols=262 Identities=24% Similarity=0.308 Sum_probs=205.5
Q ss_pred cccCHHHHHHHhcccccceeecccCceeEEEEEe--CCccEEEEEeCcChhHhHHHHHHHHHHHHcCC-----CCceeee
Q 008365 217 RKYTIEEIEEATDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIR-----HPNMVLL 289 (568)
Q Consensus 217 ~~~~~~ei~~~~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~-----HpnIv~l 289 (568)
..+.+.+...+.++|.+.++||+|+||.||+|.+ +++.||||+++... .....+..|+.+++.+. |||||++
T Consensus 23 ~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~h~~iv~~ 101 (360)
T 3llt_A 23 VHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK-KYTRSAKIEADILKKIQNDDINNNNIVKY 101 (360)
T ss_dssp GSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCH-HHHHHHHHHHHHHHHTCCCSTTGGGBCCE
T ss_pred eeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccch-hhhhhhHHHHHHHHHhcccCCCCCCeecc
Confidence 3444455555778999999999999999999998 67789999997543 33456788999999986 9999999
Q ss_pred ccccCC--CceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccC----
Q 008365 290 LGACPD--YGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDR---- 363 (568)
Q Consensus 290 ~g~~~~--~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~---- 363 (568)
+++|.. ..|+||||+ +++|.+++...... .+++..+..|+.||+.||.|||+.+ |+||||||+||||+.
T Consensus 102 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~ 176 (360)
T 3llt_A 102 HGKFMYYDHMCLIFEPL-GPSLYEIITRNNYN-GFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFE 176 (360)
T ss_dssp EEEEEETTEEEEEECCC-CCBHHHHHHHTTTC-CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTCC
T ss_pred cceeeECCeeEEEEcCC-CCCHHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEcccccc
Confidence 998854 458999999 99999999876533 3889999999999999999999999 999999999999975
Q ss_pred ---------------------CceeEecccccccccCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHH
Q 008365 364 ---------------------NYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGI 422 (568)
Q Consensus 364 ---------------------~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGv 422 (568)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~---------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ 247 (360)
T 3llt_A 177 KSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY---------HGSIINTRQYRAPEVILNLGWDVSSDMWSFGC 247 (360)
T ss_dssp EEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC---------CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHH
T ss_pred ccccchhcccccccccccccCCCCEEEEeccCceecCCC---------CcCccCcccccCcHHHcCCCCCCccchHHHHH
Confidence 789999999999864321 13467999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCchHHHHHHHhCcc-----------------ccccCcc--CCCCCh--------------------H
Q 008365 423 MLLQIITARSPMGLTHHVSRAIEKGTL-----------------AEMLDPA--VTDWPA--------------------E 463 (568)
Q Consensus 423 il~elltG~~Pf~~~~~~~~~~~~~~~-----------------~~~l~~~--~~~~p~--------------------~ 463 (568)
++|+|++|+.||............... ...++.. ...+|. .
T Consensus 248 il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 327 (360)
T 3llt_A 248 VLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKII 327 (360)
T ss_dssp HHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHC
T ss_pred HHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccc
Confidence 999999999999754432211100000 0000000 001111 1
Q ss_pred HHHHHHHHHHHhhccCCCCCCChHHhHhHH
Q 008365 464 AAESFSKLAIQCAELRKKDRPDLGTVIVPE 493 (568)
Q Consensus 464 ~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~ 493 (568)
....+.+|+.+||+.||.+||++.+++.|.
T Consensus 328 ~~~~l~~li~~~L~~dP~~Rpta~elL~hp 357 (360)
T 3llt_A 328 KHELFCDFLYSILQIDPTLRPSPAELLKHK 357 (360)
T ss_dssp CCHHHHHHHHHHCCSSGGGSCCHHHHTTSG
T ss_pred hHHHHHHHHHHHhcCChhhCCCHHHHhcCc
Confidence 125688999999999999999999998654
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=378.66 Aligned_cols=252 Identities=23% Similarity=0.298 Sum_probs=203.7
Q ss_pred HHhcccccceeecccCceeEEEEEe--CCccEEEEEeCcChhH---hHHHHHHHHHHHHcCCCCceeeeccccCCCc--e
Q 008365 226 EATDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQ---GKRQFQQEVEVLSSIRHPNMVLLLGACPDYG--C 298 (568)
Q Consensus 226 ~~~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~---~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~--~ 298 (568)
...++|.+++.||+|+||.||+|++ ++..||||++.+.... ....+.+|+.+|+.++|||||+++++|.+.. |
T Consensus 66 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 145 (410)
T 3v8s_A 66 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLY 145 (410)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEE
Confidence 3567899999999999999999988 4678999999753221 1234789999999999999999999996654 8
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEeccccccccc
Q 008365 299 LVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLV 378 (568)
Q Consensus 299 lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~ 378 (568)
||||||+||+|.+++.... +++..+..++.||+.||.|||+.+ |+||||||+||||+.+|.+||+|||+|+.+
T Consensus 146 lV~E~~~gg~L~~~l~~~~----~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~a~~~ 218 (410)
T 3v8s_A 146 MVMEYMPGGDLVNLMSNYD----VPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKM 218 (410)
T ss_dssp EEECCCTTEEHHHHHHHCC----CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEeCCCCCcHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccceeEee
Confidence 9999999999999887542 889999999999999999999999 999999999999999999999999999876
Q ss_pred CCCCCccccccccccccccccCCChhhhhcCC----CCCcceehhHHHHHHHHHhCCCCCCCchHHH--HHHHhCccccc
Q 008365 379 PPSVADSVTQYHMTSAAGTFCYIDPEYQQTGM----LTTKSDIYSFGIMLLQIITARSPMGLTHHVS--RAIEKGTLAEM 452 (568)
Q Consensus 379 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~----~s~ksDvwSlGvil~elltG~~Pf~~~~~~~--~~~~~~~~~~~ 452 (568)
.... .......+||+.|+|||++.+.. ++.++|||||||++|||++|+.||....... ..+..+... .
T Consensus 219 ~~~~-----~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~-~ 292 (410)
T 3v8s_A 219 NKEG-----MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNS-L 292 (410)
T ss_dssp CTTS-----EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH-C
T ss_pred ccCC-----cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhcccc-c
Confidence 4321 12234678999999999988765 8899999999999999999999997654422 222221110 0
Q ss_pred cCccCCCCChHHHHHHHHHHHHhhccCCCC--CCChHHhHhHHH
Q 008365 453 LDPAVTDWPAEAAESFSKLAIQCAELRKKD--RPDLGTVIVPEL 494 (568)
Q Consensus 453 l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~--RPs~~~vl~~~l 494 (568)
.-+. ...++..+.+||.+||..+|.. ||++.+|+.|.+
T Consensus 293 ~~p~----~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~ 332 (410)
T 3v8s_A 293 TFPD----DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLF 332 (410)
T ss_dssp CCCT----TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGG
T ss_pred cCCC----cccccHHHHHHHHHHccChhhhCCCCCHHHHhcCcc
Confidence 0011 1235677999999999998988 999999987655
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=364.41 Aligned_cols=261 Identities=25% Similarity=0.326 Sum_probs=201.6
Q ss_pred HHHHhcccccceeecccCceeEEEEEe--CCccEEEEEeCcCh-----hHhHHHHHHHHHHHHcCCCCceeeeccccCCC
Q 008365 224 IEEATDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDA-----AQGKRQFQQEVEVLSSIRHPNMVLLLGACPDY 296 (568)
Q Consensus 224 i~~~~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~-----~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~ 296 (568)
+..+.++|.+.+.||+|+||.||+|.+ ++..||||++.... ......+.+|+.+|+.++|||||+++++|.+.
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 456788999999999999999999987 45689999986542 23456789999999999999999999999655
Q ss_pred c--eEEEEecCCCCHHHHHhhcC-------------------------------------CCCCCCHHHHHHHHHHHHHH
Q 008365 297 G--CLVYEYMHNGSLEDRLLRRG-------------------------------------NTPVIPWRKRFKIAAEIATA 337 (568)
Q Consensus 297 ~--~lV~E~~~ggsL~~~l~~~~-------------------------------------~~~~l~~~~~~~i~~qia~a 337 (568)
. ++|||||+||+|.+++.... ....+++..+..|+.||+.|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 4 89999999999999885210 01124677788899999999
Q ss_pred HHHHHHcCCCCcccCCCCCCCeeccCCc--eeEecccccccccCCCCCccccccccccccccccCCChhhhhc--CCCCC
Q 008365 338 LLFLHQAKPEPLVHRDLKPANILLDRNY--VSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQT--GMLTT 413 (568)
Q Consensus 338 L~yLH~~~~~~IiHrDIKp~NILld~~~--~vKL~DFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~--~~~s~ 413 (568)
|.|||+.+ |+||||||+||||+.++ .+||+|||+++.+...... .........||+.|+|||++.+ ..++.
T Consensus 181 l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 255 (345)
T 3hko_A 181 LHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNG--EYYGMTTKAGTPYFVAPEVLNTTNESYGP 255 (345)
T ss_dssp HHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC----------CCCGGGCCHHHHTCSSSCCCT
T ss_pred HHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCcc--ccccccccCCCccccCchhhccCCCCCCc
Confidence 99999999 99999999999998766 8999999999865322111 1122345679999999999875 67899
Q ss_pred cceehhHHHHHHHHHhCCCCCCCchHHHHH--HHhCccccccCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHh
Q 008365 414 KSDIYSFGIMLLQIITARSPMGLTHHVSRA--IEKGTLAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIV 491 (568)
Q Consensus 414 ksDvwSlGvil~elltG~~Pf~~~~~~~~~--~~~~~~~~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~ 491 (568)
++|||||||++|+|++|+.||......... +...... ...+ ....++..+.+|+.+||+.+|.+||++.+++.
T Consensus 256 ~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~-~~~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 330 (345)
T 3hko_A 256 KCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLC-FENP----NYNVLSPLARDLLSNLLNRNVDERFDAMRALQ 330 (345)
T ss_dssp HHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC-TTSG----GGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHH
T ss_pred HHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccc-cCCc----ccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 999999999999999999999765443222 1111110 0011 11235677999999999999999999999987
Q ss_pred HHH
Q 008365 492 PEL 494 (568)
Q Consensus 492 ~~l 494 (568)
+.+
T Consensus 331 hp~ 333 (345)
T 3hko_A 331 HPW 333 (345)
T ss_dssp SHH
T ss_pred Chh
Confidence 665
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-43 Score=361.69 Aligned_cols=247 Identities=26% Similarity=0.442 Sum_probs=195.2
Q ss_pred hcccccceeecccCceeEEEEEe--CCcc----EEEEEeCcC-hhHhHHHHHHHHHHHHcCCCCceeeeccccCCC-ceE
Q 008365 228 TDKFSEAMKIGEGGYGPVYRGKL--DHTP----VAIKVLRPD-AAQGKRQFQQEVEVLSSIRHPNMVLLLGACPDY-GCL 299 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~~~~--~~~~----vAvK~l~~~-~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~-~~l 299 (568)
.++|++.++||+|+||.||+|.+ ++.. ||+|.+... .......+.+|+.+++.++||||++++++|.+. .++
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 93 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQL 93 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSSEEE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCCceE
Confidence 36799999999999999999987 3444 577777543 233456789999999999999999999998554 589
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccC
Q 008365 300 VYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVP 379 (568)
Q Consensus 300 V~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~ 379 (568)
||+|+.+|+|.+++..... .+++..++.|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+.
T Consensus 94 v~~~~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~ 168 (327)
T 3lzb_A 94 ITQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp EECCCSSCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred EEEecCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence 9999999999999987543 3889999999999999999999999 9999999999999999999999999998764
Q ss_pred CCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh-CCCCCCCchH--HHHHHHhCccccccCcc
Q 008365 380 PSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPMGLTHH--VSRAIEKGTLAEMLDPA 456 (568)
Q Consensus 380 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~--~~~~~~~~~~~~~l~~~ 456 (568)
... .........||+.|+|||++.+..++.++|||||||++|+|++ |..||..... +...+..+.
T Consensus 169 ~~~----~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~-------- 236 (327)
T 3lzb_A 169 AEE----KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE-------- 236 (327)
T ss_dssp ---------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC--------
T ss_pred Ccc----ccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC--------
Confidence 322 1122234567889999999999999999999999999999999 9999965332 333332221
Q ss_pred CCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHh
Q 008365 457 VTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIV 491 (568)
Q Consensus 457 ~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~ 491 (568)
....+..++..+.+|+.+||..+|.+||++.+++.
T Consensus 237 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 271 (327)
T 3lzb_A 237 RLPQPPICTIDVYMIMRKCWMIDADSRPKFRELII 271 (327)
T ss_dssp CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 11234456678999999999999999999999874
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=350.67 Aligned_cols=251 Identities=28% Similarity=0.449 Sum_probs=207.9
Q ss_pred HhcccccceeecccCceeEEEEEeC--CccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCceeeeccccCCC--ceEEEE
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKLD--HTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACPDY--GCLVYE 302 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~~--~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~--~~lV~E 302 (568)
..++|.+.+.||+|+||.||+|.+. +..||||++..... ..+.+.+|+.+++.++||||++++++|.+. .++|||
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 89 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 89 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCST-HHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHH-HHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence 4578999999999999999999984 67899999976543 356789999999999999999999998654 489999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCC
Q 008365 303 YMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSV 382 (568)
Q Consensus 303 ~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~ 382 (568)
|++|++|.+++..... ..+++..++.|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++.......
T Consensus 90 ~~~~~~L~~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 165 (288)
T 3kfa_A 90 FMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 165 (288)
T ss_dssp CCTTEEHHHHHHHCCT-TTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS
T ss_pred cCCCCcHHHHHHhccc-CCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccCCc
Confidence 9999999999977544 34899999999999999999999999 9999999999999999999999999998764322
Q ss_pred CccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh-CCCCCCCchH--HHHHHHhCccccccCccCCC
Q 008365 383 ADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPMGLTHH--VSRAIEKGTLAEMLDPAVTD 459 (568)
Q Consensus 383 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~--~~~~~~~~~~~~~l~~~~~~ 459 (568)
........||+.|+|||++.+..++.++|||||||++|+|++ |..||..... +...+.... ...
T Consensus 166 -----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~--------~~~ 232 (288)
T 3kfa_A 166 -----YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY--------RME 232 (288)
T ss_dssp -----SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC--------CCC
T ss_pred -----cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccC--------CCC
Confidence 122234567889999999999999999999999999999999 9999964332 222222211 112
Q ss_pred CChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHHH
Q 008365 460 WPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPELN 495 (568)
Q Consensus 460 ~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l~ 495 (568)
.+..++..+.+|+..||..+|.+||++.+++..+..
T Consensus 233 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~ 268 (288)
T 3kfa_A 233 RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFET 268 (288)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHH
Confidence 345566789999999999999999999999754433
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-43 Score=369.54 Aligned_cols=245 Identities=22% Similarity=0.313 Sum_probs=197.6
Q ss_pred ceeecccCceeEEEEEe--CCccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCceeeeccccCCC--ceEEEEecCCCCH
Q 008365 234 AMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACPDY--GCLVYEYMHNGSL 309 (568)
Q Consensus 234 ~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~--~~lV~E~~~ggsL 309 (568)
.+.||+|+||.||+|.+ ++..||||+++.........+.+|+.+|+.++|||||+++++|.+. .+||||||++|+|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 56899999999999987 5779999999877666677899999999999999999999998654 4899999999999
Q ss_pred HHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeec--cCCceeEecccccccccCCCCCcccc
Q 008365 310 EDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILL--DRNYVSKISDVGLARLVPPSVADSVT 387 (568)
Q Consensus 310 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILl--d~~~~vKL~DFGla~~~~~~~~~~~~ 387 (568)
.+++..... .+++..+..|+.||+.||.|||+.+ |+||||||+|||| +.++.+||+|||+++.+....
T Consensus 174 ~~~l~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~----- 243 (373)
T 2x4f_A 174 FDRIIDESY--NLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE----- 243 (373)
T ss_dssp HHHHHHTGG--GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC-----
T ss_pred HHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc-----
Confidence 998876432 3889999999999999999999999 9999999999999 667899999999998764332
Q ss_pred ccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHH--HHHhCccccccCccCCCCChHHH
Q 008365 388 QYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSR--AIEKGTLAEMLDPAVTDWPAEAA 465 (568)
Q Consensus 388 ~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~--~~~~~~~~~~l~~~~~~~p~~~~ 465 (568)
.....+||+.|+|||++.+..++.++|||||||++|+|++|..||........ .+...... .... ....++
T Consensus 244 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~-~~~~----~~~~~~ 316 (373)
T 2x4f_A 244 --KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWD-LEDE----EFQDIS 316 (373)
T ss_dssp --BCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCC-SCSG----GGTTSC
T ss_pred --ccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC-CChh----hhccCC
Confidence 12345799999999999999999999999999999999999999976544322 22221110 0011 112445
Q ss_pred HHHHHHHHHhhccCCCCCCChHHhHhHHHH
Q 008365 466 ESFSKLAIQCAELRKKDRPDLGTVIVPELN 495 (568)
Q Consensus 466 ~~l~~li~~Cl~~dP~~RPs~~~vl~~~l~ 495 (568)
..+.+|+.+||+.+|.+||++.+++.+.+-
T Consensus 317 ~~~~~li~~~L~~dp~~Rps~~e~l~hp~~ 346 (373)
T 2x4f_A 317 EEAKEFISKLLIKEKSWRISASEALKHPWL 346 (373)
T ss_dssp HHHHHHHHTTSCSSGGGSCCHHHHHHSHHH
T ss_pred HHHHHHHHHHcCCChhhCCCHHHHhcCcCc
Confidence 679999999999999999999999987663
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=377.94 Aligned_cols=255 Identities=25% Similarity=0.268 Sum_probs=203.3
Q ss_pred HHHhcccccceeecccCceeEEEEEe--CCccEEEEEeCcChhH---hHHHHHHHHHHHHcCCCCceeeeccccCCCc--
Q 008365 225 EEATDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQ---GKRQFQQEVEVLSSIRHPNMVLLLGACPDYG-- 297 (568)
Q Consensus 225 ~~~~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~---~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~-- 297 (568)
....++|++.+.||+|+||.||++++ +++.||||++++.... ....+.+|+.+|..++|||||+++++|.+..
T Consensus 57 ~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~ 136 (412)
T 2vd5_A 57 RLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYL 136 (412)
T ss_dssp SCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEE
T ss_pred cCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEE
Confidence 33567899999999999999999987 5789999999754322 2234789999999999999999999986544
Q ss_pred eEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccc
Q 008365 298 CLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARL 377 (568)
Q Consensus 298 ~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~ 377 (568)
|||||||+||+|.+++...+. .+++..+..++.||+.||.|||+.+ ||||||||+||||+.+|++||+|||+++.
T Consensus 137 ~lVmE~~~gg~L~~~l~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DFGla~~ 211 (412)
T 2vd5_A 137 YLVMEYYVGGDLLTLLSKFGE--RIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGSCLK 211 (412)
T ss_dssp EEEECCCCSCBHHHHHHHHSS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEcCCCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeechhhee
Confidence 899999999999999987543 3889999999999999999999999 99999999999999999999999999987
Q ss_pred cCCCCCccccccccccccccccCCChhhhh-------cCCCCCcceehhHHHHHHHHHhCCCCCCCchHHH--HHHHhCc
Q 008365 378 VPPSVADSVTQYHMTSAAGTFCYIDPEYQQ-------TGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVS--RAIEKGT 448 (568)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-------~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~--~~~~~~~ 448 (568)
+..... ......+||+.|+|||++. +..|+.++|||||||++|||++|+.||....... ..+....
T Consensus 212 ~~~~~~-----~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~ 286 (412)
T 2vd5_A 212 LRADGT-----VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYK 286 (412)
T ss_dssp CCTTSC-----EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHH
T ss_pred ccCCCc-----cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Confidence 643211 1223568999999999887 3568999999999999999999999997654422 2221111
Q ss_pred cccccCccCCCCChHHHHHHHHHHHHhhccCCCCC---CChHHhHhHHH
Q 008365 449 LAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDR---PDLGTVIVPEL 494 (568)
Q Consensus 449 ~~~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~R---Ps~~~vl~~~l 494 (568)
..+ ..+..+..++..+.+||.+||. +|.+| |++.+++.|.+
T Consensus 287 --~~~--~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpf 330 (412)
T 2vd5_A 287 --EHL--SLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPF 330 (412)
T ss_dssp --HHC--CCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGG
T ss_pred --cCc--CCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCC
Confidence 001 1111223456789999999999 99998 58888876654
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=382.66 Aligned_cols=246 Identities=25% Similarity=0.322 Sum_probs=195.8
Q ss_pred hcccccceeecccCceeEEEEEe--CCccEEEEEeCcCh---hHhHHHHHHHHHHHHcCCCCceeeeccccCCC--ceEE
Q 008365 228 TDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDA---AQGKRQFQQEVEVLSSIRHPNMVLLLGACPDY--GCLV 300 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~--~~lV 300 (568)
.++|++.+.||+|+||.||+|.+ ++..||||++.... ......+.+|+.+|+.++||||++++++|.+. .|||
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 46799999999999999999987 57799999997542 22335677899999999999999999998543 4899
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCCCCcccCCCCCCCeeccCCceeEecccccccccC
Q 008365 301 YEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQ-AKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVP 379 (568)
Q Consensus 301 ~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~-~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~ 379 (568)
||||+||+|.+++.... .+++..+..|+.||+.||.|||+ .+ ||||||||+||||+.++.+||+|||+++...
T Consensus 227 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 300 (446)
T 4ejn_A 227 MEYANGGELFFHLSRER---VFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGI 300 (446)
T ss_dssp ECCCSSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred EeeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence 99999999999997754 38899999999999999999998 88 9999999999999999999999999997542
Q ss_pred CCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHH--HHHHHhCccccccCccC
Q 008365 380 PSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHV--SRAIEKGTLAEMLDPAV 457 (568)
Q Consensus 380 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~--~~~~~~~~~~~~l~~~~ 457 (568)
.. .......+||+.|+|||++.+..++.++|||||||++|||++|+.||...... ...+....
T Consensus 301 ~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~--------- 365 (446)
T 4ejn_A 301 KD------GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE--------- 365 (446)
T ss_dssp C-----------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC---------
T ss_pred CC------CcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCC---------
Confidence 21 11234578999999999999999999999999999999999999999655432 22222221
Q ss_pred CCCChHHHHHHHHHHHHhhccCCCCCC-----ChHHhHhHHH
Q 008365 458 TDWPAEAAESFSKLAIQCAELRKKDRP-----DLGTVIVPEL 494 (568)
Q Consensus 458 ~~~p~~~~~~l~~li~~Cl~~dP~~RP-----s~~~vl~~~l 494 (568)
..+|..++..+.+||.+||+.||.+|| ++.+++.|.+
T Consensus 366 ~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~ 407 (446)
T 4ejn_A 366 IRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRF 407 (446)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGG
T ss_pred CCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCcc
Confidence 123455667899999999999999999 9999886543
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=349.82 Aligned_cols=245 Identities=24% Similarity=0.378 Sum_probs=205.5
Q ss_pred HhcccccceeecccCceeEEEEEeC--CccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCceeeeccccCCCc--eEEEE
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKLD--HTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACPDYG--CLVYE 302 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~~--~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~--~lV~E 302 (568)
..++|.+.+.||+|+||.||+|.+. +..||+|++..........+.+|+.+++.++||||++++++|.+.. ++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 4578999999999999999999884 4589999997765555678999999999999999999999986554 89999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeec---cCCceeEecccccccccC
Q 008365 303 YMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILL---DRNYVSKISDVGLARLVP 379 (568)
Q Consensus 303 ~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILl---d~~~~vKL~DFGla~~~~ 379 (568)
|+++++|.+++.... .+++..+..|+.||+.||.|||+.+ |+||||||+|||| +.++.+||+|||++..+.
T Consensus 87 ~~~~~~L~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~ 160 (277)
T 3f3z_A 87 LCTGGELFERVVHKR---VFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK 160 (277)
T ss_dssp CCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred ccCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence 999999999887754 3889999999999999999999999 9999999999999 788999999999998764
Q ss_pred CCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHH--HHHHhCccccccCccC
Q 008365 380 PSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVS--RAIEKGTLAEMLDPAV 457 (568)
Q Consensus 380 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~--~~~~~~~~~~~l~~~~ 457 (568)
... ......||+.|+|||++.+. ++.++|||||||++|+|++|..||....... ..+..+..
T Consensus 161 ~~~-------~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-------- 224 (277)
T 3f3z_A 161 PGK-------MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTF-------- 224 (277)
T ss_dssp TTS-------CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC--------
T ss_pred Ccc-------chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCC--------
Confidence 322 12345799999999988765 8999999999999999999999997654322 22222211
Q ss_pred CCCCh----HHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 458 TDWPA----EAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 458 ~~~p~----~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
..+. .++..+.+|+.+||+.+|.+||++.+++.+.+
T Consensus 225 -~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~ 264 (277)
T 3f3z_A 225 -TFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEW 264 (277)
T ss_dssp -CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHH
T ss_pred -CCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHH
Confidence 1121 34577999999999999999999999998766
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-43 Score=351.02 Aligned_cols=245 Identities=27% Similarity=0.428 Sum_probs=202.6
Q ss_pred HhcccccceeecccCceeEEEEEe--CCccEEEEEeCcChh---HhHHHHHHHHHHHHcCCCCceeeeccccCCCc--eE
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAA---QGKRQFQQEVEVLSSIRHPNMVLLLGACPDYG--CL 299 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~---~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~--~l 299 (568)
..++|.+.+.||+|+||.||+|.+ ++..||||++..... .....+.+|+.+++.++||||++++++|.+.. ++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 357899999999999999999987 456799999865432 22456889999999999999999999986544 89
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccC
Q 008365 300 VYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVP 379 (568)
Q Consensus 300 V~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~ 379 (568)
||||+++|+|.+++.... .+++..+..|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++....
T Consensus 87 v~e~~~~~~l~~~l~~~~---~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~ 160 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP 160 (279)
T ss_dssp EECCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC-
T ss_pred EEecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCC
Confidence 999999999999997764 3889999999999999999999999 9999999999999999999999999986543
Q ss_pred CCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHH--HHHhCccccccCccC
Q 008365 380 PSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSR--AIEKGTLAEMLDPAV 457 (568)
Q Consensus 380 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~--~~~~~~~~~~l~~~~ 457 (568)
.. ......||+.|+|||++.+..++.++|||||||++|+|++|..||........ .+....
T Consensus 161 ~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--------- 223 (279)
T 3fdn_A 161 SS--------RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE--------- 223 (279)
T ss_dssp ---------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC---------
T ss_pred cc--------cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCC---------
Confidence 22 12345799999999999999999999999999999999999999975543222 222211
Q ss_pred CCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 458 TDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 458 ~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
..+|..++..+.+|+.+||+.+|.+||++.+++.|.+
T Consensus 224 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~ 260 (279)
T 3fdn_A 224 FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 260 (279)
T ss_dssp CCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHH
T ss_pred CCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCcc
Confidence 1234456677999999999999999999999998766
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-43 Score=363.71 Aligned_cols=254 Identities=26% Similarity=0.405 Sum_probs=203.5
Q ss_pred HhcccccceeecccCceeEEEEEe-------CCccEEEEEeCcCh-hHhHHHHHHHHHHHHcC-CCCceeeeccccCC--
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKL-------DHTPVAIKVLRPDA-AQGKRQFQQEVEVLSSI-RHPNMVLLLGACPD-- 295 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~-------~~~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l-~HpnIv~l~g~~~~-- 295 (568)
..++|.+.+.||+|+||.||+|.+ .+..||||++.... ......+.+|+.+|+.+ +||||++++++|.+
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 122 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 122 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence 457899999999999999999986 23479999997543 23346789999999999 89999999999854
Q ss_pred CceEEEEecCCCCHHHHHhhcCCC--------------------CCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCC
Q 008365 296 YGCLVYEYMHNGSLEDRLLRRGNT--------------------PVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLK 355 (568)
Q Consensus 296 ~~~lV~E~~~ggsL~~~l~~~~~~--------------------~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIK 355 (568)
..++||||+++|+|.+++...... ..+++..++.|+.||+.||.|||+.+ |+|||||
T Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dik 199 (344)
T 1rjb_A 123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLA 199 (344)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCS
T ss_pred ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCC
Confidence 458999999999999999765421 23789999999999999999999999 9999999
Q ss_pred CCCeeccCCceeEecccccccccCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh-CCCCC
Q 008365 356 PANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPM 434 (568)
Q Consensus 356 p~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf 434 (568)
|+||||+.++.+||+|||+++.+.... .........||+.|+|||++.+..++.++|||||||++|+|++ |..||
T Consensus 200 p~NIll~~~~~~kL~Dfg~~~~~~~~~----~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 275 (344)
T 1rjb_A 200 ARNVLVTHGKVVKICDFGLARDIMSDS----NYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY 275 (344)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCT----TSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred hhhEEEcCCCcEEeCCCccCcccccCc----cceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCc
Confidence 999999999999999999998653321 1112344568899999999999999999999999999999998 99999
Q ss_pred CCch---HHHHHHHhCccccccCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHHH
Q 008365 435 GLTH---HVSRAIEKGTLAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPELN 495 (568)
Q Consensus 435 ~~~~---~~~~~~~~~~~~~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l~ 495 (568)
.... .+...+..+. ....+..++..+.+|+.+||..+|.+||++.+++.++..
T Consensus 276 ~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~ 331 (344)
T 1rjb_A 276 PGIPVDANFYKLIQNGF--------KMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 331 (344)
T ss_dssp TTCCCSHHHHHHHHTTC--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ccCCcHHHHHHHHhcCC--------CCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHH
Confidence 6532 2222222221 112344566789999999999999999999999754433
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-43 Score=366.74 Aligned_cols=247 Identities=28% Similarity=0.390 Sum_probs=188.6
Q ss_pred HhcccccceeecccCceeEEEEEeC--CccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCceeeeccccCCC--ceEEEE
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKLD--HTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACPDY--GCLVYE 302 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~~--~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~--~~lV~E 302 (568)
+.++|.+.+.||+|+||.||+|.+. ++.||||+++... ..+.+.+|+.+|+.++||||++++++|.+. .++|||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 128 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE 128 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence 5678999999999999999999984 5689999997653 345688999999999999999999998654 489999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccC---CceeEecccccccccC
Q 008365 303 YMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDR---NYVSKISDVGLARLVP 379 (568)
Q Consensus 303 ~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~---~~~vKL~DFGla~~~~ 379 (568)
|+++|+|.+++...+ .+++..+..|+.||+.||.|||+.+ |+||||||+||||+. ++.+||+|||+++...
T Consensus 129 ~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~ 202 (349)
T 2w4o_A 129 LVTGGELFDRIVEKG---YYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE 202 (349)
T ss_dssp CCCSCBHHHHHTTCS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred eCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence 999999999987643 3889999999999999999999999 999999999999975 8999999999998653
Q ss_pred CCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHH---HHHHHhCccccccCcc
Q 008365 380 PSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHV---SRAIEKGTLAEMLDPA 456 (568)
Q Consensus 380 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~---~~~~~~~~~~~~l~~~ 456 (568)
... .....+||+.|+|||++.+..++.++|||||||++|+|++|..||...... ...+..... ..
T Consensus 203 ~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~-----~~ 270 (349)
T 2w4o_A 203 HQV-------LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEY-----YF 270 (349)
T ss_dssp -----------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCC-----CC
T ss_pred ccc-------ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCC-----cc
Confidence 221 123467999999999999999999999999999999999999999644322 222222211 11
Q ss_pred CCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHH
Q 008365 457 VTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPE 493 (568)
Q Consensus 457 ~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~ 493 (568)
...+...++..+.+|+.+||..||.+||++.+++.+.
T Consensus 271 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp 307 (349)
T 2w4o_A 271 ISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHP 307 (349)
T ss_dssp CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHST
T ss_pred CCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence 1122345567799999999999999999999998543
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-43 Score=368.29 Aligned_cols=250 Identities=22% Similarity=0.294 Sum_probs=191.8
Q ss_pred hcccccceeecccCceeEEEEEe--CCccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCceeeeccccCCC--ceEEEEe
Q 008365 228 TDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACPDY--GCLVYEY 303 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~--~~lV~E~ 303 (568)
.++|.+.+.||+|+||.||++++ +++.||||++...... ...+.+|+.+++.++|||||+++++|.+. .++||||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI-DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS-CHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc-cHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 46899999999999999999998 5778999999765432 35678999999999999999999998554 4899999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCce--eEecccccccccCCC
Q 008365 304 MHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYV--SKISDVGLARLVPPS 381 (568)
Q Consensus 304 ~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~--vKL~DFGla~~~~~~ 381 (568)
+++|+|.+++...+. +++..+..|+.||+.||.|||+.+ |+||||||+||||+.++. +||+|||+++.....
T Consensus 98 ~~~~~L~~~l~~~~~---~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~ 171 (361)
T 3uc3_A 98 ASGGELYERICNAGR---FSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 171 (361)
T ss_dssp CCSCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred CCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCcccccccc
Confidence 999999999977543 899999999999999999999999 999999999999987765 999999999743221
Q ss_pred CCccccccccccccccccCCChhhhhcCCCCCc-ceehhHHHHHHHHHhCCCCCCCchH---HHHHHHhCccccccCccC
Q 008365 382 VADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTK-SDIYSFGIMLLQIITARSPMGLTHH---VSRAIEKGTLAEMLDPAV 457 (568)
Q Consensus 382 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~k-sDvwSlGvil~elltG~~Pf~~~~~---~~~~~~~~~~~~~l~~~~ 457 (568)
......+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||..... ....+... ... ....
T Consensus 172 -------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~-~~~--~~~~ 241 (361)
T 3uc3_A 172 -------SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRI-LSV--KYSI 241 (361)
T ss_dssp ----------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHH-HTT--CCCC
T ss_pred -------CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHH-hcC--CCCC
Confidence 12244679999999999988887766 8999999999999999999964322 11111100 000 0001
Q ss_pred CCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHHH
Q 008365 458 TDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPELN 495 (568)
Q Consensus 458 ~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l~ 495 (568)
. ....++..+.+|+.+||..+|.+||++.+++.|.+-
T Consensus 242 ~-~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f 278 (361)
T 3uc3_A 242 P-DDIRISPECCHLISRIFVADPATRISIPEIKTHSWF 278 (361)
T ss_dssp C-TTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHH
T ss_pred C-CcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcch
Confidence 1 111345678999999999999999999999987663
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=352.79 Aligned_cols=253 Identities=24% Similarity=0.319 Sum_probs=197.0
Q ss_pred cccccceeecccCceeEEEEEe--CCccEEEEEeCcCh--hHhHHHHHHHHHHHHcCCCCceeeeccccCCC--ceEEEE
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDA--AQGKRQFQQEVEVLSSIRHPNMVLLLGACPDY--GCLVYE 302 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~--~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~--~~lV~E 302 (568)
++|++.++||+|+||.||+|.+ +++.||||++.... ......+.+|+.+++.++||||++++++|.+. .++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 5799999999999999999998 56789999986543 23346788999999999999999999998544 489999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCC
Q 008365 303 YMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSV 382 (568)
Q Consensus 303 ~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~ 382 (568)
|+++ +|.+.+..... .+++..+..|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+....
T Consensus 82 ~~~~-~l~~~~~~~~~--~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 155 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSCNG--DLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSE-EHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSCC
T ss_pred cCCC-CHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCcc
Confidence 9964 66666655332 3899999999999999999999999 9999999999999999999999999998764321
Q ss_pred CccccccccccccccccCCChhhhhcCC-CCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHH---h--Cccccc----
Q 008365 383 ADSVTQYHMTSAAGTFCYIDPEYQQTGM-LTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIE---K--GTLAEM---- 452 (568)
Q Consensus 383 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~-~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~---~--~~~~~~---- 452 (568)
.......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.........+. . +.....
T Consensus 156 ------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 229 (292)
T 3o0g_A 156 ------RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPS 229 (292)
T ss_dssp ------SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTT
T ss_pred ------ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhh
Confidence 1224567999999999887765 89999999999999999998888633222211111 0 000000
Q ss_pred --------------cCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHH
Q 008365 453 --------------LDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPE 493 (568)
Q Consensus 453 --------------l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~ 493 (568)
.........+.++..+.+|+.+||+.||.+||++.+++.|.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 284 (292)
T 3o0g_A 230 MTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHP 284 (292)
T ss_dssp GGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred hcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCc
Confidence 00011122335667899999999999999999999998654
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-43 Score=358.67 Aligned_cols=256 Identities=26% Similarity=0.362 Sum_probs=197.8
Q ss_pred HhcccccceeecccCceeEEEEEe--CCccEEEEEeCcChh-----HhHHHHHHHHHHHHcC---CCCceeeeccccCC-
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAA-----QGKRQFQQEVEVLSSI---RHPNMVLLLGACPD- 295 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~-----~~~~~~~~Ev~iL~~l---~HpnIv~l~g~~~~- 295 (568)
..++|++.+.||+|+||.||+|.+ +++.||||++..... .....+.+|+.+++.+ +||||++++++|..
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 567999999999999999999996 677999999864321 1123566777777766 49999999998843
Q ss_pred ------CceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEe
Q 008365 296 ------YGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKI 369 (568)
Q Consensus 296 ------~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL 369 (568)
..++||||+. |+|.+++...... .+++..+..|+.||+.||.|||+.+ |+||||||+||||+.++.+||
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~-~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl 161 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPP-GLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKL 161 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCCTT-CSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEE
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhccCC-CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEE
Confidence 2389999995 6999998775433 3899999999999999999999999 999999999999999999999
Q ss_pred cccccccccCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHH--h-
Q 008365 370 SDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIE--K- 446 (568)
Q Consensus 370 ~DFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~--~- 446 (568)
+|||+++.+.... .....+||+.|+|||++.+..++.++|||||||++|+|++|++||........... .
T Consensus 162 ~Dfg~a~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~ 234 (308)
T 3g33_A 162 ADFGLARIYSYQM-------ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDL 234 (308)
T ss_dssp CSCSCTTTSTTCC-------CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHH
T ss_pred eeCccccccCCCc-------ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 9999998654321 22456799999999999999999999999999999999999999976544322211 0
Q ss_pred -Ccccc-c-----------cCcc----CCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 447 -GTLAE-M-----------LDPA----VTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 447 -~~~~~-~-----------l~~~----~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
+.... . +.+. .....+.++..+.+|+.+||+.||.+||++.+++.|.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~ 299 (308)
T 3g33_A 235 IGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSY 299 (308)
T ss_dssp HCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTT
T ss_pred hCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCcc
Confidence 00000 0 0000 00011245678899999999999999999999986544
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=351.03 Aligned_cols=254 Identities=19% Similarity=0.241 Sum_probs=201.1
Q ss_pred HhcccccceeecccCceeEEEEEe--CCccEEEEEeCcChhHhHHHHHHHHHHHHcC-CCCceeeeccccCC--CceEEE
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQGKRQFQQEVEVLSSI-RHPNMVLLLGACPD--YGCLVY 301 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l-~HpnIv~l~g~~~~--~~~lV~ 301 (568)
..++|.+.+.||+|+||.||+|.+ +++.||||++..... ...+.+|+.++..+ +|+||+++++++.+ ..++||
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~ 85 (298)
T 1csn_A 8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI 85 (298)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc--cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEE
Confidence 346799999999999999999995 678999999865432 24578899999999 79999999998854 348999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCce-----eEeccccccc
Q 008365 302 EYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYV-----SKISDVGLAR 376 (568)
Q Consensus 302 E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~-----vKL~DFGla~ 376 (568)
||+ +++|.+++...+. .+++..+..|+.||+.||.|||+.+ |+||||||+||||+.++. +||+|||+++
T Consensus 86 e~~-~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~ 159 (298)
T 1csn_A 86 DLL-GPSLEDLLDLCGR--KFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159 (298)
T ss_dssp ECC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred Eec-CCCHHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECcccc
Confidence 999 9999999987543 3899999999999999999999999 999999999999987765 9999999998
Q ss_pred ccCCCCCccc-cccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchH-----HHHHHHhCccc
Q 008365 377 LVPPSVADSV-TQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHH-----VSRAIEKGTLA 450 (568)
Q Consensus 377 ~~~~~~~~~~-~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~-----~~~~~~~~~~~ 450 (568)
.+........ .........||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ....+......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 239 (298)
T 1csn_A 160 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS 239 (298)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred ccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccC
Confidence 7654322111 11223456899999999999999999999999999999999999999965321 11111111110
Q ss_pred cccCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhH
Q 008365 451 EMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVP 492 (568)
Q Consensus 451 ~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~ 492 (568)
.. ....+..++..+.+|+.+||+.+|.+||++.+|+..
T Consensus 240 ~~----~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~ 277 (298)
T 1csn_A 240 TP----LRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGL 277 (298)
T ss_dssp SC----HHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHH
T ss_pred cc----HHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 00 111122456779999999999999999999998743
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=375.76 Aligned_cols=261 Identities=19% Similarity=0.266 Sum_probs=186.5
Q ss_pred HhcccccceeecccCceeEEEEEe--CCccEEEEEeCcC--hhHhHHHHHHHHHHHHcCCCCceeeeccccCC-------
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPD--AAQGKRQFQQEVEVLSSIRHPNMVLLLGACPD------- 295 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~------- 295 (568)
..++|.+++.||+|+||.||+|.+ +++.||||++... .....+.+.+|+.+|+.++|||||+++++|..
T Consensus 51 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 130 (458)
T 3rp9_A 51 IPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFD 130 (458)
T ss_dssp SCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred cCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCc
Confidence 347899999999999999999986 5779999998653 33445678899999999999999999998832
Q ss_pred CceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccc
Q 008365 296 YGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLA 375 (568)
Q Consensus 296 ~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla 375 (568)
..|+||||+ +|+|.+++.... .+++..+..|+.||+.||.|||+.+ ||||||||+||||+.++.+||+|||++
T Consensus 131 ~~~lv~e~~-~~~L~~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla 203 (458)
T 3rp9_A 131 ELYVVLEIA-DSDFKKLFRTPV---YLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLA 203 (458)
T ss_dssp CEEEEECCC-SEEHHHHHHSSC---CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecc-ccchhhhcccCC---CCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccc
Confidence 248999998 689999886543 3899999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCccc---------------------cccccccccccccCCChhhh-hcCCCCCcceehhHHHHHHHHHh----
Q 008365 376 RLVPPSVADSV---------------------TQYHMTSAAGTFCYIDPEYQ-QTGMLTTKSDIYSFGIMLLQIIT---- 429 (568)
Q Consensus 376 ~~~~~~~~~~~---------------------~~~~~~~~~GT~~Y~APE~~-~~~~~s~ksDvwSlGvil~ellt---- 429 (568)
+.+........ .....+..+||++|+|||++ .+..|+.++||||||||||||++
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~ 283 (458)
T 3rp9_A 204 RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKE 283 (458)
T ss_dssp BCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTT
T ss_pred hhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccc
Confidence 87643221100 01134567899999999976 56679999999999999999999
Q ss_pred -------CCCCCCCchH-----------------------HHHHHH-hCc----------------ccccc----CccCC
Q 008365 430 -------ARSPMGLTHH-----------------------VSRAIE-KGT----------------LAEML----DPAVT 458 (568)
Q Consensus 430 -------G~~Pf~~~~~-----------------------~~~~~~-~~~----------------~~~~l----~~~~~ 458 (568)
|+++|..... +...+. .+. +...+ ...+.
T Consensus 284 ~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 363 (458)
T 3rp9_A 284 NVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLA 363 (458)
T ss_dssp TCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGG
T ss_pred cccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHH
Confidence 6666643221 000000 000 00000 00011
Q ss_pred CCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 459 DWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 459 ~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
...+.++..+.+|+.+||..||.+||++.+++.|.+
T Consensus 364 ~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~ 399 (458)
T 3rp9_A 364 ERFPASSADAIHLLKRMLVFNPNKRITINECLAHPF 399 (458)
T ss_dssp GGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGG
T ss_pred HHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHh
Confidence 112344677899999999999999999999987654
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=354.15 Aligned_cols=255 Identities=26% Similarity=0.406 Sum_probs=206.6
Q ss_pred HhcccccceeecccCceeEEEEEe-------CCccEEEEEeCcCh-hHhHHHHHHHHHHHHcC-CCCceeeeccccCC--
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKL-------DHTPVAIKVLRPDA-AQGKRQFQQEVEVLSSI-RHPNMVLLLGACPD-- 295 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~-------~~~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l-~HpnIv~l~g~~~~-- 295 (568)
..++|.+.+.||+|+||.||+|.+ .+..||||+++... ....+.+.+|+.+|+.+ +||||++++++|.+
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 100 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence 346899999999999999999985 34689999997653 23456789999999999 89999999999854
Q ss_pred CceEEEEecCCCCHHHHHhhcCCC---------------CCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCee
Q 008365 296 YGCLVYEYMHNGSLEDRLLRRGNT---------------PVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANIL 360 (568)
Q Consensus 296 ~~~lV~E~~~ggsL~~~l~~~~~~---------------~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NIL 360 (568)
..++||||+++|+|.+++...... ..+++..++.++.||+.||.|||+.+ |+||||||+|||
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil 177 (313)
T 1t46_A 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNIL 177 (313)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEE
Confidence 448999999999999999875421 24899999999999999999999999 999999999999
Q ss_pred ccCCceeEecccccccccCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh-CCCCCCCch-
Q 008365 361 LDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPMGLTH- 438 (568)
Q Consensus 361 ld~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~- 438 (568)
|+.++.+||+|||+++.+..... ........||+.|+|||++.+..++.++|||||||++|+|++ |..||....
T Consensus 178 ~~~~~~~kl~Dfg~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 253 (313)
T 1t46_A 178 LTHGRITKICDFGLARDIKNDSN----YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253 (313)
T ss_dssp EETTTEEEECCCGGGSCTTSCTT----SEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred EcCCCCEEEcccccccccccccc----ceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccc
Confidence 99999999999999987644321 112234568899999999999999999999999999999999 999996532
Q ss_pred --HHHHHHHhCccccccCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHHHH
Q 008365 439 --HVSRAIEKGTLAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPELNR 496 (568)
Q Consensus 439 --~~~~~~~~~~~~~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l~~ 496 (568)
.....+..+. . ...+..++..+.+|+.+||+.+|.+||++.+++..+.+.
T Consensus 254 ~~~~~~~~~~~~-----~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 305 (313)
T 1t46_A 254 DSKFYKMIKEGF-----R---MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305 (313)
T ss_dssp SHHHHHHHHHTC-----C---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred hhHHHHHhccCC-----C---CCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 2222222211 1 112344567799999999999999999999998544333
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-43 Score=360.06 Aligned_cols=254 Identities=23% Similarity=0.357 Sum_probs=205.9
Q ss_pred cccccceeecccCceeEEEEEe------CCccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCceeeeccccC--C--Cce
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKL------DHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACP--D--YGC 298 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~------~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~--~--~~~ 298 (568)
++|++.+.||+|+||.||+|.+ .+..||||++........+.+.+|+.+|+.++||||+++++++. + ..+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 6899999999999999999984 56789999998877777778999999999999999999999873 2 247
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEeccccccccc
Q 008365 299 LVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLV 378 (568)
Q Consensus 299 lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~ 378 (568)
+||||+++++|.+++..... .+++..++.|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+
T Consensus 103 lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 177 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRHRA--RLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLL 177 (327)
T ss_dssp EEEECCTTCBHHHHHHHHGG--GCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEEC
T ss_pred EEEeecCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccceec
Confidence 99999999999999976432 3899999999999999999999999 999999999999999999999999999876
Q ss_pred CCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHh--------Cccc
Q 008365 379 PPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEK--------GTLA 450 (568)
Q Consensus 379 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~--------~~~~ 450 (568)
..... .........||+.|+|||++.+..++.++|||||||++|+|++|..||............ ..+.
T Consensus 178 ~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (327)
T 3lxl_A 178 PLDKD---YYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLL 254 (327)
T ss_dssp CTTCS---EEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHH
T ss_pred ccCCc---cceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHH
Confidence 44321 111223457899999999999999999999999999999999999999543321100000 0000
Q ss_pred c-ccCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhH
Q 008365 451 E-MLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVI 490 (568)
Q Consensus 451 ~-~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl 490 (568)
. .........+..++..+.+|+..||+.+|.+||++.+++
T Consensus 255 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell 295 (327)
T 3lxl_A 255 ELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALG 295 (327)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred HHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHH
Confidence 0 011112234556778899999999999999999999987
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=349.56 Aligned_cols=249 Identities=26% Similarity=0.391 Sum_probs=197.5
Q ss_pred hcccccceeecccCceeEEEEEeCC-----ccEEEEEeCcC-hhHhHHHHHHHHHHHHcCCCCceeeeccccCC---Cce
Q 008365 228 TDKFSEAMKIGEGGYGPVYRGKLDH-----TPVAIKVLRPD-AAQGKRQFQQEVEVLSSIRHPNMVLLLGACPD---YGC 298 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~~~~~~-----~~vAvK~l~~~-~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~---~~~ 298 (568)
...|.+.+.||+|+||.||+|.+.. ..||||++... .......+.+|+.+++.++||||++++++|.+ ..+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 3568999999999999999998632 25899998764 33445678999999999999999999998632 348
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEeccccccccc
Q 008365 299 LVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLV 378 (568)
Q Consensus 299 lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~ 378 (568)
+||||+++|+|.+++..... .+++..++.|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+
T Consensus 104 ~v~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~ 178 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRNETH--NPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDM 178 (298)
T ss_dssp EEEECCTTCBHHHHHHCTTC--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred EEEeCCCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECcccccccc
Confidence 99999999999999975432 3789999999999999999999999 999999999999999999999999999866
Q ss_pred CCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh-CCCCCCCchH--HHHHHHhCccccccCc
Q 008365 379 PPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPMGLTHH--VSRAIEKGTLAEMLDP 455 (568)
Q Consensus 379 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~--~~~~~~~~~~~~~l~~ 455 (568)
..... ..........||+.|+|||.+.+..++.++|||||||++|+|++ |.+||..... ....+..+.
T Consensus 179 ~~~~~--~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~------- 249 (298)
T 3f66_A 179 YDKEY--YSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR------- 249 (298)
T ss_dssp SCGGG--CBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTC-------
T ss_pred cccch--hccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCC-------
Confidence 43221 11222345678899999999999999999999999999999999 6667754332 222222221
Q ss_pred cCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHh
Q 008365 456 AVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIV 491 (568)
Q Consensus 456 ~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~ 491 (568)
....+..++..+.+++.+||+.+|.+||++.+++.
T Consensus 250 -~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 284 (298)
T 3f66_A 250 -RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 284 (298)
T ss_dssp -CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 11223445677999999999999999999999873
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=344.62 Aligned_cols=245 Identities=27% Similarity=0.463 Sum_probs=203.1
Q ss_pred hcccccceeecccCceeEEEEEe-CCccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCceeeeccccCC--CceEEEEec
Q 008365 228 TDKFSEAMKIGEGGYGPVYRGKL-DHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACPD--YGCLVYEYM 304 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~~~~-~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--~~~lV~E~~ 304 (568)
.++|.+.+.||+|+||.||+|.+ ++..||||++...... .+.+.+|+.+++.++||||++++++|.+ ..++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM 85 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBC-HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCC-HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence 36799999999999999999998 5678999999865433 3678999999999999999999999855 458999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCCc
Q 008365 305 HNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVAD 384 (568)
Q Consensus 305 ~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~~ 384 (568)
++++|.+++..... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 86 ~~~~L~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~-- 158 (267)
T 3t9t_A 86 EHGCLSDYLRTQRG--LFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-- 158 (267)
T ss_dssp TTCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH--
T ss_pred CCCcHHHHHhhCcc--cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEccccccccccccc--
Confidence 99999999976532 3889999999999999999999999 9999999999999999999999999998653211
Q ss_pred cccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh-CCCCCCCchHHH--HHHHhCccccccCccCCCCC
Q 008365 385 SVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPMGLTHHVS--RAIEKGTLAEMLDPAVTDWP 461 (568)
Q Consensus 385 ~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~--~~~~~~~~~~~l~~~~~~~p 461 (568)
........||+.|+|||++.+..++.++|||||||++|+|++ |..||....... ..+..+. ....+
T Consensus 159 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~--------~~~~~ 227 (267)
T 3t9t_A 159 ---YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF--------RLYKP 227 (267)
T ss_dssp ---HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC--------CCCCC
T ss_pred ---ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCC--------cCCCC
Confidence 112234567889999999999999999999999999999999 899997544322 2222221 11223
Q ss_pred hHHHHHHHHHHHHhhccCCCCCCChHHhHh
Q 008365 462 AEAAESFSKLAIQCAELRKKDRPDLGTVIV 491 (568)
Q Consensus 462 ~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~ 491 (568)
..++..+.+++.+||..+|.+||++.+++.
T Consensus 228 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 257 (267)
T 3t9t_A 228 RLASTHVYQIMNHCWRERPEDRPAFSRLLR 257 (267)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccCcHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 445677999999999999999999999874
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=350.52 Aligned_cols=253 Identities=25% Similarity=0.408 Sum_probs=205.8
Q ss_pred hcccccce-eecccCceeEEEEEe----CCccEEEEEeCcCh-hHhHHHHHHHHHHHHcCCCCceeeeccccCCC-ceEE
Q 008365 228 TDKFSEAM-KIGEGGYGPVYRGKL----DHTPVAIKVLRPDA-AQGKRQFQQEVEVLSSIRHPNMVLLLGACPDY-GCLV 300 (568)
Q Consensus 228 ~~~y~~~~-~IG~G~fg~Vy~~~~----~~~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~-~~lV 300 (568)
.++|.+.. .||+|+||.||+|.+ .+..||||+++... ....+.+.+|+.+++.++||||+++++++.+. .++|
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~lv 87 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLV 87 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEE
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEecCCCcEEE
Confidence 35677776 999999999999975 45679999998743 34466789999999999999999999998543 4899
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCC
Q 008365 301 YEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPP 380 (568)
Q Consensus 301 ~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~ 380 (568)
|||+++++|.+++.... ..+++..+..|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+..
T Consensus 88 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 162 (287)
T 1u59_A 88 MEMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA 162 (287)
T ss_dssp EECCTTEEHHHHHTTCT--TTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEeCCCCCHHHHHHhCC--ccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence 99999999999986543 24899999999999999999999999 99999999999999999999999999987643
Q ss_pred CCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh-CCCCCCCchH--HHHHHHhCccccccCccC
Q 008365 381 SVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPMGLTHH--VSRAIEKGTLAEMLDPAV 457 (568)
Q Consensus 381 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~--~~~~~~~~~~~~~l~~~~ 457 (568)
.... ........||+.|+|||++.+..++.++|||||||++|+|++ |+.||..... +...+..+. .
T Consensus 163 ~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~--------~ 231 (287)
T 1u59_A 163 DDSY---YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK--------R 231 (287)
T ss_dssp CSCE---ECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTC--------C
T ss_pred Ccce---eeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCC--------c
Confidence 3211 112234567899999999999999999999999999999998 9999965432 222232221 1
Q ss_pred CCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHHHH
Q 008365 458 TDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPELNR 496 (568)
Q Consensus 458 ~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l~~ 496 (568)
...+..++..+.+++..||..+|.+||++.+++.++..-
T Consensus 232 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 270 (287)
T 1u59_A 232 MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 270 (287)
T ss_dssp CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 234556678899999999999999999999997544333
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=357.06 Aligned_cols=247 Identities=28% Similarity=0.492 Sum_probs=195.1
Q ss_pred cccccceeecccCceeEEEEEeCC------ccEEEEEeCcCh-hHhHHHHHHHHHHHHcCCCCceeeeccccCCC--ceE
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKLDH------TPVAIKVLRPDA-AQGKRQFQQEVEVLSSIRHPNMVLLLGACPDY--GCL 299 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~~~------~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~--~~l 299 (568)
++|.+.+.||+|+||.||+|.+.. ..||||+++... ......+.+|+.+++.++||||+++++++.+. .++
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 123 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 123 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence 568889999999999999998632 259999997653 33455789999999999999999999998654 489
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccC
Q 008365 300 VYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVP 379 (568)
Q Consensus 300 V~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~ 379 (568)
||||+++|+|.+++..... .+++..++.|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+.
T Consensus 124 v~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 198 (333)
T 1mqb_A 124 ITEYMENGALDKFLREKDG--EFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE 198 (333)
T ss_dssp EEECCTTEEHHHHHHHTTT--CSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred EEeCCCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhhc
Confidence 9999999999999976532 3899999999999999999999999 9999999999999999999999999998764
Q ss_pred CCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh-CCCCCCCchH--HHHHHHhCccccccCcc
Q 008365 380 PSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPMGLTHH--VSRAIEKGTLAEMLDPA 456 (568)
Q Consensus 380 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~--~~~~~~~~~~~~~l~~~ 456 (568)
..... ........+|+.|+|||++.+..++.++|||||||++|+|++ |..||..... +...+..+.
T Consensus 199 ~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~-------- 267 (333)
T 1mqb_A 199 DDPEA---TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGF-------- 267 (333)
T ss_dssp ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC--------
T ss_pred ccccc---ccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCC--------
Confidence 32211 112233457889999999999999999999999999999999 9999965433 222222221
Q ss_pred CCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHh
Q 008365 457 VTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIV 491 (568)
Q Consensus 457 ~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~ 491 (568)
....+..++..+.+|+.+||+.+|.+||++.+++.
T Consensus 268 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 302 (333)
T 1mqb_A 268 RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVS 302 (333)
T ss_dssp CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 11224456678999999999999999999999874
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=347.44 Aligned_cols=250 Identities=22% Similarity=0.323 Sum_probs=205.3
Q ss_pred HhcccccceeecccCceeEEEEEe--CCccEEEEEeCcCh--hHhHHHHHHHHHHHHcCCCCceeeeccccCCCc--eEE
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDA--AQGKRQFQQEVEVLSSIRHPNMVLLLGACPDYG--CLV 300 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~--~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~--~lV 300 (568)
+.++|.+.+.||+|+||.||+|.+ ++..||||++.... ......+.+|+.+++.++||||++++++|.+.. ++|
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 457899999999999999999987 47799999986543 334567889999999999999999999986544 899
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCce---eEecccccccc
Q 008365 301 YEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYV---SKISDVGLARL 377 (568)
Q Consensus 301 ~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~---vKL~DFGla~~ 377 (568)
|||+++++|.+.+.... .+++..+..++.||+.||.|||+.+ |+||||||+||||+.++. +||+|||++..
T Consensus 84 ~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~ 157 (284)
T 3kk8_A 84 FDLVTGGELFEDIVARE---FYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIE 157 (284)
T ss_dssp ECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred EecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEE
Confidence 99999999999887764 3889999999999999999999999 999999999999976554 99999999976
Q ss_pred cCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHH--HHHHHhCccccccCc
Q 008365 378 VPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHV--SRAIEKGTLAEMLDP 455 (568)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~--~~~~~~~~~~~~l~~ 455 (568)
..... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...... ...+..+.... ..+
T Consensus 158 ~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~ 229 (284)
T 3kk8_A 158 VNDSE-------AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDY-PSP 229 (284)
T ss_dssp CCSSC-------BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC-CTT
T ss_pred cccCc-------cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccC-Cch
Confidence 54321 123467999999999999999999999999999999999999999654432 22233322211 111
Q ss_pred cCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 456 AVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 456 ~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
....++..+.+|+..||+.+|.+||++.+++.+.+
T Consensus 230 ----~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~ 264 (284)
T 3kk8_A 230 ----EWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPW 264 (284)
T ss_dssp ----TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHH
T ss_pred ----hhcccCHHHHHHHHHHcccChhhCCCHHHHhcCcc
Confidence 12345567999999999999999999999997765
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=358.83 Aligned_cols=262 Identities=24% Similarity=0.342 Sum_probs=194.2
Q ss_pred hcccccceeecccCceeEEEEEeCCccEEEEEeCcChhHhHHHHHHHHHH--HHcCCCCceeeecccc-----CC--Cce
Q 008365 228 TDKFSEAMKIGEGGYGPVYRGKLDHTPVAIKVLRPDAAQGKRQFQQEVEV--LSSIRHPNMVLLLGAC-----PD--YGC 298 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~i--L~~l~HpnIv~l~g~~-----~~--~~~ 298 (568)
.++|.+.+.||+|+||.||+|+++++.||||++..... ..+..|.++ +..++||||+++++.+ .+ ..+
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~---~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 88 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFANR---QNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYL 88 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTEEEEEEEEEGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEE
T ss_pred hHHhheeeecccCCCeEEEEEEECCeEEEEEEeeccch---hhHHHHHHHHHHHhccCcchhhheecccccccCCCceEE
Confidence 46899999999999999999999999999999975432 334444444 4568999999999743 22 237
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHc---------CCCCcccCCCCCCCeeccCCceeEe
Q 008365 299 LVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQA---------KPEPLVHRDLKPANILLDRNYVSKI 369 (568)
Q Consensus 299 lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~---------~~~~IiHrDIKp~NILld~~~~vKL 369 (568)
+|||||++|+|.+++.... +++..+..|+.||+.||.|||+. + |+||||||+||||+.++.+||
T Consensus 89 lv~e~~~~g~L~~~l~~~~----~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~kL 161 (336)
T 3g2f_A 89 LVMEYYPNGSLXKYLSLHT----SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGTCVI 161 (336)
T ss_dssp EEECCCTTCBHHHHHHHCC----BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSCEEE
T ss_pred EEEecCCCCcHHHHHhhcc----cchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCcEEE
Confidence 9999999999999997654 58889999999999999999999 7 999999999999999999999
Q ss_pred cccccccccCCCCCcc--ccccccccccccccCCChhhhhc-------CCCCCcceehhHHHHHHHHHhCCCCCCCchH-
Q 008365 370 SDVGLARLVPPSVADS--VTQYHMTSAAGTFCYIDPEYQQT-------GMLTTKSDIYSFGIMLLQIITARSPMGLTHH- 439 (568)
Q Consensus 370 ~DFGla~~~~~~~~~~--~~~~~~~~~~GT~~Y~APE~~~~-------~~~s~ksDvwSlGvil~elltG~~Pf~~~~~- 439 (568)
+|||+++.+....... .........+||+.|+|||++.+ ..++.++|||||||++|||++|..||.....
T Consensus 162 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~ 241 (336)
T 3g2f_A 162 SDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESV 241 (336)
T ss_dssp CCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCC
T ss_pred eeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccch
Confidence 9999998764322111 11122335679999999999876 4567789999999999999999777632110
Q ss_pred -------------------HHHHHHhCccccccCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHHHHHHHH
Q 008365 440 -------------------VSRAIEKGTLAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPELNRLKDL 500 (568)
Q Consensus 440 -------------------~~~~~~~~~~~~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l~~L~~l 500 (568)
....+........+.... .....++..+.+||.+||+.+|.+||++.+++ +.|+.+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l----~~L~~l 316 (336)
T 3g2f_A 242 PEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAW-KENSLAVRSLKETIEDCWDQDAEARLTAQXAE----ERMAEL 316 (336)
T ss_dssp CCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTC-CCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHH----HHHHHH
T ss_pred hHHHHhhhcccCCCchHHHHHhhhcccccCCCCCccc-ccccchHHHHHHHHHHHhcCChhhCcchHHHH----HHHHHH
Confidence 111111111111111111 11235778899999999999999999999987 445544
Q ss_pred hhhh
Q 008365 501 GRKL 504 (568)
Q Consensus 501 ~~~~ 504 (568)
...+
T Consensus 317 l~~~ 320 (336)
T 3g2f_A 317 MMIW 320 (336)
T ss_dssp HHCC
T ss_pred HHHH
Confidence 4433
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=363.48 Aligned_cols=245 Identities=23% Similarity=0.380 Sum_probs=179.1
Q ss_pred cccccc---eeecccCceeEEEEEe--CCccEEEEEeCcChhHhHHHHHHHHHHHHcCC-CCceeeeccccCCC--ceEE
Q 008365 229 DKFSEA---MKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIR-HPNMVLLLGACPDY--GCLV 300 (568)
Q Consensus 229 ~~y~~~---~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~-HpnIv~l~g~~~~~--~~lV 300 (568)
++|++. +.||+|+||.||+|.+ +++.||||++... ....+.+|+.+++.+. |||||+++++|.+. .++|
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv 84 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLV 84 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEE
Confidence 445554 7899999999999998 4678999999654 2356788999999997 99999999998655 4899
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCc---eeEecccccccc
Q 008365 301 YEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNY---VSKISDVGLARL 377 (568)
Q Consensus 301 ~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~---~vKL~DFGla~~ 377 (568)
|||++||+|.+++.... .+++..+..|+.||+.||.|||+.+ |+||||||+||||+.++ .+||+|||+++.
T Consensus 85 ~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~ 158 (325)
T 3kn6_A 85 MELLNGGELFERIKKKK---HFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARL 158 (325)
T ss_dssp ECCCCSCBHHHHHHHCS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEE
T ss_pred EEccCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEecccccee
Confidence 99999999999998754 3899999999999999999999999 99999999999997665 899999999986
Q ss_pred cCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchH---------HHHHHHhCc
Q 008365 378 VPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHH---------VSRAIEKGT 448 (568)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~---------~~~~~~~~~ 448 (568)
..... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||..... +...+..+.
T Consensus 159 ~~~~~------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~ 232 (325)
T 3kn6_A 159 KPPDN------QPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGD 232 (325)
T ss_dssp CCC----------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTC
T ss_pred cCCCC------CcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCC
Confidence 54322 122456789999999999999999999999999999999999999964322 112222221
Q ss_pred cccccCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHH
Q 008365 449 LAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPE 493 (568)
Q Consensus 449 ~~~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~ 493 (568)
+. + .......++..+.+|+.+||..||.+||++.+++.+.
T Consensus 233 ~~--~---~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~ 272 (325)
T 3kn6_A 233 FS--F---EGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNE 272 (325)
T ss_dssp CC--C---CSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCG
T ss_pred CC--C---CcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcCh
Confidence 10 0 0000123567899999999999999999999997543
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=364.25 Aligned_cols=251 Identities=24% Similarity=0.319 Sum_probs=197.3
Q ss_pred HhcccccceeecccCceeEEEEEe--CCccEEEEEeCcC--hhHhHHHHHHHHHHHHcCCCCceeeeccccCCC------
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPD--AAQGKRQFQQEVEVLSSIRHPNMVLLLGACPDY------ 296 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~------ 296 (568)
..++|.+.+.||+|+||.||+|.+ +++.||||++... .......+.+|+.+|+.++||||+++++++...
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 102 (367)
T 1cm8_A 23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 102 (367)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred ecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence 357899999999999999999987 5789999998553 233456788999999999999999999988542
Q ss_pred --ceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEeccccc
Q 008365 297 --GCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGL 374 (568)
Q Consensus 297 --~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGl 374 (568)
.|+||||+ +++|.+++... .+++..+..|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+
T Consensus 103 ~~~~lv~e~~-~~~L~~~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~ 174 (367)
T 1cm8_A 103 TDFYLVMPFM-GTDLGKLMKHE----KLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGL 174 (367)
T ss_dssp CCCEEEEECC-SEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred ceEEEEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeec
Confidence 38999999 89999988763 3889999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCccccccccccccccccCCChhhhhc-CCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHH----hCcc
Q 008365 375 ARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQT-GMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIE----KGTL 449 (568)
Q Consensus 375 a~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~----~~~~ 449 (568)
++..... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+....... .+..
T Consensus 175 a~~~~~~---------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~ 245 (367)
T 1cm8_A 175 ARQADSE---------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTP 245 (367)
T ss_dssp CEECCSS---------CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred ccccccc---------cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 9865321 245679999999998877 6799999999999999999999999976554332111 0100
Q ss_pred --------------------ccccCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 450 --------------------AEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 450 --------------------~~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
.......+..+...++..+.+|+.+||..||.+||++.+++.|.+
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~ 310 (367)
T 1cm8_A 246 PAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPY 310 (367)
T ss_dssp CHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGG
T ss_pred CHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChH
Confidence 000011112233455678999999999999999999999986544
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=361.92 Aligned_cols=244 Identities=27% Similarity=0.427 Sum_probs=199.5
Q ss_pred hcccccceeecccCceeEEEEEe--CCccEEEEEeCcC---hhHhHHHHHHHHHHHHcCCCCceeeeccccCC--CceEE
Q 008365 228 TDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPD---AAQGKRQFQQEVEVLSSIRHPNMVLLLGACPD--YGCLV 300 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~---~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--~~~lV 300 (568)
.+.|.+.+.||+|+||.||+|.+ +++.||||++... .......+.+|+.+|+.++|||||+++++|.+ ..++|
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 132 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 132 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence 35699999999999999999986 6789999998654 23334678899999999999999999998854 44899
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCC
Q 008365 301 YEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPP 380 (568)
Q Consensus 301 ~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~ 380 (568)
|||+. |+|.+++..... .+++..+..|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+..
T Consensus 133 ~e~~~-g~l~~~l~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 206 (348)
T 1u5q_A 133 MEYCL-GSASDLLEVHKK--PLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 206 (348)
T ss_dssp EECCS-EEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred EecCC-CCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence 99996 688888765432 3899999999999999999999999 99999999999999999999999999976532
Q ss_pred CCCccccccccccccccccCCChhhhh---cCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHH--HHhCccccccCc
Q 008365 381 SVADSVTQYHMTSAAGTFCYIDPEYQQ---TGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRA--IEKGTLAEMLDP 455 (568)
Q Consensus 381 ~~~~~~~~~~~~~~~GT~~Y~APE~~~---~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~--~~~~~~~~~l~~ 455 (568)
. ...+||+.|+|||++. +..++.++|||||||++|||++|+.||......... +..+. .+
T Consensus 207 ~----------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~-----~~ 271 (348)
T 1u5q_A 207 A----------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE-----SP 271 (348)
T ss_dssp B----------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC-----CC
T ss_pred C----------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC-----CC
Confidence 1 3457999999999885 567899999999999999999999999765443322 11111 11
Q ss_pred cCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 456 AVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 456 ~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
.. .+..++..+.+|+..||+.+|.+||++.+++.+.+
T Consensus 272 ~~--~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~ 308 (348)
T 1u5q_A 272 AL--QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 308 (348)
T ss_dssp CC--CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHH
T ss_pred CC--CCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChh
Confidence 11 12344567899999999999999999999987654
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=358.34 Aligned_cols=250 Identities=20% Similarity=0.308 Sum_probs=204.4
Q ss_pred HhcccccceeecccCceeEEEEEe--CCccEEEEEeCcChhH------hHHHHHHHHHHHHcCCCCceeeeccccCCC--
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQ------GKRQFQQEVEVLSSIRHPNMVLLLGACPDY-- 296 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~------~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~-- 296 (568)
..++|.+.+.||+|+||.||+|.+ ++..||||++...... ....+.+|+.+|+.++||||++++++|.+.
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 89 (321)
T 2a2a_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTD 89 (321)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence 456799999999999999999987 5779999998654321 356789999999999999999999998654
Q ss_pred ceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCc----eeEeccc
Q 008365 297 GCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNY----VSKISDV 372 (568)
Q Consensus 297 ~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~----~vKL~DF 372 (568)
.++||||+++++|.+++.... .+++..+..|+.||+.||.|||+.+ |+||||||+||||+.++ .+||+||
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Df 163 (321)
T 2a2a_A 90 VVLILELVSGGELFDFLAQKE---SLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (321)
T ss_dssp EEEEECCCCSCBHHHHHHTCS---CEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccC
Confidence 489999999999999997643 3899999999999999999999999 99999999999998887 7999999
Q ss_pred ccccccCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHH--HHHhCccc
Q 008365 373 GLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSR--AIEKGTLA 450 (568)
Q Consensus 373 Gla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~--~~~~~~~~ 450 (568)
|+++.+.... ......||+.|+|||++.+..++.++|||||||++|+|++|..||........ .+.....
T Consensus 164 g~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~- 235 (321)
T 2a2a_A 164 GLAHEIEDGV-------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSY- 235 (321)
T ss_dssp TTCEECCTTC-------CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCC-
T ss_pred ccceecCccc-------cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhccc-
Confidence 9998764321 12345799999999999999999999999999999999999999965443222 2222111
Q ss_pred cccCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 451 EMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 451 ~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
.+++ ..+..++..+.+|+.+||..+|.+||++.+++.+.+
T Consensus 236 -~~~~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~ 275 (321)
T 2a2a_A 236 -DFDE---EFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPW 275 (321)
T ss_dssp -CCCH---HHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTT
T ss_pred -ccCh---hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCcc
Confidence 0111 011234567899999999999999999999986544
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=367.00 Aligned_cols=248 Identities=23% Similarity=0.357 Sum_probs=202.1
Q ss_pred HhcccccceeecccCceeEEEEEe--CCccEEEEEeCcChhHhHHHHHHHHHHHHcC-CCCceeeeccccCCCc--eEEE
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQGKRQFQQEVEVLSSI-RHPNMVLLLGACPDYG--CLVY 301 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l-~HpnIv~l~g~~~~~~--~lV~ 301 (568)
..++|.+.+.||+|+||.||+|.+ +++.||||++..... .+.+|+++|.++ +|||||+++++|.+.. |+||
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 567899999999999999999988 467899999976542 235688888887 7999999999986644 8999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccC-C---ceeEecccccccc
Q 008365 302 EYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDR-N---YVSKISDVGLARL 377 (568)
Q Consensus 302 E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~-~---~~vKL~DFGla~~ 377 (568)
|||+||+|.+++...+ .+++..+..|+.||+.||.|||+.+ |+||||||+|||+.. + +.+||+|||+++.
T Consensus 96 E~~~gg~L~~~i~~~~---~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~ 169 (342)
T 2qr7_A 96 ELMKGGELLDKILRQK---FFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQ 169 (342)
T ss_dssp CCCCSCBHHHHHHTCT---TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred eCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence 9999999999987654 3899999999999999999999999 999999999999843 2 4599999999986
Q ss_pred cCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCc-----hHHHHHHHhCccccc
Q 008365 378 VPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLT-----HHVSRAIEKGTLAEM 452 (568)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~-----~~~~~~~~~~~~~~~ 452 (568)
+.... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||... ..+...+..+.+.
T Consensus 170 ~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~-- 241 (342)
T 2qr7_A 170 LRAEN------GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFS-- 241 (342)
T ss_dssp CBCTT------CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCC--
T ss_pred CcCCC------CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcc--
Confidence 64321 1224568999999999999888999999999999999999999999642 2233334333321
Q ss_pred cCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHHH
Q 008365 453 LDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPELN 495 (568)
Q Consensus 453 l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l~ 495 (568)
.....+..++..+.+|+.+||..||.+||++.+++.|.+-
T Consensus 242 ---~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~ 281 (342)
T 2qr7_A 242 ---LSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWI 281 (342)
T ss_dssp ---CCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHH
T ss_pred ---cCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCee
Confidence 1112234566789999999999999999999999987764
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=367.43 Aligned_cols=260 Identities=22% Similarity=0.299 Sum_probs=191.5
Q ss_pred HHhcccccceeecccCceeEEEEEe--CCccEEEEEeCcC--hhHhHHHHHHHHHHHHcCC-CCceeeeccccCC----C
Q 008365 226 EATDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPD--AAQGKRQFQQEVEVLSSIR-HPNMVLLLGACPD----Y 296 (568)
Q Consensus 226 ~~~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l~-HpnIv~l~g~~~~----~ 296 (568)
...++|++++.||+|+||.||+|.+ +++.||||++... .......+.+|+.+|+.+. |||||+++++|.. .
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 3567899999999999999999987 5779999998643 3344566789999999997 9999999999842 3
Q ss_pred ceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEeccccccc
Q 008365 297 GCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLAR 376 (568)
Q Consensus 297 ~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~ 376 (568)
.|+|||||+ |+|.+++... .+++..+..|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+|+
T Consensus 86 ~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~ 157 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIRAN----ILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSR 157 (388)
T ss_dssp EEEEEECCS-EEHHHHHHHT----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEecccC-cCHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCcccc
Confidence 489999996 6899988763 3888999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCCcc---------------ccccccccccccccCCChhhhhc-CCCCCcceehhHHHHHHHHHhCCCCCCCchHH
Q 008365 377 LVPPSVADS---------------VTQYHMTSAAGTFCYIDPEYQQT-GMLTTKSDIYSFGIMLLQIITARSPMGLTHHV 440 (568)
Q Consensus 377 ~~~~~~~~~---------------~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~ 440 (568)
.+....... ......+..+||+.|+|||++.+ ..++.++|||||||++|||++|++||......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~ 237 (388)
T 3oz6_A 158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTM 237 (388)
T ss_dssp ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 764311100 01122345789999999998876 67999999999999999999999999765443
Q ss_pred HHHHHhCccccc--------c-------------------CccCCC-------------CChHHHHHHHHHHHHhhccCC
Q 008365 441 SRAIEKGTLAEM--------L-------------------DPAVTD-------------WPAEAAESFSKLAIQCAELRK 480 (568)
Q Consensus 441 ~~~~~~~~~~~~--------l-------------------~~~~~~-------------~p~~~~~~l~~li~~Cl~~dP 480 (568)
......-..... + ...... .+..++..+.+|+.+||..||
T Consensus 238 ~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP 317 (388)
T 3oz6_A 238 NQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNP 317 (388)
T ss_dssp HHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSG
T ss_pred HHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCc
Confidence 322110000000 0 000000 011345678999999999999
Q ss_pred CCCCChHHhHhHH
Q 008365 481 KDRPDLGTVIVPE 493 (568)
Q Consensus 481 ~~RPs~~~vl~~~ 493 (568)
.+||++.+++.|.
T Consensus 318 ~~R~t~~e~l~Hp 330 (388)
T 3oz6_A 318 NKRISANDALKHP 330 (388)
T ss_dssp GGSCCHHHHTTST
T ss_pred ccCCCHHHHhCCH
Confidence 9999999998554
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=352.74 Aligned_cols=265 Identities=27% Similarity=0.406 Sum_probs=211.9
Q ss_pred cCHHHHHHHhcccccceeecccCceeEEEEEe-------CCccEEEEEeCcCh-hHhHHHHHHHHHHHHcC-CCCceeee
Q 008365 219 YTIEEIEEATDKFSEAMKIGEGGYGPVYRGKL-------DHTPVAIKVLRPDA-AQGKRQFQQEVEVLSSI-RHPNMVLL 289 (568)
Q Consensus 219 ~~~~ei~~~~~~y~~~~~IG~G~fg~Vy~~~~-------~~~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l-~HpnIv~l 289 (568)
+...+.....++|.+.+.||+|+||.||+|.+ .++.||||+++... ......+.+|+.++..+ +||||+++
T Consensus 17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 34444555678999999999999999999974 34689999997653 33456789999999999 69999999
Q ss_pred ccccCC---CceEEEEecCCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCC
Q 008365 290 LGACPD---YGCLVYEYMHNGSLEDRLLRRGN-------------TPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRD 353 (568)
Q Consensus 290 ~g~~~~---~~~lV~E~~~ggsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrD 353 (568)
+++|.+ ..++||||+++|+|.+++..... ...+++..++.++.||+.||.|||+.+ |+|||
T Consensus 97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~d 173 (316)
T 2xir_A 97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD 173 (316)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---ccccc
Confidence 998754 25899999999999999976543 123789999999999999999999999 99999
Q ss_pred CCCCCeeccCCceeEecccccccccCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh-CCC
Q 008365 354 LKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARS 432 (568)
Q Consensus 354 IKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-G~~ 432 (568)
|||+||||+.++.+||+|||+++.+..... ........||+.|+|||++.+..++.++|||||||++|+|++ |..
T Consensus 174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~----~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~ 249 (316)
T 2xir_A 174 LAARNILLSEKNVVKICDFGLARDIYKDPD----YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS 249 (316)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTT----SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred CccceEEECCCCCEEECCCccccccccCcc----ceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCC
Confidence 999999999999999999999986643221 122345678999999999999999999999999999999998 999
Q ss_pred CCCCch---HHHHHHHhCccccccCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHHHHHH
Q 008365 433 PMGLTH---HVSRAIEKGTLAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPELNRLK 498 (568)
Q Consensus 433 Pf~~~~---~~~~~~~~~~~~~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l~~L~ 498 (568)
||.... .+...+..+.. ...+..++..+.+++..||+.+|.+||++.+++.++-..++
T Consensus 250 p~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 310 (316)
T 2xir_A 250 PYPGVKIDEEFCRRLKEGTR--------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 310 (316)
T ss_dssp SSTTCCCSHHHHHHHHHTCC--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCcccchhHHHHHHhccCcc--------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 996432 22233332211 12234456779999999999999999999999865544443
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=350.10 Aligned_cols=240 Identities=30% Similarity=0.473 Sum_probs=195.5
Q ss_pred hcccccceeecccCceeEEEEEeCCccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCceeeeccccCC---CceEEEEec
Q 008365 228 TDKFSEAMKIGEGGYGPVYRGKLDHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACPD---YGCLVYEYM 304 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~---~~~lV~E~~ 304 (568)
.++|++.+.||+|+||.||+|.+.++.||||+++... ..+.+.+|+.+++.++||||+++++++.+ ..++||||+
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~ 97 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 97 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred hhhceEEeEEecCCCceEEEEEEcCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecC
Confidence 4689999999999999999999999999999997654 34678999999999999999999998632 358999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCCc
Q 008365 305 HNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVAD 384 (568)
Q Consensus 305 ~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~~ 384 (568)
++|+|.+++...+. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 98 ~~~~L~~~l~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~--- 170 (278)
T 1byg_A 98 AKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--- 170 (278)
T ss_dssp TTEEHHHHHHHHHH-HHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred CCCCHHHHHHhccc-ccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeecccccccccc---
Confidence 99999999976532 12788899999999999999999999 999999999999999999999999999754321
Q ss_pred cccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh-CCCCCCCchH--HHHHHHhCccccccCccCCCCC
Q 008365 385 SVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPMGLTHH--VSRAIEKGTLAEMLDPAVTDWP 461 (568)
Q Consensus 385 ~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~--~~~~~~~~~~~~~l~~~~~~~p 461 (568)
.....+|+.|+|||++.+..++.++|||||||++|+|++ |..||..... +...+..+ .....+
T Consensus 171 ------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~--------~~~~~~ 236 (278)
T 1byg_A 171 ------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG--------YKMDAP 236 (278)
T ss_dssp -----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTT--------CCCCCC
T ss_pred ------ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC--------CCCCCc
Confidence 123467899999999999999999999999999999998 9999964332 22222221 112334
Q ss_pred hHHHHHHHHHHHHhhccCCCCCCChHHhH
Q 008365 462 AEAAESFSKLAIQCAELRKKDRPDLGTVI 490 (568)
Q Consensus 462 ~~~~~~l~~li~~Cl~~dP~~RPs~~~vl 490 (568)
..++..+.+++..||+.+|.+||++.+++
T Consensus 237 ~~~~~~l~~li~~~l~~~p~~Rps~~~l~ 265 (278)
T 1byg_A 237 DGCPPAVYEVMKNCWHLDAAMRPSFLQLR 265 (278)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred ccCCHHHHHHHHHHhcCChhhCCCHHHHH
Confidence 56677899999999999999999999987
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=349.28 Aligned_cols=250 Identities=28% Similarity=0.369 Sum_probs=196.2
Q ss_pred HhcccccceeecccCceeEEEEEe--CCccEEEEEeCcCh-hHhHHHHHHHHHHHHcCCCCceeeeccccCCCc--eEEE
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDA-AQGKRQFQQEVEVLSSIRHPNMVLLLGACPDYG--CLVY 301 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~--~lV~ 301 (568)
..++|.+.++||+|+||.||++.+ ++..||||++.... ......+.+|+.+|+.++||||++++++|.+.. ++||
T Consensus 20 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 99 (285)
T 3is5_A 20 IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVM 99 (285)
T ss_dssp HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEE
Confidence 346799999999999999999987 56789999987653 223567899999999999999999999986544 8999
Q ss_pred EecCCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeec---cCCceeEecccccccc
Q 008365 302 EYMHNGSLEDRLLRRG-NTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILL---DRNYVSKISDVGLARL 377 (568)
Q Consensus 302 E~~~ggsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILl---d~~~~vKL~DFGla~~ 377 (568)
||+++|+|.+++.... ....+++..+..|+.||+.||.|||+.+ |+||||||+|||| +.++.+||+|||+++.
T Consensus 100 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~ 176 (285)
T 3is5_A 100 ETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAEL 176 (285)
T ss_dssp CCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC
T ss_pred EeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeeccee
Confidence 9999999999886531 1234899999999999999999999999 9999999999999 4568899999999976
Q ss_pred cCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHH--HHHhCccccccCc
Q 008365 378 VPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSR--AIEKGTLAEMLDP 455 (568)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~--~~~~~~~~~~l~~ 455 (568)
+.... ......||+.|+|||++. ..++.++|||||||++|+|++|+.||........ ...... +
T Consensus 177 ~~~~~-------~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~------~ 242 (285)
T 3is5_A 177 FKSDE-------HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKE------P 242 (285)
T ss_dssp -----------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC------C
T ss_pred cCCcc-------cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCC------c
Confidence 54321 123567999999999876 5689999999999999999999999975543222 111111 1
Q ss_pred cCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHH
Q 008365 456 AVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPE 493 (568)
Q Consensus 456 ~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~ 493 (568)
........+++.+.+|+.+||+.||.+||++.+++.+.
T Consensus 243 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp 280 (285)
T 3is5_A 243 NYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHE 280 (285)
T ss_dssp CCCC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSG
T ss_pred ccccccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCH
Confidence 11111112356788999999999999999999998654
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=360.06 Aligned_cols=252 Identities=22% Similarity=0.333 Sum_probs=196.8
Q ss_pred hcccccceeecccCceeEEEEEe-CCccEEEEEeCcC--hhHhHHHHHHHHHHHHcCCC--CceeeeccccCCC--ceEE
Q 008365 228 TDKFSEAMKIGEGGYGPVYRGKL-DHTPVAIKVLRPD--AAQGKRQFQQEVEVLSSIRH--PNMVLLLGACPDY--GCLV 300 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~~~~-~~~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l~H--pnIv~l~g~~~~~--~~lV 300 (568)
.++|.+.+.||+|+||.||++.+ +++.||||++... .......+.+|+.+|..++| |||+++++++.+. .+||
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 46799999999999999999987 5678999998654 33445678999999999986 9999999998554 4899
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCC
Q 008365 301 YEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPP 380 (568)
Q Consensus 301 ~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~ 380 (568)
||| .+|+|.+++.... .+++..+..|+.||+.||.|||+.+ |+||||||+||||+ ++.+||+|||+++.+..
T Consensus 88 ~e~-~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~ 159 (343)
T 3dbq_A 88 MEC-GNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 159 (343)
T ss_dssp ECC-CSEEHHHHHHHSC---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred EeC-CCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence 995 5899999998754 3889999999999999999999999 99999999999997 57899999999987643
Q ss_pred CCCccccccccccccccccCCChhhhhc-----------CCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHhCcc
Q 008365 381 SVADSVTQYHMTSAAGTFCYIDPEYQQT-----------GMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTL 449 (568)
Q Consensus 381 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~-----------~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~ 449 (568)
... .......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.........+
T Consensus 160 ~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~----- 230 (343)
T 3dbq_A 160 DTT----SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKL----- 230 (343)
T ss_dssp --------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHH-----
T ss_pred ccc----cccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHH-----
Confidence 221 112345689999999999875 678999999999999999999999996432211111
Q ss_pred ccccCcc-CCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHHHH
Q 008365 450 AEMLDPA-VTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPELNR 496 (568)
Q Consensus 450 ~~~l~~~-~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l~~ 496 (568)
...+++. ...+|...+..+.+|+..||+.+|.+||++.+++.+.+-.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~ 278 (343)
T 3dbq_A 231 HAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 278 (343)
T ss_dssp HHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred HHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcccc
Confidence 1111111 1233444556799999999999999999999999887754
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=356.66 Aligned_cols=257 Identities=25% Similarity=0.349 Sum_probs=187.2
Q ss_pred hcccccceeecccCceeEEEEEe--CCccEEEEEeCcChh-HhHHHHHHHHHHHHcCCCCceeeeccccCCC--ceEEEE
Q 008365 228 TDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAA-QGKRQFQQEVEVLSSIRHPNMVLLLGACPDY--GCLVYE 302 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~-~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~--~~lV~E 302 (568)
.++|++++.||+|+||.||+|.+ ++..||||+++.... .....+.+|+.+|+.++|||||+++++|.+. .++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 46799999999999999999987 577999999875432 2335688999999999999999999998654 489999
Q ss_pred ecCCCCHHHHHhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccC
Q 008365 303 YMHNGSLEDRLLRRG---NTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVP 379 (568)
Q Consensus 303 ~~~ggsL~~~l~~~~---~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~ 379 (568)
|++ |+|.+++.... ....+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+.
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 997 69999887542 1234889999999999999999999999 9999999999999999999999999998764
Q ss_pred CCCCccccccccccccccccCCChhhhhc-CCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHH--HHh--Ccccccc-
Q 008365 380 PSVADSVTQYHMTSAAGTFCYIDPEYQQT-GMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRA--IEK--GTLAEML- 453 (568)
Q Consensus 380 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~--~~~--~~~~~~l- 453 (568)
... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......... +.. +.....+
T Consensus 160 ~~~------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 233 (317)
T 2pmi_A 160 IPV------NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLW 233 (317)
T ss_dssp SCC------CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTC
T ss_pred CCc------ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHh
Confidence 321 11234579999999998876 46899999999999999999999999765432211 110 1100000
Q ss_pred ---------CccCC-------------CCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 454 ---------DPAVT-------------DWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 454 ---------~~~~~-------------~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
.+... ..+..++..+.+|+.+||+.||.+||++.+++.+.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~ 296 (317)
T 2pmi_A 234 PSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPW 296 (317)
T ss_dssp GGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGG
T ss_pred hhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChh
Confidence 00000 011134567999999999999999999999986543
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=356.02 Aligned_cols=255 Identities=28% Similarity=0.421 Sum_probs=206.7
Q ss_pred HHHHHhcccccceeecccCceeEEEEEeC-------CccEEEEEeCcCh-hHhHHHHHHHHHHHHcCCCCceeeeccccC
Q 008365 223 EIEEATDKFSEAMKIGEGGYGPVYRGKLD-------HTPVAIKVLRPDA-AQGKRQFQQEVEVLSSIRHPNMVLLLGACP 294 (568)
Q Consensus 223 ei~~~~~~y~~~~~IG~G~fg~Vy~~~~~-------~~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~ 294 (568)
+.....++|.+.+.||+|+||.||+|.+. +..||||++.... ......+.+|+.+++.++||||+++++++.
T Consensus 19 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 98 (322)
T 1p4o_A 19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 98 (322)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred hhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEc
Confidence 34446788999999999999999999764 4689999997543 334557889999999999999999999985
Q ss_pred C--CceEEEEecCCCCHHHHHhhcC-------CCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCc
Q 008365 295 D--YGCLVYEYMHNGSLEDRLLRRG-------NTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNY 365 (568)
Q Consensus 295 ~--~~~lV~E~~~ggsL~~~l~~~~-------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~ 365 (568)
+ ..++||||+++|+|.+++.... ....+++..++.|+.||+.||.|||+.+ |+||||||+||||+.++
T Consensus 99 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~~ 175 (322)
T 1p4o_A 99 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDF 175 (322)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTC
T ss_pred cCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCCC
Confidence 5 4489999999999999987532 1134789999999999999999999999 99999999999999999
Q ss_pred eeEecccccccccCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh-CCCCCCCchHH--HH
Q 008365 366 VSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPMGLTHHV--SR 442 (568)
Q Consensus 366 ~vKL~DFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~--~~ 442 (568)
.+||+|||+++...... .........||+.|+|||++.+..++.++|||||||++|+|++ |..||...... ..
T Consensus 176 ~~kl~Dfg~~~~~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~ 251 (322)
T 1p4o_A 176 TVKIGDFGMTRDIYETD----YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 251 (322)
T ss_dssp CEEECCTTCCCGGGGGG----CEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHH
T ss_pred eEEECcCcccccccccc----ccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHH
Confidence 99999999997653211 1112234567899999999999999999999999999999999 89999754332 22
Q ss_pred HHHhCccccccCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhH
Q 008365 443 AIEKGTLAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVP 492 (568)
Q Consensus 443 ~~~~~~~~~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~ 492 (568)
.+..+. ....+..++..+.+|+.+||+.+|.+||++.+++.+
T Consensus 252 ~~~~~~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~ 293 (322)
T 1p4o_A 252 FVMEGG--------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293 (322)
T ss_dssp HHHTTC--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHcCC--------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 222221 223345566789999999999999999999998743
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=355.92 Aligned_cols=245 Identities=23% Similarity=0.296 Sum_probs=193.2
Q ss_pred HhcccccceeecccCceeEEEEEe--CCccEEEEEeCcCh--hHhHHHHHHHHHHHHcC-CCCceeeeccccCCC--ceE
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDA--AQGKRQFQQEVEVLSSI-RHPNMVLLLGACPDY--GCL 299 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~--~~~~~~~~~Ev~iL~~l-~HpnIv~l~g~~~~~--~~l 299 (568)
..++|++.++||+|+||+||+|.+ +++.||||++.... ......+..|+..+..+ +|||||+++++|.+. .++
T Consensus 55 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~l 134 (311)
T 3p1a_A 55 FQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYL 134 (311)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEE
Confidence 347899999999999999999998 57899999986542 22333445566555544 899999999998554 489
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccC
Q 008365 300 VYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVP 379 (568)
Q Consensus 300 V~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~ 379 (568)
||||+ +++|.+++...+. .+++..++.|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++...
T Consensus 135 v~e~~-~~~L~~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~ 208 (311)
T 3p1a_A 135 QTELC-GPSLQQHCEAWGA--SLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELG 208 (311)
T ss_dssp EEECC-CCBHHHHHHHHCS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC
T ss_pred EEecc-CCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeecc
Confidence 99999 7899998877653 4899999999999999999999999 9999999999999999999999999998664
Q ss_pred CCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHhCccccccCccCCC
Q 008365 380 PSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAVTD 459 (568)
Q Consensus 380 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~l~~~~~~ 459 (568)
... ......||+.|+|||++.+ .++.++|||||||++|||++|..||........ +..+.. .+ .
T Consensus 209 ~~~-------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~-~~~~~~----~~---~ 272 (311)
T 3p1a_A 209 TAG-------AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGWQQ-LRQGYL----PP---E 272 (311)
T ss_dssp -------------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHHH-HTTTCC----CH---H
T ss_pred cCC-------CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHH-HhccCC----Cc---c
Confidence 321 1234569999999998876 799999999999999999999776654433222 222111 11 1
Q ss_pred CChHHHHHHHHHHHHhhccCCCCCCChHHhHhHH
Q 008365 460 WPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPE 493 (568)
Q Consensus 460 ~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~ 493 (568)
++..++..+.+|+.+||+.+|.+||++.+++.+.
T Consensus 273 ~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp 306 (311)
T 3p1a_A 273 FTAGLSSELRSVLVMMLEPDPKLRATAEALLALP 306 (311)
T ss_dssp HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSG
T ss_pred cccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCc
Confidence 1234567799999999999999999999998654
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=379.64 Aligned_cols=246 Identities=28% Similarity=0.464 Sum_probs=205.4
Q ss_pred HhcccccceeecccCceeEEEEEeC--CccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCceeeeccccCC--CceEEEE
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKLD--HTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACPD--YGCLVYE 302 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~~--~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--~~~lV~E 302 (568)
..++|.+.++||+|+||.||+|.+. +..||||+++.... ..+.|.+|+.+|+.++|||||+++++|.+ ..+||||
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E 296 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 296 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc-chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEE
Confidence 3467999999999999999999984 67899999976543 35679999999999999999999999854 4589999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCC
Q 008365 303 YMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSV 382 (568)
Q Consensus 303 ~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~ 382 (568)
||++|+|.+++...... .+++..++.|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+....
T Consensus 297 ~~~~g~L~~~l~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 372 (495)
T 1opk_A 297 FMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT 372 (495)
T ss_dssp CCTTCBHHHHHHHSCTT-TSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTCC
T ss_pred ccCCCCHHHHHHhcCcC-CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCCc
Confidence 99999999999875432 4899999999999999999999999 9999999999999999999999999998764321
Q ss_pred CccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh-CCCCCCCchH--HHHHHHhCccccccCccCCC
Q 008365 383 ADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPMGLTHH--VSRAIEKGTLAEMLDPAVTD 459 (568)
Q Consensus 383 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~--~~~~~~~~~~~~~l~~~~~~ 459 (568)
........+|+.|+|||++.+..++.++|||||||+||||++ |..||..... +...+..+. ...
T Consensus 373 -----~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~--------~~~ 439 (495)
T 1opk_A 373 -----YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY--------RME 439 (495)
T ss_dssp -----EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC--------CCC
T ss_pred -----eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC--------CCC
Confidence 112234567889999999999999999999999999999999 9999965432 222232221 123
Q ss_pred CChHHHHHHHHHHHHhhccCCCCCCChHHhH
Q 008365 460 WPAEAAESFSKLAIQCAELRKKDRPDLGTVI 490 (568)
Q Consensus 460 ~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl 490 (568)
.|..++..+.+||.+||+.+|.+||++.+|+
T Consensus 440 ~~~~~~~~l~~li~~cl~~dP~~RPs~~el~ 470 (495)
T 1opk_A 440 RPEGCPEKVYELMRACWQWNPSDRPSFAEIH 470 (495)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CCCCCCHHHHHHHHHHcCcChhHCcCHHHHH
Confidence 3556778899999999999999999999986
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-42 Score=354.56 Aligned_cols=247 Identities=21% Similarity=0.310 Sum_probs=206.5
Q ss_pred HhcccccceeecccCceeEEEEEe--CCccEEEEEeCcC---hhHhHHHHHHHHHHHHcCCCCceeeeccccCCC--ceE
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPD---AAQGKRQFQQEVEVLSSIRHPNMVLLLGACPDY--GCL 299 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~---~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~--~~l 299 (568)
..++|.+.+.||+|+||.||++.+ ++..||+|++... .......+.+|+.+++.++||||++++++|.+. .++
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 118 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 118 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence 346899999999999999999998 4668999998654 234456788999999999999999999998654 489
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccC
Q 008365 300 VYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVP 379 (568)
Q Consensus 300 V~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~ 379 (568)
||||+++++|.+++.... .+++..++.|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+.
T Consensus 119 v~e~~~~~~L~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 192 (335)
T 2owb_A 119 VLELCRRRSLLELHKRRK---ALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 192 (335)
T ss_dssp EECCCTTCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEecCCCCCHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceecc
Confidence 999999999999887654 3889999999999999999999999 9999999999999999999999999998764
Q ss_pred CCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHH--HHHHhCccccccCccC
Q 008365 380 PSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVS--RAIEKGTLAEMLDPAV 457 (568)
Q Consensus 380 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~--~~~~~~~~~~~l~~~~ 457 (568)
... .......||+.|+|||++.+..++.++|||||||++|+|++|..||....... ..+..+.
T Consensus 193 ~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~--------- 257 (335)
T 2owb_A 193 YDG------ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNE--------- 257 (335)
T ss_dssp STT------CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC---------
T ss_pred cCc------ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCC---------
Confidence 321 11234679999999999999999999999999999999999999997654322 2222221
Q ss_pred CCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 458 TDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 458 ~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
...+..++..+.+|+.+||+.||.+||++.+++.+.+
T Consensus 258 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~ 294 (335)
T 2owb_A 258 YSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEF 294 (335)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHH
T ss_pred CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCcc
Confidence 1234455677899999999999999999999997655
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=356.38 Aligned_cols=256 Identities=25% Similarity=0.374 Sum_probs=197.5
Q ss_pred HHHHHHHhcccccceeecccCceeEEEEEeCCccEEEEEeCcChhHhHHHHHHHHHHHHcC--CCCceeeeccccCC---
Q 008365 221 IEEIEEATDKFSEAMKIGEGGYGPVYRGKLDHTPVAIKVLRPDAAQGKRQFQQEVEVLSSI--RHPNMVLLLGACPD--- 295 (568)
Q Consensus 221 ~~ei~~~~~~y~~~~~IG~G~fg~Vy~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l--~HpnIv~l~g~~~~--- 295 (568)
........++|.+.+.||+|+||.||+|++.++.||||++..... ..+..|.+++..+ +||||+++++++.+
T Consensus 29 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~---~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~ 105 (337)
T 3mdy_A 29 LLVQRTIAKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTEE---ASWFRETEIYQTVLMRHENILGFIAADIKGTG 105 (337)
T ss_dssp HHHHTTHHHHCEEEEEEEEETTEEEEEEEETTEEEEEEEEEGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEESCG
T ss_pred cccccccccceEEEeEeecCCCeEEEEEEECCceEEEEEEecccc---chhhhHHHHHHHHhhcCCCeeeEEEEEccCCC
Confidence 334445678999999999999999999999999999999864432 3445566666554 89999999998743
Q ss_pred ---CceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHc--------CCCCcccCCCCCCCeeccCC
Q 008365 296 ---YGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQA--------KPEPLVHRDLKPANILLDRN 364 (568)
Q Consensus 296 ---~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~--------~~~~IiHrDIKp~NILld~~ 364 (568)
..++||||+++|+|.+++... .+++..++.|+.|++.||.|||+. + |+||||||+||||+.+
T Consensus 106 ~~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dikp~Nill~~~ 178 (337)
T 3mdy_A 106 SWTQLYLITDYHENGSLYDYLKST----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA---IAHRDLKSKNILVKKN 178 (337)
T ss_dssp GGCEEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC---EECSCCCGGGEEECTT
T ss_pred CCCceEEEEeccCCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC---EEecccchHHEEECCC
Confidence 348999999999999999664 389999999999999999999998 7 9999999999999999
Q ss_pred ceeEecccccccccCCCCCccccccccccccccccCCChhhhhcCCCCCc------ceehhHHHHHHHHHhC--------
Q 008365 365 YVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTK------SDIYSFGIMLLQIITA-------- 430 (568)
Q Consensus 365 ~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~k------sDvwSlGvil~elltG-------- 430 (568)
+.+||+|||+++.+...... ........+||+.|+|||++.+..++.. +|||||||++|||++|
T Consensus 179 ~~~kl~Dfg~a~~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~ 256 (337)
T 3mdy_A 179 GTCCIADLGLAVKFISDTNE--VDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVE 256 (337)
T ss_dssp SCEEECCCTTCEECC-----------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCC
T ss_pred CCEEEEeCCCceeecccccc--ccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccc
Confidence 99999999999766433211 1112235689999999999988777665 9999999999999999
Q ss_pred --CCCCCCc-------hHHHHHHHhCccccccCccCCC--CChHHHHHHHHHHHHhhccCCCCCCChHHhHhH
Q 008365 431 --RSPMGLT-------HHVSRAIEKGTLAEMLDPAVTD--WPAEAAESFSKLAIQCAELRKKDRPDLGTVIVP 492 (568)
Q Consensus 431 --~~Pf~~~-------~~~~~~~~~~~~~~~l~~~~~~--~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~ 492 (568)
..||... ......+... .+.+.... .+..++..+.+|+.+||+.+|.+||++.+|+.+
T Consensus 257 ~~~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 257 EYQLPYHDLVPSDPSYEDMREIVCIK----KLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325 (337)
T ss_dssp CCCCTTTTTSCSSCCHHHHHHHHTTS----CCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred cccccHhhhcCCCCchhhhHHHHhhh----ccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence 6676421 1111111111 11221111 123788999999999999999999999998743
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=349.22 Aligned_cols=241 Identities=25% Similarity=0.400 Sum_probs=196.1
Q ss_pred hcccccceeecccCceeEEEEEeCC---------ccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCceeeeccccCC--C
Q 008365 228 TDKFSEAMKIGEGGYGPVYRGKLDH---------TPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACPD--Y 296 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~~~~~~---------~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--~ 296 (568)
.++|.+.+.||+|+||.||+|.+.. ..||+|++........+.+.+|+.+++.++||||++++++|.+ .
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 4679999999999999999998732 4699999987766667889999999999999999999999854 4
Q ss_pred ceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCce--------eE
Q 008365 297 GCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYV--------SK 368 (568)
Q Consensus 297 ~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~--------vK 368 (568)
.++||||+++|+|.+++..... .+++..+..|+.||+.||.|||+.+ |+||||||+||||+.++. +|
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~k 161 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKNKN--CINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIK 161 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHTGG--GCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred CEEEEECCCCCCHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceee
Confidence 5899999999999999977542 3889999999999999999999999 999999999999988876 99
Q ss_pred ecccccccccCCCCCccccccccccccccccCCChhhhhc-CCCCCcceehhHHHHHHHHHhC-CCCCCCchHHHHHHHh
Q 008365 369 ISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQT-GMLTTKSDIYSFGIMLLQIITA-RSPMGLTHHVSRAIEK 446 (568)
Q Consensus 369 L~DFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDvwSlGvil~elltG-~~Pf~~~~~~~~~~~~ 446 (568)
|+|||++..... .....||+.|+|||++.+ ..++.++|||||||++|+|++| .+||............
T Consensus 162 l~Dfg~~~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~ 231 (289)
T 4fvq_A 162 LSDPGISITVLP----------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFY 231 (289)
T ss_dssp ECCCCSCTTTSC----------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH
T ss_pred eccCcccccccC----------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHh
Confidence 999999865422 123468999999999887 6799999999999999999995 5556443332211111
Q ss_pred CccccccCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHh
Q 008365 447 GTLAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIV 491 (568)
Q Consensus 447 ~~~~~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~ 491 (568)
.. ....+...+..+.+|+..||+.+|.+||++.+++.
T Consensus 232 ~~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 268 (289)
T 4fvq_A 232 ED--------RHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIR 268 (289)
T ss_dssp HT--------TCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred hc--------cCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 00 01112233456899999999999999999999873
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=375.96 Aligned_cols=246 Identities=33% Similarity=0.507 Sum_probs=199.3
Q ss_pred HhcccccceeecccCceeEEEEEeCC-ccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCceeeeccccCC-CceEEEEec
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKLDH-TPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACPD-YGCLVYEYM 304 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~~~-~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~-~~~lV~E~~ 304 (568)
..++|.+.++||+|+||.||+|.+.+ ..||||+++.... ..+.|.+|+.+|+.++|||||++++++.+ ..+||||||
T Consensus 182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~iv~e~~ 260 (452)
T 1fmk_A 182 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYM 260 (452)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEECCC
T ss_pred ChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEcCCceEEEehhh
Confidence 45679999999999999999999855 5799999986543 34678999999999999999999999865 448999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCCc
Q 008365 305 HNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVAD 384 (568)
Q Consensus 305 ~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~~ 384 (568)
++|+|.+++..... ..+++..+..|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+.....
T Consensus 261 ~~gsL~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~- 335 (452)
T 1fmk_A 261 SKGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY- 335 (452)
T ss_dssp TTCBHHHHHSHHHH-TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred cCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCCce-
Confidence 99999999975322 23889999999999999999999999 99999999999999999999999999986643211
Q ss_pred cccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh-CCCCCCCchH--HHHHHHhCccccccCccCCCCC
Q 008365 385 SVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPMGLTHH--VSRAIEKGTLAEMLDPAVTDWP 461 (568)
Q Consensus 385 ~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~--~~~~~~~~~~~~~l~~~~~~~p 461 (568)
.......+|+.|+|||++.+..++.++|||||||++|||++ |..||..... +...+..+. ....|
T Consensus 336 ----~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~--------~~~~~ 403 (452)
T 1fmk_A 336 ----TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY--------RMPCP 403 (452)
T ss_dssp -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC--------CCCCC
T ss_pred ----ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC--------CCCCC
Confidence 11234557889999999999999999999999999999999 9999965433 222232221 12335
Q ss_pred hHHHHHHHHHHHHhhccCCCCCCChHHhH
Q 008365 462 AEAAESFSKLAIQCAELRKKDRPDLGTVI 490 (568)
Q Consensus 462 ~~~~~~l~~li~~Cl~~dP~~RPs~~~vl 490 (568)
..++..+.+||.+||+.+|.+||++.+|+
T Consensus 404 ~~~~~~l~~li~~cl~~dP~~Rpt~~~l~ 432 (452)
T 1fmk_A 404 PECPESLHDLMCQCWRKEPEERPTFEYLQ 432 (452)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CCCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 56778899999999999999999999886
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=365.52 Aligned_cols=240 Identities=25% Similarity=0.310 Sum_probs=191.5
Q ss_pred hcccccceeecccCceeEEEEEe--CCccEEEEEeCcChh---HhHHHHHHHHHH-HHcCCCCceeeeccccCCC--ceE
Q 008365 228 TDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAA---QGKRQFQQEVEV-LSSIRHPNMVLLLGACPDY--GCL 299 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~---~~~~~~~~Ev~i-L~~l~HpnIv~l~g~~~~~--~~l 299 (568)
.++|++++.||+|+||.||+|++ ++..||||++++... .....+..|..+ ++.++|||||+++++|.+. .|+
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 46899999999999999999998 466899999976532 223456677776 5778999999999998654 489
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccC
Q 008365 300 VYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVP 379 (568)
Q Consensus 300 V~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~ 379 (568)
||||++||+|.+++...+ .+++..+..++.||+.||.|||+.+ |+||||||+||||+.+|.+||+|||+++...
T Consensus 117 v~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~ 190 (373)
T 2r5t_A 117 VLDYINGGELFYHLQRER---CFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENI 190 (373)
T ss_dssp EEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred EEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence 999999999999998754 3788999999999999999999999 9999999999999999999999999997532
Q ss_pred CCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHH--HHHHHhCccccccCccC
Q 008365 380 PSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHV--SRAIEKGTLAEMLDPAV 457 (568)
Q Consensus 380 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~--~~~~~~~~~~~~l~~~~ 457 (568)
... ......+||+.|+|||++.+..++.++|||||||++|||++|..||...+.. ...+....
T Consensus 191 ~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~--------- 255 (373)
T 2r5t_A 191 EHN------STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKP--------- 255 (373)
T ss_dssp CCC------CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSC---------
T ss_pred cCC------CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc---------
Confidence 211 1234578999999999999999999999999999999999999999755432 22222221
Q ss_pred CCCChHHHHHHHHHHHHhhccCCCCCCChHH
Q 008365 458 TDWPAEAAESFSKLAIQCAELRKKDRPDLGT 488 (568)
Q Consensus 458 ~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~ 488 (568)
..++..++..+.+|+.+||+.+|.+||++.+
T Consensus 256 ~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~ 286 (373)
T 2r5t_A 256 LQLKPNITNSARHLLEGLLQKDRTKRLGAKD 286 (373)
T ss_dssp CCCCSSSCHHHHHHHHHHTCSSGGGSTTTTT
T ss_pred cCCCCCCCHHHHHHHHHHcccCHHhCCCCCC
Confidence 1234456678999999999999999999853
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=374.02 Aligned_cols=247 Identities=15% Similarity=0.154 Sum_probs=193.2
Q ss_pred hcccccceeecccCceeEEEEEe--CCccEEEEEeCcC---hhHhHHHHHHHH---HHHHcCCCCceeeecccc------
Q 008365 228 TDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPD---AAQGKRQFQQEV---EVLSSIRHPNMVLLLGAC------ 293 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~---~~~~~~~~~~Ev---~iL~~l~HpnIv~l~g~~------ 293 (568)
.++|.+.+.||+|+||.||+|.+ +++.||||++... .....+.+.+|+ .+|+.++|||||++++.|
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 47899999999999999999986 5789999998643 333456789999 555666899999998443
Q ss_pred -CCC-------------------ceEEEEecCCCCHHHHHhhcCCC----CCCCHHHHHHHHHHHHHHHHHHHHcCCCCc
Q 008365 294 -PDY-------------------GCLVYEYMHNGSLEDRLLRRGNT----PVIPWRKRFKIAAEIATALLFLHQAKPEPL 349 (568)
Q Consensus 294 -~~~-------------------~~lV~E~~~ggsL~~~l~~~~~~----~~l~~~~~~~i~~qia~aL~yLH~~~~~~I 349 (568)
.+. .||||||+ +|+|.+++...+.. ..+++..++.|+.||+.||.|||+.+ |
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 221 57999999 78999999864321 12446888899999999999999999 9
Q ss_pred ccCCCCCCCeeccCCceeEecccccccccCCCCCccccccccccccccccCCChhhhhcC-----------CCCCcceeh
Q 008365 350 VHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTG-----------MLTTKSDIY 418 (568)
Q Consensus 350 iHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-----------~~s~ksDvw 418 (568)
+||||||+||||+.++.+||+|||+++.... .....+| +.|+|||++.+. .++.++|||
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~---------~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Dvw 297 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA---------RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAW 297 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC---------EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC---------cccCCCC-cCccChhhhcccccccccccccccCChhhhHH
Confidence 9999999999999999999999999985322 2245578 999999999887 899999999
Q ss_pred hHHHHHHHHHhCCCCCCCchHHHHHHHhCccccccCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH-HHH
Q 008365 419 SFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL-NRL 497 (568)
Q Consensus 419 SlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l-~~L 497 (568)
||||++|||++|+.||..... ...+...+ . .+..++..+.+|+.+||+.||.+||++.+++.+.+ ..+
T Consensus 298 SlG~il~elltg~~Pf~~~~~------~~~~~~~~-~----~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~ 366 (377)
T 3byv_A 298 ALGLVIYWIWCADLPITKDAA------LGGSEWIF-R----SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL 366 (377)
T ss_dssp HHHHHHHHHHHSSCCC------------CCSGGGG-S----SCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHH
T ss_pred HHHHHHHHHHHCCCCCccccc------ccchhhhh-h----hccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHH
Confidence 999999999999999954322 11111111 1 12344567999999999999999999999997654 334
Q ss_pred HH
Q 008365 498 KD 499 (568)
Q Consensus 498 ~~ 499 (568)
+.
T Consensus 367 ~~ 368 (377)
T 3byv_A 367 RT 368 (377)
T ss_dssp HH
T ss_pred HH
Confidence 33
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=351.45 Aligned_cols=249 Identities=24% Similarity=0.364 Sum_probs=204.0
Q ss_pred HhcccccceeecccCceeEEEEEe--CCccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCceeeeccccCCC--ceEEEE
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACPDY--GCLVYE 302 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~--~~lV~E 302 (568)
..++|.+.+.||+|+||.||++.+ +++.||||++..........+.+|+.+++.++||||++++++|.+. .++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 457899999999999999999987 5789999999876555556789999999999999999999998654 489999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeec---cCCceeEecccccccccC
Q 008365 303 YMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILL---DRNYVSKISDVGLARLVP 379 (568)
Q Consensus 303 ~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILl---d~~~~vKL~DFGla~~~~ 379 (568)
|+++++|.+++...+ .+++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++...
T Consensus 87 ~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 160 (304)
T 2jam_A 87 LVSGGELFDRILERG---VYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ 160 (304)
T ss_dssp CCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred cCCCccHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence 999999999987654 3889999999999999999999999 9999999999999 788999999999997543
Q ss_pred CCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchH--HHHHHHhCccccccCccC
Q 008365 380 PSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHH--VSRAIEKGTLAEMLDPAV 457 (568)
Q Consensus 380 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~--~~~~~~~~~~~~~l~~~~ 457 (568)
.. ......||+.|+|||++.+..++.++|||||||++|+|++|..||..... ....+..+... ..
T Consensus 161 ~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~-----~~ 227 (304)
T 2jam_A 161 NG--------IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYE-----FE 227 (304)
T ss_dssp CB--------TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCC-----CC
T ss_pred CC--------ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCC-----CC
Confidence 21 12345799999999999999999999999999999999999999965433 22223332211 11
Q ss_pred CCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 458 TDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 458 ~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
...+..++..+.+|+.+||..+|.+||++.+++.+.+
T Consensus 228 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~ 264 (304)
T 2jam_A 228 SPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPW 264 (304)
T ss_dssp TTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHH
T ss_pred ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcc
Confidence 1223455678999999999999999999999997665
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=354.31 Aligned_cols=251 Identities=22% Similarity=0.338 Sum_probs=194.9
Q ss_pred hcccccc-eeecccCceeEEEEEe--CCccEEEEEeCcChhHhHHHHHHHHHHHHcC-CCCceeeeccccCC--CceEEE
Q 008365 228 TDKFSEA-MKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQGKRQFQQEVEVLSSI-RHPNMVLLLGACPD--YGCLVY 301 (568)
Q Consensus 228 ~~~y~~~-~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l-~HpnIv~l~g~~~~--~~~lV~ 301 (568)
.+.|.+. +.||+|+||.||+|.+ +++.||||++..........+.+|+.+|.++ +||||++++++|.+ ..++||
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 90 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF 90 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 4678885 7899999999999986 6789999999766555567889999999885 79999999999854 448999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCce---eEeccccccccc
Q 008365 302 EYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYV---SKISDVGLARLV 378 (568)
Q Consensus 302 E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~---vKL~DFGla~~~ 378 (568)
||+++|+|.+++.... .+++..+..|+.||+.||.|||+.+ |+||||||+||||+.++. +||+|||+++.+
T Consensus 91 e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~ 164 (316)
T 2ac3_A 91 EKMRGGSILSHIHKRR---HFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGI 164 (316)
T ss_dssp ECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred EcCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence 9999999999998754 3889999999999999999999999 999999999999988765 999999999765
Q ss_pred CCCCC-ccccccccccccccccCCChhhhhc-----CCCCCcceehhHHHHHHHHHhCCCCCCCch--------------
Q 008365 379 PPSVA-DSVTQYHMTSAAGTFCYIDPEYQQT-----GMLTTKSDIYSFGIMLLQIITARSPMGLTH-------------- 438 (568)
Q Consensus 379 ~~~~~-~~~~~~~~~~~~GT~~Y~APE~~~~-----~~~s~ksDvwSlGvil~elltG~~Pf~~~~-------------- 438 (568)
..... ...........+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||....
T Consensus 165 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 244 (316)
T 2ac3_A 165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPA 244 (316)
T ss_dssp -----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHH
T ss_pred ccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchh
Confidence 32211 0111112234579999999998875 558999999999999999999999996432
Q ss_pred ---HHHHHHHhCccccccCccCCCCCh----HHHHHHHHHHHHhhccCCCCCCChHHhHhHH
Q 008365 439 ---HVSRAIEKGTLAEMLDPAVTDWPA----EAAESFSKLAIQCAELRKKDRPDLGTVIVPE 493 (568)
Q Consensus 439 ---~~~~~~~~~~~~~~l~~~~~~~p~----~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~ 493 (568)
.+...+..+.. .+|. .++..+.+|+.+||..||.+||++.+++.|.
T Consensus 245 ~~~~~~~~i~~~~~---------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp 297 (316)
T 2ac3_A 245 CQNMLFESIQEGKY---------EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHP 297 (316)
T ss_dssp HHHHHHHHHHHCCC---------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHST
T ss_pred HHHHHHHHHhccCc---------ccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcCh
Confidence 12222222211 1221 3456799999999999999999999998543
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-42 Score=347.07 Aligned_cols=247 Identities=21% Similarity=0.311 Sum_probs=206.3
Q ss_pred HhcccccceeecccCceeEEEEEeC--CccEEEEEeCcCh---hHhHHHHHHHHHHHHcCCCCceeeeccccCCC--ceE
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKLD--HTPVAIKVLRPDA---AQGKRQFQQEVEVLSSIRHPNMVLLLGACPDY--GCL 299 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~~--~~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~--~~l 299 (568)
..++|.+.+.||+|+||.||++.+. +..||+|++.... ......+.+|+.+++.++||||++++++|.+. .++
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 92 (294)
T 2rku_A 13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 92 (294)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEE
Confidence 3468999999999999999999984 6789999986542 34456788999999999999999999998654 489
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccC
Q 008365 300 VYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVP 379 (568)
Q Consensus 300 V~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~ 379 (568)
||||+++++|.+++.... .+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 93 v~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 166 (294)
T 2rku_A 93 VLELCRRRSLLELHKRRK---ALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 166 (294)
T ss_dssp EEECCTTCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceecc
Confidence 999999999999887654 3889999999999999999999999 9999999999999999999999999998764
Q ss_pred CCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHH--HHHhCccccccCccC
Q 008365 380 PSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSR--AIEKGTLAEMLDPAV 457 (568)
Q Consensus 380 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~--~~~~~~~~~~l~~~~ 457 (568)
... .......||+.|+|||++.+..++.++|||||||++|+|++|..||........ .+..+.
T Consensus 167 ~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--------- 231 (294)
T 2rku_A 167 YDG------ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNE--------- 231 (294)
T ss_dssp STT------CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC---------
T ss_pred cCc------cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcc---------
Confidence 321 112346799999999999999999999999999999999999999976543222 121111
Q ss_pred CCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 458 TDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 458 ~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
...|..++..+.+|+.+||+.+|.+||++.+++.+.+
T Consensus 232 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~ 268 (294)
T 2rku_A 232 YSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEF 268 (294)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHH
T ss_pred CCCccccCHHHHHHHHHHcccChhhCcCHHHHhhChh
Confidence 1234455677999999999999999999999997655
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-42 Score=351.78 Aligned_cols=252 Identities=23% Similarity=0.404 Sum_probs=194.5
Q ss_pred HhcccccceeecccCceeEEEEEeC-----CccEEEEEeCcC--hhHhHHHHHHHHHHHHcCCCCceeeeccccCCC---
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKLD-----HTPVAIKVLRPD--AAQGKRQFQQEVEVLSSIRHPNMVLLLGACPDY--- 296 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~~-----~~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~--- 296 (568)
..++|.+.+.||+|+||.||+|.+. +..||||++... .......+.+|+.+++.++||||++++++|.+.
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 111 (313)
T 3brb_A 32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQ 111 (313)
T ss_dssp CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC----
T ss_pred CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecccc
Confidence 4578999999999999999999763 237999998754 234456789999999999999999999988542
Q ss_pred ----ceEEEEecCCCCHHHHHhhc---CCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEe
Q 008365 297 ----GCLVYEYMHNGSLEDRLLRR---GNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKI 369 (568)
Q Consensus 297 ----~~lV~E~~~ggsL~~~l~~~---~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL 369 (568)
.++||||+++|+|.+++... .....+++..++.|+.||+.||.|||+.+ |+||||||+||||+.++.+||
T Consensus 112 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kl 188 (313)
T 3brb_A 112 GIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTVCV 188 (313)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSCEEE
T ss_pred CCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEE
Confidence 28999999999999998543 12245899999999999999999999999 999999999999999999999
Q ss_pred cccccccccCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh-CCCCCCCchH--HHHHHHh
Q 008365 370 SDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPMGLTHH--VSRAIEK 446 (568)
Q Consensus 370 ~DFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~--~~~~~~~ 446 (568)
+|||+++.+..... ........+++.|+|||.+.+..++.++|||||||++|+|++ |..||..... ....+..
T Consensus 189 ~Dfg~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~ 264 (313)
T 3brb_A 189 ADFGLSKKIYSGDY----YRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLH 264 (313)
T ss_dssp CSCSCC--------------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHT
T ss_pred eecCcceecccccc----cCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHc
Confidence 99999986543211 111234567889999999999999999999999999999999 9999965332 2222222
Q ss_pred CccccccCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHH
Q 008365 447 GTLAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPE 493 (568)
Q Consensus 447 ~~~~~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~ 493 (568)
+. ....+..++..+.+|+.+||..+|.+||++.+++..+
T Consensus 265 ~~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L 303 (313)
T 3brb_A 265 GH--------RLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQL 303 (313)
T ss_dssp TC--------CCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred CC--------CCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 21 1233455667899999999999999999999987433
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=368.83 Aligned_cols=248 Identities=22% Similarity=0.348 Sum_probs=193.1
Q ss_pred Hhcccccc-eeecccCceeEEEEEe--CCccEEEEEeCcChhHhHHHHHHHHHHH-HcCCCCceeeeccccCC------C
Q 008365 227 ATDKFSEA-MKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQGKRQFQQEVEVL-SSIRHPNMVLLLGACPD------Y 296 (568)
Q Consensus 227 ~~~~y~~~-~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ev~iL-~~l~HpnIv~l~g~~~~------~ 296 (568)
..++|.+. +.||+|+||.||+|.+ ++..||||++... ..+.+|+.++ +.++||||++++++|.. .
T Consensus 59 ~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~ 133 (400)
T 1nxk_A 59 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 133 (400)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred ccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcE
Confidence 34567776 6899999999999987 4678999999643 3467888887 45689999999998743 3
Q ss_pred ceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccC---CceeEecccc
Q 008365 297 GCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDR---NYVSKISDVG 373 (568)
Q Consensus 297 ~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~---~~~vKL~DFG 373 (568)
.|||||||+||+|.+++...+. ..+++..+..|+.||+.||.|||+.+ |+||||||+||||+. ++.+||+|||
T Consensus 134 ~~lv~E~~~gg~L~~~l~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG 209 (400)
T 1nxk_A 134 LLIVMECLDGGELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFG 209 (400)
T ss_dssp EEEEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCT
T ss_pred EEEEEEeCCCCcHHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEecc
Confidence 4899999999999999976543 24899999999999999999999999 999999999999987 7899999999
Q ss_pred cccccCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchH------HHHHHHhC
Q 008365 374 LARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHH------VSRAIEKG 447 (568)
Q Consensus 374 la~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~------~~~~~~~~ 447 (568)
+++..... ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||...+. ....+..+
T Consensus 210 ~a~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~ 282 (400)
T 1nxk_A 210 FAKETTSH-------NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMG 282 (400)
T ss_dssp TCEECC------------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHT
T ss_pred cccccCCC-------CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcC
Confidence 99865321 122456899999999999999999999999999999999999999964332 22233333
Q ss_pred ccccccCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHHH
Q 008365 448 TLAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPELN 495 (568)
Q Consensus 448 ~~~~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l~ 495 (568)
.+.. ..+ . ...++..+.+||.+||..||.+||++.+++.|.+-
T Consensus 283 ~~~~-~~~---~-~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~ 325 (400)
T 1nxk_A 283 QYEF-PNP---E-WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 325 (400)
T ss_dssp CCCC-CTT---T-TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHH
T ss_pred cccC-CCc---c-cccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccc
Confidence 2210 011 1 13456779999999999999999999999987663
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=354.20 Aligned_cols=252 Identities=27% Similarity=0.421 Sum_probs=201.1
Q ss_pred ccc-ccceeecccCceeEEEEEe------CCccEEEEEeCcCh-hHhHHHHHHHHHHHHcCCCCceeeeccccCC----C
Q 008365 229 DKF-SEAMKIGEGGYGPVYRGKL------DHTPVAIKVLRPDA-AQGKRQFQQEVEVLSSIRHPNMVLLLGACPD----Y 296 (568)
Q Consensus 229 ~~y-~~~~~IG~G~fg~Vy~~~~------~~~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~----~ 296 (568)
++| +++++||+|+||.||++.+ +++.||||+++... ......+.+|+.+|+.++||||++++++|.+ .
T Consensus 30 ~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (318)
T 3lxp_A 30 KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAAS 109 (318)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTE
T ss_pred HHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCce
Confidence 445 9999999999999998864 56789999998653 3445678999999999999999999999854 2
Q ss_pred ceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEeccccccc
Q 008365 297 GCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLAR 376 (568)
Q Consensus 297 ~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~ 376 (568)
.++||||+++|+|.+++.... +++..++.|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++
T Consensus 110 ~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~ 182 (318)
T 3lxp_A 110 LQLVMEYVPLGSLRDYLPRHS----IGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAK 182 (318)
T ss_dssp EEEEECCCTTCBHHHHGGGSC----CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCE
T ss_pred EEEEEecccCCcHHHHHhhCC----CCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCccccc
Confidence 389999999999999987653 889999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHH--------HhCc
Q 008365 377 LVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAI--------EKGT 448 (568)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~--------~~~~ 448 (568)
.+..... .........||+.|+|||++.+..++.++|||||||++|+|++|..||.......... ....
T Consensus 183 ~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 259 (318)
T 3lxp_A 183 AVPEGHE---YYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLR 259 (318)
T ss_dssp ECCTTCS---EEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHH
T ss_pred ccccccc---ccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHH
Confidence 7754321 1112234568999999999999999999999999999999999999996533211000 0000
Q ss_pred ccccc-CccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhH
Q 008365 449 LAEML-DPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVI 490 (568)
Q Consensus 449 ~~~~l-~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl 490 (568)
+...+ .......+..++..+.+|+.+||+.+|.+||++.+++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell 302 (318)
T 3lxp_A 260 LTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLI 302 (318)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred HHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHH
Confidence 11111 1112234556678899999999999999999999987
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=374.87 Aligned_cols=246 Identities=24% Similarity=0.386 Sum_probs=205.7
Q ss_pred hcccccceeecccCceeEEEEEe--CCccEEEEEeCcChh---HhHHHHHHHHHHHHcCCCCceeeeccccCCC--ceEE
Q 008365 228 TDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAA---QGKRQFQQEVEVLSSIRHPNMVLLLGACPDY--GCLV 300 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~---~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~--~~lV 300 (568)
.++|.+.+.||+|+||.||+|.+ +++.||||++..... .....+.+|+.+|+.++||||+++++++.+. .++|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 46799999999999999999987 578999999975432 2245788999999999999999999998554 4899
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCC
Q 008365 301 YEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPP 380 (568)
Q Consensus 301 ~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~ 380 (568)
|||++||+|.+++...+ .+++..+..|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+..
T Consensus 95 ~E~~~gg~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~ 168 (476)
T 2y94_A 95 MEYVSGGELFDYICKNG---RLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 168 (476)
T ss_dssp EECCSSEEHHHHTTSSS---SCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred EeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence 99999999999987543 3899999999999999999999999 99999999999999999999999999987643
Q ss_pred CCCccccccccccccccccCCChhhhhcCCC-CCcceehhHHHHHHHHHhCCCCCCCchH--HHHHHHhCccccccCccC
Q 008365 381 SVADSVTQYHMTSAAGTFCYIDPEYQQTGML-TTKSDIYSFGIMLLQIITARSPMGLTHH--VSRAIEKGTLAEMLDPAV 457 (568)
Q Consensus 381 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~-s~ksDvwSlGvil~elltG~~Pf~~~~~--~~~~~~~~~~~~~l~~~~ 457 (568)
.. .....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||..... ....+..+..
T Consensus 169 ~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-------- 233 (476)
T 2y94_A 169 GE-------FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIF-------- 233 (476)
T ss_dssp TC-------CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCC--------
T ss_pred cc-------cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCc--------
Confidence 21 2245689999999999988765 6899999999999999999999975432 2222322221
Q ss_pred CCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHHH
Q 008365 458 TDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPELN 495 (568)
Q Consensus 458 ~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l~ 495 (568)
..|..++..+.+|+.+||..||.+||++.+++.|.+-
T Consensus 234 -~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~ 270 (476)
T 2y94_A 234 -YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWF 270 (476)
T ss_dssp -CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHH
T ss_pred -CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHh
Confidence 2244456779999999999999999999999987653
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=347.49 Aligned_cols=247 Identities=30% Similarity=0.475 Sum_probs=202.8
Q ss_pred HhcccccceeecccCceeEEEEEeC-CccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCceeeeccccCC-CceEEEEec
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKLD-HTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACPD-YGCLVYEYM 304 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~~-~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~-~~~lV~E~~ 304 (568)
..++|.+.+.||+|+||.||+|.+. +..||||++..... ....+.+|+.+|+.++||||+++++++.+ ..++||||+
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~~ 89 (279)
T 1qpc_A 11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYM 89 (279)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEEECC
T ss_pred CHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcc-cHHHHHHHHHHHHhCCCcCcceEEEEEcCCCcEEEEecC
Confidence 3578999999999999999999985 45899999976542 34678999999999999999999998854 458999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCCc
Q 008365 305 HNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVAD 384 (568)
Q Consensus 305 ~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~~ 384 (568)
++++|.+++..... ..+++..+..|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+....
T Consensus 90 ~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-- 163 (279)
T 1qpc_A 90 ENGSLVDFLKTPSG-IKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNE-- 163 (279)
T ss_dssp TTCBHHHHTTSHHH-HTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSC--
T ss_pred CCCCHHHHHhcCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCcc--
Confidence 99999999865321 13889999999999999999999999 9999999999999999999999999998764321
Q ss_pred cccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh-CCCCCCCchHH--HHHHHhCccccccCccCCCCC
Q 008365 385 SVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPMGLTHHV--SRAIEKGTLAEMLDPAVTDWP 461 (568)
Q Consensus 385 ~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~--~~~~~~~~~~~~l~~~~~~~p 461 (568)
........+|+.|+|||++.+..++.++|||||||++|+|++ |..||...... ...+..+. ....+
T Consensus 164 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~--------~~~~~ 232 (279)
T 1qpc_A 164 ---YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGY--------RMVRP 232 (279)
T ss_dssp ---EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC--------CCCCC
T ss_pred ---cccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhccc--------CCCCc
Confidence 111234567889999999999999999999999999999999 99999654432 22222221 11224
Q ss_pred hHHHHHHHHHHHHhhccCCCCCCChHHhHh
Q 008365 462 AEAAESFSKLAIQCAELRKKDRPDLGTVIV 491 (568)
Q Consensus 462 ~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~ 491 (568)
..++..+.+|+..||..+|.+||++.+++.
T Consensus 233 ~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 233 DNCPEELYQLMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 456678999999999999999999999863
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=350.96 Aligned_cols=256 Identities=23% Similarity=0.384 Sum_probs=201.7
Q ss_pred hcccccceeecccCceeEEEEEe------CCccEEEEEeCcCh-hHhHHHHHHHHHHHHcCCCCceeeeccccCCC----
Q 008365 228 TDKFSEAMKIGEGGYGPVYRGKL------DHTPVAIKVLRPDA-AQGKRQFQQEVEVLSSIRHPNMVLLLGACPDY---- 296 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~~~~------~~~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~---- 296 (568)
...|++.+.||+|+||.||+|.+ .++.||||++.... ......+.+|+.+|+.++||||++++++|.+.
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 99 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 99 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence 35689999999999999999983 56789999997543 23346789999999999999999999998543
Q ss_pred ceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEeccccccc
Q 008365 297 GCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLAR 376 (568)
Q Consensus 297 ~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~ 376 (568)
.++||||+++|+|.+++..... .+++..++.|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++
T Consensus 100 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 174 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLPKNKN--KINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTK 174 (302)
T ss_dssp EEEEEECCTTCBHHHHHHHHTT--TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEEEeCCCCcHHHHHHhccc--cCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECcccccc
Confidence 4899999999999999966543 3899999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHh--------Cc
Q 008365 377 LVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEK--------GT 448 (568)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~--------~~ 448 (568)
.+..... .........||..|+|||++.+..++.++|||||||++|+|++|..|+............ ..
T Consensus 175 ~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 251 (302)
T 4e5w_A 175 AIETDKE---YYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTR 251 (302)
T ss_dssp ECCTTCC---EEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHH
T ss_pred cccCCCc---ceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHH
Confidence 7654321 112234567899999999999999999999999999999999999987433221111000 00
Q ss_pred c-ccccCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHh
Q 008365 449 L-AEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIV 491 (568)
Q Consensus 449 ~-~~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~ 491 (568)
+ ...........+..++..+.+|+.+||+.+|.+||++.+++.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 252 LVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred HHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 0 000111122345567788999999999999999999999873
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=349.06 Aligned_cols=248 Identities=27% Similarity=0.389 Sum_probs=182.5
Q ss_pred hcccccceeecccCceeEEEEEe--CCccEEEEEeCcChhH---hHHHHHHHHHHHHcCCCCceeeeccccCCCc--eEE
Q 008365 228 TDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQ---GKRQFQQEVEVLSSIRHPNMVLLLGACPDYG--CLV 300 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~---~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~--~lV 300 (568)
.++|.+.+.||+|+||.||+|.+ ++..||||++...... ....+.+|+.+++.++||||+++++++.+.. ++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 46799999999999999999987 6789999999654322 2367889999999999999999999986544 899
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCC
Q 008365 301 YEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPP 380 (568)
Q Consensus 301 ~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~ 380 (568)
|||+++++|.+++.... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 90 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 164 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNRV--KPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKM 164 (278)
T ss_dssp EECCTTEEHHHHHHTCS--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred EecCCCCcHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence 99999999999987643 24899999999999999999999999 99999999999999999999999999987643
Q ss_pred CCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHhCccccccCccCCCC
Q 008365 381 SVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAVTDW 460 (568)
Q Consensus 381 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~l~~~~~~~ 460 (568)
... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||........ +...... ....
T Consensus 165 ~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------~~~~~~~-~~~~ 231 (278)
T 3cok_A 165 PHE------KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT------LNKVVLA-DYEM 231 (278)
T ss_dssp ---------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----------CCSS-CCCC
T ss_pred CCC------cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH------HHHHhhc-ccCC
Confidence 211 12345799999999999999999999999999999999999999964332110 0111111 1123
Q ss_pred ChHHHHHHHHHHHHhhccCCCCCCChHHhHhHH
Q 008365 461 PAEAAESFSKLAIQCAELRKKDRPDLGTVIVPE 493 (568)
Q Consensus 461 p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~ 493 (568)
|..++..+.+|+.+||+.+|.+||++.+++.+.
T Consensus 232 ~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~ 264 (278)
T 3cok_A 232 PSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHP 264 (278)
T ss_dssp CTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTST
T ss_pred ccccCHHHHHHHHHHcccCHhhCCCHHHHhcCc
Confidence 455667899999999999999999999998543
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-43 Score=362.72 Aligned_cols=243 Identities=20% Similarity=0.318 Sum_probs=201.0
Q ss_pred HHhcccccceeecccCceeEEEEEe--CCccEEEEEeCcChhH--------hHHHHHHHHHHHHcCCCCceeeeccccCC
Q 008365 226 EATDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQ--------GKRQFQQEVEVLSSIRHPNMVLLLGACPD 295 (568)
Q Consensus 226 ~~~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~--------~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~ 295 (568)
...++|.+.+.||+|+||.||+|.+ +++.||||++...... ....+.+|+.+|+.++||||++++++|.+
T Consensus 21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~ 100 (335)
T 3dls_A 21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN 100 (335)
T ss_dssp HHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred ccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee
Confidence 3567899999999999999999986 6778999998765321 22356789999999999999999999865
Q ss_pred Cc--eEEEEecCCC-CHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEeccc
Q 008365 296 YG--CLVYEYMHNG-SLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDV 372 (568)
Q Consensus 296 ~~--~lV~E~~~gg-sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DF 372 (568)
.. ++||||+.+| +|.+++.... .+++..+..|+.||+.||.|||+.+ |+||||||+||||+.++.+||+||
T Consensus 101 ~~~~~lv~e~~~~g~~l~~~~~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Df 174 (335)
T 3dls_A 101 QGFFQLVMEKHGSGLDLFAFIDRHP---RLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDF 174 (335)
T ss_dssp SSEEEEEEECCTTSCBHHHHHHTCC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCC
T ss_pred CCEEEEEEEeCCCCccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeec
Confidence 44 7999999776 9999887654 3899999999999999999999999 999999999999999999999999
Q ss_pred ccccccCCCCCccccccccccccccccCCChhhhhcCCC-CCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHhCcccc
Q 008365 373 GLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGML-TTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAE 451 (568)
Q Consensus 373 Gla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~-s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~ 451 (568)
|+++.+.... .....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.....
T Consensus 175 g~a~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------------ 235 (335)
T 3dls_A 175 GSAAYLERGK-------LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE------------ 235 (335)
T ss_dssp TTCEECCTTC-------CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG------------
T ss_pred ccceECCCCC-------ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH------------
Confidence 9998764322 1234679999999999988876 8899999999999999999999954321
Q ss_pred ccCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 452 MLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 452 ~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
.+... ...|..++..+.+|+..||+.+|.+||++.+++.+.+
T Consensus 236 ~~~~~-~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~ 277 (335)
T 3dls_A 236 TVEAA-IHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPW 277 (335)
T ss_dssp GTTTC-CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTT
T ss_pred HHhhc-cCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCcc
Confidence 11111 1223345677999999999999999999999986543
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=361.27 Aligned_cols=255 Identities=25% Similarity=0.377 Sum_probs=203.3
Q ss_pred hcccccceeecccCceeEEEEEeC--CccEEEEEeCcC-hhHhHHHHHHHHHHHHcCCCCceeeeccccCC--CceEEEE
Q 008365 228 TDKFSEAMKIGEGGYGPVYRGKLD--HTPVAIKVLRPD-AAQGKRQFQQEVEVLSSIRHPNMVLLLGACPD--YGCLVYE 302 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~~~~~--~~~vAvK~l~~~-~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--~~~lV~E 302 (568)
.++|.+.+.||+|+||.||+|.+. +..||+|++... .......+.+|+.+|+.++||||++++++|.+ ..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 467999999999999999999984 779999999765 33445678999999999999999999998854 3489999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHc-CCCCcccCCCCCCCeeccCCceeEecccccccccCCC
Q 008365 303 YMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQA-KPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPS 381 (568)
Q Consensus 303 ~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~-~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~ 381 (568)
|++||+|.+++...+ .+++..+..|+.||+.||.|||+. + |+||||||+||||+.++.+||+|||++..+..
T Consensus 112 ~~~~~~L~~~l~~~~---~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~- 184 (360)
T 3eqc_A 112 HMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID- 184 (360)
T ss_dssp CCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH-
T ss_pred CCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCccccc-
Confidence 999999999998764 388999999999999999999996 8 99999999999999999999999999865421
Q ss_pred CCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHhCc-------------
Q 008365 382 VADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGT------------- 448 (568)
Q Consensus 382 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~------------- 448 (568)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||..............
T Consensus 185 -------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (360)
T 3eqc_A 185 -------SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRP 257 (360)
T ss_dssp -------HC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC--------------
T ss_pred -------ccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCc
Confidence 122346799999999999999999999999999999999999999965433211110000
Q ss_pred -----------------------cccccCccCCCC-ChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHHHH
Q 008365 449 -----------------------LAEMLDPAVTDW-PAEAAESFSKLAIQCAELRKKDRPDLGTVIVPELNR 496 (568)
Q Consensus 449 -----------------------~~~~l~~~~~~~-p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l~~ 496 (568)
+........... +..++..+.+|+.+||+.+|.+||++.+++.|.+-.
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~ 329 (360)
T 3eqc_A 258 RTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIK 329 (360)
T ss_dssp ----------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHH
T ss_pred ccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhh
Confidence 000000001111 123466799999999999999999999999887743
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-42 Score=346.41 Aligned_cols=245 Identities=24% Similarity=0.396 Sum_probs=205.3
Q ss_pred hcccccceeecccCceeEEEEEe--CCccEEEEEeCcChh---HhHHHHHHHHHHHHcCCCCceeeeccccCCC--ceEE
Q 008365 228 TDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAA---QGKRQFQQEVEVLSSIRHPNMVLLLGACPDY--GCLV 300 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~---~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~--~~lV 300 (568)
.++|.+.+.||+|+||.||+|.+ ++..||||++..... .....+.+|+.+++.++||||+++++++.+. .++|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 36799999999999999999988 456899999865432 2245788999999999999999999998654 4899
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCC
Q 008365 301 YEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPP 380 (568)
Q Consensus 301 ~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~ 380 (568)
|||+++|+|.+++...+ .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 93 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (284)
T 2vgo_A 93 LEFAPRGELYKELQKHG---RFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPS 166 (284)
T ss_dssp ECCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred EEeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence 99999999999998764 3889999999999999999999999 99999999999999999999999999976532
Q ss_pred CCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHH--HHHhCccccccCccCC
Q 008365 381 SVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSR--AIEKGTLAEMLDPAVT 458 (568)
Q Consensus 381 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~--~~~~~~~~~~l~~~~~ 458 (568)
. ......||+.|+|||++.+..++.++|||||||++|+|++|..||........ .+.... .
T Consensus 167 ~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~---------~ 229 (284)
T 2vgo_A 167 L--------RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVD---------L 229 (284)
T ss_dssp S--------CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC---------C
T ss_pred c--------ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccc---------c
Confidence 1 12345799999999999999999999999999999999999999976543222 111111 1
Q ss_pred CCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHHH
Q 008365 459 DWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPELN 495 (568)
Q Consensus 459 ~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l~ 495 (568)
.+|..++..+.+|+..||+.+|.+||++.+++.+.+-
T Consensus 230 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~ 266 (284)
T 2vgo_A 230 KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWV 266 (284)
T ss_dssp CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHH
T ss_pred CCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHH
Confidence 2345566789999999999999999999999977653
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=346.62 Aligned_cols=249 Identities=20% Similarity=0.327 Sum_probs=201.3
Q ss_pred hcccccceeecccCceeEEEEEe--CCccEEEEEeCcChhH------hHHHHHHHHHHHHcCCCCceeeeccccCCC--c
Q 008365 228 TDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQ------GKRQFQQEVEVLSSIRHPNMVLLLGACPDY--G 297 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~------~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~--~ 297 (568)
.++|.+.+.||+|+||.||+|.+ +++.||||+++..... ....+.+|+.+++.++||||++++++|.+. .
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 46799999999999999999998 4779999998654221 356789999999999999999999998654 4
Q ss_pred eEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCc----eeEecccc
Q 008365 298 CLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNY----VSKISDVG 373 (568)
Q Consensus 298 ~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~----~vKL~DFG 373 (568)
++||||+++++|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg 157 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAEKE---SLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFG 157 (283)
T ss_dssp EEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEeecCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEecc
Confidence 89999999999999997654 3899999999999999999999999 99999999999998876 89999999
Q ss_pred cccccCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHH--HHHhCcccc
Q 008365 374 LARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSR--AIEKGTLAE 451 (568)
Q Consensus 374 la~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~--~~~~~~~~~ 451 (568)
++..+.... ......||+.|+|||++.+..++.++|||||||++|+|++|..||........ .+.....
T Consensus 158 ~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-- 228 (283)
T 3bhy_A 158 IAHKIEAGN-------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNY-- 228 (283)
T ss_dssp TCEECC---------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCC--
T ss_pred cceeccCCC-------cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhccc--
Confidence 998654321 12345799999999999999999999999999999999999999976543222 1111111
Q ss_pred ccCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 452 MLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 452 ~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
.+.. ..+..++..+.+|+.+||..+|.+||++.+++.+.+
T Consensus 229 ~~~~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~ 268 (283)
T 3bhy_A 229 DFDE---EYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSW 268 (283)
T ss_dssp CCCH---HHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHH
T ss_pred CCcc---hhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHH
Confidence 0000 111234567899999999999999999999998665
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-42 Score=347.69 Aligned_cols=247 Identities=24% Similarity=0.400 Sum_probs=199.9
Q ss_pred hcccccce-eecccCceeEEEEEe----CCccEEEEEeCcChh--HhHHHHHHHHHHHHcCCCCceeeeccccCCC-ceE
Q 008365 228 TDKFSEAM-KIGEGGYGPVYRGKL----DHTPVAIKVLRPDAA--QGKRQFQQEVEVLSSIRHPNMVLLLGACPDY-GCL 299 (568)
Q Consensus 228 ~~~y~~~~-~IG~G~fg~Vy~~~~----~~~~vAvK~l~~~~~--~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~-~~l 299 (568)
.++|.+.. .||+|+||.||+|.+ .+..||||+++.... .....+.+|+.+++.++||||+++++++.+. .++
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~l 94 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWML 94 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESSSEEE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEECCCCcEE
Confidence 46788888 999999999999964 346899999976532 2356789999999999999999999998543 489
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccC
Q 008365 300 VYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVP 379 (568)
Q Consensus 300 V~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~ 379 (568)
||||+++++|.+++.... .+++..++.|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+.
T Consensus 95 v~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 168 (291)
T 1xbb_A 95 VMEMAELGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALR 168 (291)
T ss_dssp EEECCTTEEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred EEEeCCCCCHHHHHHhCc---CCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcceeec
Confidence 999999999999997753 3889999999999999999999999 9999999999999999999999999998764
Q ss_pred CCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh-CCCCCCCchH--HHHHHHhCccccccCcc
Q 008365 380 PSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPMGLTHH--VSRAIEKGTLAEMLDPA 456 (568)
Q Consensus 380 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~--~~~~~~~~~~~~~l~~~ 456 (568)
..... ........||+.|+|||++.+..++.++|||||||++|+|++ |..||..... +...+..+.
T Consensus 169 ~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~-------- 237 (291)
T 1xbb_A 169 ADENY---YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE-------- 237 (291)
T ss_dssp TTCSE---EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC--------
T ss_pred cCCCc---ccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC--------
Confidence 43211 111233457899999999999999999999999999999999 9999975443 222222221
Q ss_pred CCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHh
Q 008365 457 VTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIV 491 (568)
Q Consensus 457 ~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~ 491 (568)
....+..++..+.+++..||+.+|.+||++.+++.
T Consensus 238 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 238 RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 12335566778999999999999999999999874
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=354.63 Aligned_cols=255 Identities=24% Similarity=0.313 Sum_probs=196.3
Q ss_pred hcccccceeecccCceeEEEEEe--CCccEEEEEeCcCh--hHhHHHHHHHHHHHHcCCCCceeeeccccCCC--ceEEE
Q 008365 228 TDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDA--AQGKRQFQQEVEVLSSIRHPNMVLLLGACPDY--GCLVY 301 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~--~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~--~~lV~ 301 (568)
.++|++.+.||+|+||.||+|.+ +++.||||++.... ......+.+|+.+++.++||||++++++|.+. .++||
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 36899999999999999999998 47799999986543 23346688999999999999999999998554 48999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCC
Q 008365 302 EYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPS 381 (568)
Q Consensus 302 E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~ 381 (568)
||+++++|.+++.... .+++..+..|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+...
T Consensus 82 e~~~~~~l~~~~~~~~---~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 155 (311)
T 4agu_A 82 EYCDHTVLHELDRYQR---GVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGP 155 (311)
T ss_dssp ECCSEEHHHHHHHTSS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EeCCCchHHHHHhhhc---CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCc
Confidence 9999999988876543 3889999999999999999999999 999999999999999999999999999876432
Q ss_pred CCccccccccccccccccCCChhhhhc-CCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHh----C---------
Q 008365 382 VADSVTQYHMTSAAGTFCYIDPEYQQT-GMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEK----G--------- 447 (568)
Q Consensus 382 ~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~----~--------- 447 (568)
. ......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||............ +
T Consensus 156 ~------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (311)
T 4agu_A 156 S------DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQV 229 (311)
T ss_dssp ----------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHH
T ss_pred c------cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccc
Confidence 1 11234579999999998876 66899999999999999999999999765443222110 0
Q ss_pred ----ccc-cccCccCCCC------ChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 448 ----TLA-EMLDPAVTDW------PAEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 448 ----~~~-~~l~~~~~~~------p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
... ....+..... .+.++..+.+|+..||+.||.+||++.+++.|.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 287 (311)
T 4agu_A 230 FSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPY 287 (311)
T ss_dssp HHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGG
T ss_pred cccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChH
Confidence 000 0000000000 1245667899999999999999999999986544
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=350.95 Aligned_cols=250 Identities=22% Similarity=0.349 Sum_probs=200.0
Q ss_pred HhcccccceeecccCceeEEEEEeC--CccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCceeeeccccCC--CceEEEE
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKLD--HTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACPD--YGCLVYE 302 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~~--~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--~~~lV~E 302 (568)
..++|++.+.||+|+||.||+|.+. +..||+|++..........+.+|+.+++.++||||++++++|.+ ..++|||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 5578999999999999999999984 67899999987665666789999999999999999999998854 4489999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCC
Q 008365 303 YMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSV 382 (568)
Q Consensus 303 ~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~ 382 (568)
|+++++|.+++..... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 97 ~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~-- 169 (302)
T 2j7t_A 97 FCPGGAVDAIMLELDR--GLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLK-- 169 (302)
T ss_dssp CCTTEEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHH--
T ss_pred eCCCCcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCccccc--
Confidence 9999999998876443 3899999999999999999999999 99999999999999999999999999753211
Q ss_pred CccccccccccccccccCCChhhhh-----cCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHH--HHhCccccccCc
Q 008365 383 ADSVTQYHMTSAAGTFCYIDPEYQQ-----TGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRA--IEKGTLAEMLDP 455 (568)
Q Consensus 383 ~~~~~~~~~~~~~GT~~Y~APE~~~-----~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~--~~~~~~~~~l~~ 455 (568)
.........||+.|+|||++. +..++.++|||||||++|+|++|..||......... +.....
T Consensus 170 ----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~------ 239 (302)
T 2j7t_A 170 ----TLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDP------ 239 (302)
T ss_dssp ----HHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC------
T ss_pred ----cccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCC------
Confidence 111123457999999999873 667899999999999999999999999765543222 112211
Q ss_pred cCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHH
Q 008365 456 AVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPE 493 (568)
Q Consensus 456 ~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~ 493 (568)
.....+..++..+.+|+..||+.+|.+||++.+++.+.
T Consensus 240 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~ 277 (302)
T 2j7t_A 240 PTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHP 277 (302)
T ss_dssp CCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTST
T ss_pred cccCCccccCHHHHHHHHHHcccChhhCCCHHHHhcCh
Confidence 11112345567899999999999999999999998643
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-42 Score=355.30 Aligned_cols=251 Identities=27% Similarity=0.435 Sum_probs=204.1
Q ss_pred HhcccccceeecccCceeEEEEEeC---------CccEEEEEeCcCh-hHhHHHHHHHHHHHHcC-CCCceeeeccccCC
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKLD---------HTPVAIKVLRPDA-AQGKRQFQQEVEVLSSI-RHPNMVLLLGACPD 295 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~~---------~~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l-~HpnIv~l~g~~~~ 295 (568)
..++|.+.+.||+|+||.||+|.+. +..||||+++... ......+.+|+.+++.+ +||||++++++|.+
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 112 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence 3578999999999999999999863 4579999997653 34456789999999999 89999999999854
Q ss_pred --CceEEEEecCCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCee
Q 008365 296 --YGCLVYEYMHNGSLEDRLLRRGN-------------TPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANIL 360 (568)
Q Consensus 296 --~~~lV~E~~~ggsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NIL 360 (568)
..++||||+++|+|.+++..... ...+++..++.|+.||+.||.|||+.+ |+||||||+|||
T Consensus 113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl 189 (334)
T 2pvf_A 113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVL 189 (334)
T ss_dssp SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEE
T ss_pred CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEE
Confidence 44899999999999999976542 123889999999999999999999999 999999999999
Q ss_pred ccCCceeEecccccccccCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh-CCCCCCCchH
Q 008365 361 LDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPMGLTHH 439 (568)
Q Consensus 361 ld~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~ 439 (568)
|+.++.+||+|||+++.+..... ........||+.|+|||++.+..++.++|||||||++|+|++ |..||.....
T Consensus 190 l~~~~~~kL~Dfg~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 265 (334)
T 2pvf_A 190 VTENNVMKIADFGLARDINNIDY----YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 265 (334)
T ss_dssp ECTTCCEEECCCTTCEECTTTSS----EECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred EcCCCCEEEcccccccccccccc----ccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCH
Confidence 99999999999999987643221 112234567899999999999999999999999999999999 9999965432
Q ss_pred --HHHHHHhCccccccCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhH
Q 008365 440 --VSRAIEKGTLAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVP 492 (568)
Q Consensus 440 --~~~~~~~~~~~~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~ 492 (568)
+...+..+. ....+..++..+.+|+.+||+.+|.+||++.+++..
T Consensus 266 ~~~~~~~~~~~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 266 EELFKLLKEGH--------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp HHHHHHHHHTC--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHhcCC--------CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 222222221 112344566789999999999999999999998743
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=347.30 Aligned_cols=246 Identities=22% Similarity=0.322 Sum_probs=200.0
Q ss_pred HhcccccceeecccCceeEEEEEe--CCccEEEEEeCcC--hhHhHHHHHHHHHHHHcC-CCCceeeeccccCC--CceE
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPD--AAQGKRQFQQEVEVLSSI-RHPNMVLLLGACPD--YGCL 299 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l-~HpnIv~l~g~~~~--~~~l 299 (568)
..++|.+.+.||+|+||.||+|.+ +++.||||++... .......+.+|+.++..+ +||||++++++|.+ ..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 457899999999999999999998 5789999998754 233456788999999999 89999999999854 4489
Q ss_pred EEEecCCCCHHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCC--------------
Q 008365 300 VYEYMHNGSLEDRLLRRGN-TPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRN-------------- 364 (568)
Q Consensus 300 V~E~~~ggsL~~~l~~~~~-~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~-------------- 364 (568)
||||+++|+|.+++..... ...+++..+..|+.||+.||.|||+.+ |+||||||+||||+.+
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC----------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCccccccccccc
Confidence 9999999999999976421 134899999999999999999999999 9999999999999844
Q ss_pred -----ceeEecccccccccCCCCCccccccccccccccccCCChhhhhcC-CCCCcceehhHHHHHHHHHhCCCCCCCch
Q 008365 365 -----YVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTG-MLTTKSDIYSFGIMLLQIITARSPMGLTH 438 (568)
Q Consensus 365 -----~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDvwSlGvil~elltG~~Pf~~~~ 438 (568)
+.+||+|||++...... ....||+.|+|||++.+. .++.++|||||||++|+|++|.+|+....
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~----------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~ 235 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSP----------QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD 235 (289)
T ss_dssp ----CCCEEECCCTTCEETTCS----------CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH
T ss_pred ccCCceEEEEcccccccccCCc----------cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh
Confidence 47999999999865432 223599999999988776 56789999999999999999998876554
Q ss_pred HHHHHHHhCccccccCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 439 HVSRAIEKGTLAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 439 ~~~~~~~~~~~~~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
.... +..+. ....+..++..+.+|+.+||+.+|.+||++.+++.+.+
T Consensus 236 ~~~~-~~~~~--------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~ 282 (289)
T 1x8b_A 236 QWHE-IRQGR--------LPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSV 282 (289)
T ss_dssp HHHH-HHTTC--------CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTT
T ss_pred HHHH-HHcCC--------CCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChH
Confidence 3322 22222 22334456678999999999999999999999986543
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=364.11 Aligned_cols=248 Identities=27% Similarity=0.399 Sum_probs=189.9
Q ss_pred cccccceeecccCceeEEEEEeC---C--ccEEEEEeCcC-hhHhHHHHHHHHHHHHcCCCCceeeeccccC---CCceE
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKLD---H--TPVAIKVLRPD-AAQGKRQFQQEVEVLSSIRHPNMVLLLGACP---DYGCL 299 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~~---~--~~vAvK~l~~~-~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~---~~~~l 299 (568)
..|.+.+.||+|+||.||+|.+. + ..||||+++.. .......|.+|+.+|+.++|||||+++++|. +..++
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l 168 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 168 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence 35778899999999999999862 2 36899998653 3344577999999999999999999999863 24589
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccC
Q 008365 300 VYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVP 379 (568)
Q Consensus 300 V~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~ 379 (568)
||||+++|+|.+++..... .+++..++.|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+.
T Consensus 169 v~e~~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 243 (373)
T 3c1x_A 169 VLPYMKHGDLRNFIRNETH--NPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMY 243 (373)
T ss_dssp EEECCTTCBHHHHHHCTTC--CCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEECCCCCCHHHHHhhccc--CCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeecccccccc
Confidence 9999999999999976443 3789999999999999999999999 9999999999999999999999999998654
Q ss_pred CCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh-CCCCCCCchH--HHHHHHhCccccccCcc
Q 008365 380 PSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPMGLTHH--VSRAIEKGTLAEMLDPA 456 (568)
Q Consensus 380 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~--~~~~~~~~~~~~~l~~~ 456 (568)
..... .........||+.|+|||++.+..++.++|||||||++|||++ |.+||..... +...+..+.
T Consensus 244 ~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~-------- 313 (373)
T 3c1x_A 244 DKEFD--SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR-------- 313 (373)
T ss_dssp ----------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTC--------
T ss_pred ccccc--cccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCC--------
Confidence 32211 1112234568899999999999999999999999999999999 7788854322 222222221
Q ss_pred CCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHh
Q 008365 457 VTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIV 491 (568)
Q Consensus 457 ~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~ 491 (568)
....|..++..+.+++.+||+.+|.+||++.+++.
T Consensus 314 ~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~ 348 (373)
T 3c1x_A 314 RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 348 (373)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 11224456678999999999999999999999874
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=346.76 Aligned_cols=240 Identities=24% Similarity=0.381 Sum_probs=200.0
Q ss_pred HhcccccceeecccCceeEEEEEe--CCccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCceeeeccccCC---------
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACPD--------- 295 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--------- 295 (568)
..++|.+.+.||+|+||.||+|.+ +++.||||++.... ..+.+|+.+++.++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 567899999999999999999998 47899999997654 246789999999999999999998732
Q ss_pred ---------CceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCce
Q 008365 296 ---------YGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYV 366 (568)
Q Consensus 296 ---------~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~ 366 (568)
..++||||+++|+|.+++..... ..+++..++.|+.||+.||.|||+.+ |+||||||+||||+.++.
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~ 160 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG-EKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQ 160 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHGGG-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTE
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhccC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCC
Confidence 24799999999999999976432 24889999999999999999999999 999999999999999999
Q ss_pred eEecccccccccCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHh
Q 008365 367 SKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEK 446 (568)
Q Consensus 367 vKL~DFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~ 446 (568)
+||+|||++..+.... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.........+..
T Consensus 161 ~kl~Dfg~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~ 233 (284)
T 2a19_B 161 VKIGDFGLVTSLKNDG-------KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRD 233 (284)
T ss_dssp EEECCCTTCEESSCCS-------CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHHHHHHHHT
T ss_pred EEECcchhheeccccc-------cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHHHHHHHhhc
Confidence 9999999998764322 123457999999999999999999999999999999999999998433332222222
Q ss_pred CccccccCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhH
Q 008365 447 GTLAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVP 492 (568)
Q Consensus 447 ~~~~~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~ 492 (568)
+. .+..++..+.+|+.+||..+|.+||++.+++.+
T Consensus 234 ~~-----------~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~ 268 (284)
T 2a19_B 234 GI-----------ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRT 268 (284)
T ss_dssp TC-----------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cc-----------ccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 21 123345668999999999999999999998754
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=355.83 Aligned_cols=253 Identities=26% Similarity=0.402 Sum_probs=203.6
Q ss_pred HhcccccceeecccCceeEEEEEeCC-------ccEEEEEeCcCh-hHhHHHHHHHHHHHHcC-CCCceeeeccccCC--
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKLDH-------TPVAIKVLRPDA-AQGKRQFQQEVEVLSSI-RHPNMVLLLGACPD-- 295 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~~~-------~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l-~HpnIv~l~g~~~~-- 295 (568)
..++|.+.+.||+|+||.||+|.+.+ ..||||++.... ......+.+|+.+|+.+ +||||++++++|.+
T Consensus 44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 123 (333)
T 2i1m_A 44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGG 123 (333)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCC
Confidence 45789999999999999999998732 369999997653 34456789999999999 89999999999855
Q ss_pred CceEEEEecCCCCHHHHHhhcCC-----------CCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCC
Q 008365 296 YGCLVYEYMHNGSLEDRLLRRGN-----------TPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRN 364 (568)
Q Consensus 296 ~~~lV~E~~~ggsL~~~l~~~~~-----------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~ 364 (568)
..++||||+++|+|.+++..... ...+++..++.|+.||+.||.|||+.+ |+||||||+||||+.+
T Consensus 124 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~ 200 (333)
T 2i1m_A 124 PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNG 200 (333)
T ss_dssp SCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEEEGG
T ss_pred ceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEECCC
Confidence 45899999999999999876421 234789999999999999999999999 9999999999999999
Q ss_pred ceeEecccccccccCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh-CCCCCCCch---HH
Q 008365 365 YVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPMGLTH---HV 440 (568)
Q Consensus 365 ~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~---~~ 440 (568)
+.+||+|||+++.+.... .........||+.|+|||++.+..++.++|||||||++|+|++ |..||.... .+
T Consensus 201 ~~~kl~Dfg~~~~~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~ 276 (333)
T 2i1m_A 201 HVAKIGDFGLARDIMNDS----NYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF 276 (333)
T ss_dssp GEEEBCCCGGGCCGGGCT----TSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHH
T ss_pred CeEEECcccccccccccc----ceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHH
Confidence 999999999998653321 1112234567899999999999999999999999999999998 999996432 22
Q ss_pred HHHHHhCccccccCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 441 SRAIEKGTLAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 441 ~~~~~~~~~~~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
...+..+. . ...+..++..+.+|+..||+.+|.+||++.+|+..+.
T Consensus 277 ~~~~~~~~-----~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~ 322 (333)
T 2i1m_A 277 YKLVKDGY-----Q---MAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQ 322 (333)
T ss_dssp HHHHHHTC-----C---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHhcCC-----C---CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHH
Confidence 22222211 1 1123345677999999999999999999999975443
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-42 Score=353.14 Aligned_cols=255 Identities=24% Similarity=0.413 Sum_probs=205.2
Q ss_pred hcccccceeecccCceeEEEEEe------CCccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCceeeeccccCC----Cc
Q 008365 228 TDKFSEAMKIGEGGYGPVYRGKL------DHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACPD----YG 297 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~~~~------~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~----~~ 297 (568)
.++|++++.||+|+||.||+|.+ ++..||||++..........+.+|+.+|+.++||||+++++++.. ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 35799999999999999999984 567899999987766667789999999999999999999998743 34
Q ss_pred eEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccc
Q 008365 298 CLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARL 377 (568)
Q Consensus 298 ~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~ 377 (568)
++||||+++++|.+++..... .+++..++.|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.
T Consensus 120 ~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~ 194 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKHKE--RIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV 194 (326)
T ss_dssp EEEECCCTTCBHHHHHHHSTT--SSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEECCCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhh
Confidence 899999999999999987543 3889999999999999999999999 99999999999999999999999999987
Q ss_pred cCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchH-HHHHHHhC--------c
Q 008365 378 VPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHH-VSRAIEKG--------T 448 (568)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~-~~~~~~~~--------~ 448 (568)
+...... ........+|..|+|||++.+..++.++|||||||++|+|++|..||..... ....+... .
T Consensus 195 ~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (326)
T 2w1i_A 195 LPQDKEY---YKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 271 (326)
T ss_dssp CCSSCSE---EECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHH
T ss_pred ccccccc---cccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHH
Confidence 6543211 1112345678899999999999999999999999999999999999864321 11111000 0
Q ss_pred ccccc-CccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhH
Q 008365 449 LAEML-DPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVI 490 (568)
Q Consensus 449 ~~~~l-~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl 490 (568)
+.+.+ .......+..++..+.+|+.+||+.+|.+||++.+|+
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~ 314 (326)
T 2w1i_A 272 LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLA 314 (326)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred HHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHH
Confidence 00111 1111233556678899999999999999999999987
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-42 Score=378.29 Aligned_cols=241 Identities=24% Similarity=0.357 Sum_probs=201.2
Q ss_pred hcccccceeecccCceeEEEEEe--CCccEEEEEeCcChhH---hHHHHHHHHHHHHcCCCCceeeeccccCCC--ceEE
Q 008365 228 TDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQ---GKRQFQQEVEVLSSIRHPNMVLLLGACPDY--GCLV 300 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~---~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~--~~lV 300 (568)
.++|.+.+.||+|+||.||+|++ +++.||||++.+.... ....+.+|+.+|+.++|||||+++++|.+. .|+|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 36799999999999999999987 5789999999754322 245688999999999999999999998654 4899
Q ss_pred EEecCCCCHHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccC
Q 008365 301 YEYMHNGSLEDRLLRRGN-TPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVP 379 (568)
Q Consensus 301 ~E~~~ggsL~~~l~~~~~-~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~ 379 (568)
|||++||+|.+++..... ...+++..+..|+.||+.||.|||+.+ |+||||||+||||+.+|.+||+|||+++.+.
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 999999999999876542 345899999999999999999999999 9999999999999999999999999998764
Q ss_pred CCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCch------HHHHHHHhCcccccc
Q 008365 380 PSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTH------HVSRAIEKGTLAEML 453 (568)
Q Consensus 380 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~------~~~~~~~~~~~~~~l 453 (568)
.... .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.... .+...+...
T Consensus 341 ~~~~------~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~------ 408 (543)
T 3c4z_A 341 AGQT------KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQ------ 408 (543)
T ss_dssp TTCC------CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHC------
T ss_pred CCCc------ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhc------
Confidence 3221 1234689999999999999999999999999999999999999996532 222222221
Q ss_pred CccCCCCChHHHHHHHHHHHHhhccCCCCCCCh
Q 008365 454 DPAVTDWPAEAAESFSKLAIQCAELRKKDRPDL 486 (568)
Q Consensus 454 ~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~ 486 (568)
...+|..++..+.+|+.+||..+|.+||++
T Consensus 409 ---~~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 438 (543)
T 3c4z_A 409 ---AVTYPDKFSPASKDFCEALLQKDPEKRLGF 438 (543)
T ss_dssp ---CCCCCTTSCHHHHHHHHHHSCSSGGGSCCC
T ss_pred ---ccCCCcccCHHHHHHHHHhccCCHhHCCCC
Confidence 123455667789999999999999999976
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=349.02 Aligned_cols=252 Identities=23% Similarity=0.353 Sum_probs=199.6
Q ss_pred ccccceeecccCceeEEEEEe--CCccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCceeeeccccCCC--ceEEEEecC
Q 008365 230 KFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACPDY--GCLVYEYMH 305 (568)
Q Consensus 230 ~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~--~~lV~E~~~ 305 (568)
.|.....||+|+||.||+|.+ ++..||||++..........+.+|+.+++.++||||++++++|.+. .++||||++
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 102 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP 102 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence 345556899999999999997 5678999999776555567899999999999999999999998544 489999999
Q ss_pred CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccC-CceeEecccccccccCCCCCc
Q 008365 306 NGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDR-NYVSKISDVGLARLVPPSVAD 384 (568)
Q Consensus 306 ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~-~~~vKL~DFGla~~~~~~~~~ 384 (568)
+++|.+++........+++..+..|+.||+.||.|||+.+ |+||||||+||||+. ++.+||+|||+++.+....
T Consensus 103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~-- 177 (295)
T 2clq_A 103 GGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN-- 177 (295)
T ss_dssp EEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC----
T ss_pred CCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCC--
Confidence 9999999987654445778899999999999999999999 999999999999987 8999999999998654321
Q ss_pred cccccccccccccccCCChhhhhcCC--CCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHhCccccccCccCCCCCh
Q 008365 385 SVTQYHMTSAAGTFCYIDPEYQQTGM--LTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAVTDWPA 462 (568)
Q Consensus 385 ~~~~~~~~~~~GT~~Y~APE~~~~~~--~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~l~~~~~~~p~ 462 (568)
.......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||................ ......+.
T Consensus 178 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~----~~~~~~~~ 249 (295)
T 2clq_A 178 ----PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMF----KVHPEIPE 249 (295)
T ss_dssp -------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHH----CCCCCCCT
T ss_pred ----CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccc----cccccccc
Confidence 1123457999999999987654 8899999999999999999999996432221111110000 11123345
Q ss_pred HHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 463 EAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 463 ~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
.++..+.+|+.+||+.+|.+||++.+++.+.+
T Consensus 250 ~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~ 281 (295)
T 2clq_A 250 SMSAEAKAFILKCFEPDPDKRACANDLLVDEF 281 (295)
T ss_dssp TSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGG
T ss_pred cCCHHHHHHHHHHccCChhhCCCHHHHhcChh
Confidence 56778999999999999999999999986543
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-42 Score=374.19 Aligned_cols=250 Identities=26% Similarity=0.377 Sum_probs=206.8
Q ss_pred HhcccccceeecccCceeEEEEEe--CCccEEEEEeCcCh---hHhHHHHHHHHHHHHcCCCCceeeeccccCCC--ceE
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDA---AQGKRQFQQEVEVLSSIRHPNMVLLLGACPDY--GCL 299 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~--~~l 299 (568)
..++|.+.+.||+|+||.||+|.+ ++..||||++.... ......+.+|+.+|+.++|||||+++++|.+. .++
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 457899999999999999999987 57799999986542 23456789999999999999999999998664 489
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeec---cCCceeEeccccccc
Q 008365 300 VYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILL---DRNYVSKISDVGLAR 376 (568)
Q Consensus 300 V~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILl---d~~~~vKL~DFGla~ 376 (568)
|||||.+|+|.+++...+ .+++..+..|+.||+.||.|||+.+ |+||||||+|||| +.++.+||+|||+++
T Consensus 104 v~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 177 (484)
T 3nyv_A 104 VGEVYTGGELFDEIISRK---RFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLST 177 (484)
T ss_dssp EECCCCSCBHHHHHHTCS---CCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred EEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence 999999999999887654 3899999999999999999999999 9999999999999 567899999999998
Q ss_pred ccCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHH--HHHHHhCccccccC
Q 008365 377 LVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHV--SRAIEKGTLAEMLD 454 (568)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~--~~~~~~~~~~~~l~ 454 (568)
.+.... .....+||+.|+|||++.+ .++.++|||||||++|+|++|.+||...... ...+..+....
T Consensus 178 ~~~~~~-------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~--- 246 (484)
T 3nyv_A 178 HFEASK-------KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTF--- 246 (484)
T ss_dssp HBCCCC-------SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC---
T ss_pred Eccccc-------ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCC---
Confidence 764322 2244679999999999876 6999999999999999999999999765442 23333332211
Q ss_pred ccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHHH
Q 008365 455 PAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPELN 495 (568)
Q Consensus 455 ~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l~ 495 (568)
..+ ....++..+.+|+.+||+.+|.+||++.+++.|.+-
T Consensus 247 -~~~-~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~ 285 (484)
T 3nyv_A 247 -ELP-QWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWI 285 (484)
T ss_dssp -CSG-GGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHH
T ss_pred -CCc-ccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhh
Confidence 111 123456789999999999999999999999987763
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-42 Score=363.36 Aligned_cols=258 Identities=21% Similarity=0.290 Sum_probs=206.4
Q ss_pred hcccccceeecccCceeEEEEEeC--CccEEEEEeCcCh-hHhHHHHHHHHHHHHcCCCCceeeeccccCC----CceEE
Q 008365 228 TDKFSEAMKIGEGGYGPVYRGKLD--HTPVAIKVLRPDA-AQGKRQFQQEVEVLSSIRHPNMVLLLGACPD----YGCLV 300 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~~~~~--~~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~----~~~lV 300 (568)
.++|.+.++||+|+||.||+|.+. ++.||||++.... ......+.+|+.+|+.++|||||++++++.+ ..++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 467999999999999999999984 7799999997543 2335667899999999999999999998743 33899
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeec----cCCceeEeccccccc
Q 008365 301 YEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILL----DRNYVSKISDVGLAR 376 (568)
Q Consensus 301 ~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILl----d~~~~vKL~DFGla~ 376 (568)
||||++|+|.+++........+++..++.|+.||+.||.|||+.+ |+||||||+|||| +.++.+||+|||+++
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 999999999999987554445899999999999999999999999 9999999999999 888899999999998
Q ss_pred ccCCCCCccccccccccccccccCCChhhhhc--------CCCCCcceehhHHHHHHHHHhCCCCCCCc------hHHHH
Q 008365 377 LVPPSVADSVTQYHMTSAAGTFCYIDPEYQQT--------GMLTTKSDIYSFGIMLLQIITARSPMGLT------HHVSR 442 (568)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~--------~~~s~ksDvwSlGvil~elltG~~Pf~~~------~~~~~ 442 (568)
.+.... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||... ..+..
T Consensus 165 ~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~ 237 (396)
T 4eut_A 165 ELEDDE-------QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMY 237 (396)
T ss_dssp ECCCGG-------GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHH
T ss_pred EccCCC-------ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHH
Confidence 764321 2234679999999998875 56788999999999999999999999421 12222
Q ss_pred HHHhCcccccc----------------CccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHHH
Q 008365 443 AIEKGTLAEML----------------DPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPELN 495 (568)
Q Consensus 443 ~~~~~~~~~~l----------------~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l~ 495 (568)
.+..+.-...+ .+.....+..++..+.+++..||+.||.+||++.+++.....
T Consensus 238 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~ 306 (396)
T 4eut_A 238 KIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSD 306 (396)
T ss_dssp HHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHH
T ss_pred HHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHH
Confidence 22222111000 011123457888999999999999999999999998754433
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=381.32 Aligned_cols=247 Identities=28% Similarity=0.380 Sum_probs=206.1
Q ss_pred hcccccceeecccCceeEEEEEe--CCccEEEEEeCcChh---HhHHHHHHHHHHHHcCCCCceeeeccccCCC--ceEE
Q 008365 228 TDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAA---QGKRQFQQEVEVLSSIRHPNMVLLLGACPDY--GCLV 300 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~---~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~--~~lV 300 (568)
.++|.+.+.||+|+||.||+|.+ +++.||||++.+... .....+.+|+.+|+.++|||||+++++|.+. .|||
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 46799999999999999999987 578999999975432 2245678999999999999999999998654 4899
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCC
Q 008365 301 YEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPP 380 (568)
Q Consensus 301 ~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~ 380 (568)
||||+||+|.+++...+.. .+++..+..|+.||+.||.|||+.+ ||||||||+||||+.+|.+||+|||+++.+..
T Consensus 263 mEy~~gg~L~~~l~~~~~~-~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~~ 338 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMGQA-GFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPE 338 (576)
T ss_dssp ECCCCSCBHHHHHHSSSSC-CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEcCCCCcHHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceeccc
Confidence 9999999999998765432 3899999999999999999999999 99999999999999999999999999987643
Q ss_pred CCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCch------HHHHHHHhCccccccC
Q 008365 381 SVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTH------HVSRAIEKGTLAEMLD 454 (568)
Q Consensus 381 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~------~~~~~~~~~~~~~~l~ 454 (568)
.. .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.... .+...+...
T Consensus 339 ~~-------~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~------- 404 (576)
T 2acx_A 339 GQ-------TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV------- 404 (576)
T ss_dssp TC-------CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHC-------
T ss_pred Cc-------cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcc-------
Confidence 21 1234689999999999999999999999999999999999999996532 122222211
Q ss_pred ccCCCCChHHHHHHHHHHHHhhccCCCCCC-----ChHHhHhHHH
Q 008365 455 PAVTDWPAEAAESFSKLAIQCAELRKKDRP-----DLGTVIVPEL 494 (568)
Q Consensus 455 ~~~~~~p~~~~~~l~~li~~Cl~~dP~~RP-----s~~~vl~~~l 494 (568)
...++..++..+.+||.+||..||.+|| ++.+|+.|.+
T Consensus 405 --~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~Hpf 447 (576)
T 2acx_A 405 --PEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPL 447 (576)
T ss_dssp --CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGG
T ss_pred --cccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChh
Confidence 1234455677899999999999999999 6788876654
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=356.91 Aligned_cols=255 Identities=23% Similarity=0.311 Sum_probs=191.6
Q ss_pred HHhcccccceeecccCceeEEEEEe--CCccEEEEEeCcChhH--hHHHHHHHHHHHHcCCCCceeeeccccCCC--ceE
Q 008365 226 EATDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQ--GKRQFQQEVEVLSSIRHPNMVLLLGACPDY--GCL 299 (568)
Q Consensus 226 ~~~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~--~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~--~~l 299 (568)
...++|.+.++||+|+||.||+|.+ +++.||||+++..... ....+.+|+.+|+.++|||||++++++.+. .++
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 110 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL 110 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence 3557899999999999999999986 5779999999765332 234677999999999999999999998544 489
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeec-----cCCceeEeccccc
Q 008365 300 VYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILL-----DRNYVSKISDVGL 374 (568)
Q Consensus 300 V~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILl-----d~~~~vKL~DFGl 374 (568)
||||++ |+|.+++.... .+++..+..|+.||+.||.|||+.+ |+||||||+|||| +.++.+||+|||+
T Consensus 111 v~e~~~-~~L~~~~~~~~---~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~ 183 (329)
T 3gbz_A 111 IFEYAE-NDLKKYMDKNP---DVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGL 183 (329)
T ss_dssp EEECCS-EEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTH
T ss_pred EEecCC-CCHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCC
Confidence 999996 59999987754 3889999999999999999999999 9999999999999 4556799999999
Q ss_pred ccccCCCCCccccccccccccccccCCChhhhhcC-CCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHhCcccccc
Q 008365 375 ARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTG-MLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEML 453 (568)
Q Consensus 375 a~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~l 453 (568)
++.+.... ......+||+.|+|||++.+. .++.++|||||||++|+|++|..||...................
T Consensus 184 a~~~~~~~------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~ 257 (329)
T 3gbz_A 184 ARAFGIPI------RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLP 257 (329)
T ss_dssp HHHHC-----------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred ccccCCcc------cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCC
Confidence 98664221 122445789999999988774 48999999999999999999999997655433222110000000
Q ss_pred -Cc-------------cCCC---------CChHHHHHHHHHHHHhhccCCCCCCChHHhHhHH
Q 008365 454 -DP-------------AVTD---------WPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPE 493 (568)
Q Consensus 454 -~~-------------~~~~---------~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~ 493 (568)
+. .... .+..++..+.+|+.+||+.||.+||++.+++.|.
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 320 (329)
T 3gbz_A 258 DDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHP 320 (329)
T ss_dssp CTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred chhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCc
Confidence 00 0000 0112457789999999999999999999998544
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-42 Score=360.18 Aligned_cols=255 Identities=23% Similarity=0.387 Sum_probs=204.9
Q ss_pred HHHHHHHhcccccceeecccCceeEEEEEe--CCccEEEEEeCcCh--------hHhHHHHHHHHHHHHcC-CCCceeee
Q 008365 221 IEEIEEATDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDA--------AQGKRQFQQEVEVLSSI-RHPNMVLL 289 (568)
Q Consensus 221 ~~ei~~~~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~--------~~~~~~~~~Ev~iL~~l-~HpnIv~l 289 (568)
......+.++|.+.+.||+|+||.||+|.+ +|+.||||++.... ......+.+|+.+++.+ +||||+++
T Consensus 86 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 165 (365)
T 2y7j_A 86 WAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITL 165 (365)
T ss_dssp HHHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCE
T ss_pred chhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 334455678899999999999999999987 47899999986543 12245678999999999 79999999
Q ss_pred ccccCCC--ceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCcee
Q 008365 290 LGACPDY--GCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVS 367 (568)
Q Consensus 290 ~g~~~~~--~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~v 367 (568)
+++|... .++||||++|++|.+++.... .+++..+..|+.||+.||.|||+.+ |+||||||+||||+.++.+
T Consensus 166 ~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~i 239 (365)
T 2y7j_A 166 IDSYESSSFMFLVFDLMRKGELFDYLTEKV---ALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQI 239 (365)
T ss_dssp EEEEEBSSEEEEEECCCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCE
T ss_pred EEEEeeCCEEEEEEEeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCE
Confidence 9998543 489999999999999997653 3899999999999999999999999 9999999999999999999
Q ss_pred EecccccccccCCCCCccccccccccccccccCCChhhhhcC------CCCCcceehhHHHHHHHHHhCCCCCCCchHHH
Q 008365 368 KISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTG------MLTTKSDIYSFGIMLLQIITARSPMGLTHHVS 441 (568)
Q Consensus 368 KL~DFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~------~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~ 441 (568)
||+|||++..+.... .....+||+.|+|||++.+. .++.++|||||||++|+|++|..||.......
T Consensus 240 kl~DfG~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~ 312 (365)
T 2y7j_A 240 RLSDFGFSCHLEPGE-------KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQIL 312 (365)
T ss_dssp EECCCTTCEECCTTC-------CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred EEEecCcccccCCCc-------ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHH
Confidence 999999998764321 12456899999999988643 58899999999999999999999997544322
Q ss_pred --HHHHhCccccccCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHH
Q 008365 442 --RAIEKGTLAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPE 493 (568)
Q Consensus 442 --~~~~~~~~~~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~ 493 (568)
..+..+... ...+.. ..++..+.+|+.+||+.+|.+||++.+++.+.
T Consensus 313 ~~~~i~~~~~~-~~~~~~----~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp 361 (365)
T 2y7j_A 313 MLRMIMEGQYQ-FSSPEW----DDRSSTVKDLISRLLQVDPEARLTAEQALQHP 361 (365)
T ss_dssp HHHHHHHTCCC-CCHHHH----SSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred HHHHHHhCCCC-CCCccc----ccCCHHHHHHHHHHcCCChhHCcCHHHHhcCc
Confidence 222222211 000001 12346789999999999999999999998654
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=343.61 Aligned_cols=247 Identities=26% Similarity=0.368 Sum_probs=197.6
Q ss_pred ccccceeecccCceeEEEEEe--CCc---cEEEEEeCcCh-hHhHHHHHHHHHHHHcCCCCceeeeccccCCC--c-eEE
Q 008365 230 KFSEAMKIGEGGYGPVYRGKL--DHT---PVAIKVLRPDA-AQGKRQFQQEVEVLSSIRHPNMVLLLGACPDY--G-CLV 300 (568)
Q Consensus 230 ~y~~~~~IG~G~fg~Vy~~~~--~~~---~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~--~-~lV 300 (568)
.|.+.++||+|+||.||+|.+ ++. .||||++.... ....+.+.+|+.+++.++||||++++++|.+. . ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 467779999999999999986 222 69999987543 34456789999999999999999999998542 2 899
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCC
Q 008365 301 YEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPP 380 (568)
Q Consensus 301 ~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~ 380 (568)
|||+.+|+|.+++.... ..+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 102 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 176 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSPQ--RNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILD 176 (298)
T ss_dssp ECCCTTCBHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred EecccCCCHHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence 99999999999997643 24889999999999999999999999 99999999999999999999999999986543
Q ss_pred CCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCC-CCCCCchH--HHHHHHhCccccccCccC
Q 008365 381 SVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITAR-SPMGLTHH--VSRAIEKGTLAEMLDPAV 457 (568)
Q Consensus 381 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~-~Pf~~~~~--~~~~~~~~~~~~~l~~~~ 457 (568)
... ..........||+.|+|||.+.+..++.++|||||||++|+|++|. +||..... +...+..+. .
T Consensus 177 ~~~--~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~--------~ 246 (298)
T 3pls_A 177 REY--YSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGR--------R 246 (298)
T ss_dssp GGG--GCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTC--------C
T ss_pred Ccc--cccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCC--------C
Confidence 211 1112234567899999999999999999999999999999999955 55543322 222222221 1
Q ss_pred CCCChHHHHHHHHHHHHhhccCCCCCCChHHhHh
Q 008365 458 TDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIV 491 (568)
Q Consensus 458 ~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~ 491 (568)
...+..++..+.+|+..||+.+|.+||++.+++.
T Consensus 247 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 280 (298)
T 3pls_A 247 LPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVG 280 (298)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCccchHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 1224455678999999999999999999999874
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=344.03 Aligned_cols=250 Identities=25% Similarity=0.350 Sum_probs=201.5
Q ss_pred HhcccccceeecccCceeEEEEEe--CCccEEEEEeCcChh----HhHHHHHHHHHHHHcCCCCceeeecccc--CC--C
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAA----QGKRQFQQEVEVLSSIRHPNMVLLLGAC--PD--Y 296 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~----~~~~~~~~Ev~iL~~l~HpnIv~l~g~~--~~--~ 296 (568)
..++|.+.+.||+|+||.||++.+ ++..||||+++.... .....+.+|+.+++.++||||+++++++ .+ .
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK 82 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence 457899999999999999999988 567899999976432 2356789999999999999999999987 32 3
Q ss_pred ceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEeccccccc
Q 008365 297 GCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLAR 376 (568)
Q Consensus 297 ~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~ 376 (568)
.++||||++++ |.+++..... ..+++..+..|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++.
T Consensus 83 ~~lv~e~~~~~-l~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~ 157 (305)
T 2wtk_C 83 MYMVMEYCVCG-MQEMLDSVPE-KRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAE 157 (305)
T ss_dssp EEEEEECCSEE-HHHHHHHSTT-CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEehhccCC-HHHHHHhCcc-cccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeecccccc
Confidence 48999999766 7777766443 34899999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCCccccccccccccccccCCChhhhhcCC--CCCcceehhHHHHHHHHHhCCCCCCCchHHH--HHHHhCccccc
Q 008365 377 LVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGM--LTTKSDIYSFGIMLLQIITARSPMGLTHHVS--RAIEKGTLAEM 452 (568)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~--~s~ksDvwSlGvil~elltG~~Pf~~~~~~~--~~~~~~~~~~~ 452 (568)
.+...... .......||+.|+|||++.+.. ++.++|||||||++|+|++|..||....... ..+..+.
T Consensus 158 ~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~---- 229 (305)
T 2wtk_C 158 ALHPFAAD----DTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGS---- 229 (305)
T ss_dssp ECCTTCSS----CEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCC----
T ss_pred ccCccccc----cccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCC----
Confidence 76432211 1223457999999999987654 3789999999999999999999997654322 2222221
Q ss_pred cCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 453 LDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 453 l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
..++..++..+.+|+.+||..||.+||++.+++.+.+
T Consensus 230 -----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~ 266 (305)
T 2wtk_C 230 -----YAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSW 266 (305)
T ss_dssp -----CCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHH
T ss_pred -----CCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcc
Confidence 1234456678999999999999999999999987654
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=349.01 Aligned_cols=250 Identities=24% Similarity=0.398 Sum_probs=202.0
Q ss_pred hcccccceeecccCceeEEEEEe--CCccEEEEEeCcCh--hHhHHHHHHHHHHHHcCCCCceeeeccccC----CCceE
Q 008365 228 TDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDA--AQGKRQFQQEVEVLSSIRHPNMVLLLGACP----DYGCL 299 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~--~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~----~~~~l 299 (568)
.++|++.+.||+|+||.||++.+ +++.||||++.... ....+.+.+|+.+++.++||||++++++|. ...++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 46899999999999999999987 57789999997542 344567899999999999999999999773 23489
Q ss_pred EEEecCCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHcC--CCCcccCCCCCCCeeccCCceeEeccccccc
Q 008365 300 VYEYMHNGSLEDRLLRRG-NTPVIPWRKRFKIAAEIATALLFLHQAK--PEPLVHRDLKPANILLDRNYVSKISDVGLAR 376 (568)
Q Consensus 300 V~E~~~ggsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~--~~~IiHrDIKp~NILld~~~~vKL~DFGla~ 376 (568)
||||+++|+|.+++.... ....+++..++.|+.||+.||.|||+.+ ..+|+||||||+||||+.++.+||+|||+++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 999999999999987643 2234899999999999999999999987 2349999999999999999999999999998
Q ss_pred ccCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchH--HHHHHHhCccccccC
Q 008365 377 LVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHH--VSRAIEKGTLAEMLD 454 (568)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~--~~~~~~~~~~~~~l~ 454 (568)
.+.... .......||+.|+|||++.+..++.++|||||||++|+|++|..||..... +...+..+..
T Consensus 165 ~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~----- 233 (279)
T 2w5a_A 165 ILNHDT------SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKF----- 233 (279)
T ss_dssp HC---C------HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC-----
T ss_pred eecccc------ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhccc-----
Confidence 654321 112345799999999999999999999999999999999999999976543 2223333322
Q ss_pred ccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHh
Q 008365 455 PAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIV 491 (568)
Q Consensus 455 ~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~ 491 (568)
...+..++..+.+++.+||+.+|.+||++.+|+.
T Consensus 234 ---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 267 (279)
T 2w5a_A 234 ---RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 267 (279)
T ss_dssp ---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---ccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 2234456678999999999999999999999974
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-42 Score=384.19 Aligned_cols=246 Identities=25% Similarity=0.421 Sum_probs=197.1
Q ss_pred ccccce-eecccCceeEEEEEe----CCccEEEEEeCcCh-hHhHHHHHHHHHHHHcCCCCceeeeccccCC-CceEEEE
Q 008365 230 KFSEAM-KIGEGGYGPVYRGKL----DHTPVAIKVLRPDA-AQGKRQFQQEVEVLSSIRHPNMVLLLGACPD-YGCLVYE 302 (568)
Q Consensus 230 ~y~~~~-~IG~G~fg~Vy~~~~----~~~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~-~~~lV~E 302 (568)
+|.+.. .||+|+||.||+|.+ .+..||||+++... ....+.|.+|+.+|+.++|||||+++++|.+ ..+||||
T Consensus 336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~lv~E 415 (613)
T 2ozo_A 336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLVME 415 (613)
T ss_dssp SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEESSSEEEEEE
T ss_pred ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEeccCCeEEEEE
Confidence 344444 799999999999976 24579999997653 2345789999999999999999999999854 4589999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCC
Q 008365 303 YMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSV 382 (568)
Q Consensus 303 ~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~ 382 (568)
||++|+|.+++.... ..+++..+..|+.||+.||.|||+.+ ||||||||+||||+.++.+||+|||+++.+....
T Consensus 416 ~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~ 490 (613)
T 2ozo_A 416 MAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADD 490 (613)
T ss_dssp CCTTCBHHHHHTTCT--TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC---
T ss_pred eCCCCcHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccCCC
Confidence 999999999986543 34899999999999999999999999 9999999999999999999999999998764321
Q ss_pred CccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh-CCCCCCCchH--HHHHHHhCccccccCccCCC
Q 008365 383 ADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPMGLTHH--VSRAIEKGTLAEMLDPAVTD 459 (568)
Q Consensus 383 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~--~~~~~~~~~~~~~l~~~~~~ 459 (568)
.. ........+|+.|+|||++.+..++.++|||||||+||||++ |+.||..... +...+..+. ...
T Consensus 491 ~~---~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~--------~~~ 559 (613)
T 2ozo_A 491 SY---YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK--------RME 559 (613)
T ss_dssp --------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTC--------CCC
T ss_pred ce---eeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC--------CCC
Confidence 11 111223456789999999999999999999999999999998 9999965433 333333332 123
Q ss_pred CChHHHHHHHHHHHHhhccCCCCCCChHHhHh
Q 008365 460 WPAEAAESFSKLAIQCAELRKKDRPDLGTVIV 491 (568)
Q Consensus 460 ~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~ 491 (568)
.|..++..+.+||..||..+|.+||++.+|+.
T Consensus 560 ~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 591 (613)
T 2ozo_A 560 CPPECPPELYALMSDCWIYKWEDRPDFLTVEQ 591 (613)
T ss_dssp CCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 45667788999999999999999999999873
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=362.14 Aligned_cols=256 Identities=18% Similarity=0.291 Sum_probs=192.2
Q ss_pred hcccccceeecccCceeEEEEEe-----CCccEEEEEeCcChhHh-----------HHHHHHHHHHHHcCCCCceeeecc
Q 008365 228 TDKFSEAMKIGEGGYGPVYRGKL-----DHTPVAIKVLRPDAAQG-----------KRQFQQEVEVLSSIRHPNMVLLLG 291 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~~~~-----~~~~vAvK~l~~~~~~~-----------~~~~~~Ev~iL~~l~HpnIv~l~g 291 (568)
.++|.+.+.||+|+||.||+|.+ .+..||||++....... ...+.+|+.+++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 46899999999999999999998 34689999987653211 123568899999999999999999
Q ss_pred ccCC------CceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCc
Q 008365 292 ACPD------YGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNY 365 (568)
Q Consensus 292 ~~~~------~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~ 365 (568)
++.+ ..++||||+ +++|.+++...+ .+++..++.|+.||+.||.|||+.+ |+||||||+||||+.++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~ 188 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG---TFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKN 188 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG---BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCC
Confidence 8744 348999999 999999987654 4899999999999999999999999 99999999999998877
Q ss_pred --eeEecccccccccCCCCCc-cccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCC--chHH
Q 008365 366 --VSKISDVGLARLVPPSVAD-SVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGL--THHV 440 (568)
Q Consensus 366 --~vKL~DFGla~~~~~~~~~-~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~--~~~~ 440 (568)
.+||+|||+++.+...... ...........||+.|+|||++.+..++.++|||||||++|+|++|+.||.. ....
T Consensus 189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~ 268 (345)
T 2v62_A 189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPV 268 (345)
T ss_dssp TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHH
T ss_pred CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccH
Confidence 9999999999876432211 1111122456899999999999999999999999999999999999999943 1111
Q ss_pred HHHHHhCccccccCccCCCC--ChHHHHHHHHHHHHhhccCCCCCCChHHhH
Q 008365 441 SRAIEKGTLAEMLDPAVTDW--PAEAAESFSKLAIQCAELRKKDRPDLGTVI 490 (568)
Q Consensus 441 ~~~~~~~~~~~~l~~~~~~~--p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl 490 (568)
............+...+..+ +..++..+.+|+..||..+|.+||++.+|+
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~ 320 (345)
T 2v62_A 269 AVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALK 320 (345)
T ss_dssp HHHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHH
T ss_pred HHHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHH
Confidence 11111111111111111100 114556899999999999999999999986
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-42 Score=363.38 Aligned_cols=251 Identities=22% Similarity=0.345 Sum_probs=196.2
Q ss_pred cccccceeecccCceeEEEEEe-CCccEEEEEeCcC--hhHhHHHHHHHHHHHHcCC--CCceeeeccccCC--CceEEE
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKL-DHTPVAIKVLRPD--AAQGKRQFQQEVEVLSSIR--HPNMVLLLGACPD--YGCLVY 301 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~-~~~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l~--HpnIv~l~g~~~~--~~~lV~ 301 (568)
..|.+.+.||+|+||.||+|.+ .++.||||++... .......+.+|+.+|+.+. |||||++++++.. ..+|||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 5699999999999999999987 4678999998654 3344567899999999996 5999999988744 448999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCC
Q 008365 302 EYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPS 381 (568)
Q Consensus 302 E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~ 381 (568)
| +.+++|.+++.... .+++..+..|+.||+.||.|||+.+ |+||||||+||||+ ++.+||+|||+++.+...
T Consensus 136 E-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~ 207 (390)
T 2zmd_A 136 E-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 207 (390)
T ss_dssp E-CCSEEHHHHHHHCS---SCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC---
T ss_pred e-cCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccCC
Confidence 9 55899999998754 3788899999999999999999999 99999999999995 589999999999876432
Q ss_pred CCccccccccccccccccCCChhhhhc-----------CCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHhCccc
Q 008365 382 VADSVTQYHMTSAAGTFCYIDPEYQQT-----------GMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLA 450 (568)
Q Consensus 382 ~~~~~~~~~~~~~~GT~~Y~APE~~~~-----------~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~ 450 (568)
.. .......+||+.|+|||++.+ ..++.++|||||||+||+|++|+.||.........+ .
T Consensus 208 ~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~-----~ 278 (390)
T 2zmd_A 208 TT----SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKL-----H 278 (390)
T ss_dssp ----------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHH-----H
T ss_pred Cc----cccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHH-----H
Confidence 21 112245689999999998875 468999999999999999999999996432211111 1
Q ss_pred cccCccC-CCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHHHH
Q 008365 451 EMLDPAV-TDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPELNR 496 (568)
Q Consensus 451 ~~l~~~~-~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l~~ 496 (568)
..+++.. ..+|...+..+.+|+.+||..+|.+||++.+++.+.+-.
T Consensus 279 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~ 325 (390)
T 2zmd_A 279 AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 325 (390)
T ss_dssp HHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred HHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCcc
Confidence 1111111 123333456799999999999999999999999877644
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=358.30 Aligned_cols=252 Identities=22% Similarity=0.266 Sum_probs=192.4
Q ss_pred hcccccceeecccCceeEEEEEe--CCccEEEEEeCcC--hhHhHHHHHHHHHHHHcCCCCceeeeccccCCC-------
Q 008365 228 TDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPD--AAQGKRQFQQEVEVLSSIRHPNMVLLLGACPDY------- 296 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~------- 296 (568)
.++|.+.+.||+|+||.||+|.+ .+..||||++... .......+.+|+.+++.++||||++++++|...
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 46899999999999999999987 5778999998653 233456788999999999999999999988542
Q ss_pred -ceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccc
Q 008365 297 -GCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLA 375 (568)
Q Consensus 297 -~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla 375 (568)
.++||||++ |+|.+.+.. .+++..+..|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++
T Consensus 104 ~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 174 (371)
T 2xrw_A 104 DVYIVMELMD-ANLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 174 (371)
T ss_dssp EEEEEEECCS-EEHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred ceEEEEEcCC-CCHHHHHhh-----ccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeecc
Confidence 389999996 578887752 2788999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHhCc-c-----
Q 008365 376 RLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGT-L----- 449 (568)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~-~----- 449 (568)
+..... ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||...+........-. +
T Consensus 175 ~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 247 (371)
T 2xrw_A 175 RTAGTS-------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCP 247 (371)
T ss_dssp ----------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCH
T ss_pred cccccc-------cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence 865322 122456799999999999999999999999999999999999999976554332111000 0
Q ss_pred -------------------------ccccCccC----CCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHHH
Q 008365 450 -------------------------AEMLDPAV----TDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPELN 495 (568)
Q Consensus 450 -------------------------~~~l~~~~----~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l~ 495 (568)
...+.... ...+...+..+.+|+.+||..||.+||++.+++.|.+-
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~ 322 (371)
T 2xrw_A 248 EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 322 (371)
T ss_dssp HHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHH
T ss_pred HHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcch
Confidence 00000000 00112346789999999999999999999999987763
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-42 Score=372.63 Aligned_cols=249 Identities=24% Similarity=0.398 Sum_probs=203.1
Q ss_pred HhcccccceeecccCceeEEEEEe--CCccEEEEEeCcCh--hHhHHHHHHHHHHHHcCCCCceeeeccccCCCc--eEE
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDA--AQGKRQFQQEVEVLSSIRHPNMVLLLGACPDYG--CLV 300 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~--~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~--~lV 300 (568)
..++|.+.++||+|+||.||+|.+ +++.||||++.... ......+.+|+.+|+.++|||||+++++|.+.. ++|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 557899999999999999999997 57799999986432 123467889999999999999999999986544 899
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeecc---CCceeEecccccccc
Q 008365 301 YEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLD---RNYVSKISDVGLARL 377 (568)
Q Consensus 301 ~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld---~~~~vKL~DFGla~~ 377 (568)
||||.||+|.+.+.... .+++..+..|+.||+.||.|||+.+ |+||||||+||||+ .++.+||+|||+++.
T Consensus 100 ~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 173 (486)
T 3mwu_A 100 GELYTGGELFDEIIKRK---RFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (486)
T ss_dssp ECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred EEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence 99999999999887764 3899999999999999999999999 99999999999994 467899999999986
Q ss_pred cCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchH--HHHHHHhCccccccCc
Q 008365 378 VPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHH--VSRAIEKGTLAEMLDP 455 (568)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~--~~~~~~~~~~~~~l~~ 455 (568)
+.... .....+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||..... +...+..+.....
T Consensus 174 ~~~~~-------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~--- 242 (486)
T 3mwu_A 174 FQQNT-------KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFD--- 242 (486)
T ss_dssp BCCC-----------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSC---
T ss_pred CCCCC-------ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC---
Confidence 64321 2245679999999999876 599999999999999999999999976543 2233333322111
Q ss_pred cCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 456 AVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 456 ~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
.+ ....++..+.+|+.+||..+|.+||++.+++.|.+
T Consensus 243 -~~-~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~ 279 (486)
T 3mwu_A 243 -LP-QWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPW 279 (486)
T ss_dssp -SG-GGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHH
T ss_pred -Cc-ccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHh
Confidence 11 12345677999999999999999999999997665
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=343.36 Aligned_cols=248 Identities=26% Similarity=0.418 Sum_probs=197.9
Q ss_pred cccccceeecccCceeEEEEEe--CCccEEEEEeCcC--hhHhHHHHHHHHHHHHcCCCCceeeeccccCC------Cce
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPD--AAQGKRQFQQEVEVLSSIRHPNMVLLLGACPD------YGC 298 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~------~~~ 298 (568)
..|.+.+.||+|+||.||+|.+ ++..||+|++... .......+.+|+.+|+.++||||++++++|.+ ..+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 4588889999999999999987 4567999998654 23445678999999999999999999998743 248
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeecc-CCceeEecccccccc
Q 008365 299 LVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLD-RNYVSKISDVGLARL 377 (568)
Q Consensus 299 lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld-~~~~vKL~DFGla~~ 377 (568)
+||||+++|+|.+++.... .+++..+..|+.||+.||.|||+.+ .+|+||||||+||||+ .++.+||+|||++..
T Consensus 106 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~ 181 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EEEEecCCCCHHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence 9999999999999997754 3889999999999999999999986 3599999999999997 789999999999975
Q ss_pred cCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHhCccccccCccC
Q 008365 378 VPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAV 457 (568)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~l~~~~ 457 (568)
.... ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.............. ....+
T Consensus 182 ~~~~--------~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~--~~~~~-- 248 (290)
T 1t4h_A 182 KRAS--------FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVT--SGVKP-- 248 (290)
T ss_dssp CCTT--------SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHT--TTCCC--
T ss_pred cccc--------ccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHh--ccCCc--
Confidence 4332 1234579999999998774 599999999999999999999999975443322221110 00000
Q ss_pred CCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHH
Q 008365 458 TDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPE 493 (568)
Q Consensus 458 ~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~ 493 (568)
..++...+..+.+|+..||+.+|.+||++.+++.+.
T Consensus 249 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~ 284 (290)
T 1t4h_A 249 ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHA 284 (290)
T ss_dssp GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred cccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCc
Confidence 111223346799999999999999999999998654
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-42 Score=356.73 Aligned_cols=259 Identities=21% Similarity=0.300 Sum_probs=199.5
Q ss_pred hcccccceeecccCceeEEEEEe--CCccEEEEEeCcChh--HhHHHHHHHHHHHHcCCCCceeeeccccCC--------
Q 008365 228 TDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAA--QGKRQFQQEVEVLSSIRHPNMVLLLGACPD-------- 295 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~--~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~-------- 295 (568)
.++|.+.+.||+|+||.||+|.+ +++.||||++..... .....+.+|+.+|+.++||||++++++|.+
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 46899999999999999999997 577999999865432 223467899999999999999999998743
Q ss_pred --CceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccc
Q 008365 296 --YGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVG 373 (568)
Q Consensus 296 --~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFG 373 (568)
..++||||++ |+|.+.+..... .+++..+..|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||
T Consensus 96 ~~~~~lv~e~~~-~~l~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg 169 (351)
T 3mi9_A 96 KGSIYLVFDFCE-HDLAGLLSNVLV--KFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG 169 (351)
T ss_dssp -CEEEEEEECCS-EEHHHHHHCTTS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred CceEEEEEeccC-CCHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccch
Confidence 2489999996 577777765432 3899999999999999999999999 9999999999999999999999999
Q ss_pred cccccCCCCCccccccccccccccccCCChhhhhc-CCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHh----Cc
Q 008365 374 LARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQT-GMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEK----GT 448 (568)
Q Consensus 374 la~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~----~~ 448 (568)
+++.+...... .........||+.|+|||++.+ ..++.++|||||||++|+|++|.+||............ +.
T Consensus 170 ~a~~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~ 247 (351)
T 3mi9_A 170 LARAFSLAKNS--QPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGS 247 (351)
T ss_dssp TCEECCCCSSS--SCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred hcccccccccc--cccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence 99876533221 1223345689999999998876 45899999999999999999999999765443221111 11
Q ss_pred cccccCccCC-------------CC---ChH-----HHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 449 LAEMLDPAVT-------------DW---PAE-----AAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 449 ~~~~l~~~~~-------------~~---p~~-----~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
......+... .. ... .++.+.+|+.+||+.||.+||++.+++.|.+
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 314 (351)
T 3mi9_A 248 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDF 314 (351)
T ss_dssp CCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred CChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCC
Confidence 1100000000 00 000 1456889999999999999999999986544
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-42 Score=348.29 Aligned_cols=246 Identities=25% Similarity=0.393 Sum_probs=205.2
Q ss_pred hcccccceeecccCceeEEEEEe--CCccEEEEEeCcCh-hHhHHHHHHHHHHHHcCCCCceeeeccccCC--CceEEEE
Q 008365 228 TDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDA-AQGKRQFQQEVEVLSSIRHPNMVLLLGACPD--YGCLVYE 302 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--~~~lV~E 302 (568)
.+.|.+.+.||+|+||.||+|.+ +++.||||++.... ......+.+|+.+++.++||||++++++|.+ ..++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 45799999999999999999987 57799999986543 3345678999999999999999999998854 3489999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCC
Q 008365 303 YMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSV 382 (568)
Q Consensus 303 ~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~ 382 (568)
|+++++|.+++... .+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++..+....
T Consensus 101 ~~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 173 (303)
T 3a7i_A 101 YLGGGSALDLLEPG----PLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 173 (303)
T ss_dssp CCTTEEHHHHHTTS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred eCCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCccc
Confidence 99999999988642 3899999999999999999999999 9999999999999999999999999998664321
Q ss_pred CccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHH--HHhCccccccCccCCCC
Q 008365 383 ADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRA--IEKGTLAEMLDPAVTDW 460 (568)
Q Consensus 383 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~--~~~~~~~~~l~~~~~~~ 460 (568)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||......... +..+. ....
T Consensus 174 ------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--------~~~~ 239 (303)
T 3a7i_A 174 ------IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNN--------PPTL 239 (303)
T ss_dssp ------CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC--------CCCC
T ss_pred ------cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCC--------CCCC
Confidence 1224567999999999999999999999999999999999999999765443222 21211 1122
Q ss_pred ChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 461 PAEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 461 p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
+..++..+.+|+..||+.+|.+||++.+++.+.+
T Consensus 240 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~ 273 (303)
T 3a7i_A 240 EGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKF 273 (303)
T ss_dssp CSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHH
T ss_pred ccccCHHHHHHHHHHcCCChhhCcCHHHHhhChh
Confidence 3345667999999999999999999999987665
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=377.85 Aligned_cols=253 Identities=22% Similarity=0.306 Sum_probs=196.4
Q ss_pred HhcccccceeecccCceeEEEEEe--CCccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCceeeec-cc--cCCCceEEE
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLL-GA--CPDYGCLVY 301 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~-g~--~~~~~~lV~ 301 (568)
..++|.+.++||+|+||.||+|.+ ++..||||++...... ..+.+|+.+++.|.|++++..+ .+ ..+..+|||
T Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvm 82 (483)
T 3sv0_A 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (483)
T ss_dssp ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEE
Confidence 357899999999999999999986 5789999998654332 3578899999999875544333 33 345568999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeec---cCCceeEeccccccccc
Q 008365 302 EYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILL---DRNYVSKISDVGLARLV 378 (568)
Q Consensus 302 E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILl---d~~~~vKL~DFGla~~~ 378 (568)
||+ +++|.+++..... .+++..++.|+.||+.||.|||+.+ ||||||||+|||| +.++.+||+|||+++.+
T Consensus 83 e~~-g~sL~~ll~~~~~--~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~ 156 (483)
T 3sv0_A 83 DLL-GPSLEDLFNFCSR--KLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156 (483)
T ss_dssp ECC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred ECC-CCCHHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceec
Confidence 999 9999999976543 3899999999999999999999999 9999999999999 68899999999999876
Q ss_pred CCCCCccc-cccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchH-----HHHHHHhCccccc
Q 008365 379 PPSVADSV-TQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHH-----VSRAIEKGTLAEM 452 (568)
Q Consensus 379 ~~~~~~~~-~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~-----~~~~~~~~~~~~~ 452 (568)
........ ........+||+.|+|||++.+..++.++||||||||||+|++|+.||..... ....+....+...
T Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (483)
T 3sv0_A 157 RDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATS 236 (483)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSC
T ss_pred cCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccccc
Confidence 54322111 11122367899999999999999999999999999999999999999964321 1111111111111
Q ss_pred cCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHh
Q 008365 453 LDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIV 491 (568)
Q Consensus 453 l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~ 491 (568)
+. .++..++..+.+|+..||+.+|.+||++.+|+.
T Consensus 237 ~~----~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 237 IE----ALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp HH----HHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HH----HHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 11 112234567999999999999999999999874
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-42 Score=356.46 Aligned_cols=257 Identities=25% Similarity=0.331 Sum_probs=193.5
Q ss_pred HHHhcccccceeecccCceeEEEEEe--CCccEEEEEeCcChhHh-----HHHHHHHHHHHHcCCCCceeeeccccCC--
Q 008365 225 EEATDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQG-----KRQFQQEVEVLSSIRHPNMVLLLGACPD-- 295 (568)
Q Consensus 225 ~~~~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~-----~~~~~~Ev~iL~~l~HpnIv~l~g~~~~-- 295 (568)
....++|.+.+.||+|+||.||+|.+ +++.||||++....... ...+.+|+.+++.++||||++++++|.+
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 85 (346)
T 1ua2_A 6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS 85 (346)
T ss_dssp -------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred HHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCC
Confidence 34567899999999999999999987 47789999987543221 2357899999999999999999999854
Q ss_pred CceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccc
Q 008365 296 YGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLA 375 (568)
Q Consensus 296 ~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla 375 (568)
..++||||+++ +|.+++.... ..+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++
T Consensus 86 ~~~lv~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a 159 (346)
T 1ua2_A 86 NISLVFDFMET-DLEVIIKDNS--LVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLA 159 (346)
T ss_dssp CCEEEEECCSE-EHHHHHTTCC--SSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGG
T ss_pred ceEEEEEcCCC-CHHHHHHhcC--cCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccc
Confidence 45899999975 8888886543 24788899999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCccccccccccccccccCCChhhhhcC-CCCCcceehhHHHHHHHHHhCCCCCCCchHHHHH---HHh-Cccc
Q 008365 376 RLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTG-MLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRA---IEK-GTLA 450 (568)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~---~~~-~~~~ 450 (568)
+.+.... ......+||+.|+|||++.+. .++.++|||||||++|+|++|.+||......... +.. +...
T Consensus 160 ~~~~~~~------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~ 233 (346)
T 1ua2_A 160 KSFGSPN------RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPT 233 (346)
T ss_dssp STTTSCC------CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred eeccCCc------ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCC
Confidence 8664321 122456799999999988654 5899999999999999999999999765443221 111 1000
Q ss_pred cccCc------------cCCCCC-----hHHHHHHHHHHHHhhccCCCCCCChHHhHhHH
Q 008365 451 EMLDP------------AVTDWP-----AEAAESFSKLAIQCAELRKKDRPDLGTVIVPE 493 (568)
Q Consensus 451 ~~l~~------------~~~~~p-----~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~ 493 (568)
...-+ .....+ ..++..+.+|+.+||..||.+||++.+++.+.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~ 293 (346)
T 1ua2_A 234 EEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMK 293 (346)
T ss_dssp TTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSG
T ss_pred hhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcCh
Confidence 00000 000111 34457899999999999999999999998543
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-42 Score=354.39 Aligned_cols=258 Identities=23% Similarity=0.369 Sum_probs=200.2
Q ss_pred hcccccceeecccCceeEEEEEeC--CccEEEEEeCcCh--hHhHHHHHHHHHHHHcCCCCceeeeccccCCC--ceEEE
Q 008365 228 TDKFSEAMKIGEGGYGPVYRGKLD--HTPVAIKVLRPDA--AQGKRQFQQEVEVLSSIRHPNMVLLLGACPDY--GCLVY 301 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~~~~~--~~~vAvK~l~~~~--~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~--~~lV~ 301 (568)
.++|++.+.||+|+||.||+|.+. +..||||++.... ......+.+|+.+++.++||||++++++|.+. .++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 468999999999999999999984 7799999985542 33345688999999999999999999998554 48999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCC
Q 008365 302 EYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPS 381 (568)
Q Consensus 302 E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~ 381 (568)
||+++++|.+++.... .+++..+..|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+...
T Consensus 104 e~~~~~~l~~~~~~~~---~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 177 (331)
T 4aaa_A 104 EFVDHTILDDLELFPN---GLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 177 (331)
T ss_dssp ECCSEEHHHHHHHSTT---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred ecCCcchHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence 9999999988765443 3899999999999999999999999 999999999999999999999999999765332
Q ss_pred CCccccccccccccccccCCChhhhhcC-CCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHh----Cc--------
Q 008365 382 VADSVTQYHMTSAAGTFCYIDPEYQQTG-MLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEK----GT-------- 448 (568)
Q Consensus 382 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~----~~-------- 448 (568)
. .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||............ +.
T Consensus 178 ~------~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (331)
T 4aaa_A 178 G------EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQEL 251 (331)
T ss_dssp ------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHH
T ss_pred c------cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhH
Confidence 1 122345799999999988775 7899999999999999999999999765443221110 00
Q ss_pred ------cccccCccCCC------CChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHHHHH
Q 008365 449 ------LAEMLDPAVTD------WPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPELNRL 497 (568)
Q Consensus 449 ------~~~~l~~~~~~------~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l~~L 497 (568)
+.....+.... ..+.++..+.+|+.+||+.||.+||++.+++.+.+-..
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 312 (331)
T 4aaa_A 252 FNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQM 312 (331)
T ss_dssp HHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHG
T ss_pred hhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhcc
Confidence 00000111110 11245678999999999999999999999998877543
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=351.92 Aligned_cols=253 Identities=24% Similarity=0.389 Sum_probs=200.7
Q ss_pred HhcccccceeecccCceeEEEEEe-------CCccEEEEEeCcC-hhHhHHHHHHHHHHHHcCCCCceeeeccccCC--C
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKL-------DHTPVAIKVLRPD-AAQGKRQFQQEVEVLSSIRHPNMVLLLGACPD--Y 296 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~-------~~~~vAvK~l~~~-~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--~ 296 (568)
..++|.+.+.||+|+||.||+|.+ .+..||||++... .......+.+|+.+++.++||||+++++++.+ .
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 107 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence 347899999999999999999984 3457999999654 33445678999999999999999999999865 3
Q ss_pred ceEEEEecCCCCHHHHHhhcCCC----CCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccC---CceeEe
Q 008365 297 GCLVYEYMHNGSLEDRLLRRGNT----PVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDR---NYVSKI 369 (568)
Q Consensus 297 ~~lV~E~~~ggsL~~~l~~~~~~----~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~---~~~vKL 369 (568)
.++||||+++|+|.+++...... ..+++..++.|+.||+.||.|||+.+ |+||||||+||||+. ++.+||
T Consensus 108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl 184 (327)
T 2yfx_A 108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKI 184 (327)
T ss_dssp CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEE
T ss_pred cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEE
Confidence 48999999999999999875421 34889999999999999999999999 999999999999984 557999
Q ss_pred cccccccccCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh-CCCCCCCchHH--HHHHHh
Q 008365 370 SDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPMGLTHHV--SRAIEK 446 (568)
Q Consensus 370 ~DFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~--~~~~~~ 446 (568)
+|||+++.+..... ........||+.|+|||++.+..++.++|||||||++|+|++ |..||...... ...+..
T Consensus 185 ~Dfg~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~ 260 (327)
T 2yfx_A 185 GDFGMARDIYRASY----YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTS 260 (327)
T ss_dssp CCCHHHHHHHC----------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHT
T ss_pred Cccccccccccccc----cccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhc
Confidence 99999975432211 112234568999999999999999999999999999999998 99999754432 222222
Q ss_pred CccccccCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 447 GTLAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 447 ~~~~~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
+. ....+..++..+.+|+.+||+.+|.+||++.+++.++.
T Consensus 261 ~~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~ 300 (327)
T 2yfx_A 261 GG--------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 300 (327)
T ss_dssp TC--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CC--------CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHH
Confidence 21 12234456678999999999999999999999985443
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=344.01 Aligned_cols=253 Identities=21% Similarity=0.306 Sum_probs=195.0
Q ss_pred HhcccccceeecccCceeEEEEEe--CCccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCceeeecccc---CCCceEEE
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGAC---PDYGCLVY 301 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~---~~~~~lV~ 301 (568)
..++|.+.+.||+|+||.||+|.+ .++.||||++...... ..+.+|+.+++.++|++++..++.+ .+..++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C--CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc--hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 567899999999999999999995 6779999987554322 3578899999999999888777665 33448999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeec---cCCceeEeccccccccc
Q 008365 302 EYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILL---DRNYVSKISDVGLARLV 378 (568)
Q Consensus 302 E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILl---d~~~~vKL~DFGla~~~ 378 (568)
||+ +++|.+++..... .+++..+..|+.||+.||.|||+.+ |+||||||+|||| +.++.+||+|||+++.+
T Consensus 85 e~~-~~~L~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~ 158 (296)
T 4hgt_A 85 ELL-GPSLEDLFNFCSR--KFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp ECC-CCBHHHHHHHTTS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred Ecc-CCCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence 999 9999999875443 3899999999999999999999999 9999999999999 78899999999999876
Q ss_pred CCCCCccc-cccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchH-----HHHHHHhCccccc
Q 008365 379 PPSVADSV-TQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHH-----VSRAIEKGTLAEM 452 (568)
Q Consensus 379 ~~~~~~~~-~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~-----~~~~~~~~~~~~~ 452 (568)
........ .........||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ....+....+...
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (296)
T 4hgt_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 238 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred cCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch
Confidence 54322111 11223456899999999999999999999999999999999999999964221 1111111111111
Q ss_pred cCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHh
Q 008365 453 LDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIV 491 (568)
Q Consensus 453 l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~ 491 (568)
.. .....++..+.+|+..||+.+|.+||++.+|+.
T Consensus 239 ~~----~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 239 IE----VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HH----HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred hh----hhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 00 011234567999999999999999999999874
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=372.65 Aligned_cols=250 Identities=27% Similarity=0.446 Sum_probs=200.2
Q ss_pred HhcccccceeecccCceeEEEEEe--CCccEEEEEeCcCh--hHhHHHHHHHHHHHHcCCCCceeeeccccCCC--ceEE
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDA--AQGKRQFQQEVEVLSSIRHPNMVLLLGACPDY--GCLV 300 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~--~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~--~~lV 300 (568)
..+.|.++++||+|+||.||+|.+ ++..||||++.... ......+.+|+.+|+.++|||||+++++|.+. .++|
T Consensus 35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 114 (494)
T 3lij_A 35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV 114 (494)
T ss_dssp HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 456799999999999999999998 56789999987643 22346788999999999999999999998654 4899
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccC---CceeEecccccccc
Q 008365 301 YEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDR---NYVSKISDVGLARL 377 (568)
Q Consensus 301 ~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~---~~~vKL~DFGla~~ 377 (568)
||||+||+|.+.+..... +++..+..|+.||+.||.|||+.+ |+||||||+||||+. ++.+||+|||+++.
T Consensus 115 ~e~~~~g~L~~~~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~ 188 (494)
T 3lij_A 115 MECYKGGELFDEIIHRMK---FNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAV 188 (494)
T ss_dssp EECCCSCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred EecCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence 999999999998877643 889999999999999999999999 999999999999965 45699999999987
Q ss_pred cCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchH--HHHHHHhCccccccCc
Q 008365 378 VPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHH--VSRAIEKGTLAEMLDP 455 (568)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~--~~~~~~~~~~~~~l~~ 455 (568)
+.... .....+||+.|+|||++. ..|+.++|||||||++|+|++|.+||..... +...+..+... ...+
T Consensus 189 ~~~~~-------~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~-~~~~ 259 (494)
T 3lij_A 189 FENQK-------KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYT-FDSP 259 (494)
T ss_dssp CBTTB-------CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC-CCSG
T ss_pred CCCCc-------cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC-CCch
Confidence 64321 234567999999999886 5699999999999999999999999975543 22333333221 1111
Q ss_pred cCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHHH
Q 008365 456 AVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPELN 495 (568)
Q Consensus 456 ~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l~ 495 (568)
.+ ..++..+.+|+.+||+.+|.+||++.+++.|.+-
T Consensus 260 ~~----~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~ 295 (494)
T 3lij_A 260 EW----KNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWI 295 (494)
T ss_dssp GG----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHH
T ss_pred hc----ccCCHHHHHHHHHHCCCChhhCccHHHHhcCccc
Confidence 11 2345678999999999999999999999987663
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=347.07 Aligned_cols=248 Identities=27% Similarity=0.443 Sum_probs=190.0
Q ss_pred HhcccccceeecccCceeEEEEEe--CCccEEEEEeCcC---hhHhHHHHHHHHHHHHcCCCCceeeeccccCC--CceE
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPD---AAQGKRQFQQEVEVLSSIRHPNMVLLLGACPD--YGCL 299 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~---~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--~~~l 299 (568)
..++|.+.+.||+|+||.||+|.+ ++..||||++... .......+.+|+.+++.++||||++++++|.+ ..++
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 109 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI 109 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEE
Confidence 346899999999999999999986 6789999999753 34445678999999999999999999998854 4489
Q ss_pred EEEecCCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEeccccccccc
Q 008365 300 VYEYMHNGSLEDRLLRRG-NTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLV 378 (568)
Q Consensus 300 V~E~~~ggsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~ 378 (568)
||||+++|+|.+++.... ....+++..++.|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+
T Consensus 110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~ 186 (310)
T 2wqm_A 110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFF 186 (310)
T ss_dssp EEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC------
T ss_pred EEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeee
Confidence 999999999999987521 2234889999999999999999999999 999999999999999999999999999765
Q ss_pred CCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCch----HHHHHHHhCccccccC
Q 008365 379 PPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTH----HVSRAIEKGTLAEMLD 454 (568)
Q Consensus 379 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~----~~~~~~~~~~~~~~l~ 454 (568)
.... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.... .....+....+.
T Consensus 187 ~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---- 256 (310)
T 2wqm_A 187 SSKT------TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYP---- 256 (310)
T ss_dssp ------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSC----
T ss_pred cCCC------ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCC----
Confidence 3321 11234579999999999999999999999999999999999999996432 122222222211
Q ss_pred ccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhH
Q 008365 455 PAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVI 490 (568)
Q Consensus 455 ~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl 490 (568)
+ ..+..++..+.+|+.+||..||.+||++.+|+
T Consensus 257 ~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il 289 (310)
T 2wqm_A 257 P---LPSDHYSEELRQLVNMCINPDPEKRPDVTYVY 289 (310)
T ss_dssp C---CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred C---CcccccCHHHHHHHHHHcCCChhhCCCHHHHH
Confidence 1 11234566799999999999999999999987
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-42 Score=353.70 Aligned_cols=255 Identities=22% Similarity=0.280 Sum_probs=184.4
Q ss_pred HhcccccceeecccCceeEEEEEe--CCccEEEEEeCcChhHhHHHHHHHHHHHHcCC-CCceeeeccccC--------C
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIR-HPNMVLLLGACP--------D 295 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~-HpnIv~l~g~~~--------~ 295 (568)
...+|++.++||+|+||.||+|.+ +++.||||++..........+.+|+.++..+. ||||+++++++. .
T Consensus 26 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 105 (337)
T 3ll6_A 26 GELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG 105 (337)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred cCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence 346899999999999999999998 67899999987776666778899999999996 999999998872 1
Q ss_pred C--ceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccc
Q 008365 296 Y--GCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVG 373 (568)
Q Consensus 296 ~--~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFG 373 (568)
. .++||||+. |+|.+++........+++..++.|+.||+.||.|||+.+ .+|+||||||+||||+.++.+||+|||
T Consensus 106 ~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg 183 (337)
T 3ll6_A 106 QAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDFG 183 (337)
T ss_dssp SEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCCT
T ss_pred CceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecCc
Confidence 1 379999994 899998876433345899999999999999999999876 359999999999999999999999999
Q ss_pred cccccCCCCCcccc------ccccccccccccCCChhhh---hcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHH
Q 008365 374 LARLVPPSVADSVT------QYHMTSAAGTFCYIDPEYQ---QTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAI 444 (568)
Q Consensus 374 la~~~~~~~~~~~~------~~~~~~~~GT~~Y~APE~~---~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~ 444 (568)
+++.+......... ........||+.|+|||++ .+..++.++|||||||++|+|++|..||.........
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~- 262 (337)
T 3ll6_A 184 SATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIV- 262 (337)
T ss_dssp TCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----------
T ss_pred cceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhh-
Confidence 99876443211100 0111245699999999988 5667899999999999999999999999643321111
Q ss_pred HhCccccccCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhH
Q 008365 445 EKGTLAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVP 492 (568)
Q Consensus 445 ~~~~~~~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~ 492 (568)
.+.. .. ..+..++..+.+|+..||+.+|.+||++.+++.+
T Consensus 263 -~~~~----~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 302 (337)
T 3ll6_A 263 -NGKY----SI---PPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQ 302 (337)
T ss_dssp ----C----CC---CTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred -cCcc----cC---CcccccchHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 1111 00 1112233458899999999999999999998744
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-42 Score=358.13 Aligned_cols=261 Identities=24% Similarity=0.269 Sum_probs=196.9
Q ss_pred HHHHHHHhcccccceeecccCceeEEEEEe-CCccEEEEEeCcCh-----------hHhHHHHHHHHHHHHcCCCCceee
Q 008365 221 IEEIEEATDKFSEAMKIGEGGYGPVYRGKL-DHTPVAIKVLRPDA-----------AQGKRQFQQEVEVLSSIRHPNMVL 288 (568)
Q Consensus 221 ~~ei~~~~~~y~~~~~IG~G~fg~Vy~~~~-~~~~vAvK~l~~~~-----------~~~~~~~~~Ev~iL~~l~HpnIv~ 288 (568)
+.++..+.++|.+.+.||+|+||.||+|.+ .+..||||++.... ....+.+.+|+.+|+.++||||++
T Consensus 14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 93 (362)
T 3pg1_A 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILG 93 (362)
T ss_dssp HHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred HHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccc
Confidence 456677889999999999999999999987 57789999985432 122367899999999999999999
Q ss_pred eccccC-----C--CceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeec
Q 008365 289 LLGACP-----D--YGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILL 361 (568)
Q Consensus 289 l~g~~~-----~--~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILl 361 (568)
++++|. . ..++||||+. |+|.+++.... ..+++..+..|+.||+.||.|||+.+ |+||||||+||||
T Consensus 94 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~ 167 (362)
T 3pg1_A 94 LRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR--IVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILL 167 (362)
T ss_dssp CSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEE
T ss_pred eeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEEE
Confidence 999872 2 2389999996 68888887543 24899999999999999999999999 9999999999999
Q ss_pred cCCceeEecccccccccCCCCCccccccccccccccccCCChhhhhc-CCCCCcceehhHHHHHHHHHhCCCCCCCchHH
Q 008365 362 DRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQT-GMLTTKSDIYSFGIMLLQIITARSPMGLTHHV 440 (568)
Q Consensus 362 d~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~ 440 (568)
+.++.+||+|||+++...... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~ 240 (362)
T 3pg1_A 168 ADNNDITICDFNLAREDTADA-------NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFY 240 (362)
T ss_dssp CTTCCEEECCTTC----------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred cCCCCEEEEecCccccccccc-------ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHH
Confidence 999999999999997543221 2244679999999998876 67999999999999999999999999764432
Q ss_pred HHHH---Hh-C--c-----------cccccCccC--------CCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 441 SRAI---EK-G--T-----------LAEMLDPAV--------TDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 441 ~~~~---~~-~--~-----------~~~~l~~~~--------~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
.... .. + . ....+.... ...+..++..+.+|+.+||+.+|.+||++.+++.|.+
T Consensus 241 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 319 (362)
T 3pg1_A 241 NQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPY 319 (362)
T ss_dssp HHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred HHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCch
Confidence 2111 00 0 0 000000001 0112344567999999999999999999999986544
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=372.37 Aligned_cols=249 Identities=25% Similarity=0.416 Sum_probs=201.8
Q ss_pred HhcccccceeecccCceeEEEEEe--CCccEEEEEeCcChh-------------HhHHHHHHHHHHHHcCCCCceeeecc
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAA-------------QGKRQFQQEVEVLSSIRHPNMVLLLG 291 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~-------------~~~~~~~~Ev~iL~~l~HpnIv~l~g 291 (568)
..++|.++++||+|+||.||+|.+ .+..||||++..... .....+.+|+.+|+.++|||||++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 567899999999999999999997 467899999875432 22457889999999999999999999
Q ss_pred ccCCCc--eEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCc---e
Q 008365 292 ACPDYG--CLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNY---V 366 (568)
Q Consensus 292 ~~~~~~--~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~---~ 366 (568)
+|.+.. ++|||||+||+|.+++...+. +++..+..|+.||+.||.|||+.+ |+||||||+||||+.++ .
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~ 187 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINRHK---FDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLN 187 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHHSC---CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSS
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCcc
Confidence 996654 899999999999999877643 899999999999999999999999 99999999999998765 6
Q ss_pred eEecccccccccCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchH--HHHHH
Q 008365 367 SKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHH--VSRAI 444 (568)
Q Consensus 367 vKL~DFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~--~~~~~ 444 (568)
+||+|||+++.+.... .....+||+.|+|||++. +.++.++|||||||++|+|++|.+||..... +...+
T Consensus 188 ~kl~Dfg~a~~~~~~~-------~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 259 (504)
T 3q5i_A 188 IKIVDFGLSSFFSKDY-------KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKV 259 (504)
T ss_dssp EEECCCTTCEECCTTS-------CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred EEEEECCCCEEcCCCC-------ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 9999999998764321 224567999999999887 4699999999999999999999999976543 23333
Q ss_pred HhCccccccCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 445 EKGTLAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 445 ~~~~~~~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
..+.+.... +. ...++..+.+|+.+||..+|.+||++.+++.|.+
T Consensus 260 ~~~~~~~~~-~~----~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~ 304 (504)
T 3q5i_A 260 EKGKYYFDF-ND----WKNISDEAKELIKLMLTYDYNKRCTAEEALNSRW 304 (504)
T ss_dssp HHCCCCCCH-HH----HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred HcCCCCCCc-cc----cCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHh
Confidence 333221100 00 1234567999999999999999999999998766
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=341.83 Aligned_cols=256 Identities=25% Similarity=0.339 Sum_probs=188.5
Q ss_pred HhcccccceeecccCceeEEEEEe--CCccEEEEEeCcCh--hHhHHHHHHHHHHHHcCCCCceeeeccccCC--CceEE
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDA--AQGKRQFQQEVEVLSSIRHPNMVLLLGACPD--YGCLV 300 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~--~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--~~~lV 300 (568)
..++|++.+.||+|+||.||+|.+ +++.||||+++... ......+..+...++.++||||++++++|.+ ..++|
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv 84 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC 84 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence 357899999999999999999998 67899999997652 2223345556666888999999999999854 34899
Q ss_pred EEecCCCCHHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHHc-CCCCcccCCCCCCCeeccCCceeEeccccccccc
Q 008365 301 YEYMHNGSLEDRLLRR-GNTPVIPWRKRFKIAAEIATALLFLHQA-KPEPLVHRDLKPANILLDRNYVSKISDVGLARLV 378 (568)
Q Consensus 301 ~E~~~ggsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~yLH~~-~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~ 378 (568)
|||++ |+|.+++... .....+++..+..|+.||+.||.|||+. + |+||||||+||||+.++.+||+|||+++.+
T Consensus 85 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 85 MELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp EECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred Eehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 99996 5888877542 2223489999999999999999999998 8 999999999999999999999999999865
Q ss_pred CCCCCccccccccccccccccCCChhhh----hcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHhCccccccC
Q 008365 379 PPSVADSVTQYHMTSAAGTFCYIDPEYQ----QTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLD 454 (568)
Q Consensus 379 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~----~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~l~ 454 (568)
.... ......||+.|+|||++ .+..++.++|||||||++|+|++|+.||.........+.... ... .
T Consensus 161 ~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~-~ 231 (290)
T 3fme_A 161 VDDV-------AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVV-EEP-S 231 (290)
T ss_dssp ----------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHH-HSC-C
T ss_pred cccc-------cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHh-ccC-C
Confidence 4321 12334799999999986 566789999999999999999999999974322111111100 000 0
Q ss_pred ccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHHHHH
Q 008365 455 PAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPELNRL 497 (568)
Q Consensus 455 ~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l~~L 497 (568)
+ ...+..++..+.+|+.+||+.+|.+||++.+++.|.+-..
T Consensus 232 ~--~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~ 272 (290)
T 3fme_A 232 P--QLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTL 272 (290)
T ss_dssp C--CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred C--CcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCccccc
Confidence 1 1112345677999999999999999999999998777543
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=358.01 Aligned_cols=254 Identities=23% Similarity=0.326 Sum_probs=192.1
Q ss_pred cccccceeecccCceeEEEEEe--CCccEEEEEeCcChhHhH-HHHHHHHHHHHcCCCCceeeeccccCCC--ceEEEEe
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQGK-RQFQQEVEVLSSIRHPNMVLLLGACPDY--GCLVYEY 303 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~-~~~~~Ev~iL~~l~HpnIv~l~g~~~~~--~~lV~E~ 303 (568)
++|.+++.||+|+||.||+|.+ +++.||||++........ ..+.+|+.+|+.++||||++++++|.+. .++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 5799999999999999999988 567899999975542221 2355799999999999999999998544 4899999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCC
Q 008365 304 MHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVA 383 (568)
Q Consensus 304 ~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~ 383 (568)
++ |+|.+++...+. .+++..+..|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++......
T Consensus 82 ~~-~~l~~~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~- 154 (324)
T 3mtl_A 82 LD-KDLKQYLDDCGN--IINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT- 154 (324)
T ss_dssp CS-EEHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred cc-cCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCCc-
Confidence 96 699998877643 4889999999999999999999999 9999999999999999999999999997653221
Q ss_pred ccccccccccccccccCCChhhhhc-CCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHhCc-cccccCccC----
Q 008365 384 DSVTQYHMTSAAGTFCYIDPEYQQT-GMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGT-LAEMLDPAV---- 457 (568)
Q Consensus 384 ~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~-~~~~l~~~~---- 457 (568)
......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.............. +.......+
T Consensus 155 -----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 229 (324)
T 3mtl_A 155 -----KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGIL 229 (324)
T ss_dssp -------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGG
T ss_pred -----cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhh
Confidence 12234578999999998876 5689999999999999999999999976543222111000 000000000
Q ss_pred ------------------CCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 458 ------------------TDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 458 ------------------~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
...+..++..+.+|+.+||+.||.+||++.+++.|.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 284 (324)
T 3mtl_A 230 SNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPF 284 (324)
T ss_dssp GCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGG
T ss_pred cchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChh
Confidence 0011234567899999999999999999999986544
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=369.27 Aligned_cols=251 Identities=22% Similarity=0.324 Sum_probs=193.7
Q ss_pred HHhcccccceeecccCceeEEEEEe--CCccEEEEEeCcChh--------HhHHHHHHHHHHHHcCCCCceeeeccccCC
Q 008365 226 EATDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAA--------QGKRQFQQEVEVLSSIRHPNMVLLLGACPD 295 (568)
Q Consensus 226 ~~~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~--------~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~ 295 (568)
...++|.+.+.||+|+||.||+|.+ +++.||||++..... .....+.+|+.+|+.++|||||+++++|..
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 211 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 211 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 3568899999999999999999987 567999999865421 112247899999999999999999999854
Q ss_pred C-ceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCC---ceeEecc
Q 008365 296 Y-GCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRN---YVSKISD 371 (568)
Q Consensus 296 ~-~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~---~~vKL~D 371 (568)
. .++|||||++|+|.+++...+ .+++..+..|+.||+.||.|||+.+ |+||||||+||||+.+ +.+||+|
T Consensus 212 ~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~D 285 (419)
T 3i6u_A 212 EDYYIVLELMEGGELFDKVVGNK---RLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITD 285 (419)
T ss_dssp SEEEEEEECCTTCBGGGGTSSSC---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEECC
T ss_pred CceEEEEEcCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEee
Confidence 4 489999999999998876543 3899999999999999999999999 9999999999999654 4599999
Q ss_pred cccccccCCCCCccccccccccccccccCCChhhhh---cCCCCCcceehhHHHHHHHHHhCCCCCCCch---HHHHHHH
Q 008365 372 VGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQ---TGMLTTKSDIYSFGIMLLQIITARSPMGLTH---HVSRAIE 445 (568)
Q Consensus 372 FGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~---~~~~s~ksDvwSlGvil~elltG~~Pf~~~~---~~~~~~~ 445 (568)
||+++.+.... .....+||+.|+|||++. ...++.++|||||||++|+|++|+.||.... .+...+.
T Consensus 286 FG~a~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~ 358 (419)
T 3i6u_A 286 FGHSKILGETS-------LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT 358 (419)
T ss_dssp SSTTTSCC------------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHH
T ss_pred cccceecCCCc-------cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHh
Confidence 99998764321 224567999999999875 3668899999999999999999999996432 2223333
Q ss_pred hCccccccCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 446 KGTLAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 446 ~~~~~~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
.+.... .......++..+.+|+.+||+.+|.+||++.+++.|.+
T Consensus 359 ~~~~~~-----~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~ 402 (419)
T 3i6u_A 359 SGKYNF-----IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPW 402 (419)
T ss_dssp TTCCCC-----CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGG
T ss_pred cCCCCC-----CchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcc
Confidence 322110 00011234567999999999999999999999987655
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=347.83 Aligned_cols=252 Identities=24% Similarity=0.361 Sum_probs=201.0
Q ss_pred HhcccccceeecccCceeEEEEEeC--CccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCceeeeccccCC--CceEEEE
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKLD--HTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACPD--YGCLVYE 302 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~~--~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--~~~lV~E 302 (568)
..+.|.+.+.||+|+||.||+|.+. +..||||++.... ....+.+|+.+++.++||||+++++++.+ ..++|||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME 104 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence 4568999999999999999999884 7899999987543 23568899999999999999999998854 3489999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCC
Q 008365 303 YMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSV 382 (568)
Q Consensus 303 ~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~ 382 (568)
|+++++|.+++..... .+++..+..++.||+.||.|||+.+ |+|+||||+||||+.++.+||+|||++..+....
T Consensus 105 ~~~~~~L~~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 179 (314)
T 3com_A 105 YCGAGSVSDIIRLRNK--TLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM 179 (314)
T ss_dssp CCTTEEHHHHHHHHTC--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTTB
T ss_pred cCCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhhc
Confidence 9999999999875432 3899999999999999999999999 9999999999999999999999999997654321
Q ss_pred CccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHhCccccccCccCCCCCh
Q 008365 383 ADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAVTDWPA 462 (568)
Q Consensus 383 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~l~~~~~~~p~ 462 (568)
. ......||+.|+|||++.+..++.++|||||||++|+|++|..||.............. ...+ ....+.
T Consensus 180 ~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---~~~~-~~~~~~ 249 (314)
T 3com_A 180 A------KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPT---NPPP-TFRKPE 249 (314)
T ss_dssp S------CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH---SCCC-CCSSGG
T ss_pred c------ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhc---CCCc-ccCCcc
Confidence 1 12345799999999999999999999999999999999999999976554332221100 0011 112234
Q ss_pred HHHHHHHHHHHHhhccCCCCCCChHHhHhHHHH
Q 008365 463 EAAESFSKLAIQCAELRKKDRPDLGTVIVPELN 495 (568)
Q Consensus 463 ~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l~ 495 (568)
.++..+.+|+.+||..+|.+||++.+++.+.+-
T Consensus 250 ~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~ 282 (314)
T 3com_A 250 LWSDNFTDFVKQCLVKSPEQRATATQLLQHPFV 282 (314)
T ss_dssp GSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHH
T ss_pred cCCHHHHHHHHHHccCChhhCcCHHHHHhCHHH
Confidence 456789999999999999999999999976653
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=380.15 Aligned_cols=246 Identities=33% Similarity=0.507 Sum_probs=203.8
Q ss_pred HhcccccceeecccCceeEEEEEeCC-ccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCceeeeccccCC-CceEEEEec
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKLDH-TPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACPD-YGCLVYEYM 304 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~~~-~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~-~~~lV~E~~ 304 (568)
..++|.+.++||+|+||.||+|.+.+ ..||||+++.... ..+.|.+|+.+|+.++|||||+++++|.+ ..+||||||
T Consensus 265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~lv~e~~ 343 (535)
T 2h8h_A 265 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYM 343 (535)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEECCC
T ss_pred chhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEeeccceEeeehh
Confidence 45678999999999999999999855 5799999986543 34678999999999999999999999865 458999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCCc
Q 008365 305 HNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVAD 384 (568)
Q Consensus 305 ~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~~ 384 (568)
++|+|.++|..... ..+++..++.|+.||+.||.|||+.+ ||||||||+||||+.++.+||+|||+++.+....
T Consensus 344 ~~gsL~~~l~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-- 417 (535)
T 2h8h_A 344 SKGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE-- 417 (535)
T ss_dssp TTEEHHHHHSHHHH-TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH--
T ss_pred cCCcHHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCCCc--
Confidence 99999999975322 23889999999999999999999999 9999999999999999999999999998653211
Q ss_pred cccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh-CCCCCCCchH--HHHHHHhCccccccCccCCCCC
Q 008365 385 SVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPMGLTHH--VSRAIEKGTLAEMLDPAVTDWP 461 (568)
Q Consensus 385 ~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~--~~~~~~~~~~~~~l~~~~~~~p 461 (568)
........+|..|+|||++.+..++.++|||||||+||||++ |..||..... +...+..+. ....+
T Consensus 418 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~--------~~~~~ 486 (535)
T 2h8h_A 418 ---YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY--------RMPCP 486 (535)
T ss_dssp ---HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTC--------CCCCC
T ss_pred ---eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC--------CCCCC
Confidence 111234567889999999999999999999999999999999 9999965433 222332221 12234
Q ss_pred hHHHHHHHHHHHHhhccCCCCCCChHHhH
Q 008365 462 AEAAESFSKLAIQCAELRKKDRPDLGTVI 490 (568)
Q Consensus 462 ~~~~~~l~~li~~Cl~~dP~~RPs~~~vl 490 (568)
..++..+.+||.+||+.+|.+||++.+|+
T Consensus 487 ~~~~~~l~~li~~cl~~dP~~RPt~~~l~ 515 (535)
T 2h8h_A 487 PECPESLHDLMCQCWRKEPEERPTFEYLQ 515 (535)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CCCCHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 56677899999999999999999999886
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-42 Score=354.41 Aligned_cols=255 Identities=20% Similarity=0.295 Sum_probs=203.5
Q ss_pred HHHHhcccccc-eeecccCceeEEEEEe--CCccEEEEEeCcCh--hHhHHHHHHHHHHHHcCC-CCceeeeccccCCCc
Q 008365 224 IEEATDKFSEA-MKIGEGGYGPVYRGKL--DHTPVAIKVLRPDA--AQGKRQFQQEVEVLSSIR-HPNMVLLLGACPDYG 297 (568)
Q Consensus 224 i~~~~~~y~~~-~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~--~~~~~~~~~Ev~iL~~l~-HpnIv~l~g~~~~~~ 297 (568)
.+.+.+.|.+. +.||+|+||.||+|.+ +++.||||++.... ......+.+|+.++..+. ||||++++++|.+..
T Consensus 23 ~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~ 102 (327)
T 3lm5_A 23 MENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTS 102 (327)
T ss_dssp HHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred HHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCC
Confidence 45677889888 8999999999999987 47899999987543 223567889999999995 699999999986544
Q ss_pred --eEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccC---CceeEeccc
Q 008365 298 --CLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDR---NYVSKISDV 372 (568)
Q Consensus 298 --~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~---~~~vKL~DF 372 (568)
++||||+++|+|.+++..... ..+++..++.|+.||+.||.|||+.+ |+||||||+||||+. ++.+||+||
T Consensus 103 ~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~kL~Df 178 (327)
T 3lm5_A 103 EIILILEYAAGGEIFSLCLPELA-EMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDF 178 (327)
T ss_dssp EEEEEEECCTTEEGGGGGSSCC--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEEECCG
T ss_pred eEEEEEEecCCCcHHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEEEeeC
Confidence 899999999999998855322 34899999999999999999999999 999999999999987 789999999
Q ss_pred ccccccCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHH--HHhCccc
Q 008365 373 GLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRA--IEKGTLA 450 (568)
Q Consensus 373 Gla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~--~~~~~~~ 450 (568)
|+++.+.... .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||......... +.....
T Consensus 179 g~a~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~- 250 (327)
T 3lm5_A 179 GMSRKIGHAC-------ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNV- 250 (327)
T ss_dssp GGCEEC----------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC-
T ss_pred ccccccCCcc-------ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccc-
Confidence 9998764321 123467999999999999999999999999999999999999999765443322 211111
Q ss_pred cccCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 451 EMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 451 ~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
......+..++..+.+|+..||+.+|.+||++.+++.+.+
T Consensus 251 ----~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~ 290 (327)
T 3lm5_A 251 ----DYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSW 290 (327)
T ss_dssp ----CCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGG
T ss_pred ----ccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHh
Confidence 1111223455677999999999999999999999985543
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=383.73 Aligned_cols=240 Identities=25% Similarity=0.415 Sum_probs=195.3
Q ss_pred eeecccCceeEEEEEe----CCccEEEEEeCcChh--HhHHHHHHHHHHHHcCCCCceeeeccccCCC-ceEEEEecCCC
Q 008365 235 MKIGEGGYGPVYRGKL----DHTPVAIKVLRPDAA--QGKRQFQQEVEVLSSIRHPNMVLLLGACPDY-GCLVYEYMHNG 307 (568)
Q Consensus 235 ~~IG~G~fg~Vy~~~~----~~~~vAvK~l~~~~~--~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~-~~lV~E~~~gg 307 (568)
++||+|+||.||+|.+ .++.||||+++.... .....+.+|+.+|+.++|||||+++++|.+. .+||||||++|
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~lv~E~~~~g 454 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELG 454 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEEEECCTTE
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEEEccCCC
Confidence 4799999999999965 346899999976533 3357799999999999999999999999654 47999999999
Q ss_pred CHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCCcccc
Q 008365 308 SLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVT 387 (568)
Q Consensus 308 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~ 387 (568)
+|.+++.... .+++..++.|+.||+.||.|||+.+ ||||||||+||||+.++.+||+|||+++.+......
T Consensus 455 ~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~--- 525 (635)
T 4fl3_A 455 PLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY--- 525 (635)
T ss_dssp EHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------
T ss_pred CHHHHHhhCC---CCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccc---
Confidence 9999997653 3889999999999999999999999 999999999999999999999999999876443211
Q ss_pred ccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh-CCCCCCCchH--HHHHHHhCccccccCccCCCCChHH
Q 008365 388 QYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPMGLTHH--VSRAIEKGTLAEMLDPAVTDWPAEA 464 (568)
Q Consensus 388 ~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~--~~~~~~~~~~~~~l~~~~~~~p~~~ 464 (568)
........||+.|+|||++.+..++.++|||||||++|||++ |+.||..... +...+..+. ...+|..+
T Consensus 526 ~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~--------~~~~p~~~ 597 (635)
T 4fl3_A 526 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE--------RMGCPAGC 597 (635)
T ss_dssp ---------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC--------CCCCCTTC
T ss_pred cccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC--------CCCCCCCC
Confidence 112234567899999999999999999999999999999998 9999975543 333333322 22345667
Q ss_pred HHHHHHHHHHhhccCCCCCCChHHhHh
Q 008365 465 AESFSKLAIQCAELRKKDRPDLGTVIV 491 (568)
Q Consensus 465 ~~~l~~li~~Cl~~dP~~RPs~~~vl~ 491 (568)
+..+.+||..||+.+|.+||++.+|+.
T Consensus 598 ~~~l~~li~~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 598 PREMYDLMNLCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 788999999999999999999999873
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=342.27 Aligned_cols=245 Identities=24% Similarity=0.394 Sum_probs=196.1
Q ss_pred hcccccceeecccCceeEEEEEe--CCccEEEEEeCcChh---HhHHHHHHHHHHHHcCCCCceeeeccccCCC--ceEE
Q 008365 228 TDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAA---QGKRQFQQEVEVLSSIRHPNMVLLLGACPDY--GCLV 300 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~---~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~--~~lV 300 (568)
.++|.+.+.||+|+||.||+|.+ +++.||||++..... .....+.+|+.+++.++||||+++++++.+. .++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 46899999999999999999987 578999999865432 2245788999999999999999999998554 4899
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCC
Q 008365 301 YEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPP 380 (568)
Q Consensus 301 ~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~ 380 (568)
|||+++++|.+++...+ .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 90 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 163 (276)
T 2h6d_A 90 MEYVSGGELFDYICKHG---RVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 163 (276)
T ss_dssp EECCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred EeccCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCC
Confidence 99999999999997764 3889999999999999999999999 99999999999999999999999999986543
Q ss_pred CCCccccccccccccccccCCChhhhhcCCC-CCcceehhHHHHHHHHHhCCCCCCCchHH--HHHHHhCccccccCccC
Q 008365 381 SVADSVTQYHMTSAAGTFCYIDPEYQQTGML-TTKSDIYSFGIMLLQIITARSPMGLTHHV--SRAIEKGTLAEMLDPAV 457 (568)
Q Consensus 381 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~-s~ksDvwSlGvil~elltG~~Pf~~~~~~--~~~~~~~~~~~~l~~~~ 457 (568)
.. ......||+.|+|||++.+..+ +.++|||||||++|+|++|..||...... ...+..+.
T Consensus 164 ~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--------- 227 (276)
T 2h6d_A 164 GE-------FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGV--------- 227 (276)
T ss_dssp --------------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC---------
T ss_pred Cc-------ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc---------
Confidence 21 1234579999999999887765 68999999999999999999999754332 22222221
Q ss_pred CCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 458 TDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 458 ~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
...|..++..+.+++.+||+.+|.+||++.+++.+.+
T Consensus 228 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~ 264 (276)
T 2h6d_A 228 FYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEW 264 (276)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHH
T ss_pred ccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhChh
Confidence 1234455677999999999999999999999987655
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-42 Score=357.51 Aligned_cols=254 Identities=18% Similarity=0.217 Sum_probs=195.5
Q ss_pred hcccccceeecccCceeEEEEEeC----------CccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCceeee--------
Q 008365 228 TDKFSEAMKIGEGGYGPVYRGKLD----------HTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLL-------- 289 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~~~~~----------~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l-------- 289 (568)
.++|.+.+.||+|+||.||+|.+. +..||||++... ..+.+|+.+++.++|||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 368999999999999999999873 678999998754 357899999999999999984
Q ss_pred -------ccccC---CCceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCe
Q 008365 290 -------LGACP---DYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANI 359 (568)
Q Consensus 290 -------~g~~~---~~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NI 359 (568)
++++. ...++||||+ +++|.+++..... ..+++..++.|+.||+.||.|||+.+ |+||||||+||
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NI 190 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPK-HVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENI 190 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGG-GCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGE
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCc-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHE
Confidence 33332 3348999999 9999999986522 24899999999999999999999999 99999999999
Q ss_pred eccCCc--eeEecccccccccCCCCCcc-ccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCC
Q 008365 360 LLDRNY--VSKISDVGLARLVPPSVADS-VTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGL 436 (568)
Q Consensus 360 Lld~~~--~vKL~DFGla~~~~~~~~~~-~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~ 436 (568)
||+.++ .+||+|||+++.+....... ..........||+.|+|||++.+..++.++|||||||++|+|++|+.||..
T Consensus 191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 270 (352)
T 2jii_A 191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTN 270 (352)
T ss_dssp EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 999998 99999999998764322111 111122345899999999999999999999999999999999999999965
Q ss_pred ch-H---HHHHHHhCccccccCccCCCC--ChHHHHHHHHHHHHhhccCCCCCCChHHhHhHH
Q 008365 437 TH-H---VSRAIEKGTLAEMLDPAVTDW--PAEAAESFSKLAIQCAELRKKDRPDLGTVIVPE 493 (568)
Q Consensus 437 ~~-~---~~~~~~~~~~~~~l~~~~~~~--p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~ 493 (568)
.. . +..... .+..........+ ...++..+.+|+.+||+.+|.+||++.+|+..+
T Consensus 271 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L 331 (352)
T 2jii_A 271 CLPNTEDIMKQKQ--KFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNL 331 (352)
T ss_dssp GTTCHHHHHHHHH--HHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHH
T ss_pred CCcCHHHHHHHHH--hccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHH
Confidence 42 1 111111 1111111111111 113457799999999999999999999987433
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=365.32 Aligned_cols=251 Identities=13% Similarity=0.090 Sum_probs=182.4
Q ss_pred hcccccceeecccCceeEEEEEe--CCccEEEEEeCcCh---hHhHHHHHHHH---HHHHcCCCCceeeeccccC-----
Q 008365 228 TDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDA---AQGKRQFQQEV---EVLSSIRHPNMVLLLGACP----- 294 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~Ev---~iL~~l~HpnIv~l~g~~~----- 294 (568)
..+|.+.+.||+|+||.||+|.+ +++.||||++.... ......+.+|+ .+|+. +||||++++..+.
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~ 139 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDA 139 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehh
Confidence 34699999999999999999987 57789999998753 23445677885 45555 7999888553331
Q ss_pred ---------------------CCceEEEEecCCCCHHHHHhhcCCCCCCCHHHH------HHHHHHHHHHHHHHHHcCCC
Q 008365 295 ---------------------DYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKR------FKIAAEIATALLFLHQAKPE 347 (568)
Q Consensus 295 ---------------------~~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~------~~i~~qia~aL~yLH~~~~~ 347 (568)
...|||||||+ |+|.+++...+.. +++..+ +.|+.||+.||.|||+.+
T Consensus 140 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~--~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~-- 214 (371)
T 3q60_A 140 VAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFV--YVFRGDEGILALHILTAQLIRLAANLQSKG-- 214 (371)
T ss_dssp EEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHS--CCCCHHHHHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred eecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccc--cchhhhhhhhhHHHHHHHHHHHHHHHHHCC--
Confidence 22589999998 8999999875322 455566 778899999999999999
Q ss_pred CcccCCCCCCCeeccCCceeEecccccccccCCCCCccccccccccccccccCCChhhhhc--CCCCCcceehhHHHHHH
Q 008365 348 PLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQT--GMLTTKSDIYSFGIMLL 425 (568)
Q Consensus 348 ~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~--~~~s~ksDvwSlGvil~ 425 (568)
|+||||||+||||+.++.+||+|||+++..... .....||+.|+|||++.+ ..++.++|||||||++|
T Consensus 215 -ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~---------~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ 284 (371)
T 3q60_A 215 -LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR---------GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIY 284 (371)
T ss_dssp -EEETTCSGGGEEECTTSCEEECCGGGEEETTCE---------EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHH
T ss_pred -CccCcCCHHHEEECCCCCEEEEecceeeecCCC---------ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHH
Confidence 999999999999999999999999999865321 114467799999999987 67999999999999999
Q ss_pred HHHhCCCCCCCchHHHHH-HHhCccccccCccC-CCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 426 QIITARSPMGLTHHVSRA-IEKGTLAEMLDPAV-TDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 426 elltG~~Pf~~~~~~~~~-~~~~~~~~~l~~~~-~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
+|++|+.||......... .............. ...+..++..+.+|+.+||+.||.+||++.+++.|.+
T Consensus 285 elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~ 355 (371)
T 3q60_A 285 RVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPE 355 (371)
T ss_dssp HHHHSSCSTTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHH
T ss_pred HHHhCCCCCCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHH
Confidence 999999999644221000 00000000000000 1112356778999999999999999999999998665
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=349.81 Aligned_cols=258 Identities=25% Similarity=0.374 Sum_probs=203.9
Q ss_pred cCHHHHHHHhcccccceeecccCceeEEEEEeCCccEEEEEeCcChhHhHHHHHHHHHHHHc--CCCCceeeeccccCC-
Q 008365 219 YTIEEIEEATDKFSEAMKIGEGGYGPVYRGKLDHTPVAIKVLRPDAAQGKRQFQQEVEVLSS--IRHPNMVLLLGACPD- 295 (568)
Q Consensus 219 ~~~~ei~~~~~~y~~~~~IG~G~fg~Vy~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~--l~HpnIv~l~g~~~~- 295 (568)
..+.-.....++|.+.+.||+|+||.||+|.++++.||||++.... ...+.+|++++.. ++||||+++++++.+
T Consensus 32 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~ 108 (342)
T 1b6c_B 32 LPLLVQRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKD 108 (342)
T ss_dssp SCHHHHHHHHHHCEEEEEEEEETTEEEEEEEETTEEEEEEEECGGG---HHHHHHHHHHHHHSCCCCTTBCCEEEEEECC
T ss_pred CceeecccccccEEEEeeecCCCCcEEEEEEEcCccEEEEEeCchh---HHHHHHHHHHHHHhhcCCCcEEEEEeeeccc
Confidence 3444445577899999999999999999999999999999997543 3467788998887 789999999998743
Q ss_pred -----CceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH--------HcCCCCcccCCCCCCCeecc
Q 008365 296 -----YGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLH--------QAKPEPLVHRDLKPANILLD 362 (568)
Q Consensus 296 -----~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH--------~~~~~~IiHrDIKp~NILld 362 (568)
..++||||+++|+|.+++... .+++..++.|+.||+.||.||| +.+ |+||||||+||||+
T Consensus 109 ~~~~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~ 181 (342)
T 1b6c_B 109 NGTWTQLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVK 181 (342)
T ss_dssp CSSCCCEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEEC
T ss_pred CCccceeEEEEeecCCCcHHHHHhcc----CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEEC
Confidence 348999999999999999764 2899999999999999999999 777 99999999999999
Q ss_pred CCceeEecccccccccCCCCCccccccccccccccccCCChhhhhcCC------CCCcceehhHHHHHHHHHhC------
Q 008365 363 RNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGM------LTTKSDIYSFGIMLLQIITA------ 430 (568)
Q Consensus 363 ~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~------~s~ksDvwSlGvil~elltG------ 430 (568)
.++.+||+|||+++........ .........||+.|+|||++.+.. ++.++|||||||++|+|++|
T Consensus 182 ~~~~~kL~Dfg~~~~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~ 259 (342)
T 1b6c_B 182 KNGTCCIADLGLAVRHDSATDT--IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI 259 (342)
T ss_dssp TTSCEEECCCTTCEEEETTTTE--EEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTB
T ss_pred CCCCEEEEECCCceeccccccc--cccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCc
Confidence 9999999999999766432211 111234567999999999987763 33689999999999999999
Q ss_pred ----CCCCCCc-------hHHHHHHHhCccccccCccCCC--CChHHHHHHHHHHHHhhccCCCCCCChHHhHhH
Q 008365 431 ----RSPMGLT-------HHVSRAIEKGTLAEMLDPAVTD--WPAEAAESFSKLAIQCAELRKKDRPDLGTVIVP 492 (568)
Q Consensus 431 ----~~Pf~~~-------~~~~~~~~~~~~~~~l~~~~~~--~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~ 492 (568)
..||... ..+...+... .+.+.+.. ....++..+.+|+.+||+.+|.+||++.+|+.+
T Consensus 260 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 260 HEDYQLPYYDLVPSDPSVEEMRKVVCEQ----KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp CCCCCCTTTTTSCSSCCHHHHHHHHTTS----CCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred ccccccCccccCcCcccHHHHHHHHHHH----HhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 7888532 1122222111 12222221 124678899999999999999999999998743
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=341.71 Aligned_cols=253 Identities=21% Similarity=0.301 Sum_probs=198.8
Q ss_pred HhcccccceeecccCceeEEEEEe--CCccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCceeeecccc---CCCceEEE
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGAC---PDYGCLVY 301 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~---~~~~~lV~ 301 (568)
..++|.+.+.||+|+||.||+|.+ +++.||||++...... ..+.+|+.+++.++|++++..++.+ .+..++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC--CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch--hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence 357899999999999999999995 6789999998654332 3588999999999998877776655 33448999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeec---cCCceeEeccccccccc
Q 008365 302 EYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILL---DRNYVSKISDVGLARLV 378 (568)
Q Consensus 302 E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILl---d~~~~vKL~DFGla~~~ 378 (568)
||+ +++|.+++..... .+++..++.|+.||+.||.|||+.+ |+||||||+|||| +.++.+||+|||+++.+
T Consensus 85 e~~-~~~L~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~ 158 (296)
T 3uzp_A 85 ELL-GPSLEDLFNFCSR--KFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp ECC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred Eec-CCCHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCcccc
Confidence 999 9999999975443 3899999999999999999999999 9999999999999 58899999999999876
Q ss_pred CCCCCcccc-ccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchH-----HHHHHHhCccccc
Q 008365 379 PPSVADSVT-QYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHH-----VSRAIEKGTLAEM 452 (568)
Q Consensus 379 ~~~~~~~~~-~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~-----~~~~~~~~~~~~~ 452 (568)
......... ........||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ....+........
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (296)
T 3uzp_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 238 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred cccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc
Confidence 543221111 1123456899999999999999999999999999999999999999964211 1111111111111
Q ss_pred cCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHh
Q 008365 453 LDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIV 491 (568)
Q Consensus 453 l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~ 491 (568)
. ...+..++..+.+|+.+||+.+|.+||++.+|+.
T Consensus 239 ~----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 239 I----EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp H----HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred h----HHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence 0 0112334567999999999999999999999873
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-42 Score=359.85 Aligned_cols=247 Identities=26% Similarity=0.351 Sum_probs=199.1
Q ss_pred hcccccceeecccCceeEEEEEe-----CCccEEEEEeCcCh----hHhHHHHHHHHHHHHcC-CCCceeeeccccCC--
Q 008365 228 TDKFSEAMKIGEGGYGPVYRGKL-----DHTPVAIKVLRPDA----AQGKRQFQQEVEVLSSI-RHPNMVLLLGACPD-- 295 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~~~~-----~~~~vAvK~l~~~~----~~~~~~~~~Ev~iL~~l-~HpnIv~l~g~~~~-- 295 (568)
.++|.+.+.||+|+||.||+|++ +++.||||+++... ......+.+|+.+|+.+ +||||++++++|.+
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 36899999999999999999987 57799999987532 12234567899999999 69999999998854
Q ss_pred CceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccc
Q 008365 296 YGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLA 375 (568)
Q Consensus 296 ~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla 375 (568)
..+|||||+++|+|.+++.... .+++..+..|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a 206 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLS 206 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eEEEEeecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCC
Confidence 4489999999999999998754 3889999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCccccccccccccccccCCChhhhhcC--CCCCcceehhHHHHHHHHHhCCCCCCCchH------HHHHHHhC
Q 008365 376 RLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTG--MLTTKSDIYSFGIMLLQIITARSPMGLTHH------VSRAIEKG 447 (568)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~--~~s~ksDvwSlGvil~elltG~~Pf~~~~~------~~~~~~~~ 447 (568)
+.+.... .......+||+.|+|||++.+. .++.++|||||||++|+|++|+.||..... +...+..
T Consensus 207 ~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~- 280 (355)
T 1vzo_A 207 KEFVADE-----TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILK- 280 (355)
T ss_dssp EECCGGG-----GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHH-
T ss_pred eecccCC-----CCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhc-
Confidence 8653221 1123456799999999998863 478999999999999999999999953221 1111111
Q ss_pred ccccccCccCCCCChHHHHHHHHHHHHhhccCCCCCC-----ChHHhHhHHH
Q 008365 448 TLAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRP-----DLGTVIVPEL 494 (568)
Q Consensus 448 ~~~~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RP-----s~~~vl~~~l 494 (568)
....++..++..+.+|+.+||..||.+|| ++.+++.+.+
T Consensus 281 --------~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~ 324 (355)
T 1vzo_A 281 --------SEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLF 324 (355)
T ss_dssp --------CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGG
T ss_pred --------cCCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcc
Confidence 11234556677899999999999999999 8888875443
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=366.05 Aligned_cols=261 Identities=20% Similarity=0.254 Sum_probs=194.0
Q ss_pred HhcccccceeecccCceeEEEEEe--CCccEEEEEeCcC--hhHhHHHHHHHHHHHHcCCCCceeeeccccCCC------
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPD--AAQGKRQFQQEVEVLSSIRHPNMVLLLGACPDY------ 296 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~------ 296 (568)
..++|.+.+.||+|+||.||+|.+ ++..||||++... .......+.+|+.+|+.++|||||++++++...
T Consensus 24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 103 (432)
T 3n9x_A 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD 103 (432)
T ss_dssp CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence 457899999999999999999987 5678999999753 334456788999999999999999999988443
Q ss_pred -ceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccc
Q 008365 297 -GCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLA 375 (568)
Q Consensus 297 -~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla 375 (568)
.|+||||+. |+|.+++.... .+++..+..|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++
T Consensus 104 ~~~lv~e~~~-~~L~~~~~~~~---~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla 176 (432)
T 3n9x_A 104 ELYIVLEIAD-SDLKKLFKTPI---FLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLA 176 (432)
T ss_dssp CEEEEEECCS-EEHHHHHHSSC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecCC-cCHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCc
Confidence 489999995 69999887543 3899999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCccc----------------cccccccccccccCCChhhh-hcCCCCCcceehhHHHHHHHHHhCCCCC----
Q 008365 376 RLVPPSVADSV----------------TQYHMTSAAGTFCYIDPEYQ-QTGMLTTKSDIYSFGIMLLQIITARSPM---- 434 (568)
Q Consensus 376 ~~~~~~~~~~~----------------~~~~~~~~~GT~~Y~APE~~-~~~~~s~ksDvwSlGvil~elltG~~Pf---- 434 (568)
+.+........ .....+..+||++|+|||++ .+..++.++|||||||++|||++|..||
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~ 256 (432)
T 3n9x_A 177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDP 256 (432)
T ss_dssp EEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSG
T ss_pred ccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccccc
Confidence 87643321100 01123567899999999975 5667999999999999999999854443
Q ss_pred -------CCch--------------------HHHHHHH-hCc----------------cccccCccC----CCCChHHHH
Q 008365 435 -------GLTH--------------------HVSRAIE-KGT----------------LAEMLDPAV----TDWPAEAAE 466 (568)
Q Consensus 435 -------~~~~--------------------~~~~~~~-~~~----------------~~~~l~~~~----~~~p~~~~~ 466 (568)
.... .+...+. .|. ....+.... ....+.++.
T Consensus 257 ~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 336 (432)
T 3n9x_A 257 TNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISD 336 (432)
T ss_dssp GGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCH
T ss_pred ccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCH
Confidence 2211 0000000 000 000000000 000123567
Q ss_pred HHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 467 SFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 467 ~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
.+.+|+.+||..||.+||++.+++.|.+
T Consensus 337 ~~~dLl~~mL~~dP~~R~ta~e~L~Hp~ 364 (432)
T 3n9x_A 337 DGINLLESMLKFNPNKRITIDQALDHPY 364 (432)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHHTCGG
T ss_pred HHHHHHHHHhcCCcccCCCHHHHhcChh
Confidence 7899999999999999999999986544
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=349.56 Aligned_cols=253 Identities=21% Similarity=0.309 Sum_probs=199.1
Q ss_pred hcccccceeecccCceeEEEEEe--CCccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCceeeeccccCC------CceE
Q 008365 228 TDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACPD------YGCL 299 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~------~~~l 299 (568)
.++|.+.+.||+|+||.||++.+ +++.||||++..........+.+|+.+++.++||||++++++|.. ..++
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 46899999999999999999986 678999999977666667789999999999999999999998841 3489
Q ss_pred EEEecCCCCHHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEeccccccccc
Q 008365 300 VYEYMHNGSLEDRLLRR-GNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLV 378 (568)
Q Consensus 300 V~E~~~ggsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~ 378 (568)
||||+++|+|.+++... .....+++..++.|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++...
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~ 184 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence 99999999999998763 12235899999999999999999999999 999999999999999999999999998765
Q ss_pred CCCCCccc---cccccccccccccCCChhhhhcCC---CCCcceehhHHHHHHHHHhCCCCCCCch----HHHHHHHhCc
Q 008365 379 PPSVADSV---TQYHMTSAAGTFCYIDPEYQQTGM---LTTKSDIYSFGIMLLQIITARSPMGLTH----HVSRAIEKGT 448 (568)
Q Consensus 379 ~~~~~~~~---~~~~~~~~~GT~~Y~APE~~~~~~---~s~ksDvwSlGvil~elltG~~Pf~~~~----~~~~~~~~~~ 448 (568)
........ .........||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.... .+...+.. .
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-~ 263 (317)
T 2buj_A 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQN-Q 263 (317)
T ss_dssp CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHC-C
T ss_pred ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhc-c
Confidence 32111100 001113456899999999887554 7899999999999999999999994311 11111111 0
Q ss_pred cccccCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHh
Q 008365 449 LAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIV 491 (568)
Q Consensus 449 ~~~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~ 491 (568)
.....+..++..+.+|+.+||+.+|.+||++.+++.
T Consensus 264 -------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 299 (317)
T 2buj_A 264 -------LSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLS 299 (317)
T ss_dssp ---------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------CCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence 001112345677999999999999999999999873
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=345.17 Aligned_cols=248 Identities=21% Similarity=0.289 Sum_probs=191.2
Q ss_pred HhcccccceeecccCceeEEEEEe--CCccEEEEEeCcChh---HhHHHHHHHHHHHHcCCCCceeeeccccCC--CceE
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAA---QGKRQFQQEVEVLSSIRHPNMVLLLGACPD--YGCL 299 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~---~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--~~~l 299 (568)
..++|.+.+.||+|+||.||+|.+ +++.||||++..... .....+.+|+.+++.++||||+++++++.+ ..++
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV 111 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence 457899999999999999999987 577899999976532 234678899999999999999999999854 3489
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccC
Q 008365 300 VYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVP 379 (568)
Q Consensus 300 V~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~ 379 (568)
||||+++++|.+++...+ .+++..+..|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++....
T Consensus 112 v~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 185 (309)
T 2h34_A 112 DMRLINGVDLAAMLRRQG---PLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATT 185 (309)
T ss_dssp EEECCCCEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred EEEecCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence 999999999999998754 3889999999999999999999999 9999999999999999999999999997654
Q ss_pred CCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHH-HHhCccccccCccCC
Q 008365 380 PSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRA-IEKGTLAEMLDPAVT 458 (568)
Q Consensus 380 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~-~~~~~~~~~l~~~~~ 458 (568)
... ........||+.|+|||++.+..++.++|||||||++|+|++|+.||......... ...... +...
T Consensus 186 ~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-----~~~~ 255 (309)
T 2h34_A 186 DEK-----LTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAI-----PRPS 255 (309)
T ss_dssp ----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCC-----CCGG
T ss_pred ccc-----cccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCC-----CCcc
Confidence 321 11223457999999999999999999999999999999999999999765542111 111111 1111
Q ss_pred CCChHHHHHHHHHHHHhhccCCCCCC-ChHHhH
Q 008365 459 DWPAEAAESFSKLAIQCAELRKKDRP-DLGTVI 490 (568)
Q Consensus 459 ~~p~~~~~~l~~li~~Cl~~dP~~RP-s~~~vl 490 (568)
..+..++..+.+|+.+||+.+|.+|| ++.+++
T Consensus 256 ~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~ 288 (309)
T 2h34_A 256 TVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLS 288 (309)
T ss_dssp GTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHH
T ss_pred ccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHH
Confidence 23445567799999999999999999 777665
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-42 Score=360.65 Aligned_cols=251 Identities=23% Similarity=0.309 Sum_probs=183.5
Q ss_pred HhcccccceeecccCceeEEEEEe--CCccEEEEEeCcC--hhHhHHHHHHHHHHHHcCCCCceeeeccccCC-------
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPD--AAQGKRQFQQEVEVLSSIRHPNMVLLLGACPD------- 295 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~------- 295 (568)
..++|.+++.||+|+||.||+|.+ ++..||||++... .......+.+|+.+|+.++||||++++++|..
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 106 (367)
T 2fst_X 27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 106 (367)
T ss_dssp EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence 347899999999999999999986 5779999998653 23345678899999999999999999998743
Q ss_pred -CceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEeccccc
Q 008365 296 -YGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGL 374 (568)
Q Consensus 296 -~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGl 374 (568)
..++||||+ +++|.+++... .+++..+..|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+
T Consensus 107 ~~~~lv~e~~-~~~L~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~ 178 (367)
T 2fst_X 107 NDVYLVTHLM-GADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGL 178 (367)
T ss_dssp CCCEEEEECC-CEECC-----C----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC---
T ss_pred CeEEEEeccc-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeeccc
Confidence 348999999 78999888652 3899999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCccccccccccccccccCCChhhhhc-CCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHH--h--Ccc
Q 008365 375 ARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQT-GMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIE--K--GTL 449 (568)
Q Consensus 375 a~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~--~--~~~ 449 (568)
++..... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+....... . +..
T Consensus 179 a~~~~~~---------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p 249 (367)
T 2fst_X 179 ARHTADE---------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP 249 (367)
T ss_dssp ---------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSC
T ss_pred ccccccc---------CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 9864321 245689999999998877 6799999999999999999999999976554332111 0 000
Q ss_pred ----------------ccccCc----cCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 450 ----------------AEMLDP----AVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 450 ----------------~~~l~~----~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
...+.. .+......++..+.+|+.+||..||.+||++.+++.|.+
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~ 314 (367)
T 2fst_X 250 GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 314 (367)
T ss_dssp CHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred CHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChh
Confidence 000000 000011234567899999999999999999999986544
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=358.86 Aligned_cols=253 Identities=24% Similarity=0.339 Sum_probs=200.6
Q ss_pred HhcccccceeecccCceeEEEEEe--CCccEEEEEeCcChhHhHHHHHHHHHHHHcCC--------CCceeeeccccC--
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIR--------HPNMVLLLGACP-- 294 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~--------HpnIv~l~g~~~-- 294 (568)
..++|.+.++||+|+||.||+|.+ +++.||||+++... .....+.+|+.+|+.++ ||||++++++|.
T Consensus 35 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~ 113 (397)
T 1wak_A 35 FNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAE-HYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKIS 113 (397)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEE
T ss_pred cCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCC-cchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeec
Confidence 457899999999999999999987 56789999997653 33567889999999885 788999999875
Q ss_pred --C--CceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHc-CCCCcccCCCCCCCeeccCCc----
Q 008365 295 --D--YGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQA-KPEPLVHRDLKPANILLDRNY---- 365 (568)
Q Consensus 295 --~--~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~-~~~~IiHrDIKp~NILld~~~---- 365 (568)
+ ..||||||+ +++|.+.+..... ..+++..+..|+.||+.||.|||+. + |+||||||+||||+.++
T Consensus 114 ~~~~~~~~lv~e~~-~~~l~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~ 188 (397)
T 1wak_A 114 GVNGTHICMVFEVL-GHHLLKWIIKSNY-QGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIR 188 (397)
T ss_dssp ETTEEEEEEEECCC-CCBHHHHHHHTTT-SCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHH
T ss_pred CCCCceEEEEEecc-CccHHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhh
Confidence 2 348999999 6777777765432 2489999999999999999999998 8 99999999999998776
Q ss_pred ---------------------------------------------eeEecccccccccCCCCCccccccccccccccccC
Q 008365 366 ---------------------------------------------VSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCY 400 (568)
Q Consensus 366 ---------------------------------------------~vKL~DFGla~~~~~~~~~~~~~~~~~~~~GT~~Y 400 (568)
.+||+|||+++..... ....+||+.|
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~---------~~~~~gt~~y 259 (397)
T 1wak_A 189 RLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH---------FTEDIQTRQY 259 (397)
T ss_dssp HHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC---------SCSCCSCGGG
T ss_pred hhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc---------CccCCCCCcc
Confidence 7999999999865322 2345799999
Q ss_pred CChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCch------H---HHHHHH-hC----------ccc-cccCc----
Q 008365 401 IDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTH------H---VSRAIE-KG----------TLA-EMLDP---- 455 (568)
Q Consensus 401 ~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~------~---~~~~~~-~~----------~~~-~~l~~---- 455 (568)
+|||++.+..++.++|||||||+||+|++|+.||.... . +..... .+ ... ..+..
T Consensus 260 ~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~ 339 (397)
T 1wak_A 260 RSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDL 339 (397)
T ss_dssp CCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSB
T ss_pred cCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccc
Confidence 99999999999999999999999999999999996322 1 111110 00 000 00000
Q ss_pred ----------------cCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 456 ----------------AVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 456 ----------------~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
....++..++..+.+|+.+||+.||.+||++.+++.|.+
T Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~ 394 (397)
T 1wak_A 340 KHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPW 394 (397)
T ss_dssp SSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGG
T ss_pred ccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCcc
Confidence 011346778889999999999999999999999986543
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=355.87 Aligned_cols=249 Identities=14% Similarity=0.166 Sum_probs=197.6
Q ss_pred HhcccccceeecccCceeEEEEE-------eCCccEEEEEeCcChhHhHHHHHHHHHHHHcCC---CCceeeeccccC--
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGK-------LDHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIR---HPNMVLLLGACP-- 294 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~-------~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~---HpnIv~l~g~~~-- 294 (568)
..++|.+.++||+|+||.||+|. ..++.||||++..... ..+..|+.++..++ |+||+.+++++.
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~ 139 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANP---WEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ 139 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCH---HHHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCCh---hHHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence 45779999999999999999993 2577999999986643 45778888888887 999999999874
Q ss_pred CCceEEEEecCCCCHHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccC---------
Q 008365 295 DYGCLVYEYMHNGSLEDRLLRRG--NTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDR--------- 363 (568)
Q Consensus 295 ~~~~lV~E~~~ggsL~~~l~~~~--~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~--------- 363 (568)
+..+||||||+||+|.+++.... ....+++..+..|+.||+.||.|||+.+ ||||||||+||||+.
T Consensus 140 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~~~ 216 (365)
T 3e7e_A 140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDED 216 (365)
T ss_dssp SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC----
T ss_pred CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCccccc
Confidence 45599999999999999997532 2345899999999999999999999999 999999999999988
Q ss_pred --CceeEecccccccccCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHH
Q 008365 364 --NYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVS 441 (568)
Q Consensus 364 --~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~ 441 (568)
++.+||+|||+|+.+.... ........+||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 217 ~~~~~~kl~DFG~a~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~-- 290 (365)
T 3e7e_A 217 DLSAGLALIDLGQSIDMKLFP----KGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEG-- 290 (365)
T ss_dssp --CTTEEECCCTTCEEGGGSC----TTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEET--
T ss_pred cccCCEEEeeCchhhhhhccC----CCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCC--
Confidence 8999999999997543211 11233567899999999999999999999999999999999999999943221
Q ss_pred HHHHhCccccccCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHHHH
Q 008365 442 RAIEKGTLAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPELNR 496 (568)
Q Consensus 442 ~~~~~~~~~~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l~~ 496 (568)
+ ...+...+...+ .++.+.+++..|++.+|.+|+...+.+...+..
T Consensus 291 -----~--~~~~~~~~~~~~--~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~ 336 (365)
T 3e7e_A 291 -----G--ECKPEGLFRRLP--HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKK 336 (365)
T ss_dssp -----T--EEEECSCCTTCS--SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHH
T ss_pred -----C--ceeechhccccC--cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHH
Confidence 1 011122222222 256788999999999999997665555444433
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-42 Score=348.57 Aligned_cols=264 Identities=22% Similarity=0.315 Sum_probs=186.0
Q ss_pred HhcccccceeecccCceeEEEEEe--CCccEEEEEeCcCh-hHhHHHHHHHHHHHHcCCCCceeeeccccC--CCceEEE
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDA-AQGKRQFQQEVEVLSSIRHPNMVLLLGACP--DYGCLVY 301 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~--~~~~lV~ 301 (568)
..++|.+.+.||+|+||.||+|.+ ++..||||++.... ......+.+|+.+++.++||||++++++|. +..++||
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 92 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVM 92 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEE
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEe
Confidence 457899999999999999999987 67899999986543 233456889999999999999999999884 3458999
Q ss_pred EecCCCCHHHHHhhc-----CCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEeccccccc
Q 008365 302 EYMHNGSLEDRLLRR-----GNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLAR 376 (568)
Q Consensus 302 E~~~ggsL~~~l~~~-----~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~ 376 (568)
||+++++|.+++... .....+++..+..|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++.
T Consensus 93 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 169 (303)
T 2vwi_A 93 KLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSA 169 (303)
T ss_dssp ECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred hhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccchh
Confidence 999999999998742 12234899999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCCccccccccccccccccCCChhhhhc-CCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHH--HHhCcccccc
Q 008365 377 LVPPSVADSVTQYHMTSAAGTFCYIDPEYQQT-GMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRA--IEKGTLAEML 453 (568)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~--~~~~~~~~~l 453 (568)
.+...... ..........||+.|+|||++.+ ..++.++|||||||++|+|++|..||......... ..........
T Consensus 170 ~~~~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 248 (303)
T 2vwi_A 170 FLATGGDI-TRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLE 248 (303)
T ss_dssp HCC----------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTT
T ss_pred eeccCCCc-cchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCccc
Confidence 76432111 11112234679999999998876 56899999999999999999999999654332211 1111111000
Q ss_pred Cc-cCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 454 DP-AVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 454 ~~-~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
.. ........++..+.+|+.+||+.+|.+||++.+++.+.+
T Consensus 249 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~ 290 (303)
T 2vwi_A 249 TGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKF 290 (303)
T ss_dssp C-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTT
T ss_pred cccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChh
Confidence 00 001122345567999999999999999999999986543
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=348.09 Aligned_cols=248 Identities=22% Similarity=0.353 Sum_probs=196.8
Q ss_pred hcccccceeecccCceeEEEEEe--CCccEEEEEeCcChhHhHHHHHHHHHHHHcCC-CCceeeeccccCC----CceEE
Q 008365 228 TDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIR-HPNMVLLLGACPD----YGCLV 300 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~-HpnIv~l~g~~~~----~~~lV 300 (568)
.++|++.+.||+|+||.||+|.+ +++.||||++.... ...+.+|+.+|+.++ ||||+++++++.+ ..++|
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv 111 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence 36899999999999999999986 67799999997544 356889999999997 9999999998854 23899
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCc-eeEecccccccccC
Q 008365 301 YEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNY-VSKISDVGLARLVP 379 (568)
Q Consensus 301 ~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~-~vKL~DFGla~~~~ 379 (568)
|||+++++|.+++.. +++..+..|+.||+.||.|||+.+ |+||||||+||||+.++ .+||+|||+++.+.
T Consensus 112 ~e~~~~~~l~~~~~~------~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~ 182 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQT------LTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 182 (330)
T ss_dssp EECCCCCCHHHHGGG------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred EeccCchhHHHHHHh------CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence 999999999998743 788899999999999999999999 99999999999999776 89999999998764
Q ss_pred CCCCccccccccccccccccCCChhhhhc-CCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHH---------------
Q 008365 380 PSVADSVTQYHMTSAAGTFCYIDPEYQQT-GMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRA--------------- 443 (568)
Q Consensus 380 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~--------------- 443 (568)
... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.........
T Consensus 183 ~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 255 (330)
T 3nsz_A 183 PGQ-------EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYD 255 (330)
T ss_dssp TTC-------CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHH
T ss_pred CCC-------ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhh
Confidence 332 1234579999999998877 67999999999999999999999999432211110
Q ss_pred -HHhCcc------ccccC--------ccC-CCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 444 -IEKGTL------AEMLD--------PAV-TDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 444 -~~~~~~------~~~l~--------~~~-~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
+..... ...+. ... ...+..++..+.+|+.+||+.||.+||++.+++.|.+
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~ 322 (330)
T 3nsz_A 256 YIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 322 (330)
T ss_dssp HHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGG
T ss_pred HHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCcc
Confidence 000000 00000 000 0112235678999999999999999999999986543
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=349.95 Aligned_cols=252 Identities=25% Similarity=0.372 Sum_probs=198.1
Q ss_pred HHHhcccccceeecccCceeEEEEEe--CCccEEEEEeCcChhHhHHHHHHHHHHHHcC-CCCceeeeccccCC------
Q 008365 225 EEATDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQGKRQFQQEVEVLSSI-RHPNMVLLLGACPD------ 295 (568)
Q Consensus 225 ~~~~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l-~HpnIv~l~g~~~~------ 295 (568)
....++|++.+.||+|+||.||+|.+ +++.||||++..... ....+.+|+.+++.+ +||||+++++++..
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~ 98 (326)
T 2x7f_A 20 RDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM 98 (326)
T ss_dssp CCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-TTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CC
T ss_pred cCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc-cHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccc
Confidence 34568899999999999999999998 678999999865432 245788999999998 79999999998732
Q ss_pred --CceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccc
Q 008365 296 --YGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVG 373 (568)
Q Consensus 296 --~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFG 373 (568)
..++||||+++|+|.+++..... ..+++..+..|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||
T Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg 174 (326)
T 2x7f_A 99 DDQLWLVMEFCGAGSVTDLIKNTKG-NTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFG 174 (326)
T ss_dssp CCEEEEEEECCTTEEHHHHHHHSGG-GCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCT
T ss_pred cceEEEEEEcCCCCcHHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEEEeeCc
Confidence 34899999999999999976432 24889999999999999999999999 9999999999999999999999999
Q ss_pred cccccCCCCCccccccccccccccccCCChhhhh-----cCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHH--Hh
Q 008365 374 LARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQ-----TGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAI--EK 446 (568)
Q Consensus 374 la~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-----~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~--~~ 446 (568)
++..+.... .......||+.|+|||++. +..++.++|||||||++|+|++|..||.......... ..
T Consensus 175 ~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~ 248 (326)
T 2x7f_A 175 VSAQLDRTV------GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR 248 (326)
T ss_dssp TTC-------------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH
T ss_pred CceecCcCc------cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhc
Confidence 997653221 1123457999999999886 5678999999999999999999999997655433221 11
Q ss_pred CccccccCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 447 GTLAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 447 ~~~~~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
... +. ..+..++..+.+|+.+||..+|.+||++.+++.+.+
T Consensus 249 ~~~-----~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~ 289 (326)
T 2x7f_A 249 NPA-----PR--LKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPF 289 (326)
T ss_dssp SCC-----CC--CSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHH
T ss_pred Ccc-----cc--CCccccCHHHHHHHHHHhccChhhCCCHHHHhhChH
Confidence 111 11 112334567999999999999999999999997655
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-42 Score=343.63 Aligned_cols=249 Identities=21% Similarity=0.302 Sum_probs=200.7
Q ss_pred HhcccccceeecccCceeEEEEEe--CCccEEEEEeCcCh-hHhHHHHHHHHHHHHcCCCCceeeeccccCCC--ceEEE
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDA-AQGKRQFQQEVEVLSSIRHPNMVLLLGACPDY--GCLVY 301 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~--~~lV~ 301 (568)
..++|++.+.||+|+||.||+|.+ +++.||||++.... ......+.+|+.+++.++||||+++++++.+. .++||
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence 457899999999999999999987 57799999986543 23456789999999999999999999998544 48999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCC
Q 008365 302 EYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPS 381 (568)
Q Consensus 302 E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~ 381 (568)
||+++++|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++..+...
T Consensus 85 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 158 (276)
T 2yex_A 85 EYCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (276)
T ss_dssp ECCTTEEGGGGSBTTT---BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred EecCCCcHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCC
Confidence 9999999999886432 4889999999999999999999999 999999999999999999999999999765322
Q ss_pred CCccccccccccccccccCCChhhhhcCCC-CCcceehhHHHHHHHHHhCCCCCCCchHH---HHHHHhCccccccCccC
Q 008365 382 VADSVTQYHMTSAAGTFCYIDPEYQQTGML-TTKSDIYSFGIMLLQIITARSPMGLTHHV---SRAIEKGTLAEMLDPAV 457 (568)
Q Consensus 382 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~-s~ksDvwSlGvil~elltG~~Pf~~~~~~---~~~~~~~~~~~~l~~~~ 457 (568)
.. ........||+.|+|||++.+..+ +.++|||||||++|+|++|..||...... ...+..... .
T Consensus 159 ~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-------~ 227 (276)
T 2yex_A 159 NR----ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT-------Y 227 (276)
T ss_dssp TE----ECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCT-------T
T ss_pred cc----hhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhccc-------c
Confidence 11 112245679999999999987765 77999999999999999999999654321 111111110 0
Q ss_pred CCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhH
Q 008365 458 TDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVP 492 (568)
Q Consensus 458 ~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~ 492 (568)
......++..+.+|+.+||+.+|.+||++.+++.+
T Consensus 228 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 228 LNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred cCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence 11123456778999999999999999999998743
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=350.96 Aligned_cols=248 Identities=29% Similarity=0.474 Sum_probs=197.7
Q ss_pred cccccceeecccCceeEEEEEe--CCc--cEEEEEeCcCh-hHhHHHHHHHHHHHHcC-CCCceeeeccccCCC--ceEE
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKL--DHT--PVAIKVLRPDA-AQGKRQFQQEVEVLSSI-RHPNMVLLLGACPDY--GCLV 300 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~--~~~--~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l-~HpnIv~l~g~~~~~--~~lV 300 (568)
++|.+.+.||+|+||.||+|.+ ++. .||||++.... ......+.+|+.+|+.+ +||||+++++++.+. .++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 6799999999999999999987 444 35999886532 33345688999999999 899999999998544 4899
Q ss_pred EEecCCCCHHHHHhhcC-------------CCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCcee
Q 008365 301 YEYMHNGSLEDRLLRRG-------------NTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVS 367 (568)
Q Consensus 301 ~E~~~ggsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~v 367 (568)
|||+++|+|.+++.... ....+++..++.|+.||+.||.|||+.+ |+||||||+||||+.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeE
Confidence 99999999999997653 1235899999999999999999999999 9999999999999999999
Q ss_pred EecccccccccCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh-CCCCCCCchHHHH--HH
Q 008365 368 KISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPMGLTHHVSR--AI 444 (568)
Q Consensus 368 KL~DFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~~--~~ 444 (568)
||+|||+++..... .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||........ .+
T Consensus 182 kL~Dfg~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~ 254 (327)
T 1fvr_A 182 KIADFGLSRGQEVY-------VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 254 (327)
T ss_dssp EECCTTCEESSCEE-------CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHG
T ss_pred EEcccCcCcccccc-------ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHh
Confidence 99999999743211 11234467899999999999999999999999999999998 9999976543221 11
Q ss_pred HhCccccccCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 445 EKGTLAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 445 ~~~~~~~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
..+ .....+..++..+.+|+.+||..+|.+||++.+++.++.
T Consensus 255 ~~~--------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~ 296 (327)
T 1fvr_A 255 PQG--------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLN 296 (327)
T ss_dssp GGT--------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred hcC--------CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 111 112234456678999999999999999999999975443
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=356.98 Aligned_cols=257 Identities=23% Similarity=0.303 Sum_probs=199.9
Q ss_pred HhcccccceeecccCceeEEEEEe--CCccEEEEEeCcCh-hHhHHHHHHHHHHHHcCCCCceeeeccccCC-------C
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDA-AQGKRQFQQEVEVLSSIRHPNMVLLLGACPD-------Y 296 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~-------~ 296 (568)
..++|.+.+.||+|+||.||+|.+ ++..||||++.... ......+.+|+.+|+.++||||+++++++.. .
T Consensus 25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence 457899999999999999999987 56789999997543 3334678899999999999999999998743 2
Q ss_pred ceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEeccccccc
Q 008365 297 GCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLAR 376 (568)
Q Consensus 297 ~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~ 376 (568)
.++||||+. |+|.+++... .+++..+..|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++
T Consensus 105 ~~iv~e~~~-~~L~~~l~~~----~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~ 176 (364)
T 3qyz_A 105 VYIVQDLME-TDLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLAR 176 (364)
T ss_dssp EEEEEECCS-EEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEcccC-cCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceE
Confidence 489999996 6999988654 2899999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCCccccccccccccccccCCChhhhh-cCCCCCcceehhHHHHHHHHHhCCCCCCCchHHH---HHHHh-Cc---
Q 008365 377 LVPPSVADSVTQYHMTSAAGTFCYIDPEYQQ-TGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVS---RAIEK-GT--- 448 (568)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~---~~~~~-~~--- 448 (568)
....... ........+||+.|+|||++. +..++.++|||||||++|+|++|+.||....... ..+.. +.
T Consensus 177 ~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~ 253 (364)
T 3qyz_A 177 VADPDHD---HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 253 (364)
T ss_dssp ECCGGGC---BCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCH
T ss_pred ecCCCCC---ccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence 7643211 111124568999999999765 4558999999999999999999999996543211 11100 00
Q ss_pred -------------ccccc-CccC---CCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 449 -------------LAEML-DPAV---TDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 449 -------------~~~~l-~~~~---~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
+...+ .... ......++..+.+|+.+||..||.+||++.+++.|.+
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 316 (364)
T 3qyz_A 254 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPY 316 (364)
T ss_dssp HHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGG
T ss_pred HHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcc
Confidence 00000 0000 0112344567899999999999999999999986543
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=385.38 Aligned_cols=245 Identities=22% Similarity=0.292 Sum_probs=204.4
Q ss_pred hcccccceeecccCceeEEEEEe--CCccEEEEEeCcCh---hHhHHHHHHHHHHHHcC-CCCceeeeccccCCC--ceE
Q 008365 228 TDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDA---AQGKRQFQQEVEVLSSI-RHPNMVLLLGACPDY--GCL 299 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l-~HpnIv~l~g~~~~~--~~l 299 (568)
.++|.+++.||+|+||.||+|++ +++.||||++++.. ......+..|..+|..+ +||||+.++++|.+. .||
T Consensus 340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~l 419 (674)
T 3pfq_A 340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 419 (674)
T ss_dssp CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEE
T ss_pred ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEE
Confidence 46799999999999999999987 45689999997542 22345678899999988 699999999998664 489
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccC
Q 008365 300 VYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVP 379 (568)
Q Consensus 300 V~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~ 379 (568)
||||++||+|.+++...+. +++..+..|+.||+.||.|||+.+ ||||||||+||||+.+|.+||+|||+++...
T Consensus 420 V~E~~~gg~L~~~l~~~~~---~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~~ 493 (674)
T 3pfq_A 420 VMEYVNGGDLMYHIQQVGR---FKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENI 493 (674)
T ss_dssp EEECCCSCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEECC
T ss_pred EEeCcCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeeccc
Confidence 9999999999999987653 899999999999999999999999 9999999999999999999999999998643
Q ss_pred CCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHH--HHHHHhCccccccCccC
Q 008365 380 PSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHV--SRAIEKGTLAEMLDPAV 457 (568)
Q Consensus 380 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~--~~~~~~~~~~~~l~~~~ 457 (568)
... ......+||+.|+|||++.+..|+.++|||||||+||||++|++||...+.. ...+..+.
T Consensus 494 ~~~------~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~--------- 558 (674)
T 3pfq_A 494 WDG------VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN--------- 558 (674)
T ss_dssp CTT------CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSC---------
T ss_pred cCC------cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCC---------
Confidence 221 1234678999999999999999999999999999999999999999765432 22222221
Q ss_pred CCCChHHHHHHHHHHHHhhccCCCCCCCh-----HHhHhHH
Q 008365 458 TDWPAEAAESFSKLAIQCAELRKKDRPDL-----GTVIVPE 493 (568)
Q Consensus 458 ~~~p~~~~~~l~~li~~Cl~~dP~~RPs~-----~~vl~~~ 493 (568)
..+|..++..+.+||..||+.||.+||++ .+|+.|.
T Consensus 559 ~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ 599 (674)
T 3pfq_A 559 VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHA 599 (674)
T ss_dssp CCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSG
T ss_pred CCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCc
Confidence 23456677889999999999999999998 6665443
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=342.89 Aligned_cols=249 Identities=27% Similarity=0.416 Sum_probs=193.2
Q ss_pred hcccccceeecccCceeEEEEEeC---Cc--cEEEEEeCcCh---hHhHHHHHHHHHHHHcCCCCceeeeccccCCC-ce
Q 008365 228 TDKFSEAMKIGEGGYGPVYRGKLD---HT--PVAIKVLRPDA---AQGKRQFQQEVEVLSSIRHPNMVLLLGACPDY-GC 298 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~~~~~---~~--~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~-~~ 298 (568)
.++|++.+.||+|+||.||+|.+. ++ .||||+++... ....+.+.+|+.+++.++||||+++++++.+. .+
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 96 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMK 96 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCE
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCCce
Confidence 467999999999999999999852 22 58999987642 23456789999999999999999999998554 58
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEeccccccccc
Q 008365 299 LVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLV 378 (568)
Q Consensus 299 lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~ 378 (568)
+||||+++|+|.+++..... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+
T Consensus 97 ~v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 171 (291)
T 1u46_A 97 MVTELAPLGSLLDRLRKHQG--HFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRAL 171 (291)
T ss_dssp EEEECCTTCBHHHHHHHHGG--GSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred eeEecccCCCHHHHHHhccC--CcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEccccccccc
Confidence 99999999999999976532 3889999999999999999999999 999999999999999999999999999876
Q ss_pred CCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh-CCCCCCCchHHH--HHHHhCccccccCc
Q 008365 379 PPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPMGLTHHVS--RAIEKGTLAEMLDP 455 (568)
Q Consensus 379 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~--~~~~~~~~~~~l~~ 455 (568)
..... .........||+.|+|||++.+..++.++|||||||++|+|++ |..||....... ..+.....
T Consensus 172 ~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~------ 242 (291)
T 1u46_A 172 PQNDD---HYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGE------ 242 (291)
T ss_dssp CC-CC---EEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCC------
T ss_pred ccccc---chhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCC------
Confidence 44321 1112234568889999999999999999999999999999999 999997554322 12221111
Q ss_pred cCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHh
Q 008365 456 AVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIV 491 (568)
Q Consensus 456 ~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~ 491 (568)
....+..++..+.+++.+||..+|.+||++.+++.
T Consensus 243 -~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 277 (291)
T 1u46_A 243 -RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 277 (291)
T ss_dssp -CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -CCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 11223456678999999999999999999999874
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=347.38 Aligned_cols=253 Identities=22% Similarity=0.271 Sum_probs=200.7
Q ss_pred HhcccccceeecccCceeEEEEEe---CCccEEEEEeCcChhHhHHHHHHHHHHHHcCCCC------ceeeeccccCC--
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKL---DHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHP------NMVLLLGACPD-- 295 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~---~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~Hp------nIv~l~g~~~~-- 295 (568)
..++|++.+.||+|+||.||+|.+ ++..||||+++... .....+.+|+.+++.++|+ +|++++++|.+
T Consensus 12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~ 90 (339)
T 1z57_A 12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD-RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHG 90 (339)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETT
T ss_pred ccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC-chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCC
Confidence 456899999999999999999976 56789999997653 3356788999999988665 48999998854
Q ss_pred CceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccC------------
Q 008365 296 YGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDR------------ 363 (568)
Q Consensus 296 ~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~------------ 363 (568)
..++||||+ +++|.+++...+.. .+++..+..|+.||+.||.|||+.+ |+||||||+||||+.
T Consensus 91 ~~~lv~e~~-~~~l~~~l~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~ 165 (339)
T 1z57_A 91 HICIVFELL-GLSTYDFIKENGFL-PFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIK 165 (339)
T ss_dssp EEEEEEECC-CCBHHHHHHHTTTC-CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----
T ss_pred cEEEEEcCC-CCCHHHHHHhcCCC-CCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCccc
Confidence 448999999 89999999876543 3889999999999999999999999 999999999999987
Q ss_pred -------CceeEecccccccccCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCC
Q 008365 364 -------NYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGL 436 (568)
Q Consensus 364 -------~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~ 436 (568)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|+|++|..||..
T Consensus 166 ~~~~~~~~~~~kl~Dfg~~~~~~~~---------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 236 (339)
T 1z57_A 166 RDERTLINPDIKVVDFGSATYDDEH---------HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPT 236 (339)
T ss_dssp CEEEEESCCCEEECCCSSCEETTSC---------CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cccccccCCCceEeeCcccccCccc---------cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Confidence 668999999999764321 2345799999999999999999999999999999999999999975
Q ss_pred chHHHHH--HHh--Ccccc----------cc---------------------C--ccCCCCChHHHHHHHHHHHHhhccC
Q 008365 437 THHVSRA--IEK--GTLAE----------ML---------------------D--PAVTDWPAEAAESFSKLAIQCAELR 479 (568)
Q Consensus 437 ~~~~~~~--~~~--~~~~~----------~l---------------------~--~~~~~~p~~~~~~l~~li~~Cl~~d 479 (568)
....... +.. +.+.. .+ . ......+..++..+.+|+.+||+.|
T Consensus 237 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d 316 (339)
T 1z57_A 237 HDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYD 316 (339)
T ss_dssp SCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSS
T ss_pred CChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcC
Confidence 4432211 100 00000 00 0 0001123456788999999999999
Q ss_pred CCCCCChHHhHhHHH
Q 008365 480 KKDRPDLGTVIVPEL 494 (568)
Q Consensus 480 P~~RPs~~~vl~~~l 494 (568)
|.+||++.+++.+.+
T Consensus 317 P~~Rpt~~ell~hp~ 331 (339)
T 1z57_A 317 PAKRITLREALKHPF 331 (339)
T ss_dssp TTTSCCHHHHTTSGG
T ss_pred cccccCHHHHhcCHH
Confidence 999999999986543
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=347.29 Aligned_cols=257 Identities=22% Similarity=0.347 Sum_probs=195.5
Q ss_pred HhcccccceeecccCceeEEEEEeC--CccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCceeeeccccC----------
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKLD--HTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACP---------- 294 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~~--~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~---------- 294 (568)
..++|.+.+.||+|+||.||+|.+. ++.||||++........+.+.+|+.+++.++||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 88 (320)
T 2i6l_A 9 LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDV 88 (320)
T ss_dssp ETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC--
T ss_pred cCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccc
Confidence 3478999999999999999999984 7799999998776666778999999999999999999998763
Q ss_pred ------CCceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeecc-CCcee
Q 008365 295 ------DYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLD-RNYVS 367 (568)
Q Consensus 295 ------~~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld-~~~~v 367 (568)
...++||||++ |+|.+++... .+++..+..|+.||+.||.|||+.+ |+||||||+||||+ .++.+
T Consensus 89 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~ 160 (320)
T 2i6l_A 89 GSLTELNSVYIVQEYME-TDLANVLEQG----PLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVL 160 (320)
T ss_dssp --CCSCSEEEEEEECCS-EEHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEE
T ss_pred ccccccCceeEEeeccC-CCHHHHhhcC----CccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeE
Confidence 22379999996 6999988542 3889999999999999999999999 99999999999997 56799
Q ss_pred EecccccccccCCCCCccccccccccccccccCCChhhhhc-CCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHH--
Q 008365 368 KISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQT-GMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAI-- 444 (568)
Q Consensus 368 KL~DFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~-- 444 (568)
||+|||+++.+..... .........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||..........
T Consensus 161 kl~Dfg~~~~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 237 (320)
T 2i6l_A 161 KIGDFGLARIMDPHYS---HKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLI 237 (320)
T ss_dssp EECCCTTCBCC-----------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred EEccCccccccCCCcc---cccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 9999999987643211 1112234568999999998765 679999999999999999999999997655432211
Q ss_pred -HhCc---------cccc--------cC-c--cCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 445 -EKGT---------LAEM--------LD-P--AVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 445 -~~~~---------~~~~--------l~-~--~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
.... +... .. + .....+..++..+.+|+.+||+.||.+||++.+++.+.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 308 (320)
T 2i6l_A 238 LESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPY 308 (320)
T ss_dssp HHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHH
T ss_pred HHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcc
Confidence 0000 0000 00 0 000112345678999999999999999999999997765
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=349.83 Aligned_cols=250 Identities=22% Similarity=0.323 Sum_probs=197.9
Q ss_pred HhcccccceeecccCceeEEEEEe--CCccEEEEEeCcChh--------HhHHHHHHHHHHHHcCCCCceeeeccccCC-
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAA--------QGKRQFQQEVEVLSSIRHPNMVLLLGACPD- 295 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~--------~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~- 295 (568)
..++|.+.+.||+|+||.||+|.+ +++.||||++..... .....+.+|+.+|+.++||||+++++++..
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 567899999999999999999987 467899999875421 122357899999999999999999999854
Q ss_pred CceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCc---eeEeccc
Q 008365 296 YGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNY---VSKISDV 372 (568)
Q Consensus 296 ~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~---~vKL~DF 372 (568)
..++||||+++|+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+||||+.++ .+||+||
T Consensus 88 ~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Df 161 (322)
T 2ycf_A 88 DYYIVLELMEGGELFDKVVGNK---RLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDF 161 (322)
T ss_dssp SEEEEEECCTTEETHHHHSTTC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECCC
T ss_pred ceEEEEecCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEccC
Confidence 3589999999999999886543 3889999999999999999999999 99999999999998765 4999999
Q ss_pred ccccccCCCCCccccccccccccccccCCChhhhh---cCCCCCcceehhHHHHHHHHHhCCCCCCCch---HHHHHHHh
Q 008365 373 GLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQ---TGMLTTKSDIYSFGIMLLQIITARSPMGLTH---HVSRAIEK 446 (568)
Q Consensus 373 Gla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~---~~~~s~ksDvwSlGvil~elltG~~Pf~~~~---~~~~~~~~ 446 (568)
|+++.+.... ......||+.|+|||++. ...++.++|||||||++|+|++|..||.... .+...+..
T Consensus 162 g~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 234 (322)
T 2ycf_A 162 GHSKILGETS-------LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITS 234 (322)
T ss_dssp TTCEECCCCH-------HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHH
T ss_pred ccceeccccc-------ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHh
Confidence 9998764321 123457999999999874 4678999999999999999999999996432 22233333
Q ss_pred CccccccCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 447 GTLAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 447 ~~~~~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
+.... ....+..++..+.+|+.+||..||.+||++.+++.+.+
T Consensus 235 ~~~~~-----~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~ 277 (322)
T 2ycf_A 235 GKYNF-----IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPW 277 (322)
T ss_dssp TCCCC-----CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGG
T ss_pred Ccccc-----CchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcC
Confidence 22110 00111234567999999999999999999999987654
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=341.87 Aligned_cols=256 Identities=26% Similarity=0.369 Sum_probs=194.0
Q ss_pred HhcccccceeecccCceeEEEEEe--CCccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCceeeeccccCC---------
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACPD--------- 295 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--------- 295 (568)
..++|++.+.||+|+||.||+|.+ ++..||||++.... .....+.+|+.+++.++||||++++++|.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE-EKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccH-HHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 457899999999999999999987 57899999996543 345678899999999999999999987632
Q ss_pred ------CceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEe
Q 008365 296 ------YGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKI 369 (568)
Q Consensus 296 ------~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL 369 (568)
..++||||+++|+|.+++..... .+++..++.|+.||+.||.|||+.+ |+||||||+||||+.++.+||
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl 157 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHSENL--NQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKI 157 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHHSCG--GGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEE
T ss_pred ccccCCceEEEEecCCCCCHHHhhhcccc--ccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEE
Confidence 23899999999999999986442 3788899999999999999999999 999999999999999999999
Q ss_pred cccccccccCCCCCcc--------ccccccccccccccCCChhhhhcC-CCCCcceehhHHHHHHHHHhCCCCCCCchHH
Q 008365 370 SDVGLARLVPPSVADS--------VTQYHMTSAAGTFCYIDPEYQQTG-MLTTKSDIYSFGIMLLQIITARSPMGLTHHV 440 (568)
Q Consensus 370 ~DFGla~~~~~~~~~~--------~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDvwSlGvil~elltG~~Pf~~~~~~ 440 (568)
+|||+++.+....... ..........||+.|+|||++.+. .++.++|||||||++|+|++ ||......
T Consensus 158 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~ 234 (303)
T 1zy4_A 158 GDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMER 234 (303)
T ss_dssp CCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHH
T ss_pred eeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhH
Confidence 9999998664321000 001123456799999999998764 68999999999999999998 66433222
Q ss_pred HHHHHhCccccccCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHH
Q 008365 441 SRAIEKGTLAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPE 493 (568)
Q Consensus 441 ~~~~~~~~~~~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~ 493 (568)
...... +..........++...+..+.+|+.+||+.||.+||++.+++.+.
T Consensus 235 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~ 285 (303)
T 1zy4_A 235 VNILKK--LRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSG 285 (303)
T ss_dssp HHHHHH--HHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSS
T ss_pred HHHHHh--ccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCC
Confidence 111111 000001111234556667899999999999999999999998544
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=363.81 Aligned_cols=253 Identities=21% Similarity=0.276 Sum_probs=198.3
Q ss_pred HhcccccceeecccCceeEEEEEe--CCccEEEEEeCcChhHhHHHHHHHHHHHHcC------CCCceeeeccccCC--C
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQGKRQFQQEVEVLSSI------RHPNMVLLLGACPD--Y 296 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l------~HpnIv~l~g~~~~--~ 296 (568)
...+|++.+.||+|+||.||+|.+ .+..||||++.... .....+.+|+.+++.+ +|+||+.++++|.. .
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 173 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNH 173 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTE
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCe
Confidence 346799999999999999999987 46789999997654 3345677888888776 67899999998843 4
Q ss_pred ceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCce--eEeccccc
Q 008365 297 GCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYV--SKISDVGL 374 (568)
Q Consensus 297 ~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~--vKL~DFGl 374 (568)
.|+||||+. ++|.+++...... .+++..+..|+.||+.||.|||+.+ ||||||||+||||+.++. +||+|||+
T Consensus 174 ~~lv~e~~~-~~L~~~l~~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~ 248 (429)
T 3kvw_A 174 ICMTFELLS-MNLYELIKKNKFQ-GFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGS 248 (429)
T ss_dssp EEEEECCCC-CBHHHHHHHTTTC-CCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTT
T ss_pred EEEEEeccC-CCHHHHHHhccCC-CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeeccc
Confidence 589999994 7999988775433 3899999999999999999999999 999999999999999887 99999999
Q ss_pred ccccCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHH---Hh-Cc--
Q 008365 375 ARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAI---EK-GT-- 448 (568)
Q Consensus 375 a~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~---~~-~~-- 448 (568)
++..... ....+||+.|+|||++.+..++.++|||||||++|||++|.+||.......... .. +.
T Consensus 249 a~~~~~~---------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~ 319 (429)
T 3kvw_A 249 SCYEHQR---------VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPS 319 (429)
T ss_dssp CEETTCC---------CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred ceecCCc---------ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCC
Confidence 9764322 234679999999999999999999999999999999999999997654322211 00 00
Q ss_pred ---------cccccCc---------------------------------cCCC----CChHHHHHHHHHHHHhhccCCCC
Q 008365 449 ---------LAEMLDP---------------------------------AVTD----WPAEAAESFSKLAIQCAELRKKD 482 (568)
Q Consensus 449 ---------~~~~l~~---------------------------------~~~~----~p~~~~~~l~~li~~Cl~~dP~~ 482 (568)
....++. .... .+...+..+.+||.+||+.||.+
T Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~ 399 (429)
T 3kvw_A 320 QKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAV 399 (429)
T ss_dssp HHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTT
T ss_pred HHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhh
Confidence 0000000 0000 01122567899999999999999
Q ss_pred CCChHHhHhHHH
Q 008365 483 RPDLGTVIVPEL 494 (568)
Q Consensus 483 RPs~~~vl~~~l 494 (568)
||++.+++.|.+
T Consensus 400 Rpta~e~L~Hpw 411 (429)
T 3kvw_A 400 RMTPGQALRHPW 411 (429)
T ss_dssp SCCHHHHHTSTT
T ss_pred CCCHHHHhCChh
Confidence 999999986544
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=355.37 Aligned_cols=250 Identities=23% Similarity=0.303 Sum_probs=195.9
Q ss_pred HhcccccceeecccCceeEEEEEe--CCccEEEEEeCcC--hhHhHHHHHHHHHHHHcCCCCceeeeccccCCCc-----
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPD--AAQGKRQFQQEVEVLSSIRHPNMVLLLGACPDYG----- 297 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~----- 297 (568)
+.++|.+.+.||+|+||.||+|.+ +++.||||++... .......+.+|+.+++.++||||++++++|....
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 457899999999999999999987 5789999999764 2333567889999999999999999999885422
Q ss_pred ---eEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEeccccc
Q 008365 298 ---CLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGL 374 (568)
Q Consensus 298 ---~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGl 374 (568)
++||||+. ++|.+++.. .+++..+..|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+
T Consensus 120 ~~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~ 190 (371)
T 4exu_A 120 YDFYLVMPFMQ-TDLQKIMGM-----EFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGL 190 (371)
T ss_dssp CCCEEEEECCC-EEHHHHTTS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred eeEEEEEcccc-ccHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCc
Confidence 89999996 788877632 2899999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCccccccccccccccccCCChhhhhc-CCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHh----Ccc
Q 008365 375 ARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQT-GMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEK----GTL 449 (568)
Q Consensus 375 a~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~----~~~ 449 (568)
++..... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||............ +..
T Consensus 191 a~~~~~~---------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~ 261 (371)
T 4exu_A 191 ARHADAE---------MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVP 261 (371)
T ss_dssp C-----------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred ccccccC---------cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence 9755321 234678999999998877 67999999999999999999999999765433221110 000
Q ss_pred ----------------ccccC----ccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 450 ----------------AEMLD----PAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 450 ----------------~~~l~----~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
...+. ..+...+..++..+.+|+.+||+.||.+||++.+++.+.+
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 326 (371)
T 4exu_A 262 GTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPF 326 (371)
T ss_dssp CHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGG
T ss_pred cHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcc
Confidence 00000 0000112344678999999999999999999999986544
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-41 Score=340.45 Aligned_cols=251 Identities=22% Similarity=0.345 Sum_probs=203.4
Q ss_pred HHhcccccceeecccCceeEEEEEe--CCccEEEEEeCcCh---------hHhHHHHHHHHHHHHcCC-CCceeeecccc
Q 008365 226 EATDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDA---------AQGKRQFQQEVEVLSSIR-HPNMVLLLGAC 293 (568)
Q Consensus 226 ~~~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~---------~~~~~~~~~Ev~iL~~l~-HpnIv~l~g~~ 293 (568)
...++|.+.+.||+|+||.||+|.+ +++.||||++.... ......+.+|+.+|+++. ||||+++++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 3567899999999999999999988 56799999986542 122456789999999996 99999999998
Q ss_pred CCC--ceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecc
Q 008365 294 PDY--GCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISD 371 (568)
Q Consensus 294 ~~~--~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~D 371 (568)
.+. .++||||+++++|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~d 167 (298)
T 1phk_A 94 ETNTFFFLVFDLMKKGELFDYLTEKV---TLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTD 167 (298)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECC
T ss_pred ccCCeEEEEEeccCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEec
Confidence 654 489999999999999997754 3889999999999999999999999 99999999999999999999999
Q ss_pred cccccccCCCCCccccccccccccccccCCChhhhh------cCCCCCcceehhHHHHHHHHHhCCCCCCCchHHH--HH
Q 008365 372 VGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQ------TGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVS--RA 443 (568)
Q Consensus 372 FGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~------~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~--~~ 443 (568)
||++..+.... ......||+.|+|||++. ...++.++|||||||++|+|++|..||....... ..
T Consensus 168 fg~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~ 240 (298)
T 1phk_A 168 FGFSCQLDPGE-------KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRM 240 (298)
T ss_dssp CTTCEECCTTC-------CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred ccchhhcCCCc-------ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHH
Confidence 99998764321 123457999999999875 4568899999999999999999999996554322 22
Q ss_pred HHhCccccccCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 444 IEKGTLAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 444 ~~~~~~~~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
+..+.... . ......++..+.+|+.+||+.+|.+||++.+++.+.+
T Consensus 241 ~~~~~~~~----~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~ 286 (298)
T 1phk_A 241 IMSGNYQF----G-SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPF 286 (298)
T ss_dssp HHHTCCCC----C-TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGG
T ss_pred HhcCCccc----C-cccccccCHHHHHHHHHHccCCcccCCCHHHHHhChH
Confidence 22222110 0 1112345678999999999999999999999986443
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=351.79 Aligned_cols=260 Identities=22% Similarity=0.277 Sum_probs=199.4
Q ss_pred HhcccccceeecccCceeEEEEEeC--CccEEEEEeCcCh-hHhHHHHHHHHHHHHcCCCCceeeeccccCC-------C
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKLD--HTPVAIKVLRPDA-AQGKRQFQQEVEVLSSIRHPNMVLLLGACPD-------Y 296 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~~--~~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~-------~ 296 (568)
..++|.+.+.||+|+||.||+|.+. ++.||||++.... ......+.+|+.+|+.++||||+++++++.. .
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 4578999999999999999999984 7799999997543 3345568899999999999999999988743 3
Q ss_pred ceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEeccccccc
Q 008365 297 GCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLAR 376 (568)
Q Consensus 297 ~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~ 376 (568)
.++||||+. |+|.+++... .+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++
T Consensus 89 ~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (353)
T 2b9h_A 89 VYIIQELMQ-TDLHRVISTQ----MLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLAR 160 (353)
T ss_dssp EEEEECCCS-EEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEeccC-ccHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEeccccc
Confidence 489999996 6999988763 3899999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCCccc----cccccccccccccCCChhhhhc-CCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHh----C
Q 008365 377 LVPPSVADSV----TQYHMTSAAGTFCYIDPEYQQT-GMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEK----G 447 (568)
Q Consensus 377 ~~~~~~~~~~----~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~----~ 447 (568)
.+........ ........+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||............ +
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 240 (353)
T 2b9h_A 161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIG 240 (353)
T ss_dssp ECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred ccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC
Confidence 7653321111 0111234679999999998764 67999999999999999999999999765432221110 0
Q ss_pred ccc--------------c---ccC----ccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 448 TLA--------------E---MLD----PAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 448 ~~~--------------~---~l~----~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
... + .+. ..+...+..++..+.+|+.+||..||.+||++.+++.+.+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 308 (353)
T 2b9h_A 241 TPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPY 308 (353)
T ss_dssp CCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred CCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCcc
Confidence 000 0 000 0000112345677899999999999999999999985443
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=352.87 Aligned_cols=255 Identities=21% Similarity=0.324 Sum_probs=203.3
Q ss_pred hcccccceeecccCceeEEEEEeCCccEEEEEeCcChhHh-----------------HHHHHHHHHHHHcCCCCceeeec
Q 008365 228 TDKFSEAMKIGEGGYGPVYRGKLDHTPVAIKVLRPDAAQG-----------------KRQFQQEVEVLSSIRHPNMVLLL 290 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~~~~~~~~vAvK~l~~~~~~~-----------------~~~~~~Ev~iL~~l~HpnIv~l~ 290 (568)
.++|.+.+.||+|+||.||+|.+++..||||++....... ...+.+|+.+++.++||||++++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 109 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCE 109 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEETTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCS
T ss_pred cCceEEEEEEcCCCCeEEEEEEcCCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEE
Confidence 4789999999999999999999999999999986543221 16789999999999999999999
Q ss_pred cccCCC--ceEEEEecCCCCHHHH------HhhcCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCCCCcccCCCCCCCeec
Q 008365 291 GACPDY--GCLVYEYMHNGSLEDR------LLRRGNTPVIPWRKRFKIAAEIATALLFLHQ-AKPEPLVHRDLKPANILL 361 (568)
Q Consensus 291 g~~~~~--~~lV~E~~~ggsL~~~------l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~-~~~~~IiHrDIKp~NILl 361 (568)
+++.+. .++||||+++|+|.++ +.... ...+++..+..|+.||+.||.|||+ .+ |+||||||+||||
T Consensus 110 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil~ 185 (348)
T 2pml_X 110 GIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNY-TCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNILM 185 (348)
T ss_dssp EEEESSSEEEEEEECCTTCBSSEESSSEESSCSSS-CCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEEE
T ss_pred EEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhcc-ccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEEE
Confidence 998554 4899999999999988 44321 2458999999999999999999999 88 9999999999999
Q ss_pred cCCceeEecccccccccCCCCCccccccccccccccccCCChhhhhcC-CCCC-cceehhHHHHHHHHHhCCCCCCCchH
Q 008365 362 DRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTG-MLTT-KSDIYSFGIMLLQIITARSPMGLTHH 439 (568)
Q Consensus 362 d~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~-ksDvwSlGvil~elltG~~Pf~~~~~ 439 (568)
+.++.+||+|||++...... ......||+.|+|||++.+. .++. ++|||||||++|+|++|..||.....
T Consensus 186 ~~~~~~kl~dfg~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 257 (348)
T 2pml_X 186 DKNGRVKLSDFGESEYMVDK--------KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKIS 257 (348)
T ss_dssp CTTSCEEECCCTTCEECBTT--------EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSC
T ss_pred cCCCcEEEeccccccccccc--------cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCc
Confidence 99999999999999865332 22456799999999999877 6666 99999999999999999999975432
Q ss_pred ---HHHHHHhCccccccCcc--C--------CCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 440 ---VSRAIEKGTLAEMLDPA--V--------TDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 440 ---~~~~~~~~~~~~~l~~~--~--------~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
....+..+......... . ......++..+.+|+.+||+.+|.+||++.+++.+.+
T Consensus 258 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~ 325 (348)
T 2pml_X 258 LVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEW 325 (348)
T ss_dssp SHHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGG
T ss_pred HHHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCcc
Confidence 33333332211110000 0 0011445678999999999999999999999986543
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-41 Score=348.64 Aligned_cols=249 Identities=23% Similarity=0.301 Sum_probs=196.5
Q ss_pred hcccccceeecccCceeEEEEEe--CCccEEEEEeCcCh--hHhHHHHHHHHHHHHcCCCCceeeeccccCCC-------
Q 008365 228 TDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDA--AQGKRQFQQEVEVLSSIRHPNMVLLLGACPDY------- 296 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~--~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~------- 296 (568)
.++|.+.+.||+|+||.||+|.+ +++.||||++.... ......+.+|+.+|+.++||||+++++++.+.
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 46899999999999999999987 57899999996542 33356788999999999999999999988543
Q ss_pred -ceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccc
Q 008365 297 -GCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLA 375 (568)
Q Consensus 297 -~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla 375 (568)
.++||||+. |+|.+++.. .+++..+..|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++
T Consensus 103 ~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 173 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMGL-----KFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA 173 (353)
T ss_dssp CCEEEEECCS-EEGGGTTTS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred eEEEEecccc-CCHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccc
Confidence 289999996 688776632 2889999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCccccccccccccccccCCChhhhhc-CCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHH---HHh-Cc--
Q 008365 376 RLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQT-GMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRA---IEK-GT-- 448 (568)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~---~~~-~~-- 448 (568)
+..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||......... ... +.
T Consensus 174 ~~~~~~---------~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~ 244 (353)
T 3coi_A 174 RHADAE---------MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPG 244 (353)
T ss_dssp TC-----------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCC
T ss_pred cCCCCC---------ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 764321 234579999999998877 67899999999999999999999999765432211 110 00
Q ss_pred ------------------cccccCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 449 ------------------LAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 449 ------------------~~~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
+.......+...+..++..+.+|+.+||..||.+||++.+++.|.+
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~ 308 (353)
T 3coi_A 245 TEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPF 308 (353)
T ss_dssp HHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGG
T ss_pred HHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcc
Confidence 0000011122334456788999999999999999999999986543
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=361.84 Aligned_cols=251 Identities=22% Similarity=0.289 Sum_probs=194.0
Q ss_pred cccccceeecccCceeEEEEEe--CCccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCceeeeccccCC--------Cce
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACPD--------YGC 298 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--------~~~ 298 (568)
.+|.+.+.||+|+||.||+|++ ++..||||++..... .+.+|+++|+.++|||||+++++|.. +.+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 4699999999999999999998 578999999865432 23479999999999999999988721 136
Q ss_pred EEEEecCCCCHHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCC-ceeEeccccccc
Q 008365 299 LVYEYMHNGSLEDRLLRR-GNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRN-YVSKISDVGLAR 376 (568)
Q Consensus 299 lV~E~~~ggsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~-~~vKL~DFGla~ 376 (568)
+||||+++ +|.+.+... .....+++..+..|+.||+.||.|||+.+ |+||||||+||||+.+ +.+||+|||+++
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 89999964 666665431 12234899999999999999999999999 9999999999999954 678999999998
Q ss_pred ccCCCCCccccccccccccccccCCChhhhhcC-CCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHh----C----
Q 008365 377 LVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTG-MLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEK----G---- 447 (568)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~----~---- 447 (568)
.+.... .....+||+.|+|||++.+. .++.++|||||||+||||++|++||............ +
T Consensus 206 ~~~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~ 278 (420)
T 1j1b_A 206 QLVRGE-------PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTR 278 (420)
T ss_dssp ECCTTC-------CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCH
T ss_pred hcccCC-------CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence 764321 12346799999999988765 7999999999999999999999999765443322110 0
Q ss_pred --------ccccccCccCCC------CChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 448 --------TLAEMLDPAVTD------WPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 448 --------~~~~~l~~~~~~------~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
.+.....+.+.. ++..++..+.+|+.+||..||.+||++.+++.|.+
T Consensus 279 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~ 339 (420)
T 1j1b_A 279 EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 339 (420)
T ss_dssp HHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred HHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHh
Confidence 000000011110 22345678999999999999999999999987665
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=354.70 Aligned_cols=251 Identities=22% Similarity=0.322 Sum_probs=198.9
Q ss_pred hcccccceeecccCceeEEEEEe--CCccEEEEEeCcChhHhHHHHHHHHHHHHcCC-----------CCceeeeccccC
Q 008365 228 TDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIR-----------HPNMVLLLGACP 294 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~-----------HpnIv~l~g~~~ 294 (568)
.++|.+.+.||+|+||.||+|.+ +++.||||++..... ....+.+|+.+++.+. ||||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH-HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCcc-chhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 36899999999999999999986 678999999986543 3456889999999886 899999999885
Q ss_pred C------CceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHc-CCCCcccCCCCCCCeecc-----
Q 008365 295 D------YGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQA-KPEPLVHRDLKPANILLD----- 362 (568)
Q Consensus 295 ~------~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~-~~~~IiHrDIKp~NILld----- 362 (568)
. ..++||||+ +++|.+++...... .+++..+..|+.||+.||.|||+. + |+||||||+||||+
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~-~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~ 171 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKYEHR-GIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSP 171 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHTTTS-CCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETT
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHhhcc-CCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCC
Confidence 3 348999999 99999999875433 388999999999999999999998 8 99999999999994
Q ss_pred -CCceeEecccccccccCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchH--
Q 008365 363 -RNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHH-- 439 (568)
Q Consensus 363 -~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~-- 439 (568)
..+.+||+|||+++.+... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.....
T Consensus 172 ~~~~~~kl~Dfg~a~~~~~~---------~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 242 (373)
T 1q8y_A 172 ENLIQIKIADLGNACWYDEH---------YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHS 242 (373)
T ss_dssp TTEEEEEECCCTTCEETTBC---------CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC-------
T ss_pred cCcceEEEcccccccccCCC---------CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccc
Confidence 4458999999999865322 2345799999999999999999999999999999999999999964321
Q ss_pred -------HHHHHH-hCcccc--------------------cc-----------CccCCCCChHHHHHHHHHHHHhhccCC
Q 008365 440 -------VSRAIE-KGTLAE--------------------ML-----------DPAVTDWPAEAAESFSKLAIQCAELRK 480 (568)
Q Consensus 440 -------~~~~~~-~~~~~~--------------------~l-----------~~~~~~~p~~~~~~l~~li~~Cl~~dP 480 (568)
+...+. .+.... .+ ......++..++..+.+||.+||+.||
T Consensus 243 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 322 (373)
T 1q8y_A 243 YTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDP 322 (373)
T ss_dssp --CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSST
T ss_pred cCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCc
Confidence 111110 000000 00 001123567888999999999999999
Q ss_pred CCCCChHHhHhHH
Q 008365 481 KDRPDLGTVIVPE 493 (568)
Q Consensus 481 ~~RPs~~~vl~~~ 493 (568)
.+||++.+++.|.
T Consensus 323 ~~Rpt~~ell~hp 335 (373)
T 1q8y_A 323 RKRADAGGLVNHP 335 (373)
T ss_dssp TTCBCHHHHHTCG
T ss_pred cccCCHHHHhhCh
Confidence 9999999998544
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=355.32 Aligned_cols=255 Identities=20% Similarity=0.281 Sum_probs=196.6
Q ss_pred HHHhcccccceeecccCceeEEEEEe--CCccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCceeeeccccCC-------
Q 008365 225 EEATDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACPD------- 295 (568)
Q Consensus 225 ~~~~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~------- 295 (568)
+...++|.+.+.||+|+||.||+|.+ ++..||||++..+.. ...+|+.+|+.++|||||+++++|..
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 34567899999999999999999987 678999999865532 23479999999999999999998721
Q ss_pred ---------------------------------CceEEEEecCCCCHHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHH
Q 008365 296 ---------------------------------YGCLVYEYMHNGSLEDRLLRR-GNTPVIPWRKRFKIAAEIATALLFL 341 (568)
Q Consensus 296 ---------------------------------~~~lV~E~~~ggsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~yL 341 (568)
+.++||||++ |+|.+.+... .....+++..+..|+.||+.||.||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 157 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI 157 (383)
T ss_dssp -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 1479999997 6887777642 1223489999999999999999999
Q ss_pred HHcCCCCcccCCCCCCCeecc-CCceeEecccccccccCCCCCccccccccccccccccCCChhhhhcC-CCCCcceehh
Q 008365 342 HQAKPEPLVHRDLKPANILLD-RNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTG-MLTTKSDIYS 419 (568)
Q Consensus 342 H~~~~~~IiHrDIKp~NILld-~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDvwS 419 (568)
|+.+ |+||||||+||||+ .++.+||+|||+++.+.... ......||+.|+|||++.+. .++.++||||
T Consensus 158 H~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~Diws 227 (383)
T 3eb0_A 158 HSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE-------PSVAYICSRFYRAPELMLGATEYTPSIDLWS 227 (383)
T ss_dssp HTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS-------CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHH
T ss_pred HHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC-------CCcCcccCCCccCHHHhcCCCCCCcchhhhh
Confidence 9999 99999999999998 68999999999998764322 12345789999999988765 4999999999
Q ss_pred HHHHHHHHHhCCCCCCCchHHHHHHHh----C------------ccccccCccCC------CCChHHHHHHHHHHHHhhc
Q 008365 420 FGIMLLQIITARSPMGLTHHVSRAIEK----G------------TLAEMLDPAVT------DWPAEAAESFSKLAIQCAE 477 (568)
Q Consensus 420 lGvil~elltG~~Pf~~~~~~~~~~~~----~------------~~~~~l~~~~~------~~p~~~~~~l~~li~~Cl~ 477 (568)
|||++|+|++|+.||............ + ......-+... .++..++..+.+|+.+||.
T Consensus 228 lG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 307 (383)
T 3eb0_A 228 IGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILR 307 (383)
T ss_dssp HHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCC
T ss_pred HHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHcc
Confidence 999999999999999765443322111 0 00000000000 1234466779999999999
Q ss_pred cCCCCCCChHHhHhHHH
Q 008365 478 LRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 478 ~dP~~RPs~~~vl~~~l 494 (568)
.+|.+||++.+++.|.+
T Consensus 308 ~dP~~R~t~~e~l~hp~ 324 (383)
T 3eb0_A 308 YEPDLRINPYEAMAHPF 324 (383)
T ss_dssp SSGGGSCCHHHHHTSGG
T ss_pred CChhhCCCHHHHhcCHH
Confidence 99999999999997665
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-41 Score=350.10 Aligned_cols=260 Identities=22% Similarity=0.265 Sum_probs=188.0
Q ss_pred HHHHHhcccccceeecccCceeEEEEEe--CCccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCceeeeccccCC-----
Q 008365 223 EIEEATDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACPD----- 295 (568)
Q Consensus 223 ei~~~~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~----- 295 (568)
......++|.+.+.||+|+||.||+|.+ ++..||||++...... ...+.+++..+..++||||++++++|..
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~ 95 (360)
T 3e3p_A 17 RSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF-RNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD 95 (360)
T ss_dssp HHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC-CCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred hchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc-cHHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence 3455678999999999999999999997 4779999998654322 2355678888899999999999998732
Q ss_pred ----CceEEEEecCCCCHHHHHhh-cCCCCCCCHHHHHHHHHHHHHHHHHHH--HcCCCCcccCCCCCCCeeccC-Ccee
Q 008365 296 ----YGCLVYEYMHNGSLEDRLLR-RGNTPVIPWRKRFKIAAEIATALLFLH--QAKPEPLVHRDLKPANILLDR-NYVS 367 (568)
Q Consensus 296 ----~~~lV~E~~~ggsL~~~l~~-~~~~~~l~~~~~~~i~~qia~aL~yLH--~~~~~~IiHrDIKp~NILld~-~~~v 367 (568)
+.++||||+++ +|.+.+.. ......+++..+..|+.||+.||.||| +.+ |+||||||+||||+. ++.+
T Consensus 96 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~~ 171 (360)
T 3e3p_A 96 RRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGTL 171 (360)
T ss_dssp TTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTEE
T ss_pred ccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCcE
Confidence 14789999975 55544432 233345889999999999999999999 888 999999999999996 8999
Q ss_pred EecccccccccCCCCCccccccccccccccccCCChhhhhcCC-CCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHh
Q 008365 368 KISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGM-LTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEK 446 (568)
Q Consensus 368 KL~DFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~-~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~ 446 (568)
||+|||+++.+.... ......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||............
T Consensus 172 kl~Dfg~a~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~ 244 (360)
T 3e3p_A 172 KLCDFGSAKKLSPSE-------PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEI 244 (360)
T ss_dssp EECCCTTCBCCCTTS-------CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred EEeeCCCceecCCCC-------CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHH
Confidence 999999998764322 123457899999999886554 899999999999999999999999765432221110
Q ss_pred Cc--------cccccCc-----------------cCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 447 GT--------LAEMLDP-----------------AVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 447 ~~--------~~~~l~~-----------------~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
.. ....+++ .+...+..++..+.+|+.+||+.||.+||++.+++.|.+
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~ 317 (360)
T 3e3p_A 245 VRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPY 317 (360)
T ss_dssp HHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGG
T ss_pred HHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCcc
Confidence 00 0000000 011222335778999999999999999999999986544
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=343.23 Aligned_cols=255 Identities=25% Similarity=0.384 Sum_probs=199.3
Q ss_pred HhcccccceeecccCceeEEEEEe---CCccEEEEEeCcChhH--hHHHHHHHHHHHHcC---CCCceeeeccccC----
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKL---DHTPVAIKVLRPDAAQ--GKRQFQQEVEVLSSI---RHPNMVLLLGACP---- 294 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~---~~~~vAvK~l~~~~~~--~~~~~~~Ev~iL~~l---~HpnIv~l~g~~~---- 294 (568)
..++|.+.+.||+|+||.||+|.+ ++..||||++...... ....+.+|+.+++.+ +||||++++++|.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 457899999999999999999987 4678999998643221 123456777777665 8999999999874
Q ss_pred -C--CceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecc
Q 008365 295 -D--YGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISD 371 (568)
Q Consensus 295 -~--~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~D 371 (568)
. ..++||||+. |+|.+++...... .+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~D 163 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVPEP-GVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLAD 163 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSCTT-CSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECS
T ss_pred CCCceEEEEEecCC-CCHHHHHHhcccC-CCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEec
Confidence 2 2389999996 6999998775432 3899999999999999999999999 99999999999999999999999
Q ss_pred cccccccCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHH---HHh-C
Q 008365 372 VGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRA---IEK-G 447 (568)
Q Consensus 372 FGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~---~~~-~ 447 (568)
||+++.+... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||......... +.. +
T Consensus 164 fg~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~ 236 (326)
T 1blx_A 164 FGLARIYSFQ-------MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIG 236 (326)
T ss_dssp CCSCCCCCGG-------GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred CcccccccCC-------CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcC
Confidence 9999765321 1234567999999999999999999999999999999999999999765443221 110 0
Q ss_pred c-----ccc-------c----cCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHH
Q 008365 448 T-----LAE-------M----LDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPE 493 (568)
Q Consensus 448 ~-----~~~-------~----l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~ 493 (568)
. +.. . .......++..++..+.+|+.+||..+|.+||++.+++.+.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp 298 (326)
T 1blx_A 237 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHP 298 (326)
T ss_dssp CCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSG
T ss_pred CCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCc
Confidence 0 000 0 00011122345667899999999999999999999998543
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-41 Score=357.41 Aligned_cols=253 Identities=22% Similarity=0.280 Sum_probs=192.9
Q ss_pred hcccccceeecccCceeEEEEEe-CCccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCceeeeccccC------CC--ce
Q 008365 228 TDKFSEAMKIGEGGYGPVYRGKL-DHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACP------DY--GC 298 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~~~~-~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~------~~--~~ 298 (568)
..+|.+.+.||+|+||.||+|++ .+..||||++..... ...+|+.+|+.++|||||+++++|. +. .+
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 35799999999999999999998 445689988754432 2247999999999999999999872 11 37
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeecc-CCceeEecccccccc
Q 008365 299 LVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLD-RNYVSKISDVGLARL 377 (568)
Q Consensus 299 lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld-~~~~vKL~DFGla~~ 377 (568)
+||||++++.+............+++..+..|+.||+.||.|||+.+ |+||||||+||||+ .++.+||+|||+++.
T Consensus 115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~ 191 (394)
T 4e7w_A 115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKI 191 (394)
T ss_dssp EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence 99999976544443332222335899999999999999999999999 99999999999999 799999999999987
Q ss_pred cCCCCCccccccccccccccccCCChhhhhcC-CCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHhC---------
Q 008365 378 VPPSVADSVTQYHMTSAAGTFCYIDPEYQQTG-MLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKG--------- 447 (568)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~--------- 447 (568)
+.... .....+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.............
T Consensus 192 ~~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~ 264 (394)
T 4e7w_A 192 LIAGE-------PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSRE 264 (394)
T ss_dssp CCTTC-------CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred ccCCC-------CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 64322 12346789999999988665 59999999999999999999999997655433221100
Q ss_pred -------ccccccCccCC------CCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 448 -------TLAEMLDPAVT------DWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 448 -------~~~~~l~~~~~------~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
.+....-+... .++..++..+.+|+.+||..||.+||++.+++.|.+
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 324 (394)
T 4e7w_A 265 QIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPF 324 (394)
T ss_dssp HHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGG
T ss_pred HHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChh
Confidence 00000000100 122345678999999999999999999999986554
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=334.43 Aligned_cols=250 Identities=24% Similarity=0.393 Sum_probs=202.4
Q ss_pred HHhcccccceeecccCceeEEEEEe--CCccEEEEEeCcCh--hHhHHHHHHHHHHHHcCCCCceeeeccccCCC--ceE
Q 008365 226 EATDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDA--AQGKRQFQQEVEVLSSIRHPNMVLLLGACPDY--GCL 299 (568)
Q Consensus 226 ~~~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~--~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~--~~l 299 (568)
...++|.+.+.||+|+||.||+|.+ +++.||||++.... ......+.+|+.+++.++||||+++++++.+. .++
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence 3567899999999999999999988 57799999986542 23356788999999999999999999998654 489
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCC---ceeEeccccccc
Q 008365 300 VYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRN---YVSKISDVGLAR 376 (568)
Q Consensus 300 V~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~---~~vKL~DFGla~ 376 (568)
||||+++++|.+++.... .+++..+..|+.||+.||.|||+.+ |+||||||+||||+.+ +.+||+|||++.
T Consensus 99 v~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~ 172 (287)
T 2wei_A 99 VGELYTGGELFDEIIKRK---RFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (287)
T ss_dssp EECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGG
T ss_pred EEEccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcce
Confidence 999999999999887654 3889999999999999999999999 9999999999999654 479999999998
Q ss_pred ccCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHH--HHHHHhCccccccC
Q 008365 377 LVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHV--SRAIEKGTLAEMLD 454 (568)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~--~~~~~~~~~~~~l~ 454 (568)
.+.... ......||+.|+|||++.+. ++.++|||||||++|+|++|..||...... ...+..+.....+
T Consensus 173 ~~~~~~-------~~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~- 243 (287)
T 2wei_A 173 CFQQNT-------KMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDL- 243 (287)
T ss_dssp TBCCCS-------SCSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCS-
T ss_pred eecCCC-------ccccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc-
Confidence 654321 12334689999999988764 899999999999999999999999765432 2223333221110
Q ss_pred ccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 455 PAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 455 ~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
+. ...++..+.+|+.+||..+|.+||++.+++.+.+
T Consensus 244 ~~----~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~ 279 (287)
T 2wei_A 244 PQ----WRTISDDAKDLIRKMLTFHPSLRITATQCLEHPW 279 (287)
T ss_dssp GG----GTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHH
T ss_pred hh----hhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHH
Confidence 11 1234567999999999999999999999987654
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=374.26 Aligned_cols=248 Identities=24% Similarity=0.386 Sum_probs=201.5
Q ss_pred HhcccccceeecccCceeEEEEEeC-----CccEEEEEeCcCh-hHhHHHHHHHHHHHHcCCCCceeeeccccCC-CceE
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKLD-----HTPVAIKVLRPDA-AQGKRQFQQEVEVLSSIRHPNMVLLLGACPD-YGCL 299 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~~-----~~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~-~~~l 299 (568)
..++|.+.+.||+|+||.||+|.+. +..||||+++... ....+.+.+|+.+|+.++|||||++++++.+ ..++
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~l 467 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWI 467 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEE
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCceEE
Confidence 4578999999999999999999873 2469999987643 3445678999999999999999999999854 4589
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccC
Q 008365 300 VYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVP 379 (568)
Q Consensus 300 V~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~ 379 (568)
||||+++|+|.+++..... .+++..++.|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+.
T Consensus 468 v~E~~~~g~L~~~l~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~~~~ 542 (656)
T 2j0j_A 468 IMELCTLGELRSFLQVRKF--SLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME 542 (656)
T ss_dssp EEECCTTCBHHHHHHHTTT--TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCCSCC
T ss_pred EEEcCCCCcHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCeecC
Confidence 9999999999999976542 3889999999999999999999999 9999999999999999999999999998764
Q ss_pred CCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh-CCCCCCCchHHH--HHHHhCccccccCcc
Q 008365 380 PSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPMGLTHHVS--RAIEKGTLAEMLDPA 456 (568)
Q Consensus 380 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~--~~~~~~~~~~~l~~~ 456 (568)
... ........||+.|+|||++.+..++.++|||||||++|||++ |..||....... ..+..+.
T Consensus 543 ~~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~-------- 609 (656)
T 2j0j_A 543 DST-----YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE-------- 609 (656)
T ss_dssp C---------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTC--------
T ss_pred CCc-----ceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC--------
Confidence 321 112234567899999999999999999999999999999997 999997544322 2222221
Q ss_pred CCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhH
Q 008365 457 VTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVP 492 (568)
Q Consensus 457 ~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~ 492 (568)
....|..++..+.+|+.+||..+|.+||++.+|+..
T Consensus 610 ~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~ 645 (656)
T 2j0j_A 610 RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 645 (656)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 122355667789999999999999999999998743
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-41 Score=342.32 Aligned_cols=243 Identities=25% Similarity=0.391 Sum_probs=194.6
Q ss_pred HHHHhcccccceeecccCceeEEEEEe--CCccEEEEEeCcChhH------hHHHHHHHHHHHHcC----CCCceeeecc
Q 008365 224 IEEATDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQ------GKRQFQQEVEVLSSI----RHPNMVLLLG 291 (568)
Q Consensus 224 i~~~~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~------~~~~~~~Ev~iL~~l----~HpnIv~l~g 291 (568)
.+...++|.+.+.||+|+||.||+|.+ ++..||||++...... ....+.+|+.++..+ +||||+++++
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~ 105 (312)
T 2iwi_A 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD 105 (312)
T ss_dssp -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence 445678899999999999999999987 5678999999765321 223356799999988 8999999999
Q ss_pred ccCC--CceEEEEe-cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeecc-CCcee
Q 008365 292 ACPD--YGCLVYEY-MHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLD-RNYVS 367 (568)
Q Consensus 292 ~~~~--~~~lV~E~-~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld-~~~~v 367 (568)
+|.+ ..++|||| +.+++|.+++...+ .+++..+..|+.||+.||.|||+.+ |+||||||+||||+ .++.+
T Consensus 106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~ 179 (312)
T 2iwi_A 106 WFETQEGFMLVLERPLPAQDLFDYITEKG---PLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCA 179 (312)
T ss_dssp EC-----CEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEE
T ss_pred EEecCCeEEEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeE
Confidence 9854 45899999 78999999998754 3899999999999999999999999 99999999999999 88999
Q ss_pred EecccccccccCCCCCccccccccccccccccCCChhhhhcCCCC-CcceehhHHHHHHHHHhCCCCCCCchHHHHHHHh
Q 008365 368 KISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLT-TKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEK 446 (568)
Q Consensus 368 KL~DFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s-~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~ 446 (568)
||+|||+++.+.... .....||+.|+|||++.+..+. .++|||||||++|+|++|+.||.....+. .
T Consensus 180 kl~dfg~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----~ 247 (312)
T 2iwi_A 180 KLIDFGSGALLHDEP--------YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEIL----E 247 (312)
T ss_dssp EECCCSSCEECCSSC--------BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHH----H
T ss_pred EEEEcchhhhcccCc--------ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHHHh----h
Confidence 999999998764321 2345799999999998877764 58999999999999999999997544321 1
Q ss_pred CccccccCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHH
Q 008365 447 GTLAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPE 493 (568)
Q Consensus 447 ~~~~~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~ 493 (568)
.. ..++..++..+.+|+.+||+.+|.+||++.+++.+.
T Consensus 248 ~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~ 285 (312)
T 2iwi_A 248 AE---------LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDP 285 (312)
T ss_dssp TC---------CCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHST
T ss_pred hc---------cCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 11 123445567799999999999999999999998543
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=355.23 Aligned_cols=259 Identities=22% Similarity=0.332 Sum_probs=181.2
Q ss_pred Hhccccc-ceeecccCceeEEEEEeC----CccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCceeeeccccC----CCc
Q 008365 227 ATDKFSE-AMKIGEGGYGPVYRGKLD----HTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACP----DYG 297 (568)
Q Consensus 227 ~~~~y~~-~~~IG~G~fg~Vy~~~~~----~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~----~~~ 297 (568)
..+.|.+ .++||+|+||.||+|.+. +..||||++...... ..+.+|+.+|+.++|||||+++++|. ...
T Consensus 18 ~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 95 (405)
T 3rgf_A 18 VEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS--MSACREIALLRELKHPNVISLQKVFLSHADRKV 95 (405)
T ss_dssp HHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC--HHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEE
T ss_pred hhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC--HHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeE
Confidence 3455776 458999999999999853 578999999765332 46789999999999999999999982 234
Q ss_pred eEEEEecCCCCHHHHHhhcC------CCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeec----cCCcee
Q 008365 298 CLVYEYMHNGSLEDRLLRRG------NTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILL----DRNYVS 367 (568)
Q Consensus 298 ~lV~E~~~ggsL~~~l~~~~------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILl----d~~~~v 367 (568)
+|||||+. |+|.+++.... ....+++..+..|+.||+.||.|||+.+ |+||||||+|||| +.++.+
T Consensus 96 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~ 171 (405)
T 3rgf_A 96 WLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRV 171 (405)
T ss_dssp EEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCE
T ss_pred EEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcE
Confidence 89999995 68888775321 1123889999999999999999999999 9999999999999 678999
Q ss_pred EecccccccccCCCCCccccccccccccccccCCChhhhhcC-CCCCcceehhHHHHHHHHHhCCCCCCCchH-------
Q 008365 368 KISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTG-MLTTKSDIYSFGIMLLQIITARSPMGLTHH------- 439 (568)
Q Consensus 368 KL~DFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDvwSlGvil~elltG~~Pf~~~~~------- 439 (568)
||+|||+++.+..... ........+||+.|+|||++.+. .++.++|||||||++|+|++|++||.....
T Consensus 172 kl~Dfg~a~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~ 248 (405)
T 3rgf_A 172 KIADMGFARLFNSPLK---PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNP 248 (405)
T ss_dssp EECCTTCCC-------------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CC
T ss_pred EEEECCCceecCCCCc---ccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcccccccccc
Confidence 9999999987643211 11223456899999999988874 599999999999999999999999954321
Q ss_pred -----HHHHHHh-Cccccc-----------------cC-ccCCCC---------ChHHHHHHHHHHHHhhccCCCCCCCh
Q 008365 440 -----VSRAIEK-GTLAEM-----------------LD-PAVTDW---------PAEAAESFSKLAIQCAELRKKDRPDL 486 (568)
Q Consensus 440 -----~~~~~~~-~~~~~~-----------------l~-~~~~~~---------p~~~~~~l~~li~~Cl~~dP~~RPs~ 486 (568)
+...+.. +..... +. .....+ ....+..+.+||.+||..||.+||++
T Consensus 249 ~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta 328 (405)
T 3rgf_A 249 YHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITS 328 (405)
T ss_dssp CCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCH
T ss_pred chHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCH
Confidence 1111110 000000 00 000000 00114568899999999999999999
Q ss_pred HHhHhHHH
Q 008365 487 GTVIVPEL 494 (568)
Q Consensus 487 ~~vl~~~l 494 (568)
.+++.|.+
T Consensus 329 ~e~L~hp~ 336 (405)
T 3rgf_A 329 EQAMQDPY 336 (405)
T ss_dssp HHHHTSGG
T ss_pred HHHhcChh
Confidence 99987655
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=341.82 Aligned_cols=253 Identities=21% Similarity=0.302 Sum_probs=197.8
Q ss_pred HhcccccceeecccCceeEEEEEeC--C-ccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCc------eeeeccccC--C
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKLD--H-TPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPN------MVLLLGACP--D 295 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~~--~-~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~Hpn------Iv~l~g~~~--~ 295 (568)
..++|.+.+.||+|+||.||+|.+. + ..||||+++... .....+.+|+.+++.++|++ ++.+++++. .
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 95 (355)
T 2eu9_A 17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG-KYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHG 95 (355)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETT
T ss_pred ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc-cchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCC
Confidence 4578999999999999999999873 3 689999997653 33567889999999987665 888888774 3
Q ss_pred CceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeec--------------
Q 008365 296 YGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILL-------------- 361 (568)
Q Consensus 296 ~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILl-------------- 361 (568)
..++||||+ +++|.+++...... .+++..+..|+.||+.||.|||+.+ |+||||||+||||
T Consensus 96 ~~~lv~e~~-~~~l~~~l~~~~~~-~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~ 170 (355)
T 2eu9_A 96 HMCIAFELL-GKNTFEFLKENNFQ-PYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKS 170 (355)
T ss_dssp EEEEEEECC-CCBHHHHHHHTTTC-CCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-C
T ss_pred eEEEEEecc-CCChHHHHHhccCC-CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeccccccccccccc
Confidence 458999999 77787777665432 4899999999999999999999999 9999999999999
Q ss_pred -----cCCceeEecccccccccCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCC
Q 008365 362 -----DRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGL 436 (568)
Q Consensus 362 -----d~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~ 436 (568)
+.++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|+|++|..||..
T Consensus 171 ~~~~~~~~~~~kl~Dfg~~~~~~~~---------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 241 (355)
T 2eu9_A 171 CEEKSVKNTSIRVADFGSATFDHEH---------HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQT 241 (355)
T ss_dssp CCEEEESCCCEEECCCTTCEETTSC---------CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred ccccccCCCcEEEeecCcccccccc---------ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCC
Confidence 56789999999999764322 2345799999999999999999999999999999999999999976
Q ss_pred chHHHHHH--Hh--Ccccc----------cc-C----------------------ccCCCCChHHHHHHHHHHHHhhccC
Q 008365 437 THHVSRAI--EK--GTLAE----------ML-D----------------------PAVTDWPAEAAESFSKLAIQCAELR 479 (568)
Q Consensus 437 ~~~~~~~~--~~--~~~~~----------~l-~----------------------~~~~~~p~~~~~~l~~li~~Cl~~d 479 (568)
........ .. +.... .+ . ..........+..+.+|+.+||+.|
T Consensus 242 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d 321 (355)
T 2eu9_A 242 HENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFD 321 (355)
T ss_dssp SSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSS
T ss_pred CCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCC
Confidence 54322111 00 00000 00 0 0000112345678999999999999
Q ss_pred CCCCCChHHhHhHHH
Q 008365 480 KKDRPDLGTVIVPEL 494 (568)
Q Consensus 480 P~~RPs~~~vl~~~l 494 (568)
|.+||++.+++.|.+
T Consensus 322 P~~Rpt~~e~l~hp~ 336 (355)
T 2eu9_A 322 PAQRITLAEALLHPF 336 (355)
T ss_dssp TTTSCCHHHHTTSGG
T ss_pred hhhCcCHHHHhcChh
Confidence 999999999986544
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=340.00 Aligned_cols=255 Identities=26% Similarity=0.355 Sum_probs=177.9
Q ss_pred hcccccceeecccCceeEEEEEeC--CccEEEEEeCcCh-hHhHHHHHHHHH-HHHcCCCCceeeeccccCCC--ceEEE
Q 008365 228 TDKFSEAMKIGEGGYGPVYRGKLD--HTPVAIKVLRPDA-AQGKRQFQQEVE-VLSSIRHPNMVLLLGACPDY--GCLVY 301 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~~~~~--~~~vAvK~l~~~~-~~~~~~~~~Ev~-iL~~l~HpnIv~l~g~~~~~--~~lV~ 301 (568)
.++|.+.+.||+|+||.||+|.+. ++.||||++.... ......+..|+. +++.++||||+++++++.+. .++||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 367999999999999999999984 7899999997643 233345556665 77888999999999988544 48999
Q ss_pred EecCCCCHHHHHhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHHc-CCCCcccCCCCCCCeeccCCceeEeccccccccc
Q 008365 302 EYMHNGSLEDRLLRR--GNTPVIPWRKRFKIAAEIATALLFLHQA-KPEPLVHRDLKPANILLDRNYVSKISDVGLARLV 378 (568)
Q Consensus 302 E~~~ggsL~~~l~~~--~~~~~l~~~~~~~i~~qia~aL~yLH~~-~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~ 378 (568)
||++ |+|.+++... .....+++..+..|+.|++.||.|||+. + |+||||||+||||+.++.+||+|||+++.+
T Consensus 101 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 101 ELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQL 176 (327)
T ss_dssp CCCS-EEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred eecC-CChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence 9996 5888777631 1123489999999999999999999998 8 999999999999999999999999999765
Q ss_pred CCCCCccccccccccccccccCCChhhh----hcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHhCccccccC
Q 008365 379 PPSVADSVTQYHMTSAAGTFCYIDPEYQ----QTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLD 454 (568)
Q Consensus 379 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~----~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~l~ 454 (568)
.... ......||+.|+|||++ .+..++.++|||||||++|+|++|..||.........+.. ......
T Consensus 177 ~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~--~~~~~~ 247 (327)
T 3aln_A 177 VDSI-------AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQ--VVKGDP 247 (327)
T ss_dssp ------------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CC--CCCSCC
T ss_pred cccc-------ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHH--HhcCCC
Confidence 3321 12334799999999988 5667899999999999999999999999754432222111 000001
Q ss_pred ccCC-CCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHHH
Q 008365 455 PAVT-DWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPELN 495 (568)
Q Consensus 455 ~~~~-~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l~ 495 (568)
+.+. .....++..+.+|+..||+.+|.+||++.+++.+.+-
T Consensus 248 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~ 289 (327)
T 3aln_A 248 PQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFI 289 (327)
T ss_dssp CCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHH
T ss_pred CCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHH
Confidence 1111 1123456789999999999999999999999976653
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=347.56 Aligned_cols=257 Identities=25% Similarity=0.302 Sum_probs=198.6
Q ss_pred HHHHHhcccccceeecccCceeEEEEEe--CCccEEEEEeCcChhHhHHHHHHHHHHHHcCC-CC-----ceeeeccccC
Q 008365 223 EIEEATDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIR-HP-----NMVLLLGACP 294 (568)
Q Consensus 223 ei~~~~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~-Hp-----nIv~l~g~~~ 294 (568)
....+.++|.+.+.||+|+||.||+|.+ +++.||||+++... .....+..|+.++..++ |+ +|+.++++|.
T Consensus 48 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~ 126 (382)
T 2vx3_A 48 NGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK-AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFM 126 (382)
T ss_dssp TTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEE
T ss_pred cCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH-HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeec
Confidence 3344678999999999999999999987 46789999997553 33456788999988875 55 4888888874
Q ss_pred --CCceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHH--cCCCCcccCCCCCCCeecc--CCceeE
Q 008365 295 --DYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQ--AKPEPLVHRDLKPANILLD--RNYVSK 368 (568)
Q Consensus 295 --~~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~--~~~~~IiHrDIKp~NILld--~~~~vK 368 (568)
+..||||||+. |+|.+++...... .+++..+..|+.||+.||.|||. .+ ||||||||+||||+ .++.+|
T Consensus 127 ~~~~~~lv~e~~~-~~L~~~l~~~~~~-~~~~~~~~~i~~qi~~al~~lH~~~~~---ivHrDlkp~NIll~~~~~~~~k 201 (382)
T 2vx3_A 127 FRNHLCLVFEMLS-YNLYDLLRNTNFR-GVSLNLTRKFAQQMCTALLFLATPELS---IIHCDLKPENILLCNPKRSAIK 201 (382)
T ss_dssp ETTEEEEEEECCC-CBHHHHHHHTTTS-CCCHHHHHHHHHHHHHHHHHHTSTTTC---EECCCCSGGGEEESSTTSCCEE
T ss_pred cCCceEEEEecCC-CCHHHHHhhcCcC-CCCHHHHHHHHHHHHHHHHHhccCCCC---EEcCCCCcccEEEecCCCCcEE
Confidence 44589999995 6999998875432 38999999999999999999994 56 99999999999994 578899
Q ss_pred ecccccccccCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHH--HHh
Q 008365 369 ISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRA--IEK 446 (568)
Q Consensus 369 L~DFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~--~~~ 446 (568)
|+|||+++..... ....+||+.|+|||++.+..++.++|||||||++|+|++|+.||......... +..
T Consensus 202 L~DFG~a~~~~~~---------~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~ 272 (382)
T 2vx3_A 202 IVDFGSSCQLGQR---------IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVE 272 (382)
T ss_dssp ECCCTTCEETTCC---------CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred EEeccCceecccc---------cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 9999999876432 23467999999999999999999999999999999999999999765443221 110
Q ss_pred --Cc---------------cccccCcc--------------------------------------CCCCChHHHHHHHHH
Q 008365 447 --GT---------------LAEMLDPA--------------------------------------VTDWPAEAAESFSKL 471 (568)
Q Consensus 447 --~~---------------~~~~l~~~--------------------------------------~~~~p~~~~~~l~~l 471 (568)
+. +....+.. ...........+.+|
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dl 352 (382)
T 2vx3_A 273 VLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDL 352 (382)
T ss_dssp HHCSCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHH
T ss_pred HhCCCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHH
Confidence 00 00000000 000112334579999
Q ss_pred HHHhhccCCCCCCChHHhHhHHH
Q 008365 472 AIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 472 i~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
|.+||+.||.+||++.+++.|.+
T Consensus 353 i~~mL~~dP~~Rpta~e~L~hp~ 375 (382)
T 2vx3_A 353 ILRMLDYDPKTRIQPYYALQHSF 375 (382)
T ss_dssp HHHHTCSCTTTSCCHHHHTTSGG
T ss_pred HHHhcCCChhhCCCHHHHhcCcc
Confidence 99999999999999999986543
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=337.03 Aligned_cols=252 Identities=22% Similarity=0.326 Sum_probs=194.9
Q ss_pred HhcccccceeecccCceeEEEEEe-CCccEEEEEeCcC--hhHhHHHHHHHHHHHHcCC--CCceeeeccccCCC--ceE
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKL-DHTPVAIKVLRPD--AAQGKRQFQQEVEVLSSIR--HPNMVLLLGACPDY--GCL 299 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~-~~~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l~--HpnIv~l~g~~~~~--~~l 299 (568)
..++|.+.+.||+|+||.||++.+ +++.||||++... .......+.+|+.++..++ ||||+++++++.+. .++
T Consensus 26 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 105 (313)
T 3cek_A 26 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 105 (313)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEE
T ss_pred ccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEE
Confidence 457899999999999999999987 5678999998654 3344567899999999997 59999999988554 489
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccC
Q 008365 300 VYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVP 379 (568)
Q Consensus 300 V~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~ 379 (568)
||| +.+++|.+++.... .+++..+..|+.||+.||.|||+.+ |+||||||+||||++ +.+||+|||+++.+.
T Consensus 106 v~e-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~ 177 (313)
T 3cek_A 106 VME-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDFGIANQMQ 177 (313)
T ss_dssp EEC-CCSEEHHHHHHHCS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCCSSSCC--
T ss_pred EEe-cCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeecccccccc
Confidence 999 55899999998754 3788999999999999999999999 999999999999964 899999999998664
Q ss_pred CCCCccccccccccccccccCCChhhhhc-----------CCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHhCc
Q 008365 380 PSVADSVTQYHMTSAAGTFCYIDPEYQQT-----------GMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGT 448 (568)
Q Consensus 380 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-----------~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~ 448 (568)
.... ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.........+.
T Consensus 178 ~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~--- 250 (313)
T 3cek_A 178 PDTT----SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLH--- 250 (313)
T ss_dssp ----------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHH---
T ss_pred Cccc----cccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHH---
Confidence 3221 112234579999999998875 4688999999999999999999999965322111111
Q ss_pred cccccCccC-CCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHHH
Q 008365 449 LAEMLDPAV-TDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPELN 495 (568)
Q Consensus 449 ~~~~l~~~~-~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l~ 495 (568)
..+++.. ..++...+..+.+|+.+||+.+|.+||++.+++.+.+-
T Consensus 251 --~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~ 296 (313)
T 3cek_A 251 --AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 296 (313)
T ss_dssp --HHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred --HHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccc
Confidence 1111111 12334445779999999999999999999999977663
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=345.53 Aligned_cols=251 Identities=21% Similarity=0.290 Sum_probs=174.6
Q ss_pred Hhcccccce-eecccCceeEEEEEeC--CccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCceeeeccccCC------Cc
Q 008365 227 ATDKFSEAM-KIGEGGYGPVYRGKLD--HTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACPD------YG 297 (568)
Q Consensus 227 ~~~~y~~~~-~IG~G~fg~Vy~~~~~--~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~------~~ 297 (568)
..++|.+.+ .||+|+||.||+|.+. ++.||||++...... .......++.+.||||++++++|.. ..
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 101 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKA----RQEVDHHWQASGGPHIVCILDVYENMHHGKRCL 101 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHHH----HHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHHH----HHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence 567899965 6999999999999884 789999999754321 2223344667899999999998843 24
Q ss_pred eEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccC---CceeEeccccc
Q 008365 298 CLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDR---NYVSKISDVGL 374 (568)
Q Consensus 298 ~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~---~~~vKL~DFGl 374 (568)
++|||||+||+|.+++...+. ..+++..++.|+.||+.||.|||+.+ |+||||||+||||+. ++.+||+|||+
T Consensus 102 ~lv~e~~~gg~L~~~l~~~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~ 177 (336)
T 3fhr_A 102 LIIMECMEGGELFSRIQERGD-QAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGF 177 (336)
T ss_dssp EEEEECCTTEEHHHHHHTC-C-CCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEeccCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEecccc
Confidence 899999999999999987643 34899999999999999999999999 999999999999975 55699999999
Q ss_pred ccccCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHH--HHHhCccccc
Q 008365 375 ARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSR--AIEKGTLAEM 452 (568)
Q Consensus 375 a~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~--~~~~~~~~~~ 452 (568)
++..... ......||+.|+|||++.+..++.++|||||||++|+|++|..||........ ..........
T Consensus 178 ~~~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 249 (336)
T 3fhr_A 178 AKETTQN--------ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQ 249 (336)
T ss_dssp CEEC------------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC--------------------
T ss_pred ceecccc--------ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccc
Confidence 9765322 12345789999999999888899999999999999999999999954332111 0000000000
Q ss_pred cCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 453 LDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 453 l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
... .......++..+.+|+..||+.+|.+||++.+++.+.+
T Consensus 250 ~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 290 (336)
T 3fhr_A 250 YGF-PNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPW 290 (336)
T ss_dssp -CC-CTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHH
T ss_pred ccc-CchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcc
Confidence 000 00111345677999999999999999999999997766
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=342.10 Aligned_cols=249 Identities=22% Similarity=0.404 Sum_probs=192.5
Q ss_pred HhcccccceeecccCceeEEEEEeCCccEEEEEeCcChh--HhHHHHHHHHHHHHcCCCCceeeeccccCCC--ceEEEE
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKLDHTPVAIKVLRPDAA--QGKRQFQQEVEVLSSIRHPNMVLLLGACPDY--GCLVYE 302 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~~~~~vAvK~l~~~~~--~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~--~~lV~E 302 (568)
..++|.+.+.||+|+||.||+|.+.+ .||||+++.... ...+.+.+|+.+++.++||||+++++++.+. .++|||
T Consensus 31 ~~~~~~~~~~lg~G~~g~V~~~~~~~-~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e 109 (319)
T 2y4i_B 31 PFEQLEIGELIGKGRFGQVYHGRWHG-EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITS 109 (319)
T ss_dssp CCSCEECCCBCCCSSSSEEEEEEESS-SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECB
T ss_pred CHHHeEEeeEeccCCceEEEEEEEcC-eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEee
Confidence 45789999999999999999999865 599999875422 2234577899999999999999999998554 489999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCC
Q 008365 303 YMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSV 382 (568)
Q Consensus 303 ~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~ 382 (568)
|+++++|.+++...+ ..+++..++.|+.||+.||.|||+.+ |+||||||+||||+ ++.+||+|||+++......
T Consensus 110 ~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~ 183 (319)
T 2y4i_B 110 LCKGRTLYSVVRDAK--IVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQ 183 (319)
T ss_dssp CCCSEEHHHHTTSSC--CCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC------
T ss_pred cccCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCcccccccc
Confidence 999999999987643 24889999999999999999999999 99999999999998 6799999999987653221
Q ss_pred CccccccccccccccccCCChhhhhc---------CCCCCcceehhHHHHHHHHHhCCCCCCCchHHH--HHHHhCcccc
Q 008365 383 ADSVTQYHMTSAAGTFCYIDPEYQQT---------GMLTTKSDIYSFGIMLLQIITARSPMGLTHHVS--RAIEKGTLAE 451 (568)
Q Consensus 383 ~~~~~~~~~~~~~GT~~Y~APE~~~~---------~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~--~~~~~~~~~~ 451 (568)
.. ..........||+.|+|||++.+ ..++.++|||||||++|+|++|..||....... ..+..+..
T Consensus 184 ~~-~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~-- 260 (319)
T 2y4i_B 184 AG-RREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMK-- 260 (319)
T ss_dssp -----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCC--
T ss_pred cc-ccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCC--
Confidence 11 11122234569999999998864 457899999999999999999999997554322 22222211
Q ss_pred ccCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhH
Q 008365 452 MLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVI 490 (568)
Q Consensus 452 ~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl 490 (568)
+... +..++..+.+|+..||..+|.+||++.+++
T Consensus 261 ---~~~~--~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~ 294 (319)
T 2y4i_B 261 ---PNLS--QIGMGKEISDILLFCWAFEQEERPTFTKLM 294 (319)
T ss_dssp ---CCCC--CSSCCTTHHHHHHHHHCSSTTTSCCHHHHH
T ss_pred ---CCCC--cCCCCHHHHHHHHHHhcCChhhCcCHHHHH
Confidence 1111 113445689999999999999999999987
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=343.80 Aligned_cols=243 Identities=24% Similarity=0.367 Sum_probs=198.4
Q ss_pred HHHHhcccccceeecccCceeEEEEEe--CCccEEEEEeCcChhH------hHHHHHHHHHHHHcCC--CCceeeecccc
Q 008365 224 IEEATDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQ------GKRQFQQEVEVLSSIR--HPNMVLLLGAC 293 (568)
Q Consensus 224 i~~~~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~------~~~~~~~Ev~iL~~l~--HpnIv~l~g~~ 293 (568)
.....++|.+.+.||+|+||.||+|.+ +++.||||++...... ....+.+|+.+++.++ ||||+++++++
T Consensus 38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~ 117 (320)
T 3a99_A 38 KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF 117 (320)
T ss_dssp --CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE
T ss_pred cCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEE
Confidence 344667899999999999999999987 6779999998654321 1234678999999996 59999999998
Q ss_pred CCC--ceEEEEecCC-CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeecc-CCceeEe
Q 008365 294 PDY--GCLVYEYMHN-GSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLD-RNYVSKI 369 (568)
Q Consensus 294 ~~~--~~lV~E~~~g-gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld-~~~~vKL 369 (568)
.+. .++||||+.+ ++|.+++...+ .+++..+..|+.||+.||.|||+.+ |+||||||+||||+ .++.+||
T Consensus 118 ~~~~~~~lv~e~~~~~~~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL 191 (320)
T 3a99_A 118 ERPDSFVLILERPEPVQDLFDFITERG---ALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKL 191 (320)
T ss_dssp ECSSEEEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEE
T ss_pred ecCCcEEEEEEcCCCCccHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEE
Confidence 654 4899999976 89999998754 3889999999999999999999999 99999999999999 7899999
Q ss_pred cccccccccCCCCCccccccccccccccccCCChhhhhcCCC-CCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHhCc
Q 008365 370 SDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGML-TTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGT 448 (568)
Q Consensus 370 ~DFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~-s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~ 448 (568)
+|||+++.+... ......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.....+. .+.
T Consensus 192 ~Dfg~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~----~~~ 259 (320)
T 3a99_A 192 IDFGSGALLKDT--------VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII----RGQ 259 (320)
T ss_dssp CCCTTCEECCSS--------CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHH----HCC
T ss_pred eeCccccccccc--------cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhhhh----ccc
Confidence 999999876432 1234579999999999887765 688999999999999999999997544321 111
Q ss_pred cccccCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHH
Q 008365 449 LAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPE 493 (568)
Q Consensus 449 ~~~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~ 493 (568)
. .++..++..+.+|+.+||+.+|.+||++.+++.+.
T Consensus 260 ~---------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp 295 (320)
T 3a99_A 260 V---------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHP 295 (320)
T ss_dssp C---------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred c---------cccccCCHHHHHHHHHHccCChhhCcCHHHHhcCH
Confidence 1 12334556799999999999999999999998544
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=330.14 Aligned_cols=248 Identities=23% Similarity=0.350 Sum_probs=179.9
Q ss_pred hcccccceeecccCceeEEEEEe--CCccEEEEEeCcChh--HhHHHHHHHHHHHHcCCCCceeeeccccCCC--ceEEE
Q 008365 228 TDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAA--QGKRQFQQEVEVLSSIRHPNMVLLLGACPDY--GCLVY 301 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~--~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~--~~lV~ 301 (568)
.++|.+.+.||+|+||.||+|.+ +++.||||++..... .....+..+..+++.++||||+++++++.+. .++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 46899999999999999999998 578999999976432 2233455566678889999999999998554 48999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHc-CCCCcccCCCCCCCeeccCCceeEecccccccccCC
Q 008365 302 EYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQA-KPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPP 380 (568)
Q Consensus 302 E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~-~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~ 380 (568)
||+ ++.+..++..... .+++..+..|+.||+.||.|||+. + |+||||||+||||+.++.+||+|||++..+..
T Consensus 104 e~~-~~~~~~l~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 177 (318)
T 2dyl_A 104 ELM-GTCAEKLKKRMQG--PIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLVD 177 (318)
T ss_dssp CCC-SEEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred ecc-CCcHHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence 999 6666665554332 388999999999999999999995 8 99999999999999999999999999976533
Q ss_pred CCCccccccccccccccccCCChhhhh-----cCCCCCcceehhHHHHHHHHHhCCCCCCCchHHH---HHHHhCccccc
Q 008365 381 SVADSVTQYHMTSAAGTFCYIDPEYQQ-----TGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVS---RAIEKGTLAEM 452 (568)
Q Consensus 381 ~~~~~~~~~~~~~~~GT~~Y~APE~~~-----~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~---~~~~~~~~~~~ 452 (568)
.. ......||+.|+|||++. ...++.++|||||||++|+|++|+.||....... ..+..+.
T Consensus 178 ~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~---- 246 (318)
T 2dyl_A 178 DK-------AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEE---- 246 (318)
T ss_dssp ----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSC----
T ss_pred Cc-------cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccC----
Confidence 21 123457999999999984 5668999999999999999999999996532211 1111111
Q ss_pred cCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 453 LDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 453 l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
.+... ....++..+.+|+.+||+.+|.+||++.+++.+.+
T Consensus 247 -~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~ 286 (318)
T 2dyl_A 247 -PPLLP-GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSF 286 (318)
T ss_dssp -CCCCC-SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHH
T ss_pred -CCCCC-ccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHH
Confidence 11111 11234567999999999999999999999998665
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-40 Score=351.81 Aligned_cols=256 Identities=23% Similarity=0.313 Sum_probs=188.3
Q ss_pred hcccccceeecccCceeEEE-EEeCCccEEEEEeCcChhHhHHHHHHHHHHHHcC-CCCceeeeccccCCC--ceEEEEe
Q 008365 228 TDKFSEAMKIGEGGYGPVYR-GKLDHTPVAIKVLRPDAAQGKRQFQQEVEVLSSI-RHPNMVLLLGACPDY--GCLVYEY 303 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~-~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l-~HpnIv~l~g~~~~~--~~lV~E~ 303 (568)
.+.|.+.+.||+|+||+||. +..+++.||||++.... ...+.+|+.+|..+ +|||||++++++.+. .+|||||
T Consensus 14 ~~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~ 90 (434)
T 2rio_A 14 KNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALEL 90 (434)
T ss_dssp SSCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG---HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEec
Confidence 34566778999999999964 45588999999986543 34578899999876 899999999998654 4899999
Q ss_pred cCCCCHHHHHhhcCCCCC----CCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCC-------------ce
Q 008365 304 MHNGSLEDRLLRRGNTPV----IPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRN-------------YV 366 (568)
Q Consensus 304 ~~ggsL~~~l~~~~~~~~----l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~-------------~~ 366 (568)
|. |+|.+++........ .++..++.|+.||+.||.|||+.+ |+||||||+||||+.+ +.
T Consensus 91 ~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~ 166 (434)
T 2rio_A 91 CN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLR 166 (434)
T ss_dssp CS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCE
T ss_pred CC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceE
Confidence 95 799999976543211 123345779999999999999999 9999999999999754 48
Q ss_pred eEecccccccccCCCCCccccccccccccccccCCChhhhhc-------CCCCCcceehhHHHHHHHHHh-CCCCCCCch
Q 008365 367 SKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQT-------GMLTTKSDIYSFGIMLLQIIT-ARSPMGLTH 438 (568)
Q Consensus 367 vKL~DFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-------~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~ 438 (568)
+||+|||+++.+...... ........+||+.|+|||++.+ ..++.++|||||||++|||++ |..||....
T Consensus 167 ~kL~DFG~a~~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~ 244 (434)
T 2rio_A 167 ILISDFGLCKKLDSGQSS--FRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKY 244 (434)
T ss_dssp EEECCCTTCEECCC----------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTT
T ss_pred EEEcccccceecCCCCcc--ceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCch
Confidence 999999999876543211 1112235689999999999876 678999999999999999999 999997544
Q ss_pred HHHHHHHhCccccccCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 439 HVSRAIEKGTLAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 439 ~~~~~~~~~~~~~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
.....+..+... +.......+..++..+.+|+.+||+.+|.+||++.+|+.|.+
T Consensus 245 ~~~~~i~~~~~~--~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~ 298 (434)
T 2rio_A 245 SRESNIIRGIFS--LDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPL 298 (434)
T ss_dssp THHHHHHHTCCC--CCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred hhHHHHhcCCCC--cccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCc
Confidence 333333332211 111111124567889999999999999999999999987543
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=350.11 Aligned_cols=251 Identities=24% Similarity=0.333 Sum_probs=188.2
Q ss_pred hcccccceeecccCcee-EEEEEeCCccEEEEEeCcChhHhHHHHHHHHHHHHcC-CCCceeeeccccCCC--ceEEEEe
Q 008365 228 TDKFSEAMKIGEGGYGP-VYRGKLDHTPVAIKVLRPDAAQGKRQFQQEVEVLSSI-RHPNMVLLLGACPDY--GCLVYEY 303 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~-Vy~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l-~HpnIv~l~g~~~~~--~~lV~E~ 303 (568)
..+|.+.+.||+|+||+ ||++..+++.||||++...... .+.+|+.+|+.+ +|||||++++++.+. .+|||||
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~ 99 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL 99 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence 35699999999999998 5566778999999999754322 356899999999 799999999998554 4899999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccC-----CceeEeccccccccc
Q 008365 304 MHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDR-----NYVSKISDVGLARLV 378 (568)
Q Consensus 304 ~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~-----~~~vKL~DFGla~~~ 378 (568)
|. |+|.+++...... +....+..|+.||+.||.|||+.+ |+||||||+||||+. ...+||+|||+++.+
T Consensus 100 ~~-g~L~~~l~~~~~~--~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~ 173 (432)
T 3p23_A 100 CA-ATLQEYVEQKDFA--HLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL 173 (432)
T ss_dssp CS-EEHHHHHHSSSCC--CCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC
T ss_pred CC-CCHHHHHHhcCCC--ccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceeec
Confidence 95 6999998765432 444556789999999999999999 999999999999943 235789999999876
Q ss_pred CCCCCccccccccccccccccCCChhhhh---cCCCCCcceehhHHHHHHHHHh-CCCCCCCchHHHHHHHhCccccccC
Q 008365 379 PPSVADSVTQYHMTSAAGTFCYIDPEYQQ---TGMLTTKSDIYSFGIMLLQIIT-ARSPMGLTHHVSRAIEKGTLAEMLD 454 (568)
Q Consensus 379 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~---~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~l~ 454 (568)
..... ........+||+.|+|||++. ...++.++|||||||++|+|++ |..||.........+..+.. .
T Consensus 174 ~~~~~---~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~----~ 246 (432)
T 3p23_A 174 AVGRH---SFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGAC----S 246 (432)
T ss_dssp ---------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCC----C
T ss_pred cCCCc---ceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccC----C
Confidence 43211 112234568999999999987 4567889999999999999999 99999654332222221111 1
Q ss_pred ccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 455 PAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 455 ~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
......+...+..+.+|+.+||+.||.+||++.+|+.|.+
T Consensus 247 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~ 286 (432)
T 3p23_A 247 LDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPF 286 (432)
T ss_dssp CTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTT
T ss_pred ccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCcc
Confidence 1111223456677899999999999999999999986543
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=346.77 Aligned_cols=241 Identities=17% Similarity=0.141 Sum_probs=182.6
Q ss_pred cccccceeecccCceeEEEEEeC--CccEEEEEeCcChh---HhHHHHHHHHHHHHcCCC-Ccee---------------
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKLD--HTPVAIKVLRPDAA---QGKRQFQQEVEVLSSIRH-PNMV--------------- 287 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~~--~~~vAvK~l~~~~~---~~~~~~~~Ev~iL~~l~H-pnIv--------------- 287 (568)
..|...+.||+|+||.||+|.+. ++.||||++..... ...+.|.+|+.+++.+.| +|+.
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 45888899999999999999974 88999999974322 224678999999999987 2211
Q ss_pred ee------ccccCC-------CceEEEEecCCCCHHHHHhhc----CCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcc
Q 008365 288 LL------LGACPD-------YGCLVYEYMHNGSLEDRLLRR----GNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLV 350 (568)
Q Consensus 288 ~l------~g~~~~-------~~~lV~E~~~ggsL~~~l~~~----~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~Ii 350 (568)
.+ +.++.. ..+++|+++ +++|.+++... .....+++..++.|+.||+.||.|||+.+ ||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ii 233 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LV 233 (413)
T ss_dssp ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cc
Confidence 11 111111 225677765 79999988522 12234788899999999999999999999 99
Q ss_pred cCCCCCCCeeccCCceeEecccccccccCCCCCccccccccccccccccCCChhhh----------hcCCCCCcceehhH
Q 008365 351 HRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQ----------QTGMLTTKSDIYSF 420 (568)
Q Consensus 351 HrDIKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~----------~~~~~s~ksDvwSl 420 (568)
||||||+||||+.++.+||+|||+++..... ....+| +.|+|||++ .+..++.++|||||
T Consensus 234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~---------~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSl 303 (413)
T 3dzo_A 234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS---------AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTL 303 (413)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTEE---------ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHH
T ss_pred cCCcccceEEEecCCeEEEEeccceeecCCc---------cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHH
Confidence 9999999999999999999999999764321 345678 999999988 45558889999999
Q ss_pred HHHHHHHHhCCCCCCCchHHHHHHHhCccccccCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 421 GIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 421 Gvil~elltG~~Pf~~~~~~~~~~~~~~~~~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
||++|+|++|+.||...... ......+ .. ...++..+.+|+..||+.+|.+||++.+++.+.+
T Consensus 304 Gvil~elltg~~Pf~~~~~~------~~~~~~~----~~-~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~ 366 (413)
T 3dzo_A 304 GLAIYWIWCADLPNTDDAAL------GGSEWIF----RS-CKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPE 366 (413)
T ss_dssp HHHHHHHHHSSCCCCTTGGG------SCSGGGG----SS-CCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHH
T ss_pred HHHHHHHHHCCCCCCCcchh------hhHHHHH----hh-cccCCHHHHHHHHHHccCChhhCcCHHHHHhCHH
Confidence 99999999999999654321 1111111 11 1234567999999999999999999999987553
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=361.95 Aligned_cols=258 Identities=24% Similarity=0.323 Sum_probs=200.7
Q ss_pred HhcccccceeecccCceeEEEEEe--CCccEEEEEeCcC-hhHhHHHHHHHHHHHHcCCCCceeeeccccCC--------
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPD-AAQGKRQFQQEVEVLSSIRHPNMVLLLGACPD-------- 295 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~-~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~-------- 295 (568)
..++|.+.+.||+|+||.||+|.+ ++..||||++... .......+.+|+.+|+.++|||||++++++.+
T Consensus 12 ~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~ 91 (676)
T 3qa8_A 12 TCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPND 91 (676)
T ss_dssp -----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTS
T ss_pred CCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCC
Confidence 347899999999999999999987 5789999998764 34445678999999999999999999988643
Q ss_pred CceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCc---eeEeccc
Q 008365 296 YGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNY---VSKISDV 372 (568)
Q Consensus 296 ~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~---~vKL~DF 372 (568)
..++|||||+||+|.+++........+++..++.|+.||+.||.|||+.+ |+||||||+||||+.++ .+||+||
T Consensus 92 ~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DF 168 (676)
T 3qa8_A 92 LPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDL 168 (676)
T ss_dssp SCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSC
T ss_pred eEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEccc
Confidence 33899999999999999987665556889999999999999999999999 99999999999998665 4999999
Q ss_pred ccccccCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHH--------
Q 008365 373 GLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAI-------- 444 (568)
Q Consensus 373 Gla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~-------- 444 (568)
|+++.+.... ......||+.|+|||++.+..++.++|||||||++|+|++|..||..........
T Consensus 169 G~a~~~~~~~-------~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~ 241 (676)
T 3qa8_A 169 GYAKELDQGE-------LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSN 241 (676)
T ss_dssp CCCCBTTSCC-------CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC----
T ss_pred cccccccccc-------ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccc
Confidence 9998764322 1234679999999999999999999999999999999999999996532211100
Q ss_pred HhCccccccC---------ccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 445 EKGTLAEMLD---------PAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 445 ~~~~~~~~l~---------~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
........+. +....++..++..+.+|+..||..||.+||++.+++.+.+
T Consensus 242 ~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~ 300 (676)
T 3qa8_A 242 EHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGC 300 (676)
T ss_dssp --CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTT
T ss_pred hhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHH
Confidence 0000000000 1112345568899999999999999999999998765443
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=360.30 Aligned_cols=239 Identities=24% Similarity=0.323 Sum_probs=193.8
Q ss_pred HhcccccceeecccCceeEEEEEe---CCccEEEEEeCcC-hhHhHHHHHHHHHHHHcCCCCceeeeccccCC--C----
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKL---DHTPVAIKVLRPD-AAQGKRQFQQEVEVLSSIRHPNMVLLLGACPD--Y---- 296 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~---~~~~vAvK~l~~~-~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--~---- 296 (568)
..++|.+.+.||+|+||.||+|.+ +++.||||++... .......+.+|+.+|+.++|||||+++++|.+ .
T Consensus 78 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 157 (681)
T 2pzi_A 78 VAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDP 157 (681)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCE
T ss_pred eCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCc
Confidence 347899999999999999999987 4678999998654 33445678899999999999999999998843 2
Q ss_pred -ceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccc
Q 008365 297 -GCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLA 375 (568)
Q Consensus 297 -~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla 375 (568)
.|||||||+|++|.+++.. .+++..++.|+.||+.||.|||+.+ ||||||||+||||+.+ .+||+|||++
T Consensus 158 ~~~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a 228 (681)
T 2pzi_A 158 VGYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAV 228 (681)
T ss_dssp EEEEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTC
T ss_pred eeEEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccc
Confidence 4899999999999887643 3899999999999999999999999 9999999999999885 8999999999
Q ss_pred cccCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHhCccccccCc
Q 008365 376 RLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDP 455 (568)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~l~~ 455 (568)
+.+... ....||+.|+|||++.+.. +.++|||||||++|+|++|.+||... ....+..
T Consensus 229 ~~~~~~----------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~-----------~~~~~~~ 286 (681)
T 2pzi_A 229 SRINSF----------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGR-----------YVDGLPE 286 (681)
T ss_dssp EETTCC----------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTE-----------ECSSCCT
T ss_pred hhcccC----------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccc-----------ccccccc
Confidence 865332 3457999999999988764 89999999999999999999998431 1111110
Q ss_pred cCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHHHHHH
Q 008365 456 AVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPELNRLK 498 (568)
Q Consensus 456 ~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l~~L~ 498 (568)
.......+..+.+|+.+||+.+|.+||+..+++.+.|..+.
T Consensus 287 --~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 327 (681)
T 2pzi_A 287 --DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL 327 (681)
T ss_dssp --TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred --cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence 00112345679999999999999999998888877665543
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-39 Score=332.17 Aligned_cols=239 Identities=18% Similarity=0.197 Sum_probs=183.1
Q ss_pred hcccccceeecccCceeEEEEEeCCccEEEEEeCcChh--------HhHHHHHHHHHHHHcCC---------CCcee---
Q 008365 228 TDKFSEAMKIGEGGYGPVYRGKLDHTPVAIKVLRPDAA--------QGKRQFQQEVEVLSSIR---------HPNMV--- 287 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~~~~~~~~vAvK~l~~~~~--------~~~~~~~~Ev~iL~~l~---------HpnIv--- 287 (568)
.++|.+.+.||+|+||.||+|+++++.||||++..... .....+.+|+.+|+.++ |||||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~ 98 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLN 98 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEETTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEE
T ss_pred cccchheeeecccCceEEEEEEeCCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhc
Confidence 46799999999999999999999999999999975421 22367889999998886 55554
Q ss_pred --------------eecccc---------------CCCceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHH
Q 008365 288 --------------LLLGAC---------------PDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATAL 338 (568)
Q Consensus 288 --------------~l~g~~---------------~~~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL 338 (568)
+++++| .+..|||||||++|++.+.+.+ ..+++..+..|+.||+.||
T Consensus 99 ~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 99 SVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTASL 174 (336)
T ss_dssp EEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHHHHHH
T ss_pred ceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHHHHHH
Confidence 444444 2345999999999977666643 2379999999999999999
Q ss_pred HHHH-HcCCCCcccCCCCCCCeeccCCc--------------------eeEecccccccccCCCCCcccccccccccccc
Q 008365 339 LFLH-QAKPEPLVHRDLKPANILLDRNY--------------------VSKISDVGLARLVPPSVADSVTQYHMTSAAGT 397 (568)
Q Consensus 339 ~yLH-~~~~~~IiHrDIKp~NILld~~~--------------------~vKL~DFGla~~~~~~~~~~~~~~~~~~~~GT 397 (568)
.||| +.+ ||||||||+||||+.++ .+||+|||+|+.+.. ...+||
T Consensus 175 ~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-----------~~~~gt 240 (336)
T 2vuw_A 175 AVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-----------GIVVFC 240 (336)
T ss_dssp HHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-----------TEEECC
T ss_pred HHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-----------CcEEEe
Confidence 9999 899 99999999999999886 999999999986532 234799
Q ss_pred ccCCChhhhhcCCCCCcceehhHHHH-HHHHHhCCCCCCCchHHHH---HHH-hCccccccCccCCCCChHHHHHHHHHH
Q 008365 398 FCYIDPEYQQTGMLTTKSDIYSFGIM-LLQIITARSPMGLTHHVSR---AIE-KGTLAEMLDPAVTDWPAEAAESFSKLA 472 (568)
Q Consensus 398 ~~Y~APE~~~~~~~s~ksDvwSlGvi-l~elltG~~Pf~~~~~~~~---~~~-~~~~~~~l~~~~~~~p~~~~~~l~~li 472 (568)
+.|+|||++.+.. +.++||||||++ .+++++|..||........ .+. ..... .......+..++..+.+|+
T Consensus 241 ~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~s~~~~dli 316 (336)
T 2vuw_A 241 DVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFK---TKCNTPAMKQIKRKIQEFH 316 (336)
T ss_dssp CCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCS---SCCCSHHHHHHHHHHHHHH
T ss_pred ecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccC---cccchhhhhhcCHHHHHHH
Confidence 9999999998776 899999998776 7889999999943221111 111 11110 0111122456889999999
Q ss_pred HHhhccCCCCCCChHHhH-hHH
Q 008365 473 IQCAELRKKDRPDLGTVI-VPE 493 (568)
Q Consensus 473 ~~Cl~~dP~~RPs~~~vl-~~~ 493 (568)
.+||+.+ ++.+++ .|.
T Consensus 317 ~~~L~~d-----sa~e~l~~Hp 333 (336)
T 2vuw_A 317 RTMLNFS-----SATDLLCQHS 333 (336)
T ss_dssp HHGGGSS-----SHHHHHHHCG
T ss_pred HHHhccC-----CHHHHHhcCC
Confidence 9999976 888887 543
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=318.06 Aligned_cols=228 Identities=21% Similarity=0.353 Sum_probs=180.2
Q ss_pred Hhcccccc-eeecccCceeEEEEEe--CCccEEEEEeCcChhHhHHHHHHHHHHH-HcCCCCceeeeccccCC------C
Q 008365 227 ATDKFSEA-MKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQGKRQFQQEVEVL-SSIRHPNMVLLLGACPD------Y 296 (568)
Q Consensus 227 ~~~~y~~~-~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ev~iL-~~l~HpnIv~l~g~~~~------~ 296 (568)
..++|.+. +.||+|+||.||+|.+ ++..||||++... ..+.+|+.++ +.++||||++++++|.+ .
T Consensus 15 ~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 89 (299)
T 3m2w_A 15 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 89 (299)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred cccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCce
Confidence 45678877 7899999999999987 5779999999643 3467888888 66789999999998743 2
Q ss_pred ceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccC---CceeEecccc
Q 008365 297 GCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDR---NYVSKISDVG 373 (568)
Q Consensus 297 ~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~---~~~vKL~DFG 373 (568)
.++||||+++|+|.+++...... .+++..+..|+.||+.||.|||+.+ |+||||||+||||+. ++.+||+|||
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg 165 (299)
T 3m2w_A 90 LLIVMECLDGGELFSRIQDRGDQ-AFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFG 165 (299)
T ss_dssp EEEEECCCCSCBHHHHHHHCTTC-CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred EEEEEeecCCCcHHHHHHhccCC-CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEeccc
Confidence 48999999999999999876433 4899999999999999999999999 999999999999988 7899999999
Q ss_pred cccccCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHhCcccccc
Q 008365 374 LARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEML 453 (568)
Q Consensus 374 la~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~l 453 (568)
++.... +..++.++|||||||++|+|++|..||......... . .+...+
T Consensus 166 ~a~~~~----------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~--~-~~~~~~ 214 (299)
T 3m2w_A 166 FAKETT----------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS--P-GMKTRI 214 (299)
T ss_dssp TCEECT----------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC---------C-CSCCSS
T ss_pred cccccc----------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh--H-HHHHHH
Confidence 986432 134678999999999999999999999654332111 1 111111
Q ss_pred CccCCCCC----hHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 454 DPAVTDWP----AEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 454 ~~~~~~~p----~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
......++ ..++..+.+|+.+||+.+|.+||++.+++.|.+
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~ 259 (299)
T 3m2w_A 215 RMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPW 259 (299)
T ss_dssp CTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred hhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChh
Confidence 11111222 245678999999999999999999999997765
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-38 Score=318.42 Aligned_cols=219 Identities=15% Similarity=0.114 Sum_probs=173.8
Q ss_pred HhcccccceeecccCceeEEEEEeC--CccEEEEEeCcCh---hHhHHHHHHHHHHHHcCCCCceeeeccccCC--CceE
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKLD--HTPVAIKVLRPDA---AQGKRQFQQEVEVLSSIRHPNMVLLLGACPD--YGCL 299 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~~--~~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--~~~l 299 (568)
..++|++.+.||+|+||.||+|.+. ++.||||++.... ......+.+|+.++..++||||+++++++.+ ..|+
T Consensus 29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 108 (286)
T 3uqc_A 29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLV 108 (286)
T ss_dssp TTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred ecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEE
Confidence 3467999999999999999999984 7899999997653 3334678999999999999999999999854 4489
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccC
Q 008365 300 VYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVP 379 (568)
Q Consensus 300 V~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~ 379 (568)
||||++|++|.+++... .....+..|+.||+.||.|||+.+ |+||||||+||||+.+|.+||+++|.
T Consensus 109 v~e~~~g~~L~~~l~~~-----~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~~----- 175 (286)
T 3uqc_A 109 VAEWIRGGSLQEVADTS-----PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPAT----- 175 (286)
T ss_dssp EEECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCCC-----
T ss_pred EEEecCCCCHHHHHhcC-----CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEeccc-----
Confidence 99999999999998432 344567889999999999999999 99999999999999999999985542
Q ss_pred CCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHhCccccccCccCC-
Q 008365 380 PSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAVT- 458 (568)
Q Consensus 380 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~l~~~~~- 458 (568)
++ .++.++|||||||++|+|++|+.||......... ......+.....
T Consensus 176 ---------------------~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~---~~~~~~~~~~~~~ 224 (286)
T 3uqc_A 176 ---------------------MP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGL---APAERDTAGQPIE 224 (286)
T ss_dssp ---------------------CT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCS---EECCBCTTSCBCC
T ss_pred ---------------------cC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhh---HHHHHHhccCCCC
Confidence 33 2788999999999999999999999643321000 000011111110
Q ss_pred --CCChHHHHHHHHHHHHhhccCCCCCCChHHhH
Q 008365 459 --DWPAEAAESFSKLAIQCAELRKKDRPDLGTVI 490 (568)
Q Consensus 459 --~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl 490 (568)
..+..++..+.+|+.+||+.||.+| ++.+++
T Consensus 225 ~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~ 257 (286)
T 3uqc_A 225 PADIDRDIPFQISAVAARSVQGDGGIR-SASTLL 257 (286)
T ss_dssp HHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHH
T ss_pred hhhcccCCCHHHHHHHHHHcccCCccC-CHHHHH
Confidence 1223566789999999999999999 999886
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.6e-32 Score=300.01 Aligned_cols=181 Identities=18% Similarity=0.150 Sum_probs=126.3
Q ss_pred cccCceeEEEEE--eCCccEEEEEeCcCh----------hHhHHHHHHHHHHHHcC-CCCceeeeccccCCCc--eEEEE
Q 008365 238 GEGGYGPVYRGK--LDHTPVAIKVLRPDA----------AQGKRQFQQEVEVLSSI-RHPNMVLLLGACPDYG--CLVYE 302 (568)
Q Consensus 238 G~G~fg~Vy~~~--~~~~~vAvK~l~~~~----------~~~~~~~~~Ev~iL~~l-~HpnIv~l~g~~~~~~--~lV~E 302 (568)
+.|++|.+..++ +-|..||||++.+.. ....+.|.+|+++|+++ .|+||+++++++++.. |||||
T Consensus 243 ~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVME 322 (569)
T 4azs_A 243 YAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVME 322 (569)
T ss_dssp C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEE
T ss_pred ccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEe
Confidence 445555444332 257789999996541 23346799999999999 6999999999997654 99999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCC
Q 008365 303 YMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSV 382 (568)
Q Consensus 303 ~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~ 382 (568)
||+|++|.++|...+. ++.. .|+.||+.||.|||++| ||||||||+||||+.+|.+||+|||+|+.+....
T Consensus 323 yv~G~~L~d~i~~~~~---l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~ 393 (569)
T 4azs_A 323 KLPGRLLSDMLAAGEE---IDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC 393 (569)
T ss_dssp CCCSEEHHHHHHTTCC---CCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC---
T ss_pred cCCCCcHHHHHHhCCC---CCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCCCC
Confidence 9999999999987653 5543 48899999999999999 9999999999999999999999999998764322
Q ss_pred CccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCC
Q 008365 383 ADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPM 434 (568)
Q Consensus 383 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf 434 (568)
....+.+||+.|||||++.+. +..++|+||+|+++++|+++..||
T Consensus 394 ------~~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 394 ------SWPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp ------CCSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred ------ccccCceechhhccHHHhCCC-CCCcccccccccchhhhccccchh
Confidence 223567899999999998764 677899999999988876655443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=9.3e-29 Score=273.13 Aligned_cols=187 Identities=18% Similarity=0.191 Sum_probs=146.5
Q ss_pred ccceeecccCceeEEEEEeCCccEEEEEeCcChh--------HhHHHHHHHHHHHHcCCCCcee--eeccccCCCceEEE
Q 008365 232 SEAMKIGEGGYGPVYRGKLDHTPVAIKVLRPDAA--------QGKRQFQQEVEVLSSIRHPNMV--LLLGACPDYGCLVY 301 (568)
Q Consensus 232 ~~~~~IG~G~fg~Vy~~~~~~~~vAvK~l~~~~~--------~~~~~~~~Ev~iL~~l~HpnIv--~l~g~~~~~~~lV~ 301 (568)
...++||+|+||.||+|...+..+++|+...... ...+.+.+|+.+|++++||||+ .++++..+..||||
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVm 418 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMM 418 (540)
T ss_dssp ---------CCEEEEEEECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEE
T ss_pred CCCCEEeeCCCEEEEEEEECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEE
Confidence 4566899999999999988899999998644321 1234589999999999999999 67777777889999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCC
Q 008365 302 EYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPS 381 (568)
Q Consensus 302 E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~ 381 (568)
|||+|++|.+++.. +..|+.||+.||.|||+.+ |+||||||+||||+. .+||+|||+++.+...
T Consensus 419 E~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~~ 482 (540)
T 3en9_A 419 SYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNLD 482 (540)
T ss_dssp ECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCCH
T ss_pred ECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCCc
Confidence 99999999998864 4578999999999999999 999999999999998 9999999999876432
Q ss_pred CCcccc-ccccccccccccCCChhhhhc--CCCCCcceehhHHHHHHHHHhCCCCC
Q 008365 382 VADSVT-QYHMTSAAGTFCYIDPEYQQT--GMLTTKSDIYSFGIMLLQIITARSPM 434 (568)
Q Consensus 382 ~~~~~~-~~~~~~~~GT~~Y~APE~~~~--~~~s~ksDvwSlGvil~elltG~~Pf 434 (568)
...... .......+||+.|||||++.. ..|+..+|+|+.++-.++-+.++.+|
T Consensus 483 ~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 483 EDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred cccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 111100 001246789999999999887 56888999999999988888877766
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=6.6e-25 Score=222.70 Aligned_cols=145 Identities=14% Similarity=0.076 Sum_probs=117.1
Q ss_pred hcccccceeecccCceeEEEEEe-CCccEEEEEeCcChh------------------HhHHHHHHHHHHHHcCCCCceee
Q 008365 228 TDKFSEAMKIGEGGYGPVYRGKL-DHTPVAIKVLRPDAA------------------QGKRQFQQEVEVLSSIRHPNMVL 288 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~~~~-~~~~vAvK~l~~~~~------------------~~~~~~~~Ev~iL~~l~HpnIv~ 288 (568)
...|.+.+.||+|+||.||+|.+ +++.||||+++.... .....+.+|+.+|+.++ | ++
T Consensus 89 ~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~ 165 (282)
T 1zar_A 89 GKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LA 165 (282)
T ss_dssp TSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SS
T ss_pred CeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CC
Confidence 34567779999999999999998 577999999965322 13456889999999999 4 66
Q ss_pred eccccC-CCceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCcee
Q 008365 289 LLGACP-DYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVS 367 (568)
Q Consensus 289 l~g~~~-~~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~v 367 (568)
+++++. +..++|||||+||+|.+ +.. .....|+.||+.||.|||+.+ |+||||||+||||+ ++.+
T Consensus 166 v~~~~~~~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl~-~~~v 231 (282)
T 1zar_A 166 VPKVYAWEGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVS-EEGI 231 (282)
T ss_dssp SCCEEEEETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE-TTEE
T ss_pred cCeEEeccceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEEE-CCcE
Confidence 666553 34599999999999987 421 124469999999999999999 99999999999999 9999
Q ss_pred EecccccccccCCCCCccccccccccccccccCCChhhhhc
Q 008365 368 KISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQT 408 (568)
Q Consensus 368 KL~DFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~ 408 (568)
||+|||+|+ ++..|+|||++..
T Consensus 232 kl~DFG~a~-------------------~~~~~~a~e~l~r 253 (282)
T 1zar_A 232 WIIDFPQSV-------------------EVGEEGWREILER 253 (282)
T ss_dssp EECCCTTCE-------------------ETTSTTHHHHHHH
T ss_pred EEEECCCCe-------------------ECCCCCHHHHHHH
Confidence 999999986 3445789998754
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=5.6e-22 Score=198.28 Aligned_cols=136 Identities=19% Similarity=0.156 Sum_probs=106.6
Q ss_pred ccccceeecccCceeEEEEEe--CCcc--EEEEEeCcChhH------------------------hHHHHHHHHHHHHcC
Q 008365 230 KFSEAMKIGEGGYGPVYRGKL--DHTP--VAIKVLRPDAAQ------------------------GKRQFQQEVEVLSSI 281 (568)
Q Consensus 230 ~y~~~~~IG~G~fg~Vy~~~~--~~~~--vAvK~l~~~~~~------------------------~~~~~~~Ev~iL~~l 281 (568)
-|.+.+.||+|+||.||+|.+ +|+. ||||+++..... ....+.+|+.+|..+
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 367889999999999999988 7888 999997654211 123578999999999
Q ss_pred CCCce--eeeccccCCCceEEEEecCC-C----CHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH-HcCCCCcccCC
Q 008365 282 RHPNM--VLLLGACPDYGCLVYEYMHN-G----SLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLH-QAKPEPLVHRD 353 (568)
Q Consensus 282 ~HpnI--v~l~g~~~~~~~lV~E~~~g-g----sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH-~~~~~~IiHrD 353 (568)
.|+++ +.+++ .+..+|||||+.+ | +|.++... .++..+..++.||+.||.||| ..+ |||||
T Consensus 128 ~~~~i~~p~~~~--~~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~g---ivHrD 196 (258)
T 1zth_A 128 KEAGVSVPQPYT--YMKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEAE---LVHAD 196 (258)
T ss_dssp HHTTCCCCCEEE--EETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTSC---EECSS
T ss_pred HhCCCCCCeEEE--cCCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHCC---EEeCC
Confidence 88764 33333 2456999999942 3 67765432 234467789999999999999 888 99999
Q ss_pred CCCCCeeccCCceeEeccccccccc
Q 008365 354 LKPANILLDRNYVSKISDVGLARLV 378 (568)
Q Consensus 354 IKp~NILld~~~~vKL~DFGla~~~ 378 (568)
|||.||||+. .++|+|||+|...
T Consensus 197 lkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 197 LSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp CSTTSEEESS--SEEECCCTTCEET
T ss_pred CCHHHEEEcC--cEEEEECcccccC
Confidence 9999999998 8999999999754
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.71 E-value=6.4e-18 Score=177.62 Aligned_cols=136 Identities=13% Similarity=0.127 Sum_probs=97.1
Q ss_pred ccccceeecccCceeEEEEEe-CCccEEEEEeCcChhH--------------hHHH--------HHHHHHHHHcCCCCce
Q 008365 230 KFSEAMKIGEGGYGPVYRGKL-DHTPVAIKVLRPDAAQ--------------GKRQ--------FQQEVEVLSSIRHPNM 286 (568)
Q Consensus 230 ~y~~~~~IG~G~fg~Vy~~~~-~~~~vAvK~l~~~~~~--------------~~~~--------~~~Ev~iL~~l~HpnI 286 (568)
-|.+...||.|+||.||+|.+ +|+.||||+++..... .... ..+|...|.++.+.++
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 389999999999999999987 6889999997642100 0111 2345556665544333
Q ss_pred eeeccccCCCceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCc-
Q 008365 287 VLLLGACPDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNY- 365 (568)
Q Consensus 287 v~l~g~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~- 365 (568)
....-+.....+|||||++|++|..+.. . .....++.||+.+|.|||+.| ||||||||.||||++++
T Consensus 176 ~vp~p~~~~~~~LVME~i~G~~L~~l~~-------~--~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl~~dgd 243 (397)
T 4gyi_A 176 PVPEPIAQSRHTIVMSLVDALPMRQVSS-------V--PDPASLYADLIALILRLAKHG---LIHGDFNEFNILIREEKD 243 (397)
T ss_dssp SCCCEEEEETTEEEEECCSCEEGGGCCC-------C--SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEEEEEC
T ss_pred CCCeeeeccCceEEEEecCCccHhhhcc-------c--HHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeCCCC
Confidence 2111111234489999999988865321 1 123467889999999999999 99999999999998776
Q ss_pred ---------eeEecccccccc
Q 008365 366 ---------VSKISDVGLARL 377 (568)
Q Consensus 366 ---------~vKL~DFGla~~ 377 (568)
.+.|+||+-+..
T Consensus 244 ~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 244 AEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp SSCTTSEEEEEEECCCTTCEE
T ss_pred cccccccccceEEEEeCCccc
Confidence 489999997753
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.42 E-value=2.6e-13 Score=134.76 Aligned_cols=143 Identities=14% Similarity=0.101 Sum_probs=110.2
Q ss_pred HHhcccccceeecccCceeEEEEEeCCccEEEEEeCcChhHhHHHHHHHHHHHHcCC-CCceeeeccccCCC--ceEEEE
Q 008365 226 EATDKFSEAMKIGEGGYGPVYRGKLDHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIR-HPNMVLLLGACPDY--GCLVYE 302 (568)
Q Consensus 226 ~~~~~y~~~~~IG~G~fg~Vy~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~-HpnIv~l~g~~~~~--~~lV~E 302 (568)
...+.|.+...+|.|+++.||++...+..++||+...........+.+|+.+|+.+. +.++.++++++.+. .++|||
T Consensus 11 ~~l~~~~~~~~~~g~s~~~v~~~~~~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e 90 (263)
T 3tm0_A 11 KLIEKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMS 90 (263)
T ss_dssp HHHTTSEEEECCSCCSSSEEEEEECSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEE
T ss_pred HHhccceeEeeccCCCCCeEEEEECCCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEE
Confidence 345678888899999999999998888899999987532222345889999999885 66677787776443 479999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcC-------------------------------------
Q 008365 303 YMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAK------------------------------------- 345 (568)
Q Consensus 303 ~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~------------------------------------- 345 (568)
|++|.+|.+.+. +......++.+++.+|..||+..
T Consensus 91 ~i~G~~l~~~~~--------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (263)
T 3tm0_A 91 EADGVLCSEEYE--------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDT 162 (263)
T ss_dssp CCSSEEHHHHCC--------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTC
T ss_pred ecCCeehhhccC--------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccc
Confidence 999999987531 11223467889999999999821
Q ss_pred -------------------CCCcccCCCCCCCeeccCCceeEeccccccc
Q 008365 346 -------------------PEPLVHRDLKPANILLDRNYVSKISDVGLAR 376 (568)
Q Consensus 346 -------------------~~~IiHrDIKp~NILld~~~~vKL~DFGla~ 376 (568)
+..++|+|++|.|||+++++.+.|+||+.+.
T Consensus 163 ~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 163 PFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp SSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred cCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 1238999999999999887777899999874
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.21 E-value=1.6e-11 Score=127.82 Aligned_cols=140 Identities=16% Similarity=0.258 Sum_probs=105.1
Q ss_pred cceeecccCceeEEEEEeCCccEEEEEeC--cCh-hHhHHHHHHHHHHHHcCC--CCceeeeccccCCC-----ceEEEE
Q 008365 233 EAMKIGEGGYGPVYRGKLDHTPVAIKVLR--PDA-AQGKRQFQQEVEVLSSIR--HPNMVLLLGACPDY-----GCLVYE 302 (568)
Q Consensus 233 ~~~~IG~G~fg~Vy~~~~~~~~vAvK~l~--~~~-~~~~~~~~~Ev~iL~~l~--HpnIv~l~g~~~~~-----~~lV~E 302 (568)
.++.|+.|.++.||+....+..+++|+.. ... ......+.+|+.+|+.|. +..+.+++.++.+. .++|||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme 121 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTPGQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIME 121 (359)
T ss_dssp EEEECCC-CCSCEEEEECSSCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEE
T ss_pred eEEEcCCcccceEEEEEECCceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEE
Confidence 45689999999999998888889999876 332 122346788999999887 44577788777654 589999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcC-------------------------------------
Q 008365 303 YMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAK------------------------------------- 345 (568)
Q Consensus 303 ~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~------------------------------------- 345 (568)
|++|..+.+.. ...++...+..++.+++..|..||...
T Consensus 122 ~v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (359)
T 3dxp_A 122 FVSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA 196 (359)
T ss_dssp CCCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred ecCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence 99988874311 123667788889999999999999841
Q ss_pred ------------------CCCcccCCCCCCCeeccCCc--eeEecccccccc
Q 008365 346 ------------------PEPLVHRDLKPANILLDRNY--VSKISDVGLARL 377 (568)
Q Consensus 346 ------------------~~~IiHrDIKp~NILld~~~--~vKL~DFGla~~ 377 (568)
+..++|+|++|.|||++.++ .+.|+||+.+..
T Consensus 197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 23489999999999998764 368999999864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.18 E-value=2.6e-11 Score=123.28 Aligned_cols=181 Identities=19% Similarity=0.202 Sum_probs=122.1
Q ss_pred ceeecccCceeEEEEEeCCccEEEEEeCcChhHhHHHHHHHHHHHHcCC-CCc--eeeeccccCC-----CceEEEEecC
Q 008365 234 AMKIGEGGYGPVYRGKLDHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIR-HPN--MVLLLGACPD-----YGCLVYEYMH 305 (568)
Q Consensus 234 ~~~IG~G~fg~Vy~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~-Hpn--Iv~l~g~~~~-----~~~lV~E~~~ 305 (568)
++.|+.|.+..||+.. ..++||+.... .....+.+|+.+|+.+. +.. +..++....+ ..++||+|++
T Consensus 25 i~~~~~G~~n~v~~v~---~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~ 99 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN---RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIK 99 (304)
T ss_dssp CCEEEECSSEEEEEST---TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCC
T ss_pred eEecCCCCcceEEEEC---CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccC
Confidence 4569999999999864 67999996533 33467889999998873 322 2333333322 2378999999
Q ss_pred CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcC----------------------------------------
Q 008365 306 NGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAK---------------------------------------- 345 (568)
Q Consensus 306 ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~---------------------------------------- 345 (568)
|.+|.+.... .++..++..++.+++..|..||+..
T Consensus 100 G~~l~~~~~~-----~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 174 (304)
T 3sg8_A 100 GVPLTPLLLN-----NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVD 174 (304)
T ss_dssp CEECCHHHHH-----TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHH
T ss_pred CeECCccccc-----cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHH
Confidence 9888754332 2667777888889999999888721
Q ss_pred ---------------CCCcccCCCCCCCeeccC--CceeEecccccccccCCCCCccccccccccccccccC---CChhh
Q 008365 346 ---------------PEPLVHRDLKPANILLDR--NYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCY---IDPEY 405 (568)
Q Consensus 346 ---------------~~~IiHrDIKp~NILld~--~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~GT~~Y---~APE~ 405 (568)
+..++|+|++|.|||++. +..+.|+||+.+....+.. +. .....+ ..|+.
T Consensus 175 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~--Dl--------~~~~~~~~~~~~~~ 244 (304)
T 3sg8_A 175 DFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDN--DF--------ISLMEDDEEYGMEF 244 (304)
T ss_dssp HHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTH--HH--------HTTCCTTTSCCHHH
T ss_pred HHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHH--HH--------HHHHhhccccCHHH
Confidence 123799999999999988 5678999999987543211 00 011111 23332
Q ss_pred hhc-----CCC---------CCcceehhHHHHHHHHHhCCCCC
Q 008365 406 QQT-----GML---------TTKSDIYSFGIMLLQIITARSPM 434 (568)
Q Consensus 406 ~~~-----~~~---------s~ksDvwSlGvil~elltG~~Pf 434 (568)
... +.. ....++|++|+++|.+.+|..+|
T Consensus 245 ~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 245 VSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 111 111 12358999999999999999887
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.15 E-value=2.6e-11 Score=119.18 Aligned_cols=134 Identities=17% Similarity=0.122 Sum_probs=94.8
Q ss_pred cccccceeecccCceeEEEEEe-CCccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCc--eeeeccccCC--CceEEEEe
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKL-DHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPN--MVLLLGACPD--YGCLVYEY 303 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~-~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~Hpn--Iv~l~g~~~~--~~~lV~E~ 303 (568)
..|.+....+.|.++.||++.. ++..++||+..... ...+..|+.+|+.+.+.+ +.++++++.+ ..++||||
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~~---~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~ 96 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGE 96 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEEC
T ss_pred CCCceEecccCCCCceEEEEecCCCCeEEEEeCCccc---chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEe
Confidence 3455443334566699999876 35689999986542 235778999998886444 4457766644 34899999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcC--------------------------------------
Q 008365 304 MHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAK-------------------------------------- 345 (568)
Q Consensus 304 ~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~-------------------------------------- 345 (568)
++|.+|. ... .. ...++.+++..|..||+..
T Consensus 97 i~G~~l~--~~~------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (264)
T 1nd4_A 97 VPGQDLL--SSH------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGL 165 (264)
T ss_dssp CSSEETT--TSC------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTC
T ss_pred cCCcccC--cCc------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCc
Confidence 9998884 211 11 2246677888888888753
Q ss_pred -----------------CCCcccCCCCCCCeeccCCceeEeccccccc
Q 008365 346 -----------------PEPLVHRDLKPANILLDRNYVSKISDVGLAR 376 (568)
Q Consensus 346 -----------------~~~IiHrDIKp~NILld~~~~vKL~DFGla~ 376 (568)
+..++|+|++|.|||+++++.+.|+|||.+.
T Consensus 166 ~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 166 APAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp CHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred cHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 1129999999999999888777899999875
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.65 E-value=1.7e-07 Score=95.37 Aligned_cols=134 Identities=19% Similarity=0.224 Sum_probs=91.9
Q ss_pred ceeecccCceeEEEEEeCCccEEEEEeCcChhHhHHHHHHHHHHHHcCCCC---ceeeecccc---CCCceEEEEecCCC
Q 008365 234 AMKIGEGGYGPVYRGKLDHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHP---NMVLLLGAC---PDYGCLVYEYMHNG 307 (568)
Q Consensus 234 ~~~IG~G~fg~Vy~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~Hp---nIv~l~g~~---~~~~~lV~E~~~gg 307 (568)
+..++.|....||+. +..++||+... ......+.+|+.+|..|.+. .+...+.++ ....++||+|++|.
T Consensus 24 v~~l~~G~~n~v~~v---g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~ 98 (306)
T 3tdw_A 24 VESLGEGFRNYAILV---NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQ 98 (306)
T ss_dssp EEEEEECSSEEEEEE---TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSE
T ss_pred eeecCCCcceeEEEE---CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCe
Confidence 457888999999987 67899998532 23346788999999998642 233444333 22358999999998
Q ss_pred CHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcC------------------------------------------
Q 008365 308 SLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAK------------------------------------------ 345 (568)
Q Consensus 308 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~------------------------------------------ 345 (568)
.|.+.... .++......++.+++..|..||+..
T Consensus 99 ~l~~~~~~-----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~ 173 (306)
T 3tdw_A 99 ILGEDGMA-----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLT 173 (306)
T ss_dssp ECHHHHHT-----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHH
T ss_pred ECchhhhh-----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHH
Confidence 88763221 1344455555666666666666532
Q ss_pred ---------------CCCcccCCCCCCCeeccC---Cc-eeEecccccccc
Q 008365 346 ---------------PEPLVHRDLKPANILLDR---NY-VSKISDVGLARL 377 (568)
Q Consensus 346 ---------------~~~IiHrDIKp~NILld~---~~-~vKL~DFGla~~ 377 (568)
+..++|+|++|.|||++. ++ .+.|+||+.+..
T Consensus 174 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 174 LRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 123699999999999987 34 458999998864
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.44 E-value=6e-07 Score=94.41 Aligned_cols=74 Identities=18% Similarity=0.134 Sum_probs=50.6
Q ss_pred ceeecccCceeEEEEEe--CCccEEEEEeCcChh-------HhHHHHHHHHHHHHcCCC--C-ceeeeccccCCCceEEE
Q 008365 234 AMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAA-------QGKRQFQQEVEVLSSIRH--P-NMVLLLGACPDYGCLVY 301 (568)
Q Consensus 234 ~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~-------~~~~~~~~Ev~iL~~l~H--p-nIv~l~g~~~~~~~lV~ 301 (568)
.+.||.|.++.||++.. .+..|+||...+... .....+..|.++|+.+.. | .+.+++.+..+..++||
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d~~~~~lvm 114 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSDTEMAVTVM 114 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEETTTTEEEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEcCCccEEEE
Confidence 56899999999999964 467899998654321 112346778888887642 3 34456655566679999
Q ss_pred EecCCC
Q 008365 302 EYMHNG 307 (568)
Q Consensus 302 E~~~gg 307 (568)
||++|.
T Consensus 115 E~l~g~ 120 (397)
T 2olc_A 115 EDLSHL 120 (397)
T ss_dssp CCCTTS
T ss_pred EeCCCc
Confidence 999764
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.43 E-value=6e-07 Score=88.84 Aligned_cols=132 Identities=17% Similarity=0.127 Sum_probs=91.7
Q ss_pred eecccCce-eEEEEEe--CCccEEEEEeCcChhHhHHHHHHHHHHHHcCC-CCceeeeccccC--CCceEEEEecCCCCH
Q 008365 236 KIGEGGYG-PVYRGKL--DHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIR-HPNMVLLLGACP--DYGCLVYEYMHNGSL 309 (568)
Q Consensus 236 ~IG~G~fg-~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~-HpnIv~l~g~~~--~~~~lV~E~~~ggsL 309 (568)
.+..|..| .||+... .+..++||+-.... ...+.+|..+|+.|. +--+.++++++. +..++|||+++|.++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~~---~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGSV---ANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETHH---HHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCCC---HhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 45556555 6898765 45689999865432 346788999998774 223455566553 345899999999888
Q ss_pred HHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCC-------------------------------------------
Q 008365 310 EDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKP------------------------------------------- 346 (568)
Q Consensus 310 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~------------------------------------------- 346 (568)
.+..... ......++.+++..|..||....
T Consensus 108 ~~~~~~~-------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (272)
T 4gkh_A 108 FQVLEEY-------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW 180 (272)
T ss_dssp HHHHHHC-------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred cccccCC-------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence 7765432 12233466677777777776420
Q ss_pred ------------CCcccCCCCCCCeeccCCceeEecccccccc
Q 008365 347 ------------EPLVHRDLKPANILLDRNYVSKISDVGLARL 377 (568)
Q Consensus 347 ------------~~IiHrDIKp~NILld~~~~vKL~DFGla~~ 377 (568)
..++|+|+.+.|||++.++.+-|+||+.+..
T Consensus 181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 1278999999999999888888999998853
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.40 E-value=1.8e-07 Score=96.79 Aligned_cols=77 Identities=6% Similarity=-0.007 Sum_probs=52.2
Q ss_pred ceee-cccCceeEEEEEeC--------CccEEEEEeCcCh---hHhHHHHHHHHHHHHcCC-C--CceeeeccccCCC--
Q 008365 234 AMKI-GEGGYGPVYRGKLD--------HTPVAIKVLRPDA---AQGKRQFQQEVEVLSSIR-H--PNMVLLLGACPDY-- 296 (568)
Q Consensus 234 ~~~I-G~G~fg~Vy~~~~~--------~~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l~-H--pnIv~l~g~~~~~-- 296 (568)
.+.| +.|..+.+|+.... +..+++|+..... ......+.+|+.+|+.|. + ..+.+++.++.+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 4567 88999999988765 6789999865432 101235678888888774 2 2455666665443
Q ss_pred ---ceEEEEecCCCCHH
Q 008365 297 ---GCLVYEYMHNGSLE 310 (568)
Q Consensus 297 ---~~lV~E~~~ggsL~ 310 (568)
.++||||++|..+.
T Consensus 105 ~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp TSSCEEEEECCCCBCCC
T ss_pred cCCceEEEEecCCCChh
Confidence 47999999886653
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.21 E-value=6.3e-06 Score=83.93 Aligned_cols=139 Identities=17% Similarity=0.201 Sum_probs=78.7
Q ss_pred ceeecccCceeEEEEEeCCccEEEEEeCcChhHhHHHHHHHHHHHHcCC-----CCceeeec-c----ccCCCceEEEEe
Q 008365 234 AMKIGEGGYGPVYRGKLDHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIR-----HPNMVLLL-G----ACPDYGCLVYEY 303 (568)
Q Consensus 234 ~~~IG~G~fg~Vy~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~-----HpnIv~l~-g----~~~~~~~lV~E~ 303 (568)
+..|+.|..+.||+....+..+++|+..... ..+..|+.++..|. .|.++... | ...+..++||+|
T Consensus 37 ~~~l~gG~~n~~~~v~~~~~~~vlk~~~~~~----~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHTDSGAVCLKRIHRPE----KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EEECC----CEEEEEEETTEEEEEEEECSCH----HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeeccccccCcEEEEEeCCCCEEEEecCCCH----HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 3457777889999998766679999987632 23334555555442 34444321 1 112334799999
Q ss_pred cCCCCHH--------------HHHhhc-CCC--C--------CCCHHHHH------------------------------
Q 008365 304 MHNGSLE--------------DRLLRR-GNT--P--------VIPWRKRF------------------------------ 328 (568)
Q Consensus 304 ~~ggsL~--------------~~l~~~-~~~--~--------~l~~~~~~------------------------------ 328 (568)
++|..+. ..|+.. ... + ...|...+
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 9986542 111211 100 0 01222110
Q ss_pred -HHHHHHHHHHHHHHH----------cCCCCcccCCCCCCCeeccCCceeEeccccccc
Q 008365 329 -KIAAEIATALLFLHQ----------AKPEPLVHRDLKPANILLDRNYVSKISDVGLAR 376 (568)
Q Consensus 329 -~i~~qia~aL~yLH~----------~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~ 376 (568)
.+...+..++.+|+. ..+..++|+|+++.|||++.++.+.|+||+.+.
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 011123345666663 123459999999999999888899999999875
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=98.14 E-value=5.1e-06 Score=88.11 Aligned_cols=74 Identities=11% Similarity=0.099 Sum_probs=47.1
Q ss_pred cceeecccCceeEEEEEeCCccEEEEEeCcCh---------hHhHHHHHHHHHHHH-cCCCCceeeeccccCCCceEEEE
Q 008365 233 EAMKIGEGGYGPVYRGKLDHTPVAIKVLRPDA---------AQGKRQFQQEVEVLS-SIRHPNMVLLLGACPDYGCLVYE 302 (568)
Q Consensus 233 ~~~~IG~G~fg~Vy~~~~~~~~vAvK~l~~~~---------~~~~~~~~~Ev~iL~-~l~HpnIv~l~g~~~~~~~lV~E 302 (568)
.++.||.|..+.||++...+..++||...+.. ......+..|+..+. ......+.+++.+..+..++|||
T Consensus 38 ~i~~l~~G~~n~vyrv~~~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~~~~~~lv~e 117 (420)
T 2pyw_A 38 VIKEVGDGNLNFVFIVVGSSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFDRTMALIGMR 117 (420)
T ss_dssp EEEECCCSSSCEEEEEECSSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEETTTTEEEEC
T ss_pred EEEEccCCCcEEEEEEEcCCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEECCCccEEEEe
Confidence 35679999999999998777889999432210 012233444443332 22234556666666667799999
Q ss_pred ec-CC
Q 008365 303 YM-HN 306 (568)
Q Consensus 303 ~~-~g 306 (568)
|+ +|
T Consensus 118 ~l~~g 122 (420)
T 2pyw_A 118 YLEPP 122 (420)
T ss_dssp CCCTT
T ss_pred ecCCc
Confidence 99 76
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.89 E-value=1.8e-05 Score=79.76 Aligned_cols=71 Identities=13% Similarity=0.169 Sum_probs=47.6
Q ss_pred ceeecccCceeEEEEEeCCccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCce-eeeccccCCCceEEEEec-CCCCH
Q 008365 234 AMKIGEGGYGPVYRGKLDHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNM-VLLLGACPDYGCLVYEYM-HNGSL 309 (568)
Q Consensus 234 ~~~IG~G~fg~Vy~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnI-v~l~g~~~~~~~lV~E~~-~ggsL 309 (568)
++.|+.|....+|+. ..+++|+........ ....+|+.+++.+..-++ .++++++.+..++|+||+ +|.+|
T Consensus 23 i~~l~gG~tN~~~~~----~~~vlR~~~~~~~~~-~~r~~E~~~l~~l~~~g~~P~~~~~~~~~~~~v~e~i~~g~~l 95 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA----GDLCLRIPGKGTEEY-INRANEAVAAREAAKAGVSPEVLHVDPATGVMVTRYIAGAQTM 95 (301)
T ss_dssp CEEEESCSSEEEEEE----TTEEEEEECC----C-CCHHHHHHHHHHHHHTTSSCCEEEECTTTCCEEEECCTTCEEC
T ss_pred eeEcCCcccccccee----eeEEEECCCCCccce-eCHHHHHHHHHHHHHcCCCCceEEEECCCCEEEEeecCCCccC
Confidence 678999999999998 679999976532111 123467777776642122 456667777789999999 66544
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.85 E-value=3.3e-05 Score=78.74 Aligned_cols=136 Identities=16% Similarity=0.198 Sum_probs=86.5
Q ss_pred ceeecccCceeEEEEEeCCccEEEEEeCcChhHhHHHHHHHHHHHHcCC---CCceeeeccccC--CCceEEEEecCCCC
Q 008365 234 AMKIGEGGYGPVYRGKLDHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIR---HPNMVLLLGACP--DYGCLVYEYMHNGS 308 (568)
Q Consensus 234 ~~~IG~G~fg~Vy~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~---HpnIv~l~g~~~--~~~~lV~E~~~ggs 308 (568)
...|+.|.+..||+....+..++||+.... ....+..|...|+.|. ...+.+++.++. +..++||||++|..
T Consensus 41 ~~~l~gG~~n~~y~v~~~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~ 117 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLINDEVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSK 117 (312)
T ss_dssp EEEECCSSSSEEEEEESSSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCC
T ss_pred eEEeCCccceeeeEEEECCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCC
Confidence 467999999999999888888999987543 2456888998888774 245666665553 34589999999876
Q ss_pred HH--------H---HHhhcCCCC-------------------CCCHHHHH---HHHH----------------HHHHHH-
Q 008365 309 LE--------D---RLLRRGNTP-------------------VIPWRKRF---KIAA----------------EIATAL- 338 (568)
Q Consensus 309 L~--------~---~l~~~~~~~-------------------~l~~~~~~---~i~~----------------qia~aL- 338 (568)
+. . .|+.....+ .-+|...+ ++.. .++..+
T Consensus 118 ~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l~ 197 (312)
T 3jr1_A 118 NKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIVA 197 (312)
T ss_dssp CCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHHH
T ss_pred CCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHHH
Confidence 41 1 122222100 01343322 1111 111111
Q ss_pred HHHHHc-CCCCcccCCCCCCCeeccCCceeEecccc
Q 008365 339 LFLHQA-KPEPLVHRDLKPANILLDRNYVSKISDVG 373 (568)
Q Consensus 339 ~yLH~~-~~~~IiHrDIKp~NILld~~~~vKL~DFG 373 (568)
..|... .+..+||+|+.+.||+++.++ +.|+||+
T Consensus 198 ~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 198 DTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 233211 123599999999999999887 8899984
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.82 E-value=7e-05 Score=75.87 Aligned_cols=158 Identities=14% Similarity=0.185 Sum_probs=89.2
Q ss_pred cccCHHHHHHHhccccc-----ceeecccCceeEEEEEeCCccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCc--eeee
Q 008365 217 RKYTIEEIEEATDKFSE-----AMKIGEGGYGPVYRGKLDHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPN--MVLL 289 (568)
Q Consensus 217 ~~~~~~ei~~~~~~y~~-----~~~IG~G~fg~Vy~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~Hpn--Iv~l 289 (568)
..++..++......|.+ ++.|+.|....||+....+..+++|+..... ....+..|+.++..|...+ +..+
T Consensus 5 ~~~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~ 82 (322)
T 2ppq_A 5 TDITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDPLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLP 82 (322)
T ss_dssp CCCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCCEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCB
T ss_pred ccCCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCccEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCcc
Confidence 34555666666666654 3457778889999998766689999987631 1234556777776653212 2333
Q ss_pred ccc--------cCCCceEEEEecCCCCHH-----------H---HHhhcC-C--CCC------CCHHHHHH---------
Q 008365 290 LGA--------CPDYGCLVYEYMHNGSLE-----------D---RLLRRG-N--TPV------IPWRKRFK--------- 329 (568)
Q Consensus 290 ~g~--------~~~~~~lV~E~~~ggsL~-----------~---~l~~~~-~--~~~------l~~~~~~~--------- 329 (568)
+.. ..+..++||+|++|..+. . .++... . .+. ..|...+.
T Consensus 83 ~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~ 162 (322)
T 2ppq_A 83 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV 162 (322)
T ss_dssp CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred cCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhh
Confidence 321 123347899999886531 1 112111 0 000 11222110
Q ss_pred ---HHHHHHHHHHHHHHcC----CCCcccCCCCCCCeeccCCceeEeccccccc
Q 008365 330 ---IAAEIATALLFLHQAK----PEPLVHRDLKPANILLDRNYVSKISDVGLAR 376 (568)
Q Consensus 330 ---i~~qia~aL~yLH~~~----~~~IiHrDIKp~NILld~~~~vKL~DFGla~ 376 (568)
+...+...+.+|+... +..+||+|+.+.|||++.++.+.|+||+.+.
T Consensus 163 ~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 163 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 0112444556665432 2348999999999999988777899999875
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.79 E-value=4.1e-05 Score=76.63 Aligned_cols=78 Identities=23% Similarity=0.263 Sum_probs=56.1
Q ss_pred ccccceeecccCceeEEEEEe-CCccEEEEEeCcChhHhHHHHHHHHHHHHcCCCC---ceeeeccccCCCceEEEEecC
Q 008365 230 KFSEAMKIGEGGYGPVYRGKL-DHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHP---NMVLLLGACPDYGCLVYEYMH 305 (568)
Q Consensus 230 ~y~~~~~IG~G~fg~Vy~~~~-~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~Hp---nIv~l~g~~~~~~~lV~E~~~ 305 (568)
....+..+|.|..+.||+... +|+.|+||+...........|..|+..|+.|.-- .+.+++++ +..++||||++
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~~~~lv~e~l~ 93 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW--DDRTLAMEWVD 93 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--ETTEEEEECCC
T ss_pred CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec--cCceEEEEeec
Confidence 455677899999999999987 6889999987654433344678899999887421 23344433 34589999998
Q ss_pred CCCH
Q 008365 306 NGSL 309 (568)
Q Consensus 306 ggsL 309 (568)
++..
T Consensus 94 ~~~~ 97 (288)
T 3f7w_A 94 ERPP 97 (288)
T ss_dssp CCCC
T ss_pred ccCC
Confidence 7653
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.60 E-value=0.00022 Score=72.70 Aligned_cols=141 Identities=12% Similarity=0.076 Sum_probs=73.8
Q ss_pred eeecccCcee-EEEEEeC-CccEEEEEeCcChhHhHHHHHHHHHHHHcCCC--CceeeeccccCCCceEEEEecCCCCHH
Q 008365 235 MKIGEGGYGP-VYRGKLD-HTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRH--PNMVLLLGACPDYGCLVYEYMHNGSLE 310 (568)
Q Consensus 235 ~~IG~G~fg~-Vy~~~~~-~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~H--pnIv~l~g~~~~~~~lV~E~~~ggsL~ 310 (568)
..|+.|+... +|+.... +..+++|....... ..+..|+.++..+.. -.+.+++.+..+.+++|||++.+..+.
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g~ll~e~l~~~~l~ 100 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHARGLLLIEDLGDALFT 100 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTTTEEEECCCCSCBHH
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCCCEEEEeeCCCcchH
Confidence 4566665554 6677663 67788887554321 233456666665532 224455555555668999999776665
Q ss_pred HHHhhcC-----------------------CCCCCCHHHHH-------H-H------------HHHHHHHHHHHHH---c
Q 008365 311 DRLLRRG-----------------------NTPVIPWRKRF-------K-I------------AAEIATALLFLHQ---A 344 (568)
Q Consensus 311 ~~l~~~~-----------------------~~~~l~~~~~~-------~-i------------~~qia~aL~yLH~---~ 344 (568)
+.+.... ..+.+...... . + ...+...+..|.. .
T Consensus 101 ~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~~~ 180 (333)
T 3csv_A 101 EVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQLE 180 (333)
T ss_dssp HHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHHCC
T ss_pred HHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhccc
Confidence 4432110 01111111100 0 0 0011122222211 1
Q ss_pred CCCCcccCCCCCCCeeccCC----ceeEeccccccccc
Q 008365 345 KPEPLVHRDLKPANILLDRN----YVSKISDVGLARLV 378 (568)
Q Consensus 345 ~~~~IiHrDIKp~NILld~~----~~vKL~DFGla~~~ 378 (568)
.+..++|+|+.+.|||++.+ +.+.|+||+.+..-
T Consensus 181 ~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 181 GDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp SCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 23459999999999999874 78899999998653
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.50 E-value=7.4e-05 Score=79.58 Aligned_cols=71 Identities=14% Similarity=0.212 Sum_probs=48.7
Q ss_pred ceeecccCceeEEEEEeC---------CccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCce-eeeccccCCCceEEEEe
Q 008365 234 AMKIGEGGYGPVYRGKLD---------HTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNM-VLLLGACPDYGCLVYEY 303 (568)
Q Consensus 234 ~~~IG~G~fg~Vy~~~~~---------~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnI-v~l~g~~~~~~~lV~E~ 303 (568)
+..|+.|-...||++... +..|++|+...... ...+..|..+++.|...++ .++++.+.+ .+||+|
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~--~~~li~E~~~l~~L~~~g~~P~l~~~~~~--g~v~e~ 153 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET--ESHLVAESVIFTLLSERHLGPKLYGIFSG--GRLEEY 153 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC--HHHHHHHHHHHHHHHHTTSSSCEEEEETT--EEEECC
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc--HHHHHHHHHHHHHHHhCCCCCcEEEEeCC--CEEEEE
Confidence 457888989999998864 46799999844211 1344578888887753333 566666654 489999
Q ss_pred cCCCC
Q 008365 304 MHNGS 308 (568)
Q Consensus 304 ~~ggs 308 (568)
++|.+
T Consensus 154 l~G~~ 158 (429)
T 1nw1_A 154 IPSRP 158 (429)
T ss_dssp CCEEE
T ss_pred eCCcc
Confidence 98643
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.48 E-value=0.0012 Score=66.83 Aligned_cols=160 Identities=15% Similarity=0.150 Sum_probs=89.9
Q ss_pred ccccccCHHHHHHHhccccc-----ceeecccCceeEEEEEe-CCccEEEEEeCcChhHhHHHHHHHHHHHHcCCCC--c
Q 008365 214 VRYRKYTIEEIEEATDKFSE-----AMKIGEGGYGPVYRGKL-DHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHP--N 285 (568)
Q Consensus 214 ~~~~~~~~~ei~~~~~~y~~-----~~~IG~G~fg~Vy~~~~-~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~Hp--n 285 (568)
..|...+...+..+...|.+ +..|+ |....||+... +|..+++|+...... ....+..|+.++..|... .
T Consensus 6 ~~~~~l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~-~~~~~~~E~~~~~~L~~~g~~ 83 (328)
T 1zyl_A 6 FTFQTLHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVP 83 (328)
T ss_dssp CCCCCCCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCS
T ss_pred CCCCCCCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCCCCEEEEEEcCCCCC-CHHHHHHHHHHHHHHHHcCCe
Confidence 34566666677666655543 34577 88889998876 456899999874321 234566788887776421 2
Q ss_pred eeeeccc-------cCCCceEEEEecCCCCHH-----H------H---HhhcC------CCCCCCHHHH----HHH----
Q 008365 286 MVLLLGA-------CPDYGCLVYEYMHNGSLE-----D------R---LLRRG------NTPVIPWRKR----FKI---- 330 (568)
Q Consensus 286 Iv~l~g~-------~~~~~~lV~E~~~ggsL~-----~------~---l~~~~------~~~~l~~~~~----~~i---- 330 (568)
++.++.. ..+..++||+|++|..+. . . ++... ..+.+.+... ..+
T Consensus 84 vp~~~~~~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 163 (328)
T 1zyl_A 84 VAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDA 163 (328)
T ss_dssp BCCCCCBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTC
T ss_pred ecceeecCCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhc
Confidence 3444433 012236799999875431 1 1 11110 0111222111 001
Q ss_pred -----------HHHHHHHHHHHHHc----CCCCcccCCCCCCCeeccCCceeEecccccccc
Q 008365 331 -----------AAEIATALLFLHQA----KPEPLVHRDLKPANILLDRNYVSKISDVGLARL 377 (568)
Q Consensus 331 -----------~~qia~aL~yLH~~----~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~ 377 (568)
...+...+..+... .+..++|+|+++.|||++ + .+.|+||+.+..
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 164 TLIPSGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp SSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred CcCCHHHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 01111223333322 233489999999999999 4 889999998754
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.40 E-value=0.00017 Score=77.36 Aligned_cols=73 Identities=14% Similarity=0.077 Sum_probs=48.3
Q ss_pred ceeecccCceeEEEEEeCC--ccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCce-eeeccccCCCceEEEEecCCCCH
Q 008365 234 AMKIGEGGYGPVYRGKLDH--TPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNM-VLLLGACPDYGCLVYEYMHNGSL 309 (568)
Q Consensus 234 ~~~IG~G~fg~Vy~~~~~~--~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnI-v~l~g~~~~~~~lV~E~~~ggsL 309 (568)
+..|+.|-...+|++...+ ..+++|+........ -...+|..+|..|...++ .++++.+. ..+||||++|.+|
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~-idR~~E~~vl~~L~~~gl~P~ll~~~~--~G~v~e~I~G~~l 188 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI-INREREKKISCILYNKNIAKKIYVFFT--NGRIEEFMDGYAL 188 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC-SCHHHHHHHHHHHTTSSSBCCEEEEET--TEEEEECCCSEEC
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh-cCHHHHHHHHHHHHhcCCCCCEEEEeC--CeEEEEeeCCccC
Confidence 4578889899999998865 789999875432111 012578888888864444 56777764 3579999987443
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.30 E-value=0.00015 Score=75.23 Aligned_cols=72 Identities=17% Similarity=0.186 Sum_probs=43.8
Q ss_pred ceeecccCceeEEEEEeCC----------ccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCc-eeeeccccCCCceEEEE
Q 008365 234 AMKIGEGGYGPVYRGKLDH----------TPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPN-MVLLLGACPDYGCLVYE 302 (568)
Q Consensus 234 ~~~IG~G~fg~Vy~~~~~~----------~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~Hpn-Iv~l~g~~~~~~~lV~E 302 (568)
...|+.|....||+....+ ..+++|+....... ......|..+++.|...+ +.++++.+ ..++||+
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~~~v~e 114 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF--NGGRIEE 114 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE--TTEEEEE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec--CCcEEEE
Confidence 4578888889999987643 67899987653221 112357788877764223 33555544 3589999
Q ss_pred ecCCCC
Q 008365 303 YMHNGS 308 (568)
Q Consensus 303 ~~~ggs 308 (568)
|++|..
T Consensus 115 ~i~G~~ 120 (369)
T 3c5i_A 115 WLYGDP 120 (369)
T ss_dssp CCCSEE
T ss_pred EecCCc
Confidence 998754
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.27 E-value=0.00025 Score=74.17 Aligned_cols=141 Identities=16% Similarity=0.195 Sum_probs=81.9
Q ss_pred ceeecccCceeEEEEEeC---------CccEEEEEeCcChhHhHHHHHHHHHHHHcCC-CCceeeeccccCCCceEEEEe
Q 008365 234 AMKIGEGGYGPVYRGKLD---------HTPVAIKVLRPDAAQGKRQFQQEVEVLSSIR-HPNMVLLLGACPDYGCLVYEY 303 (568)
Q Consensus 234 ~~~IG~G~fg~Vy~~~~~---------~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~-HpnIv~l~g~~~~~~~lV~E~ 303 (568)
++.|..|-...+|++... +..|++|+.-.. ......+.+|..+++.|. +.-..++++.|.+ .+||||
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~--g~v~e~ 131 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE--GRLEQY 131 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT--EEEEEC
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC--ccEEEE
Confidence 356777888999998763 367999986332 122345668999888774 2223566677765 499999
Q ss_pred cCCCCHH--------------HHHh---hcC---CCCCC-CHHHHHHHHHHHHH-------------------HHHHHH-
Q 008365 304 MHNGSLE--------------DRLL---RRG---NTPVI-PWRKRFKIAAEIAT-------------------ALLFLH- 342 (568)
Q Consensus 304 ~~ggsL~--------------~~l~---~~~---~~~~l-~~~~~~~i~~qia~-------------------aL~yLH- 342 (568)
++|..|. +.|. ... ..... .+.++.++..++.. .+..|.
T Consensus 132 i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~ 211 (379)
T 3feg_A 132 IPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRK 211 (379)
T ss_dssp CSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHH
T ss_pred ecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHH
Confidence 9985542 1111 111 01111 24455555443321 233332
Q ss_pred ---Hc-CCCCcccCCCCCCCeeccCC----ceeEecccccccc
Q 008365 343 ---QA-KPEPLVHRDLKPANILLDRN----YVSKISDVGLARL 377 (568)
Q Consensus 343 ---~~-~~~~IiHrDIKp~NILld~~----~~vKL~DFGla~~ 377 (568)
.. .+..++|+|+.+.|||++.+ +.+.|+||..+..
T Consensus 212 ~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 212 LLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 21 12348999999999999876 7899999998853
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.63 E-value=0.0049 Score=59.02 Aligned_cols=102 Identities=17% Similarity=0.093 Sum_probs=65.8
Q ss_pred CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCCcc
Q 008365 307 GSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQ-AKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADS 385 (568)
Q Consensus 307 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~-~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~~~ 385 (568)
-+|.++|...+. +|++.++|.++.|.+.+|.-+-. .. -..+=+-|..|+|..+|.|-+.+ +.+.
T Consensus 33 vSL~eIL~~~~~--PlsEEqaWALc~Qc~~~L~~~~~~~~---~~~~i~~~~~i~l~~dG~V~f~~-~~s~--------- 97 (229)
T 2yle_A 33 LSLEEILRLYNQ--PINEEQAWAVCYQCCGSLRAAARRRQ---PRHRVRSAAQIRVWRDGAVTLAP-AADD--------- 97 (229)
T ss_dssp EEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTTC---CCCCCCSGGGEEEETTSCEEECC-C------------
T ss_pred ccHHHHHHHcCC--CcCHHHHHHHHHHHHHHHHhhhhccc---CCceecCCcceEEecCCceeccc-cccc---------
Confidence 479999987764 49999999999999999877622 22 11233457889999998887764 2211
Q ss_pred ccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCC
Q 008365 386 VTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSP 433 (568)
Q Consensus 386 ~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~P 433 (568)
.....+.+||... ...+.+.=|||||+++|..+--..|
T Consensus 98 ---------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 ---------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp ------------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred ---------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 1223456787653 3346778899999999999874433
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.62 E-value=0.0042 Score=63.61 Aligned_cols=30 Identities=27% Similarity=0.307 Sum_probs=27.2
Q ss_pred CcccCCCCCCCeeccCCceeEecccccccc
Q 008365 348 PLVHRDLKPANILLDRNYVSKISDVGLARL 377 (568)
Q Consensus 348 ~IiHrDIKp~NILld~~~~vKL~DFGla~~ 377 (568)
.++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 207 ~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 207 VLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp EEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred eeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 489999999999999888899999998764
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.86 E-value=0.014 Score=61.75 Aligned_cols=140 Identities=13% Similarity=0.173 Sum_probs=82.9
Q ss_pred ceeecccCceeEEEEEeC---------CccEEEEEeCcChhHhHHHHHHHHHHHHcCC-CCceeeeccccCCCceEEEEe
Q 008365 234 AMKIGEGGYGPVYRGKLD---------HTPVAIKVLRPDAAQGKRQFQQEVEVLSSIR-HPNMVLLLGACPDYGCLVYEY 303 (568)
Q Consensus 234 ~~~IG~G~fg~Vy~~~~~---------~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~-HpnIv~l~g~~~~~~~lV~E~ 303 (568)
++.|..|-...+|+.... +..|++++....... .-...+|..+++.|. +.-..++++.+. .++||+|
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~-~idR~~E~~~l~~L~~~gi~P~l~~~~~--~~~I~ef 151 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK-FYDSKVELDVFRYLSNINIAPNIIADFP--EGRIEEF 151 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C-CCCHHHHHHHHHHHHHTTSSCCEEEEET--TEEEEEC
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch-hcCHHHHHHHHHHHHhcCCCCCEEEEcC--CCEEEEE
Confidence 457877888999998875 578999996543211 112357888887764 222344555443 5899999
Q ss_pred cCCCCHH--------------HHHh---h--c-----C---CCCCCCHHHHHHHHHHH-------------------HHH
Q 008365 304 MHNGSLE--------------DRLL---R--R-----G---NTPVIPWRKRFKIAAEI-------------------ATA 337 (568)
Q Consensus 304 ~~ggsL~--------------~~l~---~--~-----~---~~~~l~~~~~~~i~~qi-------------------a~a 337 (568)
++|..|. ..|. . . . ...+..+.++.++..++ ...
T Consensus 152 I~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~e 231 (424)
T 3mes_A 152 IDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKILEE 231 (424)
T ss_dssp CCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHHHH
T ss_pred eCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHHHH
Confidence 9986531 1111 0 0 0 11111244444443222 222
Q ss_pred HHHHHH---------------------cCCCCcccCCCCCCCeeccCCceeEecccccccc
Q 008365 338 LLFLHQ---------------------AKPEPLVHRDLKPANILLDRNYVSKISDVGLARL 377 (568)
Q Consensus 338 L~yLH~---------------------~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~ 377 (568)
+.+|.. ..+..++|+|+.+.||+ +.++.+.|+||..|..
T Consensus 232 ~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 232 IDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp HHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 333321 11234899999999999 8888999999998853
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=94.74 E-value=0.038 Score=57.86 Aligned_cols=29 Identities=24% Similarity=0.340 Sum_probs=24.8
Q ss_pred cccCCCCCCCeec------cCCceeEecccccccc
Q 008365 349 LVHRDLKPANILL------DRNYVSKISDVGLARL 377 (568)
Q Consensus 349 IiHrDIKp~NILl------d~~~~vKL~DFGla~~ 377 (568)
++|+|+.+.|||+ +.+..++++||.+|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 5799999999999 4467899999999864
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=83.85 E-value=0.75 Score=43.69 Aligned_cols=115 Identities=10% Similarity=0.086 Sum_probs=71.8
Q ss_pred CCCceeeeccccCCCceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeec
Q 008365 282 RHPNMVLLLGACPDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILL 361 (568)
Q Consensus 282 ~HpnIv~l~g~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILl 361 (568)
.||+++.. .+-.+..-+++.|-...+...+-.- ..++...+++++..|+....+++. -+|--|.|+||++
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~i----k~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~NL~f 112 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNI----KSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDELFF 112 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGG----GGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGGEEE
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHHH----HhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecceEEE
Confidence 57877754 2222223344444333322222111 126778889999999887754432 4688899999999
Q ss_pred cCCceeEecccccccccCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCC
Q 008365 362 DRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPM 434 (568)
Q Consensus 362 d~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf 434 (568)
+.++.++|.-.|+-..++|.. +.+| .=+-.+=|++..+++++..|
T Consensus 113 ~~~~~p~i~~RGik~~l~P~~------------------~~ee----------~fL~qyKAliiall~~K~~F 157 (215)
T 4ann_A 113 TRDGLPIAKTRGLQNVVDPLP------------------VSEA----------EFLTRYKALVICAFNEKQSF 157 (215)
T ss_dssp CTTSCEEESCCEETTTBSCCC------------------CCHH----------HHHHHHHHHHHHHHCTTCCH
T ss_pred cCCCCEEEEEccCccCCCCCC------------------CCHH----------HHHHHHHHHHHHHHcCCCCH
Confidence 999999999999764432210 1112 12334678889999998888
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=82.43 E-value=0.16 Score=54.27 Aligned_cols=56 Identities=13% Similarity=0.145 Sum_probs=15.1
Q ss_pred ceeecccCceeEEEEEeCC--ccEEE------EEeCcChh--HhHHHHHHHHHHHHcCCCCceeeeccc
Q 008365 234 AMKIGEGGYGPVYRGKLDH--TPVAI------KVLRPDAA--QGKRQFQQEVEVLSSIRHPNMVLLLGA 292 (568)
Q Consensus 234 ~~~IG~G~fg~Vy~~~~~~--~~vAv------K~l~~~~~--~~~~~~~~Ev~iL~~l~HpnIv~l~g~ 292 (568)
.+.|| ||.||+|.+.+ .+||| |..+.... .....|.+|..+++.++|||+++.+++
T Consensus 147 ~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f 212 (463)
T 3cxl_A 147 YEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNF 212 (463)
T ss_dssp TTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCE
T ss_pred cccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcce
Confidence 34576 99999998864 58888 76654322 223457789999999999999987654
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=80.02 E-value=1.5 Score=41.68 Aligned_cols=114 Identities=14% Similarity=0.127 Sum_probs=70.7
Q ss_pred CCCceeeeccccCCCceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHH-HHHHcCCCCcccCCCCCCCee
Q 008365 282 RHPNMVLLLGACPDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALL-FLHQAKPEPLVHRDLKPANIL 360 (568)
Q Consensus 282 ~HpnIv~l~g~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~-yLH~~~~~~IiHrDIKp~NIL 360 (568)
.||++..-+..-.|...+.++.-+++.=...+.. ++...+++++..|+.... +++. -+|--|.|+||+
T Consensus 48 ~~~~f~~~I~~~eD~~~i~y~~~~~~~~f~~i~~------~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~NL~ 116 (219)
T 4ano_A 48 VDPCIVRDIDVSEDEVKVVIKPPSSFLTFAAIRK------TTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPENLM 116 (219)
T ss_dssp SCSSSEEEEEECSSEEEEEEECCTTCEEHHHHHT------SCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGGGEE
T ss_pred cCCCCCeEEEEeCCEEEEEEEcCcccCcHHHHHh------cCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCceEE
Confidence 4777733333333333444444323322223322 677888888888887655 4432 578889999999
Q ss_pred ccCCceeEecccccccccCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCC
Q 008365 361 LDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPM 434 (568)
Q Consensus 361 ld~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf 434 (568)
+|.++.++|.-.|+-..++|.. +.+|- =+-.+=|++..++.++..|
T Consensus 117 f~~~~~p~i~hRGi~~~lpP~e------------------~~ee~----------fl~qyKali~all~~K~~F 162 (219)
T 4ano_A 117 FNRALEPFFLHVGVKESLPPDE------------------WDDER----------LLREVKATVLALTEGEYRF 162 (219)
T ss_dssp ECTTCCEEESCCEETTTBSSCS------------------CCHHH----------HHHHHHHHHHHHTTCSSCH
T ss_pred EeCCCcEEEEEcCCcccCCCCC------------------CCHHH----------HHHHHHHHHHHHHcCCCCH
Confidence 9999999999999764432211 12221 1234678888888888777
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 568 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 4e-67 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-60 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-59 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-59 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 7e-59 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-58 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-58 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 6e-58 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 6e-56 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 4e-55 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 4e-55 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 6e-55 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-54 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-54 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-54 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 4e-54 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-53 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-53 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-52 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 6e-52 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 4e-51 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 4e-51 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-50 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-50 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-49 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-49 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 4e-49 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 6e-49 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 6e-48 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 7e-48 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 6e-46 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 8e-46 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 4e-45 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 4e-44 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 4e-44 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-43 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-43 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-42 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 5e-42 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-41 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-41 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 7e-41 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 7e-41 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-40 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 6e-40 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-39 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-38 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-37 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 4e-37 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 5e-37 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-36 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-36 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 3e-36 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 4e-36 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 5e-36 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-35 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-35 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 6e-32 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-30 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 4e-30 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-29 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 4e-27 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 4e-20 | |
| d2es4d1 | 280 | a.137.15.1 (D:53-332) Lipase chaperone LifO (LipB) | 0.001 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 217 bits (553), Expect = 4e-67
Identities = 74/289 (25%), Positives = 129/289 (44%), Gaps = 21/289 (7%)
Query: 222 EEIEEATDKFSEAMKIGEGGYGPVYRGKLDHTPVAIKVLRPDA--AQGKRQFQQEVEVLS 279
++ E + + +IG G +G VY+GK H VA+K+L A Q + F+ EV VL
Sbjct: 1 DDWEIPDGQITVGQRIGSGSFGTVYKGKW-HGDVAVKMLNVTAPTPQQLQAFKNEVGVLR 59
Query: 280 SIRHPNMVLLLGACPDYG-CLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATAL 338
RH N++L +G +V ++ SL L K IA + A +
Sbjct: 60 KTRHVNILLFMGYSTAPQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGM 117
Query: 339 LFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTF 398
+LH + ++HRDLK NI L + KI D GLA + + +G+
Sbjct: 118 DYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKS----RWSGSHQFEQLSGSI 170
Query: 399 CYIDPEY---QQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDP 455
++ PE Q + +SD+Y+FGI+L +++T + P ++ I L P
Sbjct: 171 LWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD-QIIFMVGRGYLSP 229
Query: 456 AVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPELNRLKDLGRKL 504
++ + ++ +L +C + ++ +RP + L ++ L R L
Sbjct: 230 DLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQI----LASIELLARSL 274
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (507), Expect = 2e-60
Identities = 73/274 (26%), Positives = 114/274 (41%), Gaps = 21/274 (7%)
Query: 229 DKFSEAMKIGEGGYGPVYRGKL-DHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMV 287
+ ++G G +G V+ G HT VA+K L+ + F E ++ ++H +V
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLV 71
Query: 288 LLLGACPDYG-CLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKP 346
L ++ EYM NGSL D L + K +AA+IA + F+ +
Sbjct: 72 RLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEE--- 127
Query: 347 EPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQ 406
+HRDL+ ANIL+ KI+D GLARL+ + A + PE
Sbjct: 128 RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN-----EYTAREGAKFPIKWTAPEAI 182
Query: 407 QTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAVTDWPAEAAE 466
G T KSD++SFGI+L +I+T I+ + P E
Sbjct: 183 NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQN-----LERGYRMVRPDNCPE 237
Query: 467 SFSKLAIQCAELRKKDRPDLGTVIVPELNRLKDL 500
+L C + R +DRP + + L+D
Sbjct: 238 ELYQLMRLCWKERPEDRPTFDYL----RSVLEDF 267
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (499), Expect = 2e-59
Identities = 65/269 (24%), Positives = 112/269 (41%), Gaps = 20/269 (7%)
Query: 236 KIGEGGYGPVYRGKL-DHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGAC- 293
+IG G +G V+ G + VAIK +R A + F +E EV+ + HP +V L G C
Sbjct: 12 EIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCL 70
Query: 294 -PDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHR 352
CLV+E+M +G L D R + + ++ + + ++HR
Sbjct: 71 EQAPICLVFEFMEHGCLSD--YLRTQRGLFAAETLLGMCLDVCEG---MAYLEEACVIHR 125
Query: 353 DLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLT 412
DL N L+ N V K+SD G+ R V T + PE +
Sbjct: 126 DLAARNCLVGENQVIKVSDFGMTRFVLDD-----QYTSSTGTKFPVKWASPEVFSFSRYS 180
Query: 413 TKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAVTDWPAEAAESFSKLA 472
+KSD++SFG+++ ++ + S +E + P A+ ++
Sbjct: 181 SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVED-----ISTGFRLYKPRLASTHVYQIM 235
Query: 473 IQCAELRKKDRPDLGTVIVPELNRLKDLG 501
C + R +DRP + + +L + + G
Sbjct: 236 NHCWKERPEDRPAFSRL-LRQLAEIAESG 263
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (498), Expect = 3e-59
Identities = 68/273 (24%), Positives = 113/273 (41%), Gaps = 24/273 (8%)
Query: 229 DKFSEAMKIGEGGYGPVYRGKLDHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVL 288
+ IG+G +G V G VA+K ++ DA + F E V++ +RH N+V
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQ 64
Query: 289 LLGAC---PDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAK 345
LLG +V EYM GSL D L RG + + K + ++ A+ +L
Sbjct: 65 LLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEG-- 121
Query: 346 PEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEY 405
VHRDL N+L+ + V+K+SD GL + + + + PE
Sbjct: 122 -NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---------QDTGKLPVKWTAPEA 171
Query: 406 QQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAVTDWPAEAA 465
+ +TKSD++SFGI+L +I + + + + + D P
Sbjct: 172 LREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR-----VEKGYKMDAPDGCP 226
Query: 466 ESFSKLAIQCAELRKKDRPDLGTVIVPELNRLK 498
+ ++ C L RP + +L +K
Sbjct: 227 PAVYEVMKNCWHLDAAMRPSFLQL-REQLEHIK 258
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 196 bits (498), Expect = 7e-59
Identities = 77/308 (25%), Positives = 126/308 (40%), Gaps = 32/308 (10%)
Query: 219 YTIEEIEEATDKFSEAM---------KIGEGGYGPVYRGKLDHT-----PVAIKVLRPDA 264
+T E+ EA +F++ + IG G +G V G L VAIK L+
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 265 -AQGKRQFQQEVEVLSSIRHPNMVLLLGAC--PDYGCLVYEYMHNGSLEDRLLRRGNTPV 321
+ +R F E ++ HPN++ L G ++ E+M NGSL+ R N
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDS--FLRQNDGQ 124
Query: 322 IPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPS 381
+ + IA + +L VHRDL NIL++ N V K+SD GL+R +
Sbjct: 125 FTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181
Query: 382 VADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVS 441
+D T + PE Q T+ SD++S+GI++ ++++
Sbjct: 182 TSDP-TYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ 240
Query: 442 RAIEKGTLAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPELNRLKDLG 501
I L P P + + +L + C + + RP G + +N L +
Sbjct: 241 DVINAIEQDYRLPP-----PMDCPSALHQLMLDCWQKDRNHRPKFGQI----VNTLDKMI 291
Query: 502 RKLESNKS 509
R S K+
Sbjct: 292 RNPNSLKA 299
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (498), Expect = 2e-58
Identities = 56/215 (26%), Positives = 101/215 (46%), Gaps = 18/215 (8%)
Query: 224 IEEATDKFSEAMKIGEGGYGPVYRGKLDHT--PVAIKVLRPDAAQG-KRQFQQEVEVLSS 280
+E D F + ++G G G V++ + +A K++ + + Q +E++VL
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 281 IRHPNMVLLLGAC--PDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATAL 338
P +V GA + E+M GSL+ L + G IP + K++ + L
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGL 117
Query: 339 LFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTF 398
+L + ++HRD+KP+NIL++ K+ D G++ + S+ S GT
Sbjct: 118 TYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--------ANSFVGTR 167
Query: 399 CYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSP 433
Y+ PE Q + +SDI+S G+ L+++ R P
Sbjct: 168 SYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (493), Expect = 3e-58
Identities = 71/309 (22%), Positives = 127/309 (41%), Gaps = 37/309 (11%)
Query: 222 EEIEEATDKFS-EAMKIGEGGYGPVYRGKL----DHTPVAIKVLRPDAAQG-KRQFQQEV 275
+++ D +++G G +G V +G VAIKVL+ + + +E
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60
Query: 276 EVLSSIRHPNMVLLLGACPDYG-CLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEI 334
+++ + +P +V L+G C LV E G L L+ + IP ++ ++
Sbjct: 61 QIMHQLDNPYIVRLIGVCQAEALMLVMEMAGGGPLHKFLVGKREE--IPVSNVAELLHQV 118
Query: 335 ATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSA 394
+ + +L + + VHRDL N+LL + +KISD GL++ + D ++
Sbjct: 119 SMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGA---DDSYYTARSAG 172
Query: 395 AGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSP--MGLTH-HVSRAIEKGTLAE 451
+ PE +++SD++S+G+ + + ++ + V IE+G E
Sbjct: 173 KWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRME 232
Query: 452 MLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPELNRLKDLGRKLESNKSYG 511
P E L C + +DRPD TV R++ L S
Sbjct: 233 C--------PPECPPELYALMSDCWIYKWEDRPDFLTV----EQRMRACYYSLAS----- 275
Query: 512 YAKREGHSH 520
K EGH H
Sbjct: 276 --KVEGHHH 282
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (488), Expect = 6e-58
Identities = 60/268 (22%), Positives = 113/268 (42%), Gaps = 23/268 (8%)
Query: 236 KIGEGGYGPVYRGKL-DHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGAC- 293
++G G +G V GK VAIK+++ + + +F +E +V+ ++ H +V L G C
Sbjct: 11 ELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCT 69
Query: 294 -PDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHR 352
++ EYM NG L + L + ++ ++ ++ A+ +L + +HR
Sbjct: 70 KQRPIFIITEYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAMEYLES---KQFLHR 124
Query: 353 DLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLT 412
DL N L++ V K+SD GL+R V + + PE +
Sbjct: 125 DLAARNCLVNDQGVVKVSDFGLSRYVLDD-----EYTSSVGSKFPVRWSPPEVLMYSKFS 179
Query: 413 TKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAVTDWPAEAAESFSKLA 472
+KSDI++FG+++ +I + S E + P A+E +
Sbjct: 180 SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH-----IAQGLRLYRPHLASEKVYTIM 234
Query: 473 IQCAELRKKDRPDLGTVIVPELNRLKDL 500
C + +RP + L+ + D+
Sbjct: 235 YSCWHEKADERPTFKIL----LSNILDV 258
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (479), Expect = 6e-56
Identities = 74/304 (24%), Positives = 126/304 (41%), Gaps = 27/304 (8%)
Query: 206 LTALANNDVRYRKYTIEEIEEATDKFSEAMKIGEGGYGPVYRGKLDHT-----PVAIKVL 260
L+AL V+ ++ + F+E IG G +G VY G L A+K L
Sbjct: 6 LSALNPELVQAVQHVVIGPSSLIVHFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSL 63
Query: 261 RPDAAQGK-RQFQQEVEVLSSIRHPNMVLLLGAC---PDYGCLVYEYMHNGSLEDRLLRR 316
G+ QF E ++ HPN++ LLG C +V YM +G L + +
Sbjct: 64 NRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE 123
Query: 317 GNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLAR 376
+ P + F + + + VHRDL N +LD + K++D GLAR
Sbjct: 124 THNPTVKDLIGFGLQVAKG-----MKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 178
Query: 377 LVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGL 436
+ DSV + T A ++ E QT TTKSD++SFG++L +++T +P
Sbjct: 179 DMYDKEFDSVH--NKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 236
Query: 437 THHVSRAIEKGTLAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPELNR 496
+ +L P + ++ ++C + + RP + ++R
Sbjct: 237 DVNTFDITVY-----LLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSEL----VSR 287
Query: 497 LKDL 500
+ +
Sbjct: 288 ISAI 291
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (473), Expect = 4e-55
Identities = 69/315 (21%), Positives = 113/315 (35%), Gaps = 52/315 (16%)
Query: 217 RKYTIEEIEEATDKFSEAMKIGEGGYGPVYRGKLDHTPVAIKVLRPDAAQGKRQFQQEVE 276
R ++E IG+G +G V+RGK VA+K+ + + E+
Sbjct: 3 RTIVLQE------------SIGKGRFGEVWRGKWRGEEVAVKIFSSREER-SWFREAEIY 49
Query: 277 VLSSIRHPNMVLLLGACPDYG------CLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKI 330
+RH N++ + A LV +Y +GSL D L R + K+
Sbjct: 50 QTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT----VTVEGMIKL 105
Query: 331 AAEIATALLFLHQ-----AKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADS 385
A A+ L LH + HRDLK NIL+ +N I+D+GLA +
Sbjct: 106 ALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSA--TD 163
Query: 386 VTQYHMTSAAGTFCYIDPEYQQTGM------LTTKSDIYSFGIMLLQIITARSPMG---- 435
GT Y+ PE + ++DIY+ G++ +I S G
Sbjct: 164 TIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED 223
Query: 436 ---------LTHHVSRAIEKGTLAEMLDPAVTDW--PAEAAESFSKLAIQCAELRKKDRP 484
+ + K + L P + + EA +K+ +C R
Sbjct: 224 YQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARL 283
Query: 485 DLGTVIVPELNRLKD 499
+ L++L
Sbjct: 284 TALRI-KKTLSQLSQ 297
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (471), Expect = 4e-55
Identities = 77/270 (28%), Positives = 119/270 (44%), Gaps = 19/270 (7%)
Query: 223 EIEEATDKFSEAMKIGEGGYGPVYRGKLDHT-PVAIKVLRPDAAQGKRQFQQEVEVLSSI 281
EI + +K+G+G +G V+ G + T VAIK L+P F QE +V+ +
Sbjct: 13 EIPR--ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKL 69
Query: 282 RHPNMVLLLGAC-PDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLF 340
RH +V L + +V EYM GSL D L + + +AA+IA+ + +
Sbjct: 70 RHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAY 128
Query: 341 LHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCY 400
+ + VHRDL+ ANIL+ N V K++D GLARL+ + A +
Sbjct: 129 VERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDN-----EYTARQGAKFPIKW 180
Query: 401 IDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAVTDW 460
PE G T KSD++SFGI+L ++ T +++ +
Sbjct: 181 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ-----VERGYRMPC 235
Query: 461 PAEAAESFSKLAIQCAELRKKDRPDLGTVI 490
P E ES L QC ++RP +
Sbjct: 236 PPECPESLHDLMCQCWRKEPEERPTFEYLQ 265
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (469), Expect = 6e-55
Identities = 73/290 (25%), Positives = 123/290 (42%), Gaps = 42/290 (14%)
Query: 212 NDVRYRKYTIEEIEEATDKFSEAMKIGEGGYGPVYRGKLDHT--PVAIKVLRPDAA--QG 267
ND R+ K+ I +IG G + VY+G T VA L+
Sbjct: 6 NDGRFLKFDI--------------EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSE 51
Query: 268 KRQFQQEVEVLSSIRHPNMVLLLGACPDYG------CLVYEYMHNGSLEDRLLRRGNTPV 321
+++F++E E+L ++HPN+V + LV E M +G+L+ L R V
Sbjct: 52 RQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK---V 108
Query: 322 IPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILL-DRNYVSKISDVGLARLVPP 380
+ + +I L FLH P P++HRDLK NI + KI D+GLA L
Sbjct: 109 MKIKVLRSWCRQILKGLQFLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 167
Query: 381 SVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHV 440
S A +V GT ++ PE + D+Y+FG+ +L++ T+ P +
Sbjct: 168 SFAKAV--------IGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNA 218
Query: 441 SRAIEKGTLAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVI 490
++ + + + PA + A ++ C K +R + ++
Sbjct: 219 AQIYRR--VTSGVKPA--SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLL 264
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (468), Expect = 1e-54
Identities = 73/293 (24%), Positives = 122/293 (41%), Gaps = 25/293 (8%)
Query: 223 EIEEATDKFSEAMKIGEGGYGPVYRGKLDHT------PVAIKVLRPDAAQGKR-QFQQEV 275
EI + IG G +G VY+G L + PVAIK L+ + +R F E
Sbjct: 3 EIH--PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEA 60
Query: 276 EVLSSIRHPNMVLLLGACPDYG--CLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAE 333
++ H N++ L G Y ++ EYM NG+L+ R + +
Sbjct: 61 GIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDK--FLREKDGEFSVLQLVGMLRG 118
Query: 334 IATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTS 393
IA + +L VHRDL NIL++ N V K+SD GL+R++ D Y +
Sbjct: 119 IAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED---DPEATYTTSG 172
Query: 394 AAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEML 453
+ PE T+ SD++SFGI++ +++T ++ +
Sbjct: 173 GKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKA-----IN 227
Query: 454 DPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPELNRLKDLGRKLES 506
D P + + +L +QC + + RP + V L++L L++
Sbjct: 228 DGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADI-VSILDKLIRAPDSLKT 279
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (466), Expect = 2e-54
Identities = 60/273 (21%), Positives = 105/273 (38%), Gaps = 23/273 (8%)
Query: 229 DKFSEAMKIGEGGYGPVYRG--KLDHTPVAIKVLRPDAA--QGKRQFQQEVEVLSSIRHP 284
+ + IG G YG + K D + K L + K+ EV +L ++HP
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63
Query: 285 NMVLLLGACPDYG----CLVYEYMHNGSLEDRLLRRG-NTPVIPWRKRFKIAAEIATALL 339
N+V D +V EY G L + + + ++ ++ AL
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 340 FLHQAKPE--PLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGT 397
H+ ++HRDLKPAN+ LD K+ D GLAR++ + GT
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH------DTSFAKAFVGT 177
Query: 398 FCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAV 457
Y+ PE KSDI+S G +L ++ P +K ++ +
Sbjct: 178 PYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS------QKELAGKIREGKF 231
Query: 458 TDWPAEAAESFSKLAIQCAELRKKDRPDLGTVI 490
P ++ +++ + L+ RP + ++
Sbjct: 232 RRIPYRYSDELNEIITRMLNLKDYHRPSVEEIL 264
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (466), Expect = 2e-54
Identities = 59/265 (22%), Positives = 108/265 (40%), Gaps = 27/265 (10%)
Query: 236 KIGEGGYGPVYRGKLDHT----PVAIKVLRPDAAQG--KRQFQQEVEVLSSIRHPNMVLL 289
++G G +G V +G VA+K+L+ +A K + E V+ + +P +V +
Sbjct: 14 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73
Query: 290 LGAC-PDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEP 348
+G C + LV E G L L + + + + ++ +++ + +L +
Sbjct: 74 IGICEAESWMLVMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLEE---SN 127
Query: 349 LVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQT 408
VHRDL N+LL + +KISD GL++ + T + PE
Sbjct: 128 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA---QTHGKWPVKWYAPECINY 184
Query: 409 GMLTTKSDIYSFGIMLLQIITARSP--MGLTHH-VSRAIEKGTLAEMLDPAVTDWPAEAA 465
++KSD++SFG+++ + + G+ V+ +EKG PA
Sbjct: 185 YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMG--------CPAGCP 236
Query: 466 ESFSKLAIQCAELRKKDRPDLGTVI 490
L C ++RP V
Sbjct: 237 REMYDLMNLCWTYDVENRPGFAAVE 261
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 183 bits (465), Expect = 4e-54
Identities = 72/308 (23%), Positives = 124/308 (40%), Gaps = 44/308 (14%)
Query: 221 IEEIEEATDKFSEAMKIGEGGYGPVYRGKL-------DHTPVAIKVLRPDAAQG-KRQFQ 272
+ +E + IGEG +G V++ + T VA+K+L+ +A+ + FQ
Sbjct: 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ 64
Query: 273 QEVEVLSSIRHPNMVLLLGAC--PDYGCLVYEYMHNGSLEDRLLRRG------------- 317
+E +++ +PN+V LLG C CL++EYM G L + L
Sbjct: 65 REAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLS 124
Query: 318 --------NTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKI 369
P + ++ IA ++A + +L + K VHRDL N L+ N V KI
Sbjct: 125 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKF---VHRDLATRNCLVGENMVVKI 181
Query: 370 SDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT 429
+D GL+R + + + A ++ PE TT+SD++++G++L +I +
Sbjct: 182 ADFGLSRNIYSADYYKAD----GNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 237
Query: 430 ARSPMGLTHHVSRAIEKGTLAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTV 489
I + D + P L C DRP ++
Sbjct: 238 YGLQPYYGMAHEEVIYY-----VRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSI 292
Query: 490 IVPELNRL 497
L R+
Sbjct: 293 -HRILQRM 299
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 182 bits (462), Expect = 1e-53
Identities = 73/287 (25%), Positives = 123/287 (42%), Gaps = 27/287 (9%)
Query: 216 YRKYTIEEIEEATDKFSEAMKIGEGGYGPVYRGKLDHT--PVAIKVLRPDAAQGKRQFQQ 273
Y K+ +E + K+G G YG VY G VA+K L+ D + + F +
Sbjct: 9 YDKWEMER-----TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-FLK 62
Query: 274 EVEVLSSIRHPNMVLLLGAC--PDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIA 331
E V+ I+HPN+V LLG C ++ E+M G+L D L + +A
Sbjct: 63 EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VSAVVLLYMA 121
Query: 332 AEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHM 391
+I++A+ +L + + +HRDL N L+ N++ K++D GL+RL+ T
Sbjct: 122 TQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD-----TYTAH 173
Query: 392 TSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAE 451
A + PE + KSD+++FG++L +I T I+ + E
Sbjct: 174 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP------YPGIDLSQVYE 227
Query: 452 MLDPAVT-DWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPELNRL 497
+L+ + P E +L C + DRP + +
Sbjct: 228 LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI-HQAFETM 273
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (459), Expect = 2e-53
Identities = 61/260 (23%), Positives = 109/260 (41%), Gaps = 28/260 (10%)
Query: 236 KIGEGGYGPVYRGKLDHT--PVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGAC 293
++G+G +G VY+ + T A KV+ + + + E+++L+S HPN+V LL A
Sbjct: 19 ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 78
Query: 294 --PDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVH 351
+ ++ E+ G+++ +L + + + + AL +LH K ++H
Sbjct: 79 YYENNLWILIEFCAGGAVDAVMLELERP--LTESQIQVVCKQTLDALNYLHDNK---IIH 133
Query: 352 RDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGML 411
RDLK NIL + K++D G++ T S GT ++ PE
Sbjct: 134 RDLKAGNILFTLDGDIKLADFGVSAKNTR------TIQRRDSFIGTPYWMAPEVVMCETS 187
Query: 412 -----TTKSDIYSFGIMLLQIITARSP-MGLTHH-VSRAIEKGTLAEMLDPAVTDWPAEA 464
K+D++S GI L+++ P L V I K +P P+
Sbjct: 188 KDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKS------EPPTLAQPSRW 241
Query: 465 AESFSKLAIQCAELRKKDRP 484
+ +F +C E R
Sbjct: 242 SSNFKDFLKKCLEKNVDARW 261
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 1e-52
Identities = 71/274 (25%), Positives = 116/274 (42%), Gaps = 25/274 (9%)
Query: 236 KIGEGGYGPVYRGKLDHT-----PVAIKVLRPDAA---QGKRQFQQEVEVLSSIRHPNMV 287
K+G+G +G V RG+ D VA+K L+PD + F +EV + S+ H N++
Sbjct: 15 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 74
Query: 288 LLLGACPDYG-CLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKP 346
L G +V E GSL DRL + ++ R A ++A + +L
Sbjct: 75 RLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSR--YAVQVAEGMGYLES--- 129
Query: 347 EPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQ 406
+ +HRDL N+LL + KI D GL R +P + V Q F + PE
Sbjct: 130 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQ---EHRKVPFAWCAPESL 186
Query: 407 QTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAVTDWPAEAAE 466
+T + SD + FG+ L ++ T + + S+ + K P D P +
Sbjct: 187 KTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYN 246
Query: 467 SFSKLAIQCAELRKKDRPDLGTVIVPELNRLKDL 500
+ +QC + +DRP + + L +
Sbjct: 247 ----VMVQCWAHKPEDRPTFVAL----RDFLLEA 272
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (450), Expect = 6e-52
Identities = 64/269 (23%), Positives = 109/269 (40%), Gaps = 21/269 (7%)
Query: 220 TIEEIEEATDKFSEAMKIGEGGYGPVYRG--KLDHTPVAIKVLRPDAAQGKRQFQQEVEV 277
+I + + K++ KIG+G G VY VAI+ + K E+ V
Sbjct: 11 SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILV 70
Query: 278 LSSIRHPNMVLLLGAC--PDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIA 335
+ ++PN+V L + D +V EY+ GSL D + + + E
Sbjct: 71 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM----DEGQIAAVCRECL 126
Query: 336 TALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAA 395
AL FLH + ++HRD+K NILL + K++D G + + Q ++
Sbjct: 127 QALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQI------TPEQSKRSTMV 177
Query: 396 GTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDP 455
GT ++ PE K DI+S GIM +++I P + RA+ +
Sbjct: 178 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYL-NENPLRALYLIATNGTPEL 236
Query: 456 AVTDWPAEAAESFSKLAIQCAELRKKDRP 484
P + + F +C ++ + R
Sbjct: 237 ---QNPEKLSAIFRDFLNRCLDMDVEKRG 262
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (442), Expect = 4e-51
Identities = 68/283 (24%), Positives = 118/283 (41%), Gaps = 39/283 (13%)
Query: 217 RKYTIEEIEEATDKFSEAMKIGEGGYGPVYRGKLDHT--PVAIKVLRPDA---AQGKRQF 271
R++ +E+ F +G+G +G VY + + +A+KVL A + Q
Sbjct: 1 RQWALED-------FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQL 53
Query: 272 QQEVEVLSSIRHPNMVLLLGAC--PDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFK 329
++EVE+ S +RHPN++ L G L+ EY G++ L + ++
Sbjct: 54 RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTAT 110
Query: 330 IAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQY 389
E+A AL + H + ++HRD+KP N+LL KI+D G + P S
Sbjct: 111 YITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-------- 159
Query: 390 HMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVS--RAIEKG 447
T+ GT Y+ PE + M K D++S G++ + + + P + + I +
Sbjct: 160 RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV 219
Query: 448 TLAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVI 490
+P E L + + RP L V+
Sbjct: 220 EF---------TFPDFVTEGARDLISRLLKHNPSQRPMLREVL 253
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (445), Expect = 4e-51
Identities = 80/303 (26%), Positives = 126/303 (41%), Gaps = 43/303 (14%)
Query: 229 DKFSEAMKIGEGGYGPVYRGKLDHT----PVAIKVLRPDAA-QGKRQFQQEVEVLSSI-R 282
+ IGEG +G V + ++ AIK ++ A+ R F E+EVL +
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 283 HPNMVLLLGAC--PDYGCLVYEYMHNGSLEDRLLRR-------------GNTPVIPWRKR 327
HPN++ LLGAC Y L EY +G+L D L + + ++
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 328 FKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVT 387
AA++A + +L Q + +HRDL NIL+ NYV+KI+D GL+R V
Sbjct: 130 LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV----- 181
Query: 388 QYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKG 447
T ++ E + TT SD++S+G++L +I++ + EK
Sbjct: 182 --KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 239
Query: 448 TLAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPELNRLKDLGRKLESN 507
L+ P + L QC + +RP + L L R LE
Sbjct: 240 PQGYRLEK-----PLNCDDEVYDLMRQCWREKPYERPSFAQI-------LVSLNRMLEER 287
Query: 508 KSY 510
K+Y
Sbjct: 288 KTY 290
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (439), Expect = 1e-50
Identities = 54/262 (20%), Positives = 96/262 (36%), Gaps = 20/262 (7%)
Query: 229 DKFSEAMKIGEGGYGPVYRG--KLDHTPVAIKVLRPD-AAQGKRQFQQEVEVLSSIRHPN 285
+ + +GEG YG V ++ VA+K++ A ++E+ + + H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 286 MVLLLGAC--PDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQ 343
+V G + L EY G L DR+ +P + ++ +++LH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG---MPEPDAQRFFHQLMAGVVYLHG 121
Query: 344 AKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDP 403
+ HRD+KP N+LLD KISD GLA + + + + + GT Y+ P
Sbjct: 122 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL----LNKMCGTLPYVAP 174
Query: 404 EYQQTGML-TTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAVTDWPA 462
E + D++S GI+L ++ P + + +
Sbjct: 175 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDS 234
Query: 463 EAAESFSKLAIQCAELRKKDRP 484
L + R
Sbjct: 235 APLA----LLHKILVENPSARI 252
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 174 bits (441), Expect = 2e-50
Identities = 69/306 (22%), Positives = 114/306 (37%), Gaps = 45/306 (14%)
Query: 225 EEATDKFSEAMKIGEGGYGPVYRG--KLDHTPVAIKVLRPDAAQGK---RQFQQEVEVLS 279
++ FS+ +IG G +G VY + VAIK + Q + +EV L
Sbjct: 11 DDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ 70
Query: 280 SIRHPNMVLLLGAC--PDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATA 337
+RHPN + G LV EY + + + + + + +
Sbjct: 71 KLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP---LQEVEIAAVTHGALQG 127
Query: 338 LLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGT 397
L +LH ++HRD+K NILL + K+ D G A ++ P S GT
Sbjct: 128 LAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----------ANSFVGT 174
Query: 398 FCYIDPEY---QQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLD 454
++ PE G K D++S GI +++ + P+ + +S A+ E
Sbjct: 175 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-ALYHIAQNESPA 233
Query: 455 PAVTDWPAEAAESFSKLAIQCAELRKKDRPDLG--------------TVIVPELNRLKDL 500
W C + +DRP TVI+ + R KD
Sbjct: 234 LQSGHWSEYFRN----FVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTKDA 289
Query: 501 GRKLES 506
R+L++
Sbjct: 290 VRELDN 295
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (436), Expect = 1e-49
Identities = 69/345 (20%), Positives = 129/345 (37%), Gaps = 51/345 (14%)
Query: 229 DKFSEAMKIGEGGYGPVYRGKLDHT------PVAIKVLRPDA-AQGKRQFQQEVEVLSSI 281
+F + +G G +G VY+G PVAIK LR + ++ E V++S+
Sbjct: 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 68
Query: 282 RHPNMVLLLGACPDYG-CLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLF 340
+P++ LLG C L+ + M G L D + + + +IA + +
Sbjct: 69 DNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNI--GSQYLLNWCVQIAKGMNY 126
Query: 341 LHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCY 400
L LVHRDL N+L+ KI+D GLA+L+ +YH +
Sbjct: 127 LED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE----KEYHAEGGKVPIKW 179
Query: 401 IDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPM--GLTHH-VSRAIEKGTLAEMLDPAV 457
+ E + T +SD++S+G+ + +++T S G+ +S +EKG
Sbjct: 180 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ----- 234
Query: 458 TDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPELNRLKDLGRKLESNKSYGYAKREG 517
P + ++C + RP + + + R +
Sbjct: 235 ---PPICTIDVYMIMVKCWMIDADSRPKFREL----IIEFSKMARDPQ------------ 275
Query: 518 HSHSGSGRTSHTRSNVPRSPPPLSSSSYSNSRISNPSSSQMEDSS 562
R + + P + S++ + + + D+
Sbjct: 276 -------RYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDAD 313
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (435), Expect = 1e-49
Identities = 68/288 (23%), Positives = 115/288 (39%), Gaps = 37/288 (12%)
Query: 229 DKFSEAMKIGEGGYGPVYRGKL-------DHTPVAIKVLRPDAAQGKRQ-FQQEVEVLSS 280
++ S +G G +G V VA+K+L+P A +R+ E++VLS
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 281 I-RHPNMVLLLGAC--PDYGCLVYEYMHNGSLEDRLLRRGNTPV---------------I 322
+ H N+V LLGAC ++ EY G L + L R+ ++ + +
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 323 PWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSV 382
+ ++A + FL + +HRDL NILL ++KI D GLAR +
Sbjct: 143 DLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 383 ADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSR 442
V +A ++ PE + T +SD++S+GI L ++ + S V
Sbjct: 200 NYVVK----GNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS 255
Query: 443 AIEKGTLAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVI 490
K + PAE + + C + RP ++
Sbjct: 256 KFYKMIKEGFRMLSPEHAPAEMYD----IMKTCWDADPLKRPTFKQIV 299
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (431), Expect = 4e-49
Identities = 68/289 (23%), Positives = 118/289 (40%), Gaps = 29/289 (10%)
Query: 219 YTIEEIEEATDKFSEAMKIGEGGYGPVYRGKL-------DHTPVAIKVLRPDAAQGKR-Q 270
Y +E E A +K + + ++G+G +G VY G T VAIK + A+ +R +
Sbjct: 10 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE 69
Query: 271 FQQEVEVLSSIRHPNMVLLLGAC--PDYGCLVYEYMHNGSLEDRLLRRG-------NTPV 321
F E V+ ++V LLG ++ E M G L+ L
Sbjct: 70 FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAP 129
Query: 322 IPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPS 381
K ++A EIA + +L+ VHRDL N ++ ++ KI D G+ R +
Sbjct: 130 PSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY-- 184
Query: 382 VADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVS 441
++ ++ PE + G+ TT SD++SFG++L +I T
Sbjct: 185 --ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE 242
Query: 442 RAIEKGTLAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVI 490
+ + +++ + D P + +L C + K RP +I
Sbjct: 243 QVLRF-----VMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEII 286
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (431), Expect = 6e-49
Identities = 67/286 (23%), Positives = 110/286 (38%), Gaps = 42/286 (14%)
Query: 236 KIGEGGYGPVYRGKLDHT-------PVAIKVLRPDAAQGKRQ-FQQEVEVLSSI-RHPNM 286
+G G +G V VA+K+L+ A +R+ E+++++ + H N+
Sbjct: 44 VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 103
Query: 287 VLLLGAC--PDYGCLVYEYMHNGSLEDRLLRRG--------------------NTPVIPW 324
V LLGAC L++EY G L + L + + V+ +
Sbjct: 104 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 163
Query: 325 RKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVAD 384
A ++A + FL + VHRDL N+L+ V KI D GLAR +
Sbjct: 164 EDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMS---- 216
Query: 385 SVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAI 444
+A ++ PE G+ T KSD++S+GI+L +I + V
Sbjct: 217 DSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANF 276
Query: 445 EKGTLAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVI 490
K + + D P A E + C + RP +
Sbjct: 277 YK----LIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLT 318
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 168 bits (427), Expect = 6e-48
Identities = 68/341 (19%), Positives = 130/341 (38%), Gaps = 33/341 (9%)
Query: 236 KIGEGGYGPVYRG--KLDHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGAC 293
++G G +G V+R + A K + K ++E++ +S +RHP +V L A
Sbjct: 33 ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 92
Query: 294 --PDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVH 351
+ ++YE+M G L +++ N + + + ++ L +H+ VH
Sbjct: 93 EDDNEMVMIYEFMSGGELFEKVADEHNK--MSEDEAVEYMRQVCKGLCHMHENN---YVH 147
Query: 352 RDLKPANILL--DRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTG 409
DLKP NI+ R+ K+ D GL + P + + GT + PE +
Sbjct: 148 LDLKPENIMFTTKRSNELKLIDFGLTAHLDP-------KQSVKVTTGTAEFAAPEVAEGK 200
Query: 410 MLTTKSDIYSFGIMLLQIITARSPMGLTHHVS--RAIEKGTLAEMLDPAVTDWPAEAAES 467
+ +D++S G++ +++ SP G + R ++ M D A + + +
Sbjct: 201 PVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDW-NMDDSAFSGISEDGKD- 258
Query: 468 FSKLAIQCAELRKKDRPDLGTVIV-PELNRLKDLGRKLESNKSYGYAKREGHSHSGSGRT 526
+ R + + P L GR + S R+
Sbjct: 259 ---FIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIRD-------SIK 308
Query: 527 SHTRSNVPRSPPPLSSSSYSNSRISNPSSSQMEDSSIEHEE 567
+ + PP S+YS+ R P + D+ + E
Sbjct: 309 TKYDAWPEPLPPLGRISNYSSLRKHRPQEYSIRDAFWDRSE 349
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (420), Expect = 7e-48
Identities = 61/281 (21%), Positives = 105/281 (37%), Gaps = 29/281 (10%)
Query: 236 KIGEGGYGPVYRGKLDHT-----PVAIKVLRPDAAQGKRQ-FQQEVEVLSSIRHPNMVLL 289
IGEG +G V++G VAIK + + R+ F QE + HP++V L
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 290 LGACPDYG-CLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEP 348
+G + ++ E G L + + A +++TAL +L +
Sbjct: 74 IGVITENPVWIIMELCTLGELRS--FLQVRKYSLDLASLILYAYQLSTALAYLESKR--- 128
Query: 349 LVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQT 408
VHRD+ N+L+ N K+ D GL+R + S T Y + ++ PE
Sbjct: 129 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS-----TYYKASKGKLPIKWMAPESINF 183
Query: 409 GMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAVTDWPAEAAESF 468
T+ SD++ FG+ + +I+ + I + + + P +
Sbjct: 184 RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR-----IENGERLPMPPNCPPTL 238
Query: 469 SKLAIQCAELRKKDRPDLGTVIVPELNRLKDLGRKLESNKS 509
L +C RP + L LE K+
Sbjct: 239 YSLMTKCWAYDPSRRPRFTEL-------KAQLSTILEEEKA 272
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 162 bits (412), Expect = 6e-46
Identities = 65/366 (17%), Positives = 138/366 (37%), Gaps = 40/366 (10%)
Query: 216 YRKYTIEEIEEAT----DKFSEAMKIGEGGYGPVYRG--KLDHTPVAIKVLRPDAAQGKR 269
++KY + +E D + ++G G +G V+R K K + K
Sbjct: 12 WKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKY 71
Query: 270 QFQQEVEVLSSIRHPNMVLLLGAC--PDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKR 327
+ E+ +++ + HP ++ L A L+ E++ G L DR+ + +
Sbjct: 72 TVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYK--MSEAEV 129
Query: 328 FKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVS--KISDVGLARLVPPSVADS 385
+ L +H+ +VH D+KP NI+ + S KI D GLA + P D
Sbjct: 130 INYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNP---DE 183
Query: 386 VTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVS--RA 443
+ + T + PE + +D+++ G++ +++ SP + +
Sbjct: 184 IVKVTT----ATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQN 239
Query: 444 IEKGTLAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIV-PELNR-LKDLG 501
+++ E + A + EA + + + R + + P L +L
Sbjct: 240 VKRCDW-EFDEDAFSSVSPEAKD----FIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLT 294
Query: 502 RKLESNKSYGYAKREGHSHSGSGRTSHTRSNVPRSPPPLSSSSYSNSRISNPSSSQMEDS 561
++ S++ ++ ++ P +++S+ R P Q+ DS
Sbjct: 295 SRIPSSRYNKIRQKIKEKYA---------DWPAPQPAIGRIANFSSLRKHRPQEYQIYDS 345
Query: 562 SIEHEE 567
+ +E
Sbjct: 346 YFDRKE 351
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 160 bits (406), Expect = 8e-46
Identities = 65/283 (22%), Positives = 122/283 (43%), Gaps = 23/283 (8%)
Query: 228 TDKFSEAMKIGEGGYGPVYRG--KLDHTPVAIKVLRPDAAQGK---RQFQQEVEVLSSIR 282
+D++ +G GG V+ H VA+KVLR D A+ +F++E + +++
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 283 HPNMVLLLGACPD------YGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIAT 336
HP +V + +V EY+ +L D + G + ++ ++ A+
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQ 122
Query: 337 ALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAG 396
AL F HQ ++HRD+KPANI++ K+ D G+AR + + + G
Sbjct: 123 ALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIAD---SGNSVTQTAAVIG 176
Query: 397 TFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPA 456
T Y+ PE + + +SD+YS G +L +++T P VS A + + E P
Sbjct: 177 TAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQH--VREDPIPP 234
Query: 457 VTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPELNRLKD 499
+ + ++ ++R + +L R+ +
Sbjct: 235 SARHE-GLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 276
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (402), Expect = 4e-45
Identities = 62/265 (23%), Positives = 100/265 (37%), Gaps = 28/265 (10%)
Query: 229 DKFSEAMKIGEGGYGPVYRG--KLDHTPVAIKVLRPDAA---QGKRQFQQEVEVLSSIRH 283
+ F +GEG + V AIK+L +E +V+S + H
Sbjct: 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 284 PNMVLLLGAC--PDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFL 341
P V L + Y NG L + + G+ AEI +AL +L
Sbjct: 68 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSALEYL 124
Query: 342 HQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYI 401
H + ++HRDLKP NILL+ + +I+D G A+++ P Q S GT Y+
Sbjct: 125 HG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSP----ESKQARANSFVGTAQYV 177
Query: 402 DPEYQQTGMLTTKSDIYSFGIMLLQIITARSP-MGLTHH-VSRAIEKGTLAEMLDPAVTD 459
PE SD+++ G ++ Q++ P + + + I K D
Sbjct: 178 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEY---------D 228
Query: 460 WPAEAAESFSKLAIQCAELRKKDRP 484
+P + L + L R
Sbjct: 229 FPEKFFPKARDLVEKLLVLDATKRL 253
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 155 bits (394), Expect = 4e-44
Identities = 58/278 (20%), Positives = 106/278 (38%), Gaps = 40/278 (14%)
Query: 229 DKFSEAMKIGEGGYGPVYRG--KLDHTPVAIKVLRPDAA---------QGKRQFQQEVEV 277
+ + +G G V R K A+K++ + + +EV++
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 278 LSSIR-HPNMVLLLGACPDYG--CLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEI 334
L + HPN++ L LV++ M G L D L + + ++ KI +
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT---LSEKETRKIMRAL 119
Query: 335 ATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSA 394
+ LH+ +VHRDLKP NILLD + K++D G + + P +
Sbjct: 120 LEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG-------EKLREV 169
Query: 395 AGTFCYIDPEYQQTGML------TTKSDIYSFGIMLLQIITARSPMGLTHHVS--RAIEK 446
GT Y+ PE + M + D++S G+++ ++ P + R I
Sbjct: 170 CGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMS 229
Query: 447 GTLAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRP 484
G + P D+ + L + ++ + R
Sbjct: 230 GNY-QFGSPEWDDYSDTVKD----LVSRFLVVQPQKRY 262
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (397), Expect = 4e-44
Identities = 57/342 (16%), Positives = 130/342 (38%), Gaps = 36/342 (10%)
Query: 225 EEATDKFSEAMKIGEGGYGPVYRG--KLDHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIR 282
+E +K+ A +G G +G V+R K ++ + ++E+ +L+ R
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIAR 59
Query: 283 HPNMVLLLGAC--PDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLF 340
H N++ L + + +++E++ + +R+ + R+ ++ AL F
Sbjct: 60 HRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFE--LNEREIVSYVHQVCEALQF 117
Query: 341 LHQAKPEPLVHRDLKPANILLD--RNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTF 398
LH + H D++P NI+ R+ KI + G AR + P +
Sbjct: 118 LHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG-------DNFRLLFTAP 167
Query: 399 CYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVS--RAIEKGTLAEMLDPA 456
Y PE Q +++T +D++S G ++ +++ +P + I + A
Sbjct: 168 EYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEY-TFDEEA 226
Query: 457 VTDWPAEAAESFSKLAIQCAELRKKDRPDLGTV-----IVPELNRLK-DLGRKLESNKSY 510
+ EA + + +K R + ++ R+ + R L+ + Y
Sbjct: 227 FKEISIEAMD----FVDRLLVKERKSRMTASEALQHPWLKQKIERVSTKVIRTLKHRRYY 282
Query: 511 GYAKREGHSHSGSGRTSHTRSNVPRSPPPLSSSSYSNSRISN 552
++ + S R + + S + ++++
Sbjct: 283 HTLIKKDLNM----VVSAARISCGGAIRSQKGVSVAKVKVAS 320
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 155 bits (393), Expect = 1e-43
Identities = 66/273 (24%), Positives = 110/273 (40%), Gaps = 28/273 (10%)
Query: 222 EEIEEATDKFSEAMKIGEGGYGPVYRG--KLDHTPVAIKVLRPDAAQGKRQ-FQQEVEVL 278
++ E+ D + +G G + V K VAIK + A +GK + E+ VL
Sbjct: 2 KQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVL 61
Query: 279 SSIRHPNMVLLLGAC--PDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIAT 336
I+HPN+V L + L+ + + G L DR++ +G R ++ ++
Sbjct: 62 HKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG---FYTERDASRLIFQVLD 118
Query: 337 ALLFLHQAKPEPLVHRDLKPANILL---DRNYVSKISDVGLARLVPPSVADSVTQYHMTS 393
A+ +LH +VHRDLKP N+L D + ISD GL+++ P +++
Sbjct: 119 AVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG-------SVLST 168
Query: 394 AAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVS--RAIEKGTLAE 451
A GT Y+ PE + D +S G++ ++ P + I K E
Sbjct: 169 ACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEY-E 227
Query: 452 MLDPAVTDWPAEAAESFSKLAIQCAELRKKDRP 484
P D A + E + R
Sbjct: 228 FDSPYWDDISDSAKD----FIRHLMEKDPEKRF 256
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 1e-43
Identities = 67/295 (22%), Positives = 117/295 (39%), Gaps = 39/295 (13%)
Query: 229 DKFSEAMKIGEGGYGPVYRGKL---------DHTPVAIKVLRPDAAQ-GKRQFQQEVEVL 278
D+ +GEG +G V + T VA+K+L+ DA + E+E++
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 279 SSI-RHPNMVLLLGAC--PDYGCLVYEYMHNGSLEDRLLRRGNTPV-------------I 322
I +H N++ LLGAC ++ EY G+L + L R + +
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 323 PWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSV 382
+ A ++A + +L + +HRDL N+L+ + V KI+D GLAR +
Sbjct: 133 SSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 383 ADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSR 442
T ++ PE + T +SD++SFG++L +I T V
Sbjct: 190 YYKKTTNGR----LPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 245
Query: 443 AIEKGTLAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPELNRL 497
+ + + D P+ + C RP + V +L+R+
Sbjct: 246 LFKL-----LKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQL-VEDLDRI 294
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 151 bits (383), Expect = 2e-42
Identities = 53/288 (18%), Positives = 97/288 (33%), Gaps = 24/288 (8%)
Query: 236 KIGEGGYGPVYRG--KLDHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGAC 293
KIG G +G +Y G VAIK+ Q E ++ ++ + + C
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWC 71
Query: 294 ---PDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLV 350
DY +V E + + + +A ++ + + ++H +
Sbjct: 72 GAEGDYNVMVMELLGPSLEDLFNFCSRK---FSLKTVLLLADQMISRIEYIHSKN---FI 125
Query: 351 HRDLKPANIL---LDRNYVSKISDVGLARLVPPSVADSVTQYHMTS-AAGTFCYIDPEYQ 406
HRD+KP N L + + I D GLA+ + Y GT Y
Sbjct: 126 HRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTH 185
Query: 407 QTGMLTTKSDIYSFGIMLLQIITARS--PMGLTHHVSRAIEKGTLAEMLDPAVTDWPAEA 464
+ + D+ S G +L+ + E+ + +M P
Sbjct: 186 LGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYP 245
Query: 465 AESFSKLAIQCAELRKKDRPDLGTVIVPELNRLKDLGRKLESNKSYGY 512
+E F+ C LR D+PD + ++L + + Y +
Sbjct: 246 SE-FATYLNFCRSLRFDDKPDYSYLR----QLFRNLFHRQGFSYDYVF 288
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 150 bits (380), Expect = 5e-42
Identities = 47/290 (16%), Positives = 95/290 (32%), Gaps = 26/290 (8%)
Query: 236 KIGEGGYGPVYRG--KLDHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGAC 293
+IGEG +G ++ G L++ VAIK Q + E + + +
Sbjct: 12 RIGEGSFGVIFEGTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTGIPNVYYF 69
Query: 294 ---PDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLV 350
+ LV + + + L + A ++ + +H+ LV
Sbjct: 70 GQEGLHNVLVIDLLGPSLED---LLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS---LV 123
Query: 351 HRDLKPANILLDRNYVS-----KISDVGLARLVPPSVADSVTQYH-MTSAAGTFCYIDPE 404
+RD+KP N L+ R + D G+ + V Y + +GT Y+
Sbjct: 124 YRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSIN 183
Query: 405 YQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVS--RAIEKGTLAEMLDPAVTDWPA 462
+ + D+ + G + + + P + + E+ + P + + A
Sbjct: 184 THLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP-LRELCA 242
Query: 463 EAAESFSKLAIQCAELRKKDRPDLGTVIVPELNRLKDLGRKLESNKSYGY 512
E F K L PD + + +L + + +
Sbjct: 243 GFPEEFYKYMHYARNLAFDATPDYDYLQ----GLFSKVLERLNTTEDENF 288
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 1e-41
Identities = 61/264 (23%), Positives = 99/264 (37%), Gaps = 27/264 (10%)
Query: 229 DKFSEAMKIGEGGYGPVYRGKLDHT--PVAIKVLRPDAAQGKRQ---FQQEVEVLS-SIR 282
+ F +G+G +G V+ + T AIK L+ D E VLS +
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 283 HPNMVLLLGAC--PDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLF 340
HP + + + V EY++ G L + + AAEI L F
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK---FDLSRATFYAAEIILGLQF 118
Query: 341 LHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCY 400
LH +V+RDLK NILLD++ KI+D G+ + + GT Y
Sbjct: 119 LHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLG------DAKTNTFCGTPDY 169
Query: 401 IDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAVTDW 460
I PE D +SFG++L +++ +SP ++ L + +
Sbjct: 170 IAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPF-------HGQDEEELFHSIRMDNPFY 222
Query: 461 PAEAAESFSKLAIQCAELRKKDRP 484
P + L ++ + R
Sbjct: 223 PRWLEKEAKDLLVKLFVREPEKRL 246
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (378), Expect = 1e-41
Identities = 62/304 (20%), Positives = 106/304 (34%), Gaps = 43/304 (14%)
Query: 229 DKFSEAMKIGEGGYGPVYRGKL-------DHTPVAIKVLRPDAAQG-KRQFQQEVEVLSS 280
D+ +G G +G V VA+K+L+ A R E+++L
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 281 IRHPNMVLLLGAC----PDYGCLVYEYMHNGSLEDRLLRRGNTPV-------------IP 323
I H V+ L ++ E+ G+L L + N V +
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 324 WRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVA 383
+ ++A + FL K +HRDL NILL V KI D GLAR +
Sbjct: 133 LEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIY---- 185
Query: 384 DSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRA 443
A ++ PE + T +SD++SFG++L +I + + +
Sbjct: 186 KDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 245
Query: 444 IEKGTLAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPELNRLKDLGRK 503
+ + + P + + C RP + ++ LG
Sbjct: 246 FCR----RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSEL-------VEHLGNL 294
Query: 504 LESN 507
L++N
Sbjct: 295 LQAN 298
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 7e-41
Identities = 68/285 (23%), Positives = 110/285 (38%), Gaps = 17/285 (5%)
Query: 226 EATDKFSEAMKIGEGGYGPVYRG--KLDHTPVAIKVLRPDAAQGKRQ-FQQEVEVLSSIR 282
+ +++ IGEG YG V ++ VAIK + P Q Q +E+++L R
Sbjct: 5 DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR 64
Query: 283 HPNMVLLLGAC--PDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLF 340
H N++ + P + Y+ + L + T + +I L +
Sbjct: 65 HENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKY 124
Query: 341 LHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCY 400
+H A ++HRDLKP+N+LL+ KI D GLAR+ P D +T T Y
Sbjct: 125 IHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADP---DHDHTGFLTEYVATRWY 178
Query: 401 IDPEYQQTGMLTTKS-DIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAVTD 459
PE TKS DI+S G +L ++++ R H++ L + P+ D
Sbjct: 179 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD--QLNHILGILGSPSQED 236
Query: 460 WPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPELNRLKDLGRKL 504
+ K L + DL K+
Sbjct: 237 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSK---ALDLLDKM 278
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 148 bits (374), Expect = 7e-41
Identities = 67/268 (25%), Positives = 106/268 (39%), Gaps = 33/268 (12%)
Query: 236 KIGEGGYGPVYRGKLDHT--PVAIKVLRPDAAQGKRQ---FQQEVEVLSSIRHPNMVLLL 290
+G G +G V+ + H A+KVL+ + +Q E +LS + HP ++ +
Sbjct: 11 TLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMW 70
Query: 291 GACPDYGCL--VYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEP 348
G D + + +Y+ G L L + P + AAE+ AL +LH
Sbjct: 71 GTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKF---YAAEVCLALEYLHSK---D 124
Query: 349 LVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQT 408
+++RDLKP NILLD+N KI+D G A+ VP + GT YI PE T
Sbjct: 125 IIYRDLKPENILLDKNGHIKITDFGFAKYVPD---------VTYTLCGTPDYIAPEVVST 175
Query: 409 GMLTTKSDIYSFGIMLLQIITARSPM--GLTHHVSRAIEKGTLAEMLDPAVTDWPAEAAE 466
D +SFGI++ +++ +P T I L +P E
Sbjct: 176 KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAEL---------RFPPFFNE 226
Query: 467 SFSKLAIQCAELRKKDRPDLGTVIVPEL 494
L + R ++
Sbjct: 227 DVKDLLSRLITRDLSQRLGNLQNGTEDV 254
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 148 bits (374), Expect = 2e-40
Identities = 69/277 (24%), Positives = 108/277 (38%), Gaps = 29/277 (10%)
Query: 229 DKFSEAMKIGEGGYGPVYRGKLDHT--PVAIKVLRPDAAQGK------RQFQQEVEVLSS 280
+ FS IG GG+G VY + T A+K L + K + + ++S+
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 281 IRHPNMVLLLGAC--PDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATAL 338
P +V + A PD + + M+ G L L + G AAEI L
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGV---FSEADMRFYAAEIILGL 120
Query: 339 LFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTF 398
+H +V+RDLKPANILLD + +ISD+GLA ++ GT
Sbjct: 121 EHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK--------KPHASVGTH 169
Query: 399 CYIDPEYQQTGM-LTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAV 457
Y+ PE Q G+ + +D +S G ML +++ SP + +K + M
Sbjct: 170 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPF----RQHKTKDKHEIDRMTLTMA 225
Query: 458 TDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494
+ P + L + R E+
Sbjct: 226 VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEV 262
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 6e-40
Identities = 73/293 (24%), Positives = 112/293 (38%), Gaps = 36/293 (12%)
Query: 227 ATDKFSEAMKIGEGGYGPVYRG---KLDHTPVAIKVLRPDAAQGK--RQFQQEVEV---L 278
A ++ +IGEG YG V++ K VA+K +R + +EV V L
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 279 SSIRHPNMVLLLGACPD-------YGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIA 331
+ HPN+V L C LV+E++ L + P +P +
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTT--YLDKVPEPGVPTETIKDMM 122
Query: 332 AEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHM 391
++ L FLH + +VHRDLKP NIL+ + K++D GLAR+ Q +
Sbjct: 123 FQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSF-------QMAL 172
Query: 392 TSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAE 451
TS T Y PE T D++S G + ++ + L
Sbjct: 173 TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLF--RGSSDVDQLGKILDV 230
Query: 452 MLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPELNRLKDLGRKL 504
+ P DWP + A + A+ +K D+ KDL K
Sbjct: 231 IGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDID-------ELGKDLLLKC 276
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 3e-39
Identities = 65/282 (23%), Positives = 109/282 (38%), Gaps = 23/282 (8%)
Query: 229 DKFSEAMKIGEGGYGPVYRG--KLDHTPVAIKVLRPDAA--QGKRQFQQEVEVLSSIRHP 284
+ F + KIGEG YG VY+ KL VA+K +R D +E+ +L + HP
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 285 NMVLLLGAC--PDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLH 342
N+V LL + LV+E++H + + IP ++ L F H
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLK--KFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 343 QAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYID 402
++HRDLKP N+L++ K++D GLAR V + + +
Sbjct: 120 S---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-----RTYTHEVVTLWYRAP 171
Query: 403 PEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAVTDWPA 462
+T DI+S G + +++T R+ + + + P WP
Sbjct: 172 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR--IFRTLGTPDEVVWP- 228
Query: 463 EAAESFSKLAIQCAELRKKDRPDLGTVIVPELNRLKDLGRKL 504
+ + K R D V+ P + L ++
Sbjct: 229 ----GVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQM 266
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 1e-38
Identities = 46/214 (21%), Positives = 88/214 (41%), Gaps = 24/214 (11%)
Query: 231 FSEAMKIGEGGYGPVYRGKLDHT--PVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVL 288
+++ IG G +G VY+ KL + VAIK + D KR +E++++ + H N+V
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD----KRFKNRELQIMRKLDHCNIVR 77
Query: 289 LLGACPDYG--------CLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLF 340
L G LV +Y+ +P ++ +L +
Sbjct: 78 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 341 LHQAKPEPLVHRDLKPANILLDRN-YVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFC 399
+H + HRD+KP N+LLD + V K+ D G A+ + + +++ +
Sbjct: 138 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG------EPNVSYICSRYY 188
Query: 400 YIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSP 433
T+ D++S G +L +++ +
Sbjct: 189 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPI 222
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 2e-37
Identities = 58/263 (22%), Positives = 91/263 (34%), Gaps = 40/263 (15%)
Query: 236 KIGEGGYGPVYRG--KLDHTPVAIKVLRPDAAQGK------RQFQQEVEVLSSIR--HPN 285
+G GG+G VY G D+ PVAIK + D + EV +L +
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 286 MVLLLGAC--PDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQ 343
++ LL PD L+ E + + ++ A+ H
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA--LQEELARSFFWQVLEAVRHCHN 128
Query: 344 AKPEPLVHRDLKPANILLDRN-YVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYID 402
++HRD+K NIL+D N K+ D G L+ + T GT Y
Sbjct: 129 CG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--------VYTDFDGTRVYSP 177
Query: 403 PEYQQTGMLTTKS-DIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAVTDWP 461
PE+ + +S ++S GI+L ++ P + R +
Sbjct: 178 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQ-------------VFFR 224
Query: 462 AEAAESFSKLAIQCAELRKKDRP 484
+ L C LR DRP
Sbjct: 225 QRVSSECQHLIRWCLALRPSDRP 247
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 4e-37
Identities = 60/284 (21%), Positives = 110/284 (38%), Gaps = 38/284 (13%)
Query: 216 YRKYTIEEIEEATDKFSEAMKIGEGGYGPVYRG--KLDHTPVAIKVLRPDAAQGKRQ--- 270
+R+ ++ D + ++G G + V + K A K ++ + R+
Sbjct: 3 FRQENVD------DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVS 56
Query: 271 ---FQQEVEVLSSIRHPNMVLLLGAC--PDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWR 325
++EV +L I+HPN++ L L+ E + G L D L + + +
Sbjct: 57 REDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEE 113
Query: 326 KRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVS----KISDVGLARLVPPS 381
+ + +I + +LH + H DLKP NI+L V KI D GLA +
Sbjct: 114 EATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG 170
Query: 382 VADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSP-MGLTHHV 440
+ GT ++ PE L ++D++S G++ +++ SP +G T
Sbjct: 171 -------NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE 223
Query: 441 SRAIEKGTLAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRP 484
+ A E D ++ A A + + K R
Sbjct: 224 TLANVSAVNYEFEDEYFSNTSALAKD----FIRRLLVKDPKKRM 263
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 5e-37
Identities = 48/221 (21%), Positives = 95/221 (42%), Gaps = 23/221 (10%)
Query: 229 DKFSEAMKIGEGGYGPVYRG--KLDHTPVAIKVLRPDAAQGK--RQFQQEVEVLSSIRHP 284
K+ + KIG+G +G V++ + VA+K + + + +E+++L ++H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 285 NMVLLLGACPDYG----------CLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEI 334
N+V L+ C LV+++ + + ++ +
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK---FTLSEIKRVMQML 126
Query: 335 ATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSA 394
L ++H+ K ++HRD+K AN+L+ R+ V K++D GLAR S+A + T+
Sbjct: 127 LNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAF--SLAKNSQPNRYTNR 181
Query: 395 AGTFCYIDPEYQQTGML-TTKSDIYSFGIMLLQIITARSPM 434
T Y PE D++ G ++ ++ T M
Sbjct: 182 VVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIM 222
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 1e-36
Identities = 54/266 (20%), Positives = 102/266 (38%), Gaps = 39/266 (14%)
Query: 237 IGEGGYGPVYRG--KLDHTPVAIKVLRPDAAQGKRQFQQEVEVLSSI-RHPNMVLLLGAC 293
+G G G V + K A+K+L+ + ++EVE+ + P++V ++
Sbjct: 20 LGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVY 74
Query: 294 PDYG------CLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPE 347
+ +V E + G L R+ RG+ R+ +I I A+ +LH
Sbjct: 75 ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA-FTEREASEIMKSIGEAIQYLHSIN-- 131
Query: 348 PLVHRDLKPANILLDR---NYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPE 404
+ HRD+KP N+L N + K++D G A+ + + Y T Y+ PE
Sbjct: 132 -IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY-------TPYYVAPE 183
Query: 405 YQQTGMLTTKSDIYSFGIMLLQIITARSP------MGLTHHVSRAIEKGTLAEMLDPAVT 458
D++S G+++ ++ P + ++ + I G E +P +
Sbjct: 184 VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY-EFPNPEWS 242
Query: 459 DWPAEAAESFSKLAIQCAELRKKDRP 484
+ E L + R
Sbjct: 243 EVSEEVKM----LIRNLLKTEPTQRM 264
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (342), Expect = 3e-36
Identities = 65/275 (23%), Positives = 103/275 (37%), Gaps = 30/275 (10%)
Query: 229 DKFSEAMKIGEGGYGPVYRG--KLDHTPVAIKVLRPDAAQGK---RQFQQEVEVLSSIRH 283
+ F +G+G +G V K A+K+LR + K E VL + RH
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 284 PNMVLLLGACPDYG--CLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFL 341
P + L A + C V EY + G L L R V + AEI +AL +L
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRE---RVFTEERARFYGAEIVSALEYL 121
Query: 342 HQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYI 401
H V+RD+K N++LD++ KI+D GL + M + GT Y+
Sbjct: 122 HSRDV---VYRDIKLENLMLDKDGHIKITDFGLCKEGIS------DGATMKTFCGTPEYL 172
Query: 402 DPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHH--VSRAIEKGTLAEMLDPAVTD 459
PE + D + G+++ +++ R P H + I +
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI---------R 223
Query: 460 WPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494
+P + L + K R G E+
Sbjct: 224 FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEV 258
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 134 bits (338), Expect = 3e-36
Identities = 52/281 (18%), Positives = 103/281 (36%), Gaps = 23/281 (8%)
Query: 229 DKFSEAMKIGEGGYGPVYRGKLDHT-PVAIKVLRPDA--AQGKRQFQQEVEVLSSIRHPN 285
+K+ KIGEG YG VY+ + ++ A+K +R + +E+ +L ++H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 286 MVLLLGACPD--YGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQ 343
+V L LV+E++ + + G + ++ + + H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG---LESVTAKSFLLQLLNGIAYCHD 118
Query: 344 AKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDP 403
+ ++HRDLKP N+L++R KI+D GLAR + + +
Sbjct: 119 RR---VLHRDLKPQNLLINREGELKIADFGLARAF-----GIPVRKYTHEIVTLWYRAPD 170
Query: 404 EYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAVTDWPAE 463
+ +T DI+S G + +++ + P +WP
Sbjct: 171 VLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA--DQLMRIFRILGTPNSKNWP-- 226
Query: 464 AAESFSKLAIQCAELRKKDRPDLGTVIVPELNRLKDLGRKL 504
+ ++L + + + DL K+
Sbjct: 227 ---NVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKM 264
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 4e-36
Identities = 61/301 (20%), Positives = 106/301 (35%), Gaps = 33/301 (10%)
Query: 216 YRKYTIEEIEEATDKFSEAMKIGEGGYGPVYRG--KLDHTPVAIKVLRPDAA--QGKRQF 271
YR+ + E + + +G G YG V VAIK L ++
Sbjct: 5 YRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRA 64
Query: 272 QQEVEVLSSIRHPNMVLLLGACPDYG--------CLVYEYMHNGSLEDRLLRRGNTPVIP 323
+E+ +L +RH N++ LL LV +M G+ +L++ +
Sbjct: 65 YRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEK---LG 119
Query: 324 WRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVA 383
+ + ++ L ++H A HRDLKP N+ ++ + KI D GLAR
Sbjct: 120 EDRIQFLVYQMLKGLRYIHAAGII---HRDLKPGNLAVNEDCELKILDFGLAR------- 169
Query: 384 DSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRA 443
+ T DI+S G ++ ++IT ++ + H+
Sbjct: 170 -QADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL--D 226
Query: 444 IEKGTLAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPELNRLKDLGRK 503
K + P ++ EL KKD + T P +L K
Sbjct: 227 QLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPL---AVNLLEK 283
Query: 504 L 504
+
Sbjct: 284 M 284
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (337), Expect = 5e-36
Identities = 53/208 (25%), Positives = 90/208 (43%), Gaps = 22/208 (10%)
Query: 236 KIGEGGYGPVYRGKLDHT--PVAIKVLRPDAAQGK-----RQFQQEVEVLSSIRHPNMVL 288
+GEG + VY+ + +T VAIK ++ R +E+++L + HPN++
Sbjct: 5 FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 64
Query: 289 LLGAC--PDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKP 346
LL A LV+++M ++ + N+ V+ L +LHQ
Sbjct: 65 LLDAFGHKSNISLVFDFMETDLE---VIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQ--- 118
Query: 347 EPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQ 406
++HRDLKP N+LLD N V K++D GLA+ T T Y PE
Sbjct: 119 HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGS------PNRAYTHQVVTRWYRAPELL 172
Query: 407 QTGML-TTKSDIYSFGIMLLQIITARSP 433
+ D+++ G +L +++
Sbjct: 173 FGARMYGVGVDMWAVGCILAELLLRVPF 200
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 134 bits (338), Expect = 1e-35
Identities = 59/318 (18%), Positives = 114/318 (35%), Gaps = 46/318 (14%)
Query: 174 AEKAQKLADAEAQRRKQAELKAKREAEEKNRALTALANNDVRYRKYTIEEIEEATDKFSE 233
A A+K ++ E+ + A+ K E+ + + N + ++ +
Sbjct: 3 AAAAKKGSEQESVKEFLAKAK-----EDFLKKWETPSQNTAQLDQFDRIK---------- 47
Query: 234 AMKIGEGGYGPVYRG--KLDHTPVAIKVLRPDAAQGKRQ---FQQEVEVLSSIRHPNMVL 288
+G G +G V K A+K+L +Q E +L ++ P +V
Sbjct: 48 --TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK 105
Query: 289 LLGACPDYGCL--VYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKP 346
L + D L V EY+ G + L R G AA+I +LH
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYLHSLD- 161
Query: 347 EPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQ 406
L++RDLKP N+L+D+ +++D G A+ + + GT + PE
Sbjct: 162 --LIYRDLKPENLLIDQQGYIQVTDFGFAK---------RVKGRTWTLCGTPEALAPEII 210
Query: 407 QTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAVTDWPAEAAE 466
+ D ++ G+++ ++ P + + E + +P+ +
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ-------IYEKIVSGKVRFPSHFSS 263
Query: 467 SFSKLAIQCAELRKKDRP 484
L ++ R
Sbjct: 264 DLKDLLRNLLQVDLTKRF 281
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (332), Expect = 2e-35
Identities = 61/282 (21%), Positives = 109/282 (38%), Gaps = 23/282 (8%)
Query: 229 DKFSEAMKIGEGGYGPVYRG--KLDHTPVAIKVLRPDAA--QGKRQFQQEVEVLSSIRHP 284
K+ + KIGEG YG V++ + H VA+K +R D +E+ +L ++H
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 285 NMVLLLGACPD--YGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLH 342
N+V L LV+E+ + G+ + ++ L F H
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGD---LDPEIVKSFLFQLLKGLGFCH 118
Query: 343 QAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYID 402
++HRDLKP N+L++RN K+++ GLAR + + +
Sbjct: 119 SRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIP-----VRCYSAEVVTLWYRPP 170
Query: 403 PEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAVTDWPA 462
+ +T D++S G + ++ A P+ + V +++ + P WP
Sbjct: 171 DVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKR-IFRLLGTPTEEQWP- 228
Query: 463 EAAESFSKLAIQCAELRKKDRPDLGTVIVPELNRLKDLGRKL 504
S +KL L V+ +DL + L
Sbjct: 229 ----SMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNL 266
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 123 bits (310), Expect = 6e-32
Identities = 51/229 (22%), Positives = 94/229 (41%), Gaps = 29/229 (12%)
Query: 215 RYRKYTIEEIE-EATDKFSEAMKIGEGGYGPVYRG--KLDHTPVAIKVLRPDAAQGKRQF 271
Y Y +E D + K+G G Y V+ ++ V +K+L+P K++
Sbjct: 20 EYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKI 76
Query: 272 QQEVEVLSSIR-HPNMVLLLGACPD----YGCLVYEYMHNGSLEDRLLRRGNTPVIPWRK 326
++E+++L ++R PN++ L D LV+E+++N + +
Sbjct: 77 KREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT------LTDYD 130
Query: 327 RFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDR-NYVSKISDVGLARLVPPSVADS 385
EI AL + H ++HRD+KP N+++D + ++ D GLA P
Sbjct: 131 IRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ--- 184
Query: 386 VTQYHMTSAAGTFCYIDPEYQQTGML-TTKSDIYSFGIMLLQIITARSP 433
+ + PE + D++S G ML +I + P
Sbjct: 185 ----EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 229
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (301), Expect = 1e-30
Identities = 56/301 (18%), Positives = 112/301 (37%), Gaps = 33/301 (10%)
Query: 216 YRKYTIEEIEEATDKFSEAMKIGEGGYGPVYRG--KLDHTPVAIKVLRPDAA--QGKRQF 271
YR+ + I E +++ +G G YG V VA+K L ++
Sbjct: 5 YRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT 64
Query: 272 QQEVEVLSSIRHPNMVLLLGAC------PDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWR 325
+E+ +L ++H N++ LL ++ + G+ + +++ +
Sbjct: 65 YRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK---LTDD 121
Query: 326 KRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADS 385
+ +I L ++H A ++HRDLKP+N+ ++ + KI D GLAR
Sbjct: 122 HVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR--------H 170
Query: 386 VTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVS--RA 443
A + DI+S G ++ +++T R+ T H+ +
Sbjct: 171 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 230
Query: 444 IEKGTLAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPELNRLKDLGRK 503
I + + P ++ES ++ K + ++ P DL K
Sbjct: 231 ILRL----VGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPL---AVDLLEK 283
Query: 504 L 504
+
Sbjct: 284 M 284
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (298), Expect = 4e-30
Identities = 48/232 (20%), Positives = 84/232 (36%), Gaps = 29/232 (12%)
Query: 215 RYRKYTIEEIE-EATDKFSEAMKIGEGGYGPVYRG--KLDHTPVAIKVLRPDAA--QGKR 269
++ + + ++ IG G G V + VAIK L +
Sbjct: 2 QFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAK 61
Query: 270 QFQQEVEVLSSIRHPNMVLLLGACPDYG--------CLVYEYMHNGSLEDRLLRRGNTPV 321
+ +E+ ++ + H N++ LL LV E M + +
Sbjct: 62 RAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL----- 116
Query: 322 IPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPS 381
+ + ++ + LH A +HRDLKP+NI++ + KI D GLAR S
Sbjct: 117 -DHERMSYLLYQMLCGIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 172
Query: 382 VADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSP 433
+ MT T Y PE DI+S G ++ +++ +
Sbjct: 173 -------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKIL 217
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (290), Expect = 2e-29
Identities = 63/280 (22%), Positives = 109/280 (38%), Gaps = 28/280 (10%)
Query: 229 DKFSEAMKIGEGGYGPVYRGKL-----DHTPVAIKVLRP----DAAQGKRQFQQEVEVLS 279
+ F +G G YG V+ + A+KVL+ A+ + E +VL
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 280 SIRH-PNMVLLLGAC--PDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIAT 336
IR P +V L A L+ +Y++ G L L +R + EI
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER---FTEHEVQIYVGEIVL 140
Query: 337 ALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAG 396
AL LH+ +++RD+K NILLD N ++D GL++ + G
Sbjct: 141 ALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEF-----VADETERAYDFCG 192
Query: 397 TFCYIDPEYQQTGM--LTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLD 454
T Y+ P+ + G D +S G+++ +++T SP + + E ++ +
Sbjct: 193 TIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAE---ISRRIL 249
Query: 455 PAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494
+ +P E + L + K R G E+
Sbjct: 250 KSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEI 289
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 110 bits (275), Expect = 4e-27
Identities = 49/292 (16%), Positives = 109/292 (37%), Gaps = 30/292 (10%)
Query: 236 KIGEGGYGPVYRG--KLDHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGAC 293
K+G G + V+ +++T VA+K++R D + E+++L + +
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY-TEAAEDEIKLLQRVNDADNTKEDSMG 78
Query: 294 ---------------PDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATAL 338
P+ +V + G L+++ IP +I+ ++ L
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138
Query: 339 LFLHQAKPEPLVHRDLKPANILLDRN-YVSKISDVGLARLVPPSVADSVTQYHMTSAAGT 397
++H+ ++H D+KP N+L++ + + +A L H T++ T
Sbjct: 139 DYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGN----ACWYDEHYTNSIQT 192
Query: 398 FCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLD--- 454
Y PE +DI+S ++ ++IT S + +A++++
Sbjct: 193 REYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLG 252
Query: 455 --PAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPELNRLKDLGRKL 504
P+ + +F + K L V+ + KD +++
Sbjct: 253 ELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEI 304
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 86.0 bits (212), Expect = 4e-20
Identities = 23/152 (15%), Positives = 42/152 (27%), Gaps = 19/152 (12%)
Query: 236 KIGEGGYGPVYRGKL-DHTPVAIKVLRPDAA----------QGKRQFQQEVEVLSSIRHP 284
+GEG V+ +K + G F +
Sbjct: 7 LMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFR 66
Query: 285 NMVLLLGACPDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQA 344
+ L G VY + N L + + + V ++ I + +
Sbjct: 67 ALQKLQGLAVPK---VYAWEGNAVLMELIDAKELYRVRVENPD-EVLDMILEEVAKFYH- 121
Query: 345 KPEPLVHRDLKPANILLDRNYVSKISDVGLAR 376
+VH DL N+L+ + I D +
Sbjct: 122 --RGIVHGDLSQYNVLVSEEGI-WIIDFPQSV 150
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 568 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.91 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.7 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.94 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.8 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 97.34 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.24 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.91 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-53 Score=428.12 Aligned_cols=250 Identities=26% Similarity=0.485 Sum_probs=202.5
Q ss_pred hcccccceeecccCceeEEEEEeCCccEEEEEeCcC--hhHhHHHHHHHHHHHHcCCCCceeeeccccCC-CceEEEEec
Q 008365 228 TDKFSEAMKIGEGGYGPVYRGKLDHTPVAIKVLRPD--AAQGKRQFQQEVEVLSSIRHPNMVLLLGACPD-YGCLVYEYM 304 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~~~~~~~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~-~~~lV~E~~ 304 (568)
.++|.+.+.||+|+||+||+|++.+ .||||+++.. .....+.|.+|+.+|++++|||||+++|++.+ ..+||||||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~lv~Ey~ 85 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQLAIVTQWC 85 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESSS-EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEEECC
T ss_pred cccEEEEEEEeeCCCcEEEEEEECC-EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEeccEEEEEEecC
Confidence 4678999999999999999998755 5999998654 33446789999999999999999999999854 458999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCCc
Q 008365 305 HNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVAD 384 (568)
Q Consensus 305 ~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~~ 384 (568)
+||+|.+++..... .+++..+..|+.||+.||.|||+.+ ||||||||+||||+.++.+||+|||+|+......
T Consensus 86 ~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~-- 158 (276)
T d1uwha_ 86 EGSSLYHHLHIIET--KFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS-- 158 (276)
T ss_dssp CEEEHHHHHHTSCC--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC-------
T ss_pred CCCCHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccccC--
Confidence 99999999976543 3899999999999999999999999 9999999999999999999999999998764322
Q ss_pred cccccccccccccccCCChhhhhc---CCCCCcceehhHHHHHHHHHhCCCCCCCchH---HHHHHHhCccccccCccCC
Q 008365 385 SVTQYHMTSAAGTFCYIDPEYQQT---GMLTTKSDIYSFGIMLLQIITARSPMGLTHH---VSRAIEKGTLAEMLDPAVT 458 (568)
Q Consensus 385 ~~~~~~~~~~~GT~~Y~APE~~~~---~~~s~ksDvwSlGvil~elltG~~Pf~~~~~---~~~~~~~~~~~~~l~~~~~ 458 (568)
.........||+.|||||++.+ ..|+.++|||||||+||||+||+.||..... +...+..+. ..+...
T Consensus 159 --~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~----~~p~~~ 232 (276)
T d1uwha_ 159 --GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGY----LSPDLS 232 (276)
T ss_dssp ---------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTS----CCCCGG
T ss_pred --CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCC----CCCcch
Confidence 1122345789999999999864 3589999999999999999999999965432 223333332 233334
Q ss_pred CCChHHHHHHHHHHHHhhccCCCCCCChHHhHh
Q 008365 459 DWPAEAAESFSKLAIQCAELRKKDRPDLGTVIV 491 (568)
Q Consensus 459 ~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~ 491 (568)
..+..+++.+.+|+.+||+.+|.+||++.+|+.
T Consensus 233 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~ 265 (276)
T d1uwha_ 233 KVRSNCPKAMKRLMAECLKKKRDERPLFPQILA 265 (276)
T ss_dssp GSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hccccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 455667788999999999999999999999874
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-53 Score=428.70 Aligned_cols=249 Identities=25% Similarity=0.378 Sum_probs=208.3
Q ss_pred cccccceeecccCceeEEEEEe--CCccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCceeeeccccCC--CceEEEEec
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACPD--YGCLVYEYM 304 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--~~~lV~E~~ 304 (568)
++|+++++||+|+||+||+|.+ +++.||||+++.......+.+.+|+.+|+.++|||||+++++|.+ ..|||||||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 4699999999999999999987 578999999976655556789999999999999999999999854 448999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCCc
Q 008365 305 HNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVAD 384 (568)
Q Consensus 305 ~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~~ 384 (568)
+||+|.+++... .+++..+..|+.||+.||.|||++| ||||||||+||||+.+|.+||+|||+|+.+....
T Consensus 100 ~gg~L~~~~~~~----~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~-- 170 (293)
T d1yhwa1 100 AGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-- 170 (293)
T ss_dssp TTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT--
T ss_pred CCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeecccc--
Confidence 999999987654 2899999999999999999999999 9999999999999999999999999998764322
Q ss_pred cccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHhCccccccCccCCCCChHH
Q 008365 385 SVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAVTDWPAEA 464 (568)
Q Consensus 385 ~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~l~~~~~~~p~~~ 464 (568)
......+||+.|+|||++.+..|+.++|||||||++|+|++|+.||............... . .+. ...+..+
T Consensus 171 ----~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~-~--~~~-~~~~~~~ 242 (293)
T d1yhwa1 171 ----SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN-G--TPE-LQNPEKL 242 (293)
T ss_dssp ----CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHH-C--SCC-CSSGGGS
T ss_pred ----ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhC-C--CCC-CCCcccC
Confidence 1234568999999999999999999999999999999999999999765443322111000 0 011 1234567
Q ss_pred HHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 465 AESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 465 ~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
+..+.+||.+||+.||.+||++.+++.|.+
T Consensus 243 s~~~~~li~~~L~~dP~~R~s~~eil~Hp~ 272 (293)
T d1yhwa1 243 SAIFRDFLNRCLDMDVEKRGSAKELLQHQF 272 (293)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHTTCGG
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhcCHh
Confidence 788999999999999999999999986544
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-52 Score=420.44 Aligned_cols=243 Identities=27% Similarity=0.436 Sum_probs=207.3
Q ss_pred cccccceeecccCceeEEEEEe--CCccEEEEEeCcChh---HhHHHHHHHHHHHHcCCCCceeeeccccCCCc--eEEE
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAA---QGKRQFQQEVEVLSSIRHPNMVLLLGACPDYG--CLVY 301 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~---~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~--~lV~ 301 (568)
++|++++.||+|+||.||+|++ +++.||||++.+... .....+.+|+.+|+.++|||||+++++|.+.. +|||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 5799999999999999999988 567899999875432 23467889999999999999999999996654 8999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCC
Q 008365 302 EYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPS 381 (568)
Q Consensus 302 E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~ 381 (568)
|||+||+|.+++...+. +++..+..|+.||+.||.|||+.+ ||||||||+||||+.++.+||+|||+|+.....
T Consensus 86 Ey~~~g~L~~~l~~~~~---l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~ 159 (263)
T d2j4za1 86 EYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 159 (263)
T ss_dssp ECCTTCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred eecCCCcHHHHHhhcCC---CCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCC
Confidence 99999999999987653 899999999999999999999999 999999999999999999999999999765432
Q ss_pred CCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHH--HHHHHhCccccccCccCCC
Q 008365 382 VADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHV--SRAIEKGTLAEMLDPAVTD 459 (568)
Q Consensus 382 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~--~~~~~~~~~~~~l~~~~~~ 459 (568)
.....+||+.|+|||++.+..|+.++|||||||+||+|++|+.||...... ...+..+. ..
T Consensus 160 --------~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~---------~~ 222 (263)
T d2j4za1 160 --------RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE---------FT 222 (263)
T ss_dssp --------CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC---------CC
T ss_pred --------cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCC---------CC
Confidence 124567999999999999999999999999999999999999999765432 22222221 12
Q ss_pred CChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 460 WPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 460 ~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
+|..+++.+.+|+.+||+.||.+||++.+++.|.+
T Consensus 223 ~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~ 257 (263)
T d2j4za1 223 FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 257 (263)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHH
T ss_pred CCccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcC
Confidence 35556778999999999999999999999997665
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-53 Score=426.20 Aligned_cols=251 Identities=24% Similarity=0.396 Sum_probs=197.9
Q ss_pred cccccceeecccCceeEEEEEe--CCccEEEEEeCcCh--hHhHHHHHHHHHHHHcCCCCceeeeccccCC----CceEE
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDA--AQGKRQFQQEVEVLSSIRHPNMVLLLGACPD----YGCLV 300 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~--~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~----~~~lV 300 (568)
++|++++.||+|+||.||+|++ +++.||||++.... ....+.+.+|+++|+.++|||||+++++|.+ ..+||
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 6799999999999999999987 57799999997653 3345678999999999999999999998843 24899
Q ss_pred EEecCCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHcCC--CCcccCCCCCCCeeccCCceeEecccccccc
Q 008365 301 YEYMHNGSLEDRLLRRG-NTPVIPWRKRFKIAAEIATALLFLHQAKP--EPLVHRDLKPANILLDRNYVSKISDVGLARL 377 (568)
Q Consensus 301 ~E~~~ggsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~--~~IiHrDIKp~NILld~~~~vKL~DFGla~~ 377 (568)
||||+||+|.+++.... ....+++..++.|+.||+.||.|||+.+. .+||||||||+||||+.++.+||+|||+|+.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 99999999999986532 22348999999999999999999999752 3499999999999999999999999999987
Q ss_pred cCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHH--HHHHHhCccccccCc
Q 008365 378 VPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHV--SRAIEKGTLAEMLDP 455 (568)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~--~~~~~~~~~~~~l~~ 455 (568)
+.... ......+||+.|||||++.+..|+.++|||||||++|||++|+.||...... ...+..+..
T Consensus 164 ~~~~~------~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~------ 231 (269)
T d2java1 164 LNHDT------SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKF------ 231 (269)
T ss_dssp C-----------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC------
T ss_pred cccCC------CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCC------
Confidence 64321 1234578999999999999999999999999999999999999999765432 223333322
Q ss_pred cCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHH
Q 008365 456 AVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPE 493 (568)
Q Consensus 456 ~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~ 493 (568)
...|..+++.+.+|+.+||+.||.+||++.+++.|.
T Consensus 232 --~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp 267 (269)
T d2java1 232 --RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENP 267 (269)
T ss_dssp --CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTST
T ss_pred --CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCC
Confidence 233455677899999999999999999999998653
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-53 Score=424.70 Aligned_cols=252 Identities=21% Similarity=0.305 Sum_probs=200.9
Q ss_pred hcccccceeecccCceeEEEEEe--CCccEEEEEeCcChh-HhHHHHHHHHHHHHcCCCCceeeeccccCCC--ceEEEE
Q 008365 228 TDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAA-QGKRQFQQEVEVLSSIRHPNMVLLLGACPDY--GCLVYE 302 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~-~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~--~~lV~E 302 (568)
.++|++++.||+|+||.||+|++ +++.||||++..... ...+.+.+|+.+|+.++|||||++++++.+. .|||||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 46799999999999999999987 577999999976532 3345689999999999999999999998554 489999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCC
Q 008365 303 YMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSV 382 (568)
Q Consensus 303 ~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~ 382 (568)
||+||+|.+++...+ .+++..+..|+.||+.||.|||+.+ ||||||||+||||+.++.+||+|||+|+.+....
T Consensus 84 y~~gg~L~~~l~~~~---~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~ 157 (271)
T d1nvra_ 84 YCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 157 (271)
T ss_dssp CCTTEEGGGGSBTTT---BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred ccCCCcHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCC
Confidence 999999999886543 4899999999999999999999999 9999999999999999999999999998764322
Q ss_pred CccccccccccccccccCCChhhhhcCCC-CCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHhCccccccCccCCCCC
Q 008365 383 ADSVTQYHMTSAAGTFCYIDPEYQQTGML-TTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEMLDPAVTDWP 461 (568)
Q Consensus 383 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~-s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~l~~~~~~~p 461 (568)
........+||+.|||||++.+..+ +.++|||||||++|||++|+.||.........+..... ........
T Consensus 158 ----~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~----~~~~~~~~ 229 (271)
T d1nvra_ 158 ----RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE----KKTYLNPW 229 (271)
T ss_dssp ----EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHT----TCTTSTTG
T ss_pred ----ccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhc----CCCCCCcc
Confidence 1122346789999999999988876 57899999999999999999999654321111110000 00111112
Q ss_pred hHHHHHHHHHHHHhhccCCCCCCChHHhHhHH
Q 008365 462 AEAAESFSKLAIQCAELRKKDRPDLGTVIVPE 493 (568)
Q Consensus 462 ~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~ 493 (568)
..++..+.+|+.+||+.||.+||++.+++.|.
T Consensus 230 ~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp 261 (271)
T d1nvra_ 230 KKIDSAPLALLHKILVENPSARITIPDIKKDR 261 (271)
T ss_dssp GGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCT
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHHhcCH
Confidence 34567789999999999999999999997543
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-52 Score=426.05 Aligned_cols=249 Identities=24% Similarity=0.355 Sum_probs=206.5
Q ss_pred cccccceeecccCceeEEEEEe--CCccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCceeeeccccCC--CceEEEEec
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACPD--YGCLVYEYM 304 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--~~~lV~E~~ 304 (568)
+.|++++.||+|+||.||+|++ ++..||||++........+.+.+|+++|+.++|||||+++++|.+ ..+||||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 5699999999999999999997 567899999977665666788999999999999999999999854 348999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCCc
Q 008365 305 HNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVAD 384 (568)
Q Consensus 305 ~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~~ 384 (568)
+||+|.+++..... .+++..+..|+.||+.||.|||+++ ||||||||+||||+.++.+||+|||+|+....
T Consensus 92 ~~g~L~~~~~~~~~--~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~---- 162 (288)
T d2jfla1 92 AGGAVDAVMLELER--PLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTR---- 162 (288)
T ss_dssp TTEEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHH----
T ss_pred CCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCC----
Confidence 99999998876543 3899999999999999999999999 99999999999999999999999999975421
Q ss_pred cccccccccccccccCCChhhhh-----cCCCCCcceehhHHHHHHHHHhCCCCCCCchH--HHHHHHhCccccccCccC
Q 008365 385 SVTQYHMTSAAGTFCYIDPEYQQ-----TGMLTTKSDIYSFGIMLLQIITARSPMGLTHH--VSRAIEKGTLAEMLDPAV 457 (568)
Q Consensus 385 ~~~~~~~~~~~GT~~Y~APE~~~-----~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~--~~~~~~~~~~~~~l~~~~ 457 (568)
........+||+.|+|||++. +..|+.++|||||||++|||++|+.||..... +...+..+.. ..
T Consensus 163 --~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~------~~ 234 (288)
T d2jfla1 163 --TIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEP------PT 234 (288)
T ss_dssp --HHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCC------CC
T ss_pred --CcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCC------CC
Confidence 112234678999999999884 55689999999999999999999999965433 2222222221 11
Q ss_pred CCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 458 TDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 458 ~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
...+..++..+.+|+.+||+.||.+||++.+++.|.+
T Consensus 235 ~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~ 271 (288)
T d2jfla1 235 LAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPF 271 (288)
T ss_dssp CSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGG
T ss_pred CCccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcc
Confidence 2234567788999999999999999999999986543
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-52 Score=415.25 Aligned_cols=245 Identities=27% Similarity=0.477 Sum_probs=193.9
Q ss_pred cccccceeecccCceeEEEEEe-CCccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCceeeeccccCC--CceEEEEecC
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKL-DHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACPD--YGCLVYEYMH 305 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~-~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--~~~lV~E~~~ 305 (568)
++|++++.||+|+||.||+|.+ +++.||||+++.... ..+.|.+|+.+++.++|||||+++|+|.+ ..++|||||+
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcC-cHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 4789999999999999999998 566899999976543 34679999999999999999999999854 4589999999
Q ss_pred CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCCcc
Q 008365 306 NGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADS 385 (568)
Q Consensus 306 ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~~~ 385 (568)
+|+|.+++..... .+++..++.|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+.....
T Consensus 84 ~g~L~~~l~~~~~--~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~-- 156 (263)
T d1sm2a_ 84 HGCLSDYLRTQRG--LFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-- 156 (263)
T ss_dssp TCBHHHHHHTTTT--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred CCcHHHHhhcccc--CCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCc--
Confidence 9999998876433 4889999999999999999999999 99999999999999999999999999987643221
Q ss_pred ccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh-CCCCCCCchH--HHHHHHhCccccccCccCCCCCh
Q 008365 386 VTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPMGLTHH--VSRAIEKGTLAEMLDPAVTDWPA 462 (568)
Q Consensus 386 ~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~--~~~~~~~~~~~~~l~~~~~~~p~ 462 (568)
.......||+.|+|||++.+..|+.++|||||||++|||+| |.+||..... +...+..+. ....|.
T Consensus 157 ---~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~--------~~~~p~ 225 (263)
T d1sm2a_ 157 ---TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF--------RLYKPR 225 (263)
T ss_dssp -----------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTC--------CCCCCT
T ss_pred ---eeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcC--------CCCCcc
Confidence 12234679999999999999999999999999999999999 5666654332 222233221 112345
Q ss_pred HHHHHHHHHHHHhhccCCCCCCChHHhHhH
Q 008365 463 EAAESFSKLAIQCAELRKKDRPDLGTVIVP 492 (568)
Q Consensus 463 ~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~ 492 (568)
.+++.+.+|+..||+.+|.+||++.+|+.+
T Consensus 226 ~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 226 LASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ccCHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 567789999999999999999999999754
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-52 Score=427.66 Aligned_cols=255 Identities=25% Similarity=0.396 Sum_probs=203.4
Q ss_pred HhcccccceeecccCceeEEEEEe--CCccEEEEEeCcCh-hHhHHHHHHHHHHHHcCCCCceeeeccccCCC--ceEEE
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDA-AQGKRQFQQEVEVLSSIRHPNMVLLLGACPDY--GCLVY 301 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~--~~lV~ 301 (568)
..++|+++++||+|+||+||+|++ ++..||||+++... ......+.+|+.+|+.++|||||+++++|.+. .||||
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 357899999999999999999997 57799999997542 33356789999999999999999999999654 48999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHc-CCCCcccCCCCCCCeeccCCceeEecccccccccCC
Q 008365 302 EYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQA-KPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPP 380 (568)
Q Consensus 302 E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~-~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~ 380 (568)
|||+||+|.+++.+.+. +++..+..++.||+.||.|||+. + ||||||||+||||+.+|.+||+|||+|+.+..
T Consensus 84 Ey~~gg~L~~~l~~~~~---l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 157 (322)
T d1s9ja_ 84 EHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 157 (322)
T ss_dssp ECCTTEEHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred EcCCCCcHHHHHhhcCC---CCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCC
Confidence 99999999999987653 89999999999999999999974 8 99999999999999999999999999986522
Q ss_pred CCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHH-----hCcccc----
Q 008365 381 SVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIE-----KGTLAE---- 451 (568)
Q Consensus 381 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~-----~~~~~~---- 451 (568)
....+.+||+.|+|||++.+..|+.++|||||||++|||++|+.||...+....... .+....
T Consensus 158 --------~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (322)
T d1s9ja_ 158 --------SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPR 229 (322)
T ss_dssp --------HTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC--------------
T ss_pred --------CccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcc
Confidence 123457899999999999999999999999999999999999999964322111000 000000
Q ss_pred ---------------------------ccCccCCCCC-hHHHHHHHHHHHHhhccCCCCCCChHHhHhHHHH
Q 008365 452 ---------------------------MLDPAVTDWP-AEAAESFSKLAIQCAELRKKDRPDLGTVIVPELN 495 (568)
Q Consensus 452 ---------------------------~l~~~~~~~p-~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l~ 495 (568)
.........+ ...+.++.+|+.+||..||.+||++.+++.|.+-
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~ 301 (322)
T d1s9ja_ 230 PRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFI 301 (322)
T ss_dssp ----------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred cccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhh
Confidence 0000000111 1235678999999999999999999999988764
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-52 Score=416.06 Aligned_cols=245 Identities=30% Similarity=0.480 Sum_probs=202.5
Q ss_pred hcccccceeecccCceeEEEEEeC-CccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCceeeeccccCCC-ceEEEEecC
Q 008365 228 TDKFSEAMKIGEGGYGPVYRGKLD-HTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACPDY-GCLVYEYMH 305 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~~~~~-~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~-~~lV~E~~~ 305 (568)
.++|++.+.||+|+||.||+|.+. ++.||||+++.... ..+.|.+|+.+|++++|||||+++|+|.+. .+||||||+
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~iv~Ey~~ 90 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYME 90 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEEECCT
T ss_pred HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcC-CHHHHHHHHHHHHhCCCCCEeEEEeeeccCCeEEEEEeCC
Confidence 467999999999999999999985 56899999976543 346799999999999999999999998554 489999999
Q ss_pred CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCCcc
Q 008365 306 NGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADS 385 (568)
Q Consensus 306 ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~~~ 385 (568)
+|+|.+++...... .+++..++.|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+|+.+....
T Consensus 91 ~g~L~~~~~~~~~~-~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~--- 163 (272)
T d1qpca_ 91 NGSLVDFLKTPSGI-KLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNE--- 163 (272)
T ss_dssp TCBHHHHTTSHHHH-TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSC---
T ss_pred CCcHHHHHhhcCCC-CCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCc---
Confidence 99999987654322 3899999999999999999999999 9999999999999999999999999998775322
Q ss_pred ccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCC-CCCCCchH--HHHHHHhCccccccCccCCCCCh
Q 008365 386 VTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITAR-SPMGLTHH--VSRAIEKGTLAEMLDPAVTDWPA 462 (568)
Q Consensus 386 ~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~-~Pf~~~~~--~~~~~~~~~~~~~l~~~~~~~p~ 462 (568)
........||+.|+|||++.++.++.++|||||||++|||+||. +||..... +...+..+ .....|.
T Consensus 164 --~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~--------~~~~~p~ 233 (272)
T d1qpca_ 164 --YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG--------YRMVRPD 233 (272)
T ss_dssp --EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT--------CCCCCCT
T ss_pred --cccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhc--------CCCCCcc
Confidence 12234567999999999999999999999999999999999955 45543332 22222222 1122355
Q ss_pred HHHHHHHHHHHHhhccCCCCCCChHHhH
Q 008365 463 EAAESFSKLAIQCAELRKKDRPDLGTVI 490 (568)
Q Consensus 463 ~~~~~l~~li~~Cl~~dP~~RPs~~~vl 490 (568)
.+++.+.+|+.+||+.+|.+||++.+|+
T Consensus 234 ~~~~~l~~li~~cl~~~P~~Rpt~~ei~ 261 (272)
T d1qpca_ 234 NCPEELYQLMRLCWKERPEDRPTFDYLR 261 (272)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred cChHHHHHHHHHHcCCCHhHCcCHHHHH
Confidence 6677899999999999999999999986
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.9e-51 Score=419.39 Aligned_cols=249 Identities=27% Similarity=0.455 Sum_probs=192.5
Q ss_pred cccccceeecccCceeEEEEEeC--Cc---cEEEEEeCcC-hhHhHHHHHHHHHHHHcCCCCceeeeccccCC--CceEE
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKLD--HT---PVAIKVLRPD-AAQGKRQFQQEVEVLSSIRHPNMVLLLGACPD--YGCLV 300 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~~--~~---~vAvK~l~~~-~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--~~~lV 300 (568)
+.|++.++||+|+||+||+|.+. +. .||||++... .....+.|.+|+.+|++++|||||+++|+|.+ ..++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 56788899999999999999873 22 5899998654 33445679999999999999999999999854 45899
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCC
Q 008365 301 YEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPP 380 (568)
Q Consensus 301 ~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~ 380 (568)
||||+||+|.+++..... .+++.+++.|+.||+.||.|||+.+ ||||||||+||||+.++.+||+|||+|+.+..
T Consensus 106 ~Ey~~~g~L~~~~~~~~~--~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 180 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQNDG--QFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180 (299)
T ss_dssp EECCTTEEHHHHHHTTTT--CSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEecCCCcceeeeccccC--CCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEccC
Confidence 999999999998876433 4899999999999999999999999 99999999999999999999999999987654
Q ss_pred CCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh-CCCCCCCchH--HHHHHHhCccccccCccC
Q 008365 381 SVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPMGLTHH--VSRAIEKGTLAEMLDPAV 457 (568)
Q Consensus 381 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~--~~~~~~~~~~~~~l~~~~ 457 (568)
.... ..........||+.|||||++.++.++.++|||||||+||||+| |.+||..... +...+..+ ..
T Consensus 181 ~~~~-~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~--------~~ 251 (299)
T d1jpaa_ 181 DTSD-PTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQD--------YR 251 (299)
T ss_dssp ----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT--------CC
T ss_pred CCCc-ceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcC--------CC
Confidence 3211 11112234568999999999999999999999999999999998 8999965433 22223222 11
Q ss_pred CCCChHHHHHHHHHHHHhhccCCCCCCChHHhHh
Q 008365 458 TDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIV 491 (568)
Q Consensus 458 ~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~ 491 (568)
...|.+++..+.+|+.+||+.+|.+||++.+|+.
T Consensus 252 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~ 285 (299)
T d1jpaa_ 252 LPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVN 285 (299)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 2345567788999999999999999999999874
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-51 Score=417.40 Aligned_cols=247 Identities=26% Similarity=0.431 Sum_probs=204.9
Q ss_pred cccccce-eecccCceeEEEEEeC----CccEEEEEeCcCh-hHhHHHHHHHHHHHHcCCCCceeeeccccCC-CceEEE
Q 008365 229 DKFSEAM-KIGEGGYGPVYRGKLD----HTPVAIKVLRPDA-AQGKRQFQQEVEVLSSIRHPNMVLLLGACPD-YGCLVY 301 (568)
Q Consensus 229 ~~y~~~~-~IG~G~fg~Vy~~~~~----~~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~-~~~lV~ 301 (568)
++|.+.. +||+|+||.||+|.+. +..||||+++... ....+.|.+|+.+|++++|||||+++|+|.+ ..+|||
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~lvm 87 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLVM 87 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccCeEEEEE
Confidence 5677777 4999999999999762 3479999997653 3445779999999999999999999999854 458999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCC
Q 008365 302 EYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPS 381 (568)
Q Consensus 302 E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~ 381 (568)
|||+||+|.+++..... .+++..+..|+.||+.||.|||+++ ||||||||+||||+.++.+||+|||+|+.+...
T Consensus 88 E~~~~g~L~~~l~~~~~--~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~ 162 (285)
T d1u59a_ 88 EMAGGGPLHKFLVGKRE--EIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 162 (285)
T ss_dssp ECCTTEEHHHHHTTCTT--TSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred EeCCCCcHHHHhhcccc--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhccccc
Confidence 99999999998765432 4899999999999999999999999 999999999999999999999999999877543
Q ss_pred CCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh-CCCCCCCchH--HHHHHHhCccccccCccCC
Q 008365 382 VADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPMGLTHH--VSRAIEKGTLAEMLDPAVT 458 (568)
Q Consensus 382 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~--~~~~~~~~~~~~~l~~~~~ 458 (568)
.. .........||+.|+|||++.++.++.++|||||||++|||+| |..||..... +...+..+. ..
T Consensus 163 ~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~--------~~ 231 (285)
T d1u59a_ 163 DS---YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK--------RM 231 (285)
T ss_dssp SC---EECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTC--------CC
T ss_pred cc---ccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC--------CC
Confidence 21 1122345679999999999999999999999999999999998 9999965432 333343332 22
Q ss_pred CCChHHHHHHHHHHHHhhccCCCCCCChHHhHh
Q 008365 459 DWPAEAAESFSKLAIQCAELRKKDRPDLGTVIV 491 (568)
Q Consensus 459 ~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~ 491 (568)
..|..++..+.+||.+||+.+|.+||++.+|+.
T Consensus 232 ~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~ 264 (285)
T d1u59a_ 232 ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQ 264 (285)
T ss_dssp CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred CCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 345667788999999999999999999999863
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.2e-51 Score=416.58 Aligned_cols=246 Identities=28% Similarity=0.438 Sum_probs=204.6
Q ss_pred HhcccccceeecccCceeEEEEEe--CCccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCceeeeccccCC--CceEEEE
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACPD--YGCLVYE 302 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--~~~lV~E 302 (568)
..++|++.++||+|+||+||+|.+ +++.||||+++.+.. ..+.|.+|+.+|+.++|||||+++|+|.+ ..+||||
T Consensus 15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E 93 (287)
T d1opja_ 15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 93 (287)
T ss_dssp CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc-hHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEee
Confidence 346899999999999999999988 467899999976543 35679999999999999999999999855 4589999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCC
Q 008365 303 YMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSV 382 (568)
Q Consensus 303 ~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~ 382 (568)
||++|+|.+++..... ..+++..+..|+.||+.||.|||+.+ ||||||||+||||+.++.+||+|||+|+.+....
T Consensus 94 ~~~~g~l~~~l~~~~~-~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~ 169 (287)
T d1opja_ 94 FMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 169 (287)
T ss_dssp CCTTCBHHHHHHHSCT-TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSS
T ss_pred cccCcchHHHhhhccc-cchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecCCCC
Confidence 9999999999976543 34899999999999999999999999 9999999999999999999999999998764432
Q ss_pred CccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCC-CchH--HHHHHHhCccccccCccCCC
Q 008365 383 ADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMG-LTHH--VSRAIEKGTLAEMLDPAVTD 459 (568)
Q Consensus 383 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~-~~~~--~~~~~~~~~~~~~l~~~~~~ 459 (568)
. .......||+.|+|||++.+..|+.++|||||||++|||++|..||. .... +...+..+ ....
T Consensus 170 ~-----~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~--------~~~~ 236 (287)
T d1opja_ 170 Y-----TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD--------YRME 236 (287)
T ss_dssp S-----EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT--------CCCC
T ss_pred c-----eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcC--------CCCC
Confidence 1 12244568999999999999999999999999999999999766653 2222 22222222 1123
Q ss_pred CChHHHHHHHHHHHHhhccCCCCCCChHHhH
Q 008365 460 WPAEAAESFSKLAIQCAELRKKDRPDLGTVI 490 (568)
Q Consensus 460 ~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl 490 (568)
.|..++..+.+|+..||+.||.+||++.+|+
T Consensus 237 ~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~ 267 (287)
T d1opja_ 237 RPEGCPEKVYELMRACWQWNPSDRPSFAEIH 267 (287)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CCccchHHHHHHHHHHcCCCHhHCcCHHHHH
Confidence 4556678899999999999999999999986
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-51 Score=418.84 Aligned_cols=246 Identities=26% Similarity=0.345 Sum_probs=204.4
Q ss_pred cccccceeecccCceeEEEEEe--CCccEEEEEeCcCh---hHhHHHHHHHHHHHHcCCCCceeeeccccCCC--ceEEE
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDA---AQGKRQFQQEVEVLSSIRHPNMVLLLGACPDY--GCLVY 301 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~--~~lV~ 301 (568)
++|++++.||+|+||.||+|++ +++.||||++.+.. ....+.+.+|+++|++++|||||+++++|.+. .||||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 5799999999999999999987 57799999997543 22345789999999999999999999998654 48999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCC
Q 008365 302 EYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPS 381 (568)
Q Consensus 302 E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~ 381 (568)
|||+||+|.+++...+. +++..+..++.||+.||.|||+.+ ||||||||+||||+.++.+||+|||+|+.+...
T Consensus 88 Ey~~gg~L~~~~~~~~~---l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp CCCTTEEHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EccCCCCHHHhhhccCC---CCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccC
Confidence 99999999999887653 899999999999999999999999 999999999999999999999999999876433
Q ss_pred CCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHH--HHHHhCccccccCccCCC
Q 008365 382 VADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVS--RAIEKGTLAEMLDPAVTD 459 (568)
Q Consensus 382 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~--~~~~~~~~~~~l~~~~~~ 459 (568)
.. .......+||+.|+|||++.+..|+.++|||||||+||+|++|+.||...+... ..+..+. ..
T Consensus 162 ~~----~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~---------~~ 228 (288)
T d1uu3a_ 162 SK----QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE---------YD 228 (288)
T ss_dssp ------------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTC---------CC
T ss_pred Cc----ccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCC---------CC
Confidence 21 122345689999999999999999999999999999999999999997654322 2232222 12
Q ss_pred CChHHHHHHHHHHHHhhccCCCCCCChHHhHhHH
Q 008365 460 WPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPE 493 (568)
Q Consensus 460 ~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~ 493 (568)
+|..+++.+.+||.+||+.||.+||++.+++.+.
T Consensus 229 ~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~ 262 (288)
T d1uu3a_ 229 FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYG 262 (288)
T ss_dssp CCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHH
T ss_pred CCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCH
Confidence 3555677899999999999999999999986543
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-51 Score=411.65 Aligned_cols=243 Identities=26% Similarity=0.436 Sum_probs=196.9
Q ss_pred cccceeecccCceeEEEEEe--CCccEEEEEeCcC--hhHhHHHHHHHHHHHHcCCCCceeeeccccCC------CceEE
Q 008365 231 FSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPD--AAQGKRQFQQEVEVLSSIRHPNMVLLLGACPD------YGCLV 300 (568)
Q Consensus 231 y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~------~~~lV 300 (568)
|++.++||+|+||+||+|.+ ++..||||++... .....+.|.+|+++|++++|||||+++++|.+ ..+||
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 35667899999999999988 4568999998654 23445678999999999999999999998743 23899
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeecc-CCceeEecccccccccC
Q 008365 301 YEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLD-RNYVSKISDVGLARLVP 379 (568)
Q Consensus 301 ~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld-~~~~vKL~DFGla~~~~ 379 (568)
||||+||+|.+++.... .+++..+..|+.||+.||.|||+++ .+||||||||+||||+ .++.+||+|||+|+...
T Consensus 91 mE~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~ 166 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 166 (270)
T ss_dssp EECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EeCCCCCcHHHHHhccc---cccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence 99999999999998764 3889999999999999999999976 3599999999999996 57999999999998643
Q ss_pred CCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHH---HHHHhCccccccCcc
Q 008365 380 PSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVS---RAIEKGTLAEMLDPA 456 (568)
Q Consensus 380 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~---~~~~~~~~~~~l~~~ 456 (568)
.. .....+||+.|||||++.+ .|+.++|||||||++|||++|+.||....... ..+..+...
T Consensus 167 ~~--------~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~------ 231 (270)
T d1t4ha_ 167 AS--------FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP------ 231 (270)
T ss_dssp TT--------SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCC------
T ss_pred CC--------ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCC------
Confidence 22 2245689999999998875 59999999999999999999999996543322 222222111
Q ss_pred CCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHH
Q 008365 457 VTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPE 493 (568)
Q Consensus 457 ~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~ 493 (568)
..++..+++.+.+|+.+||+.||.+||++.+++.|.
T Consensus 232 -~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp 267 (270)
T d1t4ha_ 232 -ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHA 267 (270)
T ss_dssp -GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred -cccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCc
Confidence 112233456789999999999999999999998654
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.6e-51 Score=419.97 Aligned_cols=249 Identities=24% Similarity=0.356 Sum_probs=191.2
Q ss_pred HhcccccceeecccCceeEEEEEe--CCccEEEEEeCcChh-HhHHHHHHHHHHHHcCCCCceeeeccccCCCc--eEEE
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAA-QGKRQFQQEVEVLSSIRHPNMVLLLGACPDYG--CLVY 301 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~-~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~--~lV~ 301 (568)
+.+.|++.+.||+|+||+||+|++ +++.||||++..... .....+.+|+.+|+.++|||||+++++|.+.. +|||
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm 86 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 86 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 457799999999999999999987 477899999976543 23456789999999999999999999986654 8999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeecc---CCceeEeccccccccc
Q 008365 302 EYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLD---RNYVSKISDVGLARLV 378 (568)
Q Consensus 302 E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld---~~~~vKL~DFGla~~~ 378 (568)
|||+||+|.+++...+ .+++..+..|+.||+.||.|||+.+ ||||||||+|||+. +++.+||+|||+|+..
T Consensus 87 E~~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~ 160 (307)
T d1a06a_ 87 QLVSGGELFDRIVEKG---FYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKME 160 (307)
T ss_dssp CCCCSCBHHHHHHTCS---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred eccCCCcHHHhhhccc---CCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEc
Confidence 9999999999997654 3899999999999999999999999 99999999999994 5789999999999865
Q ss_pred CCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHH--HHHHHhCccccccCcc
Q 008365 379 PPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHV--SRAIEKGTLAEMLDPA 456 (568)
Q Consensus 379 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~--~~~~~~~~~~~~l~~~ 456 (568)
.... .....+||+.|||||++.+..|+.++|||||||++|+|++|+.||...... ...+..+... .
T Consensus 161 ~~~~-------~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~-----~ 228 (307)
T d1a06a_ 161 DPGS-------VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYE-----F 228 (307)
T ss_dssp -------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCC-----C
T ss_pred cCCC-------eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCC-----C
Confidence 4321 224568999999999999999999999999999999999999999755432 2223332211 1
Q ss_pred CCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHH
Q 008365 457 VTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPE 493 (568)
Q Consensus 457 ~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~ 493 (568)
....+..+++.+.+|+.+||+.||.+||++.+++.|.
T Consensus 229 ~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp 265 (307)
T d1a06a_ 229 DSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHP 265 (307)
T ss_dssp CTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHST
T ss_pred CCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCH
Confidence 1122345667899999999999999999999998654
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-51 Score=411.27 Aligned_cols=240 Identities=25% Similarity=0.422 Sum_probs=196.6
Q ss_pred eeecccCceeEEEEEeC----CccEEEEEeCcCh--hHhHHHHHHHHHHHHcCCCCceeeeccccCCC-ceEEEEecCCC
Q 008365 235 MKIGEGGYGPVYRGKLD----HTPVAIKVLRPDA--AQGKRQFQQEVEVLSSIRHPNMVLLLGACPDY-GCLVYEYMHNG 307 (568)
Q Consensus 235 ~~IG~G~fg~Vy~~~~~----~~~vAvK~l~~~~--~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~-~~lV~E~~~gg 307 (568)
++||+|+||.||+|.+. ++.||||+++... ....+.|.+|+.+|++++|||||+++|+|.+. .+||||||++|
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~~~~lvmE~~~~g 92 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELG 92 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESSSEEEEEECCTTE
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccCCEEEEEEcCCCC
Confidence 47999999999999763 3479999997543 23356799999999999999999999999554 48999999999
Q ss_pred CHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCCcccc
Q 008365 308 SLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADSVT 387 (568)
Q Consensus 308 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~ 387 (568)
+|.+++.... .+++..+..|+.||+.||.|||+.+ ||||||||+||||+.++.+||+|||+++.+..... .
T Consensus 93 ~L~~~l~~~~---~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~---~ 163 (277)
T d1xbba_ 93 PLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN---Y 163 (277)
T ss_dssp EHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCS---E
T ss_pred cHHHHHhhcc---CCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhcccccc---c
Confidence 9999987654 3899999999999999999999999 99999999999999999999999999987643321 1
Q ss_pred ccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh-CCCCCCCchH--HHHHHHhCccccccCccCCCCChHH
Q 008365 388 QYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPMGLTHH--VSRAIEKGTLAEMLDPAVTDWPAEA 464 (568)
Q Consensus 388 ~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~--~~~~~~~~~~~~~l~~~~~~~p~~~ 464 (568)
........||+.|+|||++.+..++.++|||||||++|||++ |++||..... +...+..+. ....|..+
T Consensus 164 ~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~--------~~~~p~~~ 235 (277)
T d1xbba_ 164 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE--------RMGCPAGC 235 (277)
T ss_dssp EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC--------CCCCCTTC
T ss_pred cccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCC--------CCCCCccc
Confidence 122234679999999999999999999999999999999998 8999975433 223333322 22445667
Q ss_pred HHHHHHHHHHhhccCCCCCCChHHhHh
Q 008365 465 AESFSKLAIQCAELRKKDRPDLGTVIV 491 (568)
Q Consensus 465 ~~~l~~li~~Cl~~dP~~RPs~~~vl~ 491 (568)
+..+.+|+.+||+.+|.+||++.+|+.
T Consensus 236 ~~~~~~li~~cl~~dp~~RPs~~~i~~ 262 (277)
T d1xbba_ 236 PREMYDLMNLCWTYDVENRPGFAAVEL 262 (277)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 788999999999999999999999863
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-51 Score=406.70 Aligned_cols=246 Identities=24% Similarity=0.414 Sum_probs=206.6
Q ss_pred cccccceeecccCceeEEEEEe-CCccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCceeeeccccCCC--ceEEEEecC
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKL-DHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACPDY--GCLVYEYMH 305 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~-~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~--~~lV~E~~~ 305 (568)
++|+++++||+|+||+||+|++ +++.||||+++..... .+.|.+|+.++++++|||||+++|+|.+. .++||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~-~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSC-HHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCC-HHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 5789999999999999999998 4568999999865433 46799999999999999999999998653 489999999
Q ss_pred CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCCcc
Q 008365 306 NGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADS 385 (568)
Q Consensus 306 ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~~~ 385 (568)
+|+|.+++..... .+++..+.+|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+.....
T Consensus 83 ~g~l~~~~~~~~~--~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~-- 155 (258)
T d1k2pa_ 83 NGCLLNYLREMRH--RFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-- 155 (258)
T ss_dssp TEEHHHHHHSGGG--CCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC--
T ss_pred CCcHHHhhhcccc--CCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCc--
Confidence 9999998765443 3789999999999999999999999 99999999999999999999999999987643221
Q ss_pred ccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh-CCCCCCCchH--HHHHHHhCccccccCccCCCCCh
Q 008365 386 VTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPMGLTHH--VSRAIEKGTLAEMLDPAVTDWPA 462 (568)
Q Consensus 386 ~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~--~~~~~~~~~~~~~l~~~~~~~p~ 462 (568)
.......||+.|+|||++.+..++.++|||||||++|||+| |+.||..... +...+..+ .....|.
T Consensus 156 ---~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~--------~~~~~p~ 224 (258)
T d1k2pa_ 156 ---TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG--------LRLYRPH 224 (258)
T ss_dssp ---CCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTT--------CCCCCCT
T ss_pred ---eeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhC--------CCCCCcc
Confidence 12345679999999999999999999999999999999998 8999976543 22333322 1123355
Q ss_pred HHHHHHHHHHHHhhccCCCCCCChHHhHhHH
Q 008365 463 EAAESFSKLAIQCAELRKKDRPDLGTVIVPE 493 (568)
Q Consensus 463 ~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~ 493 (568)
.++..+.+|+.+||+.+|.+||++.+|+.++
T Consensus 225 ~~~~~l~~li~~cl~~dP~~RPt~~eil~~L 255 (258)
T d1k2pa_ 225 LASEKVYTIMYSCWHEKADERPTFKILLSNI 255 (258)
T ss_dssp TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred cccHHHHHHHHHHccCCHhHCcCHHHHHHHh
Confidence 6677899999999999999999999998654
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.3e-51 Score=416.91 Aligned_cols=243 Identities=26% Similarity=0.406 Sum_probs=200.4
Q ss_pred cccccceeecccCceeEEEEEe--CCccEEEEEeCcCh---hHhHHHHHHHHHHHHcCCCCceeeeccccCC--CceEEE
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDA---AQGKRQFQQEVEVLSSIRHPNMVLLLGACPD--YGCLVY 301 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--~~~lV~ 301 (568)
+.|+.++.||+|+||.||+|++ +++.||||++.... ....+.+.+|+.+|+.++|||||+++++|.+ ..+|||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 4599999999999999999987 56789999987543 3344678899999999999999999999854 458999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCC
Q 008365 302 EYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPS 381 (568)
Q Consensus 302 E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~ 381 (568)
|||++|+|..++...+ .+++..+..|+.||+.||.|||+++ ||||||||+||||+.++.+||+|||+|+....
T Consensus 95 E~~~~g~l~~~~~~~~---~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~- 167 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHKK---PLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP- 167 (309)
T ss_dssp ECCSEEHHHHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-
T ss_pred EecCCCchHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCC-
Confidence 9999999977665543 3899999999999999999999999 99999999999999999999999999976432
Q ss_pred CCccccccccccccccccCCChhhhhc---CCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHH--HHhCccccccCcc
Q 008365 382 VADSVTQYHMTSAAGTFCYIDPEYQQT---GMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRA--IEKGTLAEMLDPA 456 (568)
Q Consensus 382 ~~~~~~~~~~~~~~GT~~Y~APE~~~~---~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~--~~~~~~~~~l~~~ 456 (568)
....+||+.|||||++.+ +.|+.++|||||||++|||++|..||......... +..+.. +.
T Consensus 168 ---------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~-----~~ 233 (309)
T d1u5ra_ 168 ---------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES-----PA 233 (309)
T ss_dssp ---------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC-----CC
T ss_pred ---------CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCC-----CC
Confidence 134679999999998864 45899999999999999999999999755443322 222211 11
Q ss_pred CCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 457 VTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 457 ~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
. .+..+++.+.+|+.+||+.||.+||++.+++.|.+
T Consensus 234 ~--~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~ 269 (309)
T d1u5ra_ 234 L--QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 269 (309)
T ss_dssp C--SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHH
T ss_pred C--CCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHH
Confidence 1 12345677999999999999999999999987654
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=7.9e-51 Score=423.66 Aligned_cols=249 Identities=22% Similarity=0.349 Sum_probs=208.2
Q ss_pred hcccccceeecccCceeEEEEEe--CCccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCceeeeccccCCC--ceEEEEe
Q 008365 228 TDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACPDY--GCLVYEY 303 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~--~~lV~E~ 303 (568)
.++|++++.||+|+||.||+|++ +|+.||||++........+.+.+|+.+|+.|+|||||+++++|.+. .||||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 46899999999999999999987 5789999999877766677899999999999999999999998554 4899999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeecc--CCceeEecccccccccCCC
Q 008365 304 MHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLD--RNYVSKISDVGLARLVPPS 381 (568)
Q Consensus 304 ~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld--~~~~vKL~DFGla~~~~~~ 381 (568)
|+||+|.+++..... .+++..+..|+.||+.||.|||+++ ||||||||+||||+ .++.+||+|||+|+.+...
T Consensus 105 ~~gg~L~~~l~~~~~--~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~ 179 (350)
T d1koaa2 105 MSGGELFEKVADEHN--KMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 179 (350)
T ss_dssp CCSCBHHHHHTCTTS--CBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred CCCCCHHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheecccc
Confidence 999999998865432 3899999999999999999999999 99999999999995 4689999999999876433
Q ss_pred CCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHH--HHHHhCccccccCccCCC
Q 008365 382 VADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVS--RAIEKGTLAEMLDPAVTD 459 (568)
Q Consensus 382 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~--~~~~~~~~~~~l~~~~~~ 459 (568)
. .....+||+.|||||++.+..|+.++|||||||++|+|++|+.||....... ..+..+... +. ..
T Consensus 180 ~-------~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~--~~---~~ 247 (350)
T d1koaa2 180 Q-------SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWN--MD---DS 247 (350)
T ss_dssp S-------CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC--SC---CG
T ss_pred c-------ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC--CC---cc
Confidence 2 2245689999999999999999999999999999999999999997554322 223222211 00 11
Q ss_pred CChHHHHHHHHHHHHhhccCCCCCCChHHhHhHH
Q 008365 460 WPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPE 493 (568)
Q Consensus 460 ~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~ 493 (568)
.+..+++.+.+||.+||..||.+||++.+++.|.
T Consensus 248 ~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp 281 (350)
T d1koaa2 248 AFSGISEDGKDFIRKLLLADPNTRMTIHQALEHP 281 (350)
T ss_dssp GGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHST
T ss_pred cccCCCHHHHHHHHHHccCChhHCcCHHHHhcCc
Confidence 1234567899999999999999999999998653
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.1e-50 Score=422.95 Aligned_cols=250 Identities=18% Similarity=0.291 Sum_probs=209.9
Q ss_pred hcccccceeecccCceeEEEEEe--CCccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCceeeeccccCCCc--eEEEEe
Q 008365 228 TDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACPDYG--CLVYEY 303 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~--~lV~E~ 303 (568)
.++|++++.||+|+||.||+|.+ +++.||||++..........+.+|+.+|+.|+|||||+++++|.+.. ||||||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 46799999999999999999987 57899999998776666678899999999999999999999986544 899999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeecc--CCceeEecccccccccCCC
Q 008365 304 MHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLD--RNYVSKISDVGLARLVPPS 381 (568)
Q Consensus 304 ~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld--~~~~vKL~DFGla~~~~~~ 381 (568)
|+||+|.+++...+. .+++..+..|+.||+.||.|||+.| ||||||||+||||+ .++.+||+|||+|+.+...
T Consensus 108 ~~gg~L~~~~~~~~~--~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~ 182 (352)
T d1koba_ 108 LSGGELFDRIAAEDY--KMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 182 (352)
T ss_dssp CCCCBHHHHTTCTTC--CBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCCChHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCC
Confidence 999999988765432 3899999999999999999999999 99999999999997 5789999999999877543
Q ss_pred CCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHH--HHHHhCccccccCccCCC
Q 008365 382 VADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVS--RAIEKGTLAEMLDPAVTD 459 (568)
Q Consensus 382 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~--~~~~~~~~~~~l~~~~~~ 459 (568)
. ......||+.|+|||++.+..|+.++|||||||++|+|++|+.||....... ..+..+... ....
T Consensus 183 ~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~-----~~~~ 250 (352)
T d1koba_ 183 E-------IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWE-----FDED 250 (352)
T ss_dssp S-------CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCC-----CCSS
T ss_pred C-------ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC-----CCcc
Confidence 2 2245679999999999999999999999999999999999999997654433 223332211 1112
Q ss_pred CChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 460 WPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 460 ~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
.+..++..+.+||.+||+.||.+||++.+++.|.+
T Consensus 251 ~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~ 285 (352)
T d1koba_ 251 AFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPW 285 (352)
T ss_dssp TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTT
T ss_pred cccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHh
Confidence 23456678999999999999999999999986543
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-50 Score=403.96 Aligned_cols=253 Identities=27% Similarity=0.457 Sum_probs=196.6
Q ss_pred cccccceeecccCceeEEEEEeCC------ccEEEEEeCcCh-hHhHHHHHHHHHHHHcCCCCceeeeccccCC--CceE
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKLDH------TPVAIKVLRPDA-AQGKRQFQQEVEVLSSIRHPNMVLLLGACPD--YGCL 299 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~~~------~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--~~~l 299 (568)
+.|...++||+|+||.||+|.+.+ ..||||+++... ......|.+|+.+|+.++|||||+++|+|.+ ..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 568889999999999999998733 369999997643 3334578999999999999999999999854 4489
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccC
Q 008365 300 VYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVP 379 (568)
Q Consensus 300 V~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~ 379 (568)
|||||.+|+|.+++..... .+++..+..|+.||+.||.|||+.+ ||||||||+||||+.++.+||+|||+++.+.
T Consensus 87 v~e~~~~~~l~~~~~~~~~--~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 161 (283)
T d1mqba_ 87 ITEYMENGALDKFLREKDG--EFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE 161 (283)
T ss_dssp EEECCTTEEHHHHHHHTTT--CSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred EEEecccCcchhhhhcccc--cccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhccc
Confidence 9999999999998776543 4899999999999999999999999 9999999999999999999999999998764
Q ss_pred CCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCC-CCch--HHHHHHHhCccccccCcc
Q 008365 380 PSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPM-GLTH--HVSRAIEKGTLAEMLDPA 456 (568)
Q Consensus 380 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf-~~~~--~~~~~~~~~~~~~~l~~~ 456 (568)
..... ........||+.|+|||++.++.++.++|||||||++|||++|..|| .... .+...+..+ .
T Consensus 162 ~~~~~---~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~--------~ 230 (283)
T d1mqba_ 162 DDPEA---TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDG--------F 230 (283)
T ss_dssp ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT--------C
T ss_pred CCCcc---ceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhcc--------C
Confidence 33211 12234467899999999999999999999999999999999965554 3222 222333222 1
Q ss_pred CCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHHHHHH
Q 008365 457 VTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPELNRLK 498 (568)
Q Consensus 457 ~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l~~L~ 498 (568)
....|.+++..+.+|+.+||+.+|.+||++.+|+. .|+.+.
T Consensus 231 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~-~L~~l~ 271 (283)
T d1mqba_ 231 RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVS-ILDKLI 271 (283)
T ss_dssp CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH-HHHHHH
T ss_pred CCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHH-HHHHHh
Confidence 22345567788999999999999999999999874 334433
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-50 Score=417.97 Aligned_cols=251 Identities=27% Similarity=0.416 Sum_probs=202.4
Q ss_pred hcccccceeecccCceeEEEEEeCC-------ccEEEEEeCcCh-hHhHHHHHHHHHHHHcC-CCCceeeeccccCCC--
Q 008365 228 TDKFSEAMKIGEGGYGPVYRGKLDH-------TPVAIKVLRPDA-AQGKRQFQQEVEVLSSI-RHPNMVLLLGACPDY-- 296 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~~~~~~-------~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l-~HpnIv~l~g~~~~~-- 296 (568)
.++|++.++||+|+||+||+|++.+ ..||||++.... ......+.+|+.+|.++ +|||||+++++|.+.
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 115 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 115 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence 3679999999999999999998732 259999986543 33345788999999998 899999999998654
Q ss_pred ceEEEEecCCCCHHHHHhhcCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCC
Q 008365 297 GCLVYEYMHNGSLEDRLLRRGN--------------------TPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKP 356 (568)
Q Consensus 297 ~~lV~E~~~ggsL~~~l~~~~~--------------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp 356 (568)
.+||||||+||+|.++|..... ...+++..++.|+.||+.||.|||+.+ ||||||||
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp 192 (325)
T d1rjba_ 116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAA 192 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSG
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCch
Confidence 4899999999999999976432 234889999999999999999999999 99999999
Q ss_pred CCeeccCCceeEecccccccccCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh-CCCCCC
Q 008365 357 ANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPMG 435 (568)
Q Consensus 357 ~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~ 435 (568)
+|||++.++.+||+|||+|+...... .........||+.|||||++.++.|+.++|||||||+||||+| |.+||.
T Consensus 193 ~Nill~~~~~~Kl~DFGla~~~~~~~----~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~ 268 (325)
T d1rjba_ 193 RNVLVTHGKVVKICDFGLARDIMSDS----NYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 268 (325)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCT----TSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred hccccccCCeEEEeeccccccccCCC----ceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCC
Confidence 99999999999999999998653322 1122345678999999999999999999999999999999998 899996
Q ss_pred Cch---HHHHHHHhCccccccCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHH
Q 008365 436 LTH---HVSRAIEKGTLAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPE 493 (568)
Q Consensus 436 ~~~---~~~~~~~~~~~~~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~ 493 (568)
... .+...+..+. ..+.|..+++.+.+||.+||+.+|.+||++.+|+.++
T Consensus 269 ~~~~~~~~~~~~~~~~--------~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L 321 (325)
T d1rjba_ 269 GIPVDANFYKLIQNGF--------KMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 321 (325)
T ss_dssp TCCCSHHHHHHHHTTC--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCCHHHHHHHHHhcCC--------CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 432 2223332221 1234566778899999999999999999999997543
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-50 Score=403.57 Aligned_cols=248 Identities=25% Similarity=0.389 Sum_probs=195.5
Q ss_pred hcccccceeecccCceeEEEEEeCC-----ccEEEEEeCcCh-hHhHHHHHHHHHHHHcCCCCceeeeccccCC-CceEE
Q 008365 228 TDKFSEAMKIGEGGYGPVYRGKLDH-----TPVAIKVLRPDA-AQGKRQFQQEVEVLSSIRHPNMVLLLGACPD-YGCLV 300 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~~~~~~-----~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~-~~~lV 300 (568)
.++|++.+.||+|+||.||+|.+.. ..||||+++... ......|.+|+.+|++++|||||+++|+|.+ ..++|
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~iv 85 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWII 85 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSCEEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCeEEEE
Confidence 4689999999999999999998732 358899886543 3345679999999999999999999999854 45899
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCC
Q 008365 301 YEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPP 380 (568)
Q Consensus 301 ~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~ 380 (568)
||||++|+|.+++..... .+++..++.++.||+.||.|||+.+ ||||||||+|||++.++.+||+|||+|+.+..
T Consensus 86 ~E~~~~g~l~~~~~~~~~--~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~ 160 (273)
T d1mp8a_ 86 MELCTLGELRSFLQVRKY--SLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 160 (273)
T ss_dssp EECCTTEEHHHHHHHTTT--TSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC---------
T ss_pred EEeccCCcHHhhhhccCC--CCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheeccC
Confidence 999999999998766443 3899999999999999999999999 99999999999999999999999999987543
Q ss_pred CCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh-CCCCCCCchH--HHHHHHhCccccccCccC
Q 008365 381 SVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPMGLTHH--VSRAIEKGTLAEMLDPAV 457 (568)
Q Consensus 381 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~--~~~~~~~~~~~~~l~~~~ 457 (568)
.. ........||+.|+|||++.+..++.++|||||||++|||++ |.+||..... +...+..+. .
T Consensus 161 ~~-----~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~--------~ 227 (273)
T d1mp8a_ 161 ST-----YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE--------R 227 (273)
T ss_dssp ---------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC--------C
T ss_pred Cc-----ceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC--------C
Confidence 21 122345678999999999999999999999999999999998 8999964432 333333322 2
Q ss_pred CCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHH
Q 008365 458 TDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPE 493 (568)
Q Consensus 458 ~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~ 493 (568)
...|..+++.+.+||.+||+.||.+||++.+|+.++
T Consensus 228 ~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L 263 (273)
T d1mp8a_ 228 LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQL 263 (273)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHH
Confidence 234566778899999999999999999999998553
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-50 Score=414.85 Aligned_cols=246 Identities=25% Similarity=0.321 Sum_probs=207.6
Q ss_pred hcccccceeecccCceeEEEEEe--CCccEEEEEeCcChh---HhHHHHHHHHHHHHcCCCCceeeeccccCCCc--eEE
Q 008365 228 TDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAA---QGKRQFQQEVEVLSSIRHPNMVLLLGACPDYG--CLV 300 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~---~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~--~lV 300 (568)
.++|++++.||+|+||.||+|++ +++.||||++++... .....+.+|+.+|+.++|||||+++++|.+.. |+|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 36799999999999999999997 578999999976432 23467889999999999999999999996654 899
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCC
Q 008365 301 YEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPP 380 (568)
Q Consensus 301 ~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~ 380 (568)
||||+||+|.+++...+. +++..+..++.||+.||.|||+++ ||||||||+||||+.+|.+||+|||+|+....
T Consensus 84 ~ey~~gg~L~~~~~~~~~---~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~ 157 (337)
T d1o6la_ 84 MEYANGGELFFHLSRERV---FTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp EECCTTCBHHHHHHHHSC---CCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred eeccCCCchhhhhhcccC---CcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeeccccccccc
Confidence 999999999999887653 788999999999999999999999 99999999999999999999999999986533
Q ss_pred CCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHH--HHHHHhCccccccCccCC
Q 008365 381 SVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHV--SRAIEKGTLAEMLDPAVT 458 (568)
Q Consensus 381 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~--~~~~~~~~~~~~l~~~~~ 458 (568)
.. ......+||+.|+|||++.+..|+.++|||||||++|||++|++||...+.. ...+..+. .
T Consensus 158 ~~------~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~---------~ 222 (337)
T d1o6la_ 158 DG------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE---------I 222 (337)
T ss_dssp TT------CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC---------C
T ss_pred CC------cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCC---------C
Confidence 21 1234578999999999999999999999999999999999999999765442 22222222 2
Q ss_pred CCChHHHHHHHHHHHHhhccCCCCCCC-----hHHhHhHHH
Q 008365 459 DWPAEAAESFSKLAIQCAELRKKDRPD-----LGTVIVPEL 494 (568)
Q Consensus 459 ~~p~~~~~~l~~li~~Cl~~dP~~RPs-----~~~vl~~~l 494 (568)
.+|..+++.+.+||.+||+.||.+||+ +.+++.|.+
T Consensus 223 ~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~ 263 (337)
T d1o6la_ 223 RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRF 263 (337)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGG
T ss_pred CCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCcc
Confidence 345567778999999999999999995 677776544
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-50 Score=409.44 Aligned_cols=249 Identities=20% Similarity=0.312 Sum_probs=205.1
Q ss_pred HhcccccceeecccCceeEEEEEe--CCccEEEEEeCcChh------HhHHHHHHHHHHHHcCCCCceeeeccccCCCc-
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAA------QGKRQFQQEVEVLSSIRHPNMVLLLGACPDYG- 297 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~------~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~- 297 (568)
..+.|++++.||+|+||+||+|++ +|+.||||++.+... ...+.+.+|+.+|+.++|||||+++++|.+..
T Consensus 8 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 87 (293)
T d1jksa_ 8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 87 (293)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 457899999999999999999997 577999999865321 23567899999999999999999999996654
Q ss_pred -eEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCc----eeEeccc
Q 008365 298 -CLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNY----VSKISDV 372 (568)
Q Consensus 298 -~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~----~vKL~DF 372 (568)
|||||||+||+|.+++...+ .+++..+..|+.||+.||.|||+.+ ||||||||+||||+.++ .+||+||
T Consensus 88 ~~iv~E~~~gg~L~~~i~~~~---~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~Df 161 (293)
T d1jksa_ 88 VILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDF 161 (293)
T ss_dssp EEEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEEEcCCCccccchhcccc---ccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecch
Confidence 89999999999999998764 3899999999999999999999999 99999999999998766 5999999
Q ss_pred ccccccCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHH--HHHHhCccc
Q 008365 373 GLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVS--RAIEKGTLA 450 (568)
Q Consensus 373 Gla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~--~~~~~~~~~ 450 (568)
|+|+.+.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..+..+...
T Consensus 162 G~a~~~~~~~-------~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~ 234 (293)
T d1jksa_ 162 GLAHKIDFGN-------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYE 234 (293)
T ss_dssp TTCEECTTSC-------BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCC
T ss_pred hhhhhcCCCc-------cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCC
Confidence 9998764322 2245689999999999999999999999999999999999999997554332 222222110
Q ss_pred cccCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHH
Q 008365 451 EMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPE 493 (568)
Q Consensus 451 ~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~ 493 (568)
+. ...+..++..+.+||.+||+.||.+||++.+++.|.
T Consensus 235 --~~---~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp 272 (293)
T d1jksa_ 235 --FE---DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHP 272 (293)
T ss_dssp --CC---HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHST
T ss_pred --CC---chhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCc
Confidence 00 011234566789999999999999999999987543
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-49 Score=408.91 Aligned_cols=248 Identities=26% Similarity=0.446 Sum_probs=201.6
Q ss_pred cccccceeecccCceeEEEEEeC--Cc----cEEEEEeCcC-hhHhHHHHHHHHHHHHcCCCCceeeeccccCCC-ceEE
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKLD--HT----PVAIKVLRPD-AAQGKRQFQQEVEVLSSIRHPNMVLLLGACPDY-GCLV 300 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~~--~~----~vAvK~l~~~-~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~-~~lV 300 (568)
++|+++++||+|+||+||+|.+. ++ .||||+++.. .....+.|.+|+.+|++++|||||+++|+|.+. .++|
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~v 88 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLI 88 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeeEE
Confidence 36999999999999999999873 33 5899988654 334467799999999999999999999998654 4889
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCC
Q 008365 301 YEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPP 380 (568)
Q Consensus 301 ~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~ 380 (568)
|+|+.+|+|.+++..... .+++..++.|+.||+.||.|||+.+ ||||||||+||||+.++.+||+|||+|+.+..
T Consensus 89 ~e~~~~~~l~~~~~~~~~--~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~ 163 (317)
T d1xkka_ 89 TQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 163 (317)
T ss_dssp EECCTTCBHHHHHHHTSS--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred EEeccCCccccccccccc--CCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceeccc
Confidence 999999999998876543 4899999999999999999999999 99999999999999999999999999987654
Q ss_pred CCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh-CCCCCCCc--hHHHHHHHhCccccccCccC
Q 008365 381 SVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPMGLT--HHVSRAIEKGTLAEMLDPAV 457 (568)
Q Consensus 381 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~--~~~~~~~~~~~~~~~l~~~~ 457 (568)
... ........||+.|+|||++.++.|+.++|||||||++|||+| |.+||... ..+...+..+. .
T Consensus 164 ~~~----~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~--------~ 231 (317)
T d1xkka_ 164 EEK----EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE--------R 231 (317)
T ss_dssp TCC------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTC--------C
T ss_pred ccc----cccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC--------C
Confidence 321 122234579999999999999999999999999999999998 89999653 23334443332 1
Q ss_pred CCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHH
Q 008365 458 TDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPE 493 (568)
Q Consensus 458 ~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~ 493 (568)
...|..++..+.+|+.+||+.+|.+||++.+|+.++
T Consensus 232 ~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l 267 (317)
T d1xkka_ 232 LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEF 267 (317)
T ss_dssp CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHH
Confidence 234556778899999999999999999999998654
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.5e-49 Score=408.36 Aligned_cols=242 Identities=27% Similarity=0.382 Sum_probs=205.0
Q ss_pred cccccceeecccCceeEEEEEe--CCccEEEEEeCcChh---HhHHHHHHHHHHHHcCCCCceeeeccccCCCc--eEEE
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAA---QGKRQFQQEVEVLSSIRHPNMVLLLGACPDYG--CLVY 301 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~---~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~--~lV~ 301 (568)
++|++++.||+|+||+||+|++ +|+.||||++++... ...+.+.+|+.+|+.++|||||+++++|.+.. |+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 5799999999999999999997 578999999975432 23467889999999999999999999986544 8999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCC
Q 008365 302 EYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPS 381 (568)
Q Consensus 302 E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~ 381 (568)
|||+||+|..++..... +++..+..++.||+.||.|||+++ ||||||||+||||+.+|.+||+|||+|+.+...
T Consensus 84 E~~~gg~l~~~~~~~~~---~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~ 157 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQR---FPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 157 (316)
T ss_dssp CCCCSCBHHHHHHHTSS---CCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred eecCCcccccccccccc---ccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEeccc
Confidence 99999999998877653 778888899999999999999999 999999999999999999999999999876432
Q ss_pred CCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHH--HHHHhCccccccCccCCC
Q 008365 382 VADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVS--RAIEKGTLAEMLDPAVTD 459 (568)
Q Consensus 382 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~--~~~~~~~~~~~l~~~~~~ 459 (568)
....+||+.|+|||++.+..|+.++|||||||++|+|++|+.||...+... ..+..+. ..
T Consensus 158 ---------~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~---------~~ 219 (316)
T d1fota_ 158 ---------TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAE---------LR 219 (316)
T ss_dssp ---------BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCC---------CC
T ss_pred ---------cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCC---------CC
Confidence 235689999999999999999999999999999999999999997654322 2222221 12
Q ss_pred CChHHHHHHHHHHHHhhccCCCCCC-----ChHHhHhHHH
Q 008365 460 WPAEAAESFSKLAIQCAELRKKDRP-----DLGTVIVPEL 494 (568)
Q Consensus 460 ~p~~~~~~l~~li~~Cl~~dP~~RP-----s~~~vl~~~l 494 (568)
+|..+++.+.+++.+||..+|.+|| ++.+++.|.+
T Consensus 220 ~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~ 259 (316)
T d1fota_ 220 FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPW 259 (316)
T ss_dssp CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGG
T ss_pred CCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcc
Confidence 3555667899999999999999996 8888876644
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-50 Score=400.04 Aligned_cols=245 Identities=30% Similarity=0.480 Sum_probs=198.8
Q ss_pred cccccceeecccCceeEEEEEeCCccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCceeeeccccCC---CceEEEEecC
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKLDHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACPD---YGCLVYEYMH 305 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~---~~~lV~E~~~ 305 (568)
++|++.+.||+|+||.||+|.+.++.||||+++.+. ..+.|.+|+.+|++++|||||+++|+|.+ ..++||||++
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~ 84 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 84 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCT
T ss_pred HHeEEeEEEecCCCeEEEEEEECCeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccC
Confidence 568899999999999999999999999999997654 34678999999999999999999998843 3489999999
Q ss_pred CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCCcc
Q 008365 306 NGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADS 385 (568)
Q Consensus 306 ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~~~ 385 (568)
+|+|.++|...... .+++..++.|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 85 ~g~L~~~l~~~~~~-~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~---- 156 (262)
T d1byga_ 85 KGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---- 156 (262)
T ss_dssp TEEHHHHHHHHHHH-HCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred CCCHHHHHHhcCCC-CCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCC----
Confidence 99999999764322 3899999999999999999999999 999999999999999999999999999865321
Q ss_pred ccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh-CCCCCCCch--HHHHHHHhCccccccCccCCCCCh
Q 008365 386 VTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPMGLTH--HVSRAIEKGTLAEMLDPAVTDWPA 462 (568)
Q Consensus 386 ~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~--~~~~~~~~~~~~~~l~~~~~~~p~ 462 (568)
.....+|+.|+|||++.++.++.++|||||||++|||+| |++||.... .+...+..+ .....|.
T Consensus 157 -----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~--------~~~~~~~ 223 (262)
T d1byga_ 157 -----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG--------YKMDAPD 223 (262)
T ss_dssp ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTT--------CCCCCCT
T ss_pred -----CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC--------CCCCCCc
Confidence 133568999999999999999999999999999999998 788886432 233333222 2223455
Q ss_pred HHHHHHHHHHHHhhccCCCCCCChHHhHhHHHHHH
Q 008365 463 EAAESFSKLAIQCAELRKKDRPDLGTVIVPELNRL 497 (568)
Q Consensus 463 ~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l~~L 497 (568)
.+++.+.+|+.+||..||.+||++.+|+. .|+++
T Consensus 224 ~~~~~~~~li~~cl~~dP~~Rps~~~l~~-~L~~i 257 (262)
T d1byga_ 224 GCPPAVYEVMKNCWHLDAAMRPSFLQLRE-QLEHI 257 (262)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHH-HHHHH
T ss_pred cCCHHHHHHHHHHcccCHhHCcCHHHHHH-HHHHH
Confidence 66778999999999999999999999864 33443
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.3e-49 Score=405.91 Aligned_cols=249 Identities=28% Similarity=0.468 Sum_probs=204.4
Q ss_pred HhcccccceeecccCceeEEEEEeCC-------ccEEEEEeCcChh-HhHHHHHHHHHHHHcCCCCceeeeccccCC--C
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKLDH-------TPVAIKVLRPDAA-QGKRQFQQEVEVLSSIRHPNMVLLLGACPD--Y 296 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~~~-------~~vAvK~l~~~~~-~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--~ 296 (568)
..++|++++.||+|+||.||+|++.+ +.||||+++.... .....|.+|+.+|+.++||||++++++|.+ .
T Consensus 11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~ 90 (301)
T d1lufa_ 11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 90 (301)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCc
Confidence 45789999999999999999998643 5799999976543 345679999999999999999999999855 4
Q ss_pred ceEEEEecCCCCHHHHHhhcCC---------------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCC
Q 008365 297 GCLVYEYMHNGSLEDRLLRRGN---------------------TPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLK 355 (568)
Q Consensus 297 ~~lV~E~~~ggsL~~~l~~~~~---------------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIK 355 (568)
.++||||+++|+|.+++..... ...+++..++.|+.||+.||.|||+.+ |||||||
T Consensus 91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivHrDlK 167 (301)
T d1lufa_ 91 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLA 167 (301)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCS
T ss_pred eEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEeeEEc
Confidence 5899999999999999965321 234889999999999999999999999 9999999
Q ss_pred CCCeeccCCceeEecccccccccCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCC-CCC
Q 008365 356 PANILLDRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITAR-SPM 434 (568)
Q Consensus 356 p~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~-~Pf 434 (568)
|+|||||.++.+||+|||+|+.+.... .....+...||+.|+|||++.+..|+.++|||||||++|||++|. +||
T Consensus 168 p~NILld~~~~~Kl~DFGls~~~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~ 243 (301)
T d1lufa_ 168 TRNCLVGENMVVKIADFGLSRNIYSAD----YYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 243 (301)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGG----CBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred ccceEECCCCcEEEccchhheeccCCc----cccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCC
Confidence 999999999999999999998654321 112234567999999999999999999999999999999999985 677
Q ss_pred CCchHH--HHHHHhCccccccCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhH
Q 008365 435 GLTHHV--SRAIEKGTLAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVI 490 (568)
Q Consensus 435 ~~~~~~--~~~~~~~~~~~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl 490 (568)
...... ...+..+ .....|..++..+.+|+.+||+.+|.+||++.+|+
T Consensus 244 ~~~~~~e~~~~v~~~--------~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~ 293 (301)
T d1lufa_ 244 YGMAHEEVIYYVRDG--------NILACPENCPLELYNLMRLCWSKLPADRPSFCSIH 293 (301)
T ss_dssp TTSCHHHHHHHHHTT--------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CCCCHHHHHHHHHcC--------CCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 654432 2233332 22344666778899999999999999999999985
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.5e-49 Score=400.57 Aligned_cols=258 Identities=25% Similarity=0.408 Sum_probs=199.5
Q ss_pred HhcccccceeecccCceeEEEEEe--CCccEEEEEeCcCh---hHhHHHHHHHHHHHHcCCCCceeeeccccCCC-----
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDA---AQGKRQFQQEVEVLSSIRHPNMVLLLGACPDY----- 296 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~----- 296 (568)
+.++|++.+.||+|+||.||+|.+ +++.||||+++... ......|.+|+.+|+.++|||||++++++...
T Consensus 5 l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~ 84 (277)
T d1o6ya_ 5 LSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 84 (277)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSE
T ss_pred ccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCc
Confidence 357899999999999999999987 57899999997653 23345789999999999999999999987432
Q ss_pred -ceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccc
Q 008365 297 -GCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLA 375 (568)
Q Consensus 297 -~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla 375 (568)
.|||||||+||+|.+++...+. +++.++..|+.||+.||.|||+.+ ||||||||+||||+.++.++|+|||++
T Consensus 85 ~~~lvmE~~~g~~L~~~~~~~~~---l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~ 158 (277)
T d1o6ya_ 85 LPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIA 158 (277)
T ss_dssp EEEEEEECCCEEEHHHHHHHHCS---CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTC
T ss_pred eEEEEEECCCCCEehhhhcccCC---CCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhh
Confidence 4799999999999998877653 899999999999999999999999 999999999999999999999999998
Q ss_pred cccCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHH--HhCcccccc
Q 008365 376 RLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAI--EKGTLAEML 453 (568)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~--~~~~~~~~l 453 (568)
+....... ........+||+.|+|||++.+..++.++|||||||++|+|+||++||.......... ..+.. .
T Consensus 159 ~~~~~~~~---~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~---~ 232 (277)
T d1o6ya_ 159 RAIADSGN---SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDP---I 232 (277)
T ss_dssp EECC-------------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCC---C
T ss_pred hhhccccc---cccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCC---C
Confidence 76543221 1223356789999999999999999999999999999999999999997655433221 11110 0
Q ss_pred CccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHHHHHH
Q 008365 454 DPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPELNRLK 498 (568)
Q Consensus 454 ~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l~~L~ 498 (568)
.+ ......+++.+.+|+.+||+.||.+||+..+.+.+.|.++.
T Consensus 233 ~~--~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 233 PP--SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp CG--GGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred CC--chhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 00 11223456789999999999999999954444456665553
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-49 Score=402.32 Aligned_cols=245 Identities=32% Similarity=0.486 Sum_probs=196.7
Q ss_pred hcccccceeecccCceeEEEEEeCC-ccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCceeeeccccCCC-ceEEEEecC
Q 008365 228 TDKFSEAMKIGEGGYGPVYRGKLDH-TPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACPDY-GCLVYEYMH 305 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~~~~~~-~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~-~~lV~E~~~ 305 (568)
.++|++.+.||+|+||.||+|.+.+ ..||||+++.... ..+.|.+|+.+|++++|||||+++|+|.+. .++|||||+
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~lv~Ey~~ 94 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMS 94 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEECCCT
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccC-CHHHHHHHHHHHHhcccCCEeEEEEEEecCCeEEEEEecC
Confidence 3679999999999999999999844 5799999976543 356799999999999999999999998554 589999999
Q ss_pred CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCCcc
Q 008365 306 NGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVADS 385 (568)
Q Consensus 306 ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~~~ 385 (568)
+|+|..++...... .+++..++.|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+.....
T Consensus 95 ~g~l~~~~~~~~~~-~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~-- 168 (285)
T d1fmka3 95 KGSLLDFLKGETGK-YLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-- 168 (285)
T ss_dssp TCBHHHHHSHHHHT-TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred CCchhhhhhhcccc-cchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCCc--
Confidence 99999888654322 3899999999999999999999999 99999999999999999999999999987643321
Q ss_pred ccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCC-CCchH--HHHHHHhCccccccCccCCCCCh
Q 008365 386 VTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPM-GLTHH--VSRAIEKGTLAEMLDPAVTDWPA 462 (568)
Q Consensus 386 ~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf-~~~~~--~~~~~~~~~~~~~l~~~~~~~p~ 462 (568)
.......||+.|+|||++.++.++.++|||||||++|||++|..|| ..... +...+..+. ....+.
T Consensus 169 ---~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~--------~~~~~~ 237 (285)
T d1fmka3 169 ---TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY--------RMPCPP 237 (285)
T ss_dssp ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC--------CCCCCT
T ss_pred ---eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcC--------CCCCCc
Confidence 2234567999999999999999999999999999999999965554 33322 222222221 123455
Q ss_pred HHHHHHHHHHHHhhccCCCCCCChHHhH
Q 008365 463 EAAESFSKLAIQCAELRKKDRPDLGTVI 490 (568)
Q Consensus 463 ~~~~~l~~li~~Cl~~dP~~RPs~~~vl 490 (568)
.+++.+.+|+.+||+.+|.+||++.+|+
T Consensus 238 ~~~~~l~~li~~cl~~dP~~Rps~~~i~ 265 (285)
T d1fmka3 238 ECPESLHDLMCQCWRKEPEERPTFEYLQ 265 (285)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred ccCHHHHHHHHHHcccCHhHCcCHHHHH
Confidence 6778899999999999999999999986
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.6e-49 Score=411.10 Aligned_cols=242 Identities=22% Similarity=0.340 Sum_probs=205.4
Q ss_pred cccccceeecccCceeEEEEEe--CCccEEEEEeCcChh---HhHHHHHHHHHHHHcCCCCceeeeccccCCCc--eEEE
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAA---QGKRQFQQEVEVLSSIRHPNMVLLLGACPDYG--CLVY 301 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~---~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~--~lV~ 301 (568)
++|++++.||+|+||.||+|++ +++.||||++.+... ...+.+.+|+.+|+.++|||||+++++|.+.. ++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 6899999999999999999987 578999999865432 23456889999999999999999999986544 7999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCC
Q 008365 302 EYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPS 381 (568)
Q Consensus 302 E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~ 381 (568)
||+.||+|.+++...+. +++..+..|+.||+.||.|||+++ ||||||||+||||+.+|.+||+|||+|+.+...
T Consensus 121 e~~~~g~l~~~l~~~~~---l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~ 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp ECCTTCBHHHHHHHHCC---CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred ccccccchhhhHhhcCC---CCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence 99999999999987653 899999999999999999999999 999999999999999999999999999876422
Q ss_pred CCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHH--HHHHhCccccccCccCCC
Q 008365 382 VADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVS--RAIEKGTLAEMLDPAVTD 459 (568)
Q Consensus 382 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~--~~~~~~~~~~~l~~~~~~ 459 (568)
....+||+.|||||++.+..|+.++|||||||++|||++|+.||...+... ..+..+. ..
T Consensus 195 ---------~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~---------~~ 256 (350)
T d1rdqe_ 195 ---------TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK---------VR 256 (350)
T ss_dssp ---------BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC---------CC
T ss_pred ---------cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCC---------CC
Confidence 235679999999999999999999999999999999999999997654422 2222221 12
Q ss_pred CChHHHHHHHHHHHHhhccCCCCCC-----ChHHhHhHHH
Q 008365 460 WPAEAAESFSKLAIQCAELRKKDRP-----DLGTVIVPEL 494 (568)
Q Consensus 460 ~p~~~~~~l~~li~~Cl~~dP~~RP-----s~~~vl~~~l 494 (568)
.|..+++.+.+|+.+||..||.+|+ ++.+++.|.+
T Consensus 257 ~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~ 296 (350)
T d1rdqe_ 257 FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKW 296 (350)
T ss_dssp CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGG
T ss_pred CCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCcc
Confidence 3455667899999999999999994 8888876554
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-49 Score=399.23 Aligned_cols=256 Identities=27% Similarity=0.402 Sum_probs=196.5
Q ss_pred HhcccccceeecccCceeEEEEEeC-------CccEEEEEeCcCh-hHhHHHHHHHHHHHHcC-CCCceeeeccccCC--
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKLD-------HTPVAIKVLRPDA-AQGKRQFQQEVEVLSSI-RHPNMVLLLGACPD-- 295 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~~-------~~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l-~HpnIv~l~g~~~~-- 295 (568)
..++|++.++||+|+||.||+|.+. ++.||||+++... ....+.+.+|+.++.++ +|+|||.+++++.+
T Consensus 11 ~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~ 90 (299)
T d1ywna1 11 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 90 (299)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred cHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCC
Confidence 3478999999999999999999862 2479999997543 33345677888888776 68999999998743
Q ss_pred -CceEEEEecCCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeec
Q 008365 296 -YGCLVYEYMHNGSLEDRLLRRGN-------------TPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILL 361 (568)
Q Consensus 296 -~~~lV~E~~~ggsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILl 361 (568)
..++|||||++|+|.+++..... ...+++..+..|+.||+.||.|||+.+ ||||||||+||||
T Consensus 91 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~NILl 167 (299)
T d1ywna1 91 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILL 167 (299)
T ss_dssp SCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEE
T ss_pred CeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCccceeE
Confidence 34899999999999999975431 234889999999999999999999999 9999999999999
Q ss_pred cCCceeEecccccccccCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhC-CCCCCCch--
Q 008365 362 DRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITA-RSPMGLTH-- 438 (568)
Q Consensus 362 d~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG-~~Pf~~~~-- 438 (568)
+.++.+||+|||+|+....... ........||+.|+|||++.+..++.++|||||||++|||++| .+||....
T Consensus 168 ~~~~~~Kl~DFGla~~~~~~~~----~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~ 243 (299)
T d1ywna1 168 SEKNVVKICDFGLARDIYKDPD----YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 243 (299)
T ss_dssp CGGGCEEECC------CCSCTT----SCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS
T ss_pred CCCCcEEEccCcchhhcccccc----ccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHH
Confidence 9999999999999987643321 1223456899999999999999999999999999999999986 56785432
Q ss_pred -HHHHHHHhCccccccCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHHHHH
Q 008365 439 -HVSRAIEKGTLAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPELNRL 497 (568)
Q Consensus 439 -~~~~~~~~~~~~~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l~~L 497 (568)
.+...+..+.. ...|..+++.+.+|+.+||+.||.+||++.+|+.++-+-|
T Consensus 244 ~~~~~~~~~~~~--------~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~il 295 (299)
T d1ywna1 244 EEFCRRLKEGTR--------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 295 (299)
T ss_dssp HHHHHHHHHTCC--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHhcCCC--------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 33333333321 2334556778999999999999999999999986544333
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-49 Score=396.47 Aligned_cols=247 Identities=27% Similarity=0.429 Sum_probs=194.2
Q ss_pred cccccceeecccCceeEEEEEeCC-----ccEEEEEeCcCh---hHhHHHHHHHHHHHHcCCCCceeeeccccCCC-ceE
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKLDH-----TPVAIKVLRPDA---AQGKRQFQQEVEVLSSIRHPNMVLLLGACPDY-GCL 299 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~~~-----~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~-~~l 299 (568)
++|++.+.||+|+||.||+|++.+ ..||||++++.. ....+.|.+|+.+|+.++|||||+++|+|.+. .++
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~~~~l 87 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKM 87 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeecchhe
Confidence 569999999999999999998632 269999987642 33356799999999999999999999999654 489
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccC
Q 008365 300 VYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVP 379 (568)
Q Consensus 300 V~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~ 379 (568)
|||||++|+|.+++..... .+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+.
T Consensus 88 v~e~~~~~~l~~~~~~~~~--~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~~ 162 (273)
T d1u46a_ 88 VTELAPLGSLLDRLRKHQG--HFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALP 162 (273)
T ss_dssp EEECCTTCBHHHHHHHHGG--GSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred eeeeecCcchhhhhhcccC--CCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhcc
Confidence 9999999999998876543 3899999999999999999999999 9999999999999999999999999999775
Q ss_pred CCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh-CCCCCCCchHHH--HHHHhCccccccCcc
Q 008365 380 PSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPMGLTHHVS--RAIEKGTLAEMLDPA 456 (568)
Q Consensus 380 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~--~~~~~~~~~~~l~~~ 456 (568)
..... ........||+.|+|||++.+..++.++|||||||++|||+| |..||...+... ..+.... .
T Consensus 163 ~~~~~---~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~-------~ 232 (273)
T d1u46a_ 163 QNDDH---YVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEG-------E 232 (273)
T ss_dssp C-CCE---EEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSC-------C
T ss_pred cCCCc---ceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCC-------C
Confidence 43321 122334568899999999999999999999999999999998 899996554432 2222221 1
Q ss_pred CCCCChHHHHHHHHHHHHhhccCCCCCCChHHhH
Q 008365 457 VTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVI 490 (568)
Q Consensus 457 ~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl 490 (568)
....+..++..+.+|+.+||..||.+||++.+|+
T Consensus 233 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~ 266 (273)
T d1u46a_ 233 RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALR 266 (273)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CCCCcccccHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 1133455667899999999999999999999985
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.6e-48 Score=393.42 Aligned_cols=248 Identities=22% Similarity=0.358 Sum_probs=205.1
Q ss_pred hcccccceeecccCceeEEEEEe--CCccEEEEEeCcCh---------hHhHHHHHHHHHHHHcCC-CCceeeeccccCC
Q 008365 228 TDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDA---------AQGKRQFQQEVEVLSSIR-HPNMVLLLGACPD 295 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~---------~~~~~~~~~Ev~iL~~l~-HpnIv~l~g~~~~ 295 (568)
.++|++.+.||+|+||+||+|++ +++.||||++.... ....+.+.+|+.+|++++ |||||+++++|.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 36899999999999999999987 67899999986532 112346889999999997 9999999999966
Q ss_pred Cc--eEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccc
Q 008365 296 YG--CLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVG 373 (568)
Q Consensus 296 ~~--~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFG 373 (568)
.. |||||||+||+|.++|...+ .+++..+..|+.||+.||.|||+++ |+||||||+||||+.++.+||+|||
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~~---~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG 155 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEKV---TLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFG 155 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCT
T ss_pred CcceEEEEEcCCCchHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccch
Confidence 54 89999999999999998765 3899999999999999999999999 9999999999999999999999999
Q ss_pred cccccCCCCCccccccccccccccccCCChhhhhc------CCCCCcceehhHHHHHHHHHhCCCCCCCchHHH--HHHH
Q 008365 374 LARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQT------GMLTTKSDIYSFGIMLLQIITARSPMGLTHHVS--RAIE 445 (568)
Q Consensus 374 la~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~------~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~--~~~~ 445 (568)
+++.+.... .....+||+.|+|||++.+ ..++.++||||+||++|+|++|+.||....... ..+.
T Consensus 156 ~a~~~~~~~-------~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~ 228 (277)
T d1phka_ 156 FSCQLDPGE-------KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIM 228 (277)
T ss_dssp TCEECCTTC-------CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred heeEccCCC-------ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHH
Confidence 998765422 1245679999999998764 347889999999999999999999997655432 2233
Q ss_pred hCccccccCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHH
Q 008365 446 KGTLAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPE 493 (568)
Q Consensus 446 ~~~~~~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~ 493 (568)
.+... . .......+++++.+|+.+||+.+|.+||++.+|+.|.
T Consensus 229 ~~~~~-~----~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~ 271 (277)
T d1phka_ 229 SGNYQ-F----GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHP 271 (277)
T ss_dssp HTCCC-C----CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSG
T ss_pred hCCCC-C----CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCH
Confidence 33221 1 1112345677899999999999999999999998654
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.1e-48 Score=409.61 Aligned_cols=246 Identities=26% Similarity=0.315 Sum_probs=198.2
Q ss_pred cccccceeecccCceeEEEEEe--CCccEEEEEeCcChhH---hHHHHH---HHHHHHHcCCCCceeeeccccCCC--ce
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQ---GKRQFQ---QEVEVLSSIRHPNMVLLLGACPDY--GC 298 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~---~~~~~~---~Ev~iL~~l~HpnIv~l~g~~~~~--~~ 298 (568)
++|++.++||+|+||.||+|++ +|+.||||++.+.... ....+. .++.+++.++|||||+++++|.+. .|
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 6799999999999999999987 5789999998653221 122333 457778888999999999998654 48
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEeccccccccc
Q 008365 299 LVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLV 378 (568)
Q Consensus 299 lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~ 378 (568)
||||||+||+|.++|.... .+++..+..|+.||+.||.|||+.+ ||||||||+||||+.+|.+||+|||+|+.+
T Consensus 84 ivmE~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~ 157 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQHG---VFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF 157 (364)
T ss_dssp EEECCCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred EEEEecCCCcHHHHHHhcc---cccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeec
Confidence 9999999999999998764 3788999999999999999999999 999999999999999999999999999876
Q ss_pred CCCCCccccccccccccccccCCChhhhhc-CCCCCcceehhHHHHHHHHHhCCCCCCCchH--HHHHHHhCccccccCc
Q 008365 379 PPSVADSVTQYHMTSAAGTFCYIDPEYQQT-GMLTTKSDIYSFGIMLLQIITARSPMGLTHH--VSRAIEKGTLAEMLDP 455 (568)
Q Consensus 379 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDvwSlGvil~elltG~~Pf~~~~~--~~~~~~~~~~~~~l~~ 455 (568)
... .....+||+.|+|||++.. ..|+.++|||||||+||||++|+.||..... ....... ...
T Consensus 158 ~~~--------~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~------~~~ 223 (364)
T d1omwa3 158 SKK--------KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM------TLT 223 (364)
T ss_dssp SSS--------CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHH------SSS
T ss_pred CCC--------cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh------ccc
Confidence 432 2245689999999998864 5699999999999999999999999964321 1111111 111
Q ss_pred cCCCCChHHHHHHHHHHHHhhccCCCCCCC-----hHHhHhHHH
Q 008365 456 AVTDWPAEAAESFSKLAIQCAELRKKDRPD-----LGTVIVPEL 494 (568)
Q Consensus 456 ~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs-----~~~vl~~~l 494 (568)
....+|..+++.+.+||.+||+.||.+||+ +.+++.|.+
T Consensus 224 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~ 267 (364)
T d1omwa3 224 MAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPF 267 (364)
T ss_dssp CCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGG
T ss_pred CCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCcc
Confidence 112334566778999999999999999999 577776554
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-48 Score=402.84 Aligned_cols=250 Identities=19% Similarity=0.287 Sum_probs=205.7
Q ss_pred HhcccccceeecccCceeEEEEEe--CCccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCceeeeccccCC--CceEEEE
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACPD--YGCLVYE 302 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--~~~lV~E 302 (568)
+.++|.+++.||+|+||+||+|.+ +++.||||+++..... ...+.+|+.+|+.++|||||+++++|.+ ..|||||
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~-~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE 81 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHH-HHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCccc-HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 357899999999999999999987 5678999999876543 4568899999999999999999999854 3489999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccC--CceeEecccccccccCC
Q 008365 303 YMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDR--NYVSKISDVGLARLVPP 380 (568)
Q Consensus 303 ~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~--~~~vKL~DFGla~~~~~ 380 (568)
||+||+|.+++...+. .+++.++..|+.||+.||.|||+.+ |+||||||+||||+. .+.+||+|||+++....
T Consensus 82 ~~~gg~L~~~i~~~~~--~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~ 156 (321)
T d1tkia_ 82 FISGLDIFERINTSAF--ELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp CCCCCBHHHHHTSSSC--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred cCCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhcccc
Confidence 9999999999976542 3899999999999999999999999 999999999999975 45899999999987643
Q ss_pred CCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHH--HHHHHhCccccccCccCC
Q 008365 381 SVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHV--SRAIEKGTLAEMLDPAVT 458 (568)
Q Consensus 381 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~--~~~~~~~~~~~~l~~~~~ 458 (568)
.. ......||+.|+|||.+.+..|+.++|||||||++|+|++|..||...... ...+..+... ++.
T Consensus 157 ~~-------~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~--~~~--- 224 (321)
T d1tkia_ 157 GD-------NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYT--FDE--- 224 (321)
T ss_dssp TC-------EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCC--CCH---
T ss_pred CC-------cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC--CCh---
Confidence 21 224467999999999999999999999999999999999999999765432 2223222210 000
Q ss_pred CCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 459 DWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 459 ~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
..+..+++.+.+|+.+||..||.+||++.+++.|.+
T Consensus 225 ~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~ 260 (321)
T d1tkia_ 225 EAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPW 260 (321)
T ss_dssp HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred hhccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHh
Confidence 011234567899999999999999999999998765
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-48 Score=401.11 Aligned_cols=245 Identities=25% Similarity=0.331 Sum_probs=203.5
Q ss_pred cccccceeecccCceeEEEEEe--CCccEEEEEeCcChh---HhHHHHHHHHHHHH-cCCCCceeeeccccCCC--ceEE
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAA---QGKRQFQQEVEVLS-SIRHPNMVLLLGACPDY--GCLV 300 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~---~~~~~~~~Ev~iL~-~l~HpnIv~l~g~~~~~--~~lV 300 (568)
++|++++.||+|+||+||+|++ +++.||||++++... .....+..|+.++. .++|||||+++++|.+. .|||
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 6799999999999999999998 678999999975432 22345667777665 68999999999998654 4899
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCC
Q 008365 301 YEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPP 380 (568)
Q Consensus 301 ~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~ 380 (568)
||||+||+|.+++...+. +++..+..++.||+.||.|||+++ ||||||||+|||++.++.+||+|||+++....
T Consensus 82 mEy~~~g~L~~~i~~~~~---~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~ 155 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCHK---FDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML 155 (320)
T ss_dssp EECCTTCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EeecCCCcHHHHhhccCC---CCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhccc
Confidence 999999999999987653 788999999999999999999999 99999999999999999999999999986533
Q ss_pred CCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchH--HHHHHHhCccccccCccCC
Q 008365 381 SVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHH--VSRAIEKGTLAEMLDPAVT 458 (568)
Q Consensus 381 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~--~~~~~~~~~~~~~l~~~~~ 458 (568)
.. ......+||+.|+|||++.+..|+.++|||||||++|+|++|+.||..... +...+..+. .
T Consensus 156 ~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~---------~ 220 (320)
T d1xjda_ 156 GD------AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN---------P 220 (320)
T ss_dssp TT------CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC---------C
T ss_pred cc------ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCC---------C
Confidence 21 223456899999999999999999999999999999999999999975443 222232221 1
Q ss_pred CCChHHHHHHHHHHHHhhccCCCCCCChH-HhHhHHH
Q 008365 459 DWPAEAAESFSKLAIQCAELRKKDRPDLG-TVIVPEL 494 (568)
Q Consensus 459 ~~p~~~~~~l~~li~~Cl~~dP~~RPs~~-~vl~~~l 494 (568)
.+|..++..+.+|+.+||..||.+||++. +++.|.+
T Consensus 221 ~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpf 257 (320)
T d1xjda_ 221 FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPL 257 (320)
T ss_dssp CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGG
T ss_pred CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCch
Confidence 34556677899999999999999999995 6766543
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-49 Score=406.71 Aligned_cols=247 Identities=21% Similarity=0.352 Sum_probs=198.3
Q ss_pred Hhcccccce-eecccCceeEEEEEe--CCccEEEEEeCcChhHhHHHHHHHHHHHHc-CCCCceeeeccccCC------C
Q 008365 227 ATDKFSEAM-KIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQGKRQFQQEVEVLSS-IRHPNMVLLLGACPD------Y 296 (568)
Q Consensus 227 ~~~~y~~~~-~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~-l~HpnIv~l~g~~~~------~ 296 (568)
..++|.++. .||+|+||.||+|++ +++.||||+++.. ..+.+|+.++.+ ++|||||+++++|.+ .
T Consensus 9 i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~ 83 (335)
T d2ozaa1 9 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 83 (335)
T ss_dssp GGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred cccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCE
Confidence 356898875 599999999999987 5779999999643 356789998654 589999999998853 2
Q ss_pred ceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccC---CceeEecccc
Q 008365 297 GCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDR---NYVSKISDVG 373 (568)
Q Consensus 297 ~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~---~~~vKL~DFG 373 (568)
.|||||||+||+|.++|...+.. .+++..+..|+.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||
T Consensus 84 ~~ivmEy~~gg~L~~~i~~~~~~-~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG 159 (335)
T d2ozaa1 84 LLIVMECLDGGELFSRIQDRGDQ-AFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFG 159 (335)
T ss_dssp EEEEEECCCSEEHHHHHHSCSCC-CEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred EEEEEECCCCCcHHHHHHhcCCC-CcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccccccccccccccc
Confidence 48999999999999999875443 4999999999999999999999999 999999999999975 5689999999
Q ss_pred cccccCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHH--HHHHhCcccc
Q 008365 374 LARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVS--RAIEKGTLAE 451 (568)
Q Consensus 374 la~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~--~~~~~~~~~~ 451 (568)
+|+...... .....+||+.|+|||++.+..|+.++|||||||+||+|+||++||....... ..+...
T Consensus 160 ~a~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~---- 228 (335)
T d2ozaa1 160 FAKETTSHN-------SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR---- 228 (335)
T ss_dssp TCEECCCCC-------CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------C----
T ss_pred eeeeccCCC-------ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHH----
Confidence 998764332 1245689999999999999999999999999999999999999995433211 111110
Q ss_pred ccCccCCCCC----hHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 452 MLDPAVTDWP----AEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 452 ~l~~~~~~~p----~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
+......+| ..+++.+.+|+.+||+.||.+||++.+++.|.+
T Consensus 229 -i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~ 274 (335)
T d2ozaa1 229 -IRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPW 274 (335)
T ss_dssp -CCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHH
T ss_pred -HhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHH
Confidence 100011122 356778999999999999999999999987655
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-48 Score=394.50 Aligned_cols=248 Identities=23% Similarity=0.261 Sum_probs=190.1
Q ss_pred cceeecccCceeEEEEEe--CCccEEEEEeCcChhHh-----HHHHHHHHHHHHcCCCCceeeeccccCCC--ceEEEEe
Q 008365 233 EAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQG-----KRQFQQEVEVLSSIRHPNMVLLLGACPDY--GCLVYEY 303 (568)
Q Consensus 233 ~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~-----~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~--~~lV~E~ 303 (568)
.+++||+|+||+||+|++ +++.||||+++...... ...+.+|+.+|+.++|||||+++++|.+. .+|||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 467899999999999987 57789999997543221 23588999999999999999999998654 4899999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCC
Q 008365 304 MHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVA 383 (568)
Q Consensus 304 ~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~ 383 (568)
|.++++..++... ..+++..+..|+.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|+.+....
T Consensus 82 ~~~~~~~~~~~~~---~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~- 154 (299)
T d1ua2a_ 82 METDLEVIIKDNS---LVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN- 154 (299)
T ss_dssp CSEEHHHHHTTCC---SSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC-
T ss_pred hcchHHhhhhhcc---cCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCc-
Confidence 9888776554332 24888899999999999999999999 9999999999999999999999999998654322
Q ss_pred ccccccccccccccccCCChhhhhc-CCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHH--Hh--Ccccc-cc----
Q 008365 384 DSVTQYHMTSAAGTFCYIDPEYQQT-GMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAI--EK--GTLAE-ML---- 453 (568)
Q Consensus 384 ~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~--~~--~~~~~-~l---- 453 (568)
......+||+.|+|||++.+ ..|+.++|||||||++|||++|.+||.......... .. +.... ..
T Consensus 155 -----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~ 229 (299)
T d1ua2a_ 155 -----RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMC 229 (299)
T ss_dssp -----CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTT
T ss_pred -----ccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchh
Confidence 12235689999999998765 468999999999999999999999997655433221 11 00000 00
Q ss_pred -------CccCCCC-----ChHHHHHHHHHHHHhhccCCCCCCChHHhHhH
Q 008365 454 -------DPAVTDW-----PAEAAESFSKLAIQCAELRKKDRPDLGTVIVP 492 (568)
Q Consensus 454 -------~~~~~~~-----p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~ 492 (568)
....... ....++.+.+|+.+||..||.+|||+.+++.|
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 230 SLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp SSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred ccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 0000111 12345679999999999999999999998754
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-47 Score=391.05 Aligned_cols=244 Identities=27% Similarity=0.412 Sum_probs=197.6
Q ss_pred ceeecccCceeEEEEEeCC-----ccEEEEEeCcC-hhHhHHHHHHHHHHHHcCCCCceeeeccccCC---CceEEEEec
Q 008365 234 AMKIGEGGYGPVYRGKLDH-----TPVAIKVLRPD-AAQGKRQFQQEVEVLSSIRHPNMVLLLGACPD---YGCLVYEYM 304 (568)
Q Consensus 234 ~~~IG~G~fg~Vy~~~~~~-----~~vAvK~l~~~-~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~---~~~lV~E~~ 304 (568)
.++||+|+||+||+|.+.. ..||||+++.. .......|.+|+++|++++|||||+++|+|.+ ..++|||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 4689999999999998732 25899999753 44556789999999999999999999998732 348999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCCc
Q 008365 305 HNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVAD 384 (568)
Q Consensus 305 ~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~~ 384 (568)
++|+|.+++..... .+++..++.|+.|++.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+......
T Consensus 112 ~~g~l~~~~~~~~~--~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~ 186 (311)
T d1r0pa_ 112 KHGDLRNFIRNETH--NPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 186 (311)
T ss_dssp TTCBHHHHHHCTTC--CCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred ecCchhhhhccccc--cchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence 99999998875443 3778889999999999999999999 999999999999999999999999999876543221
Q ss_pred cccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchH---HHHHHHhCccccccCccCCCCC
Q 008365 385 SVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHH---VSRAIEKGTLAEMLDPAVTDWP 461 (568)
Q Consensus 385 ~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~---~~~~~~~~~~~~~l~~~~~~~p 461 (568)
.........||+.|+|||.+.++.++.++|||||||++|||++|..||..... +...+..+. ....|
T Consensus 187 --~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~--------~~~~p 256 (311)
T d1r0pa_ 187 --SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR--------RLLQP 256 (311)
T ss_dssp --CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTC--------CCCCC
T ss_pred --cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC--------CCCCc
Confidence 22223456799999999999999999999999999999999998777753322 112222221 12234
Q ss_pred hHHHHHHHHHHHHhhccCCCCCCChHHhHhH
Q 008365 462 AEAAESFSKLAIQCAELRKKDRPDLGTVIVP 492 (568)
Q Consensus 462 ~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~ 492 (568)
..+++.+.+||.+||+.||.+||++.+|+.+
T Consensus 257 ~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 257 EYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ccCcHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 5667789999999999999999999999854
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-47 Score=391.40 Aligned_cols=254 Identities=27% Similarity=0.443 Sum_probs=201.7
Q ss_pred hcccccceeecccCceeEEEEEeCC---------ccEEEEEeCcChh-HhHHHHHHHHHHHHcC-CCCceeeeccccCCC
Q 008365 228 TDKFSEAMKIGEGGYGPVYRGKLDH---------TPVAIKVLRPDAA-QGKRQFQQEVEVLSSI-RHPNMVLLLGACPDY 296 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~~~~~~---------~~vAvK~l~~~~~-~~~~~~~~Ev~iL~~l-~HpnIv~l~g~~~~~ 296 (568)
.++|++++.||+|+||.||+|++.+ ..||||+++.+.. .....+.+|+..+.++ +|||||+++++|.+.
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 4689999999999999999998632 3699999977643 3456788999999888 799999999999654
Q ss_pred --ceEEEEecCCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeec
Q 008365 297 --GCLVYEYMHNGSLEDRLLRRGN-------------TPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILL 361 (568)
Q Consensus 297 --~~lV~E~~~ggsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILl 361 (568)
.++|||||++|+|.++|..... ...+++..++.|+.||+.||.|||+.+ ||||||||+|||+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl 168 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 168 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceee
Confidence 4899999999999999975532 234899999999999999999999999 9999999999999
Q ss_pred cCCceeEecccccccccCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh-CCCCCCCchH-
Q 008365 362 DRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPMGLTHH- 439 (568)
Q Consensus 362 d~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~- 439 (568)
+.++.+||+|||+++....... ........||+.|+|||++.++.|+.++|||||||++|||++ |.+||.....
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~----~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~ 244 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDY----YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 244 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCT----TCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred cCCCCeEeccchhhcccccccc----ccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH
Confidence 9999999999999986643221 122345679999999999999999999999999999999998 7889864432
Q ss_pred -HHHHHHhCccccccCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHHHHH
Q 008365 440 -VSRAIEKGTLAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPELNRL 497 (568)
Q Consensus 440 -~~~~~~~~~~~~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l~~L 497 (568)
+...+..+ .....|..+++.+.+||.+||+.+|.+||++.+|+. .|+++
T Consensus 245 ~~~~~i~~~--------~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~-~L~~i 294 (299)
T d1fgka_ 245 ELFKLLKEG--------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE-DLDRI 294 (299)
T ss_dssp HHHHHHHTT--------CCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH-HHHHH
T ss_pred HHHHHHHcC--------CCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHH-HHHHH
Confidence 22223222 122345566778999999999999999999999974 33443
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-47 Score=391.97 Aligned_cols=250 Identities=27% Similarity=0.426 Sum_probs=205.5
Q ss_pred HhcccccceeecccCceeEEEEEeC-------CccEEEEEeCcC-hhHhHHHHHHHHHHHHcCCCCceeeeccccC--CC
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKLD-------HTPVAIKVLRPD-AAQGKRQFQQEVEVLSSIRHPNMVLLLGACP--DY 296 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~~-------~~~vAvK~l~~~-~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~--~~ 296 (568)
..++|.+.++||+|+||.||+|.+. ++.||||+++.. .......|.+|+.++++++|||||+++|+|. +.
T Consensus 18 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~ 97 (308)
T d1p4oa_ 18 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 97 (308)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSS
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCc
Confidence 3478999999999999999999864 358999999764 3344457899999999999999999999985 44
Q ss_pred ceEEEEecCCCCHHHHHhhc-------CCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEe
Q 008365 297 GCLVYEYMHNGSLEDRLLRR-------GNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKI 369 (568)
Q Consensus 297 ~~lV~E~~~ggsL~~~l~~~-------~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL 369 (568)
.++|||||++|+|.+++... .....+++..+..|+.|++.||.|||+.+ |+||||||+||||+.++++||
T Consensus 98 ~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl 174 (308)
T d1p4oa_ 98 TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 174 (308)
T ss_dssp CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEE
T ss_pred eeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEEE
Confidence 58999999999999988643 22234788999999999999999999999 999999999999999999999
Q ss_pred cccccccccCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhC-CCCCCCchH--HHHHHHh
Q 008365 370 SDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITA-RSPMGLTHH--VSRAIEK 446 (568)
Q Consensus 370 ~DFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG-~~Pf~~~~~--~~~~~~~ 446 (568)
+|||+|+.+.... .........||+.|+|||.+.+..++.++|||||||++|||+|| .+||..... +...+..
T Consensus 175 ~DFGla~~~~~~~----~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~ 250 (308)
T d1p4oa_ 175 GDFGMTRDIYETD----YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME 250 (308)
T ss_dssp CCTTCCCGGGGGG----CEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHT
T ss_pred eecccceeccCCc----ceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh
Confidence 9999998653321 22233455799999999999999999999999999999999998 577865443 2222222
Q ss_pred CccccccCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHh
Q 008365 447 GTLAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIV 491 (568)
Q Consensus 447 ~~~~~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~ 491 (568)
+ .....|..++..+.+||.+||+.+|.+||++.+|+.
T Consensus 251 ~--------~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~ 287 (308)
T d1p4oa_ 251 G--------GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 287 (308)
T ss_dssp T--------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred C--------CCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 2 223345667788999999999999999999999874
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-48 Score=394.17 Aligned_cols=246 Identities=29% Similarity=0.487 Sum_probs=197.2
Q ss_pred cccccceeecccCceeEEEEEeC--Cc--cEEEEEeCcC-hhHhHHHHHHHHHHHHcC-CCCceeeeccccCCC--ceEE
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKLD--HT--PVAIKVLRPD-AAQGKRQFQQEVEVLSSI-RHPNMVLLLGACPDY--GCLV 300 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~~--~~--~vAvK~l~~~-~~~~~~~~~~Ev~iL~~l-~HpnIv~l~g~~~~~--~~lV 300 (568)
++|++.++||+|+||.||+|.+. +. .||||.++.. .....+.|.+|+++|+++ +|||||+++|+|.+. .++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 67889999999999999999873 33 5788887543 333456799999999998 799999999998554 4899
Q ss_pred EEecCCCCHHHHHhhc-------------CCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCcee
Q 008365 301 YEYMHNGSLEDRLLRR-------------GNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVS 367 (568)
Q Consensus 301 ~E~~~ggsL~~~l~~~-------------~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~v 367 (568)
|||++||+|.++|... .....+++..+..++.||+.||.|||+.+ ||||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence 9999999999998754 12345899999999999999999999999 9999999999999999999
Q ss_pred EecccccccccCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCC-CCCCCchHHH--HHH
Q 008365 368 KISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITAR-SPMGLTHHVS--RAI 444 (568)
Q Consensus 368 KL~DFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~-~Pf~~~~~~~--~~~ 444 (568)
||+|||+++...... ......||+.|+|||.+.++.|+.++|||||||++|||++|. +||....... ..+
T Consensus 167 kl~DfG~a~~~~~~~-------~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i 239 (309)
T d1fvra_ 167 KIADFGLSRGQEVYV-------KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 239 (309)
T ss_dssp EECCTTCEESSCEEC-------CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHG
T ss_pred EEccccccccccccc-------cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence 999999998653221 123457999999999999999999999999999999999965 5675443322 222
Q ss_pred HhCccccccCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhH
Q 008365 445 EKGTLAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVP 492 (568)
Q Consensus 445 ~~~~~~~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~ 492 (568)
..+ .....|..+++.+.+||.+||+.+|++||++.+|+.+
T Consensus 240 ~~~--------~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 240 PQG--------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp GGT--------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred Hhc--------CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 221 1223456677889999999999999999999999854
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-47 Score=391.13 Aligned_cols=254 Identities=27% Similarity=0.376 Sum_probs=196.2
Q ss_pred cccccceeecccCceeEEEEEe--CCccEEEEEeCcChh--HhHHHHHHHHHHHHcCCCCceeeeccccCCC--ceEEEE
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAA--QGKRQFQQEVEVLSSIRHPNMVLLLGACPDY--GCLVYE 302 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~--~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~--~~lV~E 302 (568)
++|+++++||+|+||.||+|++ +++.||||+++.... .....+.+|+++|+.++|||||+++++|.+. .|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 6899999999999999999987 578999999975532 2246788999999999999999999999554 489999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCC
Q 008365 303 YMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSV 382 (568)
Q Consensus 303 ~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~ 382 (568)
||.+ ++.+++..... ..+++..+..|+.||+.||.|||+.+ ||||||||+|||++.++.+||+|||+|+......
T Consensus 82 ~~~~-~~~~~~~~~~~-~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~ 156 (298)
T d1gz8a_ 82 FLHQ-DLKKFMDASAL-TGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156 (298)
T ss_dssp CCSE-EHHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred ecCC-chhhhhhhhcc-cCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCCc
Confidence 9964 55555544332 24899999999999999999999999 9999999999999999999999999998764322
Q ss_pred CccccccccccccccccCCChhhhhcCC-CCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHh----CccccccCc--
Q 008365 383 ADSVTQYHMTSAAGTFCYIDPEYQQTGM-LTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEK----GTLAEMLDP-- 455 (568)
Q Consensus 383 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~-~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~----~~~~~~l~~-- 455 (568)
.......||+.|+|||.+.... ++.++|||||||++|+|++|+.||...+........ +...+...+
T Consensus 157 ------~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 230 (298)
T d1gz8a_ 157 ------RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 230 (298)
T ss_dssp ------BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTG
T ss_pred ------ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccc
Confidence 2234568999999999776655 588999999999999999999999765543322110 111110000
Q ss_pred --------cCCC--------CChHHHHHHHHHHHHhhccCCCCCCChHHhHhHH
Q 008365 456 --------AVTD--------WPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPE 493 (568)
Q Consensus 456 --------~~~~--------~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~ 493 (568)
.... ....++..+.+|+.+||..||.+||++.+++.|.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ 284 (298)
T d1gz8a_ 231 TSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHP 284 (298)
T ss_dssp GGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSG
T ss_pred ccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCH
Confidence 0000 0123456789999999999999999999998653
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-47 Score=390.94 Aligned_cols=256 Identities=25% Similarity=0.340 Sum_probs=194.1
Q ss_pred cccccceeecccCceeEEEEEeCCccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCceeeeccccCCC------ceEEEE
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKLDHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACPDY------GCLVYE 302 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~------~~lV~E 302 (568)
..|.+.+.||+|+||.||+|+++++.||||+++..... ...++.|+..+..++|||||+++++|.+. .+||||
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~g~~vAvK~~~~~~~~-~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~E 81 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD 81 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEETTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccchh-HHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEe
Confidence 46788899999999999999999999999999755332 22234455666788999999999998432 389999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcC-----CCCcccCCCCCCCeeccCCceeEecccccccc
Q 008365 303 YMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAK-----PEPLVHRDLKPANILLDRNYVSKISDVGLARL 377 (568)
Q Consensus 303 ~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~-----~~~IiHrDIKp~NILld~~~~vKL~DFGla~~ 377 (568)
||++|+|.++|.+.. ++|..++.++.|++.||.|||+.. ..+||||||||+||||+.++.+||+|||+++.
T Consensus 82 y~~~g~L~~~l~~~~----l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~ 157 (303)
T d1vjya_ 82 YHEHGSLFDYLNRYT----VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp CCTTCBHHHHHHHCC----BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred cccCCCHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcccc
Confidence 999999999997643 899999999999999999999741 12399999999999999999999999999987
Q ss_pred cCCCCCccccccccccccccccCCChhhhhcCC------CCCcceehhHHHHHHHHHhCCCCCCCch-------------
Q 008365 378 VPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGM------LTTKSDIYSFGIMLLQIITARSPMGLTH------------- 438 (568)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~------~s~ksDvwSlGvil~elltG~~Pf~~~~------------- 438 (568)
+..... .........+||+.|+|||++.+.. ++.++|||||||+||||+||..||....
T Consensus 158 ~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~ 235 (303)
T d1vjya_ 158 HDSATD--TIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235 (303)
T ss_dssp EETTTT--EECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred ccCCCc--ceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccccc
Confidence 644321 1222334578999999999987653 5778999999999999999998874211
Q ss_pred HHHHHHHhCccccccCccCCCC--ChHHHHHHHHHHHHhhccCCCCCCChHHhHh
Q 008365 439 HVSRAIEKGTLAEMLDPAVTDW--PAEAAESFSKLAIQCAELRKKDRPDLGTVIV 491 (568)
Q Consensus 439 ~~~~~~~~~~~~~~l~~~~~~~--p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~ 491 (568)
.....+........+++.+... +...+..+.+|+.+||+.||.+||++.+|+.
T Consensus 236 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~ 290 (303)
T d1vjya_ 236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290 (303)
T ss_dssp CCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred chHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 0001111111122223333221 2356677999999999999999999999863
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-48 Score=390.15 Aligned_cols=240 Identities=24% Similarity=0.368 Sum_probs=197.0
Q ss_pred hcccccceeecccCceeEEEEEe--CCccEEEEEeCcChhH------hHHHHHHHHHHHHcCC--CCceeeeccccCCC-
Q 008365 228 TDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQ------GKRQFQQEVEVLSSIR--HPNMVLLLGACPDY- 296 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~------~~~~~~~Ev~iL~~l~--HpnIv~l~g~~~~~- 296 (568)
.++|++.+.||+|+||.||+|.+ +++.||||++...... ....+.+|+.+|+.++ |||||+++++|.+.
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 46799999999999999999997 5789999998654211 1233668999999986 89999999998654
Q ss_pred -ceEEEEecCC-CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccC-CceeEecccc
Q 008365 297 -GCLVYEYMHN-GSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDR-NYVSKISDVG 373 (568)
Q Consensus 297 -~~lV~E~~~g-gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~-~~~vKL~DFG 373 (568)
.++||||+.+ +++.+++.... .+++..+..|+.||+.||.|||+.+ ||||||||+||||+. ++.+||+|||
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~~---~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG 156 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITERG---ALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG 156 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCT
T ss_pred eEEEEEEeccCcchHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECccc
Confidence 4899999976 67888877654 3899999999999999999999999 999999999999985 5899999999
Q ss_pred cccccCCCCCccccccccccccccccCCChhhhhcCCC-CCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHhCccccc
Q 008365 374 LARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGML-TTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEM 452 (568)
Q Consensus 374 la~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~-s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~ 452 (568)
+|+..... ..+..+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...+.+. .+..
T Consensus 157 ~a~~~~~~--------~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~i~----~~~~--- 221 (273)
T d1xwsa_ 157 SGALLKDT--------VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII----RGQV--- 221 (273)
T ss_dssp TCEECCSS--------CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHH----HCCC---
T ss_pred cceecccc--------cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchHHh----hccc---
Confidence 99865332 2245689999999999987765 677999999999999999999997654321 2211
Q ss_pred cCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 453 LDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 453 l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
.++..++.++.+|+.+||+.||.+||++.+++.|.+
T Consensus 222 ------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~ 257 (273)
T d1xwsa_ 222 ------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPW 257 (273)
T ss_dssp ------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred ------CCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHh
Confidence 233445677999999999999999999999986543
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-47 Score=389.76 Aligned_cols=255 Identities=25% Similarity=0.349 Sum_probs=196.8
Q ss_pred hcccccceeecccCceeEEEEEeC---CccEEEEEeCcChhH--hHHHHHHHHHHHHcC---CCCceeeeccccCC----
Q 008365 228 TDKFSEAMKIGEGGYGPVYRGKLD---HTPVAIKVLRPDAAQ--GKRQFQQEVEVLSSI---RHPNMVLLLGACPD---- 295 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~~~~~---~~~vAvK~l~~~~~~--~~~~~~~Ev~iL~~l---~HpnIv~l~g~~~~---- 295 (568)
.++|+++++||+|+||+||+|++. ++.||||+++..... ....+.+|+.+|+.| +|||||+++++|..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 478999999999999999999873 457999998653221 123456777776655 89999999998731
Q ss_pred ---CceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEeccc
Q 008365 296 ---YGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDV 372 (568)
Q Consensus 296 ---~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DF 372 (568)
..+++||||.++++........ ..+++..+..|+.||+.||.|||+.+ ||||||||+|||++.++.+||+||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~--~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~df 160 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPE--PGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF 160 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCT--TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSC
T ss_pred cCceEEEEEEeccCCchhhhhhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecch
Confidence 2389999998877654443332 34899999999999999999999999 999999999999999999999999
Q ss_pred ccccccCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHH--h--Cc
Q 008365 373 GLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIE--K--GT 448 (568)
Q Consensus 373 Gla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~--~--~~ 448 (568)
|+++.... .......+||+.|+|||++.+..|+.++|||||||++|||++|++||........... . +.
T Consensus 161 g~~~~~~~-------~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~ 233 (305)
T d1blxa_ 161 GLARIYSF-------QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGL 233 (305)
T ss_dssp CSCCCCCG-------GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred hhhhhhcc-------cccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCC
Confidence 99875432 1233567899999999999999999999999999999999999999976544322111 0 00
Q ss_pred -----c-----------ccccCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 449 -----L-----------AEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 449 -----~-----------~~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
+ ..........++..+++.+.+|+.+||+.||.+||++.+++.|.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpf 295 (305)
T d1blxa_ 234 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 295 (305)
T ss_dssp CCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGG
T ss_pred CchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChh
Confidence 0 000001111233456678899999999999999999999987654
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-46 Score=385.53 Aligned_cols=249 Identities=27% Similarity=0.421 Sum_probs=203.2
Q ss_pred hcccccceeecccCceeEEEEEe-------CCccEEEEEeCcCh-hHhHHHHHHHHHHHHcC-CCCceeeeccccCC--C
Q 008365 228 TDKFSEAMKIGEGGYGPVYRGKL-------DHTPVAIKVLRPDA-AQGKRQFQQEVEVLSSI-RHPNMVLLLGACPD--Y 296 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~~~~-------~~~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l-~HpnIv~l~g~~~~--~ 296 (568)
.++|++.++||+|+||.||+|++ .++.||||+++... ......|.+|+.+++.+ +|||||+++|+|.+ .
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~ 101 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence 46899999999999999999975 23579999997653 33455789999999999 69999999999965 3
Q ss_pred ceEEEEecCCCCHHHHHhhcCC---------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeec
Q 008365 297 GCLVYEYMHNGSLEDRLLRRGN---------------TPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILL 361 (568)
Q Consensus 297 ~~lV~E~~~ggsL~~~l~~~~~---------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILl 361 (568)
.+||||||++|+|.+++..... ...+++..+..|+.||+.||.|||+.+ ||||||||+||||
T Consensus 102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL 178 (311)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccccccccc
Confidence 5899999999999999976431 224889999999999999999999999 9999999999999
Q ss_pred cCCceeEecccccccccCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHh-CCCCCCCch--
Q 008365 362 DRNYVSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIIT-ARSPMGLTH-- 438 (568)
Q Consensus 362 d~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~-- 438 (568)
+.++.+||+|||+++.+..... .......+||+.|+|||++.++.++.++|||||||++|||+| |.+||....
T Consensus 179 ~~~~~~ki~DfG~~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~ 254 (311)
T d1t46a_ 179 THGRITKICDFGLARDIKNDSN----YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD 254 (311)
T ss_dssp ETTTEEEECCCGGGSCTTSCTT----SEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred cccCcccccccchheeccCCCc----ceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHH
Confidence 9999999999999987643321 122345789999999999999999999999999999999999 566664332
Q ss_pred -HHHHHHHhCccccccCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHh
Q 008365 439 -HVSRAIEKGTLAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIV 491 (568)
Q Consensus 439 -~~~~~~~~~~~~~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~ 491 (568)
.+...+..+. . ...|..++..+.+||.+||+.||.+||++.+|+.
T Consensus 255 ~~~~~~i~~~~-----~---~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 255 SKFYKMIKEGF-----R---MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp HHHHHHHHHTC-----C---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHhcCC-----C---CCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 2233333321 1 1223455678999999999999999999999874
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=5.7e-47 Score=383.08 Aligned_cols=254 Identities=24% Similarity=0.339 Sum_probs=196.2
Q ss_pred cccccceeecccCceeEEEEEe-CCccEEEEEeCcChhH--hHHHHHHHHHHHHcCCCCceeeeccccCCC--ceEEEEe
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKL-DHTPVAIKVLRPDAAQ--GKRQFQQEVEVLSSIRHPNMVLLLGACPDY--GCLVYEY 303 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~-~~~~vAvK~l~~~~~~--~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~--~~lV~E~ 303 (568)
++|+++++||+|+||+||+|++ +++.||||+++..... ....+.+|+.+|+.++|||||+++++|.+. .++||||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 5899999999999999999987 5689999999765332 246789999999999999999999998554 4899999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCCC
Q 008365 304 MHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSVA 383 (568)
Q Consensus 304 ~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~ 383 (568)
+.++.+..+....+ .+++..+..|+.||+.||.|||+.+ ||||||||+||||+.++.+||+|||++.......
T Consensus 82 ~~~~~~~~~~~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~- 154 (286)
T d1ob3a_ 82 LDQDLKKLLDVCEG---GLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPV- 154 (286)
T ss_dssp CSEEHHHHHHTSTT---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred ehhhhHHHHHhhcC---CcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCc-
Confidence 97766665544332 4899999999999999999999999 9999999999999999999999999998764322
Q ss_pred ccccccccccccccccCCChhhhhc-CCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHH--h--Cc--------cc
Q 008365 384 DSVTQYHMTSAAGTFCYIDPEYQQT-GMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIE--K--GT--------LA 450 (568)
Q Consensus 384 ~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~--~--~~--------~~ 450 (568)
.......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||...+....... . +. ..
T Consensus 155 -----~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 229 (286)
T d1ob3a_ 155 -----RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVT 229 (286)
T ss_dssp ------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGG
T ss_pred -----cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchh
Confidence 12244579999999998765 4579999999999999999999999975543322111 0 00 00
Q ss_pred cc--cCcc--------CCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 451 EM--LDPA--------VTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 451 ~~--l~~~--------~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
.. .... ....+..+++.+.+|+.+||+.||.+||++.+++.|.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~ 283 (286)
T d1ob3a_ 230 ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAY 283 (286)
T ss_dssp GSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGG
T ss_pred hhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcc
Confidence 00 0000 01123345678999999999999999999999986543
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-46 Score=385.90 Aligned_cols=251 Identities=25% Similarity=0.324 Sum_probs=194.9
Q ss_pred HhcccccceeecccCceeEEEEEe--CCccEEEEEeCcC--hhHhHHHHHHHHHHHHcCCCCceeeeccccCCC------
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPD--AAQGKRQFQQEVEVLSSIRHPNMVLLLGACPDY------ 296 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~------ 296 (568)
..++|+++++||+|+||+||+|.+ +++.||||+++.. .....+.+.+|+.+|+.++|||||+++++|...
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence 457899999999999999999987 4789999999754 233356788999999999999999999998542
Q ss_pred --ceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEeccccc
Q 008365 297 --GCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGL 374 (568)
Q Consensus 297 --~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGl 374 (568)
.||||||| +++|..++... .+++..+..|+.||+.||.|||+++ ||||||||+|||++.++.+||+|||+
T Consensus 96 ~~~~lv~e~~-~~~l~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~ 167 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLMKHE----KLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGL 167 (346)
T ss_dssp CCCEEEEECC-SEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred ceEEEEEecc-cccHHHHHHhc----cccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccc
Confidence 38999999 67887766543 2899999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCccccccccccccccccCCChhhhhc-CCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHh----Cc-
Q 008365 375 ARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQT-GMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEK----GT- 448 (568)
Q Consensus 375 a~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~----~~- 448 (568)
|+..... .+..+||+.|+|||++.+ ..++.++|||||||++|+|++|++||............ +.
T Consensus 168 a~~~~~~---------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~ 238 (346)
T d1cm8a_ 168 ARQADSE---------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTP 238 (346)
T ss_dssp CEECCSS---------CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred eeccCCc---------cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCC
Confidence 9865332 245689999999998876 45789999999999999999999999765433221100 00
Q ss_pred -------------------cccccCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 449 -------------------LAEMLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 449 -------------------~~~~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
+.......+......+++.+.+|+.+||..||.+|||+.+++.|.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~ 303 (346)
T d1cm8a_ 239 PAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPY 303 (346)
T ss_dssp CHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGG
T ss_pred cHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChh
Confidence 0001111111223445677899999999999999999999986543
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-46 Score=385.61 Aligned_cols=258 Identities=22% Similarity=0.277 Sum_probs=198.3
Q ss_pred HhcccccceeecccCceeEEEEEe--CCccEEEEEeCcCh-hHhHHHHHHHHHHHHcCCCCceeeeccccCCC------c
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDA-AQGKRQFQQEVEVLSSIRHPNMVLLLGACPDY------G 297 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~------~ 297 (568)
.+++|+++++||+|+||+||+|.+ +++.||||++.+.. ....+.+.+|+.+|+.|+|||||++++++... .
T Consensus 6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred cCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence 356799999999999999999987 57899999997643 34456788999999999999999999988442 2
Q ss_pred eEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccc
Q 008365 298 CLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARL 377 (568)
Q Consensus 298 ~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~ 377 (568)
+++|+|+.+|+|.+++... .+++..+..|+.||+.||.|||+++ ||||||||+||||+.++.+||+|||+|+.
T Consensus 86 ~~l~~~~~~g~L~~~l~~~----~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~ 158 (345)
T d1pmea_ 86 VYLVTHLMGADLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV 158 (345)
T ss_dssp EEEEEECCCEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEEeecCCchhhhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceee
Confidence 4566677799999998754 2899999999999999999999999 99999999999999999999999999987
Q ss_pred cCCCCCccccccccccccccccCCChhhh-hcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHhCcccccc---
Q 008365 378 VPPSVADSVTQYHMTSAAGTFCYIDPEYQ-QTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEKGTLAEML--- 453 (568)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~-~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~l--- 453 (568)
...... ........+||+.|+|||++ .+..++.++||||+||++|+|++|+.||...................
T Consensus 159 ~~~~~~---~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 235 (345)
T d1pmea_ 159 ADPDHD---HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQE 235 (345)
T ss_dssp CCGGGC---BCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHH
T ss_pred ccCCCc---cceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChh
Confidence 643221 12223557899999999987 55568999999999999999999999997554322211110000000
Q ss_pred ----------------CccCCC-----CChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 454 ----------------DPAVTD-----WPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 454 ----------------~~~~~~-----~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
.+.... ..+.++..+.+|+.+||..||.+||++.+++.|.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf 297 (345)
T d1pmea_ 236 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPY 297 (345)
T ss_dssp HHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGG
T ss_pred hhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHh
Confidence 000000 11234457899999999999999999999986543
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.4e-46 Score=378.26 Aligned_cols=254 Identities=20% Similarity=0.309 Sum_probs=192.7
Q ss_pred hcccccceeecccCceeEEEEEe--CCccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCceeeecccc---CCCceEEEE
Q 008365 228 TDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGAC---PDYGCLVYE 302 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~---~~~~~lV~E 302 (568)
.++|++.+.||+|+||.||+|++ +++.||||++...... ..+..|+++++.++|+|+|.+++.| .+..++|||
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme 83 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 83 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS--CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC--HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence 36799999999999999999997 4779999998765332 3578899999999988766665544 334588999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeecc---CCceeEecccccccccC
Q 008365 303 YMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLD---RNYVSKISDVGLARLVP 379 (568)
Q Consensus 303 ~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld---~~~~vKL~DFGla~~~~ 379 (568)
|+ +++|.+.+..... .+++..+..++.|++.||.|||+++ ||||||||+|||++ .+..+||+|||+|+.+.
T Consensus 84 ~~-~~~l~~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~ 157 (299)
T d1ckia_ 84 LL-GPSLEDLFNFCSR--KFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 157 (299)
T ss_dssp CC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECB
T ss_pred Ec-CCchhhhhhhccC--CCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceecc
Confidence 99 6777776665443 3899999999999999999999999 99999999999874 45679999999999875
Q ss_pred CCCCccc-cccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHH--HHhCccccccCcc
Q 008365 380 PSVADSV-TQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRA--IEKGTLAEMLDPA 456 (568)
Q Consensus 380 ~~~~~~~-~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~--~~~~~~~~~l~~~ 456 (568)
....... ........+||+.|+|||++.+..++.++|||||||++|||++|..||......... +..... ..+...
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~-~~~~~~ 236 (299)
T d1ckia_ 158 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE-KKMSTP 236 (299)
T ss_dssp CTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHH-HHHHSC
T ss_pred ccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhc-ccCCCC
Confidence 4332221 122234678999999999999999999999999999999999999999643321111 100000 000011
Q ss_pred CCCCChHHHHHHHHHHHHhhccCCCCCCChHHhH
Q 008365 457 VTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVI 490 (568)
Q Consensus 457 ~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl 490 (568)
....+..+++++.+|+..||+.+|.+||++.++.
T Consensus 237 ~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~ 270 (299)
T d1ckia_ 237 IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLR 270 (299)
T ss_dssp HHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHH
T ss_pred hhHhccCCCHHHHHHHHHHccCChhHCcCHHHHH
Confidence 1111234567799999999999999999998774
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-45 Score=378.83 Aligned_cols=259 Identities=20% Similarity=0.277 Sum_probs=194.5
Q ss_pred hcccccceeecccCceeEEEEEe--CCccEEEEEeCcCh--hHhHHHHHHHHHHHHcCCCCceeeeccccCC--------
Q 008365 228 TDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDA--AQGKRQFQQEVEVLSSIRHPNMVLLLGACPD-------- 295 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~--~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~-------- 295 (568)
.++|+++++||+|+||+||+|++ +++.||||++.... ......+.+|+.+|+.++||||++++++|..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 47899999999999999999997 57899999986542 2234568899999999999999999988732
Q ss_pred --CceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccc
Q 008365 296 --YGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVG 373 (568)
Q Consensus 296 --~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFG 373 (568)
..|+|||||.++.+....... ..++...+..|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~~---~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg 162 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNVL---VKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG 162 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCTT---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCT
T ss_pred CceEEEEEeccCCCccchhhhcc---cccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecc
Confidence 348999999777665443222 23888999999999999999999999 9999999999999999999999999
Q ss_pred cccccCCCCCccccccccccccccccCCChhhhhcC-CCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHH----hCc
Q 008365 374 LARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTG-MLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIE----KGT 448 (568)
Q Consensus 374 la~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~----~~~ 448 (568)
+++.+...... ........+||+.|+|||++.+. .|+.++|||||||++|||++|+.||...+....... .+.
T Consensus 163 ~~~~~~~~~~~--~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~ 240 (318)
T d3blha1 163 LARAFSLAKNS--QPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGS 240 (318)
T ss_dssp TCEECCC-------CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred eeeeccccccc--ccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 99876543221 12223456899999999988765 689999999999999999999999976554332211 111
Q ss_pred cccccCccC------------CCCCh---------HHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 449 LAEMLDPAV------------TDWPA---------EAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 449 ~~~~l~~~~------------~~~p~---------~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
......... ...+. .....+.+|+.+||..||.+||++.+++.|.+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpf 307 (318)
T d3blha1 241 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDF 307 (318)
T ss_dssp CCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGG
T ss_pred CChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChh
Confidence 110000000 00000 11345678999999999999999999986544
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=9.2e-46 Score=376.01 Aligned_cols=251 Identities=19% Similarity=0.262 Sum_probs=197.0
Q ss_pred hcccccceeecccCceeEEEEEe--CCccEEEEEeCcChhHhHHHHHHHHHHHHcCCC-CceeeeccccCC--CceEEEE
Q 008365 228 TDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRH-PNMVLLLGACPD--YGCLVYE 302 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~H-pnIv~l~g~~~~--~~~lV~E 302 (568)
.++|++.++||+|+||+||+|++ +++.||||++..... ...+.+|+++++.|.| +|++.+++++.+ ..++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 46899999999999999999987 578999999865432 2357789999999975 899988887744 4489999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccC-----CceeEecccccccc
Q 008365 303 YMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDR-----NYVSKISDVGLARL 377 (568)
Q Consensus 303 ~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~-----~~~vKL~DFGla~~ 377 (568)
|+ +++|.+++...+. .++..++..|+.|++.||.|||+.+ ||||||||+||||+. ++.+||+|||+|+.
T Consensus 82 ~~-~~~l~~~~~~~~~--~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~ 155 (293)
T d1csna_ 82 LL-GPSLEDLLDLCGR--KFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 155 (293)
T ss_dssp CC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred ec-CCCHHHHHHhhcc--chhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEE
Confidence 99 7999998876553 3899999999999999999999999 999999999999964 57899999999988
Q ss_pred cCCCCCccc-cccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCch---HH--HHHHHhCcccc
Q 008365 378 VPPSVADSV-TQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTH---HV--SRAIEKGTLAE 451 (568)
Q Consensus 378 ~~~~~~~~~-~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~---~~--~~~~~~~~~~~ 451 (568)
+........ ........+||+.|||||++.+..++.++|||||||++|||++|..||.... .. ...+.......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (293)
T d1csna_ 156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 235 (293)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred cccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCC
Confidence 754332221 2223346789999999999999999999999999999999999999996321 11 11111111100
Q ss_pred ccCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhH
Q 008365 452 MLDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVI 490 (568)
Q Consensus 452 ~l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl 490 (568)
...+.+..+|+++.+++..|+..+|.+||++..+.
T Consensus 236 ----~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~ 270 (293)
T d1csna_ 236 ----PLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQ 270 (293)
T ss_dssp ----CHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHH
T ss_pred ----ChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHH
Confidence 01112234556799999999999999999998764
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-45 Score=382.55 Aligned_cols=251 Identities=22% Similarity=0.281 Sum_probs=192.8
Q ss_pred ccccceeecccCceeEEEEEe--CCccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCceeeeccccCC--------CceE
Q 008365 230 KFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNMVLLLGACPD--------YGCL 299 (568)
Q Consensus 230 ~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~--------~~~l 299 (568)
+|..+++||+|+||+||+|++ +++.||||++..... .+.+|+.+|++++|||||+++++|.. +.+|
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 588999999999999999998 577999999976532 23579999999999999999998721 1379
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCc-eeEeccccccccc
Q 008365 300 VYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNY-VSKISDVGLARLV 378 (568)
Q Consensus 300 V~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~-~vKL~DFGla~~~ 378 (568)
|||||+++.+..+.........+++..+..|+.||+.||.|||++| ||||||||+||||+.++ .+||+|||+++.+
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhc
Confidence 9999976654444433333345899999999999999999999999 99999999999999765 8999999999876
Q ss_pred CCCCCccccccccccccccccCCChhhhhc-CCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHh----C------
Q 008365 379 PPSVADSVTQYHMTSAAGTFCYIDPEYQQT-GMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEK----G------ 447 (568)
Q Consensus 379 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~----~------ 447 (568)
.... .....+||+.|+|||.+.+ ..|+.++|||||||++|||++|+.||............ +
T Consensus 174 ~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~ 246 (350)
T d1q5ka_ 174 VRGE-------PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 246 (350)
T ss_dssp CTTS-------CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred cCCc-------ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHh
Confidence 4322 2245689999999997765 57999999999999999999999999655432221110 0
Q ss_pred ------ccccccCccC------CCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 448 ------TLAEMLDPAV------TDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 448 ------~~~~~l~~~~------~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
......-+.. ......+++.+.+|+.+||..||.+||++.+++.|.+
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~ 305 (350)
T d1q5ka_ 247 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 305 (350)
T ss_dssp HHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred hhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHh
Confidence 0000000000 0112345677999999999999999999999987654
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-44 Score=366.37 Aligned_cols=253 Identities=23% Similarity=0.309 Sum_probs=200.2
Q ss_pred cccccceeecccCceeEEEEEe--CCccEEEEEeCcCh--hHhHHHHHHHHHHHHcCCCCceeeeccccCCC--ceEEEE
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDA--AQGKRQFQQEVEVLSSIRHPNMVLLLGACPDY--GCLVYE 302 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~--~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~--~~lV~E 302 (568)
++|+++++||+|+||+||+|++ +++.||||+++... .....++.+|+.+|+.++|||||+++++|.+. .++||+
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 5799999999999999999997 56789999986543 33457889999999999999999999998554 488999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccccccCCCC
Q 008365 303 YMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLARLVPPSV 382 (568)
Q Consensus 303 ~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~ 382 (568)
|+.+++|..++...+ .+++..+..++.|++.||.|||+++ ||||||||+||||+.++.+||+|||.++.+....
T Consensus 82 ~~~~~~l~~~~~~~~---~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~ 155 (292)
T d1unla_ 82 FCDQDLKKYFDSCNG---DLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSEEHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred ecccccccccccccc---ccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCC
Confidence 999998888776543 3788999999999999999999999 9999999999999999999999999998764332
Q ss_pred CccccccccccccccccCCChhhhhcCC-CCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHHh-----Ccc-------
Q 008365 383 ADSVTQYHMTSAAGTFCYIDPEYQQTGM-LTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIEK-----GTL------- 449 (568)
Q Consensus 383 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~-~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~-----~~~------- 449 (568)
. ......+++.|+|||++.+.. ++.++|||||||++|||++|+.||.........+.. +..
T Consensus 156 ~------~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (292)
T d1unla_ 156 R------CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPS 229 (292)
T ss_dssp S------CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTT
T ss_pred c------cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhh
Confidence 1 223456889999999887665 699999999999999999999997433222221111 000
Q ss_pred -ccc----------cCccCCCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHH
Q 008365 450 -AEM----------LDPAVTDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPE 493 (568)
Q Consensus 450 -~~~----------l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~ 493 (568)
... ........+..++..+.+|+.+||+.||.+||++.+++.|.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp 284 (292)
T d1unla_ 230 MTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHP 284 (292)
T ss_dssp GGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSG
T ss_pred hhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcCh
Confidence 000 00111123345567899999999999999999999998654
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.2e-44 Score=371.14 Aligned_cols=247 Identities=22% Similarity=0.354 Sum_probs=194.2
Q ss_pred cccccceeecccCceeEEEEEe--CCccEEEEEeCcChhHhHHHHHHHHHHHHcCC-CCceeeeccccCC----CceEEE
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIR-HPNMVLLLGACPD----YGCLVY 301 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~-HpnIv~l~g~~~~----~~~lV~ 301 (568)
++|+++++||+|+||+||+|++ +++.||||+++... .+.+.+|+.+|+.+. ||||++++++|.. ..++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 6899999999999999999997 57899999997654 356889999999995 9999999998742 348899
Q ss_pred EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCC-ceeEecccccccccCC
Q 008365 302 EYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRN-YVSKISDVGLARLVPP 380 (568)
Q Consensus 302 E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~-~~vKL~DFGla~~~~~ 380 (568)
|||.+++|..+. ..+++..+..|+.||+.||.|||++| ||||||||+||||+.+ +.+||+|||+|+.+..
T Consensus 112 e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 112 EHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp ECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred eecCCCcHHHHh------cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccC
Confidence 999999987643 23899999999999999999999999 9999999999999865 5799999999987643
Q ss_pred CCCccccccccccccccccCCChhhhhcC-CCCCcceehhHHHHHHHHHhCCCCCCCchHHHHH---H------------
Q 008365 381 SVADSVTQYHMTSAAGTFCYIDPEYQQTG-MLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRA---I------------ 444 (568)
Q Consensus 381 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~---~------------ 444 (568)
.. .....+||+.|+|||.+.+. .++.++|||||||++|+|++|+.||...+..... +
T Consensus 183 ~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~ 255 (328)
T d3bqca1 183 GQ-------EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDY 255 (328)
T ss_dssp TC-------CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHH
T ss_pred CC-------cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhh
Confidence 32 22456799999999987765 4799999999999999999999999643321110 0
Q ss_pred -HhCc------cccccCcc--------C-CCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 445 -EKGT------LAEMLDPA--------V-TDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 445 -~~~~------~~~~l~~~--------~-~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
.... +...+... . ......+++++.+||.+||..||.+|||+.+++.|.+
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~ 321 (328)
T d3bqca1 256 IDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 321 (328)
T ss_dssp HHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred hhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcc
Confidence 0000 00000000 0 0112345677999999999999999999999986543
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-44 Score=374.02 Aligned_cols=251 Identities=20% Similarity=0.258 Sum_probs=188.9
Q ss_pred hcccccceeecccCceeEEEEEe--CCccEEEEEeCcCh--hHhHHHHHHHHHHHHcCCCCceeeeccccCC--------
Q 008365 228 TDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDA--AQGKRQFQQEVEVLSSIRHPNMVLLLGACPD-------- 295 (568)
Q Consensus 228 ~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~--~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~-------- 295 (568)
.++|+++++||+|+||+||+|.+ +++.||||++.... ......+.+|+.+|+.++|||||+++++|..
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 36799999999999999999998 47899999997542 3344568899999999999999999999842
Q ss_pred CceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccc
Q 008365 296 YGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLA 375 (568)
Q Consensus 296 ~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla 375 (568)
..|+|||||.++.+ +.+.. .+++..+..++.||+.||.|||+.| |+||||||+|||++.++.+||+|||++
T Consensus 96 ~~~iv~Ey~~~~l~-~~~~~-----~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~ 166 (355)
T d2b1pa1 96 DVYLVMELMDANLC-QVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_dssp EEEEEEECCSEEHH-HHHTS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred eeEEEEeccchHHH-Hhhhc-----CCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhh
Confidence 23899999965544 44432 3889999999999999999999999 999999999999999999999999998
Q ss_pred cccCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHHHHHHH----------
Q 008365 376 RLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRAIE---------- 445 (568)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~---------- 445 (568)
+..... ......+||+.|+|||++.+..++.++||||+||++|+|++|++||...+.......
T Consensus 167 ~~~~~~-------~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~ 239 (355)
T d2b1pa1 167 RTAGTS-------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCP 239 (355)
T ss_dssp ---------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred hccccc-------cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCH
Confidence 765332 223456799999999999999999999999999999999999999965443221110
Q ss_pred --------------hCc-------cccccCccC----CCCChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 446 --------------KGT-------LAEMLDPAV----TDWPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 446 --------------~~~-------~~~~l~~~~----~~~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
... ....+.... ...+...+..+.+|+.+||..||.+||++.+++.|.+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw 313 (355)
T d2b1pa1 240 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPY 313 (355)
T ss_dssp HHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTT
T ss_pred HHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcc
Confidence 000 000000000 0112346778999999999999999999999997765
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-45 Score=373.41 Aligned_cols=250 Identities=25% Similarity=0.342 Sum_probs=198.1
Q ss_pred cccccceeecccCceeEEEEEe-----CCccEEEEEeCcCh----hHhHHHHHHHHHHHHcCCC-CceeeeccccCCC--
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKL-----DHTPVAIKVLRPDA----AQGKRQFQQEVEVLSSIRH-PNMVLLLGACPDY-- 296 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~-----~~~~vAvK~l~~~~----~~~~~~~~~Ev~iL~~l~H-pnIv~l~g~~~~~-- 296 (568)
++|++++.||+|+||+||+|++ +++.||||+++... ....+.+.+|+.+|++++| |||+++++++.+.
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 6799999999999999999976 35789999987542 1224567899999999976 8999999998544
Q ss_pred ceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEeccccccc
Q 008365 297 GCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLAR 376 (568)
Q Consensus 297 ~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~ 376 (568)
.++||||+.+|+|.+++...+. ++...+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~~---~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~ 177 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRER---FTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 177 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHSC---CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred eeeeeecccccHHHHHHHhccc---ccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchh
Confidence 4899999999999999987754 677888999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCCccccccccccccccccCCChhhhhcC--CCCCcceehhHHHHHHHHHhCCCCCCCchH--HHHHHHhCccccc
Q 008365 377 LVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTG--MLTTKSDIYSFGIMLLQIITARSPMGLTHH--VSRAIEKGTLAEM 452 (568)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~--~~s~ksDvwSlGvil~elltG~~Pf~~~~~--~~~~~~~~~~~~~ 452 (568)
.+.... ........||+.|++||.+.+. .++.++|||||||+||+|++|+.||..... ....+..+...
T Consensus 178 ~~~~~~-----~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~-- 250 (322)
T d1vzoa_ 178 EFVADE-----TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILK-- 250 (322)
T ss_dssp ECCGGG-----GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHH--
T ss_pred hhcccc-----cccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhccc--
Confidence 764321 2223456899999999988764 478899999999999999999999954321 11111111111
Q ss_pred cCccCCCCChHHHHHHHHHHHHhhccCCCCCCC-----hHHhHhHHH
Q 008365 453 LDPAVTDWPAEAAESFSKLAIQCAELRKKDRPD-----LGTVIVPEL 494 (568)
Q Consensus 453 l~~~~~~~p~~~~~~l~~li~~Cl~~dP~~RPs-----~~~vl~~~l 494 (568)
.....|..++..+.+|+.+||..||.+||+ +.+++.|.+
T Consensus 251 ---~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpf 294 (322)
T d1vzoa_ 251 ---SEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLF 294 (322)
T ss_dssp ---CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGG
T ss_pred ---CCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHh
Confidence 112335567788999999999999999995 667765443
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-44 Score=373.36 Aligned_cols=252 Identities=22% Similarity=0.309 Sum_probs=195.0
Q ss_pred HhcccccceeecccCceeEEEEEe--CCccEEEEEeCcCh--hHhHHHHHHHHHHHHcCCCCceeeeccccCC-------
Q 008365 227 ATDKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDA--AQGKRQFQQEVEVLSSIRHPNMVLLLGACPD------- 295 (568)
Q Consensus 227 ~~~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~--~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~------- 295 (568)
+.++|+++++||+|+||+||+|++ +++.||||++.... ....+.+.+|+.+|+.++|||||+++++|..
T Consensus 16 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~ 95 (348)
T d2gfsa1 16 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 95 (348)
T ss_dssp EETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred CCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccC
Confidence 357899999999999999999987 57899999997643 3344578899999999999999999998732
Q ss_pred CceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecccccc
Q 008365 296 YGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISDVGLA 375 (568)
Q Consensus 296 ~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~DFGla 375 (568)
..++||+|+.||+|.+++... .+++..+..|+.||+.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 96 ~~~~i~~~~~gg~L~~~~~~~----~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a 168 (348)
T d2gfsa1 96 NDVYLVTHLMGADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA 168 (348)
T ss_dssp CCCEEEEECCSEEHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC---
T ss_pred ceEEEEEeecCCchhhhcccc----cccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchh
Confidence 236778888899999988543 3899999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCccccccccccccccccCCChhhhhcC-CCCCcceehhHHHHHHHHHhCCCCCCCchHHHHH--HHh--Cccc
Q 008365 376 RLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTG-MLTTKSDIYSFGIMLLQIITARSPMGLTHHVSRA--IEK--GTLA 450 (568)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~--~~~--~~~~ 450 (568)
..... ......||+.|+|||.+.+. .++.++|||||||++|+|++|++||...+..... +.. +...
T Consensus 169 ~~~~~---------~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~ 239 (348)
T d2gfsa1 169 RHTDD---------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG 239 (348)
T ss_dssp -CCTG---------GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred cccCc---------ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 75422 23456799999999976665 5689999999999999999999999755432221 110 0000
Q ss_pred c-cc------------C--ccCCC-----CChHHHHHHHHHHHHhhccCCCCCCChHHhHhHHH
Q 008365 451 E-ML------------D--PAVTD-----WPAEAAESFSKLAIQCAELRKKDRPDLGTVIVPEL 494 (568)
Q Consensus 451 ~-~l------------~--~~~~~-----~p~~~~~~l~~li~~Cl~~dP~~RPs~~~vl~~~l 494 (568)
. .. . ..... ....++..+.+||.+||..||.+||++.+++.|.+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~ 303 (348)
T d2gfsa1 240 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 303 (348)
T ss_dssp HHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred hHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHh
Confidence 0 00 0 00000 11234567899999999999999999999986543
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.6e-40 Score=343.15 Aligned_cols=253 Identities=22% Similarity=0.309 Sum_probs=191.1
Q ss_pred cccccceeecccCceeEEEEEe--CCccEEEEEeCcChhHhHHHHHHHHHHHHcCC-----------CCceeeeccccCC
Q 008365 229 DKFSEAMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIR-----------HPNMVLLLGACPD 295 (568)
Q Consensus 229 ~~y~~~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~-----------HpnIv~l~g~~~~ 295 (568)
++|+++++||+|+||+||+|++ +++.||||+++++... .+.+.+|+.+|+.++ |+|||++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~-~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY-TEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHH-HHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccc-hHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 3599999999999999999987 5789999999876543 456788999988875 5788999888733
Q ss_pred ----CceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCCCCcccCCCCCCCeeccCCc-----
Q 008365 296 ----YGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQ-AKPEPLVHRDLKPANILLDRNY----- 365 (568)
Q Consensus 296 ----~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~-~~~~~IiHrDIKp~NILld~~~----- 365 (568)
..++||+++..+..............+++..+..++.||+.||.|||+ .+ |+||||||+||||+.++
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTE
T ss_pred ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCccccc
Confidence 336777777665544444444444558899999999999999999998 77 99999999999997654
Q ss_pred -eeEecccccccccCCCCCccccccccccccccccCCChhhhhcCCCCCcceehhHHHHHHHHHhCCCCCCCchHH----
Q 008365 366 -VSKISDVGLARLVPPSVADSVTQYHMTSAAGTFCYIDPEYQQTGMLTTKSDIYSFGIMLLQIITARSPMGLTHHV---- 440 (568)
Q Consensus 366 -~vKL~DFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~---- 440 (568)
.+||+|||.+..... .....+||+.|+|||++.+..++.++|||||||++++|++|+.||......
T Consensus 169 ~~~kl~dfg~s~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~ 239 (362)
T d1q8ya_ 169 IQIKIADLGNACWYDE---------HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTK 239 (362)
T ss_dssp EEEEECCCTTCEETTB---------CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------C
T ss_pred ceeeEeeccccccccc---------ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccc
Confidence 499999999975422 124567999999999999999999999999999999999999999532210
Q ss_pred -----HHHHH-hCcc-----------ccccC---------c-----------cCCCCChHHHHHHHHHHHHhhccCCCCC
Q 008365 441 -----SRAIE-KGTL-----------AEMLD---------P-----------AVTDWPAEAAESFSKLAIQCAELRKKDR 483 (568)
Q Consensus 441 -----~~~~~-~~~~-----------~~~l~---------~-----------~~~~~p~~~~~~l~~li~~Cl~~dP~~R 483 (568)
...+. -+.. ...++ . .....+...+..+.+|+.+||..||.+|
T Consensus 240 ~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R 319 (362)
T d1q8ya_ 240 DDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKR 319 (362)
T ss_dssp HHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTC
T ss_pred hhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHC
Confidence 00000 0000 00000 0 0112345678899999999999999999
Q ss_pred CChHHhHhHHH
Q 008365 484 PDLGTVIVPEL 494 (568)
Q Consensus 484 Ps~~~vl~~~l 494 (568)
||+.+++.|.+
T Consensus 320 pta~e~L~Hp~ 330 (362)
T d1q8ya_ 320 ADAGGLVNHPW 330 (362)
T ss_dssp BCHHHHHTCGG
T ss_pred cCHHHHhcCcc
Confidence 99999986543
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.91 E-value=2e-25 Score=210.86 Aligned_cols=163 Identities=15% Similarity=0.094 Sum_probs=121.3
Q ss_pred cccceeecccCceeEEEEEe-CCccEEEEEeCcChh------------------HhHHHHHHHHHHHHcCCCCceeeecc
Q 008365 231 FSEAMKIGEGGYGPVYRGKL-DHTPVAIKVLRPDAA------------------QGKRQFQQEVEVLSSIRHPNMVLLLG 291 (568)
Q Consensus 231 y~~~~~IG~G~fg~Vy~~~~-~~~~vAvK~l~~~~~------------------~~~~~~~~Ev~iL~~l~HpnIv~l~g 291 (568)
+.+.++||+|+||+||+|.+ +|+.||||+++.... .....+..|...+.++.|++++..++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 45678999999999999986 678999999764211 11223457899999999999998876
Q ss_pred ccCCCceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCcccCCCCCCCeeccCCceeEecc
Q 008365 292 ACPDYGCLVYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKPEPLVHRDLKPANILLDRNYVSKISD 371 (568)
Q Consensus 292 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILld~~~~vKL~D 371 (568)
+. ..++||||++++.+.+ ++......++.|++.+|.|||+.+ |+||||||+|||+++++ ++|+|
T Consensus 82 ~~--~~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~~-~~liD 145 (191)
T d1zara2 82 WE--GNAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEEG-IWIID 145 (191)
T ss_dssp EE--TTEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETTE-EEECC
T ss_pred ec--CCEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCCC-EEEEE
Confidence 54 3489999998766532 334456679999999999999999 99999999999999765 88999
Q ss_pred cccccccCCCCCccccccccccccccccCCC------hhhhhcCCCCCcceehhHHHHH
Q 008365 372 VGLARLVPPSVADSVTQYHMTSAAGTFCYID------PEYQQTGMLTTKSDIYSFGIML 424 (568)
Q Consensus 372 FGla~~~~~~~~~~~~~~~~~~~~GT~~Y~A------PE~~~~~~~s~ksDvwSlGvil 424 (568)
||+|+........ .|.. .+++ ...|+.++|+||+.--+
T Consensus 146 FG~a~~~~~~~~~--------------~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 146 FPQSVEVGEEGWR--------------EILERDVRNIITYF-SRTYRTEKDINSAIDRI 189 (191)
T ss_dssp CTTCEETTSTTHH--------------HHHHHHHHHHHHHH-HHHHCCCCCHHHHHHHH
T ss_pred CCCcccCCCCCcH--------------HHHHHHHHHHHHHH-cCCCCCcccHHHHHHHH
Confidence 9999765432211 1111 1222 35688999999986544
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.70 E-value=1.3e-08 Score=98.09 Aligned_cols=146 Identities=14% Similarity=0.138 Sum_probs=99.7
Q ss_pred HHHHHhcccccceeecccCceeEEEEEeCCccEEEEEeCcChhHhHHHHHHHHHHHHcCC-CCceeeeccccC--CCceE
Q 008365 223 EIEEATDKFSEAMKIGEGGYGPVYRGKLDHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIR-HPNMVLLLGACP--DYGCL 299 (568)
Q Consensus 223 ei~~~~~~y~~~~~IG~G~fg~Vy~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~-HpnIv~l~g~~~--~~~~l 299 (568)
++......|+..+..+.|+.+.||+...++..++||+...........+.+|+.++..+. +--+.+++.++. +..++
T Consensus 8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~l 87 (263)
T d1j7la_ 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL 87 (263)
T ss_dssp HHHHHHTTSEEEECSCCCSSSEEEEEECSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred HHHHhhhceEEEEcCCCCCCCcEEEEEeCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEE
Confidence 455566778877766656667999998888889999886554444445678888877664 322444555443 34589
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHcCC---------------------------------
Q 008365 300 VYEYMHNGSLEDRLLRRGNTPVIPWRKRFKIAAEIATALLFLHQAKP--------------------------------- 346 (568)
Q Consensus 300 V~E~~~ggsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~--------------------------------- 346 (568)
||++++|.++.+..... .....++.+++..|..||+...
T Consensus 88 v~~~l~G~~~~~~~~~~--------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (263)
T d1j7la_ 88 LMSEADGVLCSEEYEDE--------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE 159 (263)
T ss_dssp EEECCSSEEHHHHTTTC--------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGS
T ss_pred EEEeccccccccccccc--------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccc
Confidence 99999998886543211 1122345566666666665320
Q ss_pred -----------------------CCcccCCCCCCCeeccCCceeEeccccccc
Q 008365 347 -----------------------EPLVHRDLKPANILLDRNYVSKISDVGLAR 376 (568)
Q Consensus 347 -----------------------~~IiHrDIKp~NILld~~~~vKL~DFGla~ 376 (568)
..++|+|+.|.|||+++++.+-|+||+.+.
T Consensus 160 ~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp TTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 127899999999999988777899999875
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.94 E-value=6e-06 Score=84.46 Aligned_cols=75 Identities=16% Similarity=0.090 Sum_probs=50.9
Q ss_pred ceeecccCceeEEEEEe--CCccEEEEEeCcCh-------hHhHHHHHHHHHHHHcCC---CCceeeeccccCCCceEEE
Q 008365 234 AMKIGEGGYGPVYRGKL--DHTPVAIKVLRPDA-------AQGKRQFQQEVEVLSSIR---HPNMVLLLGACPDYGCLVY 301 (568)
Q Consensus 234 ~~~IG~G~fg~Vy~~~~--~~~~vAvK~l~~~~-------~~~~~~~~~Ev~iL~~l~---HpnIv~l~g~~~~~~~lV~ 301 (568)
.+.||.|....||+... .+..|+||.-.+.. .....+...|...|+.+. ...+.+++.+..+..++||
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d~~~~~lvm 110 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSDTEMAVTVM 110 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEETTTTEEEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEcCCCCEEEE
Confidence 45799999999999876 35679999754321 111233456787777653 2346677777788889999
Q ss_pred EecCCCC
Q 008365 302 EYMHNGS 308 (568)
Q Consensus 302 E~~~ggs 308 (568)
|++.+..
T Consensus 111 E~L~~~~ 117 (392)
T d2pula1 111 EDLSHLK 117 (392)
T ss_dssp CCCTTSE
T ss_pred eccCCcc
Confidence 9997654
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.80 E-value=2.5e-05 Score=73.92 Aligned_cols=127 Identities=18% Similarity=0.158 Sum_probs=77.0
Q ss_pred eecccCc-eeEEEEEeC-CccEEEEEeCcChhHhHHHHHHHHHHHHcCCCC--ceeeeccccCC--CceEEEEecCCCCH
Q 008365 236 KIGEGGY-GPVYRGKLD-HTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHP--NMVLLLGACPD--YGCLVYEYMHNGSL 309 (568)
Q Consensus 236 ~IG~G~f-g~Vy~~~~~-~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~Hp--nIv~l~g~~~~--~~~lV~E~~~ggsL 309 (568)
.+..|.. +.||+.... +..+++|........ .+..|+..|+.+... .+.+++.++.+ ..++||+|++|.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~~---~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGALN---ELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTTS---CHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccCHh---HHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 4555554 679988874 456888987655432 456777777766422 24455555433 44899999988665
Q ss_pred HHHHhhcCCCCCCCHHHHHHHHHHHHHHH---------------------------------------------------
Q 008365 310 EDRLLRRGNTPVIPWRKRFKIAAEIATAL--------------------------------------------------- 338 (568)
Q Consensus 310 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL--------------------------------------------------- 338 (568)
.+.. ... ..++.++...|
T Consensus 94 ~~~~--------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (255)
T d1nd4a_ 94 LSSH--------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF 162 (255)
T ss_dssp TTSC--------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred cccc--------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHH
Confidence 3200 000 01112222222
Q ss_pred HHHHHcCC----CCcccCCCCCCCeeccCCceeEeccccccc
Q 008365 339 LFLHQAKP----EPLVHRDLKPANILLDRNYVSKISDVGLAR 376 (568)
Q Consensus 339 ~yLH~~~~----~~IiHrDIKp~NILld~~~~vKL~DFGla~ 376 (568)
..+....+ ..+||+|+.|.|||++++..+-|+||+.+.
T Consensus 163 ~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 163 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 33332221 127999999999999988778899999875
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=97.34 E-value=0.0002 Score=70.02 Aligned_cols=156 Identities=12% Similarity=0.087 Sum_probs=81.2
Q ss_pred cCHHHHHHHhccccccee-----ecccCceeEEEEEeCCccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCc-----eee
Q 008365 219 YTIEEIEEATDKFSEAMK-----IGEGGYGPVYRGKLDHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPN-----MVL 288 (568)
Q Consensus 219 ~~~~ei~~~~~~y~~~~~-----IG~G~fg~Vy~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~Hpn-----Iv~ 288 (568)
.+..++..+..+|.+... |..|---+.|+...++..+++|++.... ....+..|+.+|..|...+ .+.
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi~ 80 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDPLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLP 80 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCCEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCC
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCcEEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccce
Confidence 456677777788876443 4466668899998888889999986532 1234455666666653222 221
Q ss_pred ec-cc----cCCCceEEEEecCCCCHH--------------HHHhhcCCC---C----CCCH-----------------H
Q 008365 289 LL-GA----CPDYGCLVYEYMHNGSLE--------------DRLLRRGNT---P----VIPW-----------------R 325 (568)
Q Consensus 289 l~-g~----~~~~~~lV~E~~~ggsL~--------------~~l~~~~~~---~----~l~~-----------------~ 325 (568)
.. |. .......++.++.|.... ..+...... + ...+ .
T Consensus 81 ~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (316)
T d2ppqa1 81 RKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEK 160 (316)
T ss_dssp BTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTST
T ss_pred ecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcch
Confidence 11 11 122224566666553321 011110000 0 0000 0
Q ss_pred HHHHHHHHHHHHHHHHHH-cCCCCcccCCCCCCCeeccCCceeEeccccccc
Q 008365 326 KRFKIAAEIATALLFLHQ-AKPEPLVHRDLKPANILLDRNYVSKISDVGLAR 376 (568)
Q Consensus 326 ~~~~i~~qia~aL~yLH~-~~~~~IiHrDIKp~NILld~~~~vKL~DFGla~ 376 (568)
.....+..+...+.-.+. .-+.++||+|+.++||+++++...-|+||+.|.
T Consensus 161 ~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 161 GLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp THHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 011111222222222221 113359999999999999999888999999885
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.24 E-value=0.0012 Score=64.93 Aligned_cols=92 Identities=12% Similarity=0.125 Sum_probs=52.7
Q ss_pred ccccccCHHHHHHHhccccc-----ceeecccCceeEEEEEe-CCccEEEEEeCcChhHhHHHHHHHHHHHHcCCCCce-
Q 008365 214 VRYRKYTIEEIEEATDKFSE-----AMKIGEGGYGPVYRGKL-DHTPVAIKVLRPDAAQGKRQFQQEVEVLSSIRHPNM- 286 (568)
Q Consensus 214 ~~~~~~~~~ei~~~~~~y~~-----~~~IG~G~fg~Vy~~~~-~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnI- 286 (568)
..|...+.+-+..+...+-+ +..|+ +---.||++.. +|..|++|+.++.. ....++..|...|..|...+|
T Consensus 3 ~~f~~L~pd~i~~al~~~g~~~~~~~~~L~-s~EN~vy~v~~~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gip 80 (325)
T d1zyla1 3 FTFQTLHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVP 80 (325)
T ss_dssp CCCCCCCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCS
T ss_pred CCccccCHHHHHHHHHHcCCCCCcCccccc-cccceeEEEEcCCCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCC
Confidence 34556666666555543321 11222 22358999986 67889999987653 234567788888877642222
Q ss_pred -eeeccc-------cCCCceEEEEecCCC
Q 008365 287 -VLLLGA-------CPDYGCLVYEYMHNG 307 (568)
Q Consensus 287 -v~l~g~-------~~~~~~lV~E~~~gg 307 (568)
+..+.. .....+.|+++++|.
T Consensus 81 v~~p~~~~g~~~~~~~~~~~~l~~~~~G~ 109 (325)
T d1zyla1 81 VAAPVAFNGQTLLNHQGFYFAVFPSVGGR 109 (325)
T ss_dssp BCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred CCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence 111111 122336789998763
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.91 E-value=0.00039 Score=70.41 Aligned_cols=72 Identities=15% Similarity=0.178 Sum_probs=48.5
Q ss_pred ceeecccCceeEEEEEeCC---------ccEEEEEeCcChhHhHHHHHHHHHHHHcCC-CCceeeeccccCCCceEEEEe
Q 008365 234 AMKIGEGGYGPVYRGKLDH---------TPVAIKVLRPDAAQGKRQFQQEVEVLSSIR-HPNMVLLLGACPDYGCLVYEY 303 (568)
Q Consensus 234 ~~~IG~G~fg~Vy~~~~~~---------~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~-HpnIv~l~g~~~~~~~lV~E~ 303 (568)
++.|+.|-.-.+|++.... ..|++++.-... ......+|..+++.+. +.-..+++++|.+ .+||||
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~--~~idr~~E~~i~~~ls~~gl~Pkll~~~~~--g~I~ef 122 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFSG--GRLEEY 122 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEETT--EEEECC
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcc--hhhHHHHHHHHHHHHHhCCCCCeEEEEcCC--ceEEEE
Confidence 4578889999999987532 357777764221 1234567888888775 4334577777754 789999
Q ss_pred cCCCCH
Q 008365 304 MHNGSL 309 (568)
Q Consensus 304 ~~ggsL 309 (568)
++|..|
T Consensus 123 i~g~~l 128 (395)
T d1nw1a_ 123 IPSRPL 128 (395)
T ss_dssp CCEEEC
T ss_pred eccccC
Confidence 987543
|